Citrus Sinensis ID: 003504

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-----
Protein Sequence
MSSKSFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIESTA
Secondary Structure (PSIPRED)
cccccccccccccccccccEEEEccccccccEEEccccccEEEcccccccccccccEEEccccccccccccccccccccEEEcccccccccccHHccccccccEEEccccEEEEcccHHHHccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHHHccccccEEEccccccccccccccccccccEEEcccccccccccHHHHHcccEEEcccccccccccHHHHHcccccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHHcccccccEEccccccccccHHHHHccccccEEEcccccccccccHHcccccccEEcccccccccccHHHHHcccccccEEccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHcccHHHcccccccccccccccccccccccccccEEEEEccccccccHHHHHHHHcccccccEEcccccccEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHccccccccccEEEEEEcccEEEEEEcccccccHHHHHHccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHccccccEEcccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccEccccccccEEEEEEcccccccccccHHHcccccccEEEccccccccccHHHcccccccEEEcccccccccccHHHHccccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcHHcccEEEEccccccccccccccccccEEEEcccccccccccHHHHHHccEEEcccccccccccHHHHHHHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHHHHccEEEcccccccccccHHHHHccccccEEEEccccccccccccHccccccHHccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccEEEEcccHccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHcccccccHHHHHEEEcccccEEEEEEccccccHHHHHcccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEEccccHHHHHHHcHHHEEcccccccEEcccccccccHccccccEEEcccccHEHHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccHHHccHcHcccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHcccc
Coil and Loop (DISEMBL)
mssksfqasyfsasfcswrgvvcdsnkqHVTDFlasnsglsgsvpdttigklsklqsldlsennitalpsdlwslgslkslnlsynrisgslpsnignfgllevfdlsnnnfsgeIPAAISSLVSLRVLKldgnmfqwsippgllncqsLVTVDLSmnqlngslpdgfgaafpklkslnlagneikgrdthFAGLksitnlnisgnlfqgsVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVdlsenqlsgeiFHNFSQAQNLKHLSLAYNRftrqefpqigtllglehlnlsrtsligdipseilQLSSLHTLDLsmnhltgqiptvsaknlgiidmshnnlsgeipaslleklpqmerfnfsynnltlcaselspetlqtaffgssndcpiaanpsffkRKAANHKGLKLALALTLSMICLLAGLLCLafgcrrkpkrwVVKQTsykeeqnvsgpfsfqtdsttwvadvkhansVQVVIfekpllnitFADLlsatsnfdrgtllaegkfgpvyrgflpggIHVAVKVLVHGSTLTDQEAARELEYLgrikhpnlvpltgyciagdqriAIYDYMEngnlqnllhdlplgvqttedwstdtweedgtnsiqnvgsegllttwRFRHKIALGTARALAFLhhgcsppiihrdiKASSVYldmnleprlsdfglakifgngldeeiargspgyippefaqpdsdfptpksdvyCYGVVLLELItgkkplgddypeekegnLVSWVRGLvrnnkgsraidpkirdtgpeKQMEEALKIGYLctadlplkrpsMQQIVGLLKDIESTA
Flexible Loop (DISEMBL)
MSSKSFQASYFSASFCSWRGVVCDSNKQHVTDFLasnsglsgsvPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMICLLAGLLCLAFGCRRKPKRWVVKQtsykeeqnvsgpfsFQTDSTTWVADVKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLgrikhpnlvPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWeedgtnsiqnvgseglLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGkkplgddypeekEGNLVSWVRglvrnnkgsraidpkirdtgpeKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIESTA
Low Complexity Region (SEG)
MSSKSFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMIcllagllclafgcRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQttedwstdtweedgtNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIESTA
Disordered region (IsUnstruct)
********SYFSASFCSWRGVVCDSNKQHVTDFLA**********************LDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR*********************SDVYCYGVVLLELITGKKPLGDDY****EGNLVSWVRGLVR***********************ALKIGYLCTADLPLKRP*MQQIVGLL*******
Disordered Region (DISOPRED)
*SSKSFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDC**********************LALTLSMICLLAGLLCLAFGCRRKPKR************************************VQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGST**DQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRG*VR**K**RAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES**
Disordered Region (DISEMBL)
*********YFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIESTA
Disordered Region (DISPRO)
****SFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDL*********WSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSSKSFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIESTA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	815	2.2.26 [Sep-21-2011]
C0LGK9	853	Probable LRR receptor-lik	yes	no	0.991	0.947	0.730	0.0
Q9LVN2	785	Probably inactive leucine	no	no	0.896	0.931	0.519	0.0
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.879	0.601	0.327	1e-108
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.844	0.575	0.358	1e-106
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.868	0.586	0.347	1e-105
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.868	0.586	0.346	1e-104
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.879	0.614	0.332	1e-98
Q9LJF3	1164	Receptor-like protein kin	no	no	0.876	0.613	0.321	2e-95
Q9ZPS9	1143	Serine/threonine-protein	no	no	0.896	0.639	0.314	7e-92
C0LGJ1	1106	Probable LRR receptor-lik	no	no	0.851	0.627	0.310	6e-83

>sp|C0LGK9|Y2242_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g24230 OS=Arabidopsis thaliana GN=At2g24230 PE=2 SV=1

 Score = 1158 bits (2995), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 594/813 (73%), Positives = 678/813 (83%), Gaps = 5/813 (0%)

Query: 1   MSSKSFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDL 60
           M   S QA  FSA FCSW+G+ CDS  +HV   +AS   LSG +PD TIGKLSKLQSLDL
Sbjct: 40  MGLSSSQAYNFSAPFCSWQGLFCDSKNEHVIMLIASGMSLSGQIPDNTIGKLSKLQSLDL 99

Query: 61  SENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAI 120
           S N I+ALPSD WSL +LK+LNLS+N+ISGS  SN+GNFG LE+ D+S NNFSG IP A+
Sbjct: 100 SNNKISALPSDFWSLNTLKNLNLSFNKISGSFSSNVGNFGQLELLDISYNNFSGAIPEAV 159

Query: 121 SSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNL 180
            SLVSLRVLKLD N FQ SIP GLL CQSLV++DLS NQL GSLPDGFG+AFPKL++L+L
Sbjct: 160 DSLVSLRVLKLDHNGFQMSIPRGLLGCQSLVSIDLSSNQLEGSLPDGFGSAFPKLETLSL 219

Query: 181 AGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFN 240
           AGN+I GRDT FA +KSI+ LNISGN F GSV GVF E+LEV DL  N+FQGHIS  Q +
Sbjct: 220 AGNKIHGRDTDFADMKSISFLNISGNQFDGSVTGVFKETLEVADLSKNRFQGHISS-QVD 278

Query: 241 SSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLN 300
           S  NW  LVY+DLSEN+LSG +  N +  + LKHL+LA+NRF R  FP+I  L GLE+LN
Sbjct: 279 S--NWFSLVYLDLSENELSG-VIKNLTLLKKLKHLNLAWNRFNRGMFPRIEMLSGLEYLN 335

Query: 301 LSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASL 360
           LS T+L G IP EI +LS L TLD+S NHL G IP +S KNL  ID+S NNL+GEIP S+
Sbjct: 336 LSNTNLSGHIPREISKLSDLSTLDVSGNHLAGHIPILSIKNLVAIDVSRNNLTGEIPMSI 395

Query: 361 LEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLK 420
           LEKLP MERFNFS+NNLT C+ + S ETL  +FFGS+N CPIAANP+ FKRK +   GLK
Sbjct: 396 LEKLPWMERFNFSFNNLTFCSGKFSAETLNRSFFGSTNSCPIAANPALFKRKRSVTGGLK 455

Query: 421 LALALTLSMICLLAG-LLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVAD 479
           LALA+TLS +CLL G L+ +AFGCRRK K    K  S KEEQ++SGPFSFQTDSTTWVAD
Sbjct: 456 LALAVTLSTMCLLIGALIFVAFGCRRKTKSGEAKDLSVKEEQSISGPFSFQTDSTTWVAD 515

Query: 480 VKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKV 539
           VK AN+V VVIFEKPLLNITF+DLLSATSNFDR TLLA+GKFGPVYRGFLPGGIHVAVKV
Sbjct: 516 VKQANAVPVVIFEKPLLNITFSDLLSATSNFDRDTLLADGKFGPVYRGFLPGGIHVAVKV 575

Query: 540 LVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLP 599
           LVHGSTL+DQEAARELE+LGRIKHPNLVPLTGYCIAGDQRIAIY+YMENGNLQNLLHDLP
Sbjct: 576 LVHGSTLSDQEAARELEFLGRIKHPNLVPLTGYCIAGDQRIAIYEYMENGNLQNLLHDLP 635

Query: 600 LGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII 659
            GVQTT+DW+TDTWEE+  N  QN+G+EG + TWRFRHKIALGTARALAFLHHGCSPPII
Sbjct: 636 FGVQTTDDWTTDTWEEETDNGTQNIGTEGPVATWRFRHKIALGTARALAFLHHGCSPPII 695

Query: 660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS 719
           HRD+KASSVYLD N EPRLSDFGLAK+FGNGLD+EI  GSPGY+PPEF QP+ + PTPKS
Sbjct: 696 HRDVKASSVYLDQNWEPRLSDFGLAKVFGNGLDDEIIHGSPGYLPPEFLQPEHELPTPKS 755

Query: 720 DVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQ 779
           DVYC+GVVL EL+TGKKP+ DDY +EK+ NLVSWVR LVR N+ S+AIDPKI++TG E+Q
Sbjct: 756 DVYCFGVVLFELMTGKKPIEDDYLDEKDTNLVSWVRSLVRKNQASKAIDPKIQETGSEEQ 815

Query: 780 MEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE 812
           MEEALKIGYLCTADLP KRPSMQQ+VGLLKDIE
Sbjct: 816 MEEALKIGYLCTADLPSKRPSMQQVVGLLKDIE 848

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LVN2|Y5815_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At5g58150 OS=Arabidopsis thaliana GN=At5g58150 PE=1 SV=1

 Score =  725 bits (1871), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/811 (51%), Positives = 529/811 (65%), Gaps = 80/811 (9%)

Query: 7   QASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT 66
           QA  FS S CSW GVV   + ++V    AS   LSGS+PD TIGK+SKLQ+LDLS N IT
Sbjct: 45  QAHTFS-SLCSWPGVVVCDSSENVLHISASGLDLSGSIPDNTIGKMSKLQTLDLSGNKIT 103

Query: 67  ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSL 126
           +LPSDLWSL  L+SLNLS NRIS  LPSNIGNF  L   DLS N+ SG+IPAAIS+LV+L
Sbjct: 104 SLPSDLWSLSLLESLNLSSNRISEPLPSNIGNFMSLHTLDLSFNSISGKIPAAISNLVNL 163

Query: 127 RVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIK 186
             LKL  N FQ+ +PP L++C+SL+++DLS N+LN SLP GFG+AFP LKSLNL      
Sbjct: 164 TTLKLHNNDFQFGVPPELVHCRSLLSIDLSSNRLNESLPVGFGSAFPLLKSLNL------ 217

Query: 187 GRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWS 246
                            S NLFQGS++GV  E++E +DL  N+F GHI Q+     +NWS
Sbjct: 218 -----------------SRNLFQGSLIGVLHENVETVDLSENRFDGHILQLIPGHKHNWS 260

Query: 247 RLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSL 306
            L+++DLS+N   G IF+  S A  L HL+LA NRF  QEFP+IG L  L +LNLSRT+L
Sbjct: 261 SLIHLDLSDNSFVGHIFNGLSSAHKLGHLNLACNRFRAQEFPEIGKLSALHYLNLSRTNL 320

Query: 307 IGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQ 366
              IP EI +LS L  LDLS N+LTG +P +S KN+ ++D+S N L G+IP  LLEKL  
Sbjct: 321 TNIIPREISRLSHLKVLDLSSNNLTGHVPMLSVKNIEVLDLSLNKLDGDIPRPLLEKLAM 380

Query: 367 MERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHK--GLKLALA 424
           M+RFNFS+NNLT C    S ET+Q +F    N+CP AA P   K K  N K  GLK+ L 
Sbjct: 381 MQRFNFSFNNLTFCNPNFSQETIQRSFINIRNNCPFAAKPIITKGKKVNKKNTGLKIGLG 440

Query: 425 LTLSM--ICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKH 482
           L +SM  + +   L+ +A   RRK + W  K      E N       Q DSTT   D+K 
Sbjct: 441 LAISMAFLLIGLLLILVALRVRRKSRTWATKLAINNTEPNSPD----QHDSTT---DIKQ 493

Query: 483 ANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVH 542
           A  + VV+ +KPL+ +T ADL +AT NFDRGT+L EGK GP Y   LPGG   A+KV+  
Sbjct: 494 ATQIPVVMIDKPLMKMTLADLKAATFNFDRGTMLWEGKSGPTYGAVLPGGFRAALKVIPS 553

Query: 543 GSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGV 602
           G+TLTD E +   E L RI HPNL PL GYCIA +QRIAIY+ ++  NLQ+LLH+     
Sbjct: 554 GTTLTDTEVSIAFERLARINHPNLFPLCGYCIATEQRIAIYEDLDMVNLQSLLHN----- 608

Query: 603 QTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD 662
                        +G +S            WR RHKIALGTARALAFLHHGC PP++H +
Sbjct: 609 -------------NGDDS----------APWRLRHKIALGTARALAFLHHGCIPPMVHGE 645

Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI--ARGSPGYIPPEFAQPDSDFPTPKSD 720
           +KA+++ LD + EPRL+DFGL K+    LDE+   +    GY PPE  Q  +  PT +SD
Sbjct: 646 VKAATILLDSSQEPRLADFGLVKL----LDEQFPGSESLDGYTPPE--QERNASPTLESD 699

Query: 721 VYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQM 780
           VY +GVVLLEL++GKKP         EG+LV+WVRGLVR  +G RAIDP +++T PE ++
Sbjct: 700 VYSFGVVLLELVSGKKP---------EGDLVNWVRGLVRQGQGLRAIDPTMQETVPEDEI 750

Query: 781 EEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
            EA+KIGYLCTADLP KRP+MQQ+VGLLKDI
Sbjct: 751 AEAVKIGYLCTADLPWKRPTMQQVVGLLKDI 781

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  394 bits (1011), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 279/851 (32%), Positives = 414/851 (48%), Gaps = 134/851 (15%)

Query: 32   DFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISG 90
            + L +N+ ++GS+P+  + KL  L +LDL  NN T  +P  LW   +L     SYNR+ G
Sbjct: 405  ELLLTNNQINGSIPED-LWKL-PLMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEG 462

Query: 91   SLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSL 150
             LP+ IGN   L+   LS+N  +GEIP  I  L SL VL L+ NMFQ  IP  L +C SL
Sbjct: 463  YLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSL 522

Query: 151  VTVDLSMNQLNGSLPDGFGAAFPKLKSL-----NLAGN---------------------- 183
             T+DL  N L G +PD    A  +L+ L     NL+G+                      
Sbjct: 523  TTLDLGSNNLQGQIPDKI-TALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQH 581

Query: 184  --------------------------EIKGRDTHFAG--------LKSITNLNISGNLFQ 209
                                      EI   + H +G        L ++T L++SGN   
Sbjct: 582  HGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALT 641

Query: 210  GSV---MGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNF 266
            GS+   MG  L+ L+ ++L +NQ  GHI +    S      LV ++L++N+L G +  + 
Sbjct: 642  GSIPKEMGNSLK-LQGLNLANNQLNGHIPE----SFGLLGSLVKLNLTKNKLDGPVPASL 696

Query: 267  SQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLS 326
               + L H+ L++N  + +   ++ T+  L  L + +    G+IPSE+  L+ L  LD+S
Sbjct: 697  GNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVS 756

Query: 327  MNHLTGQIPT--VSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASEL 384
             N L+G+IPT      NL  ++++ NNL GE+P+  + + P     +    N  LC   +
Sbjct: 757  ENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLS---GNKELCGRVV 813

Query: 385  SPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMICLLAGLLCLAFGCR 444
                         +DC I        R A    GL L   + +             F  R
Sbjct: 814  G------------SDCKIEGTK---LRSAWGIAGLMLGFTIIV---------FVFVFSLR 849

Query: 445  RKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHAN--SVQVVIFEKPLLNITFAD 502
            R      VKQ    E    S    F   +  +++  +     S+ + +FE+PLL +   D
Sbjct: 850  RWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGD 909

Query: 503  LLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK 562
            ++ AT +F +  ++ +G FG VY+  LPG   VAVK L    T  ++E   E+E LG++K
Sbjct: 910  IVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVK 969

Query: 563  HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
            HPNLV L GYC   ++++ +Y+YM NG+L                   D W  + T  ++
Sbjct: 970  HPNLVSLLGYCSFSEEKLLVYEYMVNGSL-------------------DHWLRNQTGMLE 1010

Query: 623  NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
                   +  W  R KIA+G AR LAFLHHG  P IIHRDIKAS++ LD + EP+++DFG
Sbjct: 1011 -------VLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFG 1063

Query: 683  LAKIFGNGLDE--EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
            LA++          +  G+ GYIPPE+ Q  S   T K DVY +GV+LLEL+TGK+P G 
Sbjct: 1064 LARLISACESHVSTVIAGTFGYIPPEYGQ--SARATTKGDVYSFGVILLELVTGKEPTGP 1121

Query: 741  DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
            D+ E + GNLV W    +   K    IDP +     +      L+I  LC A+ P KRP+
Sbjct: 1122 DFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPN 1181

Query: 801  MQQIVGLLKDI 811
            M  ++  LK+I
Sbjct: 1182 MLDVLKALKEI 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  385 bits (990), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 285/795 (35%), Positives = 424/795 (53%), Gaps = 107/795 (13%)

Query: 40   LSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISGSLPSNIGN 98
            LSG++P +++G LSKL+ L L  N +   +P +L  + +L++L L +N ++G +PS + N
Sbjct: 452  LSGTIP-SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 510

Query: 99   FGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMN 158
               L    LSNN  +GEIP  I  L +L +LKL  N F  +IP  L +C+SL+ +DL+ N
Sbjct: 511  CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 570

Query: 159  QLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFA---GLKSITNLNISGNLFQGSVMGV 215
              NG++P    AA  K +S  +A N I G+   +    G+K     + +GNL +    G+
Sbjct: 571  LFNGTIP----AAMFK-QSGKIAANFIAGKRYVYIKNDGMKK--ECHGAGNLLE--FQGI 621

Query: 216  FLESLEVIDLR------SNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQA 269
              E L  +  R      S  + GH S    N+      ++++D+S N LSG I       
Sbjct: 622  RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG----SMMFLDMSYNMLSGYIPK----- 672

Query: 270  QNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNH 329
                               +IG++  L  LNL    + G IP E+  L  L+ LDLS N 
Sbjct: 673  -------------------EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 713

Query: 330  LTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFS--YNNLTLCASELS 385
            L G+IP    +   L  ID+S+NNLSG IP     ++ Q E F  +   NN  LC   L 
Sbjct: 714  LDGRIPQAMSALTMLTEIDLSNNNLSGPIP-----EMGQFETFPPAKFLNNPGLCGYPL- 767

Query: 386  PETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMICLLAGLLCLAFGCRR 445
            P          SN    A +     R+ A+  G  +A+ L  S +C+  GL+ +    R+
Sbjct: 768  PRC------DPSNADGYAHHQRSHGRRPASLAG-SVAMGLLFSFVCIF-GLILVGREMRK 819

Query: 446  KPKRWVVKQTSYKEEQNVSGPFSFQTDSTTW-VADVKHANSVQVVIFEKPLLNITFADLL 504
            + ++   +   Y E    SG  +   ++T W +  VK A S+ +  FEKPL  +TFADLL
Sbjct: 820  RRRKKEAELEMYAEGHGNSGDRT--ANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLL 877

Query: 505  SATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHP 564
             AT+ F   +L+  G FG VY+  L  G  VA+K L+H S   D+E   E+E +G+IKH 
Sbjct: 878  QATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHR 937

Query: 565  NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
            NLVPL GYC  GD+R+ +Y++M+ G+L+++LHD P       +WST              
Sbjct: 938  NLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHD-PKKAGVKLNWST-------------- 982

Query: 625  GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
                       R KIA+G+AR LAFLHH CSP IIHRD+K+S+V LD NLE R+SDFG+A
Sbjct: 983  -----------RRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMA 1031

Query: 685  KIFGNGLDEEIA----RGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
            ++  + +D  ++     G+PGY+PPE+ Q  S   + K DVY YGVVLLEL+TGK+P   
Sbjct: 1032 RLM-SAMDTHLSVSTLAGTPGYVPPEYYQ--SFRCSTKGDVYSYGVVLLELLTGKRP--T 1086

Query: 741  DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQME--EALKIGYLCTADLPLKR 798
            D P+  + NLV WV+   +  + S   DP++    P  ++E  + LK+   C  D   +R
Sbjct: 1087 DSPDFGDNNLVGWVKQHAK-LRISDVFDPELMKEDPALEIELLQHLKVAVACLDDRAWRR 1145

Query: 799  PSMQQIVGLLKDIES 813
            P+M Q++ + K+I++
Sbjct: 1146 PTMVQVMAMFKEIQA 1160

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  382 bits (980), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 283/815 (34%), Positives = 430/815 (52%), Gaps = 107/815 (13%)

Query: 18   WRGVVCDS--NKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWS 74
            ++G + DS  N   +     S + L+GS+P +++G LSKL+ L L  N ++  +P +L  
Sbjct: 439  FKGPIPDSLSNCSQLVSLDLSFNYLTGSIP-SSLGSLSKLKDLILWLNQLSGEIPQELMY 497

Query: 75   LGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGN 134
            L +L++L L +N ++G +P+++ N   L    LSNN  SGEIPA++  L +L +LKL  N
Sbjct: 498  LQALENLILDFNDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNN 557

Query: 135  MFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKL--KSLNLAGNEIKGRDTHF 192
                +IP  L NCQSL+ +DL+ N LNGS+P       P L  +S N+A   + G+   +
Sbjct: 558  SISGNIPAELGNCQSLIWLDLNTNFLNGSIP-------PPLFKQSGNIAVALLTGKRYVY 610

Query: 193  AGLKSITNLNISGNLFQGSVMGVFLESLEVIDLR-----SNQFQGHISQVQFNSSYNWSR 247
                     + +GNL +    G+  E L+ I  R     +  ++G I+Q  FN  +N S 
Sbjct: 611  IKNDGSKECHGAGNLLE--FGGIRQEQLDRISTRHPCNFTRVYRG-ITQPTFN--HNGS- 664

Query: 248  LVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLI 307
            ++++DLS N+L G I                          ++G +  L  LNL    L 
Sbjct: 665  MIFLDLSYNKLEGSIPK------------------------ELGAMYYLSILNLGHNDLS 700

Query: 308  GDIPSEILQLSSLHTLDLSMNHLTGQIPT--VSAKNLGIIDMSHNNLSGEIPASLLEKLP 365
            G IP ++  L ++  LDLS N   G IP    S   LG ID+S+NNLSG IP    E  P
Sbjct: 701  GMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIP----ESAP 756

Query: 366  QMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALAL 425
                 ++ + N +LC   L P    +   G  +D   A       R+ A+  G  +A+ L
Sbjct: 757  FDTFPDYRFANNSLCGYPL-PLPCSS---GPKSD---ANQHQKSHRRQASLAG-SVAMGL 808

Query: 426  TLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTW-VADVKHAN 484
              S+ C+  GL+ +A   +++ ++      +Y +  + S      T ++ W     + A 
Sbjct: 809  LFSLFCIF-GLIIVAIETKKRRRKKEAALEAYMDGHSHSA-----TANSAWKFTSAREAL 862

Query: 485  SVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGS 544
            S+ +  FEKPL  +TFADLL AT+ F   +L+  G FG VY+  L  G  VA+K L+H S
Sbjct: 863  SINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVS 922

Query: 545  TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQT 604
               D+E   E+E +G+IKH NLVPL GYC  G++R+ +Y+YM+ G+L+++LHD       
Sbjct: 923  GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRK----- 977

Query: 605  TEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK 664
                                   G+   W  R KIA+G AR LAFLHH C P IIHRD+K
Sbjct: 978  ---------------------KTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMK 1016

Query: 665  ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA----RGSPGYIPPEFAQPDSDFPTPKSD 720
            +S+V LD NLE R+SDFG+A++  + +D  ++     G+PGY+PPE+ Q  S   + K D
Sbjct: 1017 SSNVLLDENLEARVSDFGMARLM-SAMDTHLSVSTLAGTPGYVPPEYYQ--SFRCSTKGD 1073

Query: 721  VYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKI--RDTGPEK 778
            VY YGVVLLEL+TGK+P   D  +  + NLV WV+ L    K +   D ++   D   E 
Sbjct: 1074 VYSYGVVLLELLTGKQP--TDSADFGDNNLVGWVK-LHAKGKITDVFDRELLKEDASIEI 1130

Query: 779  QMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES 813
            ++ + LK+   C  D   KRP+M Q++ + K+I++
Sbjct: 1131 ELLQHLKVACACLDDRHWKRPTMIQVMAMFKEIQA 1165

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  380 bits (977), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 282/815 (34%), Positives = 427/815 (52%), Gaps = 107/815 (13%)

Query: 18   WRGVVCDS--NKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWS 74
            ++G + DS  N   +     S + L+GS+P +++G LSKL+ L L  N ++  +P +L  
Sbjct: 439  FKGPIPDSLSNCSQLVSLDLSFNYLTGSIP-SSLGSLSKLKDLILWLNQLSGEIPQELMY 497

Query: 75   LGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGN 134
            L +L++L L +N ++G +P+++ N   L    LSNN  SGEIPA++  L +L +LKL  N
Sbjct: 498  LQALENLILDFNDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNN 557

Query: 135  MFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKL--KSLNLAGNEIKGRDTHF 192
                +IP  L NCQSL+ +DL+ N LNGS+P       P L  +S N+A   + G+   +
Sbjct: 558  SISGNIPAELGNCQSLIWLDLNTNFLNGSIP-------PPLFKQSGNIAVALLTGKRYVY 610

Query: 193  AGLKSITNLNISGNLFQGSVMGVFLESLEVIDLR-----SNQFQGHISQVQFNSSYNWSR 247
                     + +GNL +    G+  E L+ I  R     +  ++G I+Q  FN  +N S 
Sbjct: 611  IKNDGSKECHGAGNLLE--FGGIRQEQLDRISTRHPCNFTRVYRG-ITQPTFN--HNGS- 664

Query: 248  LVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLI 307
            ++++DLS N+L G I                          ++G +  L  LNL    L 
Sbjct: 665  MIFLDLSYNKLEGSIPK------------------------ELGAMYYLSILNLGHNDLS 700

Query: 308  GDIPSEILQLSSLHTLDLSMNHLTGQIPT--VSAKNLGIIDMSHNNLSGEIPASLLEKLP 365
            G IP ++  L ++  LDLS N   G IP    S   LG ID+S+NNLSG IP    E  P
Sbjct: 701  GMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIP----ESAP 756

Query: 366  QMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALAL 425
                 ++ + N +LC   L           SS     A       R+ A+  G  +A+ L
Sbjct: 757  FDTFPDYRFANNSLCGYPLPIPC-------SSGPKSDANQHQKSHRRQASLAG-SVAMGL 808

Query: 426  TLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTW-VADVKHAN 484
              S+ C+  GL+ +A   +++ ++      +Y +  + S      T ++ W     + A 
Sbjct: 809  LFSLFCIF-GLIIVAIETKKRRRKKEAALEAYMDGHSHSA-----TANSAWKFTSAREAL 862

Query: 485  SVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGS 544
            S+ +  FEKPL  +TFADLL AT+ F   +L+  G FG VY+  L  G  VA+K L+H S
Sbjct: 863  SINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVS 922

Query: 545  TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQT 604
               D+E   E+E +G+IKH NLVPL GYC  G++R+ +Y+YM+ G+L+++LHD       
Sbjct: 923  GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRK----- 977

Query: 605  TEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK 664
                                   G+   W  R KIA+G AR LAFLHH C P IIHRD+K
Sbjct: 978  ---------------------KIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMK 1016

Query: 665  ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA----RGSPGYIPPEFAQPDSDFPTPKSD 720
            +S+V LD NLE R+SDFG+A++  + +D  ++     G+PGY+PPE+ Q  S   + K D
Sbjct: 1017 SSNVLLDENLEARVSDFGMARLM-SAMDTHLSVSTLAGTPGYVPPEYYQ--SFRCSTKGD 1073

Query: 721  VYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKI--RDTGPEK 778
            VY YGVVLLEL+TGK+P   D  +  + NLV WV+ L    K +   D ++   D   E 
Sbjct: 1074 VYSYGVVLLELLTGKQP--TDSADFGDNNLVGWVK-LHAKGKITDVFDRELLKEDASIEI 1130

Query: 779  QMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES 813
            ++ + LK+   C  D   KRP+M Q++ + K+I++
Sbjct: 1131 ELLQHLKVACACLDDRHWKRPTMIQVMAMFKEIQA 1165

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  361 bits (926), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 265/797 (33%), Positives = 406/797 (50%), Gaps = 80/797 (10%)

Query: 33   FLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISGS 91
             L +N+ LSG+VP   +GK   L+++DLS N +T  +P ++W L +L  L +  N ++G+
Sbjct: 407  ILIANNYLSGTVP-MELGKCKSLKTIDLSFNELTGPIPKEIWMLPNLSDLVMWANNLTGT 465

Query: 92   LPSNIG-NFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSL 150
            +P  +    G LE   L+NN  +G IP +IS   ++  + L  N     IP G+ N   L
Sbjct: 466  IPEGVCVKGGNLETLILNNNLLTGSIPESISRCTNMIWISLSSNRLTGKIPSGIGNLSKL 525

Query: 151  VTVDLSMNQLNGSLPDGFGAA----FPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGN 206
              + L  N L+G++P   G      +  L S NL G ++ G     AGL  +   ++SG 
Sbjct: 526  AILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTG-DLPGELASQAGL--VMPGSVSGK 582

Query: 207  LFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRL--VYVDLSENQLSGEIFH 264
             F       F+ +    D R     G + + +   +    RL  V+   +    SG   +
Sbjct: 583  QF------AFVRNEGGTDCRG---AGGLVEFEGIRAERLERLPMVHSCPATRIYSGMTMY 633

Query: 265  NFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLD 324
             FS   ++ +  ++YN  +    P  G +  L+ LNL    + G IP     L ++  LD
Sbjct: 634  TFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLD 693

Query: 325  LSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIP-ASLLEKLPQMERFNFSYNNLTLCA 381
            LS N+L G +P    S   L  +D+S+NNL+G IP    L   P + R+    NN  LC 
Sbjct: 694  LSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFP-VSRY---ANNSGLCG 749

Query: 382  SELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMICLLAGLLCLAF 441
              L P        GS+   PI +     K+  A      +   +  S +C +  +L +A 
Sbjct: 750  VPLRP-------CGSAPRRPITSRIHAKKQTVAT----AVIAGIAFSFMCFV--MLVMAL 796

Query: 442  GCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIFEKPLLNITFA 501
               RK ++   K+  Y E    SG  S++  S      V    S+ V  FEKPL  +TFA
Sbjct: 797  YRVRKVQKKEQKREKYIESLPTSGSCSWKLSS------VPEPLSINVATFEKPLRKLTFA 850

Query: 502  DLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI 561
             LL AT+ F   T++  G FG VY+  L  G  VA+K L+  +   D+E   E+E +G+I
Sbjct: 851  HLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKI 910

Query: 562  KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
            KH NLVPL GYC  G++R+ +Y+YM+ G+L+ +LH+                        
Sbjct: 911  KHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHE------------------------ 946

Query: 622  QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            ++    G+   W  R KIA+G AR LAFLHH C P IIHRD+K+S+V LD + E R+SDF
Sbjct: 947  KSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDF 1006

Query: 682  GLAKIFGNGLDEEIA----RGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
            G+A++  + LD  ++     G+PGY+PPE+ Q  S   T K DVY YGV+LLEL++GKKP
Sbjct: 1007 GMARLV-SALDTHLSVSTLAGTPGYVPPEYYQ--SFRCTAKGDVYSYGVILLELLSGKKP 1063

Query: 738  LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPK-IRDTGPEKQMEEALKIGYLCTADLPL 796
            + D     ++ NLV W + L R  +G+  +DP+ + D   + ++   LKI   C  D P 
Sbjct: 1064 I-DPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPF 1122

Query: 797  KRPSMQQIVGLLKDIES 813
            KRP+M Q++ + K++++
Sbjct: 1123 KRPTMIQLMAMFKEMKA 1139

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  351 bits (900), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 274/851 (32%), Positives = 414/851 (48%), Gaps = 137/851 (16%)

Query: 1    MSSKSFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDL 60
            +SS  F     S  FCS +      +   +   L +N+ LSG+VP   +GK   L+++DL
Sbjct: 382  LSSNEFTGEVPSG-FCSLQ------SSSVLEKLLIANNYLSGTVP-VELGKCKSLKTIDL 433

Query: 61   SENNITAL-PSDLWSL-------------------------GSLKSLNLSYNRISGSLPS 94
            S N +T L P ++W+L                         G+L++L L+ N ++GSLP 
Sbjct: 434  SFNALTGLIPKEIWTLPKLSDLVMWANNLTGGIPESICVDGGNLETLILNNNLLTGSLPE 493

Query: 95   NIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVD 154
            +I     +    LS+N  +GEIP  I  L  L +L+L  N    +IP  L NC++L+ +D
Sbjct: 494  SISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLD 553

Query: 155  LSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMG 214
            L+ N L G+LP    +       L + G+ + G+   F   +  T+   +G L +    G
Sbjct: 554  LNSNNLTGNLPGELASQ----AGLVMPGS-VSGKQFAFVRNEGGTDCRGAGGLVE--FEG 606

Query: 215  VFLESLE----VIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQ 270
            +  E LE    V      +    ++   F+S+     ++Y+DLS N +SG I        
Sbjct: 607  IRAERLEHFPMVHSCPKTRIYSGMTMYMFSSN---GSMIYLDLSYNAVSGSI-------- 655

Query: 271  NLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHL 330
                  L Y           G +  L+ LNL    L G IP     L ++  LDLS N L
Sbjct: 656  -----PLGY-----------GAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDL 699

Query: 331  TGQIPTV--SAKNLGIIDMSHNNLSGEIP-ASLLEKLPQMERFNFSYNNLTLCASELSPE 387
             G +P        L  +D+S+NNL+G IP    L   P + R+    NN  LC   L P 
Sbjct: 700  QGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFP-LTRY---ANNSGLCGVPLPP- 754

Query: 388  TLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMICLLAGLLCLAFGCRRKP 447
                        C   + P+   R  A+ K   +A  ++  ++     ++ L     R  
Sbjct: 755  ------------CSSGSRPT---RSHAHPKKQSIATGMSAGIVFSFMCIVMLIMALYRA- 798

Query: 448  KRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIFEKPLLNITFADLLSAT 507
             R V K+   +E+   S P S  +      + V    S+ V  FEKPL  +TFA LL AT
Sbjct: 799  -RKVQKKEKQREKYIESLPTSGSSSWKL--SSVHEPLSINVATFEKPLRKLTFAHLLEAT 855

Query: 508  SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
            + F   +++  G FG VY+  L  G  VA+K L+  +   D+E   E+E +G+IKH NLV
Sbjct: 856  NGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLV 915

Query: 568  PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            PL GYC  G++R+ +Y+YM+ G+L+ +LH                         +     
Sbjct: 916  PLLGYCKIGEERLLVYEYMKYGSLETVLH-------------------------EKTKKG 950

Query: 628  GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            G+   W  R KIA+G AR LAFLHH C P IIHRD+K+S+V LD +   R+SDFG+A++ 
Sbjct: 951  GIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLV 1010

Query: 688  GNGLDEEIA----RGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
             + LD  ++     G+PGY+PPE+ Q  S   T K DVY YGV+LLEL++GKKP+    P
Sbjct: 1011 -SALDTHLSVSTLAGTPGYVPPEYYQ--SFRCTAKGDVYSYGVILLELLSGKKPID---P 1064

Query: 744  EE--KEGNLVSWVRGLVRNNKGSRAIDPK-IRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
            EE  ++ NLV W + L R  +G+  +DP+ + D   + ++   LKI   C  D P KRP+
Sbjct: 1065 EEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPT 1124

Query: 801  MQQIVGLLKDI 811
            M Q++ + K++
Sbjct: 1125 MIQVMTMFKEL 1135

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1

 Score =  338 bits (868), Expect = 7e-92,   Method: Compositional matrix adjust.
 Identities = 263/835 (31%), Positives = 399/835 (47%), Gaps = 104/835 (12%)

Query: 29   HVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNR 87
             + DF  S++  SG +P       + L+ L L +N +T  +P  +     L++++LS N 
Sbjct: 353  RIADF--SSNRFSGVIPPDLCPGAASLEELRLPDNLVTGEIPPAISQCSELRTIDLSLNY 410

Query: 88   ISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNC 147
            ++G++P  IGN   LE F    NN +GEIP  I  L +L+ L L+ N     IPP   NC
Sbjct: 411  LNGTIPPEIGNLQKLEQFIAWYNNIAGEIPPEIGKLQNLKDLILNNNQLTGEIPPEFFNC 470

Query: 148  QSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGR-DTHFAGLKSITNLNISGN 206
             ++  V  + N+L G +P  FG    +L  L L  N   G          ++  L+++ N
Sbjct: 471  SNIEWVSFTSNRLTGEVPKDFGI-LSRLAVLQLGNNNFTGEIPPELGKCTTLVWLDLNTN 529

Query: 207  LFQGSV------------MGVFLESLEVIDLRS--NQFQGHISQVQFNSSYNWSRLVYV- 251
               G +            +   L    +  +R+  N  +G    V+F S     RL+ + 
Sbjct: 530  HLTGEIPPRLGRQPGSKALSGLLSGNTMAFVRNVGNSCKGVGGLVEF-SGIRPERLLQIP 588

Query: 252  -----DLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSL 306
                 D +    SG I   F++ Q +++L L+YN+   +   +IG ++ L+ L LS   L
Sbjct: 589  SLKSCDFTR-MYSGPILSLFTRYQTIEYLDLSYNQLRGKIPDEIGEMIALQVLELSHNQL 647

Query: 307  IGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGI---IDMSHNNLSGEIPA-SLLE 362
             G+IP  I QL +L   D S N L GQIP  S  NL     ID+S+N L+G IP    L 
Sbjct: 648  SGEIPFTIGQLKNLGVFDASDNRLQGQIPE-SFSNLSFLVQIDLSNNELTGPIPQRGQLS 706

Query: 363  KLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLA 422
             LP  +      NN  LC   L PE         +N  P        KR     +    A
Sbjct: 707  TLPATQY----ANNPGLCGVPL-PECKN-----GNNQLPAGTEEG--KRAKHGTRAASWA 754

Query: 423  LALTLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPF-SFQT--DSTTW-VA 478
             ++ L ++   A +  L          W +   + + + + +    S Q    +TTW + 
Sbjct: 755  NSIVLGVLISAASVCILIV--------WAIAVRARRRDADDAKMLHSLQAVNSATTWKIE 806

Query: 479  DVKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVK 538
              K   S+ V  F++ L  + F+ L+ AT+ F   +++  G FG V++  L  G  VA+K
Sbjct: 807  KEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIK 866

Query: 539  VLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDL 598
             L+  S   D+E   E+E LG+IKH NLVPL GYC  G++R+ +Y++M+ G+L+ +LH  
Sbjct: 867  KLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLH-- 924

Query: 599  PLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI 658
              G +T E      WEE                    R KIA G A+ L FLHH C P I
Sbjct: 925  --GPRTGEKRRILGWEE--------------------RKKIAKGAAKGLCFLHHNCIPHI 962

Query: 659  IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA----RGSPGYIPPEFAQPDSDF 714
            IHRD+K+S+V LD ++E R+SDFG+A++  + LD  ++     G+PGY+PPE+ Q  S  
Sbjct: 963  IHRDMKSSNVLLDQDMEARVSDFGMARLI-SALDTHLSVSTLAGTPGYVPPEYYQ--SFR 1019

Query: 715  PTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT 774
             T K DVY  GVV+LE+++GK+P   D  E  + NLV W +   R  K    ID  +   
Sbjct: 1020 CTAKGDVYSIGVVMLEILSGKRP--TDKEEFGDTNLVGWSKMKAREGKHMEVIDEDLLKE 1077

Query: 775  GPE---------------KQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST 814
            G                 K+M   L+I   C  D P KRP+M Q+V  L+++  +
Sbjct: 1078 GSSESLNEKEGFEGGVIVKEMLRYLEIALRCVDDFPSKRPNMLQVVASLRELRGS 1132

Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGJ1|Y1743_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g74360 OS=Arabidopsis thaliana GN=At1g74360 PE=1 SV=1

 Score =  309 bits (791), Expect = 6e-83,   Method: Compositional matrix adjust.
 Identities = 252/811 (31%), Positives = 371/811 (45%), Gaps = 117/811 (14%)

Query: 42   GSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFG 100
            G +  + I KL  L  LDL  NN +  LP+++  + SLK L L+YN  SG +P   GN  
Sbjct: 362  GGINSSNILKLPNLSRLDLGYNNFSGQLPTEISQIQSLKFLILAYNNFSGDIPQEYGNMP 421

Query: 101  LLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQL 160
             L+  DLS N  +G IPA+   L SL  L L  N     IP  + NC SL+  +++ NQ 
Sbjct: 422  GLQALDLSFNKLTGSIPASFGKLTSLLWLMLANNSLSGEIPREIGNCTSLLWFNVANNQ- 480

Query: 161  NGSLPDGFGAAFPKLKSLNLAGNEI--KGRDTHFAGLKSITNLN--ISGNLFQGSVMGVF 216
               L   F     ++ S      E+  + +D   AG      +   I       + +   
Sbjct: 481  ---LSGRFHPELTRMGSNPSPTFEVNRQNKDKIIAGSGECLAMKRWIPAEFPPFNFVYAI 537

Query: 217  LESLEVIDLRSNQFQGH--ISQVQFNSSYNWSRL-VYVDLSENQLSGEIFHNFSQAQNLK 273
            L       L  +  +G+         S+    ++  Y+ LS N+ SGEI  + SQ   L 
Sbjct: 538  LTKKSCRSLWDHVLKGYGLFPVCSAGSTVRTLKISAYLQLSGNKFSGEIPASISQMDRLS 597

Query: 274  HLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQ 333
             L L +N F  +  P+IG L  L  LNL+R +  G+IP EI  L  L  LDLS N     
Sbjct: 598  TLHLGFNEFEGKLPPEIGQL-PLAFLNLTRNNFSGEIPQEIGNLKCLQNLDLSFN----- 651

Query: 334  IPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAF 393
                             N SG  P SL   L ++ +FN SYN      S   P T Q A 
Sbjct: 652  -----------------NFSGNFPTSL-NDLNELSKFNISYNPFI---SGAIPTTGQVAT 690

Query: 394  FGSSN--DCPIAANPSFFKRKAANHKGLK-----------------LALALTLSMICLLA 434
            F   +    P+   PSFF +   N + +                  LALAL      +++
Sbjct: 691  FDKDSFLGNPLLRFPSFFNQSGNNTRKISNQVLGNRPRTLLLIWISLALALAFIACLVVS 750

Query: 435  GLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIFEKP 494
            G++ +     R+ +  ++  +  + +   S        S+ W++       ++V+  +K 
Sbjct: 751  GIVLMVVKASREAEIDLLDGSKTRHDMTSS-----SGGSSPWLS-----GKIKVIRLDKS 800

Query: 495  LLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARE 554
                T+AD+L ATSNF    ++  G +G VYRG LP G  VAVK L    T  ++E   E
Sbjct: 801  --TFTYADILKATSNFSEERVVGRGGYGTVYRGVLPDGREVAVKKLQREGTEAEKEFRAE 858

Query: 555  LEYL-----GRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWS 609
            +E L     G   HPNLV L G+C+ G ++I +++YM  G+L+ L+ D            
Sbjct: 859  MEVLSANAFGDWAHPNLVRLYGWCLDGSEKILVHEYMGGGSLEELITD------------ 906

Query: 610  TDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY 669
                       +Q          W+ R  IA   AR L FLHH C P I+HRD+KAS+V 
Sbjct: 907  --------KTKLQ----------WKKRIDIATDVARGLVFLHHECYPSIVHRDVKASNVL 948

Query: 670  LDMNLEPRLSDFGLAKIF--GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
            LD +   R++DFGLA++   G+     +  G+ GY+ PE+ Q      T + DVY YGV+
Sbjct: 949  LDKHGNARVTDFGLARLLNVGDSHVSTVIAGTIGYVAPEYGQTWQ--ATTRGDVYSYGVL 1006

Query: 728  LLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGP---EKQMEEAL 784
             +EL TG++ +  D  EE    LV W R ++  N  ++     +  T P    +QM E L
Sbjct: 1007 TMELATGRRAV--DGGEEC---LVEWARRVMTGNMTAKGSPITLSGTKPGNGAEQMTELL 1061

Query: 785  KIGYLCTADLPLKRPSMQQIVGLLKDIESTA 815
            KIG  CTAD P  RP+M++++ +L  I   A
Sbjct: 1062 KIGVKCTADHPQARPNMKEVLAMLVKISGKA 1092

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	815
255584451	839	ATP binding protein, putative [Ricinus c	0.986	0.958	0.807	0.0
224143959	854	predicted protein [Populus trichocarpa]	0.987	0.942	0.802	0.0
224088270	854	predicted protein [Populus trichocarpa]	0.986	0.941	0.807	0.0
225468025	853	PREDICTED: probable LRR receptor-like se	0.998	0.954	0.780	0.0
356562577	853	PREDICTED: probable LRR receptor-like se	0.998	0.954	0.75	0.0
449519838	850	PREDICTED: probable LRR receptor-like se	0.986	0.945	0.760	0.0
357480079	851	Receptor-like protein kinase [Medicago t	0.981	0.940	0.754	0.0
356514447	856	PREDICTED: probable LRR receptor-like se	0.990	0.942	0.751	0.0
356498764	854	PREDICTED: probable LRR receptor-like se	1.0	0.954	0.746	0.0
449457975	798	PREDICTED: probable LRR receptor-like se	0.922	0.942	0.754	0.0

>gi|255584451|ref|XP_002532956.1| ATP binding protein, putative [Ricinus communis] gi|223527266|gb|EEF29422.1| ATP binding protein, putative [Ricinus communis]

 Score = 1328 bits (3436), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 650/805 (80%), Positives = 716/805 (88%), Gaps = 1/805 (0%)

Query: 11  FSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPS 70
           FSA  CSW+GV CDS K  V+  +AS  GLSGS+PD TIGKL+KL++LDLS N ITALPS
Sbjct: 34  FSAPVCSWQGVFCDS-KGSVSGLVASGYGLSGSIPDITIGKLTKLRTLDLSNNKITALPS 92

Query: 71  DLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLK 130
           DLWSLGSL +LNLS N++SG L SNIGNFG+LE  DLS+NNFSGEIPAAISSL SLRVLK
Sbjct: 93  DLWSLGSLITLNLSSNQVSGFLASNIGNFGMLETIDLSSNNFSGEIPAAISSLSSLRVLK 152

Query: 131 LDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT 190
           L+ N FQ SIP G+LNC+SL  +DLS+N+L+GSLPDGFGAAFPKLKSLN+AGN IKGRD+
Sbjct: 153 LNRNGFQGSIPVGILNCRSLTLIDLSLNKLDGSLPDGFGAAFPKLKSLNIAGNRIKGRDS 212

Query: 191 HFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVY 250
            F  +KSIT+LNIS NLF G VMGVFLE LEVIDL  NQFQGHISQVQFNSS+NWS L++
Sbjct: 213 DFLEMKSITSLNISQNLFHGPVMGVFLEMLEVIDLSRNQFQGHISQVQFNSSFNWSHLIH 272

Query: 251 VDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDI 310
           +DLSENQLSG+IF N +QAQNLKHL+LA+NRF RQE PQI  L  LE+LNLS+TSLIG +
Sbjct: 273 LDLSENQLSGDIFPNLNQAQNLKHLNLAFNRFARQEIPQIDMLWELEYLNLSKTSLIGLV 332

Query: 311 PSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERF 370
           PS++ QLS LHTLDLS NHL+G IP    KNL ++D+SHNNLSGEIP SLL+KLP MERF
Sbjct: 333 PSKVAQLSKLHTLDLSDNHLSGHIPPFPVKNLQVLDVSHNNLSGEIPLSLLQKLPWMERF 392

Query: 371 NFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMI 430
           NFSYNNLTLCASE S ETLQ  F+GS N CPIAANP  F+RKA  HKGLKLALAL LSM+
Sbjct: 393 NFSYNNLTLCASEFSLETLQRQFYGSLNSCPIAANPDLFRRKATKHKGLKLALALALSMV 452

Query: 431 CLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVI 490
           CLLAGLL +A GCRRK  RW VKQ SYKEEQN+SGPFSFQTDSTTWVADVK A SV VV+
Sbjct: 453 CLLAGLLFIAVGCRRKSSRWAVKQNSYKEEQNISGPFSFQTDSTTWVADVKQATSVAVVL 512

Query: 491 FEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQE 550
           FEKPLLNITFADLLSATS+FDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQE
Sbjct: 513 FEKPLLNITFADLLSATSSFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQE 572

Query: 551 AARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWST 610
           AARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWST
Sbjct: 573 AARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWST 632

Query: 611 DTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL 670
           DTWEED  N IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP+IHRD+KASSVYL
Sbjct: 633 DTWEEDDHNGIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPLIHRDVKASSVYL 692

Query: 671 DMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE 730
           D NLEPRLSDFGLAK+FGNGLDEEIARGSPGY+PPEF+ P++++PTPKSDVYC+G+VL E
Sbjct: 693 DYNLEPRLSDFGLAKVFGNGLDEEIARGSPGYVPPEFSDPENNYPTPKSDVYCFGIVLFE 752

Query: 731 LITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLC 790
           LITGKKP+GDDYPEEK+  LVSWVRGLVR N+ SRAIDPKIR+TGPE++MEEALKIGYLC
Sbjct: 753 LITGKKPIGDDYPEEKDATLVSWVRGLVRKNQMSRAIDPKIRNTGPEQEMEEALKIGYLC 812

Query: 791 TADLPLKRPSMQQIVGLLKDIESTA 815
           TAD+PLKRPSMQQIVGLLKDIE T 
Sbjct: 813 TADIPLKRPSMQQIVGLLKDIEPTV 837

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224143959|ref|XP_002325137.1| predicted protein [Populus trichocarpa] gi|222866571|gb|EEF03702.1| predicted protein [Populus trichocarpa]

 Score = 1306 bits (3381), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 646/805 (80%), Positives = 715/805 (88%)

Query: 11  FSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPS 70
           FSAS CSW+GV CD+ K+HV  FLAS  GLSGS+PDTTIGKLSKLQ+LDLS N IT+ PS
Sbjct: 48  FSASVCSWQGVFCDAKKEHVVKFLASGLGLSGSIPDTTIGKLSKLQTLDLSNNKITSFPS 107

Query: 71  DLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLK 130
           DLWSLG L  LNLS N+ISG LPSN+GNFG+LE  DLS+NNFSGEIPAAISSLVSLRVLK
Sbjct: 108 DLWSLGFLNLLNLSSNKISGPLPSNVGNFGVLETIDLSSNNFSGEIPAAISSLVSLRVLK 167

Query: 131 LDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT 190
           L+ N F+ SIP G+L+CQSL  +DLSMN+L+GSLPDGFGAAFPKLK+LNLAGN I+GRD+
Sbjct: 168 LERNGFEGSIPSGILSCQSLHFIDLSMNKLDGSLPDGFGAAFPKLKTLNLAGNGIQGRDS 227

Query: 191 HFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVY 250
            F+ +KSIT LNISGN FQGSVMGVF E LEV+DL  NQF+GHISQVQFNS+YNWSRLVY
Sbjct: 228 DFSLMKSITTLNISGNSFQGSVMGVFQELLEVMDLSKNQFEGHISQVQFNSTYNWSRLVY 287

Query: 251 VDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDI 310
           +DLS+NQLSGEIFH+FS A NLK+L+LA+NRFT +EFP+I  L  LE+LNLS+TSL G I
Sbjct: 288 LDLSDNQLSGEIFHDFSHASNLKYLNLAFNRFTEEEFPRIDMLSELEYLNLSKTSLSGHI 347

Query: 311 PSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERF 370
           PSEI QLS+LHTLDLS NHL+G+IP ++ KNL ++DMS NNLSGEIP SLLE LP ME +
Sbjct: 348 PSEITQLSNLHTLDLSQNHLSGRIPLLTIKNLQVLDMSQNNLSGEIPVSLLENLPWMESY 407

Query: 371 NFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMI 430
           NFSYNNLTLCASE SPET Q+ F GS + CPIAANP  F+RK +NHKGLKL+L L LS++
Sbjct: 408 NFSYNNLTLCASEFSPETFQSHFSGSLDSCPIAANPGLFQRKVSNHKGLKLSLGLALSVV 467

Query: 431 CLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVI 490
            +LAGLL LAFGCRRK K W  KQTSYKEEQN+SGPFSFQTDSTTWVADVK ANSV VVI
Sbjct: 468 FMLAGLLFLAFGCRRKSKMWEAKQTSYKEEQNISGPFSFQTDSTTWVADVKQANSVPVVI 527

Query: 491 FEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQE 550
           FEKPL NITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGI VAVKVLVHGSTL DQE
Sbjct: 528 FEKPLSNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIQVAVKVLVHGSTLIDQE 587

Query: 551 AARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWST 610
           AARELEYLGRIKHPNLVPLTGYC+AGDQRIAIYDYMENGNLQNLLHDLPLG++TTE+WST
Sbjct: 588 AARELEYLGRIKHPNLVPLTGYCLAGDQRIAIYDYMENGNLQNLLHDLPLGIRTTEEWST 647

Query: 611 DTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL 670
           +TWEED  N IQNVG+EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD+KASSVYL
Sbjct: 648 ETWEEDHNNGIQNVGTEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDVKASSVYL 707

Query: 671 DMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE 730
           D NLEPRLSDFGLAKIFGNGLDEEIARGSPGY+PPEF  PD+D PTPKSDVYC+GVVL E
Sbjct: 708 DYNLEPRLSDFGLAKIFGNGLDEEIARGSPGYVPPEFTDPDNDSPTPKSDVYCFGVVLFE 767

Query: 731 LITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLC 790
           LITGK+P+GDDY EEK   LVSWVRGLVR ++GSRAIDPKIR+TGPE++MEEALKIGYLC
Sbjct: 768 LITGKRPIGDDYAEEKNSTLVSWVRGLVRKSEGSRAIDPKIRNTGPEREMEEALKIGYLC 827

Query: 791 TADLPLKRPSMQQIVGLLKDIESTA 815
           TADL  KRPSMQQIVGLLKDIE T 
Sbjct: 828 TADLNSKRPSMQQIVGLLKDIEPTC 852

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224088270|ref|XP_002308399.1| predicted protein [Populus trichocarpa] gi|222854375|gb|EEE91922.1| predicted protein [Populus trichocarpa]

 Score = 1303 bits (3371), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 649/804 (80%), Positives = 717/804 (89%)

Query: 12  SASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD 71
           SAS CSW+GV CD+ K+HV +FLAS  GLSGS+PDTTIGKLSKLQ+LDLS N IT+LPSD
Sbjct: 49  SASVCSWQGVFCDAKKEHVVEFLASGLGLSGSIPDTTIGKLSKLQTLDLSNNKITSLPSD 108

Query: 72  LWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKL 131
           LWSLG+LK LNLS N+ISG LP+NIGNFG LE  DLS+NNFSGEIPAAISSL  LRVLKL
Sbjct: 109 LWSLGTLKVLNLSSNQISGPLPNNIGNFGALETIDLSSNNFSGEIPAAISSLGGLRVLKL 168

Query: 132 DGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH 191
           D N F+ SIP G+L+CQSL  +DLSMN+L+GSLPDGFGAAFPKLK+LNLAGN I+GRD+ 
Sbjct: 169 DRNGFEGSIPSGILSCQSLYFIDLSMNKLDGSLPDGFGAAFPKLKTLNLAGNGIQGRDSD 228

Query: 192 FAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYV 251
           F+ +KSIT+LNISGN FQGSVMGVF E +EV+DL  NQFQGHISQV FNS+YNWSRLVY+
Sbjct: 229 FSLMKSITSLNISGNSFQGSVMGVFQELVEVMDLSKNQFQGHISQVHFNSTYNWSRLVYL 288

Query: 252 DLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIP 311
           DLSENQLSGEIF +FSQA NLK+L+LA+NRFT+++FP+I  L  LE+LNLS+TS+ G IP
Sbjct: 289 DLSENQLSGEIFQDFSQAPNLKYLNLAFNRFTKEDFPRIDMLSELEYLNLSKTSVTGHIP 348

Query: 312 SEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFN 371
           SEI QLSSLHTLDLS NHL+GQIP ++ KNL ++D+SHNNLSGEIP SLL+KLP+ME +N
Sbjct: 349 SEIAQLSSLHTLDLSQNHLSGQIPRLTIKNLQVLDVSHNNLSGEIPVSLLQKLPRMESYN 408

Query: 372 FSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMIC 431
           FSYNNLTLC +E S ET QT F GS + CPIAANP  FKRK  NHKGLKLAL L LS++ 
Sbjct: 409 FSYNNLTLCGTEFSRETFQTHFHGSLDSCPIAANPGLFKRKVTNHKGLKLALGLALSLVF 468

Query: 432 LLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIF 491
           LLAGLL LAFGCRRKPK W VKQTSYKEEQN+SGPFSFQTDSTTWVADVK ANSV VVIF
Sbjct: 469 LLAGLLFLAFGCRRKPKTWEVKQTSYKEEQNISGPFSFQTDSTTWVADVKQANSVPVVIF 528

Query: 492 EKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEA 551
           EKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEA
Sbjct: 529 EKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEA 588

Query: 552 ARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTD 611
           ARELEYLG IKHPNLVPLTGYC+AGDQRIAIYDYMENGNLQNLLHDLPLG+Q TEDWS +
Sbjct: 589 ARELEYLGGIKHPNLVPLTGYCLAGDQRIAIYDYMENGNLQNLLHDLPLGIQITEDWSRE 648

Query: 612 TWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD 671
           TWEED  N IQNVGSEGLLTTWRFRHKIALGTARAL+FLHHGCSPPIIHRD+KASSVYLD
Sbjct: 649 TWEEDDNNGIQNVGSEGLLTTWRFRHKIALGTARALSFLHHGCSPPIIHRDVKASSVYLD 708

Query: 672 MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
            NLEPRLSDFGLA++ GNGLDEEIARGSPGY+PPEF  PD+D PTPKSDVYC+GVVL EL
Sbjct: 709 YNLEPRLSDFGLARVLGNGLDEEIARGSPGYVPPEFTDPDNDSPTPKSDVYCFGVVLFEL 768

Query: 732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCT 791
           IT KKP+GDDYP EK   LVSWVRGLVR ++GSRAIDPKIR+TGPE++MEEALKIGYLCT
Sbjct: 769 ITRKKPIGDDYPGEKNSTLVSWVRGLVRKSQGSRAIDPKIRNTGPEREMEEALKIGYLCT 828

Query: 792 ADLPLKRPSMQQIVGLLKDIESTA 815
           ADLP KRPSMQQIVGLLKDIE T 
Sbjct: 829 ADLPSKRPSMQQIVGLLKDIEPTT 852

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225468025|ref|XP_002271577.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230 [Vitis vinifera]

 Score = 1294 bits (3349), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 636/815 (78%), Positives = 701/815 (86%), Gaps = 1/815 (0%)

Query: 1   MSSKSFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDL 60
           M   S Q   FS  FCSW GV CD+ +++V   +AS  GLSG +PDTTIGKLSKLQSLDL
Sbjct: 38  MGLTSSQVYNFSIPFCSWPGVFCDAKEENVVGLVASGLGLSGLIPDTTIGKLSKLQSLDL 97

Query: 61  SENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAI 120
           S N IT L SD WSLGSLK+LNLS N ISGSLPSNIGNFG+LE+ DLSNNNFSGEIPAAI
Sbjct: 98  SNNKITGLSSDFWSLGSLKALNLSSNLISGSLPSNIGNFGVLEILDLSNNNFSGEIPAAI 157

Query: 121 SSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNL 180
           SSL SL+VLKLD N F+W+IP G+LNCQSLV++DLS N+ NG++PDGFGAAFPK++ LNL
Sbjct: 158 SSLTSLQVLKLDHNGFEWNIPLGILNCQSLVSMDLSFNRFNGTVPDGFGAAFPKIRILNL 217

Query: 181 AGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFN 240
           AGNEI GR + F  LKSIT LNIS N FQGSVM VF E L+VIDL  N FQGHISQV  N
Sbjct: 218 AGNEIHGRVSDFLELKSITVLNISRNQFQGSVMAVFQEPLQVIDLSKNHFQGHISQVHSN 277

Query: 241 SSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLN 300
           SS+NWS L Y+DLSEN LSGEIFH  ++AQNLK+L+LA+NRF+ QEFPQIG L  LE+LN
Sbjct: 278 SSFNWSHLFYLDLSENDLSGEIFHYLNEAQNLKYLNLAHNRFSEQEFPQIGMLFSLEYLN 337

Query: 301 LSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASL 360
           LS T L G IP++I QLSSL+TLDLS NHL+GQ+P  S KNL I D+SHNNLSGEIP SL
Sbjct: 338 LSETRLTGPIPTDISQLSSLNTLDLSKNHLSGQVPLPSIKNLQIFDISHNNLSGEIPLSL 397

Query: 361 LEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLK 420
           LEKLP MERFNFSYNNL+LC+SE S ETLQT+F GS++ CPIAANP+FFK+K   H GLK
Sbjct: 398 LEKLPWMERFNFSYNNLSLCSSEFSQETLQTSFLGSTDSCPIAANPAFFKKKTPRHDGLK 457

Query: 421 LALALTLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADV 480
           LAL LTLSMICL  GLL LAFGCRRK   W VKQ SYKEEQ +SGPFSFQTDSTTWVADV
Sbjct: 458 LALVLTLSMICLFVGLLFLAFGCRRKTTMWAVKQLSYKEEQTISGPFSFQTDSTTWVADV 517

Query: 481 KHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVL 540
           K A SV VVIFEKPLLN TFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVL
Sbjct: 518 KLATSVPVVIFEKPLLNFTFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVL 577

Query: 541 VHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPL 600
           VHG T+TDQEAARELE+LGRIKHPNLVPLTGYC+AGDQRIAIY+YMENGNLQNLLHDLPL
Sbjct: 578 VHGFTMTDQEAARELEHLGRIKHPNLVPLTGYCLAGDQRIAIYEYMENGNLQNLLHDLPL 637

Query: 601 GVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH 660
           GVQTTEDWSTDTWEED  + IQNVGSEGLLTTWRFRHKI LGTARALAFLHHGCSPPIIH
Sbjct: 638 GVQTTEDWSTDTWEEDDNHGIQNVGSEGLLTTWRFRHKIVLGTARALAFLHHGCSPPIIH 697

Query: 661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSD 720
           RD+KASSVYLD NLEPRLSDFGLAKI G+GL+++I+RGS GY+PPE + P+S  PTPKSD
Sbjct: 698 RDVKASSVYLDTNLEPRLSDFGLAKIVGSGLEDDISRGSQGYMPPELSDPESGTPTPKSD 757

Query: 721 VYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQM 780
           VY +GVVLLELITGKKP+GDDYP EKE +LV+WVRGLVR N+GSRAIDPKIR TGP+ QM
Sbjct: 758 VYGFGVVLLELITGKKPIGDDYP-EKESSLVNWVRGLVRKNQGSRAIDPKIRGTGPDAQM 816

Query: 781 EEALKIGYLCTADLPLKRPSMQQIVGLLKDIESTA 815
           EEALKIGYLCTADLP KRPSMQQIVGLLKDIE  A
Sbjct: 817 EEALKIGYLCTADLPSKRPSMQQIVGLLKDIEPVA 851

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356562577|ref|XP_003549546.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Glycine max]

 Score = 1267 bits (3278), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 612/816 (75%), Positives = 702/816 (86%), Gaps = 2/816 (0%)

Query: 1   MSSKSFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDL 60
           M   S Q   FSAS CSW+GV CD+N++HV D + S   LSG++PD TIGKL KLQSLDL
Sbjct: 39  MGLASSQGYNFSASVCSWKGVSCDANREHVVDLVFSGMDLSGTIPDNTIGKLGKLQSLDL 98

Query: 61  SENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAI 120
           S N IT LPSD WSL ++KSLNLS N+ISGSL +NIGNFGLLE  DLS+NNFS EIP A+
Sbjct: 99  SHNKITDLPSDFWSLSTVKSLNLSSNQISGSLTNNIGNFGLLESIDLSSNNFSEEIPEAV 158

Query: 121 SSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNL 180
           SSL+SLRVLKLD N F  +IP G+L CQSLV++D+S NQLNG+LP+GFGAAFPKL+ LNL
Sbjct: 159 SSLLSLRVLKLDQNRFAHNIPSGILKCQSLVSIDVSSNQLNGTLPEGFGAAFPKLRVLNL 218

Query: 181 AGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFN 240
           +GN + G  +  +GLKSI NLNISGN FQGS++ +F   LEV+DL  NQFQGHI QV +N
Sbjct: 219 SGNNMYGHISDISGLKSIVNLNISGNSFQGSIVDLFQGRLEVLDLSRNQFQGHIPQVLYN 278

Query: 241 -SSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHL 299
            SSYNWS LVY+DLSEN+LSG+ F N +++ NLKH++LA+NRF RQ+FPQI  LL LE+L
Sbjct: 279 FSSYNWSHLVYLDLSENKLSGDFFQNLNESLNLKHINLAHNRFARQKFPQIEMLLKLEYL 338

Query: 300 NLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPAS 359
           NLS+TSL G+IP EI Q+S+L  LDLSMNHL+G+IP +  ++L ++D+S+NNL+G +P S
Sbjct: 339 NLSKTSLGGEIPHEISQMSNLSALDLSMNHLSGRIPLLRNEHLQVLDLSNNNLTGVVPPS 398

Query: 360 LLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGL 419
           +LEKLP ME++NFSYNNL+LCASE+ PE LQTAFFGS N CPIAANP  FKR   N KG+
Sbjct: 399 VLEKLPLMEKYNFSYNNLSLCASEIKPEILQTAFFGSLNSCPIAANPRLFKRDTGN-KGM 457

Query: 420 KLALALTLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVAD 479
           KLALALT SMI +LAGLL LAFGCRRK K W  KQTSYKEEQN+SGPFSFQTDSTTWVAD
Sbjct: 458 KLALALTFSMIFVLAGLLFLAFGCRRKTKMWEFKQTSYKEEQNISGPFSFQTDSTTWVAD 517

Query: 480 VKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKV 539
           VK A SV VVIFEKPLLNITFADLL+ATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKV
Sbjct: 518 VKQATSVPVVIFEKPLLNITFADLLAATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKV 577

Query: 540 LVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLP 599
           LV GSTLTD+EAARELE+LGRIKHPNLVPLTGYC+AGDQRIAIYDYMENGNLQNLL+DLP
Sbjct: 578 LVAGSTLTDEEAARELEFLGRIKHPNLVPLTGYCVAGDQRIAIYDYMENGNLQNLLYDLP 637

Query: 600 LGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII 659
           LGVQ+T+DWSTDTWEE   N IQN GSEGLLT+WRFRH+IALGTARALAFLHHGCSPPII
Sbjct: 638 LGVQSTDDWSTDTWEEADNNGIQNAGSEGLLTSWRFRHRIALGTARALAFLHHGCSPPII 697

Query: 660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS 719
           HR +KASSVYLD +LEPRLSDFGLAKIFG+GLD++IARGSPGY+PPEF QP+ D PTPKS
Sbjct: 698 HRAVKASSVYLDYDLEPRLSDFGLAKIFGSGLDDQIARGSPGYVPPEFTQPELDTPTPKS 757

Query: 720 DVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQ 779
           DVYC+GVVL EL+TGKKP+ DDYP++KE  LVSWVRGLVR N+ SRAIDPKIRDTGP++Q
Sbjct: 758 DVYCFGVVLFELVTGKKPIEDDYPDDKEETLVSWVRGLVRKNQASRAIDPKIRDTGPDEQ 817

Query: 780 MEEALKIGYLCTADLPLKRPSMQQIVGLLKDIESTA 815
           +EEALKIGYLCTADLP KRPSMQQIVGLLKDIE T 
Sbjct: 818 IEEALKIGYLCTADLPFKRPSMQQIVGLLKDIEPTG 853

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449519838|ref|XP_004166941.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Cucumis sativus]

 Score = 1255 bits (3248), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 612/805 (76%), Positives = 691/805 (85%), Gaps = 1/805 (0%)

Query: 11  FSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPS 70
           FSA  CSW+GV CD  K +V +F+AS  GLSG++PD T+GKLS+LQSLDLS N IT  P+
Sbjct: 47  FSAPVCSWKGVFCD-KKGNVIEFVASGIGLSGAIPDNTLGKLSRLQSLDLSNNKITGFPT 105

Query: 71  DLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLK 130
           D WSLG LK LNLS N+ISG L  +I NFG LE  D+S NNFSG+IP +ISSL+SLRVLK
Sbjct: 106 DFWSLGLLKRLNLSSNQISGPLGDSICNFGQLESVDISVNNFSGKIPESISSLLSLRVLK 165

Query: 131 LDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT 190
           LD N F  SIP G+LNCQSLV++DLS N+LNGSLP GFGAAFPKL+SLNLAGN I G D+
Sbjct: 166 LDHNRFGESIPSGILNCQSLVSMDLSYNRLNGSLPGGFGAAFPKLESLNLAGNGIHGLDS 225

Query: 191 HFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVY 250
            F+GL ++T LNISGNLFQGSVMG+F E L+V+D+  NQFQG+ISQVQ NSSYNWS L+Y
Sbjct: 226 DFSGLTALTALNISGNLFQGSVMGLFKEQLKVLDVSRNQFQGNISQVQLNSSYNWSHLLY 285

Query: 251 VDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDI 310
           +DLS+N L GEIF+   +AQNLK+L+LAYN+F+  EFP +  L  LE+LNLS++ L   I
Sbjct: 286 LDLSQNHLGGEIFNILEKAQNLKYLNLAYNKFSSLEFPHVSLLSSLEYLNLSKSGLTNHI 345

Query: 311 PSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERF 370
           P  I QLS L+TLD+S NHLTG+IP++S KNL I+D+S NNLSGEIP SLLEKLP MERF
Sbjct: 346 PPGISQLSHLNTLDISQNHLTGRIPSLSVKNLLILDVSQNNLSGEIPLSLLEKLPWMERF 405

Query: 371 NFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMI 430
           NFSYNNLT C S++S +TLQ AF GS+N CPIAANPS F RK + H+ LKLALA+T SMI
Sbjct: 406 NFSYNNLTFCDSKISFKTLQAAFLGSANSCPIAANPSLFVRKPSKHEVLKLALAVTFSMI 465

Query: 431 CLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVI 490
           CLL  ++ LAFGCRRK + WVVKQ SYKEEQN+SGPFSFQTDSTTWVADVK A SV VVI
Sbjct: 466 CLLLAVIFLAFGCRRKSRTWVVKQASYKEEQNISGPFSFQTDSTTWVADVKQATSVSVVI 525

Query: 491 FEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQE 550
           F+KPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLT++E
Sbjct: 526 FQKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTERE 585

Query: 551 AARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWST 610
           AARELEYLGRIKHPNLVPLTGYC+AGDQRIAIYDYMENG LQNLLHDLPLGVQTTEDWST
Sbjct: 586 AARELEYLGRIKHPNLVPLTGYCLAGDQRIAIYDYMENGTLQNLLHDLPLGVQTTEDWST 645

Query: 611 DTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL 670
           DTWEE   N I+NVGSEG+LTTWRFRHKIALGTARALAFLHHGCSPPIIHRD+KASSVYL
Sbjct: 646 DTWEEVDNNGIENVGSEGMLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDVKASSVYL 705

Query: 671 DMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE 730
           D NLEPRLSDFGLAK+FGNGL EEI+RGSPGY PPEF QP++D  TPK+DVYC+GVVL E
Sbjct: 706 DYNLEPRLSDFGLAKVFGNGLSEEISRGSPGYAPPEFLQPENDPVTPKTDVYCFGVVLFE 765

Query: 731 LITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLC 790
           L+TGKKP+GDDYPE KE +LVSWVRGLVR N+G RAIDPKIR TGP+ QMEEALKI YLC
Sbjct: 766 LVTGKKPIGDDYPEGKEADLVSWVRGLVRKNQGLRAIDPKIRGTGPDDQMEEALKIAYLC 825

Query: 791 TADLPLKRPSMQQIVGLLKDIESTA 815
           TADLP KRPSMQQIVGLLKDIE +A
Sbjct: 826 TADLPSKRPSMQQIVGLLKDIEPSA 850

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357480079|ref|XP_003610325.1| Receptor-like protein kinase [Medicago truncatula] gi|355511380|gb|AES92522.1| Receptor-like protein kinase [Medicago truncatula]

 Score = 1249 bits (3232), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 609/807 (75%), Positives = 695/807 (86%), Gaps = 7/807 (0%)

Query: 11  FSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPS 70
           FS+S CSW+GV CDSNK+HV +   S  GL+G +PDTTIGKL+KL SLDLS N IT LPS
Sbjct: 49  FSSSVCSWKGVYCDSNKEHVVELNLSGIGLTGPIPDTTIGKLNKLHSLDLSNNKITTLPS 108

Query: 71  DLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLK 130
           D WSL SLKSLNLS N ISGSL +NIGNFGLLE FDLS N+FS EIP A+SSLVSL+VLK
Sbjct: 109 DFWSLTSLKSLNLSSNHISGSLTNNIGNFGLLENFDLSKNSFSDEIPEALSSLVSLKVLK 168

Query: 131 LDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT 190
           LD NMF  SIP G+L CQSLV++DLS NQL+G+LP GFG AFPKL++LNLA N I G  +
Sbjct: 169 LDHNMFVRSIPSGILKCQSLVSIDLSSNQLSGTLPHGFGDAFPKLRTLNLAENNIYGGVS 228

Query: 191 HFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVY 250
           +F+ LKSI +LNISGN FQGS++ VF+  LE +DL  NQFQGHISQV+    YNWS LVY
Sbjct: 229 NFSRLKSIVSLNISGNSFQGSIIEVFVLKLEALDLSRNQFQGHISQVK----YNWSHLVY 284

Query: 251 VDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDI 310
           +DLSENQLSGEIF N + + NLKHLSLA NRF+RQ+FP+I  LLGLE+LNLS+TSL+G I
Sbjct: 285 LDLSENQLSGEIFQNLNNSMNLKHLSLACNRFSRQKFPKIEMLLGLEYLNLSKTSLVGHI 344

Query: 311 PSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERF 370
           P EI  L +L+ LDLSMNHL G+IP +  K+L +ID SHNNLSG +P+ +L+ LP+M+++
Sbjct: 345 PDEISHLGNLNALDLSMNHLDGKIPLLKNKHLQVIDFSHNNLSGPVPSFILKSLPKMKKY 404

Query: 371 NFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFK-RKAANHKGLKLALALTLSM 429
           NFSYNNLTLCASE+ P+ ++T+FFGS N CPIAANPSFFK R+   H+G+KLAL LTLS+
Sbjct: 405 NFSYNNLTLCASEIKPDIMKTSFFGSVNSCPIAANPSFFKKRRDVGHRGMKLALVLTLSL 464

Query: 430 ICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVV 489
           I  LAG+L LAFGCRRK K W VKQ SY+EEQN+SGPFSFQTDSTTWVADVK A SV VV
Sbjct: 465 IFALAGILFLAFGCRRKNKMWEVKQGSYREEQNISGPFSFQTDSTTWVADVKQATSVPVV 524

Query: 490 IFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQ 549
           IFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPG IHVAVKVLV GSTLTD+
Sbjct: 525 IFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGNIHVAVKVLVVGSTLTDE 584

Query: 550 EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWS 609
           EAARELE+LGRIKHPNLVPLTGYC+AGDQRIAIYDYMENGNLQNLL+DLPLGVQ+T+DWS
Sbjct: 585 EAARELEFLGRIKHPNLVPLTGYCVAGDQRIAIYDYMENGNLQNLLYDLPLGVQSTDDWS 644

Query: 610 TDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY 669
           TDTWEE   N IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR +KASSVY
Sbjct: 645 TDTWEE-ADNGIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRAVKASSVY 703

Query: 670 LDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLL 729
           LD +LEPRLSDFGLAKIFG+GLDEEIARGSPGY+PPEF+QP+ + PTPKSDVYC+GVVL 
Sbjct: 704 LDYDLEPRLSDFGLAKIFGSGLDEEIARGSPGYVPPEFSQPEFESPTPKSDVYCFGVVLF 763

Query: 730 ELITGKKPLGDDYPEEKEG-NLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGY 788
           EL+TGKKP+GDDY ++KE   LVSWVRGLVR N+ SRAIDPKI DTG ++Q+EEALK+GY
Sbjct: 764 ELLTGKKPVGDDYTDDKEATTLVSWVRGLVRKNQTSRAIDPKICDTGSDEQIEEALKVGY 823

Query: 789 LCTADLPLKRPSMQQIVGLLKDIESTA 815
           LCTADLP KRP+MQQIVGLLKDIE T 
Sbjct: 824 LCTADLPFKRPTMQQIVGLLKDIEPTT 850

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356514447|ref|XP_003525917.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Glycine max]

 Score = 1244 bits (3220), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 608/809 (75%), Positives = 692/809 (85%), Gaps = 2/809 (0%)

Query: 9   SYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITAL 68
           ++ SAS CSW GV CD+ ++HV   + S  G+SG VPDTTIGKLSKLQ+LDLS N IT L
Sbjct: 47  NFSSASVCSWHGVSCDAKREHVVGLVFSGMGISGPVPDTTIGKLSKLQALDLSHNKITDL 106

Query: 69  PSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRV 128
           PSD WS G LKSLNLS N+ISGSL +NIGNFGLL+VFDLS+NNFSG+IP AISSL+SL+V
Sbjct: 107 PSDFWSFGLLKSLNLSSNQISGSLTNNIGNFGLLQVFDLSSNNFSGQIPEAISSLMSLKV 166

Query: 129 LKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGR 188
           LKLD N FQ  IP G+L C SLV++DLS NQL+G++PDGFG AFP L SLNL+GN I G 
Sbjct: 167 LKLDHNRFQQRIPSGILKCHSLVSIDLSSNQLSGAVPDGFGDAFPNLISLNLSGNSINGS 226

Query: 189 DTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRL 248
           D   +GLKSI +LNISGN F GSVM +F   LEV+DL  NQF+GHISQV   S+YNWS L
Sbjct: 227 DLDVSGLKSIVSLNISGNSFNGSVMSMFHGRLEVMDLSRNQFEGHISQVHSISNYNWSHL 286

Query: 249 VYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIG 308
           VY+DLSENQL GEIF N ++++NLKHL+LA+NRF+RQ+FP+I  L  LE+LNLS+TSLIG
Sbjct: 287 VYLDLSENQLVGEIFQNLNESKNLKHLNLAHNRFSRQKFPKIEMLSRLEYLNLSKTSLIG 346

Query: 309 DIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQME 368
            IP+EI +LS+L  LD+SMNHL G+IP +S KNL ++D+S+NNLSG++P+S++EKLP ME
Sbjct: 347 YIPAEISKLSNLSALDVSMNHLIGKIPLLSNKNLQVLDLSNNNLSGDVPSSVIEKLPLME 406

Query: 369 RFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLS 428
           ++NFSYNNLT CA E+ P  L TAF GS N CPIAANPS  K++A   KG+KLALALTLS
Sbjct: 407 KYNFSYNNLTFCALEIKPAILLTAFHGSVNSCPIAANPSLLKKRATQDKGMKLALALTLS 466

Query: 429 MICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQV 488
           MICL+AGLL LAFGC +K K W VKQTSYKEE N+SGPFSF TDSTTWVADVK A SV V
Sbjct: 467 MICLVAGLLLLAFGCLKKTKPWPVKQTSYKEEHNMSGPFSFHTDSTTWVADVKQATSVPV 526

Query: 489 VIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTD 548
           VIF+KPLLNITFADLL+ATSNFDRGTLLAEGKFGPVYRGFLPGGI VAVKVLV GSTLTD
Sbjct: 527 VIFDKPLLNITFADLLAATSNFDRGTLLAEGKFGPVYRGFLPGGIQVAVKVLVVGSTLTD 586

Query: 549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGV-QTTED 607
           +EAARELEYLGRIKHPNLVPLTGYC+AGDQRIAIYDYMENGNLQNLL+DLPLGV Q  +D
Sbjct: 587 KEAARELEYLGRIKHPNLVPLTGYCVAGDQRIAIYDYMENGNLQNLLYDLPLGVLQRPDD 646

Query: 608 WSTDTW-EEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS 666
           WSTDTW EED +N I+N GSE +LTTWRFRHKIALGTARALAFLHHGCSPPIIHRD+KAS
Sbjct: 647 WSTDTWEEEDDSNGIRNAGSERVLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDVKAS 706

Query: 667 SVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGV 726
           SVYLD NLEPRLSDFGLAKIFG+GLDEEIA  SPGY PPEF+QP+ D   PKSDVYC+GV
Sbjct: 707 SVYLDYNLEPRLSDFGLAKIFGSGLDEEIALCSPGYAPPEFSQPEFDASVPKSDVYCFGV 766

Query: 727 VLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKI 786
           VL EL+TGKKP+GDDYP+EKE +LVSWVRGLVR NK SRAIDPKIRDTG E QMEEALKI
Sbjct: 767 VLFELLTGKKPVGDDYPDEKEASLVSWVRGLVRKNKASRAIDPKIRDTGAEVQMEEALKI 826

Query: 787 GYLCTADLPLKRPSMQQIVGLLKDIESTA 815
           GYLCTADLP KRPSMQQIVGLLKDI+ +A
Sbjct: 827 GYLCTADLPSKRPSMQQIVGLLKDIKPSA 855

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356498764|ref|XP_003518219.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Glycine max]

 Score = 1217 bits (3149), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 609/816 (74%), Positives = 697/816 (85%), Gaps = 1/816 (0%)

Query: 1   MSSKSFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDL 60
           M   S Q   FSAS CSW+GV CD+N +H+ D + S   LSG++PD TIGKLSKLQSLDL
Sbjct: 38  MGLASSQGYNFSASVCSWQGVSCDANGEHIVDLVFSGMDLSGTMPDNTIGKLSKLQSLDL 97

Query: 61  SENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAI 120
           S N IT LPSD WSL SLKSLNLS N+ISGSL +NIGNFGLLE  DLS+NNFS EIP A+
Sbjct: 98  SHNKITGLPSDFWSLSSLKSLNLSSNQISGSLTNNIGNFGLLESIDLSSNNFSEEIPEAV 157

Query: 121 SSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNL 180
           SSL+SLRVLKLD N F  SIP G+L CQSLV++D+S NQLNG+LP+GFGAAFPKL+ LNL
Sbjct: 158 SSLLSLRVLKLDHNRFAHSIPSGILKCQSLVSIDVSSNQLNGTLPEGFGAAFPKLRVLNL 217

Query: 181 AGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFN 240
           +GN + G  +  +GLKSI NLNISGN FQGS++ VF   LEV+DL  NQFQGHI QV  N
Sbjct: 218 SGNNMYGHVSDISGLKSIVNLNISGNSFQGSIVDVFQGRLEVLDLSRNQFQGHIPQVLHN 277

Query: 241 -SSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHL 299
            SSYNWS LVY+DLSEN LSG+ F N +++ NLKH++LA+NRFT+Q+FPQI  LL LE+L
Sbjct: 278 FSSYNWSHLVYLDLSENNLSGDFFQNLNESLNLKHINLAHNRFTKQKFPQIEILLKLEYL 337

Query: 300 NLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPAS 359
           NLS+TSL+G+IP EILQ+S+L  LDLSMNHL+G+IP +  ++L ++D+S+NNL+G +P S
Sbjct: 338 NLSKTSLVGEIPDEILQMSNLSALDLSMNHLSGKIPLLRNEHLQVLDLSNNNLTGAVPPS 397

Query: 360 LLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGL 419
           +LEKLP ME++NFSYNNL LCASE+ PE L TAFFGS N CPIAANP  FKR+   +KG+
Sbjct: 398 VLEKLPWMEKYNFSYNNLILCASEIKPEILTTAFFGSLNSCPIAANPRLFKRRDTGNKGM 457

Query: 420 KLALALTLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVAD 479
           KLALAL+ SMI +LAGLL LAFG RRK K W  KQTSYKEEQN+SGPFSFQTDSTTWVAD
Sbjct: 458 KLALALSFSMIFVLAGLLFLAFGFRRKTKMWEFKQTSYKEEQNISGPFSFQTDSTTWVAD 517

Query: 480 VKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKV 539
           +K A SV VVIFEKPLLNITFADLL+ATSNFDRGTLLAEGKFGPVYRGFL GG+HVAVKV
Sbjct: 518 IKQATSVPVVIFEKPLLNITFADLLAATSNFDRGTLLAEGKFGPVYRGFLLGGVHVAVKV 577

Query: 540 LVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLP 599
           LV GSTLTD+EAARELE+LGRIKHPNLVPLTGYC+AGDQRIAIYDYMENGNLQNLL+DLP
Sbjct: 578 LVVGSTLTDEEAARELEFLGRIKHPNLVPLTGYCVAGDQRIAIYDYMENGNLQNLLYDLP 637

Query: 600 LGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII 659
           LGVQ+T+DWSTD WEE   N IQN GSEGLLT+WRFRHKIALGTARALAFLHHGCSPPII
Sbjct: 638 LGVQSTDDWSTDAWEEADNNGIQNAGSEGLLTSWRFRHKIALGTARALAFLHHGCSPPII 697

Query: 660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS 719
           HR +KASSVYLD +LEPRLSD GLAKIFG+GLD+EI RGSPGY+PPEF +P+ D PTPKS
Sbjct: 698 HRAVKASSVYLDYDLEPRLSDSGLAKIFGSGLDDEIVRGSPGYVPPEFTRPELDTPTPKS 757

Query: 720 DVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQ 779
           DVYC+GVVL EL+TGK P+GDDYP++KE  LVSWVRGLVR N+ SRAIDPKI DTGP++Q
Sbjct: 758 DVYCFGVVLFELVTGKMPVGDDYPDDKEATLVSWVRGLVRKNQASRAIDPKIHDTGPDEQ 817

Query: 780 MEEALKIGYLCTADLPLKRPSMQQIVGLLKDIESTA 815
           MEEALKIGYLCTADLP KRPSMQQIVGLLKDIE TA
Sbjct: 818 MEEALKIGYLCTADLPFKRPSMQQIVGLLKDIEPTA 853

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449457975|ref|XP_004146723.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like, partial [Cucumis sativus]

 Score = 1167 bits (3019), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 568/753 (75%), Positives = 645/753 (85%), Gaps = 1/753 (0%)

Query: 11  FSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPS 70
           FSA  CSW+GV CD  K +V +F+AS  GLSG++PD T+GKLS+LQSLDLS N IT  P+
Sbjct: 47  FSAPVCSWKGVFCDK-KGNVIEFVASGIGLSGAIPDNTLGKLSRLQSLDLSNNKITGFPT 105

Query: 71  DLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLK 130
           D WSLG LK LNLS N+ISG L  +I NFG LE  D+S NNFSG+IP +ISSL+SLRVLK
Sbjct: 106 DFWSLGLLKRLNLSSNQISGPLGDSICNFGQLESVDISVNNFSGKIPESISSLLSLRVLK 165

Query: 131 LDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT 190
           LD N F  SIP G+LNCQSLV++DLS N+LNGSLP GFGAAFPKL+SLNLAGN I G D+
Sbjct: 166 LDHNRFGESIPSGILNCQSLVSMDLSYNRLNGSLPGGFGAAFPKLESLNLAGNGIHGLDS 225

Query: 191 HFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVY 250
            F+GL ++T LNISGNLFQGSVMG+F E L+V+D+  NQFQG+ISQVQ NSSYNWS L+Y
Sbjct: 226 DFSGLTALTALNISGNLFQGSVMGLFKEQLKVLDVSRNQFQGNISQVQLNSSYNWSHLLY 285

Query: 251 VDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDI 310
           +DLS+N L GEIF+   +AQNLK+L+LAYN+F+  EFP +  L  LE+LNLS++ L   I
Sbjct: 286 LDLSQNHLGGEIFNILEKAQNLKYLNLAYNKFSSLEFPHVSLLSSLEYLNLSKSGLTNHI 345

Query: 311 PSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERF 370
           P  I QLS L+TLD+S NHLTG+IP++S KNL I+D+S NNLSGEIP SLLEKLP MERF
Sbjct: 346 PPGISQLSHLNTLDISQNHLTGRIPSLSVKNLQILDVSQNNLSGEIPLSLLEKLPWMERF 405

Query: 371 NFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMI 430
           NFSYNNLT C S++S +TLQ AF GS+N CPIAANPS F RK + H+ LKLALA+T SMI
Sbjct: 406 NFSYNNLTFCDSKISFKTLQAAFLGSANSCPIAANPSLFVRKPSKHEVLKLALAVTFSMI 465

Query: 431 CLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVI 490
           CLL  ++ LAFGCRRK + WVVKQ SYKEEQN+SGPFSFQTDSTTWVADVK A SV VVI
Sbjct: 466 CLLLAVIFLAFGCRRKSRTWVVKQASYKEEQNISGPFSFQTDSTTWVADVKQATSVSVVI 525

Query: 491 FEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQE 550
           F+KPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLT++E
Sbjct: 526 FQKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTERE 585

Query: 551 AARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWST 610
           AARELEYLGRIKHPNLVPLTGYC+AGDQRIAIYDYMENG LQNLLHDLPLGVQTTEDWST
Sbjct: 586 AARELEYLGRIKHPNLVPLTGYCLAGDQRIAIYDYMENGTLQNLLHDLPLGVQTTEDWST 645

Query: 611 DTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL 670
           DTWEE   N I+NVGSEG+LTTWRFRHKIALGTARALAFLHHGCSPPIIHRD+KASSVYL
Sbjct: 646 DTWEEVDNNGIENVGSEGMLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDVKASSVYL 705

Query: 671 DMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE 730
           D NLEPRLSDFGLAK+FGNGL EEI+RGSPGY PPEF QP++D  TPK+DVYC+GVVL E
Sbjct: 706 DYNLEPRLSDFGLAKVFGNGLSEEISRGSPGYAPPEFLQPENDPVTPKTDVYCFGVVLFE 765

Query: 731 LITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKG 763
           L+TGKKP+GDDYPE KE +LVSWVRGLVR N+G
Sbjct: 766 LVTGKKPIGDDYPEGKEADLVSWVRGLVRKNQG 798

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	815
TAIR|locus:2047530	853	AT2G24230 [Arabidopsis thalian	0.991	0.947	0.708	3.4e-306
TAIR|locus:2161303	785	AT5G58150 [Arabidopsis thalian	0.699	0.726	0.430	2.8e-165
TAIR|locus:2005498	1196	BRI1 "BRASSINOSTEROID INSENSIT	0.671	0.457	0.324	7.1e-101
UNIPROTKB|Q942F3	1121	P0480C01.18-1 "cDNA clone:J033	0.707	0.514	0.315	1.5e-97
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.678	0.463	0.297	2.5e-95
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.668	0.468	0.293	2.7e-89
TAIR|locus:2041150	1143	BRL2 "BRI1-like 2" [Arabidopsi	0.662	0.472	0.306	1.4e-88
UNIPROTKB|Q8RZV7	1294	P0413C03.22 "Putative extra sp	0.660	0.415	0.308	1.8e-87
TAIR|locus:2020457	1166	BRL1 "BRI1 like" [Arabidopsis	0.662	0.463	0.291	4.1e-87
TAIR|locus:2122239	1136	AT4G36180 [Arabidopsis thalian	0.687	0.492	0.316	1.2e-85

TAIR|locus:2047530 AT2G24230 [Arabidopsis thaliana (taxid:3702)]

 Score = 2938 (1039.3 bits), Expect = 3.4e-306, P = 3.4e-306
 Identities = 576/813 (70%), Positives = 654/813 (80%)

Query:     1 MSSKSFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDL 60
             M   S QA  FSA FCSW+G+ CDS  +HV   +AS   LSG +PD TIGKLSKLQSLDL
Sbjct:    40 MGLSSSQAYNFSAPFCSWQGLFCDSKNEHVIMLIASGMSLSGQIPDNTIGKLSKLQSLDL 99

Query:    61 SENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAI 120
             S N I+ALPSD WSL +LK+LNLS+N+ISGS  SN+GNFG LE+ D+S NNFSG IP A+
Sbjct:   100 SNNKISALPSDFWSLNTLKNLNLSFNKISGSFSSNVGNFGQLELLDISYNNFSGAIPEAV 159

Query:   121 SSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNL 180
              SLVSLRVLKLD N FQ SIP GLL CQSLV++DLS NQL GSLPDGFG+AFPKL++L+L
Sbjct:   160 DSLVSLRVLKLDHNGFQMSIPRGLLGCQSLVSIDLSSNQLEGSLPDGFGSAFPKLETLSL 219

Query:   181 AGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFN 240
             AGN+I GRDT FA +KSI+ LNISGN F GSV GVF E+LEV DL  N+FQGHIS  Q +
Sbjct:   220 AGNKIHGRDTDFADMKSISFLNISGNQFDGSVTGVFKETLEVADLSKNRFQGHISS-QVD 278

Query:   241 SSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLN 300
             S  NW  LVY+DLSEN+LSG +  N +  + LKHL+LA+NRF R  FP+I  L GLE+LN
Sbjct:   279 S--NWFSLVYLDLSENELSG-VIKNLTLLKKLKHLNLAWNRFNRGMFPRIEMLSGLEYLN 335

Query:   301 LSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASL 360
             LS T+L G IP EI +LS L TLD+S NHL G IP +S KNL  ID+S NNL+GEIP S+
Sbjct:   336 LSNTNLSGHIPREISKLSDLSTLDVSGNHLAGHIPILSIKNLVAIDVSRNNLTGEIPMSI 395

Query:   361 LEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLK 420
             LEKLP MERFNFS+NNLT C+ + S ETL  +FFGS+N CPIAANP+ FKRK +   GLK
Sbjct:   396 LEKLPWMERFNFSFNNLTFCSGKFSAETLNRSFFGSTNSCPIAANPALFKRKRSVTGGLK 455

Query:   421 LALALTLS-MIXXXXXXXXXXXXXRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVAD 479
             LALA+TLS M              RRK K    K  S KEEQ++SGPFSFQTDSTTWVAD
Sbjct:   456 LALAVTLSTMCLLIGALIFVAFGCRRKTKSGEAKDLSVKEEQSISGPFSFQTDSTTWVAD 515

Query:   480 VKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKV 539
             VK AN+V VVIFEKPLLNITF+DLLSATSNFDR TLLA+GKFGPVYRGFLPGGIHVAVKV
Sbjct:   516 VKQANAVPVVIFEKPLLNITFSDLLSATSNFDRDTLLADGKFGPVYRGFLPGGIHVAVKV 575

Query:   540 LVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLP 599
             LVHGSTL+DQEAARELE+LGRIKHPNLVPLTGYCIAGDQRIAIY+YMENGNLQNLLHDLP
Sbjct:   576 LVHGSTLSDQEAARELEFLGRIKHPNLVPLTGYCIAGDQRIAIYEYMENGNLQNLLHDLP 635

Query:   600 LGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII 659
              GVQ               N  QN+G+EG + TWRFRHKIALGTARALAFLHHGCSPPII
Sbjct:   636 FGVQTTDDWTTDTWEEETDNGTQNIGTEGPVATWRFRHKIALGTARALAFLHHGCSPPII 695

Query:   660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS 719
             HRD+KASSVYLD N EPRLSDFGLAK+FGNGLD+EI  GSPGY+PPEF QP+ + PTPKS
Sbjct:   696 HRDVKASSVYLDQNWEPRLSDFGLAKVFGNGLDDEIIHGSPGYLPPEFLQPEHELPTPKS 755

Query:   720 DVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQ 779
             DVYC+GVVL EL+TGKKP+ DDY +EK+ NLVSWVR LVR N+ S+AIDPKI++TG E+Q
Sbjct:   756 DVYCFGVVLFELMTGKKPIEDDYLDEKDTNLVSWVRSLVRKNQASKAIDPKIQETGSEEQ 815

Query:   780 MEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE 812
             MEEALKIGYLCTADLP KRPSMQQ+VGLLKDIE
Sbjct:   816 MEEALKIGYLCTADLPSKRPSMQQVVGLLKDIE 848

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2161303 AT5G58150 [Arabidopsis thaliana (taxid:3702)]

 Score = 1090 (388.8 bits), Expect = 2.8e-165, Sum P(2) = 2.8e-165
 Identities = 259/601 (43%), Positives = 350/601 (58%)

Query:     8 ASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLS-KLQSLDLSENNIT 66
             A + S+ F + R  + +S + H    L S  G+   V D++   L      LDLS +   
Sbjct:    28 AYHLSSFFSAMR--LPNSPQAHTFSSLCSWPGVV--VCDSSENVLHISASGLDLSGS--- 80

Query:    67 ALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVS 125
              +P + +  +  L++L+LS N+I+ SLPS++ +  LLE  +LS+N  S  +P+ I + +S
Sbjct:    81 -IPDNTIGKMSKLQTLDLSGNKIT-SLPSDLWSLSLLESLNLSSNRISEPLPSNIGNFMS 138

Query:   126 LRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEI 185
             L  L L  N     IP  + N  +L T+ L  N     +P         L S++L+ N +
Sbjct:   139 LHTLDLSFNSISGKIPAAISNLVNLTTLKLHNNDFQFGVPPEL-VHCRSLLSIDLSSNRL 197

Query:   186 K-----GRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFN 240
                   G  + F  LKS   LN+S NLFQGS++GV  E++E +DL  N+F GHI Q+   
Sbjct:   198 NESLPVGFGSAFPLLKS---LNLSRNLFQGSLIGVLHENVETVDLSENRFDGHILQLIPG 254

Query:   241 SSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLN 300
               +NWS L+++DLS+N   G IF+  S A  L HL+LA NRF  QEFP+IG L  L +LN
Sbjct:   255 HKHNWSSLIHLDLSDNSFVGHIFNGLSSAHKLGHLNLACNRFRAQEFPEIGKLSALHYLN 314

Query:   301 LSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASL 360
             LSRT+L   IP EI +LS L  LDLS N+LTG +P +S KN+ ++D+S N L G+IP  L
Sbjct:   315 LSRTNLTNIIPREISRLSHLKVLDLSSNNLTGHVPMLSVKNIEVLDLSLNKLDGDIPRPL 374

Query:   361 LEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHK--G 418
             LEKL  M+RFNFS+NNLT C    S ET+Q +F    N+CP AA P   K K  N K  G
Sbjct:   375 LEKLAMMQRFNFSFNNLTFCNPNFSQETIQRSFINIRNNCPFAAKPIITKGKKVNKKNTG 434

Query:   419 LKLALALTLSM--IXXXXXXXXXXXXXRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTW 476
             LK+ L L +SM  +             RRK + W  K      E N   P   Q DSTT 
Sbjct:   435 LKIGLGLAISMAFLLIGLLLILVALRVRRKSRTWATKLAINNTEPN--SPD--QHDSTT- 489

Query:   477 VADVKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVA 536
               D+K A  + VV+ +KPL+ +T ADL +AT NFDRGT+L EGK GP Y   LPGG   A
Sbjct:   490 --DIKQATQIPVVMIDKPLMKMTLADLKAATFNFDRGTMLWEGKSGPTYGAVLPGGFRAA 547

Query:   537 VKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH 596
             +KV+  G+TLTD E +   E L RI HPNL PL GYCIA +QRIAIY+ ++  NLQ+LLH
Sbjct:   548 LKVIPSGTTLTDTEVSIAFERLARINHPNLFPLCGYCIATEQRIAIYEDLDMVNLQSLLH 607

Query:   597 D 597
             +
Sbjct:   608 N 608

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005773 "vacuole" evidence=IDA

TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 639 (230.0 bits), Expect = 7.1e-101, Sum P(2) = 7.1e-101
 Identities = 192/591 (32%), Positives = 292/591 (49%)

Query:    34 LASNSGLSGSV-PDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISGS 91
             L+SN+  SG + P+      + LQ L L  N  T  +P  L +   L SL+LS+N +SG+
Sbjct:   397 LSSNN-FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGT 455

Query:    92 LPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLV 151
             +PS++G+   L    L  N   GEIP  +  + +L  L LD N     IP GL NC +L 
Sbjct:   456 IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLN 515

Query:   152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGR-DTHFAGLKSITNLNISGNLFQG 210
              + LS N+L G +P   G     L  L L+ N   G         +S+  L+++ NLF G
Sbjct:   516 WISLSNNRLTGEIPKWIGR-LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 574

Query:   211 SV-MGVFLESLEV----------IDLRSNQFQ------GHISQVQFNSSYNWSRLVY--- 250
             ++   +F +S ++          + ++++  +      G++ + Q   S   +RL     
Sbjct:   575 TIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 634

Query:   251 VDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDI 310
              +++     G     F    ++  L ++YN  +     +IG++  L  LNL    + G I
Sbjct:   635 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 694

Query:   311 PSEILQLSSLHTLDLSMNHLTGQIP-TVSAKN-LGIIDMSHNNLSGEIPA-SLLEKLPQM 367
             P E+  L  L+ LDLS N L G+IP  +SA   L  ID+S+NNLSG IP     E  P  
Sbjct:   695 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPA 754

Query:   368 ERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTL 427
              +F    NN  LC   L P          SN    A +     R+ A+  G  +A+ L  
Sbjct:   755 -KF---LNNPGLCGYPL-PRC------DPSNADGYAHHQRSHGRRPASLAG-SVAMGLLF 802

Query:   428 SMIXXXXXXXXXXXXXRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTW-VADVKHANSV 486
             S +             +R+ K+   +   Y E    SG  +   ++T W +  VK A S+
Sbjct:   803 SFVCIFGLILVGREMRKRRRKK-EAELEMYAEGHGNSGDRT--ANNTNWKLTGVKEALSI 859

Query:   487 QVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTL 546
              +  FEKPL  +TFADLL AT+ F   +L+  G FG VY+  L  G  VA+K L+H S  
Sbjct:   860 NLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQ 919

Query:   547 TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHD 597
              D+E   E+E +G+IKH NLVPL GYC  GD+R+ +Y++M+ G+L+++LHD
Sbjct:   920 GDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHD 970

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0042802 "identical protein binding" evidence=IPI

GO:0010224 "response to UV-B" evidence=IGI

GO:0005768 "endosome" evidence=IDA

GO:0046982 "protein heterodimerization activity" evidence=IPI

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0010268 "brassinosteroid homeostasis" evidence=IEP

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0043234 "protein complex" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0009911 "positive regulation of flower development" evidence=IGI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IEP;IMP

GO:0010584 "pollen exine formation" evidence=IMP

GO:0048657 "tapetal cell differentiation" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0005496 "steroid binding" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 623 (224.4 bits), Expect = 1.5e-97, Sum P(2) = 1.5e-97
 Identities = 196/622 (31%), Positives = 304/622 (48%)

Query:     3 SKSFQASYFSASFCSWRGVVCDS--NKQHVTDFLASNSGLSGSVPDTTI-GKLSKLQSLD 59
             +K  Q +  S SF  + G + D+  +   +     S++  SG++P +      SKL  L 
Sbjct:   291 AKLQQLTALSLSFNHFNGSIPDTVASLPELQQLDLSSNTFSGTIPSSLCQDPNSKLHLLY 350

Query:    60 LSENNITA-LPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPA 118
             L  N +T  +P  + +  SL SL+LS N I+GS+P+++G+ G L+   L  N   GEIPA
Sbjct:   351 LQNNYLTGGIPDAVSNCTSLVSLDLSLNYINGSIPASLGDLGNLQDLILWQNELEGEIPA 410

Query:   119 AISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSL 178
             ++S +  L  L LD N    SIPP L  C  L  + L+ N+L+G +P   G     L  L
Sbjct:   411 SLSRIQGLEHLILDYNGLTGSIPPELAKCTKLNWISLASNRLSGPIPSWLGK-LSYLAIL 469

Query:   179 NLAGNEIKGR-DTHFAGLKSITNLNISGNLFQGSV----------MGV-FLESLEVIDLR 226
              L+ N   G         +S+  L+++ N   GS+          M V  +     + LR
Sbjct:   470 KLSNNSFSGPIPPELGDCQSLVWLDLNSNQLNGSIPKELAKQSGKMNVGLIVGRPYVYLR 529

Query:   227 ----SNQFQGHISQVQFNSSY--NWSRLVYVDLSE--NQLSGEIFHNFSQAQNLKHLSLA 278
                 S++ +G  S ++F S    + SR+    L        G   + F++  ++  L L+
Sbjct:   530 NDELSSECRGKGSLLEFTSIRPDDLSRMPSKKLCNFTRMYVGSTEYTFNKNGSMIFLDLS 589

Query:   279 YNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIP-TV 337
             YN+       ++G +  L  +NL    L G IPS + +   L  LDLS N L G IP + 
Sbjct:   590 YNQLDSAIPGELGDMFYLMIMNLGHNLLSGTIPSRLAEAKKLAVLDLSYNQLEGPIPNSF 649

Query:   338 SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSS 397
             SA +L  I++S+N L+G IP   L  L    +  +  NN  LC   L P    +    SS
Sbjct:   650 SALSLSEINLSNNQLNGTIPE--LGSLATFPKSQYE-NNTGLCGFPLPPCDHSSP--RSS 704

Query:   398 NDCPIAANPSFFKRKAANHKGLKLALALTLSMIXXXXXXXXXXXXXRRKPKRWVVKQTSY 457
             ND     + S  +R+A+    + + L  +L  I             RR+ K    ++ S 
Sbjct:   705 ND-----HQSH-RRQASMASSIAMGLLFSLFCIIVIIIAIGSK---RRRLKN---EEAST 752

Query:   458 KEEQNVSGPFSFQTDSTTWVADVKHAN--SVQVVIFEKPLLNITFADLLSATSNFDRGTL 515
               +  +       T ++ W  ++   N  S+ +  FEKPL N+T ADL+ AT+ F     
Sbjct:   753 SRDIYIDSRSHSATMNSDWRQNLSGTNLLSINLAAFEKPLQNLTLADLVEATNGFHIACQ 812

Query:   516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
             +  G FG VY+  L  G  VA+K L+H S   D+E   E+E +G+IKH NLVPL GYC A
Sbjct:   813 IGSGGFGDVYKAQLKDGKVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKA 872

Query:   576 GDQRIAIYDYMENGNLQNLLHD 597
             G++R+ +YDYM+ G+L+++LHD
Sbjct:   873 GEERLLVYDYMKFGSLEDVLHD 894

GO:0001578 "microtubule bundle formation" evidence=IMP

GO:0009647 "skotomorphogenesis" evidence=IMP

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 586 (211.3 bits), Expect = 2.5e-95, Sum P(2) = 2.5e-95
 Identities = 174/585 (29%), Positives = 276/585 (47%)

Query:    34 LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISGSL 92
             L SN+  +G +P + + K + L     S N +   LP+++ +  SLK L LS N+++G +
Sbjct:   431 LDSNN-FTGEIPKS-LWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEI 488

Query:    93 PSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVT 152
             P  IG    L V +L+ N F G+IP  +    SL  L L  N  Q  IP  +     L  
Sbjct:   489 PREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQC 548

Query:   153 VDLSMNQLNGSLPDGFGAAF-----PKLKSL------NLAGNEIKGRDTHFAG-LKSITN 200
             + LS N L+GS+P    A F     P L  L      +L+ N + G      G    +  
Sbjct:   549 LVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVE 608

Query:   201 LNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQL 258
             +++S N   G +      L +L ++DL  N   G I +   NS     +L  ++L+ NQL
Sbjct:   609 ISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSL----KLQGLNLANNQL 664

Query:   259 SGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLS 318
             +G I  +F    +L  L+L  N+        +G L  L H++LS  +L G++ SE+  + 
Sbjct:   665 NGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTME 724

Query:   319 SLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNN 376
              L  L +  N  TG+IP+   +   L  +D+S N LSGEIP  +   LP +E  N + NN
Sbjct:   725 KLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICG-LPNLEFLNLAKNN 783

Query:   377 LT--LCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSMIXXXX 434
             L   + +  +  +  +    G+   C           K    K L+ A  +   M+    
Sbjct:   784 LRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDC---KIEGTK-LRSAWGIAGLMLGFTI 839

Query:   435 XXXXXXXXXRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHAN--SVQVVIFE 492
                      RR      VKQ    E    S    F   +  +++  +     S+ + +FE
Sbjct:   840 IVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFE 899

Query:   493 KPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA 552
             +PLL +   D++ AT +F +  ++ +G FG VY+  LPG   VAVK L    T  ++E  
Sbjct:   900 QPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFM 959

Query:   553 RELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHD 597
              E+E LG++KHPNLV L GYC   ++++ +Y+YM NG+L + L +
Sbjct:   960 AEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRN 1004

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 552 (199.4 bits), Expect = 2.7e-89, Sum P(2) = 2.7e-89
 Identities = 171/583 (29%), Positives = 279/583 (47%)

Query:    34 LASNSGLSGSVPD--TTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISG 90
             L+SN   +G VP    ++   S L+ L ++ N ++  +P +L    SLK+++LS+N ++G
Sbjct:   382 LSSNE-FTGEVPSGFCSLQSSSVLEKLLIANNYLSGTVPVELGKCKSLKTIDLSFNALTG 440

Query:    91 SLPSNIGNFGLLEVFDLSNNNFSGEIPAAIS-SLVSLRVLKLDGNMFQWSIPPGLLNCQS 149
              +P  I     L    +  NN +G IP +I     +L  L L+ N+   S+P  +  C +
Sbjct:   441 LIPKEIWTLPKLSDLVMWANNLTGGIPESICVDGGNLETLILNNNLLTGSLPESISKCTN 500

Query:   150 LVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGR-DTHFAGLKSITNLNISGNLF 208
             ++ + LS N L G +P G G    KL  L L  N + G   +     K++  L+++ N  
Sbjct:   501 MLWISLSSNLLTGEIPVGIGK-LEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNL 559

Query:   209 QGSVMGVFLESLEVIDLRSNQFQGHISQVQF----NSSYNWSRLVYVDLSENQLSGEIFH 264
              G++ G       ++        G +S  QF    N      R     +    +  E   
Sbjct:   560 TGNLPGELASQAGLV------MPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLE 613

Query:   265 NFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLD 324
             +F    +     + Y+  T   F   G+++   +L+LS  ++ G IP     +  L  L+
Sbjct:   614 HFPMVHSCPKTRI-YSGMTMYMFSSNGSMI---YLDLSYNAVSGSIPLGYGAMGYLQVLN 669

Query:   325 LSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT---L 379
             L  N LTG IP      K +G++D+SHN+L G +P SL   L  +   + S NNLT    
Sbjct:   670 LGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSL-GGLSFLSDLDVSNNNLTGPIP 728

Query:   380 CASELSPETLQTAFFGSSNDCPIAANP-SFFKRKAANH---KGLKLALALTLSMIXXXXX 435
                +L+   L T +  +S  C +   P S   R   +H   K   +A  ++  ++     
Sbjct:   729 FGGQLTTFPL-TRYANNSGLCGVPLPPCSSGSRPTRSHAHPKKQSIATGMSAGIVFSFMC 787

Query:   436 XXXXXXXXRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTW-VADVKHANSVQVVIFEKP 494
                      R  K  V K+   +E+   S P S    S++W ++ V    S+ V  FEKP
Sbjct:   788 IVMLIMALYRARK--VQKKEKQREKYIESLPTS---GSSSWKLSSVHEPLSINVATFEKP 842

Query:   495 LLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARE 554
             L  +TFA LL AT+ F   +++  G FG VY+  L  G  VA+K L+  +   D+E   E
Sbjct:   843 LRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAE 902

Query:   555 LEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHD 597
             +E +G+IKH NLVPL GYC  G++R+ +Y+YM+ G+L+ +LH+
Sbjct:   903 METIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHE 945

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2041150 BRL2 "BRI1-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 581 (209.6 bits), Expect = 1.4e-88, Sum P(2) = 1.4e-88
 Identities = 183/598 (30%), Positives = 286/598 (47%)

Query:    30 VTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRI 88
             + DF  S++  SG +P       + L+ L L +N +T  +P  +     L++++LS N +
Sbjct:   354 IADF--SSNRFSGVIPPDLCPGAASLEELRLPDNLVTGEIPPAISQCSELRTIDLSLNYL 411

Query:    89 SGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQ 148
             +G++P  IGN   LE F    NN +GEIP  I  L +L+ L L+ N     IPP   NC 
Sbjct:   412 NGTIPPEIGNLQKLEQFIAWYNNIAGEIPPEIGKLQNLKDLILNNNQLTGEIPPEFFNCS 471

Query:   149 SLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGN----EIK---GRDTHFAGLKSITNL 201
             ++  V  + N+L G +P  FG    +L  L L  N    EI    G+ T    L   TN 
Sbjct:   472 NIEWVSFTSNRLTGEVPKDFGI-LSRLAVLQLGNNNFTGEIPPELGKCTTLVWLDLNTN- 529

Query:   202 NISGNL------FQGS-VMGVFLESLEVIDLRS--NQFQGHISQVQFNSSYNWSRLVYVD 252
             +++G +        GS  +   L    +  +R+  N  +G    V+F S     RL+ + 
Sbjct:   530 HLTGEIPPRLGRQPGSKALSGLLSGNTMAFVRNVGNSCKGVGGLVEF-SGIRPERLLQIP 588

Query:   253 LSEN-----QLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFP-QIGTLLGLEHLNLSRTSL 306
               ++       SG I   F++ Q +++L L+YN+  R + P +IG ++ L+ L LS   L
Sbjct:   589 SLKSCDFTRMYSGPILSLFTRYQTIEYLDLSYNQL-RGKIPDEIGEMIALQVLELSHNQL 647

Query:   307 IGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGI---IDMSHNNLSGEIPA-SLLE 362
              G+IP  I QL +L   D S N L GQIP  S  NL     ID+S+N L+G IP    L 
Sbjct:   648 SGEIPFTIGQLKNLGVFDASDNRLQGQIPE-SFSNLSFLVQIDLSNNELTGPIPQRGQLS 706

Query:   363 KLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLA 422
              LP  +   ++ NN  LC   L PE         +N  P        KR     +    A
Sbjct:   707 TLPATQ---YA-NNPGLCGVPL-PECKN-----GNNQLPAGTEEG--KRAKHGTRAASWA 754

Query:   423 LALTLSMIXXXXXXXXXXXXXRRKPKRWVVK-QTSYKEEQNVSGPFSFQT--DSTTW-VA 478
              ++ L ++                   W +  +   ++  +     S Q    +TTW + 
Sbjct:   755 NSIVLGVLISAASVCILIV--------WAIAVRARRRDADDAKMLHSLQAVNSATTWKIE 806

Query:   479 DVKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVK 538
               K   S+ V  F++ L  + F+ L+ AT+ F   +++  G FG V++  L  G  VA+K
Sbjct:   807 KEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIK 866

Query:   539 VLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH 596
              L+  S   D+E   E+E LG+IKH NLVPL GYC  G++R+ +Y++M+ G+L+ +LH
Sbjct:   867 KLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLH 924

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0010233 "phloem transport" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009734 "auxin mediated signaling pathway" evidence=RCA;IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 560 (202.2 bits), Expect = 1.8e-87, Sum P(2) = 1.8e-87
 Identities = 182/589 (30%), Positives = 280/589 (47%)

Query:    36 SNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISGSLPS 94
             SN+ ++G +P++ IGKLS LQ L +  N +   +P  +  L +L +L+L  NR+SG +P 
Sbjct:   526 SNNEITGPIPES-IGKLSVLQRLHIDNNLLEGPIPQSVGDLRNLTNLSLRGNRLSGIIPL 584

Query:    95 NIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPP----GLLN---- 146
              + N   L   DLS NN +G IP+AIS L  L  L L  N    SIP     G  N    
Sbjct:   585 ALFNCRKLATLDLSYNNLTGNIPSAISHLTLLDSLILSSNQLSGSIPAEICVGFENEAHP 644

Query:   147 ----CQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGR-DTHFAGLKSITNL 201
                  Q    +DLS NQL G +P         +  LNL GN + G        L ++T++
Sbjct:   645 DSEFLQHHGLLDLSYNQLTGQIPTSIKNC-AMVMVLNLQGNLLNGTIPVELGELTNLTSI 703

Query:   202 NISGNLFQGSVM---GVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQL 258
             N+S N F G ++   G  ++ L+ + L +N   G I            ++  +DLS N L
Sbjct:   704 NLSFNEFVGPMLPWSGPLVQ-LQGLILSNNHLDGSIPA---KIGQILPKIAVLDLSSNAL 759

Query:   259 SGEIFHNFSQAQNLKHLSLAYNRFTRQ-EF--PQ----IGTLLGLEHLNLSRTSLIGDIP 311
             +G +  +      L HL ++ N  +   +F  P       TLL     N S     G + 
Sbjct:   760 TGTLPQSLLCNNYLNHLDVSNNHLSGHIQFSCPDGKEYSSTLL---FFNSSSNHFSGSLD 816

Query:   312 SEILQLSSLHTLDLSMNHLTGQIPTVSA--KNLGIIDMSHNNLSGEIPASLLEKLPQMER 369
               I   + L TLD+  N LTG++P+  +   +L  +D+S NNL G IP  +   +  +  
Sbjct:   817 ESISNFTQLSTLDIHNNSLTGRLPSALSDLSSLNYLDLSSNNLYGAIPCGICN-IFGLSF 875

Query:   370 FNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLSM 429
              NFS N + + +  L+ +        ++     A +P    R+A         + + L +
Sbjct:   876 ANFSGNYIDMYS--LA-DCAAGGICSTNGTDHKALHPYHRVRRAITICAFTFVIIIVLVL 932

Query:   430 IXXXXXXXXXXXXXRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVV 489
             +             R +P  +   +++ K +  V  P S  TD        +   S+ + 
Sbjct:   933 LAVYLRRKLV----RSRPLAF---ESASKAKATVE-PTS--TDELLGKKS-REPLSINLA 981

Query:   490 IFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLT-D 548
              FE  LL +T  D+L AT NF +  ++ +G FG VY+  LP G  VA+K L  G     D
Sbjct:   982 TFEHALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGD 1041

Query:   549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHD 597
             +E   E+E +G++KHPNLVPL GYC+ GD+R  IY+YMENG+L+  L +
Sbjct:  1042 REFLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRN 1090

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0009554 "megasporogenesis" evidence=IMP

GO:0009556 "microsporogenesis" evidence=IMP

GO:0048658 "tapetal layer development" evidence=IMP

TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)]

 Score = 534 (193.0 bits), Expect = 4.1e-87, Sum P(2) = 4.1e-87
 Identities = 171/586 (29%), Positives = 277/586 (47%)

Query:    36 SNSGLSGSVPDTTIGKLSK--LQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISGSL 92
             S++G +G+VP       S   L+ + ++ N ++  +P +L    SLK+++LS+N ++G +
Sbjct:   383 SSNGFTGNVPSGFCSLQSSPVLEKILIANNYLSGTVPMELGKCKSLKTIDLSFNELTGPI 442

Query:    93 PSNIGNFGLLEVFDLSNNNFSGEIPAAISSLV-SLRVLKLDGNMFQWSIPPGLLNCQSLV 151
             P  I     L    +  NN +G IP  +     +L  L L+ N+   SIP  +  C +++
Sbjct:   443 PKEIWMLPNLSDLVMWANNLTGTIPEGVCVKGGNLETLILNNNLLTGSIPESISRCTNMI 502

Query:   152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAG-LKSITNLNISGNLFQG 210
              + LS N+L G +P G G    KL  L L  N + G      G  KS+  L+++ N   G
Sbjct:   503 WISLSSNRLTGKIPSGIGN-LSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTG 561

Query:   211 SVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQ 270
              + G       ++        G +S  QF    N       D       G +     +A+
Sbjct:   562 DLPGELASQAGLV------MPGSVSGKQFAFVRNEGG---TDC--RGAGGLVEFEGIRAE 610

Query:   271 NLKHLSLA--------YNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHT 322
              L+ L +         Y+  T   F   G+++   + ++S  ++ G IP     +  L  
Sbjct:   611 RLERLPMVHSCPATRIYSGMTMYTFSANGSMI---YFDISYNAVSGFIPPGYGNMGYLQV 667

Query:   323 LDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT-- 378
             L+L  N +TG IP      K +G++D+SHNNL G +P SL   L  +   + S NNLT  
Sbjct:   668 LNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSL-GSLSFLSDLDVSNNNLTGP 726

Query:   379 -LCASELSPETLQTAFFGSSNDCPIAANP--SFFKRKAAN--H-KGLKLALALTLSMIXX 432
                  +L+   + + +  +S  C +   P  S  +R   +  H K   +A A+   +   
Sbjct:   727 IPFGGQLTTFPV-SRYANNSGLCGVPLRPCGSAPRRPITSRIHAKKQTVATAVIAGIAFS 785

Query:   433 XXXXXXXXXXXRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTW-VADVKHANSVQVVIF 491
                         R  K  V K+   +E+   S P S    S +W ++ V    S+ V  F
Sbjct:   786 FMCFVMLVMALYRVRK--VQKKEQKREKYIESLPTS---GSCSWKLSSVPEPLSINVATF 840

Query:   492 EKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEA 551
             EKPL  +TFA LL AT+ F   T++  G FG VY+  L  G  VA+K L+  +   D+E 
Sbjct:   841 EKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREF 900

Query:   552 ARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHD 597
               E+E +G+IKH NLVPL GYC  G++R+ +Y+YM+ G+L+ +LH+
Sbjct:   901 MAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHE 946

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)]

 Score = 613 (220.8 bits), Expect = 1.2e-85, Sum P(2) = 1.2e-85
 Identities = 186/588 (31%), Positives = 294/588 (50%)

Query:    26 NKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLS 84
             N + + +   +N+ L+G +P   I +   L  LD   N++   +P  L  + +LK L+L 
Sbjct:   354 NLKRLEELKLANNSLTGEIP-VEIKQCGSLDVLDFEGNSLKGQIPEFLGYMKALKVLSLG 412

Query:    85 YNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGL 144
              N  SG +PS++ N   LE  +L  NN +G  P  + +L SL  L L GN F  ++P  +
Sbjct:   413 RNSFSGYVPSSMVNLQQLERLNLGENNLNGSFPVELMALTSLSELDLSGNRFSGAVPVSI 472

Query:   145 LNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGR-DTHFAGLKSITNLNI 203
              N  +L  ++LS N  +G +P   G  F KL +L+L+   + G      +GL ++  + +
Sbjct:   473 SNLSNLSFLNLSGNGFSGEIPASVGNLF-KLTALDLSKQNMSGEVPVELSGLPNVQVIAL 531

Query:   204 SGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRL-VYVDLSENQLSG 260
              GN F G V   F  L SL  ++L SN F G I Q     ++ + RL V + LS+N +SG
Sbjct:   532 QGNNFSGVVPEGFSSLVSLRYVNLSSNSFSGEIPQ-----TFGFLRLLVSLSLSDNHISG 586

Query:   261 EIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSL 320
              I         L+ L L  NR        +  L  L+ L+L + +L G+IP EI Q SSL
Sbjct:   587 SIPPEIGNCSALEVLELRSNRLMGHIPADLSRLPRLKVLDLGQNNLSGEIPPEISQSSSL 646

Query:   321 HTLDLSMNHLTGQIP-TVSA-KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
             ++L L  NHL+G IP + S   NL  +D+S NNL+GEIPASL      +  FN S NNL 
Sbjct:   647 NSLSLDHNHLSGVIPGSFSGLSNLTKMDLSVNNLTGEIPASLALISSNLVYFNVSSNNLK 706

Query:   379 --LCASELSPETLQTAFFGSSNDCPIAANPSFFKRKA-ANHKGLKLALALTLSMIXXXXX 435
               + AS  S     + F G++  C    N       A    K  K+ L + ++ I     
Sbjct:   707 GEIPASLGSRINNTSEFSGNTELCGKPLNRRCESSTAEGKKKKRKMILMIVMAAIGAFLL 766

Query:   436 XXX--XXXXXRRKPKRWVVKQTSYKEEQNVSGPFSF--QTDSTTWVADVKHANSVQVVIF 491
                         K ++ + +Q++  E++   G  S   +  S+T  +  ++    ++V+F
Sbjct:   767 SLFCCFYVYTLLKWRKKLKQQSTTGEKKRSPGRTSAGSRVRSSTSRSSTENGEP-KLVMF 825

Query:   492 EKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEA 551
                   IT A+ + AT  FD   +L+  ++G +++     G+ ++++ L +GS L +   
Sbjct:   826 NN---KITLAETIEATRQFDEENVLSRTRYGLLFKANYNDGMVLSIRRLPNGSLLNENLF 882

Query:   552 ARELEYLGRIKHPNLVPLTGYCIAG--DQRIAIYDYMENGNLQNLLHD 597
              +E E LG++KH N+  L GY  AG  D R+ +YDYM NGNL  LL +
Sbjct:   883 KKEAEVLGKVKHRNITVLRGY-YAGPPDLRLLVYDYMPNGNLSTLLQE 929

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0030244 "cellulose biosynthetic process" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGK9	Y2242_ARATH	2, ., 7, ., 1, 1, ., 1	0.7306	0.9914	0.9472	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pm.C_LG_XVIII000357 hypothetical protein (854 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	815
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-63
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-47
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-36
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-35
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-34
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-34
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-34
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-33
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-29
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-22
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-20
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-19
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-18
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-16
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-16
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-15
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-13
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-13
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-12
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-12
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-11
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-11
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-11
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-11
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-10
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-10
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-10
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-10
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-09
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-09
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-09
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-08
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-08
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-08
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-08
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-08
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-07
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-07
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-07
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-07
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-07
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	7e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-07
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-06
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-06
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-06
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-05
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-05
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-05
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-05
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-05
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-05
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-05
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-05
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-05
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-05
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	8e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-05
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-04
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-04
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-04
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-04
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-04
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-04
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-04
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-04
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	4e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-04
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.001
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	0.001
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	0.001
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	0.001
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	0.002
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	0.002
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.002
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.002
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	0.002
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.003
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.003
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	0.003
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.003
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	0.004
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	0.004
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  228 bits (583), Expect = 6e-63
 Identities = 227/795 (28%), Positives = 337/795 (42%), Gaps = 151/795 (18%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISGSLPS 94
           S++ LSG +P+  I +L  L+ L L  NN T  +P  L SL  L+ L L  N+ SG +P 
Sbjct: 292 SDNSLSGEIPELVI-QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350

Query: 95  NIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVD 154
           N+G    L V DLS NN +GEIP  + S  +L  L L  N  +  IP  L  C+SL  V 
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR 410

Query: 155 LSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMG 214
           L  N  +G LP  F     KL  +                      L+IS N  QG +  
Sbjct: 411 LQDNSFSGELPSEF----TKLPLVYF--------------------LDISNNNLQGRINS 446

Query: 215 VFLE--SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNL 272
              +  SL+++ L  N+F G +       S+   RL  +DLS NQ SG +          
Sbjct: 447 RKWDMPSLQMLSLARNKFFGGLPD-----SFGSKRLENLDLSRNQFSGAVPRKL------ 495

Query: 273 KHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTG 332
                             G+L  L  L LS   L G+IP E+     L +LDLS N L+G
Sbjct: 496 ------------------GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSG 537

Query: 333 QIPTVSAKN--LGIIDMSHNNLSGEIPASL--LEKLPQMERFNFSYNNLTLCASELSPET 388
           QIP   ++   L  +D+S N LSGEIP +L  +E L Q+   N S+N+L      L    
Sbjct: 538 QIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQV---NISHNHL---HGSLPS-- 589

Query: 389 LQTAFFGSSNDCPIAANPSFFKRKAANHKGLKLALALTLS------MICLLAGLLCLAFG 442
             T  F + N   +A N         +  GL     +  +      + C L   L LA  
Sbjct: 590 --TGAFLAINASAVAGNIDLCGGDTTS--GLPPCKRVRKTPSWWFYITCTLGAFLVLAL- 644

Query: 443 CRRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIFEKPLLNITFAD 502
                   V     +   +N       + +  TW  +++  +S       K   +IT  D
Sbjct: 645 --------VAFGFVFIRGRNNLELKRVENEDGTW--ELQFFDS-------KVSKSITIND 687

Query: 503 LLSATSNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI 561
           +LS+        +++ GK G  Y+G  +  G+   VK +   +++   E A     +G++
Sbjct: 688 ILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKL 740

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           +HPN+V L G C +      I++Y+E  NL  +L +L                       
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL----------------------- 777

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                     +W  R KIA+G A+AL FLH  CSP ++  ++    + +D   EP L   
Sbjct: 778 ----------SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
            L  +        I   S  Y+ PE    ++   T KSD+Y +G++L+EL+TGK P   D
Sbjct: 827 SLPGLLCTDTKCFI---SSAYVAPE--TRETKDITEKSDIYGFGLILIELLTGKSP--AD 879

Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGP--EKQMEEALKIGYLCTADLPLKRP 799
                 G++V W R    +      IDP IR      + ++ E + +   CTA  P  RP
Sbjct: 880 AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939

Query: 800 SMQQIVGLLKDIEST 814
               +   LK +ES 
Sbjct: 940 CANDV---LKTLESA 951

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  181 bits (462), Expect = 2e-47
 Identities = 136/392 (34%), Positives = 198/392 (50%), Gaps = 22/392 (5%)

Query: 12  SASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-LPS 70
           SA  C W+G+ C +N   V     S   +SG +       L  +Q+++LS N ++  +P 
Sbjct: 54  SADVCLWQGITC-NNSSRVVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPD 111

Query: 71  DLWSLG-SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVL 129
           D+++   SL+ LNLS N  +GS+P   G+   LE  DLSNN  SGEIP  I S  SL+VL
Sbjct: 112 DIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVL 169

Query: 130 KLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGR- 188
            L GN+    IP  L N  SL  + L+ NQL G +P   G     LK + L  N + G  
Sbjct: 170 DLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG-QMKSLKWIYLGYNNLSGEI 228

Query: 189 DTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWS 246
                GL S+ +L++  N   G +      L++L+ + L  N+  G I      S ++  
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP----PSIFSLQ 284

Query: 247 RLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSL 306
           +L+ +DLS+N LSGEI     Q QNL+ L L  N FT +    + +L  L+ L L     
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344

Query: 307 IGDIPSEILQLSSLHTLDLSMNHLTGQIPT--VSAKNLGIIDMSHNNLSGEIPASLLEKL 364
            G+IP  + + ++L  LDLS N+LTG+IP    S+ NL  + +  N+L GEIP S L   
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS-LGAC 403

Query: 365 PQMERFNFSYNNLTLCASELSPE--TLQTAFF 394
             + R     N+ +    EL  E   L   +F
Sbjct: 404 RSLRRVRLQDNSFS---GELPSEFTKLPLVYF 432

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  146 bits (370), Expect = 5e-36
 Identities = 110/354 (31%), Positives = 172/354 (48%), Gaps = 17/354 (4%)

Query: 40  LSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISGSLPSNIGN 98
           L G +P  ++  L+ L+ L L+ N +   +P +L  + SLK + L YN +SG +P  IG 
Sbjct: 176 LVGKIP-NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG 234

Query: 99  FGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMN 158
              L   DL  NN +G IP+++ +L +L+ L L  N     IPP + + Q L+++DLS N
Sbjct: 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294

Query: 159 QLNGSLPDGFGAAFPKLKSLNLAGNEIKGR-DTHFAGLKSITNLNISGNLFQGSV---MG 214
            L+G +P+        L+ L+L  N   G+       L  +  L +  N F G +   +G
Sbjct: 295 SLSGEIPE-LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG 353

Query: 215 VFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKH 274
               +L V+DL +N   G I +   +S      L  + L  N L GEI  +    ++L+ 
Sbjct: 354 KH-NNLTVLDLSTNNLTGEIPEGLCSS----GNLFKLILFSNSLEGEIPKSLGACRSLRR 408

Query: 275 LSLAYNRFTRQEFPQIGTLLGLEH-LNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQ 333
           + L  N F+  E P   T L L + L++S  +L G I S    + SL  L L+ N   G 
Sbjct: 409 VRLQDNSFS-GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467

Query: 334 IPTVS-AKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT-LCASELS 385
           +P    +K L  +D+S N  SG +P  L   L ++ +   S N L+     ELS
Sbjct: 468 LPDSFGSKRLENLDLSRNQFSGAVPRKLG-SLSELMQLKLSENKLSGEIPDELS 520

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  131 bits (333), Expect = 6e-35
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 37/220 (16%)

Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTD-QEAARELEYLGRIKHPNLVPLTGYC 573
           L EG FG VY       G  VA+K++    + +  +E  RE+E L ++ HPN+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 574 IAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTW 633
              +    + +Y E G+L++LL +    +                             + 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKL-----------------------------SE 91

Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD-MNLEPRLSDFGLAKIFGNGLD 692
               +I L     L +LH   S  IIHRD+K  ++ LD  N + +L+DFGL+K+  +   
Sbjct: 92  DEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148

Query: 693 EEI-ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
                 G+P Y+ PE       + + KSD++  GV+L EL
Sbjct: 149 LLKTIVGTPAYMAPEVLLGKGYY-SEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  131 bits (332), Expect = 3e-34
 Identities = 81/308 (26%), Positives = 129/308 (41%), Gaps = 71/308 (23%)

Query: 516 LAEGKFGPVYRGFLPGGIH-----VAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPL 569
           L EG FG VY+G L G        VAVK L   ++    E   RE   + ++ HPN+V L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL 629
            G C   +  + + +YM  G+L + L                              +   
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRK----------------------------NRPK 98

Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
             +       AL  AR + +L    S   IHRD+ A +  +  NL  ++SDFGL++   +
Sbjct: 99  ELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR---D 152

Query: 690 GLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
             D++  +   G +P     PE  + +  F T KSDV+ +GV+L E+ T G++P    YP
Sbjct: 153 LYDDDYYKVKGGKLPIRWMAPESLK-EGKF-TSKSDVWSFGVLLWEIFTLGEEP----YP 206

Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPE---KQMEEALKIGYLCTADLPLKRPS 800
                 ++ +++      KG R          P    K M +       C A+ P  RP+
Sbjct: 207 GMSNAEVLEYLK------KGYR---LPKPPNCPPELYKLMLQ-------CWAEDPEDRPT 250

Query: 801 MQQIVGLL 808
             ++V +L
Sbjct: 251 FSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  130 bits (330), Expect = 6e-34
 Identities = 82/306 (26%), Positives = 136/306 (44%), Gaps = 58/306 (18%)

Query: 516 LAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPLT 570
           L EG FG VY+G L G       VAVK L   ++  +++   +E   + ++ HPN+V L 
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
           G C   +    + +YME G+L + L                +     +     +  + LL
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLR--------------KSRPVFPSPEKSTLSLKDLL 108

Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
                    A+  A+ + +L    S   +HRD+ A +  +  +L  ++SDFGL++   + 
Sbjct: 109 -------SFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR---DV 155

Query: 691 LDEEIAR-GSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
            D++  R  + G +P     PE  + D  F T KSDV+ +GV+L E+ T G  P    YP
Sbjct: 156 YDDDYYRKKTGGKLPIRWMAPESLK-DGIF-TSKSDVWSFGVLLWEIFTLGATP----YP 209

Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
                 ++ ++R      KG R   PK     PE   +E  ++   C    P  RP+  +
Sbjct: 210 GLSNEEVLEYLR------KGYRL--PK-----PEYCPDELYELMLSCWQLDPEDRPTFSE 256

Query: 804 IVGLLK 809
           +V  L+
Sbjct: 257 LVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  130 bits (329), Expect = 6e-34
 Identities = 87/301 (28%), Positives = 123/301 (40%), Gaps = 51/301 (16%)

Query: 510 FDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVL--VHGSTLTDQEAARELEYLGRIKHPNL 566
           ++    L  G FG VY+    G G  VAVK+L      +  DQ A RE+  L R+ HPN+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 567 VPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
           V L       D    + +Y E G+L + L                               
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS-----------------------------R 91

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
            G L+    + KIAL   R L +LH   S  IIHRD+K  ++ LD N   +++DFGLAK 
Sbjct: 92  GGPLSEDEAK-KIALQILRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKK 147

Query: 687 F-GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
              +        G+P Y+ PE     + +  PK DV+  GV+L EL+TGK P    +  E
Sbjct: 148 LLKSSSSLTTFVGTPWYMAPEVLLGGNGY-GPKVDVWSLGVILYELLTGKPP----FSGE 202

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK-IGYLCTADLPLKRPSMQQI 804
              +       L    +                  EEA   I      D P KRP+ ++I
Sbjct: 203 NILD------QLQLIRRILGPPLEFDEPKWSSG-SEEAKDLIKKCLNKD-PSKRPTAEEI 254

Query: 805 V 805
           +
Sbjct: 255 L 255

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  128 bits (324), Expect = 3e-33
 Identities = 82/308 (26%), Positives = 128/308 (41%), Gaps = 72/308 (23%)

Query: 516 LAEGKFGPVYRGFLPGGIH-----VAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPL 569
           L EG FG VY+G L G        VAVK L   ++    E   RE   + ++ HPN+V L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL 629
            G C   +    + +YME G+L + L                              +   
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRK----------------------------NRPK 98

Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
           L+        AL  AR + +L    S   IHRD+ A +  +  NL  ++SDFGL++   +
Sbjct: 99  LSL-SDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR---D 151

Query: 690 GLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
             D++  R   G +P     PE  + +  F T KSDV+ +GV+L E+ T G++P    YP
Sbjct: 152 LYDDDYYRKRGGKLPIRWMAPESLK-EGKF-TSKSDVWSFGVLLWEIFTLGEQP----YP 205

Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPE---KQMEEALKIGYLCTADLPLKRPS 800
                 ++ +++       G R          P      M +       C A+ P  RP+
Sbjct: 206 GMSNEEVLEYLK------NGYR---LPQPPNCPPELYDLMLQ-------CWAEDPEDRPT 249

Query: 801 MQQIVGLL 808
             ++V +L
Sbjct: 250 FSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  117 bits (296), Expect = 2e-29
 Identities = 83/306 (27%), Positives = 132/306 (43%), Gaps = 67/306 (21%)

Query: 516 LAEGKFGPVYRGFL-----PGGIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPL 569
           L EG FG VY+G L          VAVK L  G++  ++E    E   + ++ HPN+V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL 629
            G C  G+    + +YM  G+L + L                          + +  + L
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG----------------------EKLTLKDL 104

Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IFG 688
           L       ++AL  A+ + +L    S   +HRD+ A +  +  NL  ++SDFGL++ I+ 
Sbjct: 105 L-------QMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE 154

Query: 689 NGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
              D+   +   G +P     PE  + D  F T KSDV+ +GV+L E+ T G++P     
Sbjct: 155 ---DDYYRKRGGGKLPIKWMAPESLK-DGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMS 209

Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
            EE        V  L+ +           R   PE   +E  ++   C A  P  RP+  
Sbjct: 210 NEE--------VLELLEDGY---------RLPRPENCPDELYELMLQCWAYDPEDRPTFS 252

Query: 803 QIVGLL 808
           ++V  L
Sbjct: 253 ELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  112 bits (282), Expect = 1e-27
 Identities = 80/302 (26%), Positives = 118/302 (39%), Gaps = 61/302 (20%)

Query: 510 FDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEAA-RELEYLGRIKHPNLV 567
           ++    L EG FG VY       G  VA+KV+       D+E   RE++ L ++KHPN+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L       D+   + +Y E G+L +LL                                
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLK-----------------------------KR 91

Query: 628 GLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           G L+    R         AL +LH  G    I+HRD+K  ++ LD +   +L+DFGLA+ 
Sbjct: 92  GRLSEDEARF-YLRQILSALEYLHSKG----IVHRDLKPENILLDEDGHVKLADFGLARQ 146

Query: 687 FGNG--LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE 744
              G  L   +  G+P Y+ PE             D++  GV+L EL+TGK P   D   
Sbjct: 147 LDPGEKLTTFV--GTPEYMAPEVLLGKG--YGKAVDIWSLGVILYELLTGKPPFPGDDQL 202

Query: 745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK--IGYLCTADLPLKRPSMQ 802
            +    +                 PK     PE  +    K  I  L   D P KR + +
Sbjct: 203 LELFKKI---------------GKPKPPFPPPEWDISPEAKDLIRKLLVKD-PEKRLTAE 246

Query: 803 QI 804
           + 
Sbjct: 247 EA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 59/304 (19%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVP 568
           F+    + +G FG VY+      G  VA+KV+   S    ++   E++ L + KHPN+V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
             G  +  D+   + ++   G+L++LL         TE              I       
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT--LTESQ------------IA------ 101

Query: 629 LLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
                     +     + L +LH +G    IIHRDIKA+++ L  + E +L DFGL+   
Sbjct: 102 ---------YVCKELLKGLEYLHSNG----IIHRDIKAANILLTSDGEVKLIDFGLSAQL 148

Query: 688 GNGLDEEIARGSPGYIPPE--FAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
            +        G+P ++ PE    +P       K+D++  G+  +EL  GK P  +  P  
Sbjct: 149 SDTKARNTMVGTPYWMAPEVINGKPYD----YKADIWSLGITAIELAEGKPPYSELPP-- 202

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
                   ++ L +         P +R+  PEK  +E       C    P KRP+ +Q  
Sbjct: 203 --------MKALFKIATNGP---PGLRN--PEKWSDEFKDFLKKCLQKNPEKRPTAEQ-- 247

Query: 806 GLLK 809
            LLK
Sbjct: 248 -LLK 250

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 99.0 bits (245), Expect = 4e-22
 Identities = 70/310 (22%), Positives = 115/310 (37%), Gaps = 50/310 (16%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIKHP- 564
           ++     L EG FG VY         VA+KVL        +E     RE++ L  + HP 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
           N+V L  +         + +Y++ G+L++LL  +      +E  +               
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL-------------- 104

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNL-EPRLSDFGL 683
                         I      AL +LH      IIHRDIK  ++ LD +    +L DFGL
Sbjct: 105 -------------FILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGL 148

Query: 684 AKIFGNGLDEEIAR-------GSPGYIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGK 735
           AK+  +               G+PGY+ PE        + +  SD++  G+ L EL+TG 
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
            P   +         +  +         + ++   +  + PE   + A  +     A  P
Sbjct: 209 PPFEGEKNSSATSQTLKIIL-----ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDP 263

Query: 796 LKRPSMQQIV 805
             R S    +
Sbjct: 264 KNRLSSSSDL 273

Length = 384

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 91.8 bits (229), Expect = 1e-20
 Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 47/242 (19%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLP--GGIHVAVK-VLVHGSTLTDQEA-ARELEYLGRIKHP 564
            + RG LL  G FG VY       G + +AVK V + G +  + EA  RE+  L  ++HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGEL-MAVKSVELSGDSEEELEALEREIRILSSLQHP 59

Query: 565 NLVPLTGYCIAGDQR-IAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           N+V   G     ++  + I+ +Y+  G+L +LL                           
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-------------------------- 93

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             G        ++  +I  G    LA+LH +G    I+HRDIK +++ +D +   +L+DF
Sbjct: 94  KFGKLPEPVIRKYTRQILEG----LAYLHSNG----IVHRDIKGANILVDSDGVVKLADF 145

Query: 682 GLAKIFGNGLDEEI---ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G AK  G+    E     RG+P ++ PE  + +       +D++  G  ++E+ TGK P 
Sbjct: 146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY--GRAADIWSLGCTVIEMATGKPPW 203

Query: 739 GD 740
            +
Sbjct: 204 SE 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 41/236 (17%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVL-VHGSTLTDQEAARELEYLGRIKHPN 565
           S+ +R  +L +G  G VY+    P G   A+K + V G     ++  REL+ L   + P 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 566 LVPLTG-YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
           +V   G +   G+  I + +YM+ G+L +LL  +                E     I   
Sbjct: 61  VVKCYGAFYKEGEISIVL-EYMDGGSLADLLKKVG------------KIPEPVLAYIA-- 105

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
                        +I  G    L +LH      IIHRDIK S++ ++   E +++DFG++
Sbjct: 106 ------------RQILKG----LDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGIS 147

Query: 685 KIFGNGLDEEI-ARGSPGYIPPEFAQPDSD-FPTPKSDVYCYGVVLLELITGKKPL 738
           K+  N LD+     G+  Y+ PE  Q +S  +    +D++  G+ LLE   GK P 
Sbjct: 148 KVLENTLDQCNTFVGTVTYMSPERIQGESYSYA---ADIWSLGLTLLECALGKFPF 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 73/311 (23%), Positives = 134/311 (43%), Gaps = 47/311 (15%)

Query: 509 NFDRGTLLAEGKFGPVYRGF------LPGGIHVAVKVLVHGSTLTDQEAA-RELEYLGRI 561
           N   G  L EG+FG V +          G   VAVK+L   ++ ++      E   L ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDL----PLGVQTTEDWSTDTWEEDG 617
            HP+++ L G C      + I +Y + G+L++ L +     P  + +  + ++   +   
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
             ++  +G   L++        A   +R + +L       ++HRD+ A +V +    + +
Sbjct: 121 ERAL-TMGD--LIS-------FAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMK 167

Query: 678 LSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT- 733
           +SDFGL++      ++   + S G IP ++   +S F    T +SDV+ +GV+L E++T 
Sbjct: 168 ISDFGLSRDVYE--EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 225

Query: 734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTAD 793
           G  P    YP      L + ++   R  +             PE   EE   +   C   
Sbjct: 226 GGNP----YPGIAPERLFNLLKTGYRMER-------------PENCSEEMYNLMLTCWKQ 268

Query: 794 LPLKRPSMQQI 804
            P KRP+   I
Sbjct: 269 EPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 41/227 (18%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G FG V+ G     + VA+K+L     L  Q+  +E++ L R++H +L+ L   C  
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRF 635
           G+    I + ME G+L   L   P G                    Q +    L+     
Sbjct: 74  GEPVYIITELMEKGSLLAFLRS-PEG--------------------QVLPVASLI----- 107

Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
              +A   A  +A+L        IHRD+ A ++ +  +L  +++DFGLA++    + E++
Sbjct: 108 --DMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARL----IKEDV 158

Query: 696 ARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKP 737
              S   IP ++  P++     F T KSDV+ +G++L E+ T G+ P
Sbjct: 159 YLSSDKKIPYKWTAPEAASHGTFST-KSDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.6 bits (217), Expect = 4e-19
 Identities = 68/241 (28%), Positives = 102/241 (42%), Gaps = 43/241 (17%)

Query: 516 LAEGKFGPVYRGFLPGGIHV-AVKV--LVHGSTLTDQEAARELEYLGRIKHPNLVPLTGY 572
           + +G FG V++        V A+K   L   +    +EA  E   L ++    ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 573 CIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTT 632
            +   +   + +Y ENG+L  LL  +  G    ED                         
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLK-MQRGRPLPED-----------------------QV 103

Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG-NGL 691
           WRF  +I LG    LA LH   S  I+HRDIK+ +++LD     ++ D G+AK+   N  
Sbjct: 104 WRFFIQILLG----LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156

Query: 692 DEEIARGSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
                 G+P Y+ PE  +   D P   KSDV+  GVVL E  TGK P    +    +G L
Sbjct: 157 FANTIVGTPYYLSPELCE---DKPYNEKSDVWALGVVLYECCTGKHP----FDANNQGAL 209

Query: 751 V 751
           +
Sbjct: 210 I 210

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 80/295 (27%), Positives = 120/295 (40%), Gaps = 55/295 (18%)

Query: 511 DRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLT 570
             G  + +G+FG V  G   G   VAVK L   ST      A E   +  ++HPNLV L 
Sbjct: 9   KLGATIGKGEFGDVMLGDYRGQ-KVAVKCLKDDSTAAQAFLA-EASVMTTLRHPNLVQLL 66

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
           G  + G+    + +YM  G+L + L      V T                          
Sbjct: 67  GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQ----------------------- 103

Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
                +   AL     + +L        +HRD+ A +V +  +L  ++SDFGLAK    G
Sbjct: 104 -----QLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155

Query: 691 LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGN 749
            D    +    +  PE A  +  F T KSDV+ +G++L E+ + G+ P    YP     +
Sbjct: 156 QD--SGKLPVKWTAPE-ALREKKFST-KSDVWSFGILLWEIYSFGRVP----YPRIPLKD 207

Query: 750 LVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +V  V       KG R ++       PE    E  K+   C    P KRP+ +Q+
Sbjct: 208 VVPHVE------KGYR-MEA------PEGCPPEVYKVMKDCWELDPAKRPTFKQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 67/236 (28%), Positives = 108/236 (45%), Gaps = 47/236 (19%)

Query: 516 LAEGKFGPVYRGFL--PGG--IHVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVPLT 570
           +  G+FG V RG L  PG   I VA+K L  GS+   + +   E   +G+  HPN++ L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS-IQNVGSEGL 629
           G        + I +YMENG+L   L                  E DG  +  Q VG    
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLR-----------------ENDGKFTVGQLVG---- 110

Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
                    +  G A  + +L        +HRD+ A ++ ++ NL  ++SDFGL++   +
Sbjct: 111 ---------MLRGIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLED 158

Query: 690 GLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGD 740
                  +G  G IP  +  P++     F T  SDV+ +G+V+ E+++ G++P  D
Sbjct: 159 SEATYTTKG--GKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 83.8 bits (208), Expect = 6e-18
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 51/242 (21%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA-----RELEYLGRIK 562
           N+  G L+  G FG VY+G  L  G  VA+K +   S    +E A     +E++ L  +K
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQI---SLEKIKEEALKSIMQEIDLLKNLK 57

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH---DLPLGVQTTEDWSTDTWEEDGTN 619
           HPN+V   G     D    I +Y ENG+L+ ++      P                    
Sbjct: 58  HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-------------------- 97

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                  E L+    + +++  G    LA+LH      +IHRDIKA+++    +   +L+
Sbjct: 98  -------ESLVA--VYVYQVLQG----LAYLH---EQGVIHRDIKAANILTTKDGVVKLA 141

Query: 680 DFGLA-KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           DFG+A K+     D+    G+P ++ PE  +      +  SD++  G  ++EL+TG  P 
Sbjct: 142 DFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG--ASTASDIWSLGCTVIELLTGNPPY 199

Query: 739 GD 740
            D
Sbjct: 200 YD 201

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 45/233 (19%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G   G   VAVK L  G T++ +   +E + + +++H  LV L   C  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRF 635
            +    + +YM  G+L + L                    +G    + +    L+     
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKS-----------------GEG----KKLRLPQLVD---M 108

Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
             +IA G    +A+L    S   IHRD+ A ++ +  NL  +++DFGLA++  +  DE  
Sbjct: 109 AAQIAEG----MAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIED--DEYT 159

Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
           AR      P ++  P+      F T KSDV+ +G++L E++T G+ P    YP
Sbjct: 160 AREG-AKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVP----YP 206

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 83.7 bits (207), Expect = 2e-17
 Identities = 88/316 (27%), Positives = 127/316 (40%), Gaps = 65/316 (20%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPGGIH------VAVKVLVHGSTLTDQEA-ARELE---YL 558
           N   G  L  G FG V      G         VAVK+L   +  +++EA   EL+   +L
Sbjct: 36  NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95

Query: 559 GRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGT 618
           G   H N+V L G C  G   + I +Y   G+L N L                       
Sbjct: 96  G--NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--------------------- 132

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRL 678
                   E  LT        +   A+ +AFL    S   IHRD+ A +V L      ++
Sbjct: 133 ------KRESFLTLEDLLS-FSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKI 182

Query: 679 SDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-G 734
            DFGLA+   N     + +G+   +P ++  P+S F    T +SDV+ YG++L E+ + G
Sbjct: 183 CDFGLARDIMND-SNYVVKGN-ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG 240

Query: 735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL 794
             P    YP            G+  ++K  + I    R   PE    E   I   C    
Sbjct: 241 SNP----YP------------GMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDAD 284

Query: 795 PLKRPSMQQIVGLLKD 810
           PLKRP+ +QIV L+  
Sbjct: 285 PLKRPTFKQIVQLIGK 300

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 68/238 (28%), Positives = 102/238 (42%), Gaps = 42/238 (17%)

Query: 516 LAEGKFGPVYRG----FLPGG--IHVAVKVLVHGSTLTDQEA--ARELEYLGRIKHPNLV 567
           L EG FG V+ G      P      VAVK L   +   D      RE E L   +H N+V
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNFQHENIV 71

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
              G C  GD  I +++YME+G+L   L  H                   D         
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHG-----------------PDAAFLKSPDS 114

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
             G LT  +   +IA+  A  + +L    S   +HRD+   +  +  +L  ++ DFG+++
Sbjct: 115 PMGELTLSQL-LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Query: 686 -IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKP 737
            ++    D     G    +P  +  P+S     F T +SDV+ +GVVL E+ T GK+P
Sbjct: 171 DVYTT--DYYRVGGHT-MLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 68/242 (28%), Positives = 110/242 (45%), Gaps = 49/242 (20%)

Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           +  ++  +L  G FG VY+G ++P G    I VA+KVL   ++   ++E   E   +  +
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
            HP++V L G C+   Q   I   M  G L + +                       N  
Sbjct: 67  DHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVR----------------------NHK 103

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFL--HHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
            N+GS+ LL  W       +  A+ +++L         ++HRD+ A +V +      +++
Sbjct: 104 DNIGSQYLLN-W------CVQIAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKIT 151

Query: 680 DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GK 735
           DFGLAK+      E  A G  G +P ++   +S      T KSDV+ YGV + EL+T G 
Sbjct: 152 DFGLAKLLDVDEKEYHAEG--GKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGA 209

Query: 736 KP 737
           KP
Sbjct: 210 KP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 79/315 (25%), Positives = 134/315 (42%), Gaps = 62/315 (19%)

Query: 513 GTLLAEGKFGPVYRGFL--PGG--IHVAVKVL-VHGSTLTD-QEAARELEYLGRIKHPNL 566
           G +L EG+FG V  G L    G  + VAVK + +   T ++ +E   E   +    HPN+
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 567 VPLTGYCIAGDQR------IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
           + L G C            + I  +M++G+L + L    LG                   
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP---------------- 107

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
            + +  + LL   +F   IALG       + +  +   IHRD+ A +  L  ++   ++D
Sbjct: 108 -EKLPLQTLL---KFMVDIALG-------MEYLSNRNFIHRDLAARNCMLREDMTVCVAD 156

Query: 681 FGLAKIFGNG---LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKK 736
           FGL+K   +G       IA+    +I  E +  D  + T KSDV+ +GV + E+ T G+ 
Sbjct: 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIE-SLADRVY-TSKSDVWAFGVTMWEIATRGQT 214

Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL 796
           P    YP  +   +  ++R   R  +             PE  ++E   + Y C    P 
Sbjct: 215 P----YPGVENHEIYDYLRHGNRLKQ-------------PEDCLDELYDLMYSCWRADPK 257

Query: 797 KRPSMQQIVGLLKDI 811
            RP+  ++  +L++I
Sbjct: 258 DRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 66/236 (27%), Positives = 98/236 (41%), Gaps = 44/236 (18%)

Query: 512 RGTLLAEGKFGPVYRGF-LPGGIHVAVKV--LVHGSTLTDQEAARELEYLGRIKHPNLVP 568
           RG  +  G FG VY    L  G  +AVK   +      T +E A E++ L  +KHPNLV 
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
             G  +  ++     +Y   G L+ LL                           +     
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLE--------------------------HGRILD 97

Query: 629 LLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
                 +  ++       LA+LH HG    I+HRDIK ++++LD N   +L DFG A   
Sbjct: 98  EHVIRVYTLQLL----EGLAYLHSHG----IVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149

Query: 688 GNGLD---EEIA--RGSPGYIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
            N      EE+    G+P Y+ PE             +D++  G V+LE+ TGK+P
Sbjct: 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 59/296 (19%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V  G   G   VA+K++  GS +++ E   E + + ++ H  LV L G C  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRF 635
                 + +YM NG L N L +     Q ++                      LL     
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ----------------------LL----- 103

Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
             ++       +A+L    S   IHRD+ A +  +D     ++SDFGL++     LD+E 
Sbjct: 104 --EMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV---LDDEY 155

Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
                   P  ++ P+    S F + KSDV+ +GV++ E+ + GK P  + +   +    
Sbjct: 156 TSSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPY-ERFNNSETVEK 213

Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG 806
           VS    L R                P    E+   I Y C  +   +RP+ QQ++ 
Sbjct: 214 VSQGLRLYR----------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 67/239 (28%), Positives = 104/239 (43%), Gaps = 42/239 (17%)

Query: 512 RGTLLAEGKFGPVYRGF-LPGGIHVAVK-VLVHGSTLTDQEAARELE----YLGRIKHPN 565
           +G LL  G FG VY G  L  G   AVK V +     T QEA ++LE     L +++HPN
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63

Query: 566 LVPLTGYCIAGDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
           +V   G     D  + I+ + +  G+L  LL                ++ E     I+  
Sbjct: 64  IVQYLGTEREED-NLYIFLELVPGGSLAKLLKKY------------GSFPEP---VIRL- 106

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
                     +  +I LG    L +LH       +HRDIK +++ +D N   +L+DFG+A
Sbjct: 107 ----------YTRQILLG----LEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMA 149

Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           K        +  +GSP ++ PE       +    +D++  G  +LE+ TGK P      
Sbjct: 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLA-ADIWSLGCTVLEMATGKPPWSQLEG 207

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 78/298 (26%), Positives = 128/298 (42%), Gaps = 59/298 (19%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G   G I VA+K++  G+ +++ +   E + + ++ HPNLV L G C  
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRF 635
                 + +YM NG L N L +                          +G+E LL     
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERK----------------------GKLGTEWLL----- 103

Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
              +      A+ +L        IHRD+ A +  +  +   ++SDFGLA+     LD++ 
Sbjct: 104 --DMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV---LDDQY 155

Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
                   P ++A P+    S F + KSDV+ +GV++ E+ + GK P    Y       +
Sbjct: 156 TSSQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMP----YERFSNSEV 210

Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL 808
           V  V      + G R   PK+  T       E   I Y C  + P  RP+ ++++  L
Sbjct: 211 VESV------SAGYRLYRPKLAPT-------EVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 49/235 (20%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G       VAVK L  G T+  ++   E + + +++HP L+ L   C  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI-QNVGSEGLLTTWR 634
            +    + + M+ G+L   L                         + Q +          
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQG----------------GAGRALKLPQLID--------- 107

Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A+L    +   IHRD+ A +V +  N   +++DFGLA++      E+
Sbjct: 108 ----MAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVI----KED 156

Query: 695 IARGSPGY-IPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
           I     G   P ++  P+    + F + KSDV+ +G++L E++T G+ P    YP
Sbjct: 157 IYEAREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMP----YP 206

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 41/239 (17%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD-QEAARELEYLGRIKH-- 563
           S + R  L+  G +G VYRG  +P G  VA+K++   +   D  +  RE+  L +++   
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60

Query: 564 -PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
            PN+    G  + G +   I +Y E G+++ L+   P+              E       
Sbjct: 61  PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPI-------------AE------- 100

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
                      ++   I      AL ++H      +IHRDIKA+++ +      +L DFG
Sbjct: 101 -----------KYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146

Query: 683 LAKIFGNGLDEEIA-RGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
           +A +      +     G+P ++ PE       + T K+D++  G+ + E+ TG  P  D
Sbjct: 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT-KADIWSLGITIYEMATGNPPYSD 204

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 46/244 (18%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFL--PGG--IHVAVKVLVHGSTLTD-QEAARELEYLGRIK 562
           S+  +  ++  G+FG V+RG L  PG   + VA+K L  G T    Q+   E   +G+  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGT-NSI 621
           H N++ L G        + I +YMENG L   L D                  DG  +S 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-----------------HDGEFSSY 107

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           Q VG             +  G A  + +L        +HRD+ A ++ ++ NLE ++SDF
Sbjct: 108 QLVG-------------MLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDF 151

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKK 736
           GL+++  +   E     S G IP  +  P++     F T  SDV+ +G+V+ E+++ G++
Sbjct: 152 GLSRVLEDD-PEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGER 209

Query: 737 PLGD 740
           P  D
Sbjct: 210 PYWD 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 74.8 bits (185), Expect = 8e-15
 Identities = 58/240 (24%), Positives = 103/240 (42%), Gaps = 49/240 (20%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL-VHGSTLTDQEAA-RELEYLGRIKHPN 565
            ++    + +G FG VY       G    +K + +   +  ++E A  E++ L ++ HPN
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 566 LVPLTGY--CIAGDQRIAI-YDYMENGNLQNLLHD-LPLGVQTTEDWSTDTWEEDGTNSI 621
           ++    Y        ++ I  +Y + G+L   +      G    E+              
Sbjct: 61  II---KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-------------- 103

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                        +  ++ L    AL +LH   S  I+HRDIK  +++L  N   +L DF
Sbjct: 104 ---------QILDWFVQLCL----ALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDF 147

Query: 682 GLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKP 737
           G++K+  +    ++A+   G+P Y+ PE  Q    ++   KSD++  G VL EL T K P
Sbjct: 148 GISKVLSS--TVDLAKTVVGTPYYLSPELCQNKPYNY---KSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.2 bits (190), Expect = 2e-14
 Identities = 48/131 (36%), Positives = 63/131 (48%), Gaps = 28/131 (21%)

Query: 18  WRGVVC--DSNKQH-VTDFLA-SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW 73
           W G  C  DS K     D L   N GL G +P+  I KL  LQS+               
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPND-ISKLRHLQSI--------------- 447

Query: 74  SLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG 133
                   NLS N I G++P ++G+   LEV DLS N+F+G IP ++  L SLR+L L+G
Sbjct: 448 --------NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499

Query: 134 NMFQWSIPPGL 144
           N     +P  L
Sbjct: 500 NSLSGRVPAAL 510

Length = 623

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 69/258 (26%), Positives = 113/258 (43%), Gaps = 39/258 (15%)

Query: 516 LAEGKFGPVYR----GFLPGG--IHVAVKVLVHG-STLTDQEAARELEYLGRIKHPNLVP 568
           + +G FG V++    G LP      VAVK+L    S     +  RE   +    HPN+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           L G C  G     +++YM  G+L   L              +   +   ++S  +    G
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRH-----------RSPRAQCSLSHSTSSARKCG 121

Query: 629 L----LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
           L    L+    +  IA   A  +A+L        +HRD+   +  +  N+  +++DFGL+
Sbjct: 122 LNPLPLSC-TEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLS 177

Query: 685 KIFGNGLDEEIARGSPG-YIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLG 739
           +   N    +  + S    IP  +  P+S F    T +SDV+ YGVVL E+ + G +P  
Sbjct: 178 R---NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234

Query: 740 DDYPEE-----KEGNLVS 752
               EE     ++GN++S
Sbjct: 235 GMAHEEVIYYVRDGNVLS 252

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 34/235 (14%)

Query: 516 LAEGKFGPVYRG--FLPGG----IHVAVKVLV-HGSTLTDQEAARELEYLGRIKHPNLVP 568
           L EG FG VY+G    P        VA+K L  +      QE  +E E +  ++HPN+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           L G C        +++Y+ +G+    LH+  +      D   ++ +E   +S+       
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGD----LHEFLVRNSPHSDVGAESGDETVKSSLDCSD--- 125

Query: 629 LLTTWRFRHKIALGTARALAFL--HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
                 F H IA+  A  + +L  HH      +HRD+ A +  +   L  ++SDFGL++ 
Sbjct: 126 ------FLH-IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRD 173

Query: 687 FGNGLDEEIARGSP---GYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP 737
             +     +   S     ++PPE A     F T +SD++ +GVVL E+ + G +P
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPE-AILYGKF-TTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 77/301 (25%), Positives = 138/301 (45%), Gaps = 61/301 (20%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VA+K L  G +++ +    E   + +++HP LV L  Y + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRL--YAVV 70

Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L                               EG+  T  
Sbjct: 71  TQEPIYIITEYMENGSLVDFLKT----------------------------PEGIKLTIN 102

Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 103 KLIDMAAQIAEGMAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLIED--NEY 157

Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGN 749
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P    YP      
Sbjct: 158 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIP----YPG----- 206

Query: 750 LVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK 809
                   + N +  + ++   R   P+   EE  ++  LC  + P +RP+ + +  +L+
Sbjct: 207 --------MTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258

Query: 810 D 810
           D
Sbjct: 259 D 259

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 67/290 (23%), Positives = 123/290 (42%), Gaps = 59/290 (20%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           +  G+FG V+ G+      VA+K +  G+ +++++   E + + ++ HP LV L G C  
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRF 635
                 ++++ME+G L + L                   + G  S      E LL     
Sbjct: 71  RSPICLVFEFMEHGCLSDYLR-----------------AQRGKFS-----QETLL----- 103

Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
              + L     +A+L       +IHRD+ A +  +  N   ++SDFG+ +     LD++ 
Sbjct: 104 --GMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV---LDDQY 155

Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
              +    P +++ P+    S + + KSDV+ +GV++ E+ + GK P    Y       +
Sbjct: 156 TSSTGTKFPVKWSSPEVFSFSKYSS-KSDVWSFGVLMWEVFSEGKTP----YENRSNSEV 210

Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
           V  +      N G R   P++      + M+        C  + P  RPS
Sbjct: 211 VETI------NAGFRLYKPRLASQSVYELMQH-------CWKERPEDRPS 247

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 78/300 (26%), Positives = 138/300 (46%), Gaps = 59/300 (19%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T+  +   +E + + +++H  LVPL  Y + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPL--YAVV 70

Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWR 634
            ++ I I  ++M  G+L + L                  E DG    + +    L+    
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLK-----------------EGDG----KYLKLPQLV---- 105

Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        IHRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 106 ---DMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIED--NEY 157

Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL+T G+ P    YP       
Sbjct: 158 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP----YP------- 205

Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P+   E   ++  LC    P +RP+ + I   L+D
Sbjct: 206 -----GMV-NREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 74/298 (24%), Positives = 119/298 (39%), Gaps = 62/298 (20%)

Query: 515 LLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKHPNLVPLTG 571
            + +G FG VY+G L G   VAVK     STL      +   E E L +  HPN+V L G
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTC--RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 572 YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLT 631
            C+       + + +  G+L   L                               +  LT
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLR----------------------------KKKNRLT 91

Query: 632 TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL 691
             +    ++L  A  + +L        IHRD+ A +  +  N   ++SDFG+++    G 
Sbjct: 92  VKKLLQ-MSLDAAAGMEYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSREEEGG- 146

Query: 692 DEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKE 747
                      IP ++  P++ ++   T +SDV+ YG++L E  + G  P    YP    
Sbjct: 147 -IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP----YP---- 197

Query: 748 GNLVSWVRGLVRNNKGSRA-IDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
                   G+  +N+ +R  I+   R   P+   EE  ++   C A  P  RPS  +I
Sbjct: 198 --------GM--SNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 72.2 bits (177), Expect = 6e-14
 Identities = 70/238 (29%), Positives = 110/238 (46%), Gaps = 54/238 (22%)

Query: 515 LLAEGKFGPVYRGFL--PGG--IHVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVPL 569
           ++  G+FG V  G L  PG   I VA+K L  G T   + +   E   +G+  HPN++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            G        + + +YMENG+L   L  HD    V                  IQ VG  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV------------------IQLVG-- 110

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
                      +  G A  + +L        +HRD+ A ++ ++ NL  ++SDFGL+++ 
Sbjct: 111 -----------MLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156

Query: 688 GNGLDEEIA---RGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKP 737
            +  D E A   RG  G IP  +  P++     F T  SDV+ YG+V+ E+++ G++P
Sbjct: 157 ED--DPEAAYTTRG--GKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 76/299 (25%), Positives = 132/299 (44%), Gaps = 56/299 (18%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+      VAVK L  G T++ Q    E   +  ++H  LV L      
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRF 635
            +    I +YM  G+L + L                  + D    +       L     F
Sbjct: 73  EEPIYIITEYMAKGSLLDFL------------------KSDEGGKVL------LPKLIDF 108

Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
             +IA G    +A++        IHRD++A++V +  +L  +++DFGLA++  +  +E  
Sbjct: 109 SAQIAEG----MAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYT 159

Query: 696 ARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLV 751
           AR    + P ++  P++ +F   T KSDV+ +G++L E++T GK P    YP     +++
Sbjct: 160 AREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP----YPGMSNSDVM 214

Query: 752 SWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
           S ++      +G R   P+      E   +E   I   C  +   +RP+   +  +L D
Sbjct: 215 SALQ------RGYRM--PR-----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 69/233 (29%), Positives = 96/233 (41%), Gaps = 52/233 (22%)

Query: 516 LAEGKFGPVYRG---FLPG--GIHVAVKVLVH---GSTLTDQEAARELEYLGRIKHPNLV 567
           L EG FG V       L    G  VAVK L H       +D E  RE+E L  + H N+V
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE--REIEILRTLDHENIV 69

Query: 568 PLTGYCIAGDQRI--AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
              G C     R    I +Y+ +G+L++ L       Q   D                + 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-------QRHRD---------------QIN 107

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + LL    F  +I  G    + +L    S   IHRD+ A ++ ++     ++SDFGLAK
Sbjct: 108 LKRLL---LFSSQICKG----MDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAK 157

Query: 686 IFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT 733
           +     D    +  PG  P     PE     S F +  SDV+ +GV L EL T
Sbjct: 158 VLPEDKDYYYVK-EPGESPIFWYAPE-CLRTSKF-SSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 68/238 (28%), Positives = 112/238 (47%), Gaps = 46/238 (19%)

Query: 515 LLAEGKFGPVYRGFL--PGG--IHVAVKVLVHGSTLTD-QEAARELEYLGRIKHPNLVPL 569
           ++  G+FG V RG L  PG   I VA+K L  G T    ++   E   +G+  HPN++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS-IQNVGSEG 628
            G        + I ++MENG L + L                  + DG  + IQ VG   
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLR-----------------QNDGQFTVIQLVG--- 110

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
                     IA G  + L+ +++      +HRD+ A ++ ++ NL  ++SDFGL++   
Sbjct: 111 ------MLRGIAAGM-KYLSEMNY------VHRDLAARNILVNSNLVCKVSDFGLSRFLE 157

Query: 689 NGLDEEIARGS-PGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGD 740
           +   +     S  G IP  +  P++     F T  SDV+ YG+V+ E+++ G++P  D
Sbjct: 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 70/316 (22%), Positives = 124/316 (39%), Gaps = 75/316 (23%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQE---AARELEYLGRIK 562
              +     + EG  G VY+      G  VA+K +     L  Q       E+  +   K
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM----RLRKQNKELIINEILIMKDCK 73

Query: 563 HPNLVPLTG-YCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTN 619
           HPN+V     Y +  +  + + +YM+ G+L +++  + + +                   
Sbjct: 74  HPNIVDYYDSYLVGDELWVVM-EYMDGGSLTDIITQNFVRM------------------- 113

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                 +E  +        +     + L +LH   S  +IHRDIK+ ++ L  +   +L+
Sbjct: 114 ------NEPQIAY------VCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLA 158

Query: 680 DFGLAKIFGNGLDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
           DFG A        +   R    G+P ++ PE  +   D+  PK D++  G++ +E+  G+
Sbjct: 159 DFGFAAQLTKEKSK---RNSVVGTPYWMAPEVIK-RKDY-GPKVDIWSLGIMCIEMAEGE 213

Query: 736 KPLGDDYPEEKEGNLVSWVRGLVR-NNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL 794
            P   + P          +R L     KG     P +++  PEK   E       C    
Sbjct: 214 PPYLREPP----------LRALFLITTKGI----PPLKN--PEKWSPEFKDFLNKCLVKD 257

Query: 795 PLKRPSMQQIVGLLKD 810
           P KRPS ++   LL+ 
Sbjct: 258 PEKRPSAEE---LLQH 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 79/307 (25%), Positives = 135/307 (43%), Gaps = 52/307 (16%)

Query: 513 GTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRI-K 562
           G  L EG FG V +              VAVK+L      T+++ +    E+E +  I K
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--KDDATEKDLSDLVSEMEMMKMIGK 74

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHD-LPLGVQTTEDWSTDTWEEDGTNSI 621
           H N++ L G C        + +Y  +GNL++ L    P G    E  S D    D     
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPG----EYASPD----DPRPPE 126

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           + +  + L++        A   AR + FL    S   IHRD+ A +V +  +   +++DF
Sbjct: 127 ETLTQKDLVS-------FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADF 176

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELITGKKPL 738
           GLA+   + +D      + G +P ++  P++ F    T +SDV+ +GV+L E+ T     
Sbjct: 177 GLARDIHH-IDYYRKTTN-GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---LG 231

Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
           G  YP      L   ++      +G R ++       P+   +E   +   C  ++P +R
Sbjct: 232 GSPYPGIPVEELFKLLK------EGYR-MEK------PQNCTQELYHLMRDCWHEVPSQR 278

Query: 799 PSMQQIV 805
           P+ +Q+V
Sbjct: 279 PTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 47/240 (19%)

Query: 518 EGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD-QEAARELEYLGRIKHPNLVPLTGYC-- 573
            G    VY    LP    VA+K +      T   E  +E++ + +  HPN+V    Y   
Sbjct: 11  VGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV--KYYTSF 68

Query: 574 IAGDQRIAIYDYMENGNLQNLL-HDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTT 632
           + GD+   +  Y+  G+L +++    P G            +E     I  V  E L   
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGL----------DE---AIIATVLKEVL--- 112

Query: 633 WRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNG 690
                       + L +LH +G     IHRDIKA ++ L  +   +++DFG+ A +   G
Sbjct: 113 ------------KGLEYLHSNG----QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156

Query: 691 LDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEK 746
                 R    G+P ++ PE  +    +   K+D++ +G+  +EL TG  P    YP  K
Sbjct: 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGY-DFKADIWSFGITAIELATGAAP-YSKYPPMK 214

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 70.8 bits (173), Expect = 8e-13
 Identities = 64/261 (24%), Positives = 109/261 (41%), Gaps = 16/261 (6%)

Query: 46  DTTIGKLSKLQSLDLSENNITALPSDL-WSLGSLKSLNLSYNRISGSLPSNIGNFGLLEV 104
            + + +L+ L SLDL  NNIT +P  +     +LK L+LS N+I  SLPS + N   L+ 
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKN 167

Query: 105 FDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSL 164
            DLS N+ S ++P  +S+L +L  L L GN     +PP +    +L  +DLS N +   L
Sbjct: 168 LDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-EL 224

Query: 165 PDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVID 224
                     L  L L+ N+++        L ++  L++S N          + S+  + 
Sbjct: 225 LSSLS-NLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQ---------ISSISSLG 274

Query: 225 LRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTR 284
             +N  +  +S    +++     L+ + L                 N   L+        
Sbjct: 275 SLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGE 334

Query: 285 QEFPQ-IGTLLGLEHLNLSRT 304
              P+ +  L  L +L     
Sbjct: 335 TSSPEALSILESLNNLWTLDN 355

Length = 394

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 62/240 (25%), Positives = 92/240 (38%), Gaps = 40/240 (16%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTD--QEAARELEYLGRIKHPNLVPLTGYC 573
           L EG  G V +  L     +     +      D  ++  RELE     K P +V   G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 574 IA-GDQRIAI-YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLT 631
           +      I I  +Y E G+L ++                           + V   G   
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDSIY--------------------------KKVKKRGGRI 102

Query: 632 TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL 691
             +   KIA    + L++LH   S  IIHRDIK S++ L    + +L DFG++    N L
Sbjct: 103 GEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159

Query: 692 DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV 751
                 G+  Y+ PE  Q      +  SDV+  G+ LLE+   + P    +P E E  L 
Sbjct: 160 AGTFT-GTSFYMAPERIQGKP--YSITSDVWSLGLTLLEVAQNRFP----FPPEGEPPLG 212

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 69.1 bits (169), Expect = 9e-13
 Identities = 60/246 (24%), Positives = 111/246 (45%), Gaps = 51/246 (20%)

Query: 512 RGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAAR----------ELEYLGR 560
           +G L+ +G +G VY    +  G  +AVK +   +T+  +  +R          E+E L  
Sbjct: 5   KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 561 IKHPNLVPLTGYCIAGDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           + H N+V   G     ++ ++I+ +Y+  G++ + L             +   +EE    
Sbjct: 65  LDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLR------------TYGRFEEQLVR 111

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                  EGL                  A+LH   S  I+HRD+KA ++ +D +   ++S
Sbjct: 112 FFTEQVLEGL------------------AYLH---SKGILHRDLKADNLLVDADGICKIS 150

Query: 680 DFGLAK----IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
           DFG++K    I+ N  +  + +GS  ++ PE     S   + K D++  G V+LE+  G+
Sbjct: 151 DFGISKKSDDIYDNDQNMSM-QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Query: 736 KPLGDD 741
           +P  D+
Sbjct: 210 RPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 76/308 (24%), Positives = 128/308 (41%), Gaps = 57/308 (18%)

Query: 516 LAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G         VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           L G    G   + + + M  G+L++ L       +  E               +N    G
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRS-----RRPEA--------------ENNPGLG 114

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IF 687
             T  +F  ++A   A  +A+L    +   +HRD+ A +  +  +L  ++ DFG+ + I+
Sbjct: 115 PPTLQKF-IQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY 170

Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS--D--FPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
                +   +G  G +P  +  P+S  D  F T KSDV+ +GVVL E+ T  ++P    Y
Sbjct: 171 ET---DYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQP----Y 222

Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
                        GL         ID    D  PE   ++ L++  +C    P  RP+  
Sbjct: 223 Q------------GLSNEEVLKFVIDGGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFL 269

Query: 803 QIVGLLKD 810
           +IV  LKD
Sbjct: 270 EIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 50/233 (21%)

Query: 516 LAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPLTGYC 573
           L  G  G V +    P G  +AVK +        Q+   REL+ L +   P +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 574 IAGDQRIAIYDYMENGNLQNLLH-------DLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
                     +YM+ G+L  +L        +  LG                         
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILG------------------------- 103

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
                      KIA+   + L +LH      IIHRD+K S++ ++   + +L DFG++  
Sbjct: 104 -----------KIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150

Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
             N L +    G+  Y+ PE  Q +    + KSD++  G+ L+EL TG+ P  
Sbjct: 151 LVNSLAKTFV-GTSSYMAPERIQGND--YSVKSDIWSLGLSLIELATGRFPYP 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 72/271 (26%), Positives = 110/271 (40%), Gaps = 78/271 (28%)

Query: 503 LLSATSNFDRGTLLAEGKFGPVYRGFLPGGIH------VAVKVLVHGSTLTDQEAARELE 556
           L   T  F+   ++ EG +G VY+       H      VA+K++     + D+E   + E
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKA-----RHKKTGQLVAIKIM---DIIEDEEEEIKEE 52

Query: 557 YLGRI-----KHPNLVPLTG------YCIAGDQRIAIYDYMENGNLQNLLHDL-PLGVQT 604
           Y   I      HPN+    G           DQ   + +    G++ +L+  L   G + 
Sbjct: 53  Y--NILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110

Query: 605 TEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIAL---GTARALAFLHHGCSPPIIHR 661
            E+W                              IA     T R LA+LH      +IHR
Sbjct: 111 KEEW------------------------------IAYILRETLRGLAYLH---ENKVIHR 137

Query: 662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPEF----AQPDS 712
           DIK  ++ L  N E +L DFG++      LD  + R     G+P ++ PE      QPD+
Sbjct: 138 DIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDA 193

Query: 713 DFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
            +   +SDV+  G+  +EL  GK PL D +P
Sbjct: 194 SY-DARSDVWSLGITAIELADGKPPLCDMHP 223

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 68.6 bits (167), Expect = 2e-12
 Identities = 69/234 (29%), Positives = 105/234 (44%), Gaps = 36/234 (15%)

Query: 516 LAEGKFGPVYRG----FLP--GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPL 569
           L EG FG V+        P    I VAVK L   S    ++  RE E L  ++H ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDL-PLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
            G C+ GD  I +++YM++G+L   L    P  V   E                N  +E 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG---------------NRPAE- 116

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
            LT  +  H IA   A  + +L    S   +HRD+   +  +  NL  ++ DFG+++   
Sbjct: 117 -LTQSQMLH-IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--- 168

Query: 689 NGLDEEIAR-GSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
           +    +  R G    +P  +  P+S      T +SDV+  GVVL E+ T GK+P
Sbjct: 169 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 63/234 (26%), Positives = 98/234 (41%), Gaps = 34/234 (14%)

Query: 516 LAEGKFGPVY----RGFLPGG--IHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPL 569
           L EG FG V+       LP    + VAVK L   S    Q+  RE E L  ++H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL 629
            G C  G   + +++YM +G+L   L       +                     G   L
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAG-----------GEDVAPGQLTL 121

Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IFG 688
                   +IA G    LA LH       +HRD+   +  +   L  ++ DFG+++ I+ 
Sbjct: 122 GQMLAIASQIASGMVY-LASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 174

Query: 689 NGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKP 737
               +    G    +P  +  P+S     F T +SD++ +GVVL E+ T GK+P
Sbjct: 175 T---DYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 36/102 (35%), Positives = 59/102 (57%), Gaps = 4/102 (3%)

Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           KIA+   +AL +LH   S  +IHRD+K S+V ++ N + +L DFG++    + + + I  
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164

Query: 698 GSPGYIPPEFAQPDSDFP--TPKSDVYCYGVVLLELITGKKP 737
           G   Y+ PE   P+ +      KSDV+  G+ ++EL TG+ P
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 46/233 (19%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G   G   VAVK L  G T++ +    E + + +++H  LV L  Y + 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQL--YAVV 70

Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L D                             EG      
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKD----------------------------GEGRALKLP 102

Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        IHRD++++++ +   L  +++DFGLA++  +  +E 
Sbjct: 103 NLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIED--NEY 157

Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
            AR    + P ++  P++      T KSDV+ +G++L EL+T G+ P    YP
Sbjct: 158 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP----YP 205

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 58/240 (24%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGY 572
           G ++ EG+FG V +G   G   VAVK +     +T Q    E   + ++ H NLV L G 
Sbjct: 11  GEIIGEGEFGAVLQGEYTGQ-KVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 573 CIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTT 632
            +     I + + M  GNL N L                                     
Sbjct: 68  ILHNGLYI-VMELMSKGNLVNFL------------------------------------- 89

Query: 633 WRFRHKIALGTARALAFLHHGC-------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            R R +  +   + L F            S  ++HRD+ A ++ +  +   ++SDFGLA+
Sbjct: 90  -RTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148

Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE 744
           +   G+D   ++    +  PE A     F + KSDV+ YGV+L E+ + G+ P    YP+
Sbjct: 149 VGSMGVDN--SKLPVKWTAPE-ALKHKKFSS-KSDVWSYGVLLWEVFSYGRAP----YPK 200

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 68.8 bits (168), Expect = 3e-12
 Identities = 98/367 (26%), Positives = 146/367 (39%), Gaps = 104/367 (28%)

Query: 513 GTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEAA----RELEYLGRIK 562
           G  L  G FG V      G       + VAVK+L   + LT++EA     + L YLG   
Sbjct: 40  GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--N 97

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNL-------------------------QNLLH- 596
           H N+V L G C  G   + I +Y   G+L                         +NLLH 
Sbjct: 98  HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQ 157

Query: 597 ------------DLPLGVQ------------------TTEDWSTDTWEEDGTNSIQNVGS 626
                       D+  GV                     +D +++  EED       + +
Sbjct: 158 REMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELA----LDT 213

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           E LL+   F +++A G    ++FL    S   IHRD+ A ++ L      ++ DFGLA+ 
Sbjct: 214 EDLLS---FSYQVAKG----MSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD 263

Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDY 742
             N  D          +P ++  P+S F    T +SDV+ YG++L E+ + G  P    Y
Sbjct: 264 IRN--DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP----Y 317

Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
           P            G+  ++K  + I    R   PE    E   I   C    PLKRP+ +
Sbjct: 318 P------------GMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFK 365

Query: 803 QIVGLLK 809
           QIV L++
Sbjct: 366 QIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 81/308 (26%), Positives = 128/308 (41%), Gaps = 52/308 (16%)

Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQTTEDWSTDTWEEDGTNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++ + D             I
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-------------I 126

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 127 ARVPDEQM--TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 181

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T G  P
Sbjct: 182 GLARDVNN--IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
               YP      L   ++   R +K             P     E   +   C   +P  
Sbjct: 240 ----YPGIPVEELFKLLKEGHRMDK-------------PANCTNELYMMMRDCWHAIPSH 282

Query: 798 RPSMQQIV 805
           RP+ +Q+V
Sbjct: 283 RPTFKQLV 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 84/302 (27%), Positives = 140/302 (46%), Gaps = 54/302 (17%)

Query: 515 LLAEGKFGPVYRGFLPGG---IHVAVKVLVHGSTLTD-QEAARELEYLGRI-KHPNLVPL 569
           ++ EG FG V R  +      ++ A+K+L   ++  D ++ A ELE L ++  HPN++ L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 570 TGYCI-AGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
            G C   G   IAI +Y   GNL + L    + ++T   ++    +E GT S   + S+ 
Sbjct: 69  LGACENRGYLYIAI-EYAPYGNLLDFLRKSRV-LETDPAFA----KEHGTAS--TLTSQQ 120

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           LL   +F   +A G       + +      IHRD+ A +V +  NL  +++DFGL++   
Sbjct: 121 LL---QFASDVATG-------MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--- 167

Query: 689 NGLDEEI-ARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDY 742
               EE+  + + G +P  +   +S      T KSDV+ +GV+L E+++ G  P  G   
Sbjct: 168 ---GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224

Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
            E  E           +  +G R   P+  D       +E  ++   C  D P +RP   
Sbjct: 225 AELYE-----------KLPQGYRMEKPRNCD-------DEVYELMRQCWRDRPYERPPFA 266

Query: 803 QI 804
           QI
Sbjct: 267 QI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.9 bits (163), Expect = 5e-12
 Identities = 79/318 (24%), Positives = 134/318 (42%), Gaps = 62/318 (19%)

Query: 510 FDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVL-VHGSTLTD-QEAARELEYLGRIKH 563
           F  G +L +G+FG V    L         VAVK+L     + +D +E  RE   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 564 PNLVPLTGYCIAGDQR------IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDG 617
           PN++ L G  +    +      + I  +M++G+L   L    +G            EE  
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG------------EEPF 108

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
           T  +Q        T  RF   IA G       + +  S   IHRD+ A +  L+ N+   
Sbjct: 109 TLPLQ--------TLVRFMIDIASG-------MEYLSSKNFIHRDLAARNCMLNENMTVC 153

Query: 678 LSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT- 733
           ++DFGL+K   +G  +   +G    +P ++   +S   +  T  SDV+ +GV + E++T 
Sbjct: 154 VADFGLSKKIYSG--DYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Query: 734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTAD 793
           G+ P    Y   +   + ++   L++ N          R   P   +E+  ++   C + 
Sbjct: 212 GQTP----YAGVENSEIYNY---LIKGN----------RLKQPPDCLEDVYELMCQCWSP 254

Query: 794 LPLKRPSMQQIVGLLKDI 811
            P  RPS Q +   L+ I
Sbjct: 255 EPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 66.4 bits (162), Expect = 6e-12
 Identities = 81/308 (26%), Positives = 126/308 (40%), Gaps = 64/308 (20%)

Query: 515 LLAEGKFGPVYRGFL-------PGGIHVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNL 566
            L  G FG VY G          G I VAVK L  G+T  ++ E  +E   +    HPN+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 567 VPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
           V L G C+  + +  I + ME G+L + L D                       ++  G 
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDA---------------------RVERFGP 100

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA-----SSVYLDMNLEPRLSDF 681
             L  T +    I L  A+   +L        IHRD+ A     S    D +   ++ DF
Sbjct: 101 PLL--TLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155

Query: 682 GLAK-IFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKK 736
           GLA+ I+ +  D     G  G +P  +  P+S      T +SDV+ +GV++ E++T G++
Sbjct: 156 GLARDIYKS--DYYRKEGE-GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212

Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL 796
           P    YP      ++  V    R  K             PE   ++  ++   C A  P 
Sbjct: 213 P----YPALNNQEVLQHVTAGGRLQK-------------PENCPDKIYQLMTNCWAQDPS 255

Query: 797 KRPSMQQI 804
           +RP+  +I
Sbjct: 256 ERPTFDRI 263

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 67.6 bits (165), Expect = 6e-12
 Identities = 84/316 (26%), Positives = 128/316 (40%), Gaps = 61/316 (19%)

Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCI-AGDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++ +A   EL+ L  I  H N+V L G C   G   + I +Y + GNL
Sbjct: 40  VAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNL 99

Query: 592 QNLLHDLPLGVQTTEDWSTDTWEE----------DGTNSIQNVGSEGLLTTWRFRH---- 637
            N L           + ST   E           D  +S Q+  S G +           
Sbjct: 100 SNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159

Query: 638 -----------------KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
                              +   AR + FL    S   IHRD+ A ++ L  N   ++ D
Sbjct: 160 EEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICD 216

Query: 681 FGLAK-IFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GK 735
           FGLA+ I+    D +  R     +P ++  P+S F    T +SDV+ +GV+L E+ + G 
Sbjct: 217 FGLARDIYK---DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 273

Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
            P    YP            G+  + +  R +    R   PE    E   I   C  + P
Sbjct: 274 SP----YP------------GVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNP 317

Query: 796 LKRPSMQQIVGLLKDI 811
             RP+  ++V +L D+
Sbjct: 318 EDRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 67.4 bits (164), Expect = 7e-12
 Identities = 84/307 (27%), Positives = 132/307 (42%), Gaps = 50/307 (16%)

Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQTTEDWSTDTWEEDGTNSI 621
           H N++ L G C        + +Y   GNL+  L    P G+    D+S DT +       
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM----DYSFDTCK------- 125

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             +  E L  T++     A   AR + +L    S   IHRD+ A +V +  +   +++DF
Sbjct: 126 --LPEEQL--TFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADF 178

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELITGKKPL 738
           GLA+   N +D    + + G +P ++  P++ F    T +SDV+ +GV+L E+ T     
Sbjct: 179 GLARDVHN-ID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---LG 233

Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
           G  YP      L   ++   R +K             P     E   I   C   +P +R
Sbjct: 234 GSPYPGIPVEELFKLLKEGHRMDK-------------PANCTHELYMIMRECWHAVPSQR 280

Query: 799 PSMQQIV 805
           P+ +Q+V
Sbjct: 281 PTFKQLV 287

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 67.7 bits (165), Expect = 8e-12
 Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 9/233 (3%)

Query: 53  SKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNF 112
           S L+ LDLS+N I +LPS L +L +LK+L+LS+N +S  LP  + N   L   DLS N  
Sbjct: 140 SNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198

Query: 113 SGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAF 172
           S ++P  I  L +L  L L  N     +   L N ++L  ++LS N+L   LP+  G   
Sbjct: 199 S-DLPPEIELLSALEELDLSNN-SIIELLSSLSNLKNLSGLELSNNKLE-DLPESIG-NL 254

Query: 173 PKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQG---SVMGVFLESLEVIDLRSNQ 229
             L++L+L+ N+I    +    L ++  L++SGN        +  + L    +++L    
Sbjct: 255 SNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL 313

Query: 230 FQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRF 282
               +       + N          E     E  +N     N    S      
Sbjct: 314 KALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYI 366

Length = 394

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 67.6 bits (165), Expect = 8e-12
 Identities = 92/357 (25%), Positives = 143/357 (40%), Gaps = 81/357 (22%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEA-ARELEYLGRI 561
           N   G  L  G FG V      G       + VAVK+L   +   ++EA   EL+ L  +
Sbjct: 39  NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHL 98

Query: 562 -KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-----------DLPLGVQTTEDW- 608
            +H N+V L G C  G   + I +Y   G+L N L             LP   +T+ D+ 
Sbjct: 99  GQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYK 158

Query: 609 ------------------STDTWEE---------DGTNSIQNVGSEGL--LTTW---RFR 636
                              +DT+ E           ++S     +E    L      RF 
Sbjct: 159 NITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFS 218

Query: 637 HKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA 696
            ++A G    + FL    S   IHRD+ A +V L      ++ DFGLA+   N  D    
Sbjct: 219 SQVAQG----MDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN--DSNYV 269

Query: 697 RGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVS 752
                 +P ++  P+S F    T +SDV+ YG++L E+ + GK P    YP         
Sbjct: 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP----YP--------- 316

Query: 753 WVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK 809
              G++ N+K  + +    + + P+    E   I  +C    P +RP+  QI  L++
Sbjct: 317 ---GILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 65.6 bits (160), Expect = 9e-12
 Identities = 73/300 (24%), Positives = 129/300 (43%), Gaps = 69/300 (23%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G     I VA+K +  G+ +++++   E + + ++ HP LV L G C  
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT- 69

Query: 576 GDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTT 632
             Q+  +Y   ++MENG L N L                  +  G      +  + LL+ 
Sbjct: 70  --QQKPLYIVTEFMENGCLLNYLR-----------------QRQG-----KLSKDMLLS- 104

Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD 692
                 +       + +L        IHRD+ A +  +      ++SDFG+ +     LD
Sbjct: 105 ------MCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV---LD 152

Query: 693 EEIARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKE 747
           +E    S    P +++ P+    S + + KSDV+ +GV++ E+ T GK P       EK+
Sbjct: 153 DEYTSSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPF------EKK 205

Query: 748 GNL--VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
            N   V  +      ++G R   PK+        + E +   Y C  + P  RP+  +++
Sbjct: 206 SNYEVVEMI------SRGFRLYRPKL----ASMTVYEVM---YSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 65.7 bits (161), Expect = 9e-12
 Identities = 54/239 (22%), Positives = 97/239 (40%), Gaps = 44/239 (18%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVP 568
           FD    L EG +G VY+      G  VA+KV+     L +    +E+  L +   P +V 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII--KEISILKQCDSPYIVK 62

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
             G          + +Y   G++ +++                              +E 
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIM-----------------------KITNKTLTEE 99

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
            +        I   T + L +LH   S   IHRDIKA ++ L+   + +L+DFG++    
Sbjct: 100 EIAA------ILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150

Query: 689 NGLDE-EIARGSPGYIPPEFAQP---DSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           + + +     G+P ++ PE  Q    ++     K+D++  G+  +E+  GK P  D +P
Sbjct: 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNN-----KADIWSLGITAIEMAEGKPPYSDIHP 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 41/238 (17%)

Query: 516 LAEGKFGPVYRG----FLPGG--IHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPL 569
           L EG FG V+        P    + VAVK L   +    ++  RE E L  ++H ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLH----DLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
            G C  GD  I +++YM++G+L   L     D  + V             DG    Q   
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV-------------DG----QPRQ 115

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
           ++G L   +  H IA   A  + +L    S   +HRD+   +  +  NL  ++ DFG+++
Sbjct: 116 AKGELGLSQMLH-IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Query: 686 -IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKP 737
            ++     +    G    +P  +  P+S     F T +SDV+ +GV+L E+ T GK+P
Sbjct: 172 DVYST---DYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 65.7 bits (161), Expect = 1e-11
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 58/221 (26%)

Query: 538 KVLV----HGSTLTDQEA---ARELEYLGRIKHPNLVPLTGYCIAGDQRI------AIYD 584
           K+LV        +T++E      E+  L  +KHPN+V    Y      RI       +Y 
Sbjct: 26  KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RYY----DRIIDRSNQTLYI 78

Query: 585 YME---NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIAL 641
            ME    G+L  L+       +  ++      EE+                WR   ++ L
Sbjct: 79  VMEYCEGGDLAQLIQ------KCKKE--RKYIEEE--------------FIWRILTQLLL 116

Query: 642 GTARALAFLHHGC--SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-- 697
               AL   H+       ++HRD+K ++++LD N   +L DFGLAKI G+      A+  
Sbjct: 117 ----ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTY 170

Query: 698 -GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
            G+P Y+ PE  Q +      KSD++  G ++ EL     P
Sbjct: 171 VGTPYYMSPE--QLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 70

Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLK----------------------------GEMGKYLRLP 102

Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 103 QLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 157

Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 158 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 205

Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 206 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 60/247 (24%), Positives = 107/247 (43%), Gaps = 56/247 (22%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEY-----LGRIK 562
           S  D    + EG  G V    +        +V V    L  Q+  REL +     +   +
Sbjct: 19  SYLDNFVKIGEGSTGIVC---IATDKSTGRQVAVKKMDLRKQQR-RELLFNEVVIMRDYQ 74

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           HPN+V +    + GD+   + +++E G L +++              T T          
Sbjct: 75  HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV--------------THT---------- 110

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +  E + T       + L   +AL+FLH   +  +IHRDIK+ S+ L  +   +LSDFG
Sbjct: 111 RMNEEQIAT-------VCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFG 160

Query: 683 LAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGKK 736
               F   + +E+ R     G+P ++ PE     S  P   + D++  G++++E++ G+ 
Sbjct: 161 ----FCAQVSKEVPRRKSLVGTPYWMAPEVI---SRLPYGTEVDIWSLGIMVIEMVDGEP 213

Query: 737 PLGDDYP 743
           P  ++ P
Sbjct: 214 PYFNEPP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 71/274 (25%), Positives = 114/274 (41%), Gaps = 38/274 (13%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGL-LEVFDLSNN 110
           L  L SLDL+ N + +  S+L  L +L SL+L  N I+  +P  IG     L+  DLS+N
Sbjct: 92  LLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDN 150

Query: 111 NFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGA 170
                                       S+P  L N  +L  +DLS N L+  LP     
Sbjct: 151 KIE-------------------------SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSN 184

Query: 171 AFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF-LESLEVIDLRSNQ 229
               L +L+L+GN+I         L ++  L++S N     +  +  L++L  ++L +N+
Sbjct: 185 L-SNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNK 243

Query: 230 FQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQ 289
            +     +      N S L  +DLS NQ+S     +     NL+ L L+ N  +      
Sbjct: 244 LEDLPESIG-----NLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLI 296

Query: 290 IGT-LLGLEHLNLSRTSLIGDIPSEILQLSSLHT 322
               LL    LNL  T    ++    + L++   
Sbjct: 297 ALLLLLLELLLNLLLTLKALELKLNSILLNNNIL 330

Length = 394

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 75/306 (24%), Positives = 119/306 (38%), Gaps = 63/306 (20%)

Query: 516 LAEGKFGPVYRGF--LPGG--IHVAVKVLVHGSTLTD-QEAARELEYLGRIKHPNLVPLT 570
           L  G FG V +G   +  G  + VAVK L         +E  RE   + ++ HP +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
           G C  G+  + + +    G L   L                         I        L
Sbjct: 63  GVCK-GEPLMLVMELAPLGPLLKYLKKRR--------------------EIPVSD----L 97

Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
                 H++A+G    +A+L    S   +HRD+ A +V L    + ++SDFG+++  G G
Sbjct: 98  KELA--HQVAMG----MAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148

Query: 691 LDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEE 745
            D   A  + G  P ++  P+      F + KSDV+ YGV L E  + G KP    Y E 
Sbjct: 149 SDYYRAT-TAGRWPLKWYAPECINYGKFSS-KSDVWSYGVTLWEAFSYGAKP----YGEM 202

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
           K   +++ +    R  +             PE+  +E   I   C    P  RP+  ++ 
Sbjct: 203 KGAEVIAMLESGERLPR-------------PEECPQEIYSIMLSCWKYRPEDRPTFSELE 249

Query: 806 GLLKDI 811
              +  
Sbjct: 250 STFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 55/274 (20%)

Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHG-STLTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L    S   ++E   E   +  +
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
            +P++  L G C+    ++ I   M  G L +        V+  +D              
Sbjct: 67  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDY-------VREHKD-------------- 104

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 105 -NIGSQYLLN-W------CVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDF 153

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+   G DE+      G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 154 GLAKLL--GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKI 771
             D  P  +  +++          KG R   P I
Sbjct: 212 Y-DGIPASEISSILE---------KGERLPQPPI 235

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 82/324 (25%), Positives = 123/324 (37%), Gaps = 74/324 (22%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIH------VAVKVLVHGSTLTDQEAA-----RELE 556
           SN    T L  G+FG V+     G         V VK L      T  E       REL+
Sbjct: 5   SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK----TKDENLQSEFRRELD 60

Query: 557 YLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEED 616
              ++ H N+V L G C   +    I +Y + G+L+  L       + T+        +D
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFL-------RATK-------SKD 106

Query: 617 GTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP 676
                  + +         + K+AL T  AL  + H  +   +HRD+ A +  +    E 
Sbjct: 107 EKLKPPPLST---------KQKVALCTQIALG-MDHLSNARFVHRDLAARNCLVSSQREV 156

Query: 677 RLSDFGLAK--------IFGNGLDEEIARGSP-GYIPPEFAQPDSDFPTPKSDVYCYGVV 727
           ++S   L+K           N L        P  ++ PE  Q D DF T KSDV+ +GV+
Sbjct: 157 KVSLLSLSKDVYNSEYYKLRNAL-------IPLRWLAPEAVQED-DFST-KSDVWSFGVL 207

Query: 728 LLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKI 786
           + E+ T G+ P      EE            V N   +     K+    PE       K+
Sbjct: 208 MWEVFTQGELPFYGLSDEE------------VLNRLQAG----KLELPVPEGCPSRLYKL 251

Query: 787 GYLCTADLPLKRPSMQQIVGLLKD 810
              C A  P  RPS  ++V  L +
Sbjct: 252 MTRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 56/248 (22%)

Query: 512 RGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---------ARELEYLGRI 561
           +G L+  G FG VY G     G  +AVK +   S     +          ARE+  L  +
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           +H N+V   G  +  D      +Y+  G++  LL                          
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL-------------------------- 97

Query: 622 QNVGS--EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
            N G+  E L+    F  +I  G    L +LH   +  IIHRDIK +++ +D     ++S
Sbjct: 98  NNYGAFEETLVRN--FVRQILKG----LNYLH---NRGIIHRDIKGANILVDNKGGIKIS 148

Query: 680 DFGLAK-------IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
           DFG++K                  +GS  ++ PE  +  S   T K+D++  G +++E++
Sbjct: 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY--TRKADIWSLGCLVVEML 206

Query: 733 TGKKPLGD 740
           TGK P  D
Sbjct: 207 TGKHPFPD 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 64/244 (26%), Positives = 109/244 (44%), Gaps = 56/244 (22%)

Query: 512 RGTLLAEGKFGPVYRGFLPGGIHVAVK-VLVHGSTLTDQEAAR--------ELEYLGRIK 562
           +G +L +G +G VY G    G  +AVK V +  S   +  AA         E++ L  +K
Sbjct: 4   KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTS---NVLAAEKEYEKLQEEVDLLKSLK 60

Query: 563 HPNLVPLTGYCIAGDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           H N+V   G C+  D  I+I+ +++  G++ ++L                          
Sbjct: 61  HVNIVQYLGTCLD-DNTISIFMEFVPGGSISSIL-------------------------- 93

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
              G        ++  +I  G    +A+LH+ C   ++HRDIK ++V L  N   +L DF
Sbjct: 94  NRFGPLPEPVFCKYTKQILDG----VAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDF 146

Query: 682 GLAK----IFGNGLDEEI---ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
           G A+    +  +G    +     G+P ++ PE    +S +   KSD++  G  + E+ TG
Sbjct: 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN-ESGYGR-KSDIWSIGCTVFEMATG 204

Query: 735 KKPL 738
           K PL
Sbjct: 205 KPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 75/302 (24%), Positives = 132/302 (43%), Gaps = 54/302 (17%)

Query: 515 LLAEGKFGPVYRGFLPGG---IHVAVKVLVHGSTLTD-QEAARELEYLGRI-KHPNLVPL 569
           ++ EG FG V +  +      +  A+K +   ++  D ++ A ELE L ++  HPN++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 570 TGYCI-AGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
            G C   G   +AI +Y  +GNL + L    + ++T   ++      + T S   + S+ 
Sbjct: 62  LGACEHRGYLYLAI-EYAPHGNLLDFLRKSRV-LETDPAFA----IANSTAS--TLSSQQ 113

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           LL    F   +A G       + +      IHRD+ A ++ +  N   +++DFGL++   
Sbjct: 114 LL---HFAADVARG-------MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--- 160

Query: 689 NGLDEEI-ARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT--GKKPLGDDY 742
               +E+  + + G +P  +   +S      T  SDV+ YGV+L E+++  G    G   
Sbjct: 161 ---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 217

Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
            E  E           +  +G R   P   D       +E   +   C  + P +RPS  
Sbjct: 218 AELYE-----------KLPQGYRLEKPLNCD-------DEVYDLMRQCWREKPYERPSFA 259

Query: 803 QI 804
           QI
Sbjct: 260 QI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 64.4 bits (158), Expect = 4e-11
 Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 53/240 (22%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE-------AARELEYLGRI 561
           +++   L EG +G VY+      G  VA+K +       D E       A RE+  L  +
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL-----DNEEEGIPSTALREISLLKEL 55

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           KHPN+V L        +   +++Y +  +L+  L   P  +                  I
Sbjct: 56  KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL--------------I 100

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           +                I     R LA+ H      I+HRD+K  ++ ++ +   +L+DF
Sbjct: 101 K---------------SIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADF 142

Query: 682 GLAKIFG---NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           GLA+ FG        E+   +  Y  PE     S   +   D++  G +  E+ITG KPL
Sbjct: 143 GLARAFGIPLRTYTHEVV--TLWYRAPEILL-GSKHYSTAVDIWSVGCIFAEMITG-KPL 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.7 bits (160), Expect = 5e-11
 Identities = 54/173 (31%), Positives = 88/173 (50%), Gaps = 29/173 (16%)

Query: 635 FR-HKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           FR H+  L   + L  +HH  S  +IHRDIK++++ L  N   +L DFG +K++   + +
Sbjct: 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199

Query: 694 EIAR---GSPGYIPPEF--AQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDYPEEKE 747
           ++ R   G+P Y+ PE    +P S     K+D++  GV+L EL+T K+P  G++  E   
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKPYSK----KADMFSLGVLLYELLTLKRPFDGENMEE--- 252

Query: 748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
                     V +   +   DP      PE  M+E   +  L ++D P +RPS
Sbjct: 253 ----------VMHKTLAGRYDPLPPSISPE--MQEI--VTALLSSD-PKRRPS 290

Length = 496

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 61/304 (20%), Positives = 111/304 (36%), Gaps = 58/304 (19%)

Query: 509 NFDRGTLLAEGKFGPVYR-GFLPGGIHVAVKVLVHGSTLTDQE---AARELEYLGRIKHP 564
           +F     L +G +G VY+   L      A+K  V   +++ +E   A  E+  L  + HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKE-VDLGSMSQKEREDAVNEIRILASVNHP 59

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLL-HDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           N++      + G++   + +Y   G+L   +           E                 
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQ---------------- 103

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
                    WR   ++  G    L  LH      I+HRD+K++++ L  N   ++ D G+
Sbjct: 104 -------EIWRIFIQLLRG----LQALH---EQKILHRDLKSANILLVANDLVKIGDLGI 149

Query: 684 AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGKKPLGDDY 742
           +K+    + +    G+P Y+ PE  +     P + KSD++  G +L E+ T   P     
Sbjct: 150 SKVLKKNMAKTQI-GTPHYMAPEVWK---GRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205

Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
            ++                K  R   P I    P    ++            P  RP+  
Sbjct: 206 MQD-------------LRYKVQRGKYPPI----PPIYSQDLQNFIRSMLQVKPKLRPNCD 248

Query: 803 QIVG 806
           +I+ 
Sbjct: 249 KILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 61/296 (20%)

Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRE---------------------CNRQEVNAVVLL---- 107

Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++    +  +
Sbjct: 108 ---YMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL----MTGD 157

Query: 695 IARGSPGY-IPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEG 748
                 G   P ++  P+S     F   KSDV+ +GV+L E+ T G  P    YP    G
Sbjct: 158 TYTAHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSP----YP----G 208

Query: 749 NLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
             +S V  L+             R   PE    +  ++   C    P  RPS  +I
Sbjct: 209 IDLSQVYELLEKG---------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 63.2 bits (154), Expect = 8e-11
 Identities = 80/311 (25%), Positives = 123/311 (39%), Gaps = 68/311 (21%)

Query: 513 GTLLAEGKFGPVYRGF--LPGG--IHVAVKVLVHGSTLTDQEAARELEYLGR-IKHPNLV 567
           G  + EG+FG VY+G    P    I VAVK   + ++ + +E   +  Y+ R   HP++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L G     +  + I   ME   L  L   L    Q  +                     
Sbjct: 71  KLIGVIT--ENPVWI--VMELAPLGELRSYL----QVNKYSLD----------------- 105

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L +   + +++    + ALA+L    S   +HRDI A +V +      +L DFGL++  
Sbjct: 106 -LASLILYSYQL----STALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157

Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLE-LITGKKPLGDDYP 743
               DE   + S G +P ++  P+S +F   T  SDV+ +GV + E L+ G KP      
Sbjct: 158 E---DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF----- 209

Query: 744 EEKEGNLVSWVRG---LVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
                     V+    + R   G R   P      P         +   C A  P KRP 
Sbjct: 210 --------QGVKNNDVIGRIENGERL--PM-----PPNCPPTLYSLMTKCWAYDPSKRPR 254

Query: 801 MQQIVGLLKDI 811
             ++   L DI
Sbjct: 255 FTELKAQLSDI 265

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 46/239 (19%)

Query: 509 NFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTLTDQEAAR-ELEYLGRIKHPN 565
            ++    + EG FG +Y  +        V  ++ +    + ++EA++ E+  L ++KHPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           +V          +   + +Y + G+L   + +   GV  +ED                  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQ----------------- 102

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMN-LEPRLSDFGLA 684
               + +W    +I+LG       L H     I+HRDIK+ +++L  N +  +L DFG+A
Sbjct: 103 ----ILSWFV--QISLG-------LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149

Query: 685 KIFGNGLDEEIAR---GSPGYIPPEFAQ--PDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           +   + +  E+A    G+P Y+ PE  Q  P ++    K+D++  G VL EL T K P 
Sbjct: 150 RQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNN----KTDIWSLGCVLYELCTLKHPF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 63.0 bits (154), Expect = 1e-10
 Identities = 58/265 (21%), Positives = 92/265 (34%), Gaps = 79/265 (29%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVL----------VHGSTLTDQEAARELE 556
            +F  G ++ EG F  V            A+K+L          V            E E
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVK-------YVKIEKE 53

Query: 557 YLGRIK-HPNLVPLTGYCIAGDQR--IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTW 613
            L R+  HP ++ L  Y    D+     + +Y  NG L   +             S D  
Sbjct: 54  VLTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYG---------SLDE- 101

Query: 614 EEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMN 673
                   +   +E LL               AL +LH   S  IIHRD+K  ++ LD +
Sbjct: 102 -----KCTRFYAAEILL---------------ALEYLH---SKGIIHRDLKPENILLDKD 138

Query: 674 LEPRLSDFGLAKIFGNGLDEEIAR---------------------GSPGYIPPEFAQPDS 712
           +  +++DFG AK+       E  +                     G+  Y+ PE      
Sbjct: 139 MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP 198

Query: 713 DFPTPKSDVYCYGVVLLELITGKKP 737
                 SD++  G ++ +++TGK P
Sbjct: 199 --AGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 90/346 (26%), Positives = 139/346 (40%), Gaps = 70/346 (20%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIH-------VAVKVLVHGSTLTDQEA-ARELEYLGRI-KH 563
           G +L  G FG V       GI        VAVK+L  G+T ++ +A   EL+ L  I  H
Sbjct: 12  GKVLGHGAFGKVVEASA-FGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNH 70

Query: 564 PNLVPLTGYCIAGD-QRIAIYDYMENGNLQNLLH--------------DLPLGVQTTEDW 608
            N+V L G C   +   + I ++ + GNL N L                     +   + 
Sbjct: 71  LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130

Query: 609 S-TDTWEEDGTNSI---QNVGSEGLLTT--------WRFRHKI------ALGTARALAFL 650
           S  D   E G  S+   +   S    T         W+    +      +   AR + FL
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190

Query: 651 HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IFGNGLDEEIARGSPGYIPPEFAQ 709
               S   IHRD+ A ++ L  N   ++ DFGLA+ I+    D +  R     +P ++  
Sbjct: 191 ---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK---DPDYVRKGSARLPLKWMA 244

Query: 710 PDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSR 765
           P+S F    T +SDV+ +GV+L E+ + G  P    YP            G+  N +  +
Sbjct: 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASP----YP------------GVQINEEFCQ 288

Query: 766 AIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
            +    R   PE    E  +I   C    P +RP+   +V +L D+
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 66/258 (25%), Positives = 111/258 (43%), Gaps = 48/258 (18%)

Query: 513 GTLLAEGKFGPVYRGFLPGG---IHVAVKVL-VHGSTLTDQEA-ARELEYLGRIKHPNLV 567
           G  L EG+FG V  G L      + VAVK + +   T ++ E    E   +    HPN++
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 568 PLTGYCIAGDQR------IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
            L G C+   +       + I  +M++G+L + L    LG                    
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP----------------- 106

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           Q + ++ L+       K     A  + +L    S   IHRD+ A +  L+ N+   ++DF
Sbjct: 107 QYLPTQMLV-------KFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADF 156

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GL+K   NG  +   +G    +P ++   +S      T KSDV+ +GV + E+ T G+ P
Sbjct: 157 GLSKKIYNG--DYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Query: 738 LGDDYPEEKEGNLVSWVR 755
               YP  +   +  ++R
Sbjct: 215 ----YPGVENSEIYDYLR 228

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 48/195 (24%)

Query: 549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTT 605
           +E+ +E+  L  +KHPN+V    Y  + ++   +Y   DY E G+L   ++    GV   
Sbjct: 44  EESRKEVAVLSNMKHPNIVQ---YQESFEENGNLYIVMDYCEGGDLYKKINA-QRGVLFP 99

Query: 606 EDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA 665
           ED   D                     W    +I L        L H     I+HRDIK+
Sbjct: 100 EDQILD---------------------WFV--QICLA-------LKHVHDRKILHRDIKS 129

Query: 666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQ--PDSDFPTPKSD 720
            +++L  +   +L DFG+A++  + +  E+AR   G+P Y+ PE  +  P ++    KSD
Sbjct: 130 QNIFLTKDGTIKLGDFGIARVLNSTV--ELARTCIGTPYYLSPEICENRPYNN----KSD 183

Query: 721 VYCYGVVLLELITGK 735
           ++  G VL E+ T K
Sbjct: 184 IWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 62/256 (24%), Positives = 112/256 (43%), Gaps = 41/256 (16%)

Query: 490 IFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD 548
           I EK    ++  D     + F++   + +G  G VY    +  G  VA+K +        
Sbjct: 4   ILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60

Query: 549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDW 608
           +    E+  +   K+PN+V      + GD+   + +Y+  G+L +++             
Sbjct: 61  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------------- 107

Query: 609 STDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV 668
            T+T  ++G   I  V  E L               +AL FLH   S  +IHRDIK+ ++
Sbjct: 108 -TETCMDEG--QIAAVCRECL---------------QALDFLH---SNQVIHRDIKSDNI 146

Query: 669 YLDMNLEPRLSDFGL-AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
            L M+   +L+DFG  A+I           G+P ++ PE     +    PK D++  G++
Sbjct: 147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIM 204

Query: 728 LLELITGKKPLGDDYP 743
            +E++ G+ P  ++ P
Sbjct: 205 AIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 42/237 (17%)

Query: 516 LAEGKFGPVY-------RGFLPGG--------IHVAVKVLVHGSTLTDQ-EAARELEYLG 559
           L EG+FG V+         FL  G        + VAVK+L    T T + +  +E++ + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 560 RIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           R+K+PN++ L G C++ D    I +YMENG+L   L    +    T             N
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH-----------AN 121

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
           +I +V    LL        +A+  A  + +L    S   +HRD+   +  +  +   +++
Sbjct: 122 NIPSVSIANLL-------YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIA 171

Query: 680 DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           DFG+++   +G D    +G    +P  +   +S      T  SDV+ +GV L E+ T
Sbjct: 172 DFGMSRNLYSG-DYYRIQGR-AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 61.5 bits (150), Expect = 3e-10
 Identities = 39/120 (32%), Positives = 58/120 (48%), Gaps = 22/120 (18%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI----------FGNGLDEE 694
           AL +LH +G    IIHRD+K  ++ +D N   +L+DFGL+K+               D+ 
Sbjct: 105 ALEYLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160

Query: 695 IARGSPGYIPPE--FAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVS 752
           I  G+P YI PE    Q  S       D +  G +L E + G  P   + PEE   N+++
Sbjct: 161 IV-GTPDYIAPEVILGQGHS----KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 61.9 bits (151), Expect = 3e-10
 Identities = 65/267 (24%), Positives = 104/267 (38%), Gaps = 83/267 (31%)

Query: 505 SATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVK-VLVH----GSTLTDQEAARELEYL 558
           S   +++    L EG FG VY+   +  G  VA+K +L+H    G  +T   A RE++ L
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT---ALREIKIL 61

Query: 559 GRIKHPNLVPLTGYCI-----AGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWST 610
            ++KHPN+VPL    +     +  +R ++Y    YM+        HDL            
Sbjct: 62  KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--------HDL------------ 101

Query: 611 DTWEEDGTNSIQNVGSEGLLTTWRFRHK------IALGTARALAFLHHGCSPPIIHRDIK 664
                            GLL     +          L     + +LH      I+HRDIK
Sbjct: 102 ----------------SGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIK 142

Query: 665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI-ARGSPG---------------YIPPEFA 708
           A+++ +D     +++DFGLA+ +    D         G               Y PPE  
Sbjct: 143 AANILIDNQGILKIADFGLARPY----DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELL 198

Query: 709 QPDSDFPTPKSDVYCYGVVLLELITGK 735
             +  + T   D++  G V  E+ T +
Sbjct: 199 LGERRY-TTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 54/268 (20%)

Query: 493 KPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEA 551
           + L +I  + L      F+   ++  G +G VY+G  +  G   A+KV+   +   ++E 
Sbjct: 1   RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEI 59

Query: 552 ARELEYLGRIKH-PNLVPLTGYCIA------GDQRIAIYDYMENGNLQNLLHDLPLGVQT 604
             E+  L +  H  N+    G  I        DQ   + ++   G++ +L+ +   G   
Sbjct: 60  KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNAL 118

Query: 605 TEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK 664
            EDW            I  +  E L               R LA LH   +  +IHRDIK
Sbjct: 119 KEDW------------IAYICREIL---------------RGLAHLH---AHKVIHRDIK 148

Query: 665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPEF----AQPDSDFP 715
             +V L  N E +L DFG++      LD  + R     G+P ++ PE       PD+ + 
Sbjct: 149 GQNVLLTENAEVKLVDFGVSA----QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 204

Query: 716 TPKSDVYCYGVVLLELITGKKPLGDDYP 743
             +SD++  G+  +E+  G  PL D +P
Sbjct: 205 Y-RSDIWSLGITAIEMAEGAPPLCDMHP 231

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 86/316 (27%), Positives = 131/316 (41%), Gaps = 56/316 (17%)

Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V R    G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQTTEDWSTDTWEEDGTNSI 621
           H N++ L G C        I +Y   GNL+  L    P G   T D          T   
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD---------ITKV- 126

Query: 622 QNVGSEGLLTTWRFRHKI--ALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                E  L+   F+  +  A   AR + +L    S   IHRD+ A +V +  +   +++
Sbjct: 127 ----PEEQLS---FKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIA 176

Query: 680 DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GK 735
           DFGLA+  G    +   + S G +P ++  P++ F    T +SDV+ +G+++ E+ T G 
Sbjct: 177 DFGLAR--GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234

Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
            P    YP      L   +R      +G R   P          M E       C   +P
Sbjct: 235 SP----YPGIPVEELFKLLR------EGHRMDKPSNCTHELYMLMRE-------CWHAVP 277

Query: 796 LKRPSMQQIVGLLKDI 811
            +RP+ +Q+V  L  +
Sbjct: 278 TQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 80/317 (25%), Positives = 139/317 (43%), Gaps = 73/317 (23%)

Query: 515 LLAEGKFGPVYRGFL----PGGIHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++ +G FG VY G L       IH AVK L   + +TD E   +    G I     HPN+
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSL---NRITDLEEVEQFLKEGIIMKDFSHPNV 58

Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                   E    +++++ 
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS-----------------ETHNPTVKDLI 101

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
             GL              A+ + +L    S   +HRD+ A +  LD +   +++DFGLA+
Sbjct: 102 GFGL------------QVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Query: 686 IFGNGLDEE---IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKP 737
              +  D+E   +   +   +P ++   +S     F T KSDV+ +GV+L EL+T G  P
Sbjct: 147 ---DIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPP 202

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
               YP+    ++  ++       +G R + P+     P+   E  L     C    P  
Sbjct: 203 ----YPDVDSFDITVYLL------QGRRLLQPEY---CPDPLYEVMLS----CWHPKPEM 245

Query: 798 RPSMQQIVGLLKDIEST 814
           RP+  ++V  ++ I ST
Sbjct: 246 RPTFSELVSRIEQIFST 262

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 8/104 (7%)

Query: 638 KIALGTARALAFL--HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
           K+ +   +AL +L   HG    +IHRD+K S++ LD +   +L DFG++    +   +  
Sbjct: 118 KMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTR 173

Query: 696 ARGSPGYIPPEFAQPDSDFPT--PKSDVYCYGVVLLELITGKKP 737
           + G   Y+ PE   P    P    ++DV+  G+ L+EL TG+ P
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 55/242 (22%), Positives = 102/242 (42%), Gaps = 48/242 (19%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA----ARELEYLGRI 561
             NF     + +G+F  VY+   L  G  VA+K  V    + D +A     +E++ L ++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKK-VQIFEMMDAKARQDCLKEIDLLKQL 59

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
            HPN++      I  ++   + +  + G+L  +                          I
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRM--------------------------I 93

Query: 622 QNVGSEGLL----TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
           ++   +  L    T W++  ++      AL  +H   S  I+HRDIK ++V++      +
Sbjct: 94  KHFKKQKRLIPERTIWKYFVQLC----SALEHMH---SKRIMHRDIKPANVFITATGVVK 146

Query: 678 LSDFGLAKIFGNGLDEEIAR-GSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGK 735
           L D GL + F +      +  G+P Y+ PE    +  +F   KSD++  G +L E+   +
Sbjct: 147 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF---KSDIWSLGCLLYEMAALQ 203

Query: 736 KP 737
            P
Sbjct: 204 SP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 57/275 (20%)

Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGS-TLTDQEAARELEYLGRI 561
           +   R  +L  G FG VY+G ++P G    I VA+K+L   +    + E   E   +  +
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
            HP+LV L G C++   ++ +   M +G L + +H+                 +D     
Sbjct: 67  DHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHE----------------HKD----- 104

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 105 -NIGSQ-LLLNW------CVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDF 153

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKK 736
           GLA++     DE+      G +P ++   +      F T +SDV+ YGV + EL+T G K
Sbjct: 154 GLARLLEG--DEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGK 210

Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKI 771
           P  D  P  +  +L+          KG R   P I
Sbjct: 211 PY-DGIPTREIPDLLE---------KGERLPQPPI 235

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 63/238 (26%), Positives = 105/238 (44%), Gaps = 47/238 (19%)

Query: 516 LAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPL-TGYC 573
           L +G FG VY+      G+  A K++   S    ++   E++ L   KHPN+V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 574 IAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTW 633
                 I I ++ + G L +++ +L  G+  TE              I+ V  + L    
Sbjct: 73  YENKLWILI-EFCDGGALDSIMLELERGL--TEP------------QIRYVCRQML---- 113

Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGLD 692
                       AL FLH   S  +IHRD+KA ++ L ++ + +L+DFG+ AK       
Sbjct: 114 -----------EALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK----NKS 155

Query: 693 EEIAR----GSPGYIPPEFAQPDSDFPTP---KSDVYCYGVVLLELITGKKPLGDDYP 743
               R    G+P ++ PE    ++    P   K+D++  G+ L+EL   + P  +  P
Sbjct: 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 60.8 bits (148), Expect = 6e-10
 Identities = 43/115 (37%), Positives = 59/115 (51%), Gaps = 21/115 (18%)

Query: 638 KIALGTARALAFL---HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
           KIA+ T +AL +L          IIHRD+K S++ LD N   +L DFG   I G  L + 
Sbjct: 111 KIAVATVKALNYLKEELK-----IIHRDVKPSNILLDRNGNIKLCDFG---ISGQ-LVDS 161

Query: 695 IAR----GSPGYIPPEFAQPDSDFPTP-KSDVYCYGVVLLELITGKKPLGDDYPE 744
           IA+    G   Y+ PE   P +      +SDV+  G+ L E+ TGK P    YP+
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP----YPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 60.9 bits (147), Expect = 7e-10
 Identities = 62/256 (24%), Positives = 112/256 (43%), Gaps = 41/256 (16%)

Query: 490 IFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD 548
           I EK    ++  D     + F++   + +G  G VY    +  G  VA++ +        
Sbjct: 5   ILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61

Query: 549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDW 608
           +    E+  +   K+PN+V      + GD+   + +Y+  G+L +++             
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------------- 108

Query: 609 STDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV 668
            T+T  ++G   I  V  E L               +AL FLH   S  +IHRDIK+ ++
Sbjct: 109 -TETCMDEG--QIAAVCRECL---------------QALEFLH---SNQVIHRDIKSDNI 147

Query: 669 YLDMNLEPRLSDFGL-AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
            L M+   +L+DFG  A+I           G+P ++ PE     +    PK D++  G++
Sbjct: 148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIM 205

Query: 728 LLELITGKKPLGDDYP 743
            +E+I G+ P  ++ P
Sbjct: 206 AIEMIEGEPPYLNENP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 9e-10
 Identities = 60/241 (24%), Positives = 101/241 (41%), Gaps = 55/241 (22%)

Query: 516 LAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEA----ARELEYLGRIKHPNLVPLT 570
           +  G +G VY+   +  G  VA+KV+     L   +      +E+  L   +HPN+V   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVI----KLEPGDDFEIIQQEISMLKECRHPNIVAYF 66

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDL--PLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           G  +  D+   + +Y   G+LQ++      PL              E     I  V  E 
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL-------------SEL---QIAYVCRET 110

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           L               + LA+LH       IHRDIK +++ L  + + +L+DFG++    
Sbjct: 111 L---------------KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ-- 150

Query: 689 NGLDEEIAR-----GSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGKKPLGDDY 742
             L   IA+     G+P ++ PE A  +       K D++  G+  +EL   + P+ D +
Sbjct: 151 --LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208

Query: 743 P 743
           P
Sbjct: 209 P 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 46/234 (19%)

Query: 516 LAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAAR----ELEYLGRIKHPNLVPLT 570
           + +G  G VY    +  G  VA+K +     L  Q        E+  +   KHPN+V   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM----NLQQQPKKELIINEILVMRENKHPNIVNYL 82

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
              + GD+   + +Y+  G+L +++              T+T  ++G   I  V  E L 
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVV--------------TETCMDEG--QIAAVCRECL- 125

Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGN 689
                         +AL FLH   S  +IHRDIK+ ++ L M+   +L+DFG  A+I   
Sbjct: 126 --------------QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168

Query: 690 GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
                   G+P ++ PE     +    PK D++  G++ +E++ G+ P  ++ P
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.6 bits (147), Expect = 2e-09
 Identities = 35/103 (33%), Positives = 50/103 (48%)

Query: 81  LNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSI 140
           L L    + G +P++I     L+  +LS N+  G IP ++ S+ SL VL L  N F  SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 141 PPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGN 183
           P  L    SL  ++L+ N L+G +P   G       S N   N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 62/241 (25%), Positives = 100/241 (41%), Gaps = 47/241 (19%)

Query: 510 FDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQ--EAARELEYLGRIKHPNLV 567
           F +   + +G FG VY+G       V    ++      D+  +  +E+  L +   P + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
              G  + G +   I +Y+  G+  +LL   PL                          E
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPL-------------------------EE 100

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
             + T      I     + L +LH   S   IHRDIKA++V L    + +L+DFG+A   
Sbjct: 101 TYIAT------ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVA--- 148

Query: 688 GNGLDEEIAR----GSPGYIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY 742
           G   D +I R    G+P ++ PE   Q   DF   K+D++  G+  +EL  G+ P  D +
Sbjct: 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF---KADIWSLGITAIELAKGEPPNSDLH 205

Query: 743 P 743
           P
Sbjct: 206 P 206

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 67/252 (26%), Positives = 108/252 (42%), Gaps = 56/252 (22%)

Query: 510 FDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVL-VHGSTLTDQEAARELEYLGRIKH-PNL 566
           F+   L+  G +G VY+G  +  G   A+KV+ V G    ++E  +E+  L +  H  N+
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNI 65

Query: 567 VPLTGYCIA------GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
               G  I        DQ   + ++   G++ +L+ +   G    E+W            
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEW------------ 112

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
           I  +  E L               R L+ LH      +IHRDIK  +V L  N E +L D
Sbjct: 113 IAYICREIL---------------RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154

Query: 681 FGLAKIFGNGLDEEIAR-----GSPGYIPPEF----AQPDSDFPTPKSDVYCYGVVLLEL 731
           FG++      LD  + R     G+P ++ PE       PD+ +   KSD++  G+  +E+
Sbjct: 155 FGVSA----QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF-KSDLWSLGITAIEM 209

Query: 732 ITGKKPLGDDYP 743
             G  PL D +P
Sbjct: 210 AEGAPPLCDMHP 221

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 71/300 (23%), Positives = 131/300 (43%), Gaps = 59/300 (19%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+         VAVK +  G +++ +    E   +  ++H  LV L    + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA-VVT 71

Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRF 635
            +    I ++M  G+L + L                  + D  +         L     F
Sbjct: 72  KEPIYIITEFMAKGSLLDFL------------------KSDEGSKQP------LPKLIDF 107

Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
             +IA G    +AF+        IHRD++A+++ +  +L  +++DFGLA++  +  +E  
Sbjct: 108 SAQIAEG----MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYT 158

Query: 696 ARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
           AR    + P ++  P++     F T KSDV+ +G++L+E++T G+ P    YP      +
Sbjct: 159 AREGAKF-PIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIP----YPGMSNPEV 212

Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
              +R L R  +  R       +  PE+     ++    C  + P +RP+ + I  +L D
Sbjct: 213 ---IRALERGYRMPRP------ENCPEELYNIMMR----CWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 64/246 (26%), Positives = 111/246 (45%), Gaps = 53/246 (21%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG--STLTDQEAAR---ELEYLGRIK 562
           N+ RG LL +G FG VY  + +  G  +AVK +     S  T +E      E++ L  ++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 563 HPNLVPLTGYCIAGDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           H  +V   G C+  D+ ++I+ +YM  G++++ L                          
Sbjct: 63  HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLK------------------------- 96

Query: 622 QNVGSEGLLT---TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRL 678
               + G LT   T ++  +I  G    + +LH   S  I+HRDIK +++  D     +L
Sbjct: 97  ----AYGALTETVTRKYTRQILEG----VEYLH---SNMIVHRDIKGANILRDSAGNVKL 145

Query: 679 SDFGLAK----IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
            DFG +K    I  +G   +   G+P ++ PE    +      K+DV+  G  ++E++T 
Sbjct: 146 GDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY--GRKADVWSVGCTVVEMLTE 203

Query: 735 KKPLGD 740
           K P  +
Sbjct: 204 KPPWAE 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 30/93 (32%), Positives = 42/93 (45%), Gaps = 7/93 (7%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPP 705
           AL +LH   S  IIHRDIK  ++ LD      ++DF +A             G+PGY+ P
Sbjct: 112 ALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168

Query: 706 E-FAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           E   +          D +  GV   E + GK+P
Sbjct: 169 EVLCRQGYSVA---VDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 25/165 (15%)

Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG-LDEEIARGSPG 701
              A++++H      I+HRDIK  +++L      +L DFG++KI G+     E   G+P 
Sbjct: 110 IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166

Query: 702 YIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRN 760
           Y+ PE  Q    +F   KSD++  G VL EL+T K+            N ++ V  +V+ 
Sbjct: 167 YMSPELCQGVKYNF---KSDIWALGCVLYELLTLKRTFDAT-------NPLNLVVKIVQG 216

Query: 761 NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
           N                    E + + +      P KRP+  +++
Sbjct: 217 N----------YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 77/308 (25%), Positives = 128/308 (41%), Gaps = 52/308 (16%)

Query: 513 GTLLAEGKFGPVYRGFLPGG--------IHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G           VAVK+L   +T  D  +   E+E +  I K
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQTTEDWSTDTWEEDGTNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++   + +            
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ--------VPE 134

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           + +  + L++        A   AR + +L    S   IHRD+ A +V +  +   +++DF
Sbjct: 135 EQLSFKDLVSC-------AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADF 184

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
           GLA+   +   +   + + G +P ++  P++ F    T +SDV+ +GV+L E+ T G  P
Sbjct: 185 GLARDIHH--IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
               YP      L   ++   R +K             P     E   +   C   +P +
Sbjct: 243 ----YPGVPVEELFKLLKEGHRMDK-------------PSNCTNELYMMMRDCWHAVPSQ 285

Query: 798 RPSMQQIV 805
           RP+ +Q+V
Sbjct: 286 RPTFKQLV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 81/312 (25%), Positives = 127/312 (40%), Gaps = 65/312 (20%)

Query: 515 LLAEGKFGPVYRGFL----PGGIH-VAVKVLVHGSTLTD-----QEAARELEYLGRIKHP 564
           LL EG FG ++ G L    PG    V VK +   ++        QE+      L  + H 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCL----LYGLSHQ 68

Query: 565 NLVPLTGYCIA-GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           N++P+   CI  G+    +Y YM  GNL+  L    LG              +  N    
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG--------------EANNPQA- 113

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
                 L+T +  H +A+  A  +++LH      +IH+DI A +  +D  L+ +++D  L
Sbjct: 114 ------LSTQQLVH-MAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNAL 163

Query: 684 AK-IFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPL 738
           ++ +F          G     P ++   +S      +  SDV+ +GV+L EL+T G+ P 
Sbjct: 164 SRDLFPMDYH---CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220

Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
            +  P E    L            G R   P      P    +E   +   C A  P +R
Sbjct: 221 VEIDPFEMAAYL----------KDGYRLAQP---INCP----DELFAVMACCWALDPEER 263

Query: 799 PSMQQIVGLLKD 810
           PS  Q+V  L D
Sbjct: 264 PSFSQLVQCLTD 275

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 58.6 bits (141), Expect = 3e-09
 Identities = 56/236 (23%), Positives = 104/236 (44%), Gaps = 38/236 (16%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVP 568
           + R   + +G  G V+    +  G  VA+K +        +    E+  +  +K+PN+V 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
                + GD+   + +Y+  G+L +++              T+T  ++    I  V  E 
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLTDVV--------------TETCMDEA--QIAAVCREC 124

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIF 687
           L               +AL FLH   +  +IHRDIK+ +V L M+   +L+DFG  A+I 
Sbjct: 125 L---------------QALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166

Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
                     G+P ++ PE     +    PK D++  G++ +E++ G+ P  ++ P
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 57.9 bits (141), Expect = 3e-09
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 12/104 (11%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPG 701
           AL +LH  G    II+RD+K  ++ LD +   +L+DFGLAK   +           G+P 
Sbjct: 105 ALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPE 158

Query: 702 YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
           Y+ PE       +     D +  GV+L E++TGK P   +  +E
Sbjct: 159 YLAPEVLL-GKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKE 200

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 60/240 (25%), Positives = 93/240 (38%), Gaps = 58/240 (24%)

Query: 515 LLAEGKFGPVYRG--FLPGG--IHVAVKVLVHGSTLTD--QEAARELEYLGRIKHPNLVP 568
            L +G FG V RG     GG  I VAVK L     L+D   +  +E   +  + H NL+ 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK-LSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           L G  +     + + +    G+L + L    LG                           
Sbjct: 61  LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFL------------------------ 95

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           + T   +  +IA G    + +L    S   IHRD+ A ++ L  + + ++ DFGL +   
Sbjct: 96  ISTLCDYAVQIANG----MRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALP 148

Query: 689 NGLDE---EIARGSP-GYIPPE------FAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP 737
              D    E     P  +  PE      F        +  SDV+ +GV L E+ T G++P
Sbjct: 149 QNEDHYVMEEHLKVPFAWCAPESLRTRTF--------SHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 57.6 bits (140), Expect = 7e-09
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 43/189 (22%)

Query: 509 NFDRGTLLAEGKFGPVYRGF--LPGGIHVAVKVLVHGSTLTDQE-----AARELEYLGRI 561
            +++G  L EG +  VY+      G I VA+K +  G     ++     A RE++ L  +
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRI-VAIKKIKLGERKEAKDGINFTALREIKLLQEL 59

Query: 562 KHPNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
           KHPN++ L          I + +++ME  +L+ ++ D                      S
Sbjct: 60  KHPNIIGLLD-VFGHKSNINLVFEFME-TDLEKVIKD---------------------KS 96

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
           I  V +   + ++       L T R L +LH   S  I+HRD+K +++ +  +   +L+D
Sbjct: 97  I--VLTPADIKSY------MLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLAD 145

Query: 681 FGLAKIFGN 689
           FGLA+ FG+
Sbjct: 146 FGLARSFGS 154

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 36/192 (18%)

Query: 549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDW 608
           +++ +E   L ++KHPN+V       A      + +Y + G+L          +Q  +  
Sbjct: 43  EDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL----------MQKIKLQ 92

Query: 609 STDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV 668
               + ED              T  ++  ++ LG       + H     ++HRDIK+ ++
Sbjct: 93  RGKLFPED--------------TILQWFVQMCLG-------VQHIHEKRVLHRDIKSKNI 131

Query: 669 YLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPEFAQPDSDFP-TPKSDVYCYGV 726
           +L  N + +L DFG A++  +         G+P Y+PPE  +   + P   KSD++  G 
Sbjct: 132 FLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE---NMPYNNKSDIWSLGC 188

Query: 727 VLLELITGKKPL 738
           +L EL T K P 
Sbjct: 189 ILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.1 bits (143), Expect = 8e-09
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 50/216 (23%)

Query: 535 VAVKVLVHGSTLTDQEAAR---ELEYLGRIKHPNLVPLTGYCIAGDQRI-AIYDYMENGN 590
           VA+K+L   +   + + AR   E     R+ HPN+V L     A    + A+++Y+    
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 591 LQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFL 650
           L+ +L                             G+     T R    + L    ALA  
Sbjct: 66  LREVL--------------------------AADGALPAGETGR----LMLQVLDALACA 95

Query: 651 HHGCSPPIIHRDIKASSVYLDM-NLEP--RLSDFGLAKI---FGNGLDEEIAR-----GS 699
           H   +  I+HRD+K  ++ +    + P  ++ DFG+  +     +     + R     G+
Sbjct: 96  H---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGT 152

Query: 700 PGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
           P Y  PE  Q   +  TP SD+Y +G++ LE +TG+
Sbjct: 153 PTYCAPE--QLRGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 56.5 bits (136), Expect = 9e-09
 Identities = 77/302 (25%), Positives = 122/302 (40%), Gaps = 71/302 (23%)

Query: 515 LLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKHPNLVPLTG 571
           LL +G FG V++G L     VAVK       L  +   +   E   L +  HPN+V L G
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTC--KEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 572 YCIAGDQRIAIYDYME---NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
            C    QR  IY  ME    G+  + L                  ++D   + Q V    
Sbjct: 60  VCT---QRQPIYIVMELVPGGDFLSFLRK----------------KKDELKTKQLV---- 96

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
                    K AL  A  +A+L    S   IHRD+ A +  +  N   ++SDFG+++   
Sbjct: 97  ---------KFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQED 144

Query: 689 NGLDEEIARGSPGY--IPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
           +G+       S G   IP ++  P++      + +SDV+ YG++L E  + G  P    Y
Sbjct: 145 DGI-----YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCP----Y 195

Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
           P            G+  N +    ++   R + P+K  ++  K+   C    P  RP   
Sbjct: 196 P------------GMT-NQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFS 242

Query: 803 QI 804
           ++
Sbjct: 243 EL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 42/239 (17%)

Query: 516 LAEGKFGPVYRG--FLPGGIH---VAVKVLVHGSTLTD-QEAARELEYLGRIKHPNLVPL 569
           L E  FG +Y+G  +LPG  H   VA+K L   +      E  +E   +  + HPN+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL 629
            G          +++Y+  G+L   L  +     +    S+D   EDGT     V S   
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFL--IMRSPHSDVGCSSD---EDGT-----VKSS-- 120

Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IFG 688
           L    F H IA+  A  + +L    S   +H+D+ A ++ +   L  ++SD GL++ I+ 
Sbjct: 121 LDHGDFLH-IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176

Query: 689 NGLDEEIARGSPG------YIPPE---FAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP 737
                +  R  P       ++PPE   + +  SD     SD++ +GVVL E+ + G +P
Sbjct: 177 A----DYYRVQPKSLLPIRWMPPEAIMYGKFSSD-----SDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 56/261 (21%), Positives = 101/261 (38%), Gaps = 57/261 (21%)

Query: 509 NFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTLTDQEAAR-ELEYLGRIKHPN 565
            +++  ++  G FG V+  R      + +  ++ V   T  ++ AA+ E + L  + HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           ++      +     + + +Y   G L   +          +       +ED         
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYI----------QKRCNSLLDED--------- 101

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMN-LEPRLSDFGLA 684
                T   F  +I L        LHH  +  I+HRD+K  ++ LD + +  ++ DFG++
Sbjct: 102 -----TILHFFVQILLA-------LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149

Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK-------- 736
           KI  +        G+P YI PE  +        KSD++  G VL EL + K+        
Sbjct: 150 KILSSKSKAYTVVGTPCYISPELCE--GKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207

Query: 737 ------------PLGDDYPEE 745
                       P+ D Y  +
Sbjct: 208 ALVLKIMSGTFAPISDRYSPD 228

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 39/228 (17%)

Query: 516 LAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTG-YC 573
           L +G FG VY+      G   A KV+   S    ++   E+E L    HP +V L G + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 574 IAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTW 633
             G   I I ++   G +  ++ +L  G+   +              IQ +  + L    
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQ--------------IQVICRQML---- 120

Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGLD 692
                       AL +LH   S  IIHRD+KA +V L ++ + +L+DFG+ AK       
Sbjct: 121 -----------EALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166

Query: 693 EEIARGSPGYIPPEFAQPDSDFPTP---KSDVYCYGVVLLELITGKKP 737
            +   G+P ++ PE    ++   TP   K+D++  G+ L+E+   + P
Sbjct: 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 56.8 bits (138), Expect = 1e-08
 Identities = 57/242 (23%), Positives = 94/242 (38%), Gaps = 69/242 (28%)

Query: 518 EGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE-------AARELEYLGRIKHPNLVPL 569
           EG +G VY+      G  VA+K +       + E       A RE++ L +++HPN+V L
Sbjct: 9   EGTYGQVYKARNKKTGELVALKKI-----RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 570 TGYCIA-GDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
               I     + +IY   +YM++ +L  LL                    +   +   + 
Sbjct: 64  --KEIVTSKGKGSIYMVFEYMDH-DLTGLLD-----------------SPEVKFTESQIK 103

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
                                L +LH      I+HRDIK S++ ++ +   +L+DFGLA+
Sbjct: 104 C------------YMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148

Query: 686 IFGNGLDEEIARGSPGYI---------PPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
            +         R S  Y          PPE     + +  P+ D++  G +L EL  GK 
Sbjct: 149 PYTK-------RNSADYTNRVITLWYRPPELLLGATRY-GPEVDMWSVGCILAELFLGKP 200

Query: 737 PL 738
             
Sbjct: 201 IF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 49/192 (25%), Positives = 79/192 (41%), Gaps = 48/192 (25%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE-------AARELEYLG 559
           + F++   + EG +G VYR      G  VA+K         D E       + RE+  L 
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALK-----KVRMDNERDGIPISSLREITLLL 61

Query: 560 RIKHPNLVPLTGYCIAGDQRIAIYDYME--NGNLQNLLHDLPLGVQTTEDWSTDTWEEDG 617
            ++HPN+V L    + G    +I+  ME    +L +LL ++P     ++           
Sbjct: 62  NLRHPNIVELK-EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ----------- 109

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
                 V              + L   R L +LH      IIHRD+K S++ L      +
Sbjct: 110 ------VKC------------LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLK 148

Query: 678 LSDFGLAKIFGN 689
           ++DFGLA+ +G 
Sbjct: 149 IADFGLARTYGL 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 43/230 (18%)

Query: 516 LAEGKFGPVYR-GFLPGGIHVAVK-VLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYC 573
           L  G  G V +   +P G  +A K V +   +   ++  REL+ +   + P +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 574 IAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTW 633
           +  +      ++M+ G+L  +                   ++ G   ++ +G        
Sbjct: 73  LNENNICMCMEFMDCGSLDRIY------------------KKGGPIPVEILG-------- 106

Query: 634 RFRHKIALGTARALAFL---HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
               KIA+     L +L   H      I+HRDIK S++ ++   + +L DFG++    N 
Sbjct: 107 ----KIAVAVVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157

Query: 691 LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
           + +    G+  Y+ PE  Q      T KSDV+  G+ ++EL  GK P   
Sbjct: 158 IADTFV-GTSTYMSPERIQ--GGKYTVKSDVWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 45/188 (23%), Positives = 87/188 (46%), Gaps = 47/188 (25%)

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           +H N+V +    + GD+   + +++E G L +++                      T++ 
Sbjct: 75  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV----------------------THTR 112

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N   E +         + L   +AL+ LH   +  +IHRDIK+ S+ L  +   +LSDF
Sbjct: 113 MN--EEQIAA-------VCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDF 160

Query: 682 GLAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGK 735
           G    F   + +E+ R     G+P ++ PE     S  P  P+ D++  G++++E++ G+
Sbjct: 161 G----FCAQVSKEVPRRKSLVGTPYWMAPELI---SRLPYGPEVDIWSLGIMVIEMVDGE 213

Query: 736 KPLGDDYP 743
            P  ++ P
Sbjct: 214 PPYFNEPP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 5/95 (5%)

Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTP 717
           IIHRDIK  ++ +D     +L+DFGL++   NGL+ +   G+P Y+ PE      D    
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSR---NGLENKKFVGTPDYLAPETILGVGD--DK 172

Query: 718 KSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVS 752
            SD +  G V+ E + G  P   + P+    N++S
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 52/239 (21%), Positives = 95/239 (39%), Gaps = 47/239 (19%)

Query: 516 LAEGKFGPVYRGF-LPGGIHVAVK--VLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGY 572
           + EG +G VY+      G  VA+K   L   S    + A RE++ L  + HPN++ L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 573 CIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTT 632
                    ++++M+     +L   +                            +  L  
Sbjct: 67  FRHKGDLYLVFEFMD----TDLYKLIK-------------------------DRQRGLPE 97

Query: 633 WRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL 691
              +        + LAF H HG    I+HRD+K  ++ ++     +L+DFGLA+ FG+ +
Sbjct: 98  SLIKS-YLYQLLQGLAFCHSHG----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152

Query: 692 D---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GDDYPEE 745
                 +   +  Y  PE    D  + +   D++  G +  EL++  +PL  G    ++
Sbjct: 153 RPYTHYVV--TRWYRAPELLLGDKGY-STPVDIWSVGCIFAELLSR-RPLFPGKSEIDQ 207

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 73/271 (26%), Positives = 108/271 (39%), Gaps = 38/271 (14%)

Query: 51  KLSKLQSLDLSENNIT-----ALPSDLWSLGSLKSLNLSYN------RISGSLPSNIGNF 99
           KL  LQ L L  N +      AL S L    SLK L LS N      R   SL   +   
Sbjct: 21  KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80

Query: 100 GLLEVFDLSNNNFSGEIPAAISSL---VSLRVLKLDGNMFQWSIPP----GLLNCQ-SLV 151
             L+  DLS+N    +    + SL    SL+ LKL+ N            GL +   +L 
Sbjct: 81  CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140

Query: 152 TVDLSMNQLNGSLPDGFGAAFP---KLKSLNLAGNEIKGRDTH--FAGLKSITNL---NI 203
            + L  N+L G+  +    A      LK LNLA N I          GLK+  NL   ++
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200

Query: 204 SGNLF--QGSVM--GVF--LESLEVIDLRSNQFQGH-ISQVQFNSSYNWSRLVYVDLSEN 256
           + N    +G+         L+SLEV++L  N       + +          L+ + LS N
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260

Query: 257 QLSGEIFHNFSQAQ----NLKHLSLAYNRFT 283
            ++ +   + ++      +L  L L  N+F 
Sbjct: 261 DITDDGAKDLAEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 36/230 (15%)

Query: 515 LLAEGKFGPVYRGFLPGG---IHVAVKVLVHGSTLTD-QEAARELEYLGRI-KHPNLVPL 569
           ++ EG FG V +  +      +  A+K +   ++  D ++ A ELE L ++  HPN++ L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 570 TGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
            G C   + R  +Y   +Y  +GNL + L              +   E D   +I N  +
Sbjct: 74  LGAC---EHRGYLYLAIEYAPHGNLLDFLR------------KSRVLETDPAFAIAN-ST 117

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
              L++ +  H  A   AR + +L        IHRD+ A ++ +  N   +++DFGL++ 
Sbjct: 118 ASTLSSQQLLH-FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR- 172

Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                 E   + + G +P  +   +S      T  SDV+ YGV+L E+++
Sbjct: 173 ----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 3e-08
 Identities = 39/130 (30%), Positives = 62/130 (47%), Gaps = 23/130 (17%)

Query: 251 VDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDI 310
           + L    L G I ++ S+ ++L+ ++L+ N       P +G++  LE L+LS  S  G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 311 PSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERF 370
           P  + QL+SL  L+L+ N L                      SG +PA+L  +L     F
Sbjct: 483 PESLGQLTSLRILNLNGNSL----------------------SGRVPAALGGRLLHRASF 520

Query: 371 NFSYNNLTLC 380
           NF+ +N  LC
Sbjct: 521 NFT-DNAGLC 529

Length = 623

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 33/85 (38%), Positives = 47/85 (55%), Gaps = 5/85 (5%)

Query: 659 IHRDIKASSVYLDMNLEPRLSDFG-LAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFP- 715
           +HRDIK  +V LDMN   RL+DFG   K+  +G +   +A G+P YI PE  Q   D   
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 716 --TPKSDVYCYGVVLLELITGKKPL 738
              P+ D +  GV + E++ G+ P 
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 12/103 (11%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----GSP 700
           + L +LH   S   IHRDIKA++V L    + +L+DFG+A   G   D +I R    G+P
Sbjct: 112 KGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTP 165

Query: 701 GYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
            ++ PE  Q  +     K+D++  G+  +EL  G+ P  D +P
Sbjct: 166 FWMAPEVIQQSA--YDSKADIWSLGITAIELAKGEPPNSDMHP 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 5/99 (5%)

Query: 659 IHRDIKASSVYLDMNLEPRLSDFG-LAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFP- 715
           +HRDIK  ++ +DMN   RL+DFG   K+  +G +   +A G+P YI PE  Q   D   
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 716 --TPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVS 752
              P+ D +  GV + E++ G+ P   +   E  G +++
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 76/307 (24%), Positives = 119/307 (38%), Gaps = 48/307 (15%)

Query: 516 LAEGKFGPV--YRGFLPG----GIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVP 568
           L EG FG V  Y  + P     G  VAVK L       +     +E+  L  + H N+V 
Sbjct: 12  LGEGHFGKVSLYC-YDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
             G C     +           LQ ++  +PLG  +  D+               +    
Sbjct: 71  YKGCCSEQGGKG----------LQLIMEYVPLG--SLRDYLPK----------HKLNLAQ 108

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           LL    F  +I  G    +A+LH   S   IHRD+ A +V LD +   ++ DFGLAK   
Sbjct: 109 LLL---FAQQICEG----MAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158

Query: 689 NGLDEEIARGSPGYIPPEFAQPDSDFPTPK----SDVYCYGVVLLELITGKKPLGDDYPE 744
            G   E  R       P F          K    SDV+ +GV L EL+T         P 
Sbjct: 159 EG--HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDS--KQSPP 214

Query: 745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +K   ++   +G +   +    ++  +R   P+   +E   +   C       RP+ + +
Sbjct: 215 KKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL 274

Query: 805 VGLLKDI 811
           + +LK++
Sbjct: 275 IPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)

Query: 535 VAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQN 593
           VAVK+L   +    + +  +E++ L R+K PN++ L G C+  D    I +YMENG+L  
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 594 LLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRH--KIALGTARALAFLH 651
            L             S+   ++   N    V     L    +     +AL  A  + +L 
Sbjct: 109 FL-------------SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL- 154

Query: 652 HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
              S   +HRD+   +  +  NL  +++DFG+++
Sbjct: 155 --SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 55.6 bits (134), Expect = 5e-08
 Identities = 58/240 (24%), Positives = 103/240 (42%), Gaps = 47/240 (19%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLV--HGSTLTDQEAARELEYLGRIKHP 564
           S  +R   +  G  G VY+    P G   A+KV+   H  T+  Q   RE+E L  + HP
Sbjct: 74  SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ-ICREIEILRDVNHP 132

Query: 565 NLVPLTG-YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           N+V     +   G+ ++ + ++M+ G+L+                 T   +E        
Sbjct: 133 NVVKCHDMFDHNGEIQV-LLEFMDGGSLEG----------------THIADE-------- 167

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
                     +F   +A      +A+LH      I+HRDIK S++ ++     +++DFG+
Sbjct: 168 ----------QFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGV 214

Query: 684 AKIFGNGLDE-EIARGSPGYIPPEFAQPDSD---FPTPKSDVYCYGVVLLELITGKKPLG 739
           ++I    +D    + G+  Y+ PE    D +   +     D++  GV +LE   G+ P G
Sbjct: 215 SRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274

Length = 353

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 35/166 (21%)

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALA----FLHHGCSPPIIHRDIKASSVYLDMNLEP 676
           IQ VG        RF+   A+  A  +A    FLH   S  II+RD+K  +V LD     
Sbjct: 92  IQQVG--------RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHI 140

Query: 677 RLSDFGLAKI-FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITG 734
           +++DFG+ K    +G+  +   G+P YI PE        P  KS D + +GV+L E++ G
Sbjct: 141 KIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVLLYEMLAG 197

Query: 735 KKPL-GDD--------------YPEEKEGNLVSWVRGLVRNNKGSR 765
           + P  G+D              YP+      V+  +GL+  + G R
Sbjct: 198 QAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 45/233 (19%)

Query: 515 LLAEGKFGPVYRG-FLPGG----IHVAVKVLVHG-STLTDQEAARELEYLGRIKHPNLVP 568
           +L  G FG VY+G ++P G    I VA+KVL    S   ++E   E   +  +  P +  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           L G C+    ++ +   M  G L +        V+  +D                +GS+ 
Sbjct: 74  LLGICLTSTVQL-VTQLMPYGCLLDY-------VRENKD---------------RIGSQD 110

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           LL  W       +  A+ +++L       ++HRD+ A +V +      +++DFGLA++  
Sbjct: 111 LLN-W------CVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL- 159

Query: 689 NGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
             +DE       G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 160 -DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 52/234 (22%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           + +G+FG V  G   G   VAVK + + +T   Q    E   + +++H NLV L G  + 
Sbjct: 14  IGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWR 634
               + I  +YM  G+L + L      V                     +G + LL    
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSV---------------------LGGDCLL---- 105

Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
              K +L    A+ +L    +   +HRD+ A +V +  +   ++SDFGL K       E 
Sbjct: 106 ---KFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EA 152

Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
            +    G +P ++  P++     F T KSDV+ +G++L E+ + G+ P    YP
Sbjct: 153 SSTQDTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVP----YP 201

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 80/322 (24%), Positives = 128/322 (39%), Gaps = 67/322 (20%)

Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 40  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 99

Query: 592 QNLLHD-----LPLGVQTTE---------DWSTDTWEE-DGTNSIQNVGSEGLLTTWRF- 635
            N L       +P   +            D S D     D   S Q+  S G +      
Sbjct: 100 SNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159

Query: 636 -------------------RHKI--ALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNL 674
                                 I  +   A+ + FL    S   IHRD+ A ++ L  N 
Sbjct: 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENN 216

Query: 675 EPRLSDFGLAK-IFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLE 730
             ++ DFGLA+ I+    D +  R     +P ++  P++ F    T +SDV+ +GV+L E
Sbjct: 217 VVKICDFGLARDIYK---DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 273

Query: 731 LIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL 789
           + + G  P    YP            G+  + +  R +    R   P+    E  +    
Sbjct: 274 IFSLGASP----YP------------GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 317

Query: 790 CTADLPLKRPSMQQIVGLLKDI 811
           C    P +RP+  ++V  L ++
Sbjct: 318 CWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.9 bits (132), Expect = 6e-08
 Identities = 37/95 (38%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK--IFGNGLDEEIARGSPGYI 703
           AL FLH      II+RD+K  +V LD     +L+DFG+ K  IF NG       G+P YI
Sbjct: 108 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTPDYI 163

Query: 704 PPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            PE  Q       P  D +  GV+L E++ G  P 
Sbjct: 164 APEILQ--EMLYGPSVDWWAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 54.2 bits (131), Expect = 7e-08
 Identities = 65/234 (27%), Positives = 91/234 (38%), Gaps = 47/234 (20%)

Query: 516 LAEGKFGPVYRGFL-PGGIHVAVKVLV-HGSTLTDQEA--ARELEYLGRIKHPNLVPLTG 571
           L  G FG V    +       A+K +       T Q+     E E L    HP +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 572 YCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           Y    D++  IY   +Y   G L  +L D                              G
Sbjct: 59  YRTFKDKK-YIYMLMEYCLGGELWTILRD-----------------------------RG 88

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           L   +  R  IA     A  +LH   +  II+RD+K  ++ LD N   +L DFG AK   
Sbjct: 89  LFDEYTARFYIA-CVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK 144

Query: 689 NGLDEEIARGSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
           +G       G+P Y+ PE       DF     D +  G++L EL+TG+ P G+D
Sbjct: 145 SGQKTWTFCGTPEYVAPEIILNKGYDF---SVDYWSLGILLYELLTGRPPFGED 195

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 54.3 bits (131), Expect = 7e-08
 Identities = 67/264 (25%), Positives = 109/264 (41%), Gaps = 66/264 (25%)

Query: 510 FDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPN 565
           +++ + + EG +G V+  R    G I VA+K  V      +  + A RE+  L ++KHPN
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNRETGQI-VAIKKFVESEDDPVIKKIALREIRMLKQLKHPN 61

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDL---PLGVQTTEDWSTDTWEEDGTNSIQ 622
           LV L        +   +++Y ++     +L++L   P GV            E     I 
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYCDH----TVLNELEKNPRGV-----------PEHLIKKI- 105

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                     W+        T +A+ F H H C    IHRD+K  ++ +    + +L DF
Sbjct: 106 ---------IWQ--------TLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDF 144

Query: 682 GLAKIFGNGLDEEIAR--GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG----- 734
           G A+I   G  ++      +  Y  PE    D+ +  P  DV+  G V  EL+TG     
Sbjct: 145 GFARIL-TGPGDDYTDYVATRWYRAPELLVGDTQYGPP-VDVWAIGCVFAELLTGQPLWP 202

Query: 735 -----------KKPLGDDYPEEKE 747
                      +K LGD  P  ++
Sbjct: 203 GKSDVDQLYLIRKTLGDLIPRHQQ 226

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 54.8 bits (132), Expect = 8e-08
 Identities = 53/167 (31%), Positives = 76/167 (45%), Gaps = 37/167 (22%)

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALA----FLHHGCSPPIIHRDIKASSVYLDMNLEP 676
           IQ VG        +F+   A+  A  +A    FLH   S  II+RD+K  +V LD     
Sbjct: 92  IQQVG--------KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHI 140

Query: 677 RLSDFGLAK--IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELIT 733
           +++DFG+ K  IFG G       G+P YI PE        P  KS D + +GV+L E++ 
Sbjct: 141 KIADFGMCKENIFG-GKTTRTFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVLLYEMLA 196

Query: 734 GKKPL-GDD--------------YPEEKEGNLVSWVRGLVRNNKGSR 765
           G+ P  G+D              YP+      VS  +GL+  +   R
Sbjct: 197 GQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 51/246 (20%), Positives = 97/246 (39%), Gaps = 48/246 (19%)

Query: 509 NFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTLTDQEAA-----RELEYLGRI 561
            + +G  L  G F   Y  R    G +    +V    +T ++QE       +E+  + R+
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
            HP+++ + G            ++M  G++ +LL                 ++E      
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY------------GAFKEAVII-- 106

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP-RLSD 680
                        +  ++  G    L++LH      IIHRD+K +++ +D   +  R++D
Sbjct: 107 ------------NYTEQLLRG----LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIAD 147

Query: 681 FGLA-----KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
           FG A     K  G G  +    G+  ++ PE  + +        DV+  G V++E+ T K
Sbjct: 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ--YGRSCDVWSVGCVIIEMATAK 205

Query: 736 KPLGDD 741
            P   +
Sbjct: 206 PPWNAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 58/249 (23%), Positives = 108/249 (43%), Gaps = 52/249 (20%)

Query: 532 GIHVAVKVLVHGSTLTDQEAARELEY-----LGRIKHPNLVPLTGYCIAGDQRIAIYDYM 586
           G  VAVK++     L  Q+  REL +     +   +H N+V +    + G++   + +++
Sbjct: 46  GRQVAVKMM----DLRKQQR-RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100

Query: 587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARA 646
           + G L +++    L     E  +T                            +     +A
Sbjct: 101 QGGALTDIVSQTRL---NEEQIAT----------------------------VCESVLQA 129

Query: 647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGLDEEIARGSPGYIPP 705
           L +LH   S  +IHRDIK+ S+ L ++   +LSDFG  A+I  +    +   G+P ++ P
Sbjct: 130 LCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186

Query: 706 EFAQPDSDFP-TPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGS 764
           E     S  P   + D++  G++++E++ G+ P   D P +    L       ++N   +
Sbjct: 187 EVI---SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN---A 240

Query: 765 RAIDPKIRD 773
             I P +RD
Sbjct: 241 HKISPVLRD 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 58/242 (23%), Positives = 94/242 (38%), Gaps = 66/242 (27%)

Query: 515 LLAEGKFGPVY--RGFLPGGIHVAVKVL--VHGSTLTDQEAARELEYLGRIKHPNLVPLT 570
           ++ EG +G V   R    G I VA+K            + A RE++ L +++H N+V L 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEI-VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDL---PLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
                  +   +++Y+E    + LL  L   P G+             D   S       
Sbjct: 67  EAFRRKGRLYLVFEYVE----RTLLELLEASPGGL-----------PPDAVRSY------ 105

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
                W+          +A+A+ H   S  IIHRDIK  ++ +  +   +L DFG A+  
Sbjct: 106 ----IWQ--------LLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARAL 150

Query: 688 GNGLDEEIARGSPG-----------YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
                    R  P            Y  PE    D+++     DV+  G ++ EL+ G +
Sbjct: 151 ---------RARPASPLTDYVATRWYRAPELLVGDTNY-GKPVDVWAIGCIMAELLDG-E 199

Query: 737 PL 738
           PL
Sbjct: 200 PL 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 58/250 (23%), Positives = 95/250 (38%), Gaps = 54/250 (21%)

Query: 516 LAEGKFGPVYRGFL-------PGGIHVAVKVLVH--GSTLTDQEAAREL-EYLGRIKHPN 565
           L +G F  +Y+G L         G    V V++   GS   D  A  E    + ++ H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           LV L G C+  D+ I + +Y++ G L   LH     V                       
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLH-------------------- 101

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL---DMNLEP----RL 678
                  W+    +A   A AL +L       ++H ++   ++ +    +N       +L
Sbjct: 102 -------WKL--DVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149

Query: 679 SDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP 737
           SD G+         EE     P +I PE  +      T  +D + +G  LLE+ + G++P
Sbjct: 150 SDPGIPI--TVLSREERVERIP-WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP 206

Query: 738 LGDDYPEEKE 747
           L      EKE
Sbjct: 207 LSTLSSSEKE 216

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 23/137 (16%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYI 703
           AL FLH HG    +I+RD+K  ++ LD     +L+DFG+ K    NG+      G+P YI
Sbjct: 108 ALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYI 163

Query: 704 PPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP-------------LGDD--YPEEKEG 748
            PE  Q + ++  P  D +  GV++ E++ G+ P             L DD  YP     
Sbjct: 164 APEILQ-ELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSK 221

Query: 749 NLVSWVRGLVRNNKGSR 765
             VS ++  +  N   R
Sbjct: 222 EAVSILKAFMTKNPNKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 5/99 (5%)

Query: 659 IHRDIKASSVYLDMNLEPRLSDFG-LAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFP- 715
           +HRDIK  +V LD N   RL+DFG   ++  +G +   +A G+P YI PE  Q   D   
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 716 --TPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVS 752
              P+ D +  GV + E++ G+ P   +   E  G +++
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 62/245 (25%), Positives = 92/245 (37%), Gaps = 59/245 (24%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLT-DQEAARELEYL------GRI 561
           +      L  G FG VY G   G    AV++ V   TL        E ++L       + 
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL-HDLPLGVQTTEDWSTDTWEEDGTNS 620
            H N+V L G       R  + + M  G+L++ L  + P   + +     D         
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD--------- 117

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR--- 677
                   LL         A   A+   +L        IHRDI A +  L      R   
Sbjct: 118 --------LL-------FCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAK 159

Query: 678 LSDFGLAKIFGNGLDEEIARGS----------P-GYIPPEFAQPDSDFPTPKSDVYCYGV 726
           ++DFG+A+        +I R S          P  ++PPE A  D  F T K+DV+ +GV
Sbjct: 160 IADFGMAR--------DIYRASYYRKGGRAMLPIKWMPPE-AFLDGIF-TSKTDVWSFGV 209

Query: 727 VLLEL 731
           +L E+
Sbjct: 210 LLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 40/137 (29%), Positives = 57/137 (41%), Gaps = 23/137 (16%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYI 703
            L FLH  G    II+RD+K  +V LD     +++DFG+ K     G+      G+P YI
Sbjct: 108 GLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYI 163

Query: 704 PPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDD--------------YPEEKEG 748
            PE          P  D +  GV+L E++ G+ P  GDD              YP     
Sbjct: 164 APEILSYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSK 221

Query: 749 NLVSWVRGLVRNNKGSR 765
              S ++  +  N   R
Sbjct: 222 EAKSILKSFLTKNPEKR 238

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 38/101 (37%), Positives = 55/101 (54%), Gaps = 9/101 (8%)

Query: 647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK--IFGNGLDEEIARGSPGYIP 704
           L FLH   S  II+RD+K  +V LD +   +++DFG+ K  +FG+        G+P YI 
Sbjct: 109 LQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIA 164

Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDYPE 744
           PE  Q      T   D + +GV+L E++ G+ P  GDD  E
Sbjct: 165 PEILQGLK--YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 35/103 (33%), Positives = 57/103 (55%), Gaps = 12/103 (11%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----GSP 700
           + L +LH   S   IHRDIKA++V L  + E +L+DFG+A   G   D +I R    G+P
Sbjct: 112 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNTFVGTP 165

Query: 701 GYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
            ++ PE  +  +     K+D++  G+  +EL  G+ P  + +P
Sbjct: 166 FWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPHSELHP 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 33/178 (18%)

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
           IQ VG         +  +I++G    L FLH      II+RD+K  +V LD     +++D
Sbjct: 92  IQQVGKFKEPQAVFYAAEISVG----LFFLHR---RGIIYRDLKLDNVMLDSEGHIKIAD 144

Query: 681 FGLAK-IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKPL 738
           FG+ K    +G+      G+P YI PE        P  KS D + YGV+L E++ G+ P 
Sbjct: 145 FGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQ---PYGKSVDWWAYGVLLYEMLAGQPPF 201

Query: 739 -GDD--------------YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQME 781
            G+D              YP+      VS  +GL+  +   R         GPE + +
Sbjct: 202 DGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRL------GCGPEGERD 253

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 54/245 (22%)

Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQEAARELEYL-GRIKHPNLVP 568
           L E +FG VY+G L G         VA+K L   +    +E  +    +  R++HPN+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 569 LTGYCIAGDQRIA-IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
           L G  +  +Q ++ I+ Y  + +L   L              +D    D   ++++    
Sbjct: 73  LLG-VVTKEQPLSMIFSYCSHSDLHEFL--------VMRSPHSDVGSTDDDKTVKST--- 120

Query: 628 GLLTTWRFRHKIALGTARALAFL--HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-- 683
             L    F H I    A  + FL  HH     ++H+D+   +V +   L  ++SD GL  
Sbjct: 121 --LEPADFVH-IVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFR 172

Query: 684 -------AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
                   K+ GN L           +P  +  P++      +  SD++ YGVVL E+ +
Sbjct: 173 EVYAADYYKLMGNSL-----------LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Query: 734 -GKKP 737
            G +P
Sbjct: 222 YGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 29/206 (14%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS 108
           +  L  L++LDLS N+++ LP  L +L +L +L+LS N+IS  LP  I     LE  DLS
Sbjct: 159 LRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217

Query: 109 NN----------------------NFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLN 146
           NN                      N   ++P +I +L +L  L L  N  Q S    L +
Sbjct: 218 NNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN--QISSISSLGS 275

Query: 147 CQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGN 206
             +L  +DLS N L+ +LP     A   L    L    +  +         + N NI  N
Sbjct: 276 LTNLRELDLSGNSLSNALPL---IALLLLLLELLLNLLLTLKALELKLNSILLNNNILSN 332

Query: 207 LFQGSVMGVF-LESLEVIDLRSNQFQ 231
               S   +  LESL  +    N   
Sbjct: 333 GETSSPEALSILESLNNLWTLDNALD 358

Length = 394

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 40/235 (17%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL-VHGSTLTDQEAARELEYLGRIKHPNL 566
           NF +   L EG +  VY+G     G  VA+K + +     T   A RE+  +  +KH N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 567 VPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
           V L       ++ + +++YM+         DL   + T                    G+
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDK--------DLKKYMDTH----------------GVRGA 96

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
               T   F +++  G    +AF H      ++HRD+K  ++ ++   E +L+DFGLA+ 
Sbjct: 97  LDPNTVKSFTYQLLKG----IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARA 149

Query: 687 FG---NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           FG   N    E+   +  Y  P+       + T   D++  G ++ E+ITG +PL
Sbjct: 150 FGIPVNTFSNEVV--TLWYRAPDVLLGSRTYST-SIDIWSVGCIMAEMITG-RPL 200

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.5 bits (114), Expect = 3e-07
 Identities = 19/47 (40%), Positives = 28/47 (59%), Gaps = 1/47 (2%)

Query: 43 SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRI 88
           +PD     L  L+ LDLS NN+T++  +    L SL+SL+LS N +
Sbjct: 14 VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.8 bits (125), Expect = 4e-07
 Identities = 53/244 (21%), Positives = 98/244 (40%), Gaps = 53/244 (21%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD-QEAARELEYLGRIKHPNLV 567
           F     + +G FG VY+         VA+KV+       + ++  +E+++L + + P + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI- 61

Query: 568 PLTGY--CIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
             T Y        ++ I  +Y   G+  +LL    L                   +    
Sbjct: 62  --TKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYI--------------AF--- 102

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
                         I       L +LH       IHRDIKA+++ L    + +L+DFG++
Sbjct: 103 --------------ILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS 145

Query: 685 KIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
                 L   +++     G+P ++ PE  +  S +   K+D++  G+  +EL  G+ PL 
Sbjct: 146 ----GQLTSTMSKRNTFVGTPFWMAPEVIK-QSGYDE-KADIWSLGITAIELAKGEPPLS 199

Query: 740 DDYP 743
           D +P
Sbjct: 200 DLHP 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 9/102 (8%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK--IFGNGLDEEIARGSPGYI 703
            L FLH      II+RD+K  +V LD +   +++DFG+ K  + G G       G+P YI
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYI 163

Query: 704 PPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDYPE 744
            PE  +          D + +GV+L E++ G+ P  G+D  E
Sbjct: 164 APEILK--GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 47/187 (25%)

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           H N+V +    + GD+   + +++E G L +++                      T++  
Sbjct: 78  HENVVDMYNSYLVGDELWVVMEFLEGGALTDIV----------------------THTRM 115

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
           N   E + T       + L   RAL++LH   +  +IHRDIK+ S+ L  +   +LSDFG
Sbjct: 116 N--EEQIAT-------VCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFG 163

Query: 683 LAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGKK 736
               F   + +E+ +     G+P ++ PE     S  P   + D++  G++++E+I G+ 
Sbjct: 164 ----FCAQVSKEVPKRKSLVGTPYWMAPEVI---SRLPYGTEVDIWSLGIMVIEMIDGEP 216

Query: 737 PLGDDYP 743
           P  ++ P
Sbjct: 217 PYFNEPP 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 77/305 (25%), Positives = 129/305 (42%), Gaps = 70/305 (22%)

Query: 516 LAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA-----RELEYLGRIKHPNLVPL 569
           L +G +G VY+    P G+ +A+K +     L   E+       EL+ L +   P +V  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI----RLELDESKFNQIIMELDILHKAVSPYIVDF 64

Query: 570 TGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
            G   A     A+Y   +YM+ G+L  L                      G  + + +  
Sbjct: 65  YG---AFFIEGAVYMCMEYMDAGSLDKLY--------------------AGGVATEGI-P 100

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           E +L       +I     + L FL    +  IIHRD+K ++V ++ N + +L DFG++  
Sbjct: 101 EDVLR------RITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVS-- 150

Query: 687 FGNGLDEEIAR---GSPGYIPPEFAQPD--SDFPT--PKSDVYCYGVVLLELITGKKPLG 739
            GN L   +A+   G   Y+ PE  +    +  PT   +SDV+  G+ +LE+  G+ P  
Sbjct: 151 -GN-LVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP-- 206

Query: 740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP 799
             YP E   N+ + +  +V         DP    T P    ++A      C   +P +RP
Sbjct: 207 --YPPETYANIFAQLSAIVDG-------DPP---TLPSGYSDDAQDFVAKCLNKIPNRRP 254

Query: 800 SMQQI 804
           +  Q+
Sbjct: 255 TYAQL 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.7 bits (126), Expect = 5e-07
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 38/221 (17%)

Query: 590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL--LTTWRFRHKIALGTARAL 647
           ++Q   +D P   + + D           N + + GSEGL  L    F +++A    R +
Sbjct: 202 DIQRSNYDRPASYKGSNDSEVK-------NLLSDDGSEGLTTLDLLSFTYQVA----RGM 250

Query: 648 AFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEF 707
            FL    S   +HRD+ A +V L      ++ DFGLA+   +     +++GS  ++P ++
Sbjct: 251 EFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD-SNYVSKGST-FLPVKW 305

Query: 708 AQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKG 763
             P+S F    T  SDV+ YG++L E+ + G  P    YP            G++ ++  
Sbjct: 306 MAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP----YP------------GMIVDSTF 349

Query: 764 SRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
              I    R   P+   +E   I   C    P KRPS   +
Sbjct: 350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 51.7 bits (124), Expect = 6e-07
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 5/91 (5%)

Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS-DFPT 716
           I++RD+K  +V LD +   R+SD GLA     G   +   G+PGY+ PE  Q +  DF  
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175

Query: 717 PKSDVYCYGVVLLELITGKKPLGDDYPEEKE 747
              D +  G  L E+I G+ P      E+ E
Sbjct: 176 ---DWFALGCTLYEMIAGRSPF-RQRKEKVE 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 52.8 bits (126), Expect = 7e-07
 Identities = 44/147 (29%), Positives = 75/147 (51%), Gaps = 24/147 (16%)

Query: 40  LSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNF 99
           +  ++PDT       +Q ++LS N IT LP  L S  +L+SL+L +N+IS  LP N+   
Sbjct: 235 IPATLPDT-------IQEMELSINRITELPERLPS--ALQSLDLFHNKIS-CLPENLPEE 284

Query: 100 GLLEVFDLSNNNFSGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMN 158
             L    + +N+    +PA + S +  L V          ++PPGL   ++L   + ++ 
Sbjct: 285 --LRYLSVYDNSIRT-LPAHLPSGITHLNVQSNSLTALPETLPPGL---KTLEAGENALT 338

Query: 159 QLNGSLPDGFGAAFPKLKSLNLAGNEI 185
            L  SLP       P+L+ L+++ N+I
Sbjct: 339 SLPASLP-------PELQVLDVSKNQI 358

Length = 754

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 51.5 bits (123), Expect = 7e-07
 Identities = 63/277 (22%), Positives = 109/277 (39%), Gaps = 59/277 (21%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGG----IHVAVKVLVHGST-LTDQEAARELEYLGR 560
            +   +  LL  G FG V++G  +P G    I VA+K +   S   T QE    +  +G 
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 561 IKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
           + H  +V L G C  G     +      G+L + +                         
Sbjct: 66  LDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVR------------------------ 100

Query: 621 IQNVGSEG--LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRL 678
            Q+  S     L  W       +  A+ + +L       ++HR++ A ++ L  +   ++
Sbjct: 101 -QHRDSLDPQRLLNW------CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQI 150

Query: 679 SDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDF---PTPKSDVYCYGVVLLELIT-G 734
           +DFG+A +     D++    S    P ++   +S      T +SDV+ YGV + E+++ G
Sbjct: 151 ADFGVADLLYP--DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYG 208

Query: 735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKI 771
            +P     P E        V  L+   KG R   P+I
Sbjct: 209 AEPYAGMRPHE--------VPDLLE--KGERLAQPQI 235

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 51.9 bits (124), Expect = 8e-07
 Identities = 73/307 (23%), Positives = 117/307 (38%), Gaps = 35/307 (11%)

Query: 84  SYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPG 143
             +     LPS++     L++   S  + S +    + +L+ L  L L+ N  +      
Sbjct: 54  LSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLN--RLRSNIS 110

Query: 144 LLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNI 203
            L   + +T     N     +P   G     LK L+L+ N+I+   +    L ++ NL++
Sbjct: 111 ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDL 170

Query: 204 SGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIF 263
           S N                           +S +      N S L  +DLS N++S ++ 
Sbjct: 171 SFN--------------------------DLSDL-PKLLSNLSNLNNLDLSGNKIS-DLP 202

Query: 264 HNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTL 323
                   L+ L L+ N    +    +  L  L  L LS   L  D+P  I  LS+L TL
Sbjct: 203 PEIELLSALEELDLSNNS-IIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETL 260

Query: 324 DLSMNHLTGQIPTV-SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCAS 382
           DLS N+    I ++ S  NL  +D+S N+LS  +P   L  L      N       L   
Sbjct: 261 DLS-NNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELK 319

Query: 383 ELSPETL 389
             S    
Sbjct: 320 LNSILLN 326

Length = 394

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.1 bits (122), Expect = 8e-07
 Identities = 36/120 (30%), Positives = 56/120 (46%), Gaps = 7/120 (5%)

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
           I NVG  GL        ++   +A+    + H  S  I++RD+K  +V LD     RLSD
Sbjct: 84  IYNVGERGLEME-----RVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSD 138

Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
            GLA    +G       G+ GY+ PE  + +  +  P  D +  G  + E++ G+ P  D
Sbjct: 139 LGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYP-VDWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 51.1 bits (123), Expect = 9e-07
 Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 53/231 (22%)

Query: 516 LAEGKFGPVYR-GFLPGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLVPLTG 571
           + EG  G V++      G  VA+K  V    L      +A RE++ L   +HP +V L  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALK-KVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 572 YCIAGDQRIAIYDYMENGNLQNLLHDL--PLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL 629
               G   + + +YM +  L  +L D   PL                       V S   
Sbjct: 67  VFPHGSGFVLVMEYMPSD-LSEVLRDEERPL-------------------PEAQVKS--- 103

Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
                          + +A++H   +  I+HRD+K +++ +  +   +++DFGLA++F  
Sbjct: 104 ---------YMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSE 151

Query: 690 GLD----EEIARGSPGYIPPE--FAQPDSDFPTPKSDVYCYGVVLLELITG 734
                   ++A  +  Y  PE  +     D   P  D++  G +  EL+ G
Sbjct: 152 EEPRLYSHQVA--TRWYRAPELLYGARKYD---PGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.7 bits (124), Expect = 1e-06
 Identities = 27/82 (32%), Positives = 49/82 (59%), Gaps = 4/82 (4%)

Query: 19  RGVVCD--SNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT-ALPSDLWSL 75
           RG + +  S  +H+     S + + G++P  ++G ++ L+ LDLS N+   ++P  L  L
Sbjct: 431 RGFIPNDISKLRHLQSINLSGNSIRGNIP-PSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 76  GSLKSLNLSYNRISGSLPSNIG 97
            SL+ LNL+ N +SG +P+ +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 58/255 (22%), Positives = 93/255 (36%), Gaps = 67/255 (26%)

Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLT---DQEAARELEYLGRIKH 563
            + +R   +  G FG V+         + A+KV+     +    +Q    E   L  + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           P ++ L  +    DQR           L  L+  +P                        
Sbjct: 61  PFIIRL--FWTEHDQR----------FLYMLMEYVP------------------------ 84

Query: 624 VGSEGLLTTWRFRHKIALGTAR--------ALAFLHHGCSPPIIHRDIKASSVYLDMNLE 675
            G E L +  R   + +  T          AL +LH   S  I++RD+K  ++ LD    
Sbjct: 85  -GGE-LFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGH 139

Query: 676 PRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE 730
            +L+DFG AK       +   R     G+P Y+ PE  Q  S       D +  G+++ E
Sbjct: 140 IKLTDFGFAK-------KLRDRTWTLCGTPEYLAPEVIQ--SKGHNKAVDWWALGILIYE 190

Query: 731 LITGKKPLGDDYPEE 745
           ++ G  P  DD P  
Sbjct: 191 MLVGYPPFFDDNPFG 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 32/85 (37%), Positives = 43/85 (50%), Gaps = 8/85 (9%)

Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDS 712
           II+RDIK  ++ LD      L+DFGL+K F   L EE  R     G+  Y+ PE  +  S
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEF---LAEEEERAYSFCGTIEYMAPEVIRGGS 182

Query: 713 DFPTPKSDVYCYGVVLLELITGKKP 737
                  D +  GV+  EL+TG  P
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 5/98 (5%)

Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA-RGSPG 701
           TA+ ++ L H     II+RD+K  +V LD +   R+SD GLA    +G  +     G+PG
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPG 162

Query: 702 YIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPL 738
           ++ PE  Q +  DF     D +  GV L E+I  + P 
Sbjct: 163 FMAPELLQGEEYDFSV---DYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 52/211 (24%)

Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 36  VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLRLV 85

Query: 595 LHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +H+  L   + L +    C
Sbjct: 86  MEYLPYGS---------------------------LRDYLQKHRERLDHRKLLLYASQIC 118

Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIP--- 704
                  S   +HRD+   ++ ++     ++ DFGL K+     +    R  PG  P   
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR-EPGESPIFW 177

Query: 705 --PEFAQPDSDFPTPKSDVYCYGVVLLELIT 733
             PE +  +S F +  SDV+ +GVVL EL T
Sbjct: 178 YAPE-SLTESKF-SVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 62/245 (25%), Positives = 109/245 (44%), Gaps = 55/245 (22%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG--STLTDQEAAR---ELEYLGRIK 562
           N+ RG LL +G FG VY  + +  G  +A K +     S  T +E +    E++ L  ++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 563 HPNLVPLTGYCIA--GDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           H  +V   G C+    ++ + I+ +YM  G++++ L                        
Sbjct: 63  HERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLK----------------------- 98

Query: 620 SIQNVGSEGLLT---TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP 676
                 + G LT   T ++  +I  G    +++LH   S  I+HRDIK +++  D     
Sbjct: 99  ------AYGALTESVTRKYTRQILEG----MSYLH---SNMIVHRDIKGANILRDSAGNV 145

Query: 677 RLSDFGLAK----IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
           +L DFG +K    I  +G       G+P ++ PE    +      K+DV+  G  ++E++
Sbjct: 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG--YGRKADVWSLGCTVVEML 203

Query: 733 TGKKP 737
           T K P
Sbjct: 204 TEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 55/241 (22%), Positives = 101/241 (41%), Gaps = 40/241 (16%)

Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTD----QEAARELEYLGRIK 562
           +NF     +  G+F  VYR   L  G+ VA+K  V    L D     +  +E++ L ++ 
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKK-VQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           HPN++      I  ++   + +  + G+L  ++       +   +               
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE--------------- 105

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
                   T W++   + L +A     L H  S  ++HRDIK ++V++      +L D G
Sbjct: 106 -------KTVWKYF--VQLCSA-----LEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 151

Query: 683 LAKIFGNGLDEEIAR-GSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPLGD 740
           L + F +      +  G+P Y+ PE    +  +F   KSD++  G +L E+   + P   
Sbjct: 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF---KSDIWSLGCLLYEMAALQSPFYG 208

Query: 741 D 741
           D
Sbjct: 209 D 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 35/228 (15%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARE-LEYLGR---IKHPN---LVP 568
           L +G FG VY G   G +    +  V   T+ +  + RE +E+L     +K  N   +V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L   ++     +  + ++     IQ  G   
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK----MIQMAGE-- 127

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
                          A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ +   
Sbjct: 128 --------------IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 170

Query: 689 NGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
               +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 171 E--TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 45/193 (23%), Positives = 76/193 (39%), Gaps = 24/193 (12%)

Query: 218 ESLEVIDLRSNQFQGHISQVQFNSSY--NWSRLVYVDLSENQLSGE---IFHNFSQAQNL 272
            SL+ + L  N+       +Q           L  +DLS+N L  +   +  +  ++ +L
Sbjct: 51  PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSL 110

Query: 273 KHLSLAYNRFTRQEFPQIGTLLG-----LEHLNLSRTSLIG----DIPSEILQLSSLHTL 323
           + L L  N    +    +   L      LE L L R  L G     +   +     L  L
Sbjct: 111 QELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKEL 170

Query: 324 DLSMNHLTGQ-IPTV-----SAKNLGIIDMSHNNLSGE---IPASLLEKLPQMERFNFSY 374
           +L+ N +    I  +     +  NL ++D+++N L+ E     A  L  L  +E  N   
Sbjct: 171 NLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGD 230

Query: 375 NNLTL-CASELSP 386
           NNLT   A+ L+ 
Sbjct: 231 NNLTDAGAAALAS 243

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 49/232 (21%)

Query: 516 LAEGKFGPVY--RGFLPGGIHVAVKVLVHG---STLTDQEAARELEYLGRIKHPNLVPLT 570
           +  G FG VY  R      + VA+K + +    S    Q+  +E+++L RIKHPN +   
Sbjct: 33  IGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           G  +       + +Y   G+  +LL  H  PL  Q  E  +                   
Sbjct: 92  GCYLREHTAWLVMEYCL-GSASDLLEVHKKPL--QEVEIAA------------------- 129

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
                     I  G  + LA+LH   S  +IHRDIKA ++ L    + +L+DFG A I  
Sbjct: 130 ----------ITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176

Query: 689 NGLDEEIARGSPGYIPPE--FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
                    G+P ++ PE   A  +  +   K DV+  G+  +EL   K PL
Sbjct: 177 PA---NSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 63/242 (26%), Positives = 109/242 (45%), Gaps = 49/242 (20%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVH--GSTLTDQEAAR---ELEYLGRIK 562
           N+  G LL  G FG VY  +    G  +AVK +     S  T +E      E++ L  ++
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 563 HPNLVPLTGYCIAG--DQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           H  +V   G C+    +++++I+ +YM  G++++ L     G  T               
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLK--AYGALT--------------- 104

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
             +NV       T R+  +I  G    +++LH   S  I+HRDIK +++  D     +L 
Sbjct: 105 --ENV-------TRRYTRQILQG----VSYLH---SNMIVHRDIKGANILRDSAGNVKLG 148

Query: 680 DFGLAK----IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
           DFG +K    I  +G   +   G+P ++ PE    +      K+DV+     ++E++T K
Sbjct: 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG--YGRKADVWSVACTVVEMLTEK 206

Query: 736 KP 737
            P
Sbjct: 207 PP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 35/103 (33%), Positives = 49/103 (47%), Gaps = 22/103 (21%)

Query: 644 ARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR------ 697
           A AL +LH   S  II+RD+K  ++ LD      L+DFGL K       E I        
Sbjct: 106 ASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-------EGIEHSKTTST 155

Query: 698 --GSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKP 737
             G+P Y+ PE  +     P  ++ D +C G VL E++ G  P
Sbjct: 156 FCGTPEYLAPEVLRKQ---PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 61/234 (26%), Positives = 95/234 (40%), Gaps = 53/234 (22%)

Query: 516 LAEGKFGPVYRGFLPGGIH----VAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLVP 568
           +  G FG VY        H    VAVK + +    T+   Q+  +E+++L ++KHPN + 
Sbjct: 29  IGHGSFGAVY---FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
             G  +       + +Y   G+  +LL  H  PL  Q  E  +                 
Sbjct: 86  YKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPL--QEVEIAA----------------- 125

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
                       I  G  + LA+LH      +IHRDIKA ++ L    + +L+DFG A  
Sbjct: 126 ------------ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK 170

Query: 687 FGNGLDEEIARGSPGYIPPE--FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
                      G+P ++ PE   A  +  +   K DV+  G+  +EL   K PL
Sbjct: 171 SSPA---NSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 12/106 (11%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL FLH      II+RD+K  +V LD     +L+D+G+ K     G       G+P YI 
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIA 164

Query: 705 PEFAQ-PDSDFPTPKSDVYCYGVVLLELITGKKPL----GDDYPEE 745
           PE  +  D  F     D +  GV++ E++ G+ P       D P++
Sbjct: 165 PEILRGEDYGFSV---DWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 61/250 (24%), Positives = 107/250 (42%), Gaps = 48/250 (19%)

Query: 516 LAEGKFGPVYRGFL---PGGIHVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVPLTG 571
           L  G FG V +G        I VA+KVL + +  + + E  RE E + ++ +P +V + G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 572 YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLT 631
            C A +  + + +    G L   L                   +    ++ NV       
Sbjct: 63  VCEA-EALMLVMEMASGGPLNKFLSG-----------------KKDEITVSNVV------ 98

Query: 632 TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL 691
                H++++G    + +L        +HRD+ A +V L      ++SDFGL+K  G   
Sbjct: 99  --ELMHQVSMG----MKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Query: 692 DEEIARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEK 746
               AR S G  P ++  P+      F + +SDV+ YG+ + E  + G+KP    Y + K
Sbjct: 150 SYYKAR-SAGKWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKP----YKKMK 203

Query: 747 EGNLVSWVRG 756
              ++S++  
Sbjct: 204 GPEVMSFIEQ 213

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 47/185 (25%), Positives = 80/185 (43%), Gaps = 29/185 (15%)

Query: 553 RELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDT 612
           +E++ + R+K PN++ L   CI  D    I +YMENG+L   L             S   
Sbjct: 68  KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL-------------SRHE 114

Query: 613 WEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM 672
            +E    +     S   L        +A   A  + +L    S   +HRD+   +  +  
Sbjct: 115 PQEAAEKADVVTISYSTLIF------MATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165

Query: 673 NLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVL 728
           N   +++DFG+++   +G D    +G    +P  +   +S     F T  SDV+ +GV L
Sbjct: 166 NYTIKIADFGMSRNLYSG-DYYRIQGR-AVLPIRWMSWESILLGKF-TTASDVWAFGVTL 222

Query: 729 LELIT 733
            E++T
Sbjct: 223 WEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 14/104 (13%)

Query: 640 ALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-- 697
           A   A A+ +LH   S  II+RD+K  ++ LD      L+DFGL K    G++ E     
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTST 155

Query: 698 --GSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKPL 738
             G+P Y+ PE  + +   P  ++ D +C G VL E++ G  P 
Sbjct: 156 FCGTPEYLAPEVLRKE---PYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 8/199 (4%)

Query: 47  TTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
             I  LS L+ LDLS N+I  L S L +L +L  L LS N++   LP +IGN   LE  D
Sbjct: 203 PEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLD 261

Query: 107 LSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPD 166
           LSNN       +++ SL +LR L L GN    +  P +        +   +  L  +L  
Sbjct: 262 LSNNQ--ISSISSLGSLTNLRELDLSGNSL-SNALPLIALLL---LLLELLLNLLLTLKA 315

Query: 167 GFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMG-VFLESLEVIDL 225
                   L + N+  N         + L+S+ NL    N    S +    +++   I  
Sbjct: 316 LELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIGS 375

Query: 226 RSNQFQGHISQVQFNSSYN 244
             +  + H++Q+    +YN
Sbjct: 376 LLDLVKKHVNQLLEKVNYN 394

Length = 394

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 37/199 (18%)

Query: 540 LVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDL 598
           L + S    + A +E + L ++KHPN+V         D  + I   + E G+L + L   
Sbjct: 35  LRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLK-- 92

Query: 599 PLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI 658
                          E+ G      +  E  +  W  +       A AL +LH      I
Sbjct: 93  ---------------EQKG-----KLLPENQVVEWFVQ------IAMALQYLHE---KHI 123

Query: 659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD-EEIARGSPGYIPPE-FAQPDSDFPT 716
           +HRD+K  +V+L      ++ D G+A++  N  D      G+P Y+ PE F+    ++  
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY-- 181

Query: 717 PKSDVYCYGVVLLELITGK 735
            KSDV+  G  + E+ T K
Sbjct: 182 -KSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 49.2 bits (118), Expect = 5e-06
 Identities = 38/163 (23%), Positives = 68/163 (41%), Gaps = 46/163 (28%)

Query: 532 GIHVAVKVLVHGSTL--TDQEAARELEYLGRIKHPNLVPLTGYCIA-GDQRIAIY---DY 585
           G  VA+K + H   +    +   REL+ L   KH N++ +       G     +Y   D 
Sbjct: 30  GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89

Query: 586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRH---KIALG 642
           ME+ +L +++H                             S+  LT    R+   ++   
Sbjct: 90  MES-DLHHIIH-----------------------------SDQPLTEEHIRYFLYQLL-- 117

Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
             R L ++H      +IHRD+K S++ ++ + E R+ DFG+A+
Sbjct: 118 --RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 6e-06
 Identities = 34/106 (32%), Positives = 47/106 (44%), Gaps = 12/106 (11%)

Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDS-D 713
            IHRD+K  +  +D +   +L+DFGL+K     +    A    GSP Y+ PE  +    D
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK---GIV--TYANSVVGSPDYMAPEVLRGKGYD 176

Query: 714 FPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVR 759
           F     D +  G +L E + G  P     P E   NL  W   L R
Sbjct: 177 FTV---DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR 219

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.2 bits (115), Expect = 7e-06
 Identities = 39/132 (29%), Positives = 59/132 (44%), Gaps = 33/132 (25%)

Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI--------FGNGLDEE 694
           T  AL +LH   +  I+HRD+K  ++ +      +L+DFGL+KI           G  E+
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 695 IAR--------GSPGYIPPE------FAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
             R        G+P YI PE      + +P         D +  G++L E + G  P   
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKP--------VDWWAMGIILYEFLVGCVPFFG 218

Query: 741 DYPEEKEGNLVS 752
           D PEE  G ++S
Sbjct: 219 DTPEELFGQVIS 230

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 32/110 (29%), Positives = 58/110 (52%), Gaps = 7/110 (6%)

Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           K+++   R LA+L       I+HRD+K S++ ++   E +L DFG++    + +      
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 163

Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE 747
           G+  Y+ PE  Q      + +SD++  G+ L+EL  G+ P+    P+ KE
Sbjct: 164 GTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKE 209

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 48.1 bits (114), Expect = 8e-06
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 6/103 (5%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGLDEEIARGSPGYIP 704
           AL  L H  +  IIHRD+K +++ L      +L DFG+ A++    L    + G+P ++ 
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 196

Query: 705 PEF----AQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           PE      Q D  +   + DV+  G+  +EL  G  PL D +P
Sbjct: 197 PEVIACEQQYDYSYDA-RCDVWSLGITAIELGDGDPPLFDMHP 238

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 48.1 bits (114), Expect = 9e-06
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 8/95 (8%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL FLH      II+RD+K  +V LD +   +L+D+G+ K   G G       G+P YI 
Sbjct: 108 ALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIA 164

Query: 705 PEFAQ-PDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE  +  +  F     D +  GV++ E++ G+ P 
Sbjct: 165 PEILRGEEYGFSV---DWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 1e-05
 Identities = 26/60 (43%), Positives = 32/60 (53%)

Query: 77  SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMF 136
           +LKSL+LS NR++            L+V DLS NN +   P A S L SLR L L GN  
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 48.1 bits (115), Expect = 1e-05
 Identities = 64/254 (25%), Positives = 96/254 (37%), Gaps = 56/254 (22%)

Query: 509 NFDRGTL-----LAEGKFGPVY------------RGFLPGGIH-----VAVKVLVHGSTL 546
            F R  L     L EG+FG V+            + F           VAVKVL   ++ 
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 547 TDQEA-ARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTT 605
             +E   +E++ L R+  PN+  L G C        I +YMENG+L   L       Q  
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL-------QKH 113

Query: 606 EDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA 665
                   E  G        S   L        +A   A  + +L    S   +HRD+  
Sbjct: 114 VA------ETSGLACNSKSLSFSTLL------YMATQIASGMRYLE---SLNFVHRDLAT 158

Query: 666 SSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDS---DFPTPKS 719
            +  +  N   +++DFG+       L   D    +G    +P  +   +S      T KS
Sbjct: 159 RNCLVGKNYTIKIADFGM----SRNLYSSDYYRVQGRA-PLPIRWMAWESVLLGKFTTKS 213

Query: 720 DVYCYGVVLLELIT 733
           DV+ +GV L E++T
Sbjct: 214 DVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 48.3 bits (116), Expect = 1e-05
 Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 15/106 (14%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYI- 703
           R L +LH   S  +IHRD+K S++ ++ N + ++ DFGLA+      DE+       Y+ 
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP--DEDEKGFLTEYVV 168

Query: 704 -----PPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GDDY 742
                 PE     S + T   D++  G +  EL+T  KPL  G DY
Sbjct: 169 TRWYRAPELLLSSSRY-TKAIDIWSVGCIFAELLTR-KPLFPGRDY 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 59/230 (25%), Positives = 92/230 (40%), Gaps = 60/230 (26%)

Query: 584 DYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIAL 641
           +YM  G+L NL+  +D+P      E W+                        RF      
Sbjct: 123 EYMPGGDLVNLMSNYDIP------EKWA------------------------RFY----- 147

Query: 642 GTAR---ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGL-DEEIA 696
            TA    AL  +H   S   IHRD+K  ++ LD +   +L+DFG   K+  NG+   + A
Sbjct: 148 -TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203

Query: 697 RGSPGYIPPEF--AQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWV 754
            G+P YI PE   +Q    +   + D +  GV L E++ G  P   D       +LV   
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-------SLVG-T 255

Query: 755 RGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
              + ++K S      I  +   K     L   +L   ++ L R  + +I
Sbjct: 256 YSKIMDHKNSLTFPDDIEISKQAK----DLICAFLTDREVRLGRNGVDEI 301

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 34/123 (27%), Positives = 59/123 (47%), Gaps = 9/123 (7%)

Query: 634 RFR-HKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD 692
           RF+  ++ + +   +  L H     II+RDIK  ++ LD N    L+DFGL+K F    +
Sbjct: 101 RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF---HE 157

Query: 693 EEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE 747
           +E+ R     G+  Y+ P+  +          D +  GV++ EL+TG  P   D  +  +
Sbjct: 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217

Query: 748 GNL 750
             +
Sbjct: 218 AEI 220

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 48.0 bits (115), Expect = 1e-05
 Identities = 31/112 (27%), Positives = 49/112 (43%), Gaps = 35/112 (31%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE----------- 693
           +AL ++H   S  +IHRD+K S++ L+ +   +L+DFGLA+      +            
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 694 -------EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
                  EI  GS  Y             T   D++  G +L E++ G KPL
Sbjct: 175 TRWYRAPEILLGSTRY-------------TKGVDMWSVGCILGEMLLG-KPL 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 13/104 (12%)

Query: 639 IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF--GNGLDEEIA 696
           I  G  + LA+LH       IHRDIKA ++ L      +L+DFG A +    N       
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF----- 171

Query: 697 RGSPGYIPPE--FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            G+P ++ PE   A  +  +   K DV+  G+  +EL   K PL
Sbjct: 172 VGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 45/137 (32%), Positives = 61/137 (44%), Gaps = 19/137 (13%)

Query: 647 LAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR--GSPGYI 703
           LAF + H     II+RD+K  ++ LD     +++DFG AK     + +      G+P Y+
Sbjct: 129 LAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYL 182

Query: 704 PPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP---EEK--EGNLV--SWVRG 756
            PE  Q  S       D +  GV+L E I G  P  DD P    EK   G L   +W  G
Sbjct: 183 APEVIQ--SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240

Query: 757 LVRN-NKGSRAIDPKIR 772
             R+  KG    D   R
Sbjct: 241 RARDLVKGLLQTDHTKR 257

Length = 329

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 71/308 (23%), Positives = 124/308 (40%), Gaps = 57/308 (18%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARE-LEYL-------GRIKHPNLV 567
           L +G FG VY G     I    +  V   T+ +  + RE +E+L       G   H ++V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L G    G   + + + M +G+L++ L  L                 +  N   N G  
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL---------------RPEAEN---NPGR- 113

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-I 686
               T +   ++A   A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ + I
Sbjct: 114 -PPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 169

Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
           +     +   +G  G +P  +  P+S      T  SD++ +GVVL E+ +  ++P     
Sbjct: 170 YET---DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY---- 222

Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
                       +GL         +D    D  P+   E    +  +C    P  RP+  
Sbjct: 223 ------------QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFL 269

Query: 803 QIVGLLKD 810
           +IV LLKD
Sbjct: 270 EIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 12/97 (12%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----GSPG 701
           AL +LH   S  +++RDIK  ++ LD +   +++DFGL K    G+ +        G+P 
Sbjct: 107 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPE 160

Query: 702 YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           Y+ PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 161 YLAPEVLE-DNDYGR-AVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 25/172 (14%)

Query: 644 ARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYI 703
           A  + FL    S   +HRD+ A +V +      ++ DFGLA+         I++GS  ++
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKGST-FL 303

Query: 704 PPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVR 759
           P ++  P+S F    T  SDV+ +G++L E+ T G  P    YPE            L  
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP----YPE------------LPM 347

Query: 760 NNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
           N +   AI    R   P    +E  +I   C  +    RP   Q+V L+ D+
Sbjct: 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 48/232 (20%)

Query: 516 LAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVPLTGYC 573
           L  G  G VY+ + L     +AVKV+    T+  Q +   ELE L +   P ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 574 IAGDQRIAI-YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTT 632
              + RI+I  ++M+ G+L ++   +P                           E +L  
Sbjct: 69  FV-ENRISICTEFMDGGSL-DVYRKIP---------------------------EHVLG- 98

Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD 692
                +IA+   + L +L    S  I+HRD+K S++ ++   + +L DFG++    N + 
Sbjct: 99  -----RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA 150

Query: 693 EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE 744
           +    G+  Y+ PE  +   +     SDV+  G+  +EL  G+ P    YP+
Sbjct: 151 KTYV-GTNAYMAPE--RISGEQYGIHSDVWSLGISFMELALGRFP----YPQ 195

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 47.4 bits (112), Expect = 2e-05
 Identities = 58/232 (25%), Positives = 95/232 (40%), Gaps = 49/232 (21%)

Query: 516 LAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLVPLT 570
           +  G FG VY  R      + VA+K + +    ++   Q+  +E+ +L +++HPN +   
Sbjct: 23  IGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           G  +       + +Y   G+  +LL  H  PL  Q  E  +                   
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDLLEVHKKPL--QEVEIAA------------------- 119

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
                     +  G  + LA+LH   S  +IHRD+KA ++ L      +L DFG A I  
Sbjct: 120 ----------VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

Query: 689 NGLDEEIARGSPGYIPPE--FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
                    G+P ++ PE   A  +  +   K DV+  G+  +EL   K PL
Sbjct: 167 PA---NXFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 52/240 (21%), Positives = 96/240 (40%), Gaps = 38/240 (15%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVK---VLVHGSTLTDQEAARELEYLGRIKH 563
           +NF     +  G+F  VYR   L     VA+K   +         Q+  +E++ L ++ H
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           PN++      I  ++   + +  + G+L  +                          I+ 
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQM--------------------------IKY 95

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
              +  L   R   K  +    A+  +H   S  ++HRDIK ++V++      +L D GL
Sbjct: 96  FKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGL 152

Query: 684 AKIFGNGLDEEIAR-GSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
            + F +      +  G+P Y+ PE    +  +F   KSD++  G +L E+   + P   D
Sbjct: 153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF---KSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 67/300 (22%), Positives = 111/300 (37%), Gaps = 67/300 (22%)

Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKHPNLVPLTG 571
           +  G FG V+ G L      VAVK      TL     A+   E   L +  HPN+V L G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 572 YCIAGDQRIAIYDYME---NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
            C    Q+  IY  ME    G+    L                              +EG
Sbjct: 61  VCT---QKQPIYIVMELVQGGDFLTFLR-----------------------------TEG 88

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
                +   ++    A  + +L        IHRD+ A +  +      ++SDFG+++   
Sbjct: 89  PRLKVKELIQMVENAAAGMEYLESKHC---IHRDLAARNCLVTEKNVLKISDFGMSREEE 145

Query: 689 NGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE 744
           +G+    + G    IP ++  P++      + +SDV+ +G++L E  + G  P    Y  
Sbjct: 146 DGVYA--STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVP----YAN 199

Query: 745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
                        + N +   AI+  +R   PE   +   ++   C    P +RPS   +
Sbjct: 200 -------------LSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 73/311 (23%), Positives = 111/311 (35%), Gaps = 59/311 (18%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPN 565
                   +L +G +G VY    L   + +A+K +    +   Q    E+     +KH N
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 566 LVPLTGYCIAGDQRIAIYDYMEN---GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           +V   G             +ME    G+L  LL            W      E       
Sbjct: 67  IVQYLGSDSENGF---FKIFMEQVPGGSLSALLR---------SKWGPLKDNEQ------ 108

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM-NLEPRLSDF 681
                    T  F  K  L     L +LH      I+HRDIK  +V ++  +   ++SDF
Sbjct: 109 ---------TIIFYTKQIL---EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDF 153

Query: 682 GLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
           G +K    G++   E   G+  Y+ PE            +D++  G  ++E+ TGK P  
Sbjct: 154 GTSKRLA-GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP-- 210

Query: 740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP 799
             + E  E     +  G+ +       I P+I    PE    EA      C    P KR 
Sbjct: 211 --FIELGEPQAAMFKVGMFK-------IHPEI----PESLSAEAKNFILRCFEPDPDKRA 257

Query: 800 SMQQIVGLLKD 810
           S      LL+D
Sbjct: 258 SAHD---LLQD 265

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 52/227 (22%), Positives = 95/227 (41%), Gaps = 37/227 (16%)

Query: 516 LAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L +G FG VY+      G+  A KV+   S    ++   E++ L    HPN+V L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWR 634
             +    + ++   G +  ++ +L                            E  LT  +
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLEL----------------------------ERPLTEPQ 104

Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
            R  +   T  AL +LH      IIHRD+KA ++   ++ + +L+DFG++      +   
Sbjct: 105 IR-VVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160

Query: 695 IAR-GSPGYIPPEFAQPDSDFPTP---KSDVYCYGVVLLELITGKKP 737
            +  G+P ++ PE    ++    P   K+DV+  G+ L+E+   + P
Sbjct: 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 9/101 (8%)

Query: 647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK--IFGNGLDEEIARGSPGYIP 704
           L FLH   S  I++RD+K  ++ LD +   +++DFG+ K  + G+        G+P YI 
Sbjct: 109 LQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIA 164

Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDYPE 744
           PE             D + +GV+L E++ G+ P  G D  E
Sbjct: 165 PEILLGQK--YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 35/98 (35%), Positives = 49/98 (50%), Gaps = 10/98 (10%)

Query: 644 ARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK--IFGNGLDEEIARGSPG 701
           A AL +LH   S  I++RD+K  ++ LD      L+DFGL K  I  NG       G+P 
Sbjct: 106 ASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPE 161

Query: 702 YIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKPL 738
           Y+ PE        P  ++ D +C G VL E++ G  P 
Sbjct: 162 YLAPEVLHKQ---PYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 37/157 (23%), Positives = 70/157 (44%), Gaps = 36/157 (22%)

Query: 532 GIHVAVKVLVH--GSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENG 589
           G +VA+K ++    + +  +   REL+ L  ++H N++ L+   I+  + I     +   
Sbjct: 35  GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94

Query: 590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAF 649
           +L  LL   PL  Q  +                            F ++I     R L +
Sbjct: 95  DLHRLLTSRPLEKQFIQ---------------------------YFLYQIL----RGLKY 123

Query: 650 LHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           +H   S  ++HRD+K S++ ++ N + ++ DFGLA+I
Sbjct: 124 VH---SAGVVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 30/105 (28%), Positives = 58/105 (55%), Gaps = 10/105 (9%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGY 702
           AL  +H      ++HRD+K+++++L      +L DFG +K + + +  ++A    G+P Y
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237

Query: 703 IPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE 747
           + PE  +      + K+D++  GV+L EL+T  +P     P ++E
Sbjct: 238 LAPELWERKR--YSKKADMWSLGVILYELLTLHRPFKG--PSQRE 278

Length = 478

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 12/97 (12%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----GSPG 701
           AL +LH G    I++RD+K  ++ LD +   +++DFGL K    G+ +        G+P 
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPE 160

Query: 702 YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           Y+ PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 161 YLAPEVLE-DNDYGR-AVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 6/110 (5%)

Query: 639 IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGLDEEIAR 697
           IA     AL  L H      IHRD+K +++ L      +L DFG+ A++    L    + 
Sbjct: 126 IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 185

Query: 698 GSPGYIPPEF----AQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           G+P ++ PE      Q DS +   + DV+  G+  +EL  G  PL D +P
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDA-RCDVWSLGITAIELGDGDPPLADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 5/103 (4%)

Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGLDEEIARGSPG 701
           T + LA+LH   S   +HRDIK +++ L  N + +L+DFG+ AKI       +   G+P 
Sbjct: 115 TLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY 171

Query: 702 YIPPEFAQPDSDFPTPK-SDVYCYGVVLLELITGKKPLGDDYP 743
           ++ PE A  + +    +  D++  G+  +EL   + P+ D +P
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 20/100 (20%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-------- 697
           AL +LH   S  +++RD+K  ++ LD +   +++DFGL K       E I+         
Sbjct: 107 ALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFC 156

Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           G+P Y+ PE  + D+D+     D +  GVV+ E++ G+ P
Sbjct: 157 GTPEYLAPEVLE-DNDYGR-AVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 6e-05
 Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 48/247 (19%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLV---HGSTLTDQEAARELEYLGRIKH 563
             +   + + EG +G V      P G+ VA+K +    H      Q   RE++ L R KH
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKH 62

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
            N+             I I D +   + ++  +D+ + VQ  E   TD ++   T  + N
Sbjct: 63  ENI-------------IGILDIIRPPSFESF-NDVYI-VQ--ELMETDLYKLIKTQHLSN 105

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
              +       F ++I     R L ++H   S  ++HRD+K S++ L+ N + ++ DFGL
Sbjct: 106 DHIQ------YFLYQIL----RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGL 152

Query: 684 AKI------FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           A+I          L E +A  +  Y  PE       + T   D++  G +L E+++  +P
Sbjct: 153 ARIADPEHDHTGFLTEYVA--TRWYRAPEIMLNSKGY-TKAIDIWSVGCILAEMLSN-RP 208

Query: 738 L--GDDY 742
           L  G DY
Sbjct: 209 LFPGKDY 215

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 6e-05
 Identities = 32/131 (24%), Positives = 49/131 (37%), Gaps = 32/131 (24%)

Query: 659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE------------------------ 694
           IHRDIK  ++ +D +   +L+DFGL K      D E                        
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 695 ------IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEG 748
                    G+P YI PE  +        + D +  GV+L E++ G  P   D  +E   
Sbjct: 183 RRVRANSTVGTPDYIAPEVLR--GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240

Query: 749 NLVSWVRGLVR 759
            +++W   L  
Sbjct: 241 KIINWKESLRF 251

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 45.5 bits (108), Expect = 6e-05
 Identities = 70/253 (27%), Positives = 107/253 (42%), Gaps = 68/253 (26%)

Query: 510 FDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVLV----HGSTLTDQEAARELEYLGRIKH 563
           FD    + EG +G VY  R    G +    KV +     G  +T   A RE++ L ++ H
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPIT---AIREIKILRQLNH 65

Query: 564 PNLVPLTGYCIAGDQRIA------------IYDYMENGNLQNLLHDLPLGVQTTEDWSTD 611
            N+V L    I  D++ A            +++YM+        HDL +G+  +      
Sbjct: 66  RNIVNLKE--IVTDKQDALDFKKDKGAFYLVFEYMD--------HDL-MGLLES---GLV 111

Query: 612 TWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD 671
            + ED   S      EGL     + HK          FLH         RDIK S++ L+
Sbjct: 112 HFSEDHIKSFMKQLLEGL----NYCHK--------KNFLH---------RDIKCSNILLN 150

Query: 672 MNLEPRLSDFGLAKIFGNGLDEEIARGSPG------YIPPEFAQPDSDFPTPKSDVYCYG 725
              + +L+DFGLA+++    + E +R          Y PPE    +  +  P  DV+  G
Sbjct: 151 NKGQIKLADFGLARLY----NSEESRPYTNKVITLWYRPPELLLGEERY-GPAIDVWSCG 205

Query: 726 VVLLELITGKKPL 738
            +L EL T KKP+
Sbjct: 206 CILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.0 bits (97), Expect = 7e-05
 Identities = 23/60 (38%), Positives = 30/60 (50%), Gaps = 1/60 (1%)

Query: 54  KLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNF 112
            L+SLDLS N +T +P      L +LK L+LS N ++   P        L   DLS NN 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 40.2 bits (95), Expect = 8e-05
 Identities = 18/36 (50%), Positives = 27/36 (75%), Gaps = 1/36 (2%)

Query: 54 KLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRIS 89
           L++LDLS N IT LP  L +L +L++L+LS N+I+
Sbjct: 2  NLETLDLSNNQITDLPP-LSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 44.8 bits (107), Expect = 9e-05
 Identities = 60/261 (22%), Positives = 93/261 (35%), Gaps = 83/261 (31%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFL----PGGIHVAVKVL-----VHGSTLTDQEA--ARELE 556
            +F+    L  G FG V    L      G + A+K+L     V       Q      E  
Sbjct: 1   DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVK----LKQVEHVLNEKR 53

Query: 557 YLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEED 616
            L  I+HP LV L               + ++ NL  ++  +P                 
Sbjct: 54  ILQSIRHPFLVNL------------YGSFQDDSNLYLVMEYVP----------------- 84

Query: 617 GTNSIQNVGSEGLLTTWRFRHKIALGTAR--------ALAFLHHGCSPPIIHRDIKASSV 668
                   G E L +  R   +     AR        AL +LH      I++RD+K  ++
Sbjct: 85  --------GGE-LFSHLRKSGRFPEPVARFYAAQVVLALEYLHS-LD--IVYRDLKPENL 132

Query: 669 YLDMNLEPRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKS-DVY 722
            LD +   +++DFG AK           R     G+P Y+ PE           K+ D +
Sbjct: 133 LLDSDGYIKITDFGFAKRVKG-------RTYTLCGTPEYLAPEIILSK---GYGKAVDWW 182

Query: 723 CYGVVLLELITGKKPLGDDYP 743
             G+++ E++ G  P  DD P
Sbjct: 183 ALGILIYEMLAGYPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 45.9 bits (108), Expect = 9e-05
 Identities = 32/114 (28%), Positives = 53/114 (46%), Gaps = 21/114 (18%)

Query: 646 ALAFLHHGCSPP----IIHRDIKASSVYL---------------DMNLEP--RLSDFGLA 684
           ALA+ H+    P    ++HRD+K  +++L               ++N  P  ++ DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           K  G         G+P Y  PE    ++     KSD++  G ++ EL +GK P 
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 49/198 (24%), Positives = 83/198 (41%), Gaps = 57/198 (28%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVK-VLVHG-------STLTDQEAARELEYLGR 560
           ++    + EG +G VY+   L  G  VA+K V V         STL      RE+  L +
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL------REIALLKQ 54

Query: 561 IK---HPNLVPLTGYC--IAGDQRIAIYDYME--NGNLQNLLHDLPLGVQTTEDWSTDTW 613
           ++   HPN+V L   C     D+ + +    E  + +L   L   P              
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-------------- 100

Query: 614 EEDG--TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD 671
            + G    +I+++    LL              R + FLH   S  I+HRD+K  ++ + 
Sbjct: 101 -KPGLPPETIKDL-MRQLL--------------RGVDFLH---SHRIVHRDLKPQNILVT 141

Query: 672 MNLEPRLSDFGLAKIFGN 689
            + + +++DFGLA+I+  
Sbjct: 142 SDGQVKIADFGLARIYSF 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 53/245 (21%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG--STLTDQEAAR---ELEYLGRI 561
           +N+  G LL +G FG VY  +    G  +AVK +     S  T +E      E++ L  +
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 562 KHPNLVPLTGYCIAGDQR-IAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
            H  +V   G      +R ++I+ ++M  G++++ L                        
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK----------------------- 98

Query: 620 SIQNVGSEGLLT---TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP 676
                 S G LT   T ++  +I  G    +++LH   S  I+HRDIK +++  D     
Sbjct: 99  ------SYGALTENVTRKYTRQILEG----VSYLH---SNMIVHRDIKGANILRDSVGNV 145

Query: 677 RLSDFGLAK----IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
           +L DFG +K    I  +G   +   G+P ++ PE    +      K+D++  G  ++E++
Sbjct: 146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG--YGRKADIWSVGCTVVEML 203

Query: 733 TGKKP 737
           T K P
Sbjct: 204 TEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 2/89 (2%)

Query: 650 LHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQ 709
           L H  +  +++RD+K +++ LD +   R+SD GLA  F        + G+ GY+ PE  Q
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQ 168

Query: 710 PDSDFPTPKSDVYCYGVVLLELITGKKPL 738
             + + +  +D +  G +L +L+ G  P 
Sbjct: 169 KGTAYDS-SADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL +LH      +++RD+K  ++ LD +   +++DFGL K    +G   +   G+P Y+ 
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 164

Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 165 PEVLE-DNDYGR-AVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 24/105 (22%)

Query: 644 ARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR------ 697
           A AL +LH   S  I++RD+K  ++ LD      L+DFGL K       E IA+      
Sbjct: 106 ASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK-------EGIAQSDTTTT 155

Query: 698 --GSPGYIPPEF--AQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
             G+P Y+ PE    QP  +      D +C G VL E++ G  P 
Sbjct: 156 FCGTPEYLAPEVIRKQPYDN----TVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 4/88 (4%)

Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDE-EIARGSPGYIPPEF--AQPDSD 713
           +IHRD+K  ++ LD +   +L+DFG   K+   G+   + A G+P YI PE   +Q    
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 714 FPTPKSDVYCYGVVLLELITGKKPLGDD 741
           +   + D +  GV L E++ G  P   D
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPFYAD 250

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 51/231 (22%), Positives = 96/231 (41%), Gaps = 36/231 (15%)

Query: 516 LAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           +  G +G VY+   +  G   A+KV+            +E+  +   KH N+V   G  +
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWR 634
             D+     ++   G+LQ++ H                               G L+  +
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYH-----------------------------VTGPLSESQ 107

Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGLDE 693
             + ++  T + L +LH   S   +HRDIK +++ L  N   +L+DFG+ A+I       
Sbjct: 108 IAY-VSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163

Query: 694 EIARGSPGYIPPEFAQPDSDFPTPK-SDVYCYGVVLLELITGKKPLGDDYP 743
           +   G+P ++ PE A  +      +  D++  G+  +EL   + P+ D +P
Sbjct: 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 35/113 (30%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYI- 703
           R L ++H   S  IIHRD+K S++ ++ + E ++ DFGLA+      D+E+     GY+ 
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEMT----GYVA 177

Query: 704 -----PPE-------FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GDDY 742
                 PE       + Q          D++  G ++ EL+TG K L  G D+
Sbjct: 178 TRWYRAPEIMLNWMHYNQ--------TVDIWSVGCIMAELLTG-KTLFPGSDH 221

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 9/86 (10%)

Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDS 712
           I++RDIK  ++ LD      L+DFGL+K F   L EE  R     G+  Y+ PE  +   
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEF---LSEEKERTYSFCGTIEYMAPEIIRGKG 182

Query: 713 DFPTPKSDVYCYGVVLLELITGKKPL 738
                  D +  G+++ EL+TG  P 
Sbjct: 183 GH-GKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 53/238 (22%)

Query: 516 LAEGKFGPVYRG--FLPGGIHVAVKVLVHGSTLTDQE------AARELEYLGRIKHPNLV 567
           + EG +G VY+G     G I VA+K +     L  +E      A RE+  L  ++HPN+V
Sbjct: 8   IGEGTYGVVYKGRNKKTGQI-VAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIV 62

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L    +   +   I++++   +L+  L  LP G                    Q + +E
Sbjct: 63  CLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKG--------------------QYMDAE 101

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
                  + ++I  G    + F H   S  ++HRD+K  ++ +D     +L+DFGLA+ F
Sbjct: 102 ---LVKSYLYQILQG----ILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF 151

Query: 688 G---NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GD 740
           G        E+   +  Y  PE       + TP  D++  G +  E+ T KKPL  GD
Sbjct: 152 GIPVRVYTHEVV--TLWYRAPEVLLGSPRYSTP-VDIWSIGTIFAEMAT-KKPLFHGD 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 29/87 (33%), Positives = 45/87 (51%), Gaps = 4/87 (4%)

Query: 659 IHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDE-EIARGSPGYIPPEF--AQPDSDF 714
           IHRD+K  ++ LD +   +L+DFG   K+   G+   + A G+P YI PE   +Q    +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 715 PTPKSDVYCYGVVLLELITGKKPLGDD 741
              + D +  GV L E++ G  P   D
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYAD 250

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 30/105 (28%), Positives = 52/105 (49%), Gaps = 6/105 (5%)

Query: 659 IHRDIKASSVYLDMNLEPRLSDFG-LAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPT 716
           +HRDIK  +V +D     +L+DFG  A++  N  ++ ++  G+P YI PE     +    
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 717 PKSDVYC----YGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGL 757
               V C     GV+  E+I G+ P  +    +   N++++ R L
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL 228

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 35/103 (33%), Positives = 55/103 (53%), Gaps = 12/103 (11%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPG 701
           R L ++H   S  ++HRD+K S++ L+ N + ++ DFGLA+      D   E +   +  
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TRW 173

Query: 702 YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GDDY 742
           Y  PE     S++ T   DV+  G +  EL+ G+KPL  G DY
Sbjct: 174 YRAPELLLNCSEY-TTAIDVWSVGCIFAELL-GRKPLFPGKDY 214

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 2/81 (2%)

Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTP 717
           I++RD+K  ++ LD +   R+SD GLA     G   +   G+ GY+ PE  + +    +P
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 182

Query: 718 KSDVYCYGVVLLELITGKKPL 738
             D +  G +L E+I G+ P 
Sbjct: 183 --DWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 52/213 (24%), Positives = 75/213 (35%), Gaps = 61/213 (28%)

Query: 583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALG 642
           Y + +  NL  ++  LP G   T     DT  E+ T   Q   +E +L         A+ 
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEAT---QFYIAETVL---------AID 115

Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----- 697
               L F         IHRDIK  ++ LD     +LSDFGL          E  R     
Sbjct: 116 AIHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 698 -------------------------------GSPGYIPPE-FAQPDSDFPTPKSDVYCYG 725
                                          G+P YI PE F Q   +      D +  G
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN---KLCDWWSLG 223

Query: 726 VVLLELITGKKPLGDDYPEEKEGNLVSWVRGLV 758
           V++ E++ G  P   + P+E    +++W   LV
Sbjct: 224 VIMYEMLIGYPPFCSETPQETYRKVMNWKETLV 256

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 34/138 (24%), Positives = 65/138 (47%), Gaps = 9/138 (6%)

Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           K+++   + L +L       I+HRD+K S++ ++   E +L DFG++    + +      
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 163

Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGL 757
           G+  Y+ PE  Q      + +SD++  G+ L+E+  G+ P+    P+ KE  L+      
Sbjct: 164 GTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCP-- 217

Query: 758 VRNNKGSRAIDPKIRDTG 775
           V  +       P+ R  G
Sbjct: 218 VEGDPAESETSPRPRPPG 235

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 29/101 (28%), Positives = 55/101 (54%), Gaps = 5/101 (4%)

Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           KI++   R L +L       I+HRD+K S++ ++   E +L DFG++    + +      
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 159

Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G+  Y+ PE  Q  + + T +SD++  G+ L+E+  G+ P+
Sbjct: 160 GTRSYMSPERLQ-GTHY-TVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 63/274 (22%), Positives = 107/274 (39%), Gaps = 69/274 (25%)

Query: 508 SNFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTLTDQE-------AARELEYL 558
           S +++   + +G FG V+  R      I VA+K +     L + E       A RE++ L
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQI-VALKKV-----LMENEKEGFPITALREIKIL 65

Query: 559 GRIKHPNLVPLTGYCIAGDQ-----RIAIYDYME------NGNLQNLLHDLPLGVQTTED 607
             +KH N+V L   C          + + Y   E       G L N      L       
Sbjct: 66  QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE----- 120

Query: 608 WSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS 667
                        I+ V    LL                L ++H      I+HRD+KA++
Sbjct: 121 -------------IKKVMKM-LLN--------------GLYYIH---RNKILHRDMKAAN 149

Query: 668 VYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPG-----YIPPEFAQPDSDFPTPKSDVY 722
           + +  +   +L+DFGLA+ F    + +  R +       Y PPE    + D+  P  D++
Sbjct: 150 ILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDY-GPPIDMW 208

Query: 723 CYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRG 756
             G ++ E+ T + P+     E+ +  L+S + G
Sbjct: 209 GAGCIMAEMWT-RSPIMQGNTEQHQLTLISQLCG 241

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIP 704
           R L FLH  C   I+HRD+K  ++ +    + +L+DFGLA+I+   +       +  Y  
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE     S + TP  D++  G +  E+   +KPL
Sbjct: 176 PEVLL-QSTYATP-VDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 3e-04
 Identities = 21/60 (35%), Positives = 29/60 (48%), Gaps = 3/60 (5%)

Query: 174 KLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQF 230
            LKSL+L+ N +    D  F GL ++  L++SGN         F  L SL  +DL  N  
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 12/106 (11%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL +LH      II+RD+K  +V LD     +L+D+G+ K     G       G+P YI 
Sbjct: 108 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 164

Query: 705 PEFAQ-PDSDFPTPKSDVYCYGVVLLELITGKKPL----GDDYPEE 745
           PE  +  D  F     D +  GV++ E++ G+ P       D P++
Sbjct: 165 PEILRGEDYGFSV---DWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 36/106 (33%), Positives = 53/106 (50%), Gaps = 13/106 (12%)

Query: 644 ARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----GS 699
           A AL  LH   S  II+RD+K  ++ LD     +L+DFGL+K     +D E       G+
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGT 161

Query: 700 PGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDYPE 744
             Y+ PE         T  +D + +GV++ E++TG  P  G D  E
Sbjct: 162 VEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGSLPFQGKDRKE 205

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 19/108 (17%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYI- 703
           R L ++H   S  IIHRD+K S+V ++ + E R+ DFGLA+      D+E+     GY+ 
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMT----GYVA 177

Query: 704 -----PPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDYPEE 745
                 PE       +     D++  G ++ EL+ GK    G+DY ++
Sbjct: 178 TRWYRAPEIMLNWMHY-NQTVDIWSVGCIMAELLKGKALFPGNDYIDQ 224

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 50/234 (21%)

Query: 516 LAEGKFGPVYRGFL---PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPL 569
           L  G FG V +G          VAVK+L + +    L D E  RE   + ++ +P +V +
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKD-ELLREANVMQQLDNPYIVRM 61

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL 629
            G C   +  + + +  E G L   L                  +++   + +N+     
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL------------------QKNKHVTEKNIT---- 98

Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
                  H++++G    + +L        +HRD+ A +V L      ++SDFGL+K  G 
Sbjct: 99  ----ELVHQVSMG----MKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147

Query: 690 GLDEEIARG-SPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKP 737
             DE   +  + G  P ++  P+      F + KSDV+ +GV++ E  + G+KP
Sbjct: 148 --DENYYKAKTHGKWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 43.1 bits (102), Expect = 4e-04
 Identities = 51/248 (20%), Positives = 79/248 (31%), Gaps = 68/248 (27%)

Query: 50  GKLSKLQSLDLSENNITALPSDLW----SLGSLKSLNLSYNRISG--------SLPSNIG 97
            K   LQ LDLS+N +      +        SL+ L L+ N +           L     
Sbjct: 78  TKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPP 137

Query: 98  NFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSM 157
               LE   L  N   G    A++    LR                    + L  ++L+ 
Sbjct: 138 A---LEKLVLGRNRLEGASCEALAKA--LRAN------------------RDLKELNLAN 174

Query: 158 NQLNG----SLPDGFGAAFPKLKSLNLAGNEIKGRDTH---------FAGLKSITNLNIS 204
           N +      +L +G   A   L+ L+L  N +    T           A LKS+  LN+ 
Sbjct: 175 NGIGDAGIRALAEGL-KANCNLEVLDLNNNGL----TDEGASALAETLASLKSLEVLNLG 229

Query: 205 GNLFQG-------SVMGVFLESLEVIDLRSNQFQ----GHISQVQFNSSYNWSRLVYVDL 253
            N           S +     SL  + L  N         +++V          L+ +DL
Sbjct: 230 DNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEK----ESLLELDL 285

Query: 254 SENQLSGE 261
             N+   E
Sbjct: 286 RGNKFGEE 293

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 36/116 (31%), Positives = 51/116 (43%), Gaps = 7/116 (6%)

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           EG     R R      TA  L  L +     +I+RD+K  ++ LD      L DFGL K+
Sbjct: 87  EGRFDLSRAR----FYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL 142

Query: 687 FGNGLDE-EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
                D+     G+P Y+ PE         T   D +  GV+L E++TG  P  D+
Sbjct: 143 NMKDDDKTNTFCGTPEYLAPELLLGHG--YTKAVDWWTLGVLLYEMLTGLPPFYDE 196

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 25/81 (30%), Positives = 40/81 (49%), Gaps = 2/81 (2%)

Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTP 717
           I++RD+K  ++ LD     R+SD GLA     G       G+ GY+ PE    +    +P
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSP 182

Query: 718 KSDVYCYGVVLLELITGKKPL 738
             D +  G ++ E+I G+ P 
Sbjct: 183 --DWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 6e-04
 Identities = 24/61 (39%), Positives = 37/61 (60%), Gaps = 2/61 (3%)

Query: 149 SLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNL 207
           +L ++DLS N+L   +PDG     P LK L+L+GN +       F+GL S+ +L++SGN 
Sbjct: 1   NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 208 F 208
            
Sbjct: 60  L 60

Length = 60

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 42.3 bits (99), Expect = 7e-04
 Identities = 63/244 (25%), Positives = 102/244 (41%), Gaps = 53/244 (21%)

Query: 516 LAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQE-----AARELEYLGRIKHPNLVPL 569
           L EG +  VY+G     G  VA+KV+    ++  +E     A RE   L  +KH N+V  
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIV-- 66

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE-G 628
                                   LLHD+   + T E   T  +E   T+  Q +    G
Sbjct: 67  ------------------------LLHDI---IHTKETL-TFVFEYMHTDLAQYMIQHPG 98

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK--- 685
            L  +  R        R LA++H      I+HRD+K  ++ +    E +L+DFGLA+   
Sbjct: 99  GLHPYNVR-LFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKS 154

Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK--PLGDDYP 743
           I       E+   +  Y PP+     +D+ +   D++  G + +E++ G+   P   D  
Sbjct: 155 IPSQTYSSEVV--TLWYRPPDVLLGATDYSS-ALDIWGAGCIFIEMLQGQPAFPGVSDVF 211

Query: 744 EEKE 747
           E+ E
Sbjct: 212 EQLE 215

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.3 bits (99), Expect = 7e-04
 Identities = 51/213 (23%), Positives = 76/213 (35%), Gaps = 61/213 (28%)

Query: 583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALG 642
           Y + +  NL  ++  LP G   T     DT  E+ T   Q   +E +L         A+ 
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEET---QFYIAETVL---------AID 115

Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----- 697
           +   L F         IHRDIK  ++ LD     +LSDFGL          E  R     
Sbjct: 116 SIHQLGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 698 -------------------------------GSPGYIPPE-FAQPDSDFPTPKSDVYCYG 725
                                          G+P YI PE F Q   +      D +  G
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN---KLCDWWSLG 223

Query: 726 VVLLELITGKKPLGDDYPEEKEGNLVSWVRGLV 758
           V++ E++ G  P   + P+E    +++W   L+
Sbjct: 224 VIMYEMLIGYPPFCSETPQETYKKVMNWKETLI 256

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 42.3 bits (99), Expect = 7e-04
 Identities = 32/97 (32%), Positives = 46/97 (47%), Gaps = 9/97 (9%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYI- 703
           RA+ +LH      IIHRDIKA +++++   +  L DFG A  F   ++     G  G I 
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIA 248

Query: 704 --PPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
              PE    D     P  D++  G+VL E+ T    L
Sbjct: 249 TNAPELLARDP--YGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.8 bits (98), Expect = 7e-04
 Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 46/236 (19%)

Query: 515 LLAEGKFGPVYRGFL--PGG--IHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPL 569
           +L  G+FG + RG L  P    + VA+  L  G +   +     E   LG+  H N+V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL 629
            G    G+  + + +YM NG L + L                               EG 
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRK----------------------------HEGQ 103

Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
           L   +    +  G A  + +L        +H+ + A  V ++ +L  ++S F   +    
Sbjct: 104 LVAGQLMGMLP-GLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ---E 156

Query: 690 GLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGD 740
              E I     G  P  +A P++     F +  SDV+ +G+V+ E+++ G++P  D
Sbjct: 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 42.1 bits (99), Expect = 7e-04
 Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 41/186 (22%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE-----AARELEYLGRIK 562
           NF +   + EG +G VY+      G  VA+K +      T+ E     A RE+  L  + 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI---RLDTETEGVPSTAIREISLLKELN 57

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           HPN+V L       ++   +++++ + +L+  +   PL                    I+
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLS-------------GIPLPLIK 103

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
           +           +  ++  G    LAF H   S  ++HRD+K  ++ ++     +L+DFG
Sbjct: 104 S-----------YLFQLLQG----LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFG 145

Query: 683 LAKIFG 688
           LA+ FG
Sbjct: 146 LARAFG 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 42.8 bits (101), Expect = 8e-04
 Identities = 53/244 (21%), Positives = 96/244 (39%), Gaps = 43/244 (17%)

Query: 515 LLAEGKFGPVYRGFLPG-GIHVAVKVL---VHGSTLTDQEAARELEYLGRIKHPNLVPLT 570
           L+ +G  G VY  + P     VA+K +   +  + L  +   RE +    + HP +VP+ 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
             C  GD       Y+E   L++LL                 W+++  +         + 
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKS--------------VWQKESLSKELAEK-TSVG 113

Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
                 HKI       + ++H   S  ++HRD+K  ++ L +  E  + D+G A      
Sbjct: 114 AFLSIFHKICAT----IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166

Query: 691 LDEEIA-----RGS-------PGYI--PPEFAQPDSDFPTP---KSDVYCYGVVLLELIT 733
            ++ +      R         PG I   P++  P+     P    +D+Y  GV+L +++T
Sbjct: 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Query: 734 GKKP 737
              P
Sbjct: 227 LSFP 230

Length = 932

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 41.9 bits (98), Expect = 8e-04
 Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 41/232 (17%)

Query: 516 LAEGKFGPVY--RGFLPGGIHVAVK-VLVH----GSTLTDQEAARELEYLGRIKHPNLVP 568
           + EG +G V+  R    GG  VA+K V V     G  L+       L +L   +HPN+V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 569 LTGYCIAG--DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
           L   C     D+   +    E+                         ++D T  +  V  
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEH------------------------VDQDLTTYLDKVPE 104

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
            G+ T       +     R L FLH   S  ++HRD+K  ++ +  + + +L+DFGLA+I
Sbjct: 105 PGVPT--ETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159

Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           +   +       +  Y  PE     S + TP  D++  G +  E+   +KPL
Sbjct: 160 YSFQMALTSVVVTLWYRAPEVLL-QSSYATP-VDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 41.9 bits (98), Expect = 9e-04
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 17/98 (17%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA-------KIFGNGLDEEIAR 697
           R L++ H      I+HRD+K  ++ ++   E +L+DFGLA       K + N    E+  
Sbjct: 114 RGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN----EVV- 165

Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
            +  Y PP+     +++ TP  D++  G +L E+ TG+
Sbjct: 166 -TLWYRPPDVLLGSTEYSTP-IDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 53/244 (21%), Positives = 90/244 (36%), Gaps = 49/244 (20%)

Query: 516 LAEGKFGPVYRGFLPGGIHVA---VKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPLTG 571
           +  G FG V  G    G+  A   VK L   +T  +Q    +E++    + HPN++   G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 572 YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLT 631
            CI     + + ++   G+L+N L                      +N            
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLR---------------------SNRGMVAQMAQKDV 101

Query: 632 TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL 691
             R   ++A G    L +LH       IH D+   +  L  +L  ++ D+GLA       
Sbjct: 102 LQRMACEVASG----LLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYP 152

Query: 692 DEEIARGSPGYIPPEFAQPD------SDF----PTPKSDVYCYGVVLLELIT-GKKPLGD 740
           ++         +P  +  P+       D      T KS+++  GV + EL T   +P   
Sbjct: 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP--- 209

Query: 741 DYPE 744
            YP+
Sbjct: 210 -YPD 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 19/44 (43%), Positives = 30/44 (68%), Gaps = 3/44 (6%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           + LAF H   S  ++HRD+K  ++ ++ N E +L+DFGLA+ FG
Sbjct: 110 KGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 41.2 bits (97), Expect = 0.001
 Identities = 55/243 (22%), Positives = 96/243 (39%), Gaps = 63/243 (25%)

Query: 515 LLAEGKFGPVY--RGFLPGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLT 570
           L+ EG +G V   +    G I VA+K  +      +  + A RE+  L +++H NLV L 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQI-VAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
                  +   +++++++  L +L    P G+                            
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEK-YPNGL-------------------------DES 100

Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
              ++  +I     R + F H   S  IIHRDIK  ++ +  +   +L DFG A+     
Sbjct: 101 RVRKYLFQIL----RGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--- 150

Query: 691 LDEEIARGSPG-----------YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
                   +PG           Y  PE    D+ +     D++  G ++ E++TG +PL 
Sbjct: 151 -------AAPGEVYTDYVATRWYRAPELLVGDTKYGRA-VDIWAVGCLVTEMLTG-EPLF 201

Query: 739 -GD 740
            GD
Sbjct: 202 PGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 24/80 (30%), Positives = 43/80 (53%), Gaps = 2/80 (2%)

Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTP 717
           +++RD+K +++ LD +   R+SD GLA  F        + G+ GY+ PE  Q    + + 
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDS- 175

Query: 718 KSDVYCYGVVLLELITGKKP 737
            +D +  G +L +L+ G  P
Sbjct: 176 SADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 25/75 (33%), Positives = 44/75 (58%), Gaps = 4/75 (5%)

Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD-EEIARGSPGYIPPEFAQPDSDFPT 716
           I+HRD+KA +++L  NL  ++ DFG++++     D      G+P Y+ PE A     + +
Sbjct: 127 ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE-ALKHQGYDS 184

Query: 717 PKSDVYCYGVVLLEL 731
            KSD++  G +L E+
Sbjct: 185 -KSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 22/61 (36%), Positives = 33/61 (54%), Gaps = 4/61 (6%)

Query: 295 GLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNHLTGQIPTVSAK--NLGIIDMSHNN 351
            L+ L+LS  + +  IP    + L +L  LDLS N+LT   P   +   +L  +D+S NN
Sbjct: 1   NLKSLDLSN-NRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 352 L 352
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.002
 Identities = 24/60 (40%), Positives = 30/60 (50%)

Query: 271 NLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHL 330
           NLK L L+ NR T         L  L+ L+LS  +L    P     L SL +LDLS N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 31/118 (26%), Positives = 48/118 (40%), Gaps = 7/118 (5%)

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
           I N+G+ G         +     A  L  L        ++RD+K  ++ LD     R+SD
Sbjct: 91  IYNMGNPGFE-----EERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISD 145

Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            GLA     G       G+ GY+ PE         +P  D +  G ++ E+I G+ P 
Sbjct: 146 LGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSP--DYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 2/88 (2%)

Query: 650 LHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQ 709
           L       I++RD+K  ++ LD     R+SD GLA     G       G+ GY+ PE  +
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK 174

Query: 710 PDSDFPTPKSDVYCYGVVLLELITGKKP 737
            +    +P  D +  G ++ E+I GK P
Sbjct: 175 NERYTFSP--DWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 40.8 bits (96), Expect = 0.002
 Identities = 59/241 (24%), Positives = 93/241 (38%), Gaps = 51/241 (21%)

Query: 516 LAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEA------ARELEYLGRIKHPNLVP 568
           L  G FG V    +   G   A+K L  G  +   E        R  E     +HP LV 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 569 LTGYCIAGDQRIA-IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
           L   C   +  +  + +Y   G+L   +H             TD + E          + 
Sbjct: 67  LFA-CFQTEDHVCFVMEYAAGGDLMMHIH-------------TDVFSEPRA---VFYAAC 109

Query: 628 GLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
            +L                L +LH +     I++RD+K  ++ LD     +++DFGL K 
Sbjct: 110 VVL---------------GLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCK- 149

Query: 687 FGNGLDEEIAR--GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDYP 743
            G G  +  +   G+P ++ PE     S   T   D +  GV++ E++ G+ P  GDD  
Sbjct: 150 EGMGFGDRTSTFCGTPEFLAPEVLTETS--YTRAVDWWGLGVLIYEMLVGESPFPGDDEE 207

Query: 744 E 744
           E
Sbjct: 208 E 208

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 40.7 bits (96), Expect = 0.002
 Identities = 59/253 (23%), Positives = 102/253 (40%), Gaps = 75/253 (29%)

Query: 509 NFDRGTLLAEGKFGPVYRG--FLPGGIHVAVKVL-----VHGSTLTDQEAARELEYLGRI 561
            +++   + EG +G VYR      G I VA+K L       G  +T   + RE+  L ++
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEI-VALKKLKMEKEKEGFPIT---SLREINILLKL 61

Query: 562 KHPNLVPLTGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGT 618
           +HPN+V +    + G     IY   +Y+E+ +L++L+  +      +E            
Sbjct: 62  QHPNIVTVK-EVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSE------------ 107

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRL 678
                               + L     +A LH      I+HRD+K S++ L+     ++
Sbjct: 108 -----------------VKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKI 147

Query: 679 SDFGLAKIFGNGLDE-------------EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYG 725
            DFGLA+ +G+ L               E+  G+  Y             +   D++  G
Sbjct: 148 CDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEY-------------STAIDMWSVG 194

Query: 726 VVLLELITGKKPL 738
            +  EL+T KKPL
Sbjct: 195 CIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 14/107 (13%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEP-RLSDFGLAKIFG---NGLDEEIARGSP 700
           R +A+ H   S  ++HRD+K  ++ +D      +L+DFGLA+ FG        E+   + 
Sbjct: 113 RGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TL 167

Query: 701 GYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE 747
            Y  PE       + TP  D++  G +  E++  +KPL   +P + E
Sbjct: 168 WYRAPEILLGSRHYSTP-VDIWSVGCIFAEMVN-QKPL---FPGDSE 209

Length = 294

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 41.0 bits (96), Expect = 0.002
 Identities = 32/103 (31%), Positives = 43/103 (41%), Gaps = 8/103 (7%)

Query: 639 IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARG 698
           I      ALA+LH      IIHRD+K  +++LD      L DFG A       D     G
Sbjct: 190 IQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246

Query: 699 SPGYI---PPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
             G +    PE    D      K+D++  G+VL E+      L
Sbjct: 247 WSGTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.003
 Identities = 22/62 (35%), Positives = 32/62 (51%), Gaps = 3/62 (4%)

Query: 125 SLRVLKLDGNMFQWSIPPG-LLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGN 183
           +L+ L L  N     IP G      +L  +DLS N L    P+ F +  P L+SL+L+GN
Sbjct: 1   NLKSLDLSNN-RLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAF-SGLPSLRSLDLSGN 58

Query: 184 EI 185
            +
Sbjct: 59  NL 60

Length = 60

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 34/139 (24%), Positives = 53/139 (38%), Gaps = 46/139 (33%)

Query: 659 IHRDIKASSVYLDMNLEPRLSDFGL---------AKIFGNG---------LDEEIAR--- 697
           IHRDIK  ++ +D +   +L+DFGL         +K +  G           EE +    
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 698 -----------------------GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
                                  G+P YI PE         T   D +  GV+L E++ G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY--TQLCDWWSVGVILYEMLVG 240

Query: 735 KKPLGDDYPEEKEGNLVSW 753
           + P   D P E +  +++W
Sbjct: 241 QPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 34/111 (30%), Positives = 49/111 (44%), Gaps = 13/111 (11%)

Query: 639 IALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFG-LAKIFGNGLDEEIA 696
           I  G  R L +LH +G     IHR+IKAS + +  +    LS    L  +  NG   ++ 
Sbjct: 106 ILFGALRGLNYLHQNGY----IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161

Query: 697 RGSPGY-------IPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
              P +       + PE  + D      KSD+Y  G+   EL TG+ P  D
Sbjct: 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 40.2 bits (94), Expect = 0.003
 Identities = 24/99 (24%), Positives = 44/99 (44%), Gaps = 5/99 (5%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIP 704
             L +LH   +  IIHRD+K  +++++   +  + D G A+            G+     
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224

Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           PE    D      K+D++  G+VL E++     + +D P
Sbjct: 225 PEVLARDK--YNSKADIWSAGIVLFEMLAYPSTIFEDPP 261

Length = 357

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 44/188 (23%), Positives = 71/188 (37%), Gaps = 43/188 (22%)

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           HPN+VP     IA ++   +  +M  G+ ++L+                T   DG + + 
Sbjct: 58  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC---------------THFMDGMSELA 102

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
                           I  G  +AL ++HH      +HR +KAS + + ++ +  LS  G
Sbjct: 103 IA-------------YILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS--G 144

Query: 683 LAKIFG---NGLDEEIARGSPGY-------IPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
           L        +G    +    P Y       + PE  Q +      KSD+Y  G+   EL 
Sbjct: 145 LRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 204

Query: 733 TGKKPLGD 740
            G  P  D
Sbjct: 205 NGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 0.004
 Identities = 16/44 (36%), Positives = 28/44 (63%), Gaps = 3/44 (6%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           + +A+ H   S  ++HRD+K  ++ +D     +L+DFGLA+ FG
Sbjct: 110 QGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 52/233 (22%)

Query: 516 LAEGKFGPVYRGF--LPGGIHVAVKVLVHGSTLTDQEAA-----RELEYLGRIKHPNLVP 568
           L EG +  VY+G   L   + VA+K +     L  +E A     RE+  L  +KH N+V 
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEI----RLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           L            +++Y++    Q L                    +D  NSI       
Sbjct: 69  LHDIIHTEKSLTLVFEYLDKDLKQYL--------------------DDCGNSIN------ 102

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK--- 685
                   H + L   + L  L++     ++HRD+K  ++ ++   E +L+DFGLA+   
Sbjct: 103 -------MHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155

Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           I       E+   +  Y PP+     +D+ T + D++  G +  E+ TG +PL
Sbjct: 156 IPTKTYSNEVV--TLWYRPPDILLGSTDYST-QIDMWGVGCIFYEMSTG-RPL 204

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIP 704
           R L ++H   S  IIHRD+K S++ ++ + E ++ DFGLA+   + +   +A  +  Y  
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA--TRWYRA 185

Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
           PE       +     D++  G ++ EL+TG+
Sbjct: 186 PEIMLNWMHY-NQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	815
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.97
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.89
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.89
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.8
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
PRK10345	210	hypothetical protein; Provisional	99.75
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
smart00090	237	RIO RIO-like kinase.	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.57
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.54
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.51
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.45
PLN03150	623	hypothetical protein; Provisional	99.45
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.45
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.45
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.37
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.36
PLN03150	623	hypothetical protein; Provisional	99.35
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.34
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.3
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.3
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.27
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.27
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.27
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.25
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.24
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.24
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.2
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.18
KOG1243	690	consensus Protein kinase [General function predict	99.15
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.15
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.15
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.07
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.03
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.99
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.97
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.97
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.95
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.91
KOG3087	229	consensus Serine/threonine protein kinase [General	98.86
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.78
COG4248	637	Uncharacterized protein with protein kinase and he	98.77
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.74
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.74
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.71
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.69
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.67
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.64
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.63
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.57
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.47
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.45
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.41

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.3e-85  Score=804.90  Aligned_cols=730  Identities=30%  Similarity=0.504  Sum_probs=438.2

Q ss_pred             ccccccc-CCCCcceeeeEecCCCCeEEEEecCCCCCccCCCcccccCCCCCCEEECcCCCCC-CCCcccC-CCCCCCEE
Q 003504            5 SFQASYF-SASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT-ALPSDLW-SLGSLKSL   81 (815)
Q Consensus         5 ~~~~~~~-~~~~c~w~gv~C~~~~~~~~~l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~-~lp~~~~-~l~~L~~L   81 (815)
                      .+.++|. +.+||.|.||.|+.. .+|+.++++++++.|.+++ .|..+++|+.|+|++|+++ .+|..++ .+++|++|
T Consensus        46 ~~~~~w~~~~~~c~w~gv~c~~~-~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L  123 (968)
T PLN00113         46 KYLSNWNSSADVCLWQGITCNNS-SRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL  123 (968)
T ss_pred             ccCCCCCCCCCCCcCcceecCCC-CcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEE
Confidence            3457885 468999999999853 4899999999998887765 6888888888888888886 5776665 45555555


Q ss_pred             EccCCcC----------------------CccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCCCccccc
Q 003504           82 NLSYNRI----------------------SGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWS  139 (815)
Q Consensus        82 ~L~~N~i----------------------~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  139 (815)
                      +|++|++                      ++..|..|+++++|++|+|++|.+++..|.+|.++++|++|+|++|++++.
T Consensus       124 ~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~  203 (968)
T PLN00113        124 NLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQ  203 (968)
T ss_pred             ECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCc
Confidence            5555544                      445566666777777777777777767777777777777777777777666


Q ss_pred             CCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccC-CCCCCCCCCCCCeEeccCCcCCCcchhhh--
Q 003504          140 IPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF--  216 (815)
Q Consensus       140 ~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~--  216 (815)
                      +|..|.++++|++|+|++|++++.+|..+ ..+++|++|+|++|.+++ .+..|.++++|++|+|++|.+.+..+..+  
T Consensus       204 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~  282 (968)
T PLN00113        204 IPRELGQMKSLKWIYLGYNNLSGEIPYEI-GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS  282 (968)
T ss_pred             CChHHcCcCCccEEECcCCccCCcCChhH-hcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhh
Confidence            66666666777777777776666666554 346666666666666653 34445555555555555555544332222  


Q ss_pred             hcccceeeeccccccCccccc--------------------ccc------------------------cccCCccceEEE
Q 003504          217 LESLEVIDLRSNQFQGHISQV--------------------QFN------------------------SSYNWSRLVYVD  252 (815)
Q Consensus       217 l~~L~~L~L~~N~l~~~~~~~--------------------~~~------------------------~~~~l~~L~~L~  252 (815)
                      +++|+.|+|++|.+.+.++..                    ...                        .+..+++|+.|+
T Consensus       283 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~  362 (968)
T PLN00113        283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLD  362 (968)
T ss_pred             ccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEE
Confidence            344444444444443322110                    000                        112223344444


Q ss_pred             cCCCccCcchhhc------------------------cccCCCCCEEEecCCcCcCCCcccccc----------------
Q 003504          253 LSENQLSGEIFHN------------------------FSQAQNLKHLSLAYNRFTRQEFPQIGT----------------  292 (815)
Q Consensus       253 Ls~N~l~~~~~~~------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~----------------  292 (815)
                      +++|.+.+.+|..                        +..+++|+.|+|++|++++..+..+..                
T Consensus       363 Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  442 (968)
T PLN00113        363 LSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG  442 (968)
T ss_pred             CCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccC
Confidence            4444333222211                        112222222222222221111111111                


Q ss_pred             -------------------------------ccCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcCCCCCCcc--CC
Q 003504          293 -------------------------------LLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV--SA  339 (815)
Q Consensus       293 -------------------------------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~--~~  339 (815)
                                                     .++|+.|++++|++.+.+|..+..+++|+.|+|++|++++.+|..  .+
T Consensus       443 ~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  522 (968)
T PLN00113        443 RINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC  522 (968)
T ss_pred             ccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCc
Confidence                                           112333333344444444444444455555555555555444432  33


Q ss_pred             C------------------------CccEEEccCCcCcccCChHHhhcCCCCceeeccCCCCcccCCCCCc-cccc-ccc
Q 003504          340 K------------------------NLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSP-ETLQ-TAF  393 (815)
Q Consensus       340 ~------------------------~L~~L~ls~N~l~~~~p~~~~~~l~~l~~l~l~~N~l~~~~~~~~~-~~~~-~~~  393 (815)
                      +                        +|+.|+|++|+++|.+|. .+..++.|+.+++++|+++.+.+.... .+.. ..+
T Consensus       523 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~  601 (968)
T PLN00113        523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK-NLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAV  601 (968)
T ss_pred             cCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCCh-hHhcCcccCEEeccCCcceeeCCCcchhcccChhhh
Confidence            4                        444555555555444442 233444555555555554432221100 0000 011


Q ss_pred             ccCCCCCCCC---CCCCcccccccccccchhHHHHHHHHHHHHHHHHHhhhhccccCCcceeccccchhhcccCCCcccc
Q 003504          394 FGSSNDCPIA---ANPSFFKRKAANHKGLKLALALTLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQ  470 (815)
Q Consensus       394 ~~~~~~c~~~---~~~~~~~~~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~~~~rk~~~~~~~~~~~~~~~~~~~~~~~~  470 (815)
                      .+...-|...   +.++.....+  ...+.++++++++++++++++++++++++++++.. .+..    + ...      
T Consensus       602 ~~n~~lc~~~~~~~~~~c~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~-~~~------  667 (968)
T PLN00113        602 AGNIDLCGGDTTSGLPPCKRVRK--TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLE-LKRV----E-NED------  667 (968)
T ss_pred             cCCccccCCccccCCCCCccccc--cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccc-cccc----c-ccc------
Confidence            1111123211   1111111111  11111222222222222222222333333322111 1100    0 000      


Q ss_pred             cCCcchhhcccccCcceEEEec-cCccccCHHHHHHHhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccH
Q 003504          471 TDSTTWVADVKHANSVQVVIFE-KPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTD  548 (815)
Q Consensus       471 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~  548 (815)
                         ..|..          ..+. .....++++++.   ..|...+.||+|+||.||+|+. .++..||||++.....   
T Consensus       668 ---~~~~~----------~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---  728 (968)
T PLN00113        668 ---GTWEL----------QFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---  728 (968)
T ss_pred             ---ccccc----------cccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---
Confidence               00100          0011 111224445543   3577788999999999999995 6789999999865322   


Q ss_pred             HHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCC
Q 003504          549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG  628 (815)
Q Consensus       549 ~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (815)
                       ...+|++++++++|||||+++|+|.+.+..++||||+++|+|.++++.                               
T Consensus       729 -~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------------------------------  776 (968)
T PLN00113        729 -IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------------------------------  776 (968)
T ss_pred             -ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------------------------------
Confidence             223568899999999999999999999999999999999999999953                               


Q ss_pred             cccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCccc
Q 003504          629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFA  708 (815)
Q Consensus       629 ~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~  708 (815)
                        ++|..+.+|+.|+|+||+|||+.++++|+||||||+||+++.++.+++. ||.+.....   .....|++.|+|||++
T Consensus       777 --l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~  850 (968)
T PLN00113        777 --LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETR  850 (968)
T ss_pred             --CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCccccccccCcccc
Confidence              6799999999999999999998778899999999999999999988876 665544322   1223588999999998


Q ss_pred             CCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCC--CCHHHHHHHHHH
Q 003504          709 QPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT--GPEKQMEEALKI  786 (815)
Q Consensus       709 ~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  786 (815)
                      .+..  ++.++|||||||++|||++|+.||+...  .....+.+|++...........+|+.+...  .+.++..++.++
T Consensus       851 ~~~~--~~~~sDv~S~Gvvl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  926 (968)
T PLN00113        851 ETKD--ITEKSDIYGFGLILIELLTGKSPADAEF--GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNL  926 (968)
T ss_pred             cCCC--CCcccchhhHHHHHHHHHhCCCCCCccc--CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHH
Confidence            7665  7899999999999999999999996432  234567888876655555555666666432  345677889999


Q ss_pred             HhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          787 GYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       787 ~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      +.+||+.||++||+|+||+++|+++.+
T Consensus       927 ~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        927 ALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             HHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            999999999999999999999998854

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-56  Score=479.28  Aligned_cols=288  Identities=43%  Similarity=0.761  Sum_probs=253.5

Q ss_pred             CccccCHHHHHHHhcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEE
Q 003504          494 PLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYC  573 (815)
Q Consensus       494 ~~~~~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  573 (815)
                      +...|++.++..||++|...+.||+|+||.||+|.+++|+.||||++.........+|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999999999999988764433155699999999999999999999999


Q ss_pred             EeCC-eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhc
Q 003504          574 IAGD-QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHH  652 (815)
Q Consensus       574 ~~~~-~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~  652 (815)
                      .+.+ ++++|||||++|+|.++|+...                           .. +++|..|++||.++|+||+|||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~---------------------------~~-~L~W~~R~kIa~g~A~gL~yLH~  192 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKK---------------------------GE-PLDWETRLKIALGAARGLAYLHE  192 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCC---------------------------CC-CCCHHHHHHHHHHHHHHHHHHcc
Confidence            9988 5999999999999999998631                           11 78999999999999999999999


Q ss_pred             CCCCCeeeccCCCCceEEcCCCCeeecccccceecCC-CCccccc-cccccccCCcccCCCCCCCCCcCcchhHHHHHHH
Q 003504          653 GCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN-GLDEEIA-RGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE  730 (815)
Q Consensus       653 ~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~e  730 (815)
                      .+.++||||||||+|||+|+++++||+|||+|+.... ....... .||.+|+|||++....  .++|+|||||||+|+|
T Consensus       193 ~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~--lt~KsDVySFGVvllE  270 (361)
T KOG1187|consen  193 GCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGK--LTEKSDVYSFGVVLLE  270 (361)
T ss_pred             CCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCC--cCcccccccchHHHHH
Confidence            9999999999999999999999999999999976654 3333333 7999999999998755  7999999999999999


Q ss_pred             HHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCcccccccc-CCCCH-HHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          731 LITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIR-DTGPE-KQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       731 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                      ++||++|.+... ......+..|+...+......+++||.+. ...+. .....+..++.+|++.+|.+||+|.||+++|
T Consensus       271 litgr~~~d~~~-~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L  349 (361)
T KOG1187|consen  271 LITGRKAVDQSR-PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL  349 (361)
T ss_pred             HHhCCcccCCCC-CcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence            999999887533 23344599999999999899999999987 44443 6888999999999999999999999999999


Q ss_pred             Hhhh
Q 003504          809 KDIE  812 (815)
Q Consensus       809 ~~i~  812 (815)
                      +.+.
T Consensus       350 ~~~~  353 (361)
T KOG1187|consen  350 EGIL  353 (361)
T ss_pred             Hhhc
Confidence            7765

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-49  Score=416.69  Aligned_cols=257  Identities=32%  Similarity=0.473  Sum_probs=212.9

Q ss_pred             CCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCccc--HHHHHHHHHHhcCCCCCCceeeeeEEEeCC-eeEEEEEeCC
Q 003504          511 DRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLT--DQEAARELEYLGRIKHPNLVPLTGYCIAGD-QRIAIYDYME  587 (815)
Q Consensus       511 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~ey~~  587 (815)
                      ...+.||+|+||+||+|.+.+...||||++.......  .+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            3356699999999999999866669999997643322  458999999999999999999999999887 7999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC-eeeccCCCC
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP-IIHRDIKAS  666 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~-ivHrDlk~~  666 (815)
                      +|+|.++++..                            ....++|..+++||.|||+||.|||   +.+ ||||||||+
T Consensus       124 ~GsL~~~l~~~----------------------------~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~  172 (362)
T KOG0192|consen  124 GGSLSVLLHKK----------------------------RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSD  172 (362)
T ss_pred             CCcHHHHHhhc----------------------------ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChh
Confidence            99999999862                            2457999999999999999999999   666 999999999


Q ss_pred             ceEEcCCC-CeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          667 SVYLDMNL-EPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       667 NIll~~~~-~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      |||++.++ ++||+|||+++..... .......||+.|||||++......++.|+|||||||++|||+||+.||.+..+.
T Consensus       173 NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~  252 (362)
T KOG0192|consen  173 NILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV  252 (362)
T ss_pred             hEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH
Confidence            99999997 9999999999987654 233446799999999999854222899999999999999999999999864331


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhhc
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~~  814 (815)
                             ..+......         ..+...+..++..+..++.+||..||++||++.+++..|+.+..+
T Consensus       253 -------~~~~~v~~~---------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  253 -------QVASAVVVG---------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             -------HHHHHHHhc---------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence                   111112211         222333445788899999999999999999999999999988653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-49  Score=414.72  Aligned_cols=250  Identities=30%  Similarity=0.459  Sum_probs=216.5

Q ss_pred             CCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCChh
Q 003504          513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQ  592 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~  592 (815)
                      .+.||+|-||+||.|.+++..+||||.++.. ....+.|.+|+++|.+|+|+|||+++|+|..+++.+||||||+.|+|.
T Consensus       211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl  289 (468)
T KOG0197|consen  211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL  289 (468)
T ss_pred             HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence            5789999999999999998889999999874 566788999999999999999999999999988999999999999999


Q ss_pred             hhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcC
Q 003504          593 NLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM  672 (815)
Q Consensus       593 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~  672 (815)
                      +||+..                            ++..+...+.+.+|.|||+||+||+   ++++|||||.++||||++
T Consensus       290 ~yLr~~----------------------------~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~  338 (468)
T KOG0197|consen  290 DYLRTR----------------------------EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDE  338 (468)
T ss_pred             HHhhhc----------------------------CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeecc
Confidence            999862                            3556788889999999999999999   899999999999999999


Q ss_pred             CCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCcccccc
Q 003504          673 NLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGN  749 (815)
Q Consensus       673 ~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~  749 (815)
                      +..+||+|||+|+....+.  ......-...|.|||.+.-..  ++.|||||||||+|||++| |+.||.+....+.   
T Consensus       339 ~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~--FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev---  413 (468)
T KOG0197|consen  339 DLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGK--FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV---  413 (468)
T ss_pred             CceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCC--cccccceeehhhhHHHHhccCCCCCCCCCHHHH---
Confidence            9999999999999544332  112222356899999998776  8999999999999999999 9999876432211   


Q ss_pred             HHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          750 LVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                                    .+.++.+.+...|+.|+.++.++|..||+.+|++||||+.+...|+++..
T Consensus       414 --------------~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  414 --------------LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             --------------HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence                          22345566777789999999999999999999999999999999998864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-48  Score=430.26  Aligned_cols=271  Identities=27%  Similarity=0.376  Sum_probs=219.8

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCe
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQ  578 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  578 (815)
                      ...+....+.||+|+||+||+|+..      +.+.||||.+++.+.. ..++|+||+++++.++|||||+++|+|.++++
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            3445566789999999999999843      3567999999887665 67899999999999999999999999999999


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++|+|||..|||.+||+...+......               .... ...+++-.+.+.||.|||.||+||-   ++.+
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~---------------~g~~-~~~~L~~~q~L~iA~QIAaGM~YLs---~~~F  624 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLA---------------SGQD-TPPPLSTSQFLHIATQIAAGMEYLS---SHHF  624 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCcccccc---------------CCCC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCcc
Confidence            9999999999999999986532211110               0000 1446889999999999999999999   8999


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCCCCccc---cccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-C
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE---IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-G  734 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g  734 (815)
                      |||||.++|+||+++..+||+|||+++..-..+-..   ...-..+|||||.+.-++  ++++||||||||||||+++ |
T Consensus       625 VHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k--FTteSDVWs~GVvLWEIFsyG  702 (774)
T KOG1026|consen  625 VHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK--FTTESDVWSFGVVLWEIFSYG  702 (774)
T ss_pred             cccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc--ccchhhhhhhhhhhhhhhccc
Confidence            999999999999999999999999999753322111   112357899999988666  8999999999999999999 9


Q ss_pred             CCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhhc
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       735 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~~  814 (815)
                      +.||.+...++.    .+    +++.        ..+ ..+|++|+.++.+||..||+..|++||+|+||-..|+...+.
T Consensus       703 ~QPy~glSn~EV----Ie----~i~~--------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  703 KQPYYGLSNQEV----IE----CIRA--------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             cCcccccchHHH----HH----HHHc--------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            999987544332    22    2222        222 456999999999999999999999999999999999887654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-47  Score=378.90  Aligned_cols=250  Identities=28%  Similarity=0.423  Sum_probs=210.6

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecC-CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC-eeEEEEEeC
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG-STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD-QRIAIYDYM  586 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~ey~  586 (815)
                      .+....||+|..|+|||+.+ .+++.+|+|++... .....+++.+|++++++.+||+||.++|+|.... +..++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            34468999999999999996 46888999999543 3445678999999999999999999999999988 599999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|||+.++..                              ...++....-+||.+|.+||.|||+  +++||||||||+
T Consensus       161 DgGSLd~~~k~------------------------------~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPs  208 (364)
T KOG0581|consen  161 DGGSLDDILKR------------------------------VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPS  208 (364)
T ss_pred             CCCCHHHHHhh------------------------------cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHH
Confidence            99999999974                              2356778888999999999999995  489999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEK  746 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~  746 (815)
                      |||++..|++||+|||.++.+.+. .....+||..|||||.+.+..  |+.++||||||++++|+.+|+.||...  .+.
T Consensus       209 NlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~--Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~  283 (364)
T KOG0581|consen  209 NLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGES--YSVKSDIWSLGLSLLELAIGRFPYPPP--NPP  283 (364)
T ss_pred             HeeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCc--CCcccceecccHHHHHHhhCCCCCCCc--CCC
Confidence            999999999999999999988765 556788999999999999887  799999999999999999999999753  222


Q ss_pred             cccHHHHHHHHHhcCCCCccccccccCCCCH-HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          747 EGNLVSWVRGLVRNNKGSRAIDPKIRDTGPE-KQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .....+.+..+..+.      .|.+    |. .+++++..++..|+++||.+||+++|+++
T Consensus       284 ~~~~~~Ll~~Iv~~p------pP~l----P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  284 YLDIFELLCAIVDEP------PPRL----PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCCHHHHHHHHhcCC------CCCC----CcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            334444444443322      1222    33 47889999999999999999999999975

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=406.03  Aligned_cols=253  Identities=26%  Similarity=0.394  Sum_probs=217.1

Q ss_pred             CCCCCCeecccCCeeeEEEEcC----CCcEEEEEEeecCCccc-HHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGSTLT-DQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ...+.++||.|.||+||+|.++    ....||||.++.+.... ..+|..|+.||.+++||||++|.|+.....+.++|+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            4556789999999999999964    24579999998765444 468999999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      |||++|+|+.||+++                             +..+.|.+...|.++||.||.||-   +.++|||||
T Consensus       710 EyMENGsLDsFLR~~-----------------------------DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDL  757 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQN-----------------------------DGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDL  757 (996)
T ss_pred             hhhhCCcHHHHHhhc-----------------------------CCceEeehHHHHHHHHHHHhHHHh---hcCchhhhh
Confidence            999999999999873                             345888899999999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC-cccccc---ccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPL  738 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~---gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~  738 (815)
                      .++||||+.+..+||+|||+++.+..+. ......   -..+|.|||.+.-.+  ++.+||||||||||||+++ |.+||
T Consensus       758 AARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK--FTsASDVWSyGIVmWEVmSyGERPY  835 (996)
T KOG0196|consen  758 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPY  835 (996)
T ss_pred             hhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcc--cCchhhccccceEEEEecccCCCcc
Confidence            9999999999999999999999886554 122222   246899999998766  7999999999999999999 99999


Q ss_pred             CCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      .+....+.                 ...++.+++...|.+|+..+.+||..||++|-.+||.|.||+..|+++.
T Consensus       836 WdmSNQdV-----------------IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  836 WDMSNQDV-----------------IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             cccchHHH-----------------HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence            86433221                 1223456777779999999999999999999999999999999999874

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-46  Score=374.84  Aligned_cols=253  Identities=25%  Similarity=0.412  Sum_probs=206.8

Q ss_pred             cCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcc-------cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCee
Q 003504          508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTL-------TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  579 (815)
                      +.|.+.+.+|+|+||.|-+|. ..+|+.||||++++....       ......+|+++|++|+|||||++.+++...+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            467788999999999999998 578999999999754221       223457999999999999999999999999999


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      |+|+|||++|+|.+++-...                              .+....-.-++.|+..|+.|||   ++||+
T Consensus       252 YmVlE~v~GGeLfd~vv~nk------------------------------~l~ed~~K~~f~Qll~avkYLH---~~GI~  298 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANK------------------------------YLREDLGKLLFKQLLTAVKYLH---SQGII  298 (475)
T ss_pred             EEEEEEecCccHHHHHHhcc------------------------------ccccchhHHHHHHHHHHHHHHH---HcCcc
Confidence            99999999999999996532                              2333334678999999999999   89999


Q ss_pred             eccCCCCceEEcCC---CCeeecccccceecCCCCccccccccccccCCcccCCCCCCCC-CcCcchhHHHHHHHHHhCC
Q 003504          660 HRDIKASSVYLDMN---LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPT-PKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~---~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~Dv~S~Gvvl~el~tg~  735 (815)
                      ||||||+|||+..+   ..+||+|||+|+..+.+....+.|||+.|.|||++.+....++ .++|+||+|||+|-+++|.
T Consensus       299 HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~  378 (475)
T KOG0615|consen  299 HRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGY  378 (475)
T ss_pred             cccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccC
Confidence            99999999999866   6799999999999998888899999999999999987764344 4899999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +||.+......   +.+   ++.+.   .-.    +.+....+..++..+++.+++..||++|||+.++++
T Consensus       379 pPFS~~~~~~s---l~e---QI~~G---~y~----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  379 PPFSEEYTDPS---LKE---QILKG---RYA----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             CCcccccCCcc---HHH---HHhcC---ccc----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            99987543321   111   11111   111    112235678899999999999999999999999874

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-45  Score=368.86  Aligned_cols=203  Identities=27%  Similarity=0.457  Sum_probs=181.5

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ..+|...+.||+|+||+||+|++ .++..||||.+.+.  .....+.+..|+++|+.++|||||++++++..++..++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            35788889999999999999995 56899999999765  3344566789999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      |||.+|+|.+||+..                              ..++......++.|+|.||++||   +.+||||||
T Consensus        89 EyC~gGDLs~yi~~~------------------------------~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDL  135 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR------------------------------GRLPEATARHFMQQLASALQFLH---ENNIIHRDL  135 (429)
T ss_pred             EeCCCCCHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccC
Confidence            999999999999863                              25677778899999999999999   899999999


Q ss_pred             CCCceEEcCC------CCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          664 KASSVYLDMN------LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       664 k~~NIll~~~------~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      ||.|||++..      -.+||+|||+|+.+.++....+.+|++.|||||+++...  |+.|+|+||.|+++|++++|+.|
T Consensus       136 KPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~--YdAKADLWSiG~Ilyq~l~g~~P  213 (429)
T KOG0595|consen  136 KPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQ--YDAKADLWSIGTILYQCLTGKPP  213 (429)
T ss_pred             CcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhcc--ccchhhHHHHHHHHHHHHhCCCC
Confidence            9999999865      458999999999999888888899999999999998666  89999999999999999999999


Q ss_pred             CCCCCCc
Q 003504          738 LGDDYPE  744 (815)
Q Consensus       738 ~~~~~~~  744 (815)
                      |....+.
T Consensus       214 f~a~t~~  220 (429)
T KOG0595|consen  214 FDAETPK  220 (429)
T ss_pred             ccccCHH
Confidence            9864443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-44  Score=381.88  Aligned_cols=246  Identities=25%  Similarity=0.396  Sum_probs=211.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      .+|..++.||+|+|+.||+++. ..|..||+|++.+..   ....+...+||+|-++|+|||||++++||++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688999999999999999996 889999999997642   334567889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      |+|++|+|.+++..                              .++++......+..||+.||.|||   +.+|+||||
T Consensus        98 ELC~~~sL~el~Kr------------------------------rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDL  144 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR------------------------------RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDL  144 (592)
T ss_pred             EecCCccHHHHHHh------------------------------cCCCCcHHHHHHHHHHHHHHHHHH---hcCceeccc
Confidence            99999999999874                              346788888999999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      |..|+++++++++||+|||+|..+..+ ....+.+|||.|+|||++....  .+..+||||+|||||-|+.|++||....
T Consensus       145 KLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~g--HsfEvDiWSlGcvmYtLL~G~PPFetk~  222 (592)
T KOG0575|consen  145 KLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSG--HSFEVDIWSLGCVMYTLLVGRPPFETKT  222 (592)
T ss_pred             chhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCC--CCCchhhhhhhhHHHhhhhCCCCcccch
Confidence            999999999999999999999988744 6778889999999999998665  6899999999999999999999998643


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..+....+        +.   .+..       .|...+.+..+|+.++++++|.+|||+++|+.
T Consensus       223 vkety~~I--------k~---~~Y~-------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  223 VKETYNKI--------KL---NEYS-------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHHHHHHH--------Hh---cCcc-------cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            33222111        11   1111       24456678899999999999999999999975

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=403.38  Aligned_cols=262  Identities=28%  Similarity=0.401  Sum_probs=214.0

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCC--C----cEEEEEEeecC-CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG--G----IHVAVKVLVHG-STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRI  580 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~--~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  580 (815)
                      ...+..+.||+|+||.||+|+..+  |    ..||||.+.+. +..+..+|.+|..+|+.++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            345567899999999999999532  3    35999999775 3455678999999999999999999999999999999


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +++|||++|+|..||++.+...                       .....++..+.+.+|.|||+|+.||+   ++++||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~-----------------------~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvH  825 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAP-----------------------FQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVH  825 (1025)
T ss_pred             EEehhcccCcHHHHHHhccccc-----------------------CCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcC
Confidence            9999999999999998753221                       11446888999999999999999999   899999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCCcc---ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE---EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKK  736 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~  736 (815)
                      |||.++|+|+++...+||+|||+|+..-...-.   ....-...|||||.+....  ++.|+|||||||++||++| |..
T Consensus       826 RDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i--FtskSDvWsFGVllWEifslG~~  903 (1025)
T KOG1095|consen  826 RDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI--FTSKSDVWSFGVLLWEIFSLGAT  903 (1025)
T ss_pred             cchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcc--cccccchhhhHHHHHHHHhCCCC
Confidence            999999999999999999999999954332211   1112346899999998755  8999999999999999999 999


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhhc
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~~  814 (815)
                      ||.+....+.    ..   .....         . +...|..|++.+.++|..||+.+|++||+|..+++++..+.+.
T Consensus       904 PY~~~~n~~v----~~---~~~~g---------g-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  904 PYPSRSNFEV----LL---DVLEG---------G-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             CCCCcchHHH----HH---HHHhC---------C-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            9986443222    11   11111         1 4455888999999999999999999999999999999888654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-44  Score=345.65  Aligned_cols=248  Identities=25%  Similarity=0.421  Sum_probs=202.8

Q ss_pred             cCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeE-EEeCCe-eEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGY-CIAGDQ-RIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~~~-~~lv  582 (815)
                      .+|.+.++||+|.||+|||++ ..+|..||.|.+.-+.  ....++...|+.+|++|+|||||++++. +.+..+ .++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            356778899999999999998 6789999999987432  2335678899999999999999999994 344444 7899


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC--eee
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP--IIH  660 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH  660 (815)
                      ||||..|+|...++..+                          .....++.+..++++.|+++||..+|... +.  |+|
T Consensus        99 mE~c~~GDLsqmIk~~K--------------------------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmH  151 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFK--------------------------KQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMH  151 (375)
T ss_pred             HHhhcccCHHHHHHHHH--------------------------hccccCchHHHHHHHHHHHHHHHHHhccc-cccceee
Confidence            99999999999997532                          23567788889999999999999999422 44  889


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~  739 (815)
                      |||||.||+++.+|.+|++|||+++.+.... .....+|||.||+||.+....  |+.||||||+||++|||+.-+.||.
T Consensus       152 RDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~--Y~~kSDiWslGCllyEMcaL~~PF~  229 (375)
T KOG0591|consen  152 RDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESG--YNFKSDIWSLGCLLYEMCALQSPFY  229 (375)
T ss_pred             ccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCC--CCcchhHHHHHHHHHHHHhcCCCcc
Confidence            9999999999999999999999999987654 334567999999999999887  8999999999999999999999998


Q ss_pred             CCCCccccccHHHHHHHHHhcCCCCccccccccCCCC-HHHHHHHHHHHhhccccCCCCCCCH
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGP-EKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      ++       ++.+..+.+-..         .+. ..| +..+..+..++..|+..||+.||+.
T Consensus       230 g~-------n~~~L~~KI~qg---------d~~-~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  230 GD-------NLLSLCKKIEQG---------DYP-PLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             cc-------cHHHHHHHHHcC---------CCC-CCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            63       344433333221         111 123 6678899999999999999999983

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-43  Score=363.99  Aligned_cols=263  Identities=26%  Similarity=0.370  Sum_probs=213.6

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccH-HHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTD-QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      +.+...+.+.||+|-||+|..+....+..||||.++..+..+. .+|.+|+++|.+++|||||+++|+|..+++.++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            3345667899999999999999999899999999998766655 799999999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      ||++|+|.+|+.....+                            ..+-..-.+|+.|||.||+||.   +.++||||+.
T Consensus       616 YmEnGDLnqFl~aheap----------------------------t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a  664 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELP----------------------------TAETAPGVSICTQIASGMAYLE---SLNFVHRDLA  664 (807)
T ss_pred             HHhcCcHHHHHHhccCc----------------------------ccccchhHHHHHHHHHHHHHHH---hhchhhcccc
Confidence            99999999999764211                            1233445679999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh--CCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT--GKKPLG  739 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t--g~~p~~  739 (815)
                      ++|||+|.++++||+|||.++.+-.+..   ....+-...|||||.+...+  ++.+||||+|||.+||+++  ...||.
T Consensus       665 ~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk--FttaSDvWafgvTlwE~~~~C~e~Py~  742 (807)
T KOG1094|consen  665 TRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEVFMLCREQPYS  742 (807)
T ss_pred             ccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc--ccchhhhhhhHHHHHHHHHHHhhCchh
Confidence            9999999999999999999996644432   12233467999999888776  8999999999999999988  788987


Q ss_pred             CCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      ....+    ++++-....++...      +......|.-|+..+.++|.+||+.|-++||+++++...|.+.
T Consensus       743 ~lt~e----~vven~~~~~~~~~------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  743 QLTDE----QVVENAGEFFRDQG------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhhHH----HHHHhhhhhcCCCC------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            64433    23332232332221      1112233667888999999999999999999999999988764

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-43  Score=367.61  Aligned_cols=263  Identities=25%  Similarity=0.374  Sum_probs=211.5

Q ss_pred             HHHHHhcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCee
Q 003504          502 DLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTL--TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       502 ~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  579 (815)
                      +..+..+.+.+++.||+|+||+||+|.|.+  .||||++......  ..+.|++|+..+++-+|.||+=+.|||..+.. 
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-  462 (678)
T ss_pred             ccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence            334444556668899999999999999974  4999999765443  34689999999999999999999999998766 


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      .+|+.+|++-+|+.+||..                             ...++....+.||.|||+||.|||   .++||
T Consensus       463 AIiTqwCeGsSLY~hlHv~-----------------------------etkfdm~~~idIAqQiaqGM~YLH---AK~II  510 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQ-----------------------------ETKFDMNTTIDIAQQIAQGMDYLH---AKNII  510 (678)
T ss_pred             eeeehhccCchhhhhccch-----------------------------hhhhhHHHHHHHHHHHHHhhhhhh---hhhhh
Confidence            9999999999999999963                             345778888999999999999999   99999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecC---CCCccccccccccccCCcccCCCC-CCCCCcCcchhHHHHHHHHHhCC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFG---NGLDEEIARGSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~---~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      |||||+.||++.+++++||+|||++..-.   .+.......|..-|||||++.... ..|++++||||||+|+|||++|.
T Consensus       511 HrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~  590 (678)
T KOG0193|consen  511 HRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGE  590 (678)
T ss_pred             hhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCc
Confidence            99999999999999999999999986432   222344455888999999987543 44799999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      .||.....+..    .      +..  .+....|+... ...++++++.+|+..||..++++||.+.+|+..|+++.
T Consensus       591 lPysi~~~dqI----i------fmV--GrG~l~pd~s~-~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  591 LPYSIQNRDQI----I------FMV--GRGYLMPDLSK-IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             CCcCCCChhhe----E------EEe--cccccCccchh-hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence            99985332211    0      111  11122222211 14567889999999999999999999999999888764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=346.65  Aligned_cols=241  Identities=25%  Similarity=0.315  Sum_probs=200.3

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCccc---HHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLT---DQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      .++|++.++||+|+||+||.++. ++++.+|+|++++.....   .+....|..+|.+++||.||+++..+++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            45799999999999999999995 568899999998765443   35678899999999999999999999999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      +||+.||.|..+|+..                              ..++.....-.+..|+.||.|||   +.+|||||
T Consensus       104 ld~~~GGeLf~hL~~e------------------------------g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRD  150 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQRE------------------------------GRFSEDRARFYLAEIVLALGYLH---SKGIIYRD  150 (357)
T ss_pred             EeccCCccHHHHHHhc------------------------------CCcchhHHHHHHHHHHHHHHHHH---hCCeeecc
Confidence            9999999999999752                              23444444557778999999999   89999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecC-CCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFG-NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      |||+|||+|++|+++|+|||+++..- .+....+.+||+.|||||++....  ++..+|+||+||++|||++|.+||...
T Consensus       151 lKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g--y~~~vDWWsLGillYeML~G~pPF~~~  228 (357)
T KOG0598|consen  151 LKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG--YDKAVDWWSLGILLYEMLTGKPPFYAE  228 (357)
T ss_pred             CCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCC--CCcccchHhHHHHHHHHhhCCCCCcCc
Confidence            99999999999999999999999544 445666789999999999999886  799999999999999999999999853


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP  799 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  799 (815)
                      .       ...+.+.+....          ....+.-...+..+++.+.+..||++|.
T Consensus       229 ~-------~~~~~~~I~~~k----------~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  229 D-------VKKMYDKILKGK----------LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             c-------HHHHHHHHhcCc----------CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            3       333334433322          1111333556788999999999999996

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=372.04  Aligned_cols=258  Identities=26%  Similarity=0.382  Sum_probs=209.7

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcCC--C---cEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLPG--G---IHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD  577 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~~--~---~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  577 (815)
                      .-++....+.||+|+||.||+|.+..  +   ..||||......   .....+|.+|+++|++++|||||+++|++....
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            34455667999999999999999532  2   238999987532   334568999999999999999999999999999


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      +.++|||+|+||+|.++|++.                             ...++..++++++.++|.||+|||   +.+
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~-----------------------------~~~v~~~ek~~~~~~AA~Gl~YLh---~k~  282 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKN-----------------------------KKSLPTLEKLRFCYDAARGLEYLH---SKN  282 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhC-----------------------------CCCCCHHHHHHHHHHHHhHHHHHH---HCC
Confidence            999999999999999999863                             235889999999999999999999   899


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCCccc-cccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CC
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE-IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GK  735 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~  735 (815)
                      +|||||.++|+|++.++.+||+|||+++.-....... ...-...|+|||.+....  +++++|||||||++||+++ |.
T Consensus       283 ~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~--~s~kTDV~sfGV~~~Eif~~g~  360 (474)
T KOG0194|consen  283 CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGI--FSFKTDVWSFGVLLWEIFENGA  360 (474)
T ss_pred             CcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCc--cccccchhheeeeEEeeeccCC
Confidence            9999999999999999999999999988543111111 122457899999998775  8999999999999999999 89


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      .||.+....    .+..++   .         ...++...+...+.++..++..||..+|++||+|.++.+.++.+..
T Consensus       361 ~Py~g~~~~----~v~~kI---~---------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  361 EPYPGMKNY----EVKAKI---V---------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             CCCCCCCHH----HHHHHH---H---------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence            999764332    122211   1         1223333455677889999999999999999999999999998754

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.2e-42  Score=332.62  Aligned_cols=265  Identities=22%  Similarity=0.271  Sum_probs=205.0

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      +.|+....+|+|+||.|||++. .+|+.||||++....  +.-.+-..||+++|++++|||+|.++.+|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            3577778999999999999996 569999999997632  2334567899999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      ||+. ++.+-|...+                             ...+.....+++.|+++|+.|+|   +.++||||||
T Consensus        82 ~~dh-TvL~eLe~~p-----------------------------~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIK  128 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP-----------------------------NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIK  128 (396)
T ss_pred             ecch-HHHHHHHhcc-----------------------------CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCC
Confidence            9998 4444454432                             23455667899999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecC-CCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFG-NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      |+||||+.+|.+||||||+|+.+. ++...+..+.|.+|+|||.+.+... |+..+||||.||++.||++|.+-|.+...
T Consensus       129 PENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtq-YG~pVDiWAiGCv~aEl~~G~pL~PG~SD  207 (396)
T KOG0593|consen  129 PENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQ-YGKPVDIWAIGCVFAELLTGEPLWPGRSD  207 (396)
T ss_pred             hhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCc-CCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence            999999999999999999999987 6667777889999999999998765 78899999999999999999998876332


Q ss_pred             ccccccHHHH-------HHHHHhcCC-CCccccccccCCC-----CHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSW-------VRGLVRNNK-GSRAIDPKIRDTG-----PEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      -+.---+..-       -..++..+. ...+.-|......     .......+++++..|++.||.+|++-+|++.
T Consensus       208 iDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  208 IDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1110011111       112222222 1222222222111     2234567899999999999999999999864

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-43  Score=364.91  Aligned_cols=363  Identities=29%  Similarity=0.357  Sum_probs=330.1

Q ss_pred             CCCCcceeeeEecCCC--------------CeEEEEecCCCCCccCCCcccccCCCCCCEEECcCCCCCCCCcccCCCCC
Q 003504           12 SASFCSWRGVVCDSNK--------------QHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGS   77 (815)
Q Consensus        12 ~~~~c~w~gv~C~~~~--------------~~~~~l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~~lp~~~~~l~~   77 (815)
                      .++.|.-.-..|++.+              ..+.+|++++|++.. +....|.++++|++++|.+|.++.||.......+
T Consensus        48 a~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~-id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sgh  126 (873)
T KOG4194|consen   48 ATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSH-IDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGH  126 (873)
T ss_pred             CcCCCCceeeecCccccccccccccCCcCccceeeeecccccccc-CcHHHHhcCCcceeeeeccchhhhcccccccccc
Confidence            3455666667776532              135679999999984 5556799999999999999999999987777889


Q ss_pred             CCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccC
Q 003504           78 LKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSM  157 (815)
Q Consensus        78 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  157 (815)
                      |+.|+|.+|.|+.+..+.++.++.|+.||||.|.|+.+.-.+|..-.++++|+|++|+|+....+.|..+.+|.+|.|+.
T Consensus       127 l~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsr  206 (873)
T KOG4194|consen  127 LEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSR  206 (873)
T ss_pred             eeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeeccc
Confidence            99999999999999999999999999999999999988888999999999999999999998899999999999999999


Q ss_pred             CcCCCCCCchhhccCCCCCEEEcCCCcccCC-CCCCCCCCCCCeEeccCCcCCCcchhhh--hcccceeeeccccccCcc
Q 003504          158 NQLNGSLPDGFGAAFPKLKSLNLAGNEIKGR-DTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHI  234 (815)
Q Consensus       158 N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~--l~~L~~L~L~~N~l~~~~  234 (815)
                      |+|+ .+|...|..+++|+.|+|..|+|... ...|.+|++|+.|.|..|.|..+..++|  +.+++.|+|+.|+++.  
T Consensus       207 Nrit-tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~--  283 (873)
T KOG4194|consen  207 NRIT-TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQA--  283 (873)
T ss_pred             Cccc-ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhh--
Confidence            9999 99999999999999999999999987 4679999999999999999999999999  9999999999999864  


Q ss_pred             cccccccccCCccceEEEcCCCccCcchhhccccCCCCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcCCCchhh
Q 003504          235 SQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEI  314 (815)
Q Consensus       235 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  314 (815)
                        +.-..+++++.|+.|+||.|.|..+.++.|...++|++|+|++|+|+.+++..|..+..|+.|+|++|.+...-...|
T Consensus       284 --vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af  361 (873)
T KOG4194|consen  284 --VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAF  361 (873)
T ss_pred             --hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHH
Confidence              444567789999999999999999999999999999999999999999999999999999999999999987777789


Q ss_pred             hcCCCCCEEeCCCCcCCCCCCcc-----CCCCccEEEccCCcCcccCChHHhhcCCCCceeeccCCCCcccC
Q 003504          315 LQLSSLHTLDLSMNHLTGQIPTV-----SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCA  381 (815)
Q Consensus       315 ~~l~~L~~L~ls~N~l~~~~~~~-----~~~~L~~L~ls~N~l~~~~p~~~~~~l~~l~~l~l~~N~l~~~~  381 (815)
                      ..+++|++|||++|.|+..+.+.     .++.|+.|++.+|+|. .||...|..++.|+.|||.+|.+....
T Consensus       362 ~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq  432 (873)
T KOG4194|consen  362 VGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQ  432 (873)
T ss_pred             HHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeec
Confidence            99999999999999999866543     6789999999999998 899999999999999999999986443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-42  Score=353.31  Aligned_cols=264  Identities=24%  Similarity=0.327  Sum_probs=208.2

Q ss_pred             cCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--CeeEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv  582 (815)
                      +.|+..+.||+|.||.||+|+ ..+|+.||+|+++...  .....-..|||.||++|+||||+++.+...+.  ...|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            456677899999999999999 6789999999997643  34456678999999999999999999999886  689999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      +|||+. +|.-++..                             .+..++..+...++.|++.||+|+|   .++|+|||
T Consensus       197 FeYMdh-DL~GLl~~-----------------------------p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRD  243 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS-----------------------------PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRD  243 (560)
T ss_pred             Eecccc-hhhhhhcC-----------------------------CCcccChHHHHHHHHHHHHHHHHHh---hcCeeecc
Confidence            999998 88888864                             2456788899999999999999999   89999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  740 (815)
                      ||.+|||||.+|.+||+|||+|+++....  ..+..+-|.+|+|||++.+... |+.+.|+||.||||.||++|++.|.+
T Consensus       244 IK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~-Yg~aVDlWS~GCIl~El~~gkPI~~G  322 (560)
T KOG0600|consen  244 IKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATS-YGTAVDLWSVGCILAELFLGKPILQG  322 (560)
T ss_pred             ccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcc-cccceeehhhhHHHHHHHcCCCCcCC
Confidence            99999999999999999999999876543  4556678999999999998876 79999999999999999999999987


Q ss_pred             CCCccccccHHHHHHHHHhcCCC------Ccccccc------ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKG------SRAIDPK------IRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~------~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ...-+....+.+.+..-...-|.      ...+.+.      ++.. ....+...++|+..++..||.+|.|+.++++
T Consensus       323 ~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  323 RTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            54332222333222110001011      0111111      1000 1223467889999999999999999999875

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-41  Score=340.74  Aligned_cols=261  Identities=20%  Similarity=0.312  Sum_probs=207.7

Q ss_pred             hcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCccc-HHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLT-DQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      ..+|+..+.||.|..++||+|. .+.+..||||++.-+.... .+.+.+|+..|..++||||++++..|..+...|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            3578889999999999999999 6778999999997654444 4789999999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      ||.+||+.+.+...-                            ...++......|.+++++||.|||   .+|.||||||
T Consensus       105 fMa~GS~ldIik~~~----------------------------~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvK  153 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYY----------------------------PDGLEEASIATILREVLKALDYLH---QNGHIHRDVK  153 (516)
T ss_pred             hhcCCcHHHHHHHHc----------------------------cccccHHHHHHHHHHHHHHHHHHH---hcCceecccc
Confidence            999999999997531                            223677788899999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCC-CCc----cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGN-GLD----EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~-~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~  739 (815)
                      +.||||+.+|.+||+|||.+-.+.. +..    .....||+.|||||+++..-..|+.|+||||||+...|+.+|..||.
T Consensus       154 AgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~  233 (516)
T KOG0582|consen  154 AGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS  233 (516)
T ss_pred             cccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence            9999999999999999998865532 221    14557999999999955555458999999999999999999999998


Q ss_pred             CCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ...+-       +....-+... ........+..+........+.+++..|+..||.+|||++++++
T Consensus       234 k~pPm-------kvLl~tLqn~-pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  234 KYPPM-------KVLLLTLQND-PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cCChH-------HHHHHHhcCC-CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            53221       1111111111 11111112222223345568899999999999999999999975

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=346.85  Aligned_cols=253  Identities=29%  Similarity=0.449  Sum_probs=202.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC--eeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD--QRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e  584 (815)
                      .++..++.||+|+||.||++... +|...|||..........+.+.+|+.+|.+++|||||+++|.....+  .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45667899999999999999964 48999999986543233567899999999999999999999865555  5889999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++|+|.+++...                            .+ .++.......+.||++||+|||   +++|||||||
T Consensus        97 y~~~GsL~~~~~~~----------------------------g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK  144 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRY----------------------------GG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIK  144 (313)
T ss_pred             ccCCCcHHHHHHHc----------------------------CC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcc
Confidence            99999999999753                            12 5788889999999999999999   8999999999


Q ss_pred             CCceEEcC-CCCeeecccccceecCC----CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 003504          665 ASSVYLDM-NLEPRLSDFGLAKIFGN----GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       665 ~~NIll~~-~~~~kl~Dfgla~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~  739 (815)
                      |+|||++. ++.+||+|||+++....    ........||+.|||||++..... ...++||||+||++.||+||+.||.
T Consensus       145 ~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~-~~~~sDiWSlGCtVvEM~Tg~~PW~  223 (313)
T KOG0198|consen  145 PANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEV-ARRESDIWSLGCTVVEMLTGKPPWS  223 (313)
T ss_pred             cceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCc-CCccchhhhcCCEEEeccCCCCcch
Confidence            99999999 79999999999987763    122345679999999999985321 3459999999999999999999997


Q ss_pred             CCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                      ..      .....++-......     ..|    ..|...+.+..+++.+|++.||++||||+++++.-
T Consensus       224 ~~------~~~~~~~~~ig~~~-----~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  224 EF------FEEAEALLLIGRED-----SLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             hh------cchHHHHHHHhccC-----CCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            52      11122222222111     112    23555778899999999999999999999998754

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=356.36  Aligned_cols=250  Identities=25%  Similarity=0.378  Sum_probs=209.2

Q ss_pred             cccCHHHHHHHhcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEe
Q 003504          496 LNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA  575 (815)
Q Consensus       496 ~~~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  575 (815)
                      ..+.|+++.       ..+.+|.|+-|.||+|+++ +..||||+++.-       -+.+|+-|++|+||||+.|.|+|..
T Consensus       119 WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  119 WEIPFEEIS-------ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             ccCCHHHhh-------hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecC
Confidence            345555543       3689999999999999997 668999987441       2357888999999999999999999


Q ss_pred             CCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCC
Q 003504          576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCS  655 (815)
Q Consensus       576 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~  655 (815)
                      ..-+++|||||+.|-|.+.|+.                              +.++.-.....|..+||.||.|||   .
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka------------------------------~~~itp~llv~Wsk~IA~GM~YLH---~  230 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKA------------------------------GRPITPSLLVDWSKGIAGGMNYLH---L  230 (904)
T ss_pred             CceeEEeeeccccccHHHHHhc------------------------------cCccCHHHHHHHHHHhhhhhHHHH---H
Confidence            9999999999999999999976                              345666677889999999999999   8


Q ss_pred             CCeeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          656 PPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       656 ~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      +.|||||||+-||||..+..+||+|||.++....-...-.++||..|||||++....  +++|+||||||||||||+||.
T Consensus       231 hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrneP--csEKVDIwSfGVVLWEmLT~E  308 (904)
T KOG4721|consen  231 HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEP--CSEKVDIWSFGVVLWEMLTGE  308 (904)
T ss_pred             hhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCC--cccccceehhHHHHHHHHhcC
Confidence            999999999999999999999999999999887665666778999999999999888  899999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      -||.+-.....                ...+=...+....|..|++-+.-|++.||+..|..||+|+|++..|+-.
T Consensus       309 iPYkdVdssAI----------------IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  309 IPYKDVDSSAI----------------IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             CCccccchhee----------------EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            99976322111                0011112233345788889999999999999999999999999998643

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.9e-40  Score=350.27  Aligned_cols=250  Identities=20%  Similarity=0.246  Sum_probs=201.5

Q ss_pred             CCeecccCCeeeEEEEcCCCcEEEEEEeecCCccc---HHHHHHHHHHhcCCCCCCceeeeeEEEe----CCeeEEEEEe
Q 003504          513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLT---DQEAARELEYLGRIKHPNLVPLTGYCIA----GDQRIAIYDY  585 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ey  585 (815)
                      ...||+|++|.||+|.. +|+.||||.++......   .+.+.+|+.++.+++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            46899999999999998 58899999997643333   3567899999999999999999999977    3467899999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++|+|.++++.                              ...++|..+.+++.|++.||+|||.  ..+++||||||
T Consensus       104 ~~~g~L~~~l~~------------------------------~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp  151 (283)
T PHA02988        104 CTRGYLREVLDK------------------------------EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTS  151 (283)
T ss_pred             CCCCcHHHHHhh------------------------------CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCCh
Confidence            999999999975                              2357888999999999999999993  24788999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      +||++++++.+||+|||+++.+...  .....|+..|+|||++.+....++.++|||||||++|||++|+.||...... 
T Consensus       152 ~nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-  228 (283)
T PHA02988        152 VSFLVTENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-  228 (283)
T ss_pred             hhEEECCCCcEEEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-
Confidence            9999999999999999999866432  2234588999999998763233789999999999999999999999753221 


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                            .........+.         +...+..++.++.+++.+||+.||++||+|+++++.|+.+.+
T Consensus       229 ------~~~~~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        229 ------EIYDLIINKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ------HHHHHHHhcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                  11122221111         111123456789999999999999999999999999998764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=354.84  Aligned_cols=248  Identities=24%  Similarity=0.369  Sum_probs=212.6

Q ss_pred             cCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      ..|..-..||+|+.|.||.|. ..+++.||||++....+...+-+..|+.+|+..+|+|||.++..+...++.|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            456677899999999999998 5678899999998877777888899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.+.+...                               .++..+...|+.++..||+|||   .++|+|||||.+
T Consensus       353 ~ggsLTDvVt~~-------------------------------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSD  398 (550)
T KOG0578|consen  353 EGGSLTDVVTKT-------------------------------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSD  398 (550)
T ss_pred             CCCchhhhhhcc-------------------------------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccc
Confidence            999999998642                               4677888999999999999999   999999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      |||++.+|.+||+|||++..+.... .....+||+.|||||+.....  |++|.||||||++++||+-|.+||-.+.+- 
T Consensus       399 nILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~--YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-  475 (550)
T KOG0578|consen  399 NILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKP--YGPKVDIWSLGIMAIEMVEGEPPYLNENPL-  475 (550)
T ss_pred             eeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcc--cCccccchhhhhHHHHHhcCCCCccCCChH-
Confidence            9999999999999999998776544 456677999999999998877  899999999999999999999999753331 


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                           . -++.+. .+       .......++..+.++.++..+|+..||++||++.++++
T Consensus       476 -----r-AlyLIa-~n-------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  476 -----R-ALYLIA-TN-------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             -----H-HHHHHh-hc-------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence                 1 111111 11       11222346777889999999999999999999999986

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-42  Score=358.53  Aligned_cols=260  Identities=27%  Similarity=0.383  Sum_probs=219.3

Q ss_pred             HHHHHHhcCCCCCCeecccCCeeeEEEEcCC-CcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCee
Q 003504          501 ADLLSATSNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       501 ~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  579 (815)
                      ++++-...++...+.||-|-||.||.|+|+. .-.||||.++. +....++|.+|+.+|..++|||+|+++|+|......
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4444555677778999999999999999864 56799999976 566778999999999999999999999999999999


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      |+|+|||.+|+|.+||++.+                            ...+.-...+.||.||+.||+||.   .+.+|
T Consensus       339 YIiTEfM~yGNLLdYLRecn----------------------------r~ev~avvLlyMAtQIsSaMeYLE---kknFI  387 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECN----------------------------RSEVPAVVLLYMATQISSAMEYLE---KKNFI  387 (1157)
T ss_pred             EEEEecccCccHHHHHHHhc----------------------------hhhcchhHHHHHHHHHHHHHHHHH---Hhhhh
Confidence            99999999999999999863                            223444556889999999999999   89999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCCccccccc---cccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARG---SPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~  735 (815)
                      ||||.++|+|+.++-.+||+|||+++.+..+ ..+..+|   ...|.|||-+.-..  ++.|+|||+|||+|||+.| |-
T Consensus       388 HRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYTAHAGAKFPIKWTAPEsLAyNt--FSiKSDVWAFGVLLWEIATYGM  464 (1157)
T KOG4278|consen  388 HRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNT--FSIKSDVWAFGVLLWEIATYGM  464 (1157)
T ss_pred             hhhhhhhhccccccceEEeeccchhhhhcCC-ceecccCccCcccccCcccccccc--cccchhhHHHHHHHHHHHhcCC
Confidence            9999999999999999999999999998644 2333333   56799999887666  7999999999999999999 88


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      .||.+..        ...+..         .+...++...|+.|+..+++||+.||+++|.+||+|.++-+.++.+-
T Consensus       465 sPYPGid--------lSqVY~---------LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  465 SPYPGID--------LSQVYG---------LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             CCCCCcc--------HHHHHH---------HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            8887522        111222         33456777789999999999999999999999999999999998763

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=353.39  Aligned_cols=263  Identities=21%  Similarity=0.246  Sum_probs=211.3

Q ss_pred             hcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcc-cHHHHHHHHHHhcCCC-CCCceeeeeEEEeCC-eeEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTL-TDQEAARELEYLGRIK-HPNLVPLTGYCIAGD-QRIAI  582 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lv  582 (815)
                      .++|...+.||.|.||.||+|+ ..+|..||||++++.... ++..-.||++.|+++. ||||+++..++.+.+ ..++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            3567788999999999999999 667889999999764332 2334568999999998 999999999999988 89999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      ||||+. +|+++++++                             +..++......|+.||.+||+|+|   .+|+.|||
T Consensus        89 fE~Md~-NLYqLmK~R-----------------------------~r~fse~~irnim~QilqGL~hiH---k~GfFHRD  135 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDR-----------------------------NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRD  135 (538)
T ss_pred             HHhhhh-hHHHHHhhc-----------------------------CCcCCHHHHHHHHHHHHHHHHHHH---hcCccccc
Confidence            999998 999999863                             557888999999999999999999   89999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      +||+|||+.....+||+|||+||........+..+.|.+|+|||++..... |+.+.||||+|||++|+.+-++-|.+..
T Consensus       136 lKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~-Ys~pvD~wA~GcI~aEl~sLrPLFPG~s  214 (538)
T KOG0661|consen  136 LKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGY-YSSPVDMWAVGCIMAELYSLRPLFPGAS  214 (538)
T ss_pred             CChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccc-cCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence            999999999888999999999999887777788889999999999887664 7999999999999999999999887643


Q ss_pred             CccccccHHHHHHHH--------------HhcCC--CCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          743 PEEKEGNLVSWVRGL--------------VRNNK--GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~--------------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .-   +++.+.+..+              .....  ......-.+..-.+ .+..+..+++.+|+++||.+|||++|+++
T Consensus       215 E~---Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  215 EI---DQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             HH---HHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            21   1222222110              00000  00111111111112 37788999999999999999999999986


Q ss_pred             H
Q 003504          807 L  807 (815)
Q Consensus       807 ~  807 (815)
                      .
T Consensus       291 ~  291 (538)
T KOG0661|consen  291 H  291 (538)
T ss_pred             C
Confidence            3

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1e-40  Score=318.59  Aligned_cols=262  Identities=23%  Similarity=0.320  Sum_probs=207.2

Q ss_pred             cCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      .+|...+.+|+|.||.||+|+ ..+|+.||||+++.+..  .......||++.|+.++||||+.+++++...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            357778999999999999999 57899999999976432  224567899999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      ||+. +|...+++.                             ...++-.....++.++.+|++|||   +..|+|||||
T Consensus        82 fm~t-dLe~vIkd~-----------------------------~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlK  128 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDK-----------------------------NIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLK  128 (318)
T ss_pred             eccc-cHHHHhccc-----------------------------ccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCC
Confidence            9998 999999763                             557888889999999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCc-cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLD-EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      |.|+|++.+|.+||+|||+|+.+.+... ....+-|.+|+|||++.+... |+...||||.||++.||+.|.+-|.+...
T Consensus       129 PnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~-Yg~~VDmWavGCI~AELllr~P~fpG~sD  207 (318)
T KOG0659|consen  129 PNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQ-YGTGVDMWAVGCIFAELLLRVPFFPGDSD  207 (318)
T ss_pred             ccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchh-cCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence            9999999999999999999999876543 333368999999999998876 78899999999999999999887765322


Q ss_pred             ccccccHHHHHHHHH--h-cCC-----------CCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          744 EEKEGNLVSWVRGLV--R-NNK-----------GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~--~-~~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      -   +++...++.+=  . +.|           ....-.+.... -...+..+..+++..++..||.+|++++|++++
T Consensus       208 i---dQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  208 I---DQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             H---HHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1   12222111110  0 000           01011111111 122345667999999999999999999999864

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-41  Score=350.23  Aligned_cols=248  Identities=26%  Similarity=0.349  Sum_probs=204.7

Q ss_pred             HhcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeE
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST---LTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRI  580 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  580 (815)
                      ...+|.+++.||+|+|++||+|+ ...++.+|||++.+.-.   ...+.+.+|-++|.+| .||.|++|+..|.+....|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            34689999999999999999999 56789999999966422   2334567899999999 8999999999999999999


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +|+||+++|+|.++|++.                              ..++.....-.|.+|..||+|||   +.||||
T Consensus       151 FvLe~A~nGdll~~i~K~------------------------------Gsfde~caR~YAAeIldAleylH---~~GIIH  197 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKY------------------------------GSFDETCARFYAAEILDALEYLH---SNGIIH  197 (604)
T ss_pred             EEEEecCCCcHHHHHHHh------------------------------CcchHHHHHHHHHHHHHHHHHHH---hcCcee
Confidence            999999999999999863                              23555556678999999999999   999999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCC------------cc--ccccccccccCCcccCCCCCCCCCcCcchhHHH
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGL------------DE--EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGV  726 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~------------~~--~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gv  726 (815)
                      |||||+|||+|+||++||+|||.|+.+.+..            ..  ..++||..|.+||++....  .+..+|+|+|||
T Consensus       198 RDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~--~~~~sDiWAlGC  275 (604)
T KOG0592|consen  198 RDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP--AGPSSDLWALGC  275 (604)
T ss_pred             ccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC--CCcccchHHHHH
Confidence            9999999999999999999999999875321            11  4467999999999998776  789999999999


Q ss_pred             HHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          727 VLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       727 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ++|.|+.|++||.+....-       .+++++.           +....++..++.+.+|+.+.+..||.+|++.+||.+
T Consensus       276 ilyQmlaG~PPFra~Neyl-------iFqkI~~-----------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  276 ILYQMLAGQPPFRAANEYL-------IFQKIQA-----------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHHhcCCCCCccccHHH-------HHHHHHH-----------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            9999999999997633211       1222222           112335555678999999999999999999988765

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-40  Score=358.49  Aligned_cols=287  Identities=26%  Similarity=0.355  Sum_probs=207.2

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc------CCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCC-
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGST-LTDQEAARELEYLGRI-KHPNLVPLTGYCIAGD-  577 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-  577 (815)
                      .++|.+.+.||+|+||.||+|..      .++..||||++..... .....+.+|+.++.++ +||||++++|+|.... 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46788999999999999999973      2356799999875432 2345788999999999 8999999999987644 


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccC----------------CCC------------CccccCC----CccccccC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTED----------------WST------------DTWEEDG----TNSIQNVG  625 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~----------------~~~------------~~~~~~~----~~~~~~~~  625 (815)
                      ..++||||+++|+|.++++...........                ...            ..+....    ...-....
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            578999999999999999753211000000                000            0000000    00000001


Q ss_pred             CCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCC---ccccccccccc
Q 003504          626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGY  702 (815)
Q Consensus       626 ~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y  702 (815)
                      ....++++....+++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++......   ......++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence            11346889999999999999999999   8999999999999999999999999999998654322   11223356789


Q ss_pred             cCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHH
Q 003504          703 IPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQME  781 (815)
Q Consensus       703 ~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  781 (815)
                      +|||++.+..  ++.++|||||||++|||++ |+.||......+      ..... .....         ....+..++.
T Consensus       243 ~aPE~~~~~~--~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~-~~~~~---------~~~~~~~~~~  304 (338)
T cd05102         243 MAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQR-LKDGT---------RMRAPENATP  304 (338)
T ss_pred             cCcHHhhcCC--CCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHH-HhcCC---------CCCCCCCCCH
Confidence            9999987665  7899999999999999997 999997532211      11111 11111         0111334556


Q ss_pred             HHHHHHhhccccCCCCCCCHHHHHHHHHhhhhc
Q 003504          782 EALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       782 ~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~~  814 (815)
                      ++.+++.+||+.||++||++.++++.|+++.+.
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            789999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=330.64  Aligned_cols=266  Identities=25%  Similarity=0.351  Sum_probs=208.2

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCC--CCCCceeeeeEEEeCC----eeE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI--KHPNLVPLTGYCIAGD----QRI  580 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~~----~~~  580 (815)
                      .......+.||+|+||+||+|.++ |..||||++.   ..++..+.+|.+|++.+  +|+||+.+++.-..+.    +.+
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            345677899999999999999998 7789999994   45677888888888764  9999999999765543    679


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHh-----cCCC
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-----HGCS  655 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH-----~~~~  655 (815)
                      ||++|.+.|||++||..                               ..++....++++..+|.||++||     +...
T Consensus       286 LvTdYHe~GSL~DyL~r-------------------------------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgK  334 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNR-------------------------------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGK  334 (513)
T ss_pred             EeeecccCCcHHHHHhh-------------------------------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCC
Confidence            99999999999999964                               35778889999999999999999     3347


Q ss_pred             CCeeeccCCCCceEEcCCCCeeecccccceecCCCC-----ccccccccccccCCcccCCCCC----CCCCcCcchhHHH
Q 003504          656 PPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-----DEEIARGSPGYIPPEFAQPDSD----FPTPKSDVYCYGV  726 (815)
Q Consensus       656 ~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~----~~~~~~Dv~S~Gv  726 (815)
                      +.|.|||||+.||||..++++.|+|+|+|.......     .....+||.+|||||++....+    ..-..+||||||.
T Consensus       335 PaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgL  414 (513)
T KOG2052|consen  335 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGL  414 (513)
T ss_pred             chhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHH
Confidence            899999999999999999999999999998876542     4566789999999998764321    1234689999999


Q ss_pred             HHHHHHhC----------CCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCC
Q 003504          727 VLLELITG----------KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL  796 (815)
Q Consensus       727 vl~el~tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~  796 (815)
                      |+||+.-+          +.||.+-.+.+-  + .+-++..+...+.+..++.+..   ..+.+..+.++|+.||..+|.
T Consensus       415 VlWEiarRc~~ggi~eey~~Pyyd~Vp~DP--s-~eeMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~  488 (513)
T KOG2052|consen  415 VLWEIARRCESGGIVEEYQLPYYDVVPSDP--S-FEEMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPA  488 (513)
T ss_pred             HHHHHHHHhhcCCEehhhcCCcccCCCCCC--C-HHHHhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCch
Confidence            99999863          357776433221  1 1112222222222222222222   457889999999999999999


Q ss_pred             CCCCHHHHHHHHHhhhh
Q 003504          797 KRPSMQQIVGLLKDIES  813 (815)
Q Consensus       797 ~RPs~~~v~~~L~~i~~  813 (815)
                      .|-|+-.+.+.|.++.+
T Consensus       489 aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  489 ARLTALRIKKTLAKLSN  505 (513)
T ss_pred             hhhHHHHHHHHHHHHhc
Confidence            99999999999988763

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=349.77  Aligned_cols=256  Identities=25%  Similarity=0.374  Sum_probs=215.9

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcC---CC--cEEEEEEeecC-CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCee
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLP---GG--IHVAVKVLVHG-STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~---~~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  579 (815)
                      +.+..+..+.||.|-||.||+|+..   .|  ..||||..+.+ ...+.+.|..|..+|++++||||++++|+|.+ .+.
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence            3445666789999999999999842   23  35899998874 34557789999999999999999999999976 589


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++|||.++.|.|.+||+.+                             ...++.......+.|+..||+|||   +..+|
T Consensus       466 WivmEL~~~GELr~yLq~n-----------------------------k~sL~l~tL~ly~~Qi~talaYLe---SkrfV  513 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQN-----------------------------KDSLPLRTLTLYCYQICTALAYLE---SKRFV  513 (974)
T ss_pred             eEEEecccchhHHHHHHhc-----------------------------cccchHHHHHHHHHHHHHHHHHHH---hhchh
Confidence            9999999999999999863                             445778888999999999999999   89999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCCcccccc--ccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR--GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKK  736 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~  736 (815)
                      ||||.++|||+....-+|++|||+++.+....-.....  -...|||||.+.-..  ++.+||||-|||+|||++. |.+
T Consensus       514 HRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRr--FTtASDVWMFgVCmWEIl~lGvk  591 (974)
T KOG4257|consen  514 HRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRR--FTTASDVWMFGVCMWEILSLGVK  591 (974)
T ss_pred             hhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhc--ccchhhHHHHHHHHHHHHHhcCC
Confidence            99999999999999999999999999887655333333  356899999998776  8999999999999999998 999


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      ||.+-.                 +..+...+..+-+...|+.|+..+..+|.+||+.||.+||.+.++...|.++.+
T Consensus       592 Pfqgvk-----------------NsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  592 PFQGVK-----------------NSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             cccccc-----------------ccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            998632                 222333344455666789999999999999999999999999999999988754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=333.97  Aligned_cols=264  Identities=24%  Similarity=0.326  Sum_probs=202.2

Q ss_pred             CCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcC--CCCCCceeeeeEEEeCC----eeEEEEE
Q 003504          511 DRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGR--IKHPNLVPLTGYCIAGD----QRIAIYD  584 (815)
Q Consensus       511 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lv~e  584 (815)
                      ...++||+|+||.||||++. ++.||||++.   ..+.+.|..|-+|..-  ++|+||++++++-..+.    ++++|+|
T Consensus       213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             hhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            34578999999999999987 4899999994   4566778877777664  58999999999876655    8899999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcC------CCCCe
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHG------CSPPI  658 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~------~~~~i  658 (815)
                      |.+.|+|.+||..                               ..++|....+||..+|+||+|||++      .+++|
T Consensus       289 fh~kGsL~dyL~~-------------------------------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~I  337 (534)
T KOG3653|consen  289 FHPKGSLCDYLKA-------------------------------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPI  337 (534)
T ss_pred             eccCCcHHHHHHh-------------------------------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcc
Confidence            9999999999975                               3689999999999999999999955      36789


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCC----CCcCcchhHHHHHHHH
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFP----TPKSDVYCYGVVLLEL  731 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~----~~~~Dv~S~Gvvl~el  731 (815)
                      +|||||++||||..|+++.|+|||+|..+..+..   ....+||.+|||||++.+....-    -.+.||||+|.|||||
T Consensus       338 aHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi  417 (534)
T KOG3653|consen  338 AHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEI  417 (534)
T ss_pred             ccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999998876542   23357999999999998765321    1357999999999999


Q ss_pred             HhCCCCCC--------CCCCccccc-cHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 003504          732 ITGKKPLG--------DDYPEEKEG-NLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ  802 (815)
Q Consensus       732 ~tg~~p~~--------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  802 (815)
                      +++..-+.        ..+.++... .-.+-++.++-.++.+..+.....   ....+.-+.+.+..||..||+.|.|+.
T Consensus       418 ~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~---~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  418 ASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWR---KHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhh---cCccHHHHHHHHHHHcCCchhhhhhhH
Confidence            99654332        222222211 122333333333222222222222   124566788999999999999999999


Q ss_pred             HHHHHHHhhh
Q 003504          803 QIVGLLKDIE  812 (815)
Q Consensus       803 ~v~~~L~~i~  812 (815)
                      =|-+++.++.
T Consensus       495 Cv~eR~~~l~  504 (534)
T KOG3653|consen  495 CVEERMAELM  504 (534)
T ss_pred             HHHHHHHHHh
Confidence            9988887764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-40  Score=350.77  Aligned_cols=249  Identities=26%  Similarity=0.371  Sum_probs=207.4

Q ss_pred             HhcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecC----Cc-ccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCCe
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG----ST-LTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQ  578 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  578 (815)
                      ....|.+++.||+|+||.||.|+ ..++..||||++.+.    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            34678999999999999999998 457899999977553    11 23456778999999999 9999999999999999


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++||||+.+|+|.+++..                              ...+......+++.|++.|++|+|   +++|
T Consensus        95 ~~ivmEy~~gGdL~~~i~~------------------------------~g~l~E~~ar~~F~Qlisav~y~H---~~gi  141 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN------------------------------KGRLKEDEARKYFRQLISAVAYCH---SRGI  141 (370)
T ss_pred             EEEEEEecCCccHHHHHHH------------------------------cCCCChHHHHHHHHHHHHHHHHHH---hCCE
Confidence            9999999999999999975                              234555778899999999999999   8999


Q ss_pred             eeccCCCCceEEcCC-CCeeecccccceec-CCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          659 IHRDIKASSVYLDMN-LEPRLSDFGLAKIF-GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       659 vHrDlk~~NIll~~~-~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      +||||||+|||+|.+ +++||+|||++... ..+......+||+.|+|||++.+...+.+.++||||+||++|.|++|+.
T Consensus       142 ~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~  221 (370)
T KOG0583|consen  142 VHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRL  221 (370)
T ss_pred             eeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence            999999999999999 99999999999988 4566777889999999999999876346789999999999999999999


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHH-HHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQ-MEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                      ||++..       .....+.....    +.       ..|... ..++..++.+|+..||.+|+++.+++
T Consensus       222 PF~d~~-------~~~l~~ki~~~----~~-------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  222 PFDDSN-------VPNLYRKIRKG----EF-------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             CCCCcc-------HHHHHHHHhcC----Cc-------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            998632       22222221111    01       113333 67889999999999999999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.9e-40  Score=343.07  Aligned_cols=245  Identities=23%  Similarity=0.324  Sum_probs=203.4

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccH---HHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      ..++|+...+||+|+||+||.|+. .+|..+|+|++++......   +.++.|-++|...++|+||+++..|.+.+..||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            457899999999999999999995 5699999999987543333   346789999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ||||++||++..+|..                              ...++.......+.+++-|++-+|   ..|||||
T Consensus       219 iMEylPGGD~mTLL~~------------------------------~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHR  265 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMR------------------------------KDTLTEDWARFYIAETVLAIESIH---QLGYIHR  265 (550)
T ss_pred             EEEecCCccHHHHHHh------------------------------cCcCchHHHHHHHHHHHHHHHHHH---HcCcccc
Confidence            9999999999999975                              224444445566778899999999   8999999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCC------------------C-----Cc-------------------------c
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGN------------------G-----LD-------------------------E  693 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~------------------~-----~~-------------------------~  693 (815)
                      ||||+|+|||..|++||+|||++.-+..                  .     ..                         .
T Consensus       266 DIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a  345 (550)
T KOG0605|consen  266 DIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLA  345 (550)
T ss_pred             cCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhh
Confidence            9999999999999999999999853211                  0     00                         0


Q ss_pred             ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccC
Q 003504          694 EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRD  773 (815)
Q Consensus       694 ~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  773 (815)
                      ...+|||.|||||++.+..  |+..+|+||+|||||||+.|.+||....+.+...++..|...+....            
T Consensus       346 ~StVGTPDYiAPEVll~kg--Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~------------  411 (550)
T KOG0605|consen  346 YSTVGTPDYIAPEVLLGKG--YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE------------  411 (550)
T ss_pred             hcccCCccccchHHHhcCC--CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC------------
Confidence            1123999999999999887  79999999999999999999999999999999999998876543221            


Q ss_pred             CCCHHHHHHHHHHHhhccccCCCCCCC
Q 003504          774 TGPEKQMEEALKIGYLCTADLPLKRPS  800 (815)
Q Consensus       774 ~~~~~~~~~~~~l~~~Cl~~dP~~RPs  800 (815)
                        ......+..++|.+|+. ||+.|--
T Consensus       412 --~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  412 --EVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             --cCcccHHHHHHHHHHhc-CHHHhcC
Confidence              11233678899999999 9999985

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-40  Score=311.14  Aligned_cols=248  Identities=24%  Similarity=0.346  Sum_probs=205.7

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      .++|++++.+|+|.||.||.|+. +++-.||+|++.+..   ...+.++.+|++|-..|+||||++++||+.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            45799999999999999999994 567889999997642   23456899999999999999999999999999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      +||.+.|++...|++.+                            ....+......+..|+|.||.|+|   .++++|||
T Consensus       101 lEya~~gel~k~L~~~~----------------------------~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRd  149 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGR----------------------------MKRFDEQRAATYIKQLANALLYCH---LKRVIHRD  149 (281)
T ss_pred             EEecCCchHHHHHHhcc----------------------------cccccccchhHHHHHHHHHHHHhc---cCCcccCC
Confidence            99999999999998532                            122333344567889999999999   89999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      |||+|+|++.++..||+|||.+.... .....+.+||..|.|||...+..  .+...|+|++||+.||++.|.+||....
T Consensus       150 iKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~--hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  150 IKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRG--HDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             CCHHHhccCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCC--ccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence            99999999999999999999998654 45667789999999999998877  6889999999999999999999997643


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..+.+..+.+           .+.       ..|.....++.+++.+|+..+|.+|.+..|+++
T Consensus       227 ~~etYkrI~k-----------~~~-------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  227 HSETYKRIRK-----------VDL-------KFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             hHHHHHHHHH-----------ccc-------cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence            2222211111           111       124556678899999999999999999999875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-39  Score=346.68  Aligned_cols=248  Identities=25%  Similarity=0.308  Sum_probs=214.1

Q ss_pred             cCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      .-|..++.||+|+.|.|..|+ ..+|+.+|||++.+...   .....+++|+.+|+-+.||||+++++++++..+.|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            346778999999999999999 46899999999977532   23567899999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|.|+++|-.                              ..++......+.+.||..|+.|+|   ..+|+||||
T Consensus        92 Eyv~gGELFdylv~------------------------------kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDL  138 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR------------------------------KGPLPEREAAHFFRQILDGVSYCH---AFNICHRDL  138 (786)
T ss_pred             EecCCchhHHHHHh------------------------------hCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccC
Confidence            99999999999965                              335667778899999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      ||+|+|+|..+++||+|||+|-.-.++.-..+.||++.|.|||++.+..+ .+.++||||+|||+|.|+||+.||++++ 
T Consensus       139 KpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pY-dG~~sDVWSCGVILfALLtG~LPFdDdN-  216 (786)
T KOG0588|consen  139 KPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPY-DGRPSDVWSCGVILFALLTGKLPFDDDN-  216 (786)
T ss_pred             CchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCC-CCCccccchhHHHHHHHHhCCCCCCCcc-
Confidence            99999999999999999999998888888888999999999999999885 6889999999999999999999998533 


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                            +.....+..+.           .-..|.+.+.++++|+.+++..||++|.|++||++.
T Consensus       217 ------ir~LLlKV~~G-----------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  217 ------IRVLLLKVQRG-----------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ------HHHHHHHHHcC-----------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                  22222221111           112367778899999999999999999999999874

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.4e-39  Score=341.60  Aligned_cols=250  Identities=22%  Similarity=0.247  Sum_probs=201.0

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      |+..+.||+|+||.||+|.. .+++.||||.+.....   .....+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66778999999999999985 5789999999865322   2234578899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++|+|..++...                            ....+++..+..++.|++.||+|||   +.+|+||||||
T Consensus        82 ~~~g~L~~~~~~~----------------------------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp  130 (285)
T cd05631          82 MNGGDLKFHIYNM----------------------------GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKP  130 (285)
T ss_pred             cCCCcHHHHHHhh----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCH
Confidence            9999999888542                            1235788889999999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      +|||+++++.+||+|||++.............|+..|+|||++.+..  ++.++|||||||++|||++|+.||.......
T Consensus       131 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~~g~~pf~~~~~~~  208 (285)
T cd05631         131 ENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEK--YTFSPDWWGLGCLIYEMIQGQSPFRKRKERV  208 (285)
T ss_pred             HHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCC--CCcccCchhHHHHHHHHHhCCCCCCCCCcch
Confidence            99999999999999999998765444444557999999999998765  7899999999999999999999998643221


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS-----MQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~~v~~  806 (815)
                      ....+.    ......          ....+...+.++.+++.+||+.||++||+     ++++++
T Consensus       209 ~~~~~~----~~~~~~----------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         209 KREEVD----RRVKED----------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             hHHHHH----HHhhcc----------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            111111    111100          01113344567899999999999999997     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.6e-39  Score=342.45  Aligned_cols=277  Identities=24%  Similarity=0.350  Sum_probs=205.6

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCC-----------------CcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceee
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG-----------------GIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPL  569 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l  569 (815)
                      ++|.+.+.||+|+||.||+|..++                 +..||+|.+..... .....+.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568888999999999999997532                 34699999876432 234578999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHH
Q 003504          570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAF  649 (815)
Q Consensus       570 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~y  649 (815)
                      +|++.+.+..++||||+++|+|.+++..........          ...... ........++|....+++.|++.||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~----------~~~~~~-~~~~~~~~~~~~~~~~i~~~i~~al~~  153 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE----------NGNDAV-PPAHCLPAISYSSLLHVALQIASGMKY  153 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcccccccc----------cccccc-ccccccccccHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999996532110000          000000 001123468899999999999999999


Q ss_pred             HhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHH
Q 003504          650 LHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGV  726 (815)
Q Consensus       650 LH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gv  726 (815)
                      ||   +.+|+||||||+|||++.++.+||+|||+++.......   .....++..|+|||++....  ++.++||||||+
T Consensus       154 lH---~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~  228 (304)
T cd05096         154 LS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFGV  228 (304)
T ss_pred             HH---HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC--CCchhhhHHHHH
Confidence            99   88999999999999999999999999999987643321   12233578899999987655  789999999999


Q ss_pred             HHHHHHh--CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 003504          727 VLLELIT--GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI  804 (815)
Q Consensus       727 vl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v  804 (815)
                      ++|||++  +..||......    .....+.......... .     ....+..++..+.+++.+||+.||++||+|++|
T Consensus       229 ~l~el~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i  298 (304)
T cd05096         229 TLWEILMLCKEQPYGELTDE----QVIENAGEFFRDQGRQ-V-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI  298 (304)
T ss_pred             HHHHHHHccCCCCCCcCCHH----HHHHHHHHHhhhcccc-c-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence            9999987  55677653222    2222222222221100 0     011123456688999999999999999999999


Q ss_pred             HHHHHh
Q 003504          805 VGLLKD  810 (815)
Q Consensus       805 ~~~L~~  810 (815)
                      .+.|++
T Consensus       299 ~~~l~~  304 (304)
T cd05096         299 HAFLTE  304 (304)
T ss_pred             HHHHhC
Confidence            998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=9.1e-40  Score=340.54  Aligned_cols=245  Identities=23%  Similarity=0.365  Sum_probs=208.9

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL--TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      ++|.+.+.||+|+||.||||+- .+.+.||+|.+.+....  +-+.+.+|++|+++++|||||.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4677889999999999999994 56788999998764332  33568899999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+.+ +|..+|.+                              +..+.......|+.|+..||.|||   +.+|.|||+|
T Consensus        82 ~a~g-~L~~il~~------------------------------d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~k  127 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ------------------------------DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMK  127 (808)
T ss_pred             hhhh-hHHHHHHh------------------------------ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCC
Confidence            9988 99999975                              445777888999999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      |.|||++..|.+|++|||+|+.+.... ......||+-|||||+..+..  |+..+|.||+||++||+++|++||.    
T Consensus       128 PqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~p--yd~~sDlWslGcilYE~~~G~PPF~----  201 (808)
T KOG0597|consen  128 PQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQP--YDHTSDLWSLGCILYELYVGQPPFY----  201 (808)
T ss_pred             cceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCC--ccchhhHHHHHHHHHHHhcCCCCch----
Confidence            999999999999999999999887543 334456999999999998766  7999999999999999999999997    


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                         ...+...++.+..+.        ..   .|......+..++...+.+||.+|.+..+++.
T Consensus       202 ---a~si~~Lv~~I~~d~--------v~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  202 ---ARSITQLVKSILKDP--------VK---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ---HHHHHHHHHHHhcCC--------CC---CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence               345556666555431        11   24466778899999999999999999998864

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=315.10  Aligned_cols=236  Identities=27%  Similarity=0.318  Sum_probs=199.1

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHH---HHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQ---EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|+..+.+|.|+||.|..++. .+|..+|+|++.+......+   ...+|..+|+.+.||.++++++.+.+....++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            4688899999999999999995 56889999999876554443   3567999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|.|.++|+..                              ..++.....-+|.+|+.||+|||   +..|++|||
T Consensus       124 eyv~GGElFS~Lrk~------------------------------~rF~e~~arFYAAeivlAleylH---~~~iiYRDL  170 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS------------------------------GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDL  170 (355)
T ss_pred             eccCCccHHHHHHhc------------------------------CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccC
Confidence            999999999999863                              24556667779999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      ||+|||+|.+|.+||+|||+|+.+..  ...+.|||+.|+|||++....  +..++|.|||||++|||+.|.+||.+..+
T Consensus       171 KPENiLlD~~G~iKitDFGFAK~v~~--rT~TlCGTPeYLAPEii~sk~--ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  171 KPENLLLDQNGHIKITDFGFAKRVSG--RTWTLCGTPEYLAPEIIQSKG--YNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             ChHHeeeccCCcEEEEeccceEEecC--cEEEecCCccccChHHhhcCC--CCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence            99999999999999999999998864  366789999999999999887  78899999999999999999999987655


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCC
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR  798 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R  798 (815)
                      -..+.++.       ..         .  ...|.....++.+|+...++.|-.+|
T Consensus       247 ~~iY~KI~-------~~---------~--v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  247 IQIYEKIL-------EG---------K--VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHHHHHH-------hC---------c--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            33322222       11         1  12345556678888999999998888

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.6e-39  Score=336.45  Aligned_cols=253  Identities=22%  Similarity=0.344  Sum_probs=203.0

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC----CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      .+|++.+.||+|+||.||+|++.    .+..||+|.++.... .....+.+|+.++.+++||||++++|++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46788899999999999999853    356899999876432 2345788999999999999999999999999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      |||+++|+|.+++...                             ...++|..++.++.|++.||+|||   +.+++|||
T Consensus        85 ~e~~~~~~L~~~l~~~-----------------------------~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~d  132 (266)
T cd05064          85 TEYMSNGALDSFLRKH-----------------------------EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKG  132 (266)
T ss_pred             EEeCCCCcHHHHHHhC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecc
Confidence            9999999999999652                             235789999999999999999999   88999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLG  739 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~  739 (815)
                      |||+||+++.++.+|++|||.+........  .....++..|+|||.+.+..  ++.++|||||||++||+++ |+.||.
T Consensus       133 ikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~ell~~g~~p~~  210 (266)
T cd05064         133 LAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH--FSSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             ccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCC--ccchhHHHHHHHHHHHHhcCCCCCcC
Confidence            999999999999999999998765432211  11223567899999987665  7889999999999999876 999997


Q ss_pred             CCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      .....+    +   ... ....         .....+..++..+.+++.+||+.+|++||+++++.+.|+++
T Consensus       211 ~~~~~~----~---~~~-~~~~---------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         211 DMSGQD----V---IKA-VEDG---------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             cCCHHH----H---HHH-HHCC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            532211    1   111 1111         01112344667899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=335.98  Aligned_cols=247  Identities=23%  Similarity=0.358  Sum_probs=203.4

Q ss_pred             CCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecC-CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG-STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .|...+.||+|.||.||||. ...++.||+|++.-. ....-+++.+|+.++.+++++||.+++|.+..+...+++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            46667899999999999999 467889999999754 3334568899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      .+|++.+.|...+                              .++.....-|++++..||.|||   ..+.+|||||+.
T Consensus        94 ~gGsv~~lL~~~~------------------------------~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaa  140 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN------------------------------ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAA  140 (467)
T ss_pred             cCcchhhhhccCC------------------------------CCccceeeeehHHHHHHhhhhh---hcceeccccccc
Confidence            9999999997532                              2233334457889999999999   889999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      |||+..+|.+|++|||++..+.... .....+||+.|||||++.+..  |+.|+||||+|++.+||.+|.+|+....|..
T Consensus       141 nil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~--Y~~KADIWSLGITaiEla~GePP~s~~hPmr  218 (467)
T KOG0201|consen  141 NILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSG--YDTKADIWSLGITAIELAKGEPPHSKLHPMR  218 (467)
T ss_pred             ceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhcccc--ccchhhhhhhhHHHHHHhcCCCCCcccCcce
Confidence            9999999999999999998876544 336788999999999999655  8999999999999999999999998755522


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      ..-.+             ..-..|.+.    ..+...+.+++..|+.++|+.||++.++++.
T Consensus       219 vlflI-------------pk~~PP~L~----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  219 VLFLI-------------PKSAPPRLD----GDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             EEEec-------------cCCCCCccc----cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            21110             111233332    3566779999999999999999999999863

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.7e-39  Score=351.12  Aligned_cols=284  Identities=26%  Similarity=0.352  Sum_probs=206.4

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc------CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCe
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQ  578 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  578 (815)
                      .++|++++.||+|+||.||+|+.      .++..||||+++... ....+.+.+|++++..+ +||||++++|+|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788899999999999999973      345689999986532 23345788999999999 89999999999999999


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCcc---c-----------------cCCCCCccc-----------cC-----------
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQT---T-----------------EDWSTDTWE-----------ED-----------  616 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~---~-----------------~~~~~~~~~-----------~~-----------  616 (815)
                      .++||||+++|+|.++++........   .                 .......+.           ..           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            99999999999999999754211000   0                 000000000           00           


Q ss_pred             ---CCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCcc
Q 003504          617 ---GTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE  693 (815)
Q Consensus       617 ---~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  693 (815)
                         ..............++|..+.+++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence               00000000112346889999999999999999999   889999999999999999999999999999876543211


Q ss_pred             ---ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccc
Q 003504          694 ---EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDP  769 (815)
Q Consensus       694 ---~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  769 (815)
                         ....++..|+|||.+.+..  ++.++|||||||++|||++ |..||......   .....+    +....       
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~--~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~----~~~~~-------  334 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKM----IKEGY-------  334 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCC--CCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHH----HHhCc-------
Confidence               1223456799999987665  7899999999999999998 88898653211   111211    11111       


Q ss_pred             cccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          770 KIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       770 ~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                        ....+...+.++.+++.+||+.||++||+|.+|++.|++.
T Consensus       335 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 --RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             --cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence              1111222356789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1e-38  Score=332.49  Aligned_cols=249  Identities=24%  Similarity=0.391  Sum_probs=202.2

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      ++|++.+.||+|+||.||+|.+.++..+|+|.+... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457778999999999999999988889999988643 3446788999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.++++..                             ...++|..+..++.|++.||+|||   +.+++||||||+|
T Consensus        83 ~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~n  130 (256)
T cd05114          83 NGCLLNYLRQR-----------------------------QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARN  130 (256)
T ss_pred             CCcHHHHHHhC-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcce
Confidence            99999998752                             124788999999999999999999   8899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE  744 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~  744 (815)
                      |++++++.+||+|||.++.......  .....++..|+|||.+.+..  ++.++||||||+++||+++ |+.||..... 
T Consensus       131 i~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-  207 (256)
T cd05114         131 CLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK--YSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-  207 (256)
T ss_pred             EEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCc--cchhhhhHHHHHHHHHHHcCCCCCCCCCCH-
Confidence            9999999999999999986543221  12223566899999987655  6889999999999999999 8999875322 


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                            ...+.......   ....       +...+.++.+++.+||+.+|++||+|+++++.|
T Consensus       208 ------~~~~~~i~~~~---~~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         208 ------YEVVEMISRGF---RLYR-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ------HHHHHHHHCCC---CCCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                  11122221111   1111       222345789999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4e-38  Score=388.97  Aligned_cols=348  Identities=32%  Similarity=0.522  Sum_probs=256.8

Q ss_pred             CCeEEEEecCCCCCccCCCcccccCCCCCCEEECcCCCCC-CCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEE
Q 003504           27 KQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT-ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVF  105 (815)
Q Consensus        27 ~~~~~~l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~-~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  105 (815)
                      ..+++.|++++|++.|.+|. .++.+++|++|+|++|+++ .+|..+..+++|++|+|++|.+.+.+|..|.++++|+.|
T Consensus       235 l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  313 (968)
T PLN00113        235 LTSLNHLDLVYNNLTGPIPS-SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL  313 (968)
T ss_pred             CCCCCEEECcCceeccccCh-hHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEE
Confidence            34566777777777766665 5777777777777777765 456666667777777777777777777777777777777


Q ss_pred             EccCCcCCCCChhhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhh----------------
Q 003504          106 DLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFG----------------  169 (815)
Q Consensus       106 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~----------------  169 (815)
                      +|++|.+++..|..+.++++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+.                
T Consensus       314 ~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~  393 (968)
T PLN00113        314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE  393 (968)
T ss_pred             ECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEec
Confidence            7777777766677777777777777777777666666666666666666666666655554432                


Q ss_pred             -------ccCCCCCEEEcCCCcccC-CCCCCCCCCCCCeEeccCCcCCCcchhhh--hcccceeeeccccccCccccccc
Q 003504          170 -------AAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQF  239 (815)
Q Consensus       170 -------~~l~~L~~L~L~~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~  239 (815)
                             ..+++|+.|+|++|++++ .+..|..+++|+.|+|++|.+++..+..+  +++|+.|+|++|++.+.++..  
T Consensus       394 ~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~--  471 (968)
T PLN00113        394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS--  471 (968)
T ss_pred             ccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcc--
Confidence                   234555666666665553 34456666666666666666665544433  566777777777666544432  


Q ss_pred             ccccCCccceEEEcCCCccCcchhhccccCCCCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcCCCchhhhcCCC
Q 003504          240 NSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSS  319 (815)
Q Consensus       240 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  319 (815)
                         ...++|+.|++++|++.+..|..+..+++|++|+|++|++++..+..+..+++|+.|+|++|.+++.+|..+..+++
T Consensus       472 ---~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  548 (968)
T PLN00113        472 ---FGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV  548 (968)
T ss_pred             ---cccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCccc
Confidence               24578999999999999999999999999999999999998888889999999999999999999999999999999


Q ss_pred             CCEEeCCCCcCCCCCCcc--CCCCccEEEccCCcCcccCChHHhhcCCCCceeeccCCCCcccCCC
Q 003504          320 LHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASE  383 (815)
Q Consensus       320 L~~L~ls~N~l~~~~~~~--~~~~L~~L~ls~N~l~~~~p~~~~~~l~~l~~l~l~~N~l~~~~~~  383 (815)
                      |+.|+|++|++++.+|..  .+.+|+.|++++|+++|.+|..  ..+..+....+.+|+. .|+..
T Consensus       549 L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~--~~~~~~~~~~~~~n~~-lc~~~  611 (968)
T PLN00113        549 LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST--GAFLAINASAVAGNID-LCGGD  611 (968)
T ss_pred             CCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc--chhcccChhhhcCCcc-ccCCc
Confidence            999999999999988875  6789999999999999999953  2334455556677763 46543

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-39  Score=340.24  Aligned_cols=246  Identities=32%  Similarity=0.498  Sum_probs=192.8

Q ss_pred             CCeecccCCeeeEEEEcC-----CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          513 GTLLAEGKFGPVYRGFLP-----GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .+.||.|+||.||+|.+.     .+..|+||.+..... ...+.+.+|++.+++++||||++++|+|...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999976     357899999965322 23678999999999999999999999999888899999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.++|+..                            ....+++..+.+|+.|+|+||+|||   +.+++||||+++
T Consensus        84 ~~g~L~~~L~~~----------------------------~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~  132 (259)
T PF07714_consen   84 PGGSLDDYLKSK----------------------------NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPS  132 (259)
T ss_dssp             TTEBHHHHHHHT----------------------------CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGG
T ss_pred             cccccccccccc----------------------------ccccccccccccccccccccccccc---cccccccccccc
Confidence            999999999863                            2456899999999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCC
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDY  742 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~  742 (815)
                      ||+++.++.+||+|||+++......   ......+...|+|||.+....  ++.++||||||+++||+++ |+.||.+..
T Consensus       133 nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~ksDVysfG~~l~ei~~~~~~p~~~~~  210 (259)
T PF07714_consen  133 NILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE--YTKKSDVYSFGMLLYEILTLGKFPFSDYD  210 (259)
T ss_dssp             GEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE--ESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccc
Confidence            9999999999999999998773222   122334677899999987766  6999999999999999999 788886432


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                      .       ........ ..         .+...+..++..+.+++..||+.+|++||+|+++++.|
T Consensus       211 ~-------~~~~~~~~-~~---------~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  211 N-------EEIIEKLK-QG---------QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             H-------HHHHHHHH-TT---------EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             c-------cccccccc-cc---------ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1       12222221 11         11112334567789999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.5e-38  Score=332.37  Aligned_cols=253  Identities=27%  Similarity=0.387  Sum_probs=205.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      ++|++.+.||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            468888999999999999999888889999987653 3345788999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.++++..                            .....++..+..++.|++.||+|||   +.+++||||||+|
T Consensus        85 ~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~n  133 (261)
T cd05072          85 KGSLLDFLKSD----------------------------EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAAN  133 (261)
T ss_pred             CCcHHHHHHHh----------------------------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhh
Confidence            99999999752                            1335788889999999999999999   7899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE  744 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~  744 (815)
                      |+++.++.+||+|||+++.......  .....++..|+|||++....  ++.++|||||||++|||++ |+.||......
T Consensus       134 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~  211 (261)
T cd05072         134 VLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNS  211 (261)
T ss_pred             EEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCC--CChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence            9999999999999999987654321  12233567899999987655  6889999999999999998 99998653221


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                          .....+    ....         ........+.++.+++.+||..+|++||+++++.+.|+++
T Consensus       212 ----~~~~~~----~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         212 ----DVMSAL----QRGY---------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----HHHHHH----HcCC---------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                112111    1110         0111223456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1e-38  Score=350.12  Aligned_cols=285  Identities=25%  Similarity=0.329  Sum_probs=206.6

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc------CCCcEEEEEEeecCCcc-cHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCe
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTL-TDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQ  578 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  578 (815)
                      .++|++.+.||+|+||.||+|+.      .++..||||++...... ....+.+|+++++.+ +||||++++|+|.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            45788899999999999999873      23457999999754322 345688999999999 89999999999999999


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccC-----------------------------------CCCCccccCC-----C
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTED-----------------------------------WSTDTWEEDG-----T  618 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~-----------------------------------~~~~~~~~~~-----~  618 (815)
                      .++||||+++|+|.++++...........                                   +..-......     .
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            99999999999999999753211000000                                   0000000000     0


Q ss_pred             ccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCcc---cc
Q 003504          619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE---EI  695 (815)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~---~~  695 (815)
                      ............+++....+++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++........   ..
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence            000000112346889999999999999999999   899999999999999999999999999999876433221   12


Q ss_pred             ccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCC
Q 003504          696 ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT  774 (815)
Q Consensus       696 ~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  774 (815)
                      ..++..|+|||++....  ++.++|||||||++|||++ |+.||.......   ...    ......         ....
T Consensus       274 ~~~~~~y~aPE~~~~~~--~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~----~~~~~~---------~~~~  335 (374)
T cd05106         274 ARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFY----KMVKRG---------YQMS  335 (374)
T ss_pred             CCCccceeCHHHhcCCC--CCccccHHHHHHHHHHHHhCCCCCCccccccH---HHH----HHHHcc---------cCcc
Confidence            23456899999987655  7899999999999999997 999997532211   111    111111         1111


Q ss_pred             CCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          775 GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       775 ~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      .+...+.++.+++.+||+.||++||++.+|++.|+++.
T Consensus       336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            12223567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-39  Score=326.28  Aligned_cols=259  Identities=24%  Similarity=0.317  Sum_probs=198.1

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCe-----eEEEE
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQ-----RIAIY  583 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lv~  583 (815)
                      |...+++|+|+||.||+|+. .++..||||+...+..    .-.+|+++|++++|||||++..++....+     ..+||
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            45578999999999999995 4578999998754322    23479999999999999999998876432     24799


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||||. +|.++++..-                          ..+..++.....-+..|+.+||+|||   +.+|+||||
T Consensus       102 eymP~-tL~~~~r~~~--------------------------~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDI  151 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYT--------------------------RANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDI  151 (364)
T ss_pred             HhchH-HHHHHHHHHh--------------------------hcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCC
Confidence            99999 9999997421                          11223344445668899999999999   899999999


Q ss_pred             CCCceEEcCC-CCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          664 KASSVYLDMN-LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~NIll~~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      ||.|+|+|.+ |.+||||||.|+....+........|..|+|||.+.+... |+.+.||||.|||+.||+-|++-|.++.
T Consensus       152 KPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~-Yt~~IDiWSaGCV~aELl~g~plFpG~s  230 (364)
T KOG0658|consen  152 KPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE-YTTSIDIWSAGCVMAELLKGQPLFPGDS  230 (364)
T ss_pred             ChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccc-cCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence            9999999966 9999999999999988777777778999999999998876 7999999999999999999999998743


Q ss_pred             CccccccHHHHHHH-------HHhcCCC--CccccccccCC-----CCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          743 PEEKEGNLVSWVRG-------LVRNNKG--SRAIDPKIRDT-----GPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~-------~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..   .++...++.       .+.....  .+...|.+...     .....+.+..+++.+++..+|.+|.++.|++.
T Consensus       231 ~~---dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  231 SV---DQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HH---HHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            32   222222221       1111111  11112222211     23345678999999999999999999999874

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=326.87  Aligned_cols=253  Identities=22%  Similarity=0.309  Sum_probs=200.5

Q ss_pred             HHhcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCc--------------ccHHHHHHHHHHhcCCCCCCceee
Q 003504          505 SATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST--------------LTDQEAARELEYLGRIKHPNLVPL  569 (815)
Q Consensus       505 ~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l  569 (815)
                      ...+.|++.+.||+|.||.|-+|+ ..+++.||||++.+...              ...+...+||.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            345689999999999999999999 46789999999964211              112467899999999999999999


Q ss_pred             eeEEEeC--CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcc-cCHHHHHHHHHHHHHH
Q 003504          570 TGYCIAG--DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL-TTWRFRHKIALGTARA  646 (815)
Q Consensus       570 ~g~~~~~--~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~ia~~  646 (815)
                      +.+..+.  +..|||+|||..|.+...=                               .+.+ ++..+..+++.++..|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p-------------------------------~d~~els~~~Ar~ylrDvv~G  222 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-------------------------------PDKPELSEQQARKYLRDVVLG  222 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC-------------------------------CCcccccHHHHHHHHHHHHHH
Confidence            9998774  5789999999998764322                               1223 7888889999999999


Q ss_pred             HHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCC------ccccccccccccCCcccCCCC--CCCCCc
Q 003504          647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL------DEEIARGSPGYIPPEFAQPDS--DFPTPK  718 (815)
Q Consensus       647 L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~------~~~~~~gt~~y~aPE~~~~~~--~~~~~~  718 (815)
                      |+|||   .++||||||||+|+|++++|++||+|||.+.....+.      ......||+.|+|||...++.  .+.+.+
T Consensus       223 LEYLH---~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a  299 (576)
T KOG0585|consen  223 LEYLH---YQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFA  299 (576)
T ss_pred             HHHHH---hcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchh
Confidence            99999   8999999999999999999999999999998774332      223467999999999988743  235788


Q ss_pred             CcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCC
Q 003504          719 SDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR  798 (815)
Q Consensus       719 ~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R  798 (815)
                      .||||+||+||-++.|+.||.+++..+..       .++..         ..+.....++..+++.+++.+++.+||++|
T Consensus       300 ~DiWalGVTLYCllfG~~PF~~~~~~~l~-------~KIvn---------~pL~fP~~pe~~e~~kDli~~lL~KdP~~R  363 (576)
T KOG0585|consen  300 LDIWALGVTLYCLLFGQLPFFDDFELELF-------DKIVN---------DPLEFPENPEINEDLKDLIKRLLEKDPEQR  363 (576)
T ss_pred             hhhhhhhhhHHHhhhccCCcccchHHHHH-------HHHhc---------CcccCCCcccccHHHHHHHHHHhhcChhhe
Confidence            99999999999999999999864432222       22221         122222223567789999999999999999


Q ss_pred             CCHHHHHHH
Q 003504          799 PSMQQIVGL  807 (815)
Q Consensus       799 Ps~~~v~~~  807 (815)
                      .+..+|...
T Consensus       364 i~l~~ik~H  372 (576)
T KOG0585|consen  364 ITLPDIKLH  372 (576)
T ss_pred             eehhhheec
Confidence            999988643

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-38  Score=332.83  Aligned_cols=256  Identities=28%  Similarity=0.441  Sum_probs=210.4

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +..+|++.+.||.|+||.||+|...++..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            44578889999999999999999888999999999775555567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++|+|.++++..                            ....+++..+..++.|++.||+|||   +.+++||||||
T Consensus        84 ~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~  132 (261)
T cd05148          84 MEKGSLLAFLRSP----------------------------EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAA  132 (261)
T ss_pred             cccCCHHHHHhcC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCc
Confidence            9999999999752                            2345789999999999999999999   88999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCc-cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCC
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLD-EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP  743 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~  743 (815)
                      +||+++.++.+||+|||.+........ .....++..|+|||.+....  ++.++||||||+++||+++ |+.||.....
T Consensus       133 ~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~DiwslG~~l~~l~~~g~~p~~~~~~  210 (261)
T cd05148         133 RNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT--FSTKSDVWSFGILLYEMFTYGQVPYPGMNN  210 (261)
T ss_pred             ceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCC--CCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            999999999999999999987643321 12233567899999887655  6889999999999999998 8999865321


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      .    .....   ...          ......+..++.++.+++.+||+.||++||+++++++.|+.+
T Consensus       211 ~----~~~~~---~~~----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         211 H----EVYDQ---ITA----------GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             H----HHHHH---HHh----------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            1    11111   111          111112344567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.4e-38  Score=330.00  Aligned_cols=253  Identities=26%  Similarity=0.356  Sum_probs=205.0

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .+|++.+.||+|+||.||+|... .+..||+|.+... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35777889999999999999954 5888999998653 334567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.+++...                            ....+++..+..++.|+++||+|||   +.+++||||||+
T Consensus        85 ~~~~L~~~~~~~----------------------------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~  133 (263)
T cd05052          85 TYGNLLDYLREC----------------------------NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAAR  133 (263)
T ss_pred             CCCcHHHHHHhC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcc
Confidence            999999999652                            1335788999999999999999999   889999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCCcc--ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCC
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGLDE--EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP  743 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~  743 (815)
                      ||++++++.+||+|||+++........  ....++..|+|||.+.+..  ++.++|||||||++|||++ |..||.....
T Consensus       134 nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~t~g~~p~~~~~~  211 (263)
T cd05052         134 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDL  211 (263)
T ss_pred             eEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999999876543211  1222456899999887665  6889999999999999998 9999865322


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      +       +...... .         ......+...+.++.+++.+||..+|++||++.+++++|+++
T Consensus       212 ~-------~~~~~~~-~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         212 S-------QVYELLE-K---------GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             H-------HHHHHHH-C---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            1       1111111 1         111122344567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-38  Score=328.27  Aligned_cols=254  Identities=26%  Similarity=0.394  Sum_probs=206.4

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .++|++.+.||+|+||.||+|...+++.||||.++.. ....+++.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            4568888999999999999999878889999998653 344677999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++++|.+++...                            ....++|..+..++.|++.||.|||   +.+++||||||+
T Consensus        84 ~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~  132 (261)
T cd05068          84 KYGSLLEYLQGG----------------------------AGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAAR  132 (261)
T ss_pred             cCCcHHHHHhcc----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcc
Confidence            999999999652                            1345789999999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCCcc--ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCC
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGLDE--EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP  743 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~  743 (815)
                      ||++++++.+||+|||+++........  .....+..|+|||++.+..  ++.++||||||+++||+++ |+.||.....
T Consensus       133 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~  210 (261)
T cd05068         133 NVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPGMTN  210 (261)
T ss_pred             eEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCC--CCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999999877532211  1122345799999887655  7889999999999999999 9999865321


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      .    .+..    ......         ....+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus       211 ~----~~~~----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         211 A----EVLQ----QVDQGY---------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             H----HHHH----HHHcCC---------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            1    1111    111110         1111334567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-38  Score=341.31  Aligned_cols=240  Identities=23%  Similarity=0.268  Sum_probs=194.6

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      +.||+|+||.||+|+. .+|+.||||++.....   .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 5789999999875321   22346778999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      +|.+++..                              ...+++.....++.|++.||+|||   +.+|+||||||+|||
T Consensus        81 ~L~~~l~~------------------------------~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIl  127 (323)
T cd05571          81 ELFFHLSR------------------------------ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLM  127 (323)
T ss_pred             cHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEE
Confidence            99999864                              235678888899999999999999   899999999999999


Q ss_pred             EcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccc
Q 003504          670 LDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEG  748 (815)
Q Consensus       670 l~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~  748 (815)
                      ++.++.+||+|||+++.... +.......||+.|+|||++.+..  ++.++|||||||++|||++|+.||......    
T Consensus       128 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~Pf~~~~~~----  201 (323)
T cd05571         128 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----  201 (323)
T ss_pred             ECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCC--CCccccCcccchhhhhhhcCCCCCCCCCHH----
Confidence            99999999999999975432 22334456999999999987665  789999999999999999999999753211    


Q ss_pred             cHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          749 NLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                         ..........       .    ..+...+.++.+++.+||+.||++||     ++.++++
T Consensus       202 ---~~~~~~~~~~-------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         202 ---KLFELILMEE-------I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             ---HHHHHHHcCC-------C----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence               1111111111       0    11334556788999999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=338.01  Aligned_cols=244  Identities=22%  Similarity=0.249  Sum_probs=198.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999954 688999999864321   23456889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++..                              ...+++.....++.|++.||+|||   +.+|+||||
T Consensus        81 e~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl  127 (291)
T cd05612          81 EYVPGGELFSYLRN------------------------------SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDL  127 (291)
T ss_pred             eCCCCCCHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCC
Confidence            99999999999964                              224677888899999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      ||+||+++.++.+||+|||+++.....  .....|++.|+|||++.+..  ++.++|||||||++|||++|+.||.....
T Consensus       128 kp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~l~~g~~pf~~~~~  203 (291)
T cd05612         128 KPENILLDKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKG--HNKAVDWWALGILIYEMLVGYPPFFDDNP  203 (291)
T ss_pred             CHHHeEECCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999999876432  23346899999999987765  68899999999999999999999975332


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS-----MQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~~v~~  806 (815)
                      .+       .........           ...+......+.+++.+||+.||.+||+     ++++++
T Consensus       204 ~~-------~~~~i~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         204 FG-------IYEKILAGK-----------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             HH-------HHHHHHhCC-----------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            11       112221111           0112233567889999999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=342.76  Aligned_cols=252  Identities=23%  Similarity=0.262  Sum_probs=202.4

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      +|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|++++..++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            6888899999999999999964 58899999997532   1234567889999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++|+|.+++..                              ...+++.....++.|++.||+|||   +.+|+|||||
T Consensus        82 ~~~g~~L~~~l~~------------------------------~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlk  128 (333)
T cd05600          82 YVPGGDFRTLLNN------------------------------LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLK  128 (333)
T ss_pred             CCCCCCHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence            9999999999964                              234677888899999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      |+||+++.++.+||+|||+++....  ......||+.|+|||++.+..  ++.++|||||||++|||++|+.||......
T Consensus       129 p~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~  204 (333)
T cd05600         129 PENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKG--YDFTVDYWSLGCMLYEFLCGFPPFSGSTPN  204 (333)
T ss_pred             HHHEEECCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCC--CCCccceecchHHHhhhhhCCCCCCCCCHH
Confidence            9999999999999999999986543  233456999999999988765  789999999999999999999999764432


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      +....+..|..         ....+... ......+.++.+++.+|+..+|++||+++++++.
T Consensus       205 ~~~~~i~~~~~---------~~~~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         205 ETWENLKYWKE---------TLQRPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHHHHHhccc---------cccCCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            22211111110         00011110 0012346678899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=319.29  Aligned_cols=245  Identities=22%  Similarity=0.385  Sum_probs=210.4

Q ss_pred             CCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHH---HHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQ---EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      +|++.+.+|+|.||.|-+|. ...|+.||||.+++....+++   .+.+|++||..|+||||+.++.+|+..+...+|||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            57778899999999999999 478999999999887666655   46799999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |..+|.|++|+.+                              ...++.+....++.||..|+.|+|   ..++||||||
T Consensus       134 YaS~GeLYDYiSe------------------------------r~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLK  180 (668)
T KOG0611|consen  134 YASGGELYDYISE------------------------------RGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLK  180 (668)
T ss_pred             ecCCccHHHHHHH------------------------------hccccHHHHHHHHHHHHHHHHHHh---hccceecccc
Confidence            9999999999965                              346778888899999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      .+|||+|.++++||+|||++-.+..+...+++||++-|.+||++.+..+ -++.+|-||+||++|-|+.|..||++.+  
T Consensus       181 LENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY-~GPEVDsWsLGvLLYtLVyGtMPFDG~D--  257 (668)
T KOG0611|consen  181 LENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPY-KGPEVDSWSLGVLLYTLVYGTMPFDGRD--  257 (668)
T ss_pred             hhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCC-CCCccchhhHHHHHHHHhhcccccCCch--
Confidence            9999999999999999999999988888889999999999999998875 4889999999999999999999998632  


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                           ....++++.+.    .+..|        +.+....-+++.++..+|++|-|..+|..
T Consensus       258 -----hk~lvrQIs~G----aYrEP--------~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  258 -----HKRLVRQISRG----AYREP--------ETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             -----HHHHHHHhhcc----cccCC--------CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence                 22223332221    12222        22345678899999999999999999864

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.1e-38  Score=340.52  Aligned_cols=262  Identities=21%  Similarity=0.320  Sum_probs=201.5

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      .++|++.+.||+|+||.||+|+. .++..||+|.+..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            35788999999999999999995 4688899999875422 234578999999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++|+|.+++...                              ..+++.....++.|++.||+|||+  ..+|+|||||
T Consensus        84 ~~~~~~L~~~l~~~------------------------------~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlk  131 (331)
T cd06649          84 HMDGGSLDQVLKEA------------------------------KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVK  131 (331)
T ss_pred             cCCCCcHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCC
Confidence            99999999999642                              246778889999999999999993  2469999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      |+||+++.++.+||+|||+++..... ......|+..|+|||++.+..  ++.++|||||||++|||++|+.||......
T Consensus       132 p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~  208 (331)
T cd06649         132 PSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVELAIGRYPIPPPDAK  208 (331)
T ss_pred             hhhEEEcCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999999866432 223446899999999988665  788999999999999999999999753321


Q ss_pred             cccccHHHHHHHH-HhcCCC-Cc--------------------------------cccccccCCCCHHHHHHHHHHHhhc
Q 003504          745 EKEGNLVSWVRGL-VRNNKG-SR--------------------------------AIDPKIRDTGPEKQMEEALKIGYLC  790 (815)
Q Consensus       745 ~~~~~~~~~~~~~-~~~~~~-~~--------------------------------~~~~~~~~~~~~~~~~~~~~l~~~C  790 (815)
                      +.    ...+... ...... ..                                +.............+.++.+++.+|
T Consensus       209 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  284 (331)
T cd06649         209 EL----EAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKC  284 (331)
T ss_pred             HH----HHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHH
Confidence            11    1100000 000000 00                                0000000000123456789999999


Q ss_pred             cccCCCCCCCHHHHHHH
Q 003504          791 TADLPLKRPSMQQIVGL  807 (815)
Q Consensus       791 l~~dP~~RPs~~~v~~~  807 (815)
                      |+.||++||+++++++.
T Consensus       285 L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         285 LIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccCCcccCCCHHHHhcC
Confidence            99999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.3e-38  Score=345.62  Aligned_cols=287  Identities=24%  Similarity=0.321  Sum_probs=209.2

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCC
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGST-LTDQEAARELEYLGRIK-HPNLVPLTGYCIAGD  577 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~  577 (815)
                      ..++|.+++.||+|+||.||+|+..      .+..||||++..... ...+.+.+|+++++++. ||||++++|+|.+..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            4568889999999999999999852      234699999965432 23457899999999996 999999999999999


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccc----------------cCCCCCcccc-----C-------CCcc---------
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTT----------------EDWSTDTWEE-----D-------GTNS---------  620 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~----------------~~~~~~~~~~-----~-------~~~~---------  620 (815)
                      ..++||||+++|+|.++++.........                .....+.+..     .       ....         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999997642110000                0000000000     0       0000         


Q ss_pred             ------------------c-----------cccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEc
Q 003504          621 ------------------I-----------QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD  671 (815)
Q Consensus       621 ------------------~-----------~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  671 (815)
                                        .           .........+++..+.+++.|++.||+|||   +.+|+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                              0           000011235889999999999999999999   88999999999999999


Q ss_pred             CCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCcccc
Q 003504          672 MNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKE  747 (815)
Q Consensus       672 ~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~  747 (815)
                      .++.+||+|||+++.......   .....++..|+|||.+.+..  ++.++|||||||++|||++ |..||.......  
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--  347 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--  347 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCcccchhH--
Confidence            999999999999987643221   22234678899999987665  7899999999999999997 999986432111  


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                       .+.    ......         .....+..++.++.+++.+||+.||++||++.+|.+.|+++-+
T Consensus       348 -~~~----~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 -TFY----NKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -HHH----HHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence             111    111111         1111234456789999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.7e-38  Score=338.91  Aligned_cols=254  Identities=24%  Similarity=0.374  Sum_probs=201.2

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCc----EEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGI----HVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      .+|+..+.||+|+||.||+|++. ++.    .||||.+.... ....+.+.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888999999999999999853 333    48999986532 23456788999999999999999999999864 5679


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      |+||+++|+|.++++..                             ...+++...++++.|++.||+|||   +.+|+||
T Consensus        86 v~e~~~~g~l~~~l~~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~  133 (316)
T cd05108          86 ITQLMPFGCLLDYVREH-----------------------------KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHR  133 (316)
T ss_pred             eeecCCCCCHHHHHHhc-----------------------------cccCCHHHHHHHHHHHHHHHHHHH---hcCeecc
Confidence            99999999999999752                             234678889999999999999999   8999999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCcc---ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE---EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p  737 (815)
                      ||||+|||++.++.+||+|||+++........   ....++..|+|||.+....  ++.++|||||||++||+++ |+.|
T Consensus       134 dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slGv~l~el~t~g~~p  211 (316)
T cd05108         134 DLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP  211 (316)
T ss_pred             ccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCC--CCchhhhHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999876543321   2223466899999987665  7899999999999999998 9999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      |.+....    .+..    .....  .       ....+..++.++.+++.+||..+|++||++.+++..+.++..
T Consensus       212 ~~~~~~~----~~~~----~~~~~--~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         212 YDGIPAS----EISS----ILEKG--E-------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CCCCCHH----HHHH----HHhCC--C-------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            8753221    1111    11111  0       011122345678899999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=348.13  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=208.3

Q ss_pred             CCCeecccCCeeeEEEEc-CCC----cEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          512 RGTLLAEGKFGPVYRGFL-PGG----IHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       512 ~~~~ig~G~~g~Vy~~~~-~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ..++||+|+||+||||.+ +.|    .+||+|++.... ....+++..|+-+|++++|||+++++|+|..+. ..+|++|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            368999999999999985 333    469999987653 345678999999999999999999999998765 8899999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      |+.|+|.+|++..                             ...+--...+.|..|||+||.|||   ++++|||||.+
T Consensus       779 mP~G~LlDyvr~h-----------------------------r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaa  826 (1177)
T KOG1025|consen  779 MPLGCLLDYVREH-----------------------------RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAA  826 (1177)
T ss_pred             cccchHHHHHHHh-----------------------------hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhh
Confidence            9999999999864                             334556778899999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCcccccc---ccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCC
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDD  741 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~  741 (815)
                      +||||..-..+||.|||+++....+..+....   -.+.|||-|.+.-..  ++.++|||||||.+||++| |..||++.
T Consensus       827 RNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~--~thqSDVWsfGVtiWElmTFGa~Py~gi  904 (1177)
T KOG1025|consen  827 RNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRK--YTHQSDVWSFGVTIWELMTFGAKPYDGI  904 (1177)
T ss_pred             hheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccC--CCchhhhhhhhhhHHHHHhcCCCccCCC
Confidence            99999999999999999999988766444333   356799999887666  7999999999999999999 99999874


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      ..++.        ...+         ...-+..+|+.+..++..++.+||..|+..||+|+++..++.++.
T Consensus       905 ~~~eI--------~dll---------e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  905 PAEEI--------PDLL---------EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             CHHHh--------hHHH---------hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            43322        1122         223345568889999999999999999999999999999988764

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-38  Score=341.97  Aligned_cols=244  Identities=24%  Similarity=0.287  Sum_probs=197.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||.||+|+. .+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            4688889999999999999996 468899999986532   123456889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++...                              ..+++.....++.|++.||+|||   +.+|+||||
T Consensus        98 e~~~~~~L~~~l~~~------------------------------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dl  144 (329)
T PTZ00263         98 EFVVGGELFTHLRKA------------------------------GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDL  144 (329)
T ss_pred             cCCCCChHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCC
Confidence            999999999999652                              24566777889999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      ||+|||++.++.+||+|||+++.....  .....||+.|+|||++.+..  ++.++|||||||++|||++|+.||.+..+
T Consensus       145 kp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~  220 (329)
T PTZ00263        145 KPENLLLDNKGHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQSKG--HGKAVDWWTMGVLLYEFIAGYPPFFDDTP  220 (329)
T ss_pred             CHHHEEECCCCCEEEeeccCceEcCCC--cceecCChhhcCHHHHcCCC--CCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence            999999999999999999999876432  23456999999999988766  68899999999999999999999975332


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS-----MQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~~v~~  806 (815)
                      .+       ........ .        .  ..+...+.++.+++.+||+.||.+||+     ++++++
T Consensus       221 ~~-------~~~~i~~~-~--------~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        221 FR-------IYEKILAG-R--------L--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HH-------HHHHHhcC-C--------c--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            11       11111111 0        0  112224456889999999999999996     577653

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.2e-38  Score=309.58  Aligned_cols=259  Identities=23%  Similarity=0.281  Sum_probs=202.8

Q ss_pred             cCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCCceeeeeEEEe--CCeeEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTL--TDQEAARELEYLGRIKHPNLVPLTGYCIA--GDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv  582 (815)
                      ++|+..+.|++|+||.||+|+ ..++..||+|+++-....  -.-.-.|||.+|.+.+|||||.+-.+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            457778999999999999999 467889999999754321  12345799999999999999999998875  3578999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      ||||+. +|.++++..                             .+++.......++.|+++|++|||   ...|+|||
T Consensus       156 Me~~Eh-DLksl~d~m-----------------------------~q~F~~~evK~L~~QlL~glk~lH---~~wilHRD  202 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM-----------------------------KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRD  202 (419)
T ss_pred             HHHHHh-hHHHHHHhc-----------------------------cCCCchHHHHHHHHHHHHHHHHHh---hceeEecc
Confidence            999998 999999753                             345677788899999999999999   78999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      ||++|+|++..|.+||+|||+|+.++... ..+..+-|.+|+|||++.+... |++..|+||+|||+.|++++++-|.+.
T Consensus       203 LK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~t-yst~iDMWSvGCI~aE~l~~kPlf~G~  281 (419)
T KOG0663|consen  203 LKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKT-YSTAVDMWSVGCIFAELLTQKPLFPGK  281 (419)
T ss_pred             cchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcc-cCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence            99999999999999999999999998654 3455668999999999988775 789999999999999999999988864


Q ss_pred             CCccccccHHHHHHHHHhcCCCCcccccccc-------------------CCCCH-HHHHHHHHHHhhccccCCCCCCCH
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIR-------------------DTGPE-KQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~-~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      ..-+....+...+      ....+...|++.                   ..++. ...+.-++++...+..||.+|.|+
T Consensus       282 sE~dQl~~If~ll------GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA  355 (419)
T KOG0663|consen  282 SEIDQLDKIFKLL------GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITA  355 (419)
T ss_pred             chHHHHHHHHHHh------CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccH
Confidence            3222211121111      111111112111                   01111 134678899999999999999999


Q ss_pred             HHHHH
Q 003504          802 QQIVG  806 (815)
Q Consensus       802 ~~v~~  806 (815)
                      +|.++
T Consensus       356 ~~~L~  360 (419)
T KOG0663|consen  356 EDGLK  360 (419)
T ss_pred             HHhhc
Confidence            99875

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.9e-38  Score=332.04  Aligned_cols=268  Identities=25%  Similarity=0.385  Sum_probs=206.9

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCC------CcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRI  580 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  580 (815)
                      ++|++.+.||+|+||.||+|...+      ...||+|.+..... .....+.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            367888999999999999998532      25799999865332 23457899999999999999999999999988999


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      ++|||+++|+|.+++..........              ...........+++.....++.|++.||+|||   +.+++|
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~--------------~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H  147 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVG--------------AESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVH  147 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccc--------------cccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence            9999999999999997532110000              00000011246788999999999999999999   889999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKK  736 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~  736 (815)
                      |||||+||++++++.+||+|||+++......   ......+++.|+|||.+....  ++.++|||||||++|||++ |..
T Consensus       148 ~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDv~slG~il~el~~~g~~  225 (283)
T cd05048         148 RDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK--FTTESDIWSFGVVLWEIFSYGLQ  225 (283)
T ss_pred             cccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc--CchhhhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999998654322   122334678899999887655  6899999999999999998 999


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      ||.+....+    +...    +...         .....+..++.++.+++.+||+.||++||++++|++.|+.+
T Consensus       226 p~~~~~~~~----~~~~----i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         226 PYYGFSNQE----VIEM----IRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             CCCCCCHHH----HHHH----HHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            997543221    1111    1111         11112455678899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=342.32  Aligned_cols=247  Identities=27%  Similarity=0.394  Sum_probs=205.2

Q ss_pred             CCCCeecccCCeeeEEEEcC--CC--cEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          511 DRGTLLAEGKFGPVYRGFLP--GG--IHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       511 ~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ...+.||+|.||.|++|.|.  +|  ..||||.++..... ...+|.+|+.+|.+|+|||++++||++.+ ....+|+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            34678999999999999974  33  46899999876554 56799999999999999999999999987 688899999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      ++.|||.+.|++..                            ...+-......+|.|||.||.||.   ++++|||||.+
T Consensus       192 aplGSLldrLrka~----------------------------~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAA  240 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAK----------------------------KAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAA  240 (1039)
T ss_pred             cccchHHHHHhhcc----------------------------ccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhh
Confidence            99999999998732                            223455666789999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCcccccc----ccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCC
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGD  740 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~----gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~  740 (815)
                      +|+|+-..-.+||+|||+.+.++.+...+...    -...|+|||.+....  ++.++|||+|||.+|||+| |..||.+
T Consensus       241 RNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k--FShaSDvWmyGVTiWEMFtyGEePW~G  318 (1039)
T KOG0199|consen  241 RNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRK--FSHASDVWMYGVTIWEMFTYGEEPWVG  318 (1039)
T ss_pred             hhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccc--ccccchhhhhhhhHHhhhccCCCCCCC
Confidence            99999998899999999999987665443322    356799999998777  8999999999999999999 8999976


Q ss_pred             CCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                      ....    ++.             +.+|.+-+...|..|+++++++|..||..+|++||+|.++.+.+
T Consensus       319 ~~g~----qIL-------------~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  319 CRGI----QIL-------------KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCHH----HHH-------------HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            3321    111             12333444455888999999999999999999999999998554

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.8e-38  Score=332.83  Aligned_cols=265  Identities=20%  Similarity=0.285  Sum_probs=196.2

Q ss_pred             cCCCCCCeecccCCeeeEEEEc--CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCC---CCCCceeeeeEEEe-----
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL--PGGIHVAVKVLVHGST--LTDQEAARELEYLGRI---KHPNLVPLTGYCIA-----  575 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----  575 (815)
                      ++|++.+.||+|+||.||+|+.  .+++.||||.++....  .....+.+|+.+++.+   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688899999999999999985  3478899999865322  2234566777776665   69999999999863     


Q ss_pred             CCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCC
Q 003504          576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCS  655 (815)
Q Consensus       576 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~  655 (815)
                      ....++||||++ |+|.+++...                            ....+++..+..++.|++.||+|||   +
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~----------------------------~~~~~~~~~~~~i~~qi~~aL~~lH---~  128 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV----------------------------PEPGVPTETIKDMMFQLLRGLDFLH---S  128 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence            345789999997 5999998652                            1234788899999999999999999   8


Q ss_pred             CCeeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          656 PPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       656 ~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      .+|+||||||+|||++.++.+||+|||+++............|++.|+|||.+....  ++.++|||||||++|||++|+
T Consensus       129 ~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~  206 (290)
T cd07862         129 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRK  206 (290)
T ss_pred             CCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCC--CCCccchHHHHHHHHHHHcCC
Confidence            999999999999999999999999999998766544444556899999999987655  688999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCC------CccccccccC---CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKG------SRAIDPKIRD---TGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .||.+....+....+......-......      ...+.+.-..   ......+..+.+++.+|++.||++||++.++++
T Consensus       207 ~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         207 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            9998644332222222111000000000      0000000000   001124466789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.7e-38  Score=331.16  Aligned_cols=267  Identities=26%  Similarity=0.374  Sum_probs=208.6

Q ss_pred             cCCCCCCeecccCCeeeEEEEc------CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      .+|.+.+.||+|+||.||++..      .++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4688889999999999999974      2346689999876555556679999999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ||||+++|+|.++++.......                 ..........+++..+..++.|++.||+|||   +.+++||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~-----------------~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~  144 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAV-----------------LMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHR  144 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccc-----------------cccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence            9999999999999975321100                 0001122345899999999999999999999   8899999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p  737 (815)
                      ||||+||++++++.+||+|||+++.......   .....++..|+|||.+.+..  ++.++|||||||++|||++ |+.|
T Consensus       145 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~t~g~~p  222 (288)
T cd05093         145 DLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQP  222 (288)
T ss_pred             ccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCC--CCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999986543221   12233577899999987655  7889999999999999998 8999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      |......+    .   ..... .....         ..+...+.++.+++.+||+.+|.+||++++|.+.|+++.+
T Consensus       223 ~~~~~~~~----~---~~~i~-~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         223 WYQLSNNE----V---IECIT-QGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             CCCCCHHH----H---HHHHH-cCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            86533211    1   11111 11100         0122344678999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-38  Score=338.36  Aligned_cols=237  Identities=22%  Similarity=0.255  Sum_probs=191.5

Q ss_pred             ecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCCh
Q 003504          516 LAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNL  591 (815)
Q Consensus       516 ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL  591 (815)
                      ||+|+||.||+|.. .+++.||+|++....   ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999995 468899999986532   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEc
Q 003504          592 QNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD  671 (815)
Q Consensus       592 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  671 (815)
                      .+++..                              ...+++..+..++.|++.||+|||   +.+|+||||||+||+++
T Consensus        81 ~~~l~~------------------------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~  127 (312)
T cd05585          81 FHHLQR------------------------------EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLD  127 (312)
T ss_pred             HHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEEC
Confidence            999964                              224678888999999999999999   89999999999999999


Q ss_pred             CCCCeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccH
Q 003504          672 MNLEPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL  750 (815)
Q Consensus       672 ~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~  750 (815)
                      .++.+||+|||+++..... .......||+.|+|||.+.+..  ++.++|||||||++|||++|+.||.....       
T Consensus       128 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~pf~~~~~-------  198 (312)
T cd05585         128 YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG--YTKAVDWWTLGVLLYEMLTGLPPFYDENV-------  198 (312)
T ss_pred             CCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCC--CCCccceechhHHHHHHHhCCCCcCCCCH-------
Confidence            9999999999999864322 2233456999999999987765  78999999999999999999999975322       


Q ss_pred             HHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC---HHHHH
Q 003504          751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS---MQQIV  805 (815)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs---~~~v~  805 (815)
                      ....+......           ...+...+.++.+++.+||+.||++||+   +.+++
T Consensus       199 ~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         199 NEMYRKILQEP-----------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             HHHHHHHHcCC-----------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            22222222211           0113345567889999999999999986   45554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.3e-38  Score=332.44  Aligned_cols=265  Identities=20%  Similarity=0.275  Sum_probs=199.5

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ++|+..+.||+|+||.||+|.. .++..||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            4688899999999999999985 468899999986432 22345678999999999999999999999998899999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++ +|.+++...                             ...+++.....++.|++.||+|||   +.+|+||||||
T Consensus        85 ~~~-~l~~~l~~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp  131 (288)
T cd07871          85 LDS-DLKQYLDNC-----------------------------GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKP  131 (288)
T ss_pred             CCc-CHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCH
Confidence            985 999988642                             234677888999999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +|||++.++.+||+|||+++...... ......|++.|+|||.+.+... ++.++||||+||++|||++|+.||......
T Consensus       132 ~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~~l~~l~~g~~pf~~~~~~  210 (288)
T cd07871         132 QNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE-YSTPIDMWGVGCILYEMATGRPMFPGSTVK  210 (288)
T ss_pred             HHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcc-cCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999998654322 2234468999999998865432 688999999999999999999999764332


Q ss_pred             cccccHHHHHH--------HHHhcCCCCccccccccCCC----CHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVR--------GLVRNNKGSRAIDPKIRDTG----PEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +....+.....        .............+......    ......+..+++.+|+..||.+|||++|+++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         211 EELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             HHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            22111111000        00000000111111111100    1123457889999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.6e-38  Score=337.56  Aligned_cols=240  Identities=24%  Similarity=0.274  Sum_probs=193.8

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      +.||+|+||.||+|.. .+|..||+|++.....   .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999995 5689999999975322   22345678999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      +|..++..                              ...+++.....++.|++.||+|||   +.+|+||||||+|||
T Consensus        81 ~L~~~l~~------------------------------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  127 (323)
T cd05595          81 ELFFHLSR------------------------------ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLM  127 (323)
T ss_pred             cHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEE
Confidence            99988864                              235778889999999999999999   889999999999999


Q ss_pred             EcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccc
Q 003504          670 LDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEG  748 (815)
Q Consensus       670 l~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~  748 (815)
                      ++.++.+||+|||+++.... ........||+.|+|||++.+..  ++.++|||||||++|||++|+.||......+   
T Consensus       128 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---  202 (323)
T cd05595         128 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---  202 (323)
T ss_pred             EcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCC--CCchhchhhhHHHHHHHHhCCCCCCCCCHHH---
Confidence            99999999999999876432 22233456999999999987665  6899999999999999999999997532211   


Q ss_pred             cHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          749 NLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                          .........       .    ..+...+.++.+++.+||+.||++||     ++.++++
T Consensus       203 ----~~~~~~~~~-------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         203 ----LFELILMEE-------I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ----HHHHHhcCC-------C----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                111111111       0    11334456788999999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-38  Score=325.21  Aligned_cols=248  Identities=27%  Similarity=0.422  Sum_probs=201.0

Q ss_pred             CCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +|++.+.||+|+||.||+|...++..+|+|.+... ......+.+|++++++++||||+++++++...+..++|+||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            57788999999999999999887788999998653 33456788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      ++|.++++..                             ...++|..+..++.|++.||+|||   +.+++||||||+||
T Consensus        84 ~~L~~~l~~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni  131 (256)
T cd05059          84 GCLLNYLRER-----------------------------KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNC  131 (256)
T ss_pred             CCHHHHHHhc-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhE
Confidence            9999999752                             225788999999999999999999   88999999999999


Q ss_pred             EEcCCCCeeecccccceecCCCCcc--ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCcc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNGLDE--EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEE  745 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~  745 (815)
                      +++.++.+||+|||+++........  ....++..|+|||.+.+..  ++.++||||||+++||+++ |+.||......+
T Consensus       132 ~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  209 (256)
T cd05059         132 LVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR--FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE  209 (256)
T ss_pred             EECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCC--CCchhhHHHHHHHHHHHhccCCCCCCCCCHHH
Confidence            9999999999999999866432211  1122345799999987665  6889999999999999999 899987532211


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                          ...   .. ...         .....+..++.++.+++.+||..+|++||+|.++++.|
T Consensus       210 ----~~~---~~-~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         210 ----VVE---SV-SAG---------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ----HHH---HH-HcC---------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                111   11 111         11111233567899999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=325.73  Aligned_cols=253  Identities=26%  Similarity=0.401  Sum_probs=203.9

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC----CCcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      ++|++.+.||+|+||.||+|.+.    +...||||.++..... ....|.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            56888999999999999999864    2457999988654332 345788999999999999999999999999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      |||+++|+|.+++...                             ...+++..+.+++.|++.||+|||   +.+|+|||
T Consensus        84 ~e~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~d  131 (266)
T cd05033          84 TEYMENGSLDKFLREN-----------------------------DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRD  131 (266)
T ss_pred             EEcCCCCCHHHHHHhc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence            9999999999999752                             235789999999999999999999   89999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPL  738 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~  738 (815)
                      |||+||++++++.+||+|||+++......   ......++..|+|||.+....  ++.++||||||+++||+++ |..||
T Consensus       132 i~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Dv~slG~~l~~l~~~g~~p~  209 (266)
T cd05033         132 LAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSYGERPY  209 (266)
T ss_pred             CCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCC--CccccchHHHHHHHHHHHccCCCCC
Confidence            99999999999999999999998775221   111223467899999987655  7889999999999999998 99998


Q ss_pred             CCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      ......    .+...    .....         ....+..++..+.+++.+||+.+|++||++++|++.|+++
T Consensus       210 ~~~~~~----~~~~~----~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         210 WDMSNQ----DVIKA----VEDGY---------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCHH----HHHHH----HHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            643211    11111    11110         0011234556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.2e-38  Score=325.66  Aligned_cols=250  Identities=26%  Similarity=0.378  Sum_probs=201.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      ++|.+.+.||+|+||.||+|...++..||||.+... ......+.+|+.++.+++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            457778999999999999999877778999988653 3445679999999999999999999999998888999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.+++...                             ...+++..+++++.|++.||+|||   +.+++||||||+|
T Consensus        83 ~~~l~~~i~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~n  130 (256)
T cd05113          83 NGCLLNYLREH-----------------------------GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARN  130 (256)
T ss_pred             CCcHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcce
Confidence            99999999652                             225789999999999999999999   8899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE  744 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~  744 (815)
                      |+++.++.+||+|||.++.......  .....++..|+|||.+.+..  ++.++|||||||++|||++ |+.||......
T Consensus       131 ili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~  208 (256)
T cd05113         131 CLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK--FSSKSDVWAFGVLMWEVYSLGKMPYERFNNS  208 (256)
T ss_pred             EEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCc--ccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence            9999999999999999986643321  11223567899999987655  6889999999999999999 99998643221


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                          ...   ........          ...+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       209 ----~~~---~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         209 ----ETV---EKVSQGLR----------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ----HHH---HHHhcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                111   11111110          0112223568899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.3e-38  Score=340.58  Aligned_cols=244  Identities=20%  Similarity=0.220  Sum_probs=197.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCC--CcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG--GIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      ++|++.+.||+|+||.||+|...+  +..||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468888999999999999998532  3689999986532   22345678899999999999999999999999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      |||+++|+|.+++..                              ...+++.....++.|++.||+|||   +.+|+|||
T Consensus       110 ~Ey~~~g~L~~~i~~------------------------------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrD  156 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR------------------------------NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRD  156 (340)
T ss_pred             EeCCCCCcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccC
Confidence            999999999999965                              234678888899999999999999   89999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      |||+|||++.++.+||+|||+++.....  .....||+.|+|||++.+..  ++.++|||||||++|||++|+.||....
T Consensus       157 Lkp~NILl~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~G~~Pf~~~~  232 (340)
T PTZ00426        157 LKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVG--HGKAADWWTLGIFIYEILVGCPPFYANE  232 (340)
T ss_pred             CCHHHEEECCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCC--CCccccccchhhHHHHHhcCCCCCCCCC
Confidence            9999999999999999999999876432  23456999999999987665  6889999999999999999999997543


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                      +...       ........           ...+...+..+.+++.+|++.||++|+     +++++++
T Consensus       233 ~~~~-------~~~i~~~~-----------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        233 PLLI-------YQKILEGI-----------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             HHHH-------HHHHhcCC-----------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            2111       11111111           011223345678999999999999995     8888865

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.4e-38  Score=333.04  Aligned_cols=264  Identities=19%  Similarity=0.186  Sum_probs=199.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.....  ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999964 678899999875322  234568899999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |++++.+..+...                              ...+++..+..++.|++.||+|||   +.+|+|||||
T Consensus        81 ~~~~~~l~~~~~~------------------------------~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlk  127 (287)
T cd07848          81 YVEKNMLELLEEM------------------------------PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIK  127 (287)
T ss_pred             cCCCCHHHHHHhc------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence            9999777654422                              234677888999999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      |+||+++.++.+||+|||+++......  ......|++.|+|||++.+..  ++.++|||||||++|||++|+.||....
T Consensus       128 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~pf~~~~  205 (287)
T cd07848         128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGES  205 (287)
T ss_pred             HHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCC--CCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998765332  223346899999999987665  6889999999999999999999997633


Q ss_pred             CccccccHHH--------HHHHHHhcCCCCccccccccC------CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          743 PEEKEGNLVS--------WVRGLVRNNKGSRAIDPKIRD------TGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..+....+..        +...............+....      ......+.++.+++.+|++.||++||+++++++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         206 EIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            2111111110        001000000000000011100      011224567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.3e-37  Score=330.62  Aligned_cols=270  Identities=24%  Similarity=0.334  Sum_probs=208.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEc------CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      .+|.+.+.||+|+||.||+|+.      .++..||+|.+........+.+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            3577789999999999999974      2356699999876555555679999999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ||||+++|+|.+++..........        .+..      .......++|..+++++.|++.||+|||   +.+++||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~--------~~~~------~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~  147 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMIL--------VDGQ------PRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHR  147 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccc--------cccc------cccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence            999999999999997532110000        0000      0011235789999999999999999999   8999999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p  737 (815)
                      ||||+||+++.++.+||+|||+++.......   .....++..|+|||.+.+..  ++.++|||||||++|||++ |+.|
T Consensus       148 dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p  225 (291)
T cd05094         148 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQP  225 (291)
T ss_pred             ccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC--CCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999986543221   12334678899999887665  7889999999999999999 9999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      |......+    .   ... .....         ....+..++..+.+++.+||+.+|++||++++|+++|+++..
T Consensus       226 ~~~~~~~~----~---~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         226 WFQLSNTE----V---IEC-ITQGR---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             CCCCCHHH----H---HHH-HhCCC---------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            87533211    1   111 11111         001123345678999999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1e-37  Score=336.64  Aligned_cols=240  Identities=23%  Similarity=0.271  Sum_probs=194.3

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      +.||+|+||.||+|.. .+++.||||++....   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 568999999997532   223356788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      +|..++..                              ...+++.....++.|++.||+|||   +.+|+||||||+|||
T Consensus        81 ~L~~~l~~------------------------------~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIl  127 (328)
T cd05593          81 ELFFHLSR------------------------------ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLM  127 (328)
T ss_pred             CHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeE
Confidence            99988864                              235778889999999999999999   899999999999999


Q ss_pred             EcCCCCeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccc
Q 003504          670 LDMNLEPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEG  748 (815)
Q Consensus       670 l~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~  748 (815)
                      ++.++.+||+|||+++..... .......||+.|+|||++.+..  ++.++|||||||++|||++|+.||......    
T Consensus       128 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~Pf~~~~~~----  201 (328)
T cd05593         128 LDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----  201 (328)
T ss_pred             ECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCC--CCccCCccccchHHHHHhhCCCCCCCCCHH----
Confidence            999999999999998764322 2233456999999999987665  689999999999999999999999753221    


Q ss_pred             cHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          749 NLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                         ..........       .    ..+...+.++.+++.+|++.||++||     ++.++++
T Consensus       202 ---~~~~~~~~~~-------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         202 ---KLFELILMED-------I----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             ---HHHHHhccCC-------c----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence               1111111110       1    11233456788999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.9e-37  Score=323.80  Aligned_cols=251  Identities=26%  Similarity=0.396  Sum_probs=202.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      ++|++.+.||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|||++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCC-CCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            468888999999999999999888889999998763 334567999999999999999999999875 456789999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.++++..                            ....+++..+..++.|++.||+|||   +.+++||||||+|
T Consensus        84 ~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~N  132 (260)
T cd05070          84 KGSLLDFLKDG----------------------------EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSAN  132 (260)
T ss_pred             CCcHHHHHHhc----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccce
Confidence            99999999752                            1335789999999999999999999   7899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCCcc--ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGLDE--EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE  744 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~  744 (815)
                      |++++++.+||+|||++.........  ....++..|+|||.+....  ++.++||||||+++||+++ |+.||.+....
T Consensus       133 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~  210 (260)
T cd05070         133 ILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNR  210 (260)
T ss_pred             EEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCC--CcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999876543211  1223566899999887655  6889999999999999999 88898653211


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHh
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD  810 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~  810 (815)
                             .........          .....+...+.++.+++.+|+..+|++|||+.++.+.|++
T Consensus       211 -------~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         211 -------EVLEQVERG----------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -------HHHHHHHcC----------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                   111111111          1111233456689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5e-37  Score=321.96  Aligned_cols=260  Identities=23%  Similarity=0.366  Sum_probs=207.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||.||+|+. .+++.||||.+....   ......+.+|++++++++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4788899999999999999995 478999999876422   222356889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++....                          .....++......++.|++.||+|||   +.+++||||
T Consensus        82 e~~~~~~L~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl  132 (267)
T cd08228          82 ELADAGDLSQMIKYFK--------------------------KQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDI  132 (267)
T ss_pred             EecCCCcHHHHHHHhh--------------------------hccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCC
Confidence            9999999999986421                          11234677888999999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCc-cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLD-EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      ||+||+++.++.++|+|||++........ .....|+..|+|||.+.+..  ++.++||||||+++|||++|+.||....
T Consensus       133 ~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~  210 (267)
T cd08228         133 KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             CHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCC--CCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence            99999999999999999999987653321 22345888999999987655  6889999999999999999999986432


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      .     ....+..... ..        ......+...+..+.+++.+||..+|++||++.+|++.+++++
T Consensus       211 ~-----~~~~~~~~~~-~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         211 M-----NLFSLCQKIE-QC--------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             c-----cHHHHHHHHh-cC--------CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            1     1122222211 11        0111123445678999999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=329.13  Aligned_cols=251  Identities=24%  Similarity=0.246  Sum_probs=201.0

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      +|+..+.||+|+||.||++.. .+++.||||.+.....   .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            367789999999999999995 5688999999865322   123457789999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++|+|.+++...                            ....+++.....++.|++.||+|||   +.+++|||||
T Consensus        81 ~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlk  129 (285)
T cd05605          81 LMNGGDLKFHIYNM----------------------------GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLK  129 (285)
T ss_pred             ccCCCcHHHHHHhc----------------------------CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCC
Confidence            99999999888642                            1235788899999999999999999   7899999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      |+||++++++.++|+|||+++............|+..|+|||++.+..  ++.++|||||||++||+++|+.||.+....
T Consensus       130 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Diws~G~~l~el~~g~~pf~~~~~~  207 (285)
T cd05605         130 PENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER--YTFSPDWWGLGCLIYEMIEGKSPFRQRKEK  207 (285)
T ss_pred             HHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCC--CCccccchhHHHHHHHHHHCCCCCCCCchh
Confidence            999999999999999999998765444434456899999999987655  688999999999999999999999753322


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                      ...    ..+.......          ....+...+..+.+++.+||..||++||     +++++++
T Consensus       208 ~~~----~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         208 VKR----EEVERRVKED----------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             hHH----HHHHHHhhhc----------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            111    1111111110          0112334566789999999999999999     7888854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-37  Score=326.86  Aligned_cols=254  Identities=21%  Similarity=0.314  Sum_probs=198.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCc----EEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGI----HVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      ++|.+.+.||+|+||.||+|.+ .++.    .||+|.+..... ....++..|+.++++++||||++++|++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            4677889999999999999985 3444    477887754322 223567888889999999999999998754 45778


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ++||+++|+|.++++..                             ...++|.....++.|++.||+|||   +.+++||
T Consensus        86 i~e~~~~gsL~~~l~~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~  133 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH-----------------------------RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHR  133 (279)
T ss_pred             EEEeCCCCcHHHHHHhc-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecc
Confidence            99999999999999752                             235789999999999999999999   7899999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p  737 (815)
                      ||||+||+++.++.+||+|||+++.......   .....++..|+|||.+....  ++.++|||||||++||+++ |+.|
T Consensus       134 dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~el~t~g~~p  211 (279)
T cd05111         134 NLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR--YTHQSDVWSYGVTVWEMMSYGAEP  211 (279)
T ss_pred             ccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999987643321   22334677899999987665  7899999999999999998 9999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      |.+..+.+    +.+    .....  .....       +..+..++.+++.+||..+|++||++.++++.|..+..
T Consensus       212 ~~~~~~~~----~~~----~~~~~--~~~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         212 YAGMRPHE----VPD----LLEKG--ERLAQ-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCCCHHH----HHH----HHHCC--CcCCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            97533211    111    11111  11111       22234567889999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=306.31  Aligned_cols=250  Identities=24%  Similarity=0.314  Sum_probs=204.1

Q ss_pred             cCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      +.|++.+.||+|+|+.||++. ..+|+.+|+|++.-.  .....+++++|+.|.+.++|||||++.....+....++|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            457777899999999999998 467999999987532  33467889999999999999999999999999899999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      +|.+|+|..-+-+                              ....+....-....||+++|.|+|   ..+|||||+|
T Consensus        91 ~m~G~dl~~eIV~------------------------------R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvk  137 (355)
T KOG0033|consen   91 LVTGGELFEDIVA------------------------------REFYSEADASHCIQQILEALAYCH---SNGIVHRDLK  137 (355)
T ss_pred             cccchHHHHHHHH------------------------------HHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCC
Confidence            9999999776643                              123445556678899999999999   8999999999


Q ss_pred             CCceEEcCC---CCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          665 ASSVYLDMN---LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       665 ~~NIll~~~---~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      |+|+++-..   --+|++|||+|..++.+......+|||+|||||++....  ++..+|||+.||++|-++.|..||.+.
T Consensus       138 P~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdp--y~kpvDiW~cGViLfiLL~G~~PF~~~  215 (355)
T KOG0033|consen  138 PENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPFWDE  215 (355)
T ss_pred             hhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCC--CCCcchhhhhhHHHHHHHhCCCCCCCc
Confidence            999999633   348999999999999777778889999999999998887  799999999999999999999999875


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..+...+.+.       ..   .    -.+.+.......++..+++++|+..||.+|.|+.|.++
T Consensus       216 ~~~rlye~I~-------~g---~----yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  216 DQHRLYEQIK-------AG---A----YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cHHHHHHHHh-------cc---c----cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            4433322222       11   1    11222234456678899999999999999999998864

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.7e-37  Score=327.92  Aligned_cols=266  Identities=26%  Similarity=0.358  Sum_probs=207.0

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCee
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  579 (815)
                      .++|.+.+.||+|+||.||+|...      ++..||||.+...... ..+.+.+|++++++++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            346778899999999999999863      3478999998764443 356899999999999999999999999999999


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++||||+++|+|.++++........                ..........+.+.....++.|++.|++|||   +.+++
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~----------------~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~  144 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAF----------------LKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFV  144 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhh----------------hcccccccccccHHHHHHHHHHHHHHHHHHh---hCCee
Confidence            9999999999999999753211000                0000122445789999999999999999999   88999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~  735 (815)
                      ||||||+||+++.++.+||+|||+++......   ......+++.|+|||++.+..  ++.++|||||||++|||++ |+
T Consensus       145 h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~e~~~~g~  222 (280)
T cd05049         145 HRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGK  222 (280)
T ss_pred             ccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCC--cchhhhHHHHHHHHHHHHhcCC
Confidence            99999999999999999999999998653322   122334577899999987665  7889999999999999998 99


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHh
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD  810 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~  810 (815)
                      .||.....++    ...   ... ....         ...+...+.++.+++.+||..||++||++.||++.|++
T Consensus       223 ~p~~~~~~~~----~~~---~~~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         223 QPWYGLSNEE----VIE---CIT-QGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             CCCCCCCHHH----HHH---HHH-cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            9987533221    111   111 1110         11123455678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-38  Score=336.39  Aligned_cols=242  Identities=27%  Similarity=0.334  Sum_probs=201.9

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCccc---HHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeE
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLT---DQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRI  580 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  580 (815)
                      ..++|...++||+|.||+|++|.. .++..+|||+++++....   .+..+.|-.|+... +||.++.++.++.+.+..+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            456899999999999999999995 457889999998875433   34455666666555 6999999999999999999


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      .||||+.||++..+.+.                               ..++.....-+|..|+-||.|||   +.+||+
T Consensus       446 fvmey~~Ggdm~~~~~~-------------------------------~~F~e~rarfyaAev~l~L~fLH---~~~IIY  491 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT-------------------------------DVFSEPRARFYAAEVVLGLQFLH---ENGIIY  491 (694)
T ss_pred             EEEEecCCCcEEEEEec-------------------------------ccccHHHHHHHHHHHHHHHHHHH---hcCcee
Confidence            99999999995555442                               34666777789999999999999   899999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecC-CCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFG-NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~  739 (815)
                      ||||.+|||+|.+|.+||+|||+++.-- .+....+.+||+.|||||++.+..  |+..+|+|||||+||||+.|..||.
T Consensus       492 RDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~--Yt~aVDWW~lGVLlyeML~Gq~PF~  569 (694)
T KOG0694|consen  492 RDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS--YTRAVDWWGLGVLLYEMLVGESPFP  569 (694)
T ss_pred             eecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCc--ccchhhHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999999999754 667788899999999999999887  8999999999999999999999999


Q ss_pred             CCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      +++.++.-..+.       ..       +    ...|...+.+..+++.+.+.++|++|.-+
T Consensus       570 gddEee~FdsI~-------~d-------~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  570 GDDEEEVFDSIV-------ND-------E----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCHHHHHHHHh-------cC-------C----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            765544433322       11       1    12256677889999999999999999865

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.7e-37  Score=322.94  Aligned_cols=252  Identities=25%  Similarity=0.390  Sum_probs=202.6

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      ++|.+.+.||+|+||.||+|+..++..||+|.+... ....+.+.+|++++++++||||+++++++. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            468889999999999999999877778999998753 334567899999999999999999999874 456789999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.++++..                            ....++|..+..++.|++.||+|||   +.+++||||||+|
T Consensus        84 ~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~N  132 (262)
T cd05071          84 KGSLLDFLKGE----------------------------MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAAN  132 (262)
T ss_pred             CCcHHHHHhhc----------------------------cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCccc
Confidence            99999999752                            1235688999999999999999999   8899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE  744 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~  744 (815)
                      |++++++.+||+|||.++.......  .....++..|+|||......  ++.++||||||+++||+++ |+.||......
T Consensus       133 ill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DvwslG~~l~ellt~g~~p~~~~~~~  210 (262)
T cd05071         133 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNR  210 (262)
T ss_pred             EEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence            9999999999999999987653321  12233567899999887655  6889999999999999999 88888653221


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      +    ..   .... ..         .....+...+..+.+++.+|++.+|++||+++++++.|++.
T Consensus       211 ~----~~---~~~~-~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         211 E----VL---DQVE-RG---------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             H----HH---HHHh-cC---------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            1    11   1111 10         01111334567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.8e-37  Score=322.58  Aligned_cols=253  Identities=28%  Similarity=0.472  Sum_probs=204.5

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .++|++.+.||+|+||.||+|...+++.||+|.+... ......+.+|+.++++++||||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            3568889999999999999999888999999998753 345678999999999999999999999864 45789999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.+++...                            .+..+++..+..++.|++.||+|||   +.+++||||||+
T Consensus        83 ~~~~L~~~~~~~----------------------------~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~  131 (260)
T cd05067          83 ENGSLVDFLKTP----------------------------EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAA  131 (260)
T ss_pred             CCCCHHHHHHhc----------------------------CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHH
Confidence            999999998652                            2345788999999999999999999   889999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCC
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP  743 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~  743 (815)
                      ||+++.++.++|+|||++........  .....++..|+|||.+....  ++.++|||||||++||+++ |+.||.+...
T Consensus       132 ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~  209 (260)
T cd05067         132 NILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTN  209 (260)
T ss_pred             hEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCC--cCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence            99999999999999999987653221  12234567899999987665  6889999999999999999 9999975332


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      .+    ..   ... ...         .....+...+.++.+++.+||..+|++||+++++++.|+.+
T Consensus       210 ~~----~~---~~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         210 PE----VI---QNL-ERG---------YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             HH----HH---HHH-HcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            11    11   111 111         01111233456799999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-37  Score=327.68  Aligned_cols=265  Identities=24%  Similarity=0.310  Sum_probs=201.5

Q ss_pred             CCCCCeecccCCeeeEEEE-----cCCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--CeeEE
Q 003504          510 FDRGTLLAEGKFGPVYRGF-----LPGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQRIA  581 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~-----~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  581 (815)
                      |...+.||+|+||+||++.     ..++..||+|.+..... .....+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            4778999999999998865     24678899999875432 3456788999999999999999999998764  35789


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ||||+++|+|.+++...                               .+++..+..++.|++.||+|||   +.+|+||
T Consensus        86 v~e~~~~~~l~~~~~~~-------------------------------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~  131 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH-------------------------------KLNLAQLLLFAQQICEGMAYLH---SQHYIHR  131 (283)
T ss_pred             EecCCCCCCHHHHHHHc-------------------------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence            99999999999998641                               3789999999999999999999   8899999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCc----cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLD----EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      ||||+||+++.++.+||+|||+++....+..    .....++..|+|||.+....  .+.++||||||+++|||++|+.|
T Consensus       132 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~l~el~tg~~p  209 (283)
T cd05080         132 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK--FSYASDVWSFGVTLYELLTHCDS  209 (283)
T ss_pred             ccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccC--CCcccccHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999987654321    12223566799999887655  68899999999999999999999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      |.......  .....+...........+..+.......+..++.++.+++.+||+.+|++||+++++++.|+++.
T Consensus       210 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         210 KQSPPKKF--EEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCcchh--hhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            86432110  00000000000000001111111122224456678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-38  Score=301.50  Aligned_cols=252  Identities=22%  Similarity=0.337  Sum_probs=208.3

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcc----cH----HHHHHHHHHhcCC-CCCCceeeeeEEEeCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL----TD----QEAARELEYLGRI-KHPNLVPLTGYCIAGD  577 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~----~~----~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  577 (815)
                      +.|...+.+|+|..++|.++.. .+|...|+|++......    ..    +.-.+|+.||+++ .||+|+++.++++.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4577788999999999998884 57889999998643221    11    3446799999999 5999999999999999


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++|+|.|+.|.|.++|..                              ...++.+...+|+.|+.+|++|||   ...
T Consensus        97 F~FlVFdl~prGELFDyLts------------------------------~VtlSEK~tR~iMrqlfegVeylH---a~~  143 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTS------------------------------KVTLSEKETRRIMRQLFEGVEYLH---ARN  143 (411)
T ss_pred             hhhhhhhhcccchHHHHhhh------------------------------heeecHHHHHHHHHHHHHHHHHHH---Hhh
Confidence            99999999999999999964                              446778888899999999999999   899


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCC----CCCCCcCcchhHHHHHHHHHh
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                      ||||||||+|||+|++.++||+|||+|+.+.++......+||++|+|||.+.+..    ..|+...|+||+||+||.++.
T Consensus       144 IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa  223 (411)
T KOG0599|consen  144 IVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA  223 (411)
T ss_pred             hhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc
Confidence            9999999999999999999999999999999998888899999999999887543    226889999999999999999


Q ss_pred             CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      |.+||...      .++. ..+.++. ..      -.+......+...++-+++.+|++.||.+|.|++|+++
T Consensus       224 GcpPFwHR------kQml-MLR~Ime-Gk------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  224 GCPPFWHR------KQML-MLRMIME-GK------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             CCCchhHH------HHHH-HHHHHHh-cc------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            99999741      1111 1222222 11      12333445677888999999999999999999999975

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=339.35  Aligned_cols=248  Identities=24%  Similarity=0.406  Sum_probs=193.2

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      +|+..+.||+|+||.||+|+. .+++.||||++..... .....+.+|++++++++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            455678999999999999995 4689999999865332 23467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|....                                  ...+.....++.|++.||+|||   +.+||||||||+
T Consensus       155 ~~~~L~~~~----------------------------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~  197 (353)
T PLN00034        155 DGGSLEGTH----------------------------------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPS  197 (353)
T ss_pred             CCCcccccc----------------------------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHH
Confidence            999986432                                  1234566789999999999999   889999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCC---CCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      |||+++++.+||+|||+++...... ......||..|+|||.+....   .+.+.++|||||||++|||++|+.||....
T Consensus       198 NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  277 (353)
T PLN00034        198 NLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR  277 (353)
T ss_pred             HEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999998765332 223456999999999875421   224568999999999999999999997322


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      ..    .............          ....+...+.++.+++.+||+.||++||++.|+++.
T Consensus       278 ~~----~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        278 QG----DWASLMCAICMSQ----------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             Cc----cHHHHHHHHhccC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11    1111111111000          011133456678999999999999999999999863

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.1e-37  Score=332.70  Aligned_cols=200  Identities=23%  Similarity=0.370  Sum_probs=171.5

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      .++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++||||++++++|.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999964 68889999886542 2234578999999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++|+|.+++...                              ..+++.....++.+++.||+|||+  ..+|+|||||
T Consensus        84 ~~~~~~L~~~l~~~------------------------------~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlk  131 (333)
T cd06650          84 HMDGGSLDQVLKKA------------------------------GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVK  131 (333)
T ss_pred             cCCCCcHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCC
Confidence            99999999999642                              246677888999999999999993  2479999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      |+|||++.++.+||+|||++...... ......|+..|+|||.+.+..  ++.++|||||||++||+++|+.||...
T Consensus       132 p~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         132 PSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hhhEEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            99999999999999999999765432 223346899999999987655  688999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.9e-37  Score=327.07  Aligned_cols=263  Identities=22%  Similarity=0.325  Sum_probs=203.6

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCe
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQ  578 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  578 (815)
                      ++++|+..+.||+|+||.||+|...      .+..||||.+..... ....++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999998743      356799998864322 234568899999999999999999999999899


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++||||+++|+|.++++.......                    ........+|..+..++.|++.||+|||   +.++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~  140 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEME--------------------NNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKF  140 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCcccc--------------------ccccccCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            9999999999999999975321100                    0011235688899999999999999999   7899


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-C
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-G  734 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g  734 (815)
                      +||||||+||++++++.+||+|||+++.......   .....++..|+|||++....  ++.++|||||||++|||++ |
T Consensus       141 vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~  218 (277)
T cd05062         141 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLA  218 (277)
T ss_pred             ccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC--cCchhHHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999976543221   11223577899999987655  7899999999999999999 7


Q ss_pred             CCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHh
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD  810 (815)
Q Consensus       735 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~  810 (815)
                      ..||.....+    ...   .... .....         ..+..++..+.+++.+||+.+|++||++.++++.|++
T Consensus       219 ~~p~~~~~~~----~~~---~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         219 EQPYQGMSNE----QVL---RFVM-EGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CCCCCCCCHH----HHH---HHHH-cCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            8888653221    111   1111 11100         1123345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3e-37  Score=339.34  Aligned_cols=288  Identities=24%  Similarity=0.305  Sum_probs=209.4

Q ss_pred             HHHhcCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCcc-cHHHHHHHHHHhcCCC-CCCceeeeeEEEe
Q 003504          504 LSATSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGSTL-TDQEAARELEYLGRIK-HPNLVPLTGYCIA  575 (815)
Q Consensus       504 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~  575 (815)
                      ....++|.+++.||+|+||.||+|++.      .+..||||+++..... ..+.+.+|++++.++. ||||++++|+|..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            334456888899999999999999853      3467999999754222 2346889999999997 9999999999999


Q ss_pred             CCeeEEEEEeCCCCChhhhhccCCCCCccc-----cC----CCCCccc--------------------------------
Q 003504          576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTT-----ED----WSTDTWE--------------------------------  614 (815)
Q Consensus       576 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~-----~~----~~~~~~~--------------------------------  614 (815)
                      ....++|+||+++|+|.++++..+......     ..    .......                                
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            889999999999999999998643110000     00    0000000                                


Q ss_pred             ---------------------------cCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          615 ---------------------------EDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       615 ---------------------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                                                 ................++|....+++.|++.||+|||   +.+++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcce
Confidence                                       0000000001122346789999999999999999999   8899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCC
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP  743 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~  743 (815)
                      ||+++++.+||+|||+++......   ......++..|+|||.+....  ++.++|||||||++|||++ |+.||.....
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL--YTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC--CCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999998654322   112334678899999987655  6889999999999999998 8889864321


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      .+.       ........         .+...+..++.++.+++.+||..+|++||++++|++.|+++.
T Consensus       348 ~~~-------~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NEQ-------FYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hHH-------HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            111       11111111         111123345678999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3e-37  Score=328.83  Aligned_cols=270  Identities=25%  Similarity=0.366  Sum_probs=204.5

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCC-C--cEEEEEEeecCC-cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG-G--IHVAVKVLVHGS-TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~-~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  582 (815)
                      ++|++.+.||+|+||.||+|+..+ +  ..+|+|.++... ....+.+.+|++++.++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468889999999999999998643 3  347888876422 23346788999999999 799999999999998899999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      +||+++|+|.++++........              ............+++.....++.|++.||+|||   +.+|+|||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~--------------~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~d  144 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETD--------------PAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRD  144 (297)
T ss_pred             EEecCCCcHHHHHHhccccccc--------------cccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCc
Confidence            9999999999999753211000              000000012345889999999999999999999   89999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDD  741 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~  741 (815)
                      |||+||++++++.+||+|||++..............+..|+|||++....  ++.++|||||||++|||++ |..||...
T Consensus       145 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~il~el~t~g~~pf~~~  222 (297)
T cd05089         145 LAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGM  222 (297)
T ss_pred             CCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999999987543222222223356799999887665  6889999999999999998 99999753


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      ...+       .......          ......+..++.++.+++.+||+.+|.+||+++++++.|+++.+
T Consensus       223 ~~~~-------~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         223 TCAE-------LYEKLPQ----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             CHHH-------HHHHHhc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            3211       1111111          11111233455678999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=351.49  Aligned_cols=249  Identities=21%  Similarity=0.257  Sum_probs=200.6

Q ss_pred             CCCCCeecccCCeeeEEEEc-CC-CcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      |.+.+.||+|+||.||+|.. .+ +..||+|.+..........+.+|+.+++.++|||||++++++...+..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            77789999999999999984 33 67889997755444445567889999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.++++...                          ....++++.....++.|++.||+|||   +.+||||||||+|
T Consensus       149 gg~L~~~l~~~~--------------------------~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~N  199 (478)
T PTZ00267        149 GGDLNKQIKQRL--------------------------KEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSAN  199 (478)
T ss_pred             CCCHHHHHHHHH--------------------------hccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHh
Confidence            999999886421                          11335778888999999999999999   8999999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      ||++.++.+||+|||+++......   .....+||+.|+|||++.+..  ++.++|||||||++|||++|+.||..... 
T Consensus       200 Ill~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-  276 (478)
T PTZ00267        200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR--YSKKADMWSLGVILYELLTLHRPFKGPSQ-  276 (478)
T ss_pred             EEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCC--CCcHHhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence            999999999999999998765432   123456999999999987765  78999999999999999999999975321 


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                            ...+........     +     ..+...+.++.+++.+||..||++||++++++.
T Consensus       277 ------~~~~~~~~~~~~-----~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        277 ------REIMQQVLYGKY-----D-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ------HHHHHHHHhCCC-----C-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                  122222221110     0     112334567899999999999999999999864

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.8e-37  Score=321.47  Aligned_cols=252  Identities=27%  Similarity=0.415  Sum_probs=202.2

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      ++|.+.+.||+|+||.||+|...++..||+|.+... ....+.+.+|++++++++|||++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            457788899999999999999877778999987653 334567899999999999999999999875 456789999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.++++..                            ....++|..+..++.|++.||+|||   +.+++||||||+|
T Consensus        84 ~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~N  132 (260)
T cd05069          84 KGSLLDFLKEG----------------------------DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAAN  132 (260)
T ss_pred             CCCHHHHHhhC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcce
Confidence            99999999752                            1335789999999999999999999   7899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE  744 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~  744 (815)
                      |++++++.+||+|||+++.......  .....++..|+|||...+..  ++.++|||||||++||+++ |+.||.+....
T Consensus       133 ill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  210 (260)
T cd05069         133 ILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMVNR  210 (260)
T ss_pred             EEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCC--cChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999987643321  12233567899999887655  7889999999999999999 89998753221


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      +    ...   ... ..         .....+...+..+.+++.+||+.+|++||++++|++.|+++
T Consensus       211 ~----~~~---~~~-~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         211 E----VLE---QVE-RG---------YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             H----HHH---HHH-cC---------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            1    111   111 11         01112334567899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.8e-37  Score=334.25  Aligned_cols=287  Identities=27%  Similarity=0.344  Sum_probs=205.9

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCcc-cHHHHHHHHHHhcCC-CCCCceeeeeEEEeC-C
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGSTL-TDQEAARELEYLGRI-KHPNLVPLTGYCIAG-D  577 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~  577 (815)
                      .++|.+.+.||+|+||.||+|...      +++.||+|+++..... ..+.+.+|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            346888999999999999999742      3478999998653322 235678899999999 799999999988754 4


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCc--ccc------------------------CCCCCccccCC-----CccccccCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQ--TTE------------------------DWSTDTWEEDG-----TNSIQNVGS  626 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~--~~~------------------------~~~~~~~~~~~-----~~~~~~~~~  626 (815)
                      ..++++||+++|+|.+++........  ...                        +.....+....     .........
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999999965321100  000                        00000000000     000000001


Q ss_pred             CCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCC---cccccccccccc
Q 003504          627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYI  703 (815)
Q Consensus       627 ~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~  703 (815)
                      ....++|..+.+++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+....   ......++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            1236899999999999999999999   8899999999999999999999999999998764322   112234567899


Q ss_pred             CCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHH
Q 003504          704 PPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEE  782 (815)
Q Consensus       704 aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  782 (815)
                      |||++.+..  ++.++|||||||++||+++ |+.||.+....+   .+.    .......         ....+.....+
T Consensus       243 aPE~~~~~~--~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~---------~~~~~~~~~~~  304 (337)
T cd05054         243 APESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFC----RRLKEGT---------RMRAPEYATPE  304 (337)
T ss_pred             CcHHhcCCC--CCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHH----HHHhccC---------CCCCCccCCHH
Confidence            999987765  7899999999999999998 999997532211   111    1111110         11112334567


Q ss_pred             HHHHHhhccccCCCCCCCHHHHHHHHHhhhhc
Q 003504          783 ALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       783 ~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~~  814 (815)
                      +.+++.+||+.+|++||++.++++.|+++.+.
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            89999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-37  Score=333.27  Aligned_cols=240  Identities=22%  Similarity=0.268  Sum_probs=192.5

Q ss_pred             CeecccCCeeeEEEEc----CCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          514 TLLAEGKFGPVYRGFL----PGGIHVAVKVLVHGS----TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +.||+|+||.||+++.    .+++.||||++....    ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999984    357889999987532    12234577899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++|+|.+++...                              ..+.+.....++.|++.||+|||   +.+|+||||||
T Consensus        82 ~~~~~L~~~~~~~------------------------------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp  128 (323)
T cd05584          82 LSGGELFMHLERE------------------------------GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKP  128 (323)
T ss_pred             CCCchHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCH
Confidence            9999999998642                              24566777889999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +|||++.++.+||+|||+++..... .......||+.|+|||++.+..  ++.++|||||||++|||++|+.||..... 
T Consensus       129 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~pf~~~~~-  205 (323)
T cd05584         129 ENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG--HGKAVDWWSLGALMYDMLTGAPPFTAENR-  205 (323)
T ss_pred             HHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCC--CCCcceecccHHHHHHHhcCCCCCCCCCH-
Confidence            9999999999999999999754322 2233456999999999987665  68899999999999999999999975322 


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                            ...........           ...+...+.++.+++.+||+.||++||     +++++++
T Consensus       206 ------~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         206 ------KKTIDKILKGK-----------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ------HHHHHHHHcCC-----------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                  11122222111           011233456788999999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.7e-37  Score=326.92  Aligned_cols=268  Identities=22%  Similarity=0.316  Sum_probs=204.3

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-----CCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-----PGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      ++|++.+.||+|+||.||+|+.     .++..||+|.+..... .....+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3577789999999999999984     3567899999864322 233578899999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ||||+++|+|.+++..........  +.           ....+.....+++...+.++.|++.||+|||   +.+++||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~--~~-----------~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~  148 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVG--CS-----------SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHK  148 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccc--cc-----------cccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehh
Confidence            999999999999996532110000  00           0001112345789999999999999999999   7899999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p  737 (815)
                      ||||+||++++++.+||+|||+++......   ......++..|+|||++.+..  ++.++|||||||++|||++ |..|
T Consensus       149 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~~g~~p  226 (283)
T cd05090         149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQP  226 (283)
T ss_pred             ccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCC--CCchhhhHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999998654322   122233567899999987655  6899999999999999999 9989


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD  810 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~  810 (815)
                      |....+.    .+..    ......         ....+..++.++.+++.+||+.||++||++.+|.++|..
T Consensus       227 ~~~~~~~----~~~~----~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         227 YYGFSNQ----EVIE----MVRKRQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCCCHH----HHHH----HHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            8643211    1111    111111         011233455678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-37  Score=329.24  Aligned_cols=262  Identities=24%  Similarity=0.322  Sum_probs=202.0

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-----CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--CeeE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-----PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQRI  580 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  580 (815)
                      .+|.+.+.||+|+||.||+|..     .++..||+|.+........+.+.+|++++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4677889999999999999974     35788999998765555566889999999999999999999988653  4678


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +|+||+++|+|.+++...                             ...++|..+..++.|++.||+|||   +.+++|
T Consensus        84 lv~e~~~~~~L~~~l~~~-----------------------------~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H  131 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH-----------------------------RERLDHRKLLLYASQICKGMEYLG---SKRYVH  131 (284)
T ss_pred             EEEEecCCCCHHHHHHhc-----------------------------CcCCCHHHHHHHHHHHHHHHHHHH---HCCcee
Confidence            999999999999999642                             234789999999999999999999   889999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCCcc----ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE----EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      |||||+||++++++.+||+|||+++........    ....++..|+|||.+.+..  ++.++|||||||++|||++|..
T Consensus       132 ~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~  209 (284)
T cd05081         132 RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYSD  209 (284)
T ss_pred             ccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCC--cChHHHHHHHHHHHHHHhhcCC
Confidence            999999999999999999999999876543211    1122345699999987655  6889999999999999999887


Q ss_pred             CCCCCCCccc-------c-ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          737 PLGDDYPEEK-------E-GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       737 p~~~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                      |+........       . .............         ......+..++.++.+++.+||+.+|++||||.+|++.|
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l  280 (284)
T cd05081         210 KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN---------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV  280 (284)
T ss_pred             cCCCcchhhhhhcccccccccchHHHHHHHhc---------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            7543211000       0 0001111111111         111112334567899999999999999999999999999


Q ss_pred             Hhhh
Q 003504          809 KDIE  812 (815)
Q Consensus       809 ~~i~  812 (815)
                      +.++
T Consensus       281 ~~~~  284 (284)
T cd05081         281 EAIR  284 (284)
T ss_pred             HhcC
Confidence            8763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-37  Score=322.60  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=200.5

Q ss_pred             CCCCCeecccCCeeeEEEEcCC----CcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCe-----
Q 003504          510 FDRGTLLAEGKFGPVYRGFLPG----GIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQ-----  578 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  578 (815)
                      |.+++.||+|+||.||+|....    +..||||++.....  .....+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999998532    36799999875322  234578899999999999999999999876554     


Q ss_pred             -eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          579 -RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       579 -~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                       .++|+||+++|+|..++.....+                        .....+++.....++.|++.||+|||   +.+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~------------------------~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~  133 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLG------------------------GLPEKLPLQTLLKFMVDIALGMEYLS---NRN  133 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhcc------------------------CCcccCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence             68999999999999998653111                        12335788899999999999999999   789


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-  733 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-  733 (815)
                      ++||||||+||++++++.+||+|||+++.+.....   .....++..|+|||.+....  ++.++|||||||++|||++ 
T Consensus       134 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~SlG~il~el~~~  211 (273)
T cd05035         134 FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATR  211 (273)
T ss_pred             eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCC--CCcccchHHHHHHHHHHHhC
Confidence            99999999999999999999999999987653321   11223567899999986655  7899999999999999999 


Q ss_pred             CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      |..||.+....    .+.++   .. ...         ....+..++.++.+++.+||+.||++||++.++++.|+++
T Consensus       212 g~~p~~~~~~~----~~~~~---~~-~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         212 GQTPYPGVENH----EIYDY---LR-HGN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCCCCCCHH----HHHHH---HH-cCC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            88888653221    11111   11 111         0111334567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.3e-37  Score=325.91  Aligned_cols=277  Identities=25%  Similarity=0.353  Sum_probs=207.4

Q ss_pred             CCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      +|++.+.||+|+||.||+|+..      +...||+|.+..... .....+.+|+.+++.++||||++++++|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677899999999999999842      235789998865433 234578899999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      |+||+++|+|.+++............      .+...............+++...+.++.|++.||+|||   +.+++||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~  151 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLG------SDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHR  151 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccc------cccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehh
Confidence            99999999999999754221110000      00000000011122346889999999999999999999   8899999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p  737 (815)
                      ||||+||++++++.+||+|||+++.......   .....++..|+|||.+.+..  ++.++||||||+++|||++ |..|
T Consensus       152 dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p  229 (290)
T cd05045         152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNP  229 (290)
T ss_pred             hhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC--cchHhHHHHHHHHHHHHHhcCCCC
Confidence            9999999999999999999999986533221   12233567899999887655  7899999999999999998 9999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      |....++    .+..++    ...         .....+...+.++.+++.+||+.+|++||++.++++.|+++-.
T Consensus       230 ~~~~~~~----~~~~~~----~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         230 YPGIAPE----RLFNLL----KTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CCCCCHH----HHHHHH----hCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            8653322    122211    111         1111233455678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-37  Score=347.89  Aligned_cols=265  Identities=20%  Similarity=0.293  Sum_probs=195.8

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--------C
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAG--------D  577 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~  577 (815)
                      ..+|.+.+.||+|+||.||+|+. .+++.||||++...    .....+|+.++++++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            45799999999999999999995 56889999988542    23346799999999999999999987542        1


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++||||+++ +|.+++....                          .....+++.....++.|++.||+|||   +.+
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~--------------------------~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~  190 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYA--------------------------RNNHALPLFLVKLYSYQLCRALAYIH---SKF  190 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHh--------------------------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            35689999985 7877775321                          12345788889999999999999999   899


Q ss_pred             eeeccCCCCceEEcCCC-CeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          658 IIHRDIKASSVYLDMNL-EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      |+||||||+|||++.++ .+||+|||+|+....+.......||+.|+|||++.+... ++.++|||||||++|||++|+.
T Consensus       191 IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwSlGvil~elltG~~  269 (440)
T PTZ00036        191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATN-YTTHIDLWSLGCIIAEMILGYP  269 (440)
T ss_pred             EecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCC-CCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999664 799999999987765544445678999999998865433 6889999999999999999999


Q ss_pred             CCCCCCCccccccHHHHHH----HHHh-c-CCCC-----ccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          737 PLGDDYPEEKEGNLVSWVR----GLVR-N-NKGS-----RAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~----~~~~-~-~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                      ||.+....+....+.....    .... . ....     .+....+....+...+.++.+++.+||..||.+||++.|++
T Consensus       270 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l  349 (440)
T PTZ00036        270 IFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL  349 (440)
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            9986433221111111000    0000 0 0000     01111111112333456889999999999999999999997


Q ss_pred             H
Q 003504          806 G  806 (815)
Q Consensus       806 ~  806 (815)
                      +
T Consensus       350 ~  350 (440)
T PTZ00036        350 A  350 (440)
T ss_pred             C
Confidence            4

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-38  Score=296.55  Aligned_cols=265  Identities=25%  Similarity=0.333  Sum_probs=211.0

Q ss_pred             hcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC-----eeE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD-----QRI  580 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  580 (815)
                      ..+|.+.+.+|+|||+-||.++ ..++.-+|+|++......+.+...+|++..++++|||++++++++..+.     +.|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4578899999999999999999 6778899999998766667788899999999999999999999886543     589


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      ++++|...|+|.+.+...+.                          .+..++..+.+.|+.++.+||++||+. .++++|
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~--------------------------kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH  152 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKI--------------------------KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAH  152 (302)
T ss_pred             EEeehhccccHHHHHHHHhh--------------------------cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccc
Confidence            99999999999999976432                          245688899999999999999999943 456999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCC---CC-------ccccccccccccCCcccCCCCC-CCCCcCcchhHHHHHH
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGN---GL-------DEEIARGSPGYIPPEFAQPDSD-FPTPKSDVYCYGVVLL  729 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~---~~-------~~~~~~gt~~y~aPE~~~~~~~-~~~~~~Dv~S~Gvvl~  729 (815)
                      |||||.|||+.+++.++|.|||.+....-   +.       .......|..|.|||.+....+ ..++++|||||||++|
T Consensus       153 ~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY  232 (302)
T KOG2345|consen  153 RDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY  232 (302)
T ss_pred             cCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence            99999999999999999999999876531   11       1112236889999998775542 2589999999999999


Q ss_pred             HHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          730 ELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       730 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                      +|+.|..||......+  +++.            ..+..+.+.-......++.+.+++..|++.||.+||+..+++..++
T Consensus       233 a~mf~~sPfe~~~~~G--gSla------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d  298 (302)
T KOG2345|consen  233 AMMFGESPFERIYQQG--GSLA------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLD  298 (302)
T ss_pred             HHHHcCCcchHHhhcC--CeEE------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            9999999997533311  1111            0111222222223337789999999999999999999999999988


Q ss_pred             hhh
Q 003504          810 DIE  812 (815)
Q Consensus       810 ~i~  812 (815)
                      .+.
T Consensus       299 ~Li  301 (302)
T KOG2345|consen  299 DLI  301 (302)
T ss_pred             hhc
Confidence            764

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.4e-37  Score=320.34  Aligned_cols=245  Identities=22%  Similarity=0.346  Sum_probs=195.6

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCCh
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNL  591 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL  591 (815)
                      +.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++||||++++++|......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4699999999999996 478899999876432 23345789999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEc
Q 003504          592 QNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD  671 (815)
Q Consensus       592 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  671 (815)
                      .++++..                             ...+++.....++.|++.||+|||   +.+++||||||+||+++
T Consensus        81 ~~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~  128 (252)
T cd05084          81 LTFLRTE-----------------------------GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVT  128 (252)
T ss_pred             HHHHHhC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEc
Confidence            9999642                             234788999999999999999999   88999999999999999


Q ss_pred             CCCCeeecccccceecCCCCcc---ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCcccc
Q 003504          672 MNLEPRLSDFGLAKIFGNGLDE---EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKE  747 (815)
Q Consensus       672 ~~~~~kl~Dfgla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~  747 (815)
                      .++.+||+|||++.........   ....++..|+|||.+.+..  ++.++|||||||++||+++ |..||......   
T Consensus       129 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---  203 (252)
T cd05084         129 EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR--YSSESDVWSFGILLWEAFSLGAVPYANLSNQ---  203 (252)
T ss_pred             CCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccCHH---
Confidence            9999999999998865432211   1112345699999987665  6889999999999999998 88888643221   


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                       ..    ......         ......+..++.++.+++.+||+.+|++||++.++.++|+
T Consensus       204 -~~----~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         204 -QT----REAIEQ---------GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             -HH----HHHHHc---------CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence             11    111111         1111223345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.8e-37  Score=325.33  Aligned_cols=264  Identities=25%  Similarity=0.388  Sum_probs=208.4

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcCC-----CcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEe-CCee
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPG-----GIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIA-GDQR  579 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~  579 (815)
                      .++|.+.+.||+|+||.||+|...+     +..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999999755     68899998865322 334568899999999999999999999876 4678


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++++||+++|+|.+++...+...                      ......+++..+..++.|++.||+|||   +.+++
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~----------------------~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~  139 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGE----------------------ANNPQALSTQQLVHMAIQIACGMSYLH---KRGVI  139 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccc----------------------cccccCCCHHHHHHHHHHHHHHHHHHH---HCCEe
Confidence            99999999999999997532110                      012346889999999999999999999   88999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~  735 (815)
                      ||||||+||++++++.+||+|||+++.+..+..   .....++..|+|||.+....  ++.++|||||||++||+++ |+
T Consensus       140 H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~~l~el~~~g~  217 (280)
T cd05043         140 HKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE--YSSASDVWSFGVLLWELMTLGQ  217 (280)
T ss_pred             ecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC--CCchhhHHHhHHHHHHHhcCCC
Confidence            999999999999999999999999986643321   12233567899999887655  7899999999999999999 99


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhhc
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~~  814 (815)
                      .||....+.    .+..++.    ..         .....+..++.++.+++.+||..||++||++.++++.|+++.+.
T Consensus       218 ~p~~~~~~~----~~~~~~~----~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         218 TPYVEIDPF----EMAAYLK----DG---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCcCcCCHH----HHHHHHH----cC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            999753321    1222111    11         01111223456789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.1e-37  Score=326.96  Aligned_cols=263  Identities=20%  Similarity=0.252  Sum_probs=196.8

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      .++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999964 688999999865332 223467889999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |++ ++|.+++...                             ...++......++.|++.||+|||   +.+|+|||||
T Consensus        84 ~~~-~~l~~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlk  130 (303)
T cd07869          84 YVH-TDLCQYMDKH-----------------------------PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLK  130 (303)
T ss_pred             CCC-cCHHHHHHhC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence            996 5888887642                             234667778899999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      |+||+++.++.+||+|||+++...... ......|++.|+|||++.+... ++.++||||+||++|||++|+.||.+...
T Consensus       131 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~  209 (303)
T cd07869         131 PQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE-YSTCLDMWGVGCIFVEMIQGVAAFPGMKD  209 (303)
T ss_pred             HHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            999999999999999999997653222 2234568999999998865432 67889999999999999999999975321


Q ss_pred             ccccccHHHHHHHHHhcCC---C------CccccccccCCCCH---------HHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNK---G------SRAIDPKIRDTGPE---------KQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~---------~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                      .  ...+.. +........   .      ............+.         ..+..+.+++.+|++.||++|||++|++
T Consensus       210 ~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l  286 (303)
T cd07869         210 I--QDQLER-IFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL  286 (303)
T ss_pred             H--HHHHHH-HHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence            1  111111 110000000   0      00000000000011         1235678999999999999999999997


Q ss_pred             H
Q 003504          806 G  806 (815)
Q Consensus       806 ~  806 (815)
                      +
T Consensus       287 ~  287 (303)
T cd07869         287 S  287 (303)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-37  Score=334.49  Aligned_cols=240  Identities=23%  Similarity=0.267  Sum_probs=193.3

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      +.||+|+||.||+|.. .++..||+|++.....   .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999984 5789999999975321   22346678999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeccCCCCce
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCS-PPIIHRDIKASSV  668 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlk~~NI  668 (815)
                      +|..++..                              ...+++.....++.|++.||+|||   + .+|+||||||+||
T Consensus        81 ~L~~~l~~------------------------------~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NI  127 (325)
T cd05594          81 ELFFHLSR------------------------------ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENL  127 (325)
T ss_pred             cHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeE
Confidence            99988864                              235788889999999999999999   5 7999999999999


Q ss_pred             EEcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |++.++.+||+|||+++.... ........||+.|+|||++.+..  ++.++|||||||++|||++|+.||.....+   
T Consensus       128 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tG~~Pf~~~~~~---  202 (325)
T cd05594         128 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---  202 (325)
T ss_pred             EECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCC--CCCccccccccceeeeeccCCCCCCCCCHH---
Confidence            999999999999999876432 22233456999999999987665  689999999999999999999999753221   


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                          ..........       .    ..+...+.++.+++.+|++.||++|+     +++++++
T Consensus       203 ----~~~~~i~~~~-------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         203 ----KLFELILMEE-------I----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ----HHHHHHhcCC-------C----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                1111111110       0    11233456788999999999999996     8988875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.3e-37  Score=333.12  Aligned_cols=250  Identities=25%  Similarity=0.272  Sum_probs=196.7

Q ss_pred             CCCCCCeecccCCeeeEEEEc----CCCcEEEEEEeecCC----cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCee
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL----PGGIHVAVKVLVHGS----TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  579 (815)
                      +|++.+.||+|+||.||+++.    .++..||+|++.+..    ....+.+.+|+.++.++ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999874    367899999986532    12234678899999999 599999999999999999


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++||||+++|+|.+++..                              ...+++.....++.|++.||+|||   +.+|+
T Consensus        81 ~lv~e~~~~g~L~~~l~~------------------------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~iv  127 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ------------------------------RDNFSEDEVRFYSGEIILALEHLH---KLGIV  127 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcE
Confidence            999999999999999864                              224677888899999999999999   88999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      ||||||+|||++.++.+||+|||+++......  ......||..|+|||++.+... ++.++|||||||++|||++|+.|
T Consensus       128 HrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~elltg~~p  206 (332)
T cd05614         128 YRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGG-HGKAVDWWSLGILIFELLTGASP  206 (332)
T ss_pred             ecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCC-CCCccccccchhhhhhhhcCCCC
Confidence            99999999999999999999999998654322  2234569999999999875432 57899999999999999999999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                      |.........   ..........       ++.+    +...+.++.+++.+||+.||++||     +++++++
T Consensus       207 f~~~~~~~~~---~~~~~~~~~~-------~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         207 FTLEGERNTQ---SEVSRRILKC-------DPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCCCCCCH---HHHHHHHhcC-------CCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            9753221111   1111111111       1111    233456788999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.8e-37  Score=340.49  Aligned_cols=249  Identities=23%  Similarity=0.285  Sum_probs=193.2

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      .|+..+.||+|+||.||+|+. .+++.||||++.....   .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            577889999999999999984 5688999999975322   223468899999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++|+|.+++...                              ..+++.....++.|++.||+|||   +.+|||||||
T Consensus        82 ~~~gg~L~~~l~~~------------------------------~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlK  128 (381)
T cd05626          82 YIPGGDMMSLLIRM------------------------------EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIK  128 (381)
T ss_pred             cCCCCcHHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCc
Confidence            99999999998642                              24667777889999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCC------------------------------------------------ccccc
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL------------------------------------------------DEEIA  696 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~------------------------------------------------~~~~~  696 (815)
                      |+|||++.++.+||+|||+++......                                                .....
T Consensus       129 p~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (381)
T cd05626         129 PDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSL  208 (381)
T ss_pred             HHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccc
Confidence            999999999999999999976431000                                                01124


Q ss_pred             cccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCC
Q 003504          697 RGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGP  776 (815)
Q Consensus       697 ~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  776 (815)
                      .||+.|+|||++.+..  ++.++|||||||++|||++|+.||....+.+....+       .....       .+.....
T Consensus       209 ~gt~~Y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i-------~~~~~-------~~~~~~~  272 (381)
T cd05626         209 VGTPNYIAPEVLLRKG--YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV-------INWEN-------TLHIPPQ  272 (381)
T ss_pred             cCCccccCHHHHcCCC--CCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHH-------Hcccc-------ccCCCCC
Confidence            6999999999987665  688999999999999999999999764332211111       11000       0000111


Q ss_pred             HHHHHHHHHHHhh--ccccCCCCCCCHHHHHH
Q 003504          777 EKQMEEALKIGYL--CTADLPLKRPSMQQIVG  806 (815)
Q Consensus       777 ~~~~~~~~~l~~~--Cl~~dP~~RPs~~~v~~  806 (815)
                      ...+.++.+++.+  |+..+|..||++++++.
T Consensus       273 ~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         273 VKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             CCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            1234566677766  66777778999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.8e-37  Score=320.99  Aligned_cols=260  Identities=23%  Similarity=0.389  Sum_probs=208.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||.||+|+. .++..+|||.+.....   .....+.+|+++++.++||||+++++++...+..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3677889999999999999994 5789999998865322   22357889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++++|.+++....                          .....+++.....++.|++.||+|||   +.+++|+||
T Consensus        82 e~~~~~~L~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl  132 (267)
T cd08229          82 ELADAGDLSRMIKHFK--------------------------KQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDI  132 (267)
T ss_pred             EecCCCCHHHHHHHhh--------------------------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCC
Confidence            9999999999986421                          12346789999999999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCc-cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLD-EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      ||+||+++.++.++|+|||++........ .....|+..|+|||.+....  ++.++||||||+++|||++|..||....
T Consensus       133 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08229         133 KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             CHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCC--ccchhhHHHHHHHHHHHHhCCCCccccc
Confidence            99999999999999999999886643321 22345889999999987665  6889999999999999999999986432


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      .     ....+.+.....         ......+...+.++.+++.+||+.+|++||+|.+|++.++++.
T Consensus       211 ~-----~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         211 M-----NLYSLCKKIEQC---------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             c-----hHHHHhhhhhcC---------CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            1     111221111110         1111113346678999999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.3e-37  Score=320.31  Aligned_cols=255  Identities=23%  Similarity=0.297  Sum_probs=202.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .+|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4788999999999999999995 678899999987644445567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.++++.                              ...+++..+..++.|++.||+|||   +.+|+||||||+
T Consensus        89 ~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~  135 (267)
T cd06646          89 GGGSLQDIYHV------------------------------TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGA  135 (267)
T ss_pred             CCCcHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHH
Confidence            99999999864                              224678888999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCC-CCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPD-SDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      ||+++.++.+||+|||++....... ......|+..|+|||.+... ...++.++|||||||++|||++|+.||....+.
T Consensus       136 nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~  215 (267)
T cd06646         136 NILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM  215 (267)
T ss_pred             HEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence            9999999999999999998764332 22344688999999987532 222578999999999999999999998643221


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                      +....+        ..   .....+...  .....+.++.+++.+||..+|++||+++++++.|
T Consensus       216 ~~~~~~--------~~---~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         216 RALFLM--------SK---SNFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             hhheee--------ec---CCCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            111000        00   011111111  1223457889999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.6e-37  Score=322.03  Aligned_cols=256  Identities=27%  Similarity=0.392  Sum_probs=197.6

Q ss_pred             CCCCCeecccCCeeeEEEEcCC-C--cEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeC------Ce
Q 003504          510 FDRGTLLAEGKFGPVYRGFLPG-G--IHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAG------DQ  578 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~~-~--~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~  578 (815)
                      |.+++.||+|+||.||+|+..+ +  ..||||.++...  ....+.+.+|++++++++||||++++++|...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999654 3  268999886532  23346788999999999999999999988642      24


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++|+||+++|+|.+++.....                        +.....+++.....++.|++.||+|||   +.+|
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i  133 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRL------------------------GDCPQYLPTQMLVKFMTDIASGMEYLS---SKSF  133 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcc------------------------cCCcccCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            6899999999999998853210                        012345789999999999999999999   7899


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-C
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-G  734 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g  734 (815)
                      +||||||+||++++++.+||+|||+++.+.....   .....+++.|+|||......  ++.++||||||+++||+++ |
T Consensus       134 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slG~il~el~~~g  211 (272)
T cd05075         134 IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV--YTTKSDVWSFGVTMWEIATRG  211 (272)
T ss_pred             eccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCC--cChHHHHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999987654321   12233567899999987665  7889999999999999999 8


Q ss_pred             CCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       735 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      +.||......    .+..    ........         ..+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       212 ~~p~~~~~~~----~~~~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         212 QTPYPGVENS----EIYD----YLRQGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCCCHH----HHHH----HHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            8898652221    1111    11111100         11223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.3e-37  Score=331.70  Aligned_cols=243  Identities=24%  Similarity=0.294  Sum_probs=191.9

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHH---hcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEY---LGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      |.+.+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+++   +++++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            55678999999999999985 568999999997532   1223456666655   4677899999999999999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      |||+++|+|..+++.                               ..+++.....++.|++.||+|||   +.+|+|||
T Consensus        81 ~E~~~~~~L~~~~~~-------------------------------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrd  126 (324)
T cd05589          81 MEYAAGGDLMMHIHT-------------------------------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRD  126 (324)
T ss_pred             EcCCCCCcHHHHhhc-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecC
Confidence            999999999888753                               24788899999999999999999   89999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      |||+||+++.++.+||+|||+++.... ........|++.|+|||.+.+..  ++.++|||||||++|||++|+.||...
T Consensus       127 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~G~~pf~~~  204 (324)
T cd05589         127 LKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS--YTRAVDWWGLGVLIYEMLVGESPFPGD  204 (324)
T ss_pred             CCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCC--CCcccchhhHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999875432 22234456999999999987665  688999999999999999999999753


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                      ...       ...........           ..+...+..+.+++.+||+.||++||     ++.++++
T Consensus       205 ~~~-------~~~~~i~~~~~-----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         205 DEE-------EVFDSIVNDEV-----------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CHH-------HHHHHHHhCCC-----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            221       11122211110           11333456788999999999999999     4555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.8e-37  Score=320.93  Aligned_cols=244  Identities=23%  Similarity=0.382  Sum_probs=193.9

Q ss_pred             eecccCCeeeEEEEc---CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          515 LLAEGKFGPVYRGFL---PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       515 ~ig~G~~g~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      .||+|+||.||+|.+   .++..||+|++.....  ...+++.+|+.++++++||||++++|++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999974   4578899999864332  23467889999999999999999999885 45678999999999


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      +|.+++..                              ...+++..+.+++.|++.||+|||   +++++||||||+||+
T Consensus        81 ~L~~~l~~------------------------------~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nil  127 (257)
T cd05116          81 PLNKFLQK------------------------------NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVL  127 (257)
T ss_pred             cHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEE
Confidence            99999964                              224678889999999999999999   899999999999999


Q ss_pred             EcCCCCeeecccccceecCCCCc----cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCc
Q 003504          670 LDMNLEPRLSDFGLAKIFGNGLD----EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE  744 (815)
Q Consensus       670 l~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~  744 (815)
                      ++.++.+||+|||+++.......    .....++..|+|||.+....  ++.++|||||||++||+++ |+.||......
T Consensus       128 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  205 (257)
T cd05116         128 LVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK--FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN  205 (257)
T ss_pred             EcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCC--cCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999987654322    12223457899999886554  6889999999999999998 99999753221


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                          .+.   .. .+...         ....+..++.++.+++.+||+.||++||++.+|.+.|+++
T Consensus       206 ----~~~---~~-i~~~~---------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         206 ----EVT---QM-IESGE---------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ----HHH---HH-HHCCC---------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                111   11 11111         1112334567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-37  Score=320.18  Aligned_cols=251  Identities=29%  Similarity=0.445  Sum_probs=205.0

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .++|++.+.||+|+||.||+|... |+.||||.+..... ..+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            346888899999999999999876 78899999976433 4667899999999999999999999999989999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.+++...                            ....++|..+..++.|++.||+|||   +.+++||||||+
T Consensus        83 ~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~  131 (256)
T cd05039          83 AKGSLVDYLRSR----------------------------GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAAR  131 (256)
T ss_pred             CCCcHHHHHHhc----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccc
Confidence            999999999752                            1235789999999999999999999   899999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~  745 (815)
                      ||+++.++.+||+|||.++.......  ...++..|+|||.+....  ++.++||||||+++||+++ |+.||...... 
T Consensus       132 Nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-  206 (256)
T cd05039         132 NVLVSEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-  206 (256)
T ss_pred             eEEEeCCCCEEEcccccccccccccc--cCCCcccccCchhhcCCc--CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            99999999999999999987643222  233567899999887655  6889999999999999998 99998643211 


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                         .+..    .....         .....+...+.++.+++.+||..+|++||++++++++|+.+
T Consensus       207 ---~~~~----~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         207 ---DVVP----HVEKG---------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ---HHHH----HHhcC---------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence               1111    11111         01111333467889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.7e-37  Score=321.21  Aligned_cols=254  Identities=26%  Similarity=0.432  Sum_probs=202.6

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC-CC---cEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP-GG---IHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      .++|+..+.||+|+||.||+|... ++   ..+|||.+.... ....+.+.+|++++.+++||||+++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346778899999999999999864 23   379999886542 2334678899999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ||||+++|+|.++++..                             ...+++..+..++.|++.|++|||   +.+++||
T Consensus        84 v~e~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~  131 (268)
T cd05063          84 ITEYMENGALDKYLRDH-----------------------------DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHR  131 (268)
T ss_pred             EEEcCCCCCHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence            99999999999999642                             235788999999999999999999   8899999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCcc----ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE----EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKK  736 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~  736 (815)
                      ||||+||+++.++.+||+|||++.........    .....+..|+|||++....  ++.++|||||||++||+++ |+.
T Consensus       132 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~il~ell~~g~~  209 (268)
T cd05063         132 DLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSFGER  209 (268)
T ss_pred             ccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCC--cChHhHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999876432211    1112345799999887655  6889999999999999998 999


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      ||.....       ..+..... ..         .....+..++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus       210 p~~~~~~-------~~~~~~i~-~~---------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         210 PYWDMSN-------HEVMKAIN-DG---------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCcCCH-------HHHHHHHh-cC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            9964322       11222211 11         11111334567889999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.8e-37  Score=329.56  Aligned_cols=243  Identities=20%  Similarity=0.245  Sum_probs=191.0

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|.. .+++.||+|++.....   .....+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999995 4678999999975322   2234577888888776 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|..++..                              ...+++.....++.|++.||+|||   +.+|+||||||+||
T Consensus        81 ~~L~~~~~~------------------------------~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Ni  127 (329)
T cd05618          81 GDLMFHMQR------------------------------QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNV  127 (329)
T ss_pred             CCHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHE
Confidence            999988854                              235778888999999999999999   88999999999999


Q ss_pred             EEcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc-c
Q 003504          669 YLDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE-K  746 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-~  746 (815)
                      +++.++.+||+|||+++.... ........||..|+|||++.+..  ++.++|||||||++|||++|+.||....... .
T Consensus       128 li~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~  205 (329)
T cd05618         128 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP  205 (329)
T ss_pred             EECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCC--CCCccceecccHHHHHHhhCCCCCccCCCcCCc
Confidence            999999999999999975422 22334456999999999998765  6889999999999999999999996422111 1


Q ss_pred             cccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          747 EGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      ......++.........          ..|...+.++.+++.+||+.||++||++
T Consensus       206 ~~~~~~~~~~~i~~~~~----------~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         206 DQNTEDYLFQVILEKQI----------RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ccccHHHHHHHHhcCCC----------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            12222333322222111          1133445678899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.6e-37  Score=329.79  Aligned_cols=248  Identities=20%  Similarity=0.237  Sum_probs=195.3

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|+. .++..||||+++....   .....+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4799999999999995 4688999999975322   2234577899999988 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|.+++..                              ...+++..+..++.|++.||+|||   +.+|+||||||+||
T Consensus        81 g~L~~~~~~------------------------------~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Ni  127 (329)
T cd05588          81 GDLMFHMQR------------------------------QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNV  127 (329)
T ss_pred             CCHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHe
Confidence            999988854                              235788899999999999999999   89999999999999


Q ss_pred             EEcCCCCeeecccccceecC-CCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc-c
Q 003504          669 YLDMNLEPRLSDFGLAKIFG-NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE-K  746 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-~  746 (815)
                      +++.++.+||+|||+++... .........||+.|+|||++.+..  ++.++|||||||++|||++|+.||......+ .
T Consensus       128 li~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~  205 (329)
T cd05588         128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP  205 (329)
T ss_pred             EECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCC--CCCccceechHHHHHHHHHCCCCcccccccccc
Confidence            99999999999999987532 222334457999999999998765  6889999999999999999999997422211 1


Q ss_pred             cccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC------HHHHHH
Q 003504          747 EGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS------MQQIVG  806 (815)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs------~~~v~~  806 (815)
                      ......+..........          ..|...+.++.+++.+|++.||.+||+      ++++++
T Consensus       206 ~~~~~~~~~~~~~~~~~----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         206 DQNTEDYLFQVILEKQI----------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             cccchHHHHHHHHcCCC----------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            11222333332222111          112334567889999999999999997      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=9.1e-37  Score=317.81  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=203.0

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||+|++|.||+|+. .++..||+|.+...  .......+.+|++++++++||||+++++++.+....++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            467788999999999999995 46889999998643  233456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++++|.++++..                            ....+++.....++.|++.||.|||   +.+++||||||
T Consensus        81 ~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~  129 (256)
T cd08529          81 AENGDLHKLLKMQ----------------------------RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKS  129 (256)
T ss_pred             CCCCcHHHHHHHh----------------------------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCc
Confidence            9999999999752                            1345788889999999999999999   78999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.+||+|||+++...... ......|++.|+|||+.....  ++.++|||||||++|||++|+.||......
T Consensus       130 ~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~  207 (256)
T cd08529         130 LNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP--YNEKSDVWALGVVLYECCTGKHPFDANNQG  207 (256)
T ss_pred             ceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999998765433 223346889999999987665  688999999999999999999999753311


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                          ..   ....... .         ....+...+.++.+++.+||+.+|++||+|.++++.
T Consensus       208 ----~~---~~~~~~~-~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         208 ----AL---ILKIIRG-V---------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ----HH---HHHHHcC-C---------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                11   1111111 0         111123456789999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=340.72  Aligned_cols=250  Identities=24%  Similarity=0.292  Sum_probs=201.0

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|.+.+.||+|+||.||+|... +++.||||++....   ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999954 78999999997532   133456889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++...                              ..+++.....++.|++.||+|||   +.+|+||||
T Consensus        81 e~~~~~~L~~~l~~~------------------------------~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dl  127 (350)
T cd05573          81 EYMPGGDLMNLLIRK------------------------------DVFPEETARFYIAELVLALDSVH---KLGFIHRDI  127 (350)
T ss_pred             cCCCCCCHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCC
Confidence            999999999999752                              34677888899999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC------------------------------ccccccccccccCCcccCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL------------------------------DEEIARGSPGYIPPEFAQPDSD  713 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~  713 (815)
                      ||+||+++.++.+||+|||+++......                              ......||+.|+|||++.+.. 
T Consensus       128 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-  206 (350)
T cd05573         128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-  206 (350)
T ss_pred             CHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-
Confidence            9999999999999999999998665332                              223346899999999998775 


Q ss_pred             CCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhcccc
Q 003504          714 FPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTAD  793 (815)
Q Consensus       714 ~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~  793 (815)
                       ++.++|||||||++|||++|+.||......+.       ........  .     .+........+.++.+++.+|+. 
T Consensus       207 -~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~--~-----~~~~p~~~~~~~~~~~li~~ll~-  270 (350)
T cd05573         207 -YGLECDWWSLGVILYEMLYGFPPFYSDTLQET-------YNKIINWK--E-----SLRFPPDPPVSPEAIDLICRLLC-  270 (350)
T ss_pred             -CCCceeeEecchhhhhhccCCCCCCCCCHHHH-------HHHHhccC--C-----cccCCCCCCCCHHHHHHHHHHcc-
Confidence             78999999999999999999999976432211       11111100  0     00000011145678899999997 


Q ss_pred             CCCCCCC-HHHHHHH
Q 003504          794 LPLKRPS-MQQIVGL  807 (815)
Q Consensus       794 dP~~RPs-~~~v~~~  807 (815)
                      ||.+||+ ++++++.
T Consensus       271 dp~~R~~s~~~ll~h  285 (350)
T cd05573         271 DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ChhhcCCCHHHHhcC
Confidence            9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.7e-37  Score=326.24  Aligned_cols=272  Identities=27%  Similarity=0.355  Sum_probs=207.8

Q ss_pred             HHhcCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeC
Q 003504          505 SATSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGST-LTDQEAARELEYLGRI-KHPNLVPLTGYCIAG  576 (815)
Q Consensus       505 ~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  576 (815)
                      ...++|+..+.||+|+||.||+|...      +...||+|.+..... .....+.+|++++.++ +||||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34457888899999999999999853      236799999875322 2335688999999999 799999999999999


Q ss_pred             CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 003504          577 DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSP  656 (815)
Q Consensus       577 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~  656 (815)
                      ...++||||+++|+|.++++.........              ...........+++..+++++.|++.||+|||   +.
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~--------------~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~  151 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYA--------------SPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SK  151 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCcccc--------------ccccccccccccCHHHHHHHHHHHHHHHHHHH---HC
Confidence            99999999999999999997542110000              00000122456899999999999999999999   88


Q ss_pred             CeeeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh
Q 003504          657 PIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       657 ~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                      +|+||||||+||+++.++.+||+|||+++.+.....   .....++..|+|||.+....  ++.++|||||||++||+++
T Consensus       152 ~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~  229 (293)
T cd05053         152 KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFT  229 (293)
T ss_pred             CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC--cCcccceeehhhHHHHHhc
Confidence            999999999999999999999999999987653321   12223567899999886655  6889999999999999998


Q ss_pred             -CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          734 -GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       734 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                       |..||......+.    .   . .....         .....+..++..+.+++.+||..+|++|||+.++++.|+++.
T Consensus       230 ~g~~p~~~~~~~~~----~---~-~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         230 LGGSPYPGIPVEEL----F---K-LLKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCCCCCCCCCHHHH----H---H-HHHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence             9999865322111    1   1 11111         111123345667899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.2e-37  Score=318.26  Aligned_cols=245  Identities=23%  Similarity=0.351  Sum_probs=193.9

Q ss_pred             eecccCCeeeEEEEcC---CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCC
Q 003504          515 LLAEGKFGPVYRGFLP---GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGN  590 (815)
Q Consensus       515 ~ig~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gs  590 (815)
                      .||+|+||.||+|.+.   ++..||+|++..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999753   456799999865432 22456899999999999999999999885 457889999999999


Q ss_pred             hhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEE
Q 003504          591 LQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL  670 (815)
Q Consensus       591 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  670 (815)
                      |.+++...                             ...+++..+.+++.|++.||+|||   +.+++||||||+||++
T Consensus        81 L~~~l~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~  128 (257)
T cd05115          81 LNKFLSGK-----------------------------KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLL  128 (257)
T ss_pred             HHHHHHhC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEE
Confidence            99998642                             235788999999999999999999   7899999999999999


Q ss_pred             cCCCCeeecccccceecCCCCc----cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCcc
Q 003504          671 DMNLEPRLSDFGLAKIFGNGLD----EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEE  745 (815)
Q Consensus       671 ~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~  745 (815)
                      +.++.+||+|||+++.......    .....++..|+|||.+....  ++.++|||||||++||+++ |+.||...... 
T Consensus       129 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-  205 (257)
T cd05115         129 VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-  205 (257)
T ss_pred             cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCC--CCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-
Confidence            9999999999999986543321    11122357899999887655  6889999999999999997 99999753221 


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                         .+..    .+...         .....+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       206 ---~~~~----~~~~~---------~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         206 ---EVMS----FIEQG---------KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ---HHHH----HHHCC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence               1111    11111         11122344567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.1e-36  Score=315.89  Aligned_cols=260  Identities=24%  Similarity=0.388  Sum_probs=209.2

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999965 78999999886422   223567889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++....                          .....+++..+..++.+++.||+|||   +.+++||||
T Consensus        82 e~~~~~~L~~~l~~~~--------------------------~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl  132 (267)
T cd08224          82 ELADAGDLSRMIKHFK--------------------------KQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDI  132 (267)
T ss_pred             ecCCCCCHHHHHHHhc--------------------------ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCc
Confidence            9999999999986421                          12345788899999999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      +|+||+++.++.++|+|||+++...... ......|+..|+|||.+.+..  ++.++|||||||++||+++|+.||....
T Consensus       133 ~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08224         133 KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             ChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCC--CCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence            9999999999999999999988654322 223345888999999987655  6889999999999999999999986422


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                           ....+....... .    .    .........+..+.+++.+||..+|++||++.+|+++|+++.
T Consensus       211 -----~~~~~~~~~~~~-~----~----~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         211 -----MNLYSLCKKIEK-C----D----YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----ccHHHHHhhhhc-C----C----CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 112222221111 1    0    111112245668899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-37  Score=335.58  Aligned_cols=263  Identities=21%  Similarity=0.284  Sum_probs=193.7

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC-----eeE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD-----QRI  580 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  580 (815)
                      +|++.+.||+|+||.||+|+. .++..||||++....  ......+.+|++++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477789999999999999994 578999999986432  223456889999999999999999999886532     479


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +||||+. ++|.+++..                              ...+++.....++.|++.||+|||   +.+|+|
T Consensus        81 lv~e~~~-~~L~~~l~~------------------------------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH  126 (338)
T cd07859          81 VVFELME-SDLHQVIKA------------------------------NDDLTPEHHQFFLYQLLRALKYIH---TANVFH  126 (338)
T ss_pred             EEEecCC-CCHHHHHHh------------------------------cccCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence            9999996 689888864                              234788899999999999999999   889999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCC----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      |||||+|||++.++.+||+|||+++......    ......|++.|+|||++.+....++.++|||||||++|||++|+.
T Consensus       127 ~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~  206 (338)
T cd07859         127 RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP  206 (338)
T ss_pred             CCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999998653221    113346899999999987643337889999999999999999999


Q ss_pred             CCCCCCCccccccHHH--------HHHHHHhcCCCCccc---cccccC---CCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 003504          737 PLGDDYPEEKEGNLVS--------WVRGLVRNNKGSRAI---DPKIRD---TGPEKQMEEALKIGYLCTADLPLKRPSMQ  802 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  802 (815)
                      ||...........+..        +... +......+.+   .+....   ......+.++.+++.+||+.||++||+++
T Consensus       207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  285 (338)
T cd07859         207 LFPGKNVVHQLDLITDLLGTPSPETISR-VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAE  285 (338)
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHH-hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHH
Confidence            9975322111000000        0000 0000000000   000000   00112345678999999999999999999


Q ss_pred             HHHH
Q 003504          803 QIVG  806 (815)
Q Consensus       803 ~v~~  806 (815)
                      ++++
T Consensus       286 e~l~  289 (338)
T cd07859         286 EALA  289 (338)
T ss_pred             HHhc
Confidence            9985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7e-37  Score=322.48  Aligned_cols=246  Identities=23%  Similarity=0.268  Sum_probs=194.2

Q ss_pred             ecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCCh
Q 003504          516 LAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNL  591 (815)
Q Consensus       516 ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL  591 (815)
                      ||+|+||.||++.. .+|+.||+|.+.....   .....+..|++++++++||||+++++++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999985 5689999999864221   2234556799999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEc
Q 003504          592 QNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD  671 (815)
Q Consensus       592 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  671 (815)
                      .+++...                            ....+++..+..++.|++.||+|||   +.+|+||||||+||+++
T Consensus        81 ~~~~~~~----------------------------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~  129 (277)
T cd05607          81 KYHIYNV----------------------------GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLD  129 (277)
T ss_pred             HHHHHhc----------------------------cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEc
Confidence            9888642                            1335788889999999999999999   89999999999999999


Q ss_pred             CCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHH
Q 003504          672 MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV  751 (815)
Q Consensus       672 ~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~  751 (815)
                      .++.+||+|||++.............|+..|+|||++.+..  ++.++|||||||++|||++|+.||........   ..
T Consensus       130 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---~~  204 (277)
T cd05607         130 DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP--YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---KE  204 (277)
T ss_pred             CCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---HH
Confidence            99999999999998776544444456899999999987766  78999999999999999999999975321111   11


Q ss_pred             HHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          752 SWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      .........         .... .....+.++.+++.+||+.||++||+++|+++.
T Consensus       205 ~~~~~~~~~---------~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         205 ELKRRTLED---------EVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             HHHHHhhcc---------cccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            111111111         0100 012345678999999999999999999776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.9e-37  Score=322.77  Aligned_cols=266  Identities=24%  Similarity=0.319  Sum_probs=205.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEc------CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      .+|+..+.||+|+||.||+|..      .++..+|+|.+..........+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            4577789999999999999973      2356899999876555556789999999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ||||+++|+|.++++.........        .       .........+++..++.++.|++.|++|||   +.+++||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~--------~-------~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~  146 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKIL--------A-------GGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHR  146 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhh--------c-------ccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence            999999999999997542110000        0       000112345789999999999999999999   8999999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p  737 (815)
                      ||||+||++++++.+||+|||+++.......   .....+++.|+|||.+.+..  ++.++|||||||++|||++ |+.|
T Consensus       147 dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p  224 (280)
T cd05092         147 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQP  224 (280)
T ss_pred             cccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999986543221   12223567899999887665  7899999999999999998 8999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD  810 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~  810 (815)
                      |......+    .   +.......          ....+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus       225 ~~~~~~~~----~---~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         225 WYQLSNTE----A---IECITQGR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             CccCCHHH----H---HHHHHcCc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            86432211    1   11111110          001123345678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-37  Score=318.89  Aligned_cols=254  Identities=28%  Similarity=0.426  Sum_probs=206.2

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .++|.+.+.||+|+||.||+|..++++.||||.+... ....+++.+|+.++++++||||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            4678889999999999999999888889999998753 345678999999999999999999999999888999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++++|.++++..                            ....+++..+..++.+++.|++|||   +.+++||||||+
T Consensus        84 ~~~~L~~~i~~~----------------------------~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~  132 (261)
T cd05034          84 SKGSLLDFLKSG----------------------------EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAAR  132 (261)
T ss_pred             CCCCHHHHHhcc----------------------------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchh
Confidence            999999999752                            1345789999999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCC
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP  743 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~  743 (815)
                      ||++++++.+||+|||.++.......  .....++..|+|||.+.+..  ++.++|||||||++||+++ |+.||.....
T Consensus       133 nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~il~~l~t~g~~p~~~~~~  210 (261)
T cd05034         133 NILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR--FTIKSDVWSFGILLTEIVTYGRVPYPGMTN  210 (261)
T ss_pred             eEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCC--cCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999987653221  11223456899999987655  6889999999999999999 9999864321


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      .       .........          .....+...+.++.+++.+|+..+|++||+++++.+.|+.+
T Consensus       211 ~-------~~~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         211 R-------EVLEQVERG----------YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             H-------HHHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence            1       111111111          01111223356789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.6e-37  Score=310.33  Aligned_cols=265  Identities=23%  Similarity=0.304  Sum_probs=203.3

Q ss_pred             CCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCC-ceeeeeEEEeCC------e
Q 003504          509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPN-LVPLTGYCIAGD------Q  578 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~  578 (815)
                      .|+..+.||+|+||+||+|+ ..+|+.||+|+++-...  .......+|+.++.+++|+| ||++++++...+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            45556789999999999999 56789999999976433  34556789999999999999 999999998877      6


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++||||++. +|..++...++.                          ...++-.....++.|+.+||+|||   +++|
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~--------------------------~~g~~~~~ik~~m~Qll~gl~~~H---~~~I  141 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKK--------------------------PQGLPPRLIKSFMRQLLRGLAFLH---SHGI  141 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhcccc--------------------------ccCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            7899999988 999999764311                          023444778899999999999999   8999


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecC-CCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFG-NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      +||||||.||||+++|.+||+|||+|+... +.......++|.+|+|||++.+... |+...||||+||++.||++++.-
T Consensus       142 lHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~-Ys~~vDiWs~GcIfaEm~~~~~L  220 (323)
T KOG0594|consen  142 LHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTS-YSTSVDIWSLGCIFAEMFTRRPL  220 (323)
T ss_pred             ecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCc-CCCCcchHhHHHHHHHHHhCCCC
Confidence            999999999999999999999999999776 3334566779999999999998865 78899999999999999999998


Q ss_pred             CCCCCCccccccHHHHHHHH--H-hcCCCCcccccccc----CCC-CH-------HHHHHHHHHHhhccccCCCCCCCHH
Q 003504          738 LGDDYPEEKEGNLVSWVRGL--V-RNNKGSRAIDPKIR----DTG-PE-------KQMEEALKIGYLCTADLPLKRPSMQ  802 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~----~~~-~~-------~~~~~~~~l~~~Cl~~dP~~RPs~~  802 (815)
                      |.+....   .++....+.+  . .+.|.....-|...    ... +.       .......+++.+|++.+|..|.|++
T Consensus       221 FpG~se~---~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~  297 (323)
T KOG0594|consen  221 FPGDSEI---DQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAK  297 (323)
T ss_pred             CCCCcHH---HHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHH
Confidence            8864431   1222221111  0 01111100001111    000 11       1124788999999999999999999


Q ss_pred             HHHHH
Q 003504          803 QIVGL  807 (815)
Q Consensus       803 ~v~~~  807 (815)
                      .++++
T Consensus       298 ~al~h  302 (323)
T KOG0594|consen  298 GALTH  302 (323)
T ss_pred             HHhcC
Confidence            99875

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-36  Score=316.17  Aligned_cols=245  Identities=25%  Similarity=0.370  Sum_probs=197.7

Q ss_pred             CeecccCCeeeEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCChh
Q 003504          514 TLLAEGKFGPVYRGFLPGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQ  592 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~  592 (815)
                      +.||+|+||.||+|...++..||+|.+..... .....+.+|++++++++||||+++++++......++||||+++|+|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46899999999999988899999999865432 22446889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcC
Q 003504          593 NLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM  672 (815)
Q Consensus       593 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~  672 (815)
                      +++...                             ...+++..+..++.|++.||.|+|   +.+++||||||+||+++.
T Consensus        81 ~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~  128 (250)
T cd05085          81 SFLRKK-----------------------------KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGE  128 (250)
T ss_pred             HHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcC
Confidence            998642                             234689999999999999999999   899999999999999999


Q ss_pred             CCCeeecccccceecCCCCcc--ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCcccccc
Q 003504          673 NLEPRLSDFGLAKIFGNGLDE--EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGN  749 (815)
Q Consensus       673 ~~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~  749 (815)
                      ++.+||+|||++.....+...  ....++..|+|||++.+..  ++.++|||||||++||+++ |..||.......    
T Consensus       129 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~----  202 (250)
T cd05085         129 NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMTNQQ----  202 (250)
T ss_pred             CCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCC--CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH----
Confidence            999999999999765433211  1223466799999987655  7889999999999999998 999986532211    


Q ss_pred             HHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          750 LVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                      ..    ......         .....+...+..+.+++.+||+.+|++||++.+++++|.
T Consensus       203 ~~----~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         203 AR----EQVEKG---------YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HH----HHHHcC---------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            11    111111         111123345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.2e-37  Score=327.82  Aligned_cols=269  Identities=25%  Similarity=0.362  Sum_probs=202.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCc--EEEEEEeecCC-cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGI--HVAVKVLVHGS-TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  582 (815)
                      ++|++.+.||+|+||.||+|... ++.  .+|+|.+.... ......+.+|++++.++ +||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46788899999999999999964 444  46777765432 23345788999999999 899999999999999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      +||+++|+|.++++......            .....  .........+++..++.++.|++.||+|||   +.+++|||
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~------------~~~~~--~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~d  149 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLE------------TDPAF--AIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRD  149 (303)
T ss_pred             EEeCCCCcHHHHHHhccccc------------ccccc--cccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence            99999999999997532110            00000  000112346889999999999999999999   89999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDD  741 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~  741 (815)
                      |||+|||++.++.+||+|||+++............++..|+|||++....  ++.++|||||||++||++| |..||...
T Consensus       150 lkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~  227 (303)
T cd05088         150 LAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGM  227 (303)
T ss_pred             cchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccC--CcccccchhhhhHHHHHHhcCCCCcccC
Confidence            99999999999999999999987433222222223466899999886655  6889999999999999998 99998643


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      ...+    ..   ... ..         ......+...+.++.+++.+||+.+|++||+++++++.|+++.
T Consensus       228 ~~~~----~~---~~~-~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         228 TCAE----LY---EKL-PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             ChHH----HH---HHH-hc---------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            2211    11   111 11         0111112234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.3e-37  Score=325.46  Aligned_cols=266  Identities=21%  Similarity=0.255  Sum_probs=202.9

Q ss_pred             CCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      +|.+.+.||+|+||.||+|...      ++..||||++...... ....+.+|+.++.+++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            3556789999999999999853      2578999998754322 23568899999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ++||+++++|.+++......... ..             ..........+++..+.+++.|++.||+|||   +.+|+||
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~-~~-------------~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~  148 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDV-GS-------------TDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHK  148 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccc-cc-------------cccccccccccCHHHHHHHHHHHHHHHHHHH---HcCcccc
Confidence            99999999999999643211000 00             0000112345788899999999999999999   8899999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p  737 (815)
                      ||||+||++++++.+||+|||+++.......   .....+++.|+|||.+....  ++.++|||||||++|||++ |..|
T Consensus       149 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p  226 (283)
T cd05091         149 DLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQP  226 (283)
T ss_pred             ccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC--CCcchhHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999886643221   12233577899999987655  6889999999999999998 8888


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD  810 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~  810 (815)
                      |.+...       ..+........ .         ...+..++..+.+++..||+.+|++||++++|+..|+.
T Consensus       227 ~~~~~~-------~~~~~~i~~~~-~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         227 YCGYSN-------QDVIEMIRNRQ-V---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCCCCH-------HHHHHHHHcCC-c---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            865322       11222222111 0         11234456778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.9e-37  Score=325.74  Aligned_cols=256  Identities=30%  Similarity=0.419  Sum_probs=203.3

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc------CCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCe
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGST-LTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQ  578 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  578 (815)
                      .++|.+.+.||+|+||.||+|..      .++..||||.++.... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            35688899999999999999973      2355799999875432 2345788999999999 79999999999999999


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++||||+++|+|.++++..                            ....+++..+..++.|++.||+|||   +.+|
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~----------------------------~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i  162 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRK----------------------------RESFLTLEDLLSFSYQVAKGMAFLA---SKNC  162 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            99999999999999999752                            1223789999999999999999999   8899


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-C
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-G  734 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g  734 (815)
                      +||||||+||+++.++.+|++|||+++.......   .....++..|+|||.+....  ++.++|||||||++||+++ |
T Consensus       163 vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~t~g  240 (302)
T cd05055         163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLG  240 (302)
T ss_pred             ehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC--CCcHhHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999986643321   11223567899999887665  6889999999999999998 9


Q ss_pred             CCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       735 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      +.||......+   ...    ......         .....+...+.++.+++.+||..+|++||++.++++.|+++
T Consensus       241 ~~p~~~~~~~~---~~~----~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         241 SNPYPGMPVDS---KFY----KLIKEG---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCcCCCCchH---HHH----HHHHcC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            99987532211   111    111111         11111223356789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.5e-37  Score=336.74  Aligned_cols=200  Identities=23%  Similarity=0.268  Sum_probs=171.6

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|+..+.||+|+||.||+|.. .+++.||||+++....   .....+.+|+.++.+++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4688899999999999999985 4688999999975322   22346788999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++..                              ...+++.....++.|++.||+|||   +.+||||||
T Consensus        81 E~~~gg~L~~~l~~------------------------------~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDl  127 (363)
T cd05628          81 EFLPGGDMMTLLMK------------------------------KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDI  127 (363)
T ss_pred             cCCCCCcHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCC
Confidence            99999999999964                              235778888999999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC------------------------------------ccccccccccccCCcc
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL------------------------------------DEEIARGSPGYIPPEF  707 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~------------------------------------~~~~~~gt~~y~aPE~  707 (815)
                      ||+|||++.++.+||+|||+++......                                    .....+||+.|+|||+
T Consensus       128 Kp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~  207 (363)
T cd05628         128 KPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEV  207 (363)
T ss_pred             CHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHH
Confidence            9999999999999999999987543210                                    0123469999999999


Q ss_pred             cCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          708 AQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       708 ~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      +.+..  ++.++|||||||++|||++|+.||....
T Consensus       208 ~~~~~--~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         208 FMQTG--YNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             HcCCC--CCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence            87665  7889999999999999999999997644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=342.34  Aligned_cols=257  Identities=22%  Similarity=0.252  Sum_probs=206.9

Q ss_pred             CCCCCCeecccCCeeeEEEEcCCC-cEEEEEEeecCCcccHHHHHHHHHHhcCCC-CCCceeeeeE-EEe------CCee
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLPGG-IHVAVKVLVHGSTLTDQEAARELEYLGRIK-HPNLVPLTGY-CIA------GDQR  579 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~------~~~~  579 (815)
                      ++++.+.|.+|||+.||.|+...+ .++|+|++...+....+.+.+|+++|+.|+ |||||.+++. ...      .-+.
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            345578999999999999997655 999999987766666778999999999997 9999999993 322      1367


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      +|.||||.+|+|-+++..+                            ....++..+.++|+.|+++|+++||. +.++||
T Consensus       118 llLmEyC~gg~Lvd~mn~R----------------------------lq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiI  168 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTR----------------------------LQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPII  168 (738)
T ss_pred             EeehhhccCCcHHHHHHHH----------------------------HhccCChHHHHHHHHHHHHHHHHHhc-CCCccc
Confidence            8999999999999999753                            12237888999999999999999994 478899


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCC----------ccccccccccccCCcccCCCCC-CCCCcCcchhHHHHH
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL----------DEEIARGSPGYIPPEFAQPDSD-FPTPKSDVYCYGVVL  728 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~-~~~~~~Dv~S~Gvvl  728 (815)
                      |||||-+||||+.+++.||||||.|...-...          ..-...-|+.|+|||.+--..+ ..++|+|||++||+|
T Consensus       169 HRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclL  248 (738)
T KOG1989|consen  169 HRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLL  248 (738)
T ss_pred             hhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHH
Confidence            99999999999999999999999886432211          0111226899999998653322 158999999999999


Q ss_pred             HHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          729 LELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       729 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                      |-|+....||.+...                    ..++...+.......++..+.+||..||+.+|++||++-||++.+
T Consensus       249 YkLCy~t~PFe~sg~--------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  249 YKLCYFTTPFEESGK--------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             HHHHHhCCCcCcCcc--------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence            999999999975221                    123334444443467899999999999999999999999999999


Q ss_pred             Hhhhhc
Q 003504          809 KDIEST  814 (815)
Q Consensus       809 ~~i~~~  814 (815)
                      .++...
T Consensus       309 ~~l~~~  314 (738)
T KOG1989|consen  309 FELANK  314 (738)
T ss_pred             HHHhcC
Confidence            988653

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3e-37  Score=349.02  Aligned_cols=254  Identities=22%  Similarity=0.293  Sum_probs=202.4

Q ss_pred             HhcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC-----
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD-----  577 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  577 (815)
                      ..++|.+.+.||+|+||.||+|. ..+|+.||||++....  ......+.+|+.++..++|+||+++.+.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            34689999999999999999998 4578999999986542  223456788999999999999999988775432     


Q ss_pred             ---eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCC
Q 003504          578 ---QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC  654 (815)
Q Consensus       578 ---~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~  654 (815)
                         ..++||||+++|+|.++++...                          .....+++.....++.|++.||+|||   
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~--------------------------~~~~~l~e~~~~~i~~qll~aL~~lH---  160 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRA--------------------------KTNRTFREHEAGLLFIQVLLAVHHVH---  160 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhh--------------------------ccCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence               3579999999999999997531                          12345778888999999999999999   


Q ss_pred             CCCeeeccCCCCceEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHH
Q 003504          655 SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL  731 (815)
Q Consensus       655 ~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el  731 (815)
                      +.+|+||||||+|||++.++.+||+|||+++.+....   ......||+.|+|||++.+..  ++.++|||||||++|||
T Consensus       161 ~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~k~DVwSlGvilyeL  238 (496)
T PTZ00283        161 SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP--YSKKADMFSLGVLLYEL  238 (496)
T ss_pred             hCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCC--CCcHHHHHHHHHHHHHH
Confidence            8999999999999999999999999999998765322   233456999999999998765  78999999999999999


Q ss_pred             HhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       732 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      ++|+.||.....       ...+.......     .+     ..+...+.++.+++.+||+.||++||++.++++.
T Consensus       239 ltG~~Pf~~~~~-------~~~~~~~~~~~-----~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        239 LTLKRPFDGENM-------EEVMHKTLAGR-----YD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHCCCCCCCCCH-------HHHHHHHhcCC-----CC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            999999975322       22222222111     00     1133456678999999999999999999999753

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.4e-37  Score=330.67  Aligned_cols=235  Identities=26%  Similarity=0.321  Sum_probs=188.8

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|+. .+++.||||++....   ......+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999995 468899999987532   22345667888888876 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|.+++..                              ...+++.....++.|++.||+|||   +.+|+||||||+||
T Consensus        81 g~L~~~i~~------------------------------~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NI  127 (320)
T cd05590          81 GDLMFHIQK------------------------------SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNV  127 (320)
T ss_pred             chHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHe
Confidence            999998864                              234677888899999999999999   89999999999999


Q ss_pred             EEcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |++.++.+||+|||+++.... +.......||+.|+|||++.+..  ++.++|||||||++|||++|+.||......   
T Consensus       128 li~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~Pf~~~~~~---  202 (320)
T cd05590         128 LLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML--YGPSVDWWAMGVLLYEMLCGHAPFEAENED---  202 (320)
T ss_pred             EECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCC--CCCccchhhhHHHHHHHhhCCCCCCCCCHH---
Confidence            999999999999999876432 22334456999999999987665  688999999999999999999999753321   


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                          ..........    .       ..+...+.++.+++.+|++.||++||++
T Consensus       203 ----~~~~~i~~~~----~-------~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         203 ----DLFEAILNDE----V-------VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             ----HHHHHHhcCC----C-------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence                1112222111    1       1122345678899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8.8e-37  Score=320.10  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=202.0

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC----CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      ++|.+.+.||+|+||.||+|+..    .+..+|+|.+..... ...+.+.+|+.++.+++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999853    234799998865332 2345789999999999999999999999999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      |||+++|+|.+++...                             ...+++..+..++.|++.||+|||   +.+++|||
T Consensus        84 ~e~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~d  131 (267)
T cd05066          84 TEYMENGSLDAFLRKH-----------------------------DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRD  131 (267)
T ss_pred             EEcCCCCCHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehh
Confidence            9999999999999752                             235788999999999999999999   89999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCCcc----ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDE----EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p  737 (815)
                      |||+||+++.++.+||+|||++.........    ....++..|+|||++.+..  ++.++||||||+++||+++ |+.|
T Consensus       132 lkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~l~ell~~g~~p  209 (267)
T cd05066         132 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERP  209 (267)
T ss_pred             hchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCc--cCchhhhHHHHHHHHHHhcCCCCC
Confidence            9999999999999999999999876543211    1122356799999987655  7889999999999999887 9999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      |......+    ...   ... ..  .       ....+...+..+.+++.+||+.+|++||+|.++++.|+++
T Consensus       210 ~~~~~~~~----~~~---~~~-~~--~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         210 YWEMSNQD----VIK---AIE-EG--Y-------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             cccCCHHH----HHH---HHh-CC--C-------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            87533221    111   111 11  0       0111233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5e-37  Score=330.71  Aligned_cols=240  Identities=26%  Similarity=0.323  Sum_probs=191.5

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|+. .+++.||||++....   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999995 457899999987532   22334567888888866 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|..++..                              ...+++.....++.|++.||+|||   +.+|+||||||+||
T Consensus        81 ~~L~~~l~~------------------------------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Ni  127 (321)
T cd05591          81 GDLMFQIQR------------------------------SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNI  127 (321)
T ss_pred             CcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHe
Confidence            999998864                              234678888999999999999999   88999999999999


Q ss_pred             EEcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      +++.++.+||+|||+++.... ........||+.|+|||++....  ++.++|||||||++|||++|+.||......+  
T Consensus       128 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--  203 (321)
T cd05591         128 LLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE--YGPSVDWWALGVLMYEMMAGQPPFEADNEDD--  203 (321)
T ss_pred             EECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCC--CCCccceechhHHHHHHhcCCCCCCCCCHHH--
Confidence            999999999999999976432 22233456899999999987665  7889999999999999999999997533211  


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-------CHHHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-------SMQQIVG  806 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-------s~~~v~~  806 (815)
                           .........    .       ..+...+.++.+++.+|++.||++||       +++++++
T Consensus       204 -----~~~~i~~~~----~-------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         204 -----LFESILHDD----V-------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -----HHHHHHcCC----C-------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                 112222111    0       01222456788999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.4e-36  Score=323.39  Aligned_cols=248  Identities=23%  Similarity=0.380  Sum_probs=202.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .+|+..+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4688889999999999999984 568899999987655555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.++++.                               ..+++..+..++.|++.||+|||   +.+|+||||||+
T Consensus       100 ~~~~L~~~~~~-------------------------------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~  145 (296)
T cd06654         100 AGGSLTDVVTE-------------------------------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSD  145 (296)
T ss_pred             CCCCHHHHHHh-------------------------------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHH
Confidence            99999999864                               13678888999999999999999   889999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||+++.++.+||+|||++....... ......|++.|+|||.+.+..  ++.++|||||||++|||++|+.||....+.+
T Consensus       146 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~  223 (296)
T cd06654         146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLR  223 (296)
T ss_pred             HEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999988654332 123346889999999987655  6889999999999999999999997533211


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                            .+. ......      .+  ....+...+..+.+++.+||..+|++||++.++++
T Consensus       224 ------~~~-~~~~~~------~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         224 ------ALY-LIATNG------TP--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ------hHH-HHhcCC------CC--CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                  111 111110      00  11123445567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.4e-37  Score=328.34  Aligned_cols=239  Identities=24%  Similarity=0.302  Sum_probs=188.1

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|.. .++..||||+++...   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999995 457889999987532   12234455677777654 899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|..++...                              ..++......++.|++.||+|||   +.+|+||||||+||
T Consensus        81 g~L~~~~~~~------------------------------~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Ni  127 (316)
T cd05592          81 GDLMFHIQSS------------------------------GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNV  127 (316)
T ss_pred             CcHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHe
Confidence            9999988642                              24677778889999999999999   89999999999999


Q ss_pred             EEcCCCCeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      +++.++.+||+|||+++..... .......||+.|+|||.+.+..  ++.++|||||||++|||++|+.||.+....   
T Consensus       128 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~Pf~~~~~~---  202 (316)
T cd05592         128 LLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK--YNESVDWWSFGVLLYEMLIGQSPFHGEDED---  202 (316)
T ss_pred             EECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCHH---
Confidence            9999999999999999865322 2334456999999999987765  689999999999999999999999753321   


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ-QIV  805 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~-~v~  805 (815)
                          .........       .+    ..+...+.++.+++.+||+.||++||++. +++
T Consensus       203 ----~~~~~i~~~-------~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         203 ----ELFDSILND-------RP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ----HHHHHHHcC-------CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                111111111       01    11233456788999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.4e-37  Score=330.89  Aligned_cols=240  Identities=25%  Similarity=0.298  Sum_probs=191.5

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCC-CceeeeeEEEeCCeeEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHP-NLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~  583 (815)
                      +|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999954 57889999987532   22345677899999999764 6888999998889999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++..                              ...+++.....++.|++.||+|||   +.+|+||||
T Consensus        81 E~~~~g~L~~~~~~------------------------------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dl  127 (324)
T cd05587          81 EYVNGGDLMYHIQQ------------------------------VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDL  127 (324)
T ss_pred             cCCCCCcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCC
Confidence            99999999999864                              224677888999999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      ||+|||++.++.+||+|||+++.... ........||+.|+|||++.+..  ++.++|||||||++|||++|+.||....
T Consensus       128 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~~  205 (324)
T cd05587         128 KLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGED  205 (324)
T ss_pred             CHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999875432 22333456999999999998766  6889999999999999999999997533


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      ..+.       ........           ...+...+.++.+++.+|+..||++||+.
T Consensus       206 ~~~~-------~~~i~~~~-----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         206 EDEL-------FQSIMEHN-----------VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             HHHH-------HHHHHcCC-----------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            2111       11111110           11123345678899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-37  Score=326.55  Aligned_cols=250  Identities=23%  Similarity=0.319  Sum_probs=211.9

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCccc--HHHHHHHHHHhcCCCCCCceeeeeEEEeCCe-eEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLT--DQEAARELEYLGRIKHPNLVPLTGYCIAGDQ-RIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~  583 (815)
                      ++|...+++|+|+||.++.++. .+++.+|+|.+.-.....  .+...+|+.++++++|||||.+.+.+..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5688899999999999999885 457789999987654333  3467899999999999999999999999887 89999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      +|++||++.+.+.+.+                            +..++.+...+++.|++.|+.|||   +..|+||||
T Consensus        84 ~Y~eGg~l~~~i~~~k----------------------------~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDl  132 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK----------------------------GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDL  132 (426)
T ss_pred             eecCCCCHHHHHHHHh----------------------------hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccc
Confidence            9999999999997632                            456777888999999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      |+.||+++.+..+||+|||+|+.+.+.. ......||+.||.||++.+..  |..|+||||+||++|||++-+++|...+
T Consensus       133 K~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~p--Yn~KSDiWsLGC~~yEm~~lk~aF~a~~  210 (426)
T KOG0589|consen  133 KCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIP--YNEKSDIWSLGCCLYEMCTLKPAFKASN  210 (426)
T ss_pred             hhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCC--CCccCcchhhcchHHHHHhcccccCccc
Confidence            9999999999999999999999998765 556678999999999999888  8999999999999999999999997533


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      .       ...+.+..+.          ....-|..+..++..++..|++.+|+.||++.+++.+
T Consensus       211 m-------~~Li~ki~~~----------~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  211 M-------SELILKINRG----------LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             h-------HHHHHHHhhc----------cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            2       2222222221          1122356677889999999999999999999999876

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=339.89  Aligned_cols=249  Identities=23%  Similarity=0.270  Sum_probs=196.1

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||.||+|+. .+++.||||++....   ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            3688899999999999999995 468899999997532   122345778999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++..                              ...+++.....++.|++.||+|||   +.+|+||||
T Consensus        81 E~~~~g~L~~~l~~------------------------------~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dl  127 (364)
T cd05599          81 EYLPGGDMMTLLMK------------------------------KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDI  127 (364)
T ss_pred             CCCCCcHHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccC
Confidence            99999999999964                              224678888899999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC---------------------------------------ccccccccccccC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL---------------------------------------DEEIARGSPGYIP  704 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~---------------------------------------~~~~~~gt~~y~a  704 (815)
                      ||+|||++.++.+||+|||+++.+....                                       .....+||+.|+|
T Consensus       128 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  207 (364)
T cd05599         128 KPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIA  207 (364)
T ss_pred             CHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccC
Confidence            9999999999999999999987643211                                       0012358999999


Q ss_pred             CcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHH
Q 003504          705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEAL  784 (815)
Q Consensus       705 PE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  784 (815)
                      ||++....  ++.++|||||||++|||++|+.||....+.+.       .........       .+........+.++.
T Consensus       208 PE~~~~~~--~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~-------~~~i~~~~~-------~~~~~~~~~~s~~~~  271 (364)
T cd05599         208 PEVFLQTG--YNKECDWWSLGVIMYEMLVGYPPFCSDNPQET-------YRKIINWKE-------TLQFPDEVPLSPEAK  271 (364)
T ss_pred             HHHHcCCC--CCCeeeeecchhHHHHhhcCCCCCCCCCHHHH-------HHHHHcCCC-------ccCCCCCCCCCHHHH
Confidence            99987665  78999999999999999999999976433221       111111110       000000112345678


Q ss_pred             HHHhhccccCCCCCCC---HHHHHH
Q 003504          785 KIGYLCTADLPLKRPS---MQQIVG  806 (815)
Q Consensus       785 ~l~~~Cl~~dP~~RPs---~~~v~~  806 (815)
                      +++.+|+. +|.+|++   ++++++
T Consensus       272 ~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         272 DLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            88889996 9999998   888865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.6e-37  Score=322.88  Aligned_cols=258  Identities=24%  Similarity=0.322  Sum_probs=201.9

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCee
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  579 (815)
                      +++|.+.+.||+|+||.||+|...      .+..||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            467888999999999999999964      356799998864332 2345789999999999999999999999998899


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++||||+++|+|.++++......                       .....++|..+.+++.|++.||+|||   +.+++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~-----------------------~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~iv  138 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRP-----------------------ERPSSLTMKDLLFCARDVAKGCKYLE---ENHFI  138 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCC-----------------------CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEe
Confidence            99999999999999997642110                       11235889999999999999999999   78999


Q ss_pred             eccCCCCceEEcCCC---CeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh
Q 003504          660 HRDIKASSVYLDMNL---EPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       660 HrDlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                      ||||||+||+++.++   .+||+|||+++.......   ......+..|+|||++.+..  ++.++|||||||++|||++
T Consensus       139 H~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~  216 (277)
T cd05036         139 HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI--FTSKTDVWSFGVLLWEIFS  216 (277)
T ss_pred             ecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC--cCchhHHHHHHHHHHHHHc
Confidence            999999999998654   599999999987643221   11122356799999987665  7899999999999999997


Q ss_pred             -CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          734 -GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       734 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                       |+.||.....++    +.   .......          ....+...+.++.+++.+||+.+|++||++.+|++.|.
T Consensus       217 ~g~~pf~~~~~~~----~~---~~~~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         217 LGYMPYPGRTNQE----VM---EFVTGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCCCCCCCCCHHH----HH---HHHHcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             999987533221    11   1111111          01113344567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.9e-37  Score=322.68  Aligned_cols=255  Identities=22%  Similarity=0.343  Sum_probs=201.6

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCc----EEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGI----HVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRI  580 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  580 (815)
                      .++|+..+.||+|+||.||+|.+ .++.    .||+|.+..... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            35688889999999999999984 3444    489999865332 335678899999999999999999999975 4567


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +++||+++|+|.++++..                             ...+++..++.++.|++.||+|||   +.+|+|
T Consensus        85 l~~~~~~~g~l~~~l~~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH  132 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN-----------------------------KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVH  132 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence            899999999999999752                             235788899999999999999999   899999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKK  736 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~  736 (815)
                      |||||+||+++.++.+||+|||+++.......   .....++..|+|||...+..  ++.++|||||||++||+++ |..
T Consensus       133 ~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~el~t~g~~  210 (279)
T cd05109         133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR--FTHQSDVWSYGVTVWELMTFGAK  210 (279)
T ss_pred             cccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCC--CCchhHHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999999987653322   11223467899999987665  7889999999999999998 899


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      ||.....    ..+..++.    ...         ....+..++.++.+++.+||..||++||++.++++.|+++..
T Consensus       211 p~~~~~~----~~~~~~~~----~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         211 PYDGIPA----REIPDLLE----KGE---------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             CCCCCCH----HHHHHHHH----CCC---------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            9864321    11222211    110         001123345678899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-36  Score=333.99  Aligned_cols=257  Identities=21%  Similarity=0.193  Sum_probs=194.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .+|++.+.||+|+||.||+|.. .+++.||+|...      ...+.+|++++++++||||+++++++......++|+||+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            5799999999999999999994 568899999653      235789999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      . ++|..++..                              ...+++...+.++.|++.||+|||   +.+||||||||+
T Consensus       166 ~-~~L~~~l~~------------------------------~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~  211 (391)
T PHA03212        166 K-TDLYCYLAA------------------------------KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAE  211 (391)
T ss_pred             C-CCHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChH
Confidence            6 688888854                              234678889999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCC--CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNG--LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      |||++.++.+||+|||+|+.....  .......||+.|+|||++.+..  ++.++|||||||++|||++|+.||......
T Consensus       212 NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~p~~~~~~~  289 (391)
T PHA03212        212 NIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDP--YGPAVDIWSAGIVLFEMATCHDSLFEKDGL  289 (391)
T ss_pred             hEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCC--CCcHHHHHHHHHHHHHHHHCCCCcCCcccc
Confidence            999999999999999999754321  1223456999999999987765  789999999999999999999887643211


Q ss_pred             cccccHHHHHHHHHhcCC----------------------CCccccccccCC--CCHHHHHHHHHHHhhccccCCCCCCC
Q 003504          745 EKEGNLVSWVRGLVRNNK----------------------GSRAIDPKIRDT--GPEKQMEEALKIGYLCTADLPLKRPS  800 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~dP~~RPs  800 (815)
                      .........+........                      ......+..+..  .....+.++.+++.+|++.||++|||
T Consensus       290 ~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt  369 (391)
T PHA03212        290 DGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS  369 (391)
T ss_pred             cccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC
Confidence            111000000000000000                      000000000000  01134567899999999999999999


Q ss_pred             HHHHHH
Q 003504          801 MQQIVG  806 (815)
Q Consensus       801 ~~~v~~  806 (815)
                      ++|+++
T Consensus       370 a~elL~  375 (391)
T PHA03212        370 AEALLD  375 (391)
T ss_pred             HHHHhc
Confidence            999985

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=323.88  Aligned_cols=270  Identities=23%  Similarity=0.322  Sum_probs=201.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCC---------------CcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeee
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG---------------GIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTG  571 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g  571 (815)
                      ++|.+.+.||+|+||.||+|+..+               ...||||.++.... .....+.+|++++.+++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578889999999999999987532               23589999875422 23457899999999999999999999


Q ss_pred             EEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHh
Q 003504          572 YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH  651 (815)
Q Consensus       572 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH  651 (815)
                      ++......++||||+++++|.+++........                  .........++|..+++++.|++.||+|||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~------------------~~~~~~~~~~~~~~~~~i~~~i~~al~~lH  146 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIEST------------------FTHANNIPSVSIANLLYMAVQIASGMKYLA  146 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhcccccc------------------ccccccCCcccHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999965310000                  000011234688999999999999999999


Q ss_pred             cCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHH
Q 003504          652 HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVL  728 (815)
Q Consensus       652 ~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl  728 (815)
                         +.+++||||||+||++++++.+||+|||++........   .....++..|+|||......  ++.++|||||||++
T Consensus       147 ---~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~~l  221 (295)
T cd05097         147 ---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTL  221 (295)
T ss_pred             ---hcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC--cCchhhHHHHHHHH
Confidence               88999999999999999999999999999986543221   11223567899999887655  78999999999999


Q ss_pred             HHHHh--CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          729 LELIT--GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       729 ~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      |||++  |..||......+    ............. ...     ....+...+..+.+++.+||+.+|++||+|.+|++
T Consensus       222 ~el~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         222 WEMFTLCKEQPYSLLSDEQ----VIENTGEFFRNQG-RQI-----YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHcCCCCCCcccChHH----HHHHHHHhhhhcc-ccc-----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99998  566776432211    1211111111110 000     01112234568999999999999999999999999


Q ss_pred             HHHh
Q 003504          807 LLKD  810 (815)
Q Consensus       807 ~L~~  810 (815)
                      .|++
T Consensus       292 ~l~~  295 (295)
T cd05097         292 FLRE  295 (295)
T ss_pred             HHhC
Confidence            8863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-36  Score=324.92  Aligned_cols=271  Identities=27%  Similarity=0.358  Sum_probs=207.5

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc--------CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeC
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL--------PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAG  576 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~--------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  576 (815)
                      .++|.+.+.||+|+||.||+|+.        .++..||+|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            45688889999999999999973        134579999886532 23346788999999999 899999999999999


Q ss_pred             CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 003504          577 DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSP  656 (815)
Q Consensus       577 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~  656 (815)
                      ...++||||+++|+|.+++........   .+..+         +.  ......++|..+..++.|++.||+|||   +.
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~---~~~~~---------~~--~~~~~~~~~~~~~~~~~qi~~al~~LH---~~  156 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGM---EYSYD---------IA--RVPDEQMTFKDLVSCTYQVARGMEYLA---SQ  156 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCccc---ccccc---------cc--cCCcccccHHHHHHHHHHHHHHHHHHH---HC
Confidence            999999999999999999976421100   00000         00  012346889999999999999999999   88


Q ss_pred             CeeeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh
Q 003504          657 PIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       657 ~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                      +++||||||+||+++.++.+||+|||+++.......   .....++..|+|||.+.+..  ++.++||||||+++||+++
T Consensus       157 givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~  234 (304)
T cd05101         157 KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFT  234 (304)
T ss_pred             CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC--CCchhhHHHHHHHHHHHHc
Confidence            999999999999999999999999999987653221   12233567899999887655  7889999999999999998


Q ss_pred             -CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          734 -GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       734 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                       |..||....       ...+.... ....         ....+..++.++.+++.+||+.+|++||+|.++++.|+++.
T Consensus       235 ~g~~p~~~~~-------~~~~~~~~-~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         235 LGGSPYPGIP-------VEELFKLL-KEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             CCCCCcccCC-------HHHHHHHH-HcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence             788886422       12222222 1111         11113345678899999999999999999999999999885


Q ss_pred             h
Q 003504          813 S  813 (815)
Q Consensus       813 ~  813 (815)
                      .
T Consensus       298 ~  298 (304)
T cd05101         298 T  298 (304)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-37  Score=333.99  Aligned_cols=237  Identities=24%  Similarity=0.292  Sum_probs=191.7

Q ss_pred             CeecccCCeeeEEEEc----CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          514 TLLAEGKFGPVYRGFL----PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~----~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      +.||+|+||.||++..    .+|+.||+|++.....  .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    4678999999975322  223456789999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.+++..                              ...+++.....++.|++.||+|||   +.+|+||||||+|
T Consensus        82 ~~~L~~~l~~------------------------------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~N  128 (318)
T cd05582          82 GGDLFTRLSK------------------------------EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPEN  128 (318)
T ss_pred             CCcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHH
Confidence            9999999864                              235788889999999999999999   8999999999999


Q ss_pred             eEEcCCCCeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEK  746 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~  746 (815)
                      |+++.++.+||+|||+++..... .......|++.|+|||.+....  ++.++|||||||++|||++|+.||......  
T Consensus       129 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~--  204 (318)
T cd05582         129 ILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG--HTQSADWWSFGVLMFEMLTGSLPFQGKDRK--  204 (318)
T ss_pred             eEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCC--CCCccceeccceEeeeeccCCCCCCCCCHH--
Confidence            99999999999999999865433 2233456899999999987655  688999999999999999999999753221  


Q ss_pred             cccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 003504          747 EGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ  803 (815)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~  803 (815)
                           ..........           ...+...+..+.+++.+||+.||++||++.+
T Consensus       205 -----~~~~~i~~~~-----------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         205 -----ETMTMILKAK-----------LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -----HHHHHHHcCC-----------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                 1111111111           0113334567889999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.4e-37  Score=320.84  Aligned_cols=240  Identities=23%  Similarity=0.342  Sum_probs=187.2

Q ss_pred             eecccCCeeeEEEEcCC-------------------------CcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceee
Q 003504          515 LLAEGKFGPVYRGFLPG-------------------------GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPL  569 (815)
Q Consensus       515 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l  569 (815)
                      .||+|+||.||+|.+..                         ...||+|++..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         24589998865433344578889999999999999999


Q ss_pred             eeEEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHH
Q 003504          570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAF  649 (815)
Q Consensus       570 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~y  649 (815)
                      +|+|......++||||+++|+|..++...                             ...+++..+..++.|+++||+|
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~  132 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-----------------------------KGRVPVAWKITVAQQLASALSY  132 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999998642                             2356788899999999999999


Q ss_pred             HhcCCCCCeeeccCCCCceEEcCCC-------CeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcch
Q 003504          650 LHHGCSPPIIHRDIKASSVYLDMNL-------EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVY  722 (815)
Q Consensus       650 LH~~~~~~ivHrDlk~~NIll~~~~-------~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~  722 (815)
                      ||   +.+|+||||||+||+++.++       .+|++|||.+......   ....++..|+|||.+.... .++.++|||
T Consensus       133 lH---~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~-~~~~~~Dv~  205 (274)
T cd05076         133 LE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGN-SLSTAADKW  205 (274)
T ss_pred             HH---cCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCC-CCCcHHHHH
Confidence            99   88999999999999998654       3799999988654322   2234778899999886542 268899999


Q ss_pred             hHHHHHHHHH-hCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          723 CYGVVLLELI-TGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       723 S~Gvvl~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      ||||++||++ +|+.||....+.+.    ..+    .....       ..    +......+.+++.+||+.+|++||+|
T Consensus       206 slG~~l~el~~~g~~p~~~~~~~~~----~~~----~~~~~-------~~----~~~~~~~~~~li~~cl~~~p~~Rps~  266 (274)
T cd05076         206 SFGTTLLEICFDGEVPLKERTPSEK----ERF----YEKKH-------RL----PEPSCKELATLISQCLTYEPTQRPSF  266 (274)
T ss_pred             HHHHHHHHHHhCCCCCccccChHHH----HHH----HHhcc-------CC----CCCCChHHHHHHHHHcccChhhCcCH
Confidence            9999999995 69999875432211    111    11100       00    11123468899999999999999999


Q ss_pred             HHHHHHHH
Q 003504          802 QQIVGLLK  809 (815)
Q Consensus       802 ~~v~~~L~  809 (815)
                      .+|++.|.
T Consensus       267 ~~il~~L~  274 (274)
T cd05076         267 RTILRDLT  274 (274)
T ss_pred             HHHHHhhC
Confidence            99998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-36  Score=321.00  Aligned_cols=246  Identities=23%  Similarity=0.254  Sum_probs=193.8

Q ss_pred             ecccCCeeeEEEEc-CCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCCh
Q 003504          516 LAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL---TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNL  591 (815)
Q Consensus       516 ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL  591 (815)
                      ||+|+||+||+|.. .+++.||||.+......   ..+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999985 46889999998653222   224567899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEc
Q 003504          592 QNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD  671 (815)
Q Consensus       592 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  671 (815)
                      ..++....                          .....+++..+..++.|++.||+|||   +.+|+||||||+||+++
T Consensus        81 ~~~~~~~~--------------------------~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~  131 (280)
T cd05608          81 RYHIYNVD--------------------------EENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLD  131 (280)
T ss_pred             HHHHHhcc--------------------------ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEC
Confidence            98885421                          12345788999999999999999999   88999999999999999


Q ss_pred             CCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccH
Q 003504          672 MNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL  750 (815)
Q Consensus       672 ~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~  750 (815)
                      .++.+||+|||++.....+. ......|++.|+|||.+.+..  ++.++|||||||++|||++|+.||.........   
T Consensus       132 ~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---  206 (280)
T cd05608         132 NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE--YDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---  206 (280)
T ss_pred             CCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---
Confidence            99999999999998765432 223446899999999998765  688999999999999999999999753221111   


Q ss_pred             HHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                      ........         ...  ...+...+.++.+++.+||+.||++||     +++++++
T Consensus       207 ~~~~~~~~---------~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         207 KELKQRIL---------NDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHHhhc---------ccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            11111111         010  112334567789999999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.2e-37  Score=329.34  Aligned_cols=240  Identities=25%  Similarity=0.313  Sum_probs=192.1

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc---ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST---LTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      +|.+.+.||+|+||.||+|+.. ++..||||++.....   .....+..|..++..+ +||+|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999854 578999999875422   2233466788888777 5899999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++...                              ..+++..+..++.|++.||+|||   +.+|+||||
T Consensus        81 E~~~~g~L~~~~~~~------------------------------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDl  127 (323)
T cd05616          81 EYVNGGDLMYQIQQV------------------------------GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDL  127 (323)
T ss_pred             cCCCCCCHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCC
Confidence            999999999988642                              24677888999999999999999   889999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      ||+|||++.++.+||+|||+++.... +.......||+.|+|||++....  ++.++|||||||++|||++|+.||....
T Consensus       128 kp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~  205 (323)
T cd05616         128 KLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGED  205 (323)
T ss_pred             CHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCC--CCCccchhchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999986432 22334456999999999998765  7899999999999999999999997533


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      ..+       .........           ...+...+.++.+++.+|++.||++|++.
T Consensus       206 ~~~-------~~~~i~~~~-----------~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         206 EDE-------LFQSIMEHN-----------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHH-------HHHHHHhCC-----------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            211       111111111           11133455678899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=319.54  Aligned_cols=263  Identities=25%  Similarity=0.365  Sum_probs=198.0

Q ss_pred             CeecccCCeeeEEEEcCC-Cc--EEEEEEeecCC-cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFLPG-GI--HVAVKVLVHGS-TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|+..+ +.  .+|+|.+.... ....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999643 43  47888886432 23346788999999999 799999999999998899999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|.++++.......            ..  ...........+++..+..++.|++.||+|||   +.+++||||||+||
T Consensus        81 ~~L~~~i~~~~~~~~------------~~--~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~ni  143 (270)
T cd05047          81 GNLLDFLRKSRVLET------------DP--AFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNI  143 (270)
T ss_pred             CcHHHHHHhcccccc------------cc--ccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceE
Confidence            999999975321100            00  00000112345789999999999999999999   78999999999999


Q ss_pred             EEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~  747 (815)
                      ++++++.+||+|||++..............+..|+|||++....  ++.++|||||||++|||++ |..||......   
T Consensus       144 li~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~el~~~g~~pf~~~~~~---  218 (270)
T cd05047         144 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---  218 (270)
T ss_pred             EEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCC--CCchhhHHHHHHHHHHHHcCCCCCccccCHH---
Confidence            99999999999999986433221122223456799999886655  6889999999999999997 99998643211   


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                          .........          .....+...+.++.+++.+||+.+|.+||++.++++.|+++-
T Consensus       219 ----~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         219 ----ELYEKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ----HHHHHHhCC----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                111111111          111122334567899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.6e-37  Score=326.98  Aligned_cols=271  Identities=25%  Similarity=0.304  Sum_probs=206.5

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC--------CCcEEEEEEeecCC-cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP--------GGIHVAVKVLVHGS-TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGD  577 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  577 (815)
                      ++|.+.+.||+|+||.||+|...        ++..||+|.+.... ......+.+|++++.++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            56888999999999999999742        23579999987532 23345688899999999 7999999999999999


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++||||+++|+|.+++.......  ...+...            .......++|..+++++.|++.||+|||   +.+
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~--~~~~~~~------------~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~g  160 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPG--MEYCYNP------------TQVPEEQLSFKDLVSCAYQVARGMEYLA---SKK  160 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcc--ccccccc------------ccCccccCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            9999999999999999997642110  0000000            0012345889999999999999999999   889


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-  733 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-  733 (815)
                      ++||||||+||+++.++.+||+|||.++.......   .....++..|+|||.+.+..  ++.++|||||||++|||++ 
T Consensus       161 i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~~  238 (307)
T cd05098         161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTL  238 (307)
T ss_pred             cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC--CCcHHHHHHHHHHHHHHHcC
Confidence            99999999999999999999999999986543221   11122456899999887655  6889999999999999998 


Q ss_pred             CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      |+.||.....       ...... .....         ....+...+.++.+++.+||..+|++||+|.+|++.|+++.+
T Consensus       239 g~~p~~~~~~-------~~~~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         239 GGSPYPGVPV-------EELFKL-LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             CCCCCCcCCH-------HHHHHH-HHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            8888864221       111111 11111         112233456788999999999999999999999999999865


Q ss_pred             c
Q 003504          814 T  814 (815)
Q Consensus       814 ~  814 (815)
                      .
T Consensus       302 ~  302 (307)
T cd05098         302 L  302 (307)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.5e-36  Score=316.29  Aligned_cols=249  Identities=24%  Similarity=0.336  Sum_probs=200.1

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEe-CCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA-GDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~ey~  586 (815)
                      .+|++.+.||+|+||.||+|... |..||+|.++..  ...+.+.+|+.++++++|+|++++++++.. .+..++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999875 778999988643  235678999999999999999999998654 45789999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.++++..                            ....+++..+.+++.|++.||+|||   +.+++||||||+
T Consensus        83 ~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~  131 (256)
T cd05082          83 AKGSLVDYLRSR----------------------------GRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAAR  131 (256)
T ss_pred             CCCcHHHHHHhc----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchh
Confidence            999999999752                            1234788999999999999999999   889999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~  745 (815)
                      ||++++++.+||+|||+++......  ....++..|+|||++....  ++.++|||||||++|||++ |+.||.....  
T Consensus       132 nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--  205 (256)
T cd05082         132 NVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPL--  205 (256)
T ss_pred             eEEEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999998654322  2233567899999987655  7889999999999999998 9999864221  


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                           ....... ...         .....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       206 -----~~~~~~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         206 -----KDVVPRV-EKG---------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -----HHHHHHH-hcC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                 1111111 111         01112334567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.5e-37  Score=336.92  Aligned_cols=253  Identities=21%  Similarity=0.264  Sum_probs=199.4

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      ..++|++.+.||+|+||.||+|+. .++..||+|++....   ......+.+|+.+++.++||||+++++++.+....++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            356788999999999999999995 468899999986421   1233457789999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ||||+++|+|.++++..                               .++......++.|++.||+|||   +.+|+||
T Consensus       121 v~Ey~~gg~L~~~l~~~-------------------------------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHr  166 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY-------------------------------DIPEKWARFYTAEVVLALDAIH---SMGFIHR  166 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-------------------------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence            99999999999998642                               2455667788999999999999   8999999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCC--CCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDS--DFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      ||||+|||++.++.+||+|||+++......  ......||+.|+|||++....  ..++.++|||||||++|||++|+.|
T Consensus       167 DLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P  246 (370)
T cd05596         167 DVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  246 (370)
T ss_pred             CCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCC
Confidence            999999999999999999999998765332  223456999999999986542  2368899999999999999999999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHH
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK--RPSMQQIVG  806 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~~v~~  806 (815)
                      |......       ...........       .+........+.++.+++.+|+..+|++  ||+++++++
T Consensus       247 f~~~~~~-------~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         247 FYADSLV-------GTYSKIMDHKN-------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             cCCCCHH-------HHHHHHHcCCC-------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            9753321       11122221110       0110111134567889999999999988  999999965

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.3e-37  Score=328.83  Aligned_cols=240  Identities=27%  Similarity=0.329  Sum_probs=192.7

Q ss_pred             CeecccCCeeeEEEEcC-CCcEEEEEEeecCC---cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS---TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|... ++..||||+++...   ......+.+|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 57899999997532   22334567888888887 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|..++..                              ...+++.....++.|++.||+|||   +.+|+||||||+||
T Consensus        81 ~~L~~~~~~------------------------------~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Ni  127 (318)
T cd05570          81 GDLMFHIQR------------------------------SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNV  127 (318)
T ss_pred             CCHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHe
Confidence            999988864                              235788899999999999999999   89999999999999


Q ss_pred             EEcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      +++.++.+||+|||+++.... ........|++.|+|||++.+..  ++.++|||||||++|||++|+.||......   
T Consensus       128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslGvil~~l~~G~~pf~~~~~~---  202 (318)
T cd05570         128 LLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDDED---  202 (318)
T ss_pred             EECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCC--CCcchhhhhHHHHHHHHhhCCCCCCCCCHH---
Confidence            999999999999999875322 22233456899999999997766  788999999999999999999999753211   


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM-----QQIVG  806 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~-----~~v~~  806 (815)
                          ..........       .    ..+...+.++.+++.+||+.||++||++     .++++
T Consensus       203 ----~~~~~i~~~~-------~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         203 ----ELFQSILEDE-------V----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ----HHHHHHHcCC-------C----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                1111111111       0    1123345678999999999999999999     77754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-36  Score=326.98  Aligned_cols=239  Identities=25%  Similarity=0.330  Sum_probs=189.6

Q ss_pred             CeecccCCeeeEEEEcC-CCcEEEEEEeecCC---cccHHHHHHHHHHhcC-CCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS---TLTDQEAARELEYLGR-IKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|+.. ++..||||+++...   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 57899999987532   2233456677888776 4899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|.+++..                              ...+++.....++.|++.||+|||   +.+|+||||||+||
T Consensus        81 g~L~~~l~~------------------------------~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Ni  127 (316)
T cd05619          81 GDLMFHIQS------------------------------CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNI  127 (316)
T ss_pred             CcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHE
Confidence            999999864                              224678888999999999999999   89999999999999


Q ss_pred             EEcCCCCeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |++.++.+||+|||+++..... .......||+.|+|||++.+..  ++.++|||||||++|||++|+.||......+  
T Consensus       128 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~G~~pf~~~~~~~--  203 (316)
T cd05619         128 LLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK--YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--  203 (316)
T ss_pred             EECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCC--CCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--
Confidence            9999999999999999754322 2233456899999999987665  7899999999999999999999997533211  


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ-QIV  805 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~-~v~  805 (815)
                        +.   +.. ...      .+.    .+.....++.+++.+||+.||++||++. ++.
T Consensus       204 --~~---~~i-~~~------~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         204 --LF---QSI-RMD------NPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             --HH---HHH-HhC------CCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence              11   111 111      011    1223456788999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-38  Score=331.70  Aligned_cols=247  Identities=21%  Similarity=0.311  Sum_probs=200.8

Q ss_pred             eecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCChhh
Q 003504          515 LLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQN  593 (815)
Q Consensus       515 ~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~  593 (815)
                      ++|+|.||+||-|+ ..+...+|||.+........+-+..||.+-++++|.|||+++|.|.+++..-+.||-++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999 45677899999987666666778899999999999999999999999888899999999999999


Q ss_pred             hhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEc-C
Q 003504          594 LLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD-M  672 (815)
Q Consensus       594 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~-~  672 (815)
                      +|+..=.+.                           .-.....--...||++||.|||   +..|||||||-+||||+ -
T Consensus       662 LLrskWGPl---------------------------KDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTy  711 (1226)
T KOG4279|consen  662 LLRSKWGPL---------------------------KDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTY  711 (1226)
T ss_pred             HHHhccCCC---------------------------ccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeec
Confidence            998631110                           0122334456789999999999   89999999999999997 5


Q ss_pred             CCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHH
Q 003504          673 NLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV  751 (815)
Q Consensus       673 ~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~  751 (815)
                      .|.+||+|||.++.+..-. ...++.||..|||||++-.+...|+.++|||||||.+-||.||++||........     
T Consensus       712 SGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-----  786 (1226)
T KOG4279|consen  712 SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-----  786 (1226)
T ss_pred             cceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-----
Confidence            7899999999998875322 3456679999999999988777789999999999999999999999985322211     


Q ss_pred             HHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          752 SWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..++    -+      .-...+.-|++...+...++.+|+.+||.+||+++++++
T Consensus       787 AMFk----VG------myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  787 AMFK----VG------MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             hhhh----hc------ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            1111    10      001223347888999999999999999999999999875

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=315.64  Aligned_cols=249  Identities=23%  Similarity=0.348  Sum_probs=200.3

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcc-----cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL-----TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      ++|...+.||+|++|.||+|.. .++.+||+|.+......     ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688899999999999999985 56899999998643211     23468899999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      |+||+++++|.+++...                              ..+++....+++.|++.||+|||   +.+++||
T Consensus        82 v~e~~~~~~l~~~~~~~------------------------------~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~  128 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY------------------------------GALTETVTRKYTRQILEGVEYLH---SNMIVHR  128 (263)
T ss_pred             EEEECCCCcHHHHHHHh------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            99999999999998642                              24667788899999999999999   8899999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCcc----ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE----EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      ||+|+||++++++.++|+|||+++........    ....|+..|+|||.+.+..  ++.++||||||+++||+++|+.|
T Consensus       129 dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p  206 (263)
T cd06625         129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG--YGRKADVWSVGCTVVEMLTEKPP  206 (263)
T ss_pred             CCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCC--CCchhhhHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999865432211    2345788999999998766  78999999999999999999999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      |......      .. ........         .....+......+.+++.+||..+|++||++.++++.
T Consensus       207 ~~~~~~~------~~-~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         207 WAEFEAM------AA-IFKIATQP---------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ccccchH------HH-HHHHhccC---------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            9753211      11 11111110         1112234456678999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=309.20  Aligned_cols=272  Identities=28%  Similarity=0.313  Sum_probs=221.6

Q ss_pred             cCHHHHHHHhcCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecC-CcccHHHHHHHHHHhcCCCCCCceeee
Q 003504          498 ITFADLLSATSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHG-STLTDQEAARELEYLGRIKHPNLVPLT  570 (815)
Q Consensus       498 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~  570 (815)
                      -...++.....+++....+.+|.||.||+|.|.      +.+.|.||.++.. ++..-..+..|--.+..+.|||+.++.
T Consensus       274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence            345667677778888899999999999999654      3456778877543 233345677888888899999999999


Q ss_pred             eEEEe-CCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHH
Q 003504          571 GYCIA-GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAF  649 (815)
Q Consensus       571 g~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~y  649 (815)
                      |++.+ .+.++++|.|+.-|+|..||...+...                      .+....++-.+...+|.|+|.|++|
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~----------------------~~~aqtvtt~qlV~masQla~am~h  411 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDD----------------------PSYAQTVTTIQLVLMASQLAMAMEH  411 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCC----------------------CccccchhHHHHHHHHHHHHHHHHH
Confidence            99976 457899999999999999998653110                      1224456667788999999999999


Q ss_pred             HhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCccc---cccccccccCCcccCCCCCCCCCcCcchhHHH
Q 003504          650 LHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE---IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGV  726 (815)
Q Consensus       650 LH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gv  726 (815)
                      ||   ..++||.||.++|++||+..++||+|=.+++.+-++.-..   ..-....||+||.+....  ++.++|||||||
T Consensus       412 lh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~--yssasDvWsfGV  486 (563)
T KOG1024|consen  412 LH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH--YSSASDVWSFGV  486 (563)
T ss_pred             HH---hcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh--hcchhhhHHHHH
Confidence            99   8999999999999999999999999999999875543111   112466899999998877  799999999999


Q ss_pred             HHHHHHh-CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          727 VLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       727 vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                      +||||+| |+.||.+-+|.|.+.                 ++..+++..+|.+|+.+++.+|..||+.+|++||+++|++
T Consensus       487 llWELmtlg~~PyaeIDPfEm~~-----------------ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  487 LLWELMTLGKLPYAEIDPFEMEH-----------------YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLV  549 (563)
T ss_pred             HHHHHHhcCCCCccccCHHHHHH-----------------HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence            9999999 999998776665432                 2234566777999999999999999999999999999999


Q ss_pred             HHHHhhhh
Q 003504          806 GLLKDIES  813 (815)
Q Consensus       806 ~~L~~i~~  813 (815)
                      ..|.++..
T Consensus       550 ~cLseF~~  557 (563)
T KOG1024|consen  550 ICLSEFHT  557 (563)
T ss_pred             HHHHHHHH
Confidence            99999864

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.9e-36  Score=314.80  Aligned_cols=255  Identities=21%  Similarity=0.294  Sum_probs=193.4

Q ss_pred             CeecccCCeeeEEEEcCC---CcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          514 TLLAEGKFGPVYRGFLPG---GIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      +.||+|+||.||+|...+   +..+|+|.++.... .....+.+|+.++++++||||++++|++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998543   45799998865432 23457889999999999999999999999988999999999999


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      +|.++++....                         ......++..+..++.|++.||+|||   +.+++||||||+||+
T Consensus        81 ~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil  132 (269)
T cd05087          81 DLKGYLRSCRK-------------------------AELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCL  132 (269)
T ss_pred             cHHHHHHHhhh-------------------------cccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEE
Confidence            99999975311                         11234677888899999999999999   889999999999999


Q ss_pred             EcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCC-----CCCCCcCcchhHHHHHHHHHh-CCCCCCC
Q 003504          670 LDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDS-----DFPTPKSDVYCYGVVLLELIT-GKKPLGD  740 (815)
Q Consensus       670 l~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-----~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~  740 (815)
                      ++.++.+||+|||+++.......   .....|+..|+|||++....     ..++.++||||||+++|||++ |+.||..
T Consensus       133 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~  212 (269)
T cd05087         133 LTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH  212 (269)
T ss_pred             EcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999976543321   22344678899999886432     124789999999999999996 9999975


Q ss_pred             CCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                      ....+.    ..+   .. .+......++.+..    ....++.+++..|| .+|++||++++|++.|+
T Consensus       213 ~~~~~~----~~~---~~-~~~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         213 LSDEQV----LTY---TV-REQQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CChHHH----HHH---Hh-hcccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            332211    111   01 11112222232221    23446788999999 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2e-36  Score=320.29  Aligned_cols=250  Identities=23%  Similarity=0.271  Sum_probs=199.1

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL---TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      |+..+.||+|+||.||+|.. .+++.||||.+......   ....+.+|+.++++++|+|++++++++.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            66778999999999999985 46889999998653222   234567899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++|+|.+++...                            ....+++..+..++.|++.||.|||   +.+|+||||||
T Consensus        82 ~~g~~L~~~l~~~----------------------------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp  130 (285)
T cd05630          82 MNGGDLKFHIYHM----------------------------GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKP  130 (285)
T ss_pred             cCCCcHHHHHHHh----------------------------cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCH
Confidence            9999999998642                            1234778889999999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      +||+++.++.++|+|||++.............|+..|+|||++....  ++.++|||||||++|||++|+.||.......
T Consensus       131 ~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~  208 (285)
T cd05630         131 ENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER--YTFSPDWWALGCLLYEMIAGQSPFQQRKKKI  208 (285)
T ss_pred             HHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCC--CCCccccHHHHHHHHHHHhCCCCCCCCCccc
Confidence            99999999999999999998765443334456899999999987665  7889999999999999999999997532211


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS-----MQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~~v~~  806 (815)
                      ......    .....          .....+...+.++.+++.+||+.||++||+     ++++++
T Consensus       209 ~~~~~~----~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         209 KREEVE----RLVKE----------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hHHHHH----hhhhh----------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            111111    11110          001112334567889999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.2e-36  Score=319.44  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=200.2

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CC---cEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GG---IHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      +|.+.+.||+|+||.||+|... ++   ..||||.+.... ....+.|..|+.++++++||||+++++++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            4677899999999999999964 23   369999986542 233567999999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.++++..                             ...+++..+..++.|++.||+|||   +.+++||||
T Consensus        85 e~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl  132 (269)
T cd05065          85 EFMENGALDSFLRQN-----------------------------DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDL  132 (269)
T ss_pred             ecCCCCcHHHHHhhC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccc
Confidence            999999999999752                             234788999999999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCccc---ccc---ccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEE---IAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKK  736 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~---~~~---gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~  736 (815)
                      ||+||+++.++.+||+|||+++.........   ...   .+..|+|||.+....  ++.++|||||||++||+++ |..
T Consensus       133 ~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DvwslG~~l~e~l~~g~~  210 (269)
T cd05065         133 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGER  210 (269)
T ss_pred             ChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCc--ccchhhhhhhHHHHHHHhcCCCC
Confidence            9999999999999999999987654322111   111   245799999987655  6889999999999999987 999


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      ||......    ....++.    ..         .....+.+++..+.+++.+||+.+|++||++++|++.|+++
T Consensus       211 p~~~~~~~----~~~~~i~----~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         211 PYWDMSNQ----DVINAIE----QD---------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CCCCCCHH----HHHHHHH----cC---------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            98753221    1222111    11         01111234566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-37  Score=339.62  Aligned_cols=250  Identities=20%  Similarity=0.233  Sum_probs=193.5

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++.....   ...+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3688899999999999999984 5788999999865321   22346788999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++...                              ..+++.....++.|++.||+|||   +.+|+||||
T Consensus        81 E~~~gg~L~~~l~~~------------------------------~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDl  127 (377)
T cd05629          81 EFLPGGDLMTMLIKY------------------------------DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDI  127 (377)
T ss_pred             eCCCCCcHHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCC
Confidence            999999999998642                              24566777889999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC------------------------------------------------cccc
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL------------------------------------------------DEEI  695 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~------------------------------------------------~~~~  695 (815)
                      ||+|||++.++.+||+|||+++.+....                                                ....
T Consensus       128 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (377)
T cd05629         128 KPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYS  207 (377)
T ss_pred             CHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc
Confidence            9999999999999999999996432100                                                0012


Q ss_pred             ccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCC
Q 003504          696 ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTG  775 (815)
Q Consensus       696 ~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  775 (815)
                      ..||+.|+|||++.+..  ++.++|||||||++|||++|+.||....+.+..       .......  ..     +....
T Consensus       208 ~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~--~~-----~~~p~  271 (377)
T cd05629         208 TVGTPDYIAPEIFLQQG--YGQECDWWSLGAIMFECLIGWPPFCSENSHETY-------RKIINWR--ET-----LYFPD  271 (377)
T ss_pred             cCCCccccCHHHHccCC--CCCceeeEecchhhhhhhcCCCCCCCCCHHHHH-------HHHHccC--Cc-----cCCCC
Confidence            45999999999987665  789999999999999999999999764332211       1111100  00     00001


Q ss_pred             CHHHHHHHHHHHhhccccCCCCC---CCHHHHHHH
Q 003504          776 PEKQMEEALKIGYLCTADLPLKR---PSMQQIVGL  807 (815)
Q Consensus       776 ~~~~~~~~~~l~~~Cl~~dP~~R---Ps~~~v~~~  807 (815)
                      ....+.++.+++.+|+. +|.+|   |++.++++.
T Consensus       272 ~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         272 DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            11234678899999997 67765   599988764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.8e-37  Score=334.30  Aligned_cols=252  Identities=21%  Similarity=0.219  Sum_probs=199.3

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|.+.+.||+|+||.||+|.. .+++.||||+++....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            3688889999999999999985 5688999999975322   23456889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++...                             ...+++.....++.|++.||+|||   +.+|+||||
T Consensus        81 e~~~~~~L~~~l~~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dl  128 (330)
T cd05601          81 EYQPGGDLLSLLNRY-----------------------------EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDI  128 (330)
T ss_pred             CCCCCCCHHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccC
Confidence            999999999999752                             235778888899999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCC----CCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~----~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      ||+|||++.++.+||+|||++........  .....||+.|+|||++...    ...++.++|||||||++|||++|+.|
T Consensus       129 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~P  208 (330)
T cd05601         129 KPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP  208 (330)
T ss_pred             chHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCC
Confidence            99999999999999999999987654322  2234689999999988632    12267899999999999999999999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      |......+       .............       .......+.++.+++..|+. +|++||+++++++
T Consensus       209 f~~~~~~~-------~~~~i~~~~~~~~-------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         209 FHEGTSAK-------TYNNIMNFQRFLK-------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCCCHHH-------HHHHHHcCCCccC-------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            97533221       1222221111000       00112245678899999997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.8e-36  Score=318.03  Aligned_cols=259  Identities=22%  Similarity=0.268  Sum_probs=202.5

Q ss_pred             HHHHhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          503 LLSATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       503 l~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      ++.+++.+.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            344566777778999999999999994 5678899999876555556789999999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      |+||+++++|.++++...                           .....++..+..++.|++.||+|||   +.+|+||
T Consensus        83 v~e~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~  132 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW---------------------------GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHR  132 (268)
T ss_pred             EEecCCCCCHHHHHHHhc---------------------------ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeec
Confidence            999999999999997521                           0111267778889999999999999   8899999


Q ss_pred             cCCCCceEEcC-CCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 003504          662 DIKASSVYLDM-NLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       662 Dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~  739 (815)
                      ||||+||+++. ++.+||+|||.+....... ......|+..|+|||++......++.++|||||||++||+++|+.||.
T Consensus       133 dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~  212 (268)
T cd06624         133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI  212 (268)
T ss_pred             CCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence            99999999986 6789999999997654322 222345889999999986654336889999999999999999999986


Q ss_pred             CCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ......    ...+......           .....+.....++.+++.+||..+|++||++.++++
T Consensus       213 ~~~~~~----~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         213 ELGEPQ----AAMFKVGMFK-----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             cccChh----hhHhhhhhhc-----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            422110    1111110000           011123345677899999999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.8e-36  Score=321.33  Aligned_cols=269  Identities=23%  Similarity=0.326  Sum_probs=203.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-----------------CCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceee
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-----------------GGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPL  569 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  569 (815)
                      ++|++.+.||+|+||.||++...                 ++..||+|.+.... ......+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888999999999999998532                 24468999987542 2334678999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHH
Q 003504          570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAF  649 (815)
Q Consensus       570 ~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~y  649 (815)
                      ++++...+..++||||+++|+|.+++.........                   .......+++.....++.|++.||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~i~~al~~  145 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA-------------------EKADVVTISYSTLIFMATQIASGMKY  145 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCccccc-------------------ccccccccCHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999764211000                   01223468899999999999999999


Q ss_pred             HhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHH
Q 003504          650 LHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGV  726 (815)
Q Consensus       650 LH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gv  726 (815)
                      ||   +.+++||||||+||+++.++.+||+|||+++.+.....   .....++..|+|||......  ++.++|||||||
T Consensus       146 lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~DiwSlG~  220 (296)
T cd05095         146 LS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGV  220 (296)
T ss_pred             HH---HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC--ccchhhhhHHHH
Confidence            99   88999999999999999999999999999986643321   11223467899999876655  788999999999


Q ss_pred             HHHHHHh--CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 003504          727 VLLELIT--GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI  804 (815)
Q Consensus       727 vl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v  804 (815)
                      ++|||++  |..||......+.    ............ .....     ..+..++..+.+++.+||+.||++||++.+|
T Consensus       221 ~l~el~~~~~~~p~~~~~~~~~----~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  290 (296)
T cd05095         221 TLWEILTLCKEQPYSQLSDEQV----IENTGEFFRDQG-RQVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEI  290 (296)
T ss_pred             HHHHHHHhCCCCCccccChHHH----HHHHHHHHhhcc-ccccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            9999998  7788864332221    111111111111 00111     1123345788999999999999999999999


Q ss_pred             HHHHHh
Q 003504          805 VGLLKD  810 (815)
Q Consensus       805 ~~~L~~  810 (815)
                      .+.|++
T Consensus       291 ~~~l~~  296 (296)
T cd05095         291 HATLLE  296 (296)
T ss_pred             HHHHhC
Confidence            999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-36  Score=316.70  Aligned_cols=240  Identities=22%  Similarity=0.311  Sum_probs=188.3

Q ss_pred             CeecccCCeeeEEEEcCC-------------CcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeE
Q 003504          514 TLLAEGKFGPVYRGFLPG-------------GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRI  580 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  580 (815)
                      +.||+|+||.||+|+..+             ...||+|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358999876544444567889999999999999999999999988999


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +||||+++|+|..+++..                             ...+++..+.+++.|+++||+|||   +.+|+|
T Consensus        81 lv~e~~~~~~l~~~~~~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH  128 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-----------------------------SDVLTTPWKFKVAKQLASALSYLE---DKDLVH  128 (262)
T ss_pred             EEEecccCCCHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHhh---hCCeEC
Confidence            999999999999988642                             235788889999999999999999   899999


Q ss_pred             ccCCCCceEEcCCCC-------eeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh
Q 003504          661 RDIKASSVYLDMNLE-------PRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       661 rDlk~~NIll~~~~~-------~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                      |||||+|||++.++.       +|++|||++......   ....++..|+|||.+..... ++.++|||||||++|||++
T Consensus       129 ~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~~l~el~~  204 (262)
T cd05077         129 GNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKN-LSIAADKWSFGTTLWEICY  204 (262)
T ss_pred             CCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCC-CCchhHHHHHHHHHHHHHh
Confidence            999999999987664       899999998765322   23457889999998764332 6889999999999999984


Q ss_pred             -CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          734 -GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       734 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                       |+.||......+.        .......  ...         ......++.+++.+||+.||++||++.++++.+
T Consensus       205 ~~~~p~~~~~~~~~--------~~~~~~~--~~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         205 NGEIPLKDKTLAEK--------ERFYEGQ--CML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             CCCCCCCCcchhHH--------HHHHhcC--ccC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             8888764322111        1111110  000         111245788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.2e-36  Score=316.31  Aligned_cols=250  Identities=21%  Similarity=0.336  Sum_probs=197.2

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      +|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577889999999999999984 578899999986542 233457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|..+.                                  .+++.....++.|++.||+|||   +.+|+||||||+
T Consensus        82 ~~~~l~~~~----------------------------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~  124 (279)
T cd06619          82 DGGSLDVYR----------------------------------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPS  124 (279)
T ss_pred             CCCChHHhh----------------------------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHH
Confidence            999986543                                  2356677889999999999999   899999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEK  746 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~  746 (815)
                      ||+++.++.+||+|||++...... ......|+..|+|||.+.+..  ++.++||||||+++|||++|+.||........
T Consensus       125 Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~  201 (279)
T cd06619         125 NMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQ--YGIHSDVWSLGISFMELALGRFPYPQIQKNQG  201 (279)
T ss_pred             HEEECCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCCC--CCCcchHHHHHHHHHHHHhCCCCchhhccccc
Confidence            999999999999999999876433 233456899999999987665  68899999999999999999999975332221


Q ss_pred             cccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          747 EGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      ......+........      .+...   ....+.++.+++.+||+.+|++||+++++++.
T Consensus       202 ~~~~~~~~~~~~~~~------~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         202 SLMPLQLLQCIVDED------PPVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ccchHHHHHHHhccC------CCCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            111112111111110      11111   12234578899999999999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.8e-36  Score=321.42  Aligned_cols=270  Identities=23%  Similarity=0.319  Sum_probs=205.2

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcCC-----------------CcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCcee
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPG-----------------GIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVP  568 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~  568 (815)
                      .++|++.+.||+|+||.||+|...+                 +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578899999999999999988532                 34689999875432 33567889999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHH
Q 003504          569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALA  648 (815)
Q Consensus       569 l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~  648 (815)
                      +++++...+..++|+||+++++|.+++..........                   ......+++.....++.|++.||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~i~~al~  144 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL-------------------ACNSKSLSFSTLLYMATQIASGMR  144 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc-------------------cccCCCCCHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999997532110000                   012346889999999999999999


Q ss_pred             HHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHH
Q 003504          649 FLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYG  725 (815)
Q Consensus       649 yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~G  725 (815)
                      |||   +.+++||||||+||+++.++.++|+|||+++......   ......++..|+|||.+....  ++.++||||||
T Consensus       145 ~LH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG  219 (296)
T cd05051         145 YLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFG  219 (296)
T ss_pred             HHH---HcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC--CCccchhhhhH
Confidence            999   8899999999999999999999999999998654322   122334677899999987655  78999999999


Q ss_pred             HHHHHHHh--CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 003504          726 VVLLELIT--GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ  803 (815)
Q Consensus       726 vvl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~  803 (815)
                      |++||+++  |..||.....    ..+...+.........      ......+..++.++.+++.+||+.||++||++.+
T Consensus       220 ~~l~el~~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e  289 (296)
T cd05051         220 VTLWEILTLCREQPYEHLTD----QQVIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE  289 (296)
T ss_pred             HHHHHHHhcCCCCCCCCcCh----HHHHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHH
Confidence            99999998  6777764322    1122222211111110      0111112334568999999999999999999999


Q ss_pred             HHHHHHh
Q 003504          804 IVGLLKD  810 (815)
Q Consensus       804 v~~~L~~  810 (815)
                      |++.|++
T Consensus       290 l~~~L~~  296 (296)
T cd05051         290 IHLFLQR  296 (296)
T ss_pred             HHHHhcC
Confidence            9998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.3e-36  Score=315.58  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=203.3

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .++|.+.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++.+++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            3578889999999999999999877888999988653 3345678999999999999999999999887 7789999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.+++...                            .....+|..+..++.|++.||+|||   +.+++||||||+
T Consensus        83 ~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~  131 (260)
T cd05073          83 AKGSLLDFLKSD----------------------------EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAA  131 (260)
T ss_pred             CCCcHHHHHHhC----------------------------CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcc
Confidence            999999999752                            1335788899999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCC
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP  743 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~  743 (815)
                      ||+++.++.+||+|||.+........  .....++..|+|||++....  ++.++|||||||++||+++ |+.||.....
T Consensus       132 ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~t~g~~p~~~~~~  209 (260)
T cd05073         132 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSN  209 (260)
T ss_pred             eEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCC--cCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999986643221  12233567899999987655  6889999999999999999 8999865322


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      .    .+..+    ....         .....+...+.++.+++.+||+.+|++||++.++.+.|+.+
T Consensus       210 ~----~~~~~----~~~~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         210 P----EVIRA----LERG---------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             H----HHHHH----HhCC---------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            1    11111    1111         01111234556799999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.5e-36  Score=322.08  Aligned_cols=264  Identities=22%  Similarity=0.308  Sum_probs=203.1

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCe
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQ  578 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  578 (815)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+..... .....+.+|+.++++++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4568999999999999999999743      245799998864332 223467889999999999999999999999999


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++||||+++|+|.++++.......                    ........++....+++.|++.||+|||   +++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i  140 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAE--------------------NNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKF  140 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccc--------------------cCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCC
Confidence            9999999999999999975321100                    0011234677888999999999999999   8999


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-C
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-G  734 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g  734 (815)
                      +||||||+||++++++.+||+|||+++.......   .....++..|+|||.+.+..  ++.++|||||||++||+++ |
T Consensus       141 ~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~DvwslG~~l~el~~~~  218 (288)
T cd05061         141 VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV--FTTSSDMWSFGVVLWEITSLA  218 (288)
T ss_pred             cCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCC--CChHhHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999986543221   11223567899999987655  6889999999999999999 7


Q ss_pred             CCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       735 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      ..||.....+       +..........          ...+..++..+.+++.+||+.+|++||++.++++.|++.
T Consensus       219 ~~p~~~~~~~-------~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         219 EQPYQGLSNE-------QVLKFVMDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             CCCCCCCCHH-------HHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            8888653221       11111111110          011233456899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=308.27  Aligned_cols=247  Identities=22%  Similarity=0.327  Sum_probs=207.7

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      |++...+|+|+||.||||.+ ..|+.||||.+..  ..+.+++.+|+.+|++.+.|++|++||.++.....++|||||-.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            55568999999999999985 5799999998854  34568899999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+..+.++.+                             .++++......++.+.++||+|||   ...-||||||+-||
T Consensus       113 GSiSDI~R~R-----------------------------~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNI  160 (502)
T KOG0574|consen  113 GSISDIMRAR-----------------------------RKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNI  160 (502)
T ss_pred             CcHHHHHHHh-----------------------------cCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccE
Confidence            9999999864                             456777888899999999999999   67789999999999


Q ss_pred             EEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |++.+|.+|++|||.|..+.... ...+..||+.|||||++..-.  |..++||||+|+...||..|++||.+--+-..-
T Consensus       161 LLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIG--Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI  238 (502)
T KOG0574|consen  161 LLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIG--YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI  238 (502)
T ss_pred             EEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhc--cchhhhHhhhcchhhhhhcCCCCccccccccee
Confidence            99999999999999998765433 445677999999999998666  789999999999999999999999863321110


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                                +     --...|.-.-..|+..+.++-++++.|+.+.|++|-++.++++.
T Consensus       239 ----------F-----MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  239 ----------F-----MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ----------E-----eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence                      0     00011222223488899999999999999999999999998764

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3e-36  Score=325.29  Aligned_cols=242  Identities=21%  Similarity=0.239  Sum_probs=191.2

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|.. .+++.||||++.....   ...+.+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999995 5678999999976422   2234577899999888 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|..++..                              ...+++..+..++.|++.||+|||   +.+|+||||||+||
T Consensus        81 ~~L~~~~~~------------------------------~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Ni  127 (327)
T cd05617          81 GDLMFHMQR------------------------------QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNV  127 (327)
T ss_pred             CcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHE
Confidence            999988854                              235788899999999999999999   88999999999999


Q ss_pred             EEcCCCCeeecccccceecC-CCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFG-NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |++.++.+||+|||+++... .........||+.|+|||++.+..  ++.++|||||||++|||++|+.||........ 
T Consensus       128 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-  204 (327)
T cd05617         128 LLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-  204 (327)
T ss_pred             EEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCC--CCchheeehhHHHHHHHHhCCCCCCccCCCcc-
Confidence            99999999999999998532 222334556999999999987665  68899999999999999999999974322211 


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      .....+.........        .  ..+...+..+.+++.+|++.||++||++
T Consensus       205 ~~~~~~~~~~~~~~~--------~--~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         205 MNTEDYLFQVILEKP--------I--RIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             cccHHHHHHHHHhCC--------C--CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            112222222222111        0  1123345667899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.5e-36  Score=319.27  Aligned_cols=253  Identities=25%  Similarity=0.396  Sum_probs=198.9

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeEEEeC------C
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCIAG------D  577 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------~  577 (815)
                      +++.|+..+.||+|+||.||+|.. .+++.||+|.+... ......+.+|+.++.++ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            566788889999999999999985 46889999998653 34456788999999998 699999999998763      3


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++||||+++|+|.+++...                            ....+++.....++.|++.||+|||   +.+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~----------------------------~~~~l~~~~~~~~~~qi~~~l~~LH---~~~  131 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT----------------------------KGNTLKEEWIAYICREILRGLSHLH---QHK  131 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc----------------------------cCCCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            578999999999999999752                            1235788889999999999999999   789


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCC---CCCCCCcCcchhHHHHHHHHHh
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPD---SDFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                      |+||||||+||++++++.+||+|||+++...... ......|+..|+|||++.+.   ...++.++|||||||++|||++
T Consensus       132 ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~  211 (272)
T cd06637         132 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE  211 (272)
T ss_pred             CccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999998664322 22345689999999998633   1236789999999999999999


Q ss_pred             CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      |+.||....+.      .... . .....     .+..   .+...+.++.+++.+||..+|.+||++.++++
T Consensus       212 g~~p~~~~~~~------~~~~-~-~~~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         212 GAPPLCDMHPM------RALF-L-IPRNP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCccccCHH------HHHH-H-HhcCC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            99999643211      1110 0 11111     0111   12234567899999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.1e-36  Score=320.26  Aligned_cols=250  Identities=22%  Similarity=0.232  Sum_probs=198.1

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      |+..+.||+|+||.||+|.. .+++.||+|.+.....   .....+.+|++++++++|+||+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            55678999999999999985 5688999999865322   2234577899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++|+|.+++...                            ....+++.....++.|++.||.|||   +.+|+||||||
T Consensus        82 ~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp  130 (285)
T cd05632          82 MNGGDLKFHIYNM----------------------------GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKP  130 (285)
T ss_pred             ccCccHHHHHHHh----------------------------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCH
Confidence            9999999888642                            1235889999999999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      +||++++++.+||+|||++.............|+..|+|||++.+..  ++.++|||||||++||+++|+.||.......
T Consensus       131 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~  208 (285)
T cd05632         131 ENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR--YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV  208 (285)
T ss_pred             HHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999998765443334456899999999987655  7889999999999999999999997532211


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS-----MQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~~v~~  806 (815)
                      ..   ..+.......   .    +    ..+...+.++.+++.+|++.||++||+     +.++++
T Consensus       209 ~~---~~~~~~~~~~---~----~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         209 KR---EEVDRRVLET---E----E----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             HH---HHHHHhhhcc---c----c----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            11   1111111110   0    0    112334557889999999999999999     666655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=308.81  Aligned_cols=262  Identities=19%  Similarity=0.262  Sum_probs=200.4

Q ss_pred             hcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeec--CCcccHHHHHHHHHHhcCCCCCCceeeeeEEEe-----CCe
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVH--GSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA-----GDQ  578 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~  578 (815)
                      ...|...+.||+|+||.|+.|. ..+|..||||.+..  ......+...||+++++.++|+||+.+.+.+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            3456667899999999999998 46789999999873  344556778899999999999999999998876     247


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .|+|+|+|+. +|...++.                              +..++-....-+..|+.+||.|+|   +.++
T Consensus       101 vYiV~elMet-DL~~iik~------------------------------~~~L~d~H~q~f~YQiLrgLKyiH---SAnV  146 (359)
T KOG0660|consen  101 VYLVFELMET-DLHQIIKS------------------------------QQDLTDDHAQYFLYQILRGLKYIH---SANV  146 (359)
T ss_pred             eEEehhHHhh-HHHHHHHc------------------------------CccccHHHHHHHHHHHHHhcchhh---cccc
Confidence            8999999965 99999975                              234666777789999999999999   8999


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCC---CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGN---GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      +||||||+|++++.+..+||+|||+|+....   ....+..+.|.+|.|||++..... |+...||||.||++.||++|+
T Consensus       147 iHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~-Yt~aiDiWSvGCI~AEmL~gk  225 (359)
T KOG0660|consen  147 IHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSE-YTKAIDIWSVGCILAEMLTGK  225 (359)
T ss_pred             cccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhcccc-ccchhhhhhhhHHHHHHHcCC
Confidence            9999999999999999999999999998853   223345568999999999876554 799999999999999999999


Q ss_pred             CCCCCCCCccccccHH----------------HHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC
Q 003504          736 KPLGDDYPEEKEGNLV----------------SWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP  799 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  799 (815)
                      +-|.+...-..-.-+.                ..++.+++.....  ....+... .........++..+++..||.+|+
T Consensus       226 plFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~--p~~~f~~~-fp~a~p~AidLlekmL~fdP~kRi  302 (359)
T KOG0660|consen  226 PLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQI--PKQPFSSI-FPNANPLAIDLLEKMLVFDPKKRI  302 (359)
T ss_pred             CCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCC--CCCCHHHH-cCCCCHHHHHHHHHHhccCccccC
Confidence            9888742211111110                0112222211100  00000011 123446788999999999999999


Q ss_pred             CHHHHHH
Q 003504          800 SMQQIVG  806 (815)
Q Consensus       800 s~~~v~~  806 (815)
                      |++|+++
T Consensus       303 ta~eAL~  309 (359)
T KOG0660|consen  303 TAEEALA  309 (359)
T ss_pred             CHHHHhc
Confidence            9999975

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-36  Score=326.46  Aligned_cols=239  Identities=26%  Similarity=0.301  Sum_probs=189.2

Q ss_pred             CeecccCCeeeEEEEcC-CCcEEEEEEeecCC---cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS---TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|+.. +|..||||.++...   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999964 68899999987532   12334566788877754 899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|..++..                              ...+++.....++.|++.||+|||   +.+|+||||||+||
T Consensus        81 g~L~~~i~~------------------------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Ni  127 (316)
T cd05620          81 GDLMFHIQD------------------------------KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNV  127 (316)
T ss_pred             CcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHe
Confidence            999998864                              224677888899999999999999   89999999999999


Q ss_pred             EEcCCCCeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      +++.++.+||+|||+++..... .......||+.|+|||++.+..  ++.++|||||||++|||++|+.||......   
T Consensus       128 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~Pf~~~~~~---  202 (316)
T cd05620         128 MLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK--YTFSVDWWSFGVLLYEMLIGQSPFHGDDED---  202 (316)
T ss_pred             EECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCCHH---
Confidence            9999999999999998754322 2234456899999999998765  789999999999999999999999753221   


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ-QIV  805 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~-~v~  805 (815)
                          .........       .+.+    +.....++.+++.+||+.||++||++. +++
T Consensus       203 ----~~~~~~~~~-------~~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         203 ----ELFESIRVD-------TPHY----PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----HHHHHHHhC-------CCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                111111111       1111    223456788999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.4e-36  Score=314.64  Aligned_cols=248  Identities=27%  Similarity=0.391  Sum_probs=203.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCC-CcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      ++|+..+.||+|+||.||+|...+ +..||+|.+.....  .+.+.+|++++++++||||+++++++.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578889999999999999999754 78999999865322  678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++++|.+++...                             ...+++.....++.|++.||+|||   ..+++||||+|+
T Consensus        81 ~~~~L~~~l~~~-----------------------------~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~  128 (256)
T cd06612          81 GAGSVSDIMKIT-----------------------------NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAG  128 (256)
T ss_pred             CCCcHHHHHHhC-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcc
Confidence            999999998642                             345789999999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||+++.++.+||+|||++....... ......|+..|+|||++.+..  ++.++|||||||++|||++|+.||....+..
T Consensus       129 ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~  206 (256)
T cd06612         129 NILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG--YNNKADIWSLGITAIEMAEGKPPYSDIHPMR  206 (256)
T ss_pred             eEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCC--CCchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence            9999999999999999998765433 223345888999999987665  7889999999999999999999997532211


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..       .. ....     ..+  ....+.....++.+++.+||+.+|++||+++||++
T Consensus       207 ~~-------~~-~~~~-----~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         207 AI-------FM-IPNK-----PPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hh-------hh-hccC-----CCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            10       00 0000     001  11123345677899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-36  Score=314.15  Aligned_cols=246  Identities=27%  Similarity=0.432  Sum_probs=196.2

Q ss_pred             CeecccCCeeeEEEEcC--C--CcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFLP--G--GIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~--~--~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|...  +  +..||+|.+..... ...+.+.+|++++++++||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999742  2  36899999876433 24567899999999999999999999876 4568999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|.+++...                              ..+++..+..++.|++.||+|||   ..+++||||||+||
T Consensus        80 ~~L~~~l~~~------------------------------~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~ni  126 (257)
T cd05060          80 GPLLKYLKKR------------------------------REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNV  126 (257)
T ss_pred             CcHHHHHHhC------------------------------CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceE
Confidence            9999999752                              25788999999999999999999   78999999999999


Q ss_pred             EEcCCCCeeecccccceecCCCCcc----ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCC
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNGLDE----EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP  743 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~  743 (815)
                      +++.++.+||+|||+++........    ....++..|+|||.+....  ++.++|||||||++||+++ |+.||.....
T Consensus       127 li~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~~g~~p~~~~~~  204 (257)
T cd05060         127 LLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK--FSSKSDVWSYGVTLWEAFSYGAKPYGEMKG  204 (257)
T ss_pred             EEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCC--CCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999999999999999876543321    1122356799999887655  7889999999999999998 9999875322


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                          ..+..++.    ...         ....+..++.++.+++.+||..+|++||++.++++.|+++.
T Consensus       205 ----~~~~~~~~----~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         205 ----AEVIAMLE----SGE---------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ----HHHHHHHH----cCC---------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                12222211    111         01123345568899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.9e-36  Score=333.05  Aligned_cols=262  Identities=20%  Similarity=0.235  Sum_probs=197.4

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC-----eeE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD-----QRI  580 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  580 (815)
                      +|+..+.||+|+||.||+|.. .+++.||||.+....  ....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999995 578999999986432  223457889999999999999999999998766     789


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +|+||+. ++|.+++..                              ...+++.....++.|++.||+|||   +.+|+|
T Consensus        81 lv~e~~~-~~l~~~~~~------------------------------~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH  126 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS------------------------------PQPLSSDHVKVFLYQILRGLKYLH---SAGILH  126 (372)
T ss_pred             EEeeccc-cCHHHHHhc------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeC
Confidence            9999997 478887753                              235788889999999999999999   889999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~  738 (815)
                      |||||+|||++.++.+||+|||+++......  ......+++.|+|||++.+... ++.++|||||||++|||++|+.||
T Consensus       127 ~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~el~~g~~pf  205 (372)
T cd07853         127 RDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH-YTSAVDIWSVGCIFAELLGRRILF  205 (372)
T ss_pred             CCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCC-CCcHHHHHhHHHHHHHHHcCCCCC
Confidence            9999999999999999999999998654322  2233457899999999876443 688999999999999999999999


Q ss_pred             CCCCCccccccHHHH---------------HHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 003504          739 GDDYPEEKEGNLVSW---------------VRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ  803 (815)
Q Consensus       739 ~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~  803 (815)
                      ....+.+....+.+.               ....+..........+.. .........++.+++.+|++.||++||+++|
T Consensus       206 ~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e  284 (372)
T cd07853         206 QAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAAD  284 (372)
T ss_pred             CCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHH
Confidence            764432211111110               011111100000000000 0011223567889999999999999999999


Q ss_pred             HHH
Q 003504          804 IVG  806 (815)
Q Consensus       804 v~~  806 (815)
                      +++
T Consensus       285 ~l~  287 (372)
T cd07853         285 ALA  287 (372)
T ss_pred             Hhc
Confidence            986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-36  Score=328.45  Aligned_cols=193  Identities=20%  Similarity=0.262  Sum_probs=164.6

Q ss_pred             HHhcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          505 SATSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       505 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ....+|.+.+.||+|+||.||+|... ++..||+|.....      ....|+.++++++||||+++++++......++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34467999999999999999999964 5678999975332      2356899999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+. |+|.+++...                             ...++|..+..|+.|++.||+|||   +.+||||||
T Consensus       137 e~~~-~~l~~~l~~~-----------------------------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDl  183 (357)
T PHA03209        137 PHYS-SDLYTYLTKR-----------------------------SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDV  183 (357)
T ss_pred             EccC-CcHHHHHHhc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCC
Confidence            9995 5888888642                             345789999999999999999999   889999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~  738 (815)
                      ||+|||++.++.+||+|||+++............||..|+|||++.+..  ++.++|||||||++|||+++..|+
T Consensus       184 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        184 KTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDK--YNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             CHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCCC--CCchhhHHHHHHHHHHHHHcCCcc
Confidence            9999999999999999999998644333334456999999999987765  789999999999999999965554

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-36  Score=328.44  Aligned_cols=236  Identities=25%  Similarity=0.289  Sum_probs=186.6

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHH-HhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELE-YLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|+. .+|+.||||++.....   .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4799999999999995 4789999999865321   12234445544 56789999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|..++..                              ...+++.....++.|++.||+|||   +.+|+||||||+||
T Consensus        81 g~L~~~l~~------------------------------~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NI  127 (323)
T cd05575          81 GELFFHLQR------------------------------ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENI  127 (323)
T ss_pred             CCHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHe
Confidence            999999864                              234677788899999999999999   88999999999999


Q ss_pred             EEcCCCCeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |++.++.+||+|||+++..... .......||+.|+|||++.+..  ++.++|||||||++|||++|+.||.....    
T Consensus       128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~----  201 (323)
T cd05575         128 LLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDT----  201 (323)
T ss_pred             EECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCC--CCccccccccchhhhhhhcCCCCCCCCCH----
Confidence            9999999999999998754322 2233456999999999987765  78899999999999999999999975322    


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ  802 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  802 (815)
                         ...........       ..+    +...+.++.+++.+|++.||++||++.
T Consensus       202 ---~~~~~~i~~~~-------~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         202 ---AEMYDNILNKP-------LRL----KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ---HHHHHHHHcCC-------CCC----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence               11222222111       011    222356788999999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-36  Score=319.48  Aligned_cols=262  Identities=23%  Similarity=0.332  Sum_probs=204.5

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCee
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  579 (815)
                      .++|.+.+.||+|+||.||+|...      .+..||+|.+..... .....+.+|+.++..++||||++++|++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            357888899999999999999853      246899999865432 3345788999999999999999999999999999


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++||||+++|+|.+++.........                    ......++|..+..++.|++.||+|||   +.+++
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~  141 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAEN--------------------NPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFV  141 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhh--------------------ccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            9999999999999999753211000                    011335789999999999999999999   89999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~  735 (815)
                      ||||||+||+++.++.+||+|||+++......   ......++..|+|||.+....  ++.++|||||||++||+++ |+
T Consensus       142 H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~  219 (277)
T cd05032         142 HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV--FTTKSDVWSFGVVLWEMATLAE  219 (277)
T ss_pred             ccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC--CCcccchHHHHHHHHHhhccCC
Confidence            99999999999999999999999998654332   122334678899999887655  6889999999999999998 89


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHh
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD  810 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~  810 (815)
                      .||.....+    ....+    .....         ....+..++.++.+++.+||+.+|++||++.++++.|++
T Consensus       220 ~p~~~~~~~----~~~~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         220 QPYQGLSNE----EVLKF----VIDGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CCCccCCHH----HHHHH----HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            998643221    11111    11111         001133346789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.6e-36  Score=348.85  Aligned_cols=266  Identities=21%  Similarity=0.260  Sum_probs=203.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||.||+|+. .+++.||||+++....   ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            4788899999999999999995 4689999999875322   22457889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++.......         ...          .......++...++++.|+++||+|||   +.+|+||||
T Consensus        82 EY~eGGSL~~lL~s~~~~~---------~l~----------e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDL  139 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKE---------SLS----------KELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDL  139 (932)
T ss_pred             EcCCCCCHHHHHHHhhhcc---------ccc----------hhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCC
Confidence            9999999999996421000         000          011234678888999999999999999   889999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC-------------------ccccccccccccCCcccCCCCCCCCCcCcchhH
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL-------------------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCY  724 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~  724 (815)
                      ||+||+++.++.+||+|||+++......                   ......||+.|+|||.+.+..  ++.++|||||
T Consensus       140 KPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~--~S~kSDIWSL  217 (932)
T PRK13184        140 KPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP--ASESTDIYAL  217 (932)
T ss_pred             chheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC--CCcHhHHHHH
Confidence            9999999999999999999998662110                   011235899999999987766  6899999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-CHHH
Q 003504          725 GVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-SMQQ  803 (815)
Q Consensus       725 Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~~  803 (815)
                      ||++|||++|+.||.......    +.      . ..   ...++.- .....+.+..+.+++.+|++.||++|| ++++
T Consensus       218 GVILyELLTG~~PF~~~~~~k----i~------~-~~---~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~ee  282 (932)
T PRK13184        218 GVILYQMLTLSFPYRRKKGRK----IS------Y-RD---VILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQE  282 (932)
T ss_pred             HHHHHHHHHCCCCCCCcchhh----hh------h-hh---hccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            999999999999997522111    10      0 00   0001100 011224456788999999999999996 6777


Q ss_pred             HHHHHHhhh
Q 003504          804 IVGLLKDIE  812 (815)
Q Consensus       804 v~~~L~~i~  812 (815)
                      +.+.|+...
T Consensus       283 Ll~~Le~~l  291 (932)
T PRK13184        283 LKQDLEPHL  291 (932)
T ss_pred             HHHHHHHHH
Confidence            888777653

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.3e-36  Score=314.79  Aligned_cols=249  Identities=23%  Similarity=0.403  Sum_probs=201.1

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      .+|++.+.||+|+||.||+|...++..+|+|.+... ......+.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            467778999999999999999877889999988653 3445679999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.++++..                             ...+++.....++.+++.|++|||   +.+++||||||+|
T Consensus        83 ~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~n  130 (256)
T cd05112          83 HGCLSDYLRAQ-----------------------------RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARN  130 (256)
T ss_pred             CCcHHHHHHhC-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccce
Confidence            99999998642                             234678889999999999999999   7899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE  744 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~  744 (815)
                      |+++.++.+||+|||.++.......  .....++.+|+|||.+.+..  ++.++||||||+++||+++ |+.||......
T Consensus       131 i~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  208 (256)
T cd05112         131 CLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK--YSSKSDVWSFGVLMWEVFSEGKTPYENRSNS  208 (256)
T ss_pred             EEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCC--cChHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            9999999999999999986643221  12223567899999887655  7889999999999999998 99998743221


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                             ....... ..  .....+.       ..+.++.+++.+||+.+|++||++.+++++|
T Consensus       209 -------~~~~~~~-~~--~~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         209 -------EVVETIN-AG--FRLYKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -------HHHHHHh-CC--CCCCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                   1111111 11  1111121       2346799999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-36  Score=332.38  Aligned_cols=256  Identities=20%  Similarity=0.262  Sum_probs=198.7

Q ss_pred             HHHhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCee
Q 003504          504 LSATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       504 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  579 (815)
                      ....++|++.+.||+|+||.||+|+. .+++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+....
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            33456899999999999999999995 468899999986421   22344678899999999999999999999999999


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++||||+++|+|.+++...                               .++......++.|++.||+|||   +.+|+
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-------------------------------~~~~~~~~~~~~qil~aL~~LH---~~~Iv  164 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY-------------------------------DVPEKWAKFYTAEVVLALDAIH---SMGLI  164 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-------------------------------CCCHHHHHHHHHHHHHHHHHHH---HCCeE
Confidence            9999999999999998642                               3566777889999999999999   89999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCC--CCCCCcCcchhHHHHHHHHHhCC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDS--DFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      ||||||+|||++.++.+||+|||+++......  ......||+.|+|||++....  ..++.++||||+||++|||++|+
T Consensus       165 HrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~  244 (370)
T cd05621         165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD  244 (370)
T ss_pred             ecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCC
Confidence            99999999999999999999999998765332  223456999999999986543  23678999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK--RPSMQQIVGL  807 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~~v~~~  807 (815)
                      .||......       ............       +........+..+.+++..|+..+|.+  ||+++++++.
T Consensus       245 ~Pf~~~~~~-------~~~~~i~~~~~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         245 TPFYADSLV-------GTYSKIMDHKNS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCCCCCCHH-------HHHHHHHhCCcc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            999753321       112222221110       000111234566778888899755543  8899998764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3e-36  Score=327.51  Aligned_cols=287  Identities=25%  Similarity=0.331  Sum_probs=204.0

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc------CCCcEEEEEEeecCCcc-cHHHHHHHHHHhcCC-CCCCceeeeeEEEeC-C
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTL-TDQEAARELEYLGRI-KHPNLVPLTGYCIAG-D  577 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~  577 (815)
                      .++|.+.+.||+|+||.||+|..      .+++.||||+++..... ....+.+|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35788999999999999999973      35678999999754322 235688999999999 689999999988764 4


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccc-------------------------------cCCCCCccccCCCccc-----
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTT-------------------------------EDWSTDTWEEDGTNSI-----  621 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~-----  621 (815)
                      ..++||||+++|+|.++++.........                               ..+....+.+......     
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999997532110000                               0000000000000000     


Q ss_pred             -cccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCc---ccccc
Q 003504          622 -QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIAR  697 (815)
Q Consensus       622 -~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~  697 (815)
                       .........++|..+.+++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......   .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence             000001235789999999999999999999   89999999999999999999999999999986533211   11223


Q ss_pred             ccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCC
Q 003504          698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGP  776 (815)
Q Consensus       698 gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  776 (815)
                      ++..|+|||.+.+..  ++.++||||||+++||+++ |..||......+   .+.    .......  ..       ..+
T Consensus       243 ~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~--~~-------~~~  304 (343)
T cd05103         243 LPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFC----RRLKEGT--RM-------RAP  304 (343)
T ss_pred             CCcceECcHHhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HHH----HHHhccC--CC-------CCC
Confidence            567799999987665  6889999999999999997 999986532111   111    1111111  00       111


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhhc
Q 003504          777 EKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       777 ~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~~  814 (815)
                      ...+.++.+++.+||+.+|++||++.+|++.|+.+.++
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            22345689999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.9e-37  Score=337.26  Aligned_cols=250  Identities=23%  Similarity=0.250  Sum_probs=192.6

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||.||+|+. .+++.||||++....   ......+.+|++++++++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3688899999999999999994 568899999986432   123456789999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++...                              ..++......++.|++.||+|||   +.+|+||||
T Consensus        81 E~~~~g~L~~~i~~~------------------------------~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDl  127 (376)
T cd05598          81 DYIPGGDMMSLLIRL------------------------------GIFEEDLARFYIAELTCAIESVH---KMGFIHRDI  127 (376)
T ss_pred             eCCCCCcHHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCC
Confidence            999999999999652                              23566667788999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCC--------------------------------------------Ccccccccc
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNG--------------------------------------------LDEEIARGS  699 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~--------------------------------------------~~~~~~~gt  699 (815)
                      ||+|||++.++.+||+|||+|..+...                                            .......||
T Consensus       128 kp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  207 (376)
T cd05598         128 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGT  207 (376)
T ss_pred             CHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCC
Confidence            999999999999999999997532100                                            001124699


Q ss_pred             ccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHH
Q 003504          700 PGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQ  779 (815)
Q Consensus       700 ~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  779 (815)
                      +.|+|||++.+..  ++.++|||||||++|||++|+.||....+.+..       .......  .     ..........
T Consensus       208 ~~y~aPE~~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~--~-----~~~~~~~~~~  271 (376)
T cd05598         208 PNYIAPEVLLRTG--YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQ-------LKVINWE--T-----TLHIPSQAKL  271 (376)
T ss_pred             ccccCHHHHcCCC--CCcceeeeeccceeeehhhCCCCCCCCCHHHHH-------HHHhccC--c-----cccCCCCCCC
Confidence            9999999997766  688999999999999999999999764332211       1111100  0     0111111223


Q ss_pred             HHHHHHHHhhccccCCCCCC---CHHHHHHH
Q 003504          780 MEEALKIGYLCTADLPLKRP---SMQQIVGL  807 (815)
Q Consensus       780 ~~~~~~l~~~Cl~~dP~~RP---s~~~v~~~  807 (815)
                      +.++.+++.+|+ .+|.+|+   ++.++++.
T Consensus       272 s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         272 SREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            456677777766 4999999   88888753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-36  Score=321.42  Aligned_cols=259  Identities=25%  Similarity=0.329  Sum_probs=201.4

Q ss_pred             CCCCCCeecccCCeeeEEEEc-----CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--CeeE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-----PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQRI  580 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  580 (815)
                      .|++.+.||+|+||.||.|..     .++..||+|.+.... ......+.+|++++++++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467789999999999999973     357889999986543 23346789999999999999999999999875  5678


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +||||+++|+|.+++...                             ...++|..+..++.|++.||+|||   +.+++|
T Consensus        85 lv~e~~~g~~L~~~l~~~-----------------------------~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H  132 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN-----------------------------KNKINLKQQLKYAVQICKGMDYLG---SRQYVH  132 (284)
T ss_pred             EEEEccCCCCHHHHHHhc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeee
Confidence            999999999999998642                             235789999999999999999999   899999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCCc----cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD----EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      |||||+||+++.++.+||+|||+++.......    .....++..|+|||++.+..  ++.++|||||||++||+++++.
T Consensus       133 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~ellt~~~  210 (284)
T cd05079         133 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK--FYIASDVWSFGVTLYELLTYCD  210 (284)
T ss_pred             cccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCC--CCccccchhhhhhhhhhhcCCC
Confidence            99999999999999999999999987653321    12334677899999887655  6889999999999999999887


Q ss_pred             CCCCCCC--------ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          737 PLGDDYP--------EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       737 p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                      |+.....        .........++... ....         ....+..++.++.+++.+||+.+|++||+++++++.|
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  280 (284)
T cd05079         211 SESSPMTLFLKMIGPTHGQMTVTRLVRVL-EEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF  280 (284)
T ss_pred             CCccccchhhhhcccccccccHHHHHHHH-HcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            6543111        00111112222111 1110         1111234567899999999999999999999999999


Q ss_pred             Hhh
Q 003504          809 KDI  811 (815)
Q Consensus       809 ~~i  811 (815)
                      +++
T Consensus       281 ~~~  283 (284)
T cd05079         281 EAI  283 (284)
T ss_pred             Hhh
Confidence            876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.6e-36  Score=322.38  Aligned_cols=270  Identities=27%  Similarity=0.352  Sum_probs=205.1

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC--------CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP--------GGIHVAVKVLVHGST-LTDQEAARELEYLGRI-KHPNLVPLTGYCIAGD  577 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  577 (815)
                      ++|.+.+.||+|+||.||+|+..        ....||+|.++.... .....+.+|++++.++ +||||++++++|....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46788999999999999999742        245799998875322 2345688999999999 6999999999999988


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++||||+++|+|.+++...........            ...  .......++|....+++.|++.||+|||   +.+
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~------------~~~--~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~g  154 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYT------------FDI--TKVPEEQLSFKDLVSCAYQVARGMEYLE---SRR  154 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCccccc------------ccc--cCCcccccCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            99999999999999999976421110000            000  0012346899999999999999999999   899


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-  733 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-  733 (815)
                      ++||||||+||+++.++.+||+|||+++.......   .....++..|+|||.+....  ++.++|||||||++||+++ 
T Consensus       155 i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~~  232 (314)
T cd05099         155 CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV--YTHQSDVWSFGILMWEIFTL  232 (314)
T ss_pred             eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC--cCccchhhHHHHHHHHHHhC
Confidence            99999999999999999999999999986643211   11222456799999987655  7889999999999999999 


Q ss_pred             CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      |..||.....++    +.   .. .....         ....+..++.++.+++.+||+.+|++||++.++++.|.++..
T Consensus       233 g~~p~~~~~~~~----~~---~~-~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         233 GGSPYPGIPVEE----LF---KL-LREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             CCCCCCCCCHHH----HH---HH-HHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            888986532211    11   11 11111         011133445678899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3e-36  Score=319.85  Aligned_cols=264  Identities=20%  Similarity=0.286  Sum_probs=194.9

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCC---CCCCceeeeeEEEeC-----C
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRI---KHPNLVPLTGYCIAG-----D  577 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~  577 (815)
                      +|++.+.||+|+||.||+|.. .+++.||+|.++....  .....+.+|+++++++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            477889999999999999985 4688999999865321  2234566777777665   699999999988652     3


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++||||+++ +|.+++...                            ....+++.....++.|++.||+|||   +.+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~----------------------------~~~~~~~~~~~~~~~qi~~al~~lH---~~~  128 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV----------------------------PPPGLPAETIKDLMRQFLRGLDFLH---ANC  128 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            57899999985 898888652                            1234788889999999999999999   889


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      |+||||||+||+++.++.+||+|||+++............|+..|+|||++.+..  ++.++|||||||++|||++|+.|
T Consensus       129 ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~~  206 (288)
T cd07863         129 IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPL  206 (288)
T ss_pred             eecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCC--CCCcchhhhHHHHHHHHHhCCcC
Confidence            9999999999999999999999999998775444444556899999999987665  78999999999999999999999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCC------cccccccc---CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGS------RAIDPKIR---DTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      |......+....+..++.......+..      ....+...   .......+.++.+++.+|++.||++||++.+++.
T Consensus       207 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         207 FCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            975433222111211110000000000      00000000   0011234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.6e-36  Score=314.56  Aligned_cols=249  Identities=27%  Similarity=0.399  Sum_probs=191.8

Q ss_pred             CeecccCCeeeEEEEcC----CCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEe-CCeeEEEEEeCC
Q 003504          514 TLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIA-GDQRIAIYDYME  587 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~ey~~  587 (815)
                      +.||+|+||.||+|...    +...||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    24579999885422 2334678899999999999999999998764 446789999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.++++..                             .....+..+..++.|++.||+|||   +.+++||||||+|
T Consensus        81 ~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~n  128 (262)
T cd05058          81 HGDLRNFIRSE-----------------------------THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARN  128 (262)
T ss_pred             CCCHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcce
Confidence            99999999752                             223567778899999999999999   7899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCC-----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhC-CCCCCCC
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGL-----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG-KKPLGDD  741 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~  741 (815)
                      |+++.++.+||+|||+++......     ......++..|+|||.+....  ++.++|||||||++|||++| ..||...
T Consensus       129 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~~~~~~  206 (262)
T cd05058         129 CMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDV  206 (262)
T ss_pred             EEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCc--cchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999999997653221     112234577899999887655  78899999999999999995 5555432


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      ..       ...........          ....+...+..+.+++.+||..+|++||++.++++.|+++..
T Consensus       207 ~~-------~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         207 DS-------FDITVYLLQGR----------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CH-------HHHHHHHhcCC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            11       11112111111          011122345678899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.4e-36  Score=313.73  Aligned_cols=246  Identities=24%  Similarity=0.352  Sum_probs=197.7

Q ss_pred             CeecccCCeeeEEEEcCC--C--cEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFLPG--G--IHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3699999977554 445688999999999999999999999988 889999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|.+++....                            ...++|.....++.|++.||+|||   +.+++||||||+||
T Consensus        80 ~~L~~~l~~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~ni  128 (257)
T cd05040          80 GSLLDRLRKDA----------------------------LGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNI  128 (257)
T ss_pred             CcHHHHHHhcc----------------------------cccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccE
Confidence            99999997521                            135789999999999999999999   88999999999999


Q ss_pred             EEcCCCCeeecccccceecCCCC----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCC
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP  743 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~  743 (815)
                      +++.++.+||+|||+++......    ......++..|+|||.+....  ++.++|||||||++|||++ |+.||.....
T Consensus       129 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~  206 (257)
T cd05040         129 LLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT--FSHASDVWMFGVTLWEMFTYGEEPWAGLSG  206 (257)
T ss_pred             EEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccC--cCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999998765422    112234678899999887665  7889999999999999999 9999864322


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                      .+    +.   +......  .       ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       207 ~~----~~---~~~~~~~--~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         207 SQ----IL---KKIDKEG--E-------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HH----HH---HHHHhcC--C-------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11    11   1111110  0       01113345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.9e-36  Score=315.80  Aligned_cols=255  Identities=24%  Similarity=0.344  Sum_probs=202.1

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCC----CcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG----GIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      .+|.+.+.||+|+||.||+|...+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999998543    3468999886543 3345678999999999999999999998875 457899


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      |||+++|+|.+++...                             ...+++..+..++.|++.||+|||   +.+++|||
T Consensus        85 ~e~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~d  132 (270)
T cd05056          85 MELAPLGELRSYLQVN-----------------------------KYSLDLASLILYSYQLSTALAYLE---SKRFVHRD  132 (270)
T ss_pred             EEcCCCCcHHHHHHhC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence            9999999999999642                             224789999999999999999999   88999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLG  739 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~  739 (815)
                      |||+||+++.++.+||+|||+++.......  .....++..|+|||.+....  ++.++||||||+++||+++ |..||.
T Consensus       133 l~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~pf~  210 (270)
T cd05056         133 IAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMLGVKPFQ  210 (270)
T ss_pred             cChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCC--CCchhhhHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999999987644321  11223456899999886554  6889999999999999996 999997


Q ss_pred             CCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhhc
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~~  814 (815)
                      .....+    ...+.    ...  ...       ..+..++.++.+++.+|+..+|++||++.++++.|+++...
T Consensus       211 ~~~~~~----~~~~~----~~~--~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         211 GVKNND----VIGRI----ENG--ERL-------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             CCCHHH----HHHHH----HcC--CcC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            533211    11111    111  000       11334566899999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-36  Score=335.63  Aligned_cols=248  Identities=23%  Similarity=0.248  Sum_probs=189.2

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      .|+..+.||+|+||.||+|+. .+++.||||++.....   .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            577889999999999999985 5688999999865322   223467889999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++|+|.+++...                              ..++......++.|++.||+|||   +.+|||||||
T Consensus        82 ~~~gg~L~~~l~~~------------------------------~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlK  128 (382)
T cd05625          82 YIPGGDMMSLLIRM------------------------------GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIK  128 (382)
T ss_pred             CCCCCcHHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            99999999998642                              23566667788999999999999   8899999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCC------------------------------------------------Cccccc
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNG------------------------------------------------LDEEIA  696 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~------------------------------------------------~~~~~~  696 (815)
                      |+|||++.++.+||+|||+++.....                                                ......
T Consensus       129 p~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (382)
T cd05625         129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSL  208 (382)
T ss_pred             HHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccc
Confidence            99999999999999999997532100                                                001123


Q ss_pred             cccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCC
Q 003504          697 RGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGP  776 (815)
Q Consensus       697 ~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  776 (815)
                      .||+.|+|||++.+..  ++.++|||||||++|||++|+.||....+.+..       .......  .     .......
T Consensus       209 ~gt~~Y~aPE~~~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~--~-----~~~~p~~  272 (382)
T cd05625         209 VGTPNYIAPEVLLRTG--YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQ-------MKVINWQ--T-----SLHIPPQ  272 (382)
T ss_pred             ccCcccCCHHHhcCCC--CCCeeeEEechHHHHHHHhCCCCCCCCCHHHHH-------HHHHccC--C-----CcCCCCc
Confidence            5899999999987665  789999999999999999999999764332211       1111100  0     0110111


Q ss_pred             HHHHHHHHHHHhhccccCCCCCCC---HHHHHH
Q 003504          777 EKQMEEALKIGYLCTADLPLKRPS---MQQIVG  806 (815)
Q Consensus       777 ~~~~~~~~~l~~~Cl~~dP~~RPs---~~~v~~  806 (815)
                      ...+.+..+++.+++ .+|++|++   +.++++
T Consensus       273 ~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         273 AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            123445666666655 49999997   777654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.4e-36  Score=317.47  Aligned_cols=250  Identities=22%  Similarity=0.326  Sum_probs=198.4

Q ss_pred             CCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          510 FDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      |++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++......++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            456788999999999999964 5778899998665444556788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|..++...                             ...+++..+..++.|++.||+|||   +.+++||||||+||
T Consensus        87 ~~l~~~~~~~-----------------------------~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~ni  134 (282)
T cd06643          87 GAVDAVMLEL-----------------------------ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNI  134 (282)
T ss_pred             CcHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccE
Confidence            9999988642                             235789999999999999999999   78999999999999


Q ss_pred             EEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCC---CCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPD---SDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +++.++.+||+|||++....... ......|+..|+|||++...   ...++.++|||||||++|||++|+.||....+.
T Consensus       135 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~  214 (282)
T cd06643         135 LFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM  214 (282)
T ss_pred             EEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH
Confidence            99999999999999987654322 22334589999999987532   122578999999999999999999998753221


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +       .+.......      .+..  ..+...+.++.+++.+||+.+|++||++.++++
T Consensus       215 ~-------~~~~~~~~~------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         215 R-------VLLKIAKSE------PPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             H-------HHHHHhhcC------CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1       111111111      0111  113334567899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.8e-36  Score=319.40  Aligned_cols=248  Identities=22%  Similarity=0.354  Sum_probs=203.0

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .+|+..+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5788899999999999999994 578999999997655555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++++|.+++...                               .+++..+..++.|++.||.|||   +.+++||||||+
T Consensus        99 ~~~~L~~~~~~~-------------------------------~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~  144 (297)
T cd06656          99 AGGSLTDVVTET-------------------------------CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSD  144 (297)
T ss_pred             CCCCHHHHHHhC-------------------------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHH
Confidence            999999998641                               3577888999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCCc-cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGLD-EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||+++.++.+||+|||++........ .....|++.|+|||.+.+..  ++.++|||||||++|++++|+.||....+..
T Consensus       145 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slGvil~~l~tg~~pf~~~~~~~  222 (297)
T cd06656         145 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLR  222 (297)
T ss_pred             HEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCcch
Confidence            99999999999999999987654322 22345888999999987655  6889999999999999999999997533211


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..   .    ....        ........+...+..+.+++.+||..+|++||+++++++
T Consensus       223 ~~---~----~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         223 AL---Y----LIAT--------NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             he---e----eecc--------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            10   0    0000        000011123445667889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.6e-36  Score=319.29  Aligned_cols=248  Identities=23%  Similarity=0.384  Sum_probs=202.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3577889999999999999984 678999999987655555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.+++..                               ..+++..+..++.|++.||+|||   +.+++||||||+
T Consensus        99 ~~~~L~~~~~~-------------------------------~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~  144 (296)
T cd06655          99 AGGSLTDVVTE-------------------------------TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSD  144 (296)
T ss_pred             CCCcHHHHHHh-------------------------------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHH
Confidence            99999998853                               24688999999999999999999   899999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCCc-cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGLD-EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||+++.++.+||+|||++........ .....|+..|+|||.+.+..  ++.++|||||||++||+++|+.||....+.+
T Consensus       145 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvil~~lltg~~pf~~~~~~~  222 (296)
T cd06655         145 NVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLR  222 (296)
T ss_pred             HEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999886543322 22345888999999987665  6889999999999999999999997533211


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                             ......... .     +  ....+...+..+.+++.+||..||++||++.++++
T Consensus       223 -------~~~~~~~~~-~-----~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         223 -------ALYLIATNG-T-----P--ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -------HHHHHHhcC-C-----c--ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                   111111110 0     0  01123345567889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.5e-36  Score=319.33  Aligned_cols=274  Identities=26%  Similarity=0.395  Sum_probs=206.4

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCee
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  579 (815)
                      .++|+..+.||+|+||.||+|...      ++..||+|.+..... .....+.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888999999999999999853      467899999865432 2345789999999999999999999999999999


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++|+||+++|+|.++++...........  .+      .............+++..++.++.|++.||+|||   ..+++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~--~~------~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~  152 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLS--HS------TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFV  152 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCcccccccc--cc------ccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            9999999999999999754211100000  00      0000011122345789999999999999999999   88999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~  735 (815)
                      ||||||+||++++++.+||+|||+++......   ......++..|+|||.+.+..  ++.++|||||||++|||++ |.
T Consensus       153 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~~~~  230 (288)
T cd05050         153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGM  230 (288)
T ss_pred             cccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC--CCchhHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999988654322   112223466799999887665  7889999999999999998 88


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHh
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD  810 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~  810 (815)
                      .||.+...+       ....... .....         ..+...+.++.+++.+||+.+|++||++.|+++.|++
T Consensus       231 ~p~~~~~~~-------~~~~~~~-~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         231 QPYYGMAHE-------EVIYYVR-DGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCCCCCCHH-------HHHHHHh-cCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            888643221       1122111 11110         1133456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=321.76  Aligned_cols=251  Identities=25%  Similarity=0.316  Sum_probs=212.4

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCC-CCCceeeeeEEEeCCeeEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTL---TDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l  581 (815)
                      ...|++.+.||+|.||.||+++.+ +|+.+|+|.+.+....   ....+.+|+.+|+++. |||||.+.+.+++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            356888899999999999999965 4999999999775443   3458999999999998 9999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      |||++.+|.|.+.+...                               .++......++.|++.++.|||   +.+||||
T Consensus       114 vmEL~~GGeLfd~i~~~-------------------------------~~sE~da~~~~~~il~av~~lH---~~gvvHr  159 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-------------------------------HYSERDAAGIIRQILEAVKYLH---SLGVVHR  159 (382)
T ss_pred             EEEecCCchHHHHHHHc-------------------------------cCCHHHHHHHHHHHHHHHHHHH---hCCceec
Confidence            99999999999999651                               1677788899999999999999   8999999


Q ss_pred             cCCCCceEEcCC----CCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          662 DIKASSVYLDMN----LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      ||||+|+|+...    +.+|++|||+|.....+......+||+.|+|||++....  ++..+||||.||++|.|+.|..|
T Consensus       160 DlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~--y~~~~DiWS~Gvi~yiLL~G~~P  237 (382)
T KOG0032|consen  160 DLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRP--YGDEVDVWSIGVILYILLSGVPP  237 (382)
T ss_pred             cCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCC--CCcccchhHHHHHHHHHhhCCCC
Confidence            999999999643    479999999999988766777889999999999998766  79999999999999999999999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      |.+....+...       .....+       ..+........+..+-+++..|+..||.+|+++.++++.
T Consensus       238 F~~~~~~~~~~-------~i~~~~-------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  238 FWGETEFEIFL-------AILRGD-------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CcCCChhHHHH-------HHHcCC-------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            98754332211       112211       133344456678889999999999999999999999873

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.5e-36  Score=312.46  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=200.6

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecC-CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG-STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      +|++.+.||+|+||.||+++. .++..+|+|.++.. .....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            477789999999999999995 46889999998643 2334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.+++...                            ....++......++.|++.||.|||   +.+++|+||||+
T Consensus        81 ~~~~l~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~  129 (255)
T cd08219          81 DGGDLMQKIKLQ----------------------------RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSK  129 (255)
T ss_pred             CCCcHHHHHHhc----------------------------cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcc
Confidence            999999988642                            1234677888999999999999999   899999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||++++++.++++|||.+....... ......|+..|+|||+..+..  ++.++||||||+++|+|++|+.||.....  
T Consensus       130 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--  205 (255)
T cd08219         130 NIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP--YNNKSDIWSLGCILYELCTLKHPFQANSW--  205 (255)
T ss_pred             eEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCC--cCchhhhhhhchhheehhhccCCCCCCCH--
Confidence            9999999999999999998765322 223345889999999987665  78899999999999999999999975321  


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                           ........ ....         ...+...+..+.+++.+||+.||++||++.+++..
T Consensus       206 -----~~~~~~~~-~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         206 -----KNLILKVC-QGSY---------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -----HHHHHHHh-cCCC---------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                 11111111 1110         01123345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.7e-36  Score=325.07  Aligned_cols=240  Identities=24%  Similarity=0.292  Sum_probs=191.8

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCCeeEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~  583 (815)
                      +|+..+.||+|+||.||+|.. .+|+.||||++....   ....+.+..|..+++.+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            467789999999999999985 568899999987532   222345778888888885 577888999999889999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++..                              ...+++.....++.|++.||+|||   +.+|+||||
T Consensus        81 Ey~~~g~L~~~i~~------------------------------~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDi  127 (323)
T cd05615          81 EYVNGGDLMYHIQQ------------------------------VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDL  127 (323)
T ss_pred             cCCCCCcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCC
Confidence            99999999999864                              235788899999999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      ||+|||++.++.+||+|||+++..... .......||+.|+|||++.+..  ++.++|||||||++|||++|+.||....
T Consensus       128 kp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~~  205 (323)
T cd05615         128 KLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGED  205 (323)
T ss_pred             CHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCC--CCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998864322 2233456899999999987665  6889999999999999999999997533


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      ..       ..........           ...+...+.++.+++.+|++.+|.+|++.
T Consensus       206 ~~-------~~~~~i~~~~-----------~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         206 ED-------ELFQSIMEHN-----------VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HH-------HHHHHHHhCC-----------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            21       1122222111           01123345678899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.1e-36  Score=316.71  Aligned_cols=257  Identities=24%  Similarity=0.379  Sum_probs=205.2

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            4577788999999999999995 468899999886543 23356789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++|+|.++++.                              ...+++.....++.+++.||.|||+  ..+++||||||
T Consensus        85 ~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p  132 (284)
T cd06620          85 MDCGSLDRIYKK------------------------------GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKP  132 (284)
T ss_pred             CCCCCHHHHHHh------------------------------ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCH
Confidence            999999998864                              2347888899999999999999994  35899999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      +||+++.++.++|+|||++...... ......|+..|+|||.+.+..  ++.++|||||||++||+++|+.||......+
T Consensus       133 ~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~  209 (284)
T cd06620         133 SNILVNSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGK--YTVKSDVWSLGISIIELALGKFPFAFSNIDD  209 (284)
T ss_pred             HHEEECCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccCC--CCccchHHHHHHHHHHHHhCCCCCcccchhh
Confidence            9999999999999999998765332 223446899999999987654  7889999999999999999999998644321


Q ss_pred             ----ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          746 ----KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       746 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                          ....+..+........      .+.+   .....+.++.+++.+||+.||++||++.++++..
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~------~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         210 DGQDDPMGILDLLQQIVQEP------PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             hhhhhhhHHHHHHHHHhhcc------CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                1122333333332211      1111   1223566789999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.6e-36  Score=320.66  Aligned_cols=261  Identities=21%  Similarity=0.315  Sum_probs=198.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ++|++.+.||+|+||.||+|.. .++..+|+|.+..... .....+.+|++++.+++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            3688899999999999999985 4678899998865322 2345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++|+|.++++..                              ..+++.....++.|+++||+|||+  ..+++||||||
T Consensus        81 ~~~~~L~~~l~~~------------------------------~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p  128 (308)
T cd06615          81 MDGGSLDQVLKKA------------------------------GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKP  128 (308)
T ss_pred             cCCCcHHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCCh
Confidence            9999999999652                              346778889999999999999993  25899999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      +||+++.++.+||+|||++...... ......|+..|+|||.+.+..  ++.++|||||||++||+++|+.||.......
T Consensus       129 ~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~  205 (308)
T cd06615         129 SNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH--YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE  205 (308)
T ss_pred             HHEEEecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCcchhh
Confidence            9999999999999999998765432 223456899999999986655  6889999999999999999999986432111


Q ss_pred             ccccHHHHHHHHHhcCCCC------------------------ccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          746 KEGNLVSWVRGLVRNNKGS------------------------RAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                          ...+...........                        .................++.+++.+||..+|++||++
T Consensus       206 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  281 (308)
T cd06615         206 ----LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL  281 (308)
T ss_pred             ----HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH
Confidence                111110000000000                        0000000000011245678999999999999999999


Q ss_pred             HHHHHH
Q 003504          802 QQIVGL  807 (815)
Q Consensus       802 ~~v~~~  807 (815)
                      ++|++.
T Consensus       282 ~~ll~~  287 (308)
T cd06615         282 KELTKH  287 (308)
T ss_pred             HHHhcC
Confidence            999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-36  Score=327.96  Aligned_cols=239  Identities=24%  Similarity=0.250  Sum_probs=188.0

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHH-HhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELE-YLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|.. .+|+.||||++....   ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999984 578999999986532   122344555654 56789999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|..++..                              ...+++.....++.|++.||+|||   +.+|+||||||+||
T Consensus        81 ~~L~~~l~~------------------------------~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NI  127 (325)
T cd05604          81 GELFFHLQR------------------------------ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENI  127 (325)
T ss_pred             CCHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHe
Confidence            999988864                              235678888999999999999999   89999999999999


Q ss_pred             EEcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |++.++.+||+|||+++.... ........||+.|+|||++.+..  ++.++|||||||++|||++|+.||......   
T Consensus       128 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~G~~pf~~~~~~---  202 (325)
T cd05604         128 LLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP--YDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---  202 (325)
T ss_pred             EECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCC--CCCcCccccccceehhhhcCCCCCCCCCHH---
Confidence            999999999999999875432 22334456999999999987765  688999999999999999999999753221   


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                          ...+.......       .+    +...+.++.+++.+|++.+|.+||++++.+
T Consensus       203 ----~~~~~~~~~~~-------~~----~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         203 ----EMYDNILHKPL-------VL----RPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ----HHHHHHHcCCc-------cC----CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence                11222221110       01    112345678999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.8e-36  Score=321.52  Aligned_cols=265  Identities=20%  Similarity=0.285  Sum_probs=198.6

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ++|...+.||+|+||.||+|+. .++..||+|.+..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            4688889999999999999985 4678899999875332 2344678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++ +|.+++...                             ...+++.....++.|++.||+|||   +.+|+||||||
T Consensus        86 ~~~-~l~~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp  132 (309)
T cd07872          86 LDK-DLKQYMDDC-----------------------------GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKP  132 (309)
T ss_pred             CCC-CHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCH
Confidence            985 888887642                             234678888899999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.+||+|||+++...... ......++..|+|||.+.+... ++.++|||||||++|||++|+.||......
T Consensus       133 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~  211 (309)
T cd07872         133 QNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE-YSTQIDMWGVGCIFFEMASGRPLFPGSTVE  211 (309)
T ss_pred             HHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            99999999999999999998654322 2233457899999998865432 688999999999999999999999764332


Q ss_pred             cccccHHHHH--------HHHHhcCCCCccccccccCC----CCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWV--------RGLVRNNKGSRAIDPKIRDT----GPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +....+....        ............-.+.....    .....+.++.+++.+|+..||.+|||++|+++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         212 DELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            2211111100        00000000000000000000    01234567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-36  Score=311.83  Aligned_cols=253  Identities=28%  Similarity=0.421  Sum_probs=202.6

Q ss_pred             CeecccCCeeeEEEEcCC----CcEEEEEEeecCCccc-HHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFLPG----GIHVAVKVLVHGSTLT-DQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|...+    +..||+|.+....... .+.+.+|++.+..++|+||+++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999999653    7889999987643332 57889999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|.+++.......                     .......+++..+.+++.|++.||+|||   +.+++||||||+||
T Consensus        81 ~~L~~~l~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~ni  136 (262)
T cd00192          81 GDLLDYLRKSRPVF---------------------PSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNC  136 (262)
T ss_pred             CcHHHHHhhccccc---------------------cccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceE
Confidence            99999997631100                     0011356899999999999999999999   89999999999999


Q ss_pred             EEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE  744 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~  744 (815)
                      +++.++.+||+|||.+.......   ......++..|+|||.+....  ++.++||||+|+++||+++ |..||......
T Consensus       137 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~  214 (262)
T cd00192         137 LVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI--FTSKSDVWSFGVLLWEIFTLGATPYPGLSNE  214 (262)
T ss_pred             EECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCC--cchhhccHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999998775432   223345788999999887664  7899999999999999999 69998754221


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                          .+   .......          .....+...+.++.+++.+||..+|++||++.|+++.|+
T Consensus       215 ----~~---~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         215 ----EV---LEYLRKG----------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----HH---HHHHHcC----------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                11   1111111          111123445678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9.7e-36  Score=316.52  Aligned_cols=252  Identities=25%  Similarity=0.335  Sum_probs=201.5

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      +.|++.+.||+|+||.||+|+.. ++..||+|.+........+.+.+|+++++.++||||+++++++......++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888899999999999999964 58899999987655555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++++|..++.+.                             ...+++..+..++.|++.||+|||   +.+++||||||+
T Consensus        92 ~~~~l~~~~~~~-----------------------------~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~  139 (292)
T cd06644          92 PGGAVDAIMLEL-----------------------------DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAG  139 (292)
T ss_pred             CCCcHHHHHHhh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcc
Confidence            999999887642                             235788999999999999999999   889999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCC---CCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      ||+++.++.+||+|||++....... ......++..|+|||++.+..   ..++.++|||||||++|||++|+.||....
T Consensus       140 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  219 (292)
T cd06644         140 NVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN  219 (292)
T ss_pred             eEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence            9999999999999999987643322 223445888999999885321   225779999999999999999999987532


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +.       ..........      .+..  ..+...+.++.+++.+||..+|++||+++++++
T Consensus       220 ~~-------~~~~~~~~~~------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         220 PM-------RVLLKIAKSE------PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HH-------HHHHHHhcCC------CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            21       1111111110      1111  113345567899999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-36  Score=315.70  Aligned_cols=254  Identities=25%  Similarity=0.377  Sum_probs=201.3

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CC----cEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GG----IHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      .+|+..+.||+|+||.||+|... +|    ..||+|.+..... .....+.+|+.++++++||||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46778899999999999999853 23    2589998865433 234678899999999999999999999987 78899


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      |+||+++|+|.++++..                             ...+++.....++.|++.||+|||   +.+++||
T Consensus        86 v~e~~~~g~L~~~l~~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~  133 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH-----------------------------KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHR  133 (279)
T ss_pred             EEecCCCCcHHHHHHhc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEec
Confidence            99999999999999752                             234788999999999999999999   7999999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCccc---cccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE---IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p  737 (815)
                      ||||+||++++++.+||+|||+++.........   ...++..|+|||.+....  ++.++||||||+++||+++ |+.|
T Consensus       134 di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p  211 (279)
T cd05057         134 DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI--YTHKSDVWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             ccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCC--cCchhhHHHHHHHHHHHhcCCCCC
Confidence            999999999999999999999998765433211   122356799999886554  6889999999999999999 9999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      |.....++    +.   .... ...  .       ...+..+...+.+++.+||..+|++||++.++++.|+++..
T Consensus       212 ~~~~~~~~----~~---~~~~-~~~--~-------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         212 YEGIPAVE----IP---DLLE-KGE--R-------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCCCHHH----HH---HHHh-CCC--C-------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            97533211    11   1111 110  0       01122344578899999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-36  Score=315.85  Aligned_cols=241  Identities=24%  Similarity=0.361  Sum_probs=189.4

Q ss_pred             CeecccCCeeeEEEEcCC--------CcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          514 TLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +.||+|+||.||+|....        ..+||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998532        234888987654444456788999999999999999999999998999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++|+|.++++..                             ...+++..+++++.|++.||+|||   +.+|+||||||
T Consensus        81 ~~~g~L~~~l~~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp  128 (258)
T cd05078          81 VKFGSLDTYLKKN-----------------------------KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCA  128 (258)
T ss_pred             CCCCcHHHHHhcC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCcc
Confidence            9999999999752                             225788889999999999999999   89999999999


Q ss_pred             CceEEcCCCC--------eeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC-C
Q 003504          666 SSVYLDMNLE--------PRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK-K  736 (815)
Q Consensus       666 ~NIll~~~~~--------~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~-~  736 (815)
                      +||+++.++.        ++++|||++......   ....++..|+|||++..... ++.++|||||||++||+++|. .
T Consensus       129 ~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~~l~~l~~g~~~  204 (258)
T cd05078         129 KNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQN-LSLAADKWSFGTTLWEIFSGGDK  204 (258)
T ss_pred             ceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCC-CCchhhHHHHHHHHHHHHcCCCC
Confidence            9999987765        599999988765432   23457889999999875432 588999999999999999985 5


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                      ||....+..       ... .....       .    ..+.....++.+++.+||+.+|++||+++++++.|+
T Consensus       205 ~~~~~~~~~-------~~~-~~~~~-------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         205 PLSALDSQK-------KLQ-FYEDR-------H----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ChhhccHHH-------HHH-HHHcc-------c----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            554321111       011 11110       0    112223457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-35  Score=314.56  Aligned_cols=261  Identities=26%  Similarity=0.363  Sum_probs=204.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-----CCcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCCceeeeeEEEe--CCee
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-----GGIHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGYCIA--GDQR  579 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  579 (815)
                      .+|...+.||+|+||.||+|+..     ++..||||.+...... ..+.+.+|++++++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35677789999999999999853     3678999999764433 46689999999999999999999999887  5578


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++||||+++|+|.++++..                             ...++|..+..++.|++.||+|||   +.+++
T Consensus        84 ~lv~e~~~~~~l~~~l~~~-----------------------------~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~  131 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH-----------------------------RDQINLKRLLLFSSQICKGMDYLG---SQRYI  131 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC-----------------------------ccccCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            9999999999999999752                             225789999999999999999999   78999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCCcc----ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE----EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      ||||||+||+++.++.+||+|||.+.........    ....++..|+|||......  ++.++||||||+++|||++|+
T Consensus       132 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Di~slG~~l~el~tg~  209 (284)
T cd05038         132 HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK--FSSASDVWSFGVTLYELFTYG  209 (284)
T ss_pred             cCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCC--CCcccchHHHhhhhheeeccC
Confidence            9999999999999999999999999876532211    1223456799999887665  688999999999999999999


Q ss_pred             CCCCCCCCcccc--------ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          736 KPLGDDYPEEKE--------GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       736 ~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      .|+.........        .....+.. .....         .....+..++.++.+++.+||+.+|++||+|.+|+++
T Consensus       210 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05038         210 DPSQSPPAEFLRMIGIAQGQMIVTRLLE-LLKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI  279 (284)
T ss_pred             CCcccccchhccccccccccccHHHHHH-HHHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            998653221100        01111111 11111         1111233455789999999999999999999999999


Q ss_pred             HHhhh
Q 003504          808 LKDIE  812 (815)
Q Consensus       808 L~~i~  812 (815)
                      |+++.
T Consensus       280 l~~i~  284 (284)
T cd05038         280 VDRLR  284 (284)
T ss_pred             HhhcC
Confidence            99863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-36  Score=310.55  Aligned_cols=245  Identities=27%  Similarity=0.411  Sum_probs=197.9

Q ss_pred             CeecccCCeeeEEEEcCCCcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCChh
Q 003504          514 TLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQ  592 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~  592 (815)
                      +.||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999877999999998764433 4567899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcC
Q 003504          593 NLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM  672 (815)
Q Consensus       593 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~  672 (815)
                      ++++..                             ...+++.....++.+++.||+|||   +.+++||||||+||+++.
T Consensus        81 ~~l~~~-----------------------------~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~  128 (251)
T cd05041          81 TFLRKK-----------------------------KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGE  128 (251)
T ss_pred             HHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcC
Confidence            999652                             224678889999999999999999   889999999999999999


Q ss_pred             CCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCccccc
Q 003504          673 NLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEG  748 (815)
Q Consensus       673 ~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~  748 (815)
                      ++.+||+|||+++.......   .....++..|+|||.+.+..  ++.++|||||||++||+++ |..||.......   
T Consensus       129 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---  203 (251)
T cd05041         129 NNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR--YTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---  203 (251)
T ss_pred             CCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCC--CCcchhHHHHHHHHHHHHhccCCCCccCCHHH---
Confidence            99999999999986543221   11222456799999987655  7899999999999999999 888886532211   


Q ss_pred             cHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          749 NLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                       ...   . ....         .....+...+.++.+++.+||..+|++||++.++++.|+
T Consensus       204 -~~~---~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         204 -TRE---R-IESG---------YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -HHH---H-HhcC---------CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence             111   1 1110         011123445678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-35  Score=325.36  Aligned_cols=263  Identities=22%  Similarity=0.217  Sum_probs=196.0

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC------
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD------  577 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  577 (815)
                      .++|+..+.||+|+||.||+|.. .+|..||||.+....  ......+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            46899999999999999999985 568899999986432  233456789999999999999999999986543      


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++||||+++ +|...++.                                .+++.....++.|++.||+|||   +.+
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~--------------------------------~~~~~~~~~~~~qi~~~L~~LH---~~~  143 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM--------------------------------ELDHERMSYLLYQMLCGIKHLH---SAG  143 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc--------------------------------cCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            46899999976 56666542                                2566777889999999999999   899


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      |+||||||+||+++.++.+||+|||+++............||+.|+|||.+.+..  ++.++|||||||++|||++|+.|
T Consensus       144 ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~p  221 (359)
T cd07876         144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELVKGSVI  221 (359)
T ss_pred             cccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCC--CCcchhhHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999998655444444556899999999987765  78899999999999999999999


Q ss_pred             CCCCCCcccccc---------------HHHHHHHHHhcCCCCc------ccccccc---CCCCHHHHHHHHHHHhhcccc
Q 003504          738 LGDDYPEEKEGN---------------LVSWVRGLVRNNKGSR------AIDPKIR---DTGPEKQMEEALKIGYLCTAD  793 (815)
Q Consensus       738 ~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~------~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~  793 (815)
                      |......+....               +...+...........      .......   .........++.+++.+|+..
T Consensus       222 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~  301 (359)
T cd07876         222 FQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI  301 (359)
T ss_pred             CCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhcc
Confidence            976432111000               0001111111110000      0000000   000112346788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 003504          794 LPLKRPSMQQIVGL  807 (815)
Q Consensus       794 dP~~RPs~~~v~~~  807 (815)
                      ||++|||+.|+++.
T Consensus       302 dP~~R~t~~e~l~h  315 (359)
T cd07876         302 DPDKRISVDEALRH  315 (359)
T ss_pred             CcccCCCHHHHhcC
Confidence            99999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.8e-36  Score=325.49  Aligned_cols=239  Identities=24%  Similarity=0.260  Sum_probs=185.8

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHH-HHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAAREL-EYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|+. .+++.||+|++.....   .....+.+|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4799999999999995 4678899999865321   1223344444 456788999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|.+++...                              ..+.......++.|++.||+|||   +.+|+||||||+||
T Consensus        81 ~~L~~~~~~~------------------------------~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Ni  127 (325)
T cd05602          81 GELFYHLQRE------------------------------RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENI  127 (325)
T ss_pred             CcHHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHe
Confidence            9999998642                              23455666779999999999999   89999999999999


Q ss_pred             EEcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |++.++.+||+|||+++.... ........||+.|+|||++.+..  ++.++|||||||++|||++|+.||......   
T Consensus       128 li~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~---  202 (325)
T cd05602         128 LLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---  202 (325)
T ss_pred             EECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCC--CCCccccccccHHHHHHhcCCCCCCCCCHH---
Confidence            999999999999999975432 22234456999999999988765  788999999999999999999999753321   


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                          ..........       .    ..+...+..+.+++.+|++.||.+||++.+.+
T Consensus       203 ----~~~~~i~~~~-------~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         203 ----EMYDNILNKP-------L----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             ----HHHHHHHhCC-------c----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                1112222110       0    01223456788999999999999999877543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=326.28  Aligned_cols=340  Identities=24%  Similarity=0.318  Sum_probs=299.6

Q ss_pred             eEEEEecCCCCCc--------cCCCcccccCCCCCCEEECcCCCCCCCCcc-cCCCCCCCEEEccCCcCCccCCccccCC
Q 003504           29 HVTDFLASNSGLS--------GSVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNF   99 (815)
Q Consensus        29 ~~~~l~~~~~~~~--------g~~~~~~~~~l~~L~~L~Ls~n~l~~lp~~-~~~l~~L~~L~L~~N~i~~~~~~~~~~l   99 (815)
                      ....|+++...+.        |.+|+       .-+.||||+|.|+.+... +.++++|++++|.+|.++ .+|...+-.
T Consensus        53 ~~~lldcs~~~lea~~~~~l~g~lp~-------~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~s  124 (873)
T KOG4194|consen   53 NTRLLDCSDRELEAIDKSRLKGFLPS-------QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHES  124 (873)
T ss_pred             CceeeecCccccccccccccCCcCcc-------ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccc
Confidence            4556778877653        33343       447899999999988554 557999999999999998 788777777


Q ss_pred             CCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEE
Q 003504          100 GLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLN  179 (815)
Q Consensus       100 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~  179 (815)
                      .+|+.|+|.+|.|+.+..+++..++.|+.||||.|.|+.+.-..|..-.++++|+|++|+|+ .+..+.|..+.+|..|.
T Consensus       125 ghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlk  203 (873)
T KOG4194|consen  125 GHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRIT-TLETGHFDSLNSLLTLK  203 (873)
T ss_pred             cceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccc-ccccccccccchheeee
Confidence            78999999999999999999999999999999999999766678888889999999999998 88888889999999999


Q ss_pred             cCCCcccCCCC-CCCCCCCCCeEeccCCcCCCcchhhh--hcccceeeeccccccCcccccccccccCCccceEEEcCCC
Q 003504          180 LAGNEIKGRDT-HFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSEN  256 (815)
Q Consensus       180 L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N  256 (815)
                      |+.|+|+.+|. .|..|++|+.|+|..|.|..+....|  +++|+.|.|..|.+.    .+....|+.+.+++.|+|..|
T Consensus       204 LsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~----kL~DG~Fy~l~kme~l~L~~N  279 (873)
T KOG4194|consen  204 LSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS----KLDDGAFYGLEKMEHLNLETN  279 (873)
T ss_pred             cccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc----cccCcceeeecccceeecccc
Confidence            99999999885 68889999999999999998877777  999999999999865    566778999999999999999


Q ss_pred             ccCcchhhccccCCCCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcCCCCCCc
Q 003504          257 QLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPT  336 (815)
Q Consensus       257 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~  336 (815)
                      ++...-...+.+++.|+.|+||+|.|..+.+.......+|+.|+|++|+|+...+..|..|.+|++|+|++|+++..-..
T Consensus       280 ~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~  359 (873)
T KOG4194|consen  280 RLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEG  359 (873)
T ss_pred             hhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhh
Confidence            99988888899999999999999999999988889999999999999999988999999999999999999999865443


Q ss_pred             c--CCCCccEEEccCCcCcccCCh--HHhhcCCCCceeeccCCCCcccC
Q 003504          337 V--SAKNLGIIDMSHNNLSGEIPA--SLLEKLPQMERFNFSYNNLTLCA  381 (815)
Q Consensus       337 ~--~~~~L~~L~ls~N~l~~~~p~--~~~~~l~~l~~l~l~~N~l~~~~  381 (815)
                      .  .+++|+.|||++|.|++.|-+  ..|..++.|+.|.+.||++...+
T Consensus       360 af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~  408 (873)
T KOG4194|consen  360 AFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIP  408 (873)
T ss_pred             HHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecc
Confidence            3  678999999999999986653  46788999999999999987443

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.2e-36  Score=324.56  Aligned_cols=236  Identities=25%  Similarity=0.283  Sum_probs=184.9

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHH-HhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELE-YLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|+. .++..||+|++.....   .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999996 4688999999865321   22334555554 67889999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|..++..                              ...+.......++.|++.||+|||   +.+|+||||||+||
T Consensus        81 ~~L~~~l~~------------------------------~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NI  127 (321)
T cd05603          81 GELFFHLQR------------------------------ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENI  127 (321)
T ss_pred             CCHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHe
Confidence            999988854                              223566677789999999999999   88999999999999


Q ss_pred             EEcCCCCeeecccccceecCC-CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      +++.++.+||+|||+++.... ........||+.|+|||.+.+..  ++.++|||||||++|||++|+.||.....    
T Consensus       128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~----  201 (321)
T cd05603         128 LLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDV----  201 (321)
T ss_pred             EECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCC--CCCcCcccccchhhhhhhcCCCCCCCCCH----
Confidence            999999999999999875322 22233456899999999987665  78899999999999999999999975321    


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ  802 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  802 (815)
                         .......... .          ...+.....++.+++.+|++.||.+||++.
T Consensus       202 ---~~~~~~i~~~-~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         202 ---SQMYDNILHK-P----------LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ---HHHHHHHhcC-C----------CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence               1111221111 0          011233456788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.4e-36  Score=348.12  Aligned_cols=258  Identities=19%  Similarity=0.277  Sum_probs=199.8

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--CeeE
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQRI  580 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  580 (815)
                      ..++|.+.+.||+|+||.||+|.. .++..||+|.+....  ......+..|+.++++++|||||++++++...  ...+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            446899999999999999999995 457789999886432  22345788999999999999999999988653  4688


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCC----CC
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC----SP  656 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~----~~  656 (815)
                      +||||+++|+|.++|....                          .....+++...+.|+.||+.||+|||+..    ..
T Consensus        91 IVMEY~~gGSL~~lL~k~~--------------------------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k  144 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCY--------------------------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGE  144 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHh--------------------------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccC
Confidence            9999999999999997521                          11235788999999999999999999422    14


Q ss_pred             CeeeccCCCCceEEcCC-----------------CCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcC
Q 003504          657 PIIHRDIKASSVYLDMN-----------------LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS  719 (815)
Q Consensus       657 ~ivHrDlk~~NIll~~~-----------------~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  719 (815)
                      +||||||||+|||++.+                 +.+||+|||+++............||+.|+|||++.+....++.++
T Consensus       145 ~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KS  224 (1021)
T PTZ00266        145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKS  224 (1021)
T ss_pred             CceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchh
Confidence            69999999999999642                 3589999999987654444445569999999999876544478899


Q ss_pred             cchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC
Q 003504          720 DVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP  799 (815)
Q Consensus       720 Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  799 (815)
                      |||||||++|||++|+.||....      .....+.. +...       +.+.   ....+.++.+++..||..+|.+||
T Consensus       225 DVWSLG~ILYELLTGk~PF~~~~------~~~qli~~-lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRP  287 (1021)
T PTZ00266        225 DMWALGCIIYELCSGKTPFHKAN------NFSQLISE-LKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERP  287 (1021)
T ss_pred             HHHHHHHHHHHHHHCCCCCCcCC------cHHHHHHH-HhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCc
Confidence            99999999999999999997422      11122221 1111       1111   112356789999999999999999


Q ss_pred             CHHHHHH
Q 003504          800 SMQQIVG  806 (815)
Q Consensus       800 s~~~v~~  806 (815)
                      ++.|+++
T Consensus       288 Sa~QlL~  294 (1021)
T PTZ00266        288 SALQCLG  294 (1021)
T ss_pred             CHHHHhc
Confidence            9999983

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-35  Score=311.07  Aligned_cols=246  Identities=26%  Similarity=0.392  Sum_probs=197.0

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCccc---------HHHHHHHHHHhcCCCCCCceeeeeEEEeCCe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLT---------DQEAARELEYLGRIKHPNLVPLTGYCIAGDQ  578 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~---------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  578 (815)
                      +|.++..||+|+||.||+|.. .+++.||+|.+.......         .+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367789999999999999985 467899999886543221         1467889999999999999999999999999


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++|+||+++++|.+++..                              ...+++.....++.|++.||+|||   +.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~------------------------------~~~l~~~~~~~~~~~l~~~l~~lH---~~~i  127 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN------------------------------YGAFEETLVRNFVRQILKGLNYLH---NRGI  127 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh------------------------------ccCccHHHHHHHHHHHHHHHHHHH---hcCc
Confidence            9999999999999999964                              224677888899999999999999   7899


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCCCC-------ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHH
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL  731 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el  731 (815)
                      +||||+|+||++++++.+||+|||.++......       ......|+..|+|||.+.+..  ++.++|||||||++|||
T Consensus       128 vH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~il~~l  205 (267)
T cd06628         128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS--YTRKADIWSLGCLVVEM  205 (267)
T ss_pred             ccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCC--CCchhhhHHHHHHHHHH
Confidence            999999999999999999999999998765211       111234788999999987655  68899999999999999


Q ss_pred             HhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       732 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ++|+.||......      .. +.... .     ...+    ..+...+..+.+++.+||+.||.+||++.+|++
T Consensus       206 ~~g~~p~~~~~~~------~~-~~~~~-~-----~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         206 LTGKHPFPDCTQL------QA-IFKIG-E-----NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hhCCCCCCCccHH------HH-HHHHh-c-----cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            9999999752211      00 11100 0     0111    123345678899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-35  Score=329.57  Aligned_cols=260  Identities=20%  Similarity=0.200  Sum_probs=194.7

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ..+|.+.+.||+|+||.||+|... .++.||||...      ...+.+|++++++++|||||++++++...+..++||||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            346888999999999999999964 57889999642      23467899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +. |+|.+++...                             ...++|..+..|+.|++.||+|||   +.+||||||||
T Consensus       242 ~~-~~L~~~l~~~-----------------------------~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP  288 (461)
T PHA03211        242 YR-SDLYTYLGAR-----------------------------LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKT  288 (461)
T ss_pred             cC-CCHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCH
Confidence            95 6898888642                             235889999999999999999999   88999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      +|||++.++.+||+|||+++......   ......||..|+|||++.+..  ++.++|||||||++|||++|..|+....
T Consensus       289 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~~~~sDvwSlGviL~El~~g~~~lf~~~  366 (461)
T PHA03211        289 ENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP--YTPSVDIWSAGLVIFEAAVHTASLFSAS  366 (461)
T ss_pred             HHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCC--CCchHHHHHHHHHHHHHHHcCCCcccCC
Confidence            99999999999999999998764322   122346999999999998766  7899999999999999999887654321


Q ss_pred             Cccc----cccHHHHHHHHHhc-CCCCc----------------cccccccCCCCH---HHHHHHHHHHhhccccCCCCC
Q 003504          743 PEEK----EGNLVSWVRGLVRN-NKGSR----------------AIDPKIRDTGPE---KQMEEALKIGYLCTADLPLKR  798 (815)
Q Consensus       743 ~~~~----~~~~~~~~~~~~~~-~~~~~----------------~~~~~~~~~~~~---~~~~~~~~l~~~Cl~~dP~~R  798 (815)
                      ....    ...+...++..... .....                ...+........   .....+.+++.+||+.||.+|
T Consensus       367 ~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~R  446 (461)
T PHA03211        367 RGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARR  446 (461)
T ss_pred             cccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhC
Confidence            1111    11122222111000 00000                000000000000   123468899999999999999


Q ss_pred             CCHHHHHHH
Q 003504          799 PSMQQIVGL  807 (815)
Q Consensus       799 Ps~~~v~~~  807 (815)
                      ||+.|+++.
T Consensus       447 Psa~elL~h  455 (461)
T PHA03211        447 PSAAELLRL  455 (461)
T ss_pred             cCHHHHhhC
Confidence            999999864

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.5e-36  Score=317.50  Aligned_cols=263  Identities=24%  Similarity=0.361  Sum_probs=202.4

Q ss_pred             HHHHHHHhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeEEEe--
Q 003504          500 FADLLSATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCIA--  575 (815)
Q Consensus       500 ~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~--  575 (815)
                      ++++..+.++|++.+.||+|+||.||+|.. .+++.+|+|.+... ......+.+|+.++.++ +||||+++++++..  
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            345556778999999999999999999985 56889999987542 23346788999999999 69999999998853  


Q ss_pred             ---CCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhc
Q 003504          576 ---GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHH  652 (815)
Q Consensus       576 ---~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~  652 (815)
                         ++..++||||+++|+|.++++...                          .....+++.....++.|++.||.||| 
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH-  141 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFL--------------------------KRGERMEEPIIAYILHEALMGLQHLH-  141 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhh--------------------------ccCccccHHHHHHHHHHHHHHHHHHH-
Confidence               346899999999999999886421                          11335678888999999999999999 


Q ss_pred             CCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCC---CCCCCcCcchhHHHHH
Q 003504          653 GCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVL  728 (815)
Q Consensus       653 ~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~~~Dv~S~Gvvl  728 (815)
                        +.+++||||||+||+++.++.+||+|||+++...... ......|+..|+|||++....   ..++.++|||||||++
T Consensus       142 --~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~  219 (286)
T cd06638         142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITA  219 (286)
T ss_pred             --hCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHH
Confidence              8899999999999999999999999999998764322 223446899999999875321   2267899999999999


Q ss_pred             HHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          729 LELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       729 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      |||++|+.||....+...   +.    ... ..     ..+..  ..+..+..++.+++.+||+.||++||++.++++.
T Consensus       220 ~el~~g~~p~~~~~~~~~---~~----~~~-~~-----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         220 IELGDGDPPLADLHPMRA---LF----KIP-RN-----PPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HHHhcCCCCCCCCchhHH---Hh----hcc-cc-----CCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            999999999875322110   00    000 00     00111  1122344578899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-35  Score=310.85  Aligned_cols=248  Identities=24%  Similarity=0.379  Sum_probs=197.6

Q ss_pred             CCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCc------ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGST------LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      +|...+.||+|+||.||+|...++..+|||.+.....      .....+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4778899999999999999988899999998864321      1124588999999999999999999999999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      +||+++|+|.+++...                              ..+++.....++.|++.||+|||   +.+|+|+|
T Consensus        81 ~e~~~~~~L~~~l~~~------------------------------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~d  127 (265)
T cd06631          81 MEFVPGGSISSILNRF------------------------------GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRD  127 (265)
T ss_pred             EecCCCCcHHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence            9999999999999642                              24577888899999999999999   78999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCC-------CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNG-------LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      |+|+||+++.++.+||+|||++......       .......|+..|+|||.+.+..  ++.++|||||||++||+++|+
T Consensus       128 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~  205 (265)
T cd06631         128 IKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG--YGRKSDIWSIGCTVFEMATGK  205 (265)
T ss_pred             cCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCC--CcchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999998764311       1122345889999999987665  688999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .||.......   ..    .......    ...+.    .+...+.++.+++.+||..+|++||++.++++
T Consensus       206 ~p~~~~~~~~---~~----~~~~~~~----~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         206 PPLASMDRLA---AM----FYIGAHR----GLMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CccccCChHH---HH----HHhhhcc----CCCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            9997432111   00    0001100    00111    13345667899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.5e-36  Score=317.28  Aligned_cols=264  Identities=25%  Similarity=0.360  Sum_probs=205.2

Q ss_pred             cCHHHHHHHhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeEEEe
Q 003504          498 ITFADLLSATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCIA  575 (815)
Q Consensus       498 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  575 (815)
                      +++.++..++++|++.+.||+|+||.||+|.. .+++.+|+|.+... ......+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            34455666788999999999999999999995 56889999998653 23356788899999999 79999999999876


Q ss_pred             CC-----eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHH
Q 003504          576 GD-----QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFL  650 (815)
Q Consensus       576 ~~-----~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yL  650 (815)
                      .+     ..++|+||+++|+|.++++...                          .....+++..+..++.|++.||+||
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~--------------------------~~~~~~~~~~~~~~~~qi~~al~~l  144 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLL--------------------------ICGQRLDEAMISYILYGALLGLQHL  144 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhh--------------------------hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            43     5799999999999999986421                          1134578899999999999999999


Q ss_pred             hcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCC---CCCCcCcchhHHH
Q 003504          651 HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSD---FPTPKSDVYCYGV  726 (815)
Q Consensus       651 H~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~---~~~~~~Dv~S~Gv  726 (815)
                      |   +.+++||||||+||+++.++.+||+|||+++...... ......|+..|+|||.+.....   .++.++|||||||
T Consensus       145 H---~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGv  221 (291)
T cd06639         145 H---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGI  221 (291)
T ss_pred             H---hCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHH
Confidence            9   7899999999999999999999999999988654322 2233468899999998764321   2578999999999


Q ss_pred             HHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          727 VLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       727 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ++|||++|+.||....+.+   .+..    .. ....     +.+  ..++.....+.+++.+||+.+|++||++.++++
T Consensus       222 i~~el~~g~~p~~~~~~~~---~~~~----~~-~~~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         222 TAIELGDGDPPLFDMHPVK---TLFK----IP-RNPP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHHHhhCCCCCCCCcHHH---HHHH----Hh-cCCC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            9999999999997532211   1111    11 1111     111  113344567899999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.2e-36  Score=313.12  Aligned_cols=255  Identities=23%  Similarity=0.334  Sum_probs=190.4

Q ss_pred             CeecccCCeeeEEEEcCC---CcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          514 TLLAEGKFGPVYRGFLPG---GIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      +.||+|+||.||+|...+   ...+|+|.+..... .....+.+|+.+++.++||||++++|++......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997533   35688888754322 23456889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      +|.+++...+.                         ......++.....++.|++.||+|||   +.+|+||||||+||+
T Consensus        81 ~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil  132 (269)
T cd05042          81 DLKNYLRSNRG-------------------------MVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQ  132 (269)
T ss_pred             cHHHHHHhccc-------------------------cccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheE
Confidence            99999976321                         01223467778899999999999999   889999999999999


Q ss_pred             EcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCC-----CCCCCCcCcchhHHHHHHHHHh-CCCCCCC
Q 003504          670 LDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPD-----SDFPTPKSDVYCYGVVLLELIT-GKKPLGD  740 (815)
Q Consensus       670 l~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~  740 (815)
                      +++++.+||+|||+++......   ......++..|+|||++...     ...++.++|||||||++|||++ |..||..
T Consensus       133 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  212 (269)
T cd05042         133 LTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD  212 (269)
T ss_pred             ecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999999999987543321   11223456789999987532     1225789999999999999999 7888864


Q ss_pred             CCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                      ....+    .   ....... ......++.+    +...+.++.+++..|| .||++||++++|++.|.
T Consensus       213 ~~~~~----~---~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         213 LSDEQ----V---LKQVVRE-QDIKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCHHH----H---HHHHhhc-cCccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            32211    1   1111111 1111222222    2345566778889999 49999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-35  Score=321.82  Aligned_cols=270  Identities=27%  Similarity=0.335  Sum_probs=205.3

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC--------CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP--------GGIHVAVKVLVHGST-LTDQEAARELEYLGRI-KHPNLVPLTGYCIAGD  577 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  577 (815)
                      .+|.+++.||+|+||.||+|+..        .+..||+|.+..... ...+.+.+|++++.++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999742        134689998865322 2346788999999999 7999999999999998


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++|+||+++|+|.+++.........   .           ...........++|..+++++.|++.||+|||   +.+
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~---~-----------~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~g  154 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMD---Y-----------SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQK  154 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccc---c-----------ccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            999999999999999999753211000   0           00000012346889999999999999999999   899


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-  733 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-  733 (815)
                      ++||||||+||+++.++.+||+|||+++.......   .....++..|+|||.+....  ++.++|||||||++|||++ 
T Consensus       155 ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~  232 (334)
T cd05100         155 CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTL  232 (334)
T ss_pred             eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC--cCchhhhHHHHHHHHHHHhc
Confidence            99999999999999999999999999987643221   12223456799999987665  6889999999999999998 


Q ss_pred             CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      |..||.....       ..+........          ....+..++.++.+++.+||+.+|++||+|.++++.|+++..
T Consensus       233 g~~p~~~~~~-------~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         233 GGSPYPGIPV-------EELFKLLKEGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             CCCCCCCCCH-------HHHHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            8888864321       22222221111          111123445678999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.1e-36  Score=328.45  Aligned_cols=258  Identities=21%  Similarity=0.273  Sum_probs=199.3

Q ss_pred             HHHHHhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC
Q 003504          502 DLLSATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD  577 (815)
Q Consensus       502 ~l~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  577 (815)
                      ++....++|++.+.||+|+||.||+|.. .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+..
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            4445567899999999999999999995 468899999986421   122345788999999999999999999999999


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++||||+++|+|.+++...                               .++......++.|++.||+|||   +.+
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~-------------------------------~~~~~~~~~~~~qi~~aL~~LH---~~~  162 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY-------------------------------DVPEKWARFYTAEVVLALDAIH---SMG  162 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-------------------------------CCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence            999999999999999998642                               2455667789999999999999   899


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCC--CCCCCcCcchhHHHHHHHHHh
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDS--DFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                      |+||||||+|||++.++.+||+|||+++......  ......||+.|+|||++....  ..++.++|||||||++|||++
T Consensus       163 ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~  242 (371)
T cd05622         163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  242 (371)
T ss_pred             EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh
Confidence            9999999999999999999999999998765332  223456999999999986543  236789999999999999999


Q ss_pred             CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 003504          734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK--RPSMQQIVGL  807 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~~v~~~  807 (815)
                      |+.||.....       .............       +........+.++.+++.+|+..+|.+  ||+++++++.
T Consensus       243 G~~Pf~~~~~-------~~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         243 GDTPFYADSL-------VGTYSKIMNHKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCCCCCCCH-------HHHHHHHHcCCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            9999975322       1112222221110       000112234567888999999844433  7788888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.6e-36  Score=326.43  Aligned_cols=264  Identities=19%  Similarity=0.204  Sum_probs=197.4

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC-----
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD-----  577 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  577 (815)
                      ..++|...+.||+|+||.||+|.. ..++.||||.+....  ......+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            346899999999999999999985 468899999986532  223456788999999999999999999886532     


Q ss_pred             -eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 003504          578 -QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSP  656 (815)
Q Consensus       578 -~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~  656 (815)
                       ..++||||+++ ++.+.+..                                .+++..+..++.|++.||+|||   +.
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~--------------------------------~l~~~~~~~~~~qi~~aL~~LH---~~  138 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM--------------------------------ELDHERMSYLLYQMLCGIKHLH---SA  138 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh--------------------------------cCCHHHHHHHHHHHHHHHHHHH---hC
Confidence             46899999976 66666642                                3567778899999999999999   89


Q ss_pred             CeeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          657 PIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       657 ~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      +|+||||||+||+++.++.+||+|||+++............||..|+|||++.+..  ++.++|||||||++|||++|+.
T Consensus       139 givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~  216 (355)
T cd07874         139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMVRHKI  216 (355)
T ss_pred             CcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999998765544445567899999999987665  7889999999999999999999


Q ss_pred             CCCCCCCccccccHH---------------HHHHHHHhcCC-CCcccccccc--------CCCCHHHHHHHHHHHhhccc
Q 003504          737 PLGDDYPEEKEGNLV---------------SWVRGLVRNNK-GSRAIDPKIR--------DTGPEKQMEEALKIGYLCTA  792 (815)
Q Consensus       737 p~~~~~~~~~~~~~~---------------~~~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~~l~~~Cl~  792 (815)
                      ||.+....+......               ..+........ ......+...        ...+.....++.+++.+|++
T Consensus       217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~  296 (355)
T cd07874         217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV  296 (355)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhc
Confidence            997533211110000               00111111100 0000000000        00112234678899999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 003504          793 DLPLKRPSMQQIVGL  807 (815)
Q Consensus       793 ~dP~~RPs~~~v~~~  807 (815)
                      .||++|||+.|+++.
T Consensus       297 ~dP~~Rps~~ell~h  311 (355)
T cd07874         297 IDPAKRISVDEALQH  311 (355)
T ss_pred             CCchhcCCHHHHhcC
Confidence            999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=311.96  Aligned_cols=246  Identities=24%  Similarity=0.385  Sum_probs=201.0

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      +|+..+.||.|+||.||+|.. .++..||+|.+.... ......+.+|+++++.++||||+++++++.+....++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            677889999999999999995 468899999986543 333467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++++|.++++..                               .+++.....++.|++.||.|||   +.+++||||+|+
T Consensus        82 ~~~~L~~~~~~~-------------------------------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~  127 (274)
T cd06609          82 GGGSCLDLLKPG-------------------------------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAA  127 (274)
T ss_pred             CCCcHHHHHhhc-------------------------------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHH
Confidence            999999998641                               5778899999999999999999   889999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||++++++.++|+|||+++...... ......|+..|+|||++.+..  ++.++|||||||++||+++|+.||....+. 
T Consensus       128 ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~sDv~slG~il~~l~tg~~p~~~~~~~-  204 (274)
T cd06609         128 NILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG--YDEKADIWSLGITAIELAKGEPPLSDLHPM-  204 (274)
T ss_pred             HEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccCchH-
Confidence            9999999999999999998876442 233456888999999988766  789999999999999999999999753211 


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                            ..... .....     .+.+..   ...+.++.+++.+||..+|++||+++++++
T Consensus       205 ------~~~~~-~~~~~-----~~~~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         205 ------RVLFL-IPKNN-----PPSLEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ------HHHHH-hhhcC-----CCCCcc---cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                  11111 11111     111111   114567889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.6e-36  Score=315.45  Aligned_cols=263  Identities=23%  Similarity=0.314  Sum_probs=197.5

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||+|++|.||+|+. .++..||||.++...  ......+.+|+.++++++||||+++++++.++...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            477789999999999999996 468899999986432  22346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      ++ |+|.++++...                           ....+++.....++.|++.||+|||   +.+++||||||
T Consensus        81 ~~-~~l~~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p  129 (285)
T cd07861          81 LS-MDLKKYLDSLP---------------------------KGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKP  129 (285)
T ss_pred             CC-CCHHHHHhcCC---------------------------CCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCH
Confidence            98 68988886531                           1245788899999999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.+||+|||++....... ......+++.|+|||.+.+... ++.++|||||||++|||++|+.||......
T Consensus       130 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~~l~tg~~~~~~~~~~  208 (285)
T cd07861         130 QNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR-YSTPVDIWSIGTIFAEMATKKPLFHGDSEI  208 (285)
T ss_pred             HHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCC-cCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence            99999999999999999998654322 1223357889999998765442 578999999999999999999999753221


Q ss_pred             cccccHHHHHHHHHh-------c----CCCCccccc---cccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVR-------N----NKGSRAIDP---KIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~-------~----~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..   ..........       .    ......++.   ..........+.++.+++.+||..||++||++.+|++
T Consensus       209 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         209 DQ---LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HH---HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            11   1110000000       0    000000000   0000001224567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2e-35  Score=307.81  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=202.4

Q ss_pred             CCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||.|+||.||.+. ..++..||+|.+....  ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            47788999999999999988 4568899999886532  33456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++|+|.+++...                            ....+++..+..++.|++.||+|||   +.+++||||+|
T Consensus        81 ~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p  129 (256)
T cd08221          81 ANGGTLYDKIVRQ----------------------------KGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKT  129 (256)
T ss_pred             cCCCcHHHHHHhc----------------------------cccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCh
Confidence            9999999999752                            1335788899999999999999999   78999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||++++++.+||+|||++....... ......|++.|+|||...+..  ++.++||||||+++|||++|+.||..... 
T Consensus       130 ~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-  206 (256)
T cd08221         130 LNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK--YNFKSDIWALGCVLYELLTLKRTFDATNP-  206 (256)
T ss_pred             HhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCC--CCCcchhHHHHHHHHHHHHCCCCCCCCCH-
Confidence            99999999999999999998764433 233456899999999987665  68899999999999999999999865322 


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                            ...........         .. ..+...+.++.+++.+||..+|++||+++++++.
T Consensus       207 ------~~~~~~~~~~~---------~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         207 ------LNLVVKIVQGN---------YT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ------HHHHHHHHcCC---------CC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                  12222222111         00 1123445678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=308.40  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=203.9

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      ++|+..+.||+|+||.||+|.. .++..+|+|.+........+.+.+|++++++++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            5788889999999999999995 457889999997655555678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++++|.+++...                             ...++......++.|++.||+|||   +.+++||||+|+
T Consensus        83 ~~~~l~~~~~~~-----------------------------~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~  130 (262)
T cd06613          83 GGGSLQDIYQVT-----------------------------RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGA  130 (262)
T ss_pred             CCCcHHHHHHhh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChh
Confidence            999999998652                             234677888999999999999999   889999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCC-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      ||++++++.+||+|||.+....... ......++..|+|||.+.... ..++.++|||||||++|||++|+.||....+.
T Consensus       131 ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~  210 (262)
T cd06613         131 NILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM  210 (262)
T ss_pred             hEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999999988665332 223345788999999987651 12688999999999999999999999753321


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..   ..    . .....   ...+..  ..+...+.++.+++.+||..+|.+||++++|++
T Consensus       211 ~~---~~----~-~~~~~---~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         211 RA---LF----L-ISKSN---FPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HH---HH----H-HHhcc---CCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11   11    0 11110   001111  123445678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-36  Score=315.50  Aligned_cols=254  Identities=23%  Similarity=0.367  Sum_probs=203.1

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      .++|++.+.||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            35688889999999999999996 46889999998765555566789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++|+|.+++...                             ...+++.....++.|++.||.|||   +.+|+||||||
T Consensus        84 ~~~~~L~~~~~~~-----------------------------~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p  131 (280)
T cd06611          84 CDGGALDSIMLEL-----------------------------ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKA  131 (280)
T ss_pred             cCCCcHHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCh
Confidence            9999999998652                             235778889999999999999999   88999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCC---CCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPD---SDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      +||+++.++.++|+|||++....... ......|+..|+|||.+...   ...++.++||||||+++|||++|+.||...
T Consensus       132 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~  211 (280)
T cd06611         132 GNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL  211 (280)
T ss_pred             hhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence            99999999999999999987654322 22334589999999987532   122577999999999999999999999753


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      ...       ..........      .+.+  ..+...+.++.+++.+||..+|++||++.++++.
T Consensus       212 ~~~-------~~~~~~~~~~------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         212 NPM-------RVLLKILKSE------PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CHH-------HHHHHHhcCC------CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            221       1111111110      0111  1133455678899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.8e-36  Score=319.83  Aligned_cols=254  Identities=23%  Similarity=0.381  Sum_probs=198.6

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCc----EEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGI----HVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRI  580 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  580 (815)
                      .++|+..+.||+|+||.||+|+. .++.    .||+|.+..... .....+.+|+.++++++||||++++|+|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            34677889999999999999985 3343    578998865322 2234688999999999999999999998754 467


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +++||+++|+|.+++...                             ...+++..+..++.|++.||+|||   +.+|+|
T Consensus        85 ~v~e~~~~g~l~~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH  132 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH-----------------------------KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVH  132 (303)
T ss_pred             eeehhcCCCCHHHHHHhc-----------------------------ccCCCHHHHHHHHHHHHHHHHHHh---hcCeec
Confidence            899999999999998652                             234678889999999999999999   899999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKK  736 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~  736 (815)
                      |||||+||+++.++.+||+|||+++.......   .....++..|+|||.+.+..  ++.++|||||||++||+++ |+.
T Consensus       133 ~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DiwslG~~l~el~t~g~~  210 (303)
T cd05110         133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGK  210 (303)
T ss_pred             cccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCC--CChHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999987653321   22233567899999987655  6889999999999999998 899


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      ||.+...    .....+    .....  ..       ..+..++..+.+++.+||..+|++||+++++++.|+++.
T Consensus       211 p~~~~~~----~~~~~~----~~~~~--~~-------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         211 PYDGIPT----REIPDL----LEKGE--RL-------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             CCCCCCH----HHHHHH----HHCCC--CC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            9865321    112221    11110  00       012223457889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.3e-35  Score=311.60  Aligned_cols=256  Identities=21%  Similarity=0.282  Sum_probs=200.9

Q ss_pred             CCCCCCeecccCCeeeEEEEcCC--CcEEEEEEeecCC----------cccHHHHHHHHHHhcC-CCCCCceeeeeEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLPG--GIHVAVKVLVHGS----------TLTDQEAARELEYLGR-IKHPNLVPLTGYCIA  575 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~  575 (815)
                      +|++.+.||+|+||.||+|....  +..+|||.+....          .....++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778999999999999999654  6889999885321          1122456778888765 799999999999999


Q ss_pred             CCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCC
Q 003504          576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCS  655 (815)
Q Consensus       576 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~  655 (815)
                      .+..++||||+++++|.+++....                          .....+++..+++++.|++.||.|||+  .
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~--------------------------~~~~~~~~~~~~~~~~~l~~~l~~lh~--~  132 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLK--------------------------EKKQRFTEERIWNIFVQMVLALRYLHK--E  132 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHH--------------------------hccCCCCHHHHHHHHHHHHHHHHHhcc--C
Confidence            999999999999999999885421                          113457888899999999999999993  3


Q ss_pred             CCeeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          656 PPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       656 ~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      .+++||||+|+||+++.++.+||+|||.+.............|+..|+|||.+.+..  ++.++||||||+++||+++|+
T Consensus       133 ~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~ll~~l~~g~  210 (269)
T cd08528         133 KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP--YGEKADVWAFGCILYQMCTLQ  210 (269)
T ss_pred             CceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCCC--CchHHHHHHHHHHHHHHHhCC
Confidence            689999999999999999999999999998765443334556899999999987655  688999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHh
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD  810 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~  810 (815)
                      .||.....       ...........         .........+.++.+++.+||+.||++||++.|+.+++++
T Consensus       211 ~p~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         211 PPFYSTNM-------LSLATKIVEAV---------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             CcccccCH-------HHHHHHHhhcc---------CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            99864221       11122111111         1111112345678899999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.2e-35  Score=307.89  Aligned_cols=240  Identities=25%  Similarity=0.355  Sum_probs=189.9

Q ss_pred             CeecccCCeeeEEEEcCCC-----------cEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          514 TLLAEGKFGPVYRGFLPGG-----------IHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~~-----------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      +.||+|+||.||+|...+.           ..|++|.+...... ...+.+|+.++++++||||++++|++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4689999999999997543           25788877553322 6788999999999999999999999988 788999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      |||+++|+|.+++...                             ...+++..+..++.|++.||+|||   +.+|+|||
T Consensus        79 ~e~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~d  126 (259)
T cd05037          79 EEYVKFGPLDVFLHRE-----------------------------KNNVSLHWKLDVAKQLASALHYLE---DKKLVHGN  126 (259)
T ss_pred             EEcCCCCcHHHHHHhh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeccc
Confidence            9999999999999752                             225788889999999999999999   89999999


Q ss_pred             CCCCceEEcCCC-------CeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-C
Q 003504          663 IKASSVYLDMNL-------EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-G  734 (815)
Q Consensus       663 lk~~NIll~~~~-------~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g  734 (815)
                      |||+||+++.++       .+||+|||+++....   .....++..|+|||++......++.++|||||||++||+++ |
T Consensus       127 lkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~  203 (259)
T cd05037         127 VCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG  203 (259)
T ss_pred             CccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCC
Confidence            999999999887       799999999987643   22344677899999987663337889999999999999999 5


Q ss_pred             CCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       735 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                      ..||......+       +........   .     .    +.....++.+++.+||..+|.+||++.+|++.|+
T Consensus       204 ~~p~~~~~~~~-------~~~~~~~~~---~-----~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         204 EEPLSTLSSSE-------KERFYQDQH---R-----L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCCcccCCchh-------HHHHHhcCC---C-----C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            77776432211       111111000   0     0    0111167899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.3e-35  Score=312.73  Aligned_cols=265  Identities=24%  Similarity=0.310  Sum_probs=200.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      ++|+..+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888899999999999999965 68899999986532  2234568899999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |++++.|..++..                              ...+++..+..++.|++.||+|||   +.+++|||||
T Consensus        81 ~~~~~~l~~~~~~------------------------------~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~  127 (286)
T cd07847          81 YCDHTVLNELEKN------------------------------PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVK  127 (286)
T ss_pred             ccCccHHHHHHhC------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCC
Confidence            9999988887643                              224789999999999999999999   7999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      |+||+++.++.+||+|||++....... ......++..|+|||.+.+... ++.++|||||||++|||++|+.||.+...
T Consensus       128 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~i~~~l~~g~~p~~~~~~  206 (286)
T cd07847         128 PENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ-YGPPVDVWAIGCVFAELLTGQPLWPGKSD  206 (286)
T ss_pred             hhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCC-cCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence            999999999999999999998765433 2233457889999998765432 57899999999999999999999976433


Q ss_pred             ccccccHHHHHHH-------HHhcC-CCCccccccccCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSWVRG-------LVRNN-KGSRAIDPKIRDTGP-----EKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~-------~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .+....+......       ..... .......+......+     ...+..+.+++.+||..+|++||++.++++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         207 VDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            2211111111000       00000 000001111110001     123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.5e-36  Score=318.82  Aligned_cols=265  Identities=21%  Similarity=0.272  Sum_probs=198.9

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ++|...+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            4688889999999999999985 467899999986432 23345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      ++ ++|.+++...                             ...+++.....++.|++.||+|||   +.+|+||||||
T Consensus        86 ~~-~~l~~~l~~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp  132 (301)
T cd07873          86 LD-KDLKQYLDDC-----------------------------GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKP  132 (301)
T ss_pred             cc-cCHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCH
Confidence            98 5999888642                             234678888999999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.+||+|||++....... ......+++.|+|||.+.+... ++.++|||||||++|||++|+.||......
T Consensus       133 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~Dv~slG~~l~el~tg~~~f~~~~~~  211 (301)
T cd07873         133 QNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD-YSTQIDMWGVGCIFYEMSTGRPLFPGSTVE  211 (301)
T ss_pred             HHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCC-CccHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999997654322 2223457889999998765432 678999999999999999999999764332


Q ss_pred             cccccHHHHH--------HHHHhcCCCCccccccccCC----CCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWV--------RGLVRNNKGSRAIDPKIRDT----GPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +....+....        ............-.+.....    .....+..+.+++.+|+..||.+|||++++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         212 EQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             HHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1111111000        00000000000001111111    01234567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-35  Score=313.57  Aligned_cols=255  Identities=23%  Similarity=0.369  Sum_probs=201.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecC-CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHG-STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++||||+++++++......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999965 7899999988653 223346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++++|..+++..                           .....+++.....++.+++.||.|||+  +.+|+||||||
T Consensus        81 ~~~~~l~~~~~~~---------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p  131 (286)
T cd06622          81 MDAGSLDKLYAGG---------------------------VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKP  131 (286)
T ss_pred             cCCCCHHHHHHhc---------------------------cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCH
Confidence            9999999998642                           112357889999999999999999994  35899999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCC----CCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      +||+++.++.+||+|||++....... .....|+..|+|||.+.+..    ..++.++|||||||++||+++|+.||...
T Consensus       132 ~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  210 (286)
T cd06622         132 TNVLVNGNGQVKLCDFGVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE  210 (286)
T ss_pred             HHEEECCCCCEEEeecCCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence            99999999999999999998664332 23345888999999875432    12478999999999999999999999642


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..    ..............          ....+...+.++.+++.+||..+|++||++++++.
T Consensus       211 ~~----~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         211 TY----ANIFAQLSAIVDGD----------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ch----hhHHHHHHHHhhcC----------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            21    11111111111110          11123446778899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.2e-35  Score=308.96  Aligned_cols=247  Identities=27%  Similarity=0.416  Sum_probs=197.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      ++|++.+.||+|+||.||+|.. .+..||+|.++..  ...+.+.+|+.++.+++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588899999999999999975 5778999998642  2346788999999999999999999998654 5789999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.+++...                            ....+++..+.+++.|++.||+|||   +.+++||||||+|
T Consensus        82 ~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~n  130 (254)
T cd05083          82 KGNLVNFLRTR----------------------------GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARN  130 (254)
T ss_pred             CCCHHHHHHhc----------------------------CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcce
Confidence            99999999752                            1234678889999999999999999   8999999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCccc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEK  746 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~  746 (815)
                      |+++.++.+||+|||++.......  .....+..|+|||.+.+..  ++.++|||||||++|||++ |+.||......  
T Consensus       131 ili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--  204 (254)
T cd05083         131 ILVSEDGVAKVSDFGLARVGSMGV--DNSKLPVKWTAPEALKHKK--FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--  204 (254)
T ss_pred             EEEcCCCcEEECCCccceeccccC--CCCCCCceecCHHHhccCC--cCchhhHHHHHHHHHHHHhCCCCCCccCCHH--
Confidence            999999999999999997654321  2223456899999887655  6889999999999999998 99998653221  


Q ss_pred             cccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHh
Q 003504          747 EGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD  810 (815)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~  810 (815)
                           ..... ....         .....+...+.++.+++.+||+.+|++||+++++++.|++
T Consensus       205 -----~~~~~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         205 -----EVKEC-VEKG---------YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -----HHHHH-HhCC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                 11111 1111         1111123456778899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-35  Score=310.62  Aligned_cols=253  Identities=23%  Similarity=0.325  Sum_probs=198.6

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      ++|...+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4667778999999999999985 568899999987654444556889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.+++..                              ...+++.....++.|++.||+|||   +.+++||||||+
T Consensus        89 ~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~  135 (267)
T cd06645          89 GGGSLQDIYHV------------------------------TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGA  135 (267)
T ss_pred             CCCcHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHH
Confidence            99999999864                              224678889999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCC-CCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPD-SDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      ||+++.++.+||+|||++....... ......|+..|+|||++... ...++.++|||||||++|||++|+.||....+.
T Consensus       136 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~  215 (267)
T cd06645         136 NILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM  215 (267)
T ss_pred             HEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch
Confidence            9999999999999999987654322 22344689999999987422 223688999999999999999999998653321


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..   +.    ......    ...+....  ....+..+.+++.+|++.+|++||+++++++
T Consensus       216 ~~---~~----~~~~~~----~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         216 RA---LF----LMTKSN----FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             hh---HH----hhhccC----CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            11   00    001110    11111110  1123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.5e-36  Score=315.32  Aligned_cols=244  Identities=24%  Similarity=0.360  Sum_probs=197.5

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      |+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++......++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            44567899999999999985 467889999886432 2334578899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.+++..                               ..+++.....++.|++.|+.|||   +.+++|+||+|+|
T Consensus        86 ~~~L~~~~~~-------------------------------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~n  131 (277)
T cd06642          86 GGSALDLLKP-------------------------------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAAN  131 (277)
T ss_pred             CCcHHHHhhc-------------------------------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChhe
Confidence            9999998853                               24678888999999999999999   8899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEK  746 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~  746 (815)
                      |++++++.+||+|||++....... ......|+..|+|||.+.+..  ++.++|||||||++||+++|+.||....+...
T Consensus       132 i~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~  209 (277)
T cd06642         132 VLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA--YDFKADIWSLGITAIELAKGEPPNSDLHPMRV  209 (277)
T ss_pred             EEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCC--CchhhhHHHHHHHHHHHHhCCCCCcccchhhH
Confidence            999999999999999998765432 223345788999999987665  68899999999999999999999875332111


Q ss_pred             cccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          747 EGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                          .   . ....         ......+...+.++.+++.+||+.+|++||+|.++++
T Consensus       210 ----~---~-~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         210 ----L---F-LIPK---------NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ----H---h-hhhc---------CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                0   0 0111         1111123345677899999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.5e-35  Score=325.08  Aligned_cols=262  Identities=19%  Similarity=0.206  Sum_probs=196.5

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeC------C
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAG------D  577 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~  577 (815)
                      .++|...+.||+|+||.||+|.. ..++.||||++....  ....+.+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            46799999999999999999984 468899999986532  23345678999999999999999999987643      3


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++||||+++ +|.+++..                                .+++..+..++.|++.||+|||   +.+
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--------------------------------~~~~~~~~~~~~qi~~aL~~LH---~~~  146 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--------------------------------ELDHERMSYLLYQMLCGIKHLH---SAG  146 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--------------------------------cCCHHHHHHHHHHHHHHHHHHh---hCC
Confidence            56999999976 67776642                                2567788899999999999999   899


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      |+||||||+||+++.++.+||+|||+++............||..|+|||++.+..  ++.++|||||||++|||++|+.|
T Consensus       147 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~p  224 (364)
T cd07875         147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIKGGVL  224 (364)
T ss_pred             eecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCC--CCchhhHHhHHHHHHHHHhCCCC
Confidence            9999999999999999999999999998765544445567899999999997765  78899999999999999999999


Q ss_pred             CCCCCCccccccHHH---------------HHHHHHhcCCC-Ccc----cccccc----CCCCHHHHHHHHHHHhhcccc
Q 003504          738 LGDDYPEEKEGNLVS---------------WVRGLVRNNKG-SRA----IDPKIR----DTGPEKQMEEALKIGYLCTAD  793 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~---------------~~~~~~~~~~~-~~~----~~~~~~----~~~~~~~~~~~~~l~~~Cl~~  793 (815)
                      |......+....+..               .+......... ...    ..+...    .........++.+++.+|++.
T Consensus       225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  304 (364)
T cd07875         225 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI  304 (364)
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCc
Confidence            975432211111100               00111111000 000    000000    000112345788999999999


Q ss_pred             CCCCCCCHHHHHH
Q 003504          794 LPLKRPSMQQIVG  806 (815)
Q Consensus       794 dP~~RPs~~~v~~  806 (815)
                      ||++|||+.|+++
T Consensus       305 dP~~R~t~~e~L~  317 (364)
T cd07875         305 DASKRISVDEALQ  317 (364)
T ss_pred             CcccCCCHHHHhc
Confidence            9999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.3e-35  Score=320.79  Aligned_cols=261  Identities=21%  Similarity=0.226  Sum_probs=192.6

Q ss_pred             CCCeeccc--CCeeeEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          512 RGTLLAEG--KFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       512 ~~~~ig~G--~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      +.++||+|  +||+||++.. .+|..||||++.....  ...+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  6789999985 6789999999865322  22346778999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.+++...                            ....+++..+..++.|++.||+|||   +.+|+||||||+
T Consensus        82 ~~~~l~~~~~~~----------------------------~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~  130 (327)
T cd08227          82 AYGSAKDLICTH----------------------------FMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKAS  130 (327)
T ss_pred             CCCcHHHHHHhh----------------------------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChh
Confidence            999999999642                            1224788899999999999999999   889999999999


Q ss_pred             ceEEcCCCCeeecccccceecCC-CC-------ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCC
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGN-GL-------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~-~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~  738 (815)
                      ||+++.++.++++||+.+..... +.       ......++..|+|||++......++.++|||||||++|||++|+.||
T Consensus       131 Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  210 (327)
T cd08227         131 HILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF  210 (327)
T ss_pred             hEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            99999999999999986543321 11       11223467789999998764333688999999999999999999999


Q ss_pred             CCCCCccccccHHHHHHHHHh----------c----CCCCccccccc-----------------cCCCCHHHHHHHHHHH
Q 003504          739 GDDYPEEKEGNLVSWVRGLVR----------N----NKGSRAIDPKI-----------------RDTGPEKQMEEALKIG  787 (815)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~----------~----~~~~~~~~~~~-----------------~~~~~~~~~~~~~~l~  787 (815)
                      ........   ..........          +    .......+...                 ..........++.+++
T Consensus       211 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  287 (327)
T cd08227         211 KDMPATQM---LLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFV  287 (327)
T ss_pred             CCcchhHH---HHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHH
Confidence            75321110   0000000000          0    00000000000                 0001223456889999


Q ss_pred             hhccccCCCCCCCHHHHHH
Q 003504          788 YLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       788 ~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .+||+.||++|||++++++
T Consensus       288 ~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         288 EQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             HHHHhhCchhcCCHHHHhc
Confidence            9999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-35  Score=311.85  Aligned_cols=252  Identities=28%  Similarity=0.425  Sum_probs=197.0

Q ss_pred             CeecccCCeeeEEEEcCC-------CcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          514 TLLAEGKFGPVYRGFLPG-------GIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +.||+|+||.||+|+..+       +..||||.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2579999886543 23456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++|+|.++++.....                       ......++|..++.++.|++.||+|||   +.+++||||||
T Consensus        81 ~~~~~L~~~l~~~~~~-----------------------~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p  134 (269)
T cd05044          81 MEGGDLLSYLRDARVE-----------------------RFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAA  134 (269)
T ss_pred             cCCCcHHHHHHHhhhc-----------------------ccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCCh
Confidence            9999999999753110                       001234788999999999999999999   78999999999


Q ss_pred             CceEEcCCC-----CeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCC
Q 003504          666 SSVYLDMNL-----EPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKK  736 (815)
Q Consensus       666 ~NIll~~~~-----~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~  736 (815)
                      +||+++.++     .+|++|||+++.......   .....++..|+|||++....  ++.++|||||||++|||++ |+.
T Consensus       135 ~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~ellt~g~~  212 (269)
T cd05044         135 RNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQ  212 (269)
T ss_pred             heEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCC--cccchhHHHHHHHHHHHHHcCCC
Confidence            999999877     899999999976543221   12223567899999987665  7899999999999999998 999


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHh
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD  810 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~  810 (815)
                      ||.....    ......+    ...         .....+...+..+.+++.+||..+|++||++.++++.|++
T Consensus       213 p~~~~~~----~~~~~~~----~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         213 PYPALNN----QEVLQHV----TAG---------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             CCcccCH----HHHHHHH----hcC---------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            9864321    1111111    111         1111233456788999999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.9e-36  Score=329.14  Aligned_cols=249  Identities=22%  Similarity=0.261  Sum_probs=192.2

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|+..+.||+|+||.||+|+. .+++.||||+++...   ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3688889999999999999985 468899999997532   222356788999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++..                              ...++......++.|++.||+|||   +.+|+||||
T Consensus        81 E~~~gg~L~~~l~~------------------------------~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDL  127 (360)
T cd05627          81 EFLPGGDMMTLLMK------------------------------KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDI  127 (360)
T ss_pred             eCCCCccHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCC
Confidence            99999999999964                              224677788899999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC------------------------------------ccccccccccccCCcc
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL------------------------------------DEEIARGSPGYIPPEF  707 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~------------------------------------~~~~~~gt~~y~aPE~  707 (815)
                      ||+|||++.++.+||+|||+++......                                    .....+||+.|+|||+
T Consensus       128 kp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  207 (360)
T cd05627         128 KPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEV  207 (360)
T ss_pred             CHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHH
Confidence            9999999999999999999987543210                                    0113469999999999


Q ss_pred             cCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHH
Q 003504          708 AQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIG  787 (815)
Q Consensus       708 ~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  787 (815)
                      +.+..  ++.++|||||||++|||++|+.||....+.+..       ..... ....-.+.+.      ...+.++.+++
T Consensus       208 ~~~~~--~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~-------~~i~~-~~~~~~~p~~------~~~s~~~~~li  271 (360)
T cd05627         208 FMQTG--YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY-------RKVMN-WKETLVFPPE------VPISEKAKDLI  271 (360)
T ss_pred             HcCCC--CCCcceeccccceeeecccCCCCCCCCCHHHHH-------HHHHc-CCCceecCCC------CCCCHHHHHHH
Confidence            87765  788999999999999999999999764432221       11111 0000011111      11344667777


Q ss_pred             hhccccCCCCCCC---HHHHHH
Q 003504          788 YLCTADLPLKRPS---MQQIVG  806 (815)
Q Consensus       788 ~~Cl~~dP~~RPs---~~~v~~  806 (815)
                      .+++ .||.+|++   ++++++
T Consensus       272 ~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         272 LRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             HHhc-cChhhcCCCCCHHHHhc
Confidence            7766 49999995   555543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=345.65  Aligned_cols=270  Identities=28%  Similarity=0.414  Sum_probs=211.2

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC--------CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeC
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP--------GGIHVAVKVLVHGST-LTDQEAARELEYLGRI-KHPNLVPLTGYCIAG  576 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  576 (815)
                      .++..+.+.+|+|+||.|++|...        ....||||.++.... ...+.+..|+++|..+ +||||+.++|+|...
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            344455679999999999999842        145799999976533 3456899999999999 699999999999999


Q ss_pred             CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 003504          577 DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSP  656 (815)
Q Consensus       577 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~  656 (815)
                      ...++|.||+..|+|.++|+..+.  ..       ......     ....+...+.....+.++.|||.||+||+   +.
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~--~~-------~~~~~~-----~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~  437 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRV--TE-------SIDGSG-----VFPNERDALTTKDLLSFAYQIANGMEYLA---SV  437 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccc--cc-------cccccC-----CCccccCCcCHHHHHHHHHHHHHHHHHHh---hC
Confidence            999999999999999999987540  00       000000     00011135888999999999999999999   89


Q ss_pred             CeeeccCCCCceEEcCCCCeeecccccceecCCCCccc--cccc--cccccCCcccCCCCCCCCCcCcchhHHHHHHHHH
Q 003504          657 PIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE--IARG--SPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI  732 (815)
Q Consensus       657 ~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~  732 (815)
                      ++|||||.++|||+..+..+||+|||+|+.........  ...|  ...|||||.+....  ++.|+|||||||+|||++
T Consensus       438 ~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~--ft~kSDVWSfGI~L~Eif  515 (609)
T KOG0200|consen  438 PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV--FTSKSDVWSFGILLWEIF  515 (609)
T ss_pred             CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc--ccccchhhHHHHHHHHHh
Confidence            99999999999999999999999999999765443222  1222  34599999998755  899999999999999999


Q ss_pred             h-CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          733 T-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       733 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      | |..||.+-.+   ..++.++             +.++.+...|..+..++.++|+.||+.+|++||++.++.+.++..
T Consensus       516 sLG~~PYp~~~~---~~~l~~~-------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  516 TLGGTPYPGIPP---TEELLEF-------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             hCCCCCCCCCCc---HHHHHHH-------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            9 9999975211   1112211             233455566888899999999999999999999999999999874

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.9e-35  Score=306.44  Aligned_cols=248  Identities=21%  Similarity=0.315  Sum_probs=201.0

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||+|+||.||+|.. .++..+|||.+....  ......+.+|++++++++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477789999999999999985 568899999986542  23356788999999999999999999999988999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++++|.+++...                            ....+++..+.+++.+++.||+|||   +.+++||||+|
T Consensus        81 ~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~  129 (256)
T cd08220          81 APGGTLAEYIQKR----------------------------CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKT  129 (256)
T ss_pred             CCCCCHHHHHHHh----------------------------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            9999999999752                            1335788889999999999999999   89999999999


Q ss_pred             CceEEcCC-CCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMN-LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.+ +.+||+|||.+.............|+..|+|||.+....  ++.++||||||+++|++++|+.||......
T Consensus       130 ~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~  207 (256)
T cd08220         130 QNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP--YNQKSDIWALGCVLYELASLKRAFEAANLP  207 (256)
T ss_pred             HHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCC--CCcccchHHHHHHHHHHHhCCCCcccCchH
Confidence            99999855 468999999998776544444456889999999987655  688999999999999999999998653221


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                             ..+.......          ....+...+.++.+++.+||..+|++||++.|+++
T Consensus       208 -------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         208 -------ALVLKIMSGT----------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -------HHHHHHHhcC----------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                   1122221111          00112335567889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-35  Score=327.81  Aligned_cols=258  Identities=22%  Similarity=0.202  Sum_probs=196.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC---CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP---GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      .+|.+.+.||+|+||.||+|...   .+..||||.+...     ....+|++++++++||||+++++++......++|||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            47889999999999999999743   3578999987542     345689999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+. ++|.+++..                              ...+++..+..++.|++.||+|||   +.+|||||||
T Consensus       167 ~~~-~~l~~~l~~------------------------------~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlk  212 (392)
T PHA03207        167 KYK-CDLFTYVDR------------------------------SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVK  212 (392)
T ss_pred             hcC-CCHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence            996 588888843                              235789999999999999999999   8899999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      |+|||++.++.+||+|||+++.......   .....||+.|+|||++....  ++.++|||||||++|||++|+.||.+.
T Consensus       213 p~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        213 TENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             HHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            9999999999999999999986654321   22446999999999987766  788999999999999999999999764


Q ss_pred             CCccccccHHHHHHHHHhcCCC-----------------CccccccccCC---CCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKG-----------------SRAIDPKIRDT---GPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~---~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      ........+...++. ......                 .....+.....   .......++.+++.+|+..||++||++
T Consensus       291 ~~~~~~~~l~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa  369 (392)
T PHA03207        291 QVKSSSSQLRSIIRC-MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA  369 (392)
T ss_pred             CCCCcHHHHHHHHHH-hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH
Confidence            433222222211111 100000                 00000000000   001234567889999999999999999


Q ss_pred             HHHHHH
Q 003504          802 QQIVGL  807 (815)
Q Consensus       802 ~~v~~~  807 (815)
                      .+++..
T Consensus       370 ~e~l~~  375 (392)
T PHA03207        370 QDILSL  375 (392)
T ss_pred             HHHhhC
Confidence            999753

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-35  Score=317.68  Aligned_cols=255  Identities=22%  Similarity=0.246  Sum_probs=194.0

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG---STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||.||+|+. .+++.||||++.+.   .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            3688899999999999999995 56889999998642   1223456888999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++...                             ...++......++.|++.||+|||   +.+|+||||
T Consensus        81 e~~~g~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dl  128 (331)
T cd05597          81 DYYVGGDLLTLLSKF-----------------------------EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDI  128 (331)
T ss_pred             ecCCCCcHHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCC
Confidence            999999999999642                             224667778889999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCC---CCCCCCcCcchhHHHHHHHHHhCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPD---SDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~  738 (815)
                      ||+|||++.++.+||+|||++........  .....||+.|+|||++...   ...++.++|||||||++|||++|+.||
T Consensus       129 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf  208 (331)
T cd05597         129 KPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF  208 (331)
T ss_pred             CHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCC
Confidence            99999999999999999999976643322  2234699999999998642   223678999999999999999999999


Q ss_pred             CCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhcccc--CCCCCCCHHHHHHH
Q 003504          739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTAD--LPLKRPSMQQIVGL  807 (815)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~--dP~~RPs~~~v~~~  807 (815)
                      .....       ............... +.+     .....+.++.+++.+|+..  ++..||+++++++.
T Consensus       209 ~~~~~-------~~~~~~i~~~~~~~~-~~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         209 YAESL-------VETYGKIMNHKEHFQ-FPP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCCH-------HHHHHHHHcCCCccc-CCC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            75322       111222221111111 011     0112455677777776644  34448899888754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.8e-35  Score=311.69  Aligned_cols=260  Identities=26%  Similarity=0.326  Sum_probs=201.9

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC------CCcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRI  580 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  580 (815)
                      ++|+..+.||+|+||.||+|+..      +...||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46888899999999999999853      3467999988654333 3467899999999999999999999999988999


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +||||+++|+|.++++......                     .......+++..+..++.|++.||+|||   +.+|+|
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~---------------------~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H  140 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKD---------------------EKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVH  140 (275)
T ss_pred             EEEEecCCCcHHHHHHhccccc---------------------ccccccCCCHHHHHHHHHHHHHHHHHhh---hcCccc
Confidence            9999999999999997532110                     0011235889999999999999999999   889999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p  737 (815)
                      |||||+||+++.++.++++|||+++......  ......++..|+|||.+....  .+.++||||||+++||+++ |..|
T Consensus       141 ~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~~~~~p  218 (275)
T cd05046         141 RDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD--FSTKSDVWSFGVLMWEVFTQGELP  218 (275)
T ss_pred             CcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999987543221  222334677899999887655  6889999999999999999 7888


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                      |.....    ..+.   .... .....        ...+...+.++.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~----~~~~---~~~~-~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         219 FYGLSD----EEVL---NRLQ-AGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ccccch----HHHH---HHHH-cCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            864221    1111   1111 11100        0112234568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.9e-35  Score=307.44  Aligned_cols=247  Identities=24%  Similarity=0.355  Sum_probs=192.6

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc-----ccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--Cee
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST-----LTDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQR  579 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  579 (815)
                      .+|+..+.||+|+||.||+|.. .++..||+|.+.....     .....+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3688899999999999999985 4688999998864321     1234678899999999999999999988763  567


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++++||+++++|.+++..                              ...+++.....++.|++.||+|||   +.+|+
T Consensus        82 ~l~~e~~~~~~L~~~l~~------------------------------~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~  128 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA------------------------------YGALTESVTRKYTRQILEGMSYLH---SNMIV  128 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            899999999999999964                              224678888899999999999999   88999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCC----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      ||||||+||+++.++.+||+|||+++......    ......++..|+|||.+.+..  ++.++|||||||++||+++|+
T Consensus       129 H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~i~~el~~g~  206 (266)
T cd06651         129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG--YGRKADVWSLGCTVVEMLTEK  206 (266)
T ss_pred             eCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCC--CCchhhhHHHHHHHHHHHHCC
Confidence            99999999999999999999999998654211    112345788999999987655  688999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .||......       .........     ...+.    .+......+.+++ +||..+|++||+|+||++
T Consensus       207 ~pf~~~~~~-------~~~~~~~~~-----~~~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         207 PPWAEYEAM-------AAIFKIATQ-----PTNPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCccccchH-------HHHHHHhcC-----CCCCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            999743211       111111110     01111    1333445566666 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.4e-36  Score=316.09  Aligned_cols=264  Identities=22%  Similarity=0.288  Sum_probs=199.5

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTL--TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||+|+||.||+|... +++.||+|++......  ..+.+.+|+++++.++||||+++++++......++|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            5778899999999999999975 5889999988653222  345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++++|.++...                              ...++|..+..++.|++.||+|||   +.+++||||+|
T Consensus        82 ~~~~~l~~~~~~------------------------------~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p  128 (286)
T cd07846          82 VDHTVLDDLEKY------------------------------PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKP  128 (286)
T ss_pred             CCccHHHHHHhc------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCH
Confidence            999999887653                              224789999999999999999999   78999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||++++++.+||+|||++....... ......++..|+|||++.+... ++.++|||||||++|||++|+.||......
T Consensus       129 ~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~el~~g~~~~~~~~~~  207 (286)
T cd07846         129 ENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK-YGRAVDIWAVGCLVTEMLTGEPLFPGDSDI  207 (286)
T ss_pred             HHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccc-cCchHhHHHHHHHHHHHHcCCCCCCCCchH
Confidence            99999999999999999998764432 2223457889999998865432 578999999999999999999998653321


Q ss_pred             cccccHHHHHH-------HHHhcCC-CCccccccccCC-----CCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVR-------GLVRNNK-GSRAIDPKIRDT-----GPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~-------~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +....+..+..       ....... ......+.....     .....+..+.+++.+||..+|++||++.++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         208 DQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            11111111110       0000000 000001111000     01234677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2e-35  Score=312.42  Aligned_cols=261  Identities=26%  Similarity=0.390  Sum_probs=202.6

Q ss_pred             cCHHHHHHHhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeEEEe
Q 003504          498 ITFADLLSATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCIA  575 (815)
Q Consensus       498 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  575 (815)
                      .++.++..+...|+..+.||+|+||.||+|.. .+++.||+|.+... ......+..|+.++.++ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            45566666778999999999999999999995 56889999988653 23345688899999998 69999999999863


Q ss_pred             ------CCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHH
Q 003504          576 ------GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAF  649 (815)
Q Consensus       576 ------~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~y  649 (815)
                            ....+++|||+++|+|.+++....                            ...+++..+..++.|++.||+|
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~al~~  136 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK----------------------------GNALKEDWIAYICREILRGLAH  136 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHcc----------------------------CCCCCHHHHHHHHHHHHHHHHH
Confidence                  357799999999999999986521                            2246677788999999999999


Q ss_pred             HhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCC---CCCCCCcCcchhHH
Q 003504          650 LHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPD---SDFPTPKSDVYCYG  725 (815)
Q Consensus       650 LH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~S~G  725 (815)
                      ||   +.+|+||||||+||++++++.++|+|||++....... ......|+..|+|||.+...   ...++.++||||||
T Consensus       137 LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG  213 (282)
T cd06636         137 LH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG  213 (282)
T ss_pred             HH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHH
Confidence            99   8899999999999999999999999999987654221 22345589999999987632   12267899999999


Q ss_pred             HHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          726 VVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       726 vvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                      |++|||++|+.||....+.+..       ....+      ...+..   ....++.++.+++.+||..||.+||++.|++
T Consensus       214 ~~l~el~~g~~p~~~~~~~~~~-------~~~~~------~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell  277 (282)
T cd06636         214 ITAIEMAEGAPPLCDMHPMRAL-------FLIPR------NPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL  277 (282)
T ss_pred             HHHHHHHhCCCCccccCHHhhh-------hhHhh------CCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence            9999999999999753221110       00000      001111   1234566899999999999999999999987


Q ss_pred             H
Q 003504          806 G  806 (815)
Q Consensus       806 ~  806 (815)
                      +
T Consensus       278 ~  278 (282)
T cd06636         278 K  278 (282)
T ss_pred             c
Confidence            5

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.9e-35  Score=308.59  Aligned_cols=246  Identities=23%  Similarity=0.334  Sum_probs=200.5

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .|+..+.||.|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4667789999999999999964 58899999986532 234567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.+++...                               .+++.....++.|++.||+|||   +.+++|+||+|+
T Consensus        85 ~~~~L~~~i~~~-------------------------------~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~  130 (277)
T cd06640          85 GGGSALDLLRAG-------------------------------PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAA  130 (277)
T ss_pred             CCCcHHHHHhcC-------------------------------CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChh
Confidence            999999998641                               3567778899999999999999   889999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||+++.++.++|+|||++....... ......++..|+|||++.+..  ++.++|||||||++|||++|+.||....+..
T Consensus       131 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~  208 (277)
T cd06640         131 NVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA--YDSKADIWSLGITAIELAKGEPPNSDMHPMR  208 (277)
T ss_pred             hEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCC--CccHHHHHHHHHHHHHHHHCCCCCCCcChHh
Confidence            9999999999999999998765433 223345788999999987655  6889999999999999999999987533221


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      .       .. ..         ........+...+..+.+++.+||+.+|++||+++++++.
T Consensus       209 ~-------~~-~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         209 V-------LF-LI---------PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             H-------hh-hh---------hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1       00 00         0111122345677889999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.1e-35  Score=307.53  Aligned_cols=253  Identities=19%  Similarity=0.302  Sum_probs=188.9

Q ss_pred             eecccCCeeeEEEEcCCC---cEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCC
Q 003504          515 LLAEGKFGPVYRGFLPGG---IHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGN  590 (815)
Q Consensus       515 ~ig~G~~g~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gs  590 (815)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||++++++|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999975433   346677665432 2345688999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEE
Q 003504          591 LQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL  670 (815)
Q Consensus       591 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  670 (815)
                      |.++++....                          .....++.....++.|+++||+|||   +.+++||||||+|||+
T Consensus        82 L~~~l~~~~~--------------------------~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~  132 (268)
T cd05086          82 LKSYLSQEQW--------------------------HRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFL  132 (268)
T ss_pred             HHHHHHhhhc--------------------------ccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEE
Confidence            9999975310                          1223556677889999999999999   7899999999999999


Q ss_pred             cCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCC-----CCCCCcCcchhHHHHHHHHHh-CCCCCCCC
Q 003504          671 DMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDS-----DFPTPKSDVYCYGVVLLELIT-GKKPLGDD  741 (815)
Q Consensus       671 ~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~  741 (815)
                      +.++.+||+|||++.......   ......|+..|+|||++....     ..++.++|||||||++|||++ |..||...
T Consensus       133 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  212 (268)
T cd05086         133 TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL  212 (268)
T ss_pred             cCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999986432211   122345788999999875321     124779999999999999997 56677542


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                      ..       .+........ ......++.+...    ....+.+++..|| .+|++||++++|++.|.
T Consensus       213 ~~-------~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         213 SD-------REVLNHVIKD-QQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CH-------HHHHHHHHhh-cccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            21       1122222222 1222333333322    3456778999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.3e-35  Score=306.44  Aligned_cols=248  Identities=26%  Similarity=0.369  Sum_probs=200.0

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc-----ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST-----LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      +|+..+.||+|+||.||+|+.. ++..||+|.+.....     ...+.+.+|++++++++||||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677899999999999999965 789999999865331     2345788999999999999999999999999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      +||+++++|.++++..                              ..+++..+..++.|++.||+|||   +.+++|||
T Consensus        81 ~e~~~~~~L~~~~~~~------------------------------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~d  127 (258)
T cd06632          81 LELVPGGSLAKLLKKY------------------------------GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRD  127 (258)
T ss_pred             EEecCCCcHHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCC
Confidence            9999999999999642                              24678888999999999999999   88999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      |+|+||+++.++.+||+|||++.............|+..|+|||.+.... .++.++|+|||||++||+++|+.||....
T Consensus       128 l~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~  206 (258)
T cd06632         128 IKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLE  206 (258)
T ss_pred             CCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence            99999999999999999999998765443334456889999999876543 26889999999999999999999997532


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .       ............         ....+......+.+++.+||..+|++||++.++++
T Consensus       207 ~-------~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         207 G-------VAAVFKIGRSKE---------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             H-------HHHHHHHHhccc---------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            1       111111111000         01113345567889999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.6e-35  Score=306.89  Aligned_cols=248  Identities=23%  Similarity=0.361  Sum_probs=201.3

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||+|+||.||++.. .+|+.||+|.+...  ......++.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477889999999999999984 56889999998643  223345789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++++|.+++...                            ....+++....+++.|++.||+|||   +.+++|+||+|
T Consensus        81 ~~~~~l~~~~~~~----------------------------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~  129 (256)
T cd08218          81 CEGGDLYKKINAQ----------------------------RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKS  129 (256)
T ss_pred             CCCCcHHHHHHhc----------------------------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCH
Confidence            9999999998652                            1234678888999999999999999   78999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCc-cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLD-EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.++|+|||++........ .....|+..|+|||+..+..  .+.++|||||||++||+++|+.||....  
T Consensus       130 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~--  205 (256)
T cd08218         130 QNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP--YNNKSDIWALGCVLYEMCTLKHAFEAGN--  205 (256)
T ss_pred             HHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCC--CCCccchhHHHHHHHHHHcCCCCccCCC--
Confidence            999999999999999999987654321 22345788999999987665  6889999999999999999999986422  


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                           ....+........          ...+...+.++.+++.+||+.+|++||++.+|++
T Consensus       206 -----~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         206 -----MKNLVLKIIRGSY----------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -----HHHHHHHHhcCCC----------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 1222222221110          1113345667899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.2e-35  Score=305.52  Aligned_cols=248  Identities=24%  Similarity=0.328  Sum_probs=198.9

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeC-CeeEEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAG-DQRIAIYD  584 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e  584 (815)
                      +|++.+.||+|++|.||++.. .+++.||+|.+.....  ...+.+.+|++++++++|||++++++.+... ...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            477889999999999999995 4578899999865322  3345688999999999999999999987643 35789999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++++|.+++...                            ....+++..+..++.+++.|++|||   +.+++|||||
T Consensus        81 ~~~~~~l~~~l~~~----------------------------~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~  129 (257)
T cd08223          81 FCEGGDLYHKLKEQ----------------------------KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLK  129 (257)
T ss_pred             ccCCCcHHHHHHHh----------------------------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCC
Confidence            99999999999752                            1335788999999999999999999   8899999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      |+||+++.++.++|+|||++....... ......|++.|+|||+..+..  ++.++||||||+++||+++|+.||.... 
T Consensus       130 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~~g~~~~~~~~-  206 (257)
T cd08223         130 TQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP--YNYKSDVWALGCCVYEMATLKHAFNAKD-  206 (257)
T ss_pred             chhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCC--CCchhhhHHHHHHHHHHHcCCCCCCCCC-
Confidence            999999999999999999998764322 223345889999999987665  6889999999999999999999986422 


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                            ............          ....+...+.++.+++.+||+.+|++||++.++++
T Consensus       207 ------~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         207 ------MNSLVYRIIEGK----------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ------HHHHHHHHHhcC----------CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                  122222222111          01123446678999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.9e-35  Score=308.67  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=197.1

Q ss_pred             CCCCCeecccCCeeeEEEEcC----CCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC------
Q 003504          510 FDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD------  577 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  577 (815)
                      |.+.+.||+|+||.||+|...    ++..||||++....  ....+.+.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999853    36889999986532  223456889999999999999999999887542      


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++++||+++|+|..++......                        .....+++....+++.|++.||+|||   +.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~------------------------~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~  133 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIG------------------------EEPFTLPLQTLVRFMIDIASGMEYLS---SKN  133 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhccc------------------------CCCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            247889999999999888542110                        11234778889999999999999999   789


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-  733 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-  733 (815)
                      |+||||||+||+++.++.+||+|||+++....+..   .....++..|++||.+....  ++.++||||||+++||+++ 
T Consensus       134 i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~sDi~slG~il~el~~~  211 (273)
T cd05074         134 FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTR  211 (273)
T ss_pred             EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCc--cchhhhhHHHHHHHHHHhhC
Confidence            99999999999999999999999999987643321   12233567899999887665  6889999999999999999 


Q ss_pred             CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      |+.||......    .+..+..   ....          ...+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       212 g~~p~~~~~~~----~~~~~~~---~~~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         212 GQTPYAGVENS----EIYNYLI---KGNR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCCCCCCHH----HHHHHHH---cCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            88888643221    1221111   1110          001223456899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.4e-36  Score=310.91  Aligned_cols=251  Identities=29%  Similarity=0.454  Sum_probs=196.8

Q ss_pred             CCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHH--HHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          510 FDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQ--EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      |+..+.||+|+||.||+|... ++..||+|.+.........  ...+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            455789999999999999954 5678999999875443332  3456999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++++|.+++..                              ...+++..+..++.|+++||+|||   +.+++||||||+
T Consensus        81 ~~~~L~~~l~~------------------------------~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~  127 (260)
T PF00069_consen   81 PGGSLQDYLQK------------------------------NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPE  127 (260)
T ss_dssp             TTEBHHHHHHH------------------------------HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGG
T ss_pred             ccccccccccc------------------------------cccccccccccccccccccccccc---cccccccccccc
Confidence            99999999962                              235788999999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceec-CCCCccccccccccccCCcccC-CCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIF-GNGLDEEIARGSPGYIPPEFAQ-PDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      ||++++++.++|+|||.+... ..........++..|+|||++. ...  .+.++||||+|+++|+|++|..||......
T Consensus       128 NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~il~~l~~~~~p~~~~~~~  205 (260)
T PF00069_consen  128 NILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKK--YTRKSDIWSLGIILYELLTGKLPFEESNSD  205 (260)
T ss_dssp             GEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSS--BSTHHHHHHHHHHHHHHHHSSSSSTTSSHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccch
Confidence            999999999999999999864 2223444566899999999987 444  689999999999999999999999853111


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .    ............     ......  .......++.+++.+||+.||++||++.++++
T Consensus       206 ~----~~~~~~~~~~~~-----~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  206 D----QLEIIEKILKRP-----LPSSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             H----HHHHHHHHHHTH-----HHHHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             h----hhhhhhhccccc-----cccccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1    111111111000     000000  00111378999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.9e-35  Score=311.02  Aligned_cols=265  Identities=23%  Similarity=0.281  Sum_probs=199.3

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcc-----cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL-----TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      +|+..+.||+|+||.||+|.. .+++.||||.+......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477788999999999999995 46899999999764322     234567899999999999999999999999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      |||+ +|+|.++++..                             ...+++..+..++.|+++||+|||   +.+++|||
T Consensus        81 ~e~~-~~~L~~~i~~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d  127 (298)
T cd07841          81 FEFM-ETDLEKVIKDK-----------------------------SIVLTPADIKSYMLMTLRGLEYLH---SNWILHRD  127 (298)
T ss_pred             Eccc-CCCHHHHHhcc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecC
Confidence            9999 89999999642                             125789999999999999999999   88999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      |||+||+++.++.+||+|||+++...... ......++..|+|||.+.+... ++.++|||||||++||+++|..||...
T Consensus       128 l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~e~~~g~~~~~~~  206 (298)
T cd07841         128 LKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH-YGVGVDMWSVGCIFAELLLRVPFLPGD  206 (298)
T ss_pred             CChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCC-CCcHHHHHHHHHHHHHHHcCCccccCC
Confidence            99999999999999999999998765432 2233356788999998755332 688999999999999999998777653


Q ss_pred             CCccccccHHHHHHH-----HHhcCCCCccccccccCC-----CCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          742 YPEEKEGNLVSWVRG-----LVRNNKGSRAIDPKIRDT-----GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      ...+....+...+..     ..................     .......++.+++.+||+.+|++||+++++++.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         207 SDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            322111111110000     000000000000000000     112345788999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=305.02  Aligned_cols=248  Identities=25%  Similarity=0.326  Sum_probs=211.0

Q ss_pred             cCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      .-|+..+.||+|.|+.|-.|+ .-+|.+||||++.+...  .....+.+|+..|.-++|||||++|.+...+...|+|.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            347778999999999999998 46799999999976432  334567899999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      .=++|+|++|+.+.                             ...+......+.+.||..|+.|+|   ...+||||||
T Consensus        98 LGD~GDl~DyImKH-----------------------------e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLK  145 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKH-----------------------------EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLK  145 (864)
T ss_pred             ecCCchHHHHHHhh-----------------------------hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCC
Confidence            99999999999864                             234556667889999999999999   7889999999


Q ss_pred             CCceEEc-CCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          665 ASSVYLD-MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      |+||.+- .-|-+|+.|||++-.+.++....+.+|+..|-|||++.+..+ .-++.||||+||++|-|+.|+.||.....
T Consensus       146 PENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsY-DAPAVDiWSLGVILyMLVCGq~PFqeAND  224 (864)
T KOG4717|consen  146 PENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSY-DAPAVDIWSLGVILYMLVCGQPPFQEAND  224 (864)
T ss_pred             cceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCcc-CCcchhhhHHHHHHHHHHhCCCccccccc
Confidence            9998775 557899999999999999999999999999999999998874 57899999999999999999999987554


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .+..                ..++|-.+  ..|.....+..+++..|+..||.+|-+.++|+.
T Consensus       225 SETL----------------TmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  225 SETL----------------TMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhh----------------hhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            4332                12223222  237788899999999999999999999998853

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1e-35  Score=316.03  Aligned_cols=247  Identities=23%  Similarity=0.376  Sum_probs=197.3

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      |.....||+|+||.||++.. .++..||||.+........+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            44457899999999999985 46889999998665545566788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      ++|.+++..                               ..+++.....++.|++.||+|||   +.+|+||||||+||
T Consensus       104 ~~L~~~~~~-------------------------------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Ni  149 (292)
T cd06658         104 GALTDIVTH-------------------------------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSI  149 (292)
T ss_pred             CcHHHHHhc-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHE
Confidence            999998853                               13677888999999999999999   78999999999999


Q ss_pred             EEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      +++.++.+||+|||++....... ......|+..|+|||......  ++.++|||||||++||+++|+.||.......  
T Consensus       150 ll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--  225 (292)
T cd06658         150 LLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--  225 (292)
T ss_pred             EEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence            99999999999999987654322 223345889999999987655  6889999999999999999999997532211  


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                           .+.. ...     ...+....  ....+..+.+++.+||..||++||+++++++.
T Consensus       226 -----~~~~-~~~-----~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         226 -----AMRR-IRD-----NLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -----HHHH-HHh-----cCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                 1111 111     01111111  12244578899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.9e-35  Score=304.41  Aligned_cols=249  Identities=31%  Similarity=0.462  Sum_probs=199.2

Q ss_pred             CCCCCeecccCCeeeEEEEcCC-----CcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          510 FDRGTLLAEGKFGPVYRGFLPG-----GIHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      |++.+.||+|+||.||+|+..+     +..||+|.+...... ..+.+..|++++.+++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999999653     478999999764433 4568899999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++++|.+++....                            ...+++..+..++.|++.||+|||   +.+++||||
T Consensus        81 e~~~~~~l~~~~~~~~----------------------------~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl  129 (258)
T smart00219       81 EYMEGGDLLDYLRKNR----------------------------PKELSLSDLLSFALQIARGMEYLE---SKNFIHRDL  129 (258)
T ss_pred             eccCCCCHHHHHHhhh----------------------------hccCCHHHHHHHHHHHHHHHHHHh---cCCeeeccc
Confidence            9999999999997521                            112789999999999999999999   889999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCccc--cccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEE--IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGD  740 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~  740 (815)
                      ||+||+++.++.++|+|||+++.........  ...++..|+|||.+....  ++.++||||+|+++|||++ |+.||..
T Consensus       130 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~i~~~l~~~g~~p~~~  207 (258)
T smart00219      130 AARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGK--FTSKSDVWSFGVLLWEIFTLGESPYPG  207 (258)
T ss_pred             ccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCC--CCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999998765442211  233678999999885544  7899999999999999998 7888764


Q ss_pred             CCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                      ...       ...........          ....+...+.++.+++.+|+..+|++||++.|+++.|
T Consensus       208 ~~~-------~~~~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      208 MSN-------EEVLEYLKKGY----------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCH-------HHHHHHHhcCC----------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            211       11111111111          0111233567899999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=313.49  Aligned_cols=264  Identities=21%  Similarity=0.252  Sum_probs=198.9

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||+|+||.||+|... ++..||||.+....  ....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6788899999999999999964 58899999886532  22346789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      ++++.+..+...                              ...+++.....++.|++.||+|||   ..+++||||+|
T Consensus        82 ~~~~~l~~~~~~------------------------------~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~  128 (288)
T cd07833          82 VERTLLELLEAS------------------------------PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKP  128 (288)
T ss_pred             CCCCHHHHHHhc------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCH
Confidence            998777665543                              224678889999999999999999   78999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      +||++++++.+||+|||++.......  ......++..|+|||++.+.. .++.++||||||+++||+++|+.||.....
T Consensus       129 ~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~  207 (288)
T cd07833         129 ENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT-NYGKPVDVWAIGCIMAELLDGEPLFPGDSD  207 (288)
T ss_pred             HHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999998765433  223345788999999987662 268899999999999999999999975322


Q ss_pred             ccccccHHHHHHH-------HHhc-CCCC--c---ccccc-ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSWVRG-------LVRN-NKGS--R---AIDPK-IRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~-------~~~~-~~~~--~---~~~~~-~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .+....+......       .... ....  +   ..++. .....+...+.++.+++.+||..+|++||+++++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         208 IDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            1110000000000       0000 0000  0   00000 000112234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.6e-35  Score=309.55  Aligned_cols=249  Identities=23%  Similarity=0.358  Sum_probs=201.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      ++|...+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788889999999999999984 568899999986544455667899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.+++...                               .+++..+..++.|++.||+|||   +.+++||||||+
T Consensus        99 ~~~~L~~~~~~~-------------------------------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~  144 (293)
T cd06647          99 AGGSLTDVVTET-------------------------------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSD  144 (293)
T ss_pred             CCCcHHHHHhhc-------------------------------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHH
Confidence            999999998641                               3567888999999999999999   899999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||+++.++.+||+|||++....... ......|++.|+|||.+....  ++.++|||||||++||+++|+.||....+.+
T Consensus       145 Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~  222 (293)
T cd06647         145 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLR  222 (293)
T ss_pred             HEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence            9999999999999999987654332 222345888999999887654  6889999999999999999999997532211


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      ..   .    ....        .+......+...+..+.+++.+||..+|++||++.+++..
T Consensus       223 ~~---~----~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         223 AL---Y----LIAT--------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             he---e----ehhc--------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            10   0    0000        0000111133455678899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-35  Score=298.78  Aligned_cols=248  Identities=23%  Similarity=0.281  Sum_probs=198.3

Q ss_pred             CCCCCCeecccCCeeeEEEEcCC-CcEEEEEEeecCCcccH---HHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      .|...+.||+|.-|+||++...+ +..+|+|++.+......   .....|-+||+.++||.++.+|+.++.....++|||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            34556899999999999999765 58899999977544333   345668999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      ||+||+|..+.+.++                            +..++.....-.|..|.-||+|||   -.|||.||||
T Consensus       158 yCpGGdL~~LrqkQp----------------------------~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLK  206 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQP----------------------------GKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLK  206 (459)
T ss_pred             cCCCccHHHHHhhCC----------------------------CCccchhhHHHHHHHHHHHHHHHH---hhceeeccCC
Confidence            999999999998742                            445666666778899999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCC---------------------------------C---------------------
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGN---------------------------------G---------------------  690 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~---------------------------------~---------------------  690 (815)
                      |+||||-++|++-|+||.++.....                                 .                     
T Consensus       207 PENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ae  286 (459)
T KOG0610|consen  207 PENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAE  286 (459)
T ss_pred             cceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcC
Confidence            9999999999999999998753210                                 0                     


Q ss_pred             ---CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccc
Q 003504          691 ---LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAI  767 (815)
Q Consensus       691 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (815)
                         ......+||-.|+|||++.+..  -+.++|+|+|||++|||+.|+.||-+...++.-.+++                
T Consensus       287 p~~~RSnSFVGThEYlAPEvI~G~G--HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv----------------  348 (459)
T KOG0610|consen  287 PTGARSNSFVGTHEYLAPEVIRGEG--HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV----------------  348 (459)
T ss_pred             CCCccccccccccccccceeeecCC--CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh----------------
Confidence               0111234899999999999887  5889999999999999999999999866554432222                


Q ss_pred             cccccCCCCHHHHHHHHHHHhhccccCCCCCCC----HHHHH
Q 003504          768 DPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS----MQQIV  805 (815)
Q Consensus       768 ~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs----~~~v~  805 (815)
                      -..+.-....+.+.++.+||++.+.+||++|..    ++||-
T Consensus       349 ~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  349 GQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             cCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            111221122266788999999999999999997    55553

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.2e-35  Score=315.87  Aligned_cols=255  Identities=20%  Similarity=0.236  Sum_probs=195.0

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|.+.+.||+|+||.||++... +++.||+|++.+..   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888899999999999999964 57889999986421   122345788999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.++++..                             ...+++.....++.|++.||+|||   +.+|+||||
T Consensus        81 ey~~~g~L~~~l~~~-----------------------------~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDl  128 (332)
T cd05623          81 DYYVGGDLLTLLSKF-----------------------------EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDI  128 (332)
T ss_pred             eccCCCcHHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCC
Confidence            999999999999752                             234677888899999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCC---CCCCCCcCcchhHHHHHHHHHhCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPD---SDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~  738 (815)
                      ||+|||++.++.+||+|||+++......  ......||+.|+|||++...   ...++.++|||||||++|||++|+.||
T Consensus       129 kp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf  208 (332)
T cd05623         129 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF  208 (332)
T ss_pred             CHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCC
Confidence            9999999999999999999997654322  22335699999999988632   223688999999999999999999999


Q ss_pred             CCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCC--CCCCHHHHHHH
Q 003504          739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL--KRPSMQQIVGL  807 (815)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~--~RPs~~~v~~~  807 (815)
                      .....       ............  +.   .+ .......+.++.+++.+|+..+|+  .||+++++++.
T Consensus       209 ~~~~~-------~~~~~~i~~~~~--~~---~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         209 YAESL-------VETYGKIMNHKE--RF---QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCCH-------HHHHHHHhCCCc--cc---cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            75322       122222221110  00   00 011223456778888887755444  47889988754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-34  Score=311.90  Aligned_cols=200  Identities=21%  Similarity=0.349  Sum_probs=160.3

Q ss_pred             CCeecccCCeeeEEEEcC---CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEe--CCeeEEEEEeCC
Q 003504          513 GTLLAEGKFGPVYRGFLP---GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA--GDQRIAIYDYME  587 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~ey~~  587 (815)
                      ++.||+|+||.||+|+..   +++.||+|.+...  .....+.+|++++++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            578999999999999854   4678999998643  223567899999999999999999998865  346789999987


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      + +|.+++.......                     .......+++.....++.|++.||+|||   +.+|+||||||+|
T Consensus        84 ~-~l~~~~~~~~~~~---------------------~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~N  138 (317)
T cd07868          84 H-DLWHIIKFHRASK---------------------ANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPAN  138 (317)
T ss_pred             C-CHHHHHHhccccc---------------------ccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHH
Confidence            5 8888875421100                     0011235778888999999999999999   8899999999999


Q ss_pred             eEE----cCCCCeeecccccceecCCCC----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 003504          668 VYL----DMNLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       668 Ill----~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~  739 (815)
                      ||+    +.++.+||+|||+++......    ......||+.|+|||++.+... ++.++||||+||++|||++|+.||.
T Consensus       139 il~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~el~~g~~~f~  217 (317)
T cd07868         139 ILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             EEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCC-cCchhhHHHHHHHHHHHHhCCCCcc
Confidence            999    456789999999998765322    2234568999999999876442 6889999999999999999999997


Q ss_pred             C
Q 003504          740 D  740 (815)
Q Consensus       740 ~  740 (815)
                      .
T Consensus       218 ~  218 (317)
T cd07868         218 C  218 (317)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-35  Score=307.18  Aligned_cols=256  Identities=28%  Similarity=0.420  Sum_probs=201.4

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCC------
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGD------  577 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------  577 (815)
                      ++++|++.+.||+|+||.||+|... +++.+|+|++... ....+.+.+|+.+++++ +||||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC-chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4678999999999999999999964 6788999998653 33456789999999999 6999999999997644      


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++||||+++++|.++++...                          .....+++..+..++.|++.||+|||   +.+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~--------------------------~~~~~~~~~~~~~~~~ql~~al~~lH---~~~  133 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLR--------------------------KKGKRLKEEWIAYILRETLRGLAYLH---ENK  133 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHh--------------------------hcCCCCCHHHHHHHHHHHHHHHHHHh---cCC
Confidence            4799999999999999986421                          11345788889999999999999999   899


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCC---CCCCCcCcchhHHHHHHHHHh
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                      ++||||+|+||++++++.+||+|||.+....... ......|+..|+|||.+....   ..++.++|||||||++||+++
T Consensus       134 i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~  213 (275)
T cd06608         134 VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD  213 (275)
T ss_pred             cccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh
Confidence            9999999999999999999999999987654322 223445889999999876432   235789999999999999999


Q ss_pred             CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      |+.||....+..   .+    ...... .     .+.  ...+...+.++.+++.+||..||++||+++++++
T Consensus       214 g~~p~~~~~~~~---~~----~~~~~~-~-----~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         214 GKPPLCDMHPMR---AL----FKIPRN-P-----PPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             CCCCccccchHH---HH----HHhhcc-C-----CCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            999997422111   11    111110 0     111  1123346678999999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.9e-35  Score=313.33  Aligned_cols=245  Identities=21%  Similarity=0.358  Sum_probs=197.1

Q ss_pred             CCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCC
Q 003504          512 RGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGN  590 (815)
Q Consensus       512 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gs  590 (815)
                      ....||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            345799999999999985 4688999999876555556678899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEE
Q 003504          591 LQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL  670 (815)
Q Consensus       591 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  670 (815)
                      |.+++..                               ..+++..+..++.|++.||+|||   +.+++||||||+||++
T Consensus       105 L~~~~~~-------------------------------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill  150 (297)
T cd06659         105 LTDIVSQ-------------------------------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILL  150 (297)
T ss_pred             HHHHHhh-------------------------------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEE
Confidence            9987743                               24678889999999999999999   8899999999999999


Q ss_pred             cCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccccc
Q 003504          671 DMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGN  749 (815)
Q Consensus       671 ~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~  749 (815)
                      +.++.+||+|||++....... ......|+..|+|||++.+..  ++.++|||||||++|||++|+.||....+.+.   
T Consensus       151 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---  225 (297)
T cd06659         151 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP--YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---  225 (297)
T ss_pred             ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence            999999999999987654332 223345899999999987665  68899999999999999999999974322111   


Q ss_pred             HHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          750 LVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                          ... +....     .+..  ..+...+.++.+++.+||+.+|++||+++++++.
T Consensus       226 ----~~~-~~~~~-----~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         226 ----MKR-LRDSP-----PPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ----HHH-HhccC-----CCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                111 11110     0000  1122344568899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1e-34  Score=304.18  Aligned_cols=247  Identities=21%  Similarity=0.303  Sum_probs=193.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--c---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--Cee
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--T---LTDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQR  579 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  579 (815)
                      .+|++.+.||+|+||.||+|.. .++..||||.+....  .   ...+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4688899999999999999995 568899999885321  1   1234678899999999999999999988764  457


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++||||+++|+|.+++...                              ..+++....+++.|++.||+|||   +.+++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~------------------------------~~~~~~~~~~~~~~l~~~l~~lH---~~~i~  128 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY------------------------------GALTENVTRKYTRQILEGVSYLH---SNMIV  128 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hCCEe
Confidence            7999999999999998642                              23567778899999999999999   88999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCC----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      ||||||+||+++.++.+||+|||+++......    ......|+..|+|||.+.+..  ++.++|||||||++||+++|+
T Consensus       129 H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~g~  206 (265)
T cd06652         129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG--YGRKADIWSVGCTVVEMLTEK  206 (265)
T ss_pred             cCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCC--CCcchhHHHHHHHHHHHhhCC
Confidence            99999999999999999999999998654211    122345889999999987655  688999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .||.....      .... ......         ......+......+.+++.+|+. +|++||++++|++
T Consensus       207 ~p~~~~~~------~~~~-~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         207 PPWAEFEA------MAAI-FKIATQ---------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCCCccch------HHHH-HHHhcC---------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            99964211      1111 111100         01112245566778899999995 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.4e-35  Score=306.40  Aligned_cols=253  Identities=25%  Similarity=0.382  Sum_probs=197.2

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---c-------cHHHHHHHHHHhcCCCCCCceeeeeEEEeCC
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---L-------TDQEAARELEYLGRIKHPNLVPLTGYCIAGD  577 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  577 (815)
                      +|...+.||+|+||.||+|.. .+++.||+|.+.....   .       ..+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            466789999999999999985 4688999998753211   0       1235788999999999999999999999999


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++||||+++|+|.++++..                              ..+++..+..++.|++.||.|||   +.+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~------------------------------~~l~~~~~~~~~~qi~~~l~~lH---~~~  128 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY------------------------------GRFEEQLVRFFTEQVLEGLAYLH---SKG  128 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc------------------------------cCCCHHHHHHHHHHHHHHHHHHh---hCC
Confidence            999999999999999999652                              35677888899999999999999   789


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhC
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG  734 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg  734 (815)
                      ++||||+|+||+++.++.+||+|||+++......   ......|+..|+|||.+......++.++||||||+++||+++|
T Consensus       129 i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  208 (272)
T cd06629         129 ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG  208 (272)
T ss_pred             eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhC
Confidence            9999999999999999999999999998654321   1223458889999998876543368899999999999999999


Q ss_pred             CCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       735 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..||.....      ...... .. .......+++.    .....+.++.+++.+||..+|++||++.+|++
T Consensus       209 ~~p~~~~~~------~~~~~~-~~-~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         209 RRPWSDEEA------IAAMFK-LG-NKRSAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCCCcCcch------HHHHHH-hh-ccccCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            999864211      111111 11 11111111111    12234678899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.3e-35  Score=317.69  Aligned_cols=254  Identities=20%  Similarity=0.218  Sum_probs=194.6

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|.+.+.||+|+||.||+++. .+++.||+|++.+..   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4688899999999999999995 467889999986521   122345788999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.++++..                             ...+++.....++.|++.||+|||   +.+|+||||
T Consensus        81 Ey~~gg~L~~~l~~~-----------------------------~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDl  128 (331)
T cd05624          81 DYYVGGDLLTLLSKF-----------------------------EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDI  128 (331)
T ss_pred             eCCCCCcHHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccC
Confidence            999999999999752                             224677788889999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCC---CCCCCcCcchhHHHHHHHHHhCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~  738 (815)
                      ||+|||++.++.+||+|||+++.......  .....||+.|+|||++.+..   ..++.++|||||||++|||++|+.||
T Consensus       129 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf  208 (331)
T cd05624         129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF  208 (331)
T ss_pred             chHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCc
Confidence            99999999999999999999987654322  22346999999999886521   22678999999999999999999999


Q ss_pred             CCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHH
Q 003504          739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK--RPSMQQIVG  806 (815)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~~v~~  806 (815)
                      ......       ........... .-.+++     .....+.++.+++.+|+..++++  |++++++++
T Consensus       209 ~~~~~~-------~~~~~i~~~~~-~~~~p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         209 YAESLV-------ETYGKIMNHEE-RFQFPS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cCCCHH-------HHHHHHHcCCC-cccCCC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            753221       11122221110 000111     11234567888999988865544  457887764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.4e-34  Score=303.32  Aligned_cols=255  Identities=23%  Similarity=0.381  Sum_probs=203.5

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ++|++.+.||.|+||.||+|.. .++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            3688899999999999999995 468899999986532 22456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++++|.++++...                           ....+++.....++.|++.||+|||   +.+++||||+|
T Consensus        81 ~~~~~l~~~~~~~~---------------------------~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p  130 (267)
T cd06610          81 LSGGSLLDIMKSSY---------------------------PRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKA  130 (267)
T ss_pred             cCCCcHHHHHHHhc---------------------------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            99999999997521                           1235788888999999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCcc-----ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDE-----EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  740 (815)
                      +||++++++.+||+|||++.........     ....|+..|+|||.+.... .++.++|||||||++|||++|+.||..
T Consensus       131 ~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~  209 (267)
T cd06610         131 GNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH-GYDFKADIWSFGITAIELATGAAPYSK  209 (267)
T ss_pred             HhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHcccc-CcCcccchHhHhHHHHHHHhCCCCccc
Confidence            9999999999999999998776543221     3345889999999887662 268899999999999999999999975


Q ss_pred             CCCccccccHHHHHHHHHhcCCCCccccccccCCC-CHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTG-PEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ....+.   ..    ......      .+.+.... ....+.++.+++.+||..||++||+++++++
T Consensus       210 ~~~~~~---~~----~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         210 YPPMKV---LM----LTLQND------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cChhhh---HH----HHhcCC------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            432211   11    111111      11111111 2345678899999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7.9e-35  Score=304.69  Aligned_cols=254  Identities=26%  Similarity=0.370  Sum_probs=202.6

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEe--CCeeEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIA--GDQRIAIY  583 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~  583 (815)
                      +|++.+.||.|+||.||+|.. .++..||+|.+....  ....+.+..|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999984 568899999986532  2334568889999999999999999998864  34678999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCC--CCCeeec
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC--SPPIIHR  661 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHr  661 (815)
                      ||+++++|.+++....                          .....+++.....++.+++.||+|||..+  +.+++||
T Consensus        81 e~~~~~~L~~~l~~~~--------------------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~  134 (265)
T cd08217          81 EYCEGGDLAQLIQKCK--------------------------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHR  134 (265)
T ss_pred             hhccCCCHHHHHHHHh--------------------------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceec
Confidence            9999999999996521                          12346789999999999999999999554  6789999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCc-cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLD-EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  740 (815)
                      ||||+||+++.++.+||+|||++........ .....|+..|+|||.+....  ++.++||||||+++|++++|+.||..
T Consensus       135 dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~  212 (265)
T cd08217         135 DLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS--YDEKSDIWSLGCLIYELCALSPPFTA  212 (265)
T ss_pred             CCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCC--CCchhHHHHHHHHHHHHHHCCCcccC
Confidence            9999999999999999999999987754432 33446899999999987665  68899999999999999999999975


Q ss_pred             CCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      ...    ..+.   +. .....         ....+...+.++.+++.+|++.+|++||++++|++.
T Consensus       213 ~~~----~~~~---~~-~~~~~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         213 RNQ----LQLA---SK-IKEGK---------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             cCH----HHHH---HH-HhcCC---------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            321    1111   11 11111         111234556789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=320.78  Aligned_cols=240  Identities=22%  Similarity=0.231  Sum_probs=184.5

Q ss_pred             ecccCCeeeEEEEc-CCCcEEEEEEeecCCccc---HHHHHHHHHHhcCC---CCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          516 LAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLT---DQEAARELEYLGRI---KHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       516 ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      ||+|+||.||+|+. .++..||||++.......   ...+..|..++.+.   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999985 468999999986532211   22344566666655   699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|..++..                              ...+++.....++.|++.||+|||   +.+|+||||||+||
T Consensus        81 g~L~~~l~~------------------------------~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Ni  127 (330)
T cd05586          81 GELFWHLQK------------------------------EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENI  127 (330)
T ss_pred             ChHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHe
Confidence            999998864                              234677888899999999999999   89999999999999


Q ss_pred             EEcCCCCeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |++.++.+||+|||+++..... .......||..|+|||.+.+... ++.++|||||||++|||++|+.||......   
T Consensus       128 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DvwslGvil~elltG~~Pf~~~~~~---  203 (330)
T cd05586         128 LLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG-YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---  203 (330)
T ss_pred             EECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCC-CCCccceeccccEEEEeccCCCCCCCCCHH---
Confidence            9999999999999999764322 23344569999999999875432 588999999999999999999999753221   


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC----HHHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS----MQQIVG  806 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs----~~~v~~  806 (815)
                          ..........       ..+.   ....+.++.+++.+||+.||++||+    +.++++
T Consensus       204 ----~~~~~i~~~~-------~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         204 ----QMYRNIAFGK-------VRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ----HHHHHHHcCC-------CCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                1111111111       0011   1123456789999999999999994    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.6e-35  Score=310.34  Aligned_cols=265  Identities=22%  Similarity=0.296  Sum_probs=199.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCCceeeeeEEEeC--CeeEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTL--TDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv  582 (815)
                      ++|+..+.||+|+||.||+|... +++.||+|.++.....  ....+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999964 6889999998653322  234567899999999999999999999887  789999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      |||+++ +|.+++...                             ...+++.....++.|++.||+|||   +.+++|||
T Consensus        85 ~e~~~~-~L~~~~~~~-----------------------------~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~d  131 (293)
T cd07843          85 MEYVEH-DLKSLMETM-----------------------------KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRD  131 (293)
T ss_pred             ehhcCc-CHHHHHHhc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecc
Confidence            999985 999988642                             225788999999999999999999   78999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      |||+||+++.++.+||+|||+++...... ......++..|+|||.+.+... .+.++||||||+++|||++|+.||...
T Consensus       132 l~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         132 LKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             CCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCcc-ccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999998765432 2333457889999998865442 578999999999999999999999754


Q ss_pred             CCccccccHHHHHH-----------HHH--hcCCCCccccccccCCCCHH-HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          742 YPEEKEGNLVSWVR-----------GLV--RNNKGSRAIDPKIRDTGPEK-QMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       742 ~~~~~~~~~~~~~~-----------~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ...+....+...+.           .+.  ............+....+.. ....+.+++.+||+.+|++||++.|+++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         211 SEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            33221111111100           000  00000000011111111221 3667889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-34  Score=306.41  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=195.3

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc-ccHHHHHHHHHH-hcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST-LTDQEAARELEY-LGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      ++|++.+.||+|+||.||+|+. .+|..||+|++..... .....+..|+.+ ++..+||||+++++++......++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            3688889999999999999996 4689999999875422 234456667665 566789999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSP-PIIHRDI  663 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDl  663 (815)
                      |++ |+|.++++...                          .....+++.....++.|++.||+|||   +. +++||||
T Consensus        81 ~~~-~~l~~~l~~~~--------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dl  130 (283)
T cd06617          81 VMD-TSLDKFYKKVY--------------------------DKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDV  130 (283)
T ss_pred             hhc-ccHHHHHHHhc--------------------------cCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCC
Confidence            997 68988886421                          11346789999999999999999999   65 8999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCC--CCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS--DFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      ||+||+++.++.+||+|||+++............|+..|+|||.+.+..  ..++.++|||||||++|||++|+.||...
T Consensus       131 kp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (283)
T cd06617         131 KPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW  210 (283)
T ss_pred             CHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999998765433334456889999999876522  22578999999999999999999998642


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..  .   . ..........      .+.+.   ....+.++.+++.+||..+|++||++.++++
T Consensus       211 ~~--~---~-~~~~~~~~~~------~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         211 KT--P---F-QQLKQVVEEP------SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cc--C---H-HHHHHHHhcC------CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11  0   1 1111111110      11111   1234567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.4e-34  Score=309.78  Aligned_cols=248  Identities=24%  Similarity=0.330  Sum_probs=196.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL---TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ..|+..+.||+|+||.||+|.. .+++.||+|.+......   ..+.+.+|+++++.++||||+++.++|...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4578889999999999999985 46889999998653322   2356889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||++ |++.+++...                             ...+++..+..++.|++.||.|||   +.+++||||
T Consensus        95 e~~~-g~l~~~~~~~-----------------------------~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl  141 (307)
T cd06607          95 EYCL-GSASDILEVH-----------------------------KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDI  141 (307)
T ss_pred             HhhC-CCHHHHHHHc-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCC
Confidence            9997 5777777531                             235788999999999999999999   889999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCC-CCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPD-SDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      +|+||++++++.+||+|||++......   ....|+..|+|||.+.+. ...++.++||||||+++||+++|+.||....
T Consensus       142 ~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~  218 (307)
T cd06607         142 KAGNILLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (307)
T ss_pred             CcccEEECCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence            999999999999999999999765432   234578899999987532 2236889999999999999999999986532


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      ...       .........      .+.   ..+..++.++.+++.+||..+|++||++++++..
T Consensus       219 ~~~-------~~~~~~~~~------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         219 AMS-------ALYHIAQND------SPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHH-------HHHHHhcCC------CCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            111       111111110      011   1133466789999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.7e-35  Score=309.98  Aligned_cols=261  Identities=21%  Similarity=0.276  Sum_probs=196.6

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||.|++|.||+|+. .++..||||.+.....  .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            477889999999999999985 4688999998864322  2235788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +. ++|.+++...                            ....+++.....++.|++.||+|||   ..+++||||+|
T Consensus        81 ~~-~~l~~~~~~~----------------------------~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p  128 (284)
T cd07860          81 LH-QDLKKFMDAS----------------------------PLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKP  128 (284)
T ss_pred             cc-cCHHHHHHhC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCH
Confidence            96 6899988652                            1345788999999999999999999   88999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.+||+|||+++...... ......++..|+|||.+.+... ++.++|||||||++||++||+.||......
T Consensus       129 ~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~~  207 (284)
T cd07860         129 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMVTRRALFPGDSEI  207 (284)
T ss_pred             HHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence            99999999999999999988664332 2233347889999998765432 578899999999999999999999753321


Q ss_pred             cccccHHHHHHHHHhcC---------------CCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNN---------------KGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .   ...+.....-...               .........+.. .......++.+++.+||+.||++||+++++++
T Consensus       208 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         208 D---QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             H---HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            1   1111111000000               000000000000 01123456789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.6e-35  Score=309.75  Aligned_cols=260  Identities=21%  Similarity=0.251  Sum_probs=200.1

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|++.+.||+|+||.||+|.. .+|..||||++....  ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            477889999999999999995 468999999987643  23346789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      + +++|.+++...                             ...+++..+..++.|+++||+|||   +.+++|+||||
T Consensus        81 ~-~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p  127 (286)
T cd07832          81 M-PSDLSEVLRDE-----------------------------ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKP  127 (286)
T ss_pred             c-CCCHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCH
Confidence            9 99999998652                             245788999999999999999999   88999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      +||+++.++.++|+|||.+.......  ......|+..|+|||.+.+... ++.++||||+|+++||+++|+.||.....
T Consensus       128 ~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~~l~~l~tg~~~~~~~~~  206 (286)
T cd07832         128 ANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK-YDPGVDLWAVGCIFAELLNGSPLFPGEND  206 (286)
T ss_pred             HHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeecccc-CCchhHHHHHHHHHHHHHcCCcCcCCCCH
Confidence            99999999999999999998765432  1334468999999998865432 58899999999999999999888764322


Q ss_pred             ccccccHHHHHHHHHhcC------------CCCccccccccC----CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNN------------KGSRAIDPKIRD----TGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .+.    ...+.......            .......+.-..    ....+...++.+++.+|+..+|++||+++++++
T Consensus       207 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         207 IEQ----LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HHH----HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            111    11111100000            000000000000    001234578999999999999999999999975

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9e-35  Score=304.49  Aligned_cols=252  Identities=25%  Similarity=0.403  Sum_probs=202.5

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      +|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999965 68899999987643 234567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeccCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCS-PPIIHRDIKA  665 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlk~  665 (815)
                      ++++|.+++...                             ...++.....+++.|++.||+|||   + .+++||||||
T Consensus        82 ~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~  129 (265)
T cd06605          82 DGGSLDKILKEV-----------------------------QGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKP  129 (265)
T ss_pred             CCCcHHHHHHHc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCH
Confidence            999999999752                             135677788899999999999999   7 8999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      +||+++.++.+||+|||.+.......... ..++..|+|||.+.+..  ++.++||||||+++|++++|+.||.....  
T Consensus       130 ~ni~~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--  204 (265)
T cd06605         130 SNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGND--YSVKSDIWSLGLSLIELATGRFPYPPEND--  204 (265)
T ss_pred             HHEEECCCCCEEEeecccchhhHHHHhhc-ccCChhccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCcccc--
Confidence            99999999999999999987654332222 56889999999987765  78999999999999999999999975321  


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ........++......      .+.+   .....+.++.+++.+||..+|++||++.+++.
T Consensus       205 ~~~~~~~~~~~~~~~~------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         205 PPDGIFELLQYIVNEP------PPRL---PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ccccHHHHHHHHhcCC------CCCC---ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1122233333322211      0111   11125677899999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.1e-34  Score=312.40  Aligned_cols=201  Identities=20%  Similarity=0.356  Sum_probs=160.4

Q ss_pred             CCeecccCCeeeEEEEcC---CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEe--CCeeEEEEEeCC
Q 003504          513 GTLLAEGKFGPVYRGFLP---GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA--GDQRIAIYDYME  587 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~ey~~  587 (815)
                      +..||+|+||.||+|+..   ++..||+|.+....  ....+.+|++++++++||||+++++++..  ....++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999964   45789999886532  23467899999999999999999999864  456789999987


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      + +|.+++.......                     .......+++.....++.|++.||+|||   +.+|+||||||+|
T Consensus        84 ~-~l~~~~~~~~~~~---------------------~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~N  138 (317)
T cd07867          84 H-DLWHIIKFHRASK---------------------ANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPAN  138 (317)
T ss_pred             C-cHHHHHHhhhccc---------------------cCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHH
Confidence            5 7888775321100                     0011235788889999999999999999   8899999999999


Q ss_pred             eEE----cCCCCeeecccccceecCCCC----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 003504          668 VYL----DMNLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       668 Ill----~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~  739 (815)
                      |++    +.++.+||+|||+++......    ......||+.|+|||++.+... ++.++|||||||++|||+||+.||.
T Consensus       139 il~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwSlG~il~el~tg~~~f~  217 (317)
T cd07867         139 ILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             EEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCc-cCcHHHHHhHHHHHHHHHhCCCCcc
Confidence            999    566789999999998765332    1233468999999998865432 6889999999999999999999997


Q ss_pred             CC
Q 003504          740 DD  741 (815)
Q Consensus       740 ~~  741 (815)
                      ..
T Consensus       218 ~~  219 (317)
T cd07867         218 CR  219 (317)
T ss_pred             cc
Confidence            53

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.4e-35  Score=309.52  Aligned_cols=261  Identities=21%  Similarity=0.259  Sum_probs=195.4

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||+|+||.||+|.. .+|..||+|.+.....  .....+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            477788999999999999995 4688999999865322  2235678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      ++ ++|.+++...                             ...+++.....++.|+++||.|||   +.+++||||||
T Consensus        81 ~~-~~l~~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~  127 (284)
T cd07839          81 CD-QDLKKYFDSC-----------------------------NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKP  127 (284)
T ss_pred             CC-CCHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCH
Confidence            97 4888887542                             235788899999999999999999   88999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.+||+|||+++...... ......++..|+|||.+.+... ++.++|||||||++|||++|+.|+......
T Consensus       128 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~tg~~p~~~~~~~  206 (284)
T cd07839         128 QNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRPLFPGNDV  206 (284)
T ss_pred             HHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcc-cCcHHHHHHHHHHHHHHHhcCCCCcCCCCH
Confidence            99999999999999999998664332 2233457889999998866432 588999999999999999999886542221


Q ss_pred             cccccHHHHHHHH----------HhcCCCCccccccccC-----CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGL----------VRNNKGSRAIDPKIRD-----TGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +  ..+....+..          ....... ..-+....     ......+.++.+++.+||+.||.+|||++++++
T Consensus       207 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         207 D--DQLKRIFRLLGTPTEESWPGVSKLPDY-KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             H--HHHHHHHHHhCCCChHHhHHhhhcccc-cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            1  1111000000          0000000 00000100     011234567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.7e-35  Score=310.79  Aligned_cols=252  Identities=23%  Similarity=0.281  Sum_probs=197.3

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+.....   .....+.+|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            3688889999999999999995 4578999999875432   22346789999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.+++..                              ...+++.....++.|++.||+|||   +.+++||||
T Consensus        81 e~~~g~~L~~~l~~------------------------------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl  127 (305)
T cd05609          81 EYVEGGDCATLLKN------------------------------IGALPVDMARMYFAETVLALEYLH---NYGIVHRDL  127 (305)
T ss_pred             ecCCCCcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCC
Confidence            99999999999964                              234678888899999999999999   789999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC----------------ccccccccccccCCcccCCCCCCCCCcCcchhHHHH
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL----------------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV  727 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvv  727 (815)
                      ||+||+++.++.+||+|||+++......                ......|+..|+|||.+....  ++.++|||||||+
T Consensus       128 ~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~v  205 (305)
T cd05609         128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG--YGKPVDWWAMGII  205 (305)
T ss_pred             chHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCC--CCchhhHHHHHHH
Confidence            9999999999999999999987421100                011234788999999987655  6899999999999


Q ss_pred             HHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          728 LLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       728 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      +||+++|+.||.+....       .+........    ...+..    ....+.++.+++.+||+.+|++||++.++.+.
T Consensus       206 l~el~~g~~pf~~~~~~-------~~~~~~~~~~----~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~l  270 (305)
T cd05609         206 LYEFLVGCVPFFGDTPE-------ELFGQVISDD----IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEV  270 (305)
T ss_pred             HHHHHhCCCCCCCCCHH-------HHHHHHHhcc----cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHH
Confidence            99999999999753321       1122211111    001111    11345678999999999999999997666665


Q ss_pred             HH
Q 003504          808 LK  809 (815)
Q Consensus       808 L~  809 (815)
                      |+
T Consensus       271 l~  272 (305)
T cd05609         271 KQ  272 (305)
T ss_pred             Hh
Confidence            54

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=305.16  Aligned_cols=247  Identities=24%  Similarity=0.417  Sum_probs=198.2

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCC---CCCceeeeeEEEeCCeeEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIK---HPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~  583 (815)
                      .|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999995 578999999986542 233457889999999986   999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++++|.++++.                               ..+++.....++.|++.||.|||   +.+++||||
T Consensus        82 e~~~~~~L~~~~~~-------------------------------~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl  127 (277)
T cd06917          82 EYAEGGSVRTLMKA-------------------------------GPIAEKYISVIIREVLVALKYIH---KVGVIHRDI  127 (277)
T ss_pred             ecCCCCcHHHHHHc-------------------------------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCc
Confidence            99999999998853                               14778889999999999999999   889999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      +|+||+++.++.++|+|||++....... ......|+..|+|||.+..... ++.++|||||||++|||++|+.||....
T Consensus       128 ~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~~ll~g~~p~~~~~  206 (277)
T cd06917         128 KAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY-YDTKADIWSLGITIYEMATGNPPYSDVD  206 (277)
T ss_pred             CHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCc-cccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999998765433 2233458899999998865432 5889999999999999999999997532


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..       .+... .     .....+.+..   ...+.++.+++.+||..||++||++.++++
T Consensus       207 ~~-------~~~~~-~-----~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         207 AF-------RAMML-I-----PKSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             hh-------hhhhc-c-----ccCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            21       11110 0     0001111211   124567899999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-35  Score=317.42  Aligned_cols=263  Identities=21%  Similarity=0.251  Sum_probs=192.9

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeC------
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAG------  576 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  576 (815)
                      ..++|+..+.||+|+||.||+|.. .++..||||.+.....  ...+.+.+|++++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            456899999999999999999984 5688999999865321  2335677899999999999999999987643      


Q ss_pred             CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 003504          577 DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSP  656 (815)
Q Consensus       577 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~  656 (815)
                      ...++++|++ +++|.+++..                               ..+++.....++.|++.||+|||   +.
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-------------------------------~~l~~~~~~~i~~qi~~aL~~LH---~~  137 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-------------------------------QKLSDEHVQFLIYQLLRGLKYIH---SA  137 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence            3468899987 6789887743                               24678888999999999999999   89


Q ss_pred             CeeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          657 PIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       657 ~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      +|+||||||+||+++.++.+||+|||+++.....  .....||+.|+|||++.+... ++.++|||||||++|||++|+.
T Consensus       138 ~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~el~~g~~  214 (343)
T cd07878         138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLKGKA  214 (343)
T ss_pred             CeecccCChhhEEECCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCcc-CCchhhhHhHHHHHHHHHHCCC
Confidence            9999999999999999999999999999876432  234468999999999876332 6889999999999999999999


Q ss_pred             CCCCCCCccccccHHHHHH-------HHHhcCCCCcccc--ccccCC----CCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 003504          737 PLGDDYPEEKEGNLVSWVR-------GLVRNNKGSRAID--PKIRDT----GPEKQMEEALKIGYLCTADLPLKRPSMQQ  803 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~  803 (815)
                      ||......+....+.....       .............  +.....    ........+.+++.+|+..||++|||++|
T Consensus       215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~e  294 (343)
T cd07878         215 LFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE  294 (343)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            9975322111101100000       0000000000000  000000    00112345789999999999999999999


Q ss_pred             HHH
Q 003504          804 IVG  806 (815)
Q Consensus       804 v~~  806 (815)
                      +++
T Consensus       295 ll~  297 (343)
T cd07878         295 ALA  297 (343)
T ss_pred             Hhc
Confidence            985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.4e-34  Score=301.11  Aligned_cols=251  Identities=29%  Similarity=0.439  Sum_probs=199.3

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL--TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|...+.||+|+||.||+|.. .+++.||+|.+......  ..+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            477789999999999999985 46889999998765433  456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++++|.++++.                              ...+++..+..++.+++.||+|||   +.+++||||+|
T Consensus        81 ~~~~~L~~~~~~------------------------------~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~  127 (264)
T cd06626          81 CSGGTLEELLEH------------------------------GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKP  127 (264)
T ss_pred             CCCCcHHHHHhh------------------------------cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCH
Confidence            999999999864                              224677888999999999999999   88999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCcc-----ccccccccccCCcccCCCC-CCCCCcCcchhHHHHHHHHHhCCCCCC
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDE-----EIARGSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~  739 (815)
                      +||+++.++.+||+|||++.........     ....++..|+|||++.+.. ...+.++||||||+++||+++|+.||.
T Consensus       128 ~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~  207 (264)
T cd06626         128 ANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS  207 (264)
T ss_pred             HHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence            9999999999999999999876543221     1345788999999987654 236889999999999999999999996


Q ss_pred             CCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .....      ........ ..     ..+.+..  ....+..+.+++.+||+.+|++||++.+++.
T Consensus       208 ~~~~~------~~~~~~~~-~~-----~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         208 ELDNE------FQIMFHVG-AG-----HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCcch------HHHHHHHh-cC-----CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            42211      11111111 00     0111111  1123567789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.3e-35  Score=308.17  Aligned_cols=261  Identities=19%  Similarity=0.221  Sum_probs=195.2

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCC-CCCceeeeeEEEeC--CeeEEEEE
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIK-HPNLVPLTGYCIAG--DQRIAIYD  584 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e  584 (815)
                      |.+.+.||+|+||.||+|.. .++..||+|.++... ........+|+.++.++. |||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            55678999999999999994 568899999986532 222334557899999985 99999999999987  78999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |++ |+|.+++...                             ...++|..+..++.|++.||+|||   +.+++||||+
T Consensus        81 ~~~-~~l~~~l~~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~  127 (282)
T cd07831          81 LMD-MNLYELIKGR-----------------------------KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIK  127 (282)
T ss_pred             cCC-ccHHHHHHhc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccC
Confidence            997 5888888642                             235789999999999999999999   7899999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      |+||+++. +.+||+|||+++............++..|+|||.+.... .++.++|||||||++|||++|+.||....+.
T Consensus       128 p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slGv~l~el~~~~~p~~~~~~~  205 (282)
T cd07831         128 PENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG-YYGPKMDIWAVGCVFFEILSLFPLFPGTNEL  205 (282)
T ss_pred             HHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCC-CCCcchhHHHHHHHHHHHHcCCcCCCCCCHH
Confidence            99999999 999999999998765444334455889999999765433 2688999999999999999999999764332


Q ss_pred             cccccHH--------HHHHHHHhcCCCCccccccccC----CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLV--------SWVRGLVRNNKGSRAIDPKIRD----TGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +....+.        .|. .............+....    ......+.++.+++.+||+.+|++||+++++++
T Consensus       206 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         206 DQIAKIHDVLGTPDAEVL-KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHHHHHHHcCCCCHHHH-HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            2111111        110 001000000000010000    001235688999999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.6e-34  Score=304.73  Aligned_cols=246  Identities=23%  Similarity=0.336  Sum_probs=198.3

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      -|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++.+++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            366778999999999999985 568899999876432 223457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++|+|.+++..                               ..+++.....++.+++.|+.|||   +.+++|+||+|+
T Consensus        85 ~~~~l~~~i~~-------------------------------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~  130 (277)
T cd06641          85 GGGSALDLLEP-------------------------------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAA  130 (277)
T ss_pred             CCCcHHHHHhc-------------------------------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHH
Confidence            99999999853                               24678889999999999999999   899999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||+++.++.++|+|||++....... ......|+..|+|||.+.+..  .+.++|||||||++||+++|..||....+. 
T Consensus       131 Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-  207 (277)
T cd06641         131 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPHSELHPM-  207 (277)
T ss_pred             hEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCccchH-
Confidence            9999999999999999998664332 222345788999999987654  688999999999999999999998642211 


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                            .+........          ....+...+.++.+++.+||..+|++||++.++++.
T Consensus       208 ------~~~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         208 ------KVLFLIPKNN----------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ------HHHHHHhcCC----------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                  1111111110          111123455678899999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=311.89  Aligned_cols=249  Identities=24%  Similarity=0.302  Sum_probs=198.3

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTL---TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      +|+..+.||+|+||.||+|... ++..||+|.+......   ..+.+.+|+++++.++||||+++++++......++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            6788899999999999999965 5899999999764332   34568899999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+.+++|.+++...                            ....+++.....++.|++.||+|||   +.+++|||||
T Consensus        82 ~~~~~~L~~~~~~~----------------------------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk  130 (316)
T cd05574          82 YCPGGELFRLLQRQ----------------------------PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLK  130 (316)
T ss_pred             ecCCCCHHHHHHhC----------------------------CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence            99999999998642                            1345788888999999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCC------------------------------ccccccccccccCCcccCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL------------------------------DEEIARGSPGYIPPEFAQPDSDF  714 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~  714 (815)
                      |+||+++.++.++|+|||++.......                              ......|+..|+|||++.+..  
T Consensus       131 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--  208 (316)
T cd05574         131 PENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG--  208 (316)
T ss_pred             hHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC--
Confidence            999999999999999999987543211                              011235788999999987665  


Q ss_pred             CCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccC
Q 003504          715 PTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL  794 (815)
Q Consensus       715 ~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~d  794 (815)
                      ++.++||||||+++|||++|+.||......+.       .......         ..........+.++.+++.+||..|
T Consensus       209 ~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-------~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~  272 (316)
T cd05574         209 HGSAVDWWTLGILLYEMLYGTTPFKGSNRDET-------FSNILKK---------EVTFPGSPPVSSSARDLIRKLLVKD  272 (316)
T ss_pred             CCchHHHHHHHHHHHHHhhCCCCCCCCchHHH-------HHHHhcC---------CccCCCccccCHHHHHHHHHHccCC
Confidence            68899999999999999999999975332111       1111111         1111111225678999999999999


Q ss_pred             CCCCCC----HHHHHH
Q 003504          795 PLKRPS----MQQIVG  806 (815)
Q Consensus       795 P~~RPs----~~~v~~  806 (815)
                      |++||+    +++++.
T Consensus       273 p~~R~s~~~~~~~ll~  288 (316)
T cd05574         273 PSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HhHCCCchhhHHHHHc
Confidence            999999    666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-34  Score=305.67  Aligned_cols=246  Identities=22%  Similarity=0.366  Sum_probs=198.2

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      |...+.||+|++|.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44467999999999999984 57889999998654444556788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      ++|.+++..                               ..+++..+..++.|++.||+|||   +.+++||||+|+||
T Consensus       101 ~~L~~~~~~-------------------------------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Ni  146 (285)
T cd06648         101 GALTDIVTH-------------------------------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSI  146 (285)
T ss_pred             CCHHHHHHh-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhE
Confidence            999999864                               23677888999999999999999   88999999999999


Q ss_pred             EEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      +++.++.++|+|||.+....... ......|+..|+|||...+..  ++.++|||||||++||+++|+.||....+    
T Consensus       147 l~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGv~l~ell~g~~p~~~~~~----  220 (285)
T cd06648         147 LLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPPYFNEPP----  220 (285)
T ss_pred             EEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCC--CCCcccHHHHHHHHHHHHhCCCCCcCCCH----
Confidence            99999999999999887654322 122345889999999987655  68899999999999999999999875322    


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                         .......... .     .+...  .+...+..+.+++.+||..+|++||+++++++
T Consensus       221 ---~~~~~~~~~~-~-----~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         221 ---LQAMKRIRDN-L-----PPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ---HHHHHHHHhc-C-----CCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence               1112211111 1     01111  12224567999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.4e-34  Score=298.97  Aligned_cols=251  Identities=27%  Similarity=0.375  Sum_probs=204.6

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ++|++.+.||+|++|.||+|+.. ++..||||++..... ...+.+.+|+..+.+++||||+++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999965 589999999876433 3457899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeccCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCS-PPIIHRDIK  664 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlk  664 (815)
                      +++++|.+++..                              ...++...+..++.|+++|++|||   + .+++||||+
T Consensus        81 ~~~~~L~~~l~~------------------------------~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~  127 (264)
T cd06623          81 MDGGSLADLLKK------------------------------VGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIK  127 (264)
T ss_pred             cCCCcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCC
Confidence            999999999964                              135778889999999999999999   7 999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCcc-ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDE-EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      |+||+++.++.++|+|||.+......... ....++..|+|||.+....  ++.++||||||+++||+++|+.||.....
T Consensus       128 ~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~tg~~p~~~~~~  205 (264)
T cd06623         128 PSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES--YSYAADIWSLGLTLLECALGKFPFLPPGQ  205 (264)
T ss_pred             HHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCC--CCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence            99999999999999999999876543322 2445788999999987664  78899999999999999999999976432


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEK-QMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      .    .............      .+.    .+.. .+..+.+++.+||..+|++||++.++++.
T Consensus       206 ~----~~~~~~~~~~~~~------~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         206 P----SFFELMQAICDGP------PPS----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             c----CHHHHHHHHhcCC------CCC----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1    1111111111110      111    1222 56789999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-36  Score=311.32  Aligned_cols=246  Identities=25%  Similarity=0.362  Sum_probs=200.3

Q ss_pred             CCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      |...+.||.|+||.||-|+ ..+...||||.+.-...   ...+++.+|+..|++++|||++.+-|||......|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            4445789999999999999 45678899999875433   3346889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      |-| |-.+++.-.                             .+++.......|+.|++.||+|||   +.+.||||||+
T Consensus       108 ClG-SAsDlleVh-----------------------------kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKA  154 (948)
T KOG0577|consen  108 CLG-SASDLLEVH-----------------------------KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKA  154 (948)
T ss_pred             Hhc-cHHHHHHHH-----------------------------hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccc
Confidence            976 777777543                             345667778899999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCC-CCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQP-DSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      -|||+++.|.+|++|||.|..+.+   ...++|||.|||||++.. ..+.|+-|+||||+|++..||..+++|+...+. 
T Consensus       155 GNILLse~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-  230 (948)
T KOG0577|consen  155 GNILLSEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-  230 (948)
T ss_pred             cceEecCCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-
Confidence            999999999999999999987754   356779999999998654 345588899999999999999999999764221 


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                            .+-+..+..++      .|.+.   ..+++..+..++..|+++-|.+|||.+++++.
T Consensus       231 ------MSALYHIAQNe------sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  231 ------MSALYHIAQNE------SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ------HHHHHHHHhcC------CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                  11111122221      23332   56788899999999999999999999998764

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-34  Score=302.76  Aligned_cols=250  Identities=20%  Similarity=0.326  Sum_probs=199.0

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc------ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST------LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      +|+.++.||+|+||.||+|.. .++..||+|.+.....      ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999984 6788999999864321      123578899999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      |+||+++++|.+++..                              ...+++.....++.|++.||+|||   +.+++||
T Consensus        81 v~e~~~~~~L~~~l~~------------------------------~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~  127 (268)
T cd06630          81 FVEWMAGGSVSHLLSK------------------------------YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHR  127 (268)
T ss_pred             EEeccCCCcHHHHHHH------------------------------hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            9999999999999864                              224678888999999999999999   8899999


Q ss_pred             cCCCCceEEcCCC-CeeecccccceecCCCC-----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          662 DIKASSVYLDMNL-EPRLSDFGLAKIFGNGL-----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       662 Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      ||+|+||+++.++ .+||+|||.+.......     ......|+..|+|||.+.+..  ++.++||||+|+++||+++|+
T Consensus       128 ~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~  205 (268)
T cd06630         128 DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ--YGRSCDVWSVGCVIIEMATAK  205 (268)
T ss_pred             CCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCC--CCcccchHHHHHHHHHHHhCC
Confidence            9999999998776 59999999998765321     112345788999999987655  688999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .||.......    ...........         ......+.....++.+++.+|+..+|++||++.++++
T Consensus       206 ~p~~~~~~~~----~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         206 PPWNAEKHSN----HLALIFKIASA---------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCCCCCCCcc----hHHHHHHHhcc---------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            9996432211    11111111100         1112234556678999999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.2e-35  Score=332.66  Aligned_cols=266  Identities=19%  Similarity=0.218  Sum_probs=190.2

Q ss_pred             HHHHHhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC------CCCceeeeeEEE
Q 003504          502 DLLSATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK------HPNLVPLTGYCI  574 (815)
Q Consensus       502 ~l~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~  574 (815)
                      ++...+++|.+.+.||+|+||.||+|.. .++..||||+++.. ......+..|+++++.++      |++++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3344567899999999999999999985 46788999998642 222345566777766665      456889999887


Q ss_pred             eC-CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcC
Q 003504          575 AG-DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHG  653 (815)
Q Consensus       575 ~~-~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~  653 (815)
                      .. ...++|||++ +++|.+++..                              ...+.+.....|+.|++.||+|||  
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~------------------------------~~~l~~~~~~~i~~qi~~aL~yLH--  248 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK------------------------------HGPFSHRHLAQIIFQTGVALDYFH--  248 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH--
Confidence            64 4678899987 6689888864                              235788889999999999999999  


Q ss_pred             CC-CCeeeccCCCCceEEcCCC----------------CeeecccccceecCCCCccccccccccccCCcccCCCCCCCC
Q 003504          654 CS-PPIIHRDIKASSVYLDMNL----------------EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPT  716 (815)
Q Consensus       654 ~~-~~ivHrDlk~~NIll~~~~----------------~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  716 (815)
                       . .+||||||||+|||++.++                .+||+|||.+.....  ......||+.|+|||++.+..  ++
T Consensus       249 -~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~--~~  323 (467)
T PTZ00284        249 -TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLG--WM  323 (467)
T ss_pred             -hcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCC--CC
Confidence             5 5999999999999998765                499999998864322  233457999999999998766  78


Q ss_pred             CcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHH--------HHHH--------HHhcCC-CCccccccc-----cCC
Q 003504          717 PKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVS--------WVRG--------LVRNNK-GSRAIDPKI-----RDT  774 (815)
Q Consensus       717 ~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~--------~~~~--------~~~~~~-~~~~~~~~~-----~~~  774 (815)
                      .++|||||||++|||++|+.||......+....+..        |...        +..... .....++..     ...
T Consensus       324 ~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (467)
T PTZ00284        324 YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARAR  403 (467)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhccc
Confidence            899999999999999999999976432211111110        1100        000000 000000000     000


Q ss_pred             C--CHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          775 G--PEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       775 ~--~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .  .......+.+|+.+||..||++|||++|+++
T Consensus       404 ~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        404 PVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             chhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            0  0012356789999999999999999999986

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.2e-34  Score=307.66  Aligned_cols=243  Identities=24%  Similarity=0.289  Sum_probs=197.1

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+.....   ...+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            3678889999999999999995 4689999999865322   23456889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.++++.                              ...++...+..++.|++.||+|||   +.+++||||
T Consensus        81 e~~~~~~L~~~~~~------------------------------~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl  127 (290)
T cd05580          81 EYVPGGELFSHLRK------------------------------SGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDL  127 (290)
T ss_pred             ecCCCCCHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCC
Confidence            99999999999965                              235678888999999999999999   799999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      +|+||+++.++.+||+|||+++.....  .....|++.|+|||.+....  .+.++||||||+++|||++|+.||.....
T Consensus       128 ~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~  203 (290)
T cd05580         128 KPENLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKG--YGKAVDWWALGILIYEMLAGYPPFFDDNP  203 (290)
T ss_pred             CHHHEEECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999999876543  33446899999999887654  68899999999999999999999975331


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIV  805 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~  805 (815)
                      .       ....... ...      .    ..+...+..+.+++.+||..+|.+||     ++++++
T Consensus       204 ~-------~~~~~~~-~~~------~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         204 I-------QIYEKIL-EGK------V----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             H-------HHHHHHh-cCC------c----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            1       1111111 110      0    11223356788999999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.6e-34  Score=304.57  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=203.2

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      .+..|+..+.||+|+||.||+|... ++..||+|++..... ..+.+.+|++++++++|+|++++++++......++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4556788899999999999999975 688999999976433 46678899999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++++|.+++...                             ...+++..+..++.|++.||+|||   +.+++|+||+
T Consensus        96 ~~~~~~L~~~l~~~-----------------------------~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~  143 (286)
T cd06614          96 YMDGGSLTDIITQN-----------------------------FVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIK  143 (286)
T ss_pred             ccCCCcHHHHHHHh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCC
Confidence            99999999999752                             135788999999999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      |+||+++.++.++|+|||++....... ......++..|+|||++.+..  ++.++|||||||++||+++|+.||....+
T Consensus       144 p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slGvil~~l~~g~~p~~~~~~  221 (286)
T cd06614         144 SDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD--YGPKVDIWSLGIMCIEMAEGEPPYLREPP  221 (286)
T ss_pred             hhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCC--CCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999887654322 222334788999999987655  68899999999999999999999874322


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .       .......... ..     .  ...+...+..+.+++.+||+.+|.+||++.++++
T Consensus       222 ~-------~~~~~~~~~~-~~-----~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         222 L-------RALFLITTKG-IP-----P--LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             H-------HHHHHHHhcC-CC-----C--CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            1       1111111110 00     0  1112235678899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.1e-34  Score=307.69  Aligned_cols=259  Identities=23%  Similarity=0.335  Sum_probs=196.7

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.++. ||||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            455567899999999999995 468899999986532 234457889999999996 99999999999998899999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +.. ++.++.....                         ......+++....+++.+++.||+|||+  ..+++||||||
T Consensus        85 ~~~-~l~~l~~~~~-------------------------~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp  136 (288)
T cd06616          85 MDI-SLDKFYKYVY-------------------------EVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKP  136 (288)
T ss_pred             ccC-CHHHHHHHHH-------------------------HhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCH
Confidence            875 5555432100                         0112457888899999999999999994  35899999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCC-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.+||+|||+++............|+..|+|||.+.+.. ..++.++|||||||++||+++|+.||....  
T Consensus       137 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--  214 (288)
T cd06616         137 SNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--  214 (288)
T ss_pred             HHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--
Confidence            99999999999999999998665443334446889999999987652 236889999999999999999999986421  


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                          .....+......      ..+.+....+...+.++.+++.+||+.+|++||++++|++.
T Consensus       215 ----~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         215 ----SVFDQLTQVVKG------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ----hHHHHHhhhcCC------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                111111111111      11222222234467789999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.3e-34  Score=303.74  Aligned_cols=265  Identities=21%  Similarity=0.240  Sum_probs=194.9

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++.+|...+.||+|+||.||+|.. .++..||+|++..... .....+.+|+.++++++|+||+++++++...+..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            456888999999999999999985 5688999999865432 22346788999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+. +++.+++...                             ...+.+.....++.|++.||+|||   ..+|+||||
T Consensus        83 e~~~-~~l~~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl  129 (291)
T cd07870          83 EYMH-TDLAQYMIQH-----------------------------PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDL  129 (291)
T ss_pred             eccc-CCHHHHHHhC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence            9996 6887777532                             223567778889999999999999   789999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      ||+||+++.++.+||+|||+++...... ......++..|+|||++.+... ++.++|||||||++|||++|+.||....
T Consensus       130 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD-YSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             ChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            9999999999999999999997653322 2233457889999998865432 5778999999999999999999997532


Q ss_pred             CccccccHHHHHH-----------HHHhcCCC-CccccccccCC-----CCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          743 PEEKEGNLVSWVR-----------GLVRNNKG-SRAIDPKIRDT-----GPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       743 ~~~~~~~~~~~~~-----------~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                      ..  ...+.....           ........ ...........     .....+.++.+++.+|+..||++|||++|++
T Consensus       209 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l  286 (291)
T cd07870         209 DV--FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL  286 (291)
T ss_pred             hH--HHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence            21  011111000           00000000 00000000000     0001245788999999999999999999987


Q ss_pred             H
Q 003504          806 G  806 (815)
Q Consensus       806 ~  806 (815)
                      .
T Consensus       287 ~  287 (291)
T cd07870         287 L  287 (291)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8e-34  Score=300.97  Aligned_cols=260  Identities=25%  Similarity=0.311  Sum_probs=198.9

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--CeeEEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQRIAIYD  584 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e  584 (815)
                      +|+..+.||.|++|.||+|.. .+++.+|+|.+..... .....+.+|++++++++||||+++++++.+.  ...++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            577788999999999999996 4688999999875322 3456789999999999999999999998654  36789999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++|+|.+++....                          .....++......++.|++.||+|||   +.+++||||+
T Consensus        82 ~~~~~~L~~~l~~~~--------------------------~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~  132 (287)
T cd06621          82 YCEGGSLDSIYKKVK--------------------------KRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIK  132 (287)
T ss_pred             ecCCCCHHHHHHHHH--------------------------hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence            999999999876421                          11334677888999999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      |+||+++.++.++|+|||++........ ....++..|+|||.+.+..  ++.++||||||+++|||++|+.||.....+
T Consensus       133 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  209 (287)
T cd06621         133 PSNILLTRKGQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEP  209 (287)
T ss_pred             HHHEEEecCCeEEEeecccccccccccc-ccccCCccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence            9999999999999999999876543222 2345788999999887665  688999999999999999999999864321


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .  ....+........ ... .+....  ......+.++.+++.+||+.+|++||++.|+++
T Consensus       210 ~--~~~~~~~~~~~~~-~~~-~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         210 P--LGPIELLSYIVNM-PNP-ELKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             C--CChHHHHHHHhcC-Cch-hhccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            1  1111111111111 100 011110  001234678899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.8e-34  Score=305.46  Aligned_cols=266  Identities=20%  Similarity=0.260  Sum_probs=199.7

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      +|+..+.||.|++|.||+|+.. +|..||||.+..... .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999964 688999999875432 23456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++ +|.+++....                           ....+++..+..++.|++.||+|||   +.+++||||||+
T Consensus        81 ~~-~l~~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~  129 (284)
T cd07836          81 DK-DLKKYMDTHG---------------------------VRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQ  129 (284)
T ss_pred             Cc-cHHHHHHhcC---------------------------CCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHH
Confidence            85 8988886421                           1235789999999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||++++++.+||+|||++....... ......++..|+|||.+.+... ++.++|||||||++||+++|+.||......+
T Consensus       130 ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~  208 (284)
T cd07836         130 NLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT-YSTSIDIWSVGCIMAEMITGRPLFPGTNNED  208 (284)
T ss_pred             HEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            9999999999999999997654322 1223457889999998765432 5789999999999999999999998654332


Q ss_pred             ccccHHHHH--------HHHHhcCCCCcccccc---ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWV--------RGLVRNNKGSRAIDPK---IRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ....+....        ................   .........+.++.+++.+|++.||.+||+++++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         209 QLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            221111110        0000000000000000   000001234567889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=305.30  Aligned_cols=260  Identities=20%  Similarity=0.275  Sum_probs=196.4

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      |+..+.||.|++|.||+|.. .+|..||+|++....  ......+.+|++++++++|||++++++++.+.+..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56678999999999999985 579999999986543  223456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      + ++|.+++...                            ....+++..+.+++.|+++||+|||   +.+++||||+|+
T Consensus        81 ~-~~l~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~  128 (283)
T cd07835          81 D-LDLKKYMDSS----------------------------PLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQ  128 (283)
T ss_pred             C-cCHHHHHhhC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHH
Confidence            5 6999998652                            1235789999999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||+++.++.++|+|||+++...... ......++..|+|||++.+... ++.++|||||||++|||++|+.||.......
T Consensus       129 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  207 (283)
T cd07835         129 NLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ-YSTPVDIWSIGCIFAEMVNRRPLFPGDSEID  207 (283)
T ss_pred             HEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcc-cCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999997654322 2223346889999998765432 5789999999999999999999997532211


Q ss_pred             ccccHHHHHHHHHhcC-----------C----CCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNN-----------K----GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~-----------~----~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                         .+...++......           .    ......+.. .......+.++.+++.+|++.+|++||+++++++
T Consensus       208 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         208 ---QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ---HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               1111111000000           0    000000000 0112233467889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.4e-34  Score=301.76  Aligned_cols=247  Identities=22%  Similarity=0.247  Sum_probs=201.2

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      +|++.+.||.|+||.||+|... ++..||+|.+.....   ...+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4777899999999999999964 688999999975432   234678899999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++++|.+++..                              ...+++.....++.|+++||.|||   ..+++|+||+
T Consensus        81 ~~~~~~L~~~l~~------------------------------~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~  127 (258)
T cd05578          81 LLLGGDLRYHLSQ------------------------------KVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIK  127 (258)
T ss_pred             CCCCCCHHHHHHh------------------------------cCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCC
Confidence            9999999999864                              135677888999999999999999   7899999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      |+||++++++.++|+|||++.............|+..|+|||.+....  ++.++||||||+++|++++|+.||......
T Consensus       128 ~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  205 (258)
T cd05578         128 PDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG--YSVAVDWWSLGVTAYECLRGKRPYRGHSRT  205 (258)
T ss_pred             HHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccC--CCCcccchhhHHHHHHHHhCCCCCCCCCcc
Confidence            999999999999999999998765544444556888999999987665  688999999999999999999999754321


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH--HHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM--QQIV  805 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~--~~v~  805 (815)
                           ...+.......          .....+...+..+.+++.+||..||.+||++  +|++
T Consensus       206 -----~~~~~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         206 -----IRDQIRAKQET----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -----HHHHHHHHhcc----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                 11111111111          0111233455788999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.5e-34  Score=306.01  Aligned_cols=247  Identities=26%  Similarity=0.341  Sum_probs=195.2

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL---TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      |+..+.||+|+||.||+|+. .++..||+|.+......   ....+.+|++++++++|||++++++++.+....++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            55678999999999999995 56889999998653222   234688899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      ++ |+|.+++...                             ...++|..+..++.|++.||.|||   +.+++||||+|
T Consensus       107 ~~-g~l~~~~~~~-----------------------------~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p  153 (317)
T cd06635         107 CL-GSASDLLEVH-----------------------------KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKA  153 (317)
T ss_pred             CC-CCHHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCc
Confidence            97 4887777531                             335789999999999999999999   88999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCC-CCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPD-SDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.+||+|||++......   ....|+..|+|||++... ...++.++|||||||++|||++|+.||......
T Consensus       154 ~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~  230 (317)
T cd06635         154 GNILLTEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM  230 (317)
T ss_pred             ccEEECCCCCEEEecCCCccccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence            9999999999999999998765432   234588899999987432 223688999999999999999999998652211


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                             ...........         ........+..+.+++.+||+.+|++||++.++++..
T Consensus       231 -------~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         231 -------SALYHIAQNES---------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             -------HHHHHHHhccC---------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                   11111111110         1111234556789999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.7e-34  Score=310.97  Aligned_cols=197  Identities=24%  Similarity=0.316  Sum_probs=170.4

Q ss_pred             CCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC-C-----CCceeeeeEEEeCCeeEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-H-----PNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l  581 (815)
                      +|++.+.||+|+||.|-||. ..+++.||||+++... .-..+-..|+.+|..++ |     -|+|++++|+...+..++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            78889999999999999999 4669999999997643 23345567899999886 3     389999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      |+|.+.. +|+++|+.++                            -..++......|+.||+.||.+||   +.+|||+
T Consensus       266 VfELL~~-NLYellK~n~----------------------------f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHc  313 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNK----------------------------FRGLSLPLVRKFAQQILTALLFLH---ELGIIHC  313 (586)
T ss_pred             eehhhhh-hHHHHHHhcC----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence            9999977 9999998742                            345888889999999999999999   8999999


Q ss_pred             cCCCCceEEcCCC--CeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 003504          662 DIKASSVYLDMNL--EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       662 Dlk~~NIll~~~~--~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~  739 (815)
                      ||||+|||+.+-.  .+||+|||.|+......  ....-+..|+|||++.+..  |+.+.||||||||+.||++|.+-|.
T Consensus       314 DLKPENILL~~~~r~~vKVIDFGSSc~~~q~v--ytYiQSRfYRAPEVILGlp--Y~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  314 DLKPENILLKDPKRSRIKVIDFGSSCFESQRV--YTYIQSRFYRAPEVILGLP--YDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             cCChhheeeccCCcCceeEEecccccccCCcc--eeeeeccccccchhhccCC--CCCccceeehhhhHHhHhcCccccC
Confidence            9999999997543  69999999999876543  3566789999999999998  8999999999999999999988887


Q ss_pred             CCC
Q 003504          740 DDY  742 (815)
Q Consensus       740 ~~~  742 (815)
                      ++.
T Consensus       390 G~n  392 (586)
T KOG0667|consen  390 GDN  392 (586)
T ss_pred             CCC
Confidence            653

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.1e-34  Score=295.48  Aligned_cols=249  Identities=28%  Similarity=0.434  Sum_probs=203.2

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      +|+..+.||+|++|.||+|... ++..|++|++..........+.+|++++++++|||++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4777899999999999999964 688999999977544456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +++|.+++...                             ...+++..+..++.+++.||+|||   ..+++||||+|+|
T Consensus        81 ~~~L~~~~~~~-----------------------------~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~n  128 (253)
T cd05122          81 GGSLKDLLKST-----------------------------NQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAAN  128 (253)
T ss_pred             CCcHHHHHhhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHH
Confidence            99999998652                             135788999999999999999999   7999999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |++++++.++|+|||.+.............|+..|+|||.+....  ++.++||||||+++|++++|+.||.....    
T Consensus       129 i~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~----  202 (253)
T cd05122         129 ILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP--YDYKADIWSLGITAIELAEGKPPYSELPP----  202 (253)
T ss_pred             EEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCch----
Confidence            999999999999999998776543234456889999999987665  68899999999999999999999875321    


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                         ......... ....     ...  .+...+..+.+++.+||..||++||++.++++
T Consensus       203 ---~~~~~~~~~-~~~~-----~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         203 ---MKALFKIAT-NGPP-----GLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ---HHHHHHHHh-cCCC-----CcC--cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               111111111 1000     110  11123567899999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.7e-34  Score=300.91  Aligned_cols=248  Identities=23%  Similarity=0.389  Sum_probs=198.6

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|++++++++||||+++++++......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677899999999999999964 58889999986532  23445788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++++|.+++...                            ....+++..+..++.|++.||+|||   +.+++||||||
T Consensus        81 ~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~  129 (257)
T cd08225          81 CDGGDLMKRINRQ----------------------------RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKS  129 (257)
T ss_pred             CCCCcHHHHHHhc----------------------------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCH
Confidence            9999999999652                            1235789999999999999999999   78999999999


Q ss_pred             CceEEcCCC-CeeecccccceecCCCCc-cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          666 SSVYLDMNL-EPRLSDFGLAKIFGNGLD-EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       666 ~NIll~~~~-~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      +||++++++ .+||+|||.+........ .....|++.|+|||+.....  ++.++|||||||++||+++|+.||.... 
T Consensus       130 ~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~-  206 (257)
T cd08225         130 QNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP--YNNKTDIWSLGCVLYELCTLKHPFEGNN-  206 (257)
T ss_pred             HHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCcc-
Confidence            999999886 469999999987654322 22335889999999887655  6889999999999999999999986422 


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                            ..++........     +.+     .+...+.++.+++.+||..+|++||++.++++
T Consensus       207 ------~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         207 ------LHQLVLKICQGY-----FAP-----ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ------HHHHHHHHhccc-----CCC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                  222222222111     111     11233457899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=305.45  Aligned_cols=262  Identities=20%  Similarity=0.266  Sum_probs=194.2

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ++|+..+.||+|++|.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999964 688999999865322 2234567899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++ +|.+++...                             ...+++.....++.|++.||.|||   +.+|+||||||
T Consensus        85 ~~~-~L~~~~~~~-----------------------------~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p  131 (291)
T cd07844          85 LDT-DLKQYMDDC-----------------------------GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKP  131 (291)
T ss_pred             CCC-CHHHHHHhC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCH
Confidence            985 999988652                             225678888999999999999999   88999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.+||+|||+++...... ......++..|+|||++.+... ++.++|||||||++|||++|+.||......
T Consensus       132 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~  210 (291)
T cd07844         132 QNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTE-YSTSLDMWGVGCIFYEMATGRPLFPGSTDV  210 (291)
T ss_pred             HHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcc-cCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence            99999999999999999987543211 1222346888999998765432 578999999999999999999999753311


Q ss_pred             cccccHHHHHHHHHhc---CCC--------------CccccccccCCC-CHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRN---NKG--------------SRAIDPKIRDTG-PEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~---~~~--------------~~~~~~~~~~~~-~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .  ..+. .....+..   +..              .......+.... ......++.+++.+|++.+|++||++.++++
T Consensus       211 ~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         211 E--DQLH-KIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             H--HHHH-HHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0  0000 00000000   000              000000000000 0011256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=304.93  Aligned_cols=263  Identities=24%  Similarity=0.310  Sum_probs=197.5

Q ss_pred             CCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--CeeEEEEE
Q 003504          510 FDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQRIAIYD  584 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e  584 (815)
                      |++.+.||+|+||.||+|... ++..||+|.+....  ......+.+|++++++++|||++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566789999999999999965 58899999997653  33345788999999999999999999999987  78999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++ +|.+++...                             ...+++..+..++.|+++||+|||   ..+++|+||+
T Consensus        81 ~~~~-~l~~~~~~~-----------------------------~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~  127 (287)
T cd07840          81 YMDH-DLTGLLDSP-----------------------------EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIK  127 (287)
T ss_pred             cccc-cHHHHHhcc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCc
Confidence            9985 898888642                             235788899999999999999999   7899999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      |+||++++++.+||+|||++.......  ......++..|+|||.+.+... ++.++||||||+++|||++|+.||....
T Consensus       128 p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         128 GSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR-YGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             HHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEcccc-CChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998765433  1233456888999998765432 6889999999999999999999997543


Q ss_pred             CccccccHHHHHHHHHhcCC-------------CCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNK-------------GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .......+.+.........+             ........+.......++.++.+++.+||..+|++||+++++++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         207 ELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            32111111111000000000             00000000000001112678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=312.03  Aligned_cols=249  Identities=23%  Similarity=0.358  Sum_probs=203.4

Q ss_pred             CCCCeecccCCeeeEEEEcCC-CcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          511 DRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       511 ~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      .+.-.+|.|+||.||+|+.++ +.-.|.|++...+....++|.-||+||+..+||+||++++.|+..+..+++.|||.||
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG  114 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG  114 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence            344679999999999999664 4445678886666666778999999999999999999999999889999999999999


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      -....+-..                             +.++...+..-++.+++.||.|||   +..|||||||+-|||
T Consensus       115 AVDaimlEL-----------------------------~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL  162 (1187)
T KOG0579|consen  115 AVDAIMLEL-----------------------------GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNIL  162 (1187)
T ss_pred             hHhHHHHHh-----------------------------ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceE
Confidence            999888653                             556788888889999999999999   899999999999999


Q ss_pred             EcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCC---CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          670 LDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       670 l~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ++-+|.++++|||++-...... ....+.||++|||||++++..   ..|+.++||||||+.|.||..+.+|-....+  
T Consensus       163 ~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--  240 (1187)
T KOG0579|consen  163 LTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--  240 (1187)
T ss_pred             EEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--
Confidence            9999999999999986543322 345678999999999987654   3378899999999999999999999764332  


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                           ...+-.+...+      +|.+  ..|..+...+.++..+|+.++|..||+++++++
T Consensus       241 -----MRVllKiaKSe------PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  241 -----MRVLLKIAKSE------PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -----HHHHHHHhhcC------CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                 22222222221      2222  237778889999999999999999999999975

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.3e-34  Score=298.15  Aligned_cols=242  Identities=24%  Similarity=0.280  Sum_probs=195.1

Q ss_pred             ecccCCeeeEEEEcC-CCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCCh
Q 003504          516 LAEGKFGPVYRGFLP-GGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNL  591 (815)
Q Consensus       516 ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL  591 (815)
                      ||.|+||.||+|+.. +++.||+|++.....   ...+.+.+|++++++++||||+++++++.++...++|+||+++|+|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999964 588999999865322   2346789999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEc
Q 003504          592 QNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD  671 (815)
Q Consensus       592 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  671 (815)
                      .+++...                              ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++
T Consensus        81 ~~~l~~~------------------------------~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~  127 (262)
T cd05572          81 WTILRDR------------------------------GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLD  127 (262)
T ss_pred             HHHHhhc------------------------------CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEc
Confidence            9999652                              23677888999999999999999   89999999999999999


Q ss_pred             CCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHH
Q 003504          672 MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV  751 (815)
Q Consensus       672 ~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~  751 (815)
                      .++.+||+|||+++............|+..|+|||.+....  ++.++|+||||+++||+++|+.||.....     +..
T Consensus       128 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~  200 (262)
T cd05572         128 SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG--YDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPM  200 (262)
T ss_pred             CCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCC--CCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHH
Confidence            99999999999998776543334456889999999986555  68899999999999999999999975331     112


Q ss_pred             HHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003504          752 SWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS-----MQQIVG  806 (815)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~~v~~  806 (815)
                      .........         ......+...+.++.+++.+||..+|++||+     ++|+++
T Consensus       201 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         201 EIYNDILKG---------NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHhcc---------CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            222222110         0111123334678999999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-35  Score=312.54  Aligned_cols=243  Identities=23%  Similarity=0.379  Sum_probs=190.4

Q ss_pred             CCeecccCCeeeEEEEc-CCCcEEEEEEee--cC--CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCe--eEEEEEe
Q 003504          513 GTLLAEGKFGPVYRGFL-PGGIHVAVKVLV--HG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQ--RIAIYDY  585 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~--~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lv~ey  585 (815)
                      ..+||+|+|-+||||.. .+|..||--.++  +-  +....+.|..|+.+|+.|+||||++++.++.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            46899999999999985 457788743332  11  23334789999999999999999999999988655  6789999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      |..|+|..|+.+.                              ...+.+...+|++||++||.|||+. .+||||||||.
T Consensus       125 ~TSGtLr~Y~kk~------------------------------~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKC  173 (632)
T KOG0584|consen  125 FTSGTLREYRKKH------------------------------RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKC  173 (632)
T ss_pred             ccCCcHHHHHHHh------------------------------ccCCHHHHHHHHHHHHHHhhhhhcC-CCCcccccccc
Confidence            9999999999763                              2466778899999999999999964 68999999999


Q ss_pred             CceEEcC-CCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDM-NLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+|+. .|.+||+|.|+|..+.... .....|||.|||||+.. ..  |.+..||||||++|+||+|+..||..... 
T Consensus       174 DNIFinG~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE-E~--YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-  248 (632)
T KOG0584|consen  174 DNIFVNGNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE-EN--YNELVDVYAFGMCMLEMVTSEYPYSECTN-  248 (632)
T ss_pred             ceEEEcCCcCceeecchhHHHHhhccc-cceeccCccccChHHHh-hh--cchhhhhhhhhHHHHHHHhccCChhhhCC-
Confidence            9999985 4899999999999876543 33367999999999876 33  79999999999999999999999985321 


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                        ..++.+-+   ...     +.+..+.    .-...++.+++.+|+.. .++|||+.|+++
T Consensus       249 --~AQIYKKV---~SG-----iKP~sl~----kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  249 --PAQIYKKV---TSG-----IKPAALS----KVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             --HHHHHHHH---HcC-----CCHHHhh----ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence              11222211   111     1111111    11235788999999999 999999999985

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.3e-34  Score=307.70  Aligned_cols=259  Identities=22%  Similarity=0.274  Sum_probs=192.4

Q ss_pred             Ceeccc--CCeeeEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEG--KFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G--~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      ..||+|  +||+||+|+. .+|+.||||++.....  ...+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  8999999995 5789999999865322  2235788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|.+++....                            ...+++.....++.|++.||+|||   +.+++||||||+||
T Consensus        84 ~~l~~~l~~~~----------------------------~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Ni  132 (328)
T cd08226          84 GSANSLLKTYF----------------------------PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHI  132 (328)
T ss_pred             CCHHHHHHhhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHE
Confidence            99999987521                            224678888899999999999999   88999999999999


Q ss_pred             EEcCCCCeeecccccceecCCCC-c-------cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNGL-D-------EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~~-~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  740 (815)
                      +++.++.+|++||+.+....... .       .....++..|+|||++.+....++.++|||||||++||+++|+.||..
T Consensus       133 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  212 (328)
T cd08226         133 LISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD  212 (328)
T ss_pred             EEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999998654332111 0       111235667999999876543468899999999999999999999975


Q ss_pred             CCCccccccHHHHHH--------------------------------HHHhcCCCCccccccccCCCCHHHHHHHHHHHh
Q 003504          741 DYPEEKEGNLVSWVR--------------------------------GLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGY  788 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  788 (815)
                      ....+.   ......                                ............++.+....+..+...+.+++.
T Consensus       213 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (328)
T cd08226         213 MLRTQM---LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE  289 (328)
T ss_pred             cChHHH---HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHH
Confidence            322111   000000                                000000000111112222224456788999999


Q ss_pred             hccccCCCCCCCHHHHHH
Q 003504          789 LCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       789 ~Cl~~dP~~RPs~~~v~~  806 (815)
                      +||..||++|||+.++++
T Consensus       290 ~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         290 LCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             HHccCCcccCCCHHHHhh
Confidence            999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-34  Score=300.08  Aligned_cols=264  Identities=22%  Similarity=0.278  Sum_probs=198.6

Q ss_pred             CCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCCeeEEEEEeC
Q 003504          510 FDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST-LTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      |++.+.||+|+||.||+|+.. +++.||||++..... .......+|+..+.+++ ||||+++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999965 578899999865432 22334567999999999 999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                       +|+|.+++...                            ....+++..+..++.|++.||.|||   +.+++|+||+|+
T Consensus        81 -~~~l~~~~~~~----------------------------~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~  128 (283)
T cd07830          81 -EGNLYQLMKDR----------------------------KGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPE  128 (283)
T ss_pred             -CCCHHHHHHhc----------------------------ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChh
Confidence             88999988752                            1235789999999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEK  746 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~  746 (815)
                      ||++++++.++|+|||+++............++..|+|||.+..... ++.++||||||+++||+++|+.||......+.
T Consensus       129 ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~  207 (283)
T cd07830         129 NLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS-YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ  207 (283)
T ss_pred             hEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcC-cCCccchhhHHHHHHHHHhCCCccCCCChHHH
Confidence            99999999999999999987755444444568889999998754432 68899999999999999999999865432211


Q ss_pred             cccHHH---------HHHHHHhcCCCCcccccccc---CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          747 EGNLVS---------WVRGLVRNNKGSRAIDPKIR---DTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       747 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .....+         |.............+.....   .........++.+++.+||+.+|++||+++|++.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         208 LYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             HHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            111111         11111001111111110000   0001112467899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.8e-33  Score=293.16  Aligned_cols=248  Identities=28%  Similarity=0.408  Sum_probs=203.9

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--CeeEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQRIAIY  583 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~  583 (815)
                      +|...+.||+|++|.||+|... ++..|++|++.....  ...+.+.+|++++++++||||+++++++...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999965 788999999865432  3456789999999999999999999999988  8899999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++++|.+++...                              ..+++..+..++.|++.||+|||   +.+++|+||
T Consensus        81 e~~~~~~L~~~~~~~------------------------------~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl  127 (260)
T cd06606          81 EYVSGGSLSSLLKKF------------------------------GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDI  127 (260)
T ss_pred             EecCCCcHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCC
Confidence            999999999999652                              26789999999999999999999   789999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCc---cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  740 (815)
                      +|+||+++.++.++|+|||.+........   .....++..|+|||......  .+.++||||||+++|++++|+.||..
T Consensus       128 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~  205 (260)
T cd06606         128 KGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE--YGRAADIWSLGCTVIEMATGKPPWSE  205 (260)
T ss_pred             CHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999988765442   34456889999999987765  68899999999999999999999975


Q ss_pred             CCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..      ...........         .......+...+.++.+++.+|+..+|++||++.++++
T Consensus       206 ~~------~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         206 LG------NPMAALYKIGS---------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CC------chHHHHHhccc---------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            32      11111111110         11111223445678999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.3e-34  Score=312.18  Aligned_cols=262  Identities=19%  Similarity=0.243  Sum_probs=196.7

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeC------C
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAG------D  577 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~  577 (815)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+...  .......+.+|+.++++++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            46799999999999999999994 57899999998642  223345677899999999999999999988643      2


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++||||+.+ +|.+.+..                                .++......++.|++.||+|||   +.+
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~--------------------------------~l~~~~~~~~~~ql~~aL~~LH---~~g  138 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQM--------------------------------DLDHERMSYLLYQMLCGIKHLH---SAG  138 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhh--------------------------------cCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            46899999965 88887743                                1567778889999999999999   889


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      |+||||||+||+++.++.+||+|||+++............++..|+|||.+.+..  ++.++|||||||++|+|++|+.|
T Consensus       139 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~p  216 (353)
T cd07850         139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIRGTVL  216 (353)
T ss_pred             eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCC--CCCchhhHhHHHHHHHHHHCCCC
Confidence            9999999999999999999999999998765544334456889999999987665  78999999999999999999999


Q ss_pred             CCCCCCccccccHH--------HH-------HHHHHhcCCC------Cccccccc----cCCCCHHHHHHHHHHHhhccc
Q 003504          738 LGDDYPEEKEGNLV--------SW-------VRGLVRNNKG------SRAIDPKI----RDTGPEKQMEEALKIGYLCTA  792 (815)
Q Consensus       738 ~~~~~~~~~~~~~~--------~~-------~~~~~~~~~~------~~~~~~~~----~~~~~~~~~~~~~~l~~~Cl~  792 (815)
                      |...........+.        .+       ..........      .+......    ....+...+.++.+++.+|++
T Consensus       217 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  296 (353)
T cd07850         217 FPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV  296 (353)
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcC
Confidence            97532211110100        00       0001110000      00011100    011122346678999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 003504          793 DLPLKRPSMQQIVG  806 (815)
Q Consensus       793 ~dP~~RPs~~~v~~  806 (815)
                      .||++||++.|+++
T Consensus       297 ~dP~~R~t~~eiL~  310 (353)
T cd07850         297 IDPEKRISVDDALQ  310 (353)
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-33  Score=300.76  Aligned_cols=254  Identities=22%  Similarity=0.351  Sum_probs=195.6

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCC-CcEEEEEEeecCCc-ccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCCeeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGST-LTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      ++|++.+.||+|+||.||+|...+ ++.||||.+..... .....+.+|++++.+.. ||||++++++|.+....++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567888999999999999999764 88999999875432 23455677887776665 9999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++ ++.+++...                             ...+++..+.+++.|++.||+|||+  ..+|+||||+
T Consensus        95 ~~~~-~l~~l~~~~-----------------------------~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~  142 (296)
T cd06618          95 LMST-CLDKLLKRI-----------------------------QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVK  142 (296)
T ss_pred             ccCc-CHHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCc
Confidence            9864 777776531                             2367888999999999999999993  2589999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCC--CCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS--DFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      |+||+++.++.+||+|||++.............++..|+|||.+.+..  ..++.++||||||+++|||++|+.||....
T Consensus       143 p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  222 (296)
T cd06618         143 PSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK  222 (296)
T ss_pred             HHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch
Confidence            999999999999999999998765443334445788999999987553  336789999999999999999999996421


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      ..      ............      +...  ....++.++.+++.+||..||++||++.++++.
T Consensus       223 ~~------~~~~~~~~~~~~------~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         223 TE------FEVLTKILQEEP------PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             hH------HHHHHHHhcCCC------CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11      111111221110      0110  011245678999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-33  Score=298.51  Aligned_cols=243  Identities=22%  Similarity=0.255  Sum_probs=187.1

Q ss_pred             eecccCCeeeEEEEc-CCCcEEEEEEeecCCcc---cHHHHHHHHHH---hcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          515 LLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL---TDQEAARELEY---LGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       515 ~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      .||+|+||.||+|.. .+++.||+|.+......   ....+.+|..+   +...+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999995 56889999998654221   12233444433   334479999999999999889999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|.+++..                              ...+++.....++.|++.||+|||   +.+|+||||||+|
T Consensus        81 ~~~L~~~i~~------------------------------~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~N  127 (279)
T cd05633          81 GGDLHYHLSQ------------------------------HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPAN  127 (279)
T ss_pred             CCCHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHH
Confidence            9999998864                              235789999999999999999999   8899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |++++++.+||+|||++...... ......|+..|+|||.+..... ++.++|||||||++||+++|+.||........ 
T Consensus       128 il~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-  204 (279)
T cd05633         128 ILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-  204 (279)
T ss_pred             EEECCCCCEEEccCCcceecccc-CccCcCCCcCccCHHHhcCCCC-CCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-
Confidence            99999999999999999765432 2233468999999998764332 68899999999999999999999975322111 


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVGL  807 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~~  807 (815)
                          ........          ......+...+.++.+++.+|+..||++||     +++++++.
T Consensus       205 ----~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         205 ----HEIDRMTL----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ----HHHHHHhh----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                11111110          011112344567889999999999999999     59888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-36  Score=338.36  Aligned_cols=254  Identities=28%  Similarity=0.390  Sum_probs=201.8

Q ss_pred             HHhcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          505 SATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       505 ~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      ..+.+++.+..||.|.||.||-|. .++|.-.|||.+.....  ..-..+.+|+.++..++|||+|+++|+-...+..++
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            345678889999999999999999 56788899998764322  223467899999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      .||||++|+|.+.+...                              ...+...-.....|++.|++|||   +.+||||
T Consensus      1312 FMEyC~~GsLa~ll~~g------------------------------ri~dE~vt~vyt~qll~gla~LH---~~gIVHR 1358 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG------------------------------RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHR 1358 (1509)
T ss_pred             HHHHhccCcHHHHHHhc------------------------------chhhhhHHHHHHHHHHHHHHHHH---hcCceec
Confidence            99999999999999652                              12233333446778999999999   8999999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCC-----ccccccccccccCCcccCCCCC-CCCCcCcchhHHHHHHHHHhCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGL-----DEEIARGSPGYIPPEFAQPDSD-FPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      ||||.||+++.+|.+|.+|||.|....+..     .-....||+.|||||++.+... .-.-+.||||+|||+.||+||+
T Consensus      1359 DIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGk 1438 (1509)
T KOG4645|consen 1359 DIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGK 1438 (1509)
T ss_pred             CCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCC
Confidence            999999999999999999999999876542     1234569999999999886542 1355889999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      .||...+.+        |.-.+.-        -.+-.++.|+....+-.+++..|+..||++|+++.|+++.
T Consensus      1439 rPW~~~dne--------~aIMy~V--------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1439 RPWAELDNE--------WAIMYHV--------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             Cchhhccch--------hHHHhHH--------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            999753221        2211110        1112233477788899999999999999999999988764

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.2e-34  Score=303.81  Aligned_cols=264  Identities=17%  Similarity=0.223  Sum_probs=195.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCCe-----
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQ-----  578 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~-----  578 (815)
                      ++|+..+.||+|+||.||+|.. .+++.||||.+.....  .....+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3688889999999999999995 4689999998765322  22357888999999995 6999999999987665     


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++||||+++ +|.+++.....                         .....+++.....++.|++.||+|||   +.+|
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i  131 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGR-------------------------GPGRPLPAKTIKSFMYQLLKGVAHCH---KHGV  131 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcc-------------------------cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            7999999986 89998865211                         11345789999999999999999999   8899


Q ss_pred             eeccCCCCceEEcC-CCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          659 IHRDIKASSVYLDM-NLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       659 vHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      +||||||+||+++. ++.+||+|||+++...... ......+++.|+|||++.+... ++.++|||||||++|||++|..
T Consensus       132 ~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~  210 (295)
T cd07837         132 MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQP  210 (295)
T ss_pred             eecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCC-CCchHHHHHHHHHHHHHHcCCC
Confidence            99999999999998 8899999999998654322 2223356889999998865432 6889999999999999999999


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCcccc-----------ccccC----CCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAID-----------PKIRD----TGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~----~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      ||......+.   +.+.... ... .......           +....    ......+.++.+++.+||..+|++||++
T Consensus       211 ~~~~~~~~~~---~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~  285 (295)
T cd07837         211 LFPGDSELQQ---LLHIFKL-LGT-PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA  285 (295)
T ss_pred             CCCCCCHHHH---HHHHHHH-hCC-CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH
Confidence            9975322111   1111110 000 0000000           00000    0012345778999999999999999999


Q ss_pred             HHHHH
Q 003504          802 QQIVG  806 (815)
Q Consensus       802 ~~v~~  806 (815)
                      .+++.
T Consensus       286 ~eil~  290 (295)
T cd07837         286 KAALT  290 (295)
T ss_pred             HHHhc
Confidence            99875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=8.1e-34  Score=299.31  Aligned_cols=244  Identities=25%  Similarity=0.275  Sum_probs=192.2

Q ss_pred             ecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCCh
Q 003504          516 LAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNL  591 (815)
Q Consensus       516 ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL  591 (815)
                      ||+|+||+||+|.. .+|+.||+|.+.....   .....+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999984 5688999999865321   2244567899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEc
Q 003504          592 QNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD  671 (815)
Q Consensus       592 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  671 (815)
                      .+++...                            ....+++..+..++.|++.||.|||   +.+++||||+|+||+++
T Consensus        81 ~~~l~~~----------------------------~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~  129 (277)
T cd05577          81 KYHIYNV----------------------------GEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLD  129 (277)
T ss_pred             HHHHHHc----------------------------CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEC
Confidence            9999752                            1235788889999999999999999   88999999999999999


Q ss_pred             CCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHH
Q 003504          672 MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV  751 (815)
Q Consensus       672 ~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~  751 (815)
                      .++.+||+|||.+.............++..|+|||.+.+..  ++.++|||||||++||+++|+.||...........+.
T Consensus       130 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  207 (277)
T cd05577         130 DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV--YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK  207 (277)
T ss_pred             CCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCC--CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH
Confidence            99999999999998765433334456788999999987665  6889999999999999999999997533211110010


Q ss_pred             HHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          752 SWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                         . ....          .....+...+..+.+++.+||+.+|++||     ++.+++.
T Consensus       208 ---~-~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         208 ---R-RTLE----------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ---h-cccc----------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence               0 0000          01111333466789999999999999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-34  Score=305.66  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=206.9

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL--TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ...|.+...||+|.|+.|..|+. .++..||||.+.+..-.  ..+.+.+|+++|..++|||||+++.+.......++||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            34677889999999999999994 56899999998764322  2345889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+.+|.+++++...                             + .........++.|+..|++|||   ++.||||||
T Consensus       135 eya~~ge~~~yl~~~-----------------------------g-r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdL  181 (596)
T KOG0586|consen  135 EYASGGELFDYLVKH-----------------------------G-RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDL  181 (596)
T ss_pred             EeccCchhHHHHHhc-----------------------------c-cchhhhhhhhhHHHHHHHHHHh---hcceecccc
Confidence            999999999999763                             1 1222556678899999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      |++|||++.++++||+|||++..+..+......+|++.|.|||++.+.. +.++++|+||+||++|-|+.|..||++..-
T Consensus       182 k~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~l  260 (596)
T KOG0586|consen  182 KAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQNL  260 (596)
T ss_pred             chhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCccc
Confidence            9999999999999999999999999888888999999999999999887 479999999999999999999999986433


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .+..                .+++...++.  +.....+.-+++.+.+..+|.+|++++++.+
T Consensus       261 k~Lr----------------~rvl~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  261 KELR----------------PRVLRGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             cccc----------------chheeeeecc--cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            2221                1111222222  3334456778999999999999999999864

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-35  Score=303.18  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=198.4

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCCeeEEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHG--STLTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ...|++.+.||+||.+.||++...+.+.+|+|++...  +......|..|++.|.+|+ |.+|+++++|-..++..|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3468889999999999999999988888998876542  3344567999999999995 999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||=+. +|..+|.+.                            .....+| .+..+..|++.|+.++|   ..+|||.||
T Consensus       440 E~Gd~-DL~kiL~k~----------------------------~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDL  486 (677)
T KOG0596|consen  440 ECGDI-DLNKILKKK----------------------------KSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDL  486 (677)
T ss_pred             ecccc-cHHHHHHhc----------------------------cCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCC
Confidence            98665 999999863                            1334456 67789999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCC---ccccccccccccCCcccCCCCCC---------CCCcCcchhHHHHHHHH
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDF---------PTPKSDVYCYGVVLLEL  731 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~---------~~~~~Dv~S~Gvvl~el  731 (815)
                      ||.|+|+-. |.+||+|||.|..+..+.   ....-+||+.||+||.+......         .+.++||||+||++|+|
T Consensus       487 KPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqM  565 (677)
T KOG0596|consen  487 KPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQM  565 (677)
T ss_pred             CcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHH
Confidence            999999874 689999999999887654   23445799999999987654321         57899999999999999


Q ss_pred             HhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCH-HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPE-KQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       732 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +.|+.||+.      ..+.  |.+       ...+.+|.-..++|. ....++.++|..|+++||++||+..++++
T Consensus       566 vYgktPf~~------~~n~--~aK-------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  566 VYGKTPFGQ------IINQ--IAK-------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HhcCCchHH------HHHH--HHH-------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            999999974      1111  111       223445544333221 11223899999999999999999999875

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=299.56  Aligned_cols=260  Identities=20%  Similarity=0.252  Sum_probs=194.9

Q ss_pred             CCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcc--cHHHHHHHHHHhcCC---CCCCceeeeeEEEeCCe-----
Q 003504          510 FDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTL--TDQEAARELEYLGRI---KHPNLVPLTGYCIAGDQ-----  578 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-----  578 (815)
                      |++.+.||+|+||.||+|+.. ++..||+|++......  ....+.+|+.++.++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566789999999999999975 4899999998643222  234566787776655   69999999999998776     


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .+++|||+++ +|.+++...                            ....+++..+..++.|++.||+|||   +.++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~----------------------------~~~~l~~~~~~~~~~~i~~al~~LH---~~~i  128 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKC----------------------------PKPGLPPETIKDLMRQLLRGVDFLH---SHRI  128 (287)
T ss_pred             eEEEehhccc-CHHHHHHHc----------------------------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            8999999985 899888652                            1224788999999999999999999   7899


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCC
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~  738 (815)
                      +|+||+|+||+++.++.+||+|||.+.............++..|+|||++.+..  ++.++|||||||++|||++|+.||
T Consensus       129 ~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~s~G~~l~~l~~~~~~~  206 (287)
T cd07838         129 VHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS--YATPVDMWSVGCIFAELFRRRPLF  206 (287)
T ss_pred             eeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCC--CCCcchhhhHHHHHHHHHhCCCcc
Confidence            999999999999999999999999998875544334445788999999987665  688999999999999999999998


Q ss_pred             CCCCCccccccHHHHHHHHHhcC---CCC------cccccccc---CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          739 GDDYPEEKEGNLVSWVRGLVRNN---KGS------RAIDPKIR---DTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ......+.   +.++........   ...      ........   ..........+.+++.+||+.||++||++++++.
T Consensus       207 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         207 RGTSEADQ---LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCChHHH---HHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            75433221   111111110000   000      00000000   0011234577889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.6e-33  Score=299.27  Aligned_cols=251  Identities=26%  Similarity=0.295  Sum_probs=196.3

Q ss_pred             CCCCCCeecccCCeeeEEEEc----CCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCee
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL----PGGIHVAVKVLVHGST----LTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  579 (815)
                      +|++.+.||+|+||.||+|..    .+|..||+|++.....    ...+.+.+|++++.++ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467789999999999999985    4688999999875322    2345678899999999 599999999999988899


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++||||+++|+|.+++...                              ..+.+.....++.|+++||+|||   +.+++
T Consensus        81 ~lv~e~~~~~~L~~~l~~~------------------------------~~l~~~~~~~~~~qi~~al~~lH---~~~i~  127 (290)
T cd05613          81 HLILDYINGGELFTHLSQR------------------------------ERFKEQEVQIYSGEIVLALEHLH---KLGII  127 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            9999999999999998642                              24667778889999999999999   89999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      ||||+|+||+++.++.+||+|||+++......  ......|+..|+|||.+.......+.++||||||+++||+++|+.|
T Consensus       128 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p  207 (290)
T cd05613         128 YRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP  207 (290)
T ss_pred             ccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCC
Confidence            99999999999999999999999998764322  1223458899999999876443367899999999999999999999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                      |......   .....+........       +    ..+......+.+++.+||+.||++||     +++++++
T Consensus       208 ~~~~~~~---~~~~~~~~~~~~~~-------~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         208 FTVDGEK---NSQAEISRRILKSE-------P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CCcCCcc---ccHHHHHHHhhccC-------C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            9643221   12222222221111       1    11233456788999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.4e-34  Score=302.88  Aligned_cols=261  Identities=19%  Similarity=0.284  Sum_probs=193.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.....  .....+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999954 688999998865322  223568899999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |++ ++|.+++...                            .....++.....++.|++.||+|||   +.+++||||+
T Consensus        82 ~~~-~~l~~~~~~~----------------------------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~  129 (294)
T PLN00009         82 YLD-LDLKKHMDSS----------------------------PDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLK  129 (294)
T ss_pred             ccc-ccHHHHHHhC----------------------------CCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCC
Confidence            996 5888877542                            1223467777889999999999999   7899999999


Q ss_pred             CCceEEcC-CCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          665 ASSVYLDM-NLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       665 ~~NIll~~-~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      |+||+++. ++.+||+|||++....... ......+++.|+|||++.+.. .++.++|||||||++|||++|+.||....
T Consensus       130 p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~i~~~l~tg~~pf~~~~  208 (294)
T PLN00009        130 PQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR-HYSTPVDIWSVGCIFAEMVNQKPLFPGDS  208 (294)
T ss_pred             cceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999985 5579999999997654322 123345788999999876543 26889999999999999999999997533


Q ss_pred             CccccccHHHHHHHHHhcCCCCccc------------cccccCC----CCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAI------------DPKIRDT----GPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~----~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..+.   +..... ... .......            -+.....    .....+.++.+++.+|++.+|++||++.++++
T Consensus       209 ~~~~---~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        209 EIDE---LFKIFR-ILG-TPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             HHHH---HHHHHH-HhC-CCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2111   111100 000 0000000            0000000    01223466889999999999999999999975

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.8e-34  Score=296.12  Aligned_cols=249  Identities=22%  Similarity=0.343  Sum_probs=202.5

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|++.+.||+|+||.||+++. .++..+|+|.+....  ......+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477789999999999999984 568899999987532  23345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++++|.+++....                          .....+++.....++.|++.||+|||   +.+++||||+|
T Consensus        81 ~~~~~L~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~  131 (256)
T cd08530          81 APFGDLSKAISKRK--------------------------KKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKS  131 (256)
T ss_pred             cCCCCHHHHHHHHH--------------------------hhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCc
Confidence            99999999986521                          11345788999999999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      +||+++.++.+|++|||+++..... ......|+..|+|||...+..  ++.++|+||||+++||+++|+.||.....++
T Consensus       132 ~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~  208 (256)
T cd08530         132 ANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRP--YSYKSDIWSLGCLLYEMATFAPPFEARSMQD  208 (256)
T ss_pred             ceEEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999999877654 233345889999999987665  6889999999999999999999997532211


Q ss_pred             ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                          +.   .. ....         .....+...+.++.+++.+|+..+|++||++.++++
T Consensus       209 ----~~---~~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         209 ----LR---YK-VQRG---------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ----HH---HH-HhcC---------CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                11   11 1111         111123456678999999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.6e-33  Score=301.28  Aligned_cols=260  Identities=22%  Similarity=0.207  Sum_probs=191.1

Q ss_pred             CCCeecccCCeeeEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          512 RGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       512 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      +++.+|.|+++.||++.. +++.||||+++..  .....+.+.+|++++++++||||+++++++.+.+..+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344555566666666655 6889999998764  2334467899999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      +|.++++...                            ...+++.....++.|++.||+|||   +.+|+||||||+||+
T Consensus        85 ~l~~~l~~~~----------------------------~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nil  133 (314)
T cd08216          85 SCEDLLKTHF----------------------------PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHIL  133 (314)
T ss_pred             CHHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEE
Confidence            9999997521                            224667778899999999999999   889999999999999


Q ss_pred             EcCCCCeeecccccceecCCCC--------ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          670 LDMNLEPRLSDFGLAKIFGNGL--------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       670 l~~~~~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      ++.++.+||+|||.+.......        ......++..|+|||++......++.++|||||||++|||++|+.||...
T Consensus       134 i~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             EecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999887553211        11233467889999998765333688999999999999999999999753


Q ss_pred             CCccccccHHHHHHHHH----hcC-------CCCc----cccccc----cCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 003504          742 YPEEKEGNLVSWVRGLV----RNN-------KGSR----AIDPKI----RDTGPEKQMEEALKIGYLCTADLPLKRPSMQ  802 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~----~~~-------~~~~----~~~~~~----~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  802 (815)
                      ....   ...+......    ...       ....    ..++..    ..........++.+++.+||..||++||+++
T Consensus       214 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  290 (314)
T cd08216         214 PATQ---MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS  290 (314)
T ss_pred             CHHH---HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHH
Confidence            2111   1111000000    000       0000    000000    0111334557889999999999999999999


Q ss_pred             HHHH
Q 003504          803 QIVG  806 (815)
Q Consensus       803 ~v~~  806 (815)
                      ++++
T Consensus       291 ~ll~  294 (314)
T cd08216         291 QLLN  294 (314)
T ss_pred             HHhc
Confidence            9976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.7e-34  Score=304.52  Aligned_cols=266  Identities=23%  Similarity=0.296  Sum_probs=196.3

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCCceeeeeEEEeC--CeeEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL--TDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQRIA  581 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  581 (815)
                      .++|++.+.||+|+||.||+|.. .+|..||+|.++.....  ....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            35788899999999999999995 46899999998653222  233567899999999999999999998765  46799


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ||||+.+ +|.+++...                             ...+++..+..++.|++.||+|||   +.+++||
T Consensus        86 v~e~~~~-~l~~~l~~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~  132 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM-----------------------------PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHR  132 (309)
T ss_pred             EEecCCC-CHHHHHHhc-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            9999975 888888642                             235788999999999999999999   8899999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  740 (815)
                      ||||+||+++.++.+||+|||++....... ......++..|+|||.+.+... ++.++|||||||++|||++|+.||..
T Consensus       133 dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DvwslG~il~el~~g~~~f~~  211 (309)
T cd07845         133 DLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTT-YTTAIDMWAVGCILAELLAHKPLLPG  211 (309)
T ss_pred             CCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCC-cCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998765432 2223346788999998865432 58899999999999999999999975


Q ss_pred             CCCccccccHHHHHHH----H---HhcCCC-Ccc-cccc-cc--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          741 DYPEEKEGNLVSWVRG----L---VRNNKG-SRA-IDPK-IR--DTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~----~---~~~~~~-~~~-~~~~-~~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ..+.+....+..+...    .   ...... ... .... ..  .........++.+++.+|+..||++||++++++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         212 KSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             CCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            4332221111111000    0   000000 000 0000 00  0001123567789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.7e-34  Score=302.80  Aligned_cols=263  Identities=23%  Similarity=0.292  Sum_probs=196.9

Q ss_pred             HHhcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC----
Q 003504          505 SATSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD----  577 (815)
Q Consensus       505 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  577 (815)
                      ...++|++.+.||+|+||.||+|... +++.||||.++...  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578999999999999999999964 58899999987542  223456788999999999999999999987654    


Q ss_pred             ------eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHh
Q 003504          578 ------QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH  651 (815)
Q Consensus       578 ------~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH  651 (815)
                            ..++|+||+++ ++..++...                             ...+++.....++.|++.||+|||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-----------------------------~~~~~~~~~~~i~~qi~~aL~~LH  133 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-----------------------------LVHFSEDHIKSFMKQLLEGLNYCH  133 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Confidence                  68999999986 777776531                             235788999999999999999999


Q ss_pred             cCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHH
Q 003504          652 HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLL  729 (815)
Q Consensus       652 ~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~  729 (815)
                         +.+|+||||||+||++++++.+||+|||++.......  ......++..|+|||.+.+... .+.++|||||||++|
T Consensus       134 ---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~Di~slG~~~~  209 (302)
T cd07864         134 ---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEER-YGPAIDVWSCGCILG  209 (302)
T ss_pred             ---hCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCC-CCchhHHHHHHHHHH
Confidence               7899999999999999999999999999998765432  1122346778999998764432 578999999999999


Q ss_pred             HHHhCCCCCCCCCCccccccHHHHHHHHHhcCCC---Ccc--------ccc------cccCCCCHHHHHHHHHHHhhccc
Q 003504          730 ELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKG---SRA--------IDP------KIRDTGPEKQMEEALKIGYLCTA  792 (815)
Q Consensus       730 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--------~~~------~~~~~~~~~~~~~~~~l~~~Cl~  792 (815)
                      ||++|+.||......+.   +.. +.........   ..+        .++      .... .....+..+.+++.+||.
T Consensus       210 el~~g~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~  284 (302)
T cd07864         210 ELFTKKPIFQANQELAQ---LEL-ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLT  284 (302)
T ss_pred             HHHhCCCCCCCCChHHH---HHH-HHHHhCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHcc
Confidence            99999999975322111   111 1111000000   000        000      0000 011235678999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 003504          793 DLPLKRPSMQQIVG  806 (815)
Q Consensus       793 ~dP~~RPs~~~v~~  806 (815)
                      .+|++||+++++++
T Consensus       285 ~~P~~Rp~~~~il~  298 (302)
T cd07864         285 LDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.3e-34  Score=307.68  Aligned_cols=265  Identities=22%  Similarity=0.307  Sum_probs=195.9

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecC--CcccHHHHHHHHHHhcCC-CCCCceeeeeEEEeC--CeeE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHG--STLTDQEAARELEYLGRI-KHPNLVPLTGYCIAG--DQRI  580 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~  580 (815)
                      .++|++.+.||+|+||.||+|... ++..||||++...  .......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467888999999999999999964 6889999988542  222345677899999999 999999999998654  3679


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +||||++ ++|.+++..                              . .++|..+..++.|++.||+|||   +.+|+|
T Consensus        86 lv~e~~~-~~L~~~~~~------------------------------~-~~~~~~~~~i~~qi~~~L~~LH---~~~i~H  130 (337)
T cd07852          86 LVFEYME-TDLHAVIRA------------------------------N-ILEDVHKRYIMYQLLKALKYIH---SGNVIH  130 (337)
T ss_pred             EEecccc-cCHHHHHhc------------------------------C-CCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence            9999998 599888853                              1 5678888999999999999999   889999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCC------ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGL------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG  734 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg  734 (815)
                      |||||+||+++.++.+||+|||+++......      ......|+..|+|||.+.+... .+.++||||||+++|||++|
T Consensus       131 ~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~sDi~slG~~l~el~tg  209 (337)
T cd07852         131 RDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLG  209 (337)
T ss_pred             CCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeecccc-ccccchHHHHHHHHHHHHhC
Confidence            9999999999999999999999998664322      1123458899999998765432 57899999999999999999


Q ss_pred             CCCCCCCCCccccccHHHHHH-------HHHhcCCCCcccc----cccc--CCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          735 KKPLGDDYPEEKEGNLVSWVR-------GLVRNNKGSRAID----PKIR--DTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       735 ~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      +.||......+....+.....       ..+........++    ....  .......+.++.+++.+||+.+|++||++
T Consensus       210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~  289 (337)
T cd07852         210 KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA  289 (337)
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH
Confidence            999975433221111111000       0000000000000    0000  00011246788999999999999999999


Q ss_pred             HHHHHH
Q 003504          802 QQIVGL  807 (815)
Q Consensus       802 ~~v~~~  807 (815)
                      .++++.
T Consensus       290 ~~il~~  295 (337)
T cd07852         290 EEALEH  295 (337)
T ss_pred             HHHhhC
Confidence            999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.5e-34  Score=302.02  Aligned_cols=243  Identities=22%  Similarity=0.362  Sum_probs=194.8

Q ss_pred             CCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCCh
Q 003504          513 GTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNL  591 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL  591 (815)
                      ...||+|+||.||+|.. .++..||||.+..........+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            35799999999999986 57889999998654445566789999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEc
Q 003504          592 QNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD  671 (815)
Q Consensus       592 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  671 (815)
                      .+++..                               ..+++.....++.|++.||+|||   +.+++||||+|+||+++
T Consensus       105 ~~~~~~-------------------------------~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~  150 (292)
T cd06657         105 TDIVTH-------------------------------TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLT  150 (292)
T ss_pred             HHHHhc-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEC
Confidence            998743                               13577888999999999999999   78999999999999999


Q ss_pred             CCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccH
Q 003504          672 MNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL  750 (815)
Q Consensus       672 ~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~  750 (815)
                      .++.++|+|||++....... ......|+..|+|||.+....  ++.++|||||||++||+++|+.||......      
T Consensus       151 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slGvil~el~tg~~p~~~~~~~------  222 (292)
T cd06657         151 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------  222 (292)
T ss_pred             CCCCEEEcccccceecccccccccccccCccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence            99999999999987654332 223345889999999887655  688999999999999999999998742211      


Q ss_pred             HHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                       ...... ...     ..+.+.  .....+..+.+++.+||..+|.+||++.++++
T Consensus       223 -~~~~~~-~~~-----~~~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         223 -KAMKMI-RDN-----LPPKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             -HHHHHH-Hhh-----CCcccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence             111111 111     011111  11223456789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.7e-33  Score=299.20  Aligned_cols=254  Identities=16%  Similarity=0.186  Sum_probs=182.1

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCC----CcEEEEEEeecCCccc--H---------HHHHHHHHHhcCCCCCCceeeeeE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG----GIHVAVKVLVHGSTLT--D---------QEAARELEYLGRIKHPNLVPLTGY  572 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~--~---------~~~~~E~~~l~~l~H~niv~l~g~  572 (815)
                      .+|.+.+.||+|+||.||+|...+    +..+|+|.........  +         .....+...+..++|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            578889999999999999999654    3456777543221111  1         112234455677899999999998


Q ss_pred             EEeCC----eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHH
Q 003504          573 CIAGD----QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALA  648 (815)
Q Consensus       573 ~~~~~----~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~  648 (815)
                      +....    ..++++|++.. ++.+.+...                              ...++.....|+.|++.||+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------------------------------~~~~~~~~~~i~~qi~~~l~  140 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI------------------------------KCKNKKLIKNIMKDMLTTLE  140 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhh------------------------------ccCCHHHHHHHHHHHHHHHH
Confidence            76543    34677777654 565555431                              12356777899999999999


Q ss_pred             HHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCC--------ccccccccccccCCcccCCCCCCCCCcCc
Q 003504          649 FLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL--------DEEIARGSPGYIPPEFAQPDSDFPTPKSD  720 (815)
Q Consensus       649 yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  720 (815)
                      |||   +.+|+||||||+|||++.++.++|+|||+|+.+....        ......||+.|+|||...+..  ++.++|
T Consensus       141 ~lH---~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~--~~~~~D  215 (294)
T PHA02882        141 YIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC--VTRRGD  215 (294)
T ss_pred             HHH---hCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC--CCcHHH
Confidence            999   8899999999999999999999999999998764211        122346999999999987766  789999


Q ss_pred             chhHHHHHHHHHhCCCCCCCCCCccccc--cHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCC
Q 003504          721 VYCYGVVLLELITGKKPLGDDYPEEKEG--NLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR  798 (815)
Q Consensus       721 v~S~Gvvl~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R  798 (815)
                      ||||||++|||++|+.||..........  ...++......         +...   ...++.++.+++..||..+|++|
T Consensus       216 iwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~---~~~~~~~~~~~~~~~~~~~~~~r  283 (294)
T PHA02882        216 LESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE---------GKIK---IKNANKFIYDFIECVTKLSYEEK  283 (294)
T ss_pred             HHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh---------hhhc---cCCCCHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999997642211100  00111111111         1111   22345779999999999999999


Q ss_pred             CCHHHHHHHHH
Q 003504          799 PSMQQIVGLLK  809 (815)
Q Consensus       799 Ps~~~v~~~L~  809 (815)
                      |++.++.+.++
T Consensus       284 p~~~~l~~~~~  294 (294)
T PHA02882        284 PDYDALIKIFD  294 (294)
T ss_pred             CCHHHHHHhhC
Confidence            99999998763

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=293.51  Aligned_cols=247  Identities=21%  Similarity=0.321  Sum_probs=195.0

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-----cccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--Cee
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-----TLTDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQR  579 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  579 (815)
                      .+|.+.+.||+|+||.||+|.. .++..||+|.+....     ......+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999995 568899999875321     12235788999999999999999999998764  357


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++|+||+++++|.+++...                              ..+++....+++.|++.||.|||   +.+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~------------------------------~~l~~~~~~~~~~~i~~al~~LH---~~~i~  128 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY------------------------------GALTENVTRRYTRQILQGVSYLH---SNMIV  128 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hCCEe
Confidence            8999999999999998642                              24677888899999999999999   88999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCC----CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNG----LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      ||||||+||+++.++.++|+|||+++.....    .......|+..|+|||.+.+..  ++.++|||||||++||+++|+
T Consensus       129 H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~  206 (264)
T cd06653         129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG--YGRKADVWSVACTVVEMLTEK  206 (264)
T ss_pred             cCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCC--CCccccHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999865321    1122345889999999987755  688999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .||.+....      .. +......         ......+.....++.+++.+||. +|..||++.+++.
T Consensus       207 ~p~~~~~~~------~~-~~~~~~~---------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         207 PPWAEYEAM------AA-IFKIATQ---------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCccCHH------HH-HHHHHcC---------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            999753211      11 1111110         11112244566789999999999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=291.54  Aligned_cols=246  Identities=28%  Similarity=0.452  Sum_probs=200.9

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||+|++|.||+|+.. ++..||+|.+.....  .....+.+|++++++++|||++++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777899999999999999854 678999999876543  3456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++++|.+++..                              ...+++..+..++.|++.||.|||   +.+++||||+|
T Consensus        81 ~~~~~L~~~~~~------------------------------~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p  127 (254)
T cd06627          81 AENGSLRQIIKK------------------------------FGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKA  127 (254)
T ss_pred             CCCCcHHHHHHh------------------------------ccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCH
Confidence            999999999864                              235789999999999999999999   88999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCc-cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLD-EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.+||+|||.+........ .....++..|+|||...+..  ++.++||||+|+++||+++|+.||..... 
T Consensus       128 ~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-  204 (254)
T cd06627         128 ANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLNP-  204 (254)
T ss_pred             HHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCccH-
Confidence            999999999999999999987754332 23345888999999887655  68899999999999999999999874221 


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                           ...... .. ...         ....+...+.++.+++.+||..+|++||++.+++.
T Consensus       205 -----~~~~~~-~~-~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         205 -----MAALFR-IV-QDD---------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -----HHHHHH-Hh-ccC---------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                 111111 11 000         01113344667889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=302.78  Aligned_cols=268  Identities=19%  Similarity=0.250  Sum_probs=195.6

Q ss_pred             CCCCCCeecccCCeeeEEEEcC---CCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--CeeE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP---GGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAG--DQRI  580 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  580 (815)
                      +|++.+.||+|+||.||+|+..   ++..||+|.+....   ......+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677889999999999999964   47899999987632   23345678899999999999999999999988  7899


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +||||+++ +|.+++.....                         .....++......++.|++.||+|||   +.+|+|
T Consensus        81 lv~e~~~~-~l~~~~~~~~~-------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h  131 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQ-------------------------AKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLH  131 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhcc-------------------------CCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEee
Confidence            99999986 77777653210                         11235677888999999999999999   889999


Q ss_pred             ccCCCCceEEcC----CCCeeecccccceecCCCC----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHH
Q 003504          661 RDIKASSVYLDM----NLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI  732 (815)
Q Consensus       661 rDlk~~NIll~~----~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~  732 (815)
                      |||||+||+++.    ++.+||+|||+++......    ......++..|+|||.+.+... ++.++|||||||++|||+
T Consensus       132 ~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~~l~  210 (316)
T cd07842         132 RDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARH-YTKAIDIWAIGCIFAELL  210 (316)
T ss_pred             CCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCC-CCcHHHHHHHHHHHHHHH
Confidence            999999999999    8999999999998764322    1233457889999998765432 578999999999999999


Q ss_pred             hCCCCCCCCCCcccc------ccHHHHHHHHHh-----------cCCCCc----cccccccCCCC-------HHHHHHHH
Q 003504          733 TGKKPLGDDYPEEKE------GNLVSWVRGLVR-----------NNKGSR----AIDPKIRDTGP-------EKQMEEAL  784 (815)
Q Consensus       733 tg~~p~~~~~~~~~~------~~~~~~~~~~~~-----------~~~~~~----~~~~~~~~~~~-------~~~~~~~~  784 (815)
                      +|+.||.........      ..+...+..+-.           ......    ...........       .....++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (316)
T cd07842         211 TLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF  290 (316)
T ss_pred             hcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHH
Confidence            999999864332200      011111110000           000000    00000000000       02345789


Q ss_pred             HHHhhccccCCCCCCCHHHHHH
Q 003504          785 KIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       785 ~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +++.+|++.||++|||+.++++
T Consensus       291 ~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         291 DLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHHhcCCcccCcCHHHHhc
Confidence            9999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.4e-34  Score=307.15  Aligned_cols=262  Identities=21%  Similarity=0.275  Sum_probs=196.1

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEe----CCee
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIA----GDQR  579 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~  579 (815)
                      .++|+..+.||+|+||.||+|.. .++..||+|++.....  ...+.+.+|+.++.+++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            36788899999999999999994 5689999999875322  334567889999999999999999998764    3467


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++|+||+. |+|.+++..                              ...+++.....++.|++.||+|||   ..+|+
T Consensus        84 ~lv~e~~~-~~l~~~~~~------------------------------~~~~~~~~~~~i~~qi~~aL~~LH---~~~iv  129 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS------------------------------DQPLTEEHIRYFLYQLLRGLKYIH---SANVI  129 (334)
T ss_pred             EEEEehhh-hhHHHHhcc------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            89999996 589888864                              234788899999999999999999   78999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCCc-----cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD-----EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG  734 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg  734 (815)
                      ||||||+||++++++.+||+|||+++.......     .....|+..|+|||.+..... ++.++|||||||++|||++|
T Consensus       130 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~Di~slG~~l~el~~g  208 (334)
T cd07855         130 HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGR  208 (334)
T ss_pred             cCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcc-cccccchHHHHHHHHHHHcC
Confidence            999999999999999999999999986643221     123468889999998765332 68899999999999999999


Q ss_pred             CCCCCCCCCccccccHHH----------------HHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCC
Q 003504          735 KKPLGDDYPEEKEGNLVS----------------WVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR  798 (815)
Q Consensus       735 ~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~R  798 (815)
                      +.||...........+..                .............  +... .......+.++.+++.+||+.+|++|
T Consensus       209 ~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R  285 (334)
T cd07855         209 RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQ--PVPW-SKIFPKASPEALDLLSQMLQFDPEER  285 (334)
T ss_pred             CCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCC--CCCH-HHHcccCCHHHHHHHHHHccCChhhC
Confidence            999975432111000000                0000000000000  0000 00012346789999999999999999


Q ss_pred             CCHHHHHH
Q 003504          799 PSMQQIVG  806 (815)
Q Consensus       799 Ps~~~v~~  806 (815)
                      |++++++.
T Consensus       286 pt~~~~l~  293 (334)
T cd07855         286 ITVEQALQ  293 (334)
T ss_pred             cCHHHHHh
Confidence            99999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-34  Score=307.31  Aligned_cols=261  Identities=21%  Similarity=0.288  Sum_probs=193.8

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC-----ee
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD-----QR  579 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~  579 (815)
                      +++|++.+.||+|+||.||+|+. .+|..||||.+.... ......+.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46789999999999999999984 578999999986422 223456788999999999999999999876543     57


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++|+||+++ +|.+++..                               ..+++.....++.|++.||+|||   +.+|+
T Consensus        84 ~lv~e~~~~-~l~~~~~~-------------------------------~~l~~~~~~~i~~ql~~aL~~LH---~~~iv  128 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-------------------------------QHLSNDHIQYFLYQILRGLKYIH---SANVL  128 (336)
T ss_pred             EEEehhccc-CHHHHHhc-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            899999975 88777743                               24778888999999999999999   88999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCCc----cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD----EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      ||||||+||+++.++.+||+|||+++.......    .....|+..|+|||.+.+... ++.++|||||||++|||++|+
T Consensus       129 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DvwslGvil~el~~G~  207 (336)
T cd07849         129 HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKAIDIWSVGCILAEMLSNR  207 (336)
T ss_pred             ccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCC-CCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999987643221    123458899999998755332 688999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCC---CCcccccc-------c--cCC-----CCHHHHHHHHHHHhhccccCCCCC
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNK---GSRAIDPK-------I--RDT-----GPEKQMEEALKIGYLCTADLPLKR  798 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-------~--~~~-----~~~~~~~~~~~l~~~Cl~~dP~~R  798 (815)
                      .||.+.....    ....+...+....   ...+.+..       .  ...     .....+.++.+++.+||+.+|++|
T Consensus       208 ~~f~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  283 (336)
T cd07849         208 PLFPGKDYLH----QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR  283 (336)
T ss_pred             CCCCCCCHHH----HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhC
Confidence            9997532111    0111110000000   00000000       0  000     011235678999999999999999


Q ss_pred             CCHHHHHHH
Q 003504          799 PSMQQIVGL  807 (815)
Q Consensus       799 Ps~~~v~~~  807 (815)
                      |++.++++.
T Consensus       284 pt~~e~l~h  292 (336)
T cd07849         284 ITVEEALAH  292 (336)
T ss_pred             cCHHHHhcC
Confidence            999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.3e-33  Score=292.21  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=203.2

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||+|+||.||+|... ++..||+|++.....  ...+.+.+|++++++++|||++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999964 688999999875433  4456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++++|.+++....                          .....+++.....++.+++.||+|||   +.+++|+||+|
T Consensus        81 ~~~~~L~~~l~~~~--------------------------~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~  131 (258)
T cd08215          81 ADGGDLSQKIKKQK--------------------------KEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKP  131 (258)
T ss_pred             cCCCcHHHHHHHhh--------------------------ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCCh
Confidence            99999999997531                          11356889999999999999999999   78999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.++|+|||.+....... ......|++.|+|||......  ++.++||||+|+++|++++|+.||..... 
T Consensus       132 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-  208 (258)
T cd08215         132 QNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP--YNYKSDIWSLGCVLYELCTLKHPFEGENL-  208 (258)
T ss_pred             HHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCC--CCccccHHHHHHHHHHHHcCCCCCCCCcH-
Confidence            99999999999999999998765443 223346888999999887665  68899999999999999999999864321 


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                            ...........          ....+...+.++.+++.+||..+|++||++.++++
T Consensus       209 ------~~~~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         209 ------LELALKILKGQ----------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ------HHHHHHHhcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  12222221111          01112245567899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-33  Score=299.76  Aligned_cols=255  Identities=26%  Similarity=0.272  Sum_probs=199.3

Q ss_pred             CCCCCCeecccCCeeeEEEEc----CCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCee
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL----PGGIHVAVKVLVHGST----LTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  579 (815)
                      +|++.+.||+|+||.||+|+.    .++..||||.++....    ...+.+.+|++++.++ +||||+++++++......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999984    3578899999875322    2235678999999999 599999999999988899


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++||||+++|+|.+++..                              ...+++.....++.|+++||+|||   ..+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~  127 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ------------------------------REHFTESEVRVYIAEIVLALDHLH---QLGII  127 (288)
T ss_pred             EEEEecCCCCcHHHHHhh------------------------------cCCcCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            999999999999999864                              224677888899999999999999   78999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCCc--cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      ||||+|+||+++.++.++|+|||+++.......  .....|+..|+|||.+.+.....+.++||||||+++|||++|+.|
T Consensus       128 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p  207 (288)
T cd05583         128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP  207 (288)
T ss_pred             ccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999886543321  223458899999999876543367899999999999999999999


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD  810 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~  810 (815)
                      |.......   ......+......       +    ..+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       208 ~~~~~~~~---~~~~~~~~~~~~~-------~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         208 FTVDGEQN---SQSEISRRILKSK-------P----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             cccCcccc---hHHHHHHHHHccC-------C----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            96422111   1111122221110       1    1133345678899999999999999999888777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=273.91  Aligned_cols=249  Identities=21%  Similarity=0.314  Sum_probs=194.7

Q ss_pred             CCeecccCCeeeEEEEcC-CCcEEEEEEeecCC-cccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          513 GTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS-TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      ...||.|.-|.|++++.. +|..+|||.+++.. ..+.+.+.+.++++.+- +.|+||+.+|||......++-||.|.. 
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence            457999999999999964 58899999997643 33445677788877665 489999999999999999999998865 


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      .+..+++.-                             ..++.....=++...+..||.||.+  .++|+|||+||+|||
T Consensus       176 C~ekLlkri-----------------------------k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNIL  224 (391)
T KOG0983|consen  176 CAEKLLKRI-----------------------------KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNIL  224 (391)
T ss_pred             HHHHHHHHh-----------------------------cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceE
Confidence            556666532                             2234444455778889999999986  789999999999999


Q ss_pred             EcCCCCeeecccccceecCCCCccccccccccccCCcccCCC-CCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccc
Q 003504          670 LDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPD-SDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEG  748 (815)
Q Consensus       670 l~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~  748 (815)
                      +|+.|++|++|||.+..+.........+|.+.|||||-+-.. ...|+.++||||||+.++||.||+.||.+...+    
T Consensus       225 lDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----  300 (391)
T KOG0983|consen  225 LDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----  300 (391)
T ss_pred             EccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----
Confidence            999999999999999888766666677899999999988765 344789999999999999999999999863321    


Q ss_pred             cHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          749 NLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                        .+.+...+.++      .|.+...  ...+..+.+++..|+.+|+.+||...++++.
T Consensus       301 --Fe~ltkvln~e------PP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  301 --FEVLTKVLNEE------PPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             --HHHHHHHHhcC------CCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence              11222333322      2333321  2267789999999999999999999988753

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.9e-33  Score=290.29  Aligned_cols=249  Identities=25%  Similarity=0.264  Sum_probs=191.7

Q ss_pred             HHHHHHhcCCCCCCee--cccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeEEEeC
Q 003504          501 ADLLSATSNFDRGTLL--AEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCIAG  576 (815)
Q Consensus       501 ~~l~~~~~~~~~~~~i--g~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  576 (815)
                      .+.....++|++.+.+  |+|+||.||+++. .++..+|+|.+.......   .  |+.....+ +||||+++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecC
Confidence            4444455677777776  9999999999994 568889999986532111   1  22222212 699999999999999


Q ss_pred             CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 003504          577 DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSP  656 (815)
Q Consensus       577 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~  656 (815)
                      +..++||||+++|+|.+++..                              ...++|.....++.|+++||+|||   +.
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~------------------------------~~~l~~~~~~~~~~qi~~~l~~lH---~~  128 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKK------------------------------EGKLSEAEVKKIIRQLVEALNDLH---KH  128 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence            999999999999999999964                              226789999999999999999999   88


Q ss_pred             CeeeccCCCCceEEcCCC-CeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          657 PIIHRDIKASSVYLDMNL-EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       657 ~ivHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      +++||||||+||+++.++ .++|+|||+++.....   ....|+..|+|||++.+..  ++.++|||||||++||+++|+
T Consensus       129 ~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~  203 (267)
T PHA03390        129 NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHN--YDVSFDWWAVGVLTYELLTGK  203 (267)
T ss_pred             CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCCC--CCchhhHHHHHHHHHHHHHCC
Confidence            999999999999999998 9999999999876432   2345889999999987665  688999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC-HHHHHH
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS-MQQIVG  806 (815)
Q Consensus       736 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-~~~v~~  806 (815)
                      .||.....++.  ....+.... ..           ....+...+..+.+++.+||+.+|.+||+ ++++++
T Consensus       204 ~p~~~~~~~~~--~~~~~~~~~-~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        204 HPFKEDEDEEL--DLESLLKRQ-QK-----------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             CCCCCCCcchh--hHHHHHHhh-cc-----------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            99975332221  122222111 00           00112345677899999999999999995 688874

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.5e-33  Score=305.82  Aligned_cols=263  Identities=21%  Similarity=0.280  Sum_probs=194.2

Q ss_pred             cCCC-CCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCccc--------------HHHHHHHHHHhcCCCCCCceeeee
Q 003504          508 SNFD-RGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLT--------------DQEAARELEYLGRIKHPNLVPLTG  571 (815)
Q Consensus       508 ~~~~-~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g  571 (815)
                      ++|. +.+.||+|+||.||+|.. .+++.||||.+.......              ...+.+|++++.+++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 457899999999999994 468999999986532211              124778999999999999999999


Q ss_pred             EEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHh
Q 003504          572 YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH  651 (815)
Q Consensus       572 ~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH  651 (815)
                      ++...+..++||||++ |+|.+++..                              ...+++.....++.|++.||+|||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~------------------------------~~~~~~~~~~~~~~ql~~aL~~LH  136 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR------------------------------KIRLTESQVKCILLQILNGLNVLH  136 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999997 589988853                              224677888999999999999999


Q ss_pred             cCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCC---------------CccccccccccccCCcccCCCCCCCC
Q 003504          652 HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG---------------LDEEIARGSPGYIPPEFAQPDSDFPT  716 (815)
Q Consensus       652 ~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~  716 (815)
                         +.+++||||+|+||+++.++.+||+|||.++.....               .......++..|+|||.+.+... ++
T Consensus       137 ---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~  212 (335)
T PTZ00024        137 ---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK-YH  212 (335)
T ss_pred             ---hCCeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCC-CC
Confidence               899999999999999999999999999999866511               11122346788999999875432 58


Q ss_pred             CcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCC-----------ccccccccCCCCHHHHHHHHH
Q 003504          717 PKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGS-----------RAIDPKIRDTGPEKQMEEALK  785 (815)
Q Consensus       717 ~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~  785 (815)
                      .++|||||||++|||++|+.||......+....+...........+..           ....+... ......+.++.+
T Consensus       213 ~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  291 (335)
T PTZ00024        213 FAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAID  291 (335)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHH
Confidence            899999999999999999999976443222111111110000000000           00000000 001223567889


Q ss_pred             HHhhccccCCCCCCCHHHHHH
Q 003504          786 IGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       786 l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ++.+|++.+|++||+++|++.
T Consensus       292 li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        292 LLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHcCCCchhccCHHHHhc
Confidence            999999999999999999985

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=292.94  Aligned_cols=243  Identities=21%  Similarity=0.269  Sum_probs=186.8

Q ss_pred             CeecccCCeeeEEEEc-CCCcEEEEEEeecCCccc---HHHHHHHHHHh-cCCCCCCceeeeeEEEeCCeeEEEEEeCCC
Q 003504          514 TLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLT---DQEAARELEYL-GRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lv~ey~~~  588 (815)
                      +.||+|+||.||+|.. .+++.||||++.......   ...+..|..++ ...+|||++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5789999999999985 468899999986533211   12344455444 455899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NI  668 (815)
                      |+|.+++...                              ..+++....+++.|++.||.|||   +.+++||||+|+||
T Consensus        82 ~~L~~~l~~~------------------------------~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~ni  128 (260)
T cd05611          82 GDCASLIKTL------------------------------GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENL  128 (260)
T ss_pred             CCHHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHe
Confidence            9999999642                              24677788899999999999999   78999999999999


Q ss_pred             EEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccc
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEG  748 (815)
Q Consensus       669 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~  748 (815)
                      +++.++.+||+|||+++....   .....|+..|+|||.+.+..  ++.++||||||+++||+++|..||.......   
T Consensus       129 l~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---  200 (260)
T cd05611         129 LIDQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG--DDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---  200 (260)
T ss_pred             EECCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCC--CcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---
Confidence            999999999999999886543   23345888999999987665  6889999999999999999999997532211   


Q ss_pred             cHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          749 NLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                          ..........       .........++..+.+++.+||+.+|++||++.++.+.|
T Consensus       201 ----~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         201 ----VFDNILSRRI-------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ----HHHHHHhccc-------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence                1111111110       011111223567789999999999999999776555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-33  Score=296.15  Aligned_cols=240  Identities=25%  Similarity=0.365  Sum_probs=192.6

Q ss_pred             ecccCCeeeEEEEcC-CCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCCh
Q 003504          516 LAEGKFGPVYRGFLP-GGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNL  591 (815)
Q Consensus       516 ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL  591 (815)
                      ||+|+||.||+|+.. +|..||+|.+.....   ...+.+.+|++++++++||||+++++++......++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999975 489999999865433   2345788999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEc
Q 003504          592 QNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD  671 (815)
Q Consensus       592 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  671 (815)
                      .++++..                              ..+++..+..++.|+++||+|||   +.+++||||+|+||+++
T Consensus        81 ~~~l~~~------------------------------~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~  127 (265)
T cd05579          81 ASLLENV------------------------------GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILID  127 (265)
T ss_pred             HHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEc
Confidence            9999652                              25788899999999999999999   88999999999999999


Q ss_pred             CCCCeeecccccceecCCCC---------ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 003504          672 MNLEPRLSDFGLAKIFGNGL---------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       672 ~~~~~kl~Dfgla~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  742 (815)
                      .++.+||+|||++.......         ......++..|+|||......  .+.++||||||+++||+++|+.||....
T Consensus       128 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~  205 (265)
T cd05579         128 SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG--HSKTVDWWSLGCILYEFLVGIPPFHGET  205 (265)
T ss_pred             CCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999987643321         122345788999999987665  6889999999999999999999997533


Q ss_pred             CccccccHHHHHHHHHhcCCCCccccccccCCCCHH--HHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEK--QMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                      .+       ..........         .  ..+..  .+..+.+++.+||+.+|++||++..+.+.|
T Consensus       206 ~~-------~~~~~~~~~~---------~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         206 PE-------EIFQNILNGK---------I--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             HH-------HHHHHHhcCC---------c--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            21       1111111110         0  01112  367889999999999999999996555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=298.38  Aligned_cols=262  Identities=21%  Similarity=0.251  Sum_probs=198.6

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      |+..+.||+|++|.||+|.. .++..+|+|.+.....  .....+.+|++++++++||||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            55678999999999999996 4688999999865432  23567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++ +|.+++...                             ...+++..+..++.|++.||+|||   +.+|+||||||+
T Consensus        81 ~~-~l~~~l~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~  127 (283)
T cd05118          81 DT-DLYKLIKDR-----------------------------QRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPE  127 (283)
T ss_pred             CC-CHHHHHHhh-----------------------------cccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHH
Confidence            85 888888642                             235788999999999999999999   889999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||+++.++.+||+|||.+....... ......++..|+|||.+.+.. .++.++||||||+++|++++|+.||......+
T Consensus       128 nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~  206 (283)
T cd05118         128 NLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK-GYSTPVDIWSVGCIFAELLSRRPLFPGKSEID  206 (283)
T ss_pred             HEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999998775443 222345788999999887652 27889999999999999999999986533211


Q ss_pred             ccccHHHHHHHHHhcCCCCccc---------ccccc----CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAI---------DPKIR----DTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~----~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ....+........ .+......         -+...    .....+.+.++.+++.+||+.||.+||++++++.
T Consensus       207 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         207 QLFKIFRTLGTPD-PEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             HHHHHHHHcCCCc-hHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1101000000000 00000000         00000    0112345678999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.9e-33  Score=300.25  Aligned_cols=262  Identities=22%  Similarity=0.297  Sum_probs=192.5

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC------
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGD------  577 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  577 (815)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+.....  .....+.+|++++++++||||++++++|...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            34688899999999999999995 4688999998865322  22345678999999999999999999987654      


Q ss_pred             --eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCC
Q 003504          578 --QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCS  655 (815)
Q Consensus       578 --~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~  655 (815)
                        ..++||||+.+ +|.+++...                             ...+++.....++.|++.||+|||   +
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~-----------------------------~~~~~~~~~~~i~~qi~~al~~lH---~  137 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNK-----------------------------NVKFTLSEIKKVMKMLLNGLYYIH---R  137 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhc-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---H
Confidence              34999999975 888877542                             235788899999999999999999   7


Q ss_pred             CCeeeccCCCCceEEcCCCCeeecccccceecCCCCc-----cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHH
Q 003504          656 PPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD-----EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE  730 (815)
Q Consensus       656 ~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~e  730 (815)
                      .+++||||||+||+++.++.+||+|||++........     .....++..|+|||.+.+... ++.++||||||+++||
T Consensus       138 ~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~~l~e  216 (310)
T cd07865         138 NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERD-YGPPIDMWGAGCIMAE  216 (310)
T ss_pred             CCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcc-cCchhhhHHHHHHHHH
Confidence            8999999999999999999999999999986643221     123347888999998765432 5789999999999999


Q ss_pred             HHhCCCCCCCCCCccccccHHHHHHHHHhc---CCC-----Ccccc----cc-ccCC-----CCHHHHHHHHHHHhhccc
Q 003504          731 LITGKKPLGDDYPEEKEGNLVSWVRGLVRN---NKG-----SRAID----PK-IRDT-----GPEKQMEEALKIGYLCTA  792 (815)
Q Consensus       731 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-----~~~~~----~~-~~~~-----~~~~~~~~~~~l~~~Cl~  792 (815)
                      |++|+.||....+....    ..+......   ...     ....+    +. ....     .+......+.+++.+||.
T Consensus       217 l~t~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~  292 (310)
T cd07865         217 MWTRSPIMQGNTEQHQL----TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLV  292 (310)
T ss_pred             HHhCCCCCCCCCHHHHH----HHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhc
Confidence            99999999754322111    111111000   000     00000    00 0000     001123456799999999


Q ss_pred             cCCCCCCCHHHHHH
Q 003504          793 DLPLKRPSMQQIVG  806 (815)
Q Consensus       793 ~dP~~RPs~~~v~~  806 (815)
                      .||++||+++++++
T Consensus       293 ~~P~~R~t~~e~l~  306 (310)
T cd07865         293 LDPAKRIDADTALN  306 (310)
T ss_pred             CChhhccCHHHHhc
Confidence            99999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.3e-33  Score=299.25  Aligned_cols=247  Identities=24%  Similarity=0.338  Sum_probs=193.5

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      .|+..+.||+|+||.||+|.. .++..||+|.+.....   .....+.+|+++++.++|||++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            366678899999999999995 4678899998864222   233567889999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+. |++.+++...                             ...+++..+..++.|++.||.|||   +.+++||||+
T Consensus        96 ~~~-~~l~~~~~~~-----------------------------~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~  142 (308)
T cd06634          96 YCL-GSASDLLEVH-----------------------------KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVK  142 (308)
T ss_pred             ccC-CCHHHHHHHc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            997 6888877532                             234678888999999999999999   7899999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCC-CCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPD-SDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      |+||+++.++.+||+|||++......   ....|+..|+|||.+.+. ...++.++|||||||++|||++|+.||.....
T Consensus       143 p~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  219 (308)
T cd06634         143 AGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  219 (308)
T ss_pred             HHhEEECCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence            99999999999999999998866432   234588899999987532 12268899999999999999999999864211


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      .       ..........      .+..   .....+..+.+++.+||..+|++||+++++++.
T Consensus       220 ~-------~~~~~~~~~~------~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         220 M-------SALYHIAQNE------SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             H-------HHHHHHhhcC------CCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            1       1111111111      0111   123456678999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-33  Score=307.16  Aligned_cols=263  Identities=18%  Similarity=0.232  Sum_probs=196.5

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC-----e
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD-----Q  578 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~  578 (815)
                      ..+|.+.+.||+|+||.||+|+. .++..||||.+...  .......+.+|+.+++.++||||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            34688889999999999999984 56899999998653  2223456778999999999999999999886542     4


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++|+||+. ++|.+++..                              ...+++.....++.|++.||.|||   +.++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~------------------------------~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  129 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS------------------------------SQTLSDDHCQYFLYQLLRGLKYIH---SANV  129 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCE
Confidence            799999997 688888854                              235778889999999999999999   8899


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      +||||||+||+++.++.+||+|||+++...... ......++..|+|||.+..... ++.++|||||||++|||++|+.|
T Consensus       130 ~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~~g~~p  208 (337)
T cd07858         130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE-YTTAIDVWSVGCIFAELLGRKPL  208 (337)
T ss_pred             ecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCC-CCCcccHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999998765432 2233457889999998765332 68899999999999999999999


Q ss_pred             CCCCCCccccccHHHHH----------------HHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          738 LGDDYPEEKEGNLVSWV----------------RGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      |...........+....                ......  .....++.... .....+.++.+++.+||+.+|++||++
T Consensus       209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~  285 (337)
T cd07858         209 FPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS--LPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITV  285 (337)
T ss_pred             CCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHh--cCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCH
Confidence            97532211111111000                000000  00000010000 012356778999999999999999999


Q ss_pred             HHHHHH
Q 003504          802 QQIVGL  807 (815)
Q Consensus       802 ~~v~~~  807 (815)
                      +++++.
T Consensus       286 ~ell~h  291 (337)
T cd07858         286 EEALAH  291 (337)
T ss_pred             HHHHcC
Confidence            999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=307.51  Aligned_cols=266  Identities=23%  Similarity=0.286  Sum_probs=199.5

Q ss_pred             CCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCCceeeeeEEEeC------CeeEEEE
Q 003504          512 RGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAG------DQRIAIY  583 (815)
Q Consensus       512 ~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lv~  583 (815)
                      ..+.||+|+||.||+|+ ..+|+.||||.++.... ...+...+|+++|++++|||||+++|.-.+.      ....+||
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            35789999999999999 56899999999977543 3456678999999999999999999976553      3678999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      |||.+|||+..|.+.                           .+-..++....+.+..+++.||.|||   +.+||||||
T Consensus        97 EyC~gGsL~~~L~~P---------------------------EN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDl  146 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSP---------------------------ENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDL  146 (732)
T ss_pred             eecCCCcHHHHhcCc---------------------------ccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccC
Confidence            999999999999762                           34556888899999999999999999   899999999


Q ss_pred             CCCceEEc--CCCC--eeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 003504          664 KASSVYLD--MNLE--PRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       664 k~~NIll~--~~~~--~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~  739 (815)
                      ||.||++-  ++|+  -||+|||.|+.+..+.......||..|.+||+.... .+++..+|.|||||++||++||..||-
T Consensus       147 KP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~  225 (732)
T KOG4250|consen  147 KPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFI  225 (732)
T ss_pred             CCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCC
Confidence            99999984  4454  699999999999888877888899999999998752 237889999999999999999999996


Q ss_pred             CCCCccccccHHHHHHHHHhcCCC--Ccccccc----------ccCC--CCHHHHHHHHHHHhhccccCCCCCC--CHHH
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKG--SRAIDPK----------IRDT--GPEKQMEEALKIGYLCTADLPLKRP--SMQQ  803 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----------~~~~--~~~~~~~~~~~l~~~Cl~~dP~~RP--s~~~  803 (815)
                      ..   ....+....+.........  .-...+.          +...  -.......+-......+..+|++|.  .+-+
T Consensus       226 p~---~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~  302 (732)
T KOG4250|consen  226 PF---GGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDR  302 (732)
T ss_pred             cC---CCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcch
Confidence            42   2222111111111111110  0000110          1100  1223344556666777888888888  6666


Q ss_pred             HHHHHHhh
Q 003504          804 IVGLLKDI  811 (815)
Q Consensus       804 v~~~L~~i  811 (815)
                      ....+..|
T Consensus       303 ~Fa~~~dI  310 (732)
T KOG4250|consen  303 FFAEVDDI  310 (732)
T ss_pred             HHHHHHHH
Confidence            66666555

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.4e-33  Score=291.96  Aligned_cols=242  Identities=22%  Similarity=0.244  Sum_probs=186.9

Q ss_pred             eecccCCeeeEEEEc-CCCcEEEEEEeecCCcc---cHHHHHHHH---HHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          515 LLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL---TDQEAAREL---EYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       515 ~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~---~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      .||+|+||.||+|.. .+++.||+|.+......   ....+..|.   ..++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 46889999998754222   112233343   34555689999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|+|..++..                              ...+++..+..++.|+++||+|||   +.+++||||||+|
T Consensus        81 g~~L~~~l~~------------------------------~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~n  127 (278)
T cd05606          81 GGDLHYHLSQ------------------------------HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPAN  127 (278)
T ss_pred             CCcHHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHH
Confidence            9999988853                              235889999999999999999999   7899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |+++.++.+||+|||+++..... ......|+..|+|||.+..... ++.++|||||||++|||++|+.||........ 
T Consensus       128 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-  204 (278)
T cd05606         128 ILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-  204 (278)
T ss_pred             EEECCCCCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCccch-
Confidence            99999999999999998765432 2234468999999999875432 68899999999999999999999975322111 


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~~v~~  806 (815)
                         ...... ...      ..+    ..+...+.++.+++.+|+..+|++||     ++.++++
T Consensus       205 ---~~~~~~-~~~------~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         205 ---HEIDRM-TLT------MAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ---HHHHHH-hhc------cCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence               110000 000      011    11233467889999999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-33  Score=320.84  Aligned_cols=264  Identities=19%  Similarity=0.213  Sum_probs=184.1

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcCC--CcEEEEE------------------EeecCCcccHHHHHHHHHHhcCCCCCCc
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPG--GIHVAVK------------------VLVHGSTLTDQEAARELEYLGRIKHPNL  566 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~ni  566 (815)
                      .++|.+.+.||+|+||.||+|....  +..+++|                  .+.. .......+.+|+.++++++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCc
Confidence            4689999999999999999987532  2222222                  1111 11223467899999999999999


Q ss_pred             eeeeeEEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHH
Q 003504          567 VPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARA  646 (815)
Q Consensus       567 v~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~  646 (815)
                      +++++++...+..++|+|++.. +|.+++......                         ............|+.|++.|
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------------------------~~~~~~~~~~~~i~~ql~~a  279 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFD-------------------------WKDRPLLKQTRAIMKQLLCA  279 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhcccc-------------------------ccccccHHHHHHHHHHHHHH
Confidence            9999999999999999999864 787777542100                         01112345566899999999


Q ss_pred             HHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhH
Q 003504          647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCY  724 (815)
Q Consensus       647 L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~  724 (815)
                      |+|||   +.+||||||||+|||++.++.+||+|||+++.+....  ......||..|+|||++.+..  ++.++|||||
T Consensus       280 L~yLH---~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSl  354 (501)
T PHA03210        280 VEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG--YCEITDIWSC  354 (501)
T ss_pred             HHHHH---hCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC--CCcHHHHHHH
Confidence            99999   8999999999999999999999999999998765432  223456999999999988765  7899999999


Q ss_pred             HHHHHHHHhCCCC-CCCCCCccccccHHHHHHHH-----------------HhcCCC---CccccccccCCCCHHHHHHH
Q 003504          725 GVVLLELITGKKP-LGDDYPEEKEGNLVSWVRGL-----------------VRNNKG---SRAIDPKIRDTGPEKQMEEA  783 (815)
Q Consensus       725 Gvvl~el~tg~~p-~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~---~~~~~~~~~~~~~~~~~~~~  783 (815)
                      ||++|||++|..+ +..... .....+.......                 +.....   ...+.+.+.   ....+..+
T Consensus       355 Gvil~ell~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~~~~~~~  430 (501)
T PHA03210        355 GLILLDMLSHDFCPIGDGGG-KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR---NLGLPADF  430 (501)
T ss_pred             HHHHHHHHHCCCCCccCCCC-CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH---hcCCChHH
Confidence            9999999998754 432211 1111111111110                 000000   000000000   00123456


Q ss_pred             HHHHhhccccCCCCCCCHHHHHH
Q 003504          784 LKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       784 ~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .+++.+|++.||++||++.|+++
T Consensus       431 ~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        431 EYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhccCcccCcCHHHHhh
Confidence            77899999999999999999986

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-33  Score=306.51  Aligned_cols=268  Identities=20%  Similarity=0.229  Sum_probs=202.1

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC-----eeE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD-----QRI  580 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  580 (815)
                      +|++.+.||+|+||.||+|+.. ++..||||.+....  ....+.+.+|+++++.++||||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999964 58899999987543  334567899999999999999999999998765     789


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +||||+++ +|.++++.                              ...+++..+..++.+++.||+|||   +.+|+|
T Consensus        81 lv~e~~~~-~l~~~l~~------------------------------~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H  126 (330)
T cd07834          81 IVTELMET-DLHKVIKS------------------------------PQPLTDDHIQYFLYQILRGLKYLH---SANVIH  126 (330)
T ss_pred             EEecchhh-hHHHHHhC------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence            99999985 89888864                              226788999999999999999999   889999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCC----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      |||||+||+++.++.++|+|||++.......    ......++..|+|||.+.+.. .++.++||||||+++|+|++|+.
T Consensus       127 ~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il~~l~~g~~  205 (330)
T cd07834         127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIFAELLTRKP  205 (330)
T ss_pred             CCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999998775443    123345788999999988763 27889999999999999999999


Q ss_pred             CCCCCCCccccccHHHHHHHHH-------hcCCCCcccc---ccc---cCCCCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLV-------RNNKGSRAID---PKI---RDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ  803 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~---~~~---~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~  803 (815)
                      ||......+....+........       ........+.   +..   ........+..+.+++.+||+.+|++||++++
T Consensus       206 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  285 (330)
T cd07834         206 LFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE  285 (330)
T ss_pred             CcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHH
Confidence            9976443221111111000000       0000000000   000   00001224567899999999999999999999


Q ss_pred             HHHH--HHhh
Q 003504          804 IVGL--LKDI  811 (815)
Q Consensus       804 v~~~--L~~i  811 (815)
                      +++.  ++++
T Consensus       286 ll~~~~~~~~  295 (330)
T cd07834         286 ALAHPYLAQL  295 (330)
T ss_pred             HHhCccHHhh
Confidence            9873  4444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.1e-33  Score=296.45  Aligned_cols=245  Identities=25%  Similarity=0.353  Sum_probs=192.4

Q ss_pred             CCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL---TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      |...+.||+|+||.||+|+. .++..||+|.+......   ..+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55567899999999999985 46889999998653222   234678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +. |++.+++...                             ...+++..+..++.|++.||+|||   +.+++||||+|
T Consensus       103 ~~-~~l~~~l~~~-----------------------------~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p  149 (313)
T cd06633         103 CL-GSASDLLEVH-----------------------------KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKA  149 (313)
T ss_pred             CC-CCHHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCh
Confidence            96 5788877542                             335788999999999999999999   78999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCC-CCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPD-SDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      +||+++.++.+||+|||++.....   .....|+..|+|||++... ...++.++|||||||++|||++|+.||..... 
T Consensus       150 ~nili~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-  225 (313)
T cd06633         150 GNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-  225 (313)
T ss_pred             hhEEECCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-
Confidence            999999999999999999865432   2344688999999987532 22368899999999999999999999875322 


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                            ............      +..   .....+..+.+++.+||+.+|.+||++.+++.
T Consensus       226 ------~~~~~~~~~~~~------~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         226 ------MSALYHIAQNDS------PTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ------HHHHHHHHhcCC------CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  111111111110      111   12223456889999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=291.73  Aligned_cols=246  Identities=24%  Similarity=0.251  Sum_probs=201.3

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      +.|..-++||+|+||.||-++. .+|+.+|.|.+.+...   ..+.....|-.++.+++.+.||.+-..+.+.+..++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            4577789999999999999985 5688999998855322   23445678999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ..|.+|+|.-+|...                            ....++.....-.|.+|+.||++||   ..+||.||+
T Consensus       265 tlMNGGDLkfHiyn~----------------------------g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDL  313 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNH----------------------------GNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDL  313 (591)
T ss_pred             EeecCCceeEEeecc----------------------------CCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccC
Confidence            999999999888653                            1245777778889999999999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      ||+|||+|+.|+++|+|.|+|..+..+......+||.+|||||++....  |+...|+||+||++|||+.|+.||-....
T Consensus       314 KPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~--Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke  391 (591)
T KOG0986|consen  314 KPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV--YDFSPDWFSLGCLLYEMIAGHSPFRQRKE  391 (591)
T ss_pred             ChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCc--ccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence            9999999999999999999999998888777779999999999999887  78899999999999999999999964211


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS  800 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs  800 (815)
                      ....    +.+.+...+.          ....++..+++..++....+.+||++|.-
T Consensus       392 Kvk~----eEvdrr~~~~----------~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  392 KVKR----EEVDRRTLED----------PEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             hhhH----HHHHHHHhcc----------hhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            1100    0111111110          11235667778889999999999999973

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=280.97  Aligned_cols=254  Identities=21%  Similarity=0.309  Sum_probs=196.7

Q ss_pred             CCeecccCCeeeEEEEc-CCCcEEEEEEeecCCc-ccHHHHHHHHHHhcC-CCCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          513 GTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST-LTDQEAARELEYLGR-IKHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      ...||.|+||+|+|-.+ +.|+..|||+++.... .+++++..|.+...+ =+.||||+++|.++..+..|+-||.|+- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            46799999999999884 6799999999987544 556788889886554 4799999999999999999999999976 


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      |+..+...-              |.           .....+.....-+|+.-+..||.||-+  ...|||||+||+|||
T Consensus       148 SlDklYk~v--------------y~-----------vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNIL  200 (361)
T KOG1006|consen  148 SLDKLYKRV--------------YS-----------VQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNIL  200 (361)
T ss_pred             hHHHHHHHH--------------HH-----------HHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheE
Confidence            776654321              00           012234444445677778899999986  678999999999999


Q ss_pred             EcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccccc
Q 003504          670 LDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGN  749 (815)
Q Consensus       670 l~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~  749 (815)
                      +|..|.+|++|||.+..+......+..+|...|||||-+......++.+|||||+|+.|||+.||+.||..      ..+
T Consensus       201 ldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~------w~s  274 (361)
T KOG1006|consen  201 LDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK------WDS  274 (361)
T ss_pred             EecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch------HHH
Confidence            99999999999999987776666667789999999999988776689999999999999999999999863      223


Q ss_pred             HHHHHHHHHhcCCCCccccccccCC-CCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          750 LVSWVRGLVRNNKGSRAIDPKIRDT-GPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       750 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +.+.+.+.+....      |.+... ..-+....+..++..|+.+|-+.||.+.++.+
T Consensus       275 vfeql~~Vv~gdp------p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  275 VFEQLCQVVIGDP------PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHHHHHHcCCC------CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            4444444433321      111111 12235677899999999999999999998865

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6e-33  Score=299.53  Aligned_cols=267  Identities=20%  Similarity=0.266  Sum_probs=196.4

Q ss_pred             HHHHhcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEe-CCe
Q 003504          503 LLSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIA-GDQ  578 (815)
Q Consensus       503 l~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~  578 (815)
                      +...+++|+..+.||+|+||.||+|. ..++..||||++....  ....+.+.+|++++++++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            34467889999999999999999998 4578999999885422  2234678899999999999999999999876 557


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++|+||+. ++|.++++..                               .+++.....++.|++.||+|||   +.+|
T Consensus        85 ~~lv~e~~~-~~L~~~~~~~-------------------------------~~~~~~~~~~~~ql~~aL~~LH---~~~i  129 (328)
T cd07856          85 IYFVTELLG-TDLHRLLTSR-------------------------------PLEKQFIQYFLYQILRGLKYVH---SAGV  129 (328)
T ss_pred             EEEEeehhc-cCHHHHHhcC-------------------------------CCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            889999984 5898887531                               3566677789999999999999   8899


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCC
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~  738 (815)
                      +||||+|+||+++.++.+||+|||.+......  .....++..|+|||.+.+... ++.++|||||||++||+++|+.||
T Consensus       130 iH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~el~tg~~~f  206 (328)
T cd07856         130 VHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQK-YDVEVDIWSAGCIFAEMLEGKPLF  206 (328)
T ss_pred             ccCCCCHHHEeECCCCCEEeCccccccccCCC--cCCCcccccccCceeeeccCC-cCcHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999865432  223457889999998765332 688999999999999999999999


Q ss_pred             CCCCCccccccHH--------HHHHHHHhcCCCCccccccccCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          739 GDDYPEEKEGNLV--------SWVRGLVRNNKGSRAIDPKIRDTGP-----EKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       739 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                      ...........+.        ++...............-......+     ...+.++.+++.+|++.+|++||++++++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell  286 (328)
T cd07856         207 PGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL  286 (328)
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            7533211111111        1111111110000000000000001     12346889999999999999999999987


Q ss_pred             HH
Q 003504          806 GL  807 (815)
Q Consensus       806 ~~  807 (815)
                      ..
T Consensus       287 ~~  288 (328)
T cd07856         287 AH  288 (328)
T ss_pred             cC
Confidence            53

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.5e-33  Score=300.90  Aligned_cols=266  Identities=23%  Similarity=0.278  Sum_probs=193.2

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCCceeeeeEEEeCC------
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL--TDQEAARELEYLGRIKHPNLVPLTGYCIAGD------  577 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  577 (815)
                      .++|++.+.||+|+||.||+|+. .++..||||++......  ....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            46788999999999999999995 46889999998653322  2346788999999999999999999876543      


Q ss_pred             --eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCC
Q 003504          578 --QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCS  655 (815)
Q Consensus       578 --~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~  655 (815)
                        ..++|+||+.. ++...+...                             ...+++.....++.|+++||+|||   +
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~-----------------------------~~~~~~~~~~~i~~~l~~al~~lH---~  133 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP-----------------------------SVKLTESQIKCYMLQLLEGINYLH---E  133 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---h
Confidence              35899999976 677776531                             235788999999999999999999   8


Q ss_pred             CCeeeccCCCCceEEcCCCCeeecccccceecCCCCc------------cccccccccccCCcccCCCCCCCCCcCcchh
Q 003504          656 PPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD------------EEIARGSPGYIPPEFAQPDSDFPTPKSDVYC  723 (815)
Q Consensus       656 ~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S  723 (815)
                      .+|+||||||+||++++++.+||+|||+++.......            .....|++.|+|||.+.+... ++.++||||
T Consensus       134 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~s  212 (311)
T cd07866         134 NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERR-YTTAVDIWG  212 (311)
T ss_pred             CCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCc-cCchhHhHH
Confidence            8999999999999999999999999999986543221            112246788999998765432 688999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhc-----CCCCc----cccccccCC---CCHHHHHHHHHHHhhcc
Q 003504          724 YGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRN-----NKGSR----AIDPKIRDT---GPEKQMEEALKIGYLCT  791 (815)
Q Consensus       724 ~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~----~~~~~~~~~---~~~~~~~~~~~l~~~Cl  791 (815)
                      |||++|||++|+.||.+.........+..........     .....    ...+.....   ........+.+++.+|+
T Consensus       213 lG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  292 (311)
T cd07866         213 IGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLL  292 (311)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHc
Confidence            9999999999999997543322111111110000000     00000    000000000   01122357889999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 003504          792 ADLPLKRPSMQQIVG  806 (815)
Q Consensus       792 ~~dP~~RPs~~~v~~  806 (815)
                      ..||++||++.+++.
T Consensus       293 ~~~p~~R~t~~ell~  307 (311)
T cd07866         293 SLDPYKRLTASDALE  307 (311)
T ss_pred             ccCcccCcCHHHHhc
Confidence            999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-33  Score=294.80  Aligned_cols=263  Identities=23%  Similarity=0.291  Sum_probs=197.8

Q ss_pred             CCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          510 FDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      |+..+.||+|+||.||+|+.. +++.||+|.+....  ....+.+.+|++++++++|||++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999965 58999999987643  233467788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      + ++|.+++...                             ...+++..+.+++.+++.||+|||   +.+|+||||+|+
T Consensus        81 ~-~~l~~~i~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~  127 (282)
T cd07829          81 D-MDLKKYLDKR-----------------------------PGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQ  127 (282)
T ss_pred             C-cCHHHHHHhh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChh
Confidence            8 5999999752                             135788999999999999999999   789999999999


Q ss_pred             ceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcc
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  745 (815)
                      ||++++++.+||+|||.++...... ......++..|+|||.+.+.. .++.++|||||||++||+++|+.||......+
T Consensus       128 ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~  206 (282)
T cd07829         128 NILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK-HYSTAVDIWSVGCIFAEMITGKPLFPGDSEID  206 (282)
T ss_pred             eEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCc-CCCccccHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            9999999999999999998765432 223344677899999887552 26889999999999999999999997643221


Q ss_pred             ccccHHHHHHH----HH---hcCCCCccccccccC----CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          746 KEGNLVSWVRG----LV---RNNKGSRAIDPKIRD----TGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~----~~---~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ....+.+....    .+   .........-+....    .........+.+++.+||..+|++||++++++.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         207 QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            11111111000    00   000000000000000    001123567999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-33  Score=303.35  Aligned_cols=265  Identities=20%  Similarity=0.246  Sum_probs=192.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC------e
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD------Q  578 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~  578 (815)
                      ++|...+.||+|+||.||+|+. .+|..||||++....  ......+.+|++++++++||||+++++++....      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            6888899999999999999995 568999999986532  222356789999999999999999999987542      4


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++|+||+.. +|..++.                                ..+++.....++.|++.||+|||   +.++
T Consensus        95 ~~lv~e~~~~-~l~~~~~--------------------------------~~~~~~~~~~~~~qi~~aL~~LH---~~~i  138 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG--------------------------------HPLSEDKVQYLVYQMLCGLKYIH---SAGI  138 (342)
T ss_pred             EEEEeccccc-CHHHHHc--------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            6899999975 6665542                                23677888899999999999999   8899


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCC
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~  738 (815)
                      +||||||+||+++.++.+||+|||+++.....  .....++..|+|||.+.+... ++.++|||||||++|||++|+.||
T Consensus       139 ~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slGvil~el~~g~~pf  215 (342)
T cd07879         139 IHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMH-YNQTVDIWSVGCIMAEMLTGKTLF  215 (342)
T ss_pred             ccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccc-cCchHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999865432  233457889999998865322 688999999999999999999999


Q ss_pred             CCCCCccccccHHH--------HHHHHHhcCCCCcccc--ccccCC----CCHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 003504          739 GDDYPEEKEGNLVS--------WVRGLVRNNKGSRAID--PKIRDT----GPEKQMEEALKIGYLCTADLPLKRPSMQQI  804 (815)
Q Consensus       739 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v  804 (815)
                      ...........+..        +.... ..........  +.....    .......++.+++.+||+.||++||+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~  294 (342)
T cd07879         216 KGKDYLDQLTQILKVTGVPGPEFVQKL-EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA  294 (342)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHHh-cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            75322111000000        00000 0000000000  000000    001234568899999999999999999999


Q ss_pred             HHH--HHhhh
Q 003504          805 VGL--LKDIE  812 (815)
Q Consensus       805 ~~~--L~~i~  812 (815)
                      +..  ++.++
T Consensus       295 l~h~~f~~~~  304 (342)
T cd07879         295 LEHPYFDSFR  304 (342)
T ss_pred             hcCcchhhcc
Confidence            843  55543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=9.5e-36  Score=312.94  Aligned_cols=340  Identities=23%  Similarity=0.356  Sum_probs=240.3

Q ss_pred             CCeEEEEecCCCCCccCCCcccccCCCCCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEE
Q 003504           27 KQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD  106 (815)
Q Consensus        27 ~~~~~~l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  106 (815)
                      .+-|+.+++++|.++|.--+..+..+++++.|.|.+.++..+|+++..+.+|++|.+++|++. .+-..++.|+.|+.++
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~   84 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI   84 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence            456889999999999654445799999999999999999999999999999999999999998 6677889999999999


Q ss_pred             ccCCcCC-CCChhhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcc
Q 003504          107 LSNNNFS-GEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEI  185 (815)
Q Consensus       107 Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l  185 (815)
                      +..|++. .-+|..+..|..|+.||||+|+++ ..|..+.+.+++-.|+||+|+|. +||..+|..+..|-.|+|++|++
T Consensus        85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrL  162 (1255)
T KOG0444|consen   85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRL  162 (1255)
T ss_pred             hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchh
Confidence            9999985 346788889999999999999999 78999999999999999999998 99999999999999999999999


Q ss_pred             cCCCCCCCCCCCCCeEeccCCcCCCcchhhh--hcccceeeeccccccCcccccccccccCCccceEEEcCCCccCcchh
Q 003504          186 KGRDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIF  263 (815)
Q Consensus       186 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  263 (815)
                      ..+|+....|..|++|.|++|.+.......+  +++|+.|.+++.+=+  ...++ .++..+.+|..+|+|.|.+. ..|
T Consensus       163 e~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT--l~N~P-tsld~l~NL~dvDlS~N~Lp-~vP  238 (1255)
T KOG0444|consen  163 EMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT--LDNIP-TSLDDLHNLRDVDLSENNLP-IVP  238 (1255)
T ss_pred             hhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch--hhcCC-CchhhhhhhhhccccccCCC-cch
Confidence            9999999999999999999998754332222  444555555444321  11111 11223344444555555544 344


Q ss_pred             hccccCCCCCEEEecCCcCcCCC----------------------ccccccccCCCeEecCCCcCc-CCCchhhhcCCCC
Q 003504          264 HNFSQAQNLKHLSLAYNRFTRQE----------------------FPQIGTLLGLEHLNLSRTSLI-GDIPSEILQLSSL  320 (815)
Q Consensus       264 ~~~~~l~~L~~L~L~~N~l~~~~----------------------~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L  320 (815)
                      +.+..+++|+.|+||+|.|+.+.                      |.++..+++|+.|++.+|++. .-+|+.++.|.+|
T Consensus       239 ecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~L  318 (1255)
T KOG0444|consen  239 ECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQL  318 (1255)
T ss_pred             HHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCccchhhhhhh
Confidence            44444455555555555544433                      144444444444554444443 1244445555555


Q ss_pred             CEEeCCCCcCCCCCCcc--CCCCccEEEccCCcCcccCChHHhhcCCCCceeeccCCC
Q 003504          321 HTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNN  376 (815)
Q Consensus       321 ~~L~ls~N~l~~~~~~~--~~~~L~~L~ls~N~l~~~~p~~~~~~l~~l~~l~l~~N~  376 (815)
                      +.+..++|.|. ..|..  .+..|+.|.|++|+|- ++| ..+.-++.|+.||+..|+
T Consensus       319 evf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLP-eaIHlL~~l~vLDlreNp  373 (1255)
T KOG0444|consen  319 EVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLP-EAIHLLPDLKVLDLRENP  373 (1255)
T ss_pred             HHHHhhccccc-cCchhhhhhHHHHHhccccccee-ech-hhhhhcCCcceeeccCCc
Confidence            55555555444 22322  4456666667777665 555 345666677777776665

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=9.1e-33  Score=288.45  Aligned_cols=249  Identities=22%  Similarity=0.310  Sum_probs=194.1

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecC-----CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHG-----STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      +|.+.+.||+|+||.||+|... .+..+++|.++..     .......+.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4778899999999999999854 3444666655431     122334577899999999999999999999998899999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      |||+++++|.++++...                          .....+++..+..++.|++.||.|||   +.+++|+|
T Consensus        81 ~e~~~~~~l~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~  131 (260)
T cd08222          81 TEYCEGRDLDCKLEELK--------------------------HTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRD  131 (260)
T ss_pred             EEeCCCCCHHHHHHHHh--------------------------hcccccCHHHHHHHHHHHHHHHHHHH---HcCccccC
Confidence            99999999999986421                          12346889999999999999999999   89999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      |+|+||+++. +.+||+|||+++...... ......|+..|+|||......  ++.++||||||+++|++++|..||...
T Consensus       132 l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~  208 (260)
T cd08222         132 LKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG--YDSKSDIWSLGCILYEMCCLAHAFEGQ  208 (260)
T ss_pred             CChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999985 569999999998764332 223345788999999886554  678999999999999999999998632


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .       ...........          .....+...+.++.+++.+||..+|++||++.++++
T Consensus       209 ~-------~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         209 N-------FLSVVLRIVEG----------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             c-------HHHHHHHHHcC----------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            1       11212211111          011124456678999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6e-33  Score=293.12  Aligned_cols=246  Identities=22%  Similarity=0.317  Sum_probs=198.9

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCCeeEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv  582 (815)
                      ++|...+.||+|+||.||+|+. .++..||+|++....   ....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            3688889999999999999996 478999999986532   223457889999999998 99999999999999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      |||+++++|.+++..                              ...+++.....|+.|++.||+|||   +.+++|+|
T Consensus        81 ~e~~~~~~L~~~l~~------------------------------~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~d  127 (280)
T cd05581          81 LEYAPNGELLQYIRK------------------------------YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRD  127 (280)
T ss_pred             EcCCCCCcHHHHHHH------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecC
Confidence            999999999999965                              225889999999999999999999   88999999


Q ss_pred             CCCCceEEcCCCCeeecccccceecCCCCc---------------------cccccccccccCCcccCCCCCCCCCcCcc
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLD---------------------EEIARGSPGYIPPEFAQPDSDFPTPKSDV  721 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv  721 (815)
                      |+|+||+++.++.++++|||++........                     .....|+..|+|||......  ++.++||
T Consensus       128 l~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Di  205 (280)
T cd05581         128 LKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP--AGKSSDL  205 (280)
T ss_pred             CCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC--CChhhhH
Confidence            999999999999999999999886543221                     12234788999999887655  6889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          722 YCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       722 ~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                      ||||++++|+++|+.||.....       ..........           ....+...+..+.+++.+||..+|++||++
T Consensus       206 ~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~  267 (280)
T cd05581         206 WALGCIIYQMLTGKPPFRGSNE-------YLTFQKILKL-----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGV  267 (280)
T ss_pred             HHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhc-----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence            9999999999999999975321       1111111111           111233446678999999999999999999


Q ss_pred             ----HHHHH
Q 003504          802 ----QQIVG  806 (815)
Q Consensus       802 ----~~v~~  806 (815)
                          +++++
T Consensus       268 ~~~~~~ll~  276 (280)
T cd05581         268 NEGYDELKA  276 (280)
T ss_pred             ccCHHHHhc
Confidence                77654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9e-33  Score=300.27  Aligned_cols=263  Identities=21%  Similarity=0.254  Sum_probs=191.5

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeC----------
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAG----------  576 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----------  576 (815)
                      .+|...+.||.|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            5788899999999999999995 56889999998765555566788999999999999999999876653          


Q ss_pred             ----CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhc
Q 003504          577 ----DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHH  652 (815)
Q Consensus       577 ----~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~  652 (815)
                          ...++|+||++ ++|.+++..                               ..+++.....++.|++.||.||| 
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~-------------------------------~~l~~~~~~~~~~qi~~aL~~LH-  131 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ-------------------------------GPLSEEHARLFMYQLLRGLKYIH-  131 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc-------------------------------CCCCHHHHHHHHHHHHHHHHHHH-
Confidence                35789999998 588888753                               13677888899999999999999 


Q ss_pred             CCCCCeeeccCCCCceEEc-CCCCeeecccccceecCCCC----ccccccccccccCCcccCCCCCCCCCcCcchhHHHH
Q 003504          653 GCSPPIIHRDIKASSVYLD-MNLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV  727 (815)
Q Consensus       653 ~~~~~ivHrDlk~~NIll~-~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvv  727 (815)
                        +.+|+||||||+||+++ +++.+||+|||+++......    ......|+..|+|||.+..... ++.++|||||||+
T Consensus       132 --~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwSlGvi  208 (342)
T cd07854         132 --SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN-YTKAIDMWAAGCI  208 (342)
T ss_pred             --hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccc-cCchhhHHHHHHH
Confidence              78999999999999998 45678999999998654221    1122357889999998754332 6789999999999


Q ss_pred             HHHHHhCCCCCCCCCCccccccHHH--------HHHHHHhc---CCCCcccccccc-CCCCHHHHHHHHHHHhhccccCC
Q 003504          728 LLELITGKKPLGDDYPEEKEGNLVS--------WVRGLVRN---NKGSRAIDPKIR-DTGPEKQMEEALKIGYLCTADLP  795 (815)
Q Consensus       728 l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~dP  795 (815)
                      +|||++|+.||....+.+......+        ........   ........+... .........++.+++.+|+..||
T Consensus       209 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  288 (342)
T cd07854         209 FAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP  288 (342)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCc
Confidence            9999999999975432111100000        00000000   000000000000 00011234678899999999999


Q ss_pred             CCCCCHHHHHH
Q 003504          796 LKRPSMQQIVG  806 (815)
Q Consensus       796 ~~RPs~~~v~~  806 (815)
                      ++||+++++++
T Consensus       289 ~~R~t~~ell~  299 (342)
T cd07854         289 MDRLTAEEALM  299 (342)
T ss_pred             hhccCHHHHhC
Confidence            99999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.7e-32  Score=296.95  Aligned_cols=262  Identities=20%  Similarity=0.223  Sum_probs=189.6

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-C--CcEEEEEEeecC--CcccHHHHHHHHHHhcCC-CCCCceeeeeEEEeC----Ce
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-G--GIHVAVKVLVHG--STLTDQEAARELEYLGRI-KHPNLVPLTGYCIAG----DQ  578 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~  578 (815)
                      +|++.+.||+|+||.||+|... .  +..||+|.+...  .....+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677789999999999999954 3  778999998642  222345678899999999 599999999976543    34


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++++||+. ++|.+++..                              ...+++..+..++.|++.||+|||   ..++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~------------------------------~~~~~~~~~~~~~~qi~~aL~~LH---~~gi  126 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS------------------------------GQPLTDAHFQSFIYQILCGLKYIH---SANV  126 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            678888886 589888854                              235788899999999999999999   8899


Q ss_pred             eeccCCCCceEEcCCCCeeecccccceecCCCCc-----cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD-----EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       659 vHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                      +||||||+||+++.++.+||+|||+++.......     .....|+..|+|||.+.+... ++.++|||||||++|++++
T Consensus       127 vH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~~Di~slGv~l~~l~~  205 (332)
T cd07857         127 LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS-YTKAIDVWSVGCILAELLG  205 (332)
T ss_pred             ccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCC-CCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999986543221     123458999999998765332 6889999999999999999


Q ss_pred             CCCCCCCCCCccccccHHH--------HHHHHHhcC------CCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC
Q 003504          734 GKKPLGDDYPEEKEGNLVS--------WVRGLVRNN------KGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP  799 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  799 (815)
                      |+.||...........+..        +........      .....-...+.. ........+.+++.+|++.||++||
T Consensus       206 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~  284 (332)
T cd07857         206 RKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRI  284 (332)
T ss_pred             CCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCC
Confidence            9999875332111111000        000000000      000000000000 0112356789999999999999999


Q ss_pred             CHHHHHH
Q 003504          800 SMQQIVG  806 (815)
Q Consensus       800 s~~~v~~  806 (815)
                      ++.++++
T Consensus       285 t~~~ll~  291 (332)
T cd07857         285 SVEEALE  291 (332)
T ss_pred             CHHHHhc
Confidence            9999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-32  Score=295.17  Aligned_cols=268  Identities=20%  Similarity=0.242  Sum_probs=196.4

Q ss_pred             HHHHHHHhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeC
Q 003504          500 FADLLSATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAG  576 (815)
Q Consensus       500 ~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  576 (815)
                      ..++...+++|+..+.||+|+||.||+|.. .++..||+|++....  ....+.+.+|+.++.+++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            345666788999999999999999999984 578899999986532  22345678899999999999999999988643


Q ss_pred             ------CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHH
Q 003504          577 ------DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFL  650 (815)
Q Consensus       577 ------~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yL  650 (815)
                            ...+++++++ +++|.+++..                               ..+++..+..++.|+++||+||
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-------------------------------~~l~~~~~~~i~~qi~~aL~~L  136 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC-------------------------------QKLTDDHVQFLIYQILRGLKYI  136 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc-------------------------------CCCCHHHHHHHHHHHHHHHHHH
Confidence                  2356777776 7799887753                               2467888999999999999999


Q ss_pred             hcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHH
Q 003504          651 HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE  730 (815)
Q Consensus       651 H~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~e  730 (815)
                      |   +.+|+||||||+||++++++.+||+|||+++.....  .....|+..|+|||.+.+... ++.++|||||||++||
T Consensus       137 H---~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-~~~~~DvwslG~il~e  210 (345)
T cd07877         137 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAE  210 (345)
T ss_pred             H---HCCeeecCCChHHEEEcCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccC-CCchhhHHHHHHHHHH
Confidence            9   889999999999999999999999999999865432  233457899999998765332 6889999999999999


Q ss_pred             HHhCCCCCCCCCCccccccHHHHHH----HHH---hcCCC-------CccccccccCCCCHHHHHHHHHHHhhccccCCC
Q 003504          731 LITGKKPLGDDYPEEKEGNLVSWVR----GLV---RNNKG-------SRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL  796 (815)
Q Consensus       731 l~tg~~p~~~~~~~~~~~~~~~~~~----~~~---~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~  796 (815)
                      +++|+.||...........+.....    ...   .....       ......... ........++.+++.+|+..||.
T Consensus       211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~  289 (345)
T cd07877         211 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSD  289 (345)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChh
Confidence            9999999964322111111111000    000   00000       000000000 00012345688999999999999


Q ss_pred             CCCCHHHHHH
Q 003504          797 KRPSMQQIVG  806 (815)
Q Consensus       797 ~RPs~~~v~~  806 (815)
                      +||++.+++.
T Consensus       290 ~R~t~~e~l~  299 (345)
T cd07877         290 KRITAAQALA  299 (345)
T ss_pred             hcCCHHHHhc
Confidence            9999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-34  Score=318.48  Aligned_cols=257  Identities=23%  Similarity=0.232  Sum_probs=199.3

Q ss_pred             HHHHHHhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeC
Q 003504          501 ADLLSATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAG  576 (815)
Q Consensus       501 ~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  576 (815)
                      .++....++|++.++||+|+||.|..+++ .+++.+|+|++++..   ..+..-|..|-++|..-+.+.|+++...|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            45555678899999999999999999996 467889999998742   33445688999999999999999999999999


Q ss_pred             CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 003504          577 DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSP  656 (815)
Q Consensus       577 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~  656 (815)
                      .+.|+|||||+||+|-.+|...                             + .++.....-.+..|.-||.-||   +.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~-----------------------------~-~~pE~~ArFY~aEiVlAldslH---~m  194 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF-----------------------------D-RLPEDWARFYTAEIVLALDSLH---SM  194 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc-----------------------------C-CChHHHHHHHHHHHHHHHHHHH---hc
Confidence            9999999999999999999652                             2 2333334456677889999999   89


Q ss_pred             CeeeccCCCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCC---CCCCCCcCcchhHHHHHHHH
Q 003504          657 PIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPD---SDFPTPKSDVYCYGVVLLEL  731 (815)
Q Consensus       657 ~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~S~Gvvl~el  731 (815)
                      |+|||||||+|||+|..|++|++|||.+-.+..+.  .....+|||.|++||++...   .+.|+..+|+||+||++|||
T Consensus       195 gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEM  274 (1317)
T KOG0612|consen  195 GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEM  274 (1317)
T ss_pred             cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHH
Confidence            99999999999999999999999999988776433  45677899999999987643   25589999999999999999


Q ss_pred             HhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC---HHHHH
Q 003504          732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS---MQQIV  805 (815)
Q Consensus       732 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs---~~~v~  805 (815)
                      +.|..||..+.--+.++.+..+       ......     +  .....+++..+++.+.+. +|+.|-.   .+++.
T Consensus       275 lyG~TPFYadslveTY~KIm~h-------k~~l~F-----P--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  275 LYGETPFYADSLVETYGKIMNH-------KESLSF-----P--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             HcCCCcchHHHHHHHHHHHhch-------hhhcCC-----C--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence            9999999854433444444432       111101     0  012255667777776655 5777776   66553

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=268.68  Aligned_cols=266  Identities=21%  Similarity=0.299  Sum_probs=205.8

Q ss_pred             CHHHHHHHhcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC-CCCceeeeeEEEeC
Q 003504          499 TFADLLSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-HPNLVPLTGYCIAG  576 (815)
Q Consensus       499 ~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~  576 (815)
                      +++|+..-|+     +.+|+|+|+.|--++ +.+|..+|||++.+........+.+|++++...+ |+||++++.++++.
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            4667766663     799999999999988 7889999999998765555678889999999985 99999999999999


Q ss_pred             CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 003504          577 DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSP  656 (815)
Q Consensus       577 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~  656 (815)
                      ...|+|||-|.+|.|..++++.                              .-++....-++..+||.||.|||   .+
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~------------------------------~~F~E~EAs~vvkdia~aLdFlH---~k  195 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKR------------------------------KHFNEREASRVVKDIASALDFLH---TK  195 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHh------------------------------hhccHHHHHHHHHHHHHHHHHHh---hc
Confidence            9999999999999999999863                              34566677889999999999999   89


Q ss_pred             CeeeccCCCCceEEcCCCC---eeecccccceecCCC--------CccccccccccccCCccc---CCCCCCCCCcCcch
Q 003504          657 PIIHRDIKASSVYLDMNLE---PRLSDFGLAKIFGNG--------LDEEIARGSPGYIPPEFA---QPDSDFPTPKSDVY  722 (815)
Q Consensus       657 ~ivHrDlk~~NIll~~~~~---~kl~Dfgla~~~~~~--------~~~~~~~gt~~y~aPE~~---~~~~~~~~~~~Dv~  722 (815)
                      +|.|||+||+|||-..-..   +||+||.++.-....        ....+.+|+..|||||+.   .+...+|+.++|.|
T Consensus       196 gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlw  275 (463)
T KOG0607|consen  196 GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLW  275 (463)
T ss_pred             CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHH
Confidence            9999999999999865433   799999887543211        122344688899999974   34445689999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCcc---ccccHHHHHHHHHhcCCCCccccccc--cCCCCHHHHHHHHHHHhhccccCCCC
Q 003504          723 CYGVVLLELITGKKPLGDDYPEE---KEGNLVSWVRGLVRNNKGSRAIDPKI--RDTGPEKQMEEALKIGYLCTADLPLK  797 (815)
Q Consensus       723 S~Gvvl~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~Cl~~dP~~  797 (815)
                      |+|||+|-|+.|.+||.+...++   ..+.....++..+-+..    -+..+  ...-+...+.+.-+++...+..||.+
T Consensus       276 SLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI----QEGkYeFPdkdWahIS~eakdlisnLlvrda~~  351 (463)
T KOG0607|consen  276 SLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI----QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQ  351 (463)
T ss_pred             HHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH----hccCCcCChhhhHHhhHHHHHHHHHHHhccHHh
Confidence            99999999999999999854432   22333333333322210    01111  11113456778889999999999999


Q ss_pred             CCCHHHHHH
Q 003504          798 RPSMQQIVG  806 (815)
Q Consensus       798 RPs~~~v~~  806 (815)
                      |-++.+++.
T Consensus       352 rlsa~~vln  360 (463)
T KOG0607|consen  352 RLSAAQVLN  360 (463)
T ss_pred             hhhhhhccC
Confidence            999998875

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=4.1e-32  Score=281.69  Aligned_cols=235  Identities=27%  Similarity=0.301  Sum_probs=191.0

Q ss_pred             ecccCCeeeEEEEcC-CCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCCh
Q 003504          516 LAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTL---TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNL  591 (815)
Q Consensus       516 ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL  591 (815)
                      ||+|+||.||++... ++..+|+|.+......   ....+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999964 5889999998764332   345788999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEc
Q 003504          592 QNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD  671 (815)
Q Consensus       592 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~  671 (815)
                      .+++..                              ...+++.....++.|++.||.|||   +.+++|+||+|+||+++
T Consensus        81 ~~~l~~------------------------------~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~  127 (250)
T cd05123          81 FSHLSK------------------------------EGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLD  127 (250)
T ss_pred             HHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEc
Confidence            999964                              224788889999999999999999   79999999999999999


Q ss_pred             CCCCeeecccccceecCCC-CccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccH
Q 003504          672 MNLEPRLSDFGLAKIFGNG-LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL  750 (815)
Q Consensus       672 ~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~  750 (815)
                      .++.++|+|||.+...... .......++..|+|||...+..  .+.++|+||||+++||+++|+.||.....       
T Consensus       128 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------  198 (250)
T cd05123         128 ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------  198 (250)
T ss_pred             CCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCH-------
Confidence            9999999999999876543 2233456888999999987655  68899999999999999999999964321       


Q ss_pred             HHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 003504          751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ  803 (815)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~  803 (815)
                      ..........           ....+...+..+.+++.+||..||++||++++
T Consensus       199 ~~~~~~~~~~-----------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         199 KEIYEKILKD-----------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHhcC-----------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            1111111110           01112333567889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=6.8e-32  Score=293.37  Aligned_cols=262  Identities=20%  Similarity=0.236  Sum_probs=194.1

Q ss_pred             HhcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC-----
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGD-----  577 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  577 (815)
                      ..++|+..+.||+|+||.||+|. ..++..||||++.....  .....+.+|++++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            45679999999999999999998 45789999999854322  22356789999999999999999999987643     


Q ss_pred             -eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 003504          578 -QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSP  656 (815)
Q Consensus       578 -~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~  656 (815)
                       ..++||||+ +++|.+++..                               ..+++.....++.|+++||+|||   +.
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-------------------------------~~l~~~~~~~i~~qi~~al~~LH---~~  137 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-------------------------------EKLSEDRIQFLVYQMLKGLKYIH---AA  137 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence             358999999 6688888753                               24678889999999999999999   89


Q ss_pred             CeeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          657 PIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       657 ~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      +|+||||||+||+++.++.+||+|||++......  .....+++.|+|||.+.+... ++.++|||||||++|++++|+.
T Consensus       138 gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~ll~~l~~g~~  214 (343)
T cd07880         138 GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMH-YTQTVDIWSVGCIMAEMLTGKP  214 (343)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999999865432  233457889999998865332 6889999999999999999999


Q ss_pred             CCCCCCCccccccHH--------HHHHHHHhcC------CCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 003504          737 PLGDDYPEEKEGNLV--------SWVRGLVRNN------KGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ  802 (815)
Q Consensus       737 p~~~~~~~~~~~~~~--------~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  802 (815)
                      ||...........+.        .+...+....      .......+.+. ........++.+++.+|+..||++||++.
T Consensus       215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~  293 (343)
T cd07880         215 LFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAA  293 (343)
T ss_pred             CCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHH
Confidence            997533211110100        0000000000      00000000000 00123345688999999999999999999


Q ss_pred             HHHH
Q 003504          803 QIVG  806 (815)
Q Consensus       803 ~v~~  806 (815)
                      ++++
T Consensus       294 ~~l~  297 (343)
T cd07880         294 EALA  297 (343)
T ss_pred             HHhc
Confidence            9983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.8e-32  Score=298.05  Aligned_cols=261  Identities=19%  Similarity=0.253  Sum_probs=194.4

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCe-----
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQ-----  578 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  578 (815)
                      .++|+..+.||+|+||.||+|.. .++..||||++....  ....+.+.+|+.++++++|||++++++++...+.     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            56788899999999999999996 467899999886431  2233567789999999999999999998876554     


Q ss_pred             -eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          579 -RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       579 -~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                       .++|+||+ +++|.+++..                               ..+++.....++.|+++||+|||   +.+
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~-------------------------------~~l~~~~~~~~~~ql~~aL~~LH---~~g  138 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC-------------------------------QKLSDDHIQFLVYQILRGLKYIH---SAG  138 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence             89999998 5699888853                               24788889999999999999999   889


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      |+||||||+||+++.++.+||+|||++......  .....++..|+|||.+.+.. .++.++|||||||++||+++|+.|
T Consensus       139 i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~p  215 (343)
T cd07851         139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGKTL  215 (343)
T ss_pred             eecCCCCHHHeEECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCC-CCCchHhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999999876433  23345788999999876533 268899999999999999999999


Q ss_pred             CCCCCCccccccHHHH--------HHHHHhcCC------CCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 003504          738 LGDDYPEEKEGNLVSW--------VRGLVRNNK------GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ  803 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~--------~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~  803 (815)
                      |......+....+...        .........      ......+.+.. .....+.++.+++.+|+..+|++||++.+
T Consensus       216 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~e  294 (343)
T cd07851         216 FPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAE  294 (343)
T ss_pred             CCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence            9753322111111100        000000000      00000000000 01123567899999999999999999999


Q ss_pred             HHH
Q 003504          804 IVG  806 (815)
Q Consensus       804 v~~  806 (815)
                      |++
T Consensus       295 ll~  297 (343)
T cd07851         295 ALA  297 (343)
T ss_pred             Hhc
Confidence            875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.2e-32  Score=299.05  Aligned_cols=262  Identities=26%  Similarity=0.414  Sum_probs=217.0

Q ss_pred             cCHHHHHHHhcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeEEEe
Q 003504          498 ITFADLLSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCIA  575 (815)
Q Consensus       498 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  575 (815)
                      +.++.+...++.|++.++||.|.+|.||+++ .++++.+|||++.. .....++++.|.++++.. .|||++.++|++.-
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            3444455567789999999999999999999 56788999998765 455667888999999988 59999999999874


Q ss_pred             -----CCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHH
Q 003504          576 -----GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFL  650 (815)
Q Consensus       576 -----~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yL  650 (815)
                           +++.|+|||||.+||..+++....                            +..+.|....-|++.+..|+.+|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~----------------------------g~rl~E~~IaYI~re~lrgl~HL  139 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK----------------------------GNRLKEEWIAYILREILRGLAHL  139 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc----------------------------ccchhhHHHHHHHHHHHHHHHHH
Confidence                 568999999999999999997631                            55788999999999999999999


Q ss_pred             hcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCC---CCCCcCcchhHHH
Q 003504          651 HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSD---FPTPKSDVYCYGV  726 (815)
Q Consensus       651 H~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~---~~~~~~Dv~S~Gv  726 (815)
                      |   ...++|||||-.|||+++++.+|+.|||++..+..+. ...+..||+.|||||++.....   .|+.++|+||+|+
T Consensus       140 H---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGI  216 (953)
T KOG0587|consen  140 H---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGI  216 (953)
T ss_pred             h---hcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccc
Confidence            9   8899999999999999999999999999998876543 4556779999999999987652   3578999999999


Q ss_pred             HHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          727 VLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       727 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +..||--|.+|+.+.-+-          +.++     .-.-.|......|....+++.+++..|+.+|-++||++.++++
T Consensus       217 TaIEladG~PPl~DmHPm----------raLF-----~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  217 TAIEMAEGAPPLCDMHPM----------RALF-----LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             eeehhcCCCCCccCcchh----------hhhc-----cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            999999999999864331          1111     1112233333457889999999999999999999999999875

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.98  E-value=1.6e-32  Score=310.69  Aligned_cols=282  Identities=24%  Similarity=0.335  Sum_probs=177.4

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeE---
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRI---  580 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~---  580 (815)
                      -..+|++.+.||+||||.|||++. -||+.+|||++.... ......+.+|+..+++++|||||+++..+.+.....   
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            345788889999999999999994 489999999997643 333456889999999999999999998765432111   


Q ss_pred             ---------------------EEEEeCC--CCChhhhhc---cCCCCC-----------------ccccCC---------
Q 003504          581 ---------------------AIYDYME--NGNLQNLLH---DLPLGV-----------------QTTEDW---------  608 (815)
Q Consensus       581 ---------------------lv~ey~~--~gsL~~~l~---~~~~~~-----------------~~~~~~---------  608 (815)
                                           ++++-.+  ...+...=.   +.....                 +..++.         
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                 1111100  000000000   000000                 000000         


Q ss_pred             -----CCCccccCC-----Cccccc------------------------cCCCCccc-CHHHHHHHHHHHHHHHHHHhcC
Q 003504          609 -----STDTWEEDG-----TNSIQN------------------------VGSEGLLT-TWRFRHKIALGTARALAFLHHG  653 (815)
Q Consensus       609 -----~~~~~~~~~-----~~~~~~------------------------~~~~~~~~-~~~~~~~i~~~ia~~L~yLH~~  653 (815)
                           ..+..+...     .+....                        .-..+... .-...++++++|++||+|+|  
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH--  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH--  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH--
Confidence                 000001111     111100                        00001111 23345789999999999999  


Q ss_pred             CCCCeeeccCCCCceEEcCCCCeeecccccceecC------------------C-CCccccccccccccCCcccCCCCC-
Q 003504          654 CSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG------------------N-GLDEEIARGSPGYIPPEFAQPDSD-  713 (815)
Q Consensus       654 ~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~------------------~-~~~~~~~~gt~~y~aPE~~~~~~~-  713 (815)
                       +++||||||||.||++|++..+||+|||+|+...                  . ....+..+||.-|+|||++.+... 
T Consensus       715 -~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  715 -DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             -hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence             8999999999999999999999999999998721                  0 113455679999999999876652 


Q ss_pred             CCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhcccc
Q 003504          714 FPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTAD  793 (815)
Q Consensus       714 ~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~  793 (815)
                      .|+.|+|+||+|||++||+.   ||+..   .....+..    .++.  +.-..+    .....+....-.+++..+++.
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~Ts---MERa~iL~----~LR~--g~iP~~----~~f~~~~~~~e~slI~~Ll~h  857 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGTS---MERASILT----NLRK--GSIPEP----ADFFDPEHPEEASLIRWLLSH  857 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCch---HHHHHHHH----hccc--CCCCCC----cccccccchHHHHHHHHHhcC
Confidence            47999999999999999997   56531   11111111    1111  111111    112333444557899999999


Q ss_pred             CCCCCCCHHHHHH
Q 003504          794 LPLKRPSMQQIVG  806 (815)
Q Consensus       794 dP~~RPs~~~v~~  806 (815)
                      ||.+|||+.|++.
T Consensus       858 dP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  858 DPSKRPTATELLN  870 (1351)
T ss_pred             CCccCCCHHHHhh
Confidence            9999999999975

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.98  E-value=1.2e-32  Score=268.18  Aligned_cols=203  Identities=22%  Similarity=0.345  Sum_probs=170.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEc---CC--CcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCCceeeeeEEEe-CCee
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL---PG--GIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIA-GDQR  579 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~---~~--~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~  579 (815)
                      ..|+....||+|.||.||+|+-   ++  ...+|+|.+...+.  .-.....||+.+++.++||||+.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            4688889999999999999963   22  23689999865422  223567899999999999999999999887 6678


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++++||.+. +|...++-...                         +....+.-....+|+.||..|+.|||   +.=|+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~-------------------------~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvl  154 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRA-------------------------SKAKQLPRSMVKSILWQILDGVHYLH---SNWVL  154 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhcc-------------------------chhccCCHHHHHHHHHHHHhhhHHHh---hhhee
Confidence            999999998 99999975421                         22346777888999999999999999   77899


Q ss_pred             eccCCCCceEEcCC----CCeeecccccceecCCCC----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHH
Q 003504          660 HRDIKASSVYLDMN----LEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL  731 (815)
Q Consensus       660 HrDlk~~NIll~~~----~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el  731 (815)
                      ||||||.||||..+    |.+||+|||+++.+....    .....+-|.+|+|||++.+... |+.+.||||.||++.||
T Consensus       155 HRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~h-YT~AiDvWAiGCIfaEl  233 (438)
T KOG0666|consen  155 HRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARH-YTKAIDVWAIGCIFAEL  233 (438)
T ss_pred             eccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhccccc-ccchhhhHHHHHHHHHH
Confidence            99999999999888    899999999999886543    3345567999999999998876 79999999999999999


Q ss_pred             HhCCCCCCC
Q 003504          732 ITGKKPLGD  740 (815)
Q Consensus       732 ~tg~~p~~~  740 (815)
                      +|-++-|.+
T Consensus       234 Ltl~PlF~g  242 (438)
T KOG0666|consen  234 LTLEPLFKG  242 (438)
T ss_pred             HccCccccc
Confidence            998887765

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=266.84  Aligned_cols=252  Identities=23%  Similarity=0.285  Sum_probs=197.2

Q ss_pred             hcCCCC-CCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeEEEeC----Cee
Q 003504          507 TSNFDR-GTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCIAG----DQR  579 (815)
Q Consensus       507 ~~~~~~-~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~~  579 (815)
                      +++|.+ .++||-|-.|.|-.+.. .+|.++|+|++.+     ....++|++.--+. .|||||.+++++.+.    ...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            455655 36899999999999884 5788999999865     23457788765544 599999999988752    355


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++|||.|+||.|.+.+++.                            ....++.+..-.|+.||+.|+.|||   +..|.
T Consensus       135 LiVmE~meGGeLfsriq~~----------------------------g~~afTErea~eI~~qI~~Av~~lH---~~nIA  183 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDR----------------------------GDQAFTEREASEIMKQIGLAVRYLH---SMNIA  183 (400)
T ss_pred             EeeeecccchHHHHHHHHc----------------------------ccccchHHHHHHHHHHHHHHHHHHH---hcchh
Confidence            7899999999999999863                            2456788888999999999999999   89999


Q ss_pred             eccCCCCceEEcC---CCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          660 HRDIKASSVYLDM---NLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       660 HrDlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      ||||||+|+|...   +-.+|++|||+|+.........+.+-|+.|.|||++....  |+..+|+||+||+||-|+.|.+
T Consensus       184 HRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eK--ydkscdmwSlgVimYIlLCGyP  261 (400)
T KOG0604|consen  184 HRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYP  261 (400)
T ss_pred             hccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchh--cCCCCCccchhHHHHHhhcCCC
Confidence            9999999999974   4468999999999877555566677899999999998777  7889999999999999999999


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ||...-.......    ++.-++...      -.+....+...+++.-++++..++.+|.+|.+.+++..
T Consensus       262 PFYS~hg~aispg----Mk~rI~~gq------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  262 PFYSNHGLAISPG----MKRRIRTGQ------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cccccCCccCChh----HHhHhhccC------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            9986332211111    111111110      01122234567788899999999999999999999864

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=2e-32  Score=246.08  Aligned_cols=261  Identities=22%  Similarity=0.274  Sum_probs=197.3

Q ss_pred             CCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|+..+.||+|.||+||+|+ .+++..||+|+++-.  +..-.....+|+-+++.++|+|||++++........-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45667899999999999999 566888999998753  334456788999999999999999999999888889999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      |.. +|..+....                             +..++-.....++.|+.+||.|+|   ++.+.|||+||
T Consensus        83 cdq-dlkkyfdsl-----------------------------ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkp  129 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSL-----------------------------NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKP  129 (292)
T ss_pred             hhH-HHHHHHHhc-----------------------------CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCc
Confidence            987 888887653                             335677778899999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCC
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP  743 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~  743 (815)
                      .|.||+.+|++|++|||+++.++-.. -....+-|.+|.+|+++.+..- |++..|+||-||++.|+.. |++-|.+...
T Consensus       130 qnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakl-y~tsidmwsagcifaelanagrplfpg~dv  208 (292)
T KOG0662|consen  130 QNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRPLFPGNDV  208 (292)
T ss_pred             ceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeeh-hccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence            99999999999999999999876443 2344457999999999988764 6889999999999999988 6666665332


Q ss_pred             ccccccHHHHHHHH--Hhc-CCC--CccccccccCCCC---------HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSWVRGL--VRN-NKG--SRAIDPKIRDTGP---------EKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~--~~~-~~~--~~~~~~~~~~~~~---------~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                         ..++.+.++.+  ..+ .+.  ...-|-......+         +.....-.++.++.+.-+|.+|.++++.++
T Consensus       209 ---ddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  209 ---DDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ---HHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence               22333322221  111 111  1111111111111         111233467888889999999999998875

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.5e-33  Score=270.69  Aligned_cols=240  Identities=25%  Similarity=0.311  Sum_probs=192.4

Q ss_pred             hcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHH---HHHHHHhcCCCCCCceeeeeEEEeCCeeEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~---~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  582 (815)
                      .++|+..+++|+|.||.|-.++ ..+|+.+|+|++++.-.....+.   ..|-++|+..+||.+..+-..+...+..+.|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            3578889999999999999998 56789999999987655544443   4588899999999999998889999999999


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      |||..+|.|.-+|...                              ..++.....-....|..||.|||   +++||.||
T Consensus       247 MeyanGGeLf~HLsre------------------------------r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRD  293 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRE------------------------------RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRD  293 (516)
T ss_pred             EEEccCceEeeehhhh------------------------------hcccchhhhhhhHHHHHHhhhhh---hCCeeeee
Confidence            9999999999888542                              12222222335667999999999   89999999


Q ss_pred             CCCCceEEcCCCCeeecccccceec-CCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIF-GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       663 lk~~NIll~~~~~~kl~Dfgla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      ||.+|.|+|.||++||+|||+++.- ..+....+.+||+.|+|||++....  |+...|+|.+|||||||+.|+.||...
T Consensus       294 lKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnD--YgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  294 LKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDND--YGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             chhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhcccc--ccceeehhhhhHHHHHHHhccCccccc
Confidence            9999999999999999999999853 3455677889999999999998777  789999999999999999999999863


Q ss_pred             CCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP  799 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  799 (815)
                      ..+    .+...   ++.+         .+  .+|.....+...+....+.+||.+|.
T Consensus       372 dh~----kLFeL---Il~e---------d~--kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  372 DHE----KLFEL---ILME---------DL--KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             chh----HHHHH---HHhh---------hc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence            322    22211   1111         11  12445556777888899999999997

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1e-31  Score=314.38  Aligned_cols=145  Identities=28%  Similarity=0.359  Sum_probs=128.4

Q ss_pred             cCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTL---TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ++|.+.+.||+|+||.||+|... +++.||||+++.....   ....+.+|+.++..++||||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56888899999999999999964 6889999999754322   2357889999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|+|.++++..                              ..+++.....|+.||+.||+|||   ..+||||||
T Consensus        84 Ey~~g~~L~~li~~~------------------------------~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDL  130 (669)
T cd05610          84 EYLIGGDVKSLLHIY------------------------------GYFDEEMAVKYISEVALALDYLH---RHGIIHRDL  130 (669)
T ss_pred             eCCCCCCHHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCc
Confidence            999999999999642                              24667788999999999999999   789999999


Q ss_pred             CCCceEEcCCCCeeecccccce
Q 003504          664 KASSVYLDMNLEPRLSDFGLAK  685 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~  685 (815)
                      ||+|||++.++.+||+|||+++
T Consensus       131 KP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         131 KPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             cHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999999999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2.2e-31  Score=273.67  Aligned_cols=220  Identities=22%  Similarity=0.176  Sum_probs=175.3

Q ss_pred             cCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCChhhhhcc
Q 003504          519 GKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHD  597 (815)
Q Consensus       519 G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~  597 (815)
                      |.+|.||+++. .+++.||+|.++...     .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999995 578899999986532     234455555566799999999999999999999999999999999864


Q ss_pred             CCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCee
Q 003504          598 LPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR  677 (815)
Q Consensus       598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k  677 (815)
                      .                              ..+++.....++.|++.||+|||   +.+|+||||||+||+++.++.++
T Consensus        79 ~------------------------------~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~  125 (237)
T cd05576          79 F------------------------------LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQ  125 (237)
T ss_pred             h------------------------------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence            2                              24788889999999999999999   89999999999999999999999


Q ss_pred             ecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHH
Q 003504          678 LSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGL  757 (815)
Q Consensus       678 l~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  757 (815)
                      ++|||.+......  .....++..|+|||......  ++.++||||+|+++||+++|+.|+...... .           
T Consensus       126 l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----------  189 (237)
T cd05576         126 LTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISE--ETEACDWWSLGAILFELLTGKTLVECHPSG-I-----------  189 (237)
T ss_pred             Eecccchhccccc--cccCCcCccccCCcccCCCC--CCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----------
Confidence            9999988766442  22334677899999886655  688999999999999999999887531100 0           


Q ss_pred             HhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 003504          758 VRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ  802 (815)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  802 (815)
                       ..         ......+...+..+.+++.+|++.||++||++.
T Consensus       190 -~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         190 -NT---------HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             -cc---------ccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence             00         000011233456788999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-32  Score=272.07  Aligned_cols=240  Identities=27%  Similarity=0.361  Sum_probs=190.3

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHHH---HHHHHHHhcCC-CCCCceeeeeEEEeCCeeEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQE---AARELEYLGRI-KHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~---~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  581 (815)
                      ..+|....+||+|+||.|-.|.-+ +...+|||++++.-.....+   -..|-++|+-- +-|.++++..++...+..|.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            347888999999999999999854 45679999997753322221   23455566555 57899999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ||||+.+|+|--.+++.                          |    ....+...-.|..||-||-+||   +++||.|
T Consensus       428 VMEyvnGGDLMyhiQQ~--------------------------G----kFKEp~AvFYAaEiaigLFFLh---~kgIiYR  474 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQV--------------------------G----KFKEPVAVFYAAEIAIGLFFLH---SKGIIYR  474 (683)
T ss_pred             EEEEecCchhhhHHHHh--------------------------c----ccCCchhhhhhHHHHHHhhhhh---cCCeeee
Confidence            99999999998888652                          1    2233345567889999999999   8999999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecC-CCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFG-NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  740 (815)
                      |||.+|||+|.+|++||+|||+++.-- .+....+.+||+.|+|||++.=..  |+..+|+|||||+||||+.|++||++
T Consensus       475 DLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqP--YgksvDWWa~GVLLyEmlaGQpPFdG  552 (683)
T KOG0696|consen  475 DLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDG  552 (683)
T ss_pred             eccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecc--cccchhHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999999998643 344667889999999999987666  78899999999999999999999997


Q ss_pred             CCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP  799 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  799 (815)
                      +..++.-       +.+.+.+           ...|...+.+..++....+.+.|.+|.
T Consensus       553 eDE~elF-------~aI~ehn-----------vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  553 EDEDELF-------QAIMEHN-----------VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             CCHHHHH-------HHHHHcc-----------CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            5543332       2222221           234667778888999999999999986

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=276.57  Aligned_cols=243  Identities=23%  Similarity=0.340  Sum_probs=196.5

Q ss_pred             CCeecccCCeeeEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          513 GTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      .+++|.|-||+||-|.. ++|+.||||++.+..  ...+..++.|++||++++||.||.+.-.|++.+..++|||-+.+ 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            57999999999999995 579999999997642  33456789999999999999999999999999999999999977 


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      +..+.+-.                            ++...++.+.-.-+..||+.||.|||   -.+|||+||||+|||
T Consensus       648 DMLEMILS----------------------------sEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVL  696 (888)
T KOG4236|consen  648 DMLEMILS----------------------------SEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVL  696 (888)
T ss_pred             hHHHHHHH----------------------------hhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchhee
Confidence            54444432                            23446777777788999999999999   799999999999999


Q ss_pred             EcCC---CCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccc
Q 003504          670 LDMN---LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEK  746 (815)
Q Consensus       670 l~~~---~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~  746 (815)
                      +...   -++||+|||+|+..+........+||+.|+|||++....  |...-|+||.||++|--++|..||..+  +  
T Consensus       697 Las~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkG--yNrSLDMWSVGVIiYVsLSGTFPFNEd--E--  770 (888)
T KOG4236|consen  697 LASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKG--YNRSLDMWSVGVIIYVSLSGTFPFNED--E--  770 (888)
T ss_pred             eccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcc--ccccccceeeeEEEEEEecccccCCCc--c--
Confidence            9744   479999999999999887778888999999999998776  677889999999999999999999752  2  


Q ss_pred             cccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          747 EGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                        ++-+.++..          .-.+....+.+...+..+++...++..=++|-|..+.+
T Consensus       771 --dIndQIQNA----------aFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  771 --DINDQIQNA----------AFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             --chhHHhhcc----------ccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence              222211110          00122233566778889999999999999998877654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=3.6e-30  Score=265.31  Aligned_cols=237  Identities=30%  Similarity=0.371  Sum_probs=192.5

Q ss_pred             CCeeeEEEEcC-CCcEEEEEEeecCCccc-HHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCChhhhhcc
Q 003504          520 KFGPVYRGFLP-GGIHVAVKVLVHGSTLT-DQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHD  597 (815)
Q Consensus       520 ~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~  597 (815)
                      +||.||+|+.. ++..||+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48999999997654444 67899999999999999999999999999999999999999999999864


Q ss_pred             CCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCee
Q 003504          598 LPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR  677 (815)
Q Consensus       598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k  677 (815)
                      .                              ..+++..+..++.++++++.|||   ..+++|+||+|+||+++.++.++
T Consensus        81 ~------------------------------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~  127 (244)
T smart00220       81 R------------------------------GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVK  127 (244)
T ss_pred             c------------------------------cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEE
Confidence            2                              12778889999999999999999   78999999999999999999999


Q ss_pred             ecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHH
Q 003504          678 LSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGL  757 (815)
Q Consensus       678 l~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  757 (815)
                      |+|||.+.............++..|+|||......  .+.++||||||+++|++++|..||.....   ...+..+   .
T Consensus       128 l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~--~~~~~Di~slG~~l~~l~~~~~p~~~~~~---~~~~~~~---~  199 (244)
T smart00220      128 LADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKG--YGKAVDVWSLGVILYELLTGKPPFPGDDQ---LLELFKK---I  199 (244)
T ss_pred             EccccceeeeccccccccccCCcCCCCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHH---H
Confidence            99999998876554445566889999999887554  67899999999999999999999864211   1111111   1


Q ss_pred             HhcCCCCccccccccCCCCH-HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          758 VRNNKGSRAIDPKIRDTGPE-KQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ....         ....... ..+.++.+++.+|+..+|++||++.++++
T Consensus       200 ~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      200 GKPK---------PPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             hccC---------CCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            1110         0000000 14568899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=271.10  Aligned_cols=254  Identities=27%  Similarity=0.389  Sum_probs=191.9

Q ss_pred             CCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCc---cc----HHHHHHHHHHhcCCCCCCceeeeeEEEe-CCee
Q 003504          509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST---LT----DQEAARELEYLGRIKHPNLVPLTGYCIA-GDQR  579 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~----~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~  579 (815)
                      +|-..+.+|+|+|+.||+|. +...+.||||+-.-...   ..    .+...+|.+|-..|+||.||++++|+.- .+..
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            45667789999999999998 55678899998643211   11    1235689999999999999999999864 5677


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      +-|+|||++.+|.-||.+.                              ..++......|+.||+.||.||.+ .+++||
T Consensus       544 CTVLEYceGNDLDFYLKQh------------------------------klmSEKEARSIiMQiVnAL~YLNE-ikpPII  592 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQH------------------------------KLMSEKEARSIIMQIVNALKYLNE-IKPPII  592 (775)
T ss_pred             eeeeeecCCCchhHHHHhh------------------------------hhhhHHHHHHHHHHHHHHHHHHhc-cCCCee
Confidence            8899999999999999763                              356777888999999999999984 478999


Q ss_pred             eccCCCCceEEc---CCCCeeecccccceecCCCC--------ccccccccccccCCcccCCC--CCCCCCcCcchhHHH
Q 003504          660 HRDIKASSVYLD---MNLEPRLSDFGLAKIFGNGL--------DEEIARGSPGYIPPEFAQPD--SDFPTPKSDVYCYGV  726 (815)
Q Consensus       660 HrDlk~~NIll~---~~~~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~--~~~~~~~~Dv~S~Gv  726 (815)
                      |-||||.|||+-   ..|.+||.|||+++.+..++        -....+||.+|++||.+.-.  ....+.|+||||.||
T Consensus       593 HYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGV  672 (775)
T KOG1151|consen  593 HYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGV  672 (775)
T ss_pred             eeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeeh
Confidence            999999999995   44789999999999987543        12345699999999976543  334689999999999


Q ss_pred             HHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          727 VLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       727 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                      ++|..+.|++||+.....   .++       +.++.......-.+.  .-+....+..+++++|++.--++|....++.
T Consensus       673 IFyQClYGrKPFGhnqsQ---QdI-------LqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  673 IFYQCLYGRKPFGHNQSQ---QDI-------LQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hhhhhhccCCCCCCchhH---HHH-------HhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            999999999999863221   112       222221111111111  1123456778999999999888887776654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=8.7e-33  Score=261.47  Aligned_cols=265  Identities=23%  Similarity=0.326  Sum_probs=194.5

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeec--CCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeC--------C
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVH--GSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAG--------D  577 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~  577 (815)
                      .|+....||+|.||+||+|+. ++|++||+|+..-  ....-.....+|+++++.++|+|++.++..|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            455567899999999999994 5688899986532  2233345668999999999999999999988653        2


Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++||++|+. +|.-+|..                             ....++.....+++.++..||.|+|   ...
T Consensus        98 t~ylVf~~ceh-DLaGlLsn-----------------------------~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~k  144 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN-----------------------------RKVRFSLSEIKKVMKGLMNGLYYIH---RNK  144 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC-----------------------------ccccccHHHHHHHHHHHHHHHHHHH---Hhh
Confidence            46899999998 88888853                             2356778889999999999999999   889


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCC-----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHH
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI  732 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~  732 (815)
                      |+|||+||.|+||+.+|.+||+|||+++.+....     ..+..+-|.+|++||.+.+... ++++.|||..||||.||+
T Consensus       145 ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~-yg~~iDiWgAgCimaeMw  223 (376)
T KOG0669|consen  145 ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDRE-YGPPIDIWGAGCIMAEMW  223 (376)
T ss_pred             HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccc-cCCcchhHhHHHHHHHHH
Confidence            9999999999999999999999999998765322     2233446999999999998876 799999999999999999


Q ss_pred             hCCCCCCCCCCccccccHHHHHHHHHhcCCC-------Cccc--cccccCC--CCHH------HHHHHHHHHhhccccCC
Q 003504          733 TGKKPLGDDYPEEKEGNLVSWVRGLVRNNKG-------SRAI--DPKIRDT--GPEK------QMEEALKIGYLCTADLP  795 (815)
Q Consensus       733 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~--~~~~~~~--~~~~------~~~~~~~l~~~Cl~~dP  795 (815)
                      ||.+-+.+......-.-+...+...-.+-|.       .+.+  .|-....  .-++      ...+.++++..++..||
T Consensus       224 trspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP  303 (376)
T KOG0669|consen  224 TRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDP  303 (376)
T ss_pred             ccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCc
Confidence            9998887643322111111111111111000       0000  0000000  0111      22478899999999999


Q ss_pred             CCCCCHHHHHHH
Q 003504          796 LKRPSMQQIVGL  807 (815)
Q Consensus       796 ~~RPs~~~v~~~  807 (815)
                      .+||.+.+++..
T Consensus       304 ~kR~~ad~alnh  315 (376)
T KOG0669|consen  304 TKRIDADQALNH  315 (376)
T ss_pred             ccCcchHhhhch
Confidence            999999988753

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.3e-30  Score=289.01  Aligned_cols=282  Identities=18%  Similarity=0.217  Sum_probs=186.4

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEc-----------------CCCcEEEEEEeecCCcccHHHH--------------HHH
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFL-----------------PGGIHVAVKVLVHGSTLTDQEA--------------ARE  554 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~~--------------~~E  554 (815)
                      ..++|++.++||+|+||.||+|..                 .+++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            356899999999999999999963                 2356799999865433222333              346


Q ss_pred             HHHhcCCCCCCc-----eeeeeEEEe--------CCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccc
Q 003504          555 LEYLGRIKHPNL-----VPLTGYCIA--------GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI  621 (815)
Q Consensus       555 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (815)
                      +.++.+++|.++     ++++|||..        .+..++||||+++|+|.++++.........    ...+..... .+
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~----L~e~l~~g~-~l  297 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGC----LEEFMMAGK-KI  297 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcch----HHHHHhcCC-ch
Confidence            777777776654     678888764        346899999999999999997532110000    000000000 00


Q ss_pred             cccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCcccc--cccc
Q 003504          622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI--ARGS  699 (815)
Q Consensus       622 ~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~--~~gt  699 (815)
                      . ........+|..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....+.....  ..++
T Consensus       298 ~-~~~~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~t  373 (507)
T PLN03224        298 P-DNMPQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLD  373 (507)
T ss_pred             h-hhcccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCC
Confidence            0 0001234688899999999999999999   78999999999999999999999999999986654332222  2347


Q ss_pred             ccccCCcccCCCCC--------------------CCCCcCcchhHHHHHHHHHhCCC-CCCCCCCcc-----ccccHHHH
Q 003504          700 PGYIPPEFAQPDSD--------------------FPTPKSDVYCYGVVLLELITGKK-PLGDDYPEE-----KEGNLVSW  753 (815)
Q Consensus       700 ~~y~aPE~~~~~~~--------------------~~~~~~Dv~S~Gvvl~el~tg~~-p~~~~~~~~-----~~~~~~~~  753 (815)
                      +.|+|||.+.....                    ....+.||||+||++|||++|.. ||.+.....     ....+..|
T Consensus       374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~  453 (507)
T PLN03224        374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW  453 (507)
T ss_pred             cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH
Confidence            89999998754321                    01235799999999999999875 665311100     01111111


Q ss_pred             HHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCC---CCCCCHHHHHH
Q 003504          754 VRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP---LKRPSMQQIVG  806 (815)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP---~~RPs~~~v~~  806 (815)
                      ..  ...        .............+..+++.+++..+|   .+|+|++|+++
T Consensus       454 r~--~~~--------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        454 RM--YKG--------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             Hh--hcc--------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11  000        011111123345678899999999766   68999999985

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=285.71  Aligned_cols=239  Identities=21%  Similarity=0.270  Sum_probs=191.9

Q ss_pred             hcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      ++.|.....+|.|+|+.|-.+. ..+++..+||++.+.    ..+..+|+.++... +||||+++.+.+.++.+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            5678888889999999999988 467888999999664    22345677666666 69999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      ++.+|-+.+.+...+                              ... ..+..|+.+++.|+.|||   ++++||||||
T Consensus       397 ~l~g~ell~ri~~~~------------------------------~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLk  442 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP------------------------------EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLK  442 (612)
T ss_pred             hccccHHHHHHHhcc------------------------------hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCC
Confidence            999998888776421                              112 556779999999999999   8999999999


Q ss_pred             CCceEE-cCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          665 ASSVYL-DMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~NIll-~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      |+|||+ +..++++|+|||.++.....  ....+-|..|.|||+.....  +++++|+|||||+||+|++|+.||.....
T Consensus       443 p~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~--yt~acD~WSLGvlLy~ML~G~tp~~~~P~  518 (612)
T KOG0603|consen  443 PGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQE--YTEACDWWSLGVLLYEMLTGRTLFAAHPA  518 (612)
T ss_pred             hhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCC--CCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence            999999 68999999999999987654  23335688999999998555  89999999999999999999999975322


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .   ..+..    .+.        .+    ......+.+..+|+..|++.||.+||+|.++..
T Consensus       519 ~---~ei~~----~i~--------~~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  519 G---IEIHT----RIQ--------MP----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             h---HHHHH----hhc--------CC----ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            1   11111    111        11    112566778899999999999999999999864

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.97  E-value=2e-33  Score=282.41  Aligned_cols=201  Identities=31%  Similarity=0.438  Sum_probs=124.3

Q ss_pred             CeEEEEecCCCCCccCCCcccccCCCCCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEc
Q 003504           28 QHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDL  107 (815)
Q Consensus        28 ~~~~~l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  107 (815)
                      ..++.+++++|+++ .+|+ +++.+..++.|+.|+|++..+|+.+.++.+|..|+.++|.+. ..|+.++.+..|+.|+.
T Consensus        68 ~~l~vl~~~~n~l~-~lp~-aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~  144 (565)
T KOG0472|consen   68 ACLTVLNVHDNKLS-QLPA-AIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDA  144 (565)
T ss_pred             cceeEEEeccchhh-hCCH-HHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhc
Confidence            45667777777776 4554 567777777777777777777777777777777777777776 55666666666666666


Q ss_pred             cCCcCCCCChhhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCc---
Q 003504          108 SNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNE---  184 (815)
Q Consensus       108 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~---  184 (815)
                      .+|+++ ..|+.+..+.+|..|++.+|+++.. |+..-+++.|+.||...|.++ ++|..++ ++.+|+.|+|.+|+   
T Consensus       145 ~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L~-tlP~~lg-~l~~L~~LyL~~Nki~~  220 (565)
T KOG0472|consen  145 TNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLLE-TLPPELG-GLESLELLYLRRNKIRF  220 (565)
T ss_pred             cccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhhh-cCChhhc-chhhhHHHHhhhccccc
Confidence            666666 4555555555555555555555532 222222555555555555554 4554442 34445555555554   


Q ss_pred             -------------------ccCCCCC-CCCCCCCCeEeccCCcCCCcchhhh-hcccceeeeccccccCccc
Q 003504          185 -------------------IKGRDTH-FAGLKSITNLNISGNLFQGSVMGVF-LESLEVIDLRSNQFQGHIS  235 (815)
Q Consensus       185 -------------------l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~-l~~L~~L~L~~N~l~~~~~  235 (815)
                                         |..+|.. ...+++|..|||.+|++++.|.+.. +.+|+.||+++|.+++.+.
T Consensus       221 lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is~Lp~  292 (565)
T KOG0472|consen  221 LPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDISSLPY  292 (565)
T ss_pred             CCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccccCCc
Confidence                               4444433 3356777777777777777777665 6777777777777765443

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.97  E-value=3.7e-33  Score=293.55  Aligned_cols=328  Identities=23%  Similarity=0.336  Sum_probs=250.8

Q ss_pred             EEecCCCCCccCCCcccccCCCCCCEEECcCCCCC--CCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccC
Q 003504           32 DFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT--ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSN  109 (815)
Q Consensus        32 ~l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~--~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~  109 (815)
                      .|.+.+|++.. +.. .+..|+.|+.+++.+|++.  .||.++|.|..|+.||||+|+++ ..|..+.+.+++-+|+||+
T Consensus        59 HLs~~HN~L~~-vhG-ELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~  135 (1255)
T KOG0444|consen   59 HLSMAHNQLIS-VHG-ELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSY  135 (1255)
T ss_pred             hhhhhhhhhHh-hhh-hhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEccc
Confidence            34455555542 222 3556666677777777765  57777888888888888888877 6777777777888888888


Q ss_pred             CcCCCCChhhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCccc--C
Q 003504          110 NNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIK--G  187 (815)
Q Consensus       110 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~--~  187 (815)
                      |+|..+....|.+|+.|-.||||+|++. .+|+.+..|..|++|+|++|.+. .+--.-.-.+.+|+.|.+++.+=+  .
T Consensus       136 N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~-hfQLrQLPsmtsL~vLhms~TqRTl~N  213 (1255)
T KOG0444|consen  136 NNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN-HFQLRQLPSMTSLSVLHMSNTQRTLDN  213 (1255)
T ss_pred             CccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhh-HHHHhcCccchhhhhhhcccccchhhc
Confidence            8887666666777888888888888877 56777777778888888888764 221111123567777777777543  4


Q ss_pred             CCCCCCCCCCCCeEeccCCcCCCcchhhh-hcccceeeeccccccCcccccccccccCCccceEEEcCCCccCcchhhcc
Q 003504          188 RDTHFAGLKSITNLNISGNLFQGSVMGVF-LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNF  266 (815)
Q Consensus       188 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  266 (815)
                      +|+.+..|.+|..+|||.|.+..+|...+ +.+|+.|+||+|+|+..-.     ....|.+|++|+||.|+++ .+|..+
T Consensus       214 ~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~-----~~~~W~~lEtLNlSrNQLt-~LP~av  287 (1255)
T KOG0444|consen  214 IPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNM-----TEGEWENLETLNLSRNQLT-VLPDAV  287 (1255)
T ss_pred             CCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeec-----cHHHHhhhhhhccccchhc-cchHHH
Confidence            78889999999999999999999998888 9999999999999874321     2345789999999999999 789999


Q ss_pred             ccCCCCCEEEecCCcCc--CCCccccccccCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcCCCCCCcc-CCCCcc
Q 003504          267 SQAQNLKHLSLAYNRFT--RQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV-SAKNLG  343 (815)
Q Consensus       267 ~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~~L~  343 (815)
                      ..+++|+.|++.+|+++  ++| ..|+.+.+|+.+.+++|.+. .+|..+..+..|+.|.|++|+|-..+..+ .++.|+
T Consensus       288 cKL~kL~kLy~n~NkL~FeGiP-SGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~  365 (1255)
T KOG0444|consen  288 CKLTKLTKLYANNNKLTFEGIP-SGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLK  365 (1255)
T ss_pred             hhhHHHHHHHhccCcccccCCc-cchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcc
Confidence            99999999999999984  444 68999999999999999987 89999999999999999999998766665 678999


Q ss_pred             EEEccCCcCcccCChHHhhcCCCCceeecc
Q 003504          344 IIDMSHNNLSGEIPASLLEKLPQMERFNFS  373 (815)
Q Consensus       344 ~L~ls~N~l~~~~p~~~~~~l~~l~~l~l~  373 (815)
                      .|||..|.-- ..|+.--..-..+++.++.
T Consensus       366 vLDlreNpnL-VMPPKP~da~~~lefYNID  394 (1255)
T KOG0444|consen  366 VLDLRENPNL-VMPPKPNDARKKLEFYNID  394 (1255)
T ss_pred             eeeccCCcCc-cCCCCcchhhhcceeeecc
Confidence            9999999754 3443322222456665443

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=244.62  Aligned_cols=204  Identities=22%  Similarity=0.361  Sum_probs=168.5

Q ss_pred             cCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecC-CcccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG-STLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      ++......||+|++|.|-+-+ ..+|+..|||++... ..+.++...+|+++..+- ..|.+|.++|........++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            344446789999999998887 467999999998653 223455677888876554 79999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      .|.- ||..|.++.-                          ..+..+.....=+||..|.+||.|||+  ...++|||+|
T Consensus       126 ~M~t-Sldkfy~~v~--------------------------~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvK  176 (282)
T KOG0984|consen  126 LMDT-SLDKFYRKVL--------------------------KKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVK  176 (282)
T ss_pred             Hhhh-hHHHHHHHHH--------------------------hcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCC
Confidence            9987 8888875421                          124455666677899999999999996  6789999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCC--CCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS--DFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  740 (815)
                      |+|||++.+|++||+|||.+..+......+...|...|||||.+..+.  ..|+.|+||||+|+.+.||.+++.||..
T Consensus       177 PsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  177 PSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             cceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            999999999999999999999887665556677999999999887643  2379999999999999999999999975

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=3.6e-30  Score=293.53  Aligned_cols=279  Identities=18%  Similarity=0.203  Sum_probs=170.5

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcC-C----CcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeE------EE
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLP-G----GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGY------CI  574 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~  574 (815)
                      ..++|+..+.||+|+||.||+|+.. +    +..||||++.....  .+....|  .+....+.+++.+...      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4568999999999999999999964 4    68999998754221  1111111  1122222233322221      23


Q ss_pred             eCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCC
Q 003504          575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC  654 (815)
Q Consensus       575 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~  654 (815)
                      .....++||||+++|+|.++++......      ....+....   .... .............++.|++.||+|||   
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~------~v~~~l~~~---~~~l-~~~~~r~~~~i~~i~~qll~aL~yLH---  272 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPY------NVEPYLLGK---VQDL-PKGLERENKIIQTIMRQILFALDGLH---  272 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCch------hHHHHhccc---hhhc-cccchhhHHHHHHHHHHHHHHHHHHH---
Confidence            4568899999999999999997532110      000000000   0000 00111223445679999999999999   


Q ss_pred             CCCeeeccCCCCceEEcC-CCCeeecccccceecCCCC--ccccccccccccCCcccCCCCC------------------
Q 003504          655 SPPIIHRDIKASSVYLDM-NLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSD------------------  713 (815)
Q Consensus       655 ~~~ivHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~------------------  713 (815)
                      +++||||||||+|||++. ++.+||+|||+|+.+..+.  ......|++.|+|||.+.....                  
T Consensus       273 ~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~  352 (566)
T PLN03225        273 STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW  352 (566)
T ss_pred             HCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhc
Confidence            889999999999999995 5899999999998664332  2334568999999996532221                  


Q ss_pred             --CCCCcCcchhHHHHHHHHHhCCCCCCCCCCc------cccccHHHHHHHHHhcCCCCccccccccC--CCCHHHHHHH
Q 003504          714 --FPTPKSDVYCYGVVLLELITGKKPLGDDYPE------EKEGNLVSWVRGLVRNNKGSRAIDPKIRD--TGPEKQMEEA  783 (815)
Q Consensus       714 --~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  783 (815)
                        .+..++|||||||++|||+++..|++.....      ........|.......      ..+....  ........+.
T Consensus       353 ~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~  426 (566)
T PLN03225        353 QLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAG  426 (566)
T ss_pred             cccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHH
Confidence              1234679999999999999977665421000      0001111221110000      0000000  0001112345


Q ss_pred             HHHHhhccccCCCCCCCHHHHHHH
Q 003504          784 LKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       784 ~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      .+++.+|++.||++|||++|+++.
T Consensus       427 ~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        427 WELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HHHHHHHccCCcccCCCHHHHhCC
Confidence            689999999999999999999863

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=7.7e-31  Score=244.98  Aligned_cols=256  Identities=20%  Similarity=0.321  Sum_probs=200.7

Q ss_pred             hcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCC--eeEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-HPNLVPLTGYCIAGD--QRIAI  582 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lv  582 (815)
                      .++|++.+.+|+|.|++||.|. ..+..+++||++   .+...+.+.+|++||+.++ ||||+++++...++.  .+.+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiL---KPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKIL---KPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeee---chHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            5678889999999999999998 567889999999   4567889999999999997 999999999998754  56899


Q ss_pred             EEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      +||+.+.+...+...                                 ++.....-...+++.||.|+|   ++||+|||
T Consensus       114 FE~v~n~Dfk~ly~t---------------------------------l~d~dIryY~~elLkALdyCH---S~GImHRD  157 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYPT---------------------------------LTDYDIRYYIYELLKALDYCH---SMGIMHRD  157 (338)
T ss_pred             hhhhccccHHHHhhh---------------------------------hchhhHHHHHHHHHHHHhHHH---hcCccccc
Confidence            999999887666542                                 333445567889999999999   99999999


Q ss_pred             CCCCceEEcCC-CCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 003504          663 IKASSVYLDMN-LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       663 lk~~NIll~~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  741 (815)
                      +||.|++||.. -.++|+|+|+|.++.++......+.+..|..||.+..-.. ++-.-|+|||||++.+|+..+.||...
T Consensus       158 VKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~-YDYSLD~WS~GcmlA~miFrkepFFhG  236 (338)
T KOG0668|consen  158 VKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQM-YDYSLDMWSLGCMLASMIFRKEPFFHG  236 (338)
T ss_pred             CCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechh-ccccHHHHHHHHHHHHHHhccCcccCC
Confidence            99999999954 5699999999999998888888888999999999876554 577889999999999999999998742


Q ss_pred             CCccccccHHHHHHH--------HHhcCCCCccccccccC----------------CCCHHHHHHHHHHHhhccccCCCC
Q 003504          742 YPEEKEGNLVSWVRG--------LVRNNKGSRAIDPKIRD----------------TGPEKQMEEALKIGYLCTADLPLK  797 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~l~~~Cl~~dP~~  797 (815)
                        .....++++.++.        ++..  ..-.+||.+..                ....-..++..+++.+.+..|..+
T Consensus       237 --~dN~DQLVkIakVLGt~el~~Yl~K--Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqe  312 (338)
T KOG0668|consen  237 --HDNYDQLVKIAKVLGTDELYAYLNK--YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQE  312 (338)
T ss_pred             --CCCHHHHHHHHHHhChHHHHHHHHH--HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcccc
Confidence              2223344433321        1111  11113333221                111112478899999999999999


Q ss_pred             CCCHHHHHH
Q 003504          798 RPSMQQIVG  806 (815)
Q Consensus       798 RPs~~~v~~  806 (815)
                      |||++|+..
T Consensus       313 RlTakEam~  321 (338)
T KOG0668|consen  313 RLTAKEAMA  321 (338)
T ss_pred             ccchHHHhc
Confidence            999999864

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.6e-30  Score=272.66  Aligned_cols=213  Identities=25%  Similarity=0.351  Sum_probs=172.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHH---HHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQ---EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      .-|...+.||-|+||+|.++.. ++...+|+|.+++.+.....   ..+.|.+||+.-+.+.||+|+..|.+.+..|.||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            4577789999999999999985 44566899999876554433   4578999999999999999999999999999999


Q ss_pred             EeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl  663 (815)
                      ||+++|++-.+|....                              .+......-.+..++.|+++.|   ..|+|||||
T Consensus       709 dYIPGGDmMSLLIrmg------------------------------IFeE~LARFYIAEltcAiesVH---kmGFIHRDi  755 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG------------------------------IFEEDLARFYIAELTCAIESVH---KMGFIHRDI  755 (1034)
T ss_pred             eccCCccHHHHHHHhc------------------------------cCHHHHHHHHHHHHHHHHHHHH---hccceeccc
Confidence            9999999999997631                              1222222234456899999999   899999999


Q ss_pred             CCCceEEcCCCCeeecccccceecC---------CCC----------------------------------ccccccccc
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFG---------NGL----------------------------------DEEIARGSP  700 (815)
Q Consensus       664 k~~NIll~~~~~~kl~Dfgla~~~~---------~~~----------------------------------~~~~~~gt~  700 (815)
                      ||+|||||.||++||.|||++.-+.         .+.                                  .....+||+
T Consensus       756 KPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~  835 (1034)
T KOG0608|consen  756 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTP  835 (1034)
T ss_pred             CccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCC
Confidence            9999999999999999999986431         110                                  001123999


Q ss_pred             cccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHH
Q 003504          701 GYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVR  755 (815)
Q Consensus       701 ~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~  755 (815)
                      .|+|||++....  ++.-+|+||.|||||||+.|+.||....+.+....+..|-.
T Consensus       836 nyiapevl~r~g--~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~  888 (1034)
T KOG0608|consen  836 NYIAPEVLARTG--YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN  888 (1034)
T ss_pred             cccChHHhcccC--ccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh
Confidence            999999998766  78899999999999999999999999888777666666643

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=284.63  Aligned_cols=241  Identities=27%  Similarity=0.379  Sum_probs=182.0

Q ss_pred             CCCeecccCCe-eeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          512 RGTLLAEGKFG-PVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       512 ~~~~ig~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      -.+++|.|+.| .||+|... |+.||||++-.   ....-..+|+..++.- +|||||++++.-.+....|+..|.|.. 
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-  587 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-  587 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence            34678999987 68999986 78999999843   3344567999999887 599999998877778889999999987 


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      +|.+++...  +. +.+                   ....    ..-..+..|++.||++||   +-+||||||||.|||
T Consensus       588 sL~dlie~~--~~-d~~-------------------~~~~----i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNIL  638 (903)
T KOG1027|consen  588 SLQDLIESS--GL-DVE-------------------MQSD----IDPISVLSQIASGLAHLH---SLKIVHRDLKPQNIL  638 (903)
T ss_pred             hHHHHHhcc--cc-chh-------------------hccc----ccHHHHHHHHHHHHHHHH---hcccccccCCCceEE
Confidence            999999752  00 000                   0000    223568889999999999   899999999999999


Q ss_pred             EcC---C--CCeeecccccceecCCCCc----cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh-CCCCCC
Q 003504          670 LDM---N--LEPRLSDFGLAKIFGNGLD----EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLG  739 (815)
Q Consensus       670 l~~---~--~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~  739 (815)
                      |+.   +  ..++|+|||+++.+..+..    .....||-||+|||.+....  -+.++||||+|||+|+.++ |..||+
T Consensus       639 I~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~--~~~avDiFslGCvfyYvltgG~HpFG  716 (903)
T KOG1027|consen  639 ISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR--KTQAVDIFSLGCVFYYVLTGGSHPFG  716 (903)
T ss_pred             EEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccc--cCcccchhhcCceEEEEecCCccCCC
Confidence            986   3  4699999999999876542    23456999999999998776  4668999999999999999 599998


Q ss_pred             CCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                      +....+  .++..       .+.     +-. ......++  +..+++.++++++|..||++.+|+
T Consensus       717 d~~~R~--~NIl~-------~~~-----~L~-~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  717 DSLERQ--ANILT-------GNY-----TLV-HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             chHHhh--hhhhc-------Ccc-----cee-eeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            643221  12221       110     000 00111222  788999999999999999999996

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-31  Score=274.15  Aligned_cols=241  Identities=22%  Similarity=0.260  Sum_probs=197.4

Q ss_pred             CCCCCCeecccCCeeeEEEEcCCCc-EEEEEEeecCCccc---HHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLPGGI-HVAVKVLVHGSTLT---DQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      ++.....+|-|+||.|=.+..+... .+|+|.+++....+   ++.+..|-.||...+.|.||++|-.+.+....|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            4455678999999999999865443 48999887654333   3456789999999999999999999999999999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      -|-+|.|...|+++.                              .++-....-++..+.+|++|||   +.+||.||||
T Consensus       501 aClGGElWTiLrdRg------------------------------~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLK  547 (732)
T KOG0614|consen  501 ACLGGELWTILRDRG------------------------------SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLK  547 (732)
T ss_pred             hhcCchhhhhhhhcC------------------------------CcccchhhhhHHHHHHHHHHHH---hcCceeccCC
Confidence            999999999998641                              2222333446777999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCc
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~  744 (815)
                      |+|.++|.+|-+||.|||+|+..+.+....+.+||+.|.|||++....  -+..+|.||+|+++|||++|.+||.+.++-
T Consensus       548 PENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKG--HD~avDyWaLGIli~ELL~G~pPFs~~dpm  625 (732)
T KOG0614|consen  548 PENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG--HDRAVDYWALGILIYELLTGSPPFSGVDPM  625 (732)
T ss_pred             hhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccC--cchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence            999999999999999999999999998889999999999999998776  478899999999999999999999986654


Q ss_pred             cccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCC
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS  800 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs  800 (815)
                      ..+..+.+-+..+                ..|........+++++..+.+|.+|.-
T Consensus       626 ktYn~ILkGid~i----------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  626 KTYNLILKGIDKI----------------EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             HHHHHHHhhhhhh----------------hcccccchhHHHHHHHHHhcCcHhhhc
Confidence            4443333222111                225556677889999999999999974

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=247.13  Aligned_cols=248  Identities=22%  Similarity=0.292  Sum_probs=191.8

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHH---HHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQ---EAARELEYLGRI-KHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~---~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  581 (815)
                      .++|...++||+|+|+.|-.+.+ ++.+.+|+|++++....+.+   -...|-.+..+. +||.+|-+..|+......+.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            46899999999999999999995 56778999998764332222   234455555555 69999999999999999999


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      |.||+++|+|--+++..+                              .++.....-....|.-||.|||   +++||.|
T Consensus       329 vieyv~ggdlmfhmqrqr------------------------------klpeeharfys~ei~lal~flh---~rgiiyr  375 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR------------------------------KLPEEHARFYSAEICLALNFLH---ERGIIYR  375 (593)
T ss_pred             EEEEecCcceeeehhhhh------------------------------cCcHHHhhhhhHHHHHHHHHHh---hcCeeee
Confidence            999999999987776532                              2334444445667888999999   8999999


Q ss_pred             cCCCCceEEcCCCCeeeccccccee-cCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  740 (815)
                      |||.+|||+|..|.+|+.|||.++. ..++....+.+||+.|+|||++.+..  |+...|+|++||+|+||+.|+.||+.
T Consensus       376 dlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgee--ygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  376 DLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             eccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccc--cCceehHHHHHHHHHHHHcCCCCcce
Confidence            9999999999999999999999985 44666778899999999999999988  78899999999999999999999986


Q ss_pred             CCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP  799 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  799 (815)
                      -.......+..+++-+.+-+.        .++.  |...+.....+.+.-+.+||.+|.
T Consensus       454 vgm~n~d~ntedylfqvilek--------qiri--prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  454 VGMDNPDMNTEDYLFQVILEK--------QIRI--PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ecCCCcccchhHHHHHHHhhh--------cccc--cceeehhhHHHHHHhhcCCcHHhc
Confidence            433333334444444333221        1111  333344566788889999999986

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-30  Score=258.55  Aligned_cols=263  Identities=19%  Similarity=0.241  Sum_probs=196.3

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC-C-C----CceeeeeEEEeCCee
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-H-P----NLVPLTGYCIAGDQR  579 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~g~~~~~~~~  579 (815)
                      +.+|.+...+|+|.||.|-++.. ..+..||||+++. -....+...-|+++++++. + |    -+|.+.+++.-.+..
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            56899999999999999999984 4478999999864 1222344567999999993 2 3    378888889889999


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++|+|.+.- |+.+||..+                            ...+........|+.|+.++++|||   +.+++
T Consensus       167 CivfellG~-S~~dFlk~N----------------------------~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~  214 (415)
T KOG0671|consen  167 CIVFELLGL-STFDFLKEN----------------------------NYIPFPIDHIRHMGYQLLESVAFLH---DLKLT  214 (415)
T ss_pred             EEEEeccCh-hHHHHhccC----------------------------CccccchHHHHHHHHHHHHHHHHHH---hccee
Confidence            999998743 999999863                            3567788889999999999999999   89999


Q ss_pred             eccCCCCceEEcCC--------------------CCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcC
Q 003504          660 HRDIKASSVYLDMN--------------------LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS  719 (815)
Q Consensus       660 HrDlk~~NIll~~~--------------------~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  719 (815)
                      |-||||+|||+...                    ..+||+|||.|+.....  ....+.|..|.|||++.+-.  .+..+
T Consensus       215 HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLG--wS~pC  290 (415)
T KOG0671|consen  215 HTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLG--WSQPC  290 (415)
T ss_pred             ecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccC--cCCcc
Confidence            99999999998431                    34899999999875433  24556899999999999887  89999


Q ss_pred             cchhHHHHHHHHHhCCCCCCCCCCcccc-------ccHHHHH------HHHHhcC---CC--------Ccccccccc---
Q 003504          720 DVYCYGVVLLELITGKKPLGDDYPEEKE-------GNLVSWV------RGLVRNN---KG--------SRAIDPKIR---  772 (815)
Q Consensus       720 Dv~S~Gvvl~el~tg~~p~~~~~~~~~~-------~~~~~~~------~~~~~~~---~~--------~~~~~~~~~---  772 (815)
                      ||||+||||.|+++|..-|......|.-       +.+...+      .++...+   +.        ..+.++...   
T Consensus       291 DvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~  370 (415)
T KOG0671|consen  291 DVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKK  370 (415)
T ss_pred             CceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHH
Confidence            9999999999999999998864432211       1111111      0111111   00        001111100   


Q ss_pred             -CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          773 -DTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       773 -~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                       .........++++|+.+++..||.+|+|+.|++.
T Consensus       371 ~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  371 YMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence             1123455677999999999999999999999975

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.95  E-value=4.3e-31  Score=265.69  Aligned_cols=332  Identities=27%  Similarity=0.421  Sum_probs=198.7

Q ss_pred             EecCCCCCccCCCcccccCCCCCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcC
Q 003504           33 FLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNF  112 (815)
Q Consensus        33 l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l  112 (815)
                      ++..+|+++ ++|+ .+..+.+|..|++.+|+++++|++.-+++.|++||..+|-++ .+|..++.+.+|+.|||.+|+|
T Consensus       142 l~~~~N~i~-slp~-~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki  218 (565)
T KOG0472|consen  142 LDATNNQIS-SLPE-DMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKI  218 (565)
T ss_pred             hhccccccc-cCch-HHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhccc
Confidence            344444444 2332 344444555555555555555544444555555555555444 4444555555555555555555


Q ss_pred             CCCChhhhcCCcCCCEEEcCCCcccccCCcc-cccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccCCCCC
Q 003504          113 SGEIPAAISSLVSLRVLKLDGNMFQWSIPPG-LLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH  191 (815)
Q Consensus       113 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~  191 (815)
                      . .+| .|.++..|.+|+++.|+|. .+|.. ..++++|..|||.+|+++ +.|+++. -+.+|++|+|++|.|+.+|..
T Consensus       219 ~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c-lLrsL~rLDlSNN~is~Lp~s  293 (565)
T KOG0472|consen  219 R-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC-LLRSLERLDLSNNDISSLPYS  293 (565)
T ss_pred             c-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHH-HhhhhhhhcccCCccccCCcc
Confidence            4 333 4555555555555555554 23322 224555555555555554 5555543 244455555555555555555


Q ss_pred             CCCCCCCCeEeccCCcCCCcchhhh-------------------------------------------hcccceeeeccc
Q 003504          192 FAGLKSITNLNISGNLFQGSVMGVF-------------------------------------------LESLEVIDLRSN  228 (815)
Q Consensus       192 ~~~l~~L~~L~Ls~N~l~~~~~~~~-------------------------------------------l~~L~~L~L~~N  228 (815)
                      ++++ .|+.|-+.+|.+.++-....                                           ..+.+.|+++.-
T Consensus       294 Lgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~  372 (565)
T KOG0472|consen  294 LGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDK  372 (565)
T ss_pred             cccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccc
Confidence            5555 55555555554432211100                                           011233333333


Q ss_pred             cccCcccccccccccCCccceEEEcCCCccC-----------------------cchhhccccCCCCCEEEecCCcCcCC
Q 003504          229 QFQGHISQVQFNSSYNWSRLVYVDLSENQLS-----------------------GEIFHNFSQAQNLKHLSLAYNRFTRQ  285 (815)
Q Consensus       229 ~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-----------------------~~~~~~~~~l~~L~~L~L~~N~l~~~  285 (815)
                      +++..+.++. .+. .-.-++.++++.|++.                       +.+|..+.++++|..|+|++|.+..+
T Consensus       373 qlt~VPdEVf-ea~-~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~L  450 (565)
T KOG0472|consen  373 QLTLVPDEVF-EAA-KSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLNDL  450 (565)
T ss_pred             ccccCCHHHH-HHh-hhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhhc
Confidence            3333222211 000 0011455555555543                       25566778899999999999999888


Q ss_pred             CccccccccCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcCCCCCCcc--CCCCccEEEccCCcCcccCChHHhhc
Q 003504          286 EFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEK  363 (815)
Q Consensus       286 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~--~~~~L~~L~ls~N~l~~~~p~~~~~~  363 (815)
                      | ..++.+..|+.|++|.|++. .+|..+..+..|+++-.++|++....|..  .+.+|.+|||.+|.|. .||+ .+++
T Consensus       451 P-~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp-~Lgn  526 (565)
T KOG0472|consen  451 P-EEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPP-ILGN  526 (565)
T ss_pred             c-hhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCCh-hhcc
Confidence            7 67888888999999999987 78999999999999999999999877763  7789999999999998 7885 5799


Q ss_pred             CCCCceeeccCCCCcc
Q 003504          364 LPQMERFNFSYNNLTL  379 (815)
Q Consensus       364 l~~l~~l~l~~N~l~~  379 (815)
                      +.+|+.|.+.||++..
T Consensus       527 mtnL~hLeL~gNpfr~  542 (565)
T KOG0472|consen  527 MTNLRHLELDGNPFRQ  542 (565)
T ss_pred             ccceeEEEecCCccCC
Confidence            9999999999999983

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-29  Score=241.98  Aligned_cols=265  Identities=20%  Similarity=0.269  Sum_probs=191.3

Q ss_pred             CCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC-----eeE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD-----QRI  580 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  580 (815)
                      +.+..+.||-|+||.||.++. ++|+.||.|++..-  .-...+.+-+|++++..++|.|++..++......     +.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            344468999999999999984 68999999988542  2234567889999999999999999998776543     567


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +++|.|.. +|...+-.                              ...++-....-+..||.+||.|||   +.+|.|
T Consensus       134 V~TELmQS-DLHKIIVS------------------------------PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILH  179 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVS------------------------------PQALTPDHVKVFVYQILRGLKYLH---TANILH  179 (449)
T ss_pred             HHHHHHHh-hhhheecc------------------------------CCCCCcchhhhhHHHHHhhhHHHh---hcchhh
Confidence            78888876 77666642                              233444455668899999999999   899999


Q ss_pred             ccCCCCceEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCC
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       661 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~  738 (815)
                      |||||-|.|++.+..+||+|||+++....+.  ..+..+-|..|.|||++++... |+.+.||||.||++.|++.++--|
T Consensus       180 RDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRh-Ys~AvDiWSVGCIFaELLgRrILF  258 (449)
T KOG0664|consen  180 RDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARR-YTGAVDIWSVGCIFAELLQRKILF  258 (449)
T ss_pred             ccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchh-hcCccceehhhHHHHHHHhhhhhh
Confidence            9999999999999999999999999876543  2334457889999999998876 788999999999999999998888


Q ss_pred             CCCCCccccccHHHHH-------HHHHhcCCCCcccccccc---------CCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 003504          739 GDDYPEEKEGNLVSWV-------RGLVRNNKGSRAIDPKIR---------DTGPEKQMEEALKIGYLCTADLPLKRPSMQ  802 (815)
Q Consensus       739 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  802 (815)
                      ....+-+..+-+.+..       .+...+.....++....+         ...+...-.+...+....+..||++|.+.+
T Consensus       259 QAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~  338 (449)
T KOG0664|consen  259 QAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVE  338 (449)
T ss_pred             hccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHh
Confidence            7544433222222211       011111111111111111         111223334556777788999999999988


Q ss_pred             HHHHHH
Q 003504          803 QIVGLL  808 (815)
Q Consensus       803 ~v~~~L  808 (815)
                      +.+..+
T Consensus       339 ~A~~~~  344 (449)
T KOG0664|consen  339 EALQHR  344 (449)
T ss_pred             hhcccc
Confidence            876543

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-30  Score=284.61  Aligned_cols=342  Identities=30%  Similarity=0.354  Sum_probs=256.0

Q ss_pred             CeEEEEecCCCCCccCCCcccccCCCCCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEc
Q 003504           28 QHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDL  107 (815)
Q Consensus        28 ~~~~~l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  107 (815)
                      .++..+++++|.++ .+|. .+..+.+|+.|+++.|-|..+|.++..+.+|++|+|.+|.+. ..|..+..+++|++||+
T Consensus        45 v~L~~l~lsnn~~~-~fp~-~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~Ldl  121 (1081)
T KOG0618|consen   45 VKLKSLDLSNNQIS-SFPI-QITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDL  121 (1081)
T ss_pred             eeeEEeeccccccc-cCCc-hhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhh-cCchhHHhhhccccccc
Confidence            35788899998876 5665 578888899999999999988888888888999999988887 78888888888888888


Q ss_pred             cCCcCCCCChhhhcCCc----------------------------------------CCCE-EEcCCCcccccC------
Q 003504          108 SNNNFSGEIPAAISSLV----------------------------------------SLRV-LKLDGNMFQWSI------  140 (815)
Q Consensus       108 s~N~l~~~~p~~~~~l~----------------------------------------~L~~-L~L~~N~l~~~~------  140 (815)
                      |.|++... |..+..++                                        +|++ |+|+.|.+....      
T Consensus       122 S~N~f~~~-Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dls~~~~  200 (1081)
T KOG0618|consen  122 SFNHFGPI-PLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDLSNLAN  200 (1081)
T ss_pred             chhccCCC-chhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhhhhhhhccc
Confidence            88887632 22111111                                        1111 444444433100      


Q ss_pred             -----------------------------C----cccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccC
Q 003504          141 -----------------------------P----PGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG  187 (815)
Q Consensus       141 -----------------------------~----~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~  187 (815)
                                                   |    ..-..-.+|+++++++|+++ .+| ++...+.+|+.|...+|+|+.
T Consensus       201 l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~-~lp-~wi~~~~nle~l~~n~N~l~~  278 (1081)
T KOG0618|consen  201 LEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLS-NLP-EWIGACANLEALNANHNRLVA  278 (1081)
T ss_pred             hhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhh-cch-HHHHhcccceEecccchhHHh
Confidence                                         0    00011245778888888887 788 444568899999999988877


Q ss_pred             CCCCCCCCCCCCeEeccCCcCCCcchhhh-hcccceeeeccccccCcccc---------------------cccccccCC
Q 003504          188 RDTHFAGLKSITNLNISGNLFQGSVMGVF-LESLEVIDLRSNQFQGHISQ---------------------VQFNSSYNW  245 (815)
Q Consensus       188 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-l~~L~~L~L~~N~l~~~~~~---------------------~~~~~~~~l  245 (815)
                      ++..+..+++|+.|.+.+|.++.+++..- +++|+.|+|..|+|...+..                     .+...-..+
T Consensus       279 lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~  358 (1081)
T KOG0618|consen  279 LPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNH  358 (1081)
T ss_pred             hHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhh
Confidence            77777777777777777777776666544 66777777777766533221                     001111235


Q ss_pred             ccceEEEcCCCccCcchhhccccCCCCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcCCCchhhhcCCCCCEEeC
Q 003504          246 SRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDL  325 (815)
Q Consensus       246 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  325 (815)
                      +.|+.|++.+|.+++.....+.++.+|+.|+|++|++..++...+.++..|++|+||+|+|+ .+|.++..++.|++|..
T Consensus       359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a  437 (1081)
T KOG0618|consen  359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA  437 (1081)
T ss_pred             HHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence            67999999999999999999999999999999999999999889999999999999999998 78899999999999999


Q ss_pred             CCCcCCCCCCccCCCCccEEEccCCcCcccCChHHhhcCCCCceeeccCCCC
Q 003504          326 SMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNL  377 (815)
Q Consensus       326 s~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~l~~l~~l~l~~N~l  377 (815)
                      .+|+|...+....+++|+.+|+|.|+|+- +-.......++|+.||++||.-
T Consensus       438 hsN~l~~fPe~~~l~qL~~lDlS~N~L~~-~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  438 HSNQLLSFPELAQLPQLKVLDLSCNNLSE-VTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             cCCceeechhhhhcCcceEEecccchhhh-hhhhhhCCCcccceeeccCCcc
Confidence            99999976644588999999999999973 2211222348999999999973

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=9.5e-27  Score=233.95  Aligned_cols=210  Identities=33%  Similarity=0.486  Sum_probs=180.6

Q ss_pred             ecccCCeeeEEEEcCC-CcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCChhh
Q 003504          516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQN  593 (815)
Q Consensus       516 ig~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~  593 (815)
                      ||+|.+|.||++...+ +..+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 889999998764332 34679999999999999999999999999899999999999999999


Q ss_pred             hhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcC-
Q 003504          594 LLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM-  672 (815)
Q Consensus       594 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-  672 (815)
                      ++...                             ...+++..+..++.+++++++|||   +.+++|+||+|.||+++. 
T Consensus        81 ~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~  128 (215)
T cd00180          81 LLKEN-----------------------------EGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSD  128 (215)
T ss_pred             HHHhc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCC
Confidence            98642                             135788899999999999999999   789999999999999999 


Q ss_pred             CCCeeecccccceecCCCC-ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHH
Q 003504          673 NLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV  751 (815)
Q Consensus       673 ~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~  751 (815)
                      ++.++|+|||.+....... ......+...|++||..... ...+.++|+|++|++++++                    
T Consensus       129 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l--------------------  187 (215)
T cd00180         129 NGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL--------------------  187 (215)
T ss_pred             CCcEEEecCCceEEccCCcchhhcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH--------------------
Confidence            8999999999998765432 12334578899999988765 1268899999999999999                    


Q ss_pred             HHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          752 SWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                                                   .++.+++..|+..+|++||++.++++.
T Consensus       188 -----------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -----------------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -----------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                                         457899999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=8.7e-28  Score=252.09  Aligned_cols=198  Identities=22%  Similarity=0.297  Sum_probs=168.7

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccH--------HHHHHHHHHhcCCC---CCCceeeeeEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTD--------QEAARELEYLGRIK---HPNLVPLTGYCI  574 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~--------~~~~~E~~~l~~l~---H~niv~l~g~~~  574 (815)
                      -.+|...+.+|.|+||.|+.|..+ ....|+||.+.+......        ..+-.||.||+.++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            356888999999999999999964 466799999876533221        13457999999997   999999999999


Q ss_pred             eCCeeEEEEEeCC-CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcC
Q 003504          575 AGDQRIAIYDYME-NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHG  653 (815)
Q Consensus       575 ~~~~~~lv~ey~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~  653 (815)
                      +++.++++||-.- +-+|.+++...                              ..++.....-|+.||+.|+++||  
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~k------------------------------p~m~E~eAk~IFkQV~agi~hlh--  687 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFK------------------------------PRMDEPEAKLIFKQVVAGIKHLH--  687 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhcc------------------------------CccchHHHHHHHHHHHhcccccc--
Confidence            9999999999764 44999999652                              34667778889999999999999  


Q ss_pred             CCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh
Q 003504          654 CSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       654 ~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                       +++|||||||-+||.++.+|-+||+|||.|-....+ .....+||.+|.|||++.+..+ -+..-|||++|+++|.++.
T Consensus       688 -~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y-~gk~qdiwalgillytivy  764 (772)
T KOG1152|consen  688 -DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKY-LGKPQDIWALGILLYTIVY  764 (772)
T ss_pred             -ccCceecccccccEEEecCCeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCcc-CCCcchhhhhhheeeEEEe
Confidence             899999999999999999999999999998776554 4566789999999999988874 5777899999999999999


Q ss_pred             CCCCCC
Q 003504          734 GKKPLG  739 (815)
Q Consensus       734 g~~p~~  739 (815)
                      ...||.
T Consensus       765 kenpyy  770 (772)
T KOG1152|consen  765 KENPYY  770 (772)
T ss_pred             ccCCCc
Confidence            999985

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=4.8e-28  Score=258.23  Aligned_cols=254  Identities=23%  Similarity=0.302  Sum_probs=204.8

Q ss_pred             hcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      .++|+...++|.|.||.||||+ ...+...|||+++-.......-...|+-+++..+|||||.++|.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            4678899999999999999999 567889999999877677777788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      |.+|+|.+..|.                              ..+++..+...+++...+||+|||   +++=+|||||-
T Consensus        94 cgggslQdiy~~------------------------------TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKG  140 (829)
T KOG0576|consen   94 CGGGSLQDIYHV------------------------------TGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKG  140 (829)
T ss_pred             cCCCcccceeee------------------------------cccchhHHHHHHHhhhhccchhhh---cCCcccccccc
Confidence            999999998774                              346777777788899999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCCCC-ccccccccccccCCcccCCC-CCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPD-SDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  743 (815)
                      .||++++.|.+|++|||.+-.+.... ....+.||+.|||||+..-+ .+.|..++|||+.|+...|+-.-++|..+.-+
T Consensus       141 anilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp  220 (829)
T KOG0576|consen  141 ANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP  220 (829)
T ss_pred             cceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch
Confidence            99999999999999999987766443 34566799999999986532 33478999999999999999888887543211


Q ss_pred             ccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      -.        +-.++.    ...++|.-..+ .....+.+.++++-|+.++|++||+++.++.
T Consensus       221 mr--------~l~LmT----kS~~qpp~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  221 MR--------ALFLMT----KSGFQPPTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HH--------HHHHhh----ccCCCCCcccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            10        001111    11222222222 4456778899999999999999999987754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=2.2e-26  Score=234.26  Aligned_cols=198  Identities=33%  Similarity=0.492  Sum_probs=169.8

Q ss_pred             CCCCCeecccCCeeeEEEEcCC-CcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          510 FDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      |...+.||.|++|.||+|...+ +..+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999999765 889999999765444 56788999999999999999999999999899999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +++|.+++...                             ...+++.....++.+++.++.|||   ..+++|+|++|+|
T Consensus        81 ~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~n  128 (225)
T smart00221       81 GGDLFDYLRKK-----------------------------GGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPEN  128 (225)
T ss_pred             CCCHHHHHHhc-----------------------------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHH
Confidence            99999999752                             111678889999999999999999   7899999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCC--ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  740 (815)
                      |+++.++.++|+|||.+.......  ......++..|++||... ....++.++|||+||++++|+++|+.||..
T Consensus       129 i~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      129 ILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             EEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            999999999999999998776442  223445788999999884 222367799999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=5.2e-27  Score=230.76  Aligned_cols=259  Identities=21%  Similarity=0.210  Sum_probs=191.0

Q ss_pred             CCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCC------ee
Q 003504          509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGD------QR  579 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~  579 (815)
                      +|.-.+.+|.|.- .|.-|. .-.+++||+|.+...  .....+...+|...+..+.|+||++++.++....      +.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4555677777776 444443 234788999987543  2344566789999999999999999999887543      56


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      |+|||||.. +|...++.                                .++-.....|..|+..|+.|||   +.+|+
T Consensus        97 y~v~e~m~~-nl~~vi~~--------------------------------elDH~tis~i~yq~~~~ik~lh---s~~Ii  140 (369)
T KOG0665|consen   97 YLVMELMDA-NLCQVILM--------------------------------ELDHETISYILYQMLCGIKHLH---SAGII  140 (369)
T ss_pred             HHHHHhhhh-HHHHHHHH--------------------------------hcchHHHHHHHHHHHHHHHHHH---hccee
Confidence            899999976 88888863                                3566777889999999999999   89999


Q ss_pred             eccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~  739 (815)
                      ||||||+||++..+..+||.|||+|+........+..+.|..|.|||++.+..  +.+.+||||.||++.||++|+--|.
T Consensus       141 hRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~--~ke~vdiwSvGci~gEli~~~Vlf~  218 (369)
T KOG0665|consen  141 HRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELILGTVLFP  218 (369)
T ss_pred             ecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccC--CcccchhhhhhhHHHHHhhceEEec
Confidence            99999999999999999999999999877665666778999999999998887  7899999999999999999998876


Q ss_pred             CCCCcccc---------------ccHHHHHHHHHhcCCC------Ccccc-ccccC--CCCHHHHHHHHHHHhhccccCC
Q 003504          740 DDYPEEKE---------------GNLVSWVRGLVRNNKG------SRAID-PKIRD--TGPEKQMEEALKIGYLCTADLP  795 (815)
Q Consensus       740 ~~~~~~~~---------------~~~~~~~~~~~~~~~~------~~~~~-~~~~~--~~~~~~~~~~~~l~~~Cl~~dP  795 (815)
                      +...-+..               .++..-++.+++....      .+.+. ..+..  +.+.-......+++.+++..+|
T Consensus       219 g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~p  298 (369)
T KOG0665|consen  219 GKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDP  298 (369)
T ss_pred             CchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccCh
Confidence            53211111               1111112222221100      11111 11111  1122234567899999999999


Q ss_pred             CCCCCHHHHHH
Q 003504          796 LKRPSMQQIVG  806 (815)
Q Consensus       796 ~~RPs~~~v~~  806 (815)
                      ++|.++++++.
T Consensus       299 e~Risv~daL~  309 (369)
T KOG0665|consen  299 EKRISVDDALR  309 (369)
T ss_pred             hhcccHHHHhc
Confidence            99999999875

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-28  Score=248.27  Aligned_cols=293  Identities=25%  Similarity=0.267  Sum_probs=234.4

Q ss_pred             EEEecCCCCCccCCCcccccCCCCCCEEECcCCCCCCCCcccCC-CCCCCEEEccCCcCCccCCccccCCCCCcEE-Ecc
Q 003504           31 TDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWS-LGSLKSLNLSYNRISGSLPSNIGNFGLLEVF-DLS  108 (815)
Q Consensus        31 ~~l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~~lp~~~~~-l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L-~Ls  108 (815)
                      ..++.++.+++ .||..   --+....|+|..|+|+.||+..|+ +++|++|||++|+|+.+.|++|.++++|..| +++
T Consensus        49 ~~VdCr~~GL~-eVP~~---LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg  124 (498)
T KOG4237|consen   49 GIVDCRGKGLT-EVPAN---LPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYG  124 (498)
T ss_pred             ceEEccCCCcc-cCccc---CCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhc
Confidence            34456666665 44432   123568899999999999999886 9999999999999999999999999998777 455


Q ss_pred             CCcCCCCChhhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccC-
Q 003504          109 NNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-  187 (815)
Q Consensus       109 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~-  187 (815)
                      +|+|+.+..++|.+|..|+.|.|.-|++.-...+.|..+++|..|.+.+|.+. .++...+..+..++.+.+..|.+-. 
T Consensus       125 ~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icd  203 (498)
T KOG4237|consen  125 NNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICD  203 (498)
T ss_pred             CCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccc
Confidence            59999998999999999999999999999888899999999999999999998 8998888889999999999998321 


Q ss_pred             ------------CCCCCCCCCCCCeEeccCCcCCCcchhhhhccccee--eeccccccCcccccccccccCCccceEEEc
Q 003504          188 ------------RDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVI--DLRSNQFQGHISQVQFNSSYNWSRLVYVDL  253 (815)
Q Consensus       188 ------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L--~L~~N~l~~~~~~~~~~~~~~l~~L~~L~L  253 (815)
                                  .+..+++..-..-..|.++++..+....|..+++.+  .++.+..-  ....+...|..+++|++|+|
T Consensus       204 CnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~--d~~cP~~cf~~L~~L~~lnl  281 (498)
T KOG4237|consen  204 CNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFP--DSICPAKCFKKLPNLRKLNL  281 (498)
T ss_pred             cccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCc--CCcChHHHHhhcccceEecc
Confidence                        234566666666677777788777777775555444  23322211  12234445778888888888


Q ss_pred             CCCccCcchhhccccCCCCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcC
Q 003504          254 SENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHL  330 (815)
Q Consensus       254 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  330 (815)
                      ++|+|+.+-+.+|.+...+++|.|..|+|..+....|.++.+|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|.+
T Consensus       282 snN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~  358 (498)
T KOG4237|consen  282 SNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF  358 (498)
T ss_pred             CCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence            88888888888888888888888888888777777888888888888888888888888888888888888887776

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.9e-26  Score=218.94  Aligned_cols=251  Identities=20%  Similarity=0.287  Sum_probs=183.8

Q ss_pred             CCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeE-EEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGY-CIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lv~ey  585 (815)
                      .|.+.+.+|+|.||.+-.+.++ ..+.+|+|.+.. ......+|.+|...--.| .|.||+.-++. ++..+.+..++||
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            5778899999999999999975 567899998765 456678999998876666 48999988765 4556778899999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +|.|+|.+-+...                               .+-.....+++.|++.|+.|||   +..+||||||.
T Consensus       104 aP~gdL~snv~~~-------------------------------GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~  149 (378)
T KOG1345|consen  104 APRGDLRSNVEAA-------------------------------GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKA  149 (378)
T ss_pred             CccchhhhhcCcc-------------------------------cccHHHHHHHHHHHHHHHHHhh---ccchhhccccc
Confidence            9999999887542                               2445567889999999999999   89999999999


Q ss_pred             CceEEc--CCCCeeecccccceecCCCCccccccccccccCCcccCCC---CCCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 003504          666 SSVYLD--MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPD---SDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       666 ~NIll~--~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  740 (815)
                      +||||-  +...+|++|||.++..+....  ...-+..|.|||.....   .....+.+|||.||++++.++||+.||.-
T Consensus       150 eNiLif~~df~rvKlcDFG~t~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk  227 (378)
T KOG1345|consen  150 ENILIFDADFYRVKLCDFGLTRKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK  227 (378)
T ss_pred             ceEEEecCCccEEEeeecccccccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence            999984  345799999999987654321  12235679999975432   22357789999999999999999999984


Q ss_pred             CCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      +.  -.......|.+-.-+.+.   .++..     .....+.++.+.++-+.++|++|=...++.+
T Consensus       228 a~--~~d~~Y~~~~~w~~rk~~---~~P~~-----F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  228 AS--IMDKPYWEWEQWLKRKNP---ALPKK-----FNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             hh--ccCchHHHHHHHhcccCc---cCchh-----hcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            22  223344455442222211   11111     1223456778888999999999944444433

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.93  E-value=4.8e-25  Score=252.72  Aligned_cols=260  Identities=22%  Similarity=0.230  Sum_probs=161.0

Q ss_pred             CCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCC
Q 003504           54 KLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG  133 (815)
Q Consensus        54 ~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  133 (815)
                      .-..|+|++|+|+++|..+.  ++|+.|+|++|+|+. +|.   .+++|++|+|++|+|+.+ |..   .++|+.|+|++
T Consensus       202 ~~~~LdLs~~~LtsLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls~  271 (788)
T PRK15387        202 GNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSL-PVL---PPGLLELSIFS  271 (788)
T ss_pred             CCcEEEcCCCCCCcCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcc-cCc---ccccceeeccC
Confidence            35678888888888887665  478888888888884 554   246788888888888844 432   45788888888


Q ss_pred             CcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccCCCCCCCCCCCCCeEeccCCcCCCcch
Q 003504          134 NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVM  213 (815)
Q Consensus       134 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  213 (815)
                      |.|+ .+|..+   ++|+.|+|++|+|+ .+|..    +++|+.|+|++|+|+.++...   .+|+.|++++|.|+.+|.
T Consensus       272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~----p~~L~~LdLS~N~L~~Lp~lp---~~L~~L~Ls~N~L~~LP~  339 (788)
T PRK15387        272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL----PPGLQELSVSDNQLASLPALP---SELCKLWAYNNQLTSLPT  339 (788)
T ss_pred             Cchh-hhhhch---hhcCEEECcCCccc-ccccc----ccccceeECCCCccccCCCCc---ccccccccccCccccccc
Confidence            8887 355433   56778888888887 66652    467888888888887765422   356677778887777664


Q ss_pred             hhhhcccceeeeccccccCcccccccccccCCccceEEEcCCCccCcchhhccccCCCCCEEEecCCcCcCCCccccccc
Q 003504          214 GVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTL  293 (815)
Q Consensus       214 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  293 (815)
                        +..+|+.|+|++|+|++.+. .       ..+|+.|++++|.|.. +|..   ..+|+.|+|++|+|+.++.    ..
T Consensus       340 --lp~~Lq~LdLS~N~Ls~LP~-l-------p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~LP~----l~  401 (788)
T PRK15387        340 --LPSGLQELSVSDNQLASLPT-L-------PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLPV----LP  401 (788)
T ss_pred             --cccccceEecCCCccCCCCC-C-------Ccccceehhhcccccc-Cccc---ccccceEEecCCcccCCCC----cc
Confidence              34567777777777664221 1       1346666666666663 3322   2356666666666655442    12


Q ss_pred             cCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcCCCCCCcc-CCCCccEEEccCCcCcccCC
Q 003504          294 LGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV-SAKNLGIIDMSHNNLSGEIP  357 (815)
Q Consensus       294 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~~L~~L~ls~N~l~~~~p  357 (815)
                      .+|+.|++++|.|++ +|..+   .+|+.|++++|+|+..+... .+.+|+.|+|++|+|++.+|
T Consensus       402 s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~~~  462 (788)
T PRK15387        402 SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTL  462 (788)
T ss_pred             cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCchHH
Confidence            455566666666553 34321   24455555555555322211 34555555555555554444

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.4e-25  Score=228.10  Aligned_cols=133  Identities=21%  Similarity=0.275  Sum_probs=110.9

Q ss_pred             hcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC-----C---CCceeeeeEEEe--
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-----H---PNLVPLTGYCIA--  575 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~--  575 (815)
                      ..+|.+.++||-|.|++||+|. ..+.+.||+|+.+. .+.-.+....||++|++++     |   ..||+|+++|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            3578889999999999999999 56678999999865 3444556778999999984     3   359999999975  


Q ss_pred             --CCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcC
Q 003504          576 --GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHG  653 (815)
Q Consensus       576 --~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~  653 (815)
                        +...++|+|++-. +|..+|...                            ..+.+......+|+.||+.||.|||..
T Consensus       156 pNG~HVCMVfEvLGd-nLLklI~~s----------------------------~YrGlpl~~VK~I~~qvL~GLdYLH~e  206 (590)
T KOG1290|consen  156 PNGQHVCMVFEVLGD-NLLKLIKYS----------------------------NYRGLPLSCVKEICRQVLTGLDYLHRE  206 (590)
T ss_pred             CCCcEEEEEehhhhh-HHHHHHHHh----------------------------CCCCCcHHHHHHHHHHHHHHHHHHHHh
Confidence              4578999999855 899998763                            355688889999999999999999984


Q ss_pred             CCCCeeeccCCCCceEEc
Q 003504          654 CSPPIIHRDIKASSVYLD  671 (815)
Q Consensus       654 ~~~~ivHrDlk~~NIll~  671 (815)
                        -+|||-||||+|||+.
T Consensus       207 --cgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  207 --CGIIHTDLKPENVLLC  222 (590)
T ss_pred             --cCccccCCCcceeeee
Confidence              4899999999999984

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.93  E-value=5.9e-28  Score=266.78  Aligned_cols=343  Identities=29%  Similarity=0.316  Sum_probs=253.4

Q ss_pred             eEEEEecCCCCCccCCCcccccCCCCCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEcc
Q 003504           29 HVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS  108 (815)
Q Consensus        29 ~~~~l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls  108 (815)
                      +++.++++.|-+. ..|-+.+.+--+|+.|||++|++...|..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|.|.
T Consensus        22 ~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~   99 (1081)
T KOG0618|consen   22 ALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQISSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK   99 (1081)
T ss_pred             HHHhhhccccccc-cCchHHhhheeeeEEeeccccccccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence            4667777777665 44555566666799999999999999999999999999999999998 788999999999999999


Q ss_pred             CCcCCCCChhhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccCC-------------------cCCCCCCchhh
Q 003504          109 NNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMN-------------------QLNGSLPDGFG  169 (815)
Q Consensus       109 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-------------------~l~~~lp~~~~  169 (815)
                      +|.+. ..|..+..+.+|+.|+++.|++. .+|..+..++.+..+..++|                   .+.+.++.++.
T Consensus       100 ~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~  177 (1081)
T KOG0618|consen  100 NNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIY  177 (1081)
T ss_pred             cchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchh
Confidence            99999 88999999999999999999998 57766666666665555555                   11111111110


Q ss_pred             ------------------ccCCCCCEEEcCCCcccC--------------------CCCCCCCCCCCCeEeccCCcCCCc
Q 003504          170 ------------------AAFPKLKSLNLAGNEIKG--------------------RDTHFAGLKSITNLNISGNLFQGS  211 (815)
Q Consensus       170 ------------------~~l~~L~~L~L~~N~l~~--------------------~~~~~~~l~~L~~L~Ls~N~l~~~  211 (815)
                                        ..+.+|+.|....|++..                    .... ..-.+|++++++.|+++.+
T Consensus       178 ~l~~~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~-p~p~nl~~~dis~n~l~~l  256 (1081)
T KOG0618|consen  178 NLTHQLDLRYNEMEVLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVH-PVPLNLQYLDISHNNLSNL  256 (1081)
T ss_pred             hhheeeecccchhhhhhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccc-cccccceeeecchhhhhcc
Confidence                              111222222222222221                    1000 1124677888888888888


Q ss_pred             chhhh-hcccceeeeccccccCcccccc------------------cccccCCccceEEEcCCCccCcchhhcccc----
Q 003504          212 VMGVF-LESLEVIDLRSNQFQGHISQVQ------------------FNSSYNWSRLVYVDLSENQLSGEIFHNFSQ----  268 (815)
Q Consensus       212 ~~~~~-l~~L~~L~L~~N~l~~~~~~~~------------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~----  268 (815)
                      |.... +.+|+.|+..+|+++..+..+.                  .....+++.|++|+|..|+|.......+..    
T Consensus       257 p~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~  336 (1081)
T KOG0618|consen  257 PEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNAS  336 (1081)
T ss_pred             hHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHH
Confidence            74433 7778888888887753222110                  112234788999999999987543322111    


Q ss_pred             ---------------------CCCCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCC
Q 003504          269 ---------------------AQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSM  327 (815)
Q Consensus       269 ---------------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~  327 (815)
                                           ++.|+.|+|.+|.+++.-.+.+.+.++|+.|+|++|+|.......+.++..|++|+||+
T Consensus       337 l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSG  416 (1081)
T KOG0618|consen  337 LNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSG  416 (1081)
T ss_pred             HHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhccc
Confidence                                 34588899999999888888999999999999999999855556788899999999999


Q ss_pred             CcCCCCCCcc-CCCCccEEEccCCcCcccCChHHhhcCCCCceeeccCCCCcc
Q 003504          328 NHLTGQIPTV-SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTL  379 (815)
Q Consensus       328 N~l~~~~~~~-~~~~L~~L~ls~N~l~~~~p~~~~~~l~~l~~l~l~~N~l~~  379 (815)
                      |+|+..+... .+..|++|...+|+|. .+|  -+..+++|+.+|++.|+++.
T Consensus       417 NkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP--e~~~l~qL~~lDlS~N~L~~  466 (1081)
T KOG0618|consen  417 NKLTTLPDTVANLGRLHTLRAHSNQLL-SFP--ELAQLPQLKVLDLSCNNLSE  466 (1081)
T ss_pred             chhhhhhHHHHhhhhhHHHhhcCCcee-ech--hhhhcCcceEEecccchhhh
Confidence            9999755433 7789999999999998 677  46789999999999999874

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-26  Score=220.03  Aligned_cols=250  Identities=27%  Similarity=0.389  Sum_probs=192.6

Q ss_pred             CCeecccCCeeeEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCC
Q 003504          513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGN  590 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gs  590 (815)
                      ..+|.....|+.|+|++++ ..+++|++.-.  ......+|..|.-.++-+.||||++++|.|.......++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            3468888999999999984 45777877532  23334689999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEE
Q 003504          591 LQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL  670 (815)
Q Consensus       591 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll  670 (815)
                      |+..||+.                            .+...+-.+..++|.++|+|++|||+- ++-|----|.+..|++
T Consensus       274 lynvlhe~----------------------------t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmi  324 (448)
T KOG0195|consen  274 LYNVLHEQ----------------------------TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMI  324 (448)
T ss_pred             HHHHHhcC----------------------------ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEe
Confidence            99999973                            355677788899999999999999953 2333344688999999


Q ss_pred             cCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCC-CCCcCcchhHHHHHHHHHhCCCCCCCCCCcccccc
Q 003504          671 DMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDF-PTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGN  749 (815)
Q Consensus       671 ~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~  749 (815)
                      |++.+++|+- +-+++   ........-.+.||+||.++..... --..+|+|||++++||+.|+..||.+-.+-+..-+
T Consensus       325 dedltarism-ad~kf---sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk  400 (448)
T KOG0195|consen  325 DEDLTARISM-ADTKF---SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK  400 (448)
T ss_pred             cchhhhheec-cccee---eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh
Confidence            9999998862 21221   1122223346789999998765521 24578999999999999999999987555443311


Q ss_pred             HHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          750 LVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      +.                -++++..-|+.....+.++|.-|...||.+||.+..|+-.|+++.
T Consensus       401 ia----------------leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  401 IA----------------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hh----------------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            11                123344446667788999999999999999999999999998864

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.92  E-value=1.3e-24  Score=249.13  Aligned_cols=267  Identities=26%  Similarity=0.296  Sum_probs=217.3

Q ss_pred             EecCCCCeEEEEecCCCCCccCCCcccccCCCCCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCC
Q 003504           22 VCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGL  101 (815)
Q Consensus        22 ~C~~~~~~~~~l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  101 (815)
                      .|..++  -..|++++++++ .+|+. +.  ++|+.|+|++|+|+.+|..   +++|++|+|++|+|+. +|..   .++
T Consensus       197 ~Cl~~~--~~~LdLs~~~Lt-sLP~~-l~--~~L~~L~L~~N~Lt~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~s  263 (788)
T PRK15387        197 ACLNNG--NAVLNVGESGLT-TLPDC-LP--AHITTLVIPDNNLTSLPAL---PPELRTLEVSGNQLTS-LPVL---PPG  263 (788)
T ss_pred             HHhcCC--CcEEEcCCCCCC-cCCcc-hh--cCCCEEEccCCcCCCCCCC---CCCCcEEEecCCccCc-ccCc---ccc
Confidence            465443  345789999998 68874 43  4899999999999999963   5899999999999994 5643   468


Q ss_pred             CcEEEccCCcCCCCChhhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcC
Q 003504          102 LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLA  181 (815)
Q Consensus       102 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~  181 (815)
                      |+.|+|++|.|+ .+|..+   .+|+.|+|++|+|+. +|..   +++|+.|+|++|+|+ .+|..    ..+|+.|+++
T Consensus       264 L~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~-~Lp~l----p~~L~~L~Ls  330 (788)
T PRK15387        264 LLELSIFSNPLT-HLPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLA-SLPAL----PSELCKLWAY  330 (788)
T ss_pred             cceeeccCCchh-hhhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCccc-cCCCC----cccccccccc
Confidence            999999999999 445433   678899999999994 5653   478999999999998 67752    3578999999


Q ss_pred             CCcccCCCCCCCCCCCCCeEeccCCcCCCcchhhhhcccceeeeccccccCcccccccccccCCccceEEEcCCCccCcc
Q 003504          182 GNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGE  261 (815)
Q Consensus       182 ~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~  261 (815)
                      +|.|+.+|..   ..+|+.|+|++|+|+.+|.  +..+|+.|++++|+++.. +..       ..+|+.|+|++|.|++ 
T Consensus       331 ~N~L~~LP~l---p~~Lq~LdLS~N~Ls~LP~--lp~~L~~L~Ls~N~L~~L-P~l-------~~~L~~LdLs~N~Lt~-  396 (788)
T PRK15387        331 NNQLTSLPTL---PSGLQELSVSDNQLASLPT--LPSELYKLWAYNNRLTSL-PAL-------PSGLKELIVSGNRLTS-  396 (788)
T ss_pred             cCcccccccc---ccccceEecCCCccCCCCC--CCcccceehhhccccccC-ccc-------ccccceEEecCCcccC-
Confidence            9999987742   2589999999999999875  357899999999998853 322       2579999999999995 


Q ss_pred             hhhccccCCCCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcCCCCCCc
Q 003504          262 IFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPT  336 (815)
Q Consensus       262 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~  336 (815)
                      +|..   .++|+.|+|++|+|+.++.    ...+|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|++..+.
T Consensus       397 LP~l---~s~L~~LdLS~N~LssIP~----l~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        397 LPVL---PSELKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             CCCc---ccCCCEEEccCCcCCCCCc----chhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            4432   3689999999999988763    2357899999999998 7899999999999999999999987654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=1.5e-25  Score=229.10  Aligned_cols=261  Identities=24%  Similarity=0.328  Sum_probs=193.0

Q ss_pred             HHhcCCCCCCeecccCCeeeEEEEcC----CCcEEEEEEeecCCcccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCCee
Q 003504          505 SATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       505 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~  579 (815)
                      .....|...++||.|.|++||+|+..    ..+.||+|.+..  ......+..|+++|..+. +.||+++.+++...+..
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~--ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR--TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc--ccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            34467888999999999999999853    467899998855  345667899999999995 99999999999999999


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      .+|+||++.-+-.+++..                                 ++.......+..+.+||+++|   ..|||
T Consensus       111 ~ivlp~~~H~~f~~l~~~---------------------------------l~~~~i~~Yl~~ll~Al~~~h---~~GIv  154 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS---------------------------------LSLAEIRWYLRNLLKALAHLH---KNGIV  154 (418)
T ss_pred             EEEecccCccCHHHHHhc---------------------------------CCHHHHHHHHHHHHHHhhhhh---ccCcc
Confidence            999999999998888864                                 345667778889999999999   89999


Q ss_pred             eccCCCCceEEcCC-CCeeecccccceecCC-------------------CC--------------------------cc
Q 003504          660 HRDIKASSVYLDMN-LEPRLSDFGLAKIFGN-------------------GL--------------------------DE  693 (815)
Q Consensus       660 HrDlk~~NIll~~~-~~~kl~Dfgla~~~~~-------------------~~--------------------------~~  693 (815)
                      ||||||+|+|.+.. +.-.|.|||+|.....                   +.                          ..
T Consensus       155 HRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~  234 (418)
T KOG1167|consen  155 HRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSER  234 (418)
T ss_pred             ccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcccee
Confidence            99999999999854 5679999999972110                   00                          00


Q ss_pred             ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHH--------HHH-HhcCC--
Q 003504          694 EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWV--------RGL-VRNNK--  762 (815)
Q Consensus       694 ~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~-~~~~~--  762 (815)
                      ...+||+||.|||++..... -++++||||.||+++-+++++.||......  ...+...+        +++ .-.+.  
T Consensus       235 anrAGT~GfRaPEvL~k~~~-QttaiDiws~GVI~Lslls~~~PFf~a~dd--~~al~ei~tifG~~~mrk~A~l~g~~~  311 (418)
T KOG1167|consen  235 ANRAGTPGFRAPEVLFRCPR-QTTAIDIWSAGVILLSLLSRRYPFFKAKDD--ADALAEIATIFGSAEMRKCAALPGRIL  311 (418)
T ss_pred             cccCCCCCCCchHHHhhccC-cCCccceeeccceeehhhccccccccCccc--cchHHHHHHHhChHHHHHHhhcCCcee
Confidence            11239999999999876553 588999999999999999999998753221  11111111        000 00000  


Q ss_pred             C---------------Ccccc-cccc---------CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          763 G---------------SRAID-PKIR---------DTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       763 ~---------------~~~~~-~~~~---------~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      .               .+-++ +.+.         ....+..+..++++..+|+..||.+|.++++.++
T Consensus       312 l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  312 LWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             eeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            0               00010 0000         0112233457899999999999999999999976

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=1.4e-25  Score=269.41  Aligned_cols=193  Identities=18%  Similarity=0.185  Sum_probs=138.3

Q ss_pred             CCCC-CCceeeeeEEE-------eCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCccc
Q 003504          560 RIKH-PNLVPLTGYCI-------AGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLT  631 (815)
Q Consensus       560 ~l~H-~niv~l~g~~~-------~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  631 (815)
                      .++| +||++++++|.       ..+..+.++||+ .++|.++|...                             ...+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-----------------------------~~~~   77 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-----------------------------DRSV   77 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-----------------------------cccc
Confidence            3456 68888888872       223556778887 45999999642                             3357


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcC-------------------CCCeeecccccceecCCCC-
Q 003504          632 TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM-------------------NLEPRLSDFGLAKIFGNGL-  691 (815)
Q Consensus       632 ~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~-------------------~~~~kl~Dfgla~~~~~~~-  691 (815)
                      ++..++.++.||++||+|||   +.+||||||||+||||+.                   ++.+|++|||+++...... 
T Consensus        78 ~~~~~~~i~~qi~~al~~lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~  154 (793)
T PLN00181         78 DAFECFHVFRQIVEIVNAAH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSE  154 (793)
T ss_pred             cHHHHHHHHHHHHHHHHHHH---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccc
Confidence            88999999999999999999   899999999999999953                   4567788888776432100 


Q ss_pred             ----------------ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHH
Q 003504          692 ----------------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVR  755 (815)
Q Consensus       692 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~  755 (815)
                                      ......||+.|||||++.+..  ++.++|||||||++|||++|..|+....      .   .+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~~~sDVwSlGviL~ELl~~~~~~~~~~------~---~~~  223 (793)
T PLN00181        155 RRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS--SNCASDVYRLGVLLFELFCPVSSREEKS------R---TMS  223 (793)
T ss_pred             cchhhhhccccCCCcccccccCCCcceEChhhhccCC--CCchhhhhhHHHHHHHHhhCCCchhhHH------H---HHH
Confidence                            011235788999999988766  7899999999999999999888764210      0   111


Q ss_pred             HHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          756 GLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       756 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ... .    ...++..     .........++.+||+++|.+||+|.|+++
T Consensus       224 ~~~-~----~~~~~~~-----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        224 SLR-H----RVLPPQI-----LLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHH-H----hhcChhh-----hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            110 0    0111111     112234568888999999999999999975

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.91  E-value=1.5e-25  Score=232.43  Aligned_cols=201  Identities=21%  Similarity=0.234  Sum_probs=166.9

Q ss_pred             hcCCCCCCeecccCCeeeEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC------CCCceeeeeEEEeCCee
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK------HPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~~~  579 (815)
                      ..+|.+....|+|-|+.|.+|.. ..|..||||+++... .-.+.=.+|+++|.+|.      --+.++++-.|......
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            35688888899999999999984 447799999998743 33444568999999994      34789999999999999


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      |||||-+.- +|.+.|.+.                           +....+........+.|+.-||..|-   .-+|+
T Consensus       510 ClVFE~Lsl-NLRevLKKy---------------------------G~nvGL~ikaVRsYaqQLflALklLK---~c~vl  558 (752)
T KOG0670|consen  510 CLVFEPLSL-NLREVLKKY---------------------------GRNVGLHIKAVRSYAQQLFLALKLLK---KCGVL  558 (752)
T ss_pred             EEEehhhhc-hHHHHHHHh---------------------------CcccceeehHHHHHHHHHHHHHHHHH---hcCee
Confidence            999998765 999999863                           23456777888899999999999999   78999


Q ss_pred             eccCCCCceEEcCCC-CeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCC
Q 003504          660 HRDIKASSVYLDMNL-EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       660 HrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~  738 (815)
                      |.||||+||||++.- .+||||||.|....... -+++.-+..|.|||++.+..  |+...|+||.||+||||+||+--|
T Consensus       559 HaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~--yd~~iD~WSvgctLYElYtGkIlF  635 (752)
T KOG0670|consen  559 HADIKPDNILVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLP--YDYPIDTWSVGCTLYELYTGKILF  635 (752)
T ss_pred             ecccCccceEeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCc--ccCCccceeeceeeEEeeccceec
Confidence            999999999999764 58999999998765433 33344577899999999988  788999999999999999999988


Q ss_pred             CCCC
Q 003504          739 GDDY  742 (815)
Q Consensus       739 ~~~~  742 (815)
                      .+..
T Consensus       636 pG~T  639 (752)
T KOG0670|consen  636 PGRT  639 (752)
T ss_pred             CCCC
Confidence            7743

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=3.2e-24  Score=209.58  Aligned_cols=159  Identities=22%  Similarity=0.293  Sum_probs=119.1

Q ss_pred             CcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcc
Q 003504          628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEF  707 (815)
Q Consensus       628 ~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~  707 (815)
                      +..++|..+..|+.|++.||+|||   +.+      ||+||+++.++.+|+  ||.++......    ..|++.|||||+
T Consensus        11 ~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~~y~aPE~   75 (176)
T smart00750       11 GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDPYFMAPEV   75 (176)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc----CCCcccccChHH
Confidence            346899999999999999999999   444      999999999999999  99998765422    258999999999


Q ss_pred             cCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHH--HHHH
Q 003504          708 AQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQME--EALK  785 (815)
Q Consensus       708 ~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  785 (815)
                      +.+..  ++.++|||||||++|||++|+.||.....  ....+..+.......       ++... ..+.....  ++.+
T Consensus        76 ~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~-------~~~~~-~~~~~~~~~~~~~~  143 (176)
T smart00750       76 IQGQS--YTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPAD-------DPRDR-SNLESVSAARSFAD  143 (176)
T ss_pred             hcCCC--CcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccC-------Ccccc-ccHHHHHhhhhHHH
Confidence            98766  78899999999999999999999964321  111111111111100       01000 11223333  6899


Q ss_pred             HHhhccccCCCCCCCHHHHHHHHHhhhh
Q 003504          786 IGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       786 l~~~Cl~~dP~~RPs~~~v~~~L~~i~~  813 (815)
                      ++.+||..+|++||++.++++.+..+..
T Consensus       144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      144 FMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            9999999999999999999999877644

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-25  Score=225.54  Aligned_cols=302  Identities=25%  Similarity=0.229  Sum_probs=240.3

Q ss_pred             CEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCC-C
Q 003504           56 QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG-N  134 (815)
Q Consensus        56 ~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N  134 (815)
                      ...|.++-.++++|.++  .+.-++++|..|.|+.+.|..|+.+++|+.||||+|+|+-+.|++|.++.+|..|.|.+ |
T Consensus        49 ~~VdCr~~GL~eVP~~L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N  126 (498)
T KOG4237|consen   49 GIVDCRGKGLTEVPANL--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN  126 (498)
T ss_pred             ceEEccCCCcccCcccC--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence            45688888999999877  45788999999999999999999999999999999999999999999999999988877 9


Q ss_pred             cccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccCCCC-CCCCCCCCCeEeccCCcCCC---
Q 003504          135 MFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT-HFAGLKSITNLNISGNLFQG---  210 (815)
Q Consensus       135 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~---  210 (815)
                      +|+...-+.|.+|.+|+.|.+.-|++. .++...+..+++|..|.|.+|.++.+.. .|..+..++.+.+..|.+-.   
T Consensus       127 kI~~l~k~~F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCn  205 (498)
T KOG4237|consen  127 KITDLPKGAFGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCN  205 (498)
T ss_pred             chhhhhhhHhhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccc
Confidence            999877789999999999999999998 8888888999999999999999999875 79999999999999998421   


Q ss_pred             cchhh---------h--hcccceeeeccccccCccccccccccc-CCccceEEEcCCCccCcc-hhhccccCCCCCEEEe
Q 003504          211 SVMGV---------F--LESLEVIDLRSNQFQGHISQVQFNSSY-NWSRLVYVDLSENQLSGE-IFHNFSQAQNLKHLSL  277 (815)
Q Consensus       211 ~~~~~---------~--l~~L~~L~L~~N~l~~~~~~~~~~~~~-~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L  277 (815)
                      ++-.+         +  ..-..-..+.++++.    ++....|. .+..+..-..+.+...+. ....|..+++|+.|+|
T Consensus       206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~----q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnl  281 (498)
T KOG4237|consen  206 LPWLADDLAMNPIETSGARCVSPYRLYYKRIN----QEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNL  281 (498)
T ss_pred             cchhhhHHhhchhhcccceecchHHHHHHHhc----ccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEecc
Confidence            11110         0  111222333444332    11111111 122232223333333333 3456899999999999


Q ss_pred             cCCcCcCCCccccccccCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcCCCCCCcc--CCCCccEEEccCCcCccc
Q 003504          278 AYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGE  355 (815)
Q Consensus       278 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~--~~~~L~~L~ls~N~l~~~  355 (815)
                      ++|+|+.+...+|..+..++.|.|..|+|...-...|.++..|++|+|.+|+|+..-|..  .+..|..|+|-.|.+.+.
T Consensus       282 snN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn  361 (498)
T KOG4237|consen  282 SNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN  361 (498)
T ss_pred             CCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc
Confidence            999999999999999999999999999998777788999999999999999999877765  567899999999999877


Q ss_pred             CChHHhhcC
Q 003504          356 IPASLLEKL  364 (815)
Q Consensus       356 ~p~~~~~~l  364 (815)
                      ..-.++..+
T Consensus       362 C~l~wl~~W  370 (498)
T KOG4237|consen  362 CRLAWLGEW  370 (498)
T ss_pred             cchHHHHHH
Confidence            665555543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=5e-23  Score=219.17  Aligned_cols=164  Identities=23%  Similarity=0.257  Sum_probs=127.9

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcC--CCcEEEEEEeecCC-----cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCe
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLP--GGIHVAVKVLVHGS-----TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQ  578 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  578 (815)
                      ...+|...+.||+|+||+||+|+..  +++.||||++....     ....+.+.+|++++++++|+|+++.+..   ...
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            4567999999999999999999864  57788999875321     1224568999999999999999853322   246


Q ss_pred             eEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i  658 (815)
                      .++||||+++++|.. +..                             ..       ...++.++++||+|||   +.+|
T Consensus        93 ~~LVmE~~~G~~L~~-~~~-----------------------------~~-------~~~~~~~i~~aL~~lH---~~gI  132 (365)
T PRK09188         93 DGLVRGWTEGVPLHL-ARP-----------------------------HG-------DPAWFRSAHRALRDLH---RAGI  132 (365)
T ss_pred             cEEEEEccCCCCHHH-hCc-----------------------------cc-------hHHHHHHHHHHHHHHH---HCCC
Confidence            799999999999962 211                             00       1357788999999999   8999


Q ss_pred             eeccC-CCCceEEcCCCCeeecccccceecCCCCcc---------ccccccccccCCcccCCCC
Q 003504          659 IHRDI-KASSVYLDMNLEPRLSDFGLAKIFGNGLDE---------EIARGSPGYIPPEFAQPDS  712 (815)
Q Consensus       659 vHrDl-k~~NIll~~~~~~kl~Dfgla~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~  712 (815)
                      +|||| ||+|||++.++.+||+|||+|+.+......         ....+++.|+|||++....
T Consensus       133 iHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~  196 (365)
T PRK09188        133 THNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE  196 (365)
T ss_pred             eeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence            99999 999999999999999999999976543211         2345788899999887654

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.89  E-value=2.1e-23  Score=241.08  Aligned_cols=245  Identities=23%  Similarity=0.353  Sum_probs=128.5

Q ss_pred             CCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCC
Q 003504           54 KLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG  133 (815)
Q Consensus        54 ~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  133 (815)
                      +.+.|+|++++++.+|..+.  ++|+.|+|++|+|+ .+|..+.  .+|++|+|++|+|+. +|..+.  .+|+.|+|++
T Consensus       179 ~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~  250 (754)
T PRK15370        179 NKTELRLKILGLTTIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELSI  250 (754)
T ss_pred             CceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECcC
Confidence            35566666666666665442  35666666666666 3343332  356666666666663 344332  2466666666


Q ss_pred             CcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccCCCCCCCCCCCCCeEeccCCcCCCcch
Q 003504          134 NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVM  213 (815)
Q Consensus       134 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  213 (815)
                      |+|. .+|..+.  ++|+.|+|++|+|+ .+|..++   ++|+.|+|++|+|+.+|..+.  ++|+.|++++|.++.++.
T Consensus       251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt~LP~  321 (754)
T PRK15370        251 NRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLTALPE  321 (754)
T ss_pred             CccC-cCChhHh--CCCCEEECcCCccC-ccccccC---CCCcEEECCCCccccCcccch--hhHHHHHhcCCccccCCc
Confidence            6665 3444442  35666666666665 4555432   355556666665555443322  245555555555554432


Q ss_pred             hhhhcccceeeeccccccCcccccccccccCCccceEEEcCCCccCcchhhccccCCCCCEEEecCCcCcCCCccccccc
Q 003504          214 GVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTL  293 (815)
Q Consensus       214 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  293 (815)
                      . +.+                            +|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+.++. .+  .
T Consensus       322 ~-l~~----------------------------sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~LP~-~l--p  366 (754)
T PRK15370        322 T-LPP----------------------------GLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVLPE-TL--P  366 (754)
T ss_pred             c-ccc----------------------------cceeccccCCcccc-CChhhc--CcccEEECCCCCCCcCCh-hh--c
Confidence            2 123                            45555555555543 333222  456666666666654432 22  2


Q ss_pred             cCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcCCCCCCcc-----CCCCccEEEccCCcCc
Q 003504          294 LGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV-----SAKNLGIIDMSHNNLS  353 (815)
Q Consensus       294 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-----~~~~L~~L~ls~N~l~  353 (815)
                      ++|+.|+|++|.|+ .+|..+.  ..|+.|++++|+|++.+...     ..+++..|+|.+|+++
T Consensus       367 ~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        367 PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            45666666666665 3444443  24666666666666432211     2355666777777765

>PLN03210 Resistant to P

Probab=99.89  E-value=7e-22  Score=244.63  Aligned_cols=314  Identities=22%  Similarity=0.247  Sum_probs=193.5

Q ss_pred             CCcccccCCCCCCEEECcCCCCC-------CCCcccCCC-CCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCC
Q 003504           44 VPDTTIGKLSKLQSLDLSENNIT-------ALPSDLWSL-GSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGE  115 (815)
Q Consensus        44 ~~~~~~~~l~~L~~L~Ls~n~l~-------~lp~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~  115 (815)
                      +...+|..+++|+.|.+..+...       .+|.++..+ .+|+.|++.+|.+. .+|..| .+.+|++|+|++|+|. .
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~  625 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-K  625 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-c
Confidence            45556777777777777655322       355555554 35777777777776 556666 4577777777777776 4


Q ss_pred             ChhhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCC-cccCCCCCCCC
Q 003504          116 IPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGN-EIKGRDTHFAG  194 (815)
Q Consensus       116 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~  194 (815)
                      ++..+..+++|+.|+|++|.....+|+ +..+++|++|+|++|.....+|..+ ..+++|+.|++++| .++.+|..+ +
T Consensus       626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si-~~L~~L~~L~L~~c~~L~~Lp~~i-~  702 (1153)
T PLN03210        626 LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSI-QYLNKLEDLDMSRCENLEILPTGI-N  702 (1153)
T ss_pred             cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhh-hccCCCCEEeCCCCCCcCccCCcC-C
Confidence            566667777777777776653334553 6667777777777765444677665 44677777777775 455565544 6


Q ss_pred             CCCCCeEeccCCcCCCcchhhhhcccceeeeccccccCcccccccccccCCccceEEEcCCCccC-------cchhhccc
Q 003504          195 LKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS-------GEIFHNFS  267 (815)
Q Consensus       195 l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-------~~~~~~~~  267 (815)
                      +++|+.|+|++|......+ ....+|+.|+|++|.+...+..      ..+++|++|++.++...       ...+..+.
T Consensus       703 l~sL~~L~Lsgc~~L~~~p-~~~~nL~~L~L~~n~i~~lP~~------~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~  775 (1153)
T PLN03210        703 LKSLYRLNLSGCSRLKSFP-DISTNISWLDLDETAIEEFPSN------LRLENLDELILCEMKSEKLWERVQPLTPLMTM  775 (1153)
T ss_pred             CCCCCEEeCCCCCCccccc-cccCCcCeeecCCCcccccccc------ccccccccccccccchhhccccccccchhhhh
Confidence            7777777777764322111 1245677777777776532221      23556666666653321       11112223


Q ss_pred             cCCCCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcCCCCCCccCCCCccEEEc
Q 003504          268 QAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDM  347 (815)
Q Consensus       268 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~L~~L~l  347 (815)
                      ..++|+.|+|++|......+..++++++|+.|+|++|...+.+|..+ .+++|+.|+|++|.....+|.. ..+|+.|+|
T Consensus       776 ~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~-~~nL~~L~L  853 (1153)
T PLN03210        776 LSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI-STNISDLNL  853 (1153)
T ss_pred             ccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc-ccccCEeEC
Confidence            34567777777775533334567777777777777765555566554 5677777777776554444432 356777777


Q ss_pred             cCCcCcccCChHHhhcCCCCceeeccC
Q 003504          348 SHNNLSGEIPASLLEKLPQMERFNFSY  374 (815)
Q Consensus       348 s~N~l~~~~p~~~~~~l~~l~~l~l~~  374 (815)
                      ++|.++ .+|. .+..+++|+.|++++
T Consensus       854 s~n~i~-~iP~-si~~l~~L~~L~L~~  878 (1153)
T PLN03210        854 SRTGIE-EVPW-WIEKFSNLSFLDMNG  878 (1153)
T ss_pred             CCCCCc-cChH-HHhcCCCCCEEECCC
Confidence            777776 5664 356677777777776

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.89  E-value=8.1e-22  Score=244.05  Aligned_cols=318  Identities=22%  Similarity=0.263  Sum_probs=251.1

Q ss_pred             CCCcccccCC-CCCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhc
Q 003504           43 SVPDTTIGKL-SKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAIS  121 (815)
Q Consensus        43 ~~~~~~~~~l-~~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  121 (815)
                      .+|. .|..+ .+|+.|++.+|.++.+|..+ .+.+|++|+|++|+|. .++..+..+++|+.|+|++|.....+| .++
T Consensus       579 ~lp~-~~~~lp~~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls  654 (1153)
T PLN03210        579 HLPE-GFDYLPPKLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLS  654 (1153)
T ss_pred             ecCc-chhhcCcccEEEEecCCCCCCCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccc
Confidence            4555 35555 47999999999999999775 6799999999999998 678889999999999999886544666 488


Q ss_pred             CCcCCCEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcc-cCCCCCCCCCCCCCe
Q 003504          122 SLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEI-KGRDTHFAGLKSITN  200 (815)
Q Consensus       122 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l-~~~~~~~~~l~~L~~  200 (815)
                      .+++|++|+|++|.....+|..+.++++|+.|++++|.-.+.+|..+  .+++|+.|+|++|.. ..+|.   ...+|++
T Consensus       655 ~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~---~~~nL~~  729 (1153)
T PLN03210        655 MATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--NLKSLYRLNLSGCSRLKSFPD---ISTNISW  729 (1153)
T ss_pred             cCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--CCCCCCEEeCCCCCCcccccc---ccCCcCe
Confidence            99999999999987666899999999999999999975445888865  589999999999854 33432   2468999


Q ss_pred             EeccCCcCCCcchhhhhcccceeeeccccccC---cccccccccccCCccceEEEcCCCccCcchhhccccCCCCCEEEe
Q 003504          201 LNISGNLFQGSVMGVFLESLEVIDLRSNQFQG---HISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSL  277 (815)
Q Consensus       201 L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~~---~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  277 (815)
                      |+|++|.+..+|....+++|+.|++.++....   .+..+....+...++|+.|+|++|...+.+|..+.++++|+.|+|
T Consensus       730 L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~L  809 (1153)
T PLN03210        730 LDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEI  809 (1153)
T ss_pred             eecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEEC
Confidence            99999999998876668899999988754221   111111111223478999999999888889999999999999999


Q ss_pred             cCCc-CcCCCccccccccCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcCCCCCCcc-CCCCccEEEccC-CcCcc
Q 003504          278 AYNR-FTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV-SAKNLGIIDMSH-NNLSG  354 (815)
Q Consensus       278 ~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~~L~~L~ls~-N~l~~  354 (815)
                      ++|. ++.++ ..+ .+++|+.|+|++|.....+|..   ..+|+.|+|++|.++..+... .+++|+.|+|++ |+|. 
T Consensus       810 s~C~~L~~LP-~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~iP~si~~l~~L~~L~L~~C~~L~-  883 (1153)
T PLN03210        810 ENCINLETLP-TGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNGCNNLQ-  883 (1153)
T ss_pred             CCCCCcCeeC-CCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCccChHHHhcCCCCCEEECCCCCCcC-
Confidence            9975 56554 333 7899999999998776666643   468999999999998654333 789999999998 6666 


Q ss_pred             cCChHHhhcCCCCceeeccCCC
Q 003504          355 EIPASLLEKLPQMERFNFSYNN  376 (815)
Q Consensus       355 ~~p~~~~~~l~~l~~l~l~~N~  376 (815)
                      .+|.. ...++.|+.++++++.
T Consensus       884 ~l~~~-~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        884 RVSLN-ISKLKHLETVDFSDCG  904 (1153)
T ss_pred             ccCcc-cccccCCCeeecCCCc
Confidence            56643 5678889999887763

syringae 6; Provisional

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.88  E-value=8.5e-23  Score=236.09  Aligned_cols=253  Identities=21%  Similarity=0.332  Sum_probs=182.1

Q ss_pred             eEecCCCCeEEEEecCCCCCccCCCcccccCCCCCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCC
Q 003504           21 VVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFG  100 (815)
Q Consensus        21 v~C~~~~~~~~~l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  100 (815)
                      ..|..+  ..+.+++++++++ .+|.. +  .++|+.|+|++|+|+.+|..++  ++|++|+|++|+|+ .+|..+.  .
T Consensus       173 ~~Cl~~--~~~~L~L~~~~Lt-sLP~~-I--p~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~  241 (754)
T PRK15370        173 RDCLKN--NKTELRLKILGLT-TIPAC-I--PEQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLT-SIPATLP--D  241 (754)
T ss_pred             Hhhccc--CceEEEeCCCCcC-cCCcc-c--ccCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccc-cCChhhh--c
Confidence            456543  4678999999988 57753 3  3589999999999999998775  59999999999999 5676554  4


Q ss_pred             CCcEEEccCCcCCCCChhhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEc
Q 003504          101 LLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNL  180 (815)
Q Consensus       101 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L  180 (815)
                      +|+.|+|++|+|+ .+|..+.  .+|+.|+|++|+|+ .+|+.+.  ++|+.|+|++|+|+ .+|..+.   ++|+.|+|
T Consensus       242 ~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp---~sL~~L~L  311 (754)
T PRK15370        242 TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP---SGITHLNV  311 (754)
T ss_pred             cccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch---hhHHHHHh
Confidence            7999999999999 5676664  58999999999999 5777664  58999999999998 7887653   57999999


Q ss_pred             CCCcccCCCCCCCCCCCCCeEeccCCcCCCcchhhhhcccceeeeccccccCcccccccccccCCccceEEEcCCCccCc
Q 003504          181 AGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSG  260 (815)
Q Consensus       181 ~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~  260 (815)
                      ++|.++.+|..+.  ++|+.|++++|.++.++.. +.++|+.|+|++|+++..+..+       .++|+.|+|++|.|+.
T Consensus       312 s~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt~LP~~-l~~sL~~L~Ls~N~L~~LP~~l-------p~~L~~LdLs~N~Lt~  381 (754)
T PRK15370        312 QSNSLTALPETLP--PGLKTLEAGENALTSLPAS-LPPELQVLDVSKNQITVLPETL-------PPTITTLDVSRNALTN  381 (754)
T ss_pred             cCCccccCCcccc--ccceeccccCCccccCChh-hcCcccEEECCCCCCCcCChhh-------cCCcCEEECCCCcCCC
Confidence            9999998876543  6899999999999987653 3467888888888776322111       1356666666666653


Q ss_pred             chhhccccCCCCCEEEecCCcCcCCCcc---ccccccCCCeEecCCCcCc
Q 003504          261 EIFHNFSQAQNLKHLSLAYNRFTRQEFP---QIGTLLGLEHLNLSRTSLI  307 (815)
Q Consensus       261 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~  307 (815)
                       +|..+.  ..|+.|++++|+++.++..   .+..++++..|+|.+|+++
T Consensus       382 -LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        382 -LPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             -CCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence             333322  2455556666655544311   1122344445555555443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=6.3e-22  Score=213.82  Aligned_cols=217  Identities=26%  Similarity=0.440  Sum_probs=168.5

Q ss_pred             hcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHH
Q 003504          558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRH  637 (815)
Q Consensus       558 l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  637 (815)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..                             ....++|.++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-----------------------------~~~~~d~~F~~   51 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-----------------------------EDIKLDYFFIL   51 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-----------------------------cccCccHHHHH
Confidence            4578999999999999999999999999999999999974                             25578999999


Q ss_pred             HHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCC---CccccccccccccCCcccCCCC--
Q 003504          638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG---LDEEIARGSPGYIPPEFAQPDS--  712 (815)
Q Consensus       638 ~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~--  712 (815)
                      .+..+++.||+|+|+  ++-..|+.++++|+++|....+||+|||+.......   .......-..-|.|||.+....  
T Consensus        52 s~~rdi~~Gl~ylh~--s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~  129 (484)
T KOG1023|consen   52 SFIRDISKGLAYLHN--SPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQ  129 (484)
T ss_pred             HHHHHHHHHHHHHhc--CcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccc
Confidence            999999999999994  333399999999999999999999999998776421   1111112344699999988752  


Q ss_pred             CC---CCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhh
Q 003504          713 DF---PTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL  789 (815)
Q Consensus       713 ~~---~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  789 (815)
                      ..   .+.+.||||||++++|+++.+.||+.....+....+..+++.     .....+.|.+....  +...++..++..
T Consensus       130 ~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~  202 (484)
T KOG1023|consen  130 SLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVAR  202 (484)
T ss_pred             cccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHH
Confidence            11   367899999999999999999999875444333334433322     23334444444221  445579999999


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhh
Q 003504          790 CTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       790 Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      ||..+|++||++++|...++.+.
T Consensus       203 cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  203 CWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             hcccChhhCccHHHHHhhhhhhc
Confidence            99999999999999998887664

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.7e-20  Score=201.07  Aligned_cols=257  Identities=21%  Similarity=0.197  Sum_probs=188.9

Q ss_pred             CCCCCCeecccCCeeeEEEEcCCC--cEEEEEEeecCCcccHHHHHHHHHHhcCCCC----CCceeeeeEE-EeCCeeEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLPGG--IHVAVKVLVHGSTLTDQEAARELEYLGRIKH----PNLVPLTGYC-IAGDQRIA  581 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l  581 (815)
                      +|.+.+.||+|+||.||.|.....  ..+|+|.-..........+..|+.++..+.+    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            788999999999999999996543  5789998765433333367888888888863    5788888887 46678899


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      ||+.+ +-+|.++....                            ....++-.+.++|+.|+..+|++||   +.+++||
T Consensus        99 VM~l~-G~sL~dl~~~~----------------------------~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHR  146 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRN----------------------------PPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHR  146 (322)
T ss_pred             EEecc-CccHHHHHHhC----------------------------CCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccC
Confidence            99876 55999977542                            1346778889999999999999999   8999999


Q ss_pred             cCCCCceEEcCC-----CCeeecccccce--ecCCCC--------c-cccccccccccCCcccCCCCCCCCCcCcchhHH
Q 003504          662 DIKASSVYLDMN-----LEPRLSDFGLAK--IFGNGL--------D-EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYG  725 (815)
Q Consensus       662 Dlk~~NIll~~~-----~~~kl~Dfgla~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~G  725 (815)
                      ||||.|++++..     ..+.|.|||+++  .+....        . .....||..|+++....+..  .+.+.|+||++
T Consensus       147 DiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e--~~r~DDles~~  224 (322)
T KOG1164|consen  147 DIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE--QGRRDDLESLF  224 (322)
T ss_pred             CcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc--cCCchhhhhHH
Confidence            999999999865     358999999998  321111        1 22345999999999888777  68899999999


Q ss_pred             HHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          726 VVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       726 vvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                      .++.|+..|..||...........+.    .......    ...     .....+.++.+++..+-..+..++|....+.
T Consensus       225 Y~l~el~~g~LPW~~~~~~~~~~~~~----~~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~  291 (322)
T KOG1164|consen  225 YMLLELLKGSLPWEALEMTDLKSKFE----KDPRKLL----TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLA  291 (322)
T ss_pred             HHHHHHhcCCCCCccccccchHHHHH----HHhhhhc----ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence            99999999999996533221111111    1111111    010     1222344566666666668999999999999


Q ss_pred             HHHHhhh
Q 003504          806 GLLKDIE  812 (815)
Q Consensus       806 ~~L~~i~  812 (815)
                      ..+.+..
T Consensus       292 ~~l~~~~  298 (322)
T KOG1164|consen  292 ELLKDVF  298 (322)
T ss_pred             HHHHHHH
Confidence            8887653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=5.8e-20  Score=198.78  Aligned_cols=261  Identities=27%  Similarity=0.368  Sum_probs=194.8

Q ss_pred             CCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCC-CceeeeeEEEeCCeeEEEEEe
Q 003504          510 FDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTL---TDQEAARELEYLGRIKHP-NLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~ey  585 (815)
                      |...+.||.|+||.||++...  ..+|+|.+......   ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556788999999999999977  78999998765433   366899999999999988 799999999777778999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +.++++.+++.....                           ...+.......++.+++.++.|+|   +.+++|||+||
T Consensus        80 ~~~~~l~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp  129 (384)
T COG0515          80 VDGGSLEDLLKKIGR---------------------------KGPLSESEALFILAQILSALEYLH---SKGIIHRDIKP  129 (384)
T ss_pred             CCCCcHHHHHHhccc---------------------------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCH
Confidence            999999977754210                           024667788899999999999999   78899999999


Q ss_pred             CceEEcCCC-CeeecccccceecCCCC-------ccccccccccccCCcccCCCC-CCCCCcCcchhHHHHHHHHHhCCC
Q 003504          666 SSVYLDMNL-EPRLSDFGLAKIFGNGL-------DEEIARGSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       666 ~NIll~~~~-~~kl~Dfgla~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      +||+++..+ .++++|||.++......       ......|+..|+|||.+.+.. ..+....|+||+|++++++++|..
T Consensus       130 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~  209 (384)
T COG0515         130 ENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP  209 (384)
T ss_pred             HHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCC
Confidence            999999988 79999999998665432       235567999999999988741 236889999999999999999999


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      ||..............    .+...... .................+.+++..|+..+|..|.++.+....
T Consensus       210 p~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         210 PFEGEKNSSATSQTLK----IILELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CCCCCCccccHHHHHH----HHHhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            9764322100111111    11111110 000111111012334678899999999999999998877653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=4.9e-20  Score=180.68  Aligned_cols=141  Identities=11%  Similarity=0.130  Sum_probs=107.8

Q ss_pred             CCeecccCCeeeEEEEcCCCcEEEEEEeecCCcc--c------------------------HHHHHHHHHHhcCCCCCCc
Q 003504          513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTL--T------------------------DQEAARELEYLGRIKHPNL  566 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~H~ni  566 (815)
                      ...||+|+||.||+|...+|++||||+++.....  .                        .....+|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999999754221  1                        0122359999999988776


Q ss_pred             eeeeeEEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHH
Q 003504          567 VPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARA  646 (815)
Q Consensus       567 v~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~  646 (815)
                      .....+.  ....++||||++++++......                              ...++.....+++.|++.+
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~------------------------------~~~~~~~~~~~i~~qi~~~  129 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK------------------------------DAPLSESKARELYLQVIQI  129 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhhh------------------------------cCCCCHHHHHHHHHHHHHH
Confidence            4433222  2234899999999876544321                              2246778889999999999


Q ss_pred             HHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecC
Q 003504          647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG  688 (815)
Q Consensus       647 L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~  688 (815)
                      |.|+||  ..+|+||||||+||+++ ++.++|+|||+|....
T Consensus       130 L~~l~H--~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         130 MRILYQ--DCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             HHHHHH--hCCcccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence            999943  77999999999999998 4789999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=8.9e-21  Score=215.52  Aligned_cols=251  Identities=20%  Similarity=0.195  Sum_probs=181.4

Q ss_pred             CCCeecccCCeeeEEEEc-CCCcEEEEEEeecC--CcccHH----HHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEE
Q 003504          512 RGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG--STLTDQ----EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       512 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~----~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  584 (815)
                      ...++|.|++|.|+.++. ......+.|..+..  ......    .+..|+.+-..++|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            468899999998887763 33333444433210  111111    25568888888999999998888887777777799


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      |+++ +|..++...                              ..+.-..+-.+..|+..|+.|+|   ..+|.|||+|
T Consensus       402 ~~~~-Dlf~~~~~~------------------------------~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK  447 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN------------------------------GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLK  447 (601)
T ss_pred             cccH-HHHHHHhcc------------------------------cccchhhhhHHHHHHHHHHHHHH---hcCceeccCc
Confidence            9999 999998642                              23455566789999999999999   8999999999


Q ss_pred             CCceEEcCCCCeeecccccceecCCCC-----ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL-----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~  739 (815)
                      ++|++++.+|.+||+|||.+.....+.     .....+|+..|+|||.+.+..+ .....||||.||++..|.+|+.||.
T Consensus       448 ~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~y-dpr~vDiwS~~ii~~~m~~~~~~Wk  526 (601)
T KOG0590|consen  448 LENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEY-DPRAVDVWSCGIIYICMILGRFPWK  526 (601)
T ss_pred             cccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccccccc-CcchhhhhhccceEEEEecCCCccc
Confidence            999999999999999999987654332     3345679999999999987773 3456899999999999999999997


Q ss_pred             CCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~  806 (815)
                      ....++...         .......+.-...-...-....+.+...++.++++.+|.+|.++++|++
T Consensus       527 ~a~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  527 VAKKSDNSF---------KTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccccch---------hhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            543322210         0000000000000000113345677889999999999999999999975

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=3.2e-20  Score=183.35  Aligned_cols=171  Identities=13%  Similarity=0.095  Sum_probs=131.4

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHH---------HHHHHHHhcCCCCCCceeeeeEEEeC
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQE---------AARELEYLGRIKHPNLVPLTGYCIAG  576 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~~  576 (815)
                      -..+|...+++|.|+||.||.+.. ++..+|||.++......+..         +++|+..+.++.||+|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            457899999999999999999766 56789999997654433332         68899999999999999999886643


Q ss_pred             --------CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHH
Q 003504          577 --------DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALA  648 (815)
Q Consensus       577 --------~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~  648 (815)
                              ...++||||+++.+|.++...                                  +    .....+++.++.
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~~----------------------------------~----~~~~~~i~~~l~  149 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPEI----------------------------------S----EDVKAKIKASIE  149 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhhc----------------------------------c----HHHHHHHHHHHH
Confidence                    247899999999999776421                                  1    124568999999


Q ss_pred             HHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHH
Q 003504          649 FLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVL  728 (815)
Q Consensus       649 yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl  728 (815)
                      .+|   ..+++|||+||+||+++.++ ++|+|||.............           +.....  +..++|+|||||.+
T Consensus       150 ~lH---~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d~-----------~vler~--y~~~~di~~lg~~~  212 (232)
T PRK10359        150 SLH---QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKDR-----------IDLERH--YGIKNEIKDLGYYL  212 (232)
T ss_pred             HHH---HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHHH-----------HHHHhH--hcccccccceeEee
Confidence            999   89999999999999999988 99999998875532211110           222222  45789999999987


Q ss_pred             HHHH
Q 003504          729 LELI  732 (815)
Q Consensus       729 ~el~  732 (815)
                      .-..
T Consensus       213 ~~~~  216 (232)
T PRK10359        213 LIYK  216 (232)
T ss_pred             hHHH
Confidence            6544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=7.3e-20  Score=173.19  Aligned_cols=256  Identities=18%  Similarity=0.219  Sum_probs=187.5

Q ss_pred             hcCCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCC-CCceeeeeEEEeCCeeEEEEE
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKH-PNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e  584 (815)
                      ...|...+.||.|+||.+|.|. +.+|..||||+-+...  ..-++..|.++.+.++| ..|..+..|..+.....+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            3578889999999999999999 6789999999865432  23356778888888864 677777778888888999999


Q ss_pred             eCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  664 (815)
                      ..-. ||.++..-+                             ...++..+.+-+|-|+..-++|+|   .+++||||||
T Consensus        92 LLGP-sLEdLfnfC-----------------------------~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIK  138 (341)
T KOG1163|consen   92 LLGP-SLEDLFNFC-----------------------------SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIK  138 (341)
T ss_pred             ccCc-cHHHHHHHH-----------------------------hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCC
Confidence            8754 999988653                             234667788889999999999999   8999999999


Q ss_pred             CCceEEcCC---CCeeecccccceecCCCC--------ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh
Q 003504          665 ASSVYLDMN---LEPRLSDFGLAKIFGNGL--------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       665 ~~NIll~~~---~~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                      |+|.|..-+   -.+.++|||+|+.+-...        ......||..|.+-....+..  -+.+.|+=|+|.|+.++-.
T Consensus       139 PdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e--qSRRDDmeSvgYvLmYfnr  216 (341)
T KOG1163|consen  139 PDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE--QSRRDDMESVGYVLMYFNR  216 (341)
T ss_pred             ccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh--hhhhhhhhhhcceeeeeec
Confidence            999999754   358999999999764321        122335899999888766555  4778999999999999999


Q ss_pred             CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003504          734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~  809 (815)
                      |..||.+.......+....    +.+. +.. .....+    ....+.++.-.+.-|-..--++-|...-+.+...
T Consensus       217 G~LPWQglka~tk~QKyEk----I~Ek-K~s-~~ie~L----C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  217 GSLPWQGLKAATKKQKYEK----ISEK-KMS-TPIEVL----CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             CCCcccccchhhHHHHHHH----HHHh-hcC-CCHHHH----hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            9999997543322221111    1111 100 000111    2234566777788888888888887776665543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=2.2e-19  Score=173.15  Aligned_cols=185  Identities=17%  Similarity=0.100  Sum_probs=138.4

Q ss_pred             CCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCccc----HHHHHHHHHHhcCCC-CCCceeeeeEEEeCCeeEEEEEe
Q 003504          511 DRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLT----DQEAARELEYLGRIK-HPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       511 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      .....|++|+||+||.+.- ++.+++.+.+.......    ...+.+|+++|+++. |+++.+++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999997766 57788888775532211    125789999999995 5889999886    456899999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC-C
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI-K  664 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-k  664 (815)
                      +++.+|...+..                              .       ...++.+++.+|+++|   ..+|||||| |
T Consensus        80 I~G~~L~~~~~~------------------------------~-------~~~~~~qi~~~L~~lH---~~GIvHrDL~k  119 (218)
T PRK12274         80 LAGAAMYQRPPR------------------------------G-------DLAYFRAARRLLQQLH---RCGVAHNDLAK  119 (218)
T ss_pred             ecCccHHhhhhh------------------------------h-------hHHHHHHHHHHHHHHH---HCcCccCCCCC
Confidence            999888654321                              0       1246778999999999   899999999 7


Q ss_pred             CCceEEcCCCCeeecccccceecCCCCc--------------cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHH
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGLD--------------EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE  730 (815)
Q Consensus       665 ~~NIll~~~~~~kl~Dfgla~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~e  730 (815)
                      |.|||++.++.++|+|||+|........              ..-...++.|++|+-........-.+.+.++-|.-+|.
T Consensus       120 p~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~  199 (218)
T PRK12274        120 EANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYR  199 (218)
T ss_pred             cceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHH
Confidence            9999999999999999999986553321              00112577788887543322212256789999999999


Q ss_pred             HHhCCCCCCC
Q 003504          731 LITGKKPLGD  740 (815)
Q Consensus       731 l~tg~~p~~~  740 (815)
                      ++||+.|...
T Consensus       200 ~~~~~~~~~~  209 (218)
T PRK12274        200 FVTRRVLHWE  209 (218)
T ss_pred             HHhccCCccc
Confidence            9999988664

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=3e-19  Score=175.97  Aligned_cols=140  Identities=14%  Similarity=0.177  Sum_probs=110.1

Q ss_pred             CCeecccCCeeeEEEEcCCCcEEEEEEeecCCccc--------------------------HHHHHHHHHHhcCCCCCCc
Q 003504          513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLT--------------------------DQEAARELEYLGRIKHPNL  566 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~H~ni  566 (815)
                      ...||+|+||.||+|...+|+.||||+++......                          ...+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999998789999999997642210                          1124678999999999987


Q ss_pred             eeeeeEEEeCCeeEEEEEeCCCCChhhh-hccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHH
Q 003504          567 VPLTGYCIAGDQRIAIYDYMENGNLQNL-LHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTAR  645 (815)
Q Consensus       567 v~l~g~~~~~~~~~lv~ey~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~  645 (815)
                      .....+...  ..++||||++++++... +..                               ..++.....+++.+++.
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-------------------------------~~~~~~~~~~i~~~l~~  128 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-------------------------------VPLEEEEAEELYEQVVE  128 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh-------------------------------ccCCHHHHHHHHHHHHH
Confidence            544443332  35899999998855333 321                               23456678899999999


Q ss_pred             HHHHHhcCCC-CCeeeccCCCCceEEcCCCCeeecccccceecCC
Q 003504          646 ALAFLHHGCS-PPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN  689 (815)
Q Consensus       646 ~L~yLH~~~~-~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  689 (815)
                      ++.|+|   . .+|+||||||+||+++ ++.++|+|||++.....
T Consensus       129 ~l~~lH---~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         129 QMRRLY---QEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             HHHHHH---HhCCEecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence            999999   6 8999999999999999 78999999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.80  E-value=8.1e-21  Score=204.59  Aligned_cols=129  Identities=30%  Similarity=0.285  Sum_probs=82.2

Q ss_pred             EecCCCCCccCCCcccccCCCCCCEEECcCCCCC-----CCCcccCCCCCCCEEEccCCcCCc------cCCccccCCCC
Q 003504           33 FLASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT-----ALPSDLWSLGSLKSLNLSYNRISG------SLPSNIGNFGL  101 (815)
Q Consensus        33 l~~~~~~~~g~~~~~~~~~l~~L~~L~Ls~n~l~-----~lp~~~~~l~~L~~L~L~~N~i~~------~~~~~~~~l~~  101 (815)
                      +++.++.+++.--...+..+++|++|+|+++.++     .++..+...++|++|+++++.+.+      .++..|..+++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            4566666664433456777778888888888874     355556667778888888887762      22345666667


Q ss_pred             CcEEEccCCcCCCCChhhhcCCcC---CCEEEcCCCcccc----cCCcccccc-cccceeeccCCcCC
Q 003504          102 LEVFDLSNNNFSGEIPAAISSLVS---LRVLKLDGNMFQW----SIPPGLLNC-QSLVTVDLSMNQLN  161 (815)
Q Consensus       102 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~l~~N~l~  161 (815)
                      |+.|+|++|.+.+..+..|..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.++
T Consensus        83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~  150 (319)
T cd00116          83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLE  150 (319)
T ss_pred             eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCC
Confidence            777777777776666666655555   7777777776652    122233344 56666666666665

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=1.2e-18  Score=172.59  Aligned_cols=256  Identities=18%  Similarity=0.227  Sum_probs=187.0

Q ss_pred             CCCCCCeecccCCeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .|.++++||+|+||+++.|+ +-++.+||||.-...+  +.-++..|....+.| ..+.|..++.+-.++-...+|+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            68889999999999999999 5678999999754322  233566677766666 4688888877767777888999987


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      -. ||.++..-+                             +..++.++..-||.|+..-++|+|   ++.+|.|||||+
T Consensus       107 GP-SLEDLFD~C-----------------------------gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPd  153 (449)
T KOG1165|consen  107 GP-SLEDLFDLC-----------------------------GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPD  153 (449)
T ss_pred             Cc-CHHHHHHHh-----------------------------cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCcc
Confidence            44 898888643                             446788889999999999999999   899999999999


Q ss_pred             ceEEcCCC-----CeeecccccceecCCCC--------ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh
Q 003504          667 SVYLDMNL-----EPRLSDFGLAKIFGNGL--------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       667 NIll~~~~-----~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                      |+||..-+     .+.|+|||+|+.+....        ......||..||+-....+..  -+.+.|.=|+|=|+.+.+.
T Consensus       154 NFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE--QSRRDDLEaLGHvFmYFLR  231 (449)
T KOG1165|consen  154 NFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLR  231 (449)
T ss_pred             ceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccch--hhhhhhHHHhhhhhhhhcc
Confidence            99998544     48999999999876433        223345999999999888877  4788999999999999999


Q ss_pred             CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhh
Q 003504          734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i  811 (815)
                      |..||.+........       ++-+-....+.......   .+..+.++..-+.---..+-.+-|..+-+...+..+
T Consensus       232 GsLPWQGLKA~tnK~-------kYeKIGe~Kr~T~i~~L---c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv  299 (449)
T KOG1165|consen  232 GSLPWQGLKADTNKE-------KYEKIGETKRSTPIEVL---CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV  299 (449)
T ss_pred             CCCccccccCcchHH-------HHHHhccccccCCHHHH---HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            999998743221111       11111111111111111   223455666666666667778888887776666554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=2e-19  Score=181.76  Aligned_cols=196  Identities=21%  Similarity=0.238  Sum_probs=137.9

Q ss_pred             CCCCceeeeeEEEeC---------------------------CeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccc
Q 003504          562 KHPNLVPLTGYCIAG---------------------------DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWE  614 (815)
Q Consensus       562 ~H~niv~l~g~~~~~---------------------------~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~  614 (815)
                      +|||||++.++|.+.                           ...|+||.-.+. +|.+++-..                
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----------------  336 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----------------  336 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----------------
Confidence            599999999987652                           135788877766 888888542                


Q ss_pred             cCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEE--cCCC--CeeecccccceecCC-
Q 003504          615 EDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL--DMNL--EPRLSDFGLAKIFGN-  689 (815)
Q Consensus       615 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll--~~~~--~~kl~Dfgla~~~~~-  689 (815)
                                     ..+...+.-|..|+.+|+.|||   .++|.|||+|++|||+  |+|+  .+.|+|||.+-.-.. 
T Consensus       337 ---------------~~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~h  398 (598)
T KOG4158|consen  337 ---------------HRSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNH  398 (598)
T ss_pred             ---------------CCchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeecccc
Confidence                           2344556668889999999999   8999999999999998  4444  478999998753321 


Q ss_pred             ------CCccccccccccccCCcccCCCCCC----CCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHh
Q 003504          690 ------GLDEEIARGSPGYIPPEFAQPDSDF----PTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVR  759 (815)
Q Consensus       690 ------~~~~~~~~gt~~y~aPE~~~~~~~~----~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  759 (815)
                            .+.....-|.-.-||||+.....+.    ...|+|.|+.|-+.||+++...||.....  ..          ++
T Consensus       399 Glqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~----------L~  466 (598)
T KOG4158|consen  399 GLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--ML----------LD  466 (598)
T ss_pred             ccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--he----------ec
Confidence                  1112222366778999987655432    25689999999999999999999975211  11          11


Q ss_pred             cCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003504          760 NNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       760 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L  808 (815)
                      ...+++.-    ....|+.++..+.+++...+++||++||+..-....|
T Consensus       467 ~r~Yqe~q----LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  467 TRTYQESQ----LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             hhhhhhhh----CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence            11111111    1223666777889999999999999999876554433

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=3.8e-21  Score=172.47  Aligned_cols=162  Identities=27%  Similarity=0.432  Sum_probs=132.3

Q ss_pred             ccCCCCCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCE
Q 003504           49 IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRV  128 (815)
Q Consensus        49 ~~~l~~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  128 (815)
                      +-.+++++.|.||+|+++.+|+.+..+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. ++|..|+.++-|+.
T Consensus        29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence            44566778888888888888888888888888888888887 67788888888888888888887 77888888888888


Q ss_pred             EEcCCCcccc-cCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccCCCCCCCCCCCCCeEeccCCc
Q 003504          129 LKLDGNMFQW-SIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNL  207 (815)
Q Consensus       129 L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~  207 (815)
                      |||+.|++.. .+|..|..++.|+-|+|++|.+. .+|..++ .+++|+.|.+..|.+-.+|..++.++.|++|.+.+|+
T Consensus       107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg-~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVG-KLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhh-hhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccce
Confidence            8888887763 57778888888888888888887 7887774 4788888888888888888888888888888888888


Q ss_pred             CCCcchh
Q 003504          208 FQGSVMG  214 (815)
Q Consensus       208 l~~~~~~  214 (815)
                      ++.+|+.
T Consensus       185 l~vlppe  191 (264)
T KOG0617|consen  185 LTVLPPE  191 (264)
T ss_pred             eeecChh
Confidence            8877765

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.77  E-value=7.9e-20  Score=196.90  Aligned_cols=105  Identities=22%  Similarity=0.129  Sum_probs=54.6

Q ss_pred             EEECcCCCCC--CCCcccCCCCCCCEEEccCCcCCcc----CCccccCCCCCcEEEccCCcCCC------CChhhhcCCc
Q 003504           57 SLDLSENNIT--ALPSDLWSLGSLKSLNLSYNRISGS----LPSNIGNFGLLEVFDLSNNNFSG------EIPAAISSLV  124 (815)
Q Consensus        57 ~L~Ls~n~l~--~lp~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~  124 (815)
                      .|+|..+.++  ..+.-+..+.+|++|+|+++.++..    ++..+...++|++|++++|.+.+      .++..|..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            3566666665  2222223355566666666666432    34445555566666666666552      1233445555


Q ss_pred             CCCEEEcCCCcccccCCcccccccc---cceeeccCCcCC
Q 003504          125 SLRVLKLDGNMFQWSIPPGLLNCQS---LVTVDLSMNQLN  161 (815)
Q Consensus       125 ~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~l~~N~l~  161 (815)
                      +|+.|+|++|.+....+..+..+.+   |++|++++|+++
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~  121 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG  121 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccc
Confidence            5666666655555444444444333   555555555554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=1e-20  Score=169.72  Aligned_cols=157  Identities=30%  Similarity=0.480  Sum_probs=80.7

Q ss_pred             ccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCCCcccccCCccccccccc
Q 003504           71 DLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSL  150 (815)
Q Consensus        71 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  150 (815)
                      .++.+.+++.|-|++|+++ ..|..++.+.+|+.|++++|+|+ .+|.+++.|++|+.|+++-|++. ..|..|+.++.|
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l  104 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL  104 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence            3444555555555555555 34445555555555555555555 44555555555555555555554 455555555555


Q ss_pred             ceeeccCCcCC-CCCCchhhccCCCCCEEEcCCCcccCCCCCCCCCCCCCeEeccCCcCCCcchhhh-hcccceeeeccc
Q 003504          151 VTVDLSMNQLN-GSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF-LESLEVIDLRSN  228 (815)
Q Consensus       151 ~~L~l~~N~l~-~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-l~~L~~L~L~~N  228 (815)
                      +.|||++|++. ..+|..||. +..|+-|+|++|.+..+|+..+++++|+.|.+..|.+-++|...- +..|++|.+++|
T Consensus       105 evldltynnl~e~~lpgnff~-m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgn  183 (264)
T KOG0617|consen  105 EVLDLTYNNLNENSLPGNFFY-MTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGN  183 (264)
T ss_pred             hhhhccccccccccCCcchhH-HHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccc
Confidence            55555555543 234444442 445555555555555555555555555555555555555444433 455555555555


Q ss_pred             ccc
Q 003504          229 QFQ  231 (815)
Q Consensus       229 ~l~  231 (815)
                      +++
T Consensus       184 rl~  186 (264)
T KOG0617|consen  184 RLT  186 (264)
T ss_pred             eee
Confidence            554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.7e-19  Score=194.34  Aligned_cols=225  Identities=25%  Similarity=0.283  Sum_probs=173.7

Q ss_pred             eecccCCeeeEEEE----cCCCcEEEEEEeecCCccc--HHHHHHHHHHhcCCC-CCCceeeeeEEEeCCeeEEEEEeCC
Q 003504          515 LLAEGKFGPVYRGF----LPGGIHVAVKVLVHGSTLT--DQEAARELEYLGRIK-HPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       515 ~ig~G~~g~Vy~~~----~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ey~~  587 (815)
                      ++|+|+||.|+.+.    .+.|..+|+|++++.....  ......|..+++.++ ||.+|++...++.....+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            36899999999765    3446778999886643221  124556888888887 9999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~N  667 (815)
                      +|.|...+.+.                              ...+..........+|-+++++|   +.+++|||+|++|
T Consensus        81 gg~lft~l~~~------------------------------~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~en  127 (612)
T KOG0603|consen   81 GGDLFTRLSKE------------------------------VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLEN  127 (612)
T ss_pred             cchhhhccccC------------------------------CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccc
Confidence            99998888642                              12233333445556788899999   8999999999999


Q ss_pred             eEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCcccc
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE  747 (815)
Q Consensus       668 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  747 (815)
                      |+++.+|.+++.|||+++..-...   ..+||..|||||++.+    .....|.|||||+++|++||..||..       
T Consensus       128 illd~~Ghi~~tdfglske~v~~~---~~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~-------  193 (612)
T KOG0603|consen  128 VLLLLEGHIKLTDFGLSKEAVKEK---IACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG-------  193 (612)
T ss_pred             eeecccCccccCCchhhhHhHhhh---hcccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch-------
Confidence            999999999999999998764332   2389999999999983    35689999999999999999999975       


Q ss_pred             ccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 003504          748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM  801 (815)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  801 (815)
                          ..++.++..           ....|.+....+.+++...+..+|..|--.
T Consensus       194 ----~~~~~Il~~-----------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  194 ----DTMKRILKA-----------ELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ----HHHHHHhhh-----------ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                112223221           122366777788888888888889888744

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=9.2e-19  Score=178.27  Aligned_cols=236  Identities=21%  Similarity=0.217  Sum_probs=151.4

Q ss_pred             CCCeecccCCeeeEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCC----------CCceeeeeEEEe--
Q 003504          512 RGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKH----------PNLVPLTGYCIA--  575 (815)
Q Consensus       512 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~~--  575 (815)
                      .++.||.|+++.||.++. .+++++|||++....   ....+++++|.-....+.+          -.++-.++....  
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            367999999999999996 458999999886432   2234667777765555433          122222222211  


Q ss_pred             -------CC--------eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHH
Q 003504          576 -------GD--------QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIA  640 (815)
Q Consensus       576 -------~~--------~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  640 (815)
                             ..        ..+++|+-+. ++|.+++....                       ........+....|+.+.
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~-----------------------~~~~~~~~l~~~arl~lT  151 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALF-----------------------SRAQTHSPLAFAARLSLT  151 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHH-----------------------HHTTTSHHHHHHHHHHHH
T ss_pred             CCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHh-----------------------hcccccchhHHHHHHHHH
Confidence                   11        2356777774 48888764310                       000112346677889999


Q ss_pred             HHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCC------CCC
Q 003504          641 LGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPD------SDF  714 (815)
Q Consensus       641 ~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~  714 (815)
                      .|+.+.+++||   ..++||+||+|+|++++.+|.++|+||+.....+...  .....+..|.+||.....      ...
T Consensus       152 ~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~  226 (288)
T PF14531_consen  152 VQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAP  226 (288)
T ss_dssp             HHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEE
T ss_pred             HHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEEcChHHHeecCcee--eccCCCcccCChhhhhhhcccCcccce
Confidence            99999999999   8999999999999999999999999998877654322  213356789999976432      112


Q ss_pred             CCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccC
Q 003504          715 PTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL  794 (815)
Q Consensus       715 ~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~d  794 (815)
                      ++.+.|.|++|+++|.|+.|..||+...++.....                     .-..+. +.++.+..++...++++
T Consensus       227 ~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~  284 (288)
T PF14531_consen  227 YTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRN  284 (288)
T ss_dssp             E-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SS
T ss_pred             eeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCC
Confidence            58889999999999999999999986433222110                     122334 78889999999999999


Q ss_pred             CCCC
Q 003504          795 PLKR  798 (815)
Q Consensus       795 P~~R  798 (815)
                      |++|
T Consensus       285 ~~~R  288 (288)
T PF14531_consen  285 PEDR  288 (288)
T ss_dssp             GGGS
T ss_pred             cccC
Confidence            9988

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=1.1e-17  Score=165.21  Aligned_cols=136  Identities=15%  Similarity=0.173  Sum_probs=104.9

Q ss_pred             CCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-----CCCCceeeeeEEEeCC---e-eEE
Q 003504          511 DRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-----KHPNLVPLTGYCIAGD---Q-RIA  581 (815)
Q Consensus       511 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~l  581 (815)
                      ...+.||+|+||.||. ...++.. +||++........+.+.+|+.++..+     +||||++++|++.+..   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3467999999999996 3334444 79988765445567899999999999     5799999999998864   3 337


Q ss_pred             EEEe--CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHH-HHHhcCCCCCe
Q 003504          582 IYDY--MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARAL-AFLHHGCSPPI  658 (815)
Q Consensus       582 v~ey--~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L-~yLH~~~~~~i  658 (815)
                      |+||  +++|+|.+++.+.                               .++..  ..++.++..++ +|||   +.+|
T Consensus        83 I~e~~G~~~~tL~~~l~~~-------------------------------~~~e~--~~~~~~~L~~l~~yLh---~~~I  126 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC-------------------------------RYEED--VAQLRQLLKKLKRYLL---DNRI  126 (210)
T ss_pred             EecCCCCcchhHHHHHHcc-------------------------------cccHh--HHHHHHHHHHHHHHHH---HCCE
Confidence            8999  6689999999641                               12222  34567777777 9999   8999


Q ss_pred             eeccCCCCceEEcC----CCCeeecccccc
Q 003504          659 IHRDIKASSVYLDM----NLEPRLSDFGLA  684 (815)
Q Consensus       659 vHrDlk~~NIll~~----~~~~kl~Dfgla  684 (815)
                      |||||||+|||++.    ++.++|+||+.+
T Consensus       127 vhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        127 VTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             eecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            99999999999974    347999995433

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.73  E-value=9.7e-19  Score=197.27  Aligned_cols=249  Identities=23%  Similarity=0.243  Sum_probs=175.4

Q ss_pred             CCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHH--hcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGS-TLTDQEAARELEY--LGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +|...+.+|+++|=+|.+|+.+.|. |+||++-+.. ...-..|+++++-  ..-++|||.+++.-.-......|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5677889999999999999998887 9999986654 3334445444333  4455899999997776666667788888


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      ..+ +|++.|..                              ..-+...+.+-||.|+..||.-+|   ..+|+|||||.
T Consensus       103 vkh-nLyDRlST------------------------------RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKs  148 (1431)
T KOG1240|consen  103 VKH-NLYDRLST------------------------------RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKS  148 (1431)
T ss_pred             Hhh-hhhhhhcc------------------------------chHHHHHHHHHHHHHHHHHHHHHH---HcCcccccccc
Confidence            877 88888854                              234556667789999999999999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceec--CCCC--ccc----cccccccccCCcccCCCC--------C-CCCCcCcchhHHHHH
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIF--GNGL--DEE----IARGSPGYIPPEFAQPDS--------D-FPTPKSDVYCYGVVL  728 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~--~~~~--~~~----~~~gt~~y~aPE~~~~~~--------~-~~~~~~Dv~S~Gvvl  728 (815)
                      +||||+.=.-+.|+||.--+..  ..+.  ...    +...-.-|+|||-+....        . ..+++-||||.|||+
T Consensus       149 ENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi  228 (1431)
T KOG1240|consen  149 ENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI  228 (1431)
T ss_pred             ceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence            9999998888999999865432  2211  111    111223599999765421        1 136788999999999


Q ss_pred             HHHHh-CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003504          729 LELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       729 ~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      .||++ |++||.-       .++.++-..       . ..++....+.-  ....+..++..|++.||++|.++++.++.
T Consensus       229 aELf~Eg~PlF~L-------SQL~aYr~~-------~-~~~~e~~Le~I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  229 AELFLEGRPLFTL-------SQLLAYRSG-------N-ADDPEQLLEKI--EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHhcCCCcccH-------HHHHhHhcc-------C-ccCHHHHHHhC--cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            99999 7888862       222222111       0 00110000000  11247789999999999999999999986


Q ss_pred             HH
Q 003504          808 LK  809 (815)
Q Consensus       808 L~  809 (815)
                      -.
T Consensus       292 yr  293 (1431)
T KOG1240|consen  292 YR  293 (1431)
T ss_pred             hh
Confidence            43

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=3.3e-17  Score=189.44  Aligned_cols=196  Identities=20%  Similarity=0.230  Sum_probs=156.6

Q ss_pred             HHHHhcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC---CCCceeeeeEEEeCCee
Q 003504          503 LLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK---HPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       503 l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~  579 (815)
                      .......|.+.+.||+|+||+||+|...+|+.||+|+=+.....+   |.--.+++.||+   -+-|+.+..++...+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            344456788889999999999999998889999999865543322   222223333444   23455666666677888


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++|+||.+.|+|.+++..                              .+..+|.-.+.++.++++.++.||   ..+||
T Consensus       770 ~lv~ey~~~Gtlld~~N~------------------------------~~~m~e~lv~~~~~qml~ive~lH---~~~II  816 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINT------------------------------NKVMDEYLVMFFSCQMLRIVEHLH---AMGII  816 (974)
T ss_pred             eeeeeccccccHHHhhcc------------------------------CCCCCchhhhHHHHHHHHHHHHHH---hccee
Confidence            999999999999999952                              456788888999999999999999   89999


Q ss_pred             eccCCCCceEEcC-------CCCeeecccccceecC---CCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHH
Q 003504          660 HRDIKASSVYLDM-------NLEPRLSDFGLAKIFG---NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLL  729 (815)
Q Consensus       660 HrDlk~~NIll~~-------~~~~kl~Dfgla~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~  729 (815)
                      |+||||+|.||..       ...++|+|||.+..+.   .+......++|..+-.+|...+..  .+.+.|-|.++-+++
T Consensus       817 HgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp--WtYq~DyfGlAa~~h  894 (974)
T KOG1166|consen  817 HGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP--WTYQIDYFGLAATVH  894 (974)
T ss_pred             cccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC--CchhhhhHHHHHHHH
Confidence            9999999999942       2458999999997653   444566778999999999998887  889999999999999


Q ss_pred             HHHhCCC
Q 003504          730 ELITGKK  736 (815)
Q Consensus       730 el~tg~~  736 (815)
                      -|+.|+.
T Consensus       895 ~mLFG~y  901 (974)
T KOG1166|consen  895 VMLFGKY  901 (974)
T ss_pred             HHHHHHH
Confidence            9999874

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=5.3e-17  Score=164.75  Aligned_cols=143  Identities=13%  Similarity=0.154  Sum_probs=109.8

Q ss_pred             cCCCCCCeecccCCeeeEEEE--cCCCcEEEEEEeecCCcc------------------------cHHHHHHHHHHhcCC
Q 003504          508 SNFDRGTLLAEGKFGPVYRGF--LPGGIHVAVKVLVHGSTL------------------------TDQEAARELEYLGRI  561 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l  561 (815)
                      ..|.+.+.||+|+||.||+|.  ..+|+.||||+++.....                        ....+.+|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357788999999999999998  678999999998753210                        012356899999999


Q ss_pred             CCCC--ceeeeeEEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHH
Q 003504          562 KHPN--LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKI  639 (815)
Q Consensus       562 ~H~n--iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  639 (815)
                      .+..  +.+++++    ...++||||+++++|......                              ...........+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~------------------------------~~~~~~~~~~~i  153 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK------------------------------DVEPEEEEEFEL  153 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc------------------------------cCCcchHHHHHH
Confidence            7533  3444442    235899999999888765422                              112333455789


Q ss_pred             HHHHHHHHHHHhcCCCCC-eeeccCCCCceEEcCCCCeeecccccceecC
Q 003504          640 ALGTARALAFLHHGCSPP-IIHRDIKASSVYLDMNLEPRLSDFGLAKIFG  688 (815)
Q Consensus       640 ~~~ia~~L~yLH~~~~~~-ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~  688 (815)
                      +.|++.+++|||   ..+ ++||||||+||+++ ++.++|+|||.+....
T Consensus       154 ~~qi~~~l~~LH---~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      154 YDDILEEMRKLY---KEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             HHHHHHHHHHHH---hcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            999999999999   788 99999999999999 8899999999987554

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=1.2e-16  Score=158.96  Aligned_cols=145  Identities=17%  Similarity=0.154  Sum_probs=112.0

Q ss_pred             HHHHHhcCCCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcc----------------------cHHHHHHHHHHhc
Q 003504          502 DLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTL----------------------TDQEAARELEYLG  559 (815)
Q Consensus       502 ~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~  559 (815)
                      ++......|...+.||+|+||.||+|...+|+.||||+++.....                      ....+.+|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            344444447788999999999999999888999999987643210                      0123567899999


Q ss_pred             CCCCCC--ceeeeeEEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHH
Q 003504          560 RIKHPN--LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRH  637 (815)
Q Consensus       560 ~l~H~n--iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  637 (815)
                      .+.|++  +.+.++    ....++||||+++++|......                                    ....
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------------------------------------~~~~  128 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------------------------------------EDPE  128 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------------------------------------ccHH
Confidence            988774  444443    2456899999999998765420                                    1134


Q ss_pred             HHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCC
Q 003504          638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN  689 (815)
Q Consensus       638 ~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  689 (815)
                      +++.+++.++.++|   ..+|+||||||+||++++++.++|+|||.+.....
T Consensus       129 ~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         129 EVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             HHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            68889999999999   79999999999999999999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=1.2e-16  Score=160.90  Aligned_cols=134  Identities=24%  Similarity=0.354  Sum_probs=112.9

Q ss_pred             CeecccCCeeeEEEEcCCCcEEEEEEeecCCccc--------HHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          514 TLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLT--------DQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      +.||+|++|.||+|.. .|..|+||.........        ...+.+|++++..++|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 56789999865432211        23577899999999999998888787777888999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++++|.+++...                                 .+ .+..++.+++.+|.++|   ..+++|||++|
T Consensus        81 ~~G~~L~~~~~~~---------------------------------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p  123 (211)
T PRK14879         81 IEGEPLKDLINSN---------------------------------GM-EELELSREIGRLVGKLH---SAGIIHGDLTT  123 (211)
T ss_pred             eCCcCHHHHHHhc---------------------------------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCc
Confidence            9999999988541                                 11 67889999999999999   89999999999


Q ss_pred             CceEEcCCCCeeeccccccee
Q 003504          666 SSVYLDMNLEPRLSDFGLAKI  686 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~  686 (815)
                      .||+++ ++.++|+|||.++.
T Consensus       124 ~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        124 SNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             ccEEEE-CCCEEEEECCcccC
Confidence            999999 78899999998864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.67  E-value=3.3e-17  Score=185.13  Aligned_cols=206  Identities=27%  Similarity=0.346  Sum_probs=145.8

Q ss_pred             hcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ..+|+..+.|..|+||.||.+.+. ..+++|+|+ ++.     ..+.|-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq-----~lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQ-----NLILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-ccc-----chhhhc--cccccCCccee------------------
Confidence            357888999999999999999865 356788853 321     111111  22222333333                  


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                         |+-...+....                            ..+.          +++.+++|+|   ..+|||||+||
T Consensus       136 ---gDc~tllk~~g----------------------------~lPv----------dmvla~Eylh---~ygivhrdlkp  171 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG----------------------------PLPV----------DMVLAVEYLH---SYGIVHRDLKP  171 (1205)
T ss_pred             ---chhhhhcccCC----------------------------CCcc----------hhhHHhHhhc---cCCeecCCCCC
Confidence               34344443210                            1111          2378899999   89999999999


Q ss_pred             CceEEcCCCCeeecccccceecCC----------------CCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHH
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGN----------------GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLL  729 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~  729 (815)
                      +|.+|+.-|.+|+.|||+++.-..                .......+||+.|+|||++....  |+..+|+|++|+++|
T Consensus       172 dnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg--ygkpvdwwamGiIly  249 (1205)
T KOG0606|consen  172 DNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG--YGKPVDWWAMGIILY  249 (1205)
T ss_pred             CcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc--cCCCccHHHHHHHHH
Confidence            999999999999999999875210                11334567999999999998776  789999999999999


Q ss_pred             HHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCC
Q 003504          730 ELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP  799 (815)
Q Consensus       730 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  799 (815)
                      |.+.|..||.++.+++.-+.++.....+.               +..+..+.+..+++...++.+|.+|-
T Consensus       250 eFLVgcvpffGdtpeelfg~visd~i~wp---------------E~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  250 EFLVGCVPFFGDTPEELFGQVISDDIEWP---------------EEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             HHheeeeeccCCCHHHHHhhhhhhhcccc---------------ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            99999999999888876555543221111               11233445788999999999999997

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=2e-16  Score=181.28  Aligned_cols=136  Identities=20%  Similarity=0.309  Sum_probs=110.7

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCCCcEEEEEEee-cCCc-------ccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCee
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLV-HGST-------LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~-~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  579 (815)
                      ..|...+.||+|+||.||+|.+.+.. +++|+.. +...       ...+.+.+|++++.+++|++++....++......
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34456789999999999999876544 4444322 1111       1124678999999999999999888888887788


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++||||+++++|.+++..                                      +..++.+++++|.|||   +.+++
T Consensus       412 ~lv~E~~~g~~L~~~l~~--------------------------------------~~~~~~~i~~~L~~lH---~~gii  450 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLEG--------------------------------------NPELVRKVGEIVAKLH---KAGIV  450 (535)
T ss_pred             EEEEEecCCCcHHHHHHH--------------------------------------HHHHHHHHHHHHHHHH---hCCCc
Confidence            999999999999988742                                      3578999999999999   89999


Q ss_pred             eccCCCCceEEcCCCCeeeccccccee
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKI  686 (815)
Q Consensus       660 HrDlk~~NIll~~~~~~kl~Dfgla~~  686 (815)
                      |||+||+|||+ +++.++|+|||+++.
T Consensus       451 HrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        451 HGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             cCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999 577999999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=3.1e-16  Score=156.31  Aligned_cols=130  Identities=23%  Similarity=0.353  Sum_probs=106.6

Q ss_pred             eecccCCeeeEEEEcCCCcEEEEEEeecCCcc--------cHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeC
Q 003504          515 LLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTL--------TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       515 ~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~  586 (815)
                      .||+|+||.||+|.+ ++..|++|........        ....+.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 4678999986542211        1245678999999999887766666666777789999999


Q ss_pred             CCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~  666 (815)
                      ++++|.+++...                              ..       .++.+++.+|.+||   +.+++|||++|.
T Consensus        80 ~g~~l~~~~~~~------------------------------~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~  119 (199)
T TIGR03724        80 EGKPLKDVIEEG------------------------------ND-------ELLREIGRLVGKLH---KAGIVHGDLTTS  119 (199)
T ss_pred             CCccHHHHHhhc------------------------------HH-------HHHHHHHHHHHHHH---HCCeecCCCCcc
Confidence            999999887531                              00       68999999999999   899999999999


Q ss_pred             ceEEcCCCCeeeccccccee
Q 003504          667 SVYLDMNLEPRLSDFGLAKI  686 (815)
Q Consensus       667 NIll~~~~~~kl~Dfgla~~  686 (815)
                      ||+++ ++.+++.|||+++.
T Consensus       120 Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724       120 NIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             eEEEE-CCcEEEEECCCCcC
Confidence            99999 78999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.63  E-value=1.7e-16  Score=168.17  Aligned_cols=172  Identities=21%  Similarity=0.293  Sum_probs=128.6

Q ss_pred             eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~  657 (815)
                      ..++.|++|...+|.+||...+                           .....+|...+.++.|++.|++|      ++
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~---------------------------~~e~~s~s~~~~~~~q~~~~~~y------k~  376 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR---------------------------TGEERSLSLMLDIFKQIAPAVEY------KG  376 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC---------------------------cccccchhHHHHHHHhhccchhh------cc
Confidence            4678999999999999997542                           23456788889999999999999      57


Q ss_pred             eeeccCCCCceEEcCCCCeeecccccceecCCCC-------ccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHH
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE  730 (815)
Q Consensus       658 ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~e  730 (815)
                      .+|||+||.||+...+.++||+|||+........       ......||..||+||.+.+..  |+.|+||||+|++++|
T Consensus       377 ~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~--y~~kvdIyaLGlil~E  454 (516)
T KOG1033|consen  377 LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ--YSEKVDIYALGLILAE  454 (516)
T ss_pred             chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhh--hhhhcchhhHHHHHHH
Confidence            8999999999999999999999999998776444       344556999999999999887  8999999999999999


Q ss_pred             HHh-CCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 003504          731 LIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI  804 (815)
Q Consensus       731 l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v  804 (815)
                      ++. -..++..      .         ....+.....++|......|.     -..+...++.+.|.+||++.++
T Consensus       455 L~~~f~T~~er------~---------~t~~d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  455 LLIQFSTQFER------I---------ATLTDIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             HHHHhccHHHH------H---------HhhhhhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence            998 2222210      0         000111122333333333222     3577888999999999954443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.57  E-value=1.1e-14  Score=143.59  Aligned_cols=136  Identities=18%  Similarity=0.239  Sum_probs=97.4

Q ss_pred             CCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccH--HH----------------------HHHHHHHhcCCCCCC--c
Q 003504          513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTD--QE----------------------AARELEYLGRIKHPN--L  566 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~--~~----------------------~~~E~~~l~~l~H~n--i  566 (815)
                      .+.||+|+||.||+|...+++.||||+++.......  ..                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            478999999999999988899999999875322111  11                      134555555554332  3


Q ss_pred             eeeeeEEEeCCeeEEEEEeCCCCChhhh-hccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHH
Q 003504          567 VPLTGYCIAGDQRIAIYDYMENGNLQNL-LHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTAR  645 (815)
Q Consensus       567 v~l~g~~~~~~~~~lv~ey~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~  645 (815)
                      .+.+++    ...++||||+++|++... +...                             .  .. .....++.+++.
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----------------------------~--~~-~~~~~~~~~~~~  125 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----------------------------R--LL-EDPEELYDQILE  125 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-----------------------------h--hc-ccHHHHHHHHHH
Confidence            444432    246899999999654321 1110                             0  00 345688999999


Q ss_pred             HHHHHhcCCC-CCeeeccCCCCceEEcCCCCeeecccccceecC
Q 003504          646 ALAFLHHGCS-PPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG  688 (815)
Q Consensus       646 ~L~yLH~~~~-~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~  688 (815)
                      ++.++|   . .+|+||||||+||+++ ++.++++|||.+....
T Consensus       126 ~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         126 LMRKLY---REAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             HHHHHh---hccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            999999   6 8999999999999999 8899999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=4.4e-14  Score=143.76  Aligned_cols=136  Identities=17%  Similarity=0.221  Sum_probs=104.9

Q ss_pred             CCeec-ccCCeeeEEEEcCCCcEEEEEEeecCCc-------------ccHHHHHHHHHHhcCCCCCCc--eeeeeEEEeC
Q 003504          513 GTLLA-EGKFGPVYRGFLPGGIHVAVKVLVHGST-------------LTDQEAARELEYLGRIKHPNL--VPLTGYCIAG  576 (815)
Q Consensus       513 ~~~ig-~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~  576 (815)
                      ...|| .|+.|+||.+... +..+|||.+.....             .....+.+|++++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            46788 8999999999886 66899998854211             223457889999999998875  6777765442


Q ss_pred             C----eeEEEEEeCCC-CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHh
Q 003504          577 D----QRIAIYDYMEN-GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH  651 (815)
Q Consensus       577 ~----~~~lv~ey~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH  651 (815)
                      .    ..++|+||+++ .+|.+++...                               .++.    ..+.+++.++.+||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-------------------------------~l~~----~~~~~i~~~l~~lH  159 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-------------------------------PLSE----EQWQAIGQLIARFH  159 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-------------------------------CCCH----HHHHHHHHHHHHHH
Confidence            2    23599999997 6898887531                               1121    23567999999999


Q ss_pred             cCCCCCeeeccCCCCceEEcCCCCeeecccccceec
Q 003504          652 HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF  687 (815)
Q Consensus       652 ~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~  687 (815)
                         ..+|+||||||.|||++.++.++|+|||.+...
T Consensus       160 ---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        160 ---DAGVYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             ---HCCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence               899999999999999999899999999988753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.54  E-value=3.4e-14  Score=134.70  Aligned_cols=135  Identities=17%  Similarity=0.129  Sum_probs=112.5

Q ss_pred             CCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCC--CCceeeeeEEEeCCeeEEEEEeCCCC
Q 003504          512 RGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKH--PNLVPLTGYCIAGDQRIAIYDYMENG  589 (815)
Q Consensus       512 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~ey~~~g  589 (815)
                      +.+.||+|.++.||++...+ ..++||.......  ...+.+|+.++..++|  .++.+++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35789999999999999865 7899998865332  5678999999999976  58999999888878899999999987


Q ss_pred             ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceE
Q 003504          590 NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY  669 (815)
Q Consensus       590 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIl  669 (815)
                      .+..+                                     ++..+..++.+++++++++|.....+++|||++|+||+
T Consensus        79 ~~~~~-------------------------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil  121 (155)
T cd05120          79 TLDEV-------------------------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNIL  121 (155)
T ss_pred             ecccC-------------------------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEE
Confidence            66432                                     34456778999999999999544468999999999999


Q ss_pred             EcCCCCeeeccccccee
Q 003504          670 LDMNLEPRLSDFGLAKI  686 (815)
Q Consensus       670 l~~~~~~kl~Dfgla~~  686 (815)
                      ++..+.+++.|||.++.
T Consensus       122 ~~~~~~~~l~Df~~~~~  138 (155)
T cd05120         122 VDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EECCcEEEEEecccccC
Confidence            99989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.51  E-value=5.4e-16  Score=164.11  Aligned_cols=212  Identities=29%  Similarity=0.383  Sum_probs=145.6

Q ss_pred             EEECcCCCCCCCCcccCC--CCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCCC
Q 003504           57 SLDLSENNITALPSDLWS--LGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGN  134 (815)
Q Consensus        57 ~L~Ls~n~l~~lp~~~~~--l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  134 (815)
                      .|.|++-+++.+|-..++  +..-...+|+.|++. .+|..+..+..|+.|.|..|.|. .+|..++++..|++|+|+.|
T Consensus        54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            477777788887765554  666667788888887 67777777777777777777777 66777777777777777777


Q ss_pred             cccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccCCCCCCCCCCCCCeEeccCCcCCCcchh
Q 003504          135 MFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMG  214 (815)
Q Consensus       135 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  214 (815)
                      +++ ..|..+..|+ |+.|-+++|+++ .+|+.++ .+..|..|+.+.|.|..++..+.++.+|+.|++..|.+..+|..
T Consensus       132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig-~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~~lp~E  207 (722)
T KOG0532|consen  132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIG-LLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLEDLPEE  207 (722)
T ss_pred             hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccc-cchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhhhCCHH
Confidence            777 5666666543 777777777776 7777775 56777777777777777777777777777777777777666554


Q ss_pred             hhhcccceeeeccccccCcccccccccccCCccceEEEcCCCccCcchhhccccCCCCCEEEecCCcCcCCCccccc---
Q 003504          215 VFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIG---  291 (815)
Q Consensus       215 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---  291 (815)
                      ...                            -.|..||+|+|++. .+|-.|..|..|++|-|.+|.+..-+ ..+.   
T Consensus       208 l~~----------------------------LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPP-AqIC~kG  257 (722)
T KOG0532|consen  208 LCS----------------------------LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPP-AQICEKG  257 (722)
T ss_pred             HhC----------------------------CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCCh-HHHHhcc
Confidence            321                            23666666777766 56777777888888888888776532 3332   


Q ss_pred             cccCCCeEecCCC
Q 003504          292 TLLGLEHLNLSRT  304 (815)
Q Consensus       292 ~l~~L~~L~Ls~N  304 (815)
                      ...=.++|+..-+
T Consensus       258 kVHIFKyL~~qA~  270 (722)
T KOG0532|consen  258 KVHIFKYLSTQAC  270 (722)
T ss_pred             ceeeeeeecchhc
Confidence            2223445555444

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.45  E-value=1.9e-13  Score=151.62  Aligned_cols=197  Identities=30%  Similarity=0.438  Sum_probs=124.5

Q ss_pred             EEEccCCcCCCCChhhhcCCcCCCEEEcCCCcccccCCccccccc-ccceeeccCCcCCCCCCchhhccCCCCCEEEcCC
Q 003504          104 VFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQ-SLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAG  182 (815)
Q Consensus       104 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~  182 (815)
                      .|+++.|.+. .....+..++.++.|++.+|.++ .+++....++ +|+.|++++|++. .+|..+ ..+++|+.|++++
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~-~~l~~L~~L~l~~  172 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPL-RNLPNLKNLDLSF  172 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhh-hccccccccccCC
Confidence            5777777764 23345556677777777777777 4555555553 7777777777776 665443 3467777777777


Q ss_pred             CcccCCCCCCCCCCCCCeEeccCCcCCCcchhh-hhcccceeeeccccccCcccccccccccCCccceEEEcCCCccCcc
Q 003504          183 NEIKGRDTHFAGLKSITNLNISGNLFQGSVMGV-FLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGE  261 (815)
Q Consensus       183 N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~  261 (815)
                      |+++.++.....+++|+.|++++|+++.++... .+..|++|.+++|.+...+     ....++.++..+.+.+|++.. 
T Consensus       173 N~l~~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~-----~~~~~~~~l~~l~l~~n~~~~-  246 (394)
T COG4886         173 NDLSDLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELL-----SSLSNLKNLSGLELSNNKLED-  246 (394)
T ss_pred             chhhhhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecc-----hhhhhcccccccccCCceeee-
Confidence            777777766667777788888888887777764 4555777777777422111     123345556666666666653 


Q ss_pred             hhhccccCCCCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcCCCch
Q 003504          262 IFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPS  312 (815)
Q Consensus       262 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  312 (815)
                      .+..++.+++|+.|++++|.++.++.  ++.+.+|+.|++++|.+....|.
T Consensus       247 ~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         247 LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence            24455566666666666666665543  55666666666666666544443

>PLN03150 hypothetical protein; Provisional

Probab=99.45  E-value=2.5e-13  Score=157.45  Aligned_cols=106  Identities=35%  Similarity=0.572  Sum_probs=70.4

Q ss_pred             CEEECcCCCCC-CCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCCC
Q 003504           56 QSLDLSENNIT-ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGN  134 (815)
Q Consensus        56 ~~L~Ls~n~l~-~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  134 (815)
                      +.|+|++|.++ .+|..+..+++|+.|+|++|+|.+.+|..|+++++|+.|+|++|+|++.+|..+++|++|+.|+|++|
T Consensus       421 ~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N  500 (623)
T PLN03150        421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN  500 (623)
T ss_pred             EEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence            44455555554 34455555666666666666666667767777777777777777777777777777777777777777


Q ss_pred             cccccCCcccccc-cccceeeccCCcCC
Q 003504          135 MFQWSIPPGLLNC-QSLVTVDLSMNQLN  161 (815)
Q Consensus       135 ~l~~~~~~~~~~l-~~L~~L~l~~N~l~  161 (815)
                      ++++.+|..+..+ .++..+++.+|...
T Consensus       501 ~l~g~iP~~l~~~~~~~~~l~~~~N~~l  528 (623)
T PLN03150        501 SLSGRVPAALGGRLLHRASFNFTDNAGL  528 (623)
T ss_pred             cccccCChHHhhccccCceEEecCCccc
Confidence            7777777766543 45667777777654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=1.9e-14  Score=164.08  Aligned_cols=252  Identities=21%  Similarity=0.278  Sum_probs=182.7

Q ss_pred             CCCCCCeecccCCeeeEEEEcCC--CcEEEEEEeecCC--cccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCCeeEEEE
Q 003504          509 NFDRGTLLAEGKFGPVYRGFLPG--GIHVAVKVLVHGS--TLTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~  583 (815)
                      .|...+.||+|+|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++.....+..+++.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            46667789999999998887533  4456777665432  222334455777777776 999999999999999999999


Q ss_pred             EeCCCCChhhhh-ccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          584 DYMENGNLQNLL-HDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       584 ey~~~gsL~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      +|.++|++.+-+ +..                             ....+-........|+..++.|+|.  ..++.|||
T Consensus       101 ~~s~g~~~f~~i~~~~-----------------------------~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~  149 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPD-----------------------------STGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRD  149 (601)
T ss_pred             CcccccccccccccCC-----------------------------ccCCCCcchhhhhhhhccCccccCc--ccccccCC
Confidence            999999998887 321                             0011122234577889999999995  57899999


Q ss_pred             CCCCceEEcCCC-CeeecccccceecCC-CC---ccccccc-cccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          663 IKASSVYLDMNL-EPRLSDFGLAKIFGN-GL---DEEIARG-SPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       663 lk~~NIll~~~~-~~kl~Dfgla~~~~~-~~---~~~~~~g-t~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      +||+|.+++..+ ..|++|||+|..+.. ..   .....+| ++.|+|||...+.. +..+..|+||.|+++.-+++|..
T Consensus       150 ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~-~~~~~~d~~S~g~~l~~~~~g~~  228 (601)
T KOG0590|consen  150 IKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKA-YRGPSVDVWSLGIVLSAMLTGEL  228 (601)
T ss_pred             CCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchh-hcCCCcccccccccccccccCCC
Confidence            999999999999 999999999987765 22   2334568 99999999987743 25788999999999999999999


Q ss_pred             CCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       737 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                      |+.......  .....|....           ................++..+++..+|+.|.+.+++.
T Consensus       229 p~~~~~~~~--~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  229 PWDFPSRKD--GRYSSWKSNK-----------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             Ccccccccc--ccceeecccc-----------cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence            987643322  2222222110           0111122344455677888899999999999887764

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.45  E-value=1.1e-13  Score=153.66  Aligned_cols=197  Identities=31%  Similarity=0.407  Sum_probs=109.6

Q ss_pred             EEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCc-CCCEEEcCCCcccccCCcccccccccceeeccCC
Q 003504           80 SLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLV-SLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMN  158 (815)
Q Consensus        80 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  158 (815)
                      .|.+..|.+. .....+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            4555555553 22233444455556666666655 3334444443 5666666666655 34444555566666666666


Q ss_pred             cCCCCCCchhhccCCCCCEEEcCCCcccCCCCCCCCCCCCCeEeccCCcCCCcch-hhhhcccceeeeccccccCccccc
Q 003504          159 QLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVM-GVFLESLEVIDLRSNQFQGHISQV  237 (815)
Q Consensus       159 ~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~  237 (815)
                      +++ .+|.... .+++|+.|++++|+++.++.....+..|++|.+++|.+..++. ..-+.++..|.+.+|++...+   
T Consensus       174 ~l~-~l~~~~~-~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~~---  248 (394)
T COG4886         174 DLS-DLPKLLS-NLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLP---  248 (394)
T ss_pred             hhh-hhhhhhh-hhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeecc---
Confidence            665 5554431 2455666666666666555544445556666666663322222 222555566666666654221   


Q ss_pred             ccccccCCccceEEEcCCCccCcchhhccccCCCCCEEEecCCcCcCCCcc
Q 003504          238 QFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFP  288 (815)
Q Consensus       238 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  288 (815)
                        ....+++.+++|++++|.++....  ++.+.+|+.|++++|.+....+.
T Consensus       249 --~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         249 --ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             --chhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence              223455667888888888775433  77778888888888887665533

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.44  E-value=3.9e-15  Score=157.73  Aligned_cols=180  Identities=29%  Similarity=0.447  Sum_probs=141.7

Q ss_pred             CCCCCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEE
Q 003504           51 KLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLK  130 (815)
Q Consensus        51 ~l~~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  130 (815)
                      .+..-...||+.|++.++|.....+..|..|.|.+|.|. .+|..+.++..|+.|||+.|+++ .+|..++.|+ |+.|-
T Consensus        73 ~ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli  149 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI  149 (722)
T ss_pred             cccchhhhhccccccccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence            355556788888888888888888888888888888887 78888888888888888888888 6677777765 88888


Q ss_pred             cCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccCCCCCCCCCCCCCeEeccCCcCCC
Q 003504          131 LDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQG  210 (815)
Q Consensus       131 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~  210 (815)
                      +++|+++ .+|+.++.+..|..||.+.|.|. .+|..+. ++.+|+.|.+..|++..+|..+..| .|..||+|.|++..
T Consensus       150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~-~l~slr~l~vrRn~l~~lp~El~~L-pLi~lDfScNkis~  225 (722)
T KOG0532|consen  150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLG-YLTSLRDLNVRRNHLEDLPEELCSL-PLIRLDFSCNKISY  225 (722)
T ss_pred             EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhh-hHHHHHHHHHhhhhhhhCCHHHhCC-ceeeeecccCceee
Confidence            8888888 67888888888888888888887 7887774 4788888888888888888777744 57778888888888


Q ss_pred             cchhhh-hcccceeeeccccccCccccc
Q 003504          211 SVMGVF-LESLEVIDLRSNQFQGHISQV  237 (815)
Q Consensus       211 ~~~~~~-l~~L~~L~L~~N~l~~~~~~~  237 (815)
                      +|...- |..|++|-|.+|.++..+.++
T Consensus       226 iPv~fr~m~~Lq~l~LenNPLqSPPAqI  253 (722)
T KOG0532|consen  226 LPVDFRKMRHLQVLQLENNPLQSPPAQI  253 (722)
T ss_pred             cchhhhhhhhheeeeeccCCCCCChHHH
Confidence            776543 677777777777776544443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=8e-13  Score=146.34  Aligned_cols=142  Identities=21%  Similarity=0.208  Sum_probs=101.6

Q ss_pred             CCeecccCCeeeEEEEcCCCcEEEEEEeecCCccc----------------------------------------HHHHH
Q 003504          513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLT----------------------------------------DQEAA  552 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~~  552 (815)
                      .+.||.|++|+||+|++.+|+.||||+.+.+-...                                        +-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            47899999999999999999999999986531100                                        00244


Q ss_pred             HHHHHhcCC----CCCCceeeeeEEEe-CCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCC
Q 003504          553 RELEYLGRI----KHPNLVPLTGYCIA-GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE  627 (815)
Q Consensus       553 ~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (815)
                      +|+..+.++    +|.+-+.+-.++.+ ....++||||+++++|.++.....                            
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----------------------------  253 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----------------------------  253 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----------------------------
Confidence            455555544    23333343333332 456799999999999988764310                            


Q ss_pred             CcccCHHHHHHHHHHHHH-HHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCC
Q 003504          628 GLLTTWRFRHKIALGTAR-ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN  689 (815)
Q Consensus       628 ~~~~~~~~~~~i~~~ia~-~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  689 (815)
                       ...   .+.+++..++. .+..+|   ..+++|+|++|.||+++.++.+++.|||++..+.+
T Consensus       254 -~~~---~~~~ia~~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       254 -AGL---DRKALAENLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             -cCC---CHHHHHHHHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             001   23567777666 467788   78999999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=6.3e-13  Score=132.23  Aligned_cols=203  Identities=21%  Similarity=0.340  Sum_probs=137.0

Q ss_pred             HHHhcCCCCCCceeeeeEEEeCC-----eeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCc
Q 003504          555 LEYLGRIKHPNLVPLTGYCIAGD-----QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL  629 (815)
Q Consensus       555 ~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (815)
                      ..-+-++.|.|||++..|+.+..     ....+.|||..|++..+|+..++                          ...
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--------------------------~~~  171 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--------------------------NQK  171 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--------------------------hhh
Confidence            34455667999999999987643     45788999999999999986422                          133


Q ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecC-----CCCccccccccccccC
Q 003504          630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG-----NGLDEEIARGSPGYIP  704 (815)
Q Consensus       630 ~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~-----~~~~~~~~~gt~~y~a  704 (815)
                      .+......+|+-||..||.||| .|.++|+|+++..+-|++..+|-+||+--.-.....     .........+-++|.|
T Consensus       172 a~~~~~wkkw~tqIlsal~yLh-s~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a  250 (458)
T KOG1266|consen  172 ALFQKAWKKWCTQILSALSYLH-SCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSA  250 (458)
T ss_pred             hhhHHHHHHHHHHHHhhhhhhh-ccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCcccc
Confidence            4555566789999999999999 468999999999999999999988886422111110     0111223346789999


Q ss_pred             CcccCCCCCCCCCcCcchhHHHHHHHHHhCCCCCCC-CCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHH
Q 003504          705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD-DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEA  783 (815)
Q Consensus       705 PE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  783 (815)
                      ||+-....  .+..+|||+||+...||..+.---.. ....+....+.....          -....           .-
T Consensus       251 ~~sg~~tn--~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~----------~len~-----------lq  307 (458)
T KOG1266|consen  251 PESGTTTN--TTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII----------GLENG-----------LQ  307 (458)
T ss_pred             CCcCcccc--cccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee----------eccCc-----------cc
Confidence            99755444  46789999999999999887643221 111111111111000          00000           11


Q ss_pred             HHHHhhccccCCCCCCCHHHHHHH
Q 003504          784 LKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       784 ~~l~~~Cl~~dP~~RPs~~~v~~~  807 (815)
                      ..++.+|++..|..||+|.+++..
T Consensus       308 r~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  308 RGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             cCcCcccccCCCCCCcchhhhhcC
Confidence            356778999999999999988643

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.36  E-value=4.3e-13  Score=127.34  Aligned_cols=34  Identities=26%  Similarity=0.243  Sum_probs=12.9

Q ss_pred             CCCCCCCCeEeccCCcCCCcchhh-----hhcccceeee
Q 003504          192 FAGLKSITNLNISGNLFQGSVMGV-----FLESLEVIDL  225 (815)
Q Consensus       192 ~~~l~~L~~L~Ls~N~l~~~~~~~-----~l~~L~~L~L  225 (815)
                      +..+++|+.|+|.+|+++..+...     .+++|+.||-
T Consensus       109 L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen  109 LSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             GGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             HHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            344555555555555554433211     1566666664

>PLN03150 hypothetical protein; Provisional

Probab=99.35  E-value=2.9e-12  Score=148.56  Aligned_cols=110  Identities=34%  Similarity=0.504  Sum_probs=92.8

Q ss_pred             CCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcCCCCCCcc--CCCCccEEEcc
Q 003504          271 NLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMS  348 (815)
Q Consensus       271 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~--~~~~L~~L~ls  348 (815)
                      .++.|+|++|.+++..+..++.+++|+.|+|++|.+.|.+|..+..+++|+.|+|++|++++.+|..  .+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            3778889999888777788888999999999999999899999999999999999999999888874  67899999999


Q ss_pred             CCcCcccCChHHhhcCCCCceeeccCCCCcccC
Q 003504          349 HNNLSGEIPASLLEKLPQMERFNFSYNNLTLCA  381 (815)
Q Consensus       349 ~N~l~~~~p~~~~~~l~~l~~l~l~~N~l~~~~  381 (815)
                      +|+++|.+|..+...+.++..+++.+|+.. |+
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l-c~  530 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGL-CG  530 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccc-cC
Confidence            999999999776555567788899988753 54

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.34  E-value=9.9e-13  Score=124.88  Aligned_cols=139  Identities=32%  Similarity=0.407  Sum_probs=49.4

Q ss_pred             ECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCcccc-CCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCCCccc
Q 003504           59 DLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIG-NFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQ  137 (815)
Q Consensus        59 ~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  137 (815)
                      .|+.+.|..+|. ..+...+++|+|++|.|+.+  +.++ .+.+|+.|||++|.|+.+  +.+..+++|++|+|++|+|+
T Consensus         3 ~lt~~~i~~~~~-~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~   77 (175)
T PF14580_consen    3 RLTANMIEQIAQ-YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS   77 (175)
T ss_dssp             ------------------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---
T ss_pred             cccccccccccc-cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC
Confidence            355666776663 34455789999999999854  3565 578899999999999865  35888889999999999998


Q ss_pred             ccCCccc-ccccccceeeccCCcCCCCCCc-hhhccCCCCCEEEcCCCcccCCCC----CCCCCCCCCeEecc
Q 003504          138 WSIPPGL-LNCQSLVTVDLSMNQLNGSLPD-GFGAAFPKLKSLNLAGNEIKGRDT----HFAGLKSITNLNIS  204 (815)
Q Consensus       138 ~~~~~~~-~~l~~L~~L~l~~N~l~~~lp~-~~~~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~~L~Ls  204 (815)
                      . +.+.+ ..+++|++|+|++|+|. .+.+ .....+++|+.|+|.+|.++..+.    .+..+|+|+.||-.
T Consensus        78 ~-i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen   78 S-ISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             S--CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred             c-cccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence            4 44445 46888999999999887 4432 334568888888888888876542    25678888888753

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.30  E-value=3e-13  Score=150.12  Aligned_cols=266  Identities=26%  Similarity=0.256  Sum_probs=141.7

Q ss_pred             CCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCC
Q 003504           54 KLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG  133 (815)
Q Consensus        54 ~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  133 (815)
                      .++.++..++.+.........+..++.++++.|.|.. +-..+..+.+|+.|+|.+|+|..+. ..+..+++|++|+|++
T Consensus        50 ~~~~~~~~~~~~~~~~~~~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~  127 (414)
T KOG0531|consen   50 DLEEIDLIFNLDGSDEDLVESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSF  127 (414)
T ss_pred             hhhhhcchhccccchhhhHHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcc-cchhhhhcchheeccc
Confidence            4455555555444332111235566666677777663 3344666667777777777776442 2256667777777777


Q ss_pred             CcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccCCCCC-CCCCCCCCeEeccCCcCCCcc
Q 003504          134 NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH-FAGLKSITNLNISGNLFQGSV  212 (815)
Q Consensus       134 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~  212 (815)
                      |+|+...  .+..++.|+.|++++|.|+ .++..  ..+.+|+.+++++|.++.+... ...+.+|+.+.+.+|.+..+.
T Consensus       128 N~I~~i~--~l~~l~~L~~L~l~~N~i~-~~~~~--~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~  202 (414)
T KOG0531|consen  128 NKITKLE--GLSTLTLLKELNLSGNLIS-DISGL--ESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIE  202 (414)
T ss_pred             ccccccc--chhhccchhhheeccCcch-hccCC--ccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhccc
Confidence            7776432  3555566777777777776 44332  2256666666666666655443 456666667777777666665


Q ss_pred             hhhhhcccceeeeccccccCcccccccccccCCccceEEEcCCCccCcchhhccccCCCCCEEEecCCcCcCCCcccccc
Q 003504          213 MGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGT  292 (815)
Q Consensus       213 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  292 (815)
                      ....+..+..+++..|.++.. ..     ...+..                      ..|+.+++++|++...+ ..+..
T Consensus       203 ~~~~~~~l~~~~l~~n~i~~~-~~-----l~~~~~----------------------~~L~~l~l~~n~i~~~~-~~~~~  253 (414)
T KOG0531|consen  203 GLDLLKKLVLLSLLDNKISKL-EG-----LNELVM----------------------LHLRELYLSGNRISRSP-EGLEN  253 (414)
T ss_pred             chHHHHHHHHhhcccccceec-cC-----cccchh----------------------HHHHHHhcccCcccccc-ccccc
Confidence            555555555556666655411 00     000111                      02455555555554332 33445


Q ss_pred             ccCCCeEecCCCcCcCCCchhhhcCCCCCEEeCCCCcCCCCC-----C-ccCCCCccEEEccCCcCcccCC
Q 003504          293 LLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQI-----P-TVSAKNLGIIDMSHNNLSGEIP  357 (815)
Q Consensus       293 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-----~-~~~~~~L~~L~ls~N~l~~~~p  357 (815)
                      +.++..|++++|.+...  ..+.....+..+.++.|.+....     + ....+.+..+.+..|.+....+
T Consensus       254 ~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  254 LKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             cccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            55555555555555422  12333445555555666554211     1 1244566666777776654433

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.30  E-value=1.8e-13  Score=137.67  Aligned_cols=252  Identities=25%  Similarity=0.293  Sum_probs=129.7

Q ss_pred             cccCCCCCCEEECcCCCCC-----CCCcccCCCCCCCEEEccCCcCCc----cCCcc-------ccCCCCCcEEEccCCc
Q 003504           48 TIGKLSKLQSLDLSENNIT-----ALPSDLWSLGSLKSLNLSYNRISG----SLPSN-------IGNFGLLEVFDLSNNN  111 (815)
Q Consensus        48 ~~~~l~~L~~L~Ls~n~l~-----~lp~~~~~l~~L~~L~L~~N~i~~----~~~~~-------~~~l~~L~~L~Ls~N~  111 (815)
                      .+..+..+++|+||+|.+.     .+-..+.+.++|++-++++= ++|    .+|+.       +...++|++||||+|-
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA  103 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA  103 (382)
T ss_pred             HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence            3555677888888888776     24455556667777777742 222    22332       2333455555555555


Q ss_pred             CCCCChhhh----cCCcCCCEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccC
Q 003504          112 FSGEIPAAI----SSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG  187 (815)
Q Consensus       112 l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~  187 (815)
                      |....+..|    .+++.|++|.|.+|-+.-.-...++  ..|..|.  .|+..        ..-++|+.+...+|++..
T Consensus       104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~kk~--------~~~~~Lrv~i~~rNrlen  171 (382)
T KOG1909|consen  104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VNKKA--------ASKPKLRVFICGRNRLEN  171 (382)
T ss_pred             cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HHhcc--------CCCcceEEEEeecccccc
Confidence            543333322    2344455555554444311000111  0122211  11110        123567777777777765


Q ss_pred             CC-----CCCCCCCCCCeEeccCCcCCCcchhh----h--hcccceeeeccccccCcccccccccccCCccceEEEcCCC
Q 003504          188 RD-----THFAGLKSITNLNISGNLFQGSVMGV----F--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSEN  256 (815)
Q Consensus       188 ~~-----~~~~~l~~L~~L~Ls~N~l~~~~~~~----~--l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N  256 (815)
                      .+     ..|...+.|+++.++.|.|..-....    |  ++.|+.|||+.|-|+..........+..|++|+.|+++.|
T Consensus       172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc  251 (382)
T KOG1909|consen  172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC  251 (382)
T ss_pred             ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence            43     23666677788888887775433311    1  6677777777777665444444444455556666666666


Q ss_pred             ccCcchhhccccCCCCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcCC----CchhhhcCCCCCEEeCCCCcCC
Q 003504          257 QLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGD----IPSEILQLSSLHTLDLSMNHLT  331 (815)
Q Consensus       257 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~  331 (815)
                      .+.......|..                   ..-...++|+.|.|.+|.++..    +...+...+.|..|+|++|++.
T Consensus       252 ll~~~Ga~a~~~-------------------al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  252 LLENEGAIAFVD-------------------ALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             ccccccHHHHHH-------------------HHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            555443332211                   0001234555555555555321    2233445677777777777773

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.27  E-value=5.8e-13  Score=137.47  Aligned_cols=87  Identities=24%  Similarity=0.248  Sum_probs=46.4

Q ss_pred             ccceEEEcCCCccCcch-hhccccCCCCCEEEecCCcCcCCCcccc------ccccCCCeEecCCCcCcCC-CchhhhcC
Q 003504          246 SRLVYVDLSENQLSGEI-FHNFSQAQNLKHLSLAYNRFTRQEFPQI------GTLLGLEHLNLSRTSLIGD-IPSEILQL  317 (815)
Q Consensus       246 ~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~Ls~N~l~~~-~p~~~~~l  317 (815)
                      ..|+.|||++|.+-... ....+.++.|..|+++.+.+.++..+..      ..+++|++|+++.|++..- .-..+..+
T Consensus       246 ~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l  325 (505)
T KOG3207|consen  246 QTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTL  325 (505)
T ss_pred             hHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhcc
Confidence            34444444444443221 1233455666666666666655444333      4556677777777776321 11344456


Q ss_pred             CCCCEEeCCCCcCCC
Q 003504          318 SSLHTLDLSMNHLTG  332 (815)
Q Consensus       318 ~~L~~L~ls~N~l~~  332 (815)
                      ++|+.|.+..|.|+.
T Consensus       326 ~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  326 ENLKHLRITLNYLNK  340 (505)
T ss_pred             chhhhhhcccccccc
Confidence            667777777777764

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.27  E-value=8.6e-13  Score=129.34  Aligned_cols=134  Identities=26%  Similarity=0.277  Sum_probs=88.4

Q ss_pred             CCCCCEEEcCCCcccCCCCCCCCCCCCCeEeccCCcCCCcchhhhhcccceeeeccccccCcccccccccccCCccceEE
Q 003504          172 FPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYV  251 (815)
Q Consensus       172 l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L  251 (815)
                      +.-|++|+|++|.|+.++....-++.++.|++|+|.|..+...+++++|+.|||++|.++.                   
T Consensus       283 Wq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls~-------------------  343 (490)
T KOG1259|consen  283 WQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLAE-------------------  343 (490)
T ss_pred             HhhhhhccccccchhhhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhHh-------------------
Confidence            4567778888888887777777778888888888888777776677777777777776542                   


Q ss_pred             EcCCCccCcchhhccccCCCCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcCCC-chhhhcCCCCCEEeCCCCcC
Q 003504          252 DLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDI-PSEILQLSSLHTLDLSMNHL  330 (815)
Q Consensus       252 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l  330 (815)
                                +...-..+-|++.|.|+.|.|..+  ..++.+-+|..||+++|+|.... ...+++++-|+.|.|.+|.|
T Consensus       344 ----------~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl  411 (490)
T KOG1259|consen  344 ----------CVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL  411 (490)
T ss_pred             ----------hhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence                      111122344555666666655432  34566667777777777765321 24567777888888888888


Q ss_pred             CCCCCc
Q 003504          331 TGQIPT  336 (815)
Q Consensus       331 ~~~~~~  336 (815)
                      .+.+..
T Consensus       412 ~~~vdY  417 (490)
T KOG1259|consen  412 AGSVDY  417 (490)
T ss_pred             cccchH
Confidence            765543

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.27  E-value=4.6e-13  Score=148.63  Aligned_cols=248  Identities=27%  Similarity=0.284  Sum_probs=175.2

Q ss_pred             cCCCCCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEE
Q 003504           50 GKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVL  129 (815)
Q Consensus        50 ~~l~~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  129 (815)
                      ..+..++.+++..|.|+.+-..+..+++|+.|++.+|+|..+ ...+..+++|++|+|++|+|+.+  ..+..++.|+.|
T Consensus        69 ~~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L  145 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL  145 (414)
T ss_pred             HHhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence            467788888999999998766788899999999999999854 33388899999999999999977  457888889999


Q ss_pred             EcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccCCCCCCCCCCCCCeEeccCCcCC
Q 003504          130 KLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQ  209 (815)
Q Consensus       130 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~  209 (815)
                      ++++|.|+.  ...+..+++|+.+++++|++. .++......+.+|+.+.+.+|.+..+. .+..+..+..+++..|.++
T Consensus       146 ~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~~i~-~~~~~~~l~~~~l~~n~i~  221 (414)
T KOG0531|consen  146 NLSGNLISD--ISGLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIREIE-GLDLLKKLVLLSLLDNKIS  221 (414)
T ss_pred             eeccCcchh--ccCCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchhccc-chHHHHHHHHhhcccccce
Confidence            999999984  345777999999999999998 666520246789999999999998653 2344555666699999998


Q ss_pred             Ccchhhhhcc--cceeeeccccccCcccccccccccCCccceEEEcCCCccCcchhhccccCCCCCEEEecCCcCcCCCc
Q 003504          210 GSVMGVFLES--LEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEF  287 (815)
Q Consensus       210 ~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  287 (815)
                      .+.....+..  |+.+++++|.+....     ..+..+..+..|++.+|.+.                        ..  
T Consensus       222 ~~~~l~~~~~~~L~~l~l~~n~i~~~~-----~~~~~~~~l~~l~~~~n~~~------------------------~~--  270 (414)
T KOG0531|consen  222 KLEGLNELVMLHLRELYLSGNRISRSP-----EGLENLKNLPVLDLSSNRIS------------------------NL--  270 (414)
T ss_pred             eccCcccchhHHHHHHhcccCcccccc-----ccccccccccccchhhcccc------------------------cc--
Confidence            8776555554  899999999875221     11223344445555554443                        22  


Q ss_pred             cccccccCCCeEecCCCcCcCC---Cchh-hhcCCCCCEEeCCCCcCCCCCC
Q 003504          288 PQIGTLLGLEHLNLSRTSLIGD---IPSE-ILQLSSLHTLDLSMNHLTGQIP  335 (815)
Q Consensus       288 ~~~~~l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~L~ls~N~l~~~~~  335 (815)
                      ..+.....+..+.++.|.+...   .... ....+.+..+.+..|.+....+
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  271 EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            1233444444555555554311   1111 3455677777777777766444

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.25  E-value=2e-12  Score=133.56  Aligned_cols=208  Identities=23%  Similarity=0.231  Sum_probs=124.1

Q ss_pred             ccccccceeeccCCcCCCCCCc-hhhccCCCCCEEEcCCCcccCCCC---CCCCCCCCCeEeccCCcCCCcchhhhhccc
Q 003504          145 LNCQSLVTVDLSMNQLNGSLPD-GFGAAFPKLKSLNLAGNEIKGRDT---HFAGLKSITNLNISGNLFQGSVMGVFLESL  220 (815)
Q Consensus       145 ~~l~~L~~L~l~~N~l~~~lp~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L  220 (815)
                      .++++|+.+.|.+..+. .++. .....+++++.|+|++|-+..+.+   -...|++|+.|+|+.|++...         
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~---------  187 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNF---------  187 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCC---------
Confidence            35778888888888885 4442 334556777777777776665432   234566666666666655432         


Q ss_pred             ceeeeccccccCcccccccccccCCccceEEEcCCCccCcch-hhccccCCCCCEEEecCCcCcCCCccccccccCCCeE
Q 003504          221 EVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEI-FHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHL  299 (815)
Q Consensus       221 ~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  299 (815)
                                   .+...   ...+++|+.|.|+.|.|+-.. -.....+|+|+.|+|.+|..-.+.......+..|+.|
T Consensus       188 -------------~~s~~---~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~L  251 (505)
T KOG3207|consen  188 -------------ISSNT---TLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQEL  251 (505)
T ss_pred             -------------ccccc---hhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhc
Confidence                         21111   113456666666666666322 2234556777777777774322222344556677788


Q ss_pred             ecCCCcCcCCC-chhhhcCCCCCEEeCCCCcCCCC-CCcc-------CCCCccEEEccCCcCcccCChHHhhcCCCCcee
Q 003504          300 NLSRTSLIGDI-PSEILQLSSLHTLDLSMNHLTGQ-IPTV-------SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERF  370 (815)
Q Consensus       300 ~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~-~~~~-------~~~~L~~L~ls~N~l~~~~p~~~~~~l~~l~~l  370 (815)
                      +|++|++.... -...+.++.|+.|+++.+.++.. .|..       .++.|+.|+++.|++...-...-+..+++|+.|
T Consensus       252 dLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l  331 (505)
T KOG3207|consen  252 DLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHL  331 (505)
T ss_pred             cccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhh
Confidence            88888776322 13456677788888888877752 2222       457888888888888622222334556667777


Q ss_pred             eccCCCCc
Q 003504          371 NFSYNNLT  378 (815)
Q Consensus       371 ~l~~N~l~  378 (815)
                      .+..|.++
T Consensus       332 ~~~~n~ln  339 (505)
T KOG3207|consen  332 RITLNYLN  339 (505)
T ss_pred             hccccccc
Confidence            66666664

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.24  E-value=1.8e-12  Score=127.06  Aligned_cols=204  Identities=25%  Similarity=0.243  Sum_probs=117.8

Q ss_pred             ccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCCC-cccccCCcccccccc
Q 003504           71 DLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGN-MFQWSIPPGLLNCQS  149 (815)
Q Consensus        71 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~  149 (815)
                      ++..+.+|+.+.++++.-..+ -+.-..-+.|+++.+.+..++..  +.+-.++.+..+.-+.- -.+|..-..+...+.
T Consensus       209 ~l~~f~~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~~~--~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~  285 (490)
T KOG1259|consen  209 NLNAFRNLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQDV--PSLLPETILADPSGSEPSTSNGSALVSADTWQE  285 (490)
T ss_pred             chHHhhhhheeeeeccchhhe-eceeecCchhheeeeeccccccc--ccccchhhhcCccCCCCCccCCceEEecchHhh
Confidence            334456677776666543211 11112235677777776666522  12222233332222211 122222233334567


Q ss_pred             cceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccCCCCCCCCCCCCCeEeccCCcCCCcchhhh-hcccceeeeccc
Q 003504          150 LVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF-LESLEVIDLRSN  228 (815)
Q Consensus       150 L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-l~~L~~L~L~~N  228 (815)
                      |++||||+|.|+ .+..+. .-.|+++.|++++|.|+.++. +..|++|+.||||+|.++.+..... +.++++|.|+.|
T Consensus       286 LtelDLS~N~I~-~iDESv-KL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N  362 (490)
T KOG1259|consen  286 LTELDLSGNLIT-QIDESV-KLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQN  362 (490)
T ss_pred             hhhccccccchh-hhhhhh-hhccceeEEeccccceeeehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhh
Confidence            888888888887 665554 457888888888888887655 7778888888888888888777665 777777877777


Q ss_pred             cccCcccccccccccCCccceEEEcCCCccCcchhhccccCCCCCEEEecCCcCcCCCccccccccCCCeEecCCCcCcC
Q 003504          229 QFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIG  308 (815)
Q Consensus       229 ~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  308 (815)
                      .+..      ...+..+-+|.+||+++|+|....                       ....+++++-|+++.|.+|++.+
T Consensus       363 ~iE~------LSGL~KLYSLvnLDl~~N~Ie~ld-----------------------eV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  363 KIET------LSGLRKLYSLVNLDLSSNQIEELD-----------------------EVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             hHhh------hhhhHhhhhheeccccccchhhHH-----------------------HhcccccccHHHHHhhcCCCccc
Confidence            6531      111223334444444444443211                       12456777777777777777764


Q ss_pred             C
Q 003504          309 D  309 (815)
Q Consensus       309 ~  309 (815)
                      .
T Consensus       414 ~  414 (490)
T KOG1259|consen  414 S  414 (490)
T ss_pred             c
Confidence            3

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.24  E-value=3.1e-11  Score=116.87  Aligned_cols=130  Identities=18%  Similarity=0.120  Sum_probs=94.3

Q ss_pred             CCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCce-eeeeEEEeCCeeEEEEEeCCCCCh
Q 003504          513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV-PLTGYCIAGDQRIAIYDYMENGNL  591 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~ey~~~gsL  591 (815)
                      .+.++.|.++.||+++.. +..|++|....... ....+.+|+.++..+.+.+++ +++++  .....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence            357889999999999876 67899998755321 234568899999988655554 44443  23346899999999876


Q ss_pred             hhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeccCCCCceE
Q 003504          592 QNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC--SPPIIHRDIKASSVY  669 (815)
Q Consensus       592 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlk~~NIl  669 (815)
                      ...-.                                      ....++.+++++|+.||...  ...++|||++|.||+
T Consensus        79 ~~~~~--------------------------------------~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil  120 (170)
T cd05151          79 LTEDF--------------------------------------SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFL  120 (170)
T ss_pred             ccccc--------------------------------------cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEE
Confidence            53200                                      01235678999999999321  123699999999999


Q ss_pred             EcCCCCeeecccccce
Q 003504          670 LDMNLEPRLSDFGLAK  685 (815)
Q Consensus       670 l~~~~~~kl~Dfgla~  685 (815)
                      ++ ++.+++.|||.+.
T Consensus       121 ~~-~~~~~liDf~~a~  135 (170)
T cd05151         121 LD-DGRLWLIDWEYAG  135 (170)
T ss_pred             EE-CCeEEEEeccccc
Confidence            99 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=2.9e-11  Score=131.43  Aligned_cols=247  Identities=21%  Similarity=0.190  Sum_probs=169.7

Q ss_pred             CCCCCCeecc--cCCeeeEEEEc---CCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCC-CCCceeeeeEEEeCCeeE
Q 003504          509 NFDRGTLLAE--GKFGPVYRGFL---PGGIHVAVKVLVHG--STLTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQRI  580 (815)
Q Consensus       509 ~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  580 (815)
                      .|.....+|.  |.+|.||.+..   .++..+|+|.-+..  .......=.+|+..-.+++ |+|.++....+..++..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556788999  99999999986   46788999974322  2223333456777777774 999999888888888999


Q ss_pred             EEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  660 (815)
                      +-+|++. .+|.++-+..-..                         ......|.....+...-+.||..+|   ...++|
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~-------------------------~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~  245 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNF-------------------------LPDNLLWNSLRDWLSRDVTALSHLH---SNNIVH  245 (524)
T ss_pred             eeecccc-chhHHhhhccccc-------------------------CCchhhhhHHhhhhhcccccccccC---CCcccc
Confidence            9999887 5888877642110                         0112334333333333333999999   899999


Q ss_pred             ccCCCCceEEcCC-CCeeecccccceecCCCCcc------ccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHh
Q 003504          661 RDIKASSVYLDMN-LEPRLSDFGLAKIFGNGLDE------EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       661 rDlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~t  733 (815)
                      -|+||.||++..+ ...+++|||+...+..+...      ....|...|++||...+.   ++...|+|++|.+..|..+
T Consensus       246 ~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l---~~~~~di~sl~ev~l~~~l  322 (524)
T KOG0601|consen  246 DDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL---ATFASDIFSLGEVILEAIL  322 (524)
T ss_pred             cccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc---cchHhhhcchhhhhHhhHh
Confidence            9999999999999 88999999999888765411      112477789999998766   4889999999999999999


Q ss_pred             CCCCCCCCCCccccccHHHHHHHHHhcCCCCcccccc-ccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003504          734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPK-IRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       734 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~  805 (815)
                      +..+......       ..|.+           .+.. +..+....-..++...+..+++.+|..|++++.+.
T Consensus       323 ~~~~~~~g~~-------~~W~~-----------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  323 GSHLPSVGKN-------SSWSQ-----------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             hcccccCCCC-------CCccc-----------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            8766543211       11111           0010 11111112233444578889999999999887765

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.18  E-value=1.3e-11  Score=137.93  Aligned_cols=147  Identities=16%  Similarity=0.196  Sum_probs=95.8

Q ss_pred             cCCCCCCeecccCCeeeEEEEcCC-CcEEEEEEeecCCcc--------------------------c--------H----
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTL--------------------------T--------D----  548 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~--------------------------~--------~----  548 (815)
                      .+|+. +.||.|++|+||+|++++ |+.||||+.+.+-..                          .        .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34665 799999999999999887 999999999753100                          0        0    


Q ss_pred             --HHHHHHHHHhcCCC----CCCceeeeeEEEe-CCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccc
Q 003504          549 --QEAARELEYLGRIK----HPNLVPLTGYCIA-GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI  621 (815)
Q Consensus       549 --~~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (815)
                        -++.+|+..+.+++    +.+.+.+-.++.+ ....++||||++|+.+.++-.-..                      
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~----------------------  256 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA----------------------  256 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh----------------------
Confidence              12344554444442    4444444444433 456789999999999977421100                      


Q ss_pred             cccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCC----CeeecccccceecCC
Q 003504          622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNL----EPRLSDFGLAKIFGN  689 (815)
Q Consensus       622 ~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~Dfgla~~~~~  689 (815)
                             ...+   +..++...++  .|+++-...+++|+|+||.||+++.++    .+++.|||++..+..
T Consensus       257 -------~g~d---~~~la~~~v~--~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        257 -------AGTD---MKLLAERGVE--VFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------cCCC---HHHHHHHHHH--HHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   0011   1223333222  223222367999999999999999988    999999999987754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.15  E-value=5.3e-10  Score=122.69  Aligned_cols=166  Identities=19%  Similarity=0.202  Sum_probs=124.0

Q ss_pred             cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCC
Q 003504          529 LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDW  608 (815)
Q Consensus       529 ~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~  608 (815)
                      ..++.+|.|...............+-++.|+.+|||||++++.........|+|+|-+..  |..++.+.          
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l----------  101 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL----------  101 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh----------
Confidence            557889999988765554445677888999999999999999999999999999998764  55555432          


Q ss_pred             CCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecC
Q 003504          609 STDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG  688 (815)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~  688 (815)
                                             .-...--.+.||+.||.|||+  ..+++|++|.-+-|+|++.|..||++|.++....
T Consensus       102 -----------------------~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen  102 -----------------------GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             -----------------------HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence                                   112233467889999999997  6689999999999999999999999999886543


Q ss_pred             CCCc-cccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCC
Q 003504          689 NGLD-EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK  735 (815)
Q Consensus       689 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  735 (815)
                      .... .....--..|..|+.+....    ...|.|-||++++|++.|.
T Consensus       157 ~~~~~~~~~~~~~s~~~P~~~~~s~----~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  157 GFNAPAKSLYLIESFDDPEEIDPSE----WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cCCcccccchhhhcccChhhcCccc----cchhhhhHHHHHHHHhCcc
Confidence            2211 11111223466777553222    3469999999999999993

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.15  E-value=6.3e-12  Score=126.62  Aligned_cols=246  Identities=23%  Similarity=0.253  Sum_probs=143.9

Q ss_pred             cCCCCCCCEEEccCCcCCc----cCCccccCCCCCcEEEccCC---cCCCCChhh-------hcCCcCCCEEEcCCCccc
Q 003504           72 LWSLGSLKSLNLSYNRISG----SLPSNIGNFGLLEVFDLSNN---NFSGEIPAA-------ISSLVSLRVLKLDGNMFQ  137 (815)
Q Consensus        72 ~~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~Ls~N---~l~~~~p~~-------~~~l~~L~~L~L~~N~l~  137 (815)
                      +-.+..++.|+|++|.|..    .+...+.+.++|+..++|+=   ++...+|++       +.+.++|++|+||.|.|.
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G  105 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG  105 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence            3346778888888888763    23345666677777777752   222223332       344556777777777665


Q ss_pred             ccCCccc----ccccccceeeccCCcCCCCCCchh-hccCCCCCEEEcCCCcccCCCCCCCCCCCCCeEeccCCcCCCcc
Q 003504          138 WSIPPGL----LNCQSLVTVDLSMNQLNGSLPDGF-GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSV  212 (815)
Q Consensus       138 ~~~~~~~----~~l~~L~~L~l~~N~l~~~lp~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~  212 (815)
                      -..+..|    ..+.+|+.|.|.+|-+. ...... ...   |..|.  .|      .....-++|+.+..++|.+.+-+
T Consensus       106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~~a---l~~l~--~~------kk~~~~~~Lrv~i~~rNrlen~g  173 (382)
T KOG1909|consen  106 PKGIRGLEELLSSCTDLEELYLNNCGLG-PEAGGRLGRA---LFELA--VN------KKAASKPKLRVFICGRNRLENGG  173 (382)
T ss_pred             ccchHHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHHHH---HHHHH--HH------hccCCCcceEEEEeecccccccc
Confidence            4333332    34556666666666664 222111 111   11111  11      11233466777777777776655


Q ss_pred             hhhh------hcccceeeeccccccCcccccccccccCCccceEEEcCCCccCcchhhccccCCCCCEEEecCCcCcCCC
Q 003504          213 MGVF------LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQE  286 (815)
Q Consensus       213 ~~~~------l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  286 (815)
                      ....      .+.|+.+.++.|.+...--.                        .....|..+++|+.|||..|-++...
T Consensus       174 a~~~A~~~~~~~~leevr~~qN~I~~eG~~------------------------al~eal~~~~~LevLdl~DNtft~eg  229 (382)
T KOG1909|consen  174 ATALAEAFQSHPTLEEVRLSQNGIRPEGVT------------------------ALAEALEHCPHLEVLDLRDNTFTLEG  229 (382)
T ss_pred             HHHHHHHHHhccccceEEEecccccCchhH------------------------HHHHHHHhCCcceeeecccchhhhHH
Confidence            4332      44566666666655321111                        23345566677777777777665432


Q ss_pred             c----cccccccCCCeEecCCCcCcCCCchhhh-----cCCCCCEEeCCCCcCCCC------CCccCCCCccEEEccCCc
Q 003504          287 F----PQIGTLLGLEHLNLSRTSLIGDIPSEIL-----QLSSLHTLDLSMNHLTGQ------IPTVSAKNLGIIDMSHNN  351 (815)
Q Consensus       287 ~----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~ls~N~l~~~------~~~~~~~~L~~L~ls~N~  351 (815)
                      .    ..+..+++|+.|+++++.+......+|.     ..++|+.|.|.+|.++..      .+....+.|..|+|++|.
T Consensus       230 s~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~  309 (382)
T KOG1909|consen  230 SVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNR  309 (382)
T ss_pred             HHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccc
Confidence            2    2356677888888888888755544443     368999999999999842      122256889999999999


Q ss_pred             Cc
Q 003504          352 LS  353 (815)
Q Consensus       352 l~  353 (815)
                      +.
T Consensus       310 l~  311 (382)
T KOG1909|consen  310 LG  311 (382)
T ss_pred             cc
Confidence            93

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.15  E-value=3.6e-11  Score=130.80  Aligned_cols=251  Identities=17%  Similarity=0.156  Sum_probs=175.0

Q ss_pred             HHhcCCCCCCeecccCCeeeEEEEc--CCCcEEEEEEeecCCcccHHHH--HHHHHHhcCC-CCCCceeeeeEEEeCCee
Q 003504          505 SATSNFDRGTLLAEGKFGPVYRGFL--PGGIHVAVKVLVHGSTLTDQEA--ARELEYLGRI-KHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       505 ~~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~g~~~~~~~~  579 (815)
                      ..+.+|.....||.|.|+.||+...  .++..+++|.+.........+.  ..|+-+...+ .|.++++....+..-+..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3456788899999999999999874  4678899998876544433332  3566666665 488888887777777777


Q ss_pred             EEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  659 (815)
                      ++--||++++++.....-                              ...++...++++..+++.++.++|   ++.++
T Consensus       342 ~ip~e~~~~~s~~l~~~~------------------------------~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~  388 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVT------------------------------SQMLDEDPRLRLTAQILTALNVIH---SKLFV  388 (524)
T ss_pred             cCchhhhcCcchhhhhHH------------------------------HHhcCcchhhhhHHHHHhcccccc---chhhh
Confidence            888999999988766521                              223445567888999999999999   89999


Q ss_pred             eccCCCCceEEcCC-CCeeecccccceecCCCCccccccccccccC-CcccCCCCCCCCCcCcchhHHHHHHHHHhCCCC
Q 003504          660 HRDIKASSVYLDMN-LEPRLSDFGLAKIFGNGLDEEIARGSPGYIP-PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       660 HrDlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p  737 (815)
                      |+|+||+||++..+ +..+++|||.+..+.-  ......+..++.| +|++..... +..+.|+||||+-+.|.+++..-
T Consensus       389 ~~d~~psni~i~~~~~~~~~~~~~~~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~-~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  389 HLDVKPSNILISNDGFFSKLGDFGCWTRLAF--SSGVFHHIDRLYPIAEILLEDYP-HLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             cccccccceeeccchhhhhccccccccccce--ecccccccccccccchhhccccc-cccccccccccccccccccCccc
Confidence            99999999999886 7889999999875321  1222234445552 554443332 67899999999999999997642


Q ss_pred             CCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHhhh
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~  812 (815)
                      -. ...        .|.           .+........+..- .+.+.+......+++..||.+.+.....+..+
T Consensus       466 s~-~~~--------~~~-----------~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  466 SE-SGV--------QSL-----------TIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             Cc-ccc--------cce-----------eeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            11 100        000           00111111112222 66778888899999999999998876655444

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.07  E-value=1.8e-09  Score=104.85  Aligned_cols=137  Identities=11%  Similarity=0.088  Sum_probs=97.2

Q ss_pred             CeecccCCeeeEEEEcCC-------CcEEEEEEeecC-------------C---------cccHHHH----HHHHHHhcC
Q 003504          514 TLLAEGKFGPVYRGFLPG-------GIHVAVKVLVHG-------------S---------TLTDQEA----ARELEYLGR  560 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~l~~~-------------~---------~~~~~~~----~~E~~~l~~  560 (815)
                      ..||.|.-+.||.|.-.+       +..+|||+.+..             .         ....+.+    ++|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999998553       478999987421             0         0012223    379999998


Q ss_pred             CCC--CCceeeeeEEEeCCeeEEEEEeCCCCChhh-hhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHH
Q 003504          561 IKH--PNLVPLTGYCIAGDQRIAIYDYMENGNLQN-LLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRH  637 (815)
Q Consensus       561 l~H--~niv~l~g~~~~~~~~~lv~ey~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  637 (815)
                      +..  -++.+.+++    ...++||||+.++.+.. .+.+                               ..++.....
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-------------------------------~~~~~~~~~  127 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-------------------------------AKLNDEEMK  127 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-------------------------------cccCHHHHH
Confidence            853  456666654    56789999998754321 1211                               112223445


Q ss_pred             HHHHHHHHHHHHH-hcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCC
Q 003504          638 KIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN  689 (815)
Q Consensus       638 ~i~~~ia~~L~yL-H~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  689 (815)
                      ++..+++.+|.+| |   ..++|||||++.||+++ ++.+.|+|||.+.....
T Consensus       128 ~i~~~i~~~l~~l~H---~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         128 NAYYQVLSMMKQLYK---ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            6788999999999 6   78999999999999997 46899999998876643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.03  E-value=1.3e-09  Score=110.51  Aligned_cols=142  Identities=19%  Similarity=0.223  Sum_probs=99.5

Q ss_pred             CeecccCCeeeEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCC--CCceeeeeEEEeCC---eeEEEEEeCC
Q 003504          514 TLLAEGKFGPVYRGFLPGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKH--PNLVPLTGYCIAGD---QRIAIYDYME  587 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lv~ey~~  587 (815)
                      +.|+.|.++.||++...+|..+++|....... .....+.+|+++++.+++  .++.+++++.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999987778899998755322 134578899999999975  34567777766532   5689999999


Q ss_pred             CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcC--------------
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHG--------------  653 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~--------------  653 (815)
                      ++++.+.+..                               ..++...+..++.+++++|++||+.              
T Consensus        84 G~~l~~~~~~-------------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~  132 (223)
T cd05154          84 GRVLRDRLLR-------------------------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPG  132 (223)
T ss_pred             CEecCCCCCC-------------------------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCC
Confidence            9888775521                               0122233333444444444444411              


Q ss_pred             ---------------------------------------CCCCeeeccCCCCceEEcC--CCCeeeccccccee
Q 003504          654 ---------------------------------------CSPPIIHRDIKASSVYLDM--NLEPRLSDFGLAKI  686 (815)
Q Consensus       654 ---------------------------------------~~~~ivHrDlk~~NIll~~--~~~~kl~Dfgla~~  686 (815)
                                                             ....++|+|+.+.||+++.  ++.+.|.||+.+..
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         133 GYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             chHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                                   1357899999999999998  66789999997763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.99  E-value=2.8e-10  Score=88.95  Aligned_cols=59  Identities=42%  Similarity=0.581  Sum_probs=29.6

Q ss_pred             CCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCCCc
Q 003504           77 SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNM  135 (815)
Q Consensus        77 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  135 (815)
                      +|++|+|++|+|+.+.++.|.++++|++|+|++|+|+.+.|.+|.++++|++|+|++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            44455555555554444445555555555555555554444455555555555555544

...

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.97  E-value=3.9e-09  Score=98.40  Aligned_cols=131  Identities=21%  Similarity=0.333  Sum_probs=98.3

Q ss_pred             CeecccCCeeeEEEEcCCCcEEEEEEeecCCccc--------HHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEEEe
Q 003504          514 TLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLT--------DQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ey  585 (815)
                      ..+++|+-+.+|.+.+.+ .++++|.=..+.-..        .....+|+.++.+++--.|...+=|..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            467899999999998764 346666432211111        12456799999888654444444466778888999999


Q ss_pred             CCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~  665 (815)
                      +++-.|.+++...                                     +..++..+-+-+.-||   ..+|||+||.+
T Consensus        81 I~G~~lkd~l~~~-------------------------------------~~~~~r~vG~~vg~lH---~~givHGDLTt  120 (204)
T COG3642          81 IEGELLKDALEEA-------------------------------------RPDLLREVGRLVGKLH---KAGIVHGDLTT  120 (204)
T ss_pred             eCChhHHHHHHhc-------------------------------------chHHHHHHHHHHHHHH---hcCeecCCCcc
Confidence            9999998888641                                     2457777888889999   89999999999


Q ss_pred             CceEEcCCCCeeeccccccee
Q 003504          666 SSVYLDMNLEPRLSDFGLAKI  686 (815)
Q Consensus       666 ~NIll~~~~~~kl~Dfgla~~  686 (815)
                      +||++..+. +.++|||++..
T Consensus       121 sNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642         121 SNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             ceEEEeCCc-EEEEECCcccc
Confidence            999999764 99999999874

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.97  E-value=2.9e-10  Score=134.57  Aligned_cols=103  Identities=34%  Similarity=0.436  Sum_probs=53.4

Q ss_pred             CCCEEECcCCC--CCCCCcccCC-CCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEE
Q 003504           54 KLQSLDLSENN--ITALPSDLWS-LGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLK  130 (815)
Q Consensus        54 ~L~~L~Ls~n~--l~~lp~~~~~-l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  130 (815)
                      .|++|-+..|.  +..++..+|. ++.|++|||++|.=-+.+|+.+++|-+|++|+|++..|+ .+|..|.+|.+|.+|+
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            45555555554  4444444333 555555555555433455555555555555555555555 4555555555555555


Q ss_pred             cCCCcccccCCcccccccccceeeccC
Q 003504          131 LDGNMFQWSIPPGLLNCQSLVTVDLSM  157 (815)
Q Consensus       131 L~~N~l~~~~~~~~~~l~~L~~L~l~~  157 (815)
                      +..+.-...+|.....+++|++|.+..
T Consensus       625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~  651 (889)
T KOG4658|consen  625 LEVTGRLESIPGILLELQSLRVLRLPR  651 (889)
T ss_pred             cccccccccccchhhhcccccEEEeec
Confidence            555543333444444455555555533

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.95  E-value=4.5e-10  Score=87.79  Aligned_cols=61  Identities=36%  Similarity=0.413  Sum_probs=49.3

Q ss_pred             CCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccCCcC
Q 003504          100 GLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQL  160 (815)
Q Consensus       100 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  160 (815)
                      ++|++|+|++|+|+.+.+.+|.++++|++|+|++|+|+...|+.|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4678888888888877777888888888888888888877777888888888888888875

...

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.95  E-value=2.4e-10  Score=130.51  Aligned_cols=247  Identities=21%  Similarity=0.260  Sum_probs=163.4

Q ss_pred             HhcCCCCCCeecccCCeeeEEEEcC-CCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEE
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  581 (815)
                      ..++|.+.+.+.+|.++.++-+.-. .|...+.|+.....   ....+....+-.+.-..+||-+++...-+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4456777788899999999877632 23233444332211   1112223333333333456777766555445678899


Q ss_pred             EEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      |++|..+|+|...||.....                             -....|--| ..+..+++|||   ...++||
T Consensus       882 ~~~~~~~~~~~Skl~~~~~~-----------------------------saepaRs~i-~~~vqs~e~L~---s~~r~h~  928 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGCL-----------------------------SAEPARSPI-LERVQSLESLH---SSLRKHR  928 (1205)
T ss_pred             hhHHhccCCchhhhhcCCCc-----------------------------ccccccchh-HHHHhhhhccc---cchhhcc
Confidence            99999999999999864200                             001112222 33567899999   7779999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecC---------------------CC-----------CccccccccccccCCcccC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFG---------------------NG-----------LDEEIARGSPGYIPPEFAQ  709 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~---------------------~~-----------~~~~~~~gt~~y~aPE~~~  709 (815)
                      |++|.|.+...++..+++|||.....+                     ..           .......||+.|.+||...
T Consensus       929 ~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l 1008 (1205)
T KOG0606|consen  929 DLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL 1008 (1205)
T ss_pred             cccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc
Confidence            999999999999999999998433211                     00           0122344899999999998


Q ss_pred             CCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhh
Q 003504          710 PDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL  789 (815)
Q Consensus       710 ~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  789 (815)
                      +..  ....+|+|++|++++|.++|..||....++..-+++..           ..+-.    ...+.....+..+++..
T Consensus      1009 g~~--hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~-----------~~~~~----p~g~~~~s~~aq~~~~~ 1071 (1205)
T KOG0606|consen 1009 GRR--HGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILN-----------RDIPW----PEGPEEGSYEAQDLINR 1071 (1205)
T ss_pred             ccc--CCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhcccc-----------CCCCC----CCCccccChhhhhhhhh
Confidence            877  47789999999999999999999987666544322221           11111    12245566678888888


Q ss_pred             ccccCCCCCCCHH
Q 003504          790 CTADLPLKRPSMQ  802 (815)
Q Consensus       790 Cl~~dP~~RPs~~  802 (815)
                      .+..+|.+|-.|.
T Consensus      1072 ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1072 LLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhccCchhccCcc
Confidence            9999999998665

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.91  E-value=1.4e-09  Score=128.84  Aligned_cols=152  Identities=24%  Similarity=0.361  Sum_probs=120.4

Q ss_pred             ccCCCCCCEEECcCCCCCCCCcccCCCCCCCEEEccCCc--CCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCC
Q 003504           49 IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNR--ISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSL  126 (815)
Q Consensus        49 ~~~l~~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~--i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  126 (815)
                      .......+...+-+|++..++.... .++|++|-+..|.  +..+.++.|..++.|++|||++|.=-+.+|..+++|.+|
T Consensus       519 ~~~~~~~rr~s~~~~~~~~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  519 VKSWNSVRRMSLMNNKIEHIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             ccchhheeEEEEeccchhhccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            4556788999999999998875443 3489999999996  665666678999999999999988667999999999999


Q ss_pred             CEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccCCCC---CCCCCCCCCeEec
Q 003504          127 RVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT---HFAGLKSITNLNI  203 (815)
Q Consensus       127 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~l~~L~~L~L  203 (815)
                      ++|+|++..++ .+|..+.+|++|.+|++..+.-...+ ..+...+.+|++|.|..-.......   .+..|.+|+.|..
T Consensus       598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~-~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~  675 (889)
T KOG4658|consen  598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESI-PGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI  675 (889)
T ss_pred             hcccccCCCcc-ccchHHHHHHhhheeccccccccccc-cchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence            99999999999 79999999999999999998765355 4444669999999998877333222   2344444444444

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.86  E-value=1.5e-08  Score=93.88  Aligned_cols=143  Identities=20%  Similarity=0.259  Sum_probs=100.6

Q ss_pred             CCCeecccCCeeeEEEEcCCCcEEEEE-EeecCC-------cccHHHHHHHHHHhcCCCCCCceeeeeEEEeCCeeEEEE
Q 003504          512 RGTLLAEGKFGPVYRGFLPGGIHVAVK-VLVHGS-------TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       512 ~~~~ig~G~~g~Vy~~~~~~~~~vavK-~l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  583 (815)
                      ....+-+|+-+.|+++.+. |+...|| ++.+..       ....+...+|++++.+++--.|.-..=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            3578889999999999987 5555555 333221       112345678999999886444444444666777778999


Q ss_pred             EeCCC-CChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeecc
Q 003504          584 DYMEN-GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       584 ey~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  662 (815)
                      ||+++ -++.+++...-                           +. ...-.-....+..|-+.+.-||   ...|||+|
T Consensus        90 E~~~g~~~vk~~i~~~~---------------------------~~-~~~d~~~~~~~~~iG~~igklH---~ndiiHGD  138 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTM---------------------------ED-ESEDEGLAELARRIGELIGKLH---DNDIIHGD  138 (229)
T ss_pred             EeccchhHHHHHHHHHc---------------------------cC-cccchhHHHHHHHHHHHHHHhh---hCCeeccc
Confidence            99987 47888876420                           00 1111112567888888999999   88999999


Q ss_pred             CCCCceEEcCCCC---eeeccccccee
Q 003504          663 IKASSVYLDMNLE---PRLSDFGLAKI  686 (815)
Q Consensus       663 lk~~NIll~~~~~---~kl~Dfgla~~  686 (815)
                      |..+||++..++.   +.++|||++..
T Consensus       139 LTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  139 LTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ccccceEEecCCCcCceEEEeecchhc
Confidence            9999999976653   58999998863

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.78  E-value=1.2e-07  Score=101.18  Aligned_cols=180  Identities=18%  Similarity=0.228  Sum_probs=132.1

Q ss_pred             CeeeEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCCceeeeeEEEe----CCeeEEEEEeCCCC-Chhhh
Q 003504          521 FGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA----GDQRIAIYDYMENG-NLQNL  594 (815)
Q Consensus       521 ~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ey~~~g-sL~~~  594 (815)
                      ..+.||+. ..||..++.|+++............-+++.+++.|+|+|++..++..    +...++||+|.|+. +|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            35789998 56899999999954433333344456788899999999999998863    34678999999874 78776


Q ss_pred             hccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCC
Q 003504          595 LHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNL  674 (815)
Q Consensus       595 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~  674 (815)
                      -...++....               .-.....++........+.++.|++.||.++|   +.|+.-+-|.+++|+++.+.
T Consensus       369 ~F~~~~~t~~---------------~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~  430 (655)
T KOG3741|consen  369 YFANPPFTKR---------------TNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKM  430 (655)
T ss_pred             HccCCccccc---------------cccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcc
Confidence            5543221100               00011233455677788899999999999999   78898899999999999999


Q ss_pred             CeeecccccceecCCCCccccccccccccCCcccCCCCCCCCCcCcchhHHHHHHHHHhCCC
Q 003504          675 EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       675 ~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~S~Gvvl~el~tg~~  736 (815)
                      +++|+..|.......+..             |.+..     -.+-|.-.||.+++.|.+|..
T Consensus       431 RIriS~C~i~Dvl~~d~~-------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  431 RIRISGCGIMDVLQEDPT-------------EPLES-----QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             eEEEecccceeeecCCCC-------------cchhH-----HhhhhHHHHHHHHHHHhhccc
Confidence            999999998876654320             11221     236789999999999999864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.77  E-value=7.3e-08  Score=99.94  Aligned_cols=270  Identities=16%  Similarity=0.138  Sum_probs=162.5

Q ss_pred             CCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCCceeeeeEEE------eCC-eeEEE
Q 003504          511 DRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCI------AGD-QRIAI  582 (815)
Q Consensus       511 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~------~~~-~~~lv  582 (815)
                      ..+..+|+|+-+.+|-.---  ..-+.|++.......+.+-   ++.|... .||-+-.=+.+=.      +.. ..-++
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh--hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            34788999999999954211  1235577765433333322   2333333 4664433111110      111 24456


Q ss_pred             EEeCCCC-ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 003504          583 YDYMENG-NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       583 ~ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  661 (815)
                      |..+++. -...++.                  ..+.      -..-...+|.+.++.+..+|.+-+.||   ..|.+-+
T Consensus        89 mP~v~g~~pI~~~y~------------------p~tR------Rqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vG  141 (637)
T COG4248          89 MPKVSGKEPIHMIYS------------------PATR------RQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVG  141 (637)
T ss_pred             cccCCCccchhhhcC------------------chhh------cccCCccccHHHHHHHHHHHHHHHHHH---hcCCccc
Confidence            6666553 1111111                  0000      011335789999999999999999999   8899999


Q ss_pred             cCCCCceEEcCCCCeeecccccceecCCCCccccccccccccCCcccCCCC---CCCCCcCcchhHHHHHHHHHhC-CCC
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELITG-KKP  737 (815)
Q Consensus       662 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~Dv~S~Gvvl~el~tg-~~p  737 (815)
                      |+.++|+|+++++.+.+.|=..-....++......+|...|.+||.-.-..   ...+...|-|.+||++++++.| +.|
T Consensus       142 DVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHP  221 (637)
T COG4248         142 DVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHP  221 (637)
T ss_pred             ccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCC
Confidence            999999999999999999865444444554555566889999999754111   1137789999999999999985 999


Q ss_pred             CCCCCCcc-----ccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhhccccC--CCCCCCHHHHHHHHHh
Q 003504          738 LGDDYPEE-----KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL--PLKRPSMQQIVGLLKD  810 (815)
Q Consensus       738 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~d--P~~RPs~~~v~~~L~~  810 (815)
                      |.+-....     .+..+....-.+....  ..-..|.-..-...-.+..+..+...|+...  |.-||+++.-+..|.+
T Consensus       222 ysGI~~~~~ap~p~E~~Ia~g~f~ya~~~--~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         222 YSGIPLISDAPNPLETDIAHGRFAYASDQ--RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             CCcccccCCCCCcchhhhhcceeeechhc--cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            98732111     1112221110011111  1111111111112334567888889999865  4579999999998887


Q ss_pred             hhhc
Q 003504          811 IEST  814 (815)
Q Consensus       811 i~~~  814 (815)
                      ++++
T Consensus       300 l~~~  303 (637)
T COG4248         300 LRQQ  303 (637)
T ss_pred             HHHh
Confidence            7653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.74  E-value=6.5e-08  Score=93.72  Aligned_cols=126  Identities=23%  Similarity=0.307  Sum_probs=80.5

Q ss_pred             eeEEEEcCCCcEEEEEEeecCCc-------------c---------c----HHHHHHHHHHhcCCCCC--CceeeeeEEE
Q 003504          523 PVYRGFLPGGIHVAVKVLVHGST-------------L---------T----DQEAARELEYLGRIKHP--NLVPLTGYCI  574 (815)
Q Consensus       523 ~Vy~~~~~~~~~vavK~l~~~~~-------------~---------~----~~~~~~E~~~l~~l~H~--niv~l~g~~~  574 (815)
                      .||.|...+|..||||+.+....             .         .    ....++|.+.|.++..-  ++.+.+++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            38999998999999998753200             0         0    12356899999999755  45566544  


Q ss_pred             eCCeeEEEEEeCC--CCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHH-Hh
Q 003504          575 AGDQRIAIYDYME--NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAF-LH  651 (815)
Q Consensus       575 ~~~~~~lv~ey~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~y-LH  651 (815)
                        ....+||||++  +..+.. |...                               .++......++.++...+.. +|
T Consensus        79 --~~~~ivME~I~~~G~~~~~-l~~~-------------------------------~~~~~~~~~~~~~il~~~~~~~~  124 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPR-LKDV-------------------------------DLSPEEPKELLEEILEEIIKMLH  124 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGC-HHHC-------------------------------GGGGSTHHHHHHHHHHHHHHHHH
T ss_pred             --eCCEEEEEecCCCccchhh-HHhc-------------------------------cccchhHHHHHHHHHHHHHHHHH
Confidence              24579999999  544433 3221                               00011234567777775665 46


Q ss_pred             cCCCCCeeeccCCCCceEEcCCCCeeecccccceecC
Q 003504          652 HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG  688 (815)
Q Consensus       652 ~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~  688 (815)
                         ..+|||+||.+.||+++++ .+.|+|||.+....
T Consensus       125 ---~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  125 ---KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             ---CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             ---hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence               7899999999999999988 99999999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.74  E-value=1.1e-09  Score=106.56  Aligned_cols=217  Identities=25%  Similarity=0.314  Sum_probs=128.3

Q ss_pred             ccCCCCCCEEECcCCCCCC-----CCcccCCCCCCCEEEccCCcCC---ccCCccccCCCCCcEEEccCCcCCCCChhhh
Q 003504           49 IGKLSKLQSLDLSENNITA-----LPSDLWSLGSLKSLNLSYNRIS---GSLPSNIGNFGLLEVFDLSNNNFSGEIPAAI  120 (815)
Q Consensus        49 ~~~l~~L~~L~Ls~n~l~~-----lp~~~~~l~~L~~L~L~~N~i~---~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  120 (815)
                      +.-+..++.+|||+|.|.+     +...+.+-.+|+..+++.-...   +.+++.+.                 .+-.++
T Consensus        26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~-----------------~Ll~aL   88 (388)
T COG5238          26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLV-----------------MLLKAL   88 (388)
T ss_pred             HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHH-----------------HHHHHH
Confidence            3346677777777777762     3334444556666666543222   11111110                 112234


Q ss_pred             cCCcCCCEEEcCCCcccccCCccc----ccccccceeeccCCcCCCCCCch-hh------------ccCCCCCEEEcCCC
Q 003504          121 SSLVSLRVLKLDGNMFQWSIPPGL----LNCQSLVTVDLSMNQLNGSLPDG-FG------------AAFPKLKSLNLAGN  183 (815)
Q Consensus       121 ~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~~~lp~~-~~------------~~l~~L~~L~L~~N  183 (815)
                      .++++|+..+||.|.|....|+.+    +.-+.|..|.|++|.+- .+... ++            ..-|.|+......|
T Consensus        89 lkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlG-p~aG~rigkal~~la~nKKaa~kp~Le~vicgrN  167 (388)
T COG5238          89 LKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLG-PIAGGRIGKALFHLAYNKKAADKPKLEVVICGRN  167 (388)
T ss_pred             hcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCC-ccchhHHHHHHHHHHHHhhhccCCCceEEEeccc
Confidence            445555555555555544444322    23445556666655553 22211 11            23467888888888


Q ss_pred             cccCCCC-----CCCCCCCCCeEeccCCcCCCcchhh--h-----hcccceeeeccccccCcccccccccccCCccceEE
Q 003504          184 EIKGRDT-----HFAGLKSITNLNISGNLFQGSVMGV--F-----LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYV  251 (815)
Q Consensus       184 ~l~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~~~~--~-----l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L  251 (815)
                      ++...+.     .|..-.+|+++.+..|.|..-....  |     +.+|+.|||+.|-++-..+.........|+.|+.|
T Consensus       168 Rlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL  247 (388)
T COG5238         168 RLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLREL  247 (388)
T ss_pred             hhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhc
Confidence            8876442     2344468889999999886543222  2     67899999999998877766666677788888888


Q ss_pred             EcCCCccCcchhhccc------cCCCCCEEEecCCcCc
Q 003504          252 DLSENQLSGEIFHNFS------QAQNLKHLSLAYNRFT  283 (815)
Q Consensus       252 ~Ls~N~l~~~~~~~~~------~l~~L~~L~L~~N~l~  283 (815)
                      .+..|-++......+-      ..++|+.|-+.+|-+.
T Consensus       248 ~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~  285 (388)
T COG5238         248 RLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERR  285 (388)
T ss_pred             cccchhhccccHHHHHHHhhhhcCCCccccccchhhhc
Confidence            8888888765544332      2467777777777663

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.71  E-value=2.8e-10  Score=124.27  Aligned_cols=177  Identities=27%  Similarity=0.269  Sum_probs=126.8

Q ss_pred             cccCCCCCCEEECcCCCCCCCCcccCCC-CCCCEEEccCCcCC---ccCCccccCC------CCCcEEEccCCcCCCCCh
Q 003504           48 TIGKLSKLQSLDLSENNITALPSDLWSL-GSLKSLNLSYNRIS---GSLPSNIGNF------GLLEVFDLSNNNFSGEIP  117 (815)
Q Consensus        48 ~~~~l~~L~~L~Ls~n~l~~lp~~~~~l-~~L~~L~L~~N~i~---~~~~~~~~~l------~~L~~L~Ls~N~l~~~~p  117 (815)
                      .+..+..|++|.|.++.|.... ++..+ .+|++| +-+|.+.   .++....+..      -.|..-+.+.|.+. ...
T Consensus       104 ~ifpF~sLr~LElrg~~L~~~~-GL~~lr~qLe~L-IC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~mD  180 (1096)
T KOG1859|consen  104 SIFPFRSLRVLELRGCDLSTAK-GLQELRHQLEKL-ICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LMD  180 (1096)
T ss_pred             eeccccceeeEEecCcchhhhh-hhHHHHHhhhhh-hhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-hHH
Confidence            3555667777777777776532 33332 345555 3344433   1111111111      24778888999998 667


Q ss_pred             hhhcCCcCCCEEEcCCCcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccCCCCCCCCCCC
Q 003504          118 AAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKS  197 (815)
Q Consensus       118 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~  197 (815)
                      .++.=++.|+.|+|++|+++..  +.+..|+.|+.|||+.|.+. .+|.--..+ .+|..|.|++|.++.+- .+.+|.+
T Consensus       181 ~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~g-c~L~~L~lrnN~l~tL~-gie~Lks  255 (1096)
T KOG1859|consen  181 ESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVG-CKLQLLNLRNNALTTLR-GIENLKS  255 (1096)
T ss_pred             HHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhh-hhheeeeecccHHHhhh-hHHhhhh
Confidence            8888899999999999999853  37888999999999999998 887643333 35999999999998753 4678899


Q ss_pred             CCeEeccCCcCCCcchhhh---hcccceeeeccccccC
Q 003504          198 ITNLNISGNLFQGSVMGVF---LESLEVIDLRSNQFQG  232 (815)
Q Consensus       198 L~~L~Ls~N~l~~~~~~~~---l~~L~~L~L~~N~l~~  232 (815)
                      |..|||++|.|.+.....+   +..|..|.|.+|.+-.
T Consensus       256 L~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  256 LYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             hhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            9999999999877554444   7789999999998754

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.69  E-value=1.5e-07  Score=96.80  Aligned_cols=142  Identities=18%  Similarity=0.121  Sum_probs=99.2

Q ss_pred             CCeecccCCeeeEEEEcCCCcEEEEEEeecCCcc-----------cHHHHHHHHHHhcCCCCCC--ceeeeeEEEe----
Q 003504          513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTL-----------TDQEAARELEYLGRIKHPN--LVPLTGYCIA----  575 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~----  575 (815)
                      ++.+-......|+++.+. |+.+.||........           ....+.+|...+.++...+  ..+.+++...    
T Consensus        27 ~e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         27 GEVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             CcEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            345554555557777664 678999977432211           1114778988888774322  3344555543    


Q ss_pred             -CCeeEEEEEeCCCC-ChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHHHHHHHhcC
Q 003504          576 -GDQRIAIYDYMENG-NLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHG  653 (815)
Q Consensus       576 -~~~~~lv~ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~yLH~~  653 (815)
                       ....++|+|++++- +|.+++....                            ....+...+..++.+++..+.-||  
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~----------------------------~~~~~~~~~~~ll~~la~~i~~LH--  155 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWA----------------------------TNPPDPRLKRMLIKRVATMVRDMH--  155 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHH--
Confidence             23568999999986 8988875310                            112334556789999999999999  


Q ss_pred             CCCCeeeccCCCCceEEcC-------CCCeeeccccccee
Q 003504          654 CSPPIIHRDIKASSVYLDM-------NLEPRLSDFGLAKI  686 (815)
Q Consensus       654 ~~~~ivHrDlk~~NIll~~-------~~~~kl~Dfgla~~  686 (815)
                       ..+|+|+|++++|||++.       ++.+.++||+.++.
T Consensus       156 -~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        156 -AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             -HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence             899999999999999985       46799999998864

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.67  E-value=3.4e-09  Score=104.55  Aligned_cols=62  Identities=19%  Similarity=0.147  Sum_probs=29.9

Q ss_pred             ccceEEEcCCCccCcch-hhccccCCCCCEEEecCCcCcCCC-ccccccccCCCeEecCCCcCc
Q 003504          246 SRLVYVDLSENQLSGEI-FHNFSQAQNLKHLSLAYNRFTRQE-FPQIGTLLGLEHLNLSRTSLI  307 (815)
Q Consensus       246 ~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~  307 (815)
                      +++..+.+..|.|.... .+.+..++.+..|+|+.|+|.+.. ..++..++.|..|.+++|++.
T Consensus       199 pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~  262 (418)
T KOG2982|consen  199 PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS  262 (418)
T ss_pred             ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence            45555555555554322 233444455555666666654322 223444555555555555543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.64  E-value=1.1e-08  Score=112.86  Aligned_cols=149  Identities=19%  Similarity=0.261  Sum_probs=102.2

Q ss_pred             HHHHHHHHHHHhcCCCCCeeeccCCCCceEEcCCCCeeecccccceecCCCCc-----c-----ccccccccccCCcccC
Q 003504          640 ALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD-----E-----EIARGSPGYIPPEFAQ  709 (815)
Q Consensus       640 ~~~ia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----~-----~~~~gt~~y~aPE~~~  709 (815)
                      +.+++.||.|+|.  +.++||++|.|++|.+++.+..||+.|+.+.....+..     .     ........|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3456799999997  78999999999999999999999999998876543211     0     0111355799999998


Q ss_pred             CCCCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCccccccHHHHHHHHHhcCCCCccccccccCCCCHHHHHHHHHHHhh
Q 003504          710 PDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL  789 (815)
Q Consensus       710 ~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  789 (815)
                      ...  .+.++|+||+||++|.+..|..+.......     ...+-....       ..+-... -...+.+.++.+-+.+
T Consensus       183 ~~~--~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-----~~~~~~~~~-------~~~~~~~-~~s~~~p~el~~~l~k  247 (700)
T KOG2137|consen  183 GTT--NTPASDVFSLGVLIYTIYNGGKSIIAANGG-----LLSYSFSRN-------LLNAGAF-GYSNNLPSELRESLKK  247 (700)
T ss_pred             ccc--ccccccceeeeeEEEEEecCCcchhhccCC-----cchhhhhhc-------ccccccc-cccccCcHHHHHHHHH
Confidence            855  689999999999999999655443221111     110000000       0001111 1135567788888899


Q ss_pred             ccccCCCCCCCHHHHH
Q 003504          790 CTADLPLKRPSMQQIV  805 (815)
Q Consensus       790 Cl~~dP~~RPs~~~v~  805 (815)
                      .+..++.-||++.++.
T Consensus       248 ~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  248 LLNGDSAVRPTLDLLL  263 (700)
T ss_pred             HhcCCcccCcchhhhh
Confidence            9999999999776664

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.63  E-value=6.3e-09  Score=102.65  Aligned_cols=108  Identities=27%  Similarity=0.339  Sum_probs=64.3

Q ss_pred             CCCCEEECcCCCCCCCCcc--cC-CCCCCCEEEccCCcCCc--cCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCC
Q 003504           53 SKLQSLDLSENNITALPSD--LW-SLGSLKSLNLSYNRISG--SLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLR  127 (815)
Q Consensus        53 ~~L~~L~Ls~n~l~~lp~~--~~-~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  127 (815)
                      .-++.|-+.++.|......  +. ..+.+++|||.+|.|++  .+-..+.+|+.|+.|+|+.|.++..+-..-..+.+|+
T Consensus        45 ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~  124 (418)
T KOG2982|consen   45 RALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLR  124 (418)
T ss_pred             cchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceE
Confidence            3445566666666654331  22 25667777777777774  2333456677777777777777644322224556777


Q ss_pred             EEEcCCCcccccCCcc-cccccccceeeccCCcC
Q 003504          128 VLKLDGNMFQWSIPPG-LLNCQSLVTVDLSMNQL  160 (815)
Q Consensus       128 ~L~L~~N~l~~~~~~~-~~~l~~L~~L~l~~N~l  160 (815)
                      +|.|.+..+.+.-.+. +..++.++.|++|.|.+
T Consensus       125 ~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~  158 (418)
T KOG2982|consen  125 VLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL  158 (418)
T ss_pred             EEEEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence            7777777666544333 34566777777777644

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.57  E-value=8.1e-10  Score=120.79  Aligned_cols=129  Identities=29%  Similarity=0.280  Sum_probs=88.5

Q ss_pred             CCCEEECcCCCCCCCCcccCCCCCCCEEEccCCcCCccCCccccCCCCCcEEEccCCcCCCCChhhhcCCcCCCEEEcCC
Q 003504           54 KLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG  133 (815)
Q Consensus        54 ~L~~L~Ls~n~l~~lp~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  133 (815)
                      .|...+.+.|.++.+...+.-++.|+.|||++|+++..  +.+..+++|++|||++|+++.+.--...++. |+.|.|++
T Consensus       165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn  241 (1096)
T KOG1859|consen  165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN  241 (1096)
T ss_pred             hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence            46667777777777777777777788888888887744  3677777888888888887744333333444 78888888


Q ss_pred             CcccccCCcccccccccceeeccCCcCCCCCCchhhccCCCCCEEEcCCCcccC
Q 003504          134 NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG  187 (815)
Q Consensus       134 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~  187 (815)
                      |.++..  ..+.+|++|+.|||++|-|.+.-.-.+...+..|+.|.|.+|.+-.
T Consensus       242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            877732  3467777788888888877654433444456677777777777644

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.47  E-value=8.9e-09  Score=90.14  Aligned_cols=125  Identities=27%  Similarity=0.388  Sum_probs=89.8

Q ss_pred             CcEEEccCCcCCCCChhhh---cCCcCCCEEEcCCCcccccCCcccc-cccccceeeccCCcCCCCCCchhhccCCCCCE
Q 003504          102 LEVFDLSNNNFSGEIPAAI---SSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKS  177 (815)
Q Consensus       102 L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~  177 (815)
                      +..|||++++|- -++++.   .....|+..+|++|.+. ..|+.|. ..+.+++|+|++|.|+ .+|.++ ..++.|+.
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~-Aam~aLr~  104 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEEL-AAMPALRS  104 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHH-hhhHHhhh
Confidence            455677777665 334443   44456666788888888 4666664 4457888888888887 888884 66888888


Q ss_pred             EEcCCCcccCCCCCCCCCCCCCeEeccCCcCCCcchhhhhcccc-eeeeccccc
Q 003504          178 LNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLE-VIDLRSNQF  230 (815)
Q Consensus       178 L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~-~L~L~~N~l  230 (815)
                      |+++.|.+...+..+..|.+|-.|+..+|.+..++...|.+++. ..++.++.+
T Consensus       105 lNl~~N~l~~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl  158 (177)
T KOG4579|consen  105 LNLRFNPLNAEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPL  158 (177)
T ss_pred             cccccCccccchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcc
Confidence            88888888888877777888889999999988888887644433 334444443

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.45  E-value=1.2e-06  Score=86.96  Aligned_cols=135  Identities=22%  Similarity=0.209  Sum_probs=93.7

Q ss_pred             CCCCCeecccCCeeeEEEEcCCCcEEEEEEeecCCc----------------------ccHHHHHHHHHHhcCCCCC--C
Q 003504          510 FDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGST----------------------LTDQEAARELEYLGRIKHP--N  565 (815)
Q Consensus       510 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~H~--n  565 (815)
                      ..++..||-|.-+.||.|..+.|.++|||.-+.+..                      ......++|.++|++|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            456789999999999999999999999997643211                      0112356899999999644  6


Q ss_pred             ceeeeeEEEeCCeeEEEEEeCCCCChhhhhccCCCCCccccCCCCCccccCCCccccccCCCCcccCHHHHHHHHHHHHH
Q 003504          566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTAR  645 (815)
Q Consensus       566 iv~l~g~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~  645 (815)
                      +.+.++    .+...+||||+++--|...=-                                   +-...-.|+..|.+
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~r~-----------------------------------~~en~~~il~~il~  213 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRLRL-----------------------------------DVENPDEILDKILE  213 (304)
T ss_pred             CCCccc----cccceeeeehcccceeecccC-----------------------------------cccCHHHHHHHHHH
Confidence            666655    346689999999855533210                                   00111123333333


Q ss_pred             HHHHHhcCCCCCeeeccCCCCceEEcCCCCeeeccccccee
Q 003504          646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI  686 (815)
Q Consensus       646 ~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~  686 (815)
                      -+.-.-   ..||||+|+.+-||++++||.+.++||--+..
T Consensus       214 ~~~~~~---~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         214 EVRKAY---RRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             HHHHHH---HcCccccCCchheEEEecCCCEEEEeCccccc
Confidence            333333   46799999999999999999999999975543

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.41  E-value=7.5e-08  Score=94.01  Aligned_cols=199  Identities=21%  Similarity=0.247  Sum_probs=99.3

Q ss_pred             cccccccccceeeccCCcCCCCCCchhh---ccCCCCCEEEcCCCcccCCCC-CC-------------CCCCCCCeEecc
Q 003504          142 PGLLNCQSLVTVDLSMNQLNGSLPDGFG---AAFPKLKSLNLAGNEIKGRDT-HF-------------AGLKSITNLNIS  204 (815)
Q Consensus       142 ~~~~~l~~L~~L~l~~N~l~~~lp~~~~---~~l~~L~~L~L~~N~l~~~~~-~~-------------~~l~~L~~L~Ls  204 (815)
                      +.+.+|+.|+.++||+|.+....|..+.   +..+.|.+|.|++|.+..+.. .+             ..-+.|+.....
T Consensus        86 ~aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicg  165 (388)
T COG5238          86 KALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICG  165 (388)
T ss_pred             HHHhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEec
Confidence            3566789999999999998767775443   334667777777777654321 11             122334444444


Q ss_pred             CCcCCCcchhhhhcccceeeeccccccCcccccccccccCCccceEEEcCCCccCcc-----hhhccccCCCCCEEEecC
Q 003504          205 GNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGE-----IFHNFSQAQNLKHLSLAY  279 (815)
Q Consensus       205 ~N~l~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~L~~  279 (815)
                      .|++..-+..                      .....+..-..|+.+.+..|.|.-.     ....+..+.+|+.|||..
T Consensus       166 rNRlengs~~----------------------~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqD  223 (388)
T COG5238         166 RNRLENGSKE----------------------LSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQD  223 (388)
T ss_pred             cchhccCcHH----------------------HHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccc
Confidence            4444332221                      1111111112344444444444322     111223445666666666


Q ss_pred             CcCcCCCcc----ccccccCCCeEecCCCcCcCCCchhhh------cCCCCCEEeCCCCcCCCCCCccCCCCccEEEccC
Q 003504          280 NRFTRQEFP----QIGTLLGLEHLNLSRTSLIGDIPSEIL------QLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSH  349 (815)
Q Consensus       280 N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~------~l~~L~~L~ls~N~l~~~~~~~~~~~L~~L~ls~  349 (815)
                      |-++.....    .+..++.|+.|.+..|-++.....++.      ..++|..|-..+|...+-+-         ++.+ 
T Consensus       224 Ntft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i---------~~~~-  293 (388)
T COG5238         224 NTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGII---------LDIS-  293 (388)
T ss_pred             cchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCcee---------eeec-
Confidence            666543322    234455566666666666544333322      13455555555555543211         1111 


Q ss_pred             CcCcccCChHHhhcCCCCceeeccCCCCc
Q 003504          350 NNLSGEIPASLLEKLPQMERFNFSYNNLT  378 (815)
Q Consensus       350 N~l~~~~p~~~~~~l~~l~~l~l~~N~l~  378 (815)
                            .|.-.-..+|-|..+.+.||.+.
T Consensus       294 ------l~~~e~~~~p~L~~le~ngNr~~  316 (388)
T COG5238         294 ------LNEFEQDAVPLLVDLERNGNRIK  316 (388)
T ss_pred             ------hhhhhhcccHHHHHHHHccCcch
Confidence                  22222345666777777888764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	815
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-42
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-42
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-35
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-34
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		7e-29
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		7e-29
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-27
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-27
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-27
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-16
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-15
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-15
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-15
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-15
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
3t6q_A	606	Crystal Structure Of Mouse Rp105MD-1 Complex Length		9e-13
3t6q_A	606	Crystal Structure Of Mouse Rp105MD-1 Complex Length		9e-05
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		8e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-07
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-07
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-07
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-07
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-07
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-07
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-07
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-07
3v47_A	455	Crystal Structure Of The N-Tetminal Fragment Of Zeb		6e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-07
3cig_A	697	Crystal Structure Of Mouse Tlr3 Ectodomain Length =		8e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-06
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		1e-06
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		2e-04
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-06
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-06
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-06
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-05
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		1e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-05
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-05
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-05
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		3e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
3rg1_A	612	Crystal Structure Of The Rp105MD-1 Complex Length =		3e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-05
3o6n_A	390	Crystal Structure Of Apl1 Leucine-Rich Repeat Domai		4e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
3oja_B	597	Crystal Structure Of Lrim1APL1C COMPLEX Length = 59		4e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-05
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-05
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		6e-05
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-04
2z7x_B	520	Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu		1e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-04
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-04
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-04
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-04
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-04
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		2e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-04
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-04
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-04
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-04
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  169 bits (429), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 104/319 (32%), Positives = 166/319 (52%), Gaps = 32/319 (10%)
Query: 495 LLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQ-EAAR 553
           L   +  +L  A+ NF    +L  G FG VY+G L  G  VAVK L    T   + +   
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 554 ELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXX 613
           E+E +    H NL+ L G+C+   +R+ +Y YM NG++ + L + P              
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP-------------- 122
Query: 614 XXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMN 673
                       S+  L  W  R +IALG+AR LA+LH  C P IIHRD+KA+++ LD  
Sbjct: 123 -----------ESQPPLD-WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170
Query: 674 LEPRLSDFGLAKI--FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
            E  + DFGLAK+  + +       RG  G+I PE+        + K+DV+ YGV+LLEL
Sbjct: 171 FEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGK--SSEKTDVFGYGVMLLEL 228
Query: 732 ITGKKPLG-DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLC 790
           ITG++         + +  L+ WV+GL++  K    +D  ++    ++++E+ +++  LC
Sbjct: 229 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLC 288
Query: 791 TADLPLKRPSMQQIVGLLK 809
           T   P++RP M ++V +L+
Sbjct: 289 TQSSPMERPKMSEVVRMLE 307

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  169 bits (429), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/322 (32%), Positives = 167/322 (51%), Gaps = 38/322 (11%)
Query: 495 LLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVL----VHGSTLTDQE 550
           L   +  +L  A+ NF    +L  G FG VY+G L  G  VAVK L      G  L  Q 
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 551 AARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXX 610
              E+E +    H NL+ L G+C+   +R+ +Y YM NG++ + L + P           
Sbjct: 85  ---EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP----------- 130
Query: 611 XXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL 670
                          S+  L  W  R +IALG+AR LA+LH  C P IIHRD+KA+++ L
Sbjct: 131 --------------ESQPPLD-WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 175
Query: 671 DMNLEPRLSDFGLAKI--FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVL 728
           D   E  + DFGLAK+  + +       RG+ G+I PE+        + K+DV+ YGV+L
Sbjct: 176 DEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVML 233
Query: 729 LELITGKKPLG-DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIG 787
           LELITG++         + +  L+ WV+GL++  K    +D  ++    ++++E+ +++ 
Sbjct: 234 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVA 293
Query: 788 YLCTADLPLKRPSMQQIVGLLK 809
            LCT   P++RP M ++V +L+
Sbjct: 294 LLCTQSSPMERPKMSEVVRMLE 315

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  146 bits (369), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 109/322 (33%), Positives = 158/322 (49%), Gaps = 49/322 (15%)
Query: 498 ITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEY 557
           +   DL  AT+NFD   L+  G FG VY+G L  G  VA+K     S+   +E   E+E 
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH--DLPLGVQXXXXXXXXXXXX 615
           L   +HP+LV L G+C   ++ I IY YMENGNL+  L+  DLP                
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--------------- 133
Query: 616 XXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE 675
                        +  +W  R +I +G AR L +LH   +  IIHRD+K+ ++ LD N  
Sbjct: 134 -------------MSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFV 177
Query: 676 PRLSDFGLAKIFGNGLDE----EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
           P+++DFG++K  G  LD+     + +G+ GYI PE+        T KSDVY +GVVL E+
Sbjct: 178 PKITDFGISKK-GTELDQTHLXXVVKGTLGYIDPEYFIKGR--LTEKSDVYSFGVVLFEV 234
Query: 732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDP----KIRDTGPEKQMEEALKIG 787
           +  +  +    P E   NL  W      N +  + +DP    KIR     K  + A+K  
Sbjct: 235 LCARSAIVQSLPREMV-NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 788 YLCTADLPLKRPSMQQIVGLLK 809
            L + D    RPSM  ++  L+
Sbjct: 294 ALSSED----RPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 107/321 (33%), Positives = 155/321 (48%), Gaps = 47/321 (14%)
Query: 498 ITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEY 557
           +   DL  AT+NFD   L+  G FG VY+G L  G  VA+K     S+   +E   E+E 
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH--DLPLGVQXXXXXXXXXXXX 615
           L   +HP+LV L G+C   ++ I IY YMENGNL+  L+  DLP                
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--------------- 133
Query: 616 XXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE 675
                        +  +W  R +I +G AR L +LH   +  IIHRD+K+ ++ LD N  
Sbjct: 134 -------------MSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFV 177
Query: 676 PRLSDFGLAKI---FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
           P+++DFG++K     G      + +G+ GYI PE+        T KSDVY +GVVL E++
Sbjct: 178 PKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGR--LTEKSDVYSFGVVLFEVL 235
Query: 733 TGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDP----KIRDTGPEKQMEEALKIGY 788
             +  +    P E   NL  W      N +  + +DP    KIR     K  + A+K   
Sbjct: 236 CARSAIVQSLPREMV-NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 789 LCTADLPLKRPSMQQIVGLLK 809
           L + D    RPSM  ++  L+
Sbjct: 295 LSSED----RPSMGDVLWKLE 311

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  125 bits (315), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 120/359 (33%), Positives = 179/359 (49%), Gaps = 57/359 (15%)
Query: 40  LSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISGSLPSNIGN 98
           LSG++P +++G LSKL+ L L  N +   +P +L  + +L++L L +N ++G +PS + N
Sbjct: 427 LSGTIP-SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 485
Query: 99  FGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMN 158
              L    LSNN  +GEIP  I  L +L +LKL  N F  +IP  L +C+SL+ +DL+ N
Sbjct: 486 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 545
Query: 159 QLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFA---GLKSITNLNISGNLFQGSVMGV 215
             NG++P    AA  K +S  +A N I G+   +    G+K     + +GNL +    G+
Sbjct: 546 LFNGTIP----AAMFK-QSGKIAANFIAGKRYVYIKNDGMKK--ECHGAGNLLE--FQGI 596
Query: 216 FLESLEVIDLR------SNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQA 269
             E L  +  R      S  + GH S    N+      ++++D+S N LSG I       
Sbjct: 597 RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN----GSMMFLDMSYNMLSGYIPK----- 647
Query: 270 QNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNH 329
                              +IG++  L  LNL    + G IP E+  L  L+ LDLS N 
Sbjct: 648 -------------------EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 688
Query: 330 LTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFS--YNNLTLCASEL 384
           L G+IP    +   L  ID+S+NNLSG IP     ++ Q E F  +   NN  LC   L
Sbjct: 689 LDGRIPQAMSALTMLTEIDLSNNNLSGPIP-----EMGQFETFPPAKFLNNPGLCGYPL 742

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  125 bits (315), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 120/359 (33%), Positives = 179/359 (49%), Gaps = 57/359 (15%)
Query: 40  LSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLWSLGSLKSLNLSYNRISGSLPSNIGN 98
           LSG++P +++G LSKL+ L L  N +   +P +L  + +L++L L +N ++G +PS + N
Sbjct: 430 LSGTIP-SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 99  FGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMN 158
              L    LSNN  +GEIP  I  L +L +LKL  N F  +IP  L +C+SL+ +DL+ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 159 QLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFA---GLKSITNLNISGNLFQGSVMGV 215
             NG++P    AA  K +S  +A N I G+   +    G+K     + +GNL +    G+
Sbjct: 549 LFNGTIP----AAMFK-QSGKIAANFIAGKRYVYIKNDGMKK--ECHGAGNLLE--FQGI 599
Query: 216 FLESLEVIDLR------SNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQA 269
             E L  +  R      S  + GH S    N+      ++++D+S N LSG I       
Sbjct: 600 RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN----GSMMFLDMSYNMLSGYIPK----- 650
Query: 270 QNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNH 329
                              +IG++  L  LNL    + G IP E+  L  L+ LDLS N 
Sbjct: 651 -------------------EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 330 LTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFS--YNNLTLCASEL 384
           L G+IP    +   L  ID+S+NNLSG IP     ++ Q E F  +   NN  LC   L
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIP-----EMGQFETFPPAKFLNNPGLCGYPL 745

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 99/329 (30%), Positives = 153/329 (46%), Gaps = 50/329 (15%)
Query: 499 TFADLLSATSNFDR------GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA 552
           +F +L + T+NFD       G  + EG FG VY+G++     VAVK L     +T +E  
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 553 R----ELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXX 608
           +    E++ + + +H NLV L G+   GD    +Y YM NG+L + L  L          
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--------- 125
Query: 609 XXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV 668
                           G+  L  +W  R KIA G A  + FLH       IHRDIK++++
Sbjct: 126 ----------------GTPPL--SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANI 164
Query: 669 YLDMNLEPRLSDFGLAKI---FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYG 725
            LD     ++SDFGLA+    F   +      G+  Y+ PE  + +    TPKSD+Y +G
Sbjct: 165 LLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGE---ITPKSDIYSFG 221
Query: 726 VVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK 785
           VVLLE+ITG  P  D++  E +  L                ID K+ D      +E    
Sbjct: 222 VVLLEIITG-LPAVDEH-REPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYS 278
Query: 786 IGYLCTADLPLKRPSMQQIVGLLKDIEST 814
           +   C  +   KRP ++++  LL+++ ++
Sbjct: 279 VASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  121 bits (303), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 99/329 (30%), Positives = 153/329 (46%), Gaps = 50/329 (15%)
Query: 499 TFADLLSATSNFDR------GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA 552
           +F +L + T+NFD       G  + EG FG VY+G++     VAVK L     +T +E  
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 553 R----ELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXX 608
           +    E++ + + +H NLV L G+   GD    +Y YM NG+L + L  L          
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--------- 125
Query: 609 XXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV 668
                           G+  L  +W  R KIA G A  + FLH       IHRDIK++++
Sbjct: 126 ----------------GTPPL--SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANI 164
Query: 669 YLDMNLEPRLSDFGLAKI---FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYG 725
            LD     ++SDFGLA+    F   +      G+  Y+ PE  + +    TPKSD+Y +G
Sbjct: 165 LLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGE---ITPKSDIYSFG 221
Query: 726 VVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK 785
           VVLLE+ITG  P  D++  E +  L                ID K+ D      +E    
Sbjct: 222 VVLLEIITG-LPAVDEH-REPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYS 278
Query: 786 IGYLCTADLPLKRPSMQQIVGLLKDIEST 814
           +   C  +   KRP ++++  LL+++ ++
Sbjct: 279 VASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 99/331 (29%), Positives = 154/331 (46%), Gaps = 50/331 (15%)
Query: 497 NITFADLLSATSNFDR------GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQE 550
           + +F +L + T+NFD       G  + EG FG VY+G++     VAVK L     +T +E
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 66
Query: 551 AAR----ELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXX 606
             +    E++ + + +H NLV L G+   GD    +Y YM NG+L + L  L        
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD------- 119
Query: 607 XXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS 666
                             G+  L  +W  R KIA G A  + FLH       IHRDIK++
Sbjct: 120 ------------------GTPPL--SWHMRCKIAQGAANGINFLHENHH---IHRDIKSA 156
Query: 667 SVYLDMNLEPRLSDFGLAKI---FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYC 723
           ++ LD     ++SDFGLA+    F   +      G+  Y+ PE  + +    TPKSD+Y 
Sbjct: 157 NILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGE---ITPKSDIYS 213
Query: 724 YGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEA 783
           +GVVLLE+ITG  P  D++  E +  L                ID K+ D      +E  
Sbjct: 214 FGVVLLEIITG-LPAVDEH-REPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAM 270
Query: 784 LKIGYLCTADLPLKRPSMQQIVGLLKDIEST 814
             +   C  +   KRP ++++  LL+++ ++
Sbjct: 271 YSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 98/327 (29%), Positives = 146/327 (44%), Gaps = 50/327 (15%)
Query: 497 NITFADLLSATSNFDR------GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQE 550
           + +F +L + T+NFD       G    EG FG VY+G++     VAVK L     +T +E
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 63
Query: 551 AAR----ELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXX 606
             +    E++   + +H NLV L G+   GD    +Y Y  NG+L + L  L        
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLD------- 116
Query: 607 XXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS 666
                             G+  L  +W  R KIA G A  + FLH       IHRDIK++
Sbjct: 117 ------------------GTPPL--SWHXRCKIAQGAANGINFLHENHH---IHRDIKSA 153
Query: 667 SVYLDMNLEPRLSDFGLAKI---FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYC 723
           ++ LD     ++SDFGLA+    F   +      G+  Y  PE  + +    TPKSD+Y 
Sbjct: 154 NILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGE---ITPKSDIYS 210
Query: 724 YGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEA 783
           +GVVLLE+ITG  P  D++  E +  L                ID K  D      +E  
Sbjct: 211 FGVVLLEIITG-LPAVDEH-REPQLLLDIKEEIEDEEKTIEDYIDKKXND-ADSTSVEAX 267
Query: 784 LKIGYLCTADLPLKRPSMQQIVGLLKD 810
             +   C  +   KRP ++++  LL++
Sbjct: 268 YSVASQCLHEKKNKRPDIKKVQQLLQE 294

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 52/304 (17%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQ--EAARELEYLGRIKHPNLVPLTGYC 573
           +  G FG V+R    G   VAVK+L+      ++  E  RE+  + R++HPN+V   G  
Sbjct: 45  IGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 574 IAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTW 633
                   + +Y+  G+L  LLH                            G+   L   
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH--------------------------KSGAREQLDE- 136
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG-LD 692
           R R  +A   A+ + +LH+  +PPI+HRD+K+ ++ +D     ++ DFGL+++  +  L 
Sbjct: 137 RRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLX 195
Query: 693 EEIARGSPGYIPPEFAQPDSDFPT-PKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV 751
            + A G+P ++ PE  +   D P+  KSDVY +GV+L EL T ++P G+  P      +V
Sbjct: 196 SKXAAGTPEWMAPEVLR---DEPSNEKSDVYSFGVILWELATLQQPWGNLNP----AQVV 248
Query: 752 SWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
           + V    +  +  R ++P++           A+  G  C  + P KRPS   I+ LL+ +
Sbjct: 249 AAVGFKCKRLEIPRNLNPQV----------AAIIEG--CWTNEPWKRPSFATIMDLLRPL 296
Query: 812 ESTA 815
             +A
Sbjct: 297 IKSA 300

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 144/304 (47%), Gaps = 52/304 (17%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQ--EAARELEYLGRIKHPNLVPLTGYC 573
           +  G FG V+R    G   VAVK+L+      ++  E  RE+  + R++HPN+V   G  
Sbjct: 45  IGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 574 IAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTW 633
                   + +Y+  G+L  LLH                            G+   L   
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH--------------------------KSGAREQLDE- 136
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG-LD 692
           R R  +A   A+ + +LH+  +PPI+HR++K+ ++ +D     ++ DFGL+++  +  L 
Sbjct: 137 RRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195
Query: 693 EEIARGSPGYIPPEFAQPDSDFPT-PKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV 751
            + A G+P ++ PE  +   D P+  KSDVY +GV+L EL T ++P G+  P +    +V
Sbjct: 196 SKSAAGTPEWMAPEVLR---DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----VV 248
Query: 752 SWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
           + V    +  +  R ++P++           A+  G  C  + P KRPS   I+ LL+ +
Sbjct: 249 AAVGFKCKRLEIPRNLNPQV----------AAIIEG--CWTNEPWKRPSFATIMDLLRPL 296
Query: 812 ESTA 815
             +A
Sbjct: 297 IKSA 300

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 94/349 (26%), Positives = 142/349 (40%), Gaps = 85/349 (24%)
Query: 8   ASYFSASFC---SWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENN 64
           +S+   + C   +W GV+CD++ Q                         ++ +LDLS  N
Sbjct: 25  SSWLPTTDCCNRTWLGVLCDTDTQTY-----------------------RVNNLDLSGLN 61
Query: 65  IT---ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAIS 121
           +     +PS   SL +L  LN  Y          IG            NN  G IP AI+
Sbjct: 62  LPKPYPIPS---SLANLPYLNFLY----------IGGI----------NNLVGPIPPAIA 98
Query: 122 SLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLA 181
            L  L  L +       +IP  L   ++LVT+D S N L+G+LP    ++ P L  +   
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFD 157
Query: 182 GNEIKGR--DTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQF 239
           GN I G   D++ +  K  T++ IS N   G +   F                       
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-------------------- 197
Query: 240 NSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHL 299
                   L +VDLS N L G+    F   +N + + LA N     +  ++G    L  L
Sbjct: 198 -------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF-DLGKVGLSKNLNGL 249
Query: 300 NLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMS 348
           +L    + G +P  + QL  LH+L++S N+L G+IP     NL   D+S
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP--QGGNLQRFDVS 296

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 55/112 (49%), Gaps = 2/112 (1%)
Query: 246 SRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTS 305
           ++L Y+ ++   +SG I    SQ + L  L  +YN  +    P I +L  L  +      
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 306 LIGDIPSEILQLSSLHT-LDLSMNHLTGQIP-TVSAKNLGIIDMSHNNLSGE 355
           + G IP      S L T + +S N LTG+IP T +  NL  +D+S N L G+
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGD 212

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 129/311 (41%), Gaps = 49/311 (15%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIH------VAVKVLVHGSTLTDQEAA----RELEYLGRIK 562
           G  L  G FG V      G I       VAVK+L   + LT++EA     + L YLG   
Sbjct: 44  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--N 101
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           H N+V L G C  G   + I +Y   G+L N L                         ++
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
           ++ S        F +++A G    +AFL    S   IHRD+ A ++ L      ++ DFG
Sbjct: 162 DLLS--------FSYQVAKG----MAFL---ASKNCIHRDLAARNILLTHGRITKICDFG 206
Query: 683 LAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPL 738
           LA+   N  D          +P ++  P+S F    T +SDV+ YG+ L EL + G  P 
Sbjct: 207 LARDIKN--DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP- 263
Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
              YP            G+  ++K  + I    R   PE    E   I   C    PLKR
Sbjct: 264 ---YP------------GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 308
Query: 799 PSMQQIVGLLK 809
           P+ +QIV L++
Sbjct: 309 PTFKQIVQLIE 319

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 129/311 (41%), Gaps = 49/311 (15%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIH------VAVKVLVHGSTLTDQEAA----RELEYLGRIK 562
           G  L  G FG V      G I       VAVK+L   + LT++EA     + L YLG   
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--N 85
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           H N+V L G C  G   + I +Y   G+L N L                         ++
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
           ++ S        F +++A G    +AFL    S   IHRD+ A ++ L      ++ DFG
Sbjct: 146 DLLS--------FSYQVAKG----MAFL---ASKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 683 LAKIFGNGLDEEIARGSPGYIPPEFAQPDSDF---PTPKSDVYCYGVVLLELIT-GKKPL 738
           LA+   N  D          +P ++  P+S F    T +SDV+ YG+ L EL + G  P 
Sbjct: 191 LARDIKN--DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP- 247
Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
              YP            G+  ++K  + I    R   PE    E   I   C    PLKR
Sbjct: 248 ---YP------------GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 799 PSMQQIVGLLK 809
           P+ +QIV L++
Sbjct: 293 PTFKQIVQLIE 303

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 129/311 (41%), Gaps = 49/311 (15%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIH------VAVKVLVHGSTLTDQEAA----RELEYLGRIK 562
           G  L  G FG V      G I       VAVK+L   + LT++EA     + L YLG   
Sbjct: 46  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--N 103
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           H N+V L G C  G   + I +Y   G+L N L                         ++
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
           ++ S        F +++A G    +AFL    S   IHRD+ A ++ L      ++ DFG
Sbjct: 164 DLLS--------FSYQVAKG----MAFL---ASKNCIHRDLAARNILLTHGRITKICDFG 208
Query: 683 LAKIFGNGLDEEIARGSPGYIPPEFAQPDSDF---PTPKSDVYCYGVVLLELIT-GKKPL 738
           LA+   N  D          +P ++  P+S F    T +SDV+ YG+ L EL + G  P 
Sbjct: 209 LARDIKN--DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP- 265
Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
              YP            G+  ++K  + I    R   PE    E   I   C    PLKR
Sbjct: 266 ---YP------------GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 310
Query: 799 PSMQQIVGLLK 809
           P+ +QIV L++
Sbjct: 311 PTFKQIVQLIE 321

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 129/311 (41%), Gaps = 49/311 (15%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIH------VAVKVLVHGSTLTDQEAA----RELEYLGRIK 562
           G  L  G FG V      G I       VAVK+L   + LT++EA     + L YLG   
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN-- 108
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           H N+V L G C  G   + I +Y   G+L N L                         ++
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
           ++ S        F +++A G    +AFL    S   IHRD+ A ++ L      ++ DFG
Sbjct: 169 DLLS--------FSYQVAKG----MAFL---ASKNCIHRDLAARNILLTHGRITKICDFG 213
Query: 683 LAKIFGNGLDEEIARGSPGYIPPEFAQPDSDF---PTPKSDVYCYGVVLLELIT-GKKPL 738
           LA+   N  D          +P ++  P+S F    T +SDV+ YG+ L EL + G  P 
Sbjct: 214 LARDIKN--DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP- 270
Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
              YP            G+  ++K  + I    R   PE    E   I   C    PLKR
Sbjct: 271 ---YP------------GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 315
Query: 799 PSMQQIVGLLK 809
           P+ +QIV L++
Sbjct: 316 PTFKQIVQLIE 326

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 129/311 (41%), Gaps = 49/311 (15%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIH------VAVKVLVHGSTLTDQEAA----RELEYLGRIK 562
           G  L  G FG V      G I       VAVK+L   + LT++EA     + L YLG   
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN-- 108
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           H N+V L G C  G   + I +Y   G+L N L                         ++
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
           ++ S        F +++A G    +AFL    S   IHRD+ A ++ L      ++ DFG
Sbjct: 169 DLLS--------FSYQVAKG----MAFL---ASKNCIHRDLAARNILLTHGRITKICDFG 213
Query: 683 LAKIFGNGLDEEIARGSPGYIPPEFAQPDSDF---PTPKSDVYCYGVVLLELIT-GKKPL 738
           LA+   N  D          +P ++  P+S F    T +SDV+ YG+ L EL + G  P 
Sbjct: 214 LARHIKN--DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP- 270
Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
              YP            G+  ++K  + I    R   PE    E   I   C    PLKR
Sbjct: 271 ---YP------------GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 315
Query: 799 PSMQQIVGLLK 809
           P+ +QIV L++
Sbjct: 316 PTFKQIVQLIE 326

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 77
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 117
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 118 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEX 164
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 165 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 218
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 219 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 808 LKD 810
           L+D
Sbjct: 264 LED 266

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 78
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 118
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 119 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEX 165
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 166 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 219
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 220 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 264
Query: 808 LKD 810
           L+D
Sbjct: 265 LED 267

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 79
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 119
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 120 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEX 166
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 167 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 220
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 221 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 265
Query: 808 LKD 810
           L+D
Sbjct: 266 LED 268

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 83
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 123
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 124 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEY 170
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 171 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 224
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 225 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 269
Query: 808 LKD 810
           L+D
Sbjct: 270 LED 272

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 82
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 122
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 123 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEY 169
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 170 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 223
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 224 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 268
Query: 808 LKD 810
           L+D
Sbjct: 269 LED 271

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 77
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 117
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 118 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEY 164
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 165 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 218
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 219 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 808 LKD 810
           L+D
Sbjct: 264 LED 266

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 86
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 126
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 127 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEX 173
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 174 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 227
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 228 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 272
Query: 808 LKD 810
           L+D
Sbjct: 273 LED 275

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 85
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 125
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 126 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEX 172
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 173 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 226
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 227 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 271
Query: 808 LKD 810
           L+D
Sbjct: 272 LED 274

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 77
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 117
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 118 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEX 164
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 165 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 218
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 219 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 808 LKD 810
           L+D
Sbjct: 264 LED 266

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 72
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 112
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 113 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEY 159
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 160 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 213
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 214 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 258
Query: 808 LKD 810
           L+D
Sbjct: 259 LED 261

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 114/256 (44%), Gaps = 54/256 (21%)
Query: 495 LLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGS----TLTDQE 550
           LL I FA+L           ++  G FG VYR F  G   VAVK   H      + T + 
Sbjct: 1   LLEIDFAELTLEE-------IIGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIEN 52
Query: 551 AARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXX 610
             +E +    +KHPN++ L G C+       + ++   G L  +L               
Sbjct: 53  VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--------------- 97
Query: 611 XXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL 670
                    S + +  + +L  W      A+  AR + +LH     PIIHRD+K+S++ +
Sbjct: 98  ---------SGKRIPPD-ILVNW------AVQIARGMNYLHDEAIVPIIHRDLKSSNILI 141
Query: 671 DMNLEP--------RLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVY 722
              +E         +++DFGLA+ + +   +  A G+  ++ PE  +  +   +  SDV+
Sbjct: 142 LQKVENGDLSNKILKITDFGLAREW-HRTTKMSAAGAYAWMAPEVIR--ASMFSKGSDVW 198
Query: 723 CYGVVLLELITGKKPL 738
            YGV+L EL+TG+ P 
Sbjct: 199 SYGVLLWELLTGEVPF 214

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 141/303 (46%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 83
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 123
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 124 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEX 170
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 171 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 224
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 225 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 269
Query: 808 LKD 810
           L+D
Sbjct: 270 LED 272

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 65/304 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 87
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 127
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 128 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED--NEY 174
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 175 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 228
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 229 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 273
Query: 808 LKDI 811
           L+D 
Sbjct: 274 LEDF 277

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 92/334 (27%), Positives = 141/334 (42%), Gaps = 73/334 (21%)
Query: 491 FEKPLLNI-TFADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGST 545
           FE P   +  FA  L AT N     ++  G+FG V  G L       I VA+K L  G T
Sbjct: 28  FEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 546 LTDQ-EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGV 602
              + +   E   +G+  HPN++ L G        + + +YMENG+L + L  HD    V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 603 QXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD 662
                             IQ VG             +  G A  + +L        +HRD
Sbjct: 147 ------------------IQLVG-------------MLRGIASGMKYL---SDMGYVHRD 172
Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFP 715
           + A ++ ++ NL  ++SDFGLA++  +  D E A   RG  G IP  +  P++     F 
Sbjct: 173 LAARNILINSNLVCKVSDFGLARVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF- 227
Query: 716 TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT 774
           T  SDV+ YG+VL E+++ G++P    Y E    +++             +A+D   R  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLP 270
Query: 775 GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL 808
            P        ++   C       RP  +QIV +L
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 141/303 (46%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 73
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 113
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHR+++A+++ +   L  +++DFGLA++  +  +E 
Sbjct: 114 --------IAEGMAFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIED--NEY 160
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 161 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 214
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 215 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 259
Query: 808 LKD 810
           L+D
Sbjct: 260 LED 262

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 91/334 (27%), Positives = 141/334 (42%), Gaps = 73/334 (21%)
Query: 491 FEKPLLNI-TFADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGST 545
           FE P   +  FA  L AT N     ++  G+FG V  G L       I VA+K L  G T
Sbjct: 28  FEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 546 LTDQ-EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGV 602
              + +   E   +G+  HPN++ L G        + + +YMENG+L + L  HD    V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 603 QXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD 662
                             IQ VG             +  G A  + +L        +HRD
Sbjct: 147 ------------------IQLVG-------------MLRGIASGMKYL---SDMGFVHRD 172
Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFP 715
           + A ++ ++ NL  ++SDFGL+++  +  D E A   RG  G IP  +  P++     F 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF- 227
Query: 716 TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT 774
           T  SDV+ YG+VL E+++ G++P    Y E    +++             +A+D   R  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLP 270
Query: 775 GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL 808
            P        ++   C       RP  +QIV +L
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 129/301 (42%), Gaps = 59/301 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           +  G+FG V+ G+      VA+K +  G+ +++++   E E + ++ HP LV L G C+ 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 ++++ME+G L + L                              +E LL     
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR----------------------TQRGLFAAETLLG---- 107
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
              + L     +A+L   C   +IHRD+ A +  +  N   ++SDFG+ +     LD++ 
Sbjct: 108 ---MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQY 158
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
              +    P ++A P+    S + + KSDV+ +GV++ E+ + GK P    Y       +
Sbjct: 159 TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEV 213
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
           V  +      + G R   P++  T   + M         C  + P  RP+  +++  L +
Sbjct: 214 VEDI------STGFRLYKPRLASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAE 260
Query: 811 I 811
           I
Sbjct: 261 I 261

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 91/334 (27%), Positives = 141/334 (42%), Gaps = 73/334 (21%)
Query: 491 FEKPLLNI-TFADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGST 545
           FE P   +  FA  L AT N     ++  G+FG V  G L       I VA+K L  G T
Sbjct: 28  FEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 546 LTDQ-EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGV 602
              + +   E   +G+  HPN++ L G        + + +YMENG+L + L  HD    V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 603 QXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD 662
                             IQ VG             +  G A  + +L        +HRD
Sbjct: 147 ------------------IQLVG-------------MLRGIASGMKYL---SDMGYVHRD 172
Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFP 715
           + A ++ ++ NL  ++SDFGL+++  +  D E A   RG  G IP  +  P++     F 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF- 227
Query: 716 TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT 774
           T  SDV+ YG+VL E+++ G++P    Y E    +++             +A+D   R  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLP 270
Query: 775 GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL 808
            P        ++   C       RP  +QIV +L
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 91/334 (27%), Positives = 141/334 (42%), Gaps = 73/334 (21%)
Query: 491 FEKPLLNI-TFADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGST 545
           FE P   +  FA  L AT N     ++  G+FG V  G L       I VA+K L  G T
Sbjct: 28  FEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 546 LTDQ-EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGV 602
              + +   E   +G+  HPN++ L G        + + +YMENG+L + L  HD    V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 603 QXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD 662
                             IQ VG             +  G A  + +L        +HRD
Sbjct: 147 ------------------IQLVG-------------MLRGIASGMKYL---SDMGYVHRD 172
Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFP 715
           + A ++ ++ NL  ++SDFGL+++  +  D E A   RG  G IP  +  P++     F 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF- 227
Query: 716 TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT 774
           T  SDV+ YG+VL E+++ G++P    Y E    +++             +A+D   R  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLP 270
Query: 775 GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL 808
            P        ++   C       RP  +QIV +L
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 129/301 (42%), Gaps = 59/301 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           +  G+FG V+ G+      VA+K +  G+ +++++   E E + ++ HP LV L G C+ 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 ++++ME+G L + L                              +E LL     
Sbjct: 77  QAPICLVFEFMEHGCLSDYLR----------------------TQRGLFAAETLLG---- 110
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
              + L     +A+L   C   +IHRD+ A +  +  N   ++SDFG+ +     LD++ 
Sbjct: 111 ---MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQY 161
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
              +    P ++A P+    S + + KSDV+ +GV++ E+ + GK P    Y       +
Sbjct: 162 TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEV 216
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
           V  +      + G R   P++  T   + M         C  + P  RP+  +++  L +
Sbjct: 217 VEDI------STGFRLYKPRLASTHVYQIMNH-------CWRERPEDRPAFSRLLRQLAE 263
Query: 811 I 811
           I
Sbjct: 264 I 264

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 129/301 (42%), Gaps = 59/301 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           +  G+FG V+ G+      VA+K +  G+ +++++   E E + ++ HP LV L G C+ 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 ++++ME+G L + L                              +E LL     
Sbjct: 72  QAPICLVFEFMEHGCLSDYLR----------------------TQRGLFAAETLLG---- 105
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
              + L     +A+L   C   +IHRD+ A +  +  N   ++SDFG+ +     LD++ 
Sbjct: 106 ---MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQY 156
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
              +    P ++A P+    S + + KSDV+ +GV++ E+ + GK P    Y       +
Sbjct: 157 TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEV 211
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
           V  +      + G R   P++  T   + M         C  + P  RP+  +++  L +
Sbjct: 212 VEDI------STGFRLYKPRLASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAE 258
Query: 811 I 811
           I
Sbjct: 259 I 259

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 59/301 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           +  G+FG V+ G+      VA+K +  GS +++ +   E E + ++ HP LV L G C+ 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 ++++ME+G L + L                              +E LL     
Sbjct: 94  QAPICLVFEFMEHGCLSDYLR----------------------TQRGLFAAETLLG---- 127
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
              + L     +A+L   C   +IHRD+ A +  +  N   ++SDFG+ +     LD++ 
Sbjct: 128 ---MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQY 178
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
              +    P ++A P+    S + + KSDV+ +GV++ E+ + GK P    Y       +
Sbjct: 179 TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEV 233
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
           V  +      + G R   P++  T   + M         C  + P  RP+  +++  L +
Sbjct: 234 VEDI------STGFRLYKPRLASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAE 280
Query: 811 I 811
           I
Sbjct: 281 I 281

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 91/334 (27%), Positives = 140/334 (41%), Gaps = 73/334 (21%)
Query: 491 FEKPLLNI-TFADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGST 545
           FE P   +  FA  L AT N     ++  G+FG V  G L       I VA+K L  G T
Sbjct: 28  FEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 546 LTDQ-EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGV 602
              + +   E   +G+  HPN++ L G        + + +YMENG+L + L  HD    V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 603 QXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD 662
                             IQ VG             +  G A  + +L        +HRD
Sbjct: 147 ------------------IQLVG-------------MLRGIASGMKYL---SDMGYVHRD 172
Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFP 715
           + A ++ ++ NL  ++SDFGL ++  +  D E A   RG  G IP  +  P++     F 
Sbjct: 173 LAARNILINSNLVCKVSDFGLGRVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF- 227
Query: 716 TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT 774
           T  SDV+ YG+VL E+++ G++P    Y E    +++             +A+D   R  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLP 270
Query: 775 GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL 808
            P        ++   C       RP  +QIV +L
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 139/303 (45%), Gaps = 65/303 (21%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+ G V+ G+  G   VAVK L  GS   D   A E   + +++H  LV L  Y + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRL--YAVV 77
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
             + I I  +YMENG+L + L   P G++               N + ++ ++       
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKT-PSGIKLTI------------NKLLDMAAQ------- 117
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
                    A  +AF+        IHRD++A+++ +   L  +++DFGLA++  +   E 
Sbjct: 118 --------IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDA--EX 164
Query: 695 IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPL-GDDYPEEKEG 748
            AR    + P ++  P++     F T KSDV+ +G++L E++T G+ P  G   PE    
Sbjct: 165 TAREGAKF-PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---- 218
Query: 749 NLVSWVRGLVRN-NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                   +++N  +G R + P   D  P    EE  ++  LC  + P  RP+   +  +
Sbjct: 219 --------VIQNLERGYRMVRP---DNCP----EELYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 808 LKD 810
           L+D
Sbjct: 264 LED 266

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 75/301 (24%), Positives = 128/301 (42%), Gaps = 60/301 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V  G   G   VAVK++  GS +++ E  +E + + ++ HP LV   G C  
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 + +Y+ NG L N L     G++                                
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL--------------------------- 107
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
             ++       +AFL    S   IHRD+ A +  +D +L  ++SDFG+ +     LD++ 
Sbjct: 108 --EMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQY 159
Query: 696 ARGSPGYIPPEFAQPD--SDFP-TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLV 751
                   P +++ P+    F  + KSDV+ +G+++ E+ + GK P           +L 
Sbjct: 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY----------DLY 209
Query: 752 SWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
           +    +++ ++G R   P +         +   +I Y C  +LP KRP+ QQ   LL  I
Sbjct: 210 TNSEVVLKVSQGHRLYRPHLAS-------DTIYQIMYSCWHELPEKRPTFQQ---LLSSI 259
Query: 812 E 812
           E
Sbjct: 260 E 260

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 37/228 (16%)
Query: 514 TLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYC 573
           T +  G FG VY+G   G + V +  +V  +    Q    E+  L + +H N++   GY 
Sbjct: 42  TRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY- 100
Query: 574 IAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTW 633
           +  D    +  + E  +L   LH      Q                              
Sbjct: 101 MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLI------------------------- 135
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI---FGNG 690
                IA  TA+ + +LH   +  IIHRD+K+++++L   L  ++ DFGLA +   +   
Sbjct: 136 ----DIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188
Query: 691 LDEEIARGSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGKKP 737
              E   GS  ++ PE  +   + P + +SDVY YG+VL EL+TG+ P
Sbjct: 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 90/334 (26%), Positives = 141/334 (42%), Gaps = 73/334 (21%)
Query: 491 FEKPLLNI-TFADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGST 545
           +E P   +  FA  L AT N     ++  G+FG V  G L       I VA+K L  G T
Sbjct: 28  YEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 546 LTDQ-EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGV 602
              + +   E   +G+  HPN++ L G        + + +YMENG+L + L  HD    V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 603 QXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD 662
                             IQ VG             +  G A  + +L        +HRD
Sbjct: 147 ------------------IQLVG-------------MLRGIASGMKYL---SDMGYVHRD 172
Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFP 715
           + A ++ ++ NL  ++SDFGL+++  +  D E A   RG  G IP  +  P++     F 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF- 227
Query: 716 TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT 774
           T  SDV+ YG+VL E+++ G++P    Y E    +++             +A+D   R  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLP 270
Query: 775 GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL 808
            P        ++   C       RP  +QIV +L
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 90/334 (26%), Positives = 141/334 (42%), Gaps = 73/334 (21%)
Query: 491 FEKPLLNI-TFADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGST 545
           +E P   +  FA  L AT N     ++  G+FG V  G L       I VA+K L  G T
Sbjct: 28  YEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 546 LTDQ-EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGV 602
              + +   E   +G+  HPN++ L G        + + +YMENG+L + L  HD    V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 603 QXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD 662
                             IQ VG             +  G A  + +L        +HRD
Sbjct: 147 ------------------IQLVG-------------MLRGIASGMKYL---SDMGYVHRD 172
Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFP 715
           + A ++ ++ NL  ++SDFGL+++  +  D E A   RG  G IP  +  P++     F 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF- 227
Query: 716 TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT 774
           T  SDV+ YG+VL E+++ G++P    Y E    +++             +A+D   R  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLP 270
Query: 775 GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL 808
            P        ++   C       RP  +QIV +L
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 90/334 (26%), Positives = 141/334 (42%), Gaps = 73/334 (21%)
Query: 491 FEKPLLNI-TFADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGST 545
           +E P   +  FA  L AT N     ++  G+FG V  G L       I VA+K L  G T
Sbjct: 26  YEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 84
Query: 546 LTDQ-EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGV 602
              + +   E   +G+  HPN++ L G        + + +YMENG+L + L  HD    V
Sbjct: 85  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 144
Query: 603 QXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD 662
                             IQ VG             +  G A  + +L        +HRD
Sbjct: 145 ------------------IQLVG-------------MLRGIASGMKYL---SDMGYVHRD 170
Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFP 715
           + A ++ ++ NL  ++SDFGL+++  +  D E A   RG  G IP  +  P++     F 
Sbjct: 171 LAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF- 225
Query: 716 TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT 774
           T  SDV+ YG+VL E+++ G++P    Y E    +++             +A+D   R  
Sbjct: 226 TSASDVWSYGIVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLP 268
Query: 775 GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL 808
            P        ++   C       RP  +QIV +L
Sbjct: 269 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 88/324 (27%), Positives = 137/324 (42%), Gaps = 72/324 (22%)
Query: 500 FADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGSTLTDQ-EAARE 554
           FA  L AT N     ++  G+FG V  G L       I VA+K L  G T   + +   E
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 555 LEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQXXXXXXXXX 612
              +G+  HPN++ L G        + + +YMENG+L + L  HD    V          
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV---------- 117
Query: 613 XXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM 672
                   IQ VG             +  G A  + +L        +HRD+ A ++ ++ 
Sbjct: 118 --------IQLVG-------------MLRGIASGMKYLS---DMGYVHRDLAARNILINS 153
Query: 673 NLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFPTPKSDVYCYG 725
           NL  ++SDFGL+++  +  D E A   RG  G IP  +  P++     F T  SDV+ YG
Sbjct: 154 NLVCKVSDFGLSRVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF-TSASDVWSYG 208
Query: 726 VVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEAL 784
           +VL E+++ G++P    Y E    +++             +A+D   R   P        
Sbjct: 209 IVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLPPPMDCPAALY 251
Query: 785 KIGYLCTADLPLKRPSMQQIVGLL 808
           ++   C       RP  +QIV +L
Sbjct: 252 QLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 88/316 (27%), Positives = 136/316 (43%), Gaps = 49/316 (15%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEA-ARELEYLGR 560
           +N   G  L  G FG V      G       + VAVK+L   +   ++EA   EL+ +  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 561 I-KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXX 618
           + +H N+V L G C  G   + I +Y   G+L N L    P G++               
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH-------- 157
Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRL 678
           N  + + S  LL    F  ++A G    +AFL    S   IHRD+ A +V L      ++
Sbjct: 158 NPEEQLSSRDLL---HFSSQVAQG----MAFL---ASKNCIHRDVAARNVLLTNGHVAKI 207
Query: 679 SDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-G 734
            DFGLA+   N     I +G+   +P ++  P+S F    T +SDV+ YG++L E+ + G
Sbjct: 208 GDFGLARDIMND-SNYIVKGN-ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 265
Query: 735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL 794
             P    YP            G++ N+K  + +    +   P    +    I   C A  
Sbjct: 266 LNP----YP------------GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALE 309
Query: 795 PLKRPSMQQIVGLLKD 810
           P  RP+ QQI   L++
Sbjct: 310 PTHRPTFQQICSFLQE 325

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 88/324 (27%), Positives = 137/324 (42%), Gaps = 72/324 (22%)
Query: 500 FADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGSTLTDQ-EAARE 554
           FA  L AT N     ++  G+FG V  G L       I VA+K L  G T   + +   E
Sbjct: 26  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 84
Query: 555 LEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQXXXXXXXXX 612
              +G+  HPN++ L G        + + +YMENG+L + L  HD    V          
Sbjct: 85  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV---------- 134
Query: 613 XXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM 672
                   IQ VG             +  G A  + +L        +HRD+ A ++ ++ 
Sbjct: 135 --------IQLVG-------------MLRGIASGMKYLS---DMGYVHRDLAARNILINS 170
Query: 673 NLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFPTPKSDVYCYG 725
           NL  ++SDFGL+++  +  D E A   RG  G IP  +  P++     F T  SDV+ YG
Sbjct: 171 NLVCKVSDFGLSRVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF-TSASDVWSYG 225
Query: 726 VVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEAL 784
           +VL E+++ G++P    Y E    +++             +A+D   R   P        
Sbjct: 226 IVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLPPPMDCPAALY 268
Query: 785 KIGYLCTADLPLKRPSMQQIVGLL 808
           ++   C       RP  +QIV +L
Sbjct: 269 QLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 128/301 (42%), Gaps = 59/301 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           +  G+FG V+ G+      VA+K +  G+ +++++   E E + ++ HP LV L G C+ 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 + ++ME+G L + L                              +E LL     
Sbjct: 75  QAPICLVTEFMEHGCLSDYLR----------------------TQRGLFAAETLLG---- 108
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
              + L     +A+L   C   +IHRD+ A +  +  N   ++SDFG+ +     LD++ 
Sbjct: 109 ---MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQY 159
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
              +    P ++A P+    S + + KSDV+ +GV++ E+ + GK P    Y       +
Sbjct: 160 TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEV 214
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
           V  +      + G R   P++  T          +I   C  + P  RP+  +++  L +
Sbjct: 215 VEDI------STGFRLYKPRLAST-------HVYQIMNHCWRERPEDRPAFSRLLRQLAE 261
Query: 811 I 811
           I
Sbjct: 262 I 262

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 90/334 (26%), Positives = 141/334 (42%), Gaps = 73/334 (21%)
Query: 491 FEKPLLNI-TFADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGST 545
           FE P   +  FA  L AT N     ++  G+FG V  G L       I VA+K L  G T
Sbjct: 28  FEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 546 LTDQ-EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGV 602
              + +   E   +G+  HPN++ L G        + + + MENG+L + L  HD    V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 146
Query: 603 QXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD 662
                             IQ VG             +  G A  + +L    +   +HRD
Sbjct: 147 ------------------IQLVG-------------MLRGIASGMKYLSDMGA---VHRD 172
Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFP 715
           + A ++ ++ NL  ++SDFGL+++  +  D E A   RG  G IP  +  P++     F 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF- 227
Query: 716 TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT 774
           T  SDV+ YG+VL E+++ G++P    Y E    +++             +A+D   R  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLP 270
Query: 775 GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL 808
            P        ++   C       RP  +QIV +L
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 140/296 (47%), Gaps = 12/296 (4%)
Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLL 102
           ++   T    S LQ LDL+  +++ LPS L  L +LK L LS N+       +  NF  L
Sbjct: 268 NISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327
Query: 103 EVFDLSNNNFSGEI-PAAISSLVSLRVLKLDGNMFQWS--IPPGLLNCQSLVTVDLSMNQ 159
               +  N    E+    + +L +LR L L  +  + S      L N   L +++LS N+
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 160 LNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH--FAGLKSITNLNISGNLFQGSVMGVF- 216
                 + F    P+L+ L+LA   +K +D    F  L  +  LN+S +L   S   +F 
Sbjct: 388 PLSLKTEAFKEC-PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446
Query: 217 -LESLEVIDLRSNQF-QGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKH 274
            L +L+ ++L+ N F +G+I +   NS     RL  + LS   LS    H F+  + + H
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKT--NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504
Query: 275 LSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHL 330
           + L++NR T      +  L G+ +LNL+   +   +PS +  LS   T++L  N L
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559

>pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 133/317 (41%), Gaps = 14/317 (4%)
Query: 77  SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMF 136
           S++S+NL  +       +    F  L+  DL+  + S E+P+ +  L +L+ L L  N F
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313
Query: 137 QWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT---HFA 193
           +        N  SL  + +  N     L  G       L+ L+L+ ++I+  D       
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
Query: 194 GLKSITNLNISGNLFQGSVMGVFLES--LEVIDLRSNQFQGHISQVQFNSSYNWSRLVYV 251
            L  + +LN+S N         F E   LE++DL   + +   +Q  F    N   L  +
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ---NLHLLKVL 430
Query: 252 DLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTR---QEFPQIGTLLGLEHLNLSRTSLIG 308
           +LS + L       F     L+HL+L  N F +   Q+   + TL  LE L LS   L  
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 309 DIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGI-IDMSHNNLSGEIPASLLEKLPQM 367
                   L  ++ +DLS N LT       +   GI ++++ N++S  +P SLL  L Q 
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILP-SLLPILSQQ 549
Query: 368 ERFNFSYNNLTLCASEL 384
              N   N L    S +
Sbjct: 550 RTINLRQNPLDCTCSNI 566

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 132/306 (43%), Gaps = 65/306 (21%)
Query: 515 LLAEGKFGPVYRGFL--PG--GIHVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVPL 569
           ++  G+FG V  G L  PG   + VA+K L  G T   + +   E   +G+  HPN+V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            G    G   + + ++MENG L   L  HD    V                  IQ VG  
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV------------------IQLVG-- 149
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
                      IA G  R LA + +      +HRD+ A ++ ++ NL  ++SDFGL+++ 
Sbjct: 150 -------MLRGIAAGM-RYLADMGY------VHRDLAARNILVNSNLVCKVSDFGLSRVI 195
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
            +   E +   + G IP  +  P++     F T  SDV+ YG+V+ E+++ G++P  D  
Sbjct: 196 EDD-PEAVYTTTGGKIPVRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWD-- 251
Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
                          + N    +AI+   R   P        ++   C      +RP  +
Sbjct: 252 ---------------MSNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFE 296
Query: 803 QIVGLL 808
           QIVG+L
Sbjct: 297 QIVGIL 302

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 41/231 (17%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY  A  Q   +  + E  +L + LH +    +                           
Sbjct: 71  GYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---------------------- 107
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI---F 687
                   IA  TA+ + +LH   +  IIHRD+K+++++L  +L  ++ DFGLA +   +
Sbjct: 108 -------DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTP-KSDVYCYGVVLLELITGKKP 737
                 E   GS  ++ PE  +     P   +SDVY +G+VL EL+TG+ P
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 136/324 (41%), Gaps = 72/324 (22%)
Query: 500 FADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGSTLTDQ-EAARE 554
           FA  L AT N     ++  G+FG V  G L       I VA+K L  G T   + +   E
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 555 LEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQXXXXXXXXX 612
              +G+  HPN++ L G        + + + MENG+L + L  HD    V          
Sbjct: 68  ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV---------- 117
Query: 613 XXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM 672
                   IQ VG             +  G A  + +L        +HRD+ A ++ ++ 
Sbjct: 118 --------IQLVG-------------MLRGIASGMKYLS---DMGYVHRDLAARNILINS 153
Query: 673 NLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFPTPKSDVYCYG 725
           NL  ++SDFGL+++  +  D E A   RG  G IP  +  P++     F T  SDV+ YG
Sbjct: 154 NLVCKVSDFGLSRVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF-TSASDVWSYG 208
Query: 726 VVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEAL 784
           +VL E+++ G++P    Y E    +++             +A+D   R   P        
Sbjct: 209 IVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLPPPMDCPAALY 251
Query: 785 KIGYLCTADLPLKRPSMQQIVGLL 808
           ++   C       RP  +QIV +L
Sbjct: 252 QLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 89/334 (26%), Positives = 140/334 (41%), Gaps = 73/334 (21%)
Query: 491 FEKPLLNI-TFADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGST 545
           +E P   +  FA  L AT N     ++  G+FG V  G L       I VA+K L  G T
Sbjct: 28  YEDPTQTVHEFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 546 LTDQ-EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGV 602
              + +   E   +G+  HPN++ L G        + + + MENG+L + L  HD    V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 146
Query: 603 QXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD 662
                             IQ VG             +  G A  + +L        +HRD
Sbjct: 147 ------------------IQLVG-------------MLRGIASGMKYL---SDMGYVHRD 172
Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDS----DFP 715
           + A ++ ++ NL  ++SDFGL+++  +  D E A   RG  G IP  +  P++     F 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRG--GKIPIRWTSPEAIAYRKF- 227
Query: 716 TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDT 774
           T  SDV+ YG+VL E+++ G++P    Y E    +++             +A+D   R  
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP----YWEMSNQDVI-------------KAVDEGYRLP 270
Query: 775 GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL 808
            P        ++   C       RP  +QIV +L
Sbjct: 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 129/304 (42%), Gaps = 59/304 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           +  G+FG V+ G+      VA+K +  G+ +++++   E E + ++ HP LV L G C+ 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 ++++ME+G L + L                              +E LL     
Sbjct: 74  QAPICLVFEFMEHGCLSDYLR----------------------TQRGLFAAETLL----- 106
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
              + L     +A+L       +IHRD+ A +  +  N   ++SDFG+ +     LD++ 
Sbjct: 107 --GMCLDVCEGMAYLEEA---SVIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQY 158
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
              +    P ++A P+    S + + KSDV+ +GV++ E+ + GK P    Y       +
Sbjct: 159 TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEV 213
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
           V  +      + G R   P++  T   + M         C  + P  RP+  +++  L  
Sbjct: 214 VEDI------STGFRLYKPRLASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAA 260
Query: 811 IEST 814
           I ++
Sbjct: 261 IAAS 264

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 133/315 (42%), Gaps = 49/315 (15%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEA-ARELEYLGR 560
           +N   G  L  G FG V      G       + VAVK+L   +   ++EA   EL+ +  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 561 I-KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXN 619
           + +H N+V L G C  G   + I +Y   G+L N L       +               N
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL-------RRKSRVLETDPAFAIAN 158
Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
           S   + +  LL    F  ++A G    +AFL    S   IHRD+ A +V L      ++ 
Sbjct: 159 S--TLSTRDLL---HFSSQVAQG----MAFL---ASKNCIHRDVAARNVLLTNGHVAKIG 206
Query: 680 DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GK 735
           DFGLA+   N     I +G+   +P ++  P+S F    T +SDV+ YG++L E+ + G 
Sbjct: 207 DFGLARDIMND-SNYIVKGN-ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264
Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
            P    YP            G++ N+K  + +    +   P    +    I   C A  P
Sbjct: 265 NP----YP------------GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP 308
Query: 796 LKRPSMQQIVGLLKD 810
             RP+ QQI   L++
Sbjct: 309 THRPTFQQICSFLQE 323

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 132/315 (41%), Gaps = 49/315 (15%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEA-ARELEYLGR 560
           +N   G  L  G FG V      G       + VAVK+L   +   ++EA   EL+ +  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 561 I-KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXN 619
           + +H N+V L G C  G   + I +Y   G+L N L       +               N
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL-------RRKSRVLETDPAFAIAN 158
Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
           S     +  LL    F  ++A G    +AFL    S   IHRD+ A +V L      ++ 
Sbjct: 159 S--TASTRDLL---HFSSQVAQG----MAFL---ASKNCIHRDVAARNVLLTNGHVAKIG 206
Query: 680 DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GK 735
           DFGLA+   N     I +G+   +P ++  P+S F    T +SDV+ YG++L E+ + G 
Sbjct: 207 DFGLARDIMND-SNYIVKGN-ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264
Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
            P    YP            G++ N+K  + +    +   P    +    I   C A  P
Sbjct: 265 NP----YP------------GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP 308
Query: 796 LKRPSMQQIVGLLKD 810
             RP+ QQI   L++
Sbjct: 309 THRPTFQQICSFLQE 323

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 113/236 (47%), Gaps = 51/236 (21%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY  A  Q   +  + E  +L + LH                             SE   
Sbjct: 87  GYSTA-PQLAIVTQWCEGSSLYHHLH----------------------------ASET-- 115
Query: 631 TTWRFRHK----IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA-- 684
              +F  K    IA  TAR + +LH   +  IIHRD+K+++++L  +   ++ DFGLA  
Sbjct: 116 ---KFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169
Query: 685 --KIFGNGLDEEIARGSPGYIPPEFAQ-PDSDFPTPKSDVYCYGVVLLELITGKKP 737
             +  G+   E+++ GS  ++ PE  +  DS+  + +SDVY +G+VL EL+TG+ P
Sbjct: 170 KSRWSGSHQFEQLS-GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 41/231 (17%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 18  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY     Q   +  + E  +L + LH +    +                           
Sbjct: 76  GYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---------------------- 112
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI---F 687
                   IA  TA+ + +LH   +  IIHRD+K+++++L  +L  ++ DFGLA +   +
Sbjct: 113 -------DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 162
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTP-KSDVYCYGVVLLELITGKKP 737
                 E   GS  ++ PE  +     P   +SDVY +G+VL EL+TG+ P
Sbjct: 163 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 41/231 (17%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 15  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY     Q   +  + E  +L + LH +    +                           
Sbjct: 73  GYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---------------------- 109
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI---F 687
                   IA  TA+ + +LH   +  IIHRD+K+++++L  +L  ++ DFGLA +   +
Sbjct: 110 -------DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 159
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTP-KSDVYCYGVVLLELITGKKP 737
                 E   GS  ++ PE  +     P   +SDVY +G+VL EL+TG+ P
Sbjct: 160 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 41/231 (17%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 40  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY     Q   +  + E  +L + LH +    +                           
Sbjct: 98  GYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---------------------- 134
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI---F 687
                   IA  TA+ + +LH   +  IIHRD+K+++++L  +L  ++ DFGLA +   +
Sbjct: 135 -------DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 184
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTP-KSDVYCYGVVLLELITGKKP 737
                 E   GS  ++ PE  +     P   +SDVY +G+VL EL+TG+ P
Sbjct: 185 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 41/231 (17%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 41  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY     Q   +  + E  +L + LH +    +                           
Sbjct: 99  GYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---------------------- 135
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI---F 687
                   IA  TA+ + +LH   +  IIHRD+K+++++L  +L  ++ DFGLA +   +
Sbjct: 136 -------DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 185
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTP-KSDVYCYGVVLLELITGKKP 737
                 E   GS  ++ PE  +     P   +SDVY +G+VL EL+TG+ P
Sbjct: 186 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 41/231 (17%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 18  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY     Q   +  + E  +L + LH +    +                           
Sbjct: 76  GYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---------------------- 112
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI---F 687
                   IA  TA+ + +LH   +  IIHRD+K+++++L  +L  ++ DFGLA +   +
Sbjct: 113 -------DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 162
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTP-KSDVYCYGVVLLELITGKKP 737
                 E   GS  ++ PE  +     P   +SDVY +G+VL EL+TG+ P
Sbjct: 163 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 41/231 (17%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY     Q   +  + E  +L + LH +    +                           
Sbjct: 71  GYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---------------------- 107
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI---F 687
                   IA  TA+ + +LH   +  IIHRD+K+++++L  +L  ++ DFGLA +   +
Sbjct: 108 -------DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTP-KSDVYCYGVVLLELITGKKP 737
                 E   GS  ++ PE  +     P   +SDVY +G+VL EL+TG+ P
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 44/237 (18%)
Query: 515 LLAEGKFGPVYRGFL--PGG--IHVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVPL 569
           ++  G+FG V  G L  PG   I VA+K L  G T   + +   E   +G+  HPN++ L
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G        + I ++MENG+L + L                          QN G   +
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLR-------------------------QNDGQFTV 134
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
           +        IA G  + LA +++      +HRD+ A ++ ++ NL  ++SDFGL++   +
Sbjct: 135 IQLVGMLRGIAAGM-KYLADMNY------VHRDLAARNILVNSNLVCKVSDFGLSRFLED 187
Query: 690 GL-DEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGD 740
              D        G IP  +  P++     F T  SDV+ YG+V+ E+++ G++P  D
Sbjct: 188 DTSDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWD 243

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 83/310 (26%), Positives = 139/310 (44%), Gaps = 63/310 (20%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 17  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY     Q   +  + E  +L + LH                             SE   
Sbjct: 75  GYSTK-PQLAIVTQWCEGSSLYHHLH----------------------------ASET-- 103
Query: 631 TTWRFRHK----IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
              +F  K    IA  TAR + +LH   +  IIHRD+K+++++L  +   ++ DFGLA +
Sbjct: 104 ---KFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATV 157
Query: 687 ---FGNGLDEEIARGSPGYIPPEFAQ-PDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY 742
              +      E   GS  ++ PE  +  DS+  + +SDVY +G+VL EL+TG+ P  +  
Sbjct: 158 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 217
Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAID-PKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
             ++   +V          +GS + D  K+R   P K+M+  +     C      +RPS 
Sbjct: 218 NRDQIIEMV---------GRGSLSPDLSKVRSNCP-KRMKRLMA---ECLKKKRDERPSF 264
Query: 802 QQIVGLLKDI 811
            +I+  ++++
Sbjct: 265 PRILAEIEEL 274

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 43/232 (18%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 33  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY     Q   +  + E  +L + LH +    +                           
Sbjct: 91  GYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---------------------- 127
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA----KI 686
                   IA  TA+ + +LH   +  IIHRD+K+++++L  +L  ++ DFGLA    + 
Sbjct: 128 -------DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRW 177
Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDSDFPTP-KSDVYCYGVVLLELITGKKP 737
            G+   E+++ GS  ++ PE  +     P   +SDVY +G+VL EL+TG+ P
Sbjct: 178 SGSHQFEQLS-GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 43/232 (18%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 41  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY     Q   +  + E  +L + LH +    +                           
Sbjct: 99  GYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---------------------- 135
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA----KI 686
                   IA  TA+ + +LH   +  IIHRD+K+++++L  +L  ++ DFGLA    + 
Sbjct: 136 -------DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRW 185
Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDSDFPTP-KSDVYCYGVVLLELITGKKP 737
            G+   E+++ GS  ++ PE  +     P   +SDVY +G+VL EL+TG+ P
Sbjct: 186 SGSHQFEQLS-GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 43/232 (18%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY     Q   +  + E  +L + LH +    +                           
Sbjct: 71  GYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---------------------- 107
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA----KI 686
                   IA  TA+ + +LH   +  IIHRD+K+++++L  +L  ++ DFGLA    + 
Sbjct: 108 -------DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRW 157
Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDSDFPTP-KSDVYCYGVVLLELITGKKP 737
            G+   E+++ GS  ++ PE  +     P   +SDVY +G+VL EL+TG+ P
Sbjct: 158 SGSHQFEQLS-GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 131
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + FL    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 132 VKDLIG-------FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +   + +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 182 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 237
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 238 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 284
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 285 SELVSRISAIFST 297

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 129
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + FL    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 130 VKDLI-------GFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +   + +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 180 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 235
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 236 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 282
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 283 SELVSRISAIFST 295

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 112/236 (47%), Gaps = 51/236 (21%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVL-VHGSTLTDQEAAR-ELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L V   T    +A + E+  L + +H N++   
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           GY     Q   +  + E  +L + LH                             SE   
Sbjct: 87  GYSTK-PQLAIVTQWCEGSSLYHHLH----------------------------ASET-- 115
Query: 631 TTWRFRHK----IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA-- 684
              +F  K    IA  TAR + +LH   +  IIHRD+K+++++L  +   ++ DFGLA  
Sbjct: 116 ---KFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169
Query: 685 --KIFGNGLDEEIARGSPGYIPPEFAQ-PDSDFPTPKSDVYCYGVVLLELITGKKP 737
             +  G+   E+++ GS  ++ PE  +  DS+  + +SDVY +G+VL EL+TG+ P
Sbjct: 170 KSRWSGSHQFEQLS-GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 132
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + FL    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 133 VKDLIG-------FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +   + +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 183 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 238
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 239 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 285
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 286 SELVSRISAIFST 298

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 132
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + FL    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 133 VKDLIG-------FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +   + +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 183 DMLDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 238
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 239 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 285
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 286 SELVSRISAIFST 298

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 136
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + FL    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 137 VKDLIG-------FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +   + +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 187 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 242
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 243 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 289
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 290 SELVSRISAIFST 302

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 131
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + FL    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 132 VKDLIG-------FGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +   + +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 182 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 237
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 238 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 284
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 285 SELVSRISAIFST 297

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 84/315 (26%), Positives = 131/315 (41%), Gaps = 40/315 (12%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEA-ARELEYLGR 560
           +N   G  L  G FG V      G       + VAVK+L   +   ++EA   EL+ +  
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 561 I-KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXN 619
           + +H N+V L G C  G   + I +Y   G+L N L      +                 
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
             + +    LL    F  ++A G    +AFL    S   IHRD+ A +V L      ++ 
Sbjct: 151 DGRPLELRDLL---HFSSQVAQG----MAFL---ASKNCIHRDVAARNVLLTNGHVAKIG 200
Query: 680 DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GK 735
           DFGLA+   N     I +G+   +P ++  P+S F    T +SDV+ YG++L E+ + G 
Sbjct: 201 DFGLARDIMND-SNYIVKGN-ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 258
Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
            P    YP            G++ N+K  + +    +   P    +    I   C A  P
Sbjct: 259 NP----YP------------GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP 302
Query: 796 LKRPSMQQIVGLLKD 810
             RP+ QQI   L++
Sbjct: 303 THRPTFQQICSFLQE 317

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 190
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + FL    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 191 VKDLI-------GFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +   + +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 296
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 297 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 343
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 344 SELVSRISAIFST 356

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/317 (25%), Positives = 130/317 (41%), Gaps = 51/317 (16%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQEA--ARELEYLGRIKHPNLV 567
           + EG FG V++   PG +       VAVK+L   ++  D +A   RE   +    +PN+V
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIV 113
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G C  G     +++YM  G+L   L  +                      + + G  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM----SPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L    +    IA   A  +A+L        +HRD+   +  +  N+  +++DFGL++  
Sbjct: 170 PLSCAEQL--CIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDF---PTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
            +  D   A G+   IP  +  P+S F    T +SDV+ YGVVL E+ + G +P      
Sbjct: 225 YSA-DYYKADGNDA-IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 744 EE-----KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
           EE     ++GN+++                       PE    E   +  LC + LP  R
Sbjct: 283 EEVIYYVRDGNILA----------------------CPENCPLELYNLMRLCWSKLPADR 320
Query: 799 PSMQQIVGLLKDIESTA 815
           PS   I  +L+ +   A
Sbjct: 321 PSFCSIHRILQRMCERA 337

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 44/237 (18%)
Query: 515 LLAEGKFGPVYRGFL--PGG--IHVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVPL 569
           ++  G+FG V  G L  PG   I VA+K L  G T   + +   E   +G+  HPN++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G        + I ++MENG+L + L                          QN G   +
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLR-------------------------QNDGQFTV 108
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
           +        IA G  + LA +++      +HR + A ++ ++ NL  ++SDFGL++   +
Sbjct: 109 IQLVGMLRGIAAGM-KYLADMNY------VHRALAARNILVNSNLVCKVSDFGLSRFLED 161
Query: 690 GL-DEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGD 740
              D        G IP  +  P++     F T  SDV+ YG+V+ E+++ G++P  D
Sbjct: 162 DTSDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWD 217

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/312 (23%), Positives = 128/312 (41%), Gaps = 62/312 (19%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGG-----IHVAVKVLVHGSTLTDQ-EAARELEYLGRI 561
           S   R  ++  G+FG VY+G L        + VA+K L  G T   + +   E   +G+ 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            H N++ L G        + I +YMENG L   L +                     + +
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE----------------KDGEFSVL 147
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           Q VG             +  G A  + +L    +   +HRD+ A ++ ++ NL  ++SDF
Sbjct: 148 QLVG-------------MLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDF 191
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKK 736
           GL+++  +   E     S G IP  +  P++     F T  SDV+ +G+V+ E++T G++
Sbjct: 192 GLSRVLEDD-PEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGER 249
Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL 796
           P  +                 + N++  +AI+   R   P        ++   C      
Sbjct: 250 PYWE-----------------LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERA 292
Query: 797 KRPSMQQIVGLL 808
           +RP    IV +L
Sbjct: 293 RRPKFADIVSIL 304

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 84/315 (26%), Positives = 130/315 (41%), Gaps = 53/315 (16%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEA-ARELEYLGR 560
           +N   G  L  G FG V      G       + VAVK+L   +   ++EA   EL+ +  
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 561 I-KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXN 619
           + +H N+V L G C  G   + I +Y   G+L N L                        
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-------------RKAEADLDKE 144
Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
             + +    LL    F  ++A G    +AFL    S   IHRD+ A +V L      ++ 
Sbjct: 145 DGRPLELRDLL---HFSSQVAQG----MAFL---ASKNCIHRDVAARNVLLTNGHVAKIG 194
Query: 680 DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GK 735
           DFGLA+   N     I +G+   +P ++  P+S F    T +SDV+ YG++L E+ + G 
Sbjct: 195 DFGLARDIMND-SNYIVKGN-ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 252
Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
            P    YP            G++ N+K  + +    +   P    +    I   C A  P
Sbjct: 253 NP----YP------------GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP 296
Query: 796 LKRPSMQQIVGLLKD 810
             RP+ QQI   L++
Sbjct: 297 THRPTFQQICSFLQE 311

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 108/239 (45%), Gaps = 50/239 (20%)
Query: 515 LLAEGKFGPVYRGFL--PGG--IHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPL 569
           ++  G+FG V  G L  PG   I VA+K L  G T    ++   E   +G+  HPN++ L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G        + I +YMENG+L   L                         IQ VG    
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLR----------------KNDGRFTVIQLVG---- 135
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
                    +  G    + +L    +   +HRD+ A ++ ++ NL  ++SDFG++++  +
Sbjct: 136 ---------MLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 690 GLDEEIA---RGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGD 740
             D E A   RG  G IP  +  P++     F T  SDV+ YG+V+ E+++ G++P  D
Sbjct: 184 --DPEAAYTTRG--GKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWD 237

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 130
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + +L    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 131 VKDLIG-------FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +     +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 181 DMYDKEXXSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 236
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 237 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 283
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 284 SELVSRISAIFST 296

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 59/301 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V  G   G   VA+K++  GS +++ E   E + +  + H  LV L G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 I +YM NG L N L ++    Q                      ++ LL     
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQ----------------------TQQLL----- 108
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
             ++      A+ +L    S   +HRD+ A +  ++     ++SDFGL++     LD+E 
Sbjct: 109 --EMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEY 160
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
                   P  ++ P+    S F + KSD++ +GV++ E+ + GK P             
Sbjct: 161 TSSRGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYER---------- 209
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                    N++ +  I   +R   P    E+   I Y C  +   +RP+ + ++  + D
Sbjct: 210 -------FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 262
Query: 811 I 811
           +
Sbjct: 263 V 263

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 50/239 (20%)
Query: 515 LLAEGKFGPVYRGFL--PGG--IHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPL 569
           ++  G+FG V  G L  PG   I VA+K L  G T    ++   E   +G+  HPN++ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G        + I +YMENG+L   L                         IQ VG    
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLR----------------KNDGRFTVIQLVG---- 114
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
                    +  G    + +L        +HRD+ A ++ ++ NL  ++SDFG++++  +
Sbjct: 115 ---------MLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED 162
Query: 690 GLDEEIA---RGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGD 740
             D E A   RG  G IP  +  P++     F T  SDV+ YG+V+ E+++ G++P  D
Sbjct: 163 --DPEAAYTTRG--GKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWD 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 59/301 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V  G   G   VA+K++  GS +++ E   E + +  + H  LV L G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 I +YM NG L N L ++    Q                      ++ LL     
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQ----------------------TQQLL----- 108
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
             ++      A+ +L    S   +HRD+ A +  ++     ++SDFGL++     LD+E 
Sbjct: 109 --EMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEY 160
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
                   P  ++ P+    S F + KSD++ +GV++ E+ + GK P             
Sbjct: 161 TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYER---------- 209
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                    N++ +  I   +R   P    E+   I Y C  +   +RP+ + ++  + D
Sbjct: 210 -------FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 262
Query: 811 I 811
           +
Sbjct: 263 V 263

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 84/315 (26%), Positives = 130/315 (41%), Gaps = 53/315 (16%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEA-ARELEYLGR 560
           +N   G  L  G FG V      G       + VAVK+L   +   ++EA   EL+ +  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 561 I-KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXN 619
           + +H N+V L G C  G   + I +Y   G+L N L                        
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-------------RKAEADLDKE 152
Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
             + +    LL    F  ++A G    +AFL    S   IHRD+ A +V L      ++ 
Sbjct: 153 DGRPLELRDLL---HFSSQVAQG----MAFL---ASKNCIHRDVAARNVLLTNGHVAKIG 202
Query: 680 DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GK 735
           DFGLA+   N     I +G+   +P ++  P+S F    T +SDV+ YG++L E+ + G 
Sbjct: 203 DFGLARDIMND-SNYIVKGN-ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 260
Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
            P    YP            G++ N+K  + +    +   P    +    I   C A  P
Sbjct: 261 NP----YP------------GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP 304
Query: 796 LKRPSMQQIVGLLKD 810
             RP+ QQI   L++
Sbjct: 305 THRPTFQQICSFLQE 319

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 50/239 (20%)
Query: 515 LLAEGKFGPVYRGFL--PGG--IHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPL 569
           ++  G+FG V  G L  PG   I VA+K L  G T    ++   E   +G+  HPN++ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G        + I +YMENG+L   L                         IQ VG    
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLR----------------KNDGRFTVIQLVG---- 120
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
                    +  G    + +L        +HRD+ A ++ ++ NL  ++SDFG++++  +
Sbjct: 121 ---------MLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED 168
Query: 690 GLDEEIA---RGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGD 740
             D E A   RG  G IP  +  P++     F T  SDV+ YG+V+ E+++ G++P  D
Sbjct: 169 --DPEAAYTTRG--GKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWD 222

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 59/302 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+         VAVK +  GS   +   A E   +  ++H  LV L    + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKLHA-VVT 80
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTW-R 634
            +    I ++M  G+L + L                           + GS+  L     
Sbjct: 81  KEPIYIITEFMAKGSLLDFLK-------------------------SDEGSKQPLPKLID 115
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
           F  +IA G    +AF+        IHRD++A+++ +  +L  +++DFGLA++  +  +E 
Sbjct: 116 FSAQIAEG----MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEY 166
Query: 695 IARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++ +F   T KSDV+ +G++L+E++T G+ P    YP       
Sbjct: 167 TAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP----YPG------ 215
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                  + N +  RA++   R   PE   EE   I   C  + P +RP+ + I  +L D
Sbjct: 216 -------MSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 268
Query: 811 IE 812
            E
Sbjct: 269 FE 270

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 44/237 (18%)
Query: 515 LLAEGKFGPVYRGFL--PGGIH--VAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVPL 569
           ++  G+FG V RG L  PG     VA+K L  G T   + E   E   +G+ +HPN++ L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G        + + ++MENG L + L                         IQ VG    
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLR----------------LNDGQFTVIQLVG---- 120
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF-G 688
                    IA G  R LA + +      +HRD+ A ++ ++ NL  ++SDFGL++    
Sbjct: 121 -----MLRGIASGM-RYLAEMSY------VHRDLAARNILVNSNLVCKVSDFGLSRFLEE 168
Query: 689 NGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGD 740
           N  D        G IP  +  P++     F T  SD + YG+V+ E+++ G++P  D
Sbjct: 169 NSSDPTYTSSLGGKIPIRWTAPEAIAFRKF-TSASDAWSYGIVMWEVMSFGERPYWD 224

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 131
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + +L    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 132 VKDLIG-------FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +     +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 182 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 237
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 238 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 284
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 285 SELVSRISAIFST 297

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 59/301 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V  G   G   VA+K++  GS +++ E   E + +  + H  LV L G C  
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 I +YM NG L N L ++    Q                      ++ LL     
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQ----------------------TQQLL----- 114
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
             ++      A+ +L    S   +HRD+ A +  ++     ++SDFGL++     LD+E 
Sbjct: 115 --EMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEY 166
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
                   P  ++ P+    S F + KSD++ +GV++ E+ + GK P             
Sbjct: 167 TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYER---------- 215
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                    N++ +  I   +R   P    E+   I Y C  +   +RP+ + ++  + D
Sbjct: 216 -------FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 268
Query: 811 I 811
           +
Sbjct: 269 V 269

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 130
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + +L    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 131 VKDLIG-------FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +     +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 181 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 236
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 237 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 283
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 284 SELVSRISAIFST 296

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 150
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + +L    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 151 VKDLI-------GFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +     +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 201 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 256
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 257 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 303
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 304 SELVSRISAIFST 316

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 149
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + +L    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 150 VKDLIG-------FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +     +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 200 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 255
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 256 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 302
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 303 SELVSRISAIFST 315

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 131
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + +L    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 132 VKDLIG-------FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +     +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 182 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 237
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 238 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 284
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 285 SELVSRISAIFST 297

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 129
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + +L    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 130 VKDLIG-------FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +     +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 180 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 235
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 236 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 282
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 283 SELVSRISAIFST 295

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 59/301 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V  G   G   VA+K++  GS +++ E   E + +  + H  LV L G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 I +YM NG L N L ++    Q                      ++ LL     
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQ----------------------TQQLL----- 123
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
             ++      A+ +L    S   +HRD+ A +  ++     ++SDFGL++     LD+E 
Sbjct: 124 --EMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEY 175
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
                   P  ++ P+    S F + KSD++ +GV++ E+ + GK P             
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYER---------- 224
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                    N++ +  I   +R   P    E+   I Y C  +   +RP+ + ++  + D
Sbjct: 225 -------FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277
Query: 811 I 811
           +
Sbjct: 278 V 278

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 123
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + +L    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 124 VKDLIG-------FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +     +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 174 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 229
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 230 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 276
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 277 SELVSRISAIFST 289

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 126
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + +L    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 127 VKDLIG-------FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +     +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 232
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 233 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 279
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 280 SELVSRISAIFST 292

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 129/313 (41%), Gaps = 65/313 (20%)
Query: 515 LLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAARELEYLGRI----KHPNL 566
           ++  G FG VY G L       IH AVK L   + +TD     +    G I     HPN+
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 567 VPLTGYCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           + L G C+  +   + +  YM++G+L+N +                       N   N  
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----------------------NETHNPT 128
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            + L+          L  A+ + +L    S   +HRD+ A +  LD     +++DFGLA+
Sbjct: 129 VKDLIG-------FGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKPLGDD 741
              +     +   +   +P ++   +S     F T KSDV+ +GV+L EL+T   P    
Sbjct: 179 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAP---P 234
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP+    ++  ++       +G R + P   +  P+   E  LK    C       RPS 
Sbjct: 235 YPDVNTFDITVYLL------QGRRLLQP---EYCPDPLYEVMLK----CWHPKAEMRPSF 281
Query: 802 QQIVGLLKDIEST 814
            ++V  +  I ST
Sbjct: 282 SELVSRISAIFST 294

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLK----------------------------GETGKYLRLP 280
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 281 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 335
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 336 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 383
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 384 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 59/301 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V  G   G   VA+K++  GS +++ E   E + +  + H  LV L G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 I +YM NG L N L ++    Q                      ++ LL     
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQ----------------------TQQLL----- 123
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
             ++      A+ +L    S   +HRD+ A +  ++     ++SDFGL++     LD+E 
Sbjct: 124 --EMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEE 175
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
                   P  ++ P+    S F + KSD++ +GV++ E+ + GK P             
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYER---------- 224
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                    N++ +  I   +R   P    E+   I Y C  +   +RP+ + ++  + D
Sbjct: 225 -------FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277
Query: 811 I 811
           +
Sbjct: 278 V 278

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLK----------------------------GETGKYLRLP 280
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 281 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 335
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 336 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 383
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 384 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFLK----------------------------GETGKYLRLP 280
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 281 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 335
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 336 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 383
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 384 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 44/237 (18%)
Query: 515 LLAEGKFGPVYRGFL--PGGIH--VAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVPL 569
           ++  G+FG V RG L  PG     VA+K L  G T   + E   E   +G+ +HPN++ L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G        + + ++MENG L + L                         IQ VG    
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLR----------------LNDGQFTVIQLVG---- 122
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF-G 688
                    IA G  R LA + +      +HRD+ A ++ ++ NL  ++SDFGL++    
Sbjct: 123 -----MLRGIASGM-RYLAEMSY------VHRDLAARNILVNSNLVCKVSDFGLSRFLEE 170
Query: 689 NGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKPLGD 740
           N  D        G IP  +  P++     F T  SD + YG+V+ E+++ G++P  D
Sbjct: 171 NSSDPTETSSLGGKIPIRWTAPEAIAFRKF-TSASDAWSYGIVMWEVMSFGERPYWD 226

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 105/237 (44%), Gaps = 42/237 (17%)
Query: 516 LAEGKFGPVYRG----FLP--GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPL 569
           L EG FG V+        P    I VAVK L   S    ++  RE E L  ++H ++V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLH----DLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
            G C+ GD  I +++YM++G+L   L     D  L  +                   N  
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG------------------NPP 122
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
           +E  LT  +  H IA   A  + +L    S   +HRD+   +  +  NL  ++ DFG+++
Sbjct: 123 TE--LTQSQMLH-IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176
Query: 686 IFGNGLDEEIAR-GSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
              +    +  R G    +P  +  P+S      T +SDV+  GVVL E+ T GK+P
Sbjct: 177 ---DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 39/237 (16%)
Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL---VHGSTLTDQEAARELEYLGRIKHP 564
           N+     L EG FG V   +    G  VA+K++   V   +       RE+ YL  ++HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNV 624
           +++ L     + D+ I + +Y  N     ++    +  Q                     
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--------------------- 112
Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
                    RF  +I      A+ + H      I+HRD+K  ++ LD +L  +++DFGL+
Sbjct: 113 ------EARRFFQQII----SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS 159
Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
            I  +G   + + GSP Y  PE       +  P+ DV+  GV+L  ++  + P  D+
Sbjct: 160 NIMTDGNFLKTSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 39/237 (16%)
Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL---VHGSTLTDQEAARELEYLGRIKHP 564
           N+     L EG FG V   +    G  VA+K++   V   +       RE+ YL  ++HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNV 624
           +++ L     + D+ I + +Y  N     ++    +  Q                     
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--------------------- 113
Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
                    RF  +I      A+ + H      I+HRD+K  ++ LD +L  +++DFGL+
Sbjct: 114 ------EARRFFQQII----SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS 160
Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
            I  +G   + + GSP Y  PE       +  P+ DV+  GV+L  ++  + P  D+
Sbjct: 161 NIMTDGNFLKTSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 216

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++                 I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY-------------DI 146
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   R++DF
Sbjct: 147 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADF 201
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 202 GLARDINNI--DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 109/237 (45%), Gaps = 52/237 (21%)
Query: 515 LLAEGKFGPVYRGFL--PGG--IHVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVPL 569
           ++  G+FG V  G L  PG   + VA+K L  G T   + +   E   +G+  HPN++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G        + + +YMENG+L   L                              ++G 
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKK----------------------------NDGQ 120
Query: 630 LTTWRFRHKIALGTARAL-AFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
            T  +      +G  R + A + +      +HRD+ A ++ ++ NL  ++SDFGL+++  
Sbjct: 121 FTVIQL-----VGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 175
Query: 689 NGLDEEIA---RGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKKP 737
           +  D E A   RG  G IP  +  P++     F T  SDV+ YG+V+ E+++ G++P
Sbjct: 176 D--DPEAAYTTRG--GKIPIRWTAPEAIAFRKF-TSASDVWSYGIVMWEVVSYGERP 227

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 108/240 (45%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L+ G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q ++  +P G                    
Sbjct: 82  DNPHVCRLLGICL-------------TSTVQLIMQLMPFGC----------LLDYVREHK 118
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 119 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 169 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++                 I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSY-------------DI 146
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 147 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 202 GLARDINNI--DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 135/300 (45%), Gaps = 58/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+      VAVK L  G T++ Q    E   +  ++H  LV L      
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTW-R 634
            +    I +YM  G+L + L                           + G + LL     
Sbjct: 80  EEPIYIITEYMAKGSLLDFLK-------------------------SDEGGKVLLPKLID 114
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
           F  +IA G    +A++        IHRD++A++V +  +L  +++DFGLA++  +  +E 
Sbjct: 115 FSAQIAEG----MAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED--NEY 165
Query: 695 IARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++ +F   T KSDV+ +G++L E++T GK P    YP     ++
Sbjct: 166 TAREGAKF-PIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIP----YPGRTNADV 220
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
           ++ +      ++G R   P++ +       +E   I  +C  +   +RP+   +  +L D
Sbjct: 221 MTAL------SQGYRM--PRVENCP-----DELYDIMKMCWKEKAEERPTFDYLQSVLDD 267

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 39/237 (16%)
Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL---VHGSTLTDQEAARELEYLGRIKHP 564
           N+     L EG FG V   +    G  VA+K++   V   +       RE+ YL  ++HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNV 624
           +++ L     + D+ I + +Y  N     ++    +  Q                     
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--------------------- 103
Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
                    RF  +I      A+ + H      I+HRD+K  ++ LD +L  +++DFGL+
Sbjct: 104 ------EARRFFQQII----SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS 150
Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
            I  +G   + + GSP Y  PE       +  P+ DV+  GV+L  ++  + P  D+
Sbjct: 151 NIMTDGNFLKTSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 206

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++                 I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY-------------DI 146
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 147 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 202 GLARDINNI--DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 72
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFLK----------------------------GETGKYLRLP 104
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 105 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEX 159
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 160 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 207
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 208 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 261

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 42/227 (18%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G   G   VA+K L  G T++ +    E + + ++KH  LV L  Y + 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPG-TMSPESFLEEAQIMKKLKHDKLVQL--YAVV 73
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L D                             EG      
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKD----------------------------GEGRALKLP 105
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        IHRD++++++ +   L  +++DFGLA++  +  +E 
Sbjct: 106 NLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGNGLICKIADFGLARLIED--NEX 160
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
            AR    + P ++  P++      T KSDV+ +G++L EL+T G+ P
Sbjct: 161 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 39/237 (16%)
Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL---VHGSTLTDQEAARELEYLGRIKHP 564
           N+     L EG FG V   +    G  VA+K++   V   +       RE+ YL  ++HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNV 624
           +++ L     + D+ I + +Y  N     ++    +  Q                     
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--------------------- 107
Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
                    RF  +I      A+ + H      I+HRD+K  ++ LD +L  +++DFGL+
Sbjct: 108 ------EARRFFQQII----SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS 154
Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
            I  +G   + + GSP Y  PE       +  P+ DV+  GV+L  ++  + P  D+
Sbjct: 155 NIMTDGNFLKTSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 210

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 132/301 (43%), Gaps = 59/301 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+         VAVK +  GS   +   A E   +  ++H  LV L    + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKLHA-VVT 253
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTW-R 634
            +    I ++M  G+L + L                           + GS+  L     
Sbjct: 254 KEPIYIITEFMAKGSLLDFLK-------------------------SDEGSKQPLPKLID 288
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
           F  +IA G    +AF+        IHRD++A+++ +  +L  +++DFGLA++  +  +E 
Sbjct: 289 FSAQIAEG----MAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED--NEY 339
Query: 695 IARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++ +F   T KSDV+ +G++L+E++T G+ P    YP       
Sbjct: 340 TAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP----YPG------ 388
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                  + N +  RA++   R   PE   EE   I   C  + P +RP+ + I  +L D
Sbjct: 389 -------MSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441
Query: 811 I 811
Sbjct: 442 F 442

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q ++  +P G                    
Sbjct: 78  DNPHVCRLLGICL-------------TSTVQLIMQLMPFGC----------LLDYVREHK 114
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 115 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 165 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q ++  +P G                    
Sbjct: 76  DNPHVCRLLGICL-------------TSTVQLIMQLMPFGC----------LLDYVREHK 112
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 113 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 162
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 163 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q ++  +P G                    
Sbjct: 75  DNPHVCRLLGICL-------------TSTVQLIMQLMPFGC----------LLDYVREHK 111
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 112 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 162 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q ++  +P G                    
Sbjct: 77  DNPHVCRLLGICL-------------TSTVQLIMQLMPFGC----------LLDYVREHK 113
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 114 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 164 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHG-STLTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L    S   ++E   E   +  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q ++  +P G                    
Sbjct: 79  DNPHVCRLLGICL-------------TSTVQLIMQLMPFGC----------LLDYVREHK 115
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 116 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 165
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 166 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 46/234 (19%)
Query: 515 LLAEGKFGPVYRGFL--PG--GIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPL 569
           ++  G  G V  G L  PG   + VA+K L  G T    ++   E   +G+  HPN++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            G    G   + + +YMENG+L   L  HD    +                  +Q VG  
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI------------------MQLVG-- 155
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
                      +  G    + +L        +HRD+ A +V +D NL  ++SDFGL+++ 
Sbjct: 156 -----------MLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFPT--PKSDVYCYGVVLLELIT-GKKP 737
            +  D      + G IP  +  P++  F T    SDV+ +GVV+ E++  G++P
Sbjct: 202 EDDPDAAYT-TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++                 I
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY-------------DI 146
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 147 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 202 GLARDINNI--DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 331
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLK----------------------------GETGKYLRLP 363
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 364 QLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 418
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 419 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 466
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 467 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 46/234 (19%)
Query: 515 LLAEGKFGPVYRGFL--PG--GIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPL 569
           ++  G  G V  G L  PG   + VA+K L  G T    ++   E   +G+  HPN++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            G    G   + + +YMENG+L   L  HD    +                  +Q VG  
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI------------------MQLVG-- 155
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
                      +  G    + +L        +HRD+ A +V +D NL  ++SDFGL+++ 
Sbjct: 156 -----------MLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFPT--PKSDVYCYGVVLLELIT-GKKP 737
            +  D      + G IP  +  P++  F T    SDV+ +GVV+ E++  G++P
Sbjct: 202 EDDPDAAXT-TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 41/239 (17%)
Query: 509 NFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHP 564
           +F  G LL +G F  VYR   +  G+ VA+K++   +       Q    E++   ++KHP
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNV 624
           +++ L  Y    +    + +   NG +   L                       N ++  
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYL----------------------KNRVKPF 109
Query: 625 GSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
                     F H+I  G    + +LH HG    I+HRD+  S++ L  N+  +++DFGL
Sbjct: 110 SEN---EARHFMHQIITG----MLYLHSHG----ILHRDLTLSNLLLTRNMNIKIADFGL 158
Query: 684 AKIFGNGLDEEIAR-GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
           A       ++     G+P YI PE A   +     +SDV+  G +   L+ G+ P   D
Sbjct: 159 ATQLKMPHEKHYTLCGTPNYISPEIATRSAH--GLESDVWSLGCMFYTLLIGRPPFDTD 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 122/313 (38%), Gaps = 40/313 (12%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEA-ARELEYLGR 560
            N + G +L  G FG V      G       I VAVK+L   +  +++EA   EL+ + +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 561 I-KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXN 619
           +  H N+V L G C        I++Y   G+L N L                        
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
            +  +  E LL         A   A+ + FL        +HRD+ A +V +      ++ 
Sbjct: 165 DLNVLTFEDLLC-------FAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKIC 214
Query: 680 DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GK 735
           DFGLA+   +     + RG+   +P ++  P+S F    T KSDV+ YG++L E+ + G 
Sbjct: 215 DFGLARDIMSD-SNYVVRGNAR-LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272
Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
            P    YP            G+  +    + I    +   P    EE   I   C A   
Sbjct: 273 NP----YP------------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDS 316
Query: 796 LKRPSMQQIVGLL 808
            KRPS   +   L
Sbjct: 317 RKRPSFPNLTSFL 329

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 121/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G+FG VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 78  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVSAVVLLY--- 113
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 114 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTX 164
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 165 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 215
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
            S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 216 PSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q ++  +P G                    
Sbjct: 76  DNPHVCRLLGICL-------------TSTVQLIMQLMPFGX----------LLDYVREHK 112
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 113 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 162
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 163 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++                 I
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY-------------DI 146
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 147 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 202 GLARDINNI--DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLREC---------------------NRQEVSAVVLLY--- 115
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 116 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 166
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 167 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 218 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLREC---------------------NRQEVSAVVLLY--- 115
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 116 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 166
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 167 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 218 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 116
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 117 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTX 167
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 168 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 218
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 219 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++                 I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY-------------DI 146
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 147 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 202 GLARDINNI--DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 120
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 121 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTX 171
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 172 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 222
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 223 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 115
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 116 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 166
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 167 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 218 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 115/257 (44%), Gaps = 51/257 (19%)
Query: 554 ELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXX 613
           EL  L R+ HPN+V L G C+  +    + +Y E G+L N+LH                 
Sbjct: 52  ELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLH----------------- 92
Query: 614 XXXXXNSIQNVGSEGL-LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM 672
                      G+E L   T        L  ++ +A+LH      +IHRD+K  ++ L  
Sbjct: 93  -----------GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA 141
Query: 673 N-LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
                ++ DFG A      +     +GS  ++ PE  +  S++ + K DV+ +G++L E+
Sbjct: 142 GGTVLKICDFGTACDIQTHMTNN--KGSAAWMAPEVFE-GSNY-SEKCDVFSWGIILWEV 197
Query: 732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCT 791
           IT +KP       ++ G     +   V N  G+R   P I++    K +E  +     C 
Sbjct: 198 ITRRKPF------DEIGGPAFRIMWAVHN--GTRP--PLIKNL--PKPIESLMT---RCW 242
Query: 792 ADLPLKRPSMQQIVGLL 808
           +  P +RPSM++IV ++
Sbjct: 243 SKDPSQRPSMEEIVKIM 259

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVSAVVLLY--- 115
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 116 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 166
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 167 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 218 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++                 I
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY-------------DI 133
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 134 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADF 188
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 189 GLARDINNI--DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 93  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 128
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 129 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 179
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 180 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 230
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 231 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L+ G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q +   +P G                    
Sbjct: 82  DNPHVCRLLGICL-------------TSTVQLITQLMPFGC----------LLDYVREHK 118
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 119 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 169 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVSAVVLLY--- 115
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 116 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 166
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 167 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 218 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVSAVVLLY--- 120
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 121 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 171
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 172 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 222
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 223 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 63/123 (51%), Gaps = 7/123 (5%)
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPP-IIHRDIKASSVYLDMNLEPRLSDFGLAK-- 685
           L+   R + K A    R +      C    I+HRD+KA ++ LD ++  +++DFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDYPE 744
            FGN LDE    GSP Y  PE  Q    +  P+ DV+  GV+L  L++G  P  G +  E
Sbjct: 164 TFGNKLDEFC--GSPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220
Query: 745 EKE 747
            +E
Sbjct: 221 LRE 223

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 75
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFLK----------------------------GETGKYLRLP 107
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 108 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 162
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 163 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 210
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 211 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 264

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +I+H  LV L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKIRHEKLVQL--YAVV 82
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLK----------------------------GEMGKYLRLP 114
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 115 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 169
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 170 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 218 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 82  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 117
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 118 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 168
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 169 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 219
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 220 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHG-STLTDQEAARELEYLGRI 561
           + F +  +L+ G FG VY+G ++P G    I VA+K L    S   ++E   E   +  +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+    ++ I   M  G L + + +                        
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE----------------------HK 111
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 112 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 162 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 120
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 121 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 171
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 172 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 222
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 223 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 82  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 117
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 118 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 168
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 169 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 219
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 220 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 120
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 121 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 171
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 172 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 222
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 223 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 115/257 (44%), Gaps = 51/257 (19%)
Query: 554 ELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXX 613
           EL  L R+ HPN+V L G C+  +    + +Y E G+L N+LH                 
Sbjct: 51  ELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLH----------------- 91
Query: 614 XXXXXNSIQNVGSEGL-LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM 672
                      G+E L   T        L  ++ +A+LH      +IHRD+K  ++ L  
Sbjct: 92  -----------GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA 140
Query: 673 N-LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
                ++ DFG A      +     +GS  ++ PE  +  S++ + K DV+ +G++L E+
Sbjct: 141 GGTVLKICDFGTACDIQTHMTNN--KGSAAWMAPEVFE-GSNY-SEKCDVFSWGIILWEV 196
Query: 732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCT 791
           IT +KP       ++ G     +   V N  G+R   P I++    K +E  +     C 
Sbjct: 197 ITRRKPF------DEIGGPAFRIMWAVHN--GTRP--PLIKNL--PKPIESLMT---RCW 241
Query: 792 ADLPLKRPSMQQIVGLL 808
           +  P +RPSM++IV ++
Sbjct: 242 SKDPSQRPSMEEIVKIM 258

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++                 I
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY-------------DI 135
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 136 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 190
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 191 GLARDINNI--DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 120
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 121 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 171
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 172 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 222
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 223 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+    ++ I   M  G L + + +                        
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE----------------------HK 111
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 112 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 162 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q +   +P G                    
Sbjct: 69  DNPHVCRLLGICL-------------TSTVQLITQLMPFGC----------LLDYVREHK 105
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 106 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 155
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 156 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q +   +P G                    
Sbjct: 85  DNPHVCRLLGICL-------------TSTVQLITQLMPFGC----------LLDYVREHK 121
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 122 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 171
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 172 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 84  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 119
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 120 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 170
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 171 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 221
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 222 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHG-STLTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L    S   ++E   E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+    ++ I   M  G L + + +                        
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVRE----------------------HK 111
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 112 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 162 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 120/258 (46%), Gaps = 37/258 (14%)
Query: 504 LSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVK-VLVHGSTLTDQEAARELEYLGRI 561
           +S++S F +   L  G +  VY+G     G++VA+K V +     T   A RE+  +  +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           KH N+V L       ++   ++++M+N +L+  +    +G                 N+ 
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVG-----------------NTP 102
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           +  G E  L  + F+ ++  G    LAF H      I+HRD+K  ++ ++   + +L DF
Sbjct: 103 R--GLELNLVKY-FQWQLLQG----LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDF 152
Query: 682 GLAKIFG---NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           GLA+ FG   N    E+   +  Y  P+       + T   D++  G +L E+ITG KPL
Sbjct: 153 GLARAFGIPVNTFSSEVV--TLWYRAPDVLMGSRTYST-SIDIWSCGCILAEMITG-KPL 208
Query: 739 GDDYPEEKEGNLVSWVRG 756
                +E++  L+  + G
Sbjct: 209 FPGTNDEEQLKLIFDIMG 226

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++                 I
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY-------------DI 138
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 139 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 193
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 194 GLARDINNI--DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLK----------------------------GEMGKYLRLP 114
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 115 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEX 169
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 170 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 218 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++                 I
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY-------------DI 192
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 193 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 247
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 248 GLARDINNI--DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHG-STLTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L    S   ++E   E   +  +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q +   +P G                    
Sbjct: 81  DNPHVCRLLGICL-------------TSTVQLITQLMPFGC----------LLDYVREHK 117
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 118 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 167
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 168 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 121/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLREC---------------------NRQEVSAVVLLY--- 113
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 114 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTX 164
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 165 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 215
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
            S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 216 PSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+    ++ I   M  G L + + +                        
Sbjct: 77  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE----------------------HK 113
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 114 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 164 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q +   +P G                    
Sbjct: 75  DNPHVCRLLGICL-------------TSTVQLITQLMPFGC----------LLDYVREHK 111
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 112 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 162 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 90/357 (25%), Positives = 135/357 (37%), Gaps = 73/357 (20%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTLTDQEA-ARELEYL 558
           A      G  L  G FG V +         P    VAVK+L  G+T ++ +A   EL+ L
Sbjct: 25  ARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKIL 84
Query: 559 GRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNLQNLLH----------DLPLGVQXXX 606
             I  H N+V L G C   G   + I +Y + GNL N L           D  L ++   
Sbjct: 85  THIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPKK 144
Query: 607 XXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALG------------------------ 642
                         + +V S     +  F+   +L                         
Sbjct: 145 EKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISY 204
Query: 643 ---TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IFGNGLDEEIARG 698
               AR + FL    S   IHRD+ A ++ L  N   ++ DFGLA+ I+ N    +  R 
Sbjct: 205 SFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN---PDYVRK 258
Query: 699 SPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWV 754
               +P ++  P+S F    + KSDV+ YGV+L E+ + G  P    YP           
Sbjct: 259 GDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP----YP----------- 303
Query: 755 RGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
            G+  +      +   +R   PE    E  +I   C    P +RP   ++V  L D+
Sbjct: 304 -GVQMDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDL 359

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+    ++ I   M  G L + + +                        
Sbjct: 78  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE----------------------HK 114
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 115 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 165 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHG-STLTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L    S   ++E   E   +  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q +   +P G                    
Sbjct: 78  DNPHVCRLLGICL-------------TSTVQLITQLMPFGC----------LLDYVREHK 114
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 115 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 165 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q +   +P G                    
Sbjct: 100 DNPHVCRLLGICL-------------TSTVQLITQLMPFGC----------LLDYVREHK 136
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 137 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 186
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 187 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q +   +P G                    
Sbjct: 82  DNPHVCRLLGICL-------------TSTVQLITQLMPFGC----------LLDYVREHK 118
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 119 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 169 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/300 (23%), Positives = 124/300 (41%), Gaps = 57/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V  G   G   VA+K++  GS +++ E   E + +  + H  LV L G C  
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 I +YM NG L N L ++    Q                      ++ LL     
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQ----------------------TQQLL----- 107
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
             ++      A+ +L    S   +HRD+ A +  ++     ++SDFGL++     LD+E 
Sbjct: 108 --EMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEY 159
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV 751
                   P  ++ P+    S F + KSD++ +GV++ E+ +  K      P E+     
Sbjct: 160 TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGK-----MPYER----- 208
Query: 752 SWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
                   N++ +  I   +R   P    E+   I Y C  +   +RP+ + ++  + D+
Sbjct: 209 ------FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 262

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/300 (23%), Positives = 124/300 (41%), Gaps = 57/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V  G   G   VA+K++  GS +++ E   E + +  + H  LV L G C  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRF 635
                 I +YM NG L N L ++    Q                      ++ LL     
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQ----------------------TQQLL----- 103
Query: 636 RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEI 695
             ++      A+ +L    S   +HRD+ A +  ++     ++SDFGL++     LD+E 
Sbjct: 104 --EMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEY 155
Query: 696 ARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV 751
                   P  ++ P+    S F + KSD++ +GV++ E+ +  K      P E+     
Sbjct: 156 TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGK-----MPYER----- 204
Query: 752 SWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
                   N++ +  I   +R   P    E+   I Y C  +   +RP+ + ++  + D+
Sbjct: 205 ------FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+    ++ I   M  G L + + +                        
Sbjct: 78  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE----------------------HK 114
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 115 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 165 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 79
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLK----------------------------GETGKYLRLP 111
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               ++   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 112 QLVDMSAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEW 166
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 167 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 214
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 215 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 268

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++                 I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY-------------DI 146
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 147 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +     + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 202 GLARDINNI--DYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 73
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFLK----------------------------GEMGKYLRLP 105
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 106 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 160
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 161 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 208
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 209 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLED 262

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLK----------------------------GEMGKYLRLP 114
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 115 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 169
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 170 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 218 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFLK----------------------------GEMGKYLRLP 114
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 115 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 169
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 170 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 218 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLK----------------------------GEMGKYLRLP 114
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 115 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 169
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 170 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 218 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I  Y   GNL+  L    P G++                 I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSY-------------DI 146
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 147 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 202 GLARDINNI--DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 71
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFLK----------------------------GEMGKYLRLP 103
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 104 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 158
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 159 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 206
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 207 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLED 260

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 34/235 (14%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D  +   E+E +  I K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I  Y   GNL+  L    P G++                 I
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSY-------------DI 146
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
             V  E +  T++         AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 147 NRVPEEQM--TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT 733
           GLA+   N   +   + + G +P ++  P++ F    T +SDV+ +GV++ E+ T
Sbjct: 202 GLARDINNI--DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 79
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLK----------------------------GETGKYLRLP 111
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               ++   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 112 QLVDMSAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 166
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 167 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 214
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 215 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 268

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 81  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 116
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 117 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 167
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 168 TAPAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 218
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 219 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 82  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 117
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 118 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 168
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 169 TAPAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 219
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 220 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 31/233 (13%)
Query: 516 LAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPL 569
           L EG FG V+             + VAVK L   +    ++  RE E L  ++H ++V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G C  GD  I +++YM++G+L   L                          Q  G  GL
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLR----------AHGPDAMILVDGQPRQAKGELGL 132
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
                   +IA G    + +L    S   +HRD+   +  +  NL  ++ DFG+++   +
Sbjct: 133 SQMLHIASQIASG----MVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---D 182
Query: 690 GLDEEIAR-GSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
               +  R G    +P  +  P+S      T +SDV+ +GV+L E+ T GK+P
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 516 LAEGKFGPVY----RGFLP--GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPL 569
           L EG FG V+       LP    + VAVK L   S    Q+  RE E L  ++H ++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G C  G   + +++YM +G+L   L       +                 +  V S+  
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ-- 143
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IFG 688
                    +A G    LA LH       +HRD+   +  +   L  ++ DFG+++ I+ 
Sbjct: 144 ---------VAAGMV-YLAGLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 187
Query: 689 NGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
               +    G    +P  +  P+S      T +SDV+ +GVVL E+ T GK+P
Sbjct: 188 T---DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 516 LAEGKFGPVY----RGFLP--GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPL 569
           L EG FG V+       LP    + VAVK L   S    Q+  RE E L  ++H ++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G C  G   + +++YM +G+L   L       +                 +  V S+  
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ-- 166
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IFG 688
                    +A G    LA LH       +HRD+   +  +   L  ++ DFG+++ I+ 
Sbjct: 167 ---------VAAGMV-YLAGLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
Query: 689 NGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
               +    G    +P  +  P+S      T +SDV+ +GVVL E+ T GK+P
Sbjct: 211 T---DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q +   +P G                    
Sbjct: 72  DNPHVCRLLGICL-------------TSTVQLITQLMPFGC----------LLDYVREHK 108
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A  + +L       ++HRD+ A +V +      +++DF
Sbjct: 109 DNIGSQYLLN-W------CVQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 158
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 159 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHG-STLTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L    S   ++E   E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q ++  +P G                    
Sbjct: 77  DNPHVCRLLGICL-------------TSTVQLIMQLMPFGC----------LLDYVREHK 113
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 114 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           G AK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 164 GRAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHG-STLTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L    S   ++E   E   +  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q ++  +P G                    
Sbjct: 79  DNPHVCRLLGICL-------------TSTVQLIMQLMPFGC----------LLDYVREHK 115
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 116 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 165
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           G AK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 166 GRAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 516 LAEGKFGPVY----RGFLP--GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPL 569
           L EG FG V+       LP    + VAVK L   S    Q+  RE E L  ++H ++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G C  G   + +++YM +G+L   L       +                 +  V S+  
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ-- 137
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IFG 688
                    +A G    LA LH       +HRD+   +  +   L  ++ DFG+++ I+ 
Sbjct: 138 ---------VAAGMV-YLAGLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 181
Query: 689 NGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
               +    G    +P  +  P+S      T +SDV+ +GVVL E+ T GK+P
Sbjct: 182 T---DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q ++  +P G                    
Sbjct: 77  DNPHVCRLLGICL-------------TSTVQLIMQLMPFGC----------LLDYVREHK 113
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 114 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           G AK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 164 GRAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLVH-----GSTLTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G  V + V +       S   ++E   E   +  +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+    ++ I   M  G L + + +                        
Sbjct: 109 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE----------------------HK 145
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 146 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 195
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           GLAK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 196 GLAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 135/300 (45%), Gaps = 58/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+ G+      VAVK L  G T++ Q    E   +  ++H  LV L      
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTW-R 634
            +    I ++M  G+L + L                           + G + LL     
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKS-------------------------DEGGKVLLPKLID 113
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
           F  +IA G    +A++        IHRD++A++V +  +L  +++DFGLA++  +  +E 
Sbjct: 114 FSAQIAEG----MAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIED--NEY 164
Query: 695 IARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++ +F   T KS+V+ +G++L E++T GK P    YP     ++
Sbjct: 165 TAREGAKF-PIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIP----YPGRTNADV 219
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
           +S +      ++G R   P++ +       +E   I  +C  +   +RP+   +  +L D
Sbjct: 220 MSAL------SQGYRM--PRMENCP-----DELYDIMKMCWKEKAEERPTFDYLQSVLDD 266

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 105/259 (40%), Gaps = 50/259 (19%)
Query: 499 TFADLLSATSNFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVL----VHGSTLTDQEAA 552
           T AD      N+     + +G F  V   R  L G   VAVK++    ++ S+L  Q+  
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGK-EVAVKIIDKTQLNSSSL--QKLF 61
Query: 553 RELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXX 612
           RE+  +  + HPN+V L            + +Y   G + + L                 
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL----------------- 104
Query: 613 XXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP-IIHRDIKASSVYLD 671
                            +   R + K A    R +      C    I+HRD+KA ++ LD
Sbjct: 105 -----------------VAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 672 MNLEPRLSDFGLAK--IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLL 729
            ++  +++DFG +    FGN LD     GSP Y  PE  Q    +  P+ DV+  GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPELFQ-GKKYDGPEVDVWSLGVILY 204
Query: 730 ELITGKKPL-GDDYPEEKE 747
            L++G  P  G +  E +E
Sbjct: 205 TLVSGSLPFDGQNLKELRE 223

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 105/259 (40%), Gaps = 50/259 (19%)
Query: 499 TFADLLSATSNFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVL----VHGSTLTDQEAA 552
           T AD      N+     + +G F  V   R  L G   VAVK++    ++ S+L  Q+  
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGK-EVAVKIIDKTQLNSSSL--QKLF 61
Query: 553 RELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXX 612
           RE+  +  + HPN+V L            + +Y   G + + L                 
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL----------------- 104
Query: 613 XXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP-IIHRDIKASSVYLD 671
                            +   R + K A    R +      C    I+HRD+KA ++ LD
Sbjct: 105 -----------------VAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 672 MNLEPRLSDFGLAK--IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLL 729
            ++  +++DFG +    FGN LD     GSP Y  PE  Q    +  P+ DV+  GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPELFQ-GKKYDGPEVDVWSLGVILY 204
Query: 730 ELITGKKPL-GDDYPEEKE 747
            L++G  P  G +  E +E
Sbjct: 205 TLVSGSLPFDGQNLKELRE 223

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 121/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 78  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVSAVVLLY--- 113
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 114 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTF 164
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 165 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 215
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
            S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 216 PSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 115
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 116 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTY 166
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 167 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 218 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 129/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G L + L                             G  G      
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFLK----------------------------GEMGKYLRLP 114
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 115 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 169
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 170 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 218 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 129/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 576 GDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G L + L                             G  G      
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFLK----------------------------GEMGKYLRLP 114
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 115 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED--NEY 169
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 170 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 218 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 287 REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVSAVVLLY--- 322
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHR++ A +  +  N   +++DFGL+++     D  
Sbjct: 323 ----MATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--DTY 373
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 374 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 424
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 425 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 108/256 (42%), Gaps = 41/256 (16%)
Query: 490 IFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD 548
           I EK    ++  D     + F++   + +G  G VY    +  G  VA++ +        
Sbjct: 5   ILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXX 608
           +    E+  +   K+PN+V      + GD+   + +Y+  G+L +++ +  +        
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------- 114
Query: 609 XXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV 668
                       I  V  E L               +AL FLH   S  +IHRDIK+ ++
Sbjct: 115 ---------EGQIAAVCRECL---------------QALEFLH---SNQVIHRDIKSDNI 147
Query: 669 YLDMNLEPRLSDFGL-AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
            L M+   +L+DFG  A+I           G+P ++ PE     +    PK D++  G++
Sbjct: 148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIM 205
Query: 728 LLELITGKKPLGDDYP 743
            +E+I G+ P  ++ P
Sbjct: 206 AIEMIEGEPPYLNENP 221

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 129/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G T++ +   +E + + +++H  LV L  Y + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLK----------------------------GEMGKYLRLP 114
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD+ A+++ +  NL  +++DFGLA++  +  +E 
Sbjct: 115 QLVDMAAQIASGMAYVERM---NYVHRDLAAANILVGENLVCKVADFGLARLIED--NEY 169
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 170 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 217
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 218 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  I ++M  GNL + L +                      + Q V +  LL    
Sbjct: 326 REPPFYIITEFMTYGNLLDYLREC---------------------NRQEVNAVVLLY--- 361
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHR++ A +  +  N   +++DFGL+++     D  
Sbjct: 362 ----MATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--DTY 412
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 413 TAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 463
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +S V  L+  +          R   PE   E+  ++   C    P  RPS  +I
Sbjct: 464 LSQVYELLEKD---------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 109/256 (42%), Gaps = 41/256 (16%)
Query: 490 IFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD 548
           I EK  + ++  D     + F++   + +G  G VY    +  G  VA++ +        
Sbjct: 6   ILEKLRIIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 62
Query: 549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXX 608
           +    E+  +   K+PN+V      + GD+   + +Y+  G+L +++ +  +        
Sbjct: 63  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------- 115
Query: 609 XXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV 668
                       I  V  E L               +AL FLH   S  +IHR+IK+ ++
Sbjct: 116 ---------EGQIAAVCRECL---------------QALEFLH---SNQVIHRNIKSDNI 148
Query: 669 YLDMNLEPRLSDFGL-AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
            L M+   +L+DFG  A+I           G+P ++ PE     +    PK D++  G++
Sbjct: 149 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY--GPKVDIWSLGIM 206
Query: 728 LLELITGKKPLGDDYP 743
            +E+I G+ P  ++ P
Sbjct: 207 AIEMIEGEPPYLNENP 222

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 129/300 (43%), Gaps = 59/300 (19%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L +G FG V+ G   G   VA+K L  G+ ++ +   +E + + +++H  LV L  Y + 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGN-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 249
Query: 576 GDQRIAIY-DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
            ++ I I  +YM  G+L + L                             G  G      
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFLK----------------------------GEMGKYLRLP 281
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   A  +A++        +HRD++A+++ +  NL  +++DFGL ++  +  +E 
Sbjct: 282 QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLGRLIED--NEY 336
Query: 695 IARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            AR    + P ++  P++      T KSDV+ +G++L EL T G+ P    YP       
Sbjct: 337 TARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YP------- 384
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                G+V N +    ++   R   P +  E    +   C    P +RP+ + +   L+D
Sbjct: 385 -----GMV-NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLED 438

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 108/256 (42%), Gaps = 41/256 (16%)
Query: 490 IFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD 548
           I EK    ++  D     + F++   + +G  G VY    +  G  VA++ +        
Sbjct: 6   ILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 62
Query: 549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXX 608
           +    E+  +   K+PN+V      + GD+   + +Y+  G+L +++ +  +        
Sbjct: 63  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------- 115
Query: 609 XXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV 668
                       I  V  E L               +AL FLH   S  +IHRDIK+ ++
Sbjct: 116 ---------EGQIAAVCRECL---------------QALEFLH---SNQVIHRDIKSDNI 148
Query: 669 YLDMNLEPRLSDFGL-AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
            L M+   +L+DFG  A+I           G+P ++ PE     +    PK D++  G++
Sbjct: 149 LLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIM 206
Query: 728 LLELITGKKPLGDDYP 743
            +E+I G+ P  ++ P
Sbjct: 207 AIEMIEGEPPYLNENP 222

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 108/256 (42%), Gaps = 41/256 (16%)
Query: 490 IFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD 548
           I EK    ++  D     + F++   + +G  G VY    +  G  VA++ +        
Sbjct: 5   ILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXX 608
           +    E+  +   K+PN+V      + GD+   + +Y+  G+L +++ +  +        
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------- 114
Query: 609 XXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV 668
                       I  V  E L               +AL FLH   S  +IHRDIK+ ++
Sbjct: 115 ---------EGQIAAVCRECL---------------QALEFLH---SNQVIHRDIKSDNI 147
Query: 669 YLDMNLEPRLSDFGL-AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
            L M+   +L+DFG  A+I           G+P ++ PE     +    PK D++  G++
Sbjct: 148 LLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIM 205
Query: 728 LLELITGKKPLGDDYP 743
            +E+I G+ P  ++ P
Sbjct: 206 AIEMIEGEPPYLNENP 221

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPP-IIHRDIKASSVYLDMNLEPRLSDFGLAK-- 685
           L+   R + K A    R +      C    I+HRD+KA ++ LD ++  +++DFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDYPE 744
            FGN LD     GSP Y  PE  Q    +  P+ DV+  GV+L  L++G  P  G +  E
Sbjct: 164 TFGNKLDTFC--GSPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220
Query: 745 EKE 747
            +E
Sbjct: 221 LRE 223

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 57/275 (20%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGS-TLTDQEAARELEYLGRI 561
           +   R  +L  G FG VY+G ++P G    I VA+K+L   +    + E   E   +  +
Sbjct: 38  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 97
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            HP+LV L G C++   ++ +   M +G L   +H+                        
Sbjct: 98  DHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHE----------------------HK 134
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 135 DNIGSQ-LLLNW------CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDF 184
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKK 736
           GLA++     DE+      G +P ++   +      F T +SDV+ YGV + EL+T G K
Sbjct: 185 GLARLLEG--DEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGK 241
Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKI 771
           P  D  P  +  +L+          KG R   P I
Sbjct: 242 PY-DGIPTREIPDLL---------EKGERLPQPPI 266

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 131/314 (41%), Gaps = 52/314 (16%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G           VAVK+L   +T  D  +   E+E +  I K
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++               N  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE--------FSFNPSHNPE 144
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           + + S+ L++        A   AR + +L    S   IHRD+ A +V +  +   +++DF
Sbjct: 145 EQLSSKDLVSC-------AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
           GLA+   +   +   + + G +P ++  P++ F    T +SDV+ +GV+L E+ T G  P
Sbjct: 195 GLARDIHHI--DXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
               YP      L   ++   R +K S   +             E   +   C   +P +
Sbjct: 253 ----YPGVPVEELFKLLKEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQ 295
Query: 798 RPSMQQIVGLLKDI 811
           RP+ +Q+V  L  I
Sbjct: 296 RPTFKQLVEDLDRI 309

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 66/125 (52%), Gaps = 10/125 (8%)
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           V +EG +T  R    IA    +AL F H      IIHRD+K +++ +      ++ DFG+
Sbjct: 107 VHTEGPMTPKRAIEVIA-DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162
Query: 684 AKIF---GNGLDEEIAR-GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
           A+     GN + +  A  G+  Y+ PE A+ DS     +SDVY  G VL E++TG+ P  
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFT 220
Query: 740 DDYPE 744
            D P+
Sbjct: 221 GDSPD 225

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 47/241 (19%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGS-TLTDQEAARELEYLGRI 561
           +   R  +L  G FG VY+G ++P G    I VA+K+L   +    + E   E   +  +
Sbjct: 15  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 74
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            HP+LV L G C++   ++ +   M +G L   +H+                        
Sbjct: 75  DHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHE----------------------HK 111
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 112 DNIGSQ-LLLNW------CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDF 161
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELIT-GKK 736
           GLA++     DE+      G +P ++   +      F T +SDV+ YGV + EL+T G K
Sbjct: 162 GLARLLEG--DEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGK 218
Query: 737 P 737
           P
Sbjct: 219 P 219

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHG-STLTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L    S   ++E   E   +  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q +   +P G                    
Sbjct: 77  DNPHVCRLLGICL-------------TSTVQLITQLMPFGC----------LLDYVREHK 113
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 114 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           G AK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 164 GRAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 140/344 (40%), Gaps = 65/344 (18%)
Query: 497 NITFADLLSATSNF------------DR---GTLLAEGKFGPVYRGFLPG--------GI 533
           N+ F  +L+  S +            DR   G  L EG FG V      G          
Sbjct: 43  NLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVT 102
Query: 534 HVAVKVLVHGSTLTD-QEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMENGNL 591
            VAVK+L   +T  D  +   E+E +  I KH N++ L G C        I +Y   GNL
Sbjct: 103 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 592 QNLLH-DLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFL 650
           +  L    P G++               N  + + S+ L++        A   AR + +L
Sbjct: 163 REYLQARRPPGLE--------YSYNPSHNPEEQLSSKDLVSC-------AYQVARGMEYL 207
Query: 651 HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQP 710
               S   IHRD+ A +V +  +   +++DFGLA+   +   +   + + G +P ++  P
Sbjct: 208 ---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH--IDYYKKTTNGRLPVKWMAP 262
Query: 711 DSDFP---TPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAI 767
           ++ F    T +SDV+ +GV+L E+ T     G  YP      L   ++   R +K S   
Sbjct: 263 EALFDRIYTHQSDVWSFGVLLWEIFTLG---GSPYPGVPVEELFKLLKEGHRMDKPSNCT 319
Query: 768 DPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
           +             E   +   C   +P +RP+ +Q+V  L  I
Sbjct: 320 N-------------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 50/259 (19%)
Query: 499 TFADLLSATSNFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVL----VHGSTLTDQEAA 552
           T AD      N+     + +G F  V   R  L G   VAVK++    ++ S+L  Q+  
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGK-EVAVKIIDKTQLNSSSL--QKLF 61
Query: 553 RELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXX 612
           RE+  +  + HPN+V L            + +Y   G + + L                 
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL----------------- 104
Query: 613 XXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP-IIHRDIKASSVYLD 671
                            +   R + K A    R +      C    I+HRD+KA ++ LD
Sbjct: 105 -----------------VAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLD 147
Query: 672 MNLEPRLSDFGLAK--IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLL 729
            ++  +++DFG +    FGN LD     G+P Y  PE  Q    +  P+ DV+  GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDAFC--GAPPYAAPELFQ-GKKYDGPEVDVWSLGVILY 204
Query: 730 ELITGKKPL-GDDYPEEKE 747
            L++G  P  G +  E +E
Sbjct: 205 TLVSGSLPFDGQNLKELRE 223

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 124/293 (42%), Gaps = 57/293 (19%)
Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNLV L G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
                  + +YM  GNL + L +                      + + V +  LL    
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLREC---------------------NREEVTAVVLLY--- 134
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
               +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++     D  
Sbjct: 135 ----MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTG--DTY 185
Query: 695 IARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
            A     + P ++  P+S   +  + KSDV+ +GV+L E+ T G  P    YP    G  
Sbjct: 186 TAHAGAKF-PIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP----YP----GID 236
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
           +S V  L+   KG R   P+    G   ++ E ++    C    P  RPS  +
Sbjct: 237 LSQVYDLL--EKGYRMEQPE----GCPPKVYELMRA---CWKWSPADRPSFAE 280

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q +   +P G                    
Sbjct: 75  DNPHVCRLLGICL-------------TSTVQLITQLMPFGC----------LLDYVREHK 111
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 112 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           G AK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 162 GRAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 45/240 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGG----IHVAVKVLVHGST-LTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G ++P G    I VA+K L   ++   ++E   E   +  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            +P++  L G C+                +Q +   +P G                    
Sbjct: 82  DNPHVCRLLGICL-------------TSTVQLITQLMPFGC----------LLDYVREHK 118
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N+GS+ LL  W       +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 119 DNIGSQYLLN-W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKP 737
           G AK+ G    E  A G  G +P ++   +S      T +SDV+ YGV + EL+T G KP
Sbjct: 169 GRAKLLGAEEKEYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 108/256 (42%), Gaps = 41/256 (16%)
Query: 490 IFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD 548
           I EK    ++  D     + F++   + +G  G VY    +  G  VA++ +        
Sbjct: 5   ILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXX 608
           +    E+  +   K+PN+V      + GD+   + +Y+  G+L +++ +  +        
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------- 114
Query: 609 XXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV 668
                       I  V  E L               +AL FLH   S  +IHRDIK+ ++
Sbjct: 115 ---------EGQIAAVCRECL---------------QALEFLH---SNQVIHRDIKSDNI 147
Query: 669 YLDMNLEPRLSDFGL-AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
            L M+   +L+DFG  A+I           G+P ++ PE     +    PK D++  G++
Sbjct: 148 LLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIM 205
Query: 728 LLELITGKKPLGDDYP 743
            +E+I G+ P  ++ P
Sbjct: 206 AIEMIEGEPPYLNENP 221

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 130/313 (41%), Gaps = 50/313 (15%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G           VAVK+L   +T  D  +   E+E +  I K
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++               N  
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE--------YSYNPSHNPE 133
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           + + S+ L++        A   AR + +L    S   IHRD+ A +V +  +   +++DF
Sbjct: 134 EQLSSKDLVSC-------AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADF 183
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELITGKKPL 738
           GLA+   +   +   + + G +P ++  P++ F    T +SDV+ +GV+L E+ T     
Sbjct: 184 GLARDIHHI--DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG--- 238
Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
           G  YP      L   ++   R +K S   +             E   +   C   +P +R
Sbjct: 239 GSPYPGVPVEELFKLLKEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQR 285
Query: 799 PSMQQIVGLLKDI 811
           P+ +Q+V  L  I
Sbjct: 286 PTFKQLVEDLDRI 298

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 65/124 (52%), Gaps = 10/124 (8%)
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           V +EG +T  R    IA    +AL F H      IIHRD+K +++ +      ++ DFG+
Sbjct: 107 VHTEGPMTPKRAIEVIA-DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162
Query: 684 AKIF---GNGLDEEIAR-GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
           A+     GN + +  A  G+  Y+ PE A+ DS     +SDVY  G VL E++TG+ P  
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFT 220
Query: 740 DDYP 743
            D P
Sbjct: 221 GDSP 224

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 130/313 (41%), Gaps = 50/313 (15%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G           VAVK+L   +T  D  +   E+E +  I K
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++               N  
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE--------YSYNPSHNPE 137
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           + + S+ L++        A   AR + +L    S   IHRD+ A +V +  +   +++DF
Sbjct: 138 EQLSSKDLVSC-------AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADF 187
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELITGKKPL 738
           GLA+   +   +   + + G +P ++  P++ F    T +SDV+ +GV+L E+ T     
Sbjct: 188 GLARDIHHI--DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG--- 242
Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
           G  YP      L   ++   R +K S   +             E   +   C   +P +R
Sbjct: 243 GSPYPGVPVEELFKLLKEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQR 289
Query: 799 PSMQQIVGLLKDI 811
           P+ +Q+V  L  I
Sbjct: 290 PTFKQLVEDLDRI 302

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 131/314 (41%), Gaps = 52/314 (16%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G           VAVK+L   +T  D  +   E+E +  I K
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++               N  
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE--------YSYNPSHNPE 136
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           + + S+ L++        A   AR + +L    S   IHRD+ A +V +  +   +++DF
Sbjct: 137 EQLSSKDLVSC-------AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADF 186
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
           GLA+   +   +   + + G +P ++  P++ F    T +SDV+ +GV+L E+ T G  P
Sbjct: 187 GLARDIHH--IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 244
Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
               YP      L   ++   R +K S   +             E   +   C   +P +
Sbjct: 245 ----YPGVPVEELFKLLKEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQ 287
Query: 798 RPSMQQIVGLLKDI 811
           RP+ +Q+V  L  I
Sbjct: 288 RPTFKQLVEDLDRI 301

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 65/124 (52%), Gaps = 10/124 (8%)
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           V +EG +T  R    IA    +AL F H      IIHRD+K +++ +      ++ DFG+
Sbjct: 107 VHTEGPMTPKRAIEVIA-DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162
Query: 684 AKIF---GNGLDEEIAR-GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
           A+     GN + +  A  G+  Y+ PE A+ DS     +SDVY  G VL E++TG+ P  
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFT 220
Query: 740 DDYP 743
            D P
Sbjct: 221 GDSP 224

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 130/313 (41%), Gaps = 50/313 (15%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G           VAVK+L   +T  D  +   E+E +  I K
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++               N  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE--------YSYNPSHNPE 144
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           + + S+ L++        A   AR + +L    S   IHRD+ A +V +  +   +++DF
Sbjct: 145 EQLSSKDLVSC-------AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELITGKKPL 738
           GLA+   +   +   + + G +P ++  P++ F    T +SDV+ +GV+L E+ T     
Sbjct: 195 GLARDIHH--IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG--- 249
Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
           G  YP      L   ++   R +K S   +             E   +   C   +P +R
Sbjct: 250 GSPYPGVPVEELFKLLKEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQR 296
Query: 799 PSMQQIVGLLKDI 811
           P+ +Q+V  L  I
Sbjct: 297 PTFKQLVEDLDRI 309

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 108/269 (40%), Gaps = 56/269 (20%)
Query: 493 KPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVL-VHGSTLTDQE 550
           + L  I  + L      F+   L+  G +G VY+G  +  G   A+KV+ V G    ++E
Sbjct: 9   RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEE 66
Query: 551 AARELEYLGRI-KHPNLVPLTGYCIA------GDQRIAIYDYMENGNLQNLLHDLPLGVQ 603
             +E+  L +   H N+    G  I        DQ   + ++   G++ +L         
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--------- 117
Query: 604 XXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI 663
                            I+N     L   W     IA      L  L H     +IHRDI
Sbjct: 118 -----------------IKNTKGNTLKEEW-----IAYICREILRGLSHLHQHKVIHRDI 155
Query: 664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPEF----AQPDSDF 714
           K  +V L  N E +L DFG++      LD  + R     G+P ++ PE       PD+ +
Sbjct: 156 KGQNVLLTENAEVKLVDFGVSA----QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY 211
Query: 715 PTPKSDVYCYGVVLLELITGKKPLGDDYP 743
              KSD++  G+  +E+  G  PL D +P
Sbjct: 212 DF-KSDLWSLGITAIEMAEGAPPLCDMHP 239

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 80/332 (24%), Positives = 137/332 (41%), Gaps = 62/332 (18%)
Query: 496 LNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLP----GGIHVAVKVLVHGSTLTD--Q 549
           L     D+L     F  G +L +G+FG V    L       + VAVK+L      +   +
Sbjct: 11  LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 550 EAARELEYLGRIKHPNLVPLTGYCIAGDQR------IAIYDYMENGNLQNLLHDLPLGVQ 603
           E  RE   +    HP++  L G  +    +      + I  +M++G+L   L    +G  
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG-- 128
Query: 604 XXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI 663
                             +N  +  L T  RF   IA G       + +  S   IHRD+
Sbjct: 129 ------------------ENPFNLPLQTLVRFMVDIACG-------MEYLSSRNFIHRDL 163
Query: 664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSD 720
            A +  L  ++   ++DFGL++   +G  +   +G    +P ++   +S   +  T  SD
Sbjct: 164 AARNCMLAEDMTVCVADFGLSRKIYSG--DYYRQGCASKLPVKWLALESLADNLYTVHSD 221
Query: 721 VYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQ 779
           V+ +GV + E++T G+ P    Y   +   + +++ G      G+R   P      PE  
Sbjct: 222 VWAFGVTMWEIMTRGQTP----YAGIENAEIYNYLIG------GNRLKQP------PE-C 264
Query: 780 MEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
           MEE   + Y C +  P +RPS   +   L++I
Sbjct: 265 MEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 41/232 (17%)
Query: 516 LAEGKFGPV-----YRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLT 570
           L EG FG V     Y+      +    + L+  S +      RE+ YL  ++HP+++ L 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDM-HMRVEREISYLKLLRHPHIIKLY 75
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
                    + + +Y   G L + +                          +    EG  
Sbjct: 76  DVITTPTDIVMVIEYA-GGELFDYI----------------------VEKKRMTEDEG-- 110
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
              RF  +I      A+ + H      I+HRD+K  ++ LD NL  +++DFGL+ I  +G
Sbjct: 111 --RRFFQQIIC----AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161
Query: 691 LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY 742
              + + GSP Y  PE       +  P+ DV+  G+VL  ++ G+ P  D++
Sbjct: 162 NFLKTSCGSPNYAAPEVINGKL-YAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 65/124 (52%), Gaps = 10/124 (8%)
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           V +EG +T  R    IA    +AL F H      IIHRD+K +++ +      ++ DFG+
Sbjct: 107 VHTEGPMTPKRAIEVIA-DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162
Query: 684 AKIF---GNGLDEEIAR-GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
           A+     GN + +  A  G+  Y+ PE A+ DS     +SDVY  G VL E++TG+ P  
Sbjct: 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFT 220
Query: 740 DDYP 743
            D P
Sbjct: 221 GDSP 224

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 65/124 (52%), Gaps = 10/124 (8%)
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           V +EG +T  R    IA    +AL F H      IIHRD+K +++ +      ++ DFG+
Sbjct: 124 VHTEGPMTPKRAIEVIA-DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 179
Query: 684 AKIF---GNGLDEEIAR-GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
           A+     GN + +  A  G+  Y+ PE A+ DS     +SDVY  G VL E++TG+ P  
Sbjct: 180 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFT 237
Query: 740 DDYP 743
            D P
Sbjct: 238 GDSP 241

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 131/314 (41%), Gaps = 52/314 (16%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G           VAVK+L   +T  D  +   E+E +  I K
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDL-PLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++               N  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLE--------YSYNPSHNPE 144
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           + + S+ L++        A   AR + +L    S   IHRD+ A +V +  +   +++DF
Sbjct: 145 EQLSSKDLVSC-------AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
           GLA+   +   +   + + G +P ++  P++ F    T +SDV+ +GV+L E+ T G  P
Sbjct: 195 GLARDIHH--IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
               YP      L   ++   R +K S   +             E   +   C   +P +
Sbjct: 253 ----YPGVPVEELFKLLKEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQ 295
Query: 798 RPSMQQIVGLLKDI 811
           RP+ +Q+V  L  I
Sbjct: 296 RPTFKQLVEDLDRI 309

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 130/313 (41%), Gaps = 50/313 (15%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G           VAVK+L   +T  D  +   E+E +  I K
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++               N  
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE--------YCYNPSHNPE 129
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           + + S+ L++        A   AR + +L    S   IHRD+ A +V +  +   +++DF
Sbjct: 130 EQLSSKDLVSC-------AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADF 179
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELITGKKPL 738
           GLA+   +   +   + + G +P ++  P++ F    T +SDV+ +GV+L E+ T     
Sbjct: 180 GLARDIHHI--DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG--- 234
Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
           G  YP      L   ++   R +K S   +             E   +   C   +P +R
Sbjct: 235 GSPYPGVPVEELFKLLKEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQR 281
Query: 799 PSMQQIVGLLKDI 811
           P+ +Q+V  L  I
Sbjct: 282 PTFKQLVEDLDRI 294

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 65/124 (52%), Gaps = 10/124 (8%)
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           V +EG +T  R    IA    +AL F H      IIHRD+K +++ +      ++ DFG+
Sbjct: 107 VHTEGPMTPKRAIEVIA-DACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGI 162
Query: 684 AKIF---GNGLDEEIAR-GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
           A+     GN + +  A  G+  Y+ PE A+ DS     +SDVY  G VL E++TG+ P  
Sbjct: 163 ARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFT 220
Query: 740 DDYP 743
            D P
Sbjct: 221 GDSP 224

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/319 (21%), Positives = 140/319 (43%), Gaps = 61/319 (19%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHGSTLTD-------QEAARELEY 557
           A +  +    + +G FG V++G L     V A+K L+ G +  +       QE  RE+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXX 617
           +  + HPN+V L  Y +  +    + +++  G+L + L D    ++              
Sbjct: 77  MSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIK-------------- 120
Query: 618 XNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL---DMN- 673
                          W  + ++ L  A  + ++ +  +PPI+HRD+++ +++L   D N 
Sbjct: 121 ---------------WSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENA 164
Query: 674 -LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
            +  +++DFGL++   + +   +  G+  ++ PE    + +  T K+D Y + ++L  ++
Sbjct: 165 PVCAKVADFGLSQQSVHSVSGLL--GNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 733 TGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTA 792
           TG+ P  D+Y   K    ++ +R            +  +R T PE        +  LC +
Sbjct: 223 TGEGPF-DEYSYGK-IKFINMIR------------EEGLRPTIPEDCPPRLRNVIELCWS 268
Query: 793 DLPLKRPSMQQIVGLLKDI 811
             P KRP    IV  L ++
Sbjct: 269 GDPKKRPHFSYIVKELSEL 287

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 131/314 (41%), Gaps = 52/314 (16%)
Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           G  L EG FG V      G           VAVK+L   +T  D  +   E+E +  I K
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLH-DLPLGVQXXXXXXXXXXXXXXXNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++               N  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE--------YCYNPSHNPE 144
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
           + + S+ L++        A   AR + +L    S   IHRD+ A +V +  +   +++DF
Sbjct: 145 EQLSSKDLVSC-------AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKP 737
           GLA+   +   +   + + G +P ++  P++ F    T +SDV+ +GV+L E+ T G  P
Sbjct: 195 GLARDIHHI--DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
               YP      L   ++   R +K S   +             E   +   C   +P +
Sbjct: 253 ----YPGVPVEELFKLLKEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQ 295
Query: 798 RPSMQQIVGLLKDI 811
           RP+ +Q+V  L  I
Sbjct: 296 RPTFKQLVEDLDRI 309

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 60/121 (49%), Gaps = 3/121 (2%)
Query: 629 LLTTWRFRHKIALGTARALAFLHHGC-SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
           L+   R + K A    R +      C    I+HRD+KA ++ LD ++  +++DFG +  F
Sbjct: 102 LVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 161
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDYPEEK 746
             G   +   GSP Y  PE  Q    +  P+ DV+  GV+L  L++G  P  G +  E +
Sbjct: 162 TVGGKLDTFCGSPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 220
Query: 747 E 747
           E
Sbjct: 221 E 221

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 126/301 (41%), Gaps = 69/301 (22%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V+         VAVK +  GS   +   A E   +  ++H  LV L    + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKLHA-VVT 247
Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTW-R 634
            +    I ++M  G+L + L                           + GS+  L     
Sbjct: 248 KEPIYIITEFMAKGSLLDFLKS-------------------------DEGSKQPLPKLID 282
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
           F  +IA G    +AF+        IHRD++A+++ +  +L  +++DFGLA++        
Sbjct: 283 FSAQIAEG----MAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVGAK----- 330
Query: 695 IARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNL 750
                    P ++  P++ +F   T KSDV+ +G++L+E++T G+ P    YP       
Sbjct: 331 --------FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP----YPG------ 372
Query: 751 VSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKD 810
                  + N +  RA++   R   PE   EE   I   C  + P +RP+ + I  +L D
Sbjct: 373 -------MSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 425
Query: 811 I 811
Sbjct: 426 F 426

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 63/304 (20%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELE-------YLGRIKHPN 565
           G +L EG+FG V  G L      ++KV V    L D  + RE+E        +    HPN
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL-DNSSQREIEEFLSEAACMKDFSHPN 97
Query: 566 LVPLTGYCIAGDQR-----IAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNS 620
           ++ L G CI    +     + I  +M+ G+L   L                         
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-----------------LYSRLETG 140
Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
            +++  + LL   +F   IALG       + +  +   +HRD+ A +  L  ++   ++D
Sbjct: 141 PKHIPLQTLL---KFMVDIALG-------MEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKK 736
           FGL+K   +G  +   +G    +P ++   +S      T KSDV+ +GV + E+ T G  
Sbjct: 191 FGLSKKIYSG--DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT 248
Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL 796
           P    YP              V+N++    +    R   PE  ++E  +I Y C    PL
Sbjct: 249 P----YPG-------------VQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPL 291
Query: 797 KRPS 800
            RP+
Sbjct: 292 DRPT 295

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL--------------------SKF 110
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 111 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 157
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 158 GWS-VHAPSSRRXXLXGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAK--IFGNGLDEEIARGSPGYIPPEFAQPDSDFP 715
           I+HRD+KA ++ LD ++  +++DFG +    FGN LD     GSP Y  PE  Q    + 
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPELFQ-GKKYD 183
Query: 716 TPKSDVYCYGVVLLELITGKKPL-GDDYPEEKE 747
            P+ DV+  GV+L  L++G  P  G +  E +E
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE 216

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPP 705
           A++FLH   +  I+HRD+K  ++ LD N++ RLSDFG +     G       G+PGY+ P
Sbjct: 212 AVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAP 268
Query: 706 EFAQPDSDFPTP----KSDVYCYGVVLLELITGKKPL 738
           E  +   D   P    + D++  GV+L  L+ G  P 
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 118/305 (38%), Gaps = 57/305 (18%)
Query: 514 TLLAEGKFGPVYRGFLPGGIHVAVKVLV--HGSTLTDQEAARELEYLGRIKHPNLVPLTG 571
           T L E   G +++G   G   + VKVL     ST   ++   E   L    HPN++P+ G
Sbjct: 16  TKLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 572 YCIA--GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            C +        I  +M  G+L N+LH+                     +  Q V     
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHE---------------GTNFVVDQSQAV----- 114
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
                   K AL  AR +AFLH    P I    + + SV +D ++  R+S   +   F  
Sbjct: 115 --------KFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-- 163
Query: 690 GLDEEIARG-SPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKPLGDDYPEEKE 747
              +   R  +P ++ PE  Q   +    +S D++ + V+L EL+T + P  D       
Sbjct: 164 ---QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD------- 213
Query: 748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                    L     G +     +R T P        K+  +C  + P KRP    IV +
Sbjct: 214 ---------LSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
Query: 808 LKDIE 812
           L+ ++
Sbjct: 265 LEKMQ 269

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 57/113 (50%), Gaps = 6/113 (5%)
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPP-IIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
           L+   R + K A    R +      C    I+HRD+KA ++ LD ++  +++DFG +  F
Sbjct: 105 LVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF 164
Query: 688 --GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
             GN LD     GSP Y  PE  Q    +  P+ DV+  GV+L  L++G  P 
Sbjct: 165 TVGNKLDTFC--GSPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/317 (23%), Positives = 132/317 (41%), Gaps = 42/317 (13%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTLTD-QEAARELEYLGR 560
            N   G  L EG+FG V +          G   VAVK+L   ++ ++ ++   E   L +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 561 IKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNS 620
           + HP+++ L G C      + I +Y + G+L+  L +                     + 
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
            +   + G L +  F  +I+ G       + +     ++HRD+ A ++ +    + ++SD
Sbjct: 143 DERALTMGDLIS--FAWQISQG-------MQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKK 736
           FGL++      ++   + S G IP ++   +S F    T +SDV+ +GV+L E++T G  
Sbjct: 194 FGLSRDVYE--EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL 796
           P     P E+  NL+           G R          P+   EE  ++   C    P 
Sbjct: 252 PY-PGIPPERLFNLL---------KTGHRM-------ERPDNCSEEMYRLMLQCWKQEPD 294
Query: 797 KRPSMQQIVGLLKDIES 813
           KRP    I    KD+E 
Sbjct: 295 KRPVFADIS---KDLEK 308

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/317 (23%), Positives = 132/317 (41%), Gaps = 42/317 (13%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTLTD-QEAARELEYLGR 560
            N   G  L EG+FG V +          G   VAVK+L   ++ ++ ++   E   L +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 561 IKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNS 620
           + HP+++ L G C      + I +Y + G+L+  L +                     + 
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
            +   + G L +  F  +I+ G       + +     ++HRD+ A ++ +    + ++SD
Sbjct: 143 DERALTMGDLIS--FAWQISQG-------MQYLAEMSLVHRDLAARNILVAEGRKMKISD 193
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKK 736
           FGL++      ++   + S G IP ++   +S F    T +SDV+ +GV+L E++T G  
Sbjct: 194 FGLSRDVYE--EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL 796
           P     P E+  NL+           G R          P+   EE  ++   C    P 
Sbjct: 252 PY-PGIPPERLFNLL---------KTGHRM-------ERPDNCSEEMYRLMLQCWKQEPD 294
Query: 797 KRPSMQQIVGLLKDIES 813
           KRP    I    KD+E 
Sbjct: 295 KRPVFADIS---KDLEK 308

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/317 (23%), Positives = 132/317 (41%), Gaps = 42/317 (13%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTLTD-QEAARELEYLGR 560
            N   G  L EG+FG V +          G   VAVK+L   ++ ++ ++   E   L +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 561 IKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNS 620
           + HP+++ L G C      + I +Y + G+L+  L +                     + 
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
            +   + G L +  F  +I+ G       + +     ++HRD+ A ++ +    + ++SD
Sbjct: 143 DERALTMGDLIS--FAWQISQG-------MQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKK 736
           FGL++      ++   + S G IP ++   +S F    T +SDV+ +GV+L E++T G  
Sbjct: 194 FGLSRDVYE--EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL 796
           P     P E+  NL+           G R          P+   EE  ++   C    P 
Sbjct: 252 PY-PGIPPERLFNLL---------KTGHRM-------ERPDNCSEEMYRLMLQCWKQEPD 294
Query: 797 KRPSMQQIVGLLKDIES 813
           KRP    I    KD+E 
Sbjct: 295 KRPVFADIS---KDLEK 308

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 1/85 (1%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTP 717
           ++HRD+K  +V LD ++  +++DFGL+ +  +G     + GSP Y  PE       +  P
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVIS-GRLYAGP 195
Query: 718 KSDVYCYGVVLLELITGKKPLGDDY 742
           + D++  GV+L  L+ G  P  DD+
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDDDH 220

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL--------------------SKF 110
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 111 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 157
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 158 GWS-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 60/121 (49%), Gaps = 3/121 (2%)
Query: 629 LLTTWRFRHKIALGTARALAFLHHGC-SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
           L+   R + K A    R +      C    I+HRD+KA ++ LD ++  +++DFG +  F
Sbjct: 105 LVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDYPEEK 746
             G   +   G+P Y  PE  Q    +  P+ DV+  GV+L  L++G  P  G +  E +
Sbjct: 165 TVGGKLDAFCGAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 223
Query: 747 E 747
           E
Sbjct: 224 E 224

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 516 LAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L +G FG VY+      G   A KV+   S    ++   E+E L    HP +V L G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
              +   + ++   G +  ++ +L  G+                  IQ V  + L     
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGL--------------TEPQIQVVCRQML----- 127
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGLDE 693
                      AL FLH   S  IIHRD+KA +V + +  + RL+DFG+ AK        
Sbjct: 128 ----------EALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174
Query: 694 EIARGSPGYIPPEFAQPDSDFPTP---KSDVYCYGVVLLELITGKKP 737
           +   G+P ++ PE    ++   TP   K+D++  G+ L+E+   + P
Sbjct: 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 516 LAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L +G FG VY+      G   A KV+   S    ++   E+E L    HP +V L G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 575 AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWR 634
              +   + ++   G +  ++ +L  G+                  IQ V  + L     
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGL--------------TEPQIQVVCRQML----- 119
Query: 635 FRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGLDE 693
                      AL FLH   S  IIHRD+KA +V + +  + RL+DFG+ AK        
Sbjct: 120 ----------EALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 166
Query: 694 EIARGSPGYIPPEFAQPDSDFPTP---KSDVYCYGVVLLELITGKKP 737
           +   G+P ++ PE    ++   TP   K+D++  G+ L+E+   + P
Sbjct: 167 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 100/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +C   D+++     Y +NG L                             I+
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 129
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 130 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 182
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 183 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 240
Query: 739 -GDDY 742
            G++Y
Sbjct: 241 AGNEY 245

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 95/237 (40%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 105
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 106 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G +    +    E+  G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 153 GWSVHAPSSRRTELC-GTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/319 (21%), Positives = 139/319 (43%), Gaps = 61/319 (19%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHGSTLTD-------QEAARELEY 557
           A +  +    + +G FG V++G L     V A+K L+ G +  +       QE  RE+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXX 617
           +  + HPN+V L  Y +  +    + +++  G+L + L D    ++              
Sbjct: 77  MSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIK-------------- 120
Query: 618 XNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL---DMN- 673
                          W  + ++ L  A  + ++ +  +PPI+HRD+++ +++L   D N 
Sbjct: 121 ---------------WSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENA 164
Query: 674 -LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
            +  +++DFG ++   + +   +  G+  ++ PE    + +  T K+D Y + ++L  ++
Sbjct: 165 PVCAKVADFGTSQQSVHSVSGLL--GNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 733 TGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTA 792
           TG+ P  D+Y   K    ++ +R            +  +R T PE        +  LC +
Sbjct: 223 TGEGPF-DEYSYGK-IKFINMIR------------EEGLRPTIPEDCPPRLRNVIELCWS 268
Query: 793 DLPLKRPSMQQIVGLLKDI 811
             P KRP    IV  L ++
Sbjct: 269 GDPKKRPHFSYIVKELSEL 287

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 94/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 106
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 107 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 153
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +       +   G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 154 GWS-VHAPSSRRDTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 50/242 (20%)
Query: 506 ATSNFDRGTLLAEGKFGPVY------RGFLPGGIHVAVKVLVHG---STLTDQEAARELE 556
           A  +F+ G  L +GKFG VY      R F+     +A+KVL          + +  RE+E
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFI-----LALKVLFKAQLEKAGVEHQLRREVE 57
Query: 557 YLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXX 616
               ++HPN++ L GY     +   I +Y   G +   L  L                  
Sbjct: 58  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL------------------ 99
Query: 617 XXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP 676
             +      +   +T            A AL++ H   S  +IHRDIK  ++ L    E 
Sbjct: 100 --SKFDEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGEL 144
Query: 677 RLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           +++DFG + +           G+  Y+PPE    +      K D++  GV+  E + GK 
Sbjct: 145 KIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKP 201
Query: 737 PL 738
           P 
Sbjct: 202 PF 203

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 48/85 (56%), Gaps = 1/85 (1%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTP 717
           ++HRD+K  +V LD ++  +++DFGL+ +  +G     + GSP Y  PE       +  P
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS-GRLYAGP 190
Query: 718 KSDVYCYGVVLLELITGKKPLGDDY 742
           + D++  GV+L  L+ G  P  D++
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEH 215

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 56/113 (49%), Gaps = 6/113 (5%)
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPP-IIHRDIKASSVYLDMNLEPRLSDFGLAK-- 685
           L+   R + K A    R +      C    I+HRD+KA ++ LD +   +++DFG +   
Sbjct: 104 LVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEF 163
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            FGN LD     G+P Y  PE  Q    +  P+ DV+  GV+L  L++G  P 
Sbjct: 164 TFGNKLDAFC--GAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/319 (21%), Positives = 139/319 (43%), Gaps = 61/319 (19%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHGSTLTD-------QEAARELEY 557
           A +  +    + +G FG V++G L     V A+K L+ G +  +       QE  RE+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXX 617
           +  + HPN+V L  Y +  +    + +++  G+L + L D    ++              
Sbjct: 77  MSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIK-------------- 120
Query: 618 XNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL---DMN- 673
                          W  + ++ L  A  + ++ +  +PPI+HRD+++ +++L   D N 
Sbjct: 121 ---------------WSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENA 164
Query: 674 -LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
            +  +++DF L++   + +   +  G+  ++ PE    + +  T K+D Y + ++L  ++
Sbjct: 165 PVCAKVADFSLSQQSVHSVSGLL--GNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 733 TGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTA 792
           TG+ P  D+Y   K    ++ +R            +  +R T PE        +  LC +
Sbjct: 223 TGEGPF-DEYSYGK-IKFINMIR------------EEGLRPTIPEDCPPRLRNVIELCWS 268
Query: 793 DLPLKRPSMQQIVGLLKDI 811
             P KRP    IV  L ++
Sbjct: 269 GDPKKRPHFSYIVKELSEL 287

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 45/240 (18%)
Query: 504 LSATSNFDRGTLLAEGKFGP--VYRGFLPGGIHVAVKV-LVHGSTLTDQEAARELEYLGR 560
             +   + R   + EG FG   + +    G  +V  ++ +   S+   +E+ RE+  L  
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 561 IKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNS 620
           +KHPN+V              + DY E G+L   + +   GV                  
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGV------------------ 120
Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
              +  E  +  W  +  +AL          H     I+HRDIK+ +++L  +   +L D
Sbjct: 121 ---LFQEDQILDWFVQICLAL---------KHVHDRKILHRDIKSQNIFLTKDGTVQLGD 168
Query: 681 FGLAKIFGNGLDEEIAR---GSPGYIPPEFAQ--PDSDFPTPKSDVYCYGVVLLELITGK 735
           FG+A++  + +  E+AR   G+P Y+ PE  +  P ++    KSD++  G VL EL T K
Sbjct: 169 FGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNN----KSDIWALGCVLYELCTLK 222

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 55/117 (47%), Gaps = 13/117 (11%)
Query: 630 LTTWRFRHKIALGTARALAFLHH-------GCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
           + +W     IA   AR LA+LH        G  P I HRDIK+ +V L  NL   ++DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 683 LAKIFGNGLDEEIARGSPG---YIPPEFAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           LA  F  G       G  G   Y+ PE  +   +F      + D+Y  G+VL EL +
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 131
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 132 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 178
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G +    +   +++  G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 179 GWSVHAPSSRRDDLC-GTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 122
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 123 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 169
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 170 GWS-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 223

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 107
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 108 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 154
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 155 GWS-VHAPSSRRXXLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 108
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 109 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 155
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 156 GWS-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 110
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 111 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 157
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G +    +    ++  G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 158 GWSVHAPSSRRTDLC-GTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 110
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 111 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 157
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 158 GWS-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 106
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 107 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 153
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G +    +    ++  G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 154 GWSVHAPSSRRTDLC-GTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 108
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 109 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 155
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G +    +   +++  G+  Y+PPE  +        K D++  GV+  E + GK P 
Sbjct: 156 GWSVHAPSSRRDDLC-GTLDYLPPEMIE--GRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 93/235 (39%), Gaps = 40/235 (17%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG---STLTDQEAARELEYLGRIKH 563
            +FD G  L +GKFG VY          +A+KVL          + +  RE+E    ++H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           PN++ L GY     +   I +Y   G +   L  L                    +    
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SRFDE 111
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
             +   +T            A AL++ H   S  +IHRDIK  ++ L  N E +++DFG 
Sbjct: 112 QRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGW 158
Query: 684 AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           + +       +   G+  Y+PPE    +      K D++  GV+  E + G  P 
Sbjct: 159 S-VHAPSSRRDTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 105
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 106 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G +    +    ++  G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 153 GWSVHAPSSRRTDLC-GTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 105
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 106 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G +    +    ++  G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 153 GWSVHAPSSRRTDLC-GTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 48/85 (56%), Gaps = 1/85 (1%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTP 717
           ++HRD+K  +V LD ++  +++DFGL+ +  +G     + GSP Y  PE       +  P
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVIS-GRLYAGP 190
Query: 718 KSDVYCYGVVLLELITGKKPLGDDY 742
           + D++  GV+L  L+ G  P  D++
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEH 215

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 105
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 106 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 153 GWS-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 108
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 109 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 155
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 156 GWS-VHAPSSRRAALCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 108
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 109 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 155
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 156 GWS-VHAPSSRRXXLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 60/112 (53%), Gaps = 15/112 (13%)
Query: 634 RFRHKIALGTARALAFLH--HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL 691
           R   K+ +   +AL +L   HG    +IHRD+K S++ LD   + +L DFG++    +  
Sbjct: 124 RILGKMTVAIVKALYYLKEKHG----VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179
Query: 692 DEEIARGSPGYI------PPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
            ++ + G   Y+      PP+  +PD D    ++DV+  G+ L+EL TG+ P
Sbjct: 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDI---RADVWSLGISLVELATGQFP 228

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKL--------------------SKF 105
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 106 DEQRTATYITE----------LANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADF 152
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 153 GWS-VHAPSSRRAALCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 108
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 109 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 155
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 156 GWS-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 92/237 (38%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 106
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 107 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 153
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G +             G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 154 GWS-CHAPSSRRTTLSGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 131
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 132 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 178
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 179 GWS-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 104
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 105 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 151
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 152 GWS-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 109
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 110 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 156
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 157 GWS-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 105
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 106 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 153 GWS-VHAPSSRRXXLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 47/241 (19%)
Query: 510 FDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVL-VHGSTLTDQEAARELEYLGRIKHPNLV 567
           F +   + +G FG VY+G       V A+K++ +  +    ++  +E+  L +   P + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
              G  +   +   I +Y+  G+  +LL   PL                          E
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPL-------------------------EE 115
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
             + T      I     + L +LH   S   IHRDIKA++V L    + +L+DFG+A   
Sbjct: 116 TYIAT------ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVA--- 163
Query: 688 GNGLDEEIAR----GSPGYIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY 742
           G   D +I R    G+P ++ PE   Q   DF   K+D++  G+  +EL  G+ P  D +
Sbjct: 164 GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDF---KADIWSLGITAIELAKGEPPNSDLH 220
Query: 743 P 743
           P
Sbjct: 221 P 221

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 105
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 106 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 153 GWS-VHAPSSRRAALCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 40/235 (17%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG---STLTDQEAARELEYLGRIKH 563
            +FD G  L +GKFG VY          +A+KVL          + +  RE+E    ++H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           PN++ L GY     +   I +Y   G +   L  L                    +    
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SRFDE 111
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
             +   +T            A AL++ H   S  +IHRDIK  ++ L  N E +++DFG 
Sbjct: 112 QRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGW 158
Query: 684 AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           + +           G+  Y+PPE    +      K D++  GV+  E + G  P 
Sbjct: 159 S-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 105
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 106 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 153 GWS-VHAPSSRRTXLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 46/235 (19%)
Query: 508 SNFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKH 563
             +++   + EG +G V+  R    G I VA+K  +      +  + A RE+  L ++KH
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQI-VAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           PNLV L        +   +++Y ++     +LH+L                    +  Q 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH----TVLHEL--------------------DRYQR 97
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
              E L+ +      I   T +A+ F H H C    IHRD+K  ++ +  +   +L DFG
Sbjct: 98  GVPEHLVKS------ITWQTLQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFG 147
Query: 683 LAKIF---GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
            A++     +  D+E+A  +  Y  PE    D+ +  P  DV+  G V  EL++G
Sbjct: 148 FARLLTGPSDYYDDEVA--TRWYRSPELLVGDTQY-GPPVDVWAIGCVFAELLSG 199

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 102/230 (44%), Gaps = 42/230 (18%)
Query: 516 LAEGKFGPVYRGFL---PGGIHVAVKVLVHGSTLTD-QEAARELEYLGRIKHPNLVPLTG 571
           L  G FG V +G        I VA+KVL  G+   D +E  RE + + ++ +P +V L G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 572 YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLT 631
            C A  + + +   M  G     LH   +G +                 + NV       
Sbjct: 78  VCQA--EALMLVMEMAGGGP---LHKFLVGKREEI-------------PVSNVAE----- 114
Query: 632 TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL 691
                H++++G    + +L        +HRD+ A +V L      ++SDFGL+K  G   
Sbjct: 115 ---LLHQVSMG----MKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
Query: 692 DEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLELIT-GKKP 737
               AR S G  P ++  P+  +F   + +SDV+ YGV + E ++ G+KP
Sbjct: 165 SYYTAR-SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 12/103 (11%)
Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----GSP 700
           + L +LH   S   IHRDIKA++V L    + +L+DFG+A   G   D +I R    G+P
Sbjct: 131 KGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTP 184
Query: 701 GYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
            ++ PE  Q  +     K+D++  G+  +EL  G+ P  D +P
Sbjct: 185 FWMAPEVIQQSA--YDSKADIWSLGITAIELAKGEPPNSDMHP 225

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 55/109 (50%), Gaps = 8/109 (7%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           KI L T +AL  L       IIHRDIK S++ LD +   +L DFG++    + + +    
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA 186
Query: 698 GSPGYIPPEFAQPDSDFP--TPKSDVYCYGVVLLELITGKKPLGDDYPE 744
           G   Y+ PE   P +       +SDV+  G+ L EL TG+ P    YP+
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP----YPK 231

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 110
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 111 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 157
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE  +        K D++  GV+  E + GK P 
Sbjct: 158 GWS-VHAPSSRRTTLCGTLDYLPPEXIEGRXH--DEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 92/236 (38%), Gaps = 42/236 (17%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHGSTL---TDQEAARELEYLGRIKH 563
            +FD G  L +GKFG VY         + A+KVL          + +  RE+E    ++H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           PN++ +  Y     +   + ++   G L                             +Q 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGEL--------------------------YKELQK 108
Query: 624 VGSEGLLTTWRFRHKIALGTARALA-FLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            G        RF  + +      LA  LH+     +IHRDIK  ++ +    E +++DFG
Sbjct: 109 HG--------RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 160
Query: 683 LAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            + +    L      G+  Y+PPE  +  +     K D++C GV+  E + G  P 
Sbjct: 161 WS-VHAPSLRRRXMCGTLDYLPPEMIEGKTH--DEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 121
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 122 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 174
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 175 TAKVLSPESKQARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 232
Query: 739 -GDDY 742
            G++Y
Sbjct: 233 AGNEY 237

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 107
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E ++++F
Sbjct: 108 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANF 154
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 155 GWS-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 121
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 122 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 174
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 175 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 232
Query: 739 -GDDY 742
            G++Y
Sbjct: 233 AGNEY 237

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 98
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 99  MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 131
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 132 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 189
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 190 WYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 96
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 97  MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 129
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 130 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 187
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 188 WYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 122
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 123 MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 213
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 91
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 92  MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 182
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 97
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 98  MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 130
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 131 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 188
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 189 WYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 91
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 92  MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 182
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 109
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 110 MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 142
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 143 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 200
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 101/245 (41%), Gaps = 65/245 (26%)
Query: 517 AEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKHPNLVPLTGYC 573
           A G+FG V++  L     VAVK+      L D+++    RE+     +KH NL+      
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIF----PLQDKQSWQSEREIFSTPGMKHENLLQF---- 74
Query: 574 IAGDQRIA--------IYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           IA ++R +        I  + + G+L + L                              
Sbjct: 75  IAAEKRGSNLEVELWLITAFHDKGSLTDYL------------------------------ 104
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHH--------GCSPPIIHRDIKASSVYLDMNLEPR 677
            +G + TW     +A   +R L++LH         G  P I HRD K+ +V L  +L   
Sbjct: 105 -KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAV 163
Query: 678 LSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTP---KSDVYCYGVVLLEL 731
           L+DFGLA  F  G    D     G+  Y+ PE  +   +F      + D+Y  G+VL EL
Sbjct: 164 LADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 223
Query: 732 ITGKK 736
           ++  K
Sbjct: 224 VSRCK 228

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 69/141 (48%), Gaps = 19/141 (13%)
Query: 639 IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGLDEEIAR 697
           +     +ALA+LH   +  +IHRDIK+ S+ L ++   +LSDFG  A+I  +    +   
Sbjct: 146 VCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV 202
Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGL 757
           G+P ++ PE           + D++  G++++E++ G+ P   D P +    L       
Sbjct: 203 GTPYWMAPEVI--SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL------- 253
Query: 758 VRNN-----KGSRAIDPKIRD 773
            R++     K S  + P +RD
Sbjct: 254 -RDSPPPKLKNSHKVSPVLRD 273

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 94
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 95  MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 127
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 185
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 47/85 (55%), Gaps = 5/85 (5%)
Query: 659 IHRDIKASSVYLDMNLEPRLSDFG-LAKIFGNG-LDEEIARGSPGYIPPEFAQPDSD--- 713
           +HRDIK  +V LD+N   RL+DFG   K+  +G +   +A G+P YI PE  Q   D   
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 714 FPTPKSDVYCYGVVLLELITGKKPL 738
              P+ D +  GV + E++ G+ P 
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 109
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 110 MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 142
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 143 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 200
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 89
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 90  MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 122
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 123 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 180
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 90
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 91  MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 123
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 124 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 181
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 182 WYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 91
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 92  MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEFFKVKEPGESPIF 182
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 47/85 (55%), Gaps = 5/85 (5%)
Query: 659 IHRDIKASSVYLDMNLEPRLSDFG-LAKIFGNG-LDEEIARGSPGYIPPEFAQPDSD--- 713
           +HRDIK  +V LD+N   RL+DFG   K+  +G +   +A G+P YI PE  Q   D   
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 714 FPTPKSDVYCYGVVLLELITGKKPL 738
              P+ D +  GV + E++ G+ P 
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 94
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 95  MEFLPYGS---------------------------LREYLQKHKERIDHIKLLQYTSQIC 127
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 185
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 74  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 106
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 107 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 159
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 160 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 217
Query: 739 -GDDY 742
            G++Y
Sbjct: 218 AGNEY 222

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 95
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 96  MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 128
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 129 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIF 186
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 187 WYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 93/237 (39%), Gaps = 40/237 (16%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHG---STLTDQEAARELEYLGRI 561
           A  +F+ G  L +GKFG VY         + A+KVL          + +  RE+E    +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           +HPN++ L GY     +   I +Y   G +   L  L                    +  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--------------------SKF 108
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               +   +T            A AL++ H   S  +IHRDIK  ++ L    E ++++F
Sbjct: 109 DEQRTATYITE----------LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANF 155
Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G + +           G+  Y+PPE    +      K D++  GV+  E + GK P 
Sbjct: 156 GWS-VHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 72/324 (22%), Positives = 126/324 (38%), Gaps = 64/324 (19%)
Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKH 563
           + N+D    L +G F  V R      G+  A K++     S    Q+  RE     +++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           PN+V L             +D ++  +   L+ DL  G +                  ++
Sbjct: 88  PNIVRL-------------HDSIQEESFHYLVFDLVTGGEL----------------FED 118
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE---PRLSD 680
           + +    +     H I      ++A+ H   S  I+HR++K  ++ L    +    +L+D
Sbjct: 119 IVAREFYSEADASHCIQ-QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
           FGLA    +        G+PGY+ PE  + D  +  P  D++  GV+L  L+ G  P  D
Sbjct: 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKP-VDIWACGVILYILLVGYPPFWD 232
Query: 741 ---------------DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK 785
                          DYP  +   +    + L+        ++PK R T      ++ALK
Sbjct: 233 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI---DSMLTVNPKKRITA-----DQALK 284
Query: 786 IGYLCTADLPLKRPSMQQIVGLLK 809
           + ++C  +        Q  V  LK
Sbjct: 285 VPWICNRERVASAIHRQDTVDCLK 308

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 113/281 (40%), Gaps = 50/281 (17%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTW-RFRHKI--ALGTARALA 648
              L                       N       E L   +    H I  +   A+ + 
Sbjct: 122 STYLR-------------------SKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGME 162
Query: 649 FLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFA 708
           FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P ++ 
Sbjct: 163 FL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXK--DPDXVRKGDARLPLKWM 217
Query: 709 QPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGS 764
            P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +  
Sbjct: 218 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEEFC 261
Query: 765 RAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
           R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 124
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 125 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 177
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 178 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 235
Query: 739 -GDDY 742
            G++Y
Sbjct: 236 AGNEY 240

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 112/302 (37%), Gaps = 57/302 (18%)
Query: 514 TLLAEGKFGPVYRGFLPGGIHVAVKVLV--HGSTLTDQEAARELEYLGRIKHPNLVPLTG 571
           T L E   G +++G   G   + VKVL     ST   ++   E   L    HPN++P+ G
Sbjct: 16  TKLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 572 YCIA--GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            C +        I  +   G+L N+LH+                     +  Q V     
Sbjct: 75  ACQSPPAPHPTLITHWXPYGSLYNVLHE---------------GTNFVVDQSQAV----- 114
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
                   K AL  AR  AFLH    P I    + + SV +D +   R+S   +   F  
Sbjct: 115 --------KFALDXARGXAFLH-TLEPLIPRHALNSRSVXIDEDXTARISXADVKFSF-- 163
Query: 690 GLDEEIARG-SPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKPLGDDYPEEKE 747
              +   R  +P ++ PE  Q   +    +S D + + V+L EL+T + P  D       
Sbjct: 164 ---QSPGRXYAPAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFAD------- 213
Query: 748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                    L     G +     +R T P        K+  +C  + P KRP    IV +
Sbjct: 214 ---------LSNXEIGXKVALEGLRPTIPPGISPHVSKLXKICXNEDPAKRPKFDXIVPI 264
Query: 808 LK 809
           L+
Sbjct: 265 LE 266

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 67  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 99
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 100 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 152
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 153 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 210
Query: 739 -GDDY 742
            G++Y
Sbjct: 211 AGNEY 215

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 68  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 100
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 101 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 153
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 154 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 211
Query: 739 -GDDY 742
            G++Y
Sbjct: 212 AGNEY 216

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 61/111 (54%), Gaps = 16/111 (14%)
Query: 639 IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR- 697
           + L   +AL+ LH   +  +IHRDIK+ S+ L  +   +LSDFG    F   + +E+ R 
Sbjct: 125 VCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRR 177
Query: 698 ----GSPGYIPPEFAQPDSDFPT-PKSDVYCYGVVLLELITGKKPLGDDYP 743
               G+P ++ PE     S  P  P+ D++  G++++E++ G+ P  ++ P
Sbjct: 178 KXLVGTPYWMAPELI---SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 225

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 61/111 (54%), Gaps = 16/111 (14%)
Query: 639 IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR- 697
           + L   +AL+ LH   +  +IHRDIK+ S+ L  +   +LSDFG    F   + +E+ R 
Sbjct: 121 VCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRR 173
Query: 698 ----GSPGYIPPEFAQPDSDFPT-PKSDVYCYGVVLLELITGKKPLGDDYP 743
               G+P ++ PE     S  P  P+ D++  G++++E++ G+ P  ++ P
Sbjct: 174 KXLVGTPYWMAPELI---SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 122
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 123 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 175
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 176 TAKVLSPESKQARANAFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 233
Query: 739 -GDDY 742
            G++Y
Sbjct: 234 AGNEY 238

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 122
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 123 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 175
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 176 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 233
Query: 739 -GDDY 742
            G++Y
Sbjct: 234 AGNEY 238

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 122
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 123 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 175
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 176 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 233
Query: 739 -GDDY 742
            G++Y
Sbjct: 234 AGNEY 238

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 124
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 125 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 177
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 178 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 235
Query: 739 -GDDY 742
            G++Y
Sbjct: 236 AGNEY 240

>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 84/358 (23%), Positives = 150/358 (41%), Gaps = 39/358 (10%)
Query: 46  DTTIGKLSKLQSLDLSENN--ITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLE 103
           +T+  +L  LQ L + +    +    +    L SL  L L YN+              LE
Sbjct: 47  ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLE 106
Query: 104 VFDLSNNNFSGEIPAA--ISSLVSLRVLKL-DGNMFQWSIPPGLLNCQSLVTVDLSMNQL 160
           V  L+  N  G + +      L SL +L L D N+ +       LN +    +DL+ N++
Sbjct: 107 VLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166
Query: 161 NGSLPDGF----GAAFPKLKSLNLAGNEIKGRDTHFAGLK---------SITNLNISGNL 207
                +      G  F  L+   L+   ++  + ++ G +         SIT L++SGN 
Sbjct: 167 KSICEEDLLNFQGKHFTLLR---LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 208 FQGSVMGVFLESLEVIDLR----SNQFQ--GHISQVQFNSSYNW-------SRLVYVDLS 254
           F+ S+   F +++    ++    SN +          F    N+       S +   DLS
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS 283
Query: 255 ENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEI 314
           ++++   +   FS   +L+ L+LA N   + +      L  L  LNLS+ + +G I S +
Sbjct: 284 KSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQ-NFLGSIDSRM 342
Query: 315 LQ-LSSLHTLDLSMNHLT--GQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMER 369
            + L  L  LDLS NH+   G    +   NL  + +  N L   +P  + ++L  +++
Sbjct: 343 FENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQK 399

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 61/111 (54%), Gaps = 16/111 (14%)
Query: 639 IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR- 697
           + L   +AL+ LH   +  +IHRDIK+ S+ L  +   +LSDFG    F   + +E+ R 
Sbjct: 132 VCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRR 184
Query: 698 ----GSPGYIPPEFAQPDSDFPT-PKSDVYCYGVVLLELITGKKPLGDDYP 743
               G+P ++ PE     S  P  P+ D++  G++++E++ G+ P  ++ P
Sbjct: 185 KXLVGTPYWMAPELI---SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 232

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 90/234 (38%), Gaps = 40/234 (17%)
Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTL---TDQEAARELEYLGRIKHP 564
           +F+ G  L +GKFG VY          VA+KVL          + +  RE+E    + HP
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNV 624
           N++ L  Y     +   I +Y   G L   L                             
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQK------------------------SCT 119
Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
             E    T      I    A AL + H      +IHRDIK  ++ L +  E +++DFG +
Sbjct: 120 FDEQRTAT------IMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWS 170
Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            +    L  +   G+  Y+PPE    +      K D++C GV+  EL+ G  P 
Sbjct: 171 -VHAPSLRRKTMCGTLDYLPPEMI--EGRMHNEKVDLWCIGVLCYELLVGNPPF 221

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 125
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 126 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 178
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 179 TAKVLSPESKQARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 236
Query: 739 -GDDY 742
            G++Y
Sbjct: 237 AGNEY 241

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 51/83 (61%), Gaps = 5/83 (6%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDEEIARGSPGYIPPE-FAQPDSDFP 715
           +IHRD+K  +++L+ +LE ++ DFGLA K+  +G  +++  G+P YI PE  ++    F 
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF- 194
Query: 716 TPKSDVYCYGVVLLELITGKKPL 738
             + DV+  G ++  L+ GK P 
Sbjct: 195 --EVDVWSIGCIMYTLLVGKPPF 215

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 61/111 (54%), Gaps = 16/111 (14%)
Query: 639 IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR- 697
           + L   +AL+ LH   +  +IHRDIK+ S+ L  +   +LSDFG    F   + +E+ R 
Sbjct: 130 VCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRR 182
Query: 698 ----GSPGYIPPEFAQPDSDFPT-PKSDVYCYGVVLLELITGKKPLGDDYP 743
               G+P ++ PE     S  P  P+ D++  G++++E++ G+ P  ++ P
Sbjct: 183 KXLVGTPYWMAPELI---SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 230

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 57/102 (55%), Gaps = 4/102 (3%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           KIA+   +AL  LH   S  +IHRD+K S+V ++   + ++ DFG++    + + ++I  
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 698 GSPGYIPPEFAQPDSDFP--TPKSDVYCYGVVLLELITGKKP 737
           G   Y+ PE   P+ +    + KSD++  G+ ++EL   + P
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 69  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 101
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 102 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 154
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 155 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 212
Query: 739 -GDDY 742
            G++Y
Sbjct: 213 AGNEY 217

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 63/240 (26%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI--KHPNLVPLTGYC 573
           + +G+FG V+RG   G   VAVK+    S+  ++   RE E    +  +H N++      
Sbjct: 17  IGKGRFGEVWRGKWRGE-EVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF---- 68
Query: 574 IAGD--------QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           IA D        Q   + DY E+G+L + L+   + V                       
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV----------------------- 105
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGC-----SPPIIHRDIKASSVYLDMNLEPRLSD 680
            EG++       K+AL TA  LA LH         P I HRD+K+ ++ +  N    ++D
Sbjct: 106 -EGMI-------KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 157
Query: 681 FGLAKIFGNGLDE-EIA----RGSPGYIPPEFAQPDSDFPT----PKSDVYCYGVVLLEL 731
            GLA    +  D  +IA     G+  Y+ PE      +        ++D+Y  G+V  E+
Sbjct: 158 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 63/240 (26%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI--KHPNLVPLTGYC 573
           + +G+FG V+RG   G   VAVK+    S+  ++   RE E    +  +H N++      
Sbjct: 11  IGKGRFGEVWRGKWRGE-EVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF---- 62
Query: 574 IAGD--------QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           IA D        Q   + DY E+G+L + L+   + V                       
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV----------------------- 99
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGC-----SPPIIHRDIKASSVYLDMNLEPRLSD 680
            EG++       K+AL TA  LA LH         P I HRD+K+ ++ +  N    ++D
Sbjct: 100 -EGMI-------KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151
Query: 681 FGLAKIFGNGLDE-EIA----RGSPGYIPPEFAQPDSDFPT----PKSDVYCYGVVLLEL 731
            GLA    +  D  +IA     G+  Y+ PE      +        ++D+Y  G+V  E+
Sbjct: 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 659 IHRDIKASSVYLDMNLEPRLSDFG-LAKIFGNG-LDEEIARGSPGYIPPEFAQP---DSD 713
           +HRDIK  ++ +DMN   RL+DFG   K+  +G +   +A G+P YI PE  Q       
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 714 FPTPKSDVYCYGVVLLELITGKKPL 738
              P+ D +  GV + E++ G+ P 
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 95  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 127
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 128 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 180
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 181 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 238
Query: 739 -GDDY 742
            G++Y
Sbjct: 239 AGNEY 243

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 100/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGCL--------------------------LKYIR 124
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 125 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 177
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S   +  SD++  G ++ +L+ G  P  
Sbjct: 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKS--ASKSSDLWALGCIIYQLVAGLPPFR 235
Query: 739 -GDDY 742
            G++Y
Sbjct: 236 AGNEY 240

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 63/240 (26%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI--KHPNLVPLTGYC 573
           + +G+FG V+RG   G   VAVK+    S+  ++   RE E    +  +H N++      
Sbjct: 12  IGKGRFGEVWRGKWRGE-EVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF---- 63
Query: 574 IAGD--------QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           IA D        Q   + DY E+G+L + L+   + V                       
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV----------------------- 100
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGC-----SPPIIHRDIKASSVYLDMNLEPRLSD 680
            EG++       K+AL TA  LA LH         P I HRD+K+ ++ +  N    ++D
Sbjct: 101 -EGMI-------KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 152
Query: 681 FGLAKIFGNGLDE-EIA----RGSPGYIPPEFAQPDSDFPT----PKSDVYCYGVVLLEL 731
            GLA    +  D  +IA     G+  Y+ PE      +        ++D+Y  G+V  E+
Sbjct: 153 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL FLH      II+RD+K  +V LD     +L+DFG+ K    NG+      G+P YI 
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIA 192
Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE  Q       P  D +  GV+L E++ G  P 
Sbjct: 193 PEILQ--EMLYGPAVDWWAMGVLLYEMLCGHAPF 224

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 124
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 125 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 177
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 178 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 235
Query: 739 -GDDY 742
            G++Y
Sbjct: 236 AGNEY 240

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 51/83 (61%), Gaps = 5/83 (6%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDEEIARGSPGYIPPE-FAQPDSDFP 715
           +IHRD+K  +++L+ +LE ++ DFGLA K+  +G  +++  G+P YI PE  ++    F 
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF- 218
Query: 716 TPKSDVYCYGVVLLELITGKKPL 738
             + DV+  G ++  L+ GK P 
Sbjct: 219 --EVDVWSIGCIMYTLLVGKPPF 239

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 63/240 (26%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI--KHPNLVPLTGYC 573
           + +G+FG V+RG   G   VAVK+    S+  ++   RE E    +  +H N++      
Sbjct: 37  IGKGRFGEVWRGKWRGE-EVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF---- 88
Query: 574 IAGD--------QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           IA D        Q   + DY E+G+L + L+   + V                       
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV----------------------- 125
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGC-----SPPIIHRDIKASSVYLDMNLEPRLSD 680
            EG++       K+AL TA  LA LH         P I HRD+K+ ++ +  N    ++D
Sbjct: 126 -EGMI-------KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 177
Query: 681 FGLAKIFGNGLDE-EIA----RGSPGYIPPEFAQPDSDFPT----PKSDVYCYGVVLLEL 731
            GLA    +  D  +IA     G+  Y+ PE      +        ++D+Y  G+V  E+
Sbjct: 178 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 125
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 126 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 178
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 179 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 236
Query: 739 -GDDY 742
            G++Y
Sbjct: 237 AGNEY 241

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 70  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 102
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 103 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 155
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 156 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 213
Query: 739 -GDDY 742
            G++Y
Sbjct: 214 AGNEY 218

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSI--QNVGSEGLLTTW-RFRHKI--ALGTARA 646
              L                       N      V  E L   +    H I  +   A+ 
Sbjct: 111 STYLRS-------------------KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 151
Query: 647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE 706
           + FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P +
Sbjct: 152 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK--DPDXVRKGDARLPLK 206
Query: 707 FAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNK 762
           +  P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +
Sbjct: 207 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEE 250
Query: 763 GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
             R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 251 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 293

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 51/83 (61%), Gaps = 5/83 (6%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDEEIARGSPGYIPPE-FAQPDSDFP 715
           +IHRD+K  +++L+ +LE ++ DFGLA K+  +G  +++  G+P YI PE  ++    F 
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF- 220
Query: 716 TPKSDVYCYGVVLLELITGKKPL 738
             + DV+  G ++  L+ GK P 
Sbjct: 221 --EVDVWSIGCIMYTLLVGKPPF 241

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 63/240 (26%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI--KHPNLVPLTGYC 573
           + +G+FG V+RG   G   VAVK+    S+  ++   RE E    +  +H N++      
Sbjct: 14  IGKGRFGEVWRGKWRGE-EVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF---- 65
Query: 574 IAGD--------QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           IA D        Q   + DY E+G+L + L+   + V                       
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV----------------------- 102
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGC-----SPPIIHRDIKASSVYLDMNLEPRLSD 680
            EG++       K+AL TA  LA LH         P I HRD+K+ ++ +  N    ++D
Sbjct: 103 -EGMI-------KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 154
Query: 681 FGLAKIFGNGLDE-EIA----RGSPGYIPPEFAQPDSDFPT----PKSDVYCYGVVLLEL 731
            GLA    +  D  +IA     G+  Y+ PE      +        ++D+Y  G+V  E+
Sbjct: 155 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 94/359 (26%), Positives = 157/359 (43%), Gaps = 46/359 (12%)
Query: 48  TIGKLSKLQSLDLSENNITALPSDLWSLG--SLKSLNLSYNRISGSLPSNIGNFGL--LE 103
           TIGKL  L  L+ ++ N        W L   S+++L+L+ N++  +  S         L 
Sbjct: 193 TIGKLFALL-LNNAQLNPHLTEKLCWELSNTSIQNLSLANNQLLATSESTFSGLKWTNLT 251
Query: 104 VFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGS 163
             DLS NN       + S L SLR L L+ N  Q   P       +L  + L       S
Sbjct: 252 QLDLSYNNLHDVGNGSFSYLPSLRYLSLEYNNIQRLSPRSFYGLSNLRYLSLKRAFTKQS 311
Query: 164 LP-------DGFGAAFPK-LKSLNLAGNEIKGRDTH-FAGLKSITNLNISGNL--FQGSV 212
           +        D F   + K L+ LN+  N I    ++ F GL S+  L++S      Q   
Sbjct: 312 VSLASHPNIDDFSFQWLKYLEYLNMDDNNIPSTKSNTFTGLVSLKYLSLSKTFTSLQTLT 371
Query: 213 MGVFLESLEVIDLRSNQFQGHISQVQFNSSYNW-SRLVYVDLS----ENQLSGEIFHNFS 267
              F+       L  N  + HIS++  N +++W  +L  +DL     E +LSG+ +    
Sbjct: 372 NETFVSLAHSPLLTLNLTKNHISKIA-NGTFSWLGQLRILDLGLNEIEQKLSGQEWRGL- 429
Query: 268 QAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSM 327
             +N+  + L+YN++ +              L+ S  +L+  +   +L+  +L  +D+S 
Sbjct: 430 --RNIFEIYLSYNKYLQ--------------LSTSSFALVPSLQRLMLRRVALKNVDISP 473
Query: 328 NHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSP 386
           +      P    +NL I+D+S+NN++  I   LLE L  +E  +F +NNL       +P
Sbjct: 474 S------PFRPLRNLTILDLSNNNIAN-INEDLLEGLENLEILDFQHNNLARLWKRANP 525

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 46/245 (18%)
Query: 508 SNFDRGTLLAEGKFGP-VYRGFLPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F   V    L      A+K+L     + + +     RE + + R+ H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 122
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 123 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 175
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL- 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P  
Sbjct: 176 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFR 233
Query: 739 -GDDY 742
            G++Y
Sbjct: 234 AGNEY 238

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 29/163 (17%)
Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAF-LHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
           IQ VG        RF+   A+  A  +A  L    S  II+RD+K  +V LD     +++
Sbjct: 112 IQQVG--------RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIA 163
Query: 680 DFGLAKI-FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKP 737
           DFG+ K    +G+  +   G+P YI PE        P  KS D + +GV+L E++ G+ P
Sbjct: 164 DFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVLLYEMLAGQAP 220
Query: 738 L-GDD--------------YPEEKEGNLVSWVRGLVRNNKGSR 765
             G+D              YP+      V+  +GL+  + G R
Sbjct: 221 FEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSI--QNVGSEGLLTTW-RFRHKI--ALGTARA 646
              L                       N      V  E L   +    H I  +   A+ 
Sbjct: 111 STYLR-------------------SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 151
Query: 647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE 706
           + FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P +
Sbjct: 152 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK--DPDXVRKGDARLPLK 206
Query: 707 FAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNK 762
           +  P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +
Sbjct: 207 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEE 250
Query: 763 GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
             R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 251 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 293

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 12/103 (11%)
Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----GSP 700
           + L +LH   S   IHRDIKA++V L  + E +L+DFG+A   G   D +I R    G+P
Sbjct: 115 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNTFVGTP 168
Query: 701 GYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
            ++ PE  +  S + + K+D++  G+  +EL  G+ P  + +P
Sbjct: 169 FWMAPEVIK-QSAYDS-KADIWSLGITAIELARGEPPHSELHP 209

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 61/111 (54%), Gaps = 16/111 (14%)
Query: 639 IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR- 697
           + L   +AL+ LH   +  +IHRDIK+ S+ L  +   +LSDFG    F   + +E+ R 
Sbjct: 175 VCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRR 227
Query: 698 ----GSPGYIPPEFAQPDSDFPT-PKSDVYCYGVVLLELITGKKPLGDDYP 743
               G+P ++ PE     S  P  P+ D++  G++++E++ G+ P  ++ P
Sbjct: 228 KXLVGTPYWMAPELI---SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 275

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 69/314 (21%), Positives = 128/314 (40%), Gaps = 66/314 (21%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA--RELEYLGRIKHPNLVPLT 570
           G L+ +G+FG VY G   G   VA++++       DQ  A  RE+    + +H N+V   
Sbjct: 38  GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
           G C++      I    +   L +++ D  + +                N  + +  E   
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDV--------------NKTRQIAQE--- 138
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG-- 688
                         + + +LH   +  I+H+D+K+ +V+ D N +  ++DFGL  I G  
Sbjct: 139 ------------IVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182
Query: 689 -NGLDEEIARGSPGY---IPPEFAQ---PDSD---FPTPK-SDVYCYGVVLLELITGKKP 737
             G  E+  R   G+   + PE  +   PD++    P  K SDV+  G +  EL   + P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
                 + +    + W  G          + P +   G  K++ + L     C A    +
Sbjct: 243 F-----KTQPAEAIIWQMGT--------GMKPNLSQIGMGKEISDIL---LFCWAFEQEE 286
Query: 798 RPSMQQIVGLLKDI 811
           RP+  +++ +L+ +
Sbjct: 287 RPTFTKLMDMLEKL 300

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 53/117 (45%), Gaps = 15/117 (12%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG------- 690
           KI   T RA+  +H    PPIIHRD+K  ++ L      +L DFG A    +        
Sbjct: 140 KIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 691 -----LDEEIARG-SPGYIPPEFAQPDSDFPT-PKSDVYCYGVVLLELITGKKPLGD 740
                ++EEI R  +P Y  PE     S+FP   K D++  G +L  L   + P  D
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 50/217 (23%)
Query: 532 GIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN 588
           G + A+KVL     +  ++      E   L  + HP ++ + G      Q   I DY+E 
Sbjct: 31  GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90
Query: 589 GNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTAR--- 645
           G L +LL                                    + RF + +A   A    
Sbjct: 91  GELFSLLR----------------------------------KSQRFPNPVAKFYAAEVC 116
Query: 646 -ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIP 704
            AL +LH   S  II+RD+K  ++ LD N   +++DFG AK   +        G+P YI 
Sbjct: 117 LALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYXLCGTPDYIA 171
Query: 705 PEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKPLGD 740
           PE     S  P  KS D + +G+++ E++ G  P  D
Sbjct: 172 PEVV---STKPYNKSIDWWSFGILIYEMLAGYTPFYD 205

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 44  VPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNF---- 99
           +  TT    ++LQ LDL+  ++  LPS +  L  LK L LS N        +  NF    
Sbjct: 266 ISSTTFQCFTQLQELDLTATHLKGLPSGMKGLNLLKKLVLSVNHFDQLCQISAANFPSLT 325
Query: 100 ---------------------GLLEVFDLSNNNFSGEIPAA--ISSLVSLRVLKLDGNMF 136
                                G L+  DLS+N+       +  + +L  L+ L L  N  
Sbjct: 326 HLYIRGNVKKLHLGVGCLEKLGNLQTLDLSHNDIEASDCCSLQLKNLSHLQTLNLSHNEP 385
Query: 137 QWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH-FAGL 195
                     C  L  +DL+  +L+ + P         L+ LNL    +   + H  AGL
Sbjct: 386 LGLQSQAFKECPQLELLDLAFTRLHINAPQSPFQNLHFLQVLNLTYCFLDTSNQHLLAGL 445
Query: 196 KSITNLNISGNLFQ-GSVMGVFL----ESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVY 250
             + +LN+ GN FQ G++    L     SLEV+ L S      I Q  F+S     ++ +
Sbjct: 446 PVLRHLNLKGNHFQDGTITKTNLLQTVGSLEVLILSSCGLLS-IDQQAFHS---LGKMSH 501
Query: 251 VDLSENQLSGEIFHNFSQAQNLKHLSLAYN 280
           VDLS N L+ +   + S  + + +L+LA N
Sbjct: 502 VDLSHNSLTCDSIDSLSHLKGI-YLNLAAN 530

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 85/317 (26%), Positives = 136/317 (42%), Gaps = 14/317 (4%)
Query: 77  SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMF 136
           S++SLNL  +R S    +    F  L+  DL+  +  G +P+ +  L  L+ L L  N F
Sbjct: 252 SVESLNLQEHRFSDISSTTFQCFTQLQELDLTATHLKG-LPSGMKGLNLLKKLVLSVNHF 310
Query: 137 QWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLK 196
                    N  SL  + +  N     L  G       L++L+L+ N+I+  D     LK
Sbjct: 311 DQLCQISAANFPSLTHLYIRGNVKKLHLGVGCLEKLGNLQTLDLSHNDIEASDCCSLQLK 370
Query: 197 SITN---LNISGNLFQGSVMGVFLES--LEVIDLRSNQFQGHISQVQFNSSYNWSRLVYV 251
           ++++   LN+S N   G     F E   LE++DL   +   +  Q  F    N   L  +
Sbjct: 371 NLSHLQTLNLSHNEPLGLQSQAFKECPQLELLDLAFTRLHINAPQSPFQ---NLHFLQVL 427
Query: 252 DLSENQLSGEIFHNFSQAQNLKHLSLAYNRF---TRQEFPQIGTLLGLEHLNLSRTSLIG 308
           +L+   L     H  +    L+HL+L  N F   T  +   + T+  LE L LS   L+ 
Sbjct: 428 NLTYCFLDTSNQHLLAGLPVLRHLNLKGNHFQDGTITKTNLLQTVGSLEVLILSSCGLLS 487
Query: 309 DIPSEILQLSSLHTLDLSMNHLT-GQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQM 367
                   L  +  +DLS N LT   I ++S      ++++ N+++  I   LL  L Q 
Sbjct: 488 IDQQAFHSLGKMSHVDLSHNSLTCDSIDSLSHLKGIYLNLAANSINI-ISPRLLPILSQQ 546
Query: 368 ERFNFSYNNLTLCASEL 384
              N S+N L    S +
Sbjct: 547 STINLSHNPLDCTCSNI 563

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 12/103 (11%)
Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----GSP 700
           + L +LH   S   IHRDIKA++V L  + E +L+DFG+A   G   D +I R    G+P
Sbjct: 115 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNXFVGTP 168
Query: 701 GYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
            ++ PE  +  S + + K+D++  G+  +EL  G+ P  + +P
Sbjct: 169 FWMAPEVIK-QSAYDS-KADIWSLGITAIELARGEPPHSELHP 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 16/111 (14%)
Query: 639 IALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR- 697
           + L   +AL+ LH      +IHRDIK+ S+ L  +   +LSDFG    F   + +E+ R 
Sbjct: 252 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRR 304
Query: 698 ----GSPGYIPPEFAQPDSDFPT-PKSDVYCYGVVLLELITGKKPLGDDYP 743
               G+P ++ PE     S  P  P+ D++  G++++E++ G+ P  ++ P
Sbjct: 305 KXLVGTPYWMAPELI---SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/314 (21%), Positives = 126/314 (40%), Gaps = 54/314 (17%)
Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEAA----RELEYLGRIK 562
           +NF     +  G+F  VYR   L  G+ VA+K  V    L D +A     +E++ L ++ 
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKK-VQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           HPN++      I  ++   + +  + G+L  +                          I+
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRM--------------------------IK 124
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
           +   +  L   R   K  +    AL  +H   S  ++HRDIK ++V++      +L D G
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG 181
Query: 683 LAKIFGNGLDEEIA-RGSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPLGD 740
           L + F +      +  G+P Y+ PE    +  +F   KSD++  G +L E+   + P   
Sbjct: 182 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF---KSDIWSLGCLLYEMAALQSPFYG 238
Query: 741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
           D     + NL S  + + + +      D            EE  ++  +C    P KRP 
Sbjct: 239 D-----KMNLYSLCKKIEQCDYPPLPSD---------HYSEELRQLVNMCINPDPEKRPD 284
Query: 801 MQQIVGLLKDIEST 814
           +  +  + K + + 
Sbjct: 285 VTYVYDVAKRMHAC 298

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 114/278 (41%), Gaps = 43/278 (15%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 120
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH 651
              L                       +  ++  +   L  + F+       A+ + FL 
Sbjct: 121 STYLR---------SKRNEFVPYKTPEDLYKDFLTLEHLICYSFQ------VAKGMEFL- 164
Query: 652 HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPD 711
              S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P ++  P+
Sbjct: 165 --ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK--DPDXVRKGDARLPLKWMAPE 220
Query: 712 SDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAI 767
           + F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +  R +
Sbjct: 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEEFCRRL 264
Query: 768 DPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
               R   P+    E  +    C    P +RP+  ++V
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSI--QNVGSEGLLTTW-RFRHKI--ALGTARA 646
              L                       N      V  E L   +    H I  +   A+ 
Sbjct: 120 STYLR-------------------SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160
Query: 647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE 706
           + FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P +
Sbjct: 161 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK--DPDXVRKGDARLPLK 215
Query: 707 FAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNK 762
           +  P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEE 259
Query: 763 GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
             R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 63/240 (26%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI--KHPNLVPLTGYC 573
           + +G+FG V+RG   G   VAVK+    S+  ++   RE E    +  +H N++      
Sbjct: 50  IGKGRFGEVWRGKWRGE-EVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF---- 101
Query: 574 IAGD--------QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           IA D        Q   + DY E+G+L + L+   + V                       
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV----------------------- 138
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGC-----SPPIIHRDIKASSVYLDMNLEPRLSD 680
            EG++       K+AL TA  LA LH         P I HRD+K+ ++ +  N    ++D
Sbjct: 139 -EGMI-------KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190
Query: 681 FGLAKIFGNGLDE-EIA----RGSPGYIPPEFAQPDSDFPT----PKSDVYCYGVVLLEL 731
            GLA    +  D  +IA     G+  Y+ PE      +        ++D+Y  G+V  E+
Sbjct: 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           KIA+   +AL  LH   S  +IHRD+K S+V ++   + ++ DFG++    + + + I  
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA 214
Query: 698 GSPGYIPPEFAQPDSDFP--TPKSDVYCYGVVLLEL 731
           G   Y+ PE   P+ +    + KSD++  G+ ++EL
Sbjct: 215 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 75/162 (46%), Gaps = 27/162 (16%)
Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
           IQ VG         +  +IA+G    L FL    S  II+RD+K  +V LD     +++D
Sbjct: 433 IQQVGRFKEPHAVFYAAEIAIG----LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIAD 485
Query: 681 FGLAKI-FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKPL 738
           FG+ K    +G+  +   G+P YI PE        P  KS D + +GV+L E++ G+ P 
Sbjct: 486 FGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVLLYEMLAGQAPF 542
Query: 739 -GDD--------------YPEEKEGNLVSWVRGLVRNNKGSR 765
            G+D              YP+      V+  +GL+  + G R
Sbjct: 543 EGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 44/239 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 124
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 125 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 177
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            AK+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P 
Sbjct: 178 TAKVLSPESKQARANXFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 515 LLAEGKFGPVYRGFLPGG---IHVAVKVLVHGSTLTD-QEAARELEYLGRI-KHPNLVPL 569
           ++ EG FG V +  +      +  A+K +   ++  D ++ A ELE L ++  HPN++ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 570 TGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGS 626
            G C   + R  +Y   +Y  +GNL + L       +               ++   + S
Sbjct: 92  LGAC---EHRGYLYLAIEYAPHGNLLDFL-------RKSRVLETDPAFAIANSTASTLSS 141
Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           + LL         A   AR + +L        IHRD+ A ++ +  N   +++DFGL++ 
Sbjct: 142 QQLL-------HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG 191
Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                 E   + + G +P  +   +S      T  SDV+ YGV+L E+++
Sbjct: 192 -----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 40/236 (16%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKH 563
           ++FD   LL +G FG V        G + A+K+L     +   E A    E   L   +H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           P L  L       D+   + +Y   G L    H                           
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--------------------------- 98
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           +  E + T  R R   A     AL +LH   S  +++RDIK  ++ LD +   +++DFGL
Sbjct: 99  LSRERVFTEERARFYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGL 154
Query: 684 AKI-FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            K    +G   +   G+P Y+ PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 155 CKEGISDGATMKTFCGTPEYLAPEVLE-DNDYGRA-VDWWGLGVVMYEMMCGRLPF 208

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 12/103 (11%)
Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----GSP 700
           + L +LH   S   IHRDIKA++V L  + E +L+DFG+A   G   D +I R    G+P
Sbjct: 130 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNXFVGTP 183
Query: 701 GYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
            ++ PE  +  S + + K+D++  G+  +EL  G+ P  + +P
Sbjct: 184 FWMAPEVIK-QSAYDS-KADIWSLGITAIELARGEPPHSELHP 224

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 12/103 (11%)
Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR----GSP 700
           + L +LH   S   IHRDIKA++V L  + E +L+DFG+A   G   D +I R    G+P
Sbjct: 135 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNTFVGTP 188
Query: 701 GYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
            ++ PE  +  S + + K+D++  G+  +EL  G+ P  + +P
Sbjct: 189 FWMAPEVIK-QSAYDS-KADIWSLGITAIELARGEPPHSELHP 229

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 46/240 (19%)
Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVP 568
           FD    L EG +G VY+      G  VA+K +   S L  QE  +E+  + +   P++V 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVK 88
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG-SE 627
             G          + +Y   G++ +++                         ++N   +E
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIR------------------------LRNKTLTE 124
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
             + T      I   T + L +LH       IHRDIKA ++ L+     +L+DFG+A   
Sbjct: 125 DEIAT------ILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVA--- 172
Query: 688 GNGLDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           G   D    R    G+P ++ PE  Q         +D++  G+  +E+  GK P  D +P
Sbjct: 173 GQLTDXMAKRNXVIGTPFWMAPEVIQEIGY--NCVADIWSLGITAIEMAEGKPPYADIHP 230

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 40/236 (16%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKH 563
           ++FD   LL +G FG V        G + A+K+L     +   E A    E   L   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           P L  L       D+   + +Y   G L    H                           
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--------------------------- 95
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           +  E + T  R R   A     AL +LH   S  +++RDIK  ++ LD +   +++DFGL
Sbjct: 96  LSRERVFTEERARFYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGL 151
Query: 684 AKI-FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            K    +G   +   G+P Y+ PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 152 CKEGISDGATMKTFCGTPEYLAPEVLE-DNDYGRA-VDWWGLGVVMYEMMCGRLPF 205

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 515 LLAEGKFGPVYRGFLPGG---IHVAVKVLVHGSTLTD-QEAARELEYLGRI-KHPNLVPL 569
           ++ EG FG V +  +      +  A+K +   ++  D ++ A ELE L ++  HPN++ L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 570 TGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGS 626
            G C   + R  +Y   +Y  +GNL + L       +               ++   + S
Sbjct: 82  LGAC---EHRGYLYLAIEYAPHGNLLDFL-------RKSRVLETDPAFAIANSTASTLSS 131
Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           + LL         A   AR + +L        IHRD+ A ++ +  N   +++DFGL++ 
Sbjct: 132 QQLL-------HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG 181
Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                 E   + + G +P  +   +S      T  SDV+ YGV+L E+++
Sbjct: 182 -----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 534 HVAVKVLVHGSTLTDQEAARELEY-----LGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN 588
           H   +V V    L  Q+  REL +     +    H N+V +    + GD+   + +++E 
Sbjct: 68  HTGKQVAVKKMDLRKQQR-RELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEG 126
Query: 589 GNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALA 648
           G L +++                        +   +  E + T       + L   RAL+
Sbjct: 127 GALTDIV------------------------THTRMNEEQIAT-------VCLSVLRALS 155
Query: 649 FLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGLDEEIARGSPGYIPPEF 707
           +LH+     +IHRDIK+ S+ L  +   +LSDFG  A++       +   G+P ++ PE 
Sbjct: 156 YLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEV 212
Query: 708 AQPDSDFPT-PKSDVYCYGVVLLELITGKKPLGDDYP 743
               S  P   + D++  G++++E+I G+ P  ++ P
Sbjct: 213 I---SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 246

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 29/188 (15%)
Query: 554 ELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXX 613
           EL+ +  IK+   +   G     D+   IY+YMEN ++  L  D    V           
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI--LKFDEYFFVLDKNYTCFI-- 148
Query: 614 XXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMN 673
                  IQ +              I      + +++H+     I HRD+K S++ +D N
Sbjct: 149 ------PIQVIKC------------IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKN 188
Query: 674 LEPRLSDFGLAKIFGNGLDEEI--ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
              +LSDFG ++     +D++I  +RG+  ++PPEF   +S +   K D++  G+ L  +
Sbjct: 189 GRVKLSDFGESEYM---VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245
Query: 732 ITGKKPLG 739
                P  
Sbjct: 246 FYNVVPFS 253

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 40/236 (16%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKH 563
           ++FD   LL +G FG V        G + A+K+L     +   E A    E   L   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           P L  L       D+   + +Y   G L    H                           
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--------------------------- 95
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           +  E + T  R R   A     AL +LH   S  +++RDIK  ++ LD +   +++DFGL
Sbjct: 96  LSRERVFTEERARFYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGL 151
Query: 684 AKI-FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            K    +G   +   G+P Y+ PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 152 CKEGISDGATMKXFCGTPEYLAPEVLE-DNDYGRA-VDWWGLGVVMYEMMCGRLPF 205

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSI--QNVGSEGLLTTW-RFRHKI--ALGTARA 646
              L                       N      V  E L   +    H I  +   A+ 
Sbjct: 111 STYLRS-------------------KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 151
Query: 647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE 706
           + FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P +
Sbjct: 152 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDYVRKGDARLPLK 206
Query: 707 FAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNK 762
           +  P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +
Sbjct: 207 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEE 250
Query: 763 GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
             R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 251 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 293

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSI--QNVGSEGLLTTW-RFRHKI--ALGTARA 646
              L                       N      V  E L   +    H I  +   A+ 
Sbjct: 111 STYLRS-------------------KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 151
Query: 647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE 706
           + FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P +
Sbjct: 152 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDYVRKGDARLPLK 206
Query: 707 FAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNK 762
           +  P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +
Sbjct: 207 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEE 250
Query: 763 GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
             R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 251 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 293

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 44/239 (18%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ 622
           P  V L  +    D+++     Y +NG L                             I+
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGEL--------------------------LKYIR 124
Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +GS     T  +  +I      AL +LH      IIHRD+K  ++ L+ ++  +++DFG
Sbjct: 125 KIGSFDETCTRFYTAEIV----SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 177
Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            AK+      +  A    G+  Y+ PE     S   +  SD++  G ++ +L+ G  P 
Sbjct: 178 TAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKS--SDLWALGCIIYQLVAGLPPF 234

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 92
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
           +  LP G                            L  +  +HK  +   + L +    C
Sbjct: 93  MEYLPYGS---------------------------LRDYLQKHKERIDHIKLLQYTSQIC 125
Query: 655 -------SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPE 706
                  +   IHR++   ++ ++     ++ DFGL K+     D+E  +   PG  P  
Sbjct: 126 KGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ--DKEYYKVKEPGESPIF 183
Query: 707 FAQPDSDFPTP---KSDVYCYGVVLLELIT 733
           +  P+S   +     SDV+ +GVVL EL T
Sbjct: 184 WYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSI--QNVGSEGLLTTW-RFRHKI--ALGTARA 646
              L                       N      V  E L   +    H I  +   A+ 
Sbjct: 157 STYLR-------------------SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 197
Query: 647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE 706
           + FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P +
Sbjct: 198 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDYVRKGDARLPLK 252
Query: 707 FAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNK 762
           +  P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +
Sbjct: 253 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEE 296
Query: 763 GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
             R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 297 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 339

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 40/236 (16%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKH 563
           ++FD   LL +G FG V        G + A+K+L     +   E A    E   L   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           P L  L       D+   + +Y   G L    H                           
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--------------------------- 95
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           +  E + T  R R   A     AL +LH   S  +++RDIK  ++ LD +   +++DFGL
Sbjct: 96  LSRERVFTEERARFYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGL 151
Query: 684 AKI-FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            K    +G   +   G+P Y+ PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 152 CKEGISDGATMKTFCGTPEYLAPEVLE-DNDYGRA-VDWWGLGVVMYEMMCGRLPF 205

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 40/236 (16%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKH 563
           ++FD   LL +G FG V        G + A+K+L     +   E A    E   L   +H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           P L  L       D+   + +Y   G L    H                           
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--------------------------- 100
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           +  E + T  R R   A     AL +LH   S  +++RDIK  ++ LD +   +++DFGL
Sbjct: 101 LSRERVFTEERARFYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGL 156
Query: 684 AKI-FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            K    +G   +   G+P Y+ PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 157 CKEGISDGATMKXFCGTPEYLAPEVLE-DNDYGRA-VDWWGLGVVMYEMMCGRLPF 210

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 40/236 (16%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKH 563
           ++FD   LL +G FG V        G + A+K+L     +   E A    E   L   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           P L  L       D+   + +Y   G L    H                           
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--------------------------- 95
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           +  E + T  R R   A     AL +LH   S  +++RDIK  ++ LD +   +++DFGL
Sbjct: 96  LSRERVFTEERARFYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGL 151
Query: 684 AKI-FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            K    +G   +   G+P Y+ PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 152 CKEGISDGATMKXFCGTPEYLAPEVLE-DNDYGRA-VDWWGLGVVMYEMMCGRLPF 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 40/236 (16%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKH 563
           ++FD   LL +G FG V        G + A+K+L     +   E A    E   L   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           P L  L       D+   + +Y   G L    H                           
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH--------------------------- 95
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           +  E + T  R R   A     AL +LH   S  +++RDIK  ++ LD +   +++DFGL
Sbjct: 96  LSRERVFTEERARFYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGL 151
Query: 684 AKI-FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            K    +G   +   G+P Y+ PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 152 CKEGISDGATMKXFCGTPEYLAPEVLE-DNDYGRA-VDWWGLGVVMYEMMCGRLPF 205

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 50/83 (60%), Gaps = 5/83 (6%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDEEIARGSPGYIPPE-FAQPDSDFP 715
           +IHRD+K  +++L+ +LE ++ DFGLA K+  +G  ++   G+P YI PE  ++    F 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF- 196
Query: 716 TPKSDVYCYGVVLLELITGKKPL 738
             + DV+  G ++  L+ GK P 
Sbjct: 197 --EVDVWSIGCIMYTLLVGKPPF 217

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 50/83 (60%), Gaps = 5/83 (6%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDEEIARGSPGYIPPE-FAQPDSDFP 715
           +IHRD+K  +++L+ +LE ++ DFGLA K+  +G  ++   G+P YI PE  ++    F 
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF- 200
Query: 716 TPKSDVYCYGVVLLELITGKKPL 738
             + DV+  G ++  L+ GK P 
Sbjct: 201 --EVDVWSIGCIMYTLLVGKPPF 221

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 50/83 (60%), Gaps = 5/83 (6%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDEEIARGSPGYIPPE-FAQPDSDFP 715
           +IHRD+K  +++L+ +LE ++ DFGLA K+  +G  ++   G+P YI PE  ++    F 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF- 196
Query: 716 TPKSDVYCYGVVLLELITGKKPL 738
             + DV+  G ++  L+ GK P 
Sbjct: 197 --EVDVWSIGCIMYTLLVGKPPF 217

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSI--QNVGSEGLLTTW-RFRHKI--ALGTARA 646
              L                       N      V  E L   +    H I  +   A+ 
Sbjct: 120 STYLR-------------------SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160
Query: 647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE 706
           + FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P +
Sbjct: 161 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDXVRKGDARLPLK 215
Query: 707 FAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNK 762
           +  P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEE 259
Query: 763 GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
             R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSI--QNVGSEGLLTTW-RFRHKI--ALGTARA 646
              L                       N      V  E L   +    H I  +   A+ 
Sbjct: 120 STYLR-------------------SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160
Query: 647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE 706
           + FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P +
Sbjct: 161 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDYVRKGDARLPLK 215
Query: 707 FAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNK 762
           +  P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEE 259
Query: 763 GSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
             R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 55/267 (20%)
Query: 515 LLAEGKFGPVYRG-FLPGG----IHVAVKVLVHG-STLTDQEAARELEYLGRIKHPNLVP 568
           +L  G FG VY+G ++P G    I VA+KVL    S   ++E   E   +  +  P +  
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G C+    ++ +   M  G L + + +                      +   +GS+ 
Sbjct: 84  LLGICLTSTVQL-VTQLMPYGCLLDHVRE----------------------NRGRLGSQD 120
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           LL  W       +  A+ +++L       ++HRD+ A +V +      +++DFGLA++  
Sbjct: 121 LLN-W------CMQIAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLL- 169
Query: 689 NGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPE 744
             +DE       G +P ++   +S      T +SDV+ YGV + EL+T G KP  D  P 
Sbjct: 170 -DIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPY-DGIPA 227
Query: 745 EKEGNLVSWVRGLVRNNKGSRAIDPKI 771
            +  +L+          KG R   P I
Sbjct: 228 REIPDLL---------EKGERLPQPPI 245

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 114/278 (41%), Gaps = 46/278 (16%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH 651
              L                       +  ++  +   L  + F+       A+ + FL 
Sbjct: 120 STYLR------------SKRNEFVPYKDLYKDFLTLEHLICYSFQ------VAKGMEFL- 160
Query: 652 HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPD 711
              S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P ++  P+
Sbjct: 161 --ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDYVRKGDARLPLKWMAPE 216
Query: 712 SDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAI 767
           + F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +  R +
Sbjct: 217 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEEFCRRL 260
Query: 768 DPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
               R   P+    E  +    C    P +RP+  ++V
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 298

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 38/204 (18%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK L H +    ++  RE+E L  ++H N+V   G C +  +R          NL+ +
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR----------NLKLI 94
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRH-KIALGTARALAFLHHG 653
           +  LP G                 + +Q           R  H K+   T++    + + 
Sbjct: 95  MEYLPYG--------------SLRDYLQAHAE-------RIDHIKLLQYTSQICKGMEYL 133
Query: 654 CSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-GSPGYIPPEFAQPDS 712
            +   IHRD+   ++ ++     ++ DFGL K+     D+E  +   PG  P  +  P+S
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--DKEXXKVKEPGESPIFWYAPES 191
Query: 713 DFPTP---KSDVYCYGVVLLELIT 733
              +     SDV+ +GVVL EL T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 107/246 (43%), Gaps = 57/246 (23%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           + +G+FG V  G   G   VAVK + + +T   Q    E   + +++H NLV L G  + 
Sbjct: 29  IGKGEFGDVMLGDYRGN-KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV- 84
Query: 576 GDQRIAIY---DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTT 632
            +++  +Y   +YM  G+L + L      V                     +G + LL  
Sbjct: 85  -EEKGGLYIVTEYMAKGSLVDYLRSRGRSV---------------------LGGDCLL-- 120
Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD 692
                K +L    A+ +L        +HRD+ A +V +  +   ++SDFGL K       
Sbjct: 121 -----KFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------- 165
Query: 693 EEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKK------PLGDDY 742
           E  +    G +P ++  P++     F T KSDV+ +G++L E+ +  +      PL D  
Sbjct: 166 EASSTQDTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224
Query: 743 PEEKEG 748
           P  ++G
Sbjct: 225 PRVEKG 230

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 114/278 (41%), Gaps = 46/278 (16%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH 651
              L                       +  ++  +   L  + F+       A+ + FL 
Sbjct: 120 STYLR------------SKRNEFVPYKDLYKDFLTLEHLIXYSFQ------VAKGMEFL- 160
Query: 652 HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPD 711
              S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P ++  P+
Sbjct: 161 --ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYK--DPDYVRKGDARLPLKWMAPE 216
Query: 712 SDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAI 767
           + F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +  R +
Sbjct: 217 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEEFXRRL 260
Query: 768 DPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
               R   P+    E  +    C    P +RP+  ++V
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 298

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 45/233 (19%)
Query: 515 LLAEGKFGPVYRGFLPG----GIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPL 569
           +L EG FG VY G         I+VAVK      TL ++E    E   +  + HP++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G  I  +    I +    G L + L                          +N  S  +
Sbjct: 79  IGI-IEEEPTWIIMELYPYGELGHYLE-------------------------RNKNSLKV 112
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
           LT   +    +L   +A+A+L    S   +HRDI   ++ +      +L DFGL++    
Sbjct: 113 LTLVLY----SLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE- 164
Query: 690 GLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLELIT-GKKPL 738
             DE+  + S   +P ++  P+S +F   T  SDV+ + V + E+++ GK+P 
Sbjct: 165 --DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 114/278 (41%), Gaps = 42/278 (15%)
Query: 535 VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLVPLTGYCIA-GDQRIAIYDYMENGNL 591
           VAVK+L  G+T ++  A   EL+ L  I  H N+V L G C   G   + I ++ + GNL
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 592 QNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH 651
              L                       +  ++  +   L  + F+       A+ + FL 
Sbjct: 122 STYLR--------SKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQ------VAKGMEFL- 166
Query: 652 HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPD 711
              S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P ++  P+
Sbjct: 167 --ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDYVRKGDARLPLKWMAPE 222
Query: 712 SDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAI 767
           + F    T +SDV+ +GV+L E+ + G  P    YP            G+  + +  R +
Sbjct: 223 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDEEFCRRL 266
Query: 768 DPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
               R   P+    E  +    C    P +RP+  ++V
Sbjct: 267 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 304

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 121/305 (39%), Gaps = 64/305 (20%)
Query: 507 TSNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHG--STLTDQEAARELEYLGRIKH 563
           + N+D    L +G F  V R      G+  A K++     S    Q+  RE     +++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           PN+V L             +D ++  +   L+ DL  G +                  ++
Sbjct: 65  PNIVRL-------------HDSIQEESFHYLVFDLVTGGEL----------------FED 95
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE---PRLSD 680
           + +    +     H I      ++A+ H   S  I+HR++K  ++ L    +    +L+D
Sbjct: 96  IVAREFYSEADASHCIQ-QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
           FGLA    +        G+PGY+ PE  + D  +  P  D++  GV+L  L+ G  P  D
Sbjct: 152 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKP-VDIWACGVILYILLVGYPPFWD 209
Query: 741 ---------------DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK 785
                          DYP  +   +    + L+        ++PK R T      ++ALK
Sbjct: 210 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI---DSMLTVNPKKRITA-----DQALK 261
Query: 786 IGYLC 790
           + ++C
Sbjct: 262 VPWIC 266

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 45/233 (19%)
Query: 515 LLAEGKFGPVYRGFLPG----GIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPL 569
           +L EG FG VY G         I+VAVK      TL ++E    E   +  + HP++V L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G  I  +    I +    G L + L                          +N  S  +
Sbjct: 91  IGI-IEEEPTWIIMELYPYGELGHYLE-------------------------RNKNSLKV 124
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
           LT   +    +L   +A+A+L    S   +HRDI   ++ +      +L DFGL++    
Sbjct: 125 LTLVLY----SLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE- 176
Query: 690 GLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLELIT-GKKPL 738
             DE+  + S   +P ++  P+S +F   T  SDV+ + V + E+++ GK+P 
Sbjct: 177 --DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 45/233 (19%)
Query: 515 LLAEGKFGPVYRGFLPG----GIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPL 569
           +L EG FG VY G         I+VAVK      TL ++E    E   +  + HP++V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G  I  +    I +    G L + L                          +N  S  +
Sbjct: 75  IGI-IEEEPTWIIMELYPYGELGHYLE-------------------------RNKNSLKV 108
Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
           LT   +    +L   +A+A+L    S   +HRDI   ++ +      +L DFGL++    
Sbjct: 109 LTLVLY----SLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE- 160
Query: 690 GLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLELIT-GKKPL 738
             DE+  + S   +P ++  P+S +F   T  SDV+ + V + E+++ GK+P 
Sbjct: 161 --DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 11/116 (9%)
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGC-------SPPIIHRDIKASSVYLDMNLEPRLSD 680
           G L  +  RH+  L  +R L +    C       S   +HRD+ A ++ ++     +++D
Sbjct: 95  GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 154
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
           FGLAK+     D  + R  PG  P  +  P+S   +  + +SDV+ +GVVL EL T
Sbjct: 155 FGLAKLLPLDKDXXVVR-EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 121/305 (39%), Gaps = 64/305 (20%)
Query: 507 TSNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHG--STLTDQEAARELEYLGRIKH 563
           + N+D    L +G F  V R      G+  A K++     S    Q+  RE     +++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           PN+V L             +D ++  +   L+ DL  G +                  ++
Sbjct: 64  PNIVRL-------------HDSIQEESFHYLVFDLVTGGEL----------------FED 94
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE---PRLSD 680
           + +    +     H I      ++A+ H   S  I+HR++K  ++ L    +    +L+D
Sbjct: 95  IVAREFYSEADASHCIQ-QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLAD 150
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
           FGLA    +        G+PGY+ PE  + D  +  P  D++  GV+L  L+ G  P  D
Sbjct: 151 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKP-VDIWACGVILYILLVGYPPFWD 208
Query: 741 ---------------DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK 785
                          DYP  +   +    + L+        ++PK R T      ++ALK
Sbjct: 209 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI---DSMLTVNPKKRITA-----DQALK 260
Query: 786 IGYLC 790
           + ++C
Sbjct: 261 VPWIC 265

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 48/84 (57%), Gaps = 7/84 (8%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDF 714
           ++HRD+K ++V+LD     +L DFGLA+I  +  DE+ A+   G+P Y+ PE  Q +   
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DEDFAKEFVGTPYYMSPE--QMNRMS 192
Query: 715 PTPKSDVYCYGVVLLELITGKKPL 738
              KSD++  G +L EL     P 
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 27/162 (16%)
Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
           IQ VG         +  +I++G    L FLH      II+RD+K  +V LD     +++D
Sbjct: 111 IQQVGKFKEPQAVFYAAEISIG----LFFLH---KRGIIYRDLKLDNVMLDSEGHIKIAD 163
Query: 681 FGLAKI-FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKPL 738
           FG+ K    +G+      G+P YI PE        P  KS D + YGV+L E++ G+ P 
Sbjct: 164 FGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQ---PYGKSVDWWAYGVLLYEMLAGQPPF 220
Query: 739 -GDD--------------YPEEKEGNLVSWVRGLVRNNKGSR 765
            G+D              YP+      VS  +GL+  +   R
Sbjct: 221 DGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPAKR 262

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 107/246 (43%), Gaps = 57/246 (23%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           + +G+FG V  G   G   VAVK + + +T   Q    E   + +++H NLV L G  + 
Sbjct: 14  IGKGEFGDVMLGDYRGN-KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV- 69
Query: 576 GDQRIAIY---DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTT 632
            +++  +Y   +YM  G+L + L      V                     +G + LL  
Sbjct: 70  -EEKGGLYIVTEYMAKGSLVDYLRSRGRSV---------------------LGGDCLL-- 105
Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD 692
                K +L    A+ +L        +HRD+ A +V +  +   ++SDFGL K       
Sbjct: 106 -----KFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------- 150
Query: 693 EEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKK------PLGDDY 742
           E  +    G +P ++  P++     F T KSDV+ +G++L E+ +  +      PL D  
Sbjct: 151 EASSTQDTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
Query: 743 PEEKEG 748
           P  ++G
Sbjct: 210 PRVEKG 215

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 121/305 (39%), Gaps = 64/305 (20%)
Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKH 563
           + N+D    L +G F  V R      G+  A K++     S    Q+  RE     +++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           PN+V L             +D ++  +   L+ DL  G +                  ++
Sbjct: 65  PNIVRL-------------HDSIQEESFHYLVFDLVTGGEL----------------FED 95
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE---PRLSD 680
           + +    +     H I      ++A+ H   S  I+HR++K  ++ L    +    +L+D
Sbjct: 96  IVAREFYSEADASHCIQ-QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
           FGLA    +        G+PGY+ PE  + D  +  P  D++  GV+L  L+ G  P  D
Sbjct: 152 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKP-VDIWACGVILYILLVGYPPFWD 209
Query: 741 ---------------DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK 785
                          DYP  +   +    + L+        ++PK R T      ++ALK
Sbjct: 210 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI---DSMLTVNPKKRITA-----DQALK 261
Query: 786 IGYLC 790
           + ++C
Sbjct: 262 VPWIC 266

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 91/236 (38%), Gaps = 42/236 (17%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHV-AVKVLVHGSTL---TDQEAARELEYLGRIKH 563
            +FD    L +GKFG VY         + A+KVL          + +  RE+E    ++H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           PN++ +  Y     +   + ++   G L                             +Q 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGEL--------------------------YKELQK 107
Query: 624 VGSEGLLTTWRFRHKIALGTARALA-FLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            G        RF  + +      LA  LH+     +IHRDIK  ++ +    E +++DFG
Sbjct: 108 HG--------RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159
Query: 683 LAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            + +    L      G+  Y+PPE  +  +     K D++C GV+  E + G  P 
Sbjct: 160 WS-VHAPSLRRRXMCGTLDYLPPEMIEGKTH--DEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 11/116 (9%)
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGC-------SPPIIHRDIKASSVYLDMNLEPRLSD 680
           G L  +  RH+  L  +R L +    C       S   +HRD+ A ++ ++     +++D
Sbjct: 98  GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 157
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
           FGLAK+     D  + R  PG  P  +  P+S   +  + +SDV+ +GVVL EL T
Sbjct: 158 FGLAKLLPLDKDYYVVR-EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 11/116 (9%)
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGC-------SPPIIHRDIKASSVYLDMNLEPRLSD 680
           G L  +  RH+  L  +R L +    C       S   +HRD+ A ++ ++     +++D
Sbjct: 111 GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 170
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
           FGLAK+     D  + R  PG  P  +  P+S   +  + +SDV+ +GVVL EL T
Sbjct: 171 FGLAKLLPLDKDYYVVR-EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 11/116 (9%)
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGC-------SPPIIHRDIKASSVYLDMNLEPRLSD 680
           G L  +  RH+  L  +R L +    C       S   +HRD+ A ++ ++     +++D
Sbjct: 99  GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 158
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
           FGLAK+     D  + R  PG  P  +  P+S   +  + +SDV+ +GVVL EL T
Sbjct: 159 FGLAKLLPLDKDYYVVR-EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 515 LLAEGKFGPVYRGFLPGG---IHVAVKVLVHGSTLTD-QEAARELEYLGRI-KHPNLVPL 569
           ++ EG FG V +  +      +  A+K +   ++  D ++ A ELE L ++  HPN++ L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 570 TGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGS 626
            G C   + R  +Y   +Y  +GNL + L       +               ++   + S
Sbjct: 89  LGAC---EHRGYLYLAIEYAPHGNLLDFL-------RKSRVLETDPAFAIANSTASTLSS 138
Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           + LL         A   AR + +L        IHR++ A ++ +  N   +++DFGL++ 
Sbjct: 139 QQLL-------HFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSRG 188
Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                 E   + + G +P  +   +S      T  SDV+ YGV+L E+++
Sbjct: 189 -----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 107/246 (43%), Gaps = 57/246 (23%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           + +G+FG V  G   G   VAVK + + +T   Q    E   + +++H NLV L G  + 
Sbjct: 201 IGKGEFGDVMLGDYRGN-KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV- 256
Query: 576 GDQRIAIY---DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTT 632
            +++  +Y   +YM  G+L + L      V                     +G + LL  
Sbjct: 257 -EEKGGLYIVTEYMAKGSLVDYLRSRGRSV---------------------LGGDCLL-- 292
Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD 692
                K +L    A+ +L        +HRD+ A +V +  +   ++SDFGL K       
Sbjct: 293 -----KFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------- 337
Query: 693 EEIARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKK------PLGDDY 742
           E  +    G +P ++  P++     F T KSDV+ +G++L E+ +  +      PL D  
Sbjct: 338 EASSTQDTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396
Query: 743 PEEKEG 748
           P  ++G
Sbjct: 397 PRVEKG 402

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 39/194 (20%)
Query: 502 DLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIH-VAVKV--LVHGSTLTD---QEAAREL 555
           D+ S    +++   L EG+F  VY+         VA+K   L H S   D   + A RE+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 556 EYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXX 615
           + L  + HPN++ L            ++D+ME  +L+ ++ D                  
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD------------------ 104
Query: 616 XXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE 675
              NS+       +LT    +  + L T + L +LH      I+HRD+K +++ LD N  
Sbjct: 105 ---NSL-------VLTPSHIKAYM-LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGV 150
Query: 676 PRLSDFGLAKIFGN 689
            +L+DFGLAK FG+
Sbjct: 151 LKLADFGLAKSFGS 164

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 107/246 (43%), Gaps = 57/246 (23%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           + +G+FG V  G   G   VAVK + + +T   Q    E   + +++H NLV L G  + 
Sbjct: 20  IGKGEFGDVMLGDYRGN-KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV- 75
Query: 576 GDQRIAIY---DYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTT 632
            +++  +Y   +YM  G+L + L      V                     +G + LL  
Sbjct: 76  -EEKGGLYIVTEYMAKGSLVDYLRSRGRSV---------------------LGGDCLL-- 111
Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD 692
                K +L    A+ +L        +HRD+ A +V +  +   ++SDFGL K       
Sbjct: 112 -----KFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------- 156
Query: 693 EEIARGSPGYIPPEFAQP----DSDFPTPKSDVYCYGVVLLELITGKK------PLGDDY 742
           E  +    G +P ++  P    ++ F T KSDV+ +G++L E+ +  +      PL D  
Sbjct: 157 EASSTQDTGKLPVKWTAPEALREAAFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 215
Query: 743 PEEKEG 748
           P  ++G
Sbjct: 216 PRVEKG 221

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDEEIARGSPG 701
           T + + +LH+     +IHRD+K  +++L+ +++ ++ DFGLA KI  +G  ++   G+P 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPN 207
Query: 702 YIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           YI PE   +    F   + D++  G +L  L+ GK P 
Sbjct: 208 YIAPEVLCKKGHSF---EVDIWSLGCILYTLLVGKPPF 242

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 42/230 (18%)
Query: 516 LAEGKFGPVYRGFL---PGGIHVAVKVLVHGSTLTD-QEAARELEYLGRIKHPNLVPLTG 571
           L  G FG V +G        I VA+KVL  G+   D +E  RE + + ++ +P +V L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 572 YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLT 631
            C A  + + +   M  G     LH   +G +                 + NV       
Sbjct: 404 VCQA--EALMLVMEMAGGGP---LHKFLVGKREEI-------------PVSNVAE----- 440
Query: 632 TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL 691
                H++++G    + +L        +HR++ A +V L      ++SDFGL+K  G   
Sbjct: 441 ---LLHQVSMG----MKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
Query: 692 DEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLELIT-GKKP 737
               AR S G  P ++  P+  +F   + +SDV+ YGV + E ++ G+KP
Sbjct: 491 SYYTAR-SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/244 (22%), Positives = 99/244 (40%), Gaps = 44/244 (18%)
Query: 497 NITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTL--TDQEAARE 554
           N+ F  L+      ++   + EG +G VY+     G  VA+K +   +        A RE
Sbjct: 13  NLYFQGLMEKYQKLEK---VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE 69
Query: 555 LEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXX 614
           +  L  + HPN+V L     +      ++++ME  +L+ +L +   G+Q           
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS--------- 119
Query: 615 XXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNL 674
                                  +I +   + L  + H     I+HRD+K  ++ ++ + 
Sbjct: 120 -----------------------QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG 156
Query: 675 EPRLSDFGLAKIFG---NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
             +L+DFGLA+ FG        E+   +  Y  P+       + T   D++  G +  E+
Sbjct: 157 ALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSKKYST-SVDIWSIGCIFAEM 213
Query: 732 ITGK 735
           ITGK
Sbjct: 214 ITGK 217

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH      I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 108 RFFHQLMAG----VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 161 RLLNKMXGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 217
Query: 751 VSW 753
             W
Sbjct: 218 SDW 220

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH      I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 108 RFFHQLMAG----VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 161 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 217
Query: 751 VSW 753
             W
Sbjct: 218 SDW 220

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH      I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 108 RFFHQLMAG----VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 161 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 217
Query: 751 VSW 753
             W
Sbjct: 218 SDW 220

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/244 (22%), Positives = 99/244 (40%), Gaps = 44/244 (18%)
Query: 497 NITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTL--TDQEAARE 554
           N+ F  L+      ++   + EG +G VY+     G  VA+K +   +        A RE
Sbjct: 13  NLYFQGLMEKYQKLEK---VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE 69
Query: 555 LEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXX 614
           +  L  + HPN+V L     +      ++++ME  +L+ +L +   G+Q           
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS--------- 119
Query: 615 XXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNL 674
                                  +I +   + L  + H     I+HRD+K  ++ ++ + 
Sbjct: 120 -----------------------QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG 156
Query: 675 EPRLSDFGLAKIFG---NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
             +L+DFGLA+ FG        E+   +  Y  P+       + T   D++  G +  E+
Sbjct: 157 ALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSKKYST-SVDIWSIGCIFAEM 213
Query: 732 ITGK 735
           ITGK
Sbjct: 214 ITGK 217

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH      I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 108 RFFHQLMAG----VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 161 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 217
Query: 751 VSW 753
             W
Sbjct: 218 SDW 220

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH      I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 109 RFFHQLMAG----VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 162 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 218
Query: 751 VSW 753
             W
Sbjct: 219 SDW 221

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDEEIARGSPG 701
           T + + +LH+     +IHRD+K  +++L+ +++ ++ DFGLA KI  +G  ++   G+P 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPN 207
Query: 702 YIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           YI PE   +    F   + D++  G +L  L+ GK P 
Sbjct: 208 YIAPEVLCKKGHSF---EVDIWSLGCILYTLLVGKPPF 242

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 110/273 (40%), Gaps = 62/273 (22%)
Query: 550 EAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL-HDLPLGVQXXXXX 608
           E  +E++ + +  HPN+V      +  D+   +   +  G++ +++ H +  G       
Sbjct: 59  ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS--- 115
Query: 609 XXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV 668
                          V  E  + T      I       L +LH       IHRD+KA ++
Sbjct: 116 --------------GVLDESTIAT------ILREVLEGLEYLHKNGQ---IHRDVKAGNI 152
Query: 669 YLDMNLEPRLSDFGLAKIFGNGLDEEIAR--------GSPGYIPPEFAQP--DSDFPTPK 718
            L  +   +++DFG++     G D  I R        G+P ++ PE  +     DF   K
Sbjct: 153 LLGEDGSVQIADFGVSAFLATGGD--ITRNKVRKTFVGTPCWMAPEVMEQVRGYDF---K 207
Query: 719 SDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTG-PE 777
           +D++ +G+  +EL TG  P    YP  K       V  L   N      DP   +TG  +
Sbjct: 208 ADIWSFGITAIELATGAAPY-HKYPPMK-------VLMLTLQN------DPPSLETGVQD 253
Query: 778 KQMEEAL-----KIGYLCTADLPLKRPSMQQIV 805
           K+M +       K+  LC    P KRP+  +++
Sbjct: 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 95/229 (41%), Gaps = 41/229 (17%)
Query: 516 LAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L +G FG VY+       +  A KV+   S    ++   E++ L    HPN+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 575 AGDQRIAIYDYMENGNLQNLLHDL--PLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTT 632
             +    + ++   G +  ++ +L  PL                  + IQ V  +     
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPL----------------TESQIQVVCKQ----- 143
Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGL 691
                     T  AL +LH      IIHRD+KA ++   ++ + +L+DFG+ AK      
Sbjct: 144 ----------TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQ 190
Query: 692 DEEIARGSPGYIPPEFAQPDSDFPTP---KSDVYCYGVVLLELITGKKP 737
             +   G+P ++ PE    ++    P   K+DV+  G+ L+E+   + P
Sbjct: 191 RRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 12/101 (11%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSV-YLDMNLEPRL--SDFGLAKIFGNGLDEEIARGSPGY 702
           A+ +LH      I+HRD+K  ++ Y   + E ++  SDFGL+K+ G G     A G+PGY
Sbjct: 132 AVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGY 188
Query: 703 IPPE-FAQPDSDFPTPKS-DVYCYGVVLLELITGKKPLGDD 741
           + PE  AQ     P  K+ D +  GV+   L+ G  P  D+
Sbjct: 189 VAPEVLAQK----PYSKAVDCWSIGVIAYILLCGYPPFYDE 225

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 101/239 (42%), Gaps = 42/239 (17%)
Query: 512 RGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLT 570
           +  +L  G+FG V++      G+ +A K++        +E   E+  + ++ H NL+ L 
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLL 630
               + +  + + +Y++ G L + + D    +                           L
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE-------------------------L 187
Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR---LSDFGLAKIF 687
            T  F  +I  G       + H     I+H D+K  ++ L +N + +   + DFGLA+ +
Sbjct: 188 DTILFMKQICEG-------IRHMHQMYILHLDLKPENI-LCVNRDAKQIKIIDFGLARRY 239
Query: 688 GNGLDEEIARGSPGYIPPEFAQPD-SDFPTPKSDVYCYGVVLLELITGKKP-LGDDYPE 744
                 ++  G+P ++ PE    D   FPT   D++  GV+   L++G  P LGD+  E
Sbjct: 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPT---DMWSVGVIAYMLLSGLSPFLGDNDAE 295

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 38/175 (21%)
Query: 647 LAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR--------G 698
           L +LH       IHRD+KA ++ L  +   +++DFG++     G D  I R        G
Sbjct: 129 LEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD--ITRNKVRKTFVG 183
Query: 699 SPGYIPPEFAQP--DSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRG 756
           +P ++ PE  +     DF   K+D++ +G+  +EL TG  P    YP  K       V  
Sbjct: 184 TPCWMAPEVMEQVRGYDF---KADIWSFGITAIELATGAAPY-HKYPPMK-------VLM 232
Query: 757 LVRNNKGSRAIDPKIRDTG-PEKQMEEAL-----KIGYLCTADLPLKRPSMQQIV 805
           L   N      DP   +TG  +K+M +       K+  LC    P KRP+  +++
Sbjct: 233 LTLQN------DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 60/137 (43%), Gaps = 16/137 (11%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMN--LEPRLSDFGLAKIF-----GNGLDEEIARG 698
           AL +LH   +  I HRDIK  +     N   E +L DFGL+K F     G         G
Sbjct: 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 699 SPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWV--RG 756
           +P ++ PE     ++   PK D +  GV+L  L+ G  P    +P   + + +S V  + 
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP----FPGVNDADTISQVLNKK 292
Query: 757 LVRNNKGSRAIDPKIRD 773
           L   N     + P  RD
Sbjct: 293 LCFENPNYNVLSPLARD 309

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 95/229 (41%), Gaps = 41/229 (17%)
Query: 516 LAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L +G FG VY+       +  A KV+   S    ++   E++ L    HPN+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 575 AGDQRIAIYDYMENGNLQNLLHDL--PLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTT 632
             +    + ++   G +  ++ +L  PL                  + IQ V  +     
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPL----------------TESQIQVVCKQ----- 143
Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL-AKIFGNGL 691
                     T  AL +LH      IIHRD+KA ++   ++ + +L+DFG+ AK      
Sbjct: 144 ----------TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 190
Query: 692 DEEIARGSPGYIPPEFAQPDSDFPTP---KSDVYCYGVVLLELITGKKP 737
             +   G+P ++ PE    ++    P   K+DV+  G+ L+E+   + P
Sbjct: 191 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 92/242 (38%), Gaps = 45/242 (18%)
Query: 505 SATSNFDRGTLLAEGKFGPVYRGFLPGG-IHVAVKVLVHGSTLTDQEAARELE----YLG 559
           +  S+F    ++ +G FG V         +  AVKVL   + L  +E    +      L 
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 560 RIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXN 619
            +KHP LV L       D+   + DY+  G L                            
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGEL---------------------------- 126
Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
              ++  E      R R   A   A AL +LH   S  I++RD+K  ++ LD      L+
Sbjct: 127 -FYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLT 181
Query: 680 DFGLAK--IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKK 736
           DFGL K  I  N        G+P Y+ PE        P  ++ D +C G VL E++ G  
Sbjct: 182 DFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHKQ---PYDRTVDWWCLGAVLYEMLYGLP 237
Query: 737 PL 738
           P 
Sbjct: 238 PF 239

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           KIA+   +AL  LH   S  +IHRD+K S+V ++   + +  DFG++    + + ++I  
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 698 GSPGYIPPEFAQPDSDFP--TPKSDVYCYGVVLLELITGKKP 737
           G   Y  PE   P+ +    + KSD++  G+  +EL   + P
Sbjct: 198 GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFP 239

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 102/262 (38%), Gaps = 50/262 (19%)
Query: 492 EKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQE 550
           E+P L I          +F+   +L +G FG V+   F       A+K L     L D +
Sbjct: 7   ERPSLQIKLK-----IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD 61
Query: 551 AARELEYLGRI-----KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXX 605
               +    R+     +HP L  +       +    + +Y+  G+L  + H         
Sbjct: 62  VECTM-VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYH--------- 109
Query: 606 XXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA 665
                          IQ+     L     +  +I LG    L FLH   S  I++RD+K 
Sbjct: 110 ---------------IQSCHKFDLSRATFYAAEIILG----LQFLH---SKGIVYRDLKL 147
Query: 666 SSVYLDMNLEPRLSDFGLAK--IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYC 723
            ++ LD +   +++DFG+ K  + G+    E   G+P YI PE             D + 
Sbjct: 148 DNILLDKDGHIKIADFGMCKENMLGDAKTNEFC-GTPDYIAPEILLGQK--YNHSVDWWS 204
Query: 724 YGVVLLELITGKKPLGDDYPEE 745
           +GV+L E++ G+ P      EE
Sbjct: 205 FGVLLYEMLIGQSPFHGQDEEE 226

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDEEIARGSPG 701
           T + + +LH+     +IHRD+K  +++L+ +++ ++ DFGLA KI  +G  ++   G+P 
Sbjct: 135 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPN 191
Query: 702 YIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           YI PE   +    F   + D++  G +L  L+ GK P 
Sbjct: 192 YIAPEVLCKKGHSF---EVDIWSLGCILYTLLVGKPPF 226

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 103/369 (27%), Positives = 149/369 (40%), Gaps = 39/369 (10%)
Query: 79  KSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQW 138
           + L+L  NRI         +F  LE  +L+ N  S   P A ++L +LR L L  N  + 
Sbjct: 35  RLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL 94
Query: 139 SIPPGLLNCQS-LVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNE-IKGRDTHFAGLK 196
            IP G+    S L  +D+S N++   L   F   +  LKSL +  N+ +      F+GL 
Sbjct: 95  -IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY-NLKSLEVGDNDLVYISHRAFSGLN 152
Query: 197 SITNLNISG-NLFQGSVMGV-FLESLEVIDLRSNQFQGHISQVQFNSSYNW-----SRLV 249
           S+  L +   NL       +  L  L V+ LR       I    F   Y       S   
Sbjct: 153 SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWP 211
Query: 250 YVD-LSENQLSG------EIFH-NFSQAQNLKHLSLAYNRFTRQEFPQIGTLLG---LEH 298
           Y+D ++ N L G       I H N +    L    L Y RF    +  I T+ G    E 
Sbjct: 212 YLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL 271
Query: 299 LNLSRTSLIGDI-----PSEILQLSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNN 351
           L L    L+G       P     L+ L  L++S N LT    +V  S  NL  + +  N 
Sbjct: 272 LRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNP 331
Query: 352 LSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKR 411
           L+ +    LL    +  R NF+    T CA   +PE +Q   F    D P    P++F  
Sbjct: 332 LACD--CRLLWVFRRRWRLNFNRQQPT-CA---TPEFVQGKEF---KDFPDVLLPNYFTC 382
Query: 412 KAANHKGLK 420
           + A  +  K
Sbjct: 383 RRARIRDRK 391

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 95/229 (41%), Gaps = 41/229 (17%)
Query: 516 LAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           L +G FG VY+       +  A KV+   S    ++   E++ L    HPN+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 575 AGDQRIAIYDYMENGNLQNLLHDL--PLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTT 632
             +    + ++   G +  ++ +L  PL                  + IQ V  +     
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPL----------------TESQIQVVCKQ----- 143
Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD 692
                     T  AL +LH      IIHRD+KA ++   ++ + +L+DFG++      + 
Sbjct: 144 ----------TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQ 190
Query: 693 EEIA-RGSPGYIPPEFAQPDSDFPTP---KSDVYCYGVVLLELITGKKP 737
              +  G+P ++ PE    ++    P   K+DV+  G+ L+E+   + P
Sbjct: 191 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDEEIARGSPG 701
           T + + +LH+     +IHRD+K  +++L+ +++ ++ DFGLA KI  +G  ++   G+P 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPN 207
Query: 702 YIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           YI PE   +    F   + D++  G +L  L+ GK P 
Sbjct: 208 YIAPEVLCKKGHSF---EVDIWSLGCILYTLLVGKPPF 242

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 35/228 (15%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G +       VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L    +                 IQ  G   
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSL----RPEMENNPVLAPPSLSKMIQMAGE-- 131
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
                          A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ +   
Sbjct: 132 --------------IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX 174
Query: 689 NGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
               +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 175 E--TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 63/240 (26%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI--KHPNLVPLTGYC 573
           + +G++G V+RG L  G  VAVK+    S+  +Q   RE E    +  +H N++   G+ 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIF---SSRDEQSWFRETEIYNTVLLRHDNIL---GF- 67
Query: 574 IAGD--------QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           IA D        Q   I  Y E+G+L + L    L                         
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLAL------------------- 108
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGC-----SPPIIHRDIKASSVYLDMNLEPRLSD 680
                       ++A+  A  LA LH         P I HRD K+ +V +  NL+  ++D
Sbjct: 109 ------------RLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIAD 156
Query: 681 FGLAKIFGNGLDE-EIAR----GSPGYIPPEF--AQPDSD-FPTPK-SDVYCYGVVLLEL 731
            GLA +   G D  +I      G+  Y+ PE    Q  +D F + K +D++ +G+VL E+
Sbjct: 157 LGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 51/253 (20%)
Query: 507 TSNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVK-VLVHGSTLTDQEAARELEYLGRIKHP 564
           +S+F   +LL EG +G V      P G  VA+K +      L      RE++ L   KH 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNV 624
           N++      I   QR    D  EN N   ++ +L                      +  V
Sbjct: 70  NII-----TIFNIQRP---DSFENFNEVYIIQEL------------------MQTDLHRV 103
Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
            S  +L+    ++ I   T RA+  LH G +  +IHRD+K S++ ++ N + ++ DFGLA
Sbjct: 104 ISTQMLSDDHIQYFI-YQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 685 KIFG-------------NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
           +I               +G+ E +A  +  Y  PE     + + +   DV+  G +L EL
Sbjct: 160 RIIDESAADNSEPTGQQSGMTEXVA--TRWYRAPEVMLTSAKY-SRAMDVWSCGCILAEL 216
Query: 732 ITGKKPL--GDDY 742
              ++P+  G DY
Sbjct: 217 FL-RRPIFPGRDY 228

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 4/98 (4%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR--GSP 700
           T + L  + H     I+HRDIK  ++ +D N   ++ DFG+AK        +     G+ 
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176
Query: 701 GYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            Y  PE A+ ++      +D+Y  G+VL E++ G+ P 
Sbjct: 177 QYFSPEQAKGEA--TDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 35/228 (15%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G +       VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L    +                 IQ  G   
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSL----RPEMENNPVLAPPSLSKMIQMAGE-- 140
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
                          A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ +   
Sbjct: 141 --------------IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX 183
Query: 689 NGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
               +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 184 E--TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 45/235 (19%)
Query: 513 GTLLAEGKFGPVYRGFL--PGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLV 567
           G  + EG+FG V++G    P    +AV +    +  +D   ++  +E   + +  HP++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G  I  +    I +    G L++ L      +                    ++ S 
Sbjct: 75  KLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSL--------------------DLASL 113
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L          A   + ALA+L    S   +HRDI A +V +  N   +L DFGL++  
Sbjct: 114 ILY---------AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 161
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLE-LITGKKPL 738
               D    + S G +P ++  P+S +F   T  SDV+ +GV + E L+ G KP 
Sbjct: 162 E---DSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 9/114 (7%)
Query: 634 RF-RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD 692
           RF  H++ +     +  L H     II+RDIK  ++ LD N    L+DFGL+K F   + 
Sbjct: 155 RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF---VA 211
Query: 693 EEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
           +E  R     G+  Y+ P+  +          D +  GV++ EL+TG  P   D
Sbjct: 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 108 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 694 EI---ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 161 RLLNKMXGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSXQEY 217
Query: 751 VSW 753
             W
Sbjct: 218 SDW 220

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 104/241 (43%), Gaps = 41/241 (17%)
Query: 509 NFDRGTLLAEGKFGPVYRG--FLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNL 566
           +F    L+  G FG V++    + G  +V  +V        +++A RE++ L ++ H N+
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV-----KYNNEKAEREVKALAKLDHVNI 67
Query: 567 VPLTGYCIAGDQRIAIYDY---MENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ- 622
           V   G C  G      +DY     + +L++  +D P   +                 IQ 
Sbjct: 68  VHYNG-CWDG------FDYDPETSDDSLESSDYD-PENSKNSSRSKTKCLF------IQM 113
Query: 623 NVGSEGLLTTWRFRHK-------IAL----GTARALAFLHHGCSPPIIHRDIKASSVYLD 671
               +G L  W  + +       +AL       + + ++H   S  +IHRD+K S+++L 
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLV 170
Query: 672 MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
              + ++ DFGL     N      ++G+  Y+ PE  Q  S     + D+Y  G++L EL
Sbjct: 171 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPE--QISSQDYGKEVDLYALGLILAEL 228
Query: 732 I 732
           +
Sbjct: 229 L 229

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 51/253 (20%)
Query: 507 TSNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVK-VLVHGSTLTDQEAARELEYLGRIKHP 564
           +S+F   +LL EG +G V      P G  VA+K +      L      RE++ L   KH 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNV 624
           N++      I   QR    D  EN N   ++ +L                      +  V
Sbjct: 70  NII-----TIFNIQRP---DSFENFNEVYIIQEL------------------MQTDLHRV 103
Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
            S  +L+    ++ I   T RA+  LH G +  +IHRD+K S++ ++ N + ++ DFGLA
Sbjct: 104 ISTQMLSDDHIQYFI-YQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 685 KIFG-------------NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
           +I               +G+ E +A  +  Y  PE     + + +   DV+  G +L EL
Sbjct: 160 RIIDESAADNSEPTGQQSGMTEYVA--TRWYRAPEVMLTSAKY-SRAMDVWSCGCILAEL 216
Query: 732 ITGKKPL--GDDY 742
              ++P+  G DY
Sbjct: 217 FL-RRPIFPGRDY 228

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 101/251 (40%), Gaps = 55/251 (21%)
Query: 508 SNFDRGTLLAEGKFGPVY---RGFLPGGIHVAVKVLVHGSTLTDQEAAR---ELEYLGRI 561
           S+F+   +L +G FG V+   +   P   H+    ++  +TL  ++  R   E + L  +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
            HP +V L        +   I D++  G+L                              
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDL-----------------------------F 118
Query: 622 QNVGSEGLLTTWRFRH---KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRL 678
             +  E + T    +    ++ALG       L H  S  II+RD+K  ++ LD     +L
Sbjct: 119 TRLSKEVMFTEEDVKFYLAELALG-------LDHLHSLGIIYRDLKPENILLDEEGHIKL 171
Query: 679 SDFGLAKIFGNGLDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
           +DFGL+K     +D E       G+  Y+ PE         +  +D + YGV++ E++TG
Sbjct: 172 TDFGLSK---EAIDHEKKAYSFCGTVEYMAPEVVNRQGH--SHSADWWSYGVLMFEMLTG 226
Query: 735 KKPL-GDDYPE 744
             P  G D  E
Sbjct: 227 SLPFQGKDRKE 237

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 81/193 (41%), Gaps = 42/193 (21%)
Query: 554 ELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXX 613
           E+  L +IKHPN+V L              D  E+G    L+  L  G +          
Sbjct: 66  EIAVLHKIKHPNIVALD-------------DIYESGGHLYLIMQLVSGGEL--------- 103
Query: 614 XXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY---L 670
                     +  +G  T  R   ++      A+ +LH      I+HRD+K  ++    L
Sbjct: 104 -------FDRIVEKGFYTE-RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSL 152
Query: 671 DMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE-FAQPDSDFPTPKS-DVYCYGVVL 728
           D + +  +SDFGL+K+   G     A G+PGY+ PE  AQ     P  K+ D +  GV+ 
Sbjct: 153 DEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK----PYSKAVDCWSIGVIA 208
Query: 729 LELITGKKPLGDD 741
             L+ G  P  D+
Sbjct: 209 YILLCGYPPFYDE 221

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 7/84 (8%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDF 714
           ++HRD+K ++V+LD     +L DFGLA+I  +  D   A+   G+P Y+ PE  Q +   
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMSPE--QMNRMS 192
Query: 715 PTPKSDVYCYGVVLLELITGKKPL 738
              KSD++  G +L EL     P 
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 7/84 (8%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDF 714
           ++HRD+K ++V+LD     +L DFGLA+I  +  D   A+   G+P Y+ PE  Q +   
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPE--QMNRMS 192
Query: 715 PTPKSDVYCYGVVLLELITGKKPL 738
              KSD++  G +L EL     P 
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/307 (22%), Positives = 121/307 (39%), Gaps = 55/307 (17%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARE-LEYL-------GRIKHPNLV 567
           L +G FG VY G     I    +  V   T+ +  + RE +E+L       G   H ++V
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 80
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G    G   + + + M +G+L++ L  L                     +  N G  
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL------------------RPEAENNPGRP 122
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
               T +   ++A   A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ +  
Sbjct: 123 P--PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 177
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
                +   +G  G +P  +  P+S      T  SD++ +GVVL E+ +  ++P      
Sbjct: 178 XE--TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY----- 230
Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
                      +GL         +D    D  P+   E    +  +C    P  RP+  +
Sbjct: 231 -----------QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLE 278
Query: 804 IVGLLKD 810
           IV LLKD
Sbjct: 279 IVNLLKD 285

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 78/193 (40%), Gaps = 42/193 (21%)
Query: 554 ELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXX 613
           E+  L +IKHPN+V L     +G     I   +  G L                      
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL---------------------- 103
Query: 614 XXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY---L 670
                     +  +G  T  R   ++      A+ +LH      I+HRD+K  ++    L
Sbjct: 104 -------FDRIVEKGFYTE-RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSL 152
Query: 671 DMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE-FAQPDSDFPTPKS-DVYCYGVVL 728
           D + +  +SDFGL+K+   G     A G+PGY+ PE  AQ     P  K+ D +  GV+ 
Sbjct: 153 DEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK----PYSKAVDCWSIGVIA 208
Query: 729 LELITGKKPLGDD 741
             L+ G  P  D+
Sbjct: 209 YILLCGYPPFYDE 221

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 104/245 (42%), Gaps = 58/245 (23%)
Query: 508 SNFDRGTLLAEGKFGPVYR-GFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNL 566
           S+   G +L +G FG   +      G  + +K L+     T +   +E++ +  ++HPN+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 567 VPLTGYCIAGDQRIA-IYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           +   G  +  D+R+  I +Y++ G L+ +                          I+++ 
Sbjct: 70  LKFIG-VLYKDKRLNFITEYIKGGTLRGI--------------------------IKSMD 102
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
           S+     W  R   A   A  +A+LH   S  IIHRD+ + +  +  N    ++DFGLA+
Sbjct: 103 SQ---YPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLAR 156
Query: 686 IFGNGLDEE------------------IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
           +    +DE+                     G+P ++ PE     S     K DV+ +G+V
Sbjct: 157 LM---VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY--DEKVDVFSFGIV 211
Query: 728 LLELI 732
           L E+I
Sbjct: 212 LCEII 216

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 31/206 (15%)
Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWS-LGSLKSLNLSYNRISGSLPSNIGNFGL 101
           S+P     +L+KL+ L L++N +  LP+ ++  L +L++L ++ N++  +LP  IG    
Sbjct: 51  SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALP--IG---- 103
Query: 102 LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVT-VDLSMNQL 160
             VFD                LV+L  L+LD N  + S+PP + +  + +T + L  N+L
Sbjct: 104 --VFD---------------QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 161 NGSLPDGFGAAFPKLKSLNLAGNEIKGR-DTHFAGLKSITNLNISGNLFQGSVMGVF--L 217
             SLP G       LK L L  N++K   +  F  L  +  L +  N  +    G F  L
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204
Query: 218 ESLEVIDLRSNQFQGHISQVQFNSSY 243
           E L+++ L+ N +    + + + + +
Sbjct: 205 EKLKMLQLQENPWDCTCNGIIYMAKW 230

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 93/238 (39%), Gaps = 59/238 (24%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA--RELEYLGRI--KHPNLVPLTG 571
           + +G++G V+ G   G   VAVKV       T +EA+  RE E    +  +H N++    
Sbjct: 45  IGKGRYGEVWMGKWRGE-KVAVKVF-----FTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 572 YCIAGD----QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
             I G     Q   I DY ENG+L + L    L  +                        
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSML--------------------- 137
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGC-----SPPIIHRDIKASSVYLDMNLEPRLSDFG 682
                     K+A  +   L  LH         P I HRD+K+ ++ +  N    ++D G
Sbjct: 138 ----------KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187
Query: 683 LAKIFGNGLDE-----EIARGSPGYIPPEFAQPDSDFPTPKS----DVYCYGVVLLEL 731
           LA  F +  +E         G+  Y+PPE      +    +S    D+Y +G++L E+
Sbjct: 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 87/214 (40%), Gaps = 45/214 (21%)
Query: 535 VAVKVLVHGSTLTDQEAARELE--YLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQ 592
           VA+K +     L  +E + E E   L +IKHPN+V L     +G     I   +  G L 
Sbjct: 46  VAIKCIAK-KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL- 103
Query: 593 NLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHH 652
                                          +  +G  T  R   ++      A+ +LH 
Sbjct: 104 ----------------------------FDRIVEKGFYTE-RDASRLIFQVLDAVKYLH- 133
Query: 653 GCSPPIIHRDIKASSVY---LDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE-FA 708
                I+HRD+K  ++    LD + +  +SDFGL+K+   G     A G+PGY+ PE  A
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 709 QPDSDFPTPKS-DVYCYGVVLLELITGKKPLGDD 741
           Q     P  K+ D +  GV+   L+ G  P  D+
Sbjct: 192 QK----PYSKAVDCWSIGVIAYILLCGYPPFYDE 221

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 97/260 (37%), Gaps = 67/260 (25%)
Query: 504 LSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG--------------STLTD 548
           L   S+F+   +L +G FG V +        + A+K + H               ++L  
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61
Query: 549 QEAARELEYLGRIKHPNLV-PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXX 607
           Q   R   Y   ++  N V P+T         I + +Y ENG L +L+H   L  Q    
Sbjct: 62  QYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQM-EYCENGTLYDLIHSENLNQQRD-- 116
Query: 608 XXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS 667
                                    WR   +I      AL+++H   S  IIHRD+K  +
Sbjct: 117 -----------------------EYWRLFRQIL----EALSYIH---SQGIIHRDLKPMN 146
Query: 668 VYLDMNLEPRLSDFGLAKIFGNGLD---------------EEIARGSPGYIPPEFAQPDS 712
           +++D +   ++ DFGLAK     LD                  A G+  Y+  E      
Sbjct: 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206
Query: 713 DFPTPKSDVYCYGVVLLELI 732
            +   K D+Y  G++  E+I
Sbjct: 207 HY-NEKIDMYSLGIIFFEMI 225

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 45/235 (19%)
Query: 513 GTLLAEGKFGPVYRGFL--PGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLV 567
           G  + EG+FG V++G    P    +AV +    +  +D   ++  +E   + +  HP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G  I  +    I +    G L++ L      +                    ++ S 
Sbjct: 455 KLIG-VITENPVWIIMELCTLGELRSFLQVRKFSL--------------------DLASL 493
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L          A   + ALA+L    S   +HRDI A +V +  N   +L DFGL++  
Sbjct: 494 ILY---------AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLE-LITGKKPL 738
               D    + S G +P ++  P+S +F   T  SDV+ +GV + E L+ G KP 
Sbjct: 542 E---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 36  SNSGLS--GSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLP 93
           S +GLS  G    +  G +S L+ LDLS N +  + S+   L  L+ L+  +        
Sbjct: 379 SRNGLSFKGCCSQSDFGTIS-LKYLDLSFNGVITMSSNFLGLEQLEHLDFQH-------- 429
Query: 94  SNIGNFGLLEVF---------DLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGL 144
           SN+       VF         D+S+ +         + L SL VLK+ GN FQ +  P +
Sbjct: 430 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 489
Query: 145 LN-CQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH-FAGLKSITNLN 202
               ++L  +DLS  QL    P  F  +   L+ LN++ N     DT  +  L S+  L+
Sbjct: 490 FTELRNLTFLDLSQCQLEQLSPTAFN-SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 548
Query: 203 ISGNLFQGSV---MGVFLESLEVIDLRSNQF 230
            S N    S    +  F  SL  ++L  N F
Sbjct: 549 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 579

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 69/307 (22%), Positives = 121/307 (39%), Gaps = 55/307 (17%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARE-LEYL-------GRIKHPNLV 567
           L +G FG VY G     I    +  V   T+ +  + RE +E+L       G   H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G    G   + + + M +G+L++ L  L                     +  N G  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL------------------RPEAENNPGRP 125
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
               T +   ++A   A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ +  
Sbjct: 126 P--PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
                +   +G  G +P  +  P+S      T  SD++ +GVVL E+ +  ++P      
Sbjct: 181 XE--TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY----- 233
Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
                      +GL         +D    D  P+   E    +  +C    P  RP+  +
Sbjct: 234 -----------QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLE 281
Query: 804 IVGLLKD 810
           IV LLKD
Sbjct: 282 IVNLLKD 288

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 108 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 694 EI---ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P
Sbjct: 161 RLLNKMXGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 134/310 (43%), Gaps = 54/310 (17%)
Query: 18  WRGVVCDSNKQHVTDFLASNSGLS--------------GSVPDTTIGKLSKLQSLDLSEN 63
           W G   D++ Q++T   A+  GL                 +  +T    +++Q LDL+  
Sbjct: 230 WLGTFEDTDDQYLTS--ATFEGLCDMSVESINLQKHRFSDLSSSTFRCFTRVQELDLTAA 287
Query: 64  NITALPSDLWSLGSLKSLNLSYNRI-------SGSLPS-------------NIGNFGLLE 103
           ++  LPS +  + SLK L L+ N         + S PS             ++G   L +
Sbjct: 288 HLNGLPSGIEGMNSLKKLVLNANSFDQLCQINAASFPSLRDLYIKGNMRKLDLGTRCLEK 347
Query: 104 VFDLSNNNFS-GEIPAAISSLVSLRVLK-LDGNMFQWSIPPGLLN-----CQSLVTVDLS 156
           + +L   + S  +I A+    + L+ L+ L      ++ P GL +     C  L  +D++
Sbjct: 348 LENLQKLDLSHSDIEASDCCNLQLKNLRHLQYLNLSYNEPLGLEDQAFKECPQLELLDVA 407
Query: 157 MNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH-FAGLKSITNLNISGNLFQ-GSVMG 214
              L+   P         L+ LNL+   +   + H  AGL+ + +LN+ GN FQ GS+  
Sbjct: 408 FTHLHVKAPHSPFQNLHLLRVLNLSHCLLDTSNQHLLAGLQDLRHLNLQGNSFQDGSISK 467
Query: 215 V----FLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQ 270
                 + SLE++ L S      I Q  F+   N + L   DLS N L+G+     S  +
Sbjct: 468 TNLLQMVGSLEILILSSCNLLS-IDQQAFHGLRNVNHL---DLSHNSLTGDSMDALSHLK 523
Query: 271 NLKHLSLAYN 280
            L +L++A N
Sbjct: 524 GL-YLNMASN 532

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 37/229 (16%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G +       VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L    +                 IQ  G   
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSL----RPEMENNPVLAPPSLSKMIQMAGE-- 137
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IF 687
                          A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ + I+
Sbjct: 138 --------------IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 180
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 181 ET---DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 37/229 (16%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G +       VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L    +                 IQ  G   
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSL----RPEMENNPVLAPPSLSKMIQMAGE-- 133
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IF 687
                          A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ + I+
Sbjct: 134 --------------IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 176
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 177 ET---DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 109 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 694 EI---ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P
Sbjct: 162 RLLNKMXGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 45/214 (21%)
Query: 535 VAVKVLVHGSTLTDQEAARELE--YLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQ 592
           VA+K +     L  +E + E E   L +IKHPN+V L              D  E+G   
Sbjct: 46  VAIKCIAK-EALEGKEGSMENEIAVLHKIKHPNIVALD-------------DIYESGGHL 91
Query: 593 NLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHH 652
            L+  L  G +                    +  +G  T  R   ++      A+ +LH 
Sbjct: 92  YLIMQLVSGGEL----------------FDRIVEKGFYTE-RDASRLIFQVLDAVKYLH- 133
Query: 653 GCSPPIIHRDIKASSVY---LDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE-FA 708
                I+HRD+K  ++    LD + +  +SDFGL+K+   G     A G+PGY+ PE  A
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 709 QPDSDFPTPKS-DVYCYGVVLLELITGKKPLGDD 741
           Q     P  K+ D +  GV+   L+ G  P  D+
Sbjct: 192 QK----PYSKAVDCWSIGVIAYILLCGYPPFYDE 221

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 37/229 (16%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G +       VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L    +                 IQ  G   
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSL----RPAMANNPVLAPPSLSKMIQMAGE-- 136
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IF 687
                          A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ + I+
Sbjct: 137 --------------IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 179
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 180 ET---DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 9/103 (8%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEP---RLSDFGLAKIFGNGLDEEIARGSPGY 702
            + +LH      I+HRD+K  ++ L+   +    ++ DFGL+ +F N    +   G+  Y
Sbjct: 148 GVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYY 204
Query: 703 IPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
           I PE  +   D    K DV+  GV+L  L+ G  P G    +E
Sbjct: 205 IAPEVLRKKYD---EKCDVWSIGVILFILLAGYPPFGGQTDQE 244

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 37/229 (16%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G +       VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L    +                 IQ  G   
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSL----RPEMENNPVLAPPSLSKMIQMAGE-- 140
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IF 687
                          A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ + I+
Sbjct: 141 --------------IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 183
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 184 ET---DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 108 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 161 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 217
Query: 751 VSW 753
             W
Sbjct: 218 SDW 220

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 108 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 694 EI---ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P
Sbjct: 161 RLLNKMXGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 45/235 (19%)
Query: 513 GTLLAEGKFGPVYRGFL--PGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLV 567
           G  + EG+FG V++G    P    +AV +    +  +D   ++  +E   + +  HP++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G  I  +    I +    G L++ L                            V   
Sbjct: 75  KLIG-VITENPVWIIMELCTLGELRSFLQ---------------------------VRKY 106
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L       +   L TA  LA+L    S   +HRDI A +V +  N   +L DFGL++  
Sbjct: 107 SLDLASLILYAYQLSTA--LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 161
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLE-LITGKKPL 738
               D    + S G +P ++  P+S +F   T  SDV+ +GV + E L+ G KP 
Sbjct: 162 E---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 97/244 (39%), Gaps = 36/244 (14%)
Query: 501 ADLLSATSNFDRG---TLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELE 556
           +DLL     +D      +L +G +G VY G  L   + +A+K +    +   Q    E+ 
Sbjct: 12  SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIA 71
Query: 557 YLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXX 616
               +KH N+V   G             + ENG ++  +  +P G               
Sbjct: 72  LHKHLKHKNIVQYLG------------SFSENGFIKIFMEQVPGG---SLSALLRSKWGP 116
Query: 617 XXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD-MNLE 675
             ++ Q +G         F  K  L     L +LH      I+HRDIK  +V ++  +  
Sbjct: 117 LKDNEQTIG---------FYTKQIL---EGLKYLHDN---QIVHRDIKGDNVLINTYSGV 161
Query: 676 PRLSDFGLAK-IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
            ++SDFG +K + G     E   G+  Y+ PE            +D++  G  ++E+ TG
Sbjct: 162 LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221
Query: 735 KKPL 738
           K P 
Sbjct: 222 KPPF 225

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 45/235 (19%)
Query: 513 GTLLAEGKFGPVYRGFLPG----GIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLV 567
           G  + EG+FG V++G         + VA+K   + ++ + +E   +E   + +  HP++V
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G  I  +    I +    G L++ L                            V   
Sbjct: 103 KLIG-VITENPVWIIMELCTLGELRSFLQ---------------------------VRKY 134
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L       +   L TA  LA+L    S   +HRDI A +V +  N   +L DFGL++  
Sbjct: 135 SLDLASLILYAYQLSTA--LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 189
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLE-LITGKKPL 738
               D    + S G +P ++  P+S +F   T  SDV+ +GV + E L+ G KP 
Sbjct: 190 E---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 241

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 7/102 (6%)
Query: 659 IHRDIKASSVYLDMNLEPRLSDFG-LAKIFGNG-LDEEIARGSPGYIPPEFAQP-----D 711
           +HRDIK  ++ LD     RL+DFG   K+  +G +   +A G+P Y+ PE  Q       
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 712 SDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSW 753
           +    P+ D +  GV   E+  G+ P   D   E  G +V +
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 109 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 162 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 218
Query: 751 VSW 753
             W
Sbjct: 219 SDW 221

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 37/229 (16%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G +       VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L    +                 IQ  G   
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSL----RPEMENNPVLAPPSLSKMIQMAGE-- 139
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IF 687
                          A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ + I+
Sbjct: 140 --------------IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 182
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 183 ET---DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 37/229 (16%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G +       VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L    +                 IQ  G   
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSL----RPEMENNPVLAPPSLSKMIQMAGE-- 139
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IF 687
                          A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ + I+
Sbjct: 140 --------------IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 182
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 183 ET---DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 45/235 (19%)
Query: 513 GTLLAEGKFGPVYRGFL--PGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLV 567
           G  + EG+FG V++G    P    +AV +    +  +D   ++  +E   + +  HP++V
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G  I  +    I +    G L++ L                            V   
Sbjct: 78  KLIG-VITENPVWIIMELCTLGELRSFLQ---------------------------VRKY 109
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L       +   L TA  LA+L    S   +HRDI A +V +  N   +L DFGL++  
Sbjct: 110 SLDLASLILYAYQLSTA--LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 164
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLE-LITGKKPL 738
               D    + S G +P ++  P+S +F   T  SDV+ +GV + E L+ G KP 
Sbjct: 165 E---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 216

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 45/235 (19%)
Query: 513 GTLLAEGKFGPVYRGFLPG----GIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLV 567
           G  + EG+FG V++G         + VA+K   + ++ + +E   +E   + +  HP++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G  I  +    I +    G L++ L                            V   
Sbjct: 80  KLIGV-ITENPVWIIMELCTLGELRSFLQ---------------------------VRKY 111
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L       +   L TA  LA+L    S   +HRDI A +V +  N   +L DFGL++  
Sbjct: 112 SLDLASLILYAYQLSTA--LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLE-LITGKKPL 738
               D    + S G +P ++  P+S +F   T  SDV+ +GV + E L+ G KP 
Sbjct: 167 E---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 37/229 (16%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G +       VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L    +                 IQ  G   
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSL----RPEMENNPVLAPPSLSKMIQMAGE-- 168
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IF 687
                          A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ + I+
Sbjct: 169 --------------IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 211
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 212 ET---DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 11/97 (11%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEP----RLSDFGLAKIFGNGLDEEIARGSPG 701
           ALA+ H   S  ++H+D+K  ++ L  +  P    ++ DFGLA++F +      A G+  
Sbjct: 136 ALAYFH---SQHVVHKDLKPENI-LFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL 191
Query: 702 YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           Y+ PE  + D  F   K D++  GVV+  L+TG  P 
Sbjct: 192 YMAPEVFKRDVTF---KCDIWSAGVVMYFLLTGCLPF 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 45/235 (19%)
Query: 513 GTLLAEGKFGPVYRGFL--PGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLV 567
           G  + EG+FG V++G    P    +AV +    +  +D   ++  +E   + +  HP++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G  I  +    I +    G L++ L                            V   
Sbjct: 75  KLIG-VITENPVWIIMELCTLGELRSFLQ---------------------------VRKY 106
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L       +   L TA  LA+L    S   +HRDI A +V +  N   +L DFGL++  
Sbjct: 107 SLDLASLILYAYQLSTA--LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 161
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLE-LITGKKPL 738
               D    + S G +P ++  P+S +F   T  SDV+ +GV + E L+ G KP 
Sbjct: 162 E---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 45/235 (19%)
Query: 513 GTLLAEGKFGPVYRGFL--PGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLV 567
           G  + EG+FG V++G    P    +AV +    +  +D   ++  +E   + +  HP++V
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G  I  +    I +    G L++ L                            V   
Sbjct: 72  KLIG-VITENPVWIIMELCTLGELRSFLQ---------------------------VRKY 103
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L       +   L TA  LA+L    S   +HRDI A +V +  N   +L DFGL++  
Sbjct: 104 SLDLASLILYAYQLSTA--LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLE-LITGKKPL 738
               D    + S G +P ++  P+S +F   T  SDV+ +GV + E L+ G KP 
Sbjct: 159 E---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 45/235 (19%)
Query: 513 GTLLAEGKFGPVYRGFL--PGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLV 567
           G  + EG+FG V++G    P    +AV +    +  +D   ++  +E   + +  HP++V
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G  I  +    I +    G L++ L                            V   
Sbjct: 77  KLIGV-ITENPVWIIMELCTLGELRSFLQ---------------------------VRKY 108
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L       +   L TA  LA+L    S   +HRDI A +V +  N   +L DFGL++  
Sbjct: 109 SLDLASLILYAYQLSTA--LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 163
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLE-LITGKKPL 738
               D    + S G +P ++  P+S +F   T  SDV+ +GV + E L+ G KP 
Sbjct: 164 E---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 215

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/308 (22%), Positives = 122/308 (39%), Gaps = 57/308 (18%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARE-LEYL-------GRIKHPNLV 567
           L +G FG VY G     I    +  V   T+ +  + RE +E+L       G   H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G    G   + + + M +G+L++ L  L                     +  N G  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL------------------RPEAENNPGRP 125
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-I 686
               T +   ++A   A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ + I
Sbjct: 126 P--PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
           +         +G  G +P  +  P+S      T  SD++ +GVVL E+ +  ++P     
Sbjct: 181 YETAY---YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY---- 233
Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
                       +GL         +D    D  P+   E    +  +C    P  RP+  
Sbjct: 234 ------------QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFL 280
Query: 803 QIVGLLKD 810
           +IV LLKD
Sbjct: 281 EIVNLLKD 288

>pdb|3O6N|A Chain A, Crystal Structure Of Apl1 Leucine-Rich Repeat Domain Length = 390

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 117/257 (45%), Gaps = 38/257 (14%)
Query: 117 PAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAFPKL 175
           P    ++  L VL L+ N    S+P G+  N   L T+ +S N L     D F A    L
Sbjct: 110 PHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT-TSL 167
Query: 176 KSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHIS 235
           ++L L+ N +   D   + + S+ + N+S NL     + + +E L+      N  +G ++
Sbjct: 168 QNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVN 225
Query: 236 ------QVQFNSS------YNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFT 283
                 ++Q N+        N+  LV VDLS N+L   ++H F + Q L+ L ++ NR  
Sbjct: 226 VELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
Query: 284 R-----QEFPQIGTLLGLEH---LNLSRTSLIGD-IPSEILQLSSLHTLDLSMNHLTGQI 334
                 Q  P +  +L L H   L++ R     D + +  L  +S+ TL LS +H     
Sbjct: 286 ALNLYGQPIPTLK-VLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHH----- 339
Query: 335 PTVSAKNLGIIDMSHNN 351
              + KNL    +SHN+
Sbjct: 340 ---TLKNLT---LSHND 350

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 109 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P
Sbjct: 162 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 50/248 (20%)
Query: 515 LLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGY 572
           +L  G F  V+  +  L G +  A+K +       D     E+  L +IKH N+V L   
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKL-FALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 573 CIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTT 632
             +      +   +  G L + +  L  GV                  IQ V S      
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDASLV---------IQQVLS------ 117
Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV-YL--DMNLEPRLSDFGLAKIFGN 689
                        A+ +LH      I+HRD+K  ++ YL  + N +  ++DFGL+K+  N
Sbjct: 118 -------------AVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
Query: 690 GLDEEIARGSPGYIPPE-FAQPDSDFPTPKS-DVYCYGVVLLELITGKKPLGDDYPEEKE 747
           G+    A G+PGY+ PE  AQ     P  K+ D +  GV+   L+ G  P    + EE E
Sbjct: 162 GI-MSTACGTPGYVAPEVLAQK----PYSKAVDCWSIGVITYILLCGYPP----FYEETE 212
Query: 748 GNLVSWVR 755
             L   ++
Sbjct: 213 SKLFEKIK 220

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 108 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P
Sbjct: 161 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 69/307 (22%), Positives = 121/307 (39%), Gaps = 55/307 (17%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARE-LEYL-------GRIKHPNLV 567
           L +G FG VY G     I    +  V   T+ +  + RE +E+L       G   H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G    G   + + + M +G+L++ L  L                     +  N G  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL------------------RPEAENNPGRP 125
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
               T +   ++A   A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ +  
Sbjct: 126 P--PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
                +   +G  G +P  +  P+S      T  SD++ +GVVL E+ +  ++P      
Sbjct: 181 XE--TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY----- 233
Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
                      +GL         +D    D  P+   E    +  +C    P  RP+  +
Sbjct: 234 -----------QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLE 281
Query: 804 IVGLLKD 810
           IV LLKD
Sbjct: 282 IVNLLKD 288

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 108 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P
Sbjct: 161 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 108 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 161 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 217
Query: 751 VSW 753
             W
Sbjct: 218 SDW 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 51/253 (20%)
Query: 507 TSNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVK-VLVHGSTLTDQEAARELEYLGRIKHP 564
           +S+F   +LL EG +G V      P G  VA+K +      L      RE++ L   KH 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNV 624
           N++      I   QR    D  EN N   ++ +L                      +  V
Sbjct: 70  NII-----TIFNIQRP---DSFENFNEVYIIQEL------------------MQTDLHRV 103
Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
            S  +L+    ++ I   T RA+  LH G +  +IHRD+K S++ ++ N + ++ DFGLA
Sbjct: 104 ISTQMLSDDHIQYFI-YQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 685 KIFG-------------NGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
           +I               +G+ E +A  +  Y  PE     + + +   DV+  G +L EL
Sbjct: 160 RIIDESAADNSEPTGQQSGMVEFVA--TRWYRAPEVMLTSAKY-SRAMDVWSCGCILAEL 216
Query: 732 ITGKKPL--GDDY 742
              ++P+  G DY
Sbjct: 217 FL-RRPIFPGRDY 228

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 108 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 161 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 217
Query: 751 VSW 753
             W
Sbjct: 218 SDW 220

>pdb|3OJA|B Chain B, Crystal Structure Of Lrim1APL1C COMPLEX Length = 597

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 85/349 (24%), Positives = 148/349 (42%), Gaps = 66/349 (18%)
Query: 26  NKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLG-SLKSLNLS 84
           N Q +  F   NS +   +P   +    +++ L+L++  I  + +  ++   +++ L + 
Sbjct: 51  NNQKIVTF--KNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107
Query: 85  YNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGL 144
           +N I    P    N  LL V  L  N+ S                         S+P G+
Sbjct: 108 FNAIRYLPPHVFQNVPLLTVLVLERNDLS-------------------------SLPRGI 142
Query: 145 L-NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNI 203
             N   L T+ +S N L     D F A    L++L L+ N +   D   + + S+ + N+
Sbjct: 143 FHNTPKLTTLSMSNNNLERIEDDTFQAT-TSLQNLQLSSNRLTHVD--LSLIPSLFHANV 199
Query: 204 SGNLFQGSVMGVFLESLEVIDLRSNQFQGHIS------QVQFNSS------YNWSRLVYV 251
           S NL     + + +E L+      N  +G ++      ++Q N+        N+  LV V
Sbjct: 200 SYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEV 259
Query: 252 DLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTR-----QEFPQIGTLLGLEH---LNLSR 303
           DLS N+L   ++H F + Q L+ L ++ NR        Q  P +  +L L H   L++ R
Sbjct: 260 DLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLK-VLDLSHNHLLHVER 318
Query: 304 TSLIGD-IPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNN 351
                D + +  L  +S+ TL LS +H        + KNL    +SHN+
Sbjct: 319 NQPQFDRLENLYLDHNSIVTLKLSTHH--------TLKNLT---LSHND 356

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 109 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 162 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 218
Query: 751 VSW 753
             W
Sbjct: 219 SDW 221

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 109 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 162 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 218
Query: 751 VSW 753
             W
Sbjct: 219 SDW 221

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 109 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 162 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 218
Query: 751 VSW 753
             W
Sbjct: 219 SDW 221

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 13/123 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 107 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P +     
Sbjct: 160 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 216
Query: 751 VSW 753
             W
Sbjct: 217 SDW 219

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           RF H++  G    + +LH G    I HRDIK  ++ LD     ++SDFGLA +F     E
Sbjct: 109 RFFHQLMAG----VVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 694 EIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
            +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P
Sbjct: 162 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 37/229 (16%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G +       VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L    +                 IQ  G   
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSL----RPEMENNPVLAPPSLSKMIQMAGE-- 133
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IF 687
                          A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ + I+
Sbjct: 134 --------------IADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIY 176
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 177 ET---DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 85/233 (36%), Gaps = 43/233 (18%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKHPNLVPLTGY 572
           +  G F  VY+G             +    LT  E  R   E E L  ++HPN+V     
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 573 ---CIAGDQRIA-IYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
               + G + I  + +   +G L+  L                            V    
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRF------------------------KVXKIK 129
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNL-EPRLSDFGLAKIF 687
           +L +W           + L FLH   +PPIIHRD+K  ++++       ++ D GLA + 
Sbjct: 130 VLRSW------CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
                + +  G+P +  PE  +   D      DVY +G   LE  T + P  +
Sbjct: 183 RASFAKAVI-GTPEFXAPEXYEEKYD---ESVDVYAFGXCXLEXATSEYPYSE 231

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 101/243 (41%), Gaps = 44/243 (18%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIH-VAVKVL--VHGSTLTDQEAARELEYLGRIK 562
           ATS ++    +  G +G VY+   P   H VA+K +   +G         RE+  L R++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 563 ---HPNLVPLTGYCIAG--DQRIAIYDYME--NGNLQNLLHDLPLGVQXXXXXXXXXXXX 615
              HPN+V L   C     D+ I +    E  + +L+  L   P                
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP-------------PPG 108
Query: 616 XXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE 675
               +I+++  + L               R L FLH  C   I+HRD+K  ++ +     
Sbjct: 109 LPAETIKDLMRQFL---------------RGLDFLHANC---IVHRDLKPENILVTSGGT 150
Query: 676 PRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
            +L+DFGLA+I+   +  +    +  Y  PE     S + TP  D++  G +  E+   +
Sbjct: 151 VKLADFGLARIYSYQMALDPVVVTLWYRAPEVLL-QSTYATP-VDMWSVGCIFAEMFR-R 207
Query: 736 KPL 738
           KPL
Sbjct: 208 KPL 210

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/308 (22%), Positives = 123/308 (39%), Gaps = 57/308 (18%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARE-LEYL-------GRIKHPNLV 567
           L +G FG VY G     I    +  V   T+ +  + RE +E+L       G   H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G    G   + + + M +G+L++ L  L                     +  N G  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL------------------RPEAENNPGRP 125
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-I 686
               T +   ++A   A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ + I
Sbjct: 126 P--PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
           +     +   +G  G +P  +  P+S      T  SD++ +GVVL E+ +  ++P     
Sbjct: 181 YET---DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY---- 233
Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
                       +GL         +D    D  P+   E    +  +C    P  RP+  
Sbjct: 234 ------------QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFL 280
Query: 803 QIVGLLKD 810
           +IV LLKD
Sbjct: 281 EIVNLLKD 288

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           K+++   + L +L       I+HRD+K S++ ++   E +L DFG++    + +      
Sbjct: 127 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 183
Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
           G+  Y+ PE  Q      + +SD++  G+ L+E+  G+ P+G
Sbjct: 184 GTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIG 223

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 80/213 (37%), Gaps = 39/213 (18%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK +  G  + D+   RE+     ++HPN+V      +       + +Y   G L   
Sbjct: 47  VAVKYIERGEKI-DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--- 102
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
                                     I N G         F  ++  G + A A      
Sbjct: 103 -----------------------FERICNAGRFSEDEARFFFQQLISGVSYAHAM----- 134
Query: 655 SPPIIHRDIKASSVYLDMNLEPRL--SDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS 712
              + HRD+K  +  LD +  PRL  +DFG +K        + A G+P YI PE      
Sbjct: 135 --QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL-KK 191
Query: 713 DFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
           ++    +DV+  GV L  ++ G  P  D  PEE
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFED--PEE 222

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 91/229 (39%), Gaps = 37/229 (16%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G +       VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L    +                 IQ  G   
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSL----RPAMANNPVLAPPSLSKMIQMAGE-- 146
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IF 687
                          A  +A+L+       +HRD+ A +  +  +   ++ DFG+ + I+
Sbjct: 147 --------------IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 190 ET---DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 76/328 (23%), Positives = 130/328 (39%), Gaps = 69/328 (21%)
Query: 504 LSATSNFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVLVHGS--TLTDQEAARELEYLG 559
             +   ++   L+ EG +G V   R    G I VA+K  +      +  + A RE++ L 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRI-VAIKKFLESDDDKMVKKIAMREIKLLK 79
Query: 560 RIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXN 619
           +++H NLV L   C    +   +++++++     +L DL L                   
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELF------------------ 117
Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                   GL   ++   K        + F H   S  IIHRDIK  ++ +  +   +L 
Sbjct: 118 ------PNGL--DYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLC 166
Query: 680 DFGLAKIF---GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           DFG A+     G   D+E+A  +  Y  PE    D  +     DV+  G ++ E+  G +
Sbjct: 167 DFGFARTLAAPGEVYDDEVA--TRWYRAPELLVGDVKYGKA-VDVWAIGCLVTEMFMG-E 222
Query: 737 PLGDDYPEEKE-----------GNLVSWVRGLVRNN---KGSRAIDPKIRDTGP-----E 777
           PL   +P + +           GNL+   + L   N    G R   P+I++  P      
Sbjct: 223 PL---FPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL--PEIKEREPLERRYP 277
Query: 778 KQMEEALKIGYLCTADLPLKRPSMQQIV 805
           K  E  + +   C    P KRP   +++
Sbjct: 278 KLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 91/229 (39%), Gaps = 37/229 (16%)
Query: 516 LAEGKFGPVYRGFLPGGI------HVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L +G FG VY G   G +       VA+K +   +++ ++ E   E   +      ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           L G    G   + I + M  G+L++ L  L    +                 IQ  G   
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSL----RPEMENNPVLAPPSLSKMIQMAGE-- 146
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-IF 687
                          A  +A+L+       +HRD+ A +  +  +   ++ DFG+ + I+
Sbjct: 147 --------------IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT 733
                +   +G  G +P  +  P+S      T  SDV+ +GVVL E+ T
Sbjct: 190 ET---DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 101/252 (40%), Gaps = 57/252 (22%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIH-------VAVKVLVHGSTLTDQEAAR---ELEY 557
           S F+   +L +G FG V   FL   I         A+KVL   +TL  ++  R   E + 
Sbjct: 24  SQFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDI 79
Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXX 617
           L  + HP +V L        +   I D++  G+L                          
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-------------------------- 113
Query: 618 XNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
                 +  E + T    +  +A   A AL  LH   S  II+RD+K  ++ LD     +
Sbjct: 114 ---FTRLSKEVMFTEEDVKFYLA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIK 166
Query: 678 LSDFGLAKIFGNGLDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT 733
           L+DFGL+K     +D E       G+  Y+ PE         T  +D + +GV++ E++T
Sbjct: 167 LTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLT 221
Query: 734 GKKPL-GDDYPE 744
           G  P  G D  E
Sbjct: 222 GTLPFQGKDRKE 233

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           K+++   R LA+L       I+HRD+K S++ ++   E +L DFG++    + +      
Sbjct: 118 KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 174
Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           G+  Y+ PE  Q      + +SD++  G+ L+EL  G+ P+
Sbjct: 175 GTRSYMAPERLQ--GTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 26/218 (11%)
Query: 29  HVTDFLASNSGLS--GSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYN 86
            +T    S++GLS  G    +  G  S L+ LDLS N +  + S+   L  L+ L+  + 
Sbjct: 53  QLTKLSLSSNGLSFKGCCSQSDFGTTS-LKYLDLSFNGVITMSSNFLGLEQLEHLDFQH- 110
Query: 87  RISGSLPSNIGNFGLLEVF---------DLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQ 137
                  SN+       VF         D+S+ +         + L SL VLK+ GN FQ
Sbjct: 111 -------SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163
Query: 138 WSIPPGLLN-CQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH-FAGL 195
            +  P +    ++L  +DLS  QL    P  F  +   L+ LN++ N     DT  +  L
Sbjct: 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN-SLSSLQVLNMSHNNFFSLDTFPYKCL 222
Query: 196 KSITNLNISGNLFQGSV---MGVFLESLEVIDLRSNQF 230
            S+  L+ S N    S    +  F  SL  ++L  N F
Sbjct: 223 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 101/252 (40%), Gaps = 57/252 (22%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIH-------VAVKVLVHGSTLTDQEAAR---ELEY 557
           S F+   +L +G FG V   FL   I         A+KVL   +TL  ++  R   E + 
Sbjct: 25  SQFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDI 80
Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXX 617
           L  + HP +V L        +   I D++  G+L                          
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-------------------------- 114
Query: 618 XNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
                 +  E + T    +  +A   A AL  LH   S  II+RD+K  ++ LD     +
Sbjct: 115 ---FTRLSKEVMFTEEDVKFYLA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIK 167
Query: 678 LSDFGLAKIFGNGLDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT 733
           L+DFGL+K     +D E       G+  Y+ PE         T  +D + +GV++ E++T
Sbjct: 168 LTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLT 222
Query: 734 GKKPL-GDDYPE 744
           G  P  G D  E
Sbjct: 223 GTLPFQGKDRKE 234

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 49/232 (21%)
Query: 516 LAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLVPLT 570
           +  G FG VY  R      + VA+K + +    ++   Q+  +E+ +L +++HPN +   
Sbjct: 23  IGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           G  +       + +Y   G+  +LL  H  PL                     Q V    
Sbjct: 82  GCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---------------------QEVEIAA 119
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
                     +  G  + LA+LH   S  +IHRD+KA ++ L      +L DFG A I  
Sbjct: 120 ----------VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166
Query: 689 NGLDEEIARGSPGYIPPE--FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
                    G+P ++ PE   A  +  +   K DV+  G+  +EL   K PL
Sbjct: 167 PA---NXFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPL 214

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL +LH      +++RD+K  ++ LD +   +++DFGL K    +G   +   G+P Y+ 
Sbjct: 260 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317
Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 318 PEVLE-DNDYGRA-VDWWGLGVVMYEMMCGRLPF 349

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL +LH      +++RD+K  ++ LD +   +++DFGL K    +G   +   G+P Y+ 
Sbjct: 263 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 320
Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 321 PEVLE-DNDYGRA-VDWWGLGVVMYEMMCGRLPF 352

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 45/235 (19%)
Query: 513 GTLLAEGKFGPVYRGFL--PGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLV 567
           G  + EG+FG V++G    P    +AV +    +  +D   ++  +E   + +  HP++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G  I  +    I +    G L++ L      +                    ++ S 
Sbjct: 75  KLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSL--------------------DLASL 113
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L          A   + ALA+L    S   +HRDI A +V +      +L DFGL++  
Sbjct: 114 ILY---------AYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM 161
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLE-LITGKKPL 738
               D    + S G +P ++  P+S +F   T  SDV+ +GV + E L+ G KP 
Sbjct: 162 E---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 70/308 (22%), Positives = 123/308 (39%), Gaps = 57/308 (18%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARE-LEYL-------GRIKHPNLV 567
           L +G FG VY G     I    +  V   T+ +  + RE +E+L       G   H ++V
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 82
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G    G   + + + M +G+L++ L  L                     +  N G  
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL------------------RPEAENNPGRP 124
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-I 686
               T +   ++A   A  +A+L+   +   +HRD+ A +  +  +   ++ DFG+ + I
Sbjct: 125 P--PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 179
Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
           +     +   +G  G +P  +  P+S      T  SD++ +GVVL E+ +  ++P     
Sbjct: 180 YET---DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY---- 232
Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
                       +GL         +D    D  P+   E    +  +C    P  RP+  
Sbjct: 233 ------------QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFL 279
Query: 803 QIVGLLKD 810
           +IV LLKD
Sbjct: 280 EIVNLLKD 287

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 61/244 (25%)
Query: 516 LAEGKFGPVYRGFL----PGGIHVAVKVLVHGSTLTD-------QEAARELEYLGRIKHP 564
           L E +FG VY+G L    PG    AV +     TL D       +E   E     R++HP
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAI----KTLKDKAEGPLREEFRHEAMLRARLQHP 89
Query: 565 NLVPLTGYCIAGDQRIA-IYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           N+V L G  +  DQ ++ I+ Y  +G+L   L                       ++  +
Sbjct: 90  NVVCLLG-VVTKDQPLSMIFSYCSHGDLHEFL-------------VMRSPHSDVGSTDDD 135
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFL--HHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
              +  L    F H +A   A  + +L  HH     ++H+D+   +V +   L  ++SD 
Sbjct: 136 RTVKSALEPPDFVHLVA-QIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDL 189
Query: 682 GL---------AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLL 729
           GL          K+ GN L           +P  +  P++      +  SD++ YGVVL 
Sbjct: 190 GLFREVYAADYYKLLGNSL-----------LPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 238
Query: 730 ELIT 733
           E+ +
Sbjct: 239 EVFS 242

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 100/243 (41%), Gaps = 44/243 (18%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIH-VAVKVL--VHGSTLTDQEAARELEYLGRIK 562
           ATS ++    +  G +G VY+   P   H VA+K +   +G         RE+  L R++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 563 ---HPNLVPLTGYCIAG--DQRIAIYDYME--NGNLQNLLHDLPLGVQXXXXXXXXXXXX 615
              HPN+V L   C     D+ I +    E  + +L+  L   P                
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP-------------PPG 108
Query: 616 XXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE 675
               +I+++  + L               R L FLH  C   I+HRD+K  ++ +     
Sbjct: 109 LPAETIKDLMRQFL---------------RGLDFLHANC---IVHRDLKPENILVTSGGT 150
Query: 676 PRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
            +L+DFGLA+I+   +       +  Y  PE     S + TP  D++  G +  E+   +
Sbjct: 151 VKLADFGLARIYSYQMALAPVVVTLWYRAPEVLL-QSTYATP-VDMWSVGCIFAEMFR-R 207
Query: 736 KPL 738
           KPL
Sbjct: 208 KPL 210

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 115/310 (37%), Gaps = 67/310 (21%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKHPNLVPL 569
           G  +  G FG V+ G L    +  V V     TL     A+   E   L +  HPN+V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRAD-NTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G C        + + ++ G+    L                              +EG 
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLR-----------------------------TEGA 208
Query: 630 LTTWRFRHKIAL----GTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
               R R K  L      A  + +L   C    IHRD+ A +  +      ++SDFG+++
Sbjct: 209 ----RLRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSR 261
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDD 741
              +G+    A G    +P ++  P++      + +SDV+ +G++L E  + G  P    
Sbjct: 262 EEADGV--XAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP---- 315
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP         +V       KG R   P++      + ME+       C A  P +RPS 
Sbjct: 316 YPNLSNQQTREFV------EKGGRLPCPELCPDAVFRLMEQ-------CWAYEPGQRPSF 362
Query: 802 QQIVGLLKDI 811
             I   L+ I
Sbjct: 363 STIYQELQSI 372

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 45/235 (19%)
Query: 513 GTLLAEGKFGPVYRGFL--PGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLV 567
           G  + EG+FG V++G    P    +AV +    +  +D   ++  +E   + +  HP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G  I  +    I +    G L++ L      +                    ++ S 
Sbjct: 455 KLIG-VITENPVWIIMELCTLGELRSFLQVRKFSL--------------------DLASL 493
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            L          A   + ALA+L    S   +HRDI A +V +      +L DFGL++  
Sbjct: 494 ILY---------AYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM 541
Query: 688 GNGLDEEIARGSPGYIPPEFAQPDS-DFP--TPKSDVYCYGVVLLE-LITGKKPL 738
               D    + S G +P ++  P+S +F   T  SDV+ +GV + E L+ G KP 
Sbjct: 542 E---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA-RGSPG 701
           TA+ ++ L H     II+RD+K  +V LD +   R+SD GLA     G  +     G+PG
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 702 YIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           ++ PE     + DF     D +  GV L E+I  + P 
Sbjct: 355 FMAPELLLGEEYDFSV---DYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA-RGSPG 701
           TA+ ++ L H     II+RD+K  +V LD +   R+SD GLA     G  +     G+PG
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 702 YIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           ++ PE     + DF     D +  GV L E+I  + P 
Sbjct: 355 FMAPELLLGEEYDFSV---DYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA-RGSPG 701
           TA+ ++ L H     II+RD+K  +V LD +   R+SD GLA     G  +     G+PG
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 702 YIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           ++ PE     + DF     D +  GV L E+I  + P 
Sbjct: 355 FMAPELLLGEEYDFSV---DYFALGVTLYEMIAARGPF 389

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 49/232 (21%)
Query: 516 LAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIKHPNLVPLT 570
           +  G FG VY  R      + VA+K + +    ++   Q+  +E+ +L +++HPN +   
Sbjct: 62  IGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 571 GYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
           G  +       + +Y   G+  +LL  H  PL                     Q V    
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASDLLEVHKKPL---------------------QEVEIAA 158
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
                     +  G  + LA+LH   S  +IHRD+KA ++ L      +L DFG A I  
Sbjct: 159 ----------VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205
Query: 689 NGLDEEIARGSPGYIPPE--FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
                    G+P ++ PE   A  +  +   K DV+  G+  +EL   K PL
Sbjct: 206 PA---NXFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPL 253

>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 81/170 (47%), Gaps = 12/170 (7%)
Query: 81  LNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFS--GEIPAAISSLVSLRVLKLDGNMFQW 138
           L+ S N ++ ++  N G+   LE   L  N      +I    + + SL+ L +  N   +
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388
Query: 139 SIPPGLLNC---QSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGL 195
               G  +C   +SL+++++S N L  ++   F    P++K L+L  N+IK        L
Sbjct: 389 DEKKG--DCSWTKSLLSLNMSSNILTDTI---FRCLPPRIKVLDLHSNKIKSIPKQVVKL 443
Query: 196 KSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSY 243
           +++  LN++ N  +    G+F  L SL+ I L +N +     ++ + S +
Sbjct: 444 EALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 493

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA-RGSPG 701
           TA+ ++ L H     II+RD+K  +V LD +   R+SD GLA     G  +     G+PG
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 702 YIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           ++ PE     + DF     D +  GV L E+I  + P 
Sbjct: 355 FMAPELLLGEEYDFSV---DYFALGVTLYEMIAARGPF 389

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTP 717
           I+HRD+K  ++ LD ++  +L+DFG +     G       G+P Y+ PE  +   +   P
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHP 204
Query: 718 ----KSDVYCYGVVLLELITGKKPL 738
               + D++  GV++  L+ G  P 
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 38/226 (16%)
Query: 515 LLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI 574
           ++  G FG V++  L     VA+K ++      +    REL+ +  +KHPN+V L  +  
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN----RELQIMRIVKHPNVVDLKAFFY 102
Query: 575 A-GDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTW 633
           + GD++  ++       L  +L  +P  V                  ++      L+  +
Sbjct: 103 SNGDKKDEVF-------LNLVLEYVPETVYRASRHYA---------KLKQTMPMLLIKLY 146
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP----RLSDFGLAKIFGN 689
            ++        R+LA++H   S  I HRDIK  ++ LD    P    +L DFG AKI   
Sbjct: 147 MYQ------LLRSLAYIH---SIGICHRDIKPQNLLLD---PPSGVLKLIDFGSAKILIA 194
Query: 690 GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
           G        S  Y  PE     +++ T   D++  G V+ EL+ G+
Sbjct: 195 GEPNVSXICSRYYRAPELIFGATNY-TTNIDIWSTGCVMAELMQGQ 239

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 61/244 (25%)
Query: 516 LAEGKFGPVYRGFL----PGGIHVAVKVLVHGSTLTD-------QEAARELEYLGRIKHP 564
           L E +FG VY+G L    PG    AV +     TL D       +E   E     R++HP
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAI----KTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 565 NLVPLTGYCIAGDQRIA-IYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQN 623
           N+V L G  +  DQ ++ I+ Y  +G+L   L                       ++  +
Sbjct: 73  NVVCLLG-VVTKDQPLSMIFSYCSHGDLHEFL-------------VMRSPHSDVGSTDDD 118
Query: 624 VGSEGLLTTWRFRHKIALGTARALAFL--HHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
              +  L    F H +A   A  + +L  HH     ++H+D+   +V +   L  ++SD 
Sbjct: 119 RTVKSALEPPDFVHLVA-QIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDL 172
Query: 682 GL---------AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLL 729
           GL          K+ GN L           +P  +  P++      +  SD++ YGVVL 
Sbjct: 173 GLFREVYAADYYKLLGNSL-----------LPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 221
Query: 730 ELIT 733
           E+ +
Sbjct: 222 EVFS 225

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 101/252 (40%), Gaps = 57/252 (22%)
Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIH-------VAVKVLVHGSTLTDQEAAR---ELEY 557
           S F+   +L +G FG V   FL   I         A+KVL   +TL  ++  R   E + 
Sbjct: 24  SQFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDI 79
Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXX 617
           L  + HP +V L        +   I D++  G+L                          
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-------------------------- 113
Query: 618 XNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
                 +  E + T    +  +A   A AL  LH   S  II+RD+K  ++ LD     +
Sbjct: 114 ---FTRLSKEVMFTEEDVKFYLA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIK 166
Query: 678 LSDFGLAKIFGNGLDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT 733
           L+DFGL+K     +D E       G+  Y+ PE         T  +D + +GV++ E++T
Sbjct: 167 LTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLT 221
Query: 734 GKKPL-GDDYPE 744
           G  P  G D  E
Sbjct: 222 GTLPFQGKDRKE 233

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 95/233 (40%), Gaps = 48/233 (20%)
Query: 515 LLAEGKFGPVYRGFLPGGI---HVAVKVLVHGSTLTDQEAA--RELEYLGRIKHPNLVPL 569
           +L +G FG V +      I     AVKV+   S      +   RE+E L ++ HPN++ L
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
                        ++ +E+ +   ++ +L  G +                       + +
Sbjct: 87  -------------FEILEDSSSFYIVGELYTGGELF---------------------DEI 112
Query: 630 LTTWRF-RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD---MNLEPRLSDFGLAK 685
           +   RF  H  A    +  + + +     I+HRD+K  ++ L+    + + ++ DFGL+ 
Sbjct: 113 IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            F      +   G+  YI PE  +   D    K DV+  GV+L  L++G  P 
Sbjct: 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYD---EKCDVWSAGVILYILLSGTPPF 222

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK--IFGNGLDEEIARGSPGYI 703
            L FLH   S  I++RD+K  ++ LD +   +++DFG+ K  + G+        G+P YI
Sbjct: 130 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC-GTPDYI 185
Query: 704 PPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
            PE             D + +GV+L E++ G+ P      EE
Sbjct: 186 APEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 25/167 (14%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGY 702
            A+ + FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDYVRKGDAR 254
Query: 703 IPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLV 758
           +P ++  P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+ 
Sbjct: 255 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVK 298
Query: 759 RNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
            + +  R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 299 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 345

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 115/310 (37%), Gaps = 67/310 (21%)
Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKHPNLVPL 569
           G  +  G FG V+ G L    +  V V     TL     A+   E   L +  HPN+V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRAD-NTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
            G C        + + ++ G+    L                              +EG 
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLR-----------------------------TEGA 208
Query: 630 LTTWRFRHKIAL----GTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
               R R K  L      A  + +L   C    IHRD+ A +  +      ++SDFG+++
Sbjct: 209 ----RLRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSR 261
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDD 741
              +G+    A G    +P ++  P++      + +SDV+ +G++L E  + G  P    
Sbjct: 262 EEADGV--YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP---- 315
Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP         +V       KG R   P++      + ME+       C A  P +RPS 
Sbjct: 316 YPNLSNQQTREFV------EKGGRLPCPELCPDAVFRLMEQ-------CWAYEPGQRPSF 362
Query: 802 QQIVGLLKDI 811
             I   L+ I
Sbjct: 363 STIYQELQSI 372

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 9/97 (9%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMN---LEPRLSDFGLAKIFGNGLDEEIARGSPGY 702
            + +LH      I+HRDIK  ++ L+     L  ++ DFGL+  F          G+  Y
Sbjct: 158 GICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 703 IPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
           I PE  +   +    K DV+  GV++  L+ G  P G
Sbjct: 215 IAPEVLKKKYN---EKCDVWSCGVIMYILLCGYPPFG 248

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTP 717
           I+HRD+K  ++ LD ++  +L+DFG +     G       G+P Y+ PE  +   +   P
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 204
Query: 718 ----KSDVYCYGVVLLELITGKKPL 738
               + D++  GV++  L+ G  P 
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGY 702
           T  ALA LH   S  ++H D+K ++++L      +L DFGL    G     E+  G P Y
Sbjct: 166 TLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRY 222
Query: 703 IPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
           + PE  Q    + T  +DV+  G+ +LE+
Sbjct: 223 MAPELLQ--GSYGT-AADVFSLGLTILEV 248

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 92/225 (40%), Gaps = 41/225 (18%)
Query: 516 LAEGKFGPVYRGF--LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYC 573
           L EG +  VY+G   L   +    ++ +         A RE+  L  +KH N+V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 574 IAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTW 633
                   +++Y++  +L+  L D                      +I N+ +  L    
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYLDDC--------------------GNIINMHNVKLF--- 105
Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK---IFGNG 690
                      R LA+ H      ++HRD+K  ++ ++   E +L+DFGLA+   I    
Sbjct: 106 ------LFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156
Query: 691 LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
            D E+   +  Y PP+     +D+ T + D++  G +  E+ TG+
Sbjct: 157 YDNEVV--TLWYRPPDILLGSTDYST-QIDMWGVGCIFYEMATGR 198

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTP 717
           I+HRD+K  ++ LD ++  +L+DFG +     G       G+P Y+ PE  +   +   P
Sbjct: 132 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 191
Query: 718 ----KSDVYCYGVVLLELITGKKPL 738
               + D++  GV++  L+ G  P 
Sbjct: 192 GYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 25/167 (14%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGY 702
            A+ + FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDYVRKGDAR 256
Query: 703 IPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLV 758
           +P ++  P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+ 
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVK 300
Query: 759 RNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
            + +  R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 347

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL +LH      +++RD+K  ++ LD +   +++DFGL K    +G   +   G+P Y+ 
Sbjct: 121 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 178
Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 179 PEVLE-DNDYGRA-VDWWGLGVVMYEMMCGRLPF 210

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 34/234 (14%)
Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNL 566
            N DR  +L +G +G VY G  L   + +A+K +    +   Q    E+     +KH N+
Sbjct: 9   ENGDR-VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 567 VPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGS 626
           V   G             + ENG ++  +  +P G                 ++ Q +G 
Sbjct: 68  VQYLG------------SFSENGFIKIFMEQVPGG---SLSALLRSKWGPLKDNEQTIG- 111
Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD-MNLEPRLSDFGLAK 685
                   F  K  L     L +LH      I+HRDIK  +V ++  +   ++SDFG +K
Sbjct: 112 --------FYTKQIL---EGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 157
Query: 686 -IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            + G     E   G+  Y+ PE            +D++  G  ++E+ TGK P 
Sbjct: 158 RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL +LH      +++RD+K  ++ LD +   +++DFGL K    +G   +   G+P Y+ 
Sbjct: 120 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 177
Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 178 PEVLE-DNDYGRA-VDWWGLGVVMYEMMCGRLPF 209

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 4/103 (3%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDE-EIARGSP 700
           TA  +  L    S  +IHRD+K  ++ LD +   +L+DFG   K+   G+   + A G+P
Sbjct: 180 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTP 239
Query: 701 GYIPPEF--AQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
            YI PE   +Q    +   + D +  GV L E++ G  P   D
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 282

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEP----RLSDFGLAKIFGNGLDEEIARGSPG 701
           A+A+LH      I+HRD+K  ++ L     P    +++DFGL+KI  + +  +   G+PG
Sbjct: 160 AVAYLHEN---GIVHRDLKPENL-LYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG 215
Query: 702 YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
           Y  PE  +  +    P+ D++  G++   L+ G +P  D+
Sbjct: 216 YCAPEILRGCA--YGPEVDMWSVGIITYILLCGFEPFYDE 253

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 98/238 (41%), Gaps = 48/238 (20%)
Query: 509 NFDRGTLLAEGKFGPVYRG--FLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNL 566
           +F    L+  G FG V++    + G  +V  +V        +++A RE++ L ++ H N+
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLDHVNI 66
Query: 567 VPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQ-NVG 625
           V   G C  G      +DY    + +N                           IQ    
Sbjct: 67  VHYNG-CWDG------FDYDPETSSKN-----------------SSRSKTKCLFIQMEFC 102
Query: 626 SEGLLTTWRFRHK-------IAL----GTARALAFLHHGCSPPIIHRDIKASSVYLDMNL 674
            +G L  W  + +       +AL       + + ++H   S  +I+RD+K S+++L    
Sbjct: 103 DKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTK 159
Query: 675 EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
           + ++ DFGL     N      ++G+  Y+ PE  Q  S     + D+Y  G++L EL+
Sbjct: 160 QVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPE--QISSQDYGKEVDLYALGLILAELL 215

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 100/243 (41%), Gaps = 44/243 (18%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIH-VAVKVL--VHGSTLTDQEAARELEYLGRIK 562
           ATS ++    +  G +G VY+   P   H VA+K +   +G         RE+  L R++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 563 ---HPNLVPLTGYCIAG--DQRIAIYDYME--NGNLQNLLHDLPLGVQXXXXXXXXXXXX 615
              HPN+V L   C     D+ I +    E  + +L+  L   P                
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP-------------PPG 108
Query: 616 XXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE 675
               +I+++  + L               R L FLH  C   I+HRD+K  ++ +     
Sbjct: 109 LPAETIKDLMRQFL---------------RGLDFLHANC---IVHRDLKPENILVTSGGT 150
Query: 676 PRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
            +L+DFGLA+I+   +       +  Y  PE     S + TP  D++  G +  E+   +
Sbjct: 151 VKLADFGLARIYSYQMALFPVVVTLWYRAPEVLL-QSTYATP-VDMWSVGCIFAEMFR-R 207
Query: 736 KPL 738
           KPL
Sbjct: 208 KPL 210

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 81/213 (38%), Gaps = 39/213 (18%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK +  G+ + D+   RE+     ++HPN+V      +       I +Y   G L   
Sbjct: 48  VAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL--- 103
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
                                     I N G         F  ++  G    +++ H   
Sbjct: 104 -----------------------YERICNAGRFSEDEARFFFQQLLSG----VSYCH--- 133
Query: 655 SPPIIHRDIKASSVYLDMNLEPRL--SDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS 712
           S  I HRD+K  +  LD +  PRL   DFG +K        +   G+P YI PE      
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQ 192
Query: 713 DFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
           ++    +DV+  GV L  ++ G  P  D  PEE
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFED--PEE 223

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL +LH      +++RD+K  ++ LD +   +++DFGL K    +G   +   G+P Y+ 
Sbjct: 122 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 179
Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE  + D+D+     D +  GVV+ E++ G+ P 
Sbjct: 180 PEVLE-DNDYGRA-VDWWGLGVVMYEMMCGRLPF 211

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 96/260 (36%), Gaps = 67/260 (25%)
Query: 504 LSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG--------------STLTD 548
           L   S+F+   +L +G FG V +        + A+K + H               ++L  
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61
Query: 549 QEAARELEYLGRIKHPNLV-PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXX 607
           Q   R   Y   ++  N V P+T         I + +Y EN  L +L+H   L  Q    
Sbjct: 62  QYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQM-EYCENRTLYDLIHSENLNQQRD-- 116
Query: 608 XXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS 667
                                    WR   +I      AL+++H   S  IIHRD+K  +
Sbjct: 117 -----------------------EYWRLFRQIL----EALSYIH---SQGIIHRDLKPMN 146
Query: 668 VYLDMNLEPRLSDFGLAKIFGNGLD---------------EEIARGSPGYIPPEFAQPDS 712
           +++D +   ++ DFGLAK     LD                  A G+  Y+  E      
Sbjct: 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206
Query: 713 DFPTPKSDVYCYGVVLLELI 732
            +   K D+Y  G++  E+I
Sbjct: 207 HY-NEKIDMYSLGIIFFEMI 225

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 25/167 (14%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGY 702
            A+ + FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDYVRKGDAR 261
Query: 703 IPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLV 758
           +P ++  P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+ 
Sbjct: 262 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVK 305
Query: 759 RNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
            + +  R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 306 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 352

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 25/167 (14%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGY 702
            A+ + FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDYVRKGDAR 263
Query: 703 IPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLV 758
           +P ++  P++ F    T +SDV+ +GV+L E+ + G  P    YP            G+ 
Sbjct: 264 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP------------GVK 307
Query: 759 RNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
            + +  R +    R   P+    E  +    C    P +RP+  ++V
Sbjct: 308 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 354

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 57/269 (21%)
Query: 507 TSNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLV-----HGSTLTDQEAARELEYLGR 560
            S +++   + +G FG V++      G  VA+K ++      G  +T   A RE++ L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT---ALREIKILQL 73
Query: 561 IKHPNLVPLTGYCIAGDQ-----RIAIY---DYMENGNLQNLLHDLPLGVQXXXXXXXXX 612
           +KH N+V L   C          + +IY   D+ E        HDL              
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCE--------HDL-------------- 111
Query: 613 XXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM 672
                   + NV  +  L+  +   ++ L     L ++H      I+HRD+KA++V +  
Sbjct: 112 -----AGLLSNVLVKFTLSEIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITR 160
Query: 673 NLEPRLSDFGLAKIFGNGLDEEIARG-----SPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
           +   +L+DFGLA+ F    + +  R      +  Y PPE    + D+  P  D++  G +
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCI 219
Query: 728 LLELITGKKPLGDDYPEEKEGNLVSWVRG 756
           + E+ T + P+     E+ +  L+S + G
Sbjct: 220 MAEMWT-RSPIMQGNTEQHQLALISQLCG 247

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 77/327 (23%), Positives = 123/327 (37%), Gaps = 65/327 (19%)
Query: 505 SATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHG--STLTDQEAARELEYLGRI 561
           S T  +     L +G F  V R   +P G   A K++     S    Q+  RE      +
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           KHPN+V L             +D +       L+ DL  G +                  
Sbjct: 61  KHPNIVRL-------------HDSISEEGFHYLVFDLVTGGEL----------------F 91
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL---DMNLEPRL 678
           +++ +    +     H I     + L  ++H     I+HRD+K  ++ L         +L
Sbjct: 92  EDIVAREYYSEADASHCIQ----QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKL 147
Query: 679 SDFGLA-KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           +DFGLA ++ G+        G+PGY+ PE  + D  +  P  D++  GV+L  L+ G  P
Sbjct: 148 ADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP-YGKP-VDMWACGVILYILLVGYPP 205
Query: 738 LGD---------------DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEE 782
             D               D+P  +   +    + L+  NK    I+P  R T       E
Sbjct: 206 FWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI--NK-MLTINPAKRITA-----SE 257
Query: 783 ALKIGYLCTADLPLKRPSMQQIVGLLK 809
           ALK  ++C           Q+ V  LK
Sbjct: 258 ALKHPWICQRSTVASMMHRQETVDCLK 284

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 113/269 (42%), Gaps = 57/269 (21%)
Query: 507 TSNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLV-----HGSTLTDQEAARELEYLGR 560
            S +++   + +G FG V++      G  VA+K ++      G  +T   A RE++ L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT---ALREIKILQL 73
Query: 561 IKHPNLVPLTGYCIAGDQRI--------AIYDYMENGNLQNLLHDLPLGVQXXXXXXXXX 612
           +KH N+V L   C                ++D+ E        HDL              
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDL-------------- 111
Query: 613 XXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM 672
                   + NV  +  L+  +   ++ L     L ++H      I+HRD+KA++V +  
Sbjct: 112 -----AGLLSNVLVKFTLSEIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITR 160
Query: 673 NLEPRLSDFGLAKIFGNGLDEEIARG-----SPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
           +   +L+DFGLA+ F    + +  R      +  Y PPE    + D+  P  D++  G +
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCI 219
Query: 728 LLELITGKKPLGDDYPEEKEGNLVSWVRG 756
           + E+ T + P+     E+ +  L+S + G
Sbjct: 220 MAEMWT-RSPIMQGNTEQHQLALISQLCG 247

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 54/86 (62%), Gaps = 2/86 (2%)
Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS 108
           I K   L  L L+ N++T LP+++ +L +L+ L+LS+NR++ SLP+ +G+   L+ F   
Sbjct: 243 IFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF 301
Query: 109 NNNFSGEIPAAISSLVSLRVLKLDGN 134
           +N  +  +P    +L +L+ L ++GN
Sbjct: 302 DNMVTT-LPWEFGNLCNLQFLGVEGN 326

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 69/308 (22%), Positives = 123/308 (39%), Gaps = 57/308 (18%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARE-LEYL-------GRIKHPNLV 567
           L +G FG VY G     I    +  V   T+ +  + RE +E+L       G   H ++V
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 84
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G    G   + + + M +G+L++ L  L                     +  N G  
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL------------------RPEAENNPGRP 126
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-I 686
               T +   ++A   A  +A+L+   +   +HR++ A +  +  +   ++ DFG+ + I
Sbjct: 127 P--PTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI 181
Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
           +     +   +G  G +P  +  P+S      T  SD++ +GVVL E+ +  ++P     
Sbjct: 182 YET---DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY---- 234
Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
                       +GL         +D    D  P+   E    +  +C    P  RP+  
Sbjct: 235 ------------QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFL 281
Query: 803 QIVGLLKD 810
           +IV LLKD
Sbjct: 282 EIVNLLKD 289

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 51/115 (44%), Gaps = 16/115 (13%)
Query: 658 IIHRDIKASSVYLDMNLEP---RLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDF 714
           I+HRD+K  ++ L+        ++ DFGL+  F  G   +   G+  YI PE  +   D 
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKYD- 183
Query: 715 PTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDP 769
              K DV+  GV+L  L+ G  P G    +E           L R  KG  + DP
Sbjct: 184 --EKCDVWSCGVILYILLCGYPPFGGQTDQEI----------LKRVEKGKFSFDP 226

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 4/103 (3%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDE-EIARGSP 700
           TA  +  L    S   IHRD+K  ++ LD +   +L+DFG   K+   G+   + A G+P
Sbjct: 179 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 701 GYIPPEF--AQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
            YI PE   +Q    +   + D +  GV L E++ G  P   D
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 281

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 51/115 (44%), Gaps = 16/115 (13%)
Query: 658 IIHRDIKASSVYLDMNLEP---RLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDF 714
           I+HRD+K  ++ L+        ++ DFGL+  F  G   +   G+  YI PE  +   D 
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKYD- 200
Query: 715 PTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDP 769
              K DV+  GV+L  L+ G  P G    +E           L R  KG  + DP
Sbjct: 201 --EKCDVWSCGVILYILLCGYPPFGGQTDQEI----------LKRVEKGKFSFDP 243

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 69/308 (22%), Positives = 123/308 (39%), Gaps = 57/308 (18%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARE-LEYL-------GRIKHPNLV 567
           L +G FG VY G     I    +  V   T+ +  + RE +E+L       G   H ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            L G    G   + + + M +G+L++ L  L                     +  N G  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL------------------RPEAENNPGRP 125
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK-I 686
               T +   ++A   A  +A+L+   +   +HR++ A +  +  +   ++ DFG+ + I
Sbjct: 126 P--PTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
           +     +   +G  G +P  +  P+S      T  SD++ +GVVL E+ +  ++P     
Sbjct: 181 YET---DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY---- 233
Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
                       +GL         +D    D  P+   E    +  +C    P  RP+  
Sbjct: 234 ------------QGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFL 280
Query: 803 QIVGLLKD 810
           +IV LLKD
Sbjct: 281 EIVNLLKD 288

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 4/103 (3%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDE-EIARGSP 700
           TA  +  L    S   IHRD+K  ++ LD +   +L+DFG   K+   G+   + A G+P
Sbjct: 179 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 701 GYIPPEF--AQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
            YI PE   +Q    +   + D +  GV L E++ G  P   D
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 281

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 4/103 (3%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA-KIFGNGLDE-EIARGSP 700
           TA  +  L    S   IHRD+K  ++ LD +   +L+DFG   K+   G+   + A G+P
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 701 GYIPPEF--AQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
            YI PE   +Q    +   + D +  GV L E++ G  P   D
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 100/236 (42%), Gaps = 49/236 (20%)
Query: 515 LLAEGKFGPVYRGFL----PGGIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPL 569
           ++ +G FG VY G         I  A+K L   + +   EA  RE   +  + HPN++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 570 TGYCIAGDQRI-AIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
            G  +  +     +  YM +G+L   +                       +  +N   + 
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIR----------------------SPQRNPTVKD 125
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           L++         L  AR + +L        +HRD+ A +  LD +   +++DFGLA+   
Sbjct: 126 LIS-------FGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR--- 172
Query: 689 NGLDEE---IARGSPGYIPPEFAQPDS----DFPTPKSDVYCYGVVLLELITGKKP 737
           + LD E   + +     +P ++   +S     F T KSDV+ +GV+L EL+T   P
Sbjct: 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAP 227

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           K+++   + L +L       I+HRD+K S++ ++   E +L DFG++    + +  E   
Sbjct: 111 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV- 167
Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           G+  Y+ PE  Q      + +SD++  G+ L+E+  G+ P
Sbjct: 168 GTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 113/269 (42%), Gaps = 57/269 (21%)
Query: 507 TSNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLV-----HGSTLTDQEAARELEYLGR 560
            S +++   + +G FG V++      G  VA+K ++      G  +T   A RE++ L  
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT---ALREIKILQL 72
Query: 561 IKHPNLVPLTGYCI--------AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXX 612
           +KH N+V L   C                ++D+ E        HDL              
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDL-------------- 110
Query: 613 XXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM 672
                   + NV  +  L+  +   ++ L     L ++H      I+HRD+KA++V +  
Sbjct: 111 -----AGLLSNVLVKFTLSEIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITR 159
Query: 673 NLEPRLSDFGLAKIFGNGLDEEIARG-----SPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
           +   +L+DFGLA+ F    + +  R      +  Y PPE    + D+  P  D++  G +
Sbjct: 160 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCI 218
Query: 728 LLELITGKKPLGDDYPEEKEGNLVSWVRG 756
           + E+ T + P+     E+ +  L+S + G
Sbjct: 219 MAEMWT-RSPIMQGNTEQHQLALISQLCG 246

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 57/238 (23%)
Query: 515 LLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTL--TDQEAA-RELEYLGRIKHPNLVPL 569
           +L +G FG V   +  + G    AVKV+        TD+E+  RE++ L ++ HPN++ L
Sbjct: 33  VLGKGSFGEVILCKDKITGQ-ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
                        Y++ E+     L+ ++  G +                       + +
Sbjct: 92  -------------YEFFEDKGYFYLVGEVYTGGELF---------------------DEI 117
Query: 630 LTTWRFRHKIALGTAR----ALAFLHHGCSPPIIHRDIKASSVYL-----DMNLEPRLSD 680
           ++  RF    A    R     + ++H      I+HRD+K  ++ L     D N+  R+ D
Sbjct: 118 ISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANI--RIID 172
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           FGL+  F      +   G+  YI PE      D    K DV+  GV+L  L++G  P 
Sbjct: 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYD---EKCDVWSTGVILYILLSGCPPF 227

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 77/327 (23%), Positives = 123/327 (37%), Gaps = 65/327 (19%)
Query: 505 SATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL--VHGSTLTDQEAARELEYLGRI 561
           S T  +     L +G F  V R   +P G   A K++     S    Q+  RE      +
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSI 621
           KHPN+V L             +D +       L+ DL  G +                  
Sbjct: 61  KHPNIVRL-------------HDSISEEGFHYLVFDLVTGGEL----------------F 91
Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL---DMNLEPRL 678
           +++ +    +     H I     + L  ++H     I+HRD+K  ++ L         +L
Sbjct: 92  EDIVAREYYSEADASHCIQ----QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKL 147
Query: 679 SDFGLA-KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           +DFGLA ++ G+        G+PGY+ PE  + D  +  P  D++  GV+L  L+ G  P
Sbjct: 148 ADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP-YGKP-VDMWACGVILYILLVGYPP 205
Query: 738 LGD---------------DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEE 782
             D               D+P  +   +    + L+  NK    I+P  R T       E
Sbjct: 206 FWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI--NK-MLTINPAKRITA-----SE 257
Query: 783 ALKIGYLCTADLPLKRPSMQQIVGLLK 809
           ALK  ++C           Q+ V  LK
Sbjct: 258 ALKHPWICQRSTVASMMHRQETVDCLK 284

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 113/269 (42%), Gaps = 57/269 (21%)
Query: 507 TSNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLV-----HGSTLTDQEAARELEYLGR 560
            S +++   + +G FG V++      G  VA+K ++      G  +T   A RE++ L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT---ALREIKILQL 73
Query: 561 IKHPNLVPLTGYCI--------AGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXX 612
           +KH N+V L   C                ++D+ E        HDL              
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDL-------------- 111
Query: 613 XXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM 672
                   + NV  +  L+  +   ++ L     L ++H      I+HRD+KA++V +  
Sbjct: 112 -----AGLLSNVLVKFTLSEIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITR 160
Query: 673 NLEPRLSDFGLAKIFGNGLDEEIARG-----SPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
           +   +L+DFGLA+ F    + +  R      +  Y PPE    + D+  P  D++  G +
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCI 219
Query: 728 LLELITGKKPLGDDYPEEKEGNLVSWVRG 756
           + E+ T + P+     E+ +  L+S + G
Sbjct: 220 MAEMWT-RSPIMQGNTEQHQLALISQLCG 247

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 95/233 (40%), Gaps = 48/233 (20%)
Query: 515 LLAEGKFGPVYRGFLPGGI---HVAVKVLVHGSTLTDQEAA--RELEYLGRIKHPNLVPL 569
           +L +G FG V +      I     AVKV+   S      +   RE+E L ++ HPN++ L
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
                        ++ +E+ +   ++ +L  G +                       + +
Sbjct: 87  -------------FEILEDSSSFYIVGELYTGGELF---------------------DEI 112
Query: 630 LTTWRF-RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD---MNLEPRLSDFGLAK 685
           +   RF  H  A    +  + + +     I+HRD+K  ++ L+    + + ++ DFGL+ 
Sbjct: 113 IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            F      +   G+  YI PE  +   D    K DV+  GV+L  L++G  P 
Sbjct: 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYD---EKCDVWSAGVILYILLSGTPPF 222

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 71/148 (47%), Gaps = 24/148 (16%)
Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR--GSPGY 702
           + + +LH+     IIHRDIK S++ +  +   +++DFG++  F  G D  ++   G+P +
Sbjct: 148 KGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLSNTVGTPAF 203
Query: 703 IPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD---------------DYPEEK 746
           + PE  ++    F     DV+  GV L   + G+ P  D               ++P++ 
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP 263
Query: 747 E--GNLVSWVRGLVRNNKGSRAIDPKIR 772
           +   +L   +  ++  N  SR + P+I+
Sbjct: 264 DIAEDLKDLITRMLDKNPESRIVVPEIK 291

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 95/233 (40%), Gaps = 48/233 (20%)
Query: 515 LLAEGKFGPVYRGFLPGGI---HVAVKVLVHGSTLTDQEAA--RELEYLGRIKHPNLVPL 569
           +L +G FG V +      I     AVKV+   S      +   RE+E L ++ HPN++ L
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
                        ++ +E+ +   ++ +L  G +                       + +
Sbjct: 87  -------------FEILEDSSSFYIVGELYTGGELF---------------------DEI 112
Query: 630 LTTWRF-RHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD---MNLEPRLSDFGLAK 685
           +   RF  H  A    +  + + +     I+HRD+K  ++ L+    + + ++ DFGL+ 
Sbjct: 113 IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            F      +   G+  YI PE  +   D    K DV+  GV+L  L++G  P 
Sbjct: 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYD---EKCDVWSAGVILYILLSGTPPF 222

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 51/101 (50%), Gaps = 11/101 (10%)
Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA--RGSPGY 702
           R L ++H   S  IIHRD+K S+V ++ + E R+ DFGLA+      DEE+     +  Y
Sbjct: 134 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTGYVATRWY 186
Query: 703 IPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDY 742
             PE       +     D++  G ++ EL+ GK    G DY
Sbjct: 187 RAPEIMLNWMHY-NQTVDIWSVGCIMAELLQGKALFPGSDY 226

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 51/235 (21%)
Query: 515 LLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTL--TDQEAA-RELEYLGRIKHPNLVPL 569
           +L +G FG V   +  + G    AVKV+        TD+E+  RE++ L ++ HPN+  L
Sbjct: 33  VLGKGSFGEVILCKDKITGQ-ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
                        Y++ E+     L+ ++  G +                       + +
Sbjct: 92  -------------YEFFEDKGYFYLVGEVYTGGELF---------------------DEI 117
Query: 630 LTTWRFRHKIALGTAR-ALAFLHHGCSPPIIHRDIKASSVYL-----DMNLEPRLSDFGL 683
           ++  RF    A    R  L+ + +     I+HRD+K  ++ L     D N+  R+ DFGL
Sbjct: 118 ISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANI--RIIDFGL 175
Query: 684 AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           +  F      +   G+  YI PE      D    K DV+  GV+L  L++G  P 
Sbjct: 176 STHFEASKKXKDKIGTAYYIAPEVLHGTYD---EKCDVWSTGVILYILLSGCPPF 227

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 50/108 (46%), Gaps = 14/108 (12%)
Query: 643 TARALAFLHHGCSPPIIHRDIKASSVYLDM-----NLEPRLSDFGLAKIFGNGLDEEIAR 697
           T   LA LH   S  I+HRD+K  ++ + M      ++  +SDFGL K    G      R
Sbjct: 127 TTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 698 ----GSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELIT-GKKPLG 739
               G+ G+I PE    D  + PT   D++  G V   +I+ G  P G
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTP 717
           I++RD+K  ++ LD +   R+SD GLA     G   +   G+ GY+ PE  + +    +P
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 718 KSDVYCYGVVLLELITGKKPL 738
             D +  G +L E+I G+ P 
Sbjct: 367 --DWWALGCLLYEMIAGQSPF 385

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL +LH      II+RD+K  +V LD     +L+D+G+ K     G       G+P YI 
Sbjct: 165 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 705 PEFAQ-PDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE  +  D  F     D +  GV++ E++ G+ P 
Sbjct: 222 PEILRGEDYGFSV---DWWALGVLMFEMMAGRSPF 253

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 77/213 (36%), Gaps = 39/213 (18%)
Query: 535 VAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNL 594
           VAVK +  G  + D+   RE+     ++HPN+V      +       + +Y   G L   
Sbjct: 46  VAVKYIERGEKI-DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--- 101
Query: 595 LHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC 654
                                     I N G         F  ++  G +   A      
Sbjct: 102 -----------------------FERICNAGRFSEDEARFFFQQLISGVSYCHAM----- 133
Query: 655 SPPIIHRDIKASSVYLDMNLEPRLS--DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS 712
              + HRD+K  +  LD +  PRL   DFG +K        +   G+P YI PE      
Sbjct: 134 --QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KK 190
Query: 713 DFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
           ++    +DV+  GV L  ++ G  P  D  PEE
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYPFED--PEE 221

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 46/99 (46%), Gaps = 6/99 (6%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGY 702
            L +LH   S  I+H+DIK  ++ L      ++S  G+A+       ++  R   GSP +
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 703 IPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
            PPE A     F   K D++  GV L  + TG  P   D
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 97/241 (40%), Gaps = 65/241 (26%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI--KHPNLVPLTGYC 573
           + +G++G V+RG   G  +VAVK+    S+  ++   RE E    +  +H N++      
Sbjct: 45  VGKGRYGEVWRGSWQGE-NVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGF---- 96
Query: 574 IAGD--------QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           IA D        Q   I  Y E G+L + L                         +  + 
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ------------------------LTTLD 132
Query: 626 SEGLLTTWRFRHKIALGTARALAFLH------HGCSPPIIHRDIKASSVYLDMNLEPRLS 679
           +   L       +I L  A  LA LH       G  P I HRD+K+ ++ +  N +  ++
Sbjct: 133 TVSCL-------RIVLSIASGLAHLHIEIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIA 184
Query: 680 DFGLAKIFG---NGLD--EEIARGSPGYIPPEF----AQPDSDFPTPKSDVYCYGVVLLE 730
           D GLA +     N LD       G+  Y+ PE      Q D      + D++ +G+VL E
Sbjct: 185 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE 244
Query: 731 L 731
           +
Sbjct: 245 V 245

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           K+++   + L +L       I+HRD+K S++ ++   E +L DFG++    + +      
Sbjct: 108 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 164
Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV 751
           G+  Y+ PE  Q      + +SD++  G+ L+E+  G+ P+    P+ KE  L+
Sbjct: 165 GTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           K+++   + L +L       I+HRD+K S++ ++   E +L DFG++    + +      
Sbjct: 108 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 164
Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV 751
           G+  Y+ PE  Q      + +SD++  G+ L+E+  G+ P+    P+ KE  L+
Sbjct: 165 GTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKELELM 214

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 57/238 (23%)
Query: 515 LLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTL--TDQEAA-RELEYLGRIKHPNLVPL 569
           +L +G FG V   +  + G    AVKV+        TD+E+  RE++ L ++ HPN++ L
Sbjct: 57  VLGKGSFGEVILCKDKITGQ-ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
                        Y++ E+     L+ ++  G +                       + +
Sbjct: 116 -------------YEFFEDKGYFYLVGEVYTGGELF---------------------DEI 141
Query: 630 LTTWRFRHKIALGTAR----ALAFLHHGCSPPIIHRDIKASSVYL-----DMNLEPRLSD 680
           ++  RF    A    R     + ++H      I+HRD+K  ++ L     D N+  R+ D
Sbjct: 142 ISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANI--RIID 196
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           FGL+  F      +   G+  YI PE      D    K DV+  GV+L  L++G  P 
Sbjct: 197 FGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYD---EKCDVWSTGVILYILLSGCPPF 251

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           K+++   + L +L       I+HRD+K S++ ++   E +L DFG++    + +      
Sbjct: 135 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 191
Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV 751
           G+  Y+ PE  Q      + +SD++  G+ L+E+  G+ P+    P+ KE  L+
Sbjct: 192 GTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKELELM 241

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 57/238 (23%)
Query: 515 LLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTL--TDQEAA-RELEYLGRIKHPNLVPL 569
           +L +G FG V   +  + G    AVKV+        TD+E+  RE++ L ++ HPN++ L
Sbjct: 56  VLGKGSFGEVILCKDKITGQ-ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
                        Y++ E+     L+ ++  G +                       + +
Sbjct: 115 -------------YEFFEDKGYFYLVGEVYTGGELF---------------------DEI 140
Query: 630 LTTWRFRHKIALGTAR----ALAFLHHGCSPPIIHRDIKASSVYL-----DMNLEPRLSD 680
           ++  RF    A    R     + ++H      I+HRD+K  ++ L     D N+  R+ D
Sbjct: 141 ISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANI--RIID 195
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           FGL+  F      +   G+  YI PE      D    K DV+  GV+L  L++G  P 
Sbjct: 196 FGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYD---EKCDVWSTGVILYILLSGCPPF 250

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 82/196 (41%), Gaps = 19/196 (9%)
Query: 628 GLLTTWRFRHKIALG--------TARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
           G L  +  RH I L             +A+LH   +   IHRD+ A +V LD +   ++ 
Sbjct: 120 GSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIG 176
Query: 680 DFGLAKIFGNGLDEEIAR---GSPGY-IPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
           DFGLAK    G +    R    SP +   PE  +    +    SDV+ +GV L EL+T  
Sbjct: 177 DFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYA--SDVWSFGVTLYELLTHC 234
Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
                  P  K   L+   +G +   + +  ++   R   P+K   E   +   C     
Sbjct: 235 D--SSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEA 292
Query: 796 LKRPSMQQIVGLLKDI 811
             RP+ + ++ +LK +
Sbjct: 293 SFRPTFENLIPILKTV 308

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTP 717
           I++RD+K  ++ LD +   R+SD GLA     G   +   G+ GY+ PE  + +    +P
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 718 KSDVYCYGVVLLELITGKKPL 738
             D +  G +L E+I G+ P 
Sbjct: 367 --DWWALGCLLYEMIAGQSPF 385

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 63/240 (26%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI--KHPNLVPLTGYC 573
           + +G++G V+RG   G  +VAVK+    S+  ++   RE E    +  +H N++   G+ 
Sbjct: 16  VGKGRYGEVWRGSWQGE-NVAVKIF---SSRDEKSWFRETELYNTVMLRHENIL---GF- 67
Query: 574 IAGD--------QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           IA D        Q   I  Y E G+L + L                         +  + 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ------------------------LTTLD 103
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGC-----SPPIIHRDIKASSVYLDMNLEPRLSD 680
           +   L       +I L  A  LA LH         P I HRD+K+ ++ +  N +  ++D
Sbjct: 104 TVSCL-------RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156
Query: 681 FGLAKIFG---NGLD--EEIARGSPGYIPPEF----AQPDSDFPTPKSDVYCYGVVLLEL 731
            GLA +     N LD       G+  Y+ PE      Q D      + D++ +G+VL E+
Sbjct: 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL +LH      II+RD+K  +V LD     +L+D+G+ K     G       G+P YI 
Sbjct: 133 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 189
Query: 705 PEFAQ-PDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE  +  D  F     D +  GV++ E++ G+ P 
Sbjct: 190 PEILRGEDYGFSV---DWWALGVLMFEMMAGRSPF 221

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 63/240 (26%)
Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI--KHPNLVPLTGYC 573
           + +G++G V+RG   G  +VAVK+    S+  ++   RE E    +  +H N++   G+ 
Sbjct: 16  VGKGRYGEVWRGSWQGE-NVAVKIF---SSRDEKSWFRETELYNTVMLRHENIL---GF- 67
Query: 574 IAGD--------QRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVG 625
           IA D        Q   I  Y E G+L + L                         +  + 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ------------------------LTTLD 103
Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGC-----SPPIIHRDIKASSVYLDMNLEPRLSD 680
           +   L       +I L  A  LA LH         P I HRD+K+ ++ +  N +  ++D
Sbjct: 104 TVSCL-------RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156
Query: 681 FGLAKIFG---NGLD--EEIARGSPGYIPPEF----AQPDSDFPTPKSDVYCYGVVLLEL 731
            GLA +     N LD       G+  Y+ PE      Q D      + D++ +G+VL E+
Sbjct: 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 99/246 (40%), Gaps = 47/246 (19%)
Query: 506 ATSNFDRGTLLAEGKFGPVYRGFLPGGIH-VAVK-VLVHGSTLTDQ----EAARELEYLG 559
           ATS ++    +  G +G VY+   P   H VA+K V V               RE+  L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 560 RIK---HPNLVPLTGYCIAG--DQRIAIYDYME--NGNLQNLLHDLPLGVQXXXXXXXXX 612
           R++   HPN+V L   C     D+ I +    E  + +L+  L   P             
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP------------- 113
Query: 613 XXXXXXNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM 672
                  +I+++  + L               R L FLH  C   I+HRD+K  ++ +  
Sbjct: 114 PPGLPAETIKDLMRQFL---------------RGLDFLHANC---IVHRDLKPENILVTS 155
Query: 673 NLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
               +L+DFGLA+I+   +       +  Y  PE     S + TP  D++  G +  E+ 
Sbjct: 156 GGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL-QSTYATP-VDMWSVGCIFAEMF 213
Query: 733 TGKKPL 738
             +KPL
Sbjct: 214 R-RKPL 218

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           K+++   + L +L       I+HRD+K S++ ++   E +L DFG++    + +      
Sbjct: 108 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 164
Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV 751
           G+  Y+ PE  Q      + +SD++  G+ L+E+  G+ P+    P+ KE  L+
Sbjct: 165 GTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKELELM 214

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 115/305 (37%), Gaps = 61/305 (20%)
Query: 516 LAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L  G FG VY G +      P  + VAVK L    +  D+ +   E   + +  H N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
             G  +    R  + + M  G+L++ L +                            S  
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRE-------------------TRPRPSQPSSLA 179
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS---DFGLAK 685
           +L        IA G  + L   H       IHRDI A +  L      R++   DFG+A+
Sbjct: 180 MLDLLHVARDIACG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
Query: 686 -IFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGD 740
            I+  G      +G    +P ++  P++      T K+D + +GV+L E+ + G  P   
Sbjct: 233 DIYRAGY---YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--- 286
Query: 741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
            YP +    ++ +V        G R +DP     GP        +I   C    P  RP+
Sbjct: 287 -YPSKSNQEVLEFV------TSGGR-MDPPKNCPGP------VYRIMTQCWQHQPEDRPN 332
Query: 801 MQQIV 805
              I+
Sbjct: 333 FAIIL 337

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           K+++   + L +L       I+HRD+K S++ ++   E +L DFG++    + +      
Sbjct: 108 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 164
Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV 751
           G+  Y+ PE  Q      + +SD++  G+ L+E+  G+ P+    P+ KE  L+
Sbjct: 165 GTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKELELM 214

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 51/101 (50%), Gaps = 11/101 (10%)
Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA--RGSPGY 702
           R L ++H   S  IIHRD+K S+V ++ + E R+ DFGLA+      DEE+     +  Y
Sbjct: 142 RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWY 194
Query: 703 IPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDY 742
             PE       +     D++  G ++ EL+ GK    G DY
Sbjct: 195 RAPEIMLNWMHY-NQTVDIWSVGCIMAELLQGKALFPGSDY 234

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 51/101 (50%), Gaps = 11/101 (10%)
Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA--RGSPGY 702
           R L ++H   S  IIHRD+K S+V ++ + E R+ DFGLA+      DEE+     +  Y
Sbjct: 142 RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWY 194
Query: 703 IPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-GDDY 742
             PE       +     D++  G ++ EL+ GK    G DY
Sbjct: 195 RAPEIMLNWMHY-NQTVDIWSVGCIMAELLQGKALFPGSDY 234

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 115/305 (37%), Gaps = 61/305 (20%)
Query: 516 LAEGKFGPVYRGFL------PGGIHVAVKVLVHGSTLTDQ-EAARELEYLGRIKHPNLVP 568
           L  G FG VY G +      P  + VAVK L    +  D+ +   E   + +  H N+V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEG 628
             G  +    R  + + M  G+L++ L +                            S  
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRE-------------------TRPRPSQPSSLA 156
Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS---DFGLAK 685
           +L        IA G  + L   H       IHRDI A +  L      R++   DFG+A+
Sbjct: 157 MLDLLHVARDIACG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209
Query: 686 -IFGNGLDEEIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELIT-GKKPLGD 740
            I+  G      +G    +P ++  P++      T K+D + +GV+L E+ + G  P   
Sbjct: 210 DIYRAGY---YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--- 263
Query: 741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
            YP +    ++ +V        G R +DP     GP        +I   C    P  RP+
Sbjct: 264 -YPSKSNQEVLEFV------TSGGR-MDPPKNCPGP------VYRIMTQCWQHQPEDRPN 309
Query: 801 MQQIV 805
              I+
Sbjct: 310 FAIIL 314

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 57/238 (23%)
Query: 515 LLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTL--TDQEAA-RELEYLGRIKHPNLVPL 569
           +L +G FG V   +  + G    AVKV+        TD+E+  RE++ L ++ HPN++ L
Sbjct: 39  VLGKGSFGEVILCKDKITGQ-ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSEGL 629
                        Y++ E+     L+ ++  G +                       + +
Sbjct: 98  -------------YEFFEDKGYFYLVGEVYTGGELF---------------------DEI 123
Query: 630 LTTWRFRHKIALGTAR----ALAFLHHGCSPPIIHRDIKASSVYL-----DMNLEPRLSD 680
           ++  RF    A    R     + ++H      I+HRD+K  ++ L     D N+  R+ D
Sbjct: 124 ISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANI--RIID 178
Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           FGL+  F      +   G+  YI PE      D    K DV+  GV+L  L++G  P 
Sbjct: 179 FGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYD---EKCDVWSTGVILYILLSGCPPF 233

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 124/306 (40%), Gaps = 50/306 (16%)
Query: 516 LAEGKFGPV-YRGFLPG----GIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPL 569
           L EG FG V    + P     G  VAVK L  G     +    RE+E L  + H ++V  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 570 TGYCI-AGDQRIA-IYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            G C   G++ +  + +Y+  G+L++ L                            VG  
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL------------------------PRHCVGLA 112
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            LL    F  +I  G    +A+LH   +   IHR + A +V LD +   ++ DFGLAK  
Sbjct: 113 QLLL---FAQQICEG----MAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAV 162
Query: 688 GNGLDEEIAR---GSPGY-IPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
             G +    R    SP +   PE  +    +    SDV+ +GV L EL+T      +  P
Sbjct: 163 PEGHEYYRVREDGDSPVFWYAPECLKECKFYYA--SDVWSFGVTLYELLTYCD--SNQSP 218
Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
             K   L+   +G +   + +  ++   R   P++   E   +   C       RP+ Q 
Sbjct: 219 HTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQN 278
Query: 804 IVGLLK 809
           +V +L+
Sbjct: 279 LVPILQ 284

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL +LH      II+RD+K  +V LD     +L+D+G+ K     G       G+P YI 
Sbjct: 118 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 174
Query: 705 PEFAQ-PDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE  +  D  F     D +  GV++ E++ G+ P 
Sbjct: 175 PEILRGEDYGFSV---DWWALGVLMFEMMAGRSPF 206

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           K+++   + L +L       I+HRD+K S++ ++   E +L DFG++    + +      
Sbjct: 170 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 226
Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLV 751
           G+  Y+ PE  Q      + +SD++  G+ L+E+  G+ P+    P+ KE  L+
Sbjct: 227 GTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKELELM 276

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 57/110 (51%), Gaps = 7/110 (6%)
Query: 638 KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR 697
           K+++   + L +L       I+HRD+K S++ ++   E +L DFG++    + +      
Sbjct: 108 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 164
Query: 698 GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE 747
           G+  Y+ PE  Q      + +SD++  G+ L+E+  G+ P+    P+ KE
Sbjct: 165 GTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKE 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 124/306 (40%), Gaps = 50/306 (16%)
Query: 516 LAEGKFGPV-YRGFLPG----GIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPL 569
           L EG FG V    + P     G  VAVK L  G     +    RE+E L  + H ++V  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 570 TGYCI-AGDQRIA-IYDYMENGNLQNLLHDLPLGVQXXXXXXXXXXXXXXXNSIQNVGSE 627
            G C   G++ +  + +Y+  G+L++ L                            VG  
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL------------------------PRHCVGLA 111
Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
            LL    F  +I  G    +A+LH   +   IHR + A +V LD +   ++ DFGLAK  
Sbjct: 112 QLLL---FAQQICEG----MAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAV 161
Query: 688 GNGLDEEIAR---GSPGY-IPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
             G +    R    SP +   PE  +    +    SDV+ +GV L EL+T      +  P
Sbjct: 162 PEGHEYYRVREDGDSPVFWYAPECLKECKFYYA--SDVWSFGVTLYELLTYCD--SNQSP 217
Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
             K   L+   +G +   + +  ++   R   P++   E   +   C       RP+ Q 
Sbjct: 218 HTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQN 277
Query: 804 IVGLLK 809
           +V +L+
Sbjct: 278 LVPILQ 283

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 6/88 (6%)
Query: 658 IIHRDIKASSVYLDMNLE---PRLSDFGLA-KIFGNGLDEEIARGSPGYIPPEFAQPDSD 713
           ++HRD+K  ++ L   L+    +L+DFGLA ++ G         G+PGY+ PE  + D  
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP- 200
Query: 714 FPTPKSDVYCYGVVLLELITGKKPLGDD 741
           +  P  D++  GV+L  L+ G  P  D+
Sbjct: 201 YGKP-VDLWACGVILYILLVGYPPFWDE 227

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI-FGNGLDEEIARGSPGYIP 704
           AL +LH      II+RD+K  +V LD     +L+D+G+ K     G       G+P YI 
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 178
Query: 705 PEFAQ-PDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           PE  +  D  F     D +  GV++ E++ G+ P 
Sbjct: 179 PEILRGEDYGFSV---DWWALGVLMFEMMAGRSPF 210

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	815
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-108
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-99
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-94
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-83
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-80
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-76
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-72
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-67
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-64
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-53
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-61
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-60
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-60
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-59
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-57
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-57
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-55
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-52
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-50
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-26
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-57
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-55
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-53
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-52
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-51
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-51
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-51
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-50
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-57
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-36
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-53
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-53
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-51
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-47
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-45
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-37
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-34
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-50
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-49
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-48
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-47
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-46
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-46
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-46
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-42
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-47
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-43
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-36
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-28
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-28
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-20
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-37
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-30
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-46
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-45
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-36
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-35
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-45
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-43
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-39
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-37
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-08
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-45
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-45
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-44
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-43
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-35
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-33
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-17
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-44
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-44
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-43
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-41
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-25
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-23
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-43
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-39
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-31
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-43
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-42
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-42
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-41
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-41
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-40
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-38
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-38
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-37
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-37
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-41
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-38
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-41
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-32
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-40
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-40
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-40
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-39
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-37
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-35
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-33
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-29
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-22
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-39
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-29
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-24
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-36
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-35
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-19
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-34
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-31
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-29
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-33
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-33
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-16
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-17
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-15
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-32
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-24
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-25
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-20
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-08
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-30
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-28
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-26
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-30
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-30
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-28
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-27
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-21
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-27
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-27
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-18
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-26
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-22
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-21
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-04
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-26
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-25
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-25
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-25
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-23
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-19
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-14
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-24
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-25
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-23
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-23
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-23
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-08
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-23
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-23
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-23
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-23
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-23
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-22
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-22
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-22
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-16
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-22
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-22
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-22
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-22
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-21
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-09
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-20
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-11
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-20
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-20
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-20
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-20
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-19
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-19
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-05
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-19
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-19
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-19
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-19
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-14
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-18
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-18
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-08
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-18
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-18
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-17
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-17
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-17
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-17
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-17
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-17
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-17
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-17
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-17
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	9e-17
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-11
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-16
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-16
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-04
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-12
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-15
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-15
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-05
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-12
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-15
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	7e-11
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	9e-09
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-15
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-14
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-14
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-05
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-14
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-06
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-13
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-13
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-13
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-13
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-13
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-13
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	8e-13
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-09
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-12
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-12
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-12
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-12
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	8e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-11
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-11
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-11
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-08
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-11
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-11
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-11
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-05
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-11
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-10
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-10
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-10
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-10
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-10
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-10
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-10
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-10
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-10
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-10
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-10
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-10
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-10
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-10
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-10
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-09
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-09
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-09
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-09
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-09
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-09
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-09
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-09
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-09
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-09
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-09
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-09
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-09
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-09
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-09
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-09
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-08
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-08
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-05
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-08
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	1e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-08
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-08
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-08
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-08
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-08
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-08
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-08
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-07
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-07
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-07
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-07
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-07
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-07
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-07
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-06
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-06
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-06
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-06
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-04
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-06
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	9e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-05
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-05
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-05
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-05
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-05
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-05
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-04
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	2e-04
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	4e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  332 bits (854), Expect = e-108
 Identities = 105/318 (33%), Positives = 167/318 (52%), Gaps = 38/318 (11%)

Query: 499 TFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTL-TDQEAARELEY 557
           +  +L  A+ NF    +L  G FG VY+G L  G  VAVK L    T   + +   E+E 
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80

Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDG 617
           +    H NL+ L G+C+   +R+ +Y YM NG++ + L + P   Q   DW         
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES-QPPLDWPK------- 132

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
                             R +IALG+AR LA+LH  C P IIHRD+KA+++ LD   E  
Sbjct: 133 ------------------RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174

Query: 678 LSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
           + DFGLAK+     D  +    RG+ G+I PE+    +   + K+DV+ YGV+LLELITG
Sbjct: 175 VGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITG 231

Query: 735 KKPLGDDY---PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCT 791
           ++    D      + +  L+ WV+GL++  K    +D  ++    ++++E+ +++  LCT
Sbjct: 232 QRAF--DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCT 289

Query: 792 ADLPLKRPSMQQIVGLLK 809
              P++RP M ++V +L+
Sbjct: 290 QSSPMERPKMSEVVRMLE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  309 bits (793), Expect = 7e-99
 Identities = 97/317 (30%), Positives = 146/317 (46%), Gaps = 35/317 (11%)

Query: 498 ITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEY 557
           +   DL  AT+NFD   L+  G FG VY+G L  G  VA+K     S+   +E   E+E 
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDG 617
           L   +HP+LV L G+C   ++ I IY YMENGNL+  L+   L   +   W         
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM-SWEQ------- 140

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
                             R +I +G AR L +LH      IIHRD+K+ ++ LD N  P+
Sbjct: 141 ------------------RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179

Query: 678 LSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
           ++DFG++K         ++   +G+ GYI PE+        T KSDVY +GVVL E++  
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFI--KGRLTEKSDVYSFGVVLFEVLCA 237

Query: 735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL 794
           +  +       +  NL  W      N +  + +DP + D    + + +       C A  
Sbjct: 238 RSAI-VQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296

Query: 795 PLKRPSMQQIVGLLKDI 811
              RPSM  ++  L+  
Sbjct: 297 SEDRPSMGDVLWKLEYA 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  296 bits (761), Expect = 2e-94
 Identities = 96/338 (28%), Positives = 151/338 (44%), Gaps = 60/338 (17%)

Query: 495 LLNITFADLLSATSNFDR------GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTD 548
             + +F +L + T+NFD       G  + EG FG VY+G++     VAVK L     +T 
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITT 70

Query: 549 QEAAR----ELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDL----PL 600
           +E  +    E++ + + +H NLV L G+   GD    +Y YM NG+L + L  L    PL
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130

Query: 601 GVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH 660
                  W                           R KIA G A  + FLH       IH
Sbjct: 131 ------SWHM-------------------------RCKIAQGAANGINFLHENH---HIH 156

Query: 661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDSDFPTP 717
           RDIK++++ LD     ++SDFGLA+         +     G+  Y+ PE  + +    TP
Sbjct: 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEI---TP 213

Query: 718 KSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKG-SRAIDPKIRDTGP 776
           KSD+Y +GVVLLE+ITG   + +    +    L+     +    K     ID K+ D   
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEHREPQ---LLLDIKEEIEDEEKTIEDYIDKKMND-AD 269

Query: 777 EKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST 814
              +E    +   C  +   KRP ++++  LL+++ ++
Sbjct: 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  281 bits (722), Expect = 2e-83
 Identities = 110/353 (31%), Positives = 171/353 (48%), Gaps = 21/353 (5%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNIT-ALPSDLWSLGSLKSLNLSYNRISGSLPS 94
           S + +SG V    + +   L+ LD+S NN +  +P  L    +L+ L++S N++SG    
Sbjct: 186 SGNKISGDVD---VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSR 241

Query: 95  NIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTV 153
            I     L++ ++S+N F G IP     L SL+ L L  N F   IP  L   C +L  +
Sbjct: 242 AISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGL 299

Query: 154 DLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGR--DTHFAGLKSITNLNISGNLFQGS 211
           DLS N   G++P  FG +   L+SL L+ N   G         ++ +  L++S N F G 
Sbjct: 300 DLSGNHFYGAVPPFFG-SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358

Query: 212 V---MGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQ 268
           +   +     SL  +DL SN F G I      +    + L  + L  N  +G+I    S 
Sbjct: 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP--KNTLQELYLQNNGFTGKIPPTLSN 416

Query: 269 AQNLKHLSLAYNRFTRQEFPQ-IGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSM 327
              L  L L++N  +    P  +G+L  L  L L    L G+IP E++ + +L TL L  
Sbjct: 417 CSELVSLHLSFNYLS-GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475

Query: 328 NHLTGQIPT--VSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           N LTG+IP+   +  NL  I +S+N L+GEIP   + +L  +     S N+ +
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW-IGRLENLAILKLSNNSFS 527

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  273 bits (701), Expect = 2e-80
 Identities = 100/386 (25%), Positives = 168/386 (43%), Gaps = 33/386 (8%)

Query: 12  SASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPD--TTIGKLSKLQSLDLSENNITALP 69
           + + C++ GV C  +   VT    S+  L+       +++  L+ L+SL LS ++I    
Sbjct: 36  NKNPCTFDGVTCRDD--KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV 93

Query: 70  SDLWSLGSLKSLNLSYNRISGSLPS--NIGNFGLLEVFDLSNNNFSGEIPA-AISSLVSL 126
           S      SL SL+LS N +SG + +  ++G+   L+  ++S+N             L SL
Sbjct: 94  SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSL 153

Query: 127 RVLKLDGNMFQWSIPPGLL---NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGN 183
            VL L  N    +   G +    C  L  + +S N+++G +          L+ L+++ N
Sbjct: 154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVS---RCVNLEFLDVSSN 210

Query: 184 EIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNS 241
                        ++ +L+ISGN   G           L+++++ SNQF G I       
Sbjct: 211 NFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI------P 264

Query: 242 SYNWSRLVYVDLSENQLSGEI----FHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLE 297
                 L Y+ L+EN+ +GEI             L  L L+ N F     P  G+   LE
Sbjct: 265 PLPLKSLQYLSLAENKFTGEIPDFLSGACD---TLTGLDLSGNHFYGAVPPFFGSCSLLE 321

Query: 298 HLNLSRTSLIGDIPSEIL-QLSSLHTLDLSMNHLTGQIPTVSAK---NLGIIDMSHNNLS 353
            L LS  +  G++P + L ++  L  LDLS N  +G++P        +L  +D+S NN S
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381

Query: 354 GEIPASLLE-KLPQMERFNFSYNNLT 378
           G I  +L +     ++      N  T
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFT 407

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  261 bits (669), Expect = 5e-76
 Identities = 91/386 (23%), Positives = 161/386 (41%), Gaps = 39/386 (10%)

Query: 1   MSSKSFQASYFSASFCSWRGVV----CDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQ 56
           +++ S        S  ++ G +    C + K  + +    N+G +G +P  T+   S+L 
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP-TLSNCSELV 421

Query: 57  SLDLSENNIT-ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGE 115
           SL LS N ++  +PS L SL  L+ L L  N + G +P  +     LE   L  N+ +GE
Sbjct: 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481

Query: 116 IPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKL 175
           IP+ +S+  +L  + L  N     IP  +   ++L  + LS N  +G++P   G      
Sbjct: 482 IPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG------ 535

Query: 176 KSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSV-MGVFLESLEVIDLRSNQFQGHI 234
                               +S+  L+++ NLF G++   +F +S     + +N   G  
Sbjct: 536 ------------------DCRSLIWLDLNTNLFNGTIPAAMFKQSG---KIAANFIAGKR 574

Query: 235 SQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLL 294
                N      +  +   +  +  G      ++       ++    +     P      
Sbjct: 575 YVYIKNDGM--KKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG 632

Query: 295 GLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPT--VSAKNLGIIDMSHNNL 352
            +  L++S   L G IP EI  +  L  L+L  N ++G IP      + L I+D+S N L
Sbjct: 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692

Query: 353 SGEIPASLLEKLPQMERFNFSYNNLT 378
            G IP + +  L  +   + S NNL+
Sbjct: 693 DGRIPQA-MSALTMLTEIDLSNNNLS 717

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  250 bits (641), Expect = 5e-72
 Identities = 111/359 (30%), Positives = 166/359 (46%), Gaps = 42/359 (11%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT-ALPSDLWSLGSLKSLNLSYNRISGSL 92
           L+ N  LSG++P + +G LSKL+ L L  N +   +P +L  + +L++L L +N ++G +
Sbjct: 425 LSFNY-LSGTIPSS-LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482

Query: 93  PSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVT 152
           PS + N   L    LSNN  +GEIP  I  L +L +LKL  N F  +IP  L +C+SL+ 
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIW 542

Query: 153 VDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSV 212
           +DL+ N  NG++P        K+ +  +AG     R  +          + +GNL     
Sbjct: 543 LDLNTNLFNGTIPAAMFKQSGKIAANFIAGK----RYVYIKNDGMKKECHGAGNL----- 593

Query: 213 MGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNL 272
                           +FQG  S          S     +++     G     F    ++
Sbjct: 594 ---------------LEFQGIRS----EQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634

Query: 273 KHLSLAYNRFTRQEFPQ-IGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLT 331
             L ++YN  +    P+ IG++  L  LNL    + G IP E+  L  L+ LDLS N L 
Sbjct: 635 MFLDMSYNMLS-GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD 693

Query: 332 GQIPT--VSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSY--NNLTLCASELSP 386
           G+IP    +   L  ID+S+NNLSG IP        Q E F  +   NN  LC   L  
Sbjct: 694 GRIPQAMSALTMLTEIDLSNNNLSGPIPEM-----GQFETFPPAKFLNNPGLCGYPLPR 747

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  237 bits (607), Expect = 2e-67
 Identities = 98/357 (27%), Positives = 152/357 (42%), Gaps = 23/357 (6%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT-ALPSDLWSLGSLKSLNLSYNRISGSL 92
           LA N   +G +PD   G    L  LDLS N+   A+P    S   L+SL LS N  SG L
Sbjct: 276 LAENK-FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334

Query: 93  P-SNIGNFGLLEVFDLSNNNFSGEIPAAISSL-VSLRVLKLDGNMFQWSIPPGLLNCQ-- 148
           P   +     L+V DLS N FSGE+P ++++L  SL  L L  N F   I P L      
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394

Query: 149 SLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGR-DTHFAGLKSITNLNISGNL 207
           +L  + L  N   G +P        +L SL+L+ N + G   +    L  + +L +  N+
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453

Query: 208 FQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN 265
            +G +      +++LE + L  N   G I         N + L ++ LS N+L+GEI   
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPS----GLSNCTNLNWISLSNNRLTGEIPKW 509

Query: 266 FSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDL 325
             + +NL  L L+ N F+     ++G    L  L+L+     G IP+ + + S      +
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKI 565

Query: 326 SMNHLTGQIPTV--SAKNLGIIDMSHN--NLSGEIPASLLEKLPQMERFNFSYNNLT 378
           + N + G+      +         + N     G     L  +L      N +     
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN-RLSTRNPCNITSRVYG 621

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  215 bits (550), Expect = 7e-64
 Identities = 76/351 (21%), Positives = 132/351 (37%), Gaps = 79/351 (22%)

Query: 12  SASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT---AL 68
                +W GV+CD+                         +  ++ +LDLS  N+     +
Sbjct: 32  DCCNRTWLGVLCDT-----------------------DTQTYRVNNLDLSGLNLPKPYPI 68

Query: 69  PSDLWSLGSLKSLNLS-YNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLR 127
           PS L +L  L  L +   N + G +P  I     L    +++ N SG IP  +S + +L 
Sbjct: 69  PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128

Query: 128 VLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG 187
            L    N    ++PP + +  +LV +    N+++G++PD +G        L         
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG----SFSKL--------- 175

Query: 188 RDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSR 247
                                              + +  N+  G I     N +     
Sbjct: 176 --------------------------------FTSMTISRNRLTGKIPPTFANLN----- 198

Query: 248 LVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLI 307
           L +VDLS N L G+    F   +N + + LA N     +  ++G    L  L+L    + 
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF-DLGKVGLSKNLNGLDLRNNRIY 257

Query: 308 GDIPSEILQLSSLHTLDLSMNHLTGQIPTVSA-KNLGIIDMSHNNLSGEIP 357
           G +P  + QL  LH+L++S N+L G+IP     +   +   ++N      P
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  186 bits (475), Expect = 3e-53
 Identities = 64/305 (20%), Positives = 110/305 (36%), Gaps = 59/305 (19%)

Query: 80  SLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGE--IPAAISSLVSLRVLKL-DGNMF 136
           + +       G L         +   DLS  N      IP+++++L  L  L +   N  
Sbjct: 30  TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89

Query: 137 QWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLK 196
              IPP +     L  + ++   ++G++PD       ++K+L                  
Sbjct: 90  VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS----QIKTL------------------ 127

Query: 197 SITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLS 254
               L+ S N   G++      L +L  I    N+  G I     + S        + +S
Sbjct: 128 --VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS---KLFTSMTIS 182

Query: 255 ENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEI 314
            N+L+G+I                         P     L L  ++LSR  L GD     
Sbjct: 183 RNRLTGKI-------------------------PPTFANLNLAFVDLSRNMLEGDASVLF 217

Query: 315 LQLSSLHTLDLSMNHLTGQIPTVS-AKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFS 373
               +   + L+ N L   +  V  +KNL  +D+ +N + G +P   L +L  +   N S
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQG-LTQLKFLHSLNVS 276

Query: 374 YNNLT 378
           +NNL 
Sbjct: 277 FNNLC 281

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  209 bits (535), Expect = 1e-61
 Identities = 74/348 (21%), Positives = 117/348 (33%), Gaps = 69/348 (19%)

Query: 496 LNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAAREL 555
           +++   +L   +       + A G+FG V++  L    +VAVK+         Q    E 
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-YVAVKIFPIQD---KQSWQNEY 67

Query: 556 E--YLGRIKHPNLVPLTGYCIAGD----QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWS 609
           E   L  +KH N++   G    G         I  + E G+L + L    +         
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVV--------- 118

Query: 610 TDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHH-------GCSPPIIHRD 662
                                 +W     IA   AR LA+LH        G  P I HRD
Sbjct: 119 ----------------------SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRD 156

Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQ--PDSDFP-T 716
           IK+ +V L  NL   ++DFGLA  F  G          G+  Y+ PE  +   +      
Sbjct: 157 IKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAF 216

Query: 717 PKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWV---------RGLVRNNKGSRAI 767
            + D+Y  G+VL EL +          E         +         + +V + K     
Sbjct: 217 LRIDMYAMGLVLWELASRCTAADGPVDEYML-PFEEEIGQHPSLEDMQEVVVHKK----K 271

Query: 768 DPKIRDTGPEKQMEEAL-KIGYLCTADLPLKRPSMQQIVGLLKDIEST 814
            P +RD   +      L +    C       R S   +   +  ++  
Sbjct: 272 RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  216 bits (553), Expect = 1e-60
 Identities = 72/364 (19%), Positives = 129/364 (35%), Gaps = 31/364 (8%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSN------ 95
            V + +   L +L+   L  NNI  L S  L  L +++ LNL  +    S+         
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321

Query: 96  ---IGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGL----LNCQ 148
                    LE  ++ +N+  G      + L++L+ L L  +              L   
Sbjct: 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381

Query: 149 SLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH--FAGLKSITNLNISGN 206
            L  ++L+ N+++    D F      L+ L+L  NEI    T   + GL++I  + +S N
Sbjct: 382 PLHILNLTKNKISKIESDAFSW-LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYN 440

Query: 207 LFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFH 264
            +       F  + SL+ + LR    +   S            L  +DLS N ++     
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ--PLRNLTILDLSNNNIANINDD 498

Query: 265 NFSQAQNLKHLSLAYNRFTR--------QEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ 316
                + L+ L L +N   R             +  L  L  LNL               
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558

Query: 317 LSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSY 374
           L  L  +DL +N+L     +V  +  +L  +++  N ++             +   +  +
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618

Query: 375 NNLT 378
           N   
Sbjct: 619 NPFD 622

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  215 bits (550), Expect = 3e-60
 Identities = 82/369 (22%), Positives = 142/369 (38%), Gaps = 29/369 (7%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSL 92
           L  N  LS  + D T    + L  L L  N+I  + ++      +L +L+LS+N +S + 
Sbjct: 80  LQHNE-LSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK 137

Query: 93  PSNIGNFGLLEVFDLSNNNFSGEIPAAISSL--VSLRVLKLDGNMFQWSIPPGLLNCQSL 150
                    L+   LSNN         +      SL+ L+L  N  +   P        L
Sbjct: 138 LGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRL 197

Query: 151 VTVDLSMNQLNGSLPDGFGAAF--PKLKSLNLAGNEIKG-RDTHFAGLK--SITNLNISG 205
             + L+  QL  SL +          +++L+L+ +++    +T F GLK  ++T L++S 
Sbjct: 198 FGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY 257

Query: 206 NLFQGSVMGVF--LESLEVIDLRSNQFQGHISQV--------QFNSSYNWSRLVYVDLSE 255
           N         F  L  LE   L  N  Q   S            N   +        +S 
Sbjct: 258 NNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS---FTKQSISL 314

Query: 256 NQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSL-IGDIPSEI 314
             L      +F   + L+HL++  N     +      L+ L++L+LS +   +  + +E 
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374

Query: 315 ---LQLSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMER 369
              L  S LH L+L+ N ++           +L ++D+  N +  E+       L  +  
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434

Query: 370 FNFSYNNLT 378
              SYN   
Sbjct: 435 IYLSYNKYL 443

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  213 bits (545), Expect = 2e-59
 Identities = 74/370 (20%), Positives = 129/370 (34%), Gaps = 28/370 (7%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
            +P     + S+L SLD+  N I+ L  +    L  LK LNL +N +S            
Sbjct: 39  RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN 98

Query: 102 LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLN 161
           L    L +N+             +L  L L  N    +     +  ++L  + LS N++ 
Sbjct: 99  LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158

Query: 162 GSLPDGFGAAF-PKLKSLNLAGNEIKGRDTH-FAGLKSITNLNISGNLFQGSVMGVF--- 216
               +         LK L L+ N+IK      F  +  +  L ++      S+       
Sbjct: 159 ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE 218

Query: 217 --LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKH 274
               S+  + L ++Q     S   F     W+ L  +DLS N L+     +F+    L++
Sbjct: 219 LANTSIRNLSLSNSQLST-TSNTTF-LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEY 276

Query: 275 LSLAYNRFTRQEFPQIGTLLGLEHLNLSR---------TSLIGDIPSEILQLSSLHTLDL 325
             L YN         +  L  + +LNL R          SL          L  L  L++
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336

Query: 326 SMNHLTGQIPTV--SAKNLGIIDMSHNNLS-GEIPASLLEKLPQM--ERFNFSYNNLTLC 380
             N + G    +     NL  + +S++  S   +       L        N + N ++  
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKIS-- 394

Query: 381 ASELSPETLQ 390
             ++  +   
Sbjct: 395 --KIESDAFS 402

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  207 bits (528), Expect = 3e-57
 Identities = 66/344 (19%), Positives = 121/344 (35%), Gaps = 27/344 (7%)

Query: 55  LQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSG 114
            +  D S   +T +P DL    ++  LNL++N++     +N   +  L   D+  N  S 
Sbjct: 6   HEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63

Query: 115 EIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPK 174
             P     L  L+VL L  N            C +L  + L  N +     + F      
Sbjct: 64  LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV-KQKN 122

Query: 175 LKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF----LESLEVIDLRSNQ 229
           L +L+L+ N +   +      L+++  L +S N  Q             SL+ ++L SNQ
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182

Query: 230 FQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQN---LKHLSLAYNRFTRQE 286
            +           +   RL  + L+  QL   +            +++LSL+ ++ +   
Sbjct: 183 IKEFSP----GCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238

Query: 287 FPQIGTL--LGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV--SAKNL 342
                 L    L  L+LS  +L          L  L    L  N++            N+
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNV 298

Query: 343 GIIDMSHNNLSG--------EIPASLLEKLPQMERFNFSYNNLT 378
             +++  +            +I     + L  +E  N   N++ 
Sbjct: 299 RYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  206 bits (527), Expect = 4e-57
 Identities = 80/374 (21%), Positives = 148/374 (39%), Gaps = 28/374 (7%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITAL-PSDLWSLGSLKSLNLSYNRISGSLPS 94
           S+  L+  VPD      + +  L+L+ N +  L  ++      L SL++ +N IS   P 
Sbjct: 12  SHLKLT-QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE 67

Query: 95  NIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVD 154
                 +L+V +L +N  S       +   +L  L L  N  Q       +  ++L+T+D
Sbjct: 68  LCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127

Query: 155 LSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG---RDTHFAGLKSITNLNISGNLFQGS 211
           LS N L+ +           L+ L L+ N+I+     +       S+  L +S N  +  
Sbjct: 128 LSHNGLSSTKLGTQV-QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEF 186

Query: 212 VMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFS-- 267
             G F  +  L  + L + Q    +++       N + +  + LS +QLS      F   
Sbjct: 187 SPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELAN-TSIRNLSLSNSQLSTTSNTTFLGL 245

Query: 268 QAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSM 327
           +  NL  L L+YN            L  LE+  L   ++       +  L ++  L+L  
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305

Query: 328 NHLTG-----QIPTVSA------KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNN 376
           +          +P +        K L  ++M  N++ G I +++   L  ++  + S + 
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSF 364

Query: 377 LTLCASELSPETLQ 390
            +L    L+ ET  
Sbjct: 365 TSL--RTLTNETFV 376

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  200 bits (512), Expect = 5e-55
 Identities = 75/370 (20%), Positives = 146/370 (39%), Gaps = 31/370 (8%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD----LWSLGSLKSLNLSYNRISGSLPSNIGN 98
                    + +L  L L+   +    ++      +  S+++L+LS +++S +  +    
Sbjct: 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG 244

Query: 99  FGL--LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLS 156
                L + DLS NN +     + + L  L    L+ N  Q      L    ++  ++L 
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304

Query: 157 MNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF 216
            +    S+          L  ++         D  F  LK + +LN+  N   G    +F
Sbjct: 305 RSFTKQSIS------LASLPKID---------DFSFQWLKCLEHLNMEDNDIPGIKSNMF 349

Query: 217 --LESLEVIDLRSNQFQ-GHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLK 273
             L +L+ + L ++      ++   F S  + S L  ++L++N++S      FS   +L+
Sbjct: 350 TGLINLKYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLGHLE 408

Query: 274 HLSLAYNRFTRQ-EFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTG 332
            L L  N   ++    +   L  +  + LS    +    +    + SL  L L    L  
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468

Query: 333 QIPTVSA----KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPET 388
              + S     +NL I+D+S+NN++  I   +LE L ++E  +  +NNL       +P  
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIAN-INDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527

Query: 389 LQTAFFGSSN 398
                 G S+
Sbjct: 528 PIYFLKGLSH 537

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  191 bits (488), Expect = 7e-52
 Identities = 77/356 (21%), Positives = 134/356 (37%), Gaps = 37/356 (10%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
            + D +   L  L+ L++ +N+I  + S+    L +LK L+LS +  S    +N     L
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378

Query: 102 ----LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLS 156
               L + +L+ N  S     A S L  L VL L  N     +        +++  + LS
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438

Query: 157 MNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH---FAGLKSITNLNISGNLFQGSVM 213
            N+      + F    P L+ L L    +K  D+    F  L+++T L++S N       
Sbjct: 439 YNKYLQLTRNSFAL-VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND 497

Query: 214 GVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQN 271
            +   LE LE++DL+ N                        L ++   G   +      +
Sbjct: 498 DMLEGLEKLEILDLQHNNLA--------------------RLWKHANPGGPIYFLKGLSH 537

Query: 272 LKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLT 331
           L  L+L  N F          L  L+ ++L   +L     S      SL +L+L  N +T
Sbjct: 538 LHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT 597

Query: 332 GQIPTV---SAKNLGIIDMSHNNLSGEIPA--SLLEKLPQMERFNFSYNNLTLCAS 382
                V   + +NL  +DM  N       +    +  + +        ++  LC +
Sbjct: 598 SVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNT 653

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  188 bits (480), Expect = 1e-50
 Identities = 67/330 (20%), Positives = 124/330 (37%), Gaps = 17/330 (5%)

Query: 77  SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMF 136
           S +  + S+ +++  +P ++     + V +L++N       A  +    L  L +  N  
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 137 QWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGL 195
               P        L  ++L  N+L+      F      L  L+L  N I+  ++  F   
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFA-FCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 196 KSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDL 253
           K++  L++S N    + +G    LE+L+ + L +N+ Q   S+      +  S L  ++L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE--LDIFANSSLKKLEL 178

Query: 254 SENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLG---LEHLNLSRTSLIGDI 310
           S NQ+       F     L  L L   +       ++   L    + +L+LS + L    
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238

Query: 311 PSEI--LQLSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQ 366
            +    L+ ++L  LDLS N+L             L    + +NN+      S L  L  
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS-LHGLFN 297

Query: 367 MERFNFSYNNLTLCASELSPETLQTAFFGS 396
           +   N   +      S  S   +    F  
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQW 327

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  112 bits (283), Expect = 6e-26
 Identities = 40/178 (22%), Positives = 63/178 (35%), Gaps = 9/178 (5%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRIS--- 89
           L   +  +     +    L  L  LDLS NNI  +  D L  L  L+ L+L +N ++   
Sbjct: 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLW 520

Query: 90  -----GSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGL 144
                G     +     L + +L +N F          L  L+++ L  N          
Sbjct: 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580

Query: 145 LNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLN 202
            N  SL +++L  N +       FG AF  L  L++  N         A   +  N  
Sbjct: 581 NNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINET 638

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  207 bits (528), Expect = 1e-57
 Identities = 79/357 (22%), Positives = 134/357 (37%), Gaps = 17/357 (4%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLG---SLKSLNLSYNRISG 90
                 L           +  L      + +   +   ++      S++S+NL  +    
Sbjct: 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268

Query: 91  SLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSL 150
              +    F  L+  DL+  + S E+P+ +  L +L+ L L  N F+        N  SL
Sbjct: 269 ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327

Query: 151 VTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH---FAGLKSITNLNISGNL 207
             + +  N     L  G       L+ L+L+ ++I+  D        L  + +LN+S N 
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387

Query: 208 FQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN 265
                   F     LE++DL   + +   +Q  F + +    L  ++LS + L       
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL---LKVLNLSHSLLDISSEQL 444

Query: 266 FSQAQNLKHLSLAYNRFTRQEFPQIGTLLG---LEHLNLSRTSLIGDIPSEILQLSSLHT 322
           F     L+HL+L  N F +    +  +L     LE L LS   L          L  ++ 
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504

Query: 323 LDLSMNHLTGQIPTV-SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           +DLS N LT       S      ++++ N++S  I  SLL  L Q    N   N L 
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGIYLNLASNHISI-ILPSLLPILSQQRTINLRQNPLD 560

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  200 bits (511), Expect = 2e-55
 Identities = 75/364 (20%), Positives = 136/364 (37%), Gaps = 20/364 (5%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSL 92
           L +N  L   + +T +     L+ L   +  I+++    L +  +L+SL L  N IS   
Sbjct: 88  LTANP-LI-FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIK 145

Query: 93  PSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNM-FQWSIPPGLLNCQSLV 151
                    L+V D  NN         +SSL     L L+ N      I PG  +     
Sbjct: 146 LPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQ 205

Query: 152 TVDLSMNQLNGSLPDGF-GAAFPKLKSLNLAGNEIKGRDTH-FAGLK--SITNLNISGNL 207
           +++    Q    +  G   +    L        + +      F GL   S+ ++N+  + 
Sbjct: 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265

Query: 208 FQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN 265
           F       F     L+ +DL +      +S++  +     S L  + LS N+       +
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATH----LSELP-SGLVGLSTLKKLVLSANKFENLCQIS 320

Query: 266 FSQAQNLKHLSLAYNRFTRQEFPQ-IGTLLGLEHLNLSRTSL--IGDIPSEILQLSSLHT 322
            S   +L HLS+  N    +     +  L  L  L+LS   +        ++  LS L +
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQS 380

Query: 323 LDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLC 380
           L+LS N               L ++D++   L  +   S  + L  ++  N S++ L + 
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440

Query: 381 ASEL 384
           + +L
Sbjct: 441 SEQL 444

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  193 bits (493), Expect = 5e-53
 Identities = 70/387 (18%), Positives = 129/387 (33%), Gaps = 47/387 (12%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
           S+    +     L+SL L  N+I+++     +    LK L+   N I      ++ +   
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178

Query: 102 LEVFDLS-NNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQ------------ 148
                L+ N N    I          + L   G      I  GL N              
Sbjct: 179 ATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238

Query: 149 ----------------SLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHF 192
                           S+ +++L  +       + F   F  L+ L+L    +    +  
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFH-CFSGLQELDLTATHLSELPSGL 297

Query: 193 AGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVY 250
            GL ++  L +S N F+           SL  + ++ N  +  +      +  N   L  
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN---LRE 354

Query: 251 VDLSENQL--SGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIG 308
           +DLS + +  S           +L+ L+L+YN     +         LE L+L+ T L  
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414

Query: 309 -DIPSEILQLSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSG--EIPASLLEK 363
            D  S    L  L  L+LS + L      +      L  +++  N+         + L+ 
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474

Query: 364 LPQMERFNFSYNNLTLCASELSPETLQ 390
           L ++E    S+ +L+     +      
Sbjct: 475 LGRLEILVLSFCDLS----SIDQHAFT 497

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  190 bits (486), Expect = 5e-52
 Identities = 68/375 (18%), Positives = 133/375 (35%), Gaps = 37/375 (9%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
           ++ +TT  +L  L  LDL+   I  +  D   S   L +L L+ N +     + +     
Sbjct: 47  TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKA 106

Query: 102 LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLN 161
           L+         S      + +  +L  L L  N       P     + L  +D   N ++
Sbjct: 107 LKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166

Query: 162 GSLPDGFGAAFPKLK--SLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF--- 216
               +    +  +    SLNL GN+I G +          +LN  G      +       
Sbjct: 167 YLSKEDMS-SLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS 225

Query: 217 -LESLEVIDLRSNQFQG----------------------HISQVQFNSSYNWSRLVYVDL 253
            ++SL +        +                       +   +  N+ + +S L  +DL
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285

Query: 254 SENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSE 313
           +   LS E+         LK L L+ N+F             L HL++   +   ++ + 
Sbjct: 286 TATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344

Query: 314 ILQ-LSSLHTLDLSMNHLTGQIPTVSA----KNLGIIDMSHNNLSGEIPASLLEKLPQME 368
            L+ L +L  LDLS + +              +L  +++S+N     +     ++ PQ+E
Sbjct: 345 CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKECPQLE 403

Query: 369 RFNFSYNNLTLCASE 383
             + ++  L +  ++
Sbjct: 404 LLDLAFTRLKVKDAQ 418

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  189 bits (481), Expect = 2e-51
 Identities = 83/297 (27%), Positives = 136/297 (45%), Gaps = 10/297 (3%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLL 102
           ++   T    S LQ LDL+  +++ LPS L  L +LK L LS N+       +  NF  L
Sbjct: 268 NISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327

Query: 103 EVFDLSNNNFSGEI-PAAISSLVSLRVLKLDGNMFQWS--IPPGLLNCQSLVTVDLSMNQ 159
               +  N    E+    + +L +LR L L  +  + S      L N   L +++LS N+
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387

Query: 160 LNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH--FAGLKSITNLNISGNLFQGSVMGVF- 216
                 + F    P+L+ L+LA   +K +D    F  L  +  LN+S +L   S   +F 
Sbjct: 388 PLSLKTEAF-KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446

Query: 217 -LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHL 275
            L +L+ ++L+ N F    +  + NS     RL  + LS   LS    H F+  + + H+
Sbjct: 447 GLPALQHLNLQGNHFPK-GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505

Query: 276 SLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTG 332
            L++NR T     +  + L   +LNL+   +   +PS +  LS   T++L  N L  
Sbjct: 506 DLSHNRLT-SSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  187 bits (478), Expect = 5e-51
 Identities = 75/365 (20%), Positives = 139/365 (38%), Gaps = 21/365 (5%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITAL-PSDLWSLGSLKSLNLSYNRISGSLPS 94
            N GL+  +P       +  + L+ S N +  +  +    L +L  L+L+  +I      
Sbjct: 20  ENLGLN-EIPG---TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75

Query: 95  NIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTV 153
              +   L+   L+ N        A+S   +L+ L         SI    L N ++L ++
Sbjct: 76  TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTLESL 134

Query: 154 DLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITN--LNISGNLFQG 210
            L  N ++ S+    G    KLK L+   N I        + L+  TN  LN++GN   G
Sbjct: 135 YLGSNHIS-SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

Query: 211 SVMGVF-LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFS-- 267
              G F     + ++    Q    I +   NS+     L      +          F   
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI--QSLWLGTFEDMDDEDISPAVFEGL 251

Query: 268 QAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSM 327
              +++ ++L  + F            GL+ L+L+ T  + ++PS ++ LS+L  L LS 
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH-LSELPSGLVGLSTLKKLVLSA 310

Query: 328 NHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELS 385
           N           +  +L  + +  N    E+    LE L  +   + S++++    S+  
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE--TSDCC 368

Query: 386 PETLQ 390
              L+
Sbjct: 369 NLQLR 373

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  187 bits (477), Expect = 7e-51
 Identities = 83/365 (22%), Positives = 138/365 (37%), Gaps = 27/365 (7%)

Query: 43  SVPDTTIGKLSKLQ--SLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFG 100
            +    +  L +    SL+L+ N+I  +    +     +SLN    +    +   + N  
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226

Query: 101 L--LEVFDLSNNNFSGEIPAAISSL--VSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDL 155
           +  L +    + +     PA    L  +S+  + L  + F  +I          L  +DL
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF-NISSNTFHCFSGLQELDL 285

Query: 156 SMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH-FAGLKSITNLNISGNLFQGSVM- 213
           +   L+  LP G       LK L L+ N+ +       +   S+T+L+I GN  +  +  
Sbjct: 286 TATHLS-ELPSGLV-GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343

Query: 214 GVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQN 271
           G    LE+L  +DL  +  +   S        N S L  ++LS N+        F +   
Sbjct: 344 GCLENLENLRELDLSHDDIET--SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ 401

Query: 272 LKHLSLAYNRFTRQEFP-QIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHL 330
           L+ L LA+ R   ++       L  L+ LNLS + L          L +L  L+L  NH 
Sbjct: 402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461

Query: 331 TGQIPTVSA-----KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELS 385
                  +        L I+ +S  +LS  I       L  M   + S+N LT      S
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLS-SIDQHAFTSLKMMNHVDLSHNRLT----SSS 516

Query: 386 PETLQ 390
            E L 
Sbjct: 517 IEALS 521

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  185 bits (471), Expect = 5e-50
 Identities = 55/344 (15%), Positives = 105/344 (30%), Gaps = 20/344 (5%)

Query: 56  QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGE 115
           ++ +     +  +P  L    S + L  S+N +     +       L   DL+       
Sbjct: 15  KTYNCENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 116 IPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKL 175
                 S   L  L L  N   +     L   ++L  +      ++             L
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLH-NQKTL 131

Query: 176 KSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQG 232
           +SL L  N I   +       + +  L+   N            L+    + L  N    
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND- 190

Query: 233 HISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN--FSQAQNLKHLSLAYNRFTR--QEFP 288
            I+ ++  +  + +    ++    Q    IF     S  Q+L   +              
Sbjct: 191 -IAGIEPGAF-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248

Query: 289 QIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPT--VSAKNLGIID 346
           +    + +E +NL +        +     S L  LDL+  HL+ ++P+  V    L  + 
Sbjct: 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLV 307

Query: 347 MSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQ 390
           +S N     +        P +   +   N   L   EL    L+
Sbjct: 308 LSANKFEN-LCQISASNFPSLTHLSIKGNTKRL---ELGTGCLE 347

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  206 bits (527), Expect = 2e-57
 Identities = 60/395 (15%), Positives = 123/395 (31%), Gaps = 58/395 (14%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISG----- 90
           ++     S+   +     K   +    NNIT +   +  L  L+   +  +         
Sbjct: 167 NSDPQQKSIK-KSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICE 225

Query: 91  --------------SLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMF 136
                         +      N   L   ++ N     ++P  + +L  ++++ +  N  
Sbjct: 226 AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285

Query: 137 --------QWSIPPGLLNCQSLVTVDLSMNQL-NGSLPDGFGAAFPKLKSLNLAGNEIKG 187
                    W         + +  + +  N L    +         KL  L    N+++G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ-KMKKLGMLECLYNQLEG 344

Query: 188 RDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNW 245
           +   F     + +LN++ N             E +E +    N+ +   +        + 
Sbjct: 345 KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK---SV 401

Query: 246 SRLVYVDLSENQLSGEIFHNFS-------QAQNLKHLSLAYNRFTRQEFPQIGTLLGLEH 298
           S +  +D S N++      NF        +  N+  ++L+ N+ ++       T   L  
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461

Query: 299 LNLSRTSL-------IGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSA---KNLGIIDMS 348
           +NL    L       + D          L ++DL  N LT       A     L  ID+S
Sbjct: 462 INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLS 521

Query: 349 HNNLSGEIPASL-----LEKLPQMERFNFSYNNLT 378
           +N+ S   P        L+      + +   N   
Sbjct: 522 YNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  199 bits (507), Expect = 1e-54
 Identities = 63/397 (15%), Positives = 129/397 (32%), Gaps = 41/397 (10%)

Query: 11  FSASFCSWR---GVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT- 66
           F+     W    GV  +SN   VT       G SG VPD  IG+L++L+ L L  +    
Sbjct: 62  FNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDA-IGQLTELEVLALGSHGEKV 119

Query: 67  ----ALPSDLWSLGSLKSLNLSYNRISGSLPSNIG--NFGLLEVFDLSNNNFSGEIPAAI 120
                 P  + +  S +           +        +F  L    ++++     I  + 
Sbjct: 120 NERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179

Query: 121 SSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNL 180
              +    +    N     +   ++    L    +  +                 ++ N 
Sbjct: 180 RITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENI------CEAWENENS 232

Query: 181 AGNEIKGR-DTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQG----H 233
              +     D  +  LK +T++ +        +      L  +++I++  N+        
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292

Query: 234 ISQVQFNSSYNWSRLVYVDLSENQL-SGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGT 292
                   +    ++  + +  N L +  +  +  + + L  L   YN+    + P  G+
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE-GKLPAFGS 351

Query: 293 LLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNHLTGQIPTV----SAKNLGIIDM 347
            + L  LNL+   +   IP+        +  L  + N L   IP +    S   +  ID 
Sbjct: 352 EIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDF 409

Query: 348 SHNNLSGEIPASL------LEKLPQMERFNFSYNNLT 378
           S+N +      +         K   +   N S N ++
Sbjct: 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  197 bits (502), Expect = 6e-54
 Identities = 64/358 (17%), Positives = 115/358 (32%), Gaps = 50/358 (13%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLP 93
           +  N+  +  V  T++ K+ KL  L+   N +        S   L SLNL+YN+I+    
Sbjct: 312 IGYNNLKTFPVE-TSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPA 370

Query: 94  SNIGNFGLLEVFDLSNNNFSGEIPAA--ISSLVSLRVLKLDGNMFQ-------WSIPPGL 144
           +  G    +E    ++N     IP      S+  +  +    N            + P  
Sbjct: 371 NFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429

Query: 145 LNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNIS 204
               ++ +++LS NQ++    + F      L S+NL GN           +   +  + +
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTG-SPLSSINLMGN-------MLTEIPKNSLKDEN 481

Query: 205 GNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFH 264
            N             L  IDLR N+        +         LV +DLS N  S     
Sbjct: 482 ENFKN-------TYLLTSIDLRFNKLTKLSDDFRAT---TLPYLVGIDLSYNSFSK-FPT 530

Query: 265 NFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLD 324
               +  LK   +                      +      + + P  I    SL  L 
Sbjct: 531 QPLNSSTLKGFGIRNQ------------------RDAQGNRTLREWPEGITLCPSLTQLQ 572

Query: 325 LSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCAS 382
           +  N +   +      N+ ++D+  N     I  S +    +   +   Y+       
Sbjct: 573 IGSNDIRK-VNEKITPNISVLDIKDNPNIS-IDLSYVCPYIEAGMYMLFYDKTQDIRG 628

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  144 bits (365), Expect = 3e-36
 Identities = 48/320 (15%), Positives = 99/320 (30%), Gaps = 46/320 (14%)

Query: 74  SLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG 133
             G+  + N   +        ++ + G +    L     SG +P AI  L  L VL L  
Sbjct: 55  QPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGS 114

Query: 134 NMFQW----SIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRD 189
           +  +       P G+    S             +  D      P+    +L  + I    
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDY----DPREDFSDLIKDCINSDP 170

Query: 190 THFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLV 249
                 KSI   +                    I   SN     +S+    +    ++L 
Sbjct: 171 ----QQKSIKKSSRI------------TLKDTQIGQLSNNITF-VSK----AVMRLTKLR 209

Query: 250 YVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGD 309
              +  +    E        +  ++ +  Y +  + E  +   L  L  + +     +  
Sbjct: 210 QFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264

Query: 310 IPSEILQLSSLHTLDLSMNHLTGQIPTVS----------AKNLGIIDMSHNNL-SGEIPA 358
           +P+ +  L  +  ++++ N                     + + II + +NNL +  +  
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324

Query: 359 SLLEKLPQMERFNFSYNNLT 378
           S L+K+ ++      YN L 
Sbjct: 325 S-LQKMKKLGMLECLYNQLE 343

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  199 bits (508), Expect = 1e-53
 Identities = 69/379 (18%), Positives = 135/379 (35%), Gaps = 47/379 (12%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNIT----------ALPSDLWSLGSLKSLNLSY 85
            N      +PD  +  L +LQSL+++ N              L  D  +   ++   + Y
Sbjct: 499 YNCPNMTQLPDF-LYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557

Query: 86  NRISGSLPSNIGNFGL--LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPG 143
           N +    P++     +  L + D  +N     + A   + V L  LKLD N  +  IP  
Sbjct: 558 NNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPED 613

Query: 144 LL-NCQSLVTVDLSMNQLNGSLPDGFGAA-FPKLKSLNLAGNEIKG------RDTHFAGL 195
                  +  +  S N+L   +P+ F A     + S++ + N+I                
Sbjct: 614 FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672

Query: 196 KSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQG---HISQVQFNSSYNWSRLVY 250
            + + + +S N  Q     +F     +  I L +N       +  + +  +  N   L  
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732

Query: 251 VDLSENQLSG---EIFHNFSQAQNLKHLSLAYNRFTRQEFP-QIGTLLGLEHLNLSRT-- 304
           +DL  N+L+    +     +    L ++ ++YN F+   FP Q      L+   +     
Sbjct: 733 IDLRFNKLTSLSDDFR--ATTLPYLSNMDVSYNCFS--SFPTQPLNSSQLKAFGIRHQRD 788

Query: 305 ----SLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASL 360
                ++   P+ I    SL  L +  N +   +       L I+D++ N     I  + 
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYILDIADNPNI-SIDVTS 846

Query: 361 LEKLPQMERFNFSYNNLTL 379
           +    +   +   Y+    
Sbjct: 847 VCPYIEAGMYVLLYDKTQD 865

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  197 bits (501), Expect = 8e-53
 Identities = 60/413 (14%), Positives = 126/413 (30%), Gaps = 66/413 (15%)

Query: 31  TDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITAL--------------------PS 70
           T      + ++  +    I +L+KLQ +  + +  T                        
Sbjct: 428 TQIGNLTNRIT-FISKA-IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEEL 485

Query: 71  DLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSG---------EIPAAIS 121
              +L  L  + L        LP  + +   L+  +++ N              +     
Sbjct: 486 SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545

Query: 122 SLVSLRVLKLDGNMFQWSIPP--GLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLN 179
           +   +++  +  N  +   P    L     L  +D   N++   L   FG    KL  L 
Sbjct: 546 TGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEA-FG-TNVKLTDLK 601

Query: 180 LAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF---LESLEVIDLRSNQFQGHIS 235
           L  N+I+   +   A    +  L  S N  +          +  +  +D   N+      
Sbjct: 602 LDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGR 661

Query: 236 QV-QFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFT-------RQEF 287
            +      Y       V LS N++       F+    +  + L+ N  T       + + 
Sbjct: 662 NISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKD 721

Query: 288 PQIGTLLGLEHLNLSRTSLIGDIPSEIL--QLSSLHTLDLSMNHLTGQIPT--VSAKNLG 343
                   L  ++L    L   +  +     L  L  +D+S N  +   PT  +++  L 
Sbjct: 722 GNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLK 779

Query: 344 IIDMSH------NNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQ 390
              + H      N +  + P   +   P + +     N++     ++  +   
Sbjct: 780 AFGIRHQRDAEGNRILRQWPTG-ITTCPSLIQLQIGSNDIR----KVDEKLTP 827

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  192 bits (489), Expect = 3e-51
 Identities = 59/379 (15%), Positives = 116/379 (30%), Gaps = 52/379 (13%)

Query: 42  GSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISG----------- 90
             +   +   L   Q +    N IT +   +  L  L+ +  + +  +            
Sbjct: 415 KPIKKDSRISLKDTQ-IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN 473

Query: 91  --------SLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQ----- 137
                   +   +  N   L   +L N     ++P  +  L  L+ L +  N        
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533

Query: 138 ----WSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFA 193
                 +         +    +  N L             KL  L+   N+++  +  F 
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEA-FG 592

Query: 194 GLKSITNLNISGNLFQG--SVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYV 251
               +T+L +  N  +        F + +E +    N+ +   +     S Y    +  V
Sbjct: 593 TNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYV---MGSV 649

Query: 252 DLSENQLSGEIFHNFS-----QAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSL 306
           D S N++  E  +        +  N   ++L+YN   +       T   +  + LS   +
Sbjct: 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM 709

Query: 307 -------IGDIPSEILQLSSLHTLDLSMNHLTG---QIPTVSAKNLGIIDMSHNNLSGEI 356
                  +            L T+DL  N LT         +   L  +D+S+N  S   
Sbjct: 710 TSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SF 768

Query: 357 PASLLEKLPQMERFNFSYN 375
           P   L    Q++ F   + 
Sbjct: 769 PTQPL-NSSQLKAFGIRHQ 786

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  179 bits (455), Expect = 7e-47
 Identities = 59/360 (16%), Positives = 112/360 (31%), Gaps = 45/360 (12%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISG----- 90
               +        +    +L   DL ++ I   P ++  +     ++L   +I       
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP-EMKPIKKDSRISLKDTQIGNLTNRI 437

Query: 91  -SLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQS 149
             +   I     L++   +N+ F+ +  A     V       D      +      N + 
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKD 492

Query: 150 LVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQ 209
           L  V+L        LPD      P+L+SLN+A N         A    + +   +     
Sbjct: 493 LTDVELYNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTRLADDEDT----- 546

Query: 210 GSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQA 269
                     +++  +  N  +   +           +L  +D   N++       F   
Sbjct: 547 -------GPKIQIFYMGYNNLEEFPASASLQ---KMVKLGLLDCVHNKVR--HLEAFGTN 594

Query: 270 QNLKHLSLAYNRFTRQEFP-QIGTLLG-LEHLNLSRTSLIGDIPS--EILQLSSLHTLDL 325
             L  L L YN+    E P         +E L  S   L   IP+      +  + ++D 
Sbjct: 595 VKLTDLKLDYNQIE--EIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDF 651

Query: 326 SMNHLTGQIPTVSA-------KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           S N +  +   +S         N   + +S+N +    P  L      +     S N +T
Sbjct: 652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMT 710

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  173 bits (440), Expect = 5e-45
 Identities = 63/393 (16%), Positives = 117/393 (29%), Gaps = 35/393 (8%)

Query: 11  FSASFCSWRGVVCDS--NKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITAL 68
           F+     W         N   VT    +  G  G VPD  IG+L++L+ L    ++ T  
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA-IGQLTELKVLSFGTHSETVS 362

Query: 69  PSDLWSLG-SLKSLNLSYNRISGSLPSNIG----NFGLLEVFDLSNNNFSGEIPAAISSL 123
                    +        +RI                L ++   + N      P    S 
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 124 VSLRVLKLDGNMFQ-WSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAG 182
           +SL+  ++     +   I   +     L  +  + +                        
Sbjct: 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDANSDYAKQYE 481

Query: 183 NEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFN 240
           NE    +  ++ LK +T++ +        +      L  L+ +++  N+           
Sbjct: 482 NE----ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537

Query: 241 SS-----YNWSRLVYVDLSENQLSG-EIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLL 294
           +          ++    +  N L       +  +   L  L   +N+         GT +
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNV 595

Query: 295 GLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNHLTGQIPTV----SAKNLGIIDMSH 349
            L  L L    +   IP +       +  L  S N L   IP +    S   +G +D S+
Sbjct: 596 KLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSY 653

Query: 350 NNLSG---EIPASL-LEKLPQMERFNFSYNNLT 378
           N +      I  S+   K         SYN + 
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ 686

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  148 bits (374), Expect = 7e-37
 Identities = 44/336 (13%), Positives = 103/336 (30%), Gaps = 41/336 (12%)

Query: 56  QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGE 115
           ++LD       +   +        + N   +        ++ N G +    L+     G 
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338

Query: 116 IPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKL 175
           +P AI  L  L+VL    +    S         +    +   +++       F     +L
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398

Query: 176 KSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHIS 235
              +L  +             +I                  ++    I L+  Q     +
Sbjct: 399 NLSDLLQD-------------AINRNPEMKP----------IKKDSRISLKDTQIGNLTN 435

Query: 236 QVQFNSS--YNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTL 293
           ++ F S      ++L  +  + +  + +       A + +  +  Y +    E      L
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPFTYDN-----IAVDWEDANSDYAKQYENEELSWSNL 490

Query: 294 LGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSA-----------KNL 342
             L  + L     +  +P  +  L  L +L+++ N         +              +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

Query: 343 GIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
            I  M +NNL     ++ L+K+ ++   +  +N + 
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR 586

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  140 bits (355), Expect = 2e-34
 Identities = 45/291 (15%), Positives = 94/291 (32%), Gaps = 41/291 (14%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD--LWSLGSLKSLNLSYNRISG---SLPSNIG 97
            +P+       +++ L  S N +  +P+     S+  + S++ SYN+I     ++  ++ 
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668

Query: 98  NFGL--LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQ-------WSIPPGLLNCQ 148
           ++         LS N          ++   +  + L  N+                 N  
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728

Query: 149 SLVTVDLSMNQLNGSLPDGFGAA-FPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNL 207
            L T+DL  N+L  SL D F A   P L +++++ N      T       +    I    
Sbjct: 729 LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQR 787

Query: 208 FQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFS 267
                           D   N+                  L+ + +  N +  ++    +
Sbjct: 788 ----------------DAEGNRILRQWP----TGITTCPSLIQLQIGSNDIR-KVDEKLT 826

Query: 268 QAQNLKHLSLAYNRFTRQEFPQIGTLL--GLEHLNLSRTSLIGDIPSEILQ 316
               L  L +A N     +   +   +  G+  L   +T  I    +  ++
Sbjct: 827 --PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 95.3 bits (237), Expect = 3e-20
 Identities = 29/164 (17%), Positives = 58/164 (35%), Gaps = 24/164 (14%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLP 93
           L  N  L+    D     L  L ++D+S N  ++ P+   +   LK+  + + R      
Sbjct: 735 LRFNK-LTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQR------ 787

Query: 94  SNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTV 153
                       D   N    + P  I++  SL  L++  N  +  +   L     L  +
Sbjct: 788 ------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLT--PQLYIL 832

Query: 154 DLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLK 196
           D++ N    S+       + +     L  ++ +  R     G++
Sbjct: 833 DIADNPNI-SIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 77.6 bits (191), Expect = 9e-15
 Identities = 31/259 (11%), Positives = 72/259 (27%), Gaps = 35/259 (13%)

Query: 152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGS 211
            V + + +    + D   A     ++L+           +        N N   +++ G 
Sbjct: 256 NVPIQLKETAEYIKDYK-ALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMW-GD 313

Query: 212 VMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQN 271
             GV L++                           R+  + L+     G +     Q   
Sbjct: 314 QPGVDLDNN-------------------------GRVTGLSLAGFGAKGRVPDAIGQLTE 348

Query: 272 LKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNHL 330
           LK LS   +  T          L  +     +  +        L     L+  DL  + +
Sbjct: 349 LKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAI 408

Query: 331 TGQIPTVSAKNLGIIDMSHNNLSG------EIPASLLEKLPQMERFNFSYNNLTLCASEL 384
                    K    I +    +         I  ++ ++L +++   F+ +  T     +
Sbjct: 409 NRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAI-QRLTKLQIIYFANSPFTYDNIAV 467

Query: 385 SPETLQTAFFGSSNDCPIA 403
             E   + +     +  ++
Sbjct: 468 DWEDANSDYAKQYENEELS 486

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  186 bits (475), Expect = 1e-50
 Identities = 67/372 (18%), Positives = 128/372 (34%), Gaps = 33/372 (8%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITAL-------PSDLWSLGSLKSLNLSYNRI 88
                 G++       L  L +L + E  +  L             L ++ S +L    I
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 89  SGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQ 148
                         +  +L N  F       + SL  L      G           ++  
Sbjct: 295 ERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLP 347

Query: 149 SLVTVDLSMNQLN--GSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGN 206
           SL  +DLS N L+  G            LK L+L+ N +    ++F GL+ + +L+   +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFG-TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406

Query: 207 LFQGSV-MGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIF 263
             +      VF  L +L  +D+     +   + +    S     L  + ++ N       
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS----SLEVLKMAGNSFQENFL 462

Query: 264 HN-FSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHT 322
            + F++ +NL  L L+  +  +       +L  L+ LN+S  +           L+SL  
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 522

Query: 323 LDLSMNHLTGQIPTV---SAKNLGIIDMSHNNLSGEIPAS-LLEKLPQMERFNFSYNNLT 378
           LD S+NH+             +L  ++++ N+ +        L+ +    +       + 
Sbjct: 523 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERME 582

Query: 379 LCASELSPETLQ 390
            CA   +P   Q
Sbjct: 583 -CA---TPSDKQ 590

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  184 bits (468), Expect = 1e-49
 Identities = 74/394 (18%), Positives = 131/394 (33%), Gaps = 48/394 (12%)

Query: 23  CDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITAL-PSDLWSLGSLKSL 81
           C     ++T +          +PD         ++LDLS N +  L     +S   L+ L
Sbjct: 3   CVEVVPNIT-YQCMELNFY-KIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVL 57

Query: 82  NLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIP 141
           +LS   I         +   L    L+ N        A S L SL+ L            
Sbjct: 58  DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

Query: 142 PGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITN 200
             + + ++L  ++++ N +       + +    L+ L+L+ N+I+    T    L  +  
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177

Query: 201 ----LNISGNLFQGSVMGVFLE-SLEVIDLRSNQFQGHISQVQFN--------------- 240
               L++S N       G F E  L  + LR+N    ++ +                   
Sbjct: 178 LNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237

Query: 241 ---------SSYNWSRLVYVDLSENQLS------GEIFHNFSQAQNLKHLSLAYNRFTRQ 285
                           L  + + E +L+       +I   F+   N+   SL      R 
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER- 296

Query: 286 EFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGII 345
                    G +HL L      G  P+  L+L SL  L  + N        V   +L  +
Sbjct: 297 -VKDFSYNFGWQHLELVNCKF-GQFPT--LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFL 352

Query: 346 DMSHNNLSG-EIPASLLEKLPQMERFNFSYNNLT 378
           D+S N LS     +        ++  + S+N + 
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  170 bits (433), Expect = 7e-48
 Identities = 63/320 (19%), Positives = 134/320 (41%), Gaps = 67/320 (20%)

Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEAA-------RELEYLG 559
           +  +    + +G FG V++G  +     VA+K L+ G +  + E         RE+  + 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 560 RIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
            + HPN+V L G     +    + +++  G+L + L D                      
Sbjct: 79  NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD---------------------- 114

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR-- 677
                  +     W  + ++ L  A  + ++ +  +PPI+HRD+++ +++L    E    
Sbjct: 115 -------KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPV 166

Query: 678 ---LSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
              ++DFGL++   + +   +  G+  ++ PE    + +  T K+D Y + ++L  ++TG
Sbjct: 167 CAKVADFGLSQQSVHSVSGLL--GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

Query: 735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL---CT 791
           + P    + +E     + ++  +    +G R   P I +  P        ++  +   C 
Sbjct: 225 EGP----F-DEYSYGKIKFINMIR--EEGLR---PTIPEDCPP-------RLRNVIELCW 267

Query: 792 ADLPLKRPSMQQIVGLLKDI 811
           +  P KRP    IV  L ++
Sbjct: 268 SGDPKKRPHFSYIVKELSEL 287

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  177 bits (452), Expect = 2e-47
 Identities = 77/365 (21%), Positives = 136/365 (37%), Gaps = 30/365 (8%)

Query: 43  SVPDTTIGKLSKL----QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSN-IG 97
           ++    +  L +      SLD+S N I  +    +    L  L L  N  S ++    + 
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQ 226

Query: 98  NFGLLEVFDLSNNNFSGEI------PAAISSLVSLRVLKLD--GNMFQWSIPPGLLNCQS 149
           N   L V  L    F  E       P+ +  L  + + +                    +
Sbjct: 227 NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN 286

Query: 150 LVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQ 209
           +  + L+   +   L D       K +SL++   ++K        L  + +L ++ N   
Sbjct: 287 VSAMSLAGVSIK-YLEDVPK--HFKWQSLSIIRCQLK--QFPTLDLPFLKSLTLTMNKGS 341

Query: 210 GSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQA 269
            S   V L SL  +DL  N           +     + L ++DLS N     +  NF   
Sbjct: 342 ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT--NSLRHLDLSFNGAI-IMSANFMGL 398

Query: 270 QNLKHLSLAYNRFTR-QEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMN 328
           + L+HL   ++   R  EF    +L  L +L++S T+   D     L L+SL+TL ++ N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458

Query: 329 HLTGQIPTV---SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELS 385
                  +    +  NL  +D+S   L  +I   + + L +++  N S+NNL      L 
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLE-QISWGVFDTLHRLQLLNMSHNNLL----FLD 513

Query: 386 PETLQ 390
                
Sbjct: 514 SSHYN 518

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  175 bits (446), Expect = 1e-46
 Identities = 65/352 (18%), Positives = 120/352 (34%), Gaps = 29/352 (8%)

Query: 57  SLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEI 116
           +    +  ++ +P D+    S K+++LS+N +      +  NF  L+  DLS        
Sbjct: 15  TYQCMDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72

Query: 117 PAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLK 176
             A   L  L  L L GN  Q   P       SL  +     +L        G     LK
Sbjct: 73  DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ-LITLK 131

Query: 177 SLNLAGNEIKG--RDTHFAGLKSITNLNISGNLFQGSVMGVF------LESLEVIDLRSN 228
            LN+A N I       +F+ L ++ ++++S N  Q   +          +    +D+  N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191

Query: 229 QFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQA-QNLKHLSLAYNRFT---R 284
                I  +Q  +     +L  + L  N  S  I     Q    L    L    F     
Sbjct: 192 P----IDFIQDQAFQG-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERN 246

Query: 285 QEFPQIGTLLGL-----EHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSA 339
            E  +   + GL     +   L+ T+   D   +   L+++  + L+   +         
Sbjct: 247 LEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKH 306

Query: 340 KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQT 391
                + +    L  + P   L  L   +    + N  ++   +++  +L  
Sbjct: 307 FKWQSLSIIRCQLK-QFPTLDLPFL---KSLTLTMNKGSISFKKVALPSLSY 354

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  174 bits (444), Expect = 2e-46
 Identities = 64/360 (17%), Positives = 120/360 (33%), Gaps = 30/360 (8%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITAL-------PSDLWSLGSL--KSLNLSYN 86
             +  S ++  T +  L+ L    L               PS +  L  +      L+Y 
Sbjct: 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271

Query: 87  RISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLN 146
                          +    L+  +        +      + L +     +   P   L+
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPT--LD 326

Query: 147 CQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRD---THFAGLKSITNLNI 203
              L ++ L+MN+ + S         P L  L+L+ N +           G  S+ +L++
Sbjct: 327 LPFLKSLTLTMNKGSISFKKVA---LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383

Query: 204 SGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGE 261
           S N     +   F  LE L+ +D + +  +       F    +  +L+Y+D+S      +
Sbjct: 384 SFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFL---SLEKLLYLDISYTNTKID 439

Query: 262 IFHNFSQAQNLKHLSLAYNRFTRQEFPQI-GTLLGLEHLNLSRTSLIGDIPSEILQLSSL 320
               F    +L  L +A N F       +      L  L+LS+  L          L  L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499

Query: 321 HTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
             L++S N+L     +      +L  +D S N +       L      +  FN + N++ 
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  173 bits (440), Expect = 5e-46
 Identities = 68/382 (17%), Positives = 122/382 (31%), Gaps = 48/382 (12%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALP-SDLWSLGSLKSLNLSYNRISGSLPS 94
            +  LS  VPD      S  +++DLS N +  L      +   L+ L+LS   I      
Sbjct: 19  MDQKLS-KVPDDI---PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK 74

Query: 95  NIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTV 153
                  L    L+ N      P + S L SL  L         S+    +    +L  +
Sbjct: 75  AWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL-ASLESFPIGQLITLKKL 133

Query: 154 DLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITN----LNISGNLF 208
           +++ N ++      + +    L  ++L+ N I+         L+        L++S N  
Sbjct: 134 NVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI 193

Query: 209 QGSVMGVF-LESLEVIDLRSNQFQGHISQVQFN--------------------------- 240
                  F    L  + LR N    +I +                               
Sbjct: 194 DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253

Query: 241 --SSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEH 298
                    +    L+      +    F    N+  +SLA           +      + 
Sbjct: 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK--YLEDVPKHFKWQS 311

Query: 299 LNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPA 358
           L++ R   +   P+  L L  L +L L+MN  +     V+  +L  +D+S N LS     
Sbjct: 312 LSIIRCQ-LKQFPT--LDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCC 368

Query: 359 SLLE-KLPQMERFNFSYNNLTL 379
           S  +     +   + S+N   +
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAII 390

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  163 bits (415), Expect = 1e-42
 Identities = 61/305 (20%), Positives = 112/305 (36%), Gaps = 19/305 (6%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLP 93
                    S        L+ + ++ L+  +I  L   +      +SL++   ++    P
Sbjct: 266 FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED-VPKHFKWQSLSIIRCQLK-QFP 323

Query: 94  SNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPG---LLNCQSL 150
           +   +   L+   L+ N  S  I     +L SL  L L  N             L   SL
Sbjct: 324 TL--DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALS-FSGCCSYSDLGTNSL 378

Query: 151 VTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH--FAGLKSITNLNISGNLF 208
             +DLS N     +   F     +L+ L+   + +K       F  L+ +  L+IS    
Sbjct: 379 RHLDLSFNGAI-IMSANF-MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436

Query: 209 QGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNF 266
           +    G+F  L SL  + +  N F+ +     F ++   + L ++DLS+ QL    +  F
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT---TNLTFLDLSKCQLEQISWGVF 493

Query: 267 SQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLS 326
                L+ L++++N     +      L  L  L+ S   +            SL   +L+
Sbjct: 494 DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLT 553

Query: 327 MNHLT 331
            N + 
Sbjct: 554 NNSVA 558

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  176 bits (449), Expect = 3e-47
 Identities = 75/376 (19%), Positives = 135/376 (35%), Gaps = 47/376 (12%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRI-SGSLPSNIGNFG 100
           S+       LS LQ L   E N+ +L +  +  L +LK LN+++N I S  LP    N  
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 101 LLEVFDLSNNNFSGEIPAAISSLVSLRV----LKLDGNMFQWSIPPGLLNCQSLVTVDLS 156
            LE  DLS+N         +  L  + +    L L  N     I PG      L  + L 
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208

Query: 157 MNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-------RDTHFAGLKSIT--NLNISG-N 206
            N  + ++          L+   L   E +          +   GL ++T     ++  +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

Query: 207 LFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNW----------------SRL 248
            +   ++ +F  L ++    L S   +  +    +N  +                    L
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL 327

Query: 249 VYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFP--QIGTLLGLEHLNLSRTSL 306
             +  + N+       +     +L+ L L+ N  + +            L++L+LS   +
Sbjct: 328 KRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385

Query: 307 IGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSA----KNLGIIDMSHNNLSGEIPASLLE 362
           I  + S  L L  L  LD   ++L  Q+   S     +NL  +D+SH +        +  
Sbjct: 386 I-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 442

Query: 363 KLPQMERFNFSYNNLT 378
            L  +E    + N+  
Sbjct: 443 GLSSLEVLKMAGNSFQ 458

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  164 bits (416), Expect = 6e-43
 Identities = 76/372 (20%), Positives = 129/372 (34%), Gaps = 32/372 (8%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
            +   +     +LQ LDLS   I  +      SL  L +L L+ N I             
Sbjct: 42  HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101

Query: 102 LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQ-WSIPPGLLNCQSLVTVDLSMNQL 160
           L+       N +      I  L +L+ L +  N+ Q + +P    N  +L  +DLS N++
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161

Query: 161 NGSLPDGFGAAFPKLK----SLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF 216
             S+         ++     SL+L+ N +            +  L +  N    +VM   
Sbjct: 162 Q-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220

Query: 217 ---LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSG------EIFHNFS 267
              L  LEV  L   +F+     ++         L  + + E +L+       +I   F+
Sbjct: 221 IQGLAGLEVHRLVLGEFRNE-GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279

Query: 268 QAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSM 327
              N+   SL                 G +HL L      G  P+  L+L SL  L  + 
Sbjct: 280 CLTNVSSFSLVSVTIE--RVKDFSYNFGWQHLELVNCK-FGQFPT--LKLKSLKRLTFTS 334

Query: 328 NHLTGQIPTVSAKNLGIIDMSHNNLSG-EIPASLLEKLPQMERFNFSYNNLTLCASELSP 386
           N        V   +L  +D+S N LS     +        ++  + S+N +         
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-------- 386

Query: 387 ETLQTAFFGSSN 398
            T+ + F G   
Sbjct: 387 -TMSSNFLGLEQ 397

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  158 bits (402), Expect = 3e-41
 Identities = 72/357 (20%), Positives = 126/357 (35%), Gaps = 33/357 (9%)

Query: 43  SVPDTTIGKLSKLQ----SLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSN-IG 97
           S+  T +  L ++     SLDLS N +  +    +    L  L L  N  S ++    I 
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222

Query: 98  NFGLLEVFDL------SNNNFSGEIPAAISSLVSLRVLKLDGN---MFQWSIPPGLLNCQ 148
               LEV  L      +  N      +A+  L +L + +        +   I        
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282

Query: 149 SLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLF 208
           ++ +  L    +       +   +  L+ +N    +          LKS+  L  + N  
Sbjct: 283 NVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP-----TLKLKSLKRLTFTSNKG 337

Query: 209 QGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQ 268
             +   V L SLE +DL  N            S +  + L Y+DLS N +   +  NF  
Sbjct: 338 GNAFSEVDLPSLEFLDLSRNGLS--FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394

Query: 269 AQNLKHLSLAYNRFTRQEFPQIGTLLG---LEHLNLSRTSLIGDIPSEILQ-LSSLHTLD 324
            + L+HL   ++   +    +    L    L +L++S T       + I   LSSL  L 
Sbjct: 395 LEQLEHLDFQHSNLKQ--MSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLK 451

Query: 325 LSMNHLTGQIPTVSAKNLG---IIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           ++ N             L     +D+S   L  ++  +    L  ++  N + N L 
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK 507

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  142 bits (360), Expect = 9e-36
 Identities = 78/354 (22%), Positives = 126/354 (35%), Gaps = 32/354 (9%)

Query: 57  SLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEI 116
           +    E N   +P +L    S K+L+LS+N +      +  +F  L+V DLS        
Sbjct: 11  TYQCMELNFYKIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68

Query: 117 PAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAFPKL 175
             A  SL  L  L L GN  Q S+  G      SL  +      L  SL +        L
Sbjct: 69  DGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTL 126

Query: 176 KSLNLAGNEIK--GRDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEV----IDLRS 227
           K LN+A N I+      +F+ L ++ +L++S N  Q         L  + +    +DL  
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 228 NQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN-FSQAQNLKHLSLAYNRFTRQ- 285
           N     I    F       RL  + L  N  S  +          L+   L    F  + 
Sbjct: 187 NPMN-FIQPGAFKE----IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241

Query: 286 --EFPQIGTLLGLEHLNLSRTSL------IGDIPSEILQLSSLHTLDLSMNHLTGQIPTV 337
             E      L GL +L +    L      + DI      L+++ +  L    +       
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301

Query: 338 SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQT 391
                  +++ +     + P   L+ L   +R  F+ N      SE+   +L+ 
Sbjct: 302 YNFGWQHLELVNCKFG-QFPTLKLKSL---KRLTFTSNKGGNAFSEVDLPSLEF 351

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  119 bits (301), Expect = 3e-28
 Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 4/181 (2%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLP 93
           L+ N          +    + L+ LDLS N +  + S+   L  L+ L+  ++ +     
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSE 413

Query: 94  SNI-GNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLV 151
            ++  +   L   D+S+ +         + L SL VLK+ GN FQ +  P +    ++L 
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473

Query: 152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQG 210
            +DLS  QL   L      +   L+ LN+A N++K   D  F  L S+  + +  N +  
Sbjct: 474 FLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532

Query: 211 S 211
           S
Sbjct: 533 S 533

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  119 bits (299), Expect = 4e-28
 Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 14/216 (6%)

Query: 51  KLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRIS--GSLPSNIGNFGLLEVFDLS 108
           KL  L+ L  + N      S++  L SL+ L+LS N +S  G    +      L+  DLS
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 109 NNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDG 167
            N     + +    L  L  L    +  +      +  + ++L+ +D+S         +G
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 439

Query: 168 FGAAFPKLKSLNLAGNEIKGRDTH--FAGLKSITNLNISGNLFQGSVMGVF--LESLEVI 223
                  L+ L +AGN  +       F  L+++T L++S    +      F  L SL+V+
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499

Query: 224 DLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS 259
           ++ SNQ    +  V        + L  + L  N   
Sbjct: 500 NMASNQ----LKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 92.9 bits (231), Expect = 9e-20
 Identities = 35/134 (26%), Positives = 56/134 (41%), Gaps = 4/134 (2%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWS-LGSLKSLNLSYNRISGSLPS 94
            +S L      +    L  L  LD+S  +     + +++ L SL+ L ++ N    +   
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463

Query: 95  NI-GNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVT 152
           +I      L   DLS        P A +SL SL+VL +  N  + S+P G+     SL  
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQK 522

Query: 153 VDLSMNQLNGSLPD 166
           + L  N  + S P 
Sbjct: 523 IWLHTNPWDCSCPR 536

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  167 bits (426), Expect = 4e-47
 Identities = 69/305 (22%), Positives = 116/305 (38%), Gaps = 55/305 (18%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLT 570
            T L E   G +++G    G  + VKVL     ST   ++   E   L    HPN++P+ 
Sbjct: 15  LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 571 GYCIAG-DQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           G C +       +   +M  G+L N+LH+                               
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHE----------------------------GTN 105

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
            +       K AL  AR +AFLH    P I    + + SV +D ++  R+S   +   F 
Sbjct: 106 FVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF- 163

Query: 689 NGLDEEIARGSPGYIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE 747
                     +P ++ PE   +   D     +D++ + V+L EL+T + P    + +   
Sbjct: 164 ---QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP----FADLSN 216

Query: 748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
             +   V       +G R   P I        + + +KI   C  + P KRP    IV +
Sbjct: 217 MEIGMKVA-----LEGLR---PTIPPGISPH-VSKLMKI---CMNEDPAKRPKFDMIVPI 264

Query: 808 LKDIE 812
           L+ ++
Sbjct: 265 LEKMQ 269

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  168 bits (428), Expect = 2e-46
 Identities = 69/333 (20%), Positives = 134/333 (40%), Gaps = 27/333 (8%)

Query: 48  TIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDL 107
           T  +L  +  L ++   + ++   +  L +L+ LNL+ N+I+    S + N   L    +
Sbjct: 39  TQEELESITKLVVAGEKVASIQ-GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYI 95

Query: 108 SNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDG 167
             N  +    +A+ +L +LR L L+ +    S    L N   + +++L  N    S    
Sbjct: 96  GTNKIT--DISALQNLTNLRELYLNEDNI--SDISPLANLTKMYSLNLGANHN-LSDLSP 150

Query: 168 FGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRS 227
                  L  L +  +++K      A L  + +L+++ N  +       L SL       
Sbjct: 151 LS-NMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYV 208

Query: 228 NQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEF 287
           NQ              N +RL  + +  N+++       +    L  L +  N+ +  + 
Sbjct: 209 NQITD------ITPVANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQIS--DI 258

Query: 288 PQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV--SAKNLGII 345
             +  L  L+ LN+     I DI   +  LS L++L L+ N L  +   V     NL  +
Sbjct: 259 NAVKDLTKLKMLNVGSNQ-ISDISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316

Query: 346 DMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
            +S N+++   P   L  L +M+  +F+   + 
Sbjct: 317 FLSQNHITDIRP---LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  162 bits (412), Expect = 3e-44
 Identities = 60/332 (18%), Positives = 127/332 (38%), Gaps = 23/332 (6%)

Query: 47  TTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
                L++     L + ++T + +    L S+  L ++  +++      I     LE  +
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72

Query: 107 LSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPD 166
           L+ N  +   P  +S+LV L  L +  N  + +    L N  +L  + L+ + ++   P 
Sbjct: 73  LNGNQITDISP--LSNLVKLTNLYIGTN--KITDISALQNLTNLRELYLNEDNISDISPL 128

Query: 167 GFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLR 226
                  K+ SLNL  N      +  + +  +  L ++ +  +       L  L  + L 
Sbjct: 129 A---NLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLN 185

Query: 227 SNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQE 286
            NQ +  IS +      + + L Y     NQ++       +    L  L +  N+ T  +
Sbjct: 186 YNQIED-ISPLA-----SLTSLHYFTAYVNQITDIT--PVANMTRLNSLKIGNNKIT--D 235

Query: 287 FPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIID 346
              +  L  L  L +    +     + +  L+ L  L++  N ++      +   L  + 
Sbjct: 236 LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLF 293

Query: 347 MSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           +++N L  E    ++  L  +     S N++T
Sbjct: 294 LNNNQLGNEDM-EVIGGLTNLTTLFLSQNHIT 324

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  141 bits (359), Expect = 4e-37
 Identities = 56/324 (17%), Positives = 114/324 (35%), Gaps = 47/324 (14%)

Query: 55  LQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSG 114
             +L      I  +  D   L       L    ++            +    ++    + 
Sbjct: 2   AATLATLPAPINQIFPDA-DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA- 57

Query: 115 EIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPK 174
            I   I  L +L  L L+GN     I P L N   L  + +  N++  +           
Sbjct: 58  SIQG-IEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKI--TDISALQN-LTN 111

Query: 175 LKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHI 234
           L+ L L  + I         +  + NL                  +  ++L +N     +
Sbjct: 112 LRELYLNEDNISD-------ISPLANLT----------------KMYSLNLGANHNLSDL 148

Query: 235 SQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLL 294
           S +      N + L Y+ ++E+++        +   +L  LSL YN+    +   + +L 
Sbjct: 149 SPLS-----NMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIE--DISPLASLT 199

Query: 295 GLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSG 354
            L +        I DI   +  ++ L++L +  N +T   P  +   L  +++  N +S 
Sbjct: 200 SLHYFTAYVNQ-ITDITP-VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISD 257

Query: 355 EIPASLLEKLPQMERFNFSYNNLT 378
            I A  ++ L +++  N   N ++
Sbjct: 258 -INA--VKDLTKLKMLNVGSNQIS 278

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  121 bits (307), Expect = 3e-30
 Identities = 44/215 (20%), Positives = 86/215 (40%), Gaps = 19/215 (8%)

Query: 47  TTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
           + +  ++ L  L ++E+ +  +   + +L  L SL+L+YN+I     S + +   L  F 
Sbjct: 149 SPLSNMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFT 205

Query: 107 LSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPD 166
              N  +   P  ++++  L  LK+  N     + P L N   L  +++  NQ++    +
Sbjct: 206 AYVNQITDITP--VANMTRLNSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQISD--IN 259

Query: 167 GFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVID 224
                  KLK LN+  N+I         L  + +L ++ N      M V   L +L  + 
Sbjct: 260 AVK-DLTKLKMLNVGSNQISDISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317

Query: 225 LRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS 259
           L  N               + S++   D +   + 
Sbjct: 318 LSQNHITD------IRPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 48.3 bits (116), Expect = 6e-06
 Identities = 18/65 (27%), Positives = 31/65 (47%), Gaps = 2/65 (3%)

Query: 25  SNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLS 84
           +N   +     +N+ L     +  IG L+ L +L LS+N+IT +   L SL  + S + +
Sbjct: 284 NNLSQLNSLFLNNNQLGNEDMEV-IGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFA 341

Query: 85  YNRIS 89
              I 
Sbjct: 342 NQVIK 346

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  169 bits (430), Expect = 3e-46
 Identities = 69/332 (20%), Positives = 128/332 (38%), Gaps = 28/332 (8%)

Query: 52  LSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNI-GNFGLLEVFDLSN 109
           L+  + +    + +  LP+  L S   ++ LNL+  +I   + +        ++   +  
Sbjct: 44  LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 102

Query: 110 NNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGF 168
           N      P    ++  L VL L+ N    S+P G+  N   L T+ +S N L   + D  
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 160

Query: 169 GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSN 228
             A   L++L L+ N +       + + S+ + N+S NL     + + +E L   D   N
Sbjct: 161 FQATTSLQNLQLSSNRLT--HVDLSLIPSLFHANVSYNLLSTLAIPIAVEEL---DASHN 215

Query: 229 QFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFP 288
                I+ V+   +     L  + L  N L+            L  + L+YN   +  + 
Sbjct: 216 S----INVVRGPVNVE---LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYH 266

Query: 289 QIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIP--TVSAKNLGIID 346
               +  LE L +S    +  +      + +L  LDLS NHL   +         L  + 
Sbjct: 267 PFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324

Query: 347 MSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           + HN++   +  S    L  +     S+N+  
Sbjct: 325 LDHNSIV-TLKLSTHHTLKNL---TLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  167 bits (425), Expect = 1e-45
 Identities = 73/336 (21%), Positives = 132/336 (39%), Gaps = 28/336 (8%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPS 94
            NS +   +P   +    +++ L+L++  I  + +       +++ L + +N I   LP 
Sbjct: 53  KNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPP 110

Query: 95  NI-GNFGLLEVFDLSNNNFSGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLV 151
           ++  N  LL V  L  N+ S  +P  I  +   L  L +  N  +  I         SL 
Sbjct: 111 HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQ 168

Query: 152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGS 211
            + LS N+L   +        P L   N++ N +    +  A   ++  L+ S N     
Sbjct: 169 NLQLSSNRLT-HVDLS---LIPSLFHANVSYNLL----STLAIPIAVEELDASHNSIN-V 219

Query: 212 VMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQN 271
           V G     L ++ L+ N               N+  LV VDLS N+L   ++H F + Q 
Sbjct: 220 VRGPVNVELTILKLQHNNLT------DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR 273

Query: 272 LKHLSLAYNRFTRQEFPQ-IGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHL 330
           L+ L ++ NR            +  L+ L+LS  + +  +     Q   L  L L  N +
Sbjct: 274 LERLYISNNRLV--ALNLYGQPIPTLKVLDLSH-NHLLHVERNQPQFDRLENLYLDHNSI 330

Query: 331 TGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQ 366
              +   +   L  + +SHN+       +L   + +
Sbjct: 331 V-TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVAR 365

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  140 bits (356), Expect = 2e-36
 Identities = 58/357 (16%), Positives = 119/357 (33%), Gaps = 40/357 (11%)

Query: 57  SLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEI 116
           ++   +     + S+L        +++                   ++    N+      
Sbjct: 2   NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP 61

Query: 117 PAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAFPKL 175
            A + S   + +L L+    +  I         ++  + +  N +   LP       P L
Sbjct: 62  AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLL 119

Query: 176 KSLNLAGNEIKGRDTH-FAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQG 232
             L L  N++       F     +T L++S N  +      F    SL+ + L SN+   
Sbjct: 120 TVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179

Query: 233 ------------HISQVQFNSSYNWSRLVYVDLSENQLS---GEIFHNFSQAQNLKHLSL 277
                       ++S    ++      +  +D S N ++   G +         L  L L
Sbjct: 180 VDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVN------VELTILKL 233

Query: 278 AYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL-QLSSLHTLDLSMNHLTGQIPT 336
            +N  T  +   +    GL  ++LS    +  I      ++  L  L +S N L   +  
Sbjct: 234 QHNNLT--DTAWLLNYPGLVEVDLSYNE-LEKIMYHPFVKMQRLERLYISNNRLV-ALNL 289

Query: 337 VSA--KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQT 391
                  L ++D+SHN+L   +  +  +   ++E     +N++      L   T  T
Sbjct: 290 YGQPIPTLKVLDLSHNHLL-HVERNQPQ-FDRLENLYLDHNSIV----TLKLSTHHT 340

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  136 bits (345), Expect = 5e-35
 Identities = 51/295 (17%), Positives = 110/295 (37%), Gaps = 28/295 (9%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDL-WSLGSLKSLNLSYNRISGSLPSNI-GNFG 100
            +P      +  L  L L  N++++LP  +  +   L +L++S N +   +  +      
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATT 165

Query: 101 LLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQL 160
            L+   LS+N  +  +   +S + SL    +  N+   ++   +    ++  +D S N +
Sbjct: 166 SLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAIPI----AVEELDASHNSI 217

Query: 161 NGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF--LE 218
           N  +         +L  L L  N +            +  +++S N  +  +   F  ++
Sbjct: 218 N-VVRGP---VNVELTILKLQHNNLTDTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272

Query: 219 SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLA 278
            LE + + +N+    +  +          L  +DLS N L   +  N  Q   L++L L 
Sbjct: 273 RLERLYISNNR----LVALNLYGQ-PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 326

Query: 279 YNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL-QLSSLHTLDLSMNHLTG 332
           +N         + T   L++L LS      +    +   ++     D   +    
Sbjct: 327 HNSIV--TLK-LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID 378

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  174 bits (442), Expect = 3e-45
 Identities = 78/372 (20%), Positives = 138/372 (37%), Gaps = 37/372 (9%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALP-SDLWSLGSLKSLNLSYNRISGSLPS 94
               L+  VP      L+  + L LS N I  +  S    L  L+ L L       ++  
Sbjct: 12  RFCNLT-QVPQV----LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66

Query: 95  NI-GNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQ-WSIPPGLL-NCQSLV 151
               N   L + DL ++      P A   L  L  L+L         +  G   N ++L 
Sbjct: 67  EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126

Query: 152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGL--KSITNLNISGNLF 208
            +DLS NQ+              LKS++ + N+I    +     L  K+++  +++ N  
Sbjct: 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL 186

Query: 209 QGSVMGVFLE--------SLEVIDLRSNQ--------FQGHISQVQFNSSYNWSRLVYVD 252
              V   + +         LE++D+  N         F   IS+ Q  S      ++   
Sbjct: 187 YSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAG 246

Query: 253 LSENQLSG---EIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGD 309
              + +       F   +++ +++HL L++            TL  L+ LNL+    I  
Sbjct: 247 FGFHNIKDPDQNTFAGLARS-SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK-INK 304

Query: 310 IPSEILQ-LSSLHTLDLSMNHLTGQIPTVSA--KNLGIIDMSHNNLSGEIPASLLEKLPQ 366
           I  E    L +L  L+LS N L     +       +  ID+  N+++  I     + L +
Sbjct: 305 IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEK 363

Query: 367 MERFNFSYNNLT 378
           ++  +   N LT
Sbjct: 364 LQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  167 bits (425), Expect = 3e-43
 Identities = 71/352 (20%), Positives = 136/352 (38%), Gaps = 36/352 (10%)

Query: 56  QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGE 115
           +       N+T +P  L    + + L LS+N I     S+      L++ +L +      
Sbjct: 7   RIAFYRFCNLTQVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63

Query: 116 I-PAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQL-NGSLPDGFGAAF 172
           I   A  +L +LR+L L  +     + P        L  + L    L +  L DG+    
Sbjct: 64  IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122

Query: 173 PKLKSLNLAGNEIK--GRDTHFAGLKSITNLNISGNLFQGSVMGVF----LESLEVIDLR 226
             L  L+L+ N+I+       F  L S+ +++ S N               ++L    L 
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182

Query: 227 SNQFQGHISQVQFN--SSYNWSRLVYVDLSENQLSGEIFHNFSQA------------QNL 272
           +N     +S       + +    L  +D+S N  + +I  NFS A             ++
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242

Query: 273 KHLSLAYNRFTRQEFPQIGTL--LGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNH 329
                 ++     +      L    + HL+LS    +  + S + + L  L  L+L+ N 
Sbjct: 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGF-VFSLNSRVFETLKDLKVLNLAYNK 301

Query: 330 LTGQIPTVS---AKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           +  +I   +     NL ++++S+N L  E+ +S    LP++   +   N++ 
Sbjct: 302 IN-KIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIA 351

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  155 bits (393), Expect = 3e-39
 Identities = 78/373 (20%), Positives = 139/373 (37%), Gaps = 39/373 (10%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD--LWSLGSLKSLNLSYNRISGS 91
           L         + D     L  L  LDLS+N I +L        L SLKS++ S N+I   
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163

Query: 92  LPSNIGNFGL--LEVFDLSNNNFSGEIPAAISSL------VSLRVLKLDGNMFQWSIPPG 143
               +       L  F L+ N+    +             + L +L + GN +       
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGW------- 216

Query: 144 LLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRD-THFAGLK--SITN 200
                ++       N ++ S           +       + IK  D   FAGL   S+ +
Sbjct: 217 -----TVDITGNFSNAISKSQAFSL-ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH 270

Query: 201 LNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQL 258
           L++S          VF  L+ L+V++L  N+    I+++   + Y    L  ++LS N L
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNK----INKIADEAFYGLDNLQVLNLSYNLL 326

Query: 259 SGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLS 318
                 NF     + ++ L  N     +      L  L+ L+L   +L     + I  + 
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIP 381

Query: 319 SLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           S+  + LS N L   +P ++     +I +S N L        L ++P ++    + N  +
Sbjct: 382 SIPDIFLSGNKLV-TLPKINL-TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439

Query: 379 LCASELSPETLQT 391
            C+ + +P    +
Sbjct: 440 SCSGDQTPSENPS 452

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  149 bits (378), Expect = 2e-37
 Identities = 77/412 (18%), Positives = 139/412 (33%), Gaps = 38/412 (9%)

Query: 51  KLSKLQSLDLSENNITALPSDLWS-LGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSN 109
             S ++ LDLS   + +L S ++  L  LK LNL+YN+I+            L+V +LS 
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323

Query: 110 NNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGF 168
           N       +    L  +  + L  N     I        + L T+DL  N L  ++    
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-TIHF-- 379

Query: 169 GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF---LESLEVIDL 225
               P +  + L+GN++    T      +   +++S N  +   +  F   +  L+++ L
Sbjct: 380 ---IPSIPDIFLSGNKLV---TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILIL 433

Query: 226 RSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN-----FSQAQNLKHLSLAYN 280
             N+F         + + +   L  + L EN L            F    +L+ L L +N
Sbjct: 434 NQNRFSSCSGDQTPSENPS---LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHN 490

Query: 281 RFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAK 340
                       L  L  L+L+    +  +    L  ++L  LD+S N L          
Sbjct: 491 YLNSLPPGVFSHLTALRGLSLNSNR-LTVLSHNDL-PANLEILDISRNQLL-APNPDVFV 547

Query: 341 NLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDC 400
           +L ++D++HN    E   S             +     +        +  + F  S+  C
Sbjct: 548 SLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGC 607

Query: 401 PIAANPSFFKRKAANHKGLKLALALTLSMICLLAGLLCLAFGCRRKPKRWVV 452
                               L  +L +     L   L       +      +
Sbjct: 608 DEEEVLKS------------LKFSLFIVCTVTLTLFLMTILTVTKFRGFCFI 647

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 66.0 bits (161), Expect = 4e-11
 Identities = 25/132 (18%), Positives = 49/132 (37%), Gaps = 11/132 (8%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITAL------PSDLWSLGSLKSLNLSYNRIS 89
           + +  S    D T  +   L+ L L EN +               L  L+ L L++N ++
Sbjct: 434 NQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493

Query: 90  GSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQS 149
              P    +   L    L++N  +  +        +L +L +  N    +  P +    S
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLT-VLSHN-DLPANLEILDISRNQLL-APNPDVF--VS 548

Query: 150 LVTVDLSMNQLN 161
           L  +D++ N+  
Sbjct: 549 LSVLDITHNKFI 560

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 65.6 bits (160), Expect = 5e-11
 Identities = 37/145 (25%), Positives = 55/145 (37%), Gaps = 13/145 (8%)

Query: 33  FLASNS---GLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWS-LGSLKSLNLSYNRI 88
           FL  N         +       LS LQ L L+ N + +LP  ++S L +L+ L+L+ NR+
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

Query: 89  SGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPG----L 144
           +  L  N      LE+ D+S N      P      VSL VL +  N F            
Sbjct: 517 T-VLSHND-LPANLEILDISRNQLLAPNP---DVFVSLSVLDITHNKFICECELSTFINW 571

Query: 145 LNCQSLVTVDLSMNQLNGSLPDGFG 169
           LN  ++       +          G
Sbjct: 572 LNHTNVTIAGPPADIYCVYPDSFSG 596

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 28/131 (21%), Positives = 57/131 (43%), Gaps = 7/131 (5%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSN 95
           +++ L+ S+P      L+ L+ L L+ N +T L  +     +L+ L++S N++  +   +
Sbjct: 488 NHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDL-PANLEILDISRNQLL-APNPD 544

Query: 96  IGNFGLLEVFDLSNNNFSGEIPAA--ISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTV 153
           +  F  L V D+++N F  E   +  I+ L    V         + + P   +  SL ++
Sbjct: 545 V--FVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSL 602

Query: 154 DLSMNQLNGSL 164
                     L
Sbjct: 603 STEGCDEEEVL 613

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  165 bits (418), Expect = 3e-45
 Identities = 65/358 (18%), Positives = 111/358 (31%), Gaps = 78/358 (21%)

Query: 496 LNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAAREL 555
           +    ++      N     L+  G++G VY+G L     VAVKV    S    Q    E 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEK 56

Query: 556 E--YLGRIKHPNLVPLTGYCIAGDQRIA-----IYDYMENGNLQNLLHDLPLGVQTTEDW 608
               +  ++H N+                    + +Y  NG+L   L             
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-------- 108

Query: 609 STDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH------HGCSPPIIHRD 662
                                   W    ++A    R LA+LH          P I HRD
Sbjct: 109 -----------------------DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRD 145

Query: 663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---------GSPGYIPPEFAQ---- 709
           + + +V +  +    +SDFGL+                      G+  Y+ PE  +    
Sbjct: 146 LNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN 205

Query: 710 -PDSDFPTPKSDVYCYGVVLLELITGKKPL--GDDYPE------EKEGNLVSW--VRGLV 758
             D +    + D+Y  G++  E+      L  G+  PE       + GN  ++  ++ LV
Sbjct: 206 LRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV 265

Query: 759 RNNKGSRAIDPKIRDTGPEKQMEEAL--KIGYLCTADLPLKRPSMQQIVGLLKDIEST 814
              K      PK  +   E  +      +    C       R + Q     + ++   
Sbjct: 266 SREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  163 bits (415), Expect = 4e-45
 Identities = 71/308 (23%), Positives = 123/308 (39%), Gaps = 52/308 (16%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
              +   ++  G FG V +        VA+K +   S    +    EL  L R+ HPN+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L G C+  +    + +Y E G+L N+LH                   +           
Sbjct: 65  KLYGACL--NPVCLVMEYAEGGSLYNVLHG-----------------AEPLPYY------ 99

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE-PRLSDFGLAKI 686
               T        L  ++ +A+LH      +IHRD+K  ++ L       ++ DFG A  
Sbjct: 100 ----TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155

Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEK 746
               +      GS  ++ PE  +      + K DV+ +G++L E+IT +KP    + E  
Sbjct: 156 IQTHMTNNK--GSAAWMAPEVFE--GSNYSEKCDVFSWGIILWEVITRRKP----FDE-- 205

Query: 747 EGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG 806
            G     +   V  + G+R   P +    P+  +E  +     C +  P +RPSM++IV 
Sbjct: 206 IGGPAFRIMWAV--HNGTR---PPLIKNLPKP-IESLMT---RCWSKDPSQRPSMEEIVK 256

Query: 807 LLKDIEST 814
           ++  +   
Sbjct: 257 IMTHLMRY 264

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  162 bits (412), Expect = 9e-45
 Identities = 77/309 (24%), Positives = 131/309 (42%), Gaps = 56/309 (18%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA--RELEYLGRIKHPNLVPLT 570
              +  G FG V+R     G  VAVK+L+      ++     RE+  + R++HPN+V   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
           G          + +Y+  G+L  LLH      Q                           
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD------------------------- 135

Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
              R R  +A   A+ + +LH+  +PPI+HR++K+ ++ +D     ++ DFGL+++  + 
Sbjct: 136 --ERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192

Query: 691 LDE-EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGN 749
               + A G+P ++ PE  + D      KSDVY +GV+L EL T ++P    +       
Sbjct: 193 FLSSKSAAGTPEWMAPEVLR-DEPS-NEKSDVYSFGVILWELATLQQP----WGNLNPAQ 246

Query: 750 LVSWVRGLVRNNKGSRAIDPKIRDTGPEKQ---MEEALKIGYLCTADLPLKRPSMQQIVG 806
           +V+ V       K  R    +I      +    +E        C  + P KRPS   I+ 
Sbjct: 247 VVAAV-----GFKCKR---LEIPRNLNPQVAAIIEG-------CWTNEPWKRPSFATIMD 291

Query: 807 LLKDIESTA 815
           LL+ +  +A
Sbjct: 292 LLRPLIKSA 300

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  169 bits (429), Expect = 1e-44
 Identities = 73/357 (20%), Positives = 134/357 (37%), Gaps = 29/357 (8%)

Query: 52  LSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNI-GNFGLLEVFDLSN 109
           L+  + +    + +  LP+  L S   ++ LNL+  +I   + +        ++   +  
Sbjct: 50  LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 108

Query: 110 NNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGF 168
           N      P    ++  L VL L+ N    S+P G+  N   L T+ +S N L   + D  
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 166

Query: 169 GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSN 228
             A   L++L L+ N +       + + S+ + N+S NL     + + +E L   D   N
Sbjct: 167 FQATTSLQNLQLSSNRL--THVDLSLIPSLFHANVSYNLLSTLAIPIAVEEL---DASHN 221

Query: 229 QFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFP 288
                I+ V+   +     L  + L  N L+            L  + L+YN   +  + 
Sbjct: 222 S----INVVRGPVNVE---LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYH 272

Query: 289 QIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIP--TVSAKNLGIID 346
               +  LE L +S    +  +      + +L  LDLS NHL   +         L  + 
Sbjct: 273 PFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330

Query: 347 MSHNNLSGEIPASLLEKLPQMERFNFSYNNLT-LCASELSPETLQTAFFGSSNDCPI 402
           + HN++   +  S    L  +     S+N+        L     + A   +   C I
Sbjct: 331 LDHNSIV-TLKLSTHHTLKNL---TLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  166 bits (421), Expect = 2e-43
 Identities = 73/335 (21%), Positives = 132/335 (39%), Gaps = 26/335 (7%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPS 94
            NS +   +P   +    +++ L+L++  I  + +       +++ L + +N I   LP 
Sbjct: 59  KNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPP 116

Query: 95  NI-GNFGLLEVFDLSNNNFSGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLV 151
           ++  N  LL V  L  N+ S  +P  I  +   L  L +  N  +  I         SL 
Sbjct: 117 HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQ 174

Query: 152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGS 211
            + LS N+L   +        P L   N++ N +    +  A   ++  L+ S N     
Sbjct: 175 NLQLSSNRLT-HVDLS---LIPSLFHANVSYNLL----STLAIPIAVEELDASHNSIN-V 225

Query: 212 VMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQN 271
           V G     L ++ L+ N               N+  LV VDLS N+L   ++H F + Q 
Sbjct: 226 VRGPVNVELTILKLQHNNLT------DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR 279

Query: 272 LKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLT 331
           L+ L ++ NR           +  L+ L+LS  + +  +     Q   L  L L  N + 
Sbjct: 280 LERLYISNNRLVALN-LYGQPIPTLKVLDLSH-NHLLHVERNQPQFDRLENLYLDHNSIV 337

Query: 332 GQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQ 366
             +   +   L  + +SHN+       +L   + +
Sbjct: 338 -TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVAR 371

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  140 bits (354), Expect = 5e-35
 Identities = 57/332 (17%), Positives = 116/332 (34%), Gaps = 29/332 (8%)

Query: 54  KLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFS 113
           +  ++   +     + S+L        +++                   ++    N+   
Sbjct: 5   QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64

Query: 114 GEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAF 172
               A + S   + +L L+    +  I         ++  + +  N +   LP       
Sbjct: 65  KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNV 122

Query: 173 PKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQ 229
           P L  L L  N++       F     +T L++S N  +      F    SL+ + L SN+
Sbjct: 123 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182

Query: 230 FQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQ 289
               ++ V  +       L + ++S N LS       +    ++ L  ++N         
Sbjct: 183 ----LTHVDLS---LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRG-- 228

Query: 290 IGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPT---VSAKNLGIID 346
               + L  L L   +L  D    +L    L  +DLS N L  +I     V  + L  + 
Sbjct: 229 -PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLY 284

Query: 347 MSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           +S+N L   +     + +P ++  + S+N+L 
Sbjct: 285 ISNNRLV-ALNLY-GQPIPTLKVLDLSHNHLL 314

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  135 bits (342), Expect = 2e-33
 Identities = 51/291 (17%), Positives = 111/291 (38%), Gaps = 28/291 (9%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWS-LGSLKSLNLSYNRISGSLPSNI-GNFG 100
            +P      +  L  L L  N++++LP  ++     L +L++S N +   +  +      
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATT 171

Query: 101 LLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQL 160
            L+   LS+N  +  +   +S + SL    +  N+   ++   +    ++  +D S N +
Sbjct: 172 SLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAIPI----AVEELDASHNSI 223

Query: 161 NGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF--LE 218
           N  +         +L  L L  N +            +  +++S N  +  +   F  ++
Sbjct: 224 N-VVRGP---VNVELTILKLQHNNLTDTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQ 278

Query: 219 SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLA 278
            LE + + +N+    +  +          L  +DLS N L   +  N  Q   L++L L 
Sbjct: 279 RLERLYISNNR----LVALNLYGQ-PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 332

Query: 279 YNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL-QLSSLHTLDLSMN 328
           +N        ++ T   L++L LS      +    +   ++     D   +
Sbjct: 333 HNSIVT---LKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 85.4 bits (211), Expect = 3e-17
 Identities = 53/335 (15%), Positives = 113/335 (33%), Gaps = 34/335 (10%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLL 102
            +      K+ +L+ L +S N + AL      + +LK L+LS+N +   +  N   F  L
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 326

Query: 103 EVFDLSNNNFSGEIPAAISSLVSLRVLKLDGN---------MFQWSIPPGLLNCQSLVTV 153
           E   L +N+    +   +S+  +L+ L L  N         +F+    P + +      +
Sbjct: 327 ENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383

Query: 154 DLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQG--S 211
           D  +                 L+ + L  + ++          +   +N   +L      
Sbjct: 384 DYQLEHGLCCKESDKPYLDRLLQYIALT-SVVEKVQRAQGRCSATDTINSVQSLSHYITQ 442

Query: 212 VMGVFLESLEVIDLRSNQFQGHISQVQFNS--------------SYNWSRLVYVDLSENQ 257
             GV L+  E ++   N+ +  + Q+                    N  R         +
Sbjct: 443 QGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLAR 502

Query: 258 LSGEIFHNFSQAQNLKHLSLAYNRFTRQE-FPQIGTLLGLEHLNLSRTSLIGDIPSEILQ 316
            S  +   F+  +  +   L   +  R E   +      LE  N++    + +  ++  +
Sbjct: 503 SSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAE 562

Query: 317 LSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNN 351
           L       L    +  Q+     +N     +SH++
Sbjct: 563 L--RQETSLKRQKVK-QLEAKKNRNPDTRRVSHHH 594

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 58.8 bits (142), Expect = 5e-09
 Identities = 19/149 (12%), Positives = 47/149 (31%), Gaps = 11/149 (7%)

Query: 246 SRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTS 305
            +  Y           I  N         + +           +  TL   + +    ++
Sbjct: 3   GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62

Query: 306 LIGDIPSEILQ-LSSLHTLDLSMNHLTGQIPTVS---AKNLGIIDMSHNNLSGEIPASLL 361
            +  +P+ +L     +  L+L+   +  +I T +   A  +  + M  N +   +P  + 
Sbjct: 63  -MRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVF 119

Query: 362 EKLPQMERFNFSYNNLTLCASELSPETLQ 390
           + +P +       N+L+     L      
Sbjct: 120 QNVPLLTVLVLERNDLS----SLPRGIFH 144

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  164 bits (418), Expect = 5e-44
 Identities = 72/337 (21%), Positives = 138/337 (40%), Gaps = 26/337 (7%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS 108
           +  L+ L  L L  N IT +   L +L +L  L LS N IS    S +     L+     
Sbjct: 108 LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG 164

Query: 109 NNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGF 168
           N   +   P  +++L +L  L +  N  + S    L    +L ++  + NQ++   P G 
Sbjct: 165 NQ-VTDLKP--LANLTTLERLDISSN--KVSDISVLAKLTNLESLIATNNQISDITPLGI 219

Query: 169 GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSN 228
                 L  L+L GN++K   T  A L ++T+L+++ N          L  L  + L +N
Sbjct: 220 ---LTNLDELSLNGNQLKDIGT-LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGAN 275

Query: 229 QFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFP 288
           Q    IS +        + L  ++L+ENQL        S  +NL +L+L +N  +  +  
Sbjct: 276 QISN-ISPLA-----GLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNIS--DIS 325

Query: 289 QIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMS 348
            + +L  L+ L      +     S +  L++++ L    N ++   P  +   +  + ++
Sbjct: 326 PVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLN 383

Query: 349 HNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELS 385
               +   P +    +  +     +     +  + +S
Sbjct: 384 DQAWTN-APVNYKANV-SIPNTVKNVTGALIAPATIS 418

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  164 bits (418), Expect = 6e-44
 Identities = 77/355 (21%), Positives = 142/355 (40%), Gaps = 30/355 (8%)

Query: 24  DSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNL 83
           D+        +   + ++ +V       L ++ +L      I ++   +  L +L  +N 
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIKSIDG-VEYLNNLTQINF 75

Query: 84  SYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPG 143
           S N+++    + + N   L    ++NN  +   P  +++L +L  L L  N     I P 
Sbjct: 76  SNNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT-DIDP- 129

Query: 144 LLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNI 203
           L N  +L  ++LS N ++             L+ L+  GN++       A L ++  L+I
Sbjct: 130 LKNLTNLNRLELSSNTISD--ISALS-GLTSLQQLSF-GNQVTDLKP-LANLTTLERLDI 184

Query: 204 SGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIF 263
           S N      +   L +LE +   +NQ           +      L  + L+ NQL     
Sbjct: 185 SSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTN------LDELSLNGNQLKD--I 236

Query: 264 HNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTL 323
              +   NL  L LA N+ +      +  L  L  L L    +     S +  L++L  L
Sbjct: 237 GTLASLTNLTDLDLANNQIS--NLAPLSGLTKLTELKLGANQISN--ISPLAGLTALTNL 292

Query: 324 DLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           +L+ N L    P  + KNL  + +  NN+S   P   +  L +++R  F  N ++
Sbjct: 293 ELNENQLEDISPISNLKNLTYLTLYFNNISDISP---VSSLTKLQRLFFYNNKVS 344

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  162 bits (411), Expect = 5e-43
 Identities = 68/332 (20%), Positives = 123/332 (37%), Gaps = 27/332 (8%)

Query: 47  TTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
            T   L++     L + N+T   S    L  + +L      I       +     L   +
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQIN 74

Query: 107 LSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPD 166
            SNN  +   P  + +L  L  + ++ N    +    L N  +L  + L  NQ+    P 
Sbjct: 75  FSNNQLTDITP--LKNLTKLVDILMNNNQI--ADITPLANLTNLTGLTLFNNQITDIDPL 130

Query: 167 GFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLR 226
                   L  L L+ N I       +GL S+  L+    +     +   L +LE +D+ 
Sbjct: 131 K---NLTNLNRLELSSNTISDISA-LSGLTSLQQLSFGNQVTDLKPLA-NLTTLERLDIS 185

Query: 227 SNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQE 286
           SN+    +S +   +    + L  +  + NQ+S           NL  LSL  N+    +
Sbjct: 186 SNK----VSDISVLA--KLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLK--D 235

Query: 287 FPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIID 346
              + +L  L  L+L+   +    P  +  L+ L  L L  N ++   P      L  ++
Sbjct: 236 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 293

Query: 347 MSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           ++ N L    P   +  L  +      +NN++
Sbjct: 294 LNENQLEDISP---ISNLKNLTYLTLYFNNIS 322

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  155 bits (394), Expect = 8e-41
 Identities = 70/332 (21%), Positives = 123/332 (37%), Gaps = 25/332 (7%)

Query: 47  TTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
             +  L+ L  L+LS N I+ + + L  L SL+ L+             + N   LE  D
Sbjct: 128 DPLKNLTNLNRLELSSNTISDISA-LSGLTSLQQLSFGNQVTD---LKPLANLTTLERLD 183

Query: 107 LSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPD 166
           +S+N  S    + ++ L +L  L    N     I P L    +L  + L+ NQL      
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQIS-DITP-LGILTNLDELSLNGNQLKD--IG 237

Query: 167 GFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLR 226
               +   L  L+LA N+I       +GL  +T L +  N          L +L  ++L 
Sbjct: 238 TLA-SLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISPLAGLTALTNLELN 295

Query: 227 SNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQE 286
            NQ +  IS +    +     L Y+ L  N +S       S    L+ L    N+ +  +
Sbjct: 296 ENQLED-ISPISNLKN-----LTYLTLYFNNISDIS--PVSSLTKLQRLFFYNNKVS--D 345

Query: 287 FPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIID 346
              +  L  +  L+     +     + +  L+ +  L L+    T   P     N+ I +
Sbjct: 346 VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTN-APVNYKANVSIPN 402

Query: 347 MSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
              N     I  + +         + ++N  +
Sbjct: 403 TVKNVTGALIAPATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  109 bits (274), Expect = 2e-25
 Identities = 52/240 (21%), Positives = 85/240 (35%), Gaps = 22/240 (9%)

Query: 47  TTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
            T+  L+ L  LDL+ N I+ L   L  L  L  L L  N+IS    S +     L   +
Sbjct: 237 GTLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNI--SPLAGLTALTNLE 293

Query: 107 LSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPD 166
           L+ N      P  IS+L +L  L L  N    S    + +   L  +    N+++     
Sbjct: 294 LNENQLEDISP--ISNLKNLTYLTLYFN--NISDISPVSSLTKLQRLFFYNNKVSD--VS 347

Query: 167 GFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF-LESLEVIDL 225
                   +  L+   N+I    T  A L  IT L ++   +  + +      S+     
Sbjct: 348 SLA-NLTNINWLSAGHNQISDL-TPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVK 405

Query: 226 RSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS--GEIFHNFSQAQNLKHLSLAYNRFT 283
                    + +    SY        D++ N  S   E+ + FSQ      +      F+
Sbjct: 406 NVTGALIAPATISDGGSYT-----EPDITWNLPSYTNEVSYTFSQPVT---IGKGTTTFS 457

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  103 bits (260), Expect = 1e-23
 Identities = 52/216 (24%), Positives = 83/216 (38%), Gaps = 18/216 (8%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS 108
           +  L+KL  L L  N I+ +   L  L +L +L L+ N++     S I N   L    L 
Sbjct: 261 LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLY 317

Query: 109 NNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGF 168
            NN S   P  +SSL  L+ L    N    S    L N  ++  +    NQ++   P   
Sbjct: 318 FNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTPLA- 372

Query: 169 GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNL--NISGNLFQGSVMGVFLESLEVIDLR 226
                ++  L L          ++    SI N   N++G L   + +     S    D+ 
Sbjct: 373 --NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATIS-DGGSYTEPDIT 429

Query: 227 SNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEI 262
            N      ++V    SY +S+ V +       SG +
Sbjct: 430 WNLPSY-TNEV----SYTFSQPVTIGKGTTTFSGTV 460

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 63.4 bits (155), Expect = 1e-10
 Identities = 23/126 (18%), Positives = 43/126 (34%), Gaps = 9/126 (7%)

Query: 253 LSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPS 312
             +  ++ +IF   +         L     T  +      L  +  L   R  +      
Sbjct: 9   TQDTPIN-QIF-TDTALAEKMKTVLGKTNVT--DTVSQTDLDQVTTLQADRLGI--KSID 62

Query: 313 EILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNF 372
            +  L++L  ++ S N LT   P  +   L  I M++N ++   P   L  L  +     
Sbjct: 63  GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP---LANLTNLTGLTL 119

Query: 373 SYNNLT 378
             N +T
Sbjct: 120 FNNQIT 125

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 47.3 bits (113), Expect = 2e-05
 Identities = 13/92 (14%), Positives = 26/92 (28%), Gaps = 24/92 (26%)

Query: 49  IGKLSKLQSLDLSENNITAL-----------------------PSDLWSLGSLKSLNLSY 85
           +  L+++  L L++   T                         P+ +   GS    ++++
Sbjct: 371 LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITW 430

Query: 86  NRISGSLPSNIGNFGLLEVFDLSNNNFSGEIP 117
           N  S         F            FSG + 
Sbjct: 431 NLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  163 bits (414), Expect = 2e-43
 Identities = 83/366 (22%), Positives = 134/366 (36%), Gaps = 22/366 (6%)

Query: 56  QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGE 115
           +++        A+P  +      + L+L  NRI         +F  LE  +L+ N  S  
Sbjct: 14  RAVLCHRKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-A 70

Query: 116 IPA-AISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAFP 173
           +   A ++L +LR L L  N  +  IP G+     +L  +D+S N++   L D       
Sbjct: 71  VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLY 128

Query: 174 KLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQF 230
            LKSL +  N++       F+GL S+  L +               L  L V+ LR    
Sbjct: 129 NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188

Query: 231 QGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQI 290
              I    F   Y    L   ++S       +  N     NL  LS+ +   T   +  +
Sbjct: 189 N-AIRDYSFKRLYRLKVL---EISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAV 244

Query: 291 GTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNHLTGQIPT---VSAKNLGIID 346
             L+ L  LNLS    I  I   +L  L  L  + L    L   +          L +++
Sbjct: 245 RHLVYLRFLNLSYNP-ISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLN 302

Query: 347 MSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANP 406
           +S N L+  +  S+   +  +E      N L  C   L     +      +   P  A P
Sbjct: 303 VSGNQLT-TLEESVFHSVGNLETLILDSNPLA-CDCRLLWVFRRRWRLNFNRQQPTCATP 360

Query: 407 SFFKRK 412
            F + K
Sbjct: 361 EFVQGK 366

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  149 bits (379), Expect = 8e-39
 Identities = 60/295 (20%), Positives = 109/295 (36%), Gaps = 15/295 (5%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNI-GNFG 100
           ++          L+ L+L+EN ++A+      +L +L++L L  NR+   +P  +     
Sbjct: 46  TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLS 104

Query: 101 LLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQ 159
            L   D+S N     +      L +L+ L++  N     I         SL  + L    
Sbjct: 105 NLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCN 163

Query: 160 LNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVFLE 218
           L  S+P    +    L  L L    I   RD  F  L  +  L IS   +  ++    L 
Sbjct: 164 LT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222

Query: 219 --SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLS 276
             +L  + +        +  +      +   L +++LS N +S        +   L+ + 
Sbjct: 223 GLNLTSLSITHCNLT-AVPYLAVR---HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278

Query: 277 LAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNHL 330
           L   +    E      L  L  LN+S  + +  +   +   + +L TL L  N L
Sbjct: 279 LVGGQLAVVEPYAFRGLNYLRVLNVSG-NQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  127 bits (322), Expect = 2e-31
 Identities = 44/222 (19%), Positives = 92/222 (41%), Gaps = 11/222 (4%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNI-GNFG 100
            + D     L  L+SL++ +N++  +       L SL+ L L    ++ S+P+    +  
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLH 176

Query: 101 LLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQL 160
            L V  L + N +     +   L  L+VL++    +  ++ P  L   +L ++ ++   L
Sbjct: 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236

Query: 161 NGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF--L 217
             ++P         L+ LNL+ N I     +    L  +  + + G          F  L
Sbjct: 237 T-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGL 295

Query: 218 ESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS 259
             L V+++  NQ    ++ ++ +  ++   L  + L  N L+
Sbjct: 296 NYLRVLNVSGNQ----LTTLEESVFHSVGNLETLILDSNPLA 333

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  157 bits (398), Expect = 3e-43
 Identities = 84/332 (25%), Positives = 127/332 (38%), Gaps = 76/332 (22%)

Query: 495 LLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHG----STLTDQE 550
           LL I FA+L           ++  G FG VYR F   G  VAVK   H      + T + 
Sbjct: 1   LLEIDFAEL-------TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIEN 52

Query: 551 AARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWST 610
             +E +    +KHPN++ L G C+       + ++   G L  +L    +          
Sbjct: 53  VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI---------- 102

Query: 611 DTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL 670
                                        A+  AR + +LH     PIIHRD+K+S++ +
Sbjct: 103 ---------------------PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILI 141

Query: 671 DMNLEPR--------LSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVY 722
              +E          ++DFGLA+ +     +  A G+  ++ PE  +  S F +  SDV+
Sbjct: 142 LQKVENGDLSNKILKITDFGLAREWHRT-TKMSAAGAYAWMAPEVIR-ASMF-SKGSDVW 198

Query: 723 CYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPE---KQ 779
            YGV+L EL+TG+ P    +       +   V                I  T PE   K 
Sbjct: 199 SYGVLLWELLTGEVP----FRGIDGLAVAYGVA-----MNKLA---LPIPSTCPEPFAKL 246

Query: 780 MEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
           ME+       C    P  RPS   I+  L  I
Sbjct: 247 MED-------CWNPDPHSRPSFTNILDQLTTI 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  155 bits (395), Expect = 1e-42
 Identities = 78/306 (25%), Positives = 130/306 (42%), Gaps = 55/306 (17%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA--RELEYLGRIKHPNLVPLT 570
           G  +  G FG VY+G   G   VAVK+L   +    Q  A   E+  L + +H N++   
Sbjct: 29  GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 571 GYCIAGDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL 629
           GY      ++AI   + E  +L + LH                             SE  
Sbjct: 87  GYST--APQLAIVTQWCEGSSLYHHLHA----------------------------SETK 116

Query: 630 LTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
               +    IA  TAR + +LH   +  IIHRD+K+++++L  +   ++ DFGLA     
Sbjct: 117 FE-MKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172

Query: 690 GLDE---EIARGSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
                  E   GS  ++ PE  +     P + +SDVY +G+VL EL+TG+ P    Y   
Sbjct: 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSNI 228

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
              + +  +  + R +        K+R   P K+M+  +     C      +RPS  +I+
Sbjct: 229 NNRDQIIEM--VGRGSL--SPDLSKVRSNCP-KRMKRLMA---ECLKKKRDERPSFPRIL 280

Query: 806 GLLKDI 811
             ++++
Sbjct: 281 AEIEEL 286

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  152 bits (386), Expect = 3e-41
 Identities = 67/335 (20%), Positives = 113/335 (33%), Gaps = 81/335 (24%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELE--YLGRIKHPNLVPLT 570
              + +G++G V+RG    G +VAVK+    S+  ++   RE E      ++H N++   
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 571 GYCIAGDQRIAIY----DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
              +              Y E G+L + L    L                          
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTL-------------------------- 102

Query: 627 EGLLTTWRFRHKIALGTARALAFLH-----HGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                      +I L  A  LA LH         P I HRD+K+ ++ +  N +  ++D 
Sbjct: 103 -----DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157

Query: 682 GLAKIFGNGLDEEIAR-----GSPGYIPPEF----AQPDSDFPTPKSDVYCYGVVLLELI 732
           GLA +     ++         G+  Y+ PE      Q D      + D++ +G+VL E+ 
Sbjct: 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

Query: 733 TGKKPLGDDYP-----EEKEGNLVSW--VRGLVRNNKGSRAIDPKIRDTGPEKQ------ 779
                 G          +   N  S+  +R +V      R   P I +            
Sbjct: 218 RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV-CVDQQR---PNIPNRWFSDPTLTSLA 273

Query: 780 --MEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE 812
             M+E       C    P  R +  +I   L  I+
Sbjct: 274 KLMKE-------CWYQNPSARLTALRIKKTLTKID 301

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  158 bits (401), Expect = 4e-41
 Identities = 71/378 (18%), Positives = 134/378 (35%), Gaps = 35/378 (9%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISG-SLPSNIGNFG 100
           ++       L  L+ LDLS+N++++L S     L SLK LNL  N      + S   N  
Sbjct: 64  TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123

Query: 101 LLEVFDLSNNNFSGEIPA-AISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMN 158
            L+   + N     EI     + L SL  L++     + +     L + + +  + L ++
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLS 182

Query: 159 QLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGN----------- 206
           +    L + F      ++ L L    +   + +     +  + +                
Sbjct: 183 ESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241

Query: 207 -LFQGSVMGVFLESLEVIDLRSNQFQ----GHISQVQFNSSYNWSRLVYVDLSENQLSGE 261
            L +     + L  +E  D   N            V          +  + + +  L  +
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301

Query: 262 IFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSR---TSLIGDIPSEILQLS 318
           +   +S  + +K +++  ++           L  LE L+LS            +      
Sbjct: 302 LSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361

Query: 319 SLHTLDLSMNHLTGQIPTVSA-----KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFS 373
           SL TL LS NHL   +          KNL  +D+S N     +P S  +   +M   N S
Sbjct: 362 SLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDS-CQWPEKMRFLNLS 418

Query: 374 YNNLTLCASELSPETLQT 391
              + +  + + P+TL+ 
Sbjct: 419 STGIRVVKTCI-PQTLEV 435

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  155 bits (393), Expect = 4e-40
 Identities = 67/370 (18%), Positives = 139/370 (37%), Gaps = 35/370 (9%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALP-SDLWSLGSLKSLNLSYNRISGSLPS 94
            +   + S+P    G  + ++SLDLS N IT +   DL +  +L+ L L  +RI+ ++  
Sbjct: 13  RSRSFT-SIPS---GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEG 67

Query: 95  NI-GNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL--NCQSLV 151
           +   + G LE  DLS+N+ S    +    L SL+ L L GN +Q ++    L  N  +L 
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQ 126

Query: 152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQG 210
           T+ +   +    +     A    L  L +    ++  +      ++ I +L +  +    
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186

Query: 211 SVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQ 268
            +      L S+  ++LR                   S +  +    + L+ E F+   +
Sbjct: 187 LLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245

Query: 269 AQN-------LKHLSLAYNRFTRQEFPQIGT--------LLGLEHLNLSRTSLIGDIPSE 313
                     ++      N        +            + +  L++ +  L  D+ + 
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305

Query: 314 ILQLSSLHTLDLSMNHLTGQIPT---VSAKNLGIIDMSHNNLSGEI--PASLLEKLPQME 368
              L  +  + +  + +   +P       K+L  +D+S N +  E    ++     P ++
Sbjct: 306 YSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364

Query: 369 RFNFSYNNLT 378
               S N+L 
Sbjct: 365 TLVLSQNHLR 374

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  149 bits (379), Expect = 2e-38
 Identities = 63/350 (18%), Positives = 128/350 (36%), Gaps = 31/350 (8%)

Query: 53  SKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNF 112
                 D    + T++PS L    ++KSL+LS+N+I+     ++     L+V  L ++  
Sbjct: 5   DASGVCDGRSRSFTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62

Query: 113 SGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAA 171
           +     A  SL SL  L L  N    S+         SL  ++L  N             
Sbjct: 63  NTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121

Query: 172 FPKLKSLNLAGNEIKG--RDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRS 227
              L++L +   E     R   FAGL S+  L I     +         +  +  + L  
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181

Query: 228 NQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEF 287
           ++    + ++  +   +   L   D +  +           +  +K L+   +  T + F
Sbjct: 182 SESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240

Query: 288 PQIG-----------------TLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHL 330
            ++                  TL GL   N S + ++ ++    ++  ++  L +   +L
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK--VETVTIRRLHIPQFYL 298

Query: 331 TGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
              + TV    + +  I + ++ +   +P S  + L  +E  + S N + 
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV 347

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  148 bits (376), Expect = 6e-38
 Identities = 63/377 (16%), Positives = 125/377 (33%), Gaps = 30/377 (7%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
            +    +   + LQ L L  + I  +  D  +SLGSL+ L+LS N +S    S  G    
Sbjct: 40  YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99

Query: 102 LEVFDLSNNNFSG-EIPAAISSLVSLRVLKLDGNMFQWSIPPG-LLNCQSLVTVDLSMNQ 159
           L+  +L  N +    + +   +L +L+ L++        I         SL  +++    
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159

Query: 160 LNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF-- 216
           L  +       +   +  L L  +E     +     L S+  L +               
Sbjct: 160 LR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218

Query: 217 ---LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSG------EIFHNFS 267
                 ++ +  R +                   L  V+  +  L+G            S
Sbjct: 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVS 278

Query: 268 QAQNLKHLSLAYNRFTRQEFPQI-----GTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLH 321
           +   ++ +++      +             L  ++ + +  +  +  +P    Q L SL 
Sbjct: 279 ELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK-VFLVPCSFSQHLKSLE 337

Query: 322 TLDLSMNHLTGQIPTVSA-----KNLGIIDMSHNNLSG-EIPASLLEKLPQMERFNFSYN 375
            LDLS N +  +    SA      +L  + +S N+L   +    +L  L  +   + S N
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN 397

Query: 376 NLTLCASELS-PETLQT 391
                      PE ++ 
Sbjct: 398 TFHPMPDSCQWPEKMRF 414

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  146 bits (370), Expect = 3e-37
 Identities = 51/360 (14%), Positives = 115/360 (31%), Gaps = 37/360 (10%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
           +    ++  +  +  L L  +    L       L S++ L L    ++    S +    +
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV 221

Query: 102 LEVFDLSNNNFSGEIPAAISSLVSL------------------RVLKLDGNMFQWSIPPG 143
                      S     + + L+ L                   +   + +        G
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281

Query: 144 LLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLN 202
            +   ++  + +    L   L   + +   K+K + +  +++     +    LKS+  L+
Sbjct: 282 KVETVTIRRLHIPQFYLFYDLSTVY-SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLD 340

Query: 203 ISGNLFQGSVMGVF-----LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQ 257
           +S NL     +          SL+ + L  N  +  + +           L  +D+S N 
Sbjct: 341 LSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILL-TLKNLTSLDISRNT 398

Query: 258 LSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQL 317
               +  +    + ++ L+L+                 LE L++S  +L          L
Sbjct: 399 FH-PMPDSCQWPEKMRFLNLSSTGIR--VVKT-CIPQTLEVLDVSNNNL-DSFSLF---L 450

Query: 318 SSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNL 377
             L  L +S N L           L ++ +S N L   +P  + ++L  +++     N  
Sbjct: 451 PRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  145 bits (368), Expect = 6e-37
 Identities = 62/363 (17%), Positives = 126/363 (34%), Gaps = 46/363 (12%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPS-DLWSLGSLKSLNLSYNRISGSL 92
           + +    S  +       L+ L  L++   ++    S  L S+  +  L L  +  +  L
Sbjct: 130 IGNVETFS-EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL 188

Query: 93  PSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQ----------WSIPP 142
                    +   +L + N +    + +        +K                   +  
Sbjct: 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248

Query: 143 GLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLN 202
            +L    +   D ++N L G           +L  +                  +I  L+
Sbjct: 249 YILELSEVEFDDCTLNGL-GDFNPSESDVVSELGKVE---------------TVTIRRLH 292

Query: 203 ISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSG 260
           I        +  V+  LE ++ I + +++    +  V  + S +   L ++DLSEN +  
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSK----VFLVPCSFSQHLKSLEFLDLSENLMVE 348

Query: 261 EIFHN---FSQAQNLKHLSLAYNRFT--RQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL 315
           E   N        +L+ L L+ N     ++    + TL  L  L++SR +    +P    
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT-FHPMPDSCQ 407

Query: 316 QLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYN 375
               +  L+LS   +   + T   + L ++D+S+NNL           LP+++    S N
Sbjct: 408 WPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLD-SFSLF----LPRLQELYISRN 461

Query: 376 NLT 378
            L 
Sbjct: 462 KLK 464

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  100 bits (251), Expect = 3e-22
 Identities = 49/269 (18%), Positives = 99/269 (36%), Gaps = 35/269 (13%)

Query: 145 LNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNIS 204
           L+C +    D        S+P G       +KSL+L+ N+I                 I 
Sbjct: 2   LSCDASGVCDGRSRSFT-SIPSGL---TAAMKSLDLSFNKIT---------------YIG 42

Query: 205 GNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFH 264
               +         +L+V+ L+S++    I+ ++ ++ Y+   L ++DLS+N LS     
Sbjct: 43  HGDLRA------CANLQVLILKSSR----INTIEGDAFYSLGSLEHLDLSDNHLSSLSSS 92

Query: 265 NFSQAQNLKHLSLAYNRFTR-QEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHT 322
            F    +LK+L+L  N +           L  L+ L +       +I       L+SL+ 
Sbjct: 93  WFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152

Query: 323 LDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT-L 379
           L++    L         S +++  + +  +  +  +     + L  +        NL   
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARF 211

Query: 380 CASELSPETLQTAFFGSSNDCPIAANPSF 408
             S L  + + +     +    +  + SF
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESF 240

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 27/117 (23%), Positives = 50/117 (42%), Gaps = 10/117 (8%)

Query: 46  DTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVF 105
             +     K++ L+LS   I  + + +    +L+ L++S N +  S    +     L+  
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIRVVKTCI--PQTLEVLDVSNNNLD-SFSLFLPR---LQEL 456

Query: 106 DLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLN 161
            +S N     +P A S    L V+K+  N  + S+P G+     SL  + L  N  +
Sbjct: 457 YISRNKLK-TLPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 510

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  156 bits (396), Expect = 5e-41
 Identities = 63/353 (17%), Positives = 130/353 (36%), Gaps = 30/353 (8%)

Query: 52  LSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNN 110
            ++ +   ++++++    +    S  ++K L+LS N +S    +++  F  LE+ +LS+N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 111 NFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGA 170
               E    + SL +LR L L+ N  Q  +  G     S+ T+  + N ++  +      
Sbjct: 69  VLY-ETL-DLESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNIS-RVSCS--- 117

Query: 171 AFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF---LESLEVIDLR 226
                K++ LA N+I   RD        +  L++  N              ++LE ++L+
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 227 SNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQE 286
            N                +++L  +DLS N+L+  +   F  A  +  +SL  N+    E
Sbjct: 178 YNFIY------DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIE 230

Query: 287 FPQIGTLLGLEHLNLSRTSLIGD-IPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGII 345
              +     LEH +L         +     +   + T+                    + 
Sbjct: 231 -KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289

Query: 346 DMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSN 398
                    ++PA   ++L  ++R      +  L       E L+      + 
Sbjct: 290 HYGAYCCE-DLPAPFADRLIALKRK----EHALLSGQGSETERLECERENQAR 337

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  149 bits (377), Expect = 2e-38
 Identities = 57/368 (15%), Positives = 110/368 (29%), Gaps = 50/368 (13%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
               +       ++ LDLS N ++ + +  L     L+ LNLS N +      ++ +   
Sbjct: 24  QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLST 81

Query: 102 LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLN 161
           L   DL+NN         +    S+  L    N     +       Q    + L+ N++ 
Sbjct: 82  LRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKIT 133

Query: 162 GSLPDGFGAAFPKLKSLNLAGNEIKG--RDTHFAGLKSITNLNISGNLFQGSVMGVFLES 219
             L D       +++ L+L  NEI         A   ++ +LN+  N        V    
Sbjct: 134 -MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAK 192

Query: 220 LEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAY 279
           L+ +DL SN+    ++ +      + + + ++ L  N+L   I      +QNL+H  L  
Sbjct: 193 LKTLDLSSNK----LAFMG-PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246

Query: 280 NRFTRQEFPQ-IGTLLGLEHLNLSRTSLIGDIPSE------------------------- 313
           N F              ++ +       +     E                         
Sbjct: 247 NGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306

Query: 314 --ILQLSSLHTLDLSMNHLTG-QIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERF 370
              L+      L    +     +    +      ID         +   +  +       
Sbjct: 307 LIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQVTLRKQAKITL 365

Query: 371 NFSYNNLT 378
                 L 
Sbjct: 366 EQKKKALD 373

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  145 bits (367), Expect = 3e-37
 Identities = 43/351 (12%), Positives = 106/351 (30%), Gaps = 18/351 (5%)

Query: 47  TTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
             +     +++L  + NNI+ +          K++ L+ N+I+     + G    ++  D
Sbjct: 93  QELLVGPSIETLHAANNNISRVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLD 150

Query: 107 LSNNNFSG-EIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLP 165
           L  N           +S  +L  L L  N     +   +     L T+DLS N+L   + 
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMG 207

Query: 166 DGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQ-GSVMGVFLESLEVID 224
             F +    +  ++L  N++   +      +++ + ++ GN F  G++   F ++  V  
Sbjct: 208 PEFQS-AAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266

Query: 225 LRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTR 284
           +        + ++   +    +                     +   LK    A      
Sbjct: 267 VAKQT----VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322

Query: 285 QEFPQIGTLLG----LEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNHLTGQIPTVSA 339
            E  ++            ++  +      +  ++     +  TL+     L  Q+     
Sbjct: 323 SETERLECERENQARQREIDALKEQ-YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381

Query: 340 KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQ 390
            +  +       +         E+   ++              E       
Sbjct: 382 AHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNN 432

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  145 bits (367), Expect = 3e-37
 Identities = 61/378 (16%), Positives = 121/378 (32%), Gaps = 39/378 (10%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISG----------SL 92
            +    +   +KL+ L+LS N +     DL SL +L++L+L+ N +              
Sbjct: 48  QISAADLAPFTKLELLNLSSNVLYETL-DLESLSTLRTLDLNNNYVQELLVGPSIETLHA 106

Query: 93  PSN------IGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL- 145
            +N             +   L+NN  +            ++ L L  N    ++    L 
Sbjct: 107 ANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELA 165

Query: 146 -NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNIS 204
            +  +L  ++L  N +   +       F KLK+L+L+ N++      F     +T +++ 
Sbjct: 166 ASSDTLEHLNLQYNFIY-DVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLR 222

Query: 205 GNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEI 262
            N     +       ++LE  DLR N F     +  F+      R+    +++  +    
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS---KNQRVQT--VAKQTVKKLT 276

Query: 263 FHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSL----IGDIPSEILQLS 318
             N  +                   P    L+ L+    +  S        +  E    +
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQA 336

Query: 319 SLHTLDLSMNHLTGQIPTVSA--KNLGIIDMSHNNLSGEIPASL--LEKLPQMERFNFSY 374
               +D         I  V+   +    ++     L  ++        +L    +     
Sbjct: 337 RQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396

Query: 375 NNLTLCASELSPETLQTA 392
             L     E SP  L  A
Sbjct: 397 IELQHATEEQSPLQLLRA 414

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  143 bits (361), Expect = 2e-36
 Identities = 61/344 (17%), Positives = 106/344 (30%), Gaps = 12/344 (3%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD--LWSLGSLKSLNLSYNRISGSLPSNIGNFG 100
            + D   G  S++Q LDL  N I  +       S  +L+ LNL YN I   +   +  F 
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191

Query: 101 LLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQL 160
            L+  DLS+N  +  +     S   +  + L  N     I   L   Q+L   DL  N  
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249

Query: 161 NGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF--LE 218
           +      F +   +++++     +              T  +      +         L 
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQN-EEECTVPTLGHYGAYCCEDLPAPFADRLI 308

Query: 219 SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLA 278
           +L+  +      QG  ++       N +R   +D  + Q    I     + Q    L   
Sbjct: 309 ALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQK 368

Query: 279 YNRFTRQEFPQIGTLLGLEHLNLSRTSLIG--DIPSEILQLSSLHTLDLSMNHLTGQIPT 336
                 Q          L+         I       E   L  L  +      +  +  +
Sbjct: 369 KKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQS 428

Query: 337 VSAKNLGIIDMSHNNLSG-EIPASLLEKLPQMERFNFSYNNLTL 379
           V    +   DM  +  +      + L+KL        +  N TL
Sbjct: 429 VQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATL 472

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  141 bits (356), Expect = 8e-36
 Identities = 56/316 (17%), Positives = 115/316 (36%), Gaps = 23/316 (7%)

Query: 67  ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSL 126
           A+     +    K   ++ + +  +L S   +   ++  DLS N  S    A ++    L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 127 RVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIK 186
            +L L  N+        L +  +L T+DL+ N +   L  G     P +++L+ A N I 
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLVG-----PSIETLHAANNNI- 111

Query: 187 GRDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSY- 243
                 +  +   N+ ++ N               ++ +DL+ N+    I  V F     
Sbjct: 112 -SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE----IDTVNFAELAA 166

Query: 244 NWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSR 303
           +   L +++L  N +             LK L L+ N+      P+  +  G+  ++L  
Sbjct: 167 SSDTLEHLNLQYNFIY--DVKGQVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRN 223

Query: 304 TSLIGDIPSEILQLSSLHTLDLSMNHL-TGQIPTVSAKNLGIIDMSHNNLSGEIPASLLE 362
             L+  I   +    +L   DL  N    G +    +KN  +  ++   +  ++     E
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEE 281

Query: 363 KLPQMERFNFSYNNLT 378
           +       ++      
Sbjct: 282 ECTVPTLGHYGAYCCE 297

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 86.4 bits (214), Expect = 7e-18
 Identities = 28/278 (10%), Positives = 66/278 (23%), Gaps = 9/278 (3%)

Query: 48  TIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDL 107
                + +  + L  N +  +   L    +L+  +L  N                 V  +
Sbjct: 209 EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTV 267

Query: 108 SNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDG 167
           +                   +        +    P      +L   + ++    GS  + 
Sbjct: 268 AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER 327

Query: 168 FGAAF---PKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVI 223
                    + + ++    + +   D      ++   L          V        E  
Sbjct: 328 LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE-- 385

Query: 224 DLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFT 283
            L     Q        +++   S L  +     +         S   N       Y    
Sbjct: 386 -LDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444

Query: 284 RQEFPQIGTLLGL-EHLNLSRTSLIGDIPSEILQLSSL 320
            Q   +   L  L    +L+  S    +   +++  +L
Sbjct: 445 TQLAEENARLKKLNGEADLALASANATLQELVVREQNL 482

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 25/130 (19%), Positives = 49/130 (37%), Gaps = 13/130 (10%)

Query: 261 EIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSL 320
           EI  N       K   +  +   +       +   ++ L+LS   L     +++   + L
Sbjct: 4   EIKQN---GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 321 HTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLC 380
             L+LS N L   +   S   L  +D+++N +        L   P +E  + + NN++  
Sbjct: 61  ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQE------LLVGPSIETLHAANNNIS-- 112

Query: 381 ASELSPETLQ 390
              +S    Q
Sbjct: 113 --RVSCSRGQ 120

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  151 bits (383), Expect = 9e-41
 Identities = 59/328 (17%), Positives = 123/328 (37%), Gaps = 26/328 (7%)

Query: 52  LSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNN 110
            ++ +   ++++++    +    S  ++K L+LS N +S    +++  F  LE+ +LS+N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 111 NFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGA 170
               E    + SL +LR L L+ N  Q  +  G     S+ T+  + N ++  +      
Sbjct: 69  VLY-ETL-DLESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNIS-RVSCS--- 117

Query: 171 AFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF---LESLEVIDLR 226
                K++ LA N+I   RD        +  L++  N              ++LE ++L+
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 227 SNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQE 286
            N                +++L  +DLS N+L+  +   F  A  +  +SL  N+    E
Sbjct: 178 YNFIY------DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIE 230

Query: 287 FPQIGTLLGLEHLNLSRTSLIGD-IPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGII 345
              +     LEH +L         +     +   + T+                    + 
Sbjct: 231 -KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289

Query: 346 DMSHNNLSGEIPASLLEKLPQMERFNFS 373
                    ++PA   ++L  +   +  
Sbjct: 290 HYG-AYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  140 bits (355), Expect = 5e-37
 Identities = 62/337 (18%), Positives = 117/337 (34%), Gaps = 45/337 (13%)

Query: 67  ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSL 126
           A+     +    K   ++ + +  +L S   +   ++  DLS N  S    A ++    L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 127 RVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIK 186
            +L L  N+        L +  +L T+DL+ N +   L  G     P +++L+ A N I 
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLVG-----PSIETLHAANNNIS 112

Query: 187 GRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWS 246
                           +S +  Q           + I L +N+    I+ ++       S
Sbjct: 113 ---------------RVSCSRGQ---------GKKNIYLANNK----ITMLRDLDEGCRS 144

Query: 247 RLVYVDLSENQLSG-EIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTS 305
           R+ Y+DL  N++         + +  L+HL+L YN     +         L+ L+LS   
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY--DVKGQVVFAKLKTLDLSSNK 202

Query: 306 LIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEK 363
           L   +  E    + +  + L  N L   I      ++NL   D+  N            K
Sbjct: 203 LA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260

Query: 364 LPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDC 400
             +++    +   +     +   E            C
Sbjct: 261 NQRVQ--TVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  126 bits (318), Expect = 5e-32
 Identities = 57/313 (18%), Positives = 113/313 (36%), Gaps = 46/313 (14%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLL 102
            +    +   +KL+ L+LS N +     DL SL +L++L+L+ N +       +     +
Sbjct: 48  QISAADLAPFTKLELLNLSSNVLYETL-DLESLSTLRTLDLNNNYV-----QELLVGPSI 101

Query: 103 EVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLN 161
           E    +NNN S  +    S     + + L  N     +          +  +DL +N+++
Sbjct: 102 ETLHAANNNIS-RVSC--SRGQGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEID 157

Query: 162 GSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLE 221
                   A+   L+ LNL  N I                ++ G         V    L+
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIY---------------DVKG--------QVVFAKLK 194

Query: 222 VIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNR 281
            +DL SN+    ++ +      + + + ++ L  N+L   I      +QNL+H  L  N 
Sbjct: 195 TLDLSSNK----LAFMG-PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248

Query: 282 FTRQEFPQ-IGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAK 340
           F              ++ +          +  +  +  ++ TL     +    +P   A 
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305

Query: 341 NLGIIDMSHNNLS 353
            L  I + H++  
Sbjct: 306 RL--IALGHHHHH 316

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  149 bits (378), Expect = 5e-40
 Identities = 62/315 (19%), Positives = 119/315 (37%), Gaps = 68/315 (21%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA--RELEYLGRIKHPNLVPLT 570
           G L+ +G+FG VY G   G   VA++++       DQ  A  RE+    + +H N+V   
Sbjct: 38  GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
           G C++      I    +   L +++ D                               ++
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRD-----------------------------AKIV 126

Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
                  +IA    + + +LH   +  I+H+D+K+ +V+ D N +  ++DFGL  I G  
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182

Query: 691 LDEE------IARGSPGYIPPE------FAQPDSDFP-TPKSDVYCYGVVLLELITGKKP 737
                     I  G   ++ PE          +   P +  SDV+  G +  EL   + P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK-IGYLCTADLPL 796
               +    +      +   +    G +   P +     +  M + +  I   C A    
Sbjct: 243 ----F----KTQPAEAIIWQM--GTGMK---PNL----SQIGMGKEISDILLFCWAFEQE 285

Query: 797 KRPSMQQIVGLLKDI 811
           +RP+  +++ +L+ +
Sbjct: 286 ERPTFTKLMDMLEKL 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  149 bits (378), Expect = 6e-40
 Identities = 69/337 (20%), Positives = 115/337 (34%), Gaps = 81/337 (24%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELE--YLGRIKHPNLVPLT 570
              + +G++G V+ G    G  VAVKV     T  +    RE E      ++H N++   
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFI 97

Query: 571 GYCIAGDQRIAIY----DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
              I G           DY ENG+L + L    L                          
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTL-------------------------- 131

Query: 627 EGLLTTWRFRHKIALGTARALAFLH-----HGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                  +   K+A  +   L  LH         P I HRD+K+ ++ +  N    ++D 
Sbjct: 132 -----DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186

Query: 682 GLAKIFGNGLDEEIA-----RGSPGYIPPEF---AQPDSDFP-TPKSDVYCYGVVLLELI 732
           GLA  F +  +E         G+  Y+PPE    +   + F     +D+Y +G++L E+ 
Sbjct: 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

Query: 733 TGKKPLGDDYP-----EEKEGNLVSW--VRGLVRNNKGSRAIDPKIRDTGPEKQ------ 779
                 G          +   +  S+  +R +V   K  R   P   +     +      
Sbjct: 247 RRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV-CIKKLR---PSFPNRWSSDECLRQMG 302

Query: 780 --MEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST 814
             M E       C A  P  R +  ++   L  +  +
Sbjct: 303 KLMTE-------CWAHNPASRLTALRVKKTLAKMSES 332

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  151 bits (384), Expect = 1e-39
 Identities = 63/359 (17%), Positives = 121/359 (33%), Gaps = 70/359 (19%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGL---------- 101
            + LQ      +N+T +P +  ++ S      +++    + P   G              
Sbjct: 10  NTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69

Query: 102 ---LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMN 158
                  +L+N   S  +P     L SL       N     +P    + +SL+  + ++ 
Sbjct: 70  DRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLK 124

Query: 159 QLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLE 218
            L+  LP       P L+ L ++ N+++           +  +++  N      +     
Sbjct: 125 ALS-DLP-------PLLEYLGVSNNQLEKLPE-LQNSSFLKIIDVDNNSL--KKLPDLPP 173

Query: 219 SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLA 278
           SLE I   +NQ +  + ++Q     N   L  +    N L  ++        +L+ +   
Sbjct: 174 SLEFIAAGNNQLE-ELPELQ-----NLPFLTAIYADNNSLK-KLPDLPL---SLESIVAG 223

Query: 279 YNRFTRQEFPQIGTLLGLEHLNLSRTSL-------------------IGDIPSEILQLSS 319
            N     E P++  L  L  +      L                   + D+P     L+ 
Sbjct: 224 NNILE--ELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTF 281

Query: 320 LHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           L   +   + L+   P     NL  ++ S N +      SL +  P +E  N S N L 
Sbjct: 282 LDVSENIFSGLSELPP-----NLYYLNASSNEIR-----SLCDLPPSLEELNVSNNKLI 330

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  143 bits (364), Expect = 5e-37
 Identities = 66/348 (18%), Positives = 123/348 (35%), Gaps = 52/348 (14%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLL 102
            +P+  +   S L+ +D+  N++  LP       SL+ +    N++   LP  + N   L
Sbjct: 145 KLPE--LQNSSFLKIIDVDNNSLKKLPD---LPPSLEFIAAGNNQLE-ELP-ELQNLPFL 197

Query: 103 EVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNG 162
                 NN+   ++P      +SL  +    N       P L N   L T+    N L  
Sbjct: 198 TAIYADNNSLK-KLP---DLPLSLESIVAGNN--ILEELPELQNLPFLTTIYADNNLLK- 250

Query: 163 SLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEV 222
           +LPD        L++LN+  N +         L  +       +            +L  
Sbjct: 251 TLPDLPP----SLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSE-----LPPNLYY 301

Query: 223 IDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRF 282
           ++  SN+ +        +       L  +++S N+L  E+         L+ L  ++N  
Sbjct: 302 LNASSNEIR--------SLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL 349

Query: 283 TRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNL 342
              E P+      L+ L++    L  + P     +  L       +HL  ++P    +NL
Sbjct: 350 A--EVPE--LPQNLKQLHVEYNPLR-EFPDIPESVEDLRMN----SHLA-EVPE-LPQNL 398

Query: 343 GIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQ 390
             + +  N L  E P    +    +E    +   +     E + ET  
Sbjct: 399 KQLHVETNPLR-EFP----DIPESVEDLRMNSERVVDP-YEFAHETTD 440

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  137 bits (348), Expect = 8e-35
 Identities = 72/345 (20%), Positives = 121/345 (35%), Gaps = 60/345 (17%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS 108
              L  L   + +   ++ LP        L+ L +S N++   LP  + N   L++ D+ 
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPP------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVD 161

Query: 109 NNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGF 168
           NN+   ++P       SL  +    N       P L N   L  +    N L   LPD  
Sbjct: 162 NNSLK-KLP---DLPPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLP 214

Query: 169 GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSN 228
                 L+S+    N ++        L  +T +    NL     +     SLE +++R N
Sbjct: 215 L----SLESIVAGNNILE-ELPELQNLPFLTTIYADNNLL--KTLPDLPPSLEALNVRDN 267

Query: 229 QFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFP 288
                    Q     + + L   +   + LS           NL +L+ + N        
Sbjct: 268 YLTDLPELPQ-----SLTFLDVSENIFSGLSELP-------PNLYYLNASSNEIR--SLC 313

Query: 289 QIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMS 348
                  LE LN+S   LI ++P+       L  L  S NHL  ++P    +NL  + + 
Sbjct: 314 --DLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE-LPQNLKQLHVE 365

Query: 349 HNNLSGEIPA---------------SLLEKLPQMERFNFSYNNLT 378
           +N L  E P                 + E    +++ +   N L 
Sbjct: 366 YNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  133 bits (336), Expect = 3e-33
 Identities = 67/330 (20%), Positives = 128/330 (38%), Gaps = 51/330 (15%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNN 111
              L+ +    N +  LP +L +L  L ++    N +   LP    +   LE     NN 
Sbjct: 172 PPSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNI 226

Query: 112 FSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAA 171
              E+P  + +L  L  +  D N+ + ++P    + ++L   ++  N L   LP+     
Sbjct: 227 LE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRDNYLT-DLPELPQ-- 277

Query: 172 FPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQ 231
              L  L+++ N   G         ++  LN S N  +   +     SLE +++ +N+  
Sbjct: 278 --SLTFLDVSENIFSGLSEL---PPNLYYLNASSN--EIRSLCDLPPSLEELNVSNNKLI 330

Query: 232 GHISQVQFNSSYNWSRLVYVDLSENQLS---GEIFHNFSQAQNLKHLSLAYNRFTRQEFP 288
                 +  +     RL  +  S N L+             QNLK L + YN     EFP
Sbjct: 331 ------ELPAL--PPRLERLIASFNHLAEVPELP-------QNLKQLHVEYNPLR--EFP 373

Query: 289 QIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMS 348
            I     +E L ++  S + ++P       +L  L +  N L  + P    +++  + M+
Sbjct: 374 DI--PESVEDLRMN--SHLAEVPELP---QNLKQLHVETNPLR-EFPD-IPESVEDLRMN 424

Query: 349 HNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
              +  +      E   ++E   F +++  
Sbjct: 425 SERVV-DPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  121 bits (306), Expect = 2e-29
 Identities = 62/300 (20%), Positives = 113/300 (37%), Gaps = 48/300 (16%)

Query: 93  PSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLN------ 146
           P N+ N  L E     ++N + E+P    ++ S        + ++ + PPG         
Sbjct: 5   PRNVSNTFLQEPL-RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 147 -------CQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSIT 199
                   +    ++L+   L+ SLP+      P L+SL  + N +         LKS+ 
Sbjct: 63  SRLRDCLDRQAHELELNNLGLS-SLPE----LPPHLESLVASCNSLTELPELPQSLKSLL 117

Query: 200 NLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS 259
             N +               LE + + +NQ +  + ++Q     N S L  +D+  N L 
Sbjct: 118 VDNNNLKALSD-----LPPLLEYLGVSNNQLE-KLPELQ-----NSSFLKIIDVDNNSLK 166

Query: 260 GEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSS 319
            ++        +L+ ++   N+    E P++  L  L  +     SL   +P       S
Sbjct: 167 -KLPDLPP---SLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDL---PLS 216

Query: 320 LHTLDLSMNHLTGQIPTVSA-KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           L ++    N L  ++P +     L  I   +N L      +L +  P +E  N   N LT
Sbjct: 217 LESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK-----TLPDLPPSLEALNVRDNYLT 270

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  100 bits (250), Expect = 3e-22
 Identities = 48/284 (16%), Positives = 93/284 (32%), Gaps = 62/284 (21%)

Query: 48  TIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDL 107
            +  L  L ++    N +  LP       SL++LN+  N ++  LP    +   L+V + 
Sbjct: 232 ELQNLPFLTTIYADNNLLKTLPD---LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSEN 287

Query: 108 SNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDG 167
             +  S   P       +L  L    N  + S+        SL  +++S N+L   LP  
Sbjct: 288 IFSGLSELPP-------NLYYLNASSNEIR-SLCDLP---PSLEELNVSNNKLI-ELPAL 335

Query: 168 FGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRS 227
                 +L+ L  + N           L  +  L                ++L+ + +  
Sbjct: 336 PP----RLERLIASFNH----------LAEVPEL---------------PQNLKQLHVEY 366

Query: 228 NQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEF 287
           N  +     +  +            + + +++  +       QNLK L +  N     EF
Sbjct: 367 NPLR-EFPDIPES------------VEDLRMNSHLAEVPELPQNLKQLHVETNPLR--EF 411

Query: 288 PQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLT 331
           P I     +E L ++   ++            L       +H  
Sbjct: 412 PDI--PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  145 bits (368), Expect = 9e-39
 Identities = 61/322 (18%), Positives = 111/322 (34%), Gaps = 65/322 (20%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNL 566
           S+   G +L +G FG   +      G  + +K L+     T +   +E++ +  ++HPN+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 567 VPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
           +   G      +   I +Y++ G L+ ++                               
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKS----------------------------M 101

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           +     W  R   A   A  +A+LH   S  IIHRD+ + +  +  N    ++DFGLA++
Sbjct: 102 DSQYP-WSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARL 157

Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDSDFPTP---------------KSDVYCYGVVLLEL 731
             +  ++    G      P+  +  +    P               K DV+ +G+VL E+
Sbjct: 158 MVD--EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

Query: 732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCT 791
           I       D  P               R       +   +    P         I   C 
Sbjct: 216 IGRVNADPDYLP---------------RTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCC 260

Query: 792 ADLPLKRPSMQQIVGLLKDIES 813
              P KRPS  ++   L+ +  
Sbjct: 261 DLDPEKRPSFVKLEHWLETLRM 282

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  144 bits (366), Expect = 3e-38
 Identities = 67/329 (20%), Positives = 115/329 (34%), Gaps = 65/329 (19%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELE--YLGRIKHPNLVPLT 570
              + +G+FG V+RG    G  VAVK+    S+  ++   RE E      ++H N++   
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 571 GYCIAGDQRIAIY----DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
                 +          DY E+G+L + L+   +                          
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV-------------------------- 136

Query: 627 EGLLTTWRFRHKIALGTARALAFLH-----HGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                T     K+AL TA  LA LH         P I HRD+K+ ++ +  N    ++D 
Sbjct: 137 -----TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191

Query: 682 GLAKIFGNGLDEEIA-----RGSPGYIPPEF---AQPDSDFP-TPKSDVYCYGVVLLELI 732
           GLA    +  D          G+  Y+ PE    +     F    ++D+Y  G+V  E+ 
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

Query: 733 TGKKPLGDDYPEEKE-GNLVSW------VRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK 785
                 G     +    +LV        +R +V   K    I  + +     + M + ++
Sbjct: 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 311

Query: 786 IGYLCTADLPLKRPSMQQIVGLLKDIEST 814
               C       R +  +I   L  +   
Sbjct: 312 ---ECWYANGAARLTALRIKKTLSQLSQQ 337

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  140 bits (354), Expect = 9e-37
 Identities = 49/337 (14%), Positives = 95/337 (28%), Gaps = 57/337 (16%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSL--GSLKSLNLSYNRISGSLP 93
            N+  +           +  Q    +   + A    L         +L L    +    P
Sbjct: 39  YNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFP 97

Query: 94  SNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTV 153
                   L+   +       E+P  +     L  L L  N  + ++P  + +   L  +
Sbjct: 98  DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155

Query: 154 DLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVM 213
            +        LP+                               + + + SG        
Sbjct: 156 SIRACPELTELPE------------------------------PLASTDASGEHQG---- 181

Query: 214 GVFLESLEVIDLRSNQFQGHISQVQFNSS-YNWSRLVYVDLSENQLSGEIFHNFSQAQNL 272
              L +L+ + L     +         +S  N   L  + +  + LS  +         L
Sbjct: 182 ---LVNLQSLRLEWTGIR------SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231

Query: 273 KHLSLAY-NRFTRQEFPQ-IGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHL 330
           + L L          +P   G    L+ L L   S +  +P +I +L+ L  LDL     
Sbjct: 232 EELDLRGCTALR--NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289

Query: 331 TGQIPT--VSAKNLGIIDMSHNNLSGEIPASLLEKLP 365
             ++P+         II +   +L  ++        P
Sbjct: 290 LSRLPSLIAQLPANCIILVP-PHLQAQLDQHRPVARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  118 bits (298), Expect = 2e-29
 Identities = 39/315 (12%), Positives = 95/315 (30%), Gaps = 26/315 (8%)

Query: 77  SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMF 136
             ++L    +         +  +      D +  + +        +  + ++    G   
Sbjct: 13  GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRAL 68

Query: 137 QWSIPPGLLNCQS--LVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAG 194
           + +    L +      V ++L    L    PD        L+ + +    +         
Sbjct: 69  K-ATADLLEDATQPGRVALELRSVPLP-QFPDQAF-RLSHLQHMTIDAAGLMELPDTMQQ 125

Query: 195 LKSITNLNISGNLFQG--SVMGVFLESLEVIDLRSN----QFQGHISQVQF-NSSYNWSR 247
              +  L ++ N  +   + +   L  L  + +R+     +    ++             
Sbjct: 126 FAGLETLTLARNPLRALPASIA-SLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN 184

Query: 248 LVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQ-IGTLLGLEHLNLSRTSL 306
           L  + L    +   +  + +  QNLK L +  +  +       I  L  LE L+L   + 
Sbjct: 185 LQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS--ALGPAIHHLPKLEELDLRGCTA 241

Query: 307 IGDIPSEILQLSSLHTLDLS-MNHLTGQIPT--VSAKNLGIIDMSHNNLSGEIPASLLEK 363
           + + P      + L  L L   ++L   +P        L  +D+        +P+  + +
Sbjct: 242 LRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSL-IAQ 299

Query: 364 LPQMERFNFSYNNLT 378
           LP         +   
Sbjct: 300 LPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  103 bits (259), Expect = 3e-24
 Identities = 27/153 (17%), Positives = 53/153 (34%), Gaps = 2/153 (1%)

Query: 13  ASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDL 72
               S           ++       +G+  S+P + I  L  L+SL +  + ++AL   +
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS-IANLQNLKSLKIRNSPLSALGPAI 225

Query: 73  WSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLD 132
             L  L+ L+L       + P   G    L+   L + +    +P  I  L  L  L L 
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLR 285

Query: 133 GNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLP 165
           G +    +P  +    +   + +  +       
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  100 bits (252), Expect = 3e-23
 Identities = 46/302 (15%), Positives = 84/302 (27%), Gaps = 30/302 (9%)

Query: 90  GSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQS 149
           GS   +  +    E      +         +S          +     W       N  +
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 150 LVTVDLSMNQLNGSLPDGFG-AAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLF 208
                 +   L  +  D    A  P   +L L    +         L  + ++ I     
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGL 116

Query: 209 QG--SVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSE-NQL------- 258
                 M      LE + L  N  +  +      S  + +RL  + +    +L       
Sbjct: 117 MELPDTMQ-QFAGLETLTLARNPLR-ALP----ASIASLNRLRELSIRACPELTELPEPL 170

Query: 259 -SGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQ-IGTLLGLEHLNLSRTSLIGDIPSEILQ 316
            S +         NL+ L L +        P  I  L  L+ L +  + L   +   I  
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIR--SLPASIANLQNLKSLKIRNSPLSA-LGPAIHH 227

Query: 317 LSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSY 374
           L  L  LDL         P +      L  + +   +    +P   + +L Q+E+ +   
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD-IHRLTQLEKLDLRG 286

Query: 375 NN 376
             
Sbjct: 287 CV 288

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  137 bits (348), Expect = 6e-36
 Identities = 55/298 (18%), Positives = 107/298 (35%), Gaps = 46/298 (15%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
            + D     L  L +L L  N I+ +       L  L+ L LS N++   LP  +     
Sbjct: 66  EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKT 122

Query: 102 LEVFDLSNNNFSGEIPAAI-SSLVSLRVLKLDGNMFQWS-IPPGLL-NCQSLVTVDLSMN 158
           L+   +  N  + ++  ++ + L  + V++L  N  + S I  G     + L  + ++  
Sbjct: 123 LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181

Query: 159 QLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLE 218
            +  ++P G     P L  L+L GN+I                 +     +G      L 
Sbjct: 182 NIT-TIPQG---LPPSLTELHLDGNKIT---------------KVDAASLKG------LN 216

Query: 219 SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLA 278
           +L  + L  N     IS V   S  N   L  + L+ N+L  ++    +  + ++ + L 
Sbjct: 217 NLAKLGLSFNS----ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271

Query: 279 YNRFTR---QEFPQIGTLLG---LEHLNLSRTSL-IGDIPSEILQ-LSSLHTLDLSMN 328
            N  +     +F   G          ++L    +   +I     + +     + L   
Sbjct: 272 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  134 bits (340), Expect = 7e-35
 Identities = 55/330 (16%), Positives = 108/330 (32%), Gaps = 42/330 (12%)

Query: 55  LQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSG 114
           L+ +  S+  +  +P DL        L+L  N+I+     +  N   L    L NN  S 
Sbjct: 33  LRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90

Query: 115 EIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPK 174
             P A + LV L  L L  N  +  +P  +   ++L  + +  N++   +         +
Sbjct: 91  ISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQ 146

Query: 175 LKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHI 234
           +  + L  N              + +  I    FQG      ++ L  I +        I
Sbjct: 147 MIVVELGTN-------------PLKSSGIENGAFQG------MKKLSYIRIADTNIT-TI 186

Query: 235 SQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLL 294
            Q           L  + L  N+++     +     NL  L L++N  +  +   +    
Sbjct: 187 PQGLP------PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 240

Query: 295 GLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLT--------GQIPTVSAKNLGIID 346
            L  L+L+   L+  +P  +     +  + L  N+++                 +   + 
Sbjct: 241 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVS 299

Query: 347 MSHNNLS-GEIPASLLEKLPQMERFNFSYN 375
           +  N +   EI  S    +           
Sbjct: 300 LFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  123 bits (311), Expect = 5e-31
 Identities = 50/257 (19%), Positives = 90/257 (35%), Gaps = 21/257 (8%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSN 95
            N+ +S  +       L KL+ L LS+N +  LP  +    +L+ L +  N I+  +  +
Sbjct: 84  INNKIS-KISPGAFAPLVKLERLYLSKNQLKELPEKM--PKTLQELRVHENEIT-KVRKS 139

Query: 96  I-GNFGLLEVFDLSNNNF-SGEIPA-AISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVT 152
           +      + V +L  N   S  I   A   +  L  +++       +IP GL    SL  
Sbjct: 140 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTE 196

Query: 153 VDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGS 211
           + L  N++   +          L  L L+ N I    +   A    +  L+++ N     
Sbjct: 197 LHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K 254

Query: 212 VMGVF--LESLEVIDLRSNQFQGHISQVQFNSSY---NWSRLVYVDLSENQLSGEIFHN- 265
           V G     + ++V+ L +N     I    F         +    V L  N +        
Sbjct: 255 VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313

Query: 266 -FSQAQNLKHLSLAYNR 281
            F        + L   +
Sbjct: 314 TFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  105 bits (264), Expect = 8e-25
 Identities = 38/182 (20%), Positives = 72/182 (39%), Gaps = 13/182 (7%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLP 93
           L +N   S  + +     + KL  + +++ NIT +P  L    SL  L+L  N+I+  + 
Sbjct: 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKIT-KVD 208

Query: 94  SNI-GNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVT 152
           +        L    LS N+ S     ++++   LR L L+ N     +P GL + + +  
Sbjct: 209 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 267

Query: 153 VDLSMNQL-----NGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH---FAGLKSITNLNIS 204
           V L  N +     N   P G+         ++L  N ++  +     F  +     + + 
Sbjct: 268 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLG 327

Query: 205 GN 206
             
Sbjct: 328 NY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 87.7 bits (218), Expect = 7e-19
 Identities = 45/238 (18%), Positives = 89/238 (37%), Gaps = 41/238 (17%)

Query: 146 NCQ-SLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNI 203
            CQ  L  V  S   L   +P       P    L+L  N+I   +D  F  LK++  L +
Sbjct: 28  RCQCHLRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLIL 83

Query: 204 SGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGE 261
             N       G F  L  LE + L  NQ +  + +    +      L  + + EN+++ +
Sbjct: 84  INNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT------LQELRVHENEIT-K 135

Query: 262 IFHN-FSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSL 320
           +  + F+    +  + L  N          G   G+                       L
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIEN-GAFQGM---------------------KKL 173

Query: 321 HTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
             + ++  ++T  IP     +L  + +  N ++ ++ A+ L+ L  + +   S+N+++
Sbjct: 174 SYIRIADTNIT-TIPQGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS 229

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  134 bits (339), Expect = 1e-34
 Identities = 51/297 (17%), Positives = 100/297 (33%), Gaps = 45/297 (15%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
            +       L  L +L L  N I+ +       L  L+ L +S N +   +P N+     
Sbjct: 68  ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSS 124

Query: 102 LEVFDLSNNNFSGEIPA-AISSLVSLRVLKLDGNMFQWS-IPPGLLNCQSLVTVDLSMNQ 159
           L    + +N    ++P    S L ++  +++ GN  + S   PG  +   L  + +S  +
Sbjct: 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183

Query: 160 LNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLES 219
           L   +P         L  L+L  N+I+                I                
Sbjct: 184 LT-GIPKD---LPETLNELHLDHNKIQ---------------AIELEDLLR------YSK 218

Query: 220 LEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAY 279
           L  + L  NQ    I  ++  S      L  + L  N+LS  +       + L+ + L  
Sbjct: 219 LYRLGLGHNQ----IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHT 273

Query: 280 NRFTR---QEFPQIGTLLG---LEHLNLSRTSL-IGDIPSEILQ-LSSLHTLDLSMN 328
           N  T+    +F  +G  +       ++L    +   ++     + ++    +     
Sbjct: 274 NNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  125 bits (316), Expect = 1e-31
 Identities = 69/335 (20%), Positives = 118/335 (35%), Gaps = 53/335 (15%)

Query: 55  LQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSN-IGNFGLLEVFDLSNNNFS 113
           L+ +  S+  + A+P ++        L+L  N IS  L  +       L    L NN  S
Sbjct: 35  LRVVQCSDLGLKAVPKEI--SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS 91

Query: 114 GEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFP 173
                A S L  L+ L +  N     IPP L    SLV + +  N++   +P G  +   
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLR 147

Query: 174 KLKSLNLAGNEIKG---RDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQF 230
            +  + + GN ++        F GLK +  L IS     G    +  E+L  + L  N+ 
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTGIPKDLP-ETLNELHLDHNK- 204

Query: 231 QGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN-FSQAQNLKHLSLAYNRFTRQEFPQ 289
              I  ++      +S+L  + L  NQ+   I +   S    L+ L L  N+ +R     
Sbjct: 205 ---IQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR----- 255

Query: 290 IGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLT--------GQIPTVSAKN 341
                               +P+ +  L  L  + L  N++T             V    
Sbjct: 256 --------------------VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAY 295

Query: 342 LGIIDMSHNNLS-GEIPASLLEKLPQMERFNFSYN 375
              I + +N +   E+  +    +       F   
Sbjct: 296 YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  118 bits (299), Expect = 2e-29
 Identities = 43/248 (17%), Positives = 86/248 (34%), Gaps = 17/248 (6%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLL 102
            + +     L KLQ L +S+N++  +P +L    SL  L +  NRI             +
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLVEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNM 149

Query: 103 EVFDLSNNNF-SGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLN 161
              ++  N   +          + L  L++        IP  L   ++L  + L  N++ 
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQ 206

Query: 162 GSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF--LE 218
            ++       + KL  L L  N+I+   +   + L ++  L++  N     V      L+
Sbjct: 207 -AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLK 264

Query: 219 SLEVIDLRSNQFQGHISQVQF---NSSYNWSRLVYVDLSENQLSGEIFHN--FSQAQNLK 273
            L+V+ L +N     +    F         +    + L  N +         F    +  
Sbjct: 265 LLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRL 323

Query: 274 HLSLAYNR 281
            +     +
Sbjct: 324 AIQFGNYK 331

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  139 bits (351), Expect = 1e-34
 Identities = 71/324 (21%), Positives = 120/324 (37%), Gaps = 61/324 (18%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSN 95
             SGL+ ++PD  +     + +L + +NN+T+LP+       L++L +S N+++ SLP  
Sbjct: 48  GESGLT-TLPDC-LPA--HITTLVIPDNNLTSLPA---LPPELRTLEVSGNQLT-SLPVL 99

Query: 96  IGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDL 155
                 L +F     +              L  L + GN    S+P      Q L    +
Sbjct: 100 PPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLPPGLQEL---SV 148

Query: 156 SMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHF-AGLKSITNLNISGNLFQ----- 209
           S NQL  SLP        +L  L    N++    T        +  L++S N        
Sbjct: 149 SDNQLA-SLPALPS----ELCKLWAYNNQL----TSLPMLPSGLQELSVSDNQLASLPTL 199

Query: 210 -GSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQ 268
                   L  L   + R        S            L  + +S N+L+  +    S 
Sbjct: 200 PSE-----LYKLWAYNNRLTSLPALPSG-----------LKELIVSGNRLT-SLPVLPS- 241

Query: 269 AQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMN 328
              LK L ++ NR T    P      GL  L++ R  L   +P  ++ LSS  T++L  N
Sbjct: 242 --ELKELMVSGNRLT--SLPM--LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294

Query: 329 HLTGQIPTVSAKNLGIIDMSHNNL 352
            L+ +    + + +         +
Sbjct: 295 PLS-ERTLQALREITSAPGYSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  114 bits (286), Expect = 2e-26
 Identities = 57/288 (19%), Positives = 99/288 (34%), Gaps = 43/288 (14%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLL 102
           S+P      L +L        ++ ALPS       L  L +  N+++ SLP        L
Sbjct: 95  SLPVL-PPGLLELSIFSNPLTHLPALPS------GLCKLWIFGNQLT-SLPVLPPG---L 143

Query: 103 EVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNG 162
           +   +S+N  +  +PA  S L  L       N    S+P      Q L    +S NQL  
Sbjct: 144 QELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPSGLQEL---SVSDNQLA- 194

Query: 163 SLPDGFGAAFPKLKSLNLAGNEIKGRDTHF-AGLKSITNLNISGNLFQGSVMGVFLESLE 221
           SLP        +L  L    N +    T   A    +  L +SGN    + + V    L+
Sbjct: 195 SLPTLPS----ELYKLWAYNNRL----TSLPALPSGLKELIVSGNRL--TSLPVLPSELK 244

Query: 222 VIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNR 281
            + +  N+    ++ +        S L+ + +  NQL+  +  +     +   ++L  N 
Sbjct: 245 ELMVSGNR----LTSL----PMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295

Query: 282 FTRQEFPQIGTLLGLEHLNLSRTS---LIGDIPSEILQLSSLHTLDLS 326
            + +    +  +      +             P E   L       L 
Sbjct: 296 LSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLV 343

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 54.5 bits (131), Expect = 9e-08
 Identities = 22/110 (20%), Positives = 35/110 (31%), Gaps = 5/110 (4%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNN 111
            S L SL +  N +T LP  L  L S  ++NL  N +S      +        +      
Sbjct: 260 PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIR 319

Query: 112 FSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLN 161
           F     +A     +L +   D     W +P             +   + N
Sbjct: 320 FDMAGASAPRETRALHLAAAD-----WLVPAREGEPAPADRWHMFGQEDN 364

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 14/62 (22%), Positives = 27/62 (43%), Gaps = 6/62 (9%)

Query: 317 LSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNN 376
            +    L++  + LT  +P     ++  + +  NNL+  +PA      P++     S N 
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPAHITTLVIPDNNLT-SLPAL----PPELRTLEVSGNQ 92

Query: 377 LT 378
           LT
Sbjct: 93  LT 94

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  134 bits (339), Expect = 1e-33
 Identities = 60/331 (18%), Positives = 122/331 (36%), Gaps = 36/331 (10%)

Query: 48  TIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDL 107
           +  +L+ L SLD   ++IT +   +  L  L  L  + N I+ +L   +     L     
Sbjct: 37  SEEQLATLTSLDCHNSSITDMT-GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC 92

Query: 108 SNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDG 167
            +N  +  +   ++ L  L  L  D N     +         L  ++ + N L   +   
Sbjct: 93  DSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTYLNCARNTLT-EIDVS 145

Query: 168 FGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRS 227
                 +L  L+   N+   +         +T L+ S N     +     + L  ++  +
Sbjct: 146 ---HNTQLTELDCHLNKKITKLD-VTPQTQLTTLDCSFNKIT-ELDVSQNKLLNRLNCDT 200

Query: 228 NQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEF 287
           N     I+++  N +     L ++D S N+L+ EI  + +    L +   + N  T  E 
Sbjct: 201 NN----ITKLDLNQNIQ---LTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLT--EL 248

Query: 288 PQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDM 347
             + TL  L  L+  +T L+ +I   +   + L            ++       L ++D 
Sbjct: 249 D-VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDC 304

Query: 348 SHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
               ++ E+    L + P++     +   LT
Sbjct: 305 QAAGIT-ELD---LSQNPKLVYLYLNNTELT 331

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  133 bits (337), Expect = 2e-33
 Identities = 65/354 (18%), Positives = 125/354 (35%), Gaps = 40/354 (11%)

Query: 25  SNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLS 84
                +T     NS ++  +    I KL+ L  L  + NNIT L  DL    +L  L   
Sbjct: 39  EQLATLTSLDCHNSSIT-DMTG--IEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACD 93

Query: 85  YNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGL 144
            N+++ +L   +     L   +   N  + ++   +S    L  L    N     I   +
Sbjct: 94  SNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--V 144

Query: 145 LNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNIS 204
            +   L  +D  +N+    L         +L +L+ + N+I   D   +  K +  LN  
Sbjct: 145 SHNTQLTELDCHLNKKITKLDVT---PQTQLTTLDCSFNKITELD--VSQNKLLNRLNCD 199

Query: 205 GNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFH 264
            N      +      L  +D  SN+    ++++        ++L Y D S N L+     
Sbjct: 200 TNNITKLDLN-QNIQLTFLDCSSNK----LTEIDVT---PLTQLTYFDCSVNPLTELDVS 251

Query: 265 NFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLD 324
             S    L  L          E   +     L +        I ++  ++   + L+ LD
Sbjct: 252 TLS---KLTTLHCIQTDLL--EID-LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLD 303

Query: 325 LSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
                +T ++       L  + +++  L+ E+  S   KL   +  +    ++ 
Sbjct: 304 CQAAGIT-ELDLSQNPKLVYLYLNNTELT-ELDVSHNTKL---KSLSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  130 bits (330), Expect = 2e-32
 Identities = 57/344 (16%), Positives = 110/344 (31%), Gaps = 39/344 (11%)

Query: 35  ASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPS 94
                 +   PD      +   +          +      L +L SL+   + I+  +  
Sbjct: 6   GQTQSFNDWFPDD---NFASEVAAAFEMQATDTI--SEEQLATLTSLDCHNSSIT-DMT- 58

Query: 95  NIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVD 154
            I     L     ++NN +  +   +S   +L  L  D N    ++   +     L  ++
Sbjct: 59  GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLN 112

Query: 155 LSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMG 214
              N+L   L        P L  LN A N +   D   +    +T L+   N     +  
Sbjct: 113 CDTNKLT-KLDVS---QNPLLTYLNCARNTLTEID--VSHNTQLTELDCHLNKKITKLDV 166

Query: 215 VFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKH 274
                L  +D   N+    I+++  +       L  ++   N ++ ++  + +Q   L  
Sbjct: 167 TPQTQLTTLDCSFNK----ITELDVS---QNKLLNRLNCDTNNIT-KL--DLNQNIQLTF 216

Query: 275 LSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQI 334
           L  + N+ T  E   +  L  L + + S   L  ++      LS L TL      L  +I
Sbjct: 217 LDCSSNKLT--EID-VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EI 269

Query: 335 PTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
                  L            E+    +    Q+   +     +T
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELD---VTHNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  117 bits (296), Expect = 3e-28
 Identities = 52/333 (15%), Positives = 112/333 (33%), Gaps = 36/333 (10%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS 108
           + +   L  L+ + N +T +  D+     L  L+   N+    L   +     L   D S
Sbjct: 123 VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCS 178

Query: 109 NNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGF 168
            N  + E+   +S    L  L  D N     +   L     L  +D S N+L   +    
Sbjct: 179 FNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVT- 230

Query: 169 GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSN 228
                +L   + + N +   D   + L  +T L+              L  +++      
Sbjct: 231 --PLTQLTYFDCSVNPLTELD--VSTLSKLTTLHCIQTD---------LLEIDLTHNTQL 277

Query: 229 QF--QGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQE 286
            +       +++     + ++L  +D     ++ E+  + SQ   L +L L     T  E
Sbjct: 278 IYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELT--E 332

Query: 287 FPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIID 346
              +     L+ L+      I D    + ++ +L+    +       +P  +  N  +  
Sbjct: 333 LD-VSHNTKLKSLSCVNAH-IQDFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTI 388

Query: 347 MSHNNLSGEIPASLLEKLPQMERFNFSYNNLTL 379
               +L  +    +  +      ++ + N +T 
Sbjct: 389 AVSPDLLDQFGNPMNIEPGDGGVYDQATNTITW 421

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 79.7 bits (197), Expect = 9e-16
 Identities = 48/225 (21%), Positives = 89/225 (39%), Gaps = 25/225 (11%)

Query: 158 NQLNGSLPDGFGAAFP--KLKSLNLAGNEIKGRDT-HFAGLKSITNLNISGNLFQGSVMG 214
           N L       F   FP     S   A  E++  DT     L ++T+L+   +     + G
Sbjct: 1   NTLKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG 59

Query: 215 V-FLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLK 273
           +  L  L  +   SN     I+ +  + + N   L Y+    N+L+     + +    L 
Sbjct: 60  IEKLTGLTKLICTSNN----ITTLDLSQNTN---LTYLACDSNKLTN---LDVTPLTKLT 109

Query: 274 HLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQ 333
           +L+   N+ T+ +         L +LN +R +L  +I   +   + L  LD  +N    +
Sbjct: 110 YLNCDTNKLTKLDV---SQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITK 163

Query: 334 IPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           +       L  +D S N ++ E+    + +   + R N   NN+T
Sbjct: 164 LDVTPQTQLTTLDCSFNKIT-ELD---VSQNKLLNRLNCDTNNIT 204

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  131 bits (330), Expect = 1e-32
 Identities = 68/357 (19%), Positives = 121/357 (33%), Gaps = 37/357 (10%)

Query: 55  LQSLDLSENNITALPS-DLWSLGSLKSLNLSYNRISGSLPSNI-GNFGLLEVFDLSNNNF 112
           +  +DLS N+I  L       L  L+ L +        + +N       L +  L  N F
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 113 SGEIPAAI-SSLVSLRVLKLDGNMFQ-WSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFG 169
             ++     + L +L VL L         +         SL  + L  N +    P  F 
Sbjct: 92  L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 170 AAFPKLKSLNLAGNEIK-----------GRDTHFAGLKSITNLNISGNLFQGSVMGVF-- 216
               +   L+L  N++K           G+      L SIT  +++         G    
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210

Query: 217 LESLEVIDLRSNQFQGHISQVQFNS---------SYNWSRLVYVDLSENQLSGEIFHNFS 267
             S+  +DL  N F+  +++  F++           + S  +                F 
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270

Query: 268 --QAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL-QLSSLHTLD 324
             +A  +K   L+ ++              LE L L++   I  I       L+ L  L+
Sbjct: 271 GLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNE-INKIDDNAFWGLTHLLKLN 329

Query: 325 LSMNHLTGQIPT---VSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           LS N L   I +    +   L ++D+S+N++   +       LP ++      N L 
Sbjct: 330 LSQNFLGS-IDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK 384

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  128 bits (323), Expect = 1e-31
 Identities = 64/354 (18%), Positives = 128/354 (36%), Gaps = 39/354 (11%)

Query: 57  SLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEI 116
           +       +  +P        +  ++LS N I+    ++      L+   +        I
Sbjct: 14  NAICINRGLHQVPE---LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVI 70

Query: 117 PA-AISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGS-LPDGFGAAFP 173
                  L SL +LKLD N F   +  G      +L  + L+   L+G+ L   F     
Sbjct: 71  RNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT 129

Query: 174 KLKSLNLAGNEIK--GRDTHFAGLKSITNLNISGNLFQGSVMGVFL----ESLEVIDLRS 227
            L+ L L  N IK     + F  ++    L+++ N  +       L    +   ++ L S
Sbjct: 130 SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189

Query: 228 NQFQ----GHISQVQFNSSYNWSRLVYVDLSENQLSG---EIFHNFSQAQNLKHLSLAYN 280
              Q      +   +  + +  + +  +DLS N       + F +      ++ L L+ +
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249

Query: 281 RFTRQEFPQIG------------TLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSM 327
                 F                   G++  +LS++  I  +   +    + L  L L+ 
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSK-IFALLKSVFSHFTDLEQLTLAQ 308

Query: 328 NHLTGQIPT---VSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           N +  +I         +L  +++S N L   I + + E L ++E  + SYN++ 
Sbjct: 309 NEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  126 bits (317), Expect = 7e-31
 Identities = 79/372 (21%), Positives = 145/372 (38%), Gaps = 45/372 (12%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNI-TALPSDL-WSLGSLKSLNLSYNRISGSLPSNI-GNF 99
            + +T+  +L  LQ L + +      + ++    L SL  L L YN+    L +      
Sbjct: 44  ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGL 102

Query: 100 GLLEVFDLSNNNF-SGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPGLL--NCQSLVTVDL 155
             LEV  L+  N     +       L SL +L L  N  +  I P     N +    +DL
Sbjct: 103 ANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDL 161

Query: 156 SMNQLNGSLPDGF-GAAFPKLKSLNLAGNEIK---------GRDTHFAGLKSITNLNISG 205
           + N++     +            L L+   ++          +  +     SIT L++SG
Sbjct: 162 TFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSG 221

Query: 206 NLFQGSVMGVFLESLEVIDLRS---NQFQGHISQVQFNS----------SYNWSRLVYVD 252
           N F+ S+   F +++    ++S   +      S     +              S +   D
Sbjct: 222 NGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCD 281

Query: 253 LSENQLS---GEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGD 309
           LS++++      +F +F+   +L+ L+LA N   + +      L  L  LNLS+   +G 
Sbjct: 282 LSKSKIFALLKSVFSHFT---DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN-FLGS 337

Query: 310 IPSEILQ-LSSLHTLDLSMNHLTGQIPT---VSAKNLGIIDMSHNNLSGEIPASLLEKLP 365
           I S + + L  L  LDLS NH+   +     +   NL  + +  N L   +P  + ++L 
Sbjct: 338 IDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLT 395

Query: 366 QMERFNFSYNNL 377
            +++     N  
Sbjct: 396 SLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  105 bits (263), Expect = 5e-24
 Identities = 64/329 (19%), Positives = 119/329 (36%), Gaps = 39/329 (11%)

Query: 33  FLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD--LWSLGSLKSLNLSYNRISG 90
            L   +     +       L+ L+ L L +NNI  +       ++     L+L++N++  
Sbjct: 109 TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168

Query: 91  SLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSL 150
               ++ NF       L               L S+ +  ++     W          S+
Sbjct: 169 ICEEDLLNFQGKHFTLL--------------RLSSITLQDMNEYWLGWEKCGNPFKNTSI 214

Query: 151 VTVDLSMNQLNGSLPDGF--GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLF 208
            T+DLS N    S+   F    A  K++SL L+ +   G        K   N        
Sbjct: 215 TTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDN-------- 266

Query: 209 QGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN-FS 267
             +  G+    ++  DL  ++    I  +  +   +++ L  + L++N+++ +I  N F 
Sbjct: 267 -FTFKGLEASGVKTCDLSKSK----IFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFW 320

Query: 268 QAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLS 326
              +L  L+L+ N     +      L  LE L+LS    I  +  +    L +L  L L 
Sbjct: 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH-IRALGDQSFLGLPNLKELALD 379

Query: 327 MNHLTGQIPT---VSAKNLGIIDMSHNNL 352
            N L   +P        +L  I +  N  
Sbjct: 380 TNQLKS-VPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 84.4 bits (209), Expect = 3e-17
 Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 30/214 (14%)

Query: 42  GSVPDTTIGKLSKLQSLDLSENNITALPS----DLWSLGSLKSLNLSYNRISGSL----- 92
           G        K + + +LDLS N      +    D  +   ++SL LS +   GS      
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260

Query: 93  ---PSNIGNFGL----LEVFDLSNNNFSGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPGL 144
              P N    GL    ++  DLS +     +  ++ S    L  L L  N     I    
Sbjct: 261 FKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNA 318

Query: 145 L-NCQSLVTVDLSMNQLNGSLPDGFGAAF---PKLKSLNLAGNEIKG-RDTHFAGLKSIT 199
                 L+ ++LS N L GS+       F    KL+ L+L+ N I+   D  F GL ++ 
Sbjct: 319 FWGLTHLLKLNLSQNFL-GSIDSR---MFENLDKLEVLDLSYNHIRALGDQSFLGLPNLK 374

Query: 200 NLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQ 231
            L +  N  +    G+F  L SL+ I L +N + 
Sbjct: 375 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 43/179 (24%), Positives = 71/179 (39%), Gaps = 11/179 (6%)

Query: 38  SGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW---SLGSLKSLNLSYNRISGSLPS 94
             ++G+   + I   S          N     +  +       +K+ +LS ++I  +L  
Sbjct: 234 DAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLK 292

Query: 95  NI-GNFGLLEVFDLSNNNFSGEIPA-AISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLV 151
           ++  +F  LE   L+ N  + +I   A   L  L  L L  N    SI   +  N   L 
Sbjct: 293 SVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLE 350

Query: 152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQ 209
            +DLS N +  +L D      P LK L L  N++K   D  F  L S+  + +  N + 
Sbjct: 351 VLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  129 bits (327), Expect = 6e-32
 Identities = 67/372 (18%), Positives = 128/372 (34%), Gaps = 30/372 (8%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSN--IGNFG 100
            +  +      +L+ LDLS N +  +        +LK L+LS+N    +LP     GN  
Sbjct: 59  YLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMS 115

Query: 101 LLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQL 160
            L+   LS  +        I+ L   +VL + G  +     P  L  Q   T  L +   
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGL--QDFNTESLHIVFP 173

Query: 161 NG----SLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKS------------ITNLNIS 204
                  + D        L+  N+       + ++F  + +            + N+  +
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233

Query: 205 GNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNW-SRLVYVDLSENQLSGEIF 263
            N F   +  V+  ++    + + + QG +    F+ S      L    +  +       
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQS 293

Query: 264 HNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTL 323
           + +    N+   +   +            +    HL+ S   L   +      L+ L TL
Sbjct: 294 YIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353

Query: 324 DLSMNHLTGQIPTVSA-----KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
            L MN L  ++  ++      K+L  +D+S N++S +           +   N S N LT
Sbjct: 354 ILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412

Query: 379 LCASELSPETLQ 390
                  P  ++
Sbjct: 413 DTIFRCLPPRIK 424

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  120 bits (303), Expect = 9e-29
 Identities = 72/375 (19%), Positives = 130/375 (34%), Gaps = 50/375 (13%)

Query: 50  GKLSKLQSLDLSENNITALP--SDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDL 107
                L+ LDLS N   ALP   +  ++  LK L LS   +  S    I +  + +V  +
Sbjct: 87  HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146

Query: 108 SNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDG 167
               +  +       L       L            +L+       +L ++ +   L D 
Sbjct: 147 LGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204

Query: 168 FGAAF----------PKLKSLNLAGNEIKGRDT----HFAGLKSITNLNISGNLFQGSVM 213
             + F          PKL +L L   E                ++   +IS    QG + 
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD 264

Query: 214 GVF-------LESLEVIDLRSNQFQG-----------------HISQVQFNSSYNWSRLV 249
                     L++L +  + S+ F                    +S  +       S++ 
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324

Query: 250 ---YVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTR--QEFPQIGTLLGLEHLNLSRT 304
              ++D S N L+  +F N      L+ L L  N+     +       +  L+ L++S+ 
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQN 384

Query: 305 SLIGDIPSEIL-QLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEK 363
           S+  D          SL +L++S N LT  I       + ++D+  N +   IP  ++ K
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVV-K 442

Query: 364 LPQMERFNFSYNNLT 378
           L  ++  N + N L 
Sbjct: 443 LEALQELNVASNQLK 457

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  110 bits (276), Expect = 2e-25
 Identities = 63/347 (18%), Positives = 113/347 (32%), Gaps = 38/347 (10%)

Query: 57  SLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEI 116
            +D S+N +  +P DL        LN+S N IS    S+I +   L +  +S+N      
Sbjct: 4   LVDRSKNGLIHVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 117 PAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLK 176
            +       L  L L  N     I        +L  +DLS N  + +LP      F  + 
Sbjct: 62  ISVFKFNQELEYLDLSHNKLV-KISCHPT--VNLKHLDLSFNAFD-ALPI--CKEFGNMS 115

Query: 177 SL---NLAGNEIKGRD-THFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQG 232
            L    L+   ++       A L     L + G  +        L+      L       
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF--- 172

Query: 233 HISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQA-----------QNLKHLSLAYNR 281
             +  +F+   + S     +L  + +   +  N                 L +L+L    
Sbjct: 173 -PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE 231

Query: 282 FTRQEFPQIGTLLG---LEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVS 338
            T   F +I  L+    + + ++S   L G +       S      LS++ +   +    
Sbjct: 232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP 291

Query: 339 A-------KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
                    N+ I + + +     +      K+      +FS N LT
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLLT 337

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 95.3 bits (237), Expect = 1e-20
 Identities = 42/173 (24%), Positives = 69/173 (39%), Gaps = 11/173 (6%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
            V      K+S    LD S N +T    +    L  L++L L  N++   L         
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQ 372

Query: 102 ---LEVFDLSNNNFSGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSM 157
              L+  D+S N+ S +      S   SL  L +  N+   +I   L     +  +DL  
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHS 430

Query: 158 NQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQ 209
           N++  S+P         L+ LN+A N++K   D  F  L S+  + +  N + 
Sbjct: 431 NKIK-SIPKQV-VKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 89.2 bits (221), Expect = 1e-18
 Identities = 42/256 (16%), Positives = 83/256 (32%), Gaps = 39/256 (15%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRISGSL 92
           +     L     D +   L  L    +  +      S ++    ++   N + +      
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316

Query: 93  PSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPG---LLNCQS 149
                        D SNN  +  +      L  L  L L  N  +  +          +S
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKS 375

Query: 150 LVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQ 209
           L  +D+S N ++     G                         +  KS+ +LN+S N+  
Sbjct: 376 LQQLDISQNSVSYDEKKGD-----------------------CSWTKSLLSLNMSSNILT 412

Query: 210 GSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS---GEIFHNF 266
            ++       ++V+DL SN+ +  I +           L  ++++ NQL      IF   
Sbjct: 413 DTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKL----EALQELNVASNQLKSVPDGIFDRL 467

Query: 267 SQAQNLKHLSLAYNRF 282
           +   +L+ + L  N +
Sbjct: 468 T---SLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 86.8 bits (215), Expect = 7e-18
 Identities = 40/259 (15%), Positives = 90/259 (34%), Gaps = 20/259 (7%)

Query: 55  LQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGL-----LEVFDLSN 109
           L +++ + N+   +   +W   ++   ++S  ++ G L     ++       L +  + +
Sbjct: 227 LNNIETTWNSFIRILQLVWHT-TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285

Query: 110 NNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFG 169
           + F            ++ +     +  +             + +D S N L         
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL-TDTVFENC 344

Query: 170 AAFPKLKSLNLAGNEIK---GRDTHFAGLKSITNLNISGNLFQGSVM-GVF--LESLEVI 223
               +L++L L  N++K           +KS+  L+IS N        G     +SL  +
Sbjct: 345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404

Query: 224 DLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFT 283
           ++ SN                  R+  +DL  N++   I     + + L+ L++A N+  
Sbjct: 405 NMSSNILT------DTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457

Query: 284 RQEFPQIGTLLGLEHLNLS 302
                    L  L+ + L 
Sbjct: 458 SVPDGIFDRLTSLQKIWLH 476

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 22/92 (23%), Positives = 44/92 (47%), Gaps = 6/92 (6%)

Query: 22  VCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSL 81
            C   K  ++  ++SN  L+ ++         +++ LDL  N I ++P  +  L +L+ L
Sbjct: 394 DCSWTKSLLSLNMSSNI-LTDTIFRCL---PPRIKVLDLHSNKIKSIPKQVVKLEALQEL 449

Query: 82  NLSYNRISGSLPSNI-GNFGLLEVFDLSNNNF 112
           N++ N++  S+P  I      L+   L  N +
Sbjct: 450 NVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  121 bits (305), Expect = 1e-30
 Identities = 63/247 (25%), Positives = 94/247 (38%), Gaps = 26/247 (10%)

Query: 22  VCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKS 80
           VC +  +  T       GL  +VP    G  +  Q + L  N I+ +P+    +  +L  
Sbjct: 7   VCYNEPKVTTS--CPQQGLQ-AVPV---GIPAASQRIFLHGNRISHVPAASFRACRNLTI 60

Query: 81  LNLSYNRISGSLPSNI-GNFGLLEVFDLSNNNFSGEIPA-AISSLVSLRVLKLDGNMFQW 138
           L L  N ++  + +       LLE  DLS+N     +       L  L  L LD    Q 
Sbjct: 61  LWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ- 118

Query: 139 SIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAF---PKLKSLNLAGNEIKG-RDTHFA 193
            + PGL     +L  + L  N L  +LPD     F     L  L L GN I    +  F 
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQ-ALPDD---TFRDLGNLTHLFLHGNRISSVPERAFR 174

Query: 194 GLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYV 251
           GL S+  L +  N         F  L  L  + L +N     +S +   +      L Y+
Sbjct: 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN----LSALPTEALAPLRALQYL 230

Query: 252 DLSENQL 258
            L++N  
Sbjct: 231 RLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  113 bits (284), Expect = 8e-28
 Identities = 55/232 (23%), Positives = 90/232 (38%), Gaps = 19/232 (8%)

Query: 57  SLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNI-GNFGLLEVFDLSNNNFSGE 115
           +    +  + A+P  +    + + + L  NRIS  +P+        L +  L +N  +  
Sbjct: 15  TTSCPQQGLQAVPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARI 71

Query: 116 IPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAFPK 174
             AA + L  L  L L  N    S+ P        L T+ L    L   L  G       
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAA 130

Query: 175 LKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQ 231
           L+ L L  N ++   D  F  L ++T+L + GN         F  L SL+ + L  N+  
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR-- 188

Query: 232 GHISQVQFNSSYNWSRLVYVDLSENQLS---GEIFHNFSQAQNLKHLSLAYN 280
             ++ V  ++  +  RL+ + L  N LS    E          L++L L  N
Sbjct: 189 --VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR---ALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  107 bits (269), Expect = 6e-26
 Identities = 44/199 (22%), Positives = 71/199 (35%), Gaps = 16/199 (8%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNI-GNFG 100
            VP  +      L  L L  N +  + +     L  L+ L+LS N    S+        G
Sbjct: 46  HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG 105

Query: 101 LLEVFDLSNNNFSGEIPA-AISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMN 158
            L    L       E+       L +L+ L L  N  Q ++P     +  +L  + L  N
Sbjct: 106 RLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGN 163

Query: 159 QLNGSLPDGFGAAF---PKLKSLNLAGNEIKGRDTH-FAGLKSITNLNISGNLFQGSVMG 214
           +++ S+P+    AF     L  L L  N +     H F  L  +  L +  N        
Sbjct: 164 RIS-SVPER---AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219

Query: 215 VF--LESLEVIDLRSNQFQ 231
               L +L+ + L  N + 
Sbjct: 220 ALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 51/236 (21%), Positives = 80/236 (33%), Gaps = 23/236 (9%)

Query: 152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQG 210
           T       L  ++P G        + + L GN I       F   +++T L +  N+   
Sbjct: 15  TTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70

Query: 211 SVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS---GEIFHN 265
                F  L  LE +DL  N     +  V   + +   RL  + L    L      +F  
Sbjct: 71  IDAAAFTGLALLEQLDLSDN---AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127

Query: 266 FSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLD 324
            +    L++L L  N            L  L HL L   + I  +P    + L SL  L 
Sbjct: 128 LA---ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG-NRISSVPERAFRGLHSLDRLL 183

Query: 325 LSMNHLTGQIPT---VSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNL 377
           L  N +   +          L  + +  NNLS  +P   L  L  ++    + N  
Sbjct: 184 LHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 15/88 (17%), Positives = 29/88 (32%), Gaps = 6/88 (6%)

Query: 295 GLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNHLTGQIPT---VSAKNLGIIDMSHN 350
             + + L     I  +P+   +   +L  L L  N L  +I          L  +D+S N
Sbjct: 33  ASQRIFLHGNR-ISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90

Query: 351 NLSGEIPASLLEKLPQMERFNFSYNNLT 378
                +  +    L ++   +     L 
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQ 118

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  121 bits (306), Expect = 1e-30
 Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 17/227 (7%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITAL---PSDLWSLGSLKSLNLSYNRISGSLPSNIGNF 99
           S+P     KL++L  L LS N ++         +   SLK L+LS+N +  ++ SN    
Sbjct: 42  SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL 100

Query: 100 GLLEVFDLSNNNFSGEIPA--AISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLS 156
             LE  D  ++N   ++       SL +L  L +     +     G+     SL  + ++
Sbjct: 101 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMA 158

Query: 157 MNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGV 215
            N    +           L  L+L+  +++    T F  L S+  LN+S N F       
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 218

Query: 216 F--LESLEVIDLRSNQFQGHISQVQFNSSYN-WSRLVYVDLSENQLS 259
           +  L SL+V+D   N     I   +     +  S L +++L++N  +
Sbjct: 219 YKCLNSLQVLDYSLNH----IMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  120 bits (303), Expect = 3e-30
 Identities = 50/205 (24%), Positives = 84/205 (40%), Gaps = 9/205 (4%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLP 93
           L+SN          +    + L+ LDLS N +  + S+   L  L+ L+  ++ +     
Sbjct: 59  LSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSE 118

Query: 94  SNI-GNFGLLEVFDLSNNNFSGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPGLL-NCQSL 150
            ++  +   L   D+S+ +        I + L SL VLK+ GN FQ +  P +    ++L
Sbjct: 119 FSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177

Query: 151 VTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQ 209
             +DLS  QL   L      +   L+ LN++ N         +  L S+  L+ S N   
Sbjct: 178 TFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236

Query: 210 GSVMGVF---LESLEVIDLRSNQFQ 231
            S          SL  ++L  N F 
Sbjct: 237 TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  102 bits (257), Expect = 4e-24
 Identities = 59/279 (21%), Positives = 100/279 (35%), Gaps = 61/279 (21%)

Query: 106 DLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLN-GS 163
             ++   +  +P  I S  S   L+L+ N  Q S+P G+      L  + LS N L+   
Sbjct: 13  RCNSKGLT-SVPTGIPS--SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKG 68

Query: 164 LPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVI 223
                      LK L+L+ N +    ++F GL                      E LE +
Sbjct: 69  CCSQSDFGTTSLKYLDLSFNGVITMSSNFLGL----------------------EQLEHL 106

Query: 224 DLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFT 283
           D + +  +       F S  N   L+Y+D+S                           F 
Sbjct: 107 DFQHSNLKQMSEFSVFLSLRN---LIYLDISHTHTR----------------VAFNGIFN 147

Query: 284 RQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNHLTGQIPTVSAKNL 342
                    L  LE L ++  S   +   +I   L +L  LDLS   L  Q+   +  +L
Sbjct: 148 G--------LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSL 198

Query: 343 G---IIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
               +++MSHNN    +     + L  ++  ++S N++ 
Sbjct: 199 SSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM 236

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (295), Expect = 1e-28
 Identities = 39/313 (12%), Positives = 75/313 (23%), Gaps = 40/313 (12%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIKHP 564
                  L  G    V+    +      A+KV   G+  +  E            R+   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWE---------E 615
           +                +    +   +Q+      L     +    +            E
Sbjct: 123 SPEEARDRR-------RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175

Query: 616 DGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNL 674
              +++  V            H +     R  A L   G    ++H      ++++  + 
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDG 231

Query: 675 EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
              L D       G             Y P EF    +   T   + +  G+ +  +   
Sbjct: 232 RLMLGDVSALWKVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289

Query: 735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK--IGYLCTA 792
             P G   P  K                  R         G    + + +K  IG     
Sbjct: 290 FLPFGLVTPGIKG----------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF 339

Query: 793 DLPLKRPSMQQIV 805
           D   +R    + +
Sbjct: 340 D-RRRRLLPLEAM 351

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  115 bits (290), Expect = 2e-27
 Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 16/223 (7%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNI-GNFG 100
            +   +   L  L+ L LS N+I  +       L +L +L L  NR++ ++P+       
Sbjct: 78  IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLS 136

Query: 101 LLEVFDLSNNNFSGEIPA-AISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMN 158
            L+   L NN     IP+ A + + SLR L L        I  G      +L  ++L+M 
Sbjct: 137 KLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC 195

Query: 159 QLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF- 216
            L   +P+       KL  L+L+GN +   R   F GL  +  L +  +  Q      F 
Sbjct: 196 NLR-EIPNLTP--LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFD 252

Query: 217 -LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQL 258
            L+SL  I+L  N     ++ +  +       L  + L  N  
Sbjct: 253 NLQSLVEINLAHNN----LTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  109 bits (275), Expect = 1e-25
 Identities = 64/345 (18%), Positives = 115/345 (33%), Gaps = 66/345 (19%)

Query: 76  GSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNM 135
                +      +   +P  I       + +L  N        +   L  L +L+L  N 
Sbjct: 43  NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 136 FQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAG 194
            + +I  G      +L T++L  N+L  ++P+G      KLK L L  N I+        
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-------- 149

Query: 195 LKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLS 254
                  +I    F        + SL  +DL        +S +   +    S L Y++L+
Sbjct: 150 -------SIPSYAFNR------IPSLRRLDLGEL---KRLSYISEGAFEGLSNLRYLNLA 193

Query: 255 ENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEI 314
              L      N +    L  L L+ N  +                          I    
Sbjct: 194 MCNLRE--IPNLTPLIKLDELDLSGNHLSA-------------------------IRPGS 226

Query: 315 LQ-LSSLHTLDLSMNHLTGQIPT---VSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERF 370
            Q L  L  L +  + +   I      + ++L  I+++HNNL+  +P  L   L  +ER 
Sbjct: 227 FQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERI 284

Query: 371 NFSYNNLTLCASELSP--ETLQTAFFGSSNDCPIAANPSFFKRKA 413
           +  +N    C  ++      ++     ++  C     P   K + 
Sbjct: 285 HLHHNPW-NCNCDILWLSWWIKDMAPSNTACCARCNTPPNLKGRY 328

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  107 bits (269), Expect = 7e-25
 Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 10/195 (5%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNI-GNFG 100
           ++       L+ L +L+L +N +T +P+     L  LK L L  N I  S+PS       
Sbjct: 102 TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIP 160

Query: 101 LLEVFDLSNNNFSGEIPA-AISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQ 159
            L   DL        I   A   L +LR L L     +  IP  L     L  +DLS N 
Sbjct: 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNH 218

Query: 160 LNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH-FAGLKSITNLNISGNLFQGSVMGVF-- 216
           L+ ++  G       L+ L +  ++I+  + + F  L+S+  +N++ N        +F  
Sbjct: 219 LS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277

Query: 217 LESLEVIDLRSNQFQ 231
           L  LE I L  N + 
Sbjct: 278 LHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 96.4 bits (240), Expect = 4e-21
 Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 20/240 (8%)

Query: 147 CQS-LVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNIS 204
           C +    V      L   +PDG        + LNL  N+I+  +   F  L+ +  L +S
Sbjct: 41  CSNQFSKVICVRKNLR-EVPDGI---STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLS 96

Query: 205 GNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEI 262
            N  +   +G F  L +L  ++L  N+    ++ +   +    S+L  + L  N +    
Sbjct: 97  RNHIRTIEIGAFNGLANLNTLELFDNR----LTTIPNGAFVYLSKLKELWLRNNPIESIP 152

Query: 263 FHNFSQAQNLKHLSLA-YNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLH 321
            + F++  +L+ L L    R +         L  L +LNL+  +L  +IP+ +  L  L 
Sbjct: 153 SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLD 210

Query: 322 TLDLSMNHLTGQIPT---VSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
            LDLS NHL+  I         +L  + M  + +   I  +  + L  +   N ++NNLT
Sbjct: 211 ELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  115 bits (289), Expect = 2e-27
 Identities = 57/281 (20%), Positives = 103/281 (36%), Gaps = 39/281 (13%)

Query: 53  SKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNF 112
           ++   +  +   ++ +P  +    + + LNL  N I         +   LEV  L  N+ 
Sbjct: 54  NQFSKVVCTRRGLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 113 SGEIPA-AISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGA 170
             +I   A + L SL  L+L  N     IP G       L  + L  N +  S+P     
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168

Query: 171 AFPKLKSLNLAG-NEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSN 228
             P L  L+L    +++   +  F GL ++  LN+     +       L  LE +++  N
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGN 228

Query: 229 QFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFP 288
                  +++  S +  S L  + +  +Q+S    + F    +L  L+LA+N  +     
Sbjct: 229 H----FPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS---- 280

Query: 289 QIGTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMN 328
                                +P ++   L  L  L L  N
Sbjct: 281 ---------------------LPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  114 bits (287), Expect = 4e-27
 Identities = 52/223 (23%), Positives = 81/223 (36%), Gaps = 16/223 (7%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNI-GNFG 100
            +   T   L  L+ L L  N+I  +       L SL +L L  N ++  +PS       
Sbjct: 89  MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLS 147

Query: 101 LLEVFDLSNNNFSGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMN 158
            L    L NN     IP+   + + SL  L L        I  G      +L  ++L M 
Sbjct: 148 KLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC 206

Query: 159 QLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF- 216
            +   +P+        L+ L ++GN     R   F GL S+  L +  +         F 
Sbjct: 207 NIK-DMPNLTP--LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFD 263

Query: 217 -LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQL 258
            L SL  ++L  N     +S +  +       LV + L  N  
Sbjct: 264 GLASLVELNLAHNN----LSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  105 bits (265), Expect = 2e-24
 Identities = 47/195 (24%), Positives = 76/195 (38%), Gaps = 10/195 (5%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNI-GNFG 100
            +       L+ L +L+L +N +T +PS     L  L+ L L  N I  S+PS       
Sbjct: 113 QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVP 171

Query: 101 LLEVFDLSNNNFSGEIPA-AISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQ 159
            L   DL        I   A   L +L+ L L     +  +P  L     L  +++S N 
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNH 229

Query: 160 LNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH-FAGLKSITNLNISGNLFQGSVMGVF-- 216
               +  G       LK L +  +++   + + F GL S+  LN++ N        +F  
Sbjct: 230 FP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288

Query: 217 LESLEVIDLRSNQFQ 231
           L  L  + L  N + 
Sbjct: 289 LRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 98.7 bits (246), Expect = 7e-22
 Identities = 53/246 (21%), Positives = 97/246 (39%), Gaps = 32/246 (13%)

Query: 147 CQS-LVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNIS 204
           C +    V  +   L+  +P G        + LNL  N I+  +   F  L  +  L + 
Sbjct: 52  CSNQFSKVVCTRRGLS-EVPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107

Query: 205 GNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS--- 259
            N  +   +G F  L SL  ++L  N     ++ +   +    S+L  + L  N +    
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNW----LTVIPSGAFEYLSKLRELWLRNNPIESIP 163

Query: 260 GEIFHNFSQAQNLKHLSLA-YNRFTRQEFPQIGTLLG---LEHLNLSRTSLIGDIPSEIL 315
              F+      +L  L L    +         G   G   L++LNL   ++  D+P+ + 
Sbjct: 164 SYAFNRVP---SLMRLDLGELKKLEY---ISEGAFEGLFNLKYLNLGMCNIK-DMPN-LT 215

Query: 316 QLSSLHTLDLSMNHLTGQIPTVSAKNLG---IIDMSHNNLSGEIPASLLEKLPQMERFNF 372
            L  L  L++S NH   +I   S   L     + + ++ +S  I  +  + L  +   N 
Sbjct: 216 PLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNL 273

Query: 373 SYNNLT 378
           ++NNL+
Sbjct: 274 AHNNLS 279

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  112 bits (281), Expect = 6e-27
 Identities = 54/295 (18%), Positives = 99/295 (33%), Gaps = 52/295 (17%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDL-WSLGSLKSLNLSYNRISGSLPSNI-GNFG 100
            + ++ + +   LQ+L L+ N I  +  D   SLGSL+ L+LSYN +S +L S+      
Sbjct: 66  YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLS 124

Query: 101 LLEVFDLSNNNFSGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMN 158
            L   +L  N +      ++ S L  L++L++        I          L  +++  +
Sbjct: 125 SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184

Query: 159 QLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVFL 217
            L  S       +   +  L L   +     +       S+  L +              
Sbjct: 185 DLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT----------- 232

Query: 218 ESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSL 277
                 DL +  F   +S  + NS         V +++  L  ++    +Q   L  L  
Sbjct: 233 ------DLDTFHFS-ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF 284

Query: 278 AYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNHLT 331
           + N+                            +P  I   L+SL  + L  N   
Sbjct: 285 SRNQLKS-------------------------VPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  110 bits (276), Expect = 3e-26
 Identities = 63/318 (19%), Positives = 112/318 (35%), Gaps = 51/318 (16%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNN 111
             +      S  ++ ++PS L    ++KSL+LS NRI+  +                   
Sbjct: 30  CDRNGICKGSSGSLNSIPSGL--TEAVKSLDLSNNRIT-YIS------------------ 68

Query: 112 FSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNC-QSLVTVDLSMNQLNGSLPDGFGA 170
                 + +   V+L+ L L  N    +I     +   SL  +DLS N L  +L   +  
Sbjct: 69  -----NSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFK 121

Query: 171 AFPKLKSLNLAGNEIK--GRDTHFAGLKSITNLNISGNLFQGSV-MGVF--LESLEVIDL 225
               L  LNL GN  K  G  + F+ L  +  L +        +    F  L  LE +++
Sbjct: 122 PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEI 181

Query: 226 RSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQ 285
            ++  Q         S  N   + ++ L   Q    +        +++ L L        
Sbjct: 182 DASDLQ-SYEPKSLKSIQN---VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF 237

Query: 286 EFPQIGT--------LLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV 337
            F ++ T             ++ ++  SL   +   + Q+S L  L+ S N L   +P  
Sbjct: 238 HFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDG 295

Query: 338 ---SAKNLGIIDMSHNNL 352
                 +L  I +  N  
Sbjct: 296 IFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 85.2 bits (211), Expect = 6e-18
 Identities = 49/253 (19%), Positives = 86/253 (33%), Gaps = 46/253 (18%)

Query: 136 FQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGL 195
            + S     L+C        S   LN S+P G       +KSL+L+ N I          
Sbjct: 19  KEESSNQASLSCDRNGICKGSSGSLN-SIPSGL---TEAVKSLDLSNNRIT--------- 65

Query: 196 KSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSE 255
                  IS +  Q         +L+ + L SN     I+ ++ +S  +   L ++DLS 
Sbjct: 66  ------YISNSDLQR------CVNLQALVLTSNG----INTIEEDSFSSLGSLEHLDLSY 109

Query: 256 NQLSG---EIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGT---LLGLEHLNLSRTSLIGD 309
           N LS      F   S   +L  L+L  N +      +      L  L+ L +        
Sbjct: 110 NYLSNLSSSWFKPLS---SLTFLNLLGNPYK--TLGETSLFSHLTKLQILRVGNMDTFTK 164

Query: 310 IPSEILQ-LSSLHTLDLSMNHLTGQIPT---VSAKNLGIIDMSHNNLSGEIPASLLEKLP 365
           I  +    L+ L  L++  + L          S +N+  + +        +    ++   
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTS 222

Query: 366 QMERFNFSYNNLT 378
            +E       +L 
Sbjct: 223 SVECLELRDTDLD 235

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  110 bits (277), Expect = 1e-26
 Identities = 67/324 (20%), Positives = 113/324 (34%), Gaps = 66/324 (20%)

Query: 509 NFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
           ++     L EG F  V     L  G   A+K ++       +EA RE +      HPN++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 568 PLTGYCI-AGDQRIAIY---DYMENGNLQNLL-HDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
            L  YC+     +   +    + + G L N +      G   TED               
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED--------------- 134

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
                           + LG  R L  +H   +    HRD+K +++ L    +P L D G
Sbjct: 135 --------QIL----WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLG 179

Query: 683 LAKIF---------GNGLDEEIAR-GSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLEL 731
                            L +  A+  +  Y  PE     S      ++DV+  G VL  +
Sbjct: 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239

Query: 732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK--IGYL 789
           + G+ P   D   +K  ++      L   N+ S    P         +   AL   +  +
Sbjct: 240 MFGEGPY--DMVFQKGDSVA-----LAVQNQLSIPQSP---------RHSSALWQLLNSM 283

Query: 790 CTADLPLKRPSMQQIVGLLKDIES 813
            T D P +RP +  ++  L+ ++ 
Sbjct: 284 MTVD-PHQRPHIPLLLSQLEALQP 306

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  109 bits (275), Expect = 3e-26
 Identities = 74/312 (23%), Positives = 126/312 (40%), Gaps = 56/312 (17%)

Query: 513 GTLLAEGKFGPVYRGFLPGG---IHVAVKVLVHGSTLTDQEA-ARELEYLGRI-KHPNLV 567
             ++ EG FG V +  +      +  A+K +   ++  D    A ELE L ++  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L G C          +Y  +GNL + L       + +    TD       ++   + S+
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFL-------RKSRVLETDPAFAIANSTASTLSSQ 142

Query: 628 GLLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
            LL         A   AR + +L         IHRD+ A ++ +  N   +++DFGL++ 
Sbjct: 143 QLL-------HFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR- 190

Query: 687 FGNGLDEEIAR-GSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLG 739
                 +E+    + G +P      E +   S + T  SDV+ YGV+L E+++ G  P  
Sbjct: 191 -----GQEVYVKKTMGRLPVRWMAIE-SLNYSVY-TTNSDVWSYGVLLWEIVSLGGTP-- 241

Query: 740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP 799
             Y       L   +       +G R    K     P    +E   +   C  + P +RP
Sbjct: 242 --YCGMTCAELYEKLP------QGYRL--EK-----PLNCDDEVYDLMRQCWREKPYERP 286

Query: 800 SMQQIVGLLKDI 811
           S  QI+  L  +
Sbjct: 287 SFAQILVSLNRM 298

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  113 bits (283), Expect = 3e-26
 Identities = 52/340 (15%), Positives = 107/340 (31%), Gaps = 64/340 (18%)

Query: 51  KLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNN 110
            +++   L L+  N+++LP +L     +  L ++ N +  SLP    +   LE  D  +N
Sbjct: 57  LINQFSELQLNRLNLSSLPDNLPP--QITVLEITQNALI-SLPELPAS---LEYLDACDN 110

Query: 111 NFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGA 170
             S  +P   +   SL+ L +D N     +P      + +   +   NQL   LP+    
Sbjct: 111 RLS-TLPELPA---SLKHLDVDNNQLT-MLPELPALLEYI---NADNNQLT-MLPELPT- 160

Query: 171 AFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQF 230
               L+ L++  N+          L  +  L                ESLE +D+ +N  
Sbjct: 161 ---SLEVLSVRNNQ----------LTFLPEL---------------PESLEALDVSTNLL 192

Query: 231 QGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQI 290
           +  +  V   + ++    ++    EN+++  I  N         + L  N  + +    +
Sbjct: 193 E-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250

Query: 291 GTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHN 350
                    +  R      +             D           +  ++          
Sbjct: 251 SQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIW-------- 300

Query: 351 NLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQ 390
                      E       F+   + L+   S  +    +
Sbjct: 301 --------HAFEHEEHANTFSAFLDRLSDTVSARNTSGFR 332

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  102 bits (255), Expect = 1e-22
 Identities = 56/306 (18%), Positives = 101/306 (33%), Gaps = 51/306 (16%)

Query: 57  SLDLSENNITALPSDLWSLGSLKSLNLSYNRISG---SLPSNIGNFGLLEVFDLSNNNFS 113
           S+ L  NN  +L           S N  YN ISG      S    +    +   + N   
Sbjct: 2   SIMLPINNNFSL-----------SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAV 50

Query: 114 GEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFP 173
             +   +  +     L+L+      S+P  L     +  ++++ N L  SLP+       
Sbjct: 51  SLLKECL--INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNAL-ISLPELPA---- 100

Query: 174 KLKSLNLAGNEIKGRDTHF-AGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQG 232
            L+ L+   N +    +       S+ +L++  N    +++      LE I+  +NQ   
Sbjct: 101 SLEYLDACDNRL----STLPELPASLKHLDVDNNQL--TMLPELPALLEYINADNNQLT- 153

Query: 233 HISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQ-IG 291
                        + L  + +  NQL+          ++L+ L ++ N       P    
Sbjct: 154 -----MLPEL--PTSLEVLSVRNNQLT----FLPELPESLEALDVSTNLLE--SLPAVPV 200

Query: 292 TLLGLE----HLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDM 347
                E             I  IP  IL L    T+ L  N L+ +I    ++     D 
Sbjct: 201 RNHHSEETEIFFRCRENR-ITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259

Query: 348 SHNNLS 353
               + 
Sbjct: 260 HGPRIY 265

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 98.5 bits (245), Expect = 1e-21
 Identities = 52/282 (18%), Positives = 101/282 (35%), Gaps = 49/282 (17%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSN 95
           +   LS S+PD  +    ++  L++++N + +LP       SL+ L+   NR+S +LP  
Sbjct: 67  NRLNLS-SLPDN-LPP--QITVLEITQNALISLPE---LPASLEYLDACDNRLS-TLPEL 118

Query: 96  IGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDL 155
             +   L+  D+ NN  +  +P   +    L  +  D N     +P       SL  + +
Sbjct: 119 PAS---LKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELP---TSLEVLSV 167

Query: 156 SMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGV 215
             NQL   LP+        L++L+++ N ++                             
Sbjct: 168 RNNQLT-FLPELPE----SLEALDVSTNLLESLPAVPVRNHHS----------------- 205

Query: 216 FLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHL 275
             E+      R N+    I+ +   +  +      + L +N LS  I  + SQ       
Sbjct: 206 -EETEIFFRCRENR----ITHIP-ENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259

Query: 276 SLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQL 317
                 F+  +  Q    L     +        +  S++ Q+
Sbjct: 260 HGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQI 299

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 68.5 bits (167), Expect = 5e-12
 Identities = 38/230 (16%), Positives = 71/230 (30%), Gaps = 19/230 (8%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKS----LNLSYNRISGSLPSNIGNFGLLEVFDL 107
              L++LD+S N + +LP+        +          NRI+  +P NI +        L
Sbjct: 179 PESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIIL 237

Query: 108 SNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDG 167
            +N  S  I  ++S   +       G    +S+  G  N       D        +    
Sbjct: 238 EDNPLSSRIRESLSQQTAQPD--YHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSD 295

Query: 168 FGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNL--FQGSVMGVFLESLEVIDL 225
               +   +    A       +T  A L  +++   + N   F+  V     +     +L
Sbjct: 296 VSQIWHAFEHEEHA-------NTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAEL 348

Query: 226 RSNQFQ---GHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNL 272
           R   F          +   +  W+ L    L      G   ++     +L
Sbjct: 349 RQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 10/75 (13%), Positives = 22/75 (29%), Gaps = 4/75 (5%)

Query: 304 TSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEK 363
           +    D  S   +         + N     +          + ++  NLS  +P +L  +
Sbjct: 23  SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPPQ 81

Query: 364 LPQMERFNFSYNNLT 378
           +        + N L 
Sbjct: 82  I---TVLEITQNALI 93

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  110 bits (277), Expect = 4e-26
 Identities = 66/304 (21%), Positives = 107/304 (35%), Gaps = 61/304 (20%)

Query: 516 LAEGKFGPVYRGFLPGG-IHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPLTGYC 573
           +  G FG V+ G L      VAVK          +    +E   L +  HPN+V L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 574 IAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTW 633
                   + + ++ G+    L                              +EG     
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR-----------------------------TEGARLRV 212

Query: 634 RFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE 693
           +   ++    A  + +L    S   IHRD+ A +  +      ++SDFG+++   +    
Sbjct: 213 KTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD--GV 267

Query: 694 EIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKE 747
             A G    +P     PE       + + +SDV+ +G++L E  + G  P    YP    
Sbjct: 268 YAASGGLRQVPVKWTAPEALN-YGRY-SSESDVWSFGILLWETFSLGASP----YP---- 317

Query: 748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL 807
                  R  V   KG R +        PE   +   ++   C A  P +RPS   I   
Sbjct: 318 NLSNQQTREFVE--KGGR-LPC------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQE 368

Query: 808 LKDI 811
           L+ I
Sbjct: 369 LQSI 372

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  106 bits (267), Expect = 1e-25
 Identities = 68/310 (21%), Positives = 112/310 (36%), Gaps = 67/310 (21%)

Query: 512 RGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKHPNLV 567
               +  G F  VY+G      + VA    +    LT  E  R   E E L  ++HPN+V
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCE-LQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88

Query: 568 PLTGYCI---AGDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
                      G + I +  + M +G L+  L                          + 
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--------------------------KR 122

Query: 624 VG--SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD-MNLEPRLSD 680
                  +L +W  R        + L FLH   +PPIIHRD+K  ++++       ++ D
Sbjct: 123 FKVMKIKVLRSW-CRQ-----ILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGD 175

Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
            GLA +      + +  G+P ++ PE  +   D      DVY +G+ +LE+ T + P   
Sbjct: 176 LGLATLKRASFAKAV-IGTPEFMAPEMYEEKYD---ESVDVYAFGMCMLEMATSEYP--- 228

Query: 741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
            Y E +  N     R         R        +  +  + E  +I   C      +R S
Sbjct: 229 -YSECQ--NAAQIYR---------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276

Query: 801 MQQIVGLLKD 810
           ++    LL  
Sbjct: 277 IKD---LLNH 283

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  111 bits (278), Expect = 1e-25
 Identities = 68/362 (18%), Positives = 131/362 (36%), Gaps = 29/362 (8%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITAL-PSDLWSLGSLKSLNLSYNRISGSLPS 94
           SN  L+  VP        + ++L LS+N+I+ L   D+  L  L+ L LS+NRI  SL  
Sbjct: 39  SNRNLT-HVPK---DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93

Query: 95  NI-GNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL--NCQSLV 151
           ++      LE  D+S+N     I      + SLR L L  N F   +P      N   L 
Sbjct: 94  HVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLT 149

Query: 152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGS 211
            + LS  +                  L+L    IKG +T    + + T L++  +     
Sbjct: 150 FLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLF 209

Query: 212 VMGVF-----LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIF--- 263
            + V      L  L++ +++ N           +       L+ V L   + + +     
Sbjct: 210 SVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL 269

Query: 264 HNFSQAQNLKHLSLAYNRFTRQEFPQIGT-----LLGLEHLNLSRTSLIGDIPSEILQLS 318
             F   + +++L++     T +   +  T     L  L   ++     +    +     +
Sbjct: 270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFA 329

Query: 319 SLHTLDLSMNHLTG--QIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNN 376
            ++   LS++       +   S  +   ++ + N  + +        L +++      N 
Sbjct: 330 EMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNG 388

Query: 377 LT 378
           L 
Sbjct: 389 LK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  109 bits (274), Expect = 4e-25
 Identities = 61/393 (15%), Positives = 118/393 (30%), Gaps = 50/393 (12%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDL-WSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
            +    I  LS+L+ L LS N I +L   +      L+ L++S+NR+  ++         
Sbjct: 66  ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMAS 122

Query: 102 LEVFDLSNNNF-SGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQL 160
           L   DLS N+F    +     +L  L  L L    F+  +    +    L  + L +   
Sbjct: 123 LRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSY 181

Query: 161 ------------------------NGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH----- 191
                                   N         +   L  L L+  ++   +       
Sbjct: 182 HIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF 241

Query: 192 ----FAGLK----SITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQF-NSS 242
                 G      ++ ++  +           +   +E +++ +      I + +F  S 
Sbjct: 242 LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSE 301

Query: 243 YNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLS 302
                L+   +            +S    +    L+ +           +      LN +
Sbjct: 302 TALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT 361

Query: 303 RTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVS-----AKNLGIIDMSHNNLSGEIP 357
           +      +      L  L TL L  N L      V+       +L  +D+S N+L+    
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAY 420

Query: 358 ASLLEKLPQMERFNFSYNNLTLCASELSPETLQ 390
                    +   N S N LT       P  ++
Sbjct: 421 DRTCAWAESILVLNLSSNMLTGSVFRCLPPKVK 453

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  103 bits (258), Expect = 4e-23
 Identities = 66/358 (18%), Positives = 131/358 (36%), Gaps = 28/358 (7%)

Query: 43  SVPDTTI-GKLSKLQSLDLSENNITALPSDLWSLGSLKS--LNLSYNRISGSLPSNI--G 97
            +P     G L+KL  L LS      L     +   L    L+L    I G    ++   
Sbjct: 135 VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP 194

Query: 98  NFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLN--CQSLVTVDL 155
           N  +L +    N+ FS ++  ++++L  L++  +  N          L+   +    +++
Sbjct: 195 NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNV 254

Query: 156 SMNQLNGSLPDGFG----AAFPKLKSLNLAGNEIKGR------DTHFAGLKSITNLNISG 205
           ++  +  +               ++ LN+    I  R            LKS+   ++  
Sbjct: 255 TLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314

Query: 206 NLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIF 263
            +F  S   ++     + +  L  +     I  V   S    S   +++ ++N  +  +F
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPF-IHMVCPPSP---SSFTFLNFTQNVFTDSVF 370

Query: 264 HNFSQAQNLKHLSLAYNRFTR--QEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQL-SSL 320
              S  + L+ L L  N      +       +  LE L++S  SL             S+
Sbjct: 371 QGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430

Query: 321 HTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
             L+LS N LTG +       + ++D+ +N +   IP   +  L  ++  N + N L 
Sbjct: 431 LVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKD-VTHLQALQELNVASNQLK 486

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 91.1 bits (226), Expect = 3e-19
 Identities = 63/342 (18%), Positives = 114/342 (33%), Gaps = 54/342 (15%)

Query: 57  SLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEI 116
            +D S  N+T +P DL      K+L+LS N IS  L                        
Sbjct: 35  MVDYSNRNLTHVPKDL--PPRTKALSLSQNSIS-ELR----------------------- 68

Query: 117 PAAISSLVSLRVLKLDGNMFQWSIPPGL-LNCQSLVTVDLSMNQLNGSLPDGFGAAFPKL 175
              IS L  LRVL+L  N  + S+   + L  Q L  +D+S N+L  ++          L
Sbjct: 69  MPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL-QNISCC---PMASL 123

Query: 176 KSLNLAGNEIK--GRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGH 233
           + L+L+ N+         F  L  +T L +S   F+  +  + +  L +  +  +    H
Sbjct: 124 RHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYH 182

Query: 234 ISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTL 293
           I   +  S         + L  +  S            L HL L+  +   +   ++ T 
Sbjct: 183 IKGGETESLQI-PNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF 241

Query: 294 LGLEHLNLSRTSLIGDIPS----------EILQLSSLHTLDLSMNHLTGQIPTVSA---- 339
           L       +  ++                +      +  L++    +T +I         
Sbjct: 242 LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSE 301

Query: 340 ---KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
              K+L I  + +         +L     +M     S ++  
Sbjct: 302 TALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISDTP 342

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 83.0 bits (205), Expect = 1e-16
 Identities = 40/189 (21%), Positives = 71/189 (37%), Gaps = 13/189 (6%)

Query: 51  KLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSN 109
             +++    LS ++   +      S  S   LN + N  + S+         L+   L  
Sbjct: 327 VFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386

Query: 110 NNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNC-----QSLVTVDLSMNQLNGSL 164
           N              ++  L+        S+     +      +S++ ++LS N L GS+
Sbjct: 387 NGLK-NFFKVALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444

Query: 165 PDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEV 222
                   PK+K L+L  N I         L+++  LN++ N  +    GVF  L SL+ 
Sbjct: 445 FRCLP---PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQY 501

Query: 223 IDLRSNQFQ 231
           I L  N + 
Sbjct: 502 IWLHDNPWD 510

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 81.1 bits (200), Expect = 4e-16
 Identities = 34/175 (19%), Positives = 64/175 (36%), Gaps = 11/175 (6%)

Query: 41  SGSVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRISGSLPSNIGNF 99
           +  +        S    L+ ++N  T        +L  L++L L  N +  +        
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMT 399

Query: 100 GLLEVFDLSNNNF----SGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDL 155
             +   +  + +     S       +   S+ VL L  NM   S+   L     +  +DL
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDL 457

Query: 156 SMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQ 209
             N++  S+P         L+ LN+A N++K   D  F  L S+  + +  N + 
Sbjct: 458 HNNRIM-SIPKDV-THLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 76.8 bits (189), Expect = 1e-14
 Identities = 50/265 (18%), Positives = 89/265 (33%), Gaps = 24/265 (9%)

Query: 32  DFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPS------DLWSLGSLKSLNLSY 85
                 +    SV          ++ L++    IT             +L SL   ++  
Sbjct: 255 TLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314

Query: 86  NRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL 145
                S  +    F  + +  LS ++          S  S   L    N+F  S+  G  
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCS 374

Query: 146 NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-----RDTHFAGLKSITN 200
             + L T+ L  N L  +           + SL      +        D   A  +SI  
Sbjct: 375 TLKRLQTLILQRNGLK-NFFKVALM-TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432

Query: 201 LNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS- 259
           LN+S N+  GSV       ++V+DL +N+       V      +   L  ++++ NQL  
Sbjct: 433 LNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVT-----HLQALQELNVASNQLKS 487

Query: 260 --GEIFHNFSQAQNLKHLSLAYNRF 282
               +F       +L+++ L  N +
Sbjct: 488 VPDGVFDRL---TSLQYIWLHDNPW 509

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (271), Expect = 2e-25
 Identities = 38/252 (15%), Positives = 73/252 (28%), Gaps = 23/252 (9%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVP 568
             RGT+L +              G    V V             +  E + R++    + 
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWE---------EDGTN 619
                    + I  +D +++   + ++    + +   + W    +          +    
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIR---VRLDERDMWVLSRFFLYPRMQSNLQTFGE 196

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRL 678
            + +  S         R ++ L   R LA LH +G    ++H  ++   + LD      L
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFL 252

Query: 679 SDFGLAKIFGNGLDEEIAR--GSPGYIPPE---FAQPDSDFPTPKSDVYCYGVVLLELIT 733
           + F      G      I R    P         F Q      T   D +  G+ +  +  
Sbjct: 253 TGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

Query: 734 GKKPLGDDYPEE 745
              P  DD    
Sbjct: 313 ADLPNTDDAALG 324

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  106 bits (266), Expect = 3e-25
 Identities = 60/294 (20%), Positives = 97/294 (32%), Gaps = 37/294 (12%)

Query: 97  GNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPG---LLNCQSLVTV 153
           G   L  +    +          I   +SL+ L +        I  G   +L    L  +
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 154 DLSMNQLNGSLP-DGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSV 212
            L   ++ G+ P     A  P L  LNL       RD   A L+                
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG---------- 150

Query: 213 MGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFS----Q 268
                  L+V+ +       H           +  L  +DLS+N   GE     +    +
Sbjct: 151 -------LKVLSIAQA----HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199

Query: 269 AQNLKHLSLAYNRFTR---QEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLD 324
              L+ L+L                   + L+ L+LS  SL     +      S L++L+
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259

Query: 325 LSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           LS   L  Q+P      L ++D+S+N L    P+    +LPQ+   +   N   
Sbjct: 260 LSFTGLK-QVPKGLPAKLSVLDLSYNRLD-RNPSPD--ELPQVGNLSLKGNPFL 309

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  103 bits (257), Expect = 3e-24
 Identities = 59/315 (18%), Positives = 103/315 (32%), Gaps = 35/315 (11%)

Query: 31  TDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISG 90
           +D     S     +    +      +SL+     +            +KSL+L    +  
Sbjct: 18  SDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRA 77

Query: 91  SLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQ-- 148
           +   +   FG L V  +S                 L+ L L+      + PP LL     
Sbjct: 78  ARIPSRILFGALRVLGISG----------------LQELTLENLEVTGTAPPPLLEATGP 121

Query: 149 SLVTVDLSMNQLNG---SLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNIS 204
            L  ++L           L +      P LK L++A                +++ L++S
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181

Query: 205 GNLFQG------SVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQL 258
            N   G      ++  +   +L+V+ LR+   +   S V    +    +L  +DLS N L
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGME-TPSGVCSALAAARVQLQGLDLSHNSL 240

Query: 259 SGEI-FHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQL 317
                  +      L  L+L++     Q    +     L  L+LS   L    PS   +L
Sbjct: 241 RDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRL-DRNPS-PDEL 295

Query: 318 SSLHTLDLSMNHLTG 332
             +  L L  N    
Sbjct: 296 PQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  101 bits (252), Expect = 1e-23
 Identities = 42/221 (19%), Positives = 71/221 (32%), Gaps = 17/221 (7%)

Query: 26  NKQHVTDFLASNSGLSGSVPDTTI-GKLSKLQSLDLSENNITALPSDL-----WSLGSLK 79
               + +    N  ++G+ P   +      L  L+L   +     + L     W    LK
Sbjct: 93  GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152

Query: 80  SLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEI-------PAAISSLVSLRVLKLD 132
            L+++           +  F  L   DLS+N   GE        P    +L  L +    
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212

Query: 133 GNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHF 192
                            L  +DLS N L  +          +L SLNL+   +       
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL---KQVP 269

Query: 193 AGL-KSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQG 232
            GL   ++ L++S N    +     L  +  + L+ N F  
Sbjct: 270 KGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 90.3 bits (224), Expect = 7e-20
 Identities = 40/185 (21%), Positives = 69/185 (37%), Gaps = 14/185 (7%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWS-LGSLKSLNLSYNRISGSLPS 94
           S +     + +        L+ L +++ +      +      +L +L+LS N   G    
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191

Query: 95  NI----GNFGLLEVFDLSNNNF---SGEIPAAISSLVSLRVLKLDGNMFQWSIPPGL-LN 146
                   F  L+V  L N      SG   A  ++ V L+ L L  N  + +        
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251

Query: 147 CQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGN 206
              L +++LS   L   +P G      KL  L+L+ N +    +    L  + NL++ GN
Sbjct: 252 PSQLNSLNLSFTGLK-QVPKGL---PAKLSVLDLSYNRLDRNPS-PDELPQVGNLSLKGN 306

Query: 207 LFQGS 211
            F  S
Sbjct: 307 PFLDS 311

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  106 bits (266), Expect = 4e-25
 Identities = 73/316 (23%), Positives = 121/316 (38%), Gaps = 59/316 (18%)

Query: 513 GTLLAEGKFGPVYRGFLPG-----GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
            + L +G FG V            G  VAVK L H      ++  RE++ L  +    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 568 PLTGYCIAGDQRIAIY---DYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
              G    G  R ++    +Y+ +G L++ L  H   L       +S+            
Sbjct: 88  KYRGVSY-GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ----------- 135

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                           I  G    + +L    C    +HRD+ A ++ ++     +++DF
Sbjct: 136 ----------------ICKG----MEYLGSRRC----VHRDLAARNILVESEAHVKIADF 171

Query: 682 GLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GK 735
           GLAK+     D  + R  PG  P     PE +  D+ F + +SDV+ +GVVL EL T   
Sbjct: 172 GLAKLLPLDKDYYVVR-EPGQSPIFWYAPE-SLSDNIF-SRQSDVWSFGVVLYELFTYCD 228

Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
           K      P  +   ++   R +   ++    ++   R   P     E  ++  LC A  P
Sbjct: 229 KSC---SPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSP 285

Query: 796 LKRPSMQQIVGLLKDI 811
             RPS   +   L  +
Sbjct: 286 QDRPSFSALGPQLDML 301

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  105 bits (265), Expect = 4e-25
 Identities = 72/322 (22%), Positives = 128/322 (39%), Gaps = 52/322 (16%)

Query: 510 FDRGTL-----LAEGKFGPVYRGFLPGG------IHVAVKVLVHGSTLTDQEA-ARELEY 557
           F R  L     L EG+FG V +              VAVK+L   ++ ++      E   
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79

Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQN-LLHDLPLGVQTTEDWSTDTWEED 616
           L ++ HP+++ L G C      + I +Y + G+L+  L     +G        +      
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139

Query: 617 GTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP 676
                + +    L+         A   ++ + +L       ++HRD+ A ++ +    + 
Sbjct: 140 DHPDERALTMGDLI-------SFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKM 189

Query: 677 RLSDFGLA-KIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLE 730
           ++SDFGL+  ++    D  + R   G IP      E +  D  + T +SDV+ +GV+L E
Sbjct: 190 KISDFGLSRDVYEE--DSYVKRSQ-GRIPVKWMAIE-SLFDHIY-TTQSDVWSFGVLLWE 244

Query: 731 LIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL 789
           ++T G  P    YP      L + ++       G R    +     P+   EE  ++   
Sbjct: 245 IVTLGGNP----YPGIPPERLFNLLK------TGHRM--ER-----PDNCSEEMYRLMLQ 287

Query: 790 CTADLPLKRPSMQQIVGLLKDI 811
           C    P KRP    I   L+ +
Sbjct: 288 CWKQEPDKRPVFADISKDLEKM 309

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  105 bits (265), Expect = 5e-25
 Identities = 73/330 (22%), Positives = 119/330 (36%), Gaps = 94/330 (28%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFL--PGG---IHVAVKVLVHGSTLTDQEA-ARELEYLGRI 561
           + F +  +L  G FG VY+G     G    I VA+K L   ++    +    E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTN 619
            +P++  L G C+    ++ I   M  G L + +  H   +G Q                
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY--------------- 118

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRL 678
                     L  W       +  A+ + +L         +HRD+ A +V +      ++
Sbjct: 119 ----------LLNW------CVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKI 158

Query: 679 SDFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT 733
           +DFGLAK+ G    E  A G  G +P      E +     + T +SDV+ YGV + EL+T
Sbjct: 159 TDFGLAKLLGAEEKEYHAEG--GKVPIKWMALE-SILHRIY-THQSDVWSYGVTVWELMT 214

Query: 734 -GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTA 792
            G KP    Y       + S +       KG R   P I                  CT 
Sbjct: 215 FGSKP----YDGIPASEISSILE------KGERLPQPPI------------------CTI 246

Query: 793 DL-----------PLKRPSMQQIVGLLKDI 811
           D+              RP  ++++     +
Sbjct: 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKM 276

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  105 bits (265), Expect = 6e-25
 Identities = 81/324 (25%), Positives = 131/324 (40%), Gaps = 56/324 (17%)

Query: 510 FDRGTL-----LAEGKFGPVYRGFLPGG------IHVAVKVLVHGSTLTDQEA-ARELEY 557
           + R  +     + EG FG V++   PG         VAVK+L   ++   Q    RE   
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103

Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDL-PLGVQTTEDWSTDTWEED 616
           +    +PN+V L G C  G     +++YM  G+L   L  + P  V +       T    
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 617 GTNSIQNVGSEGLLTTWRFRHKIALGTARALAFL--HHGCSPPIIHRDIKASSVYLDMNL 674
            +     +     L        IA   A  +A+L          +HRD+   +  +  N+
Sbjct: 164 SSPGPPPLSCAEQL-------CIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENM 211

Query: 675 EPRLSDFGLA-KIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVL 728
             +++DFGL+  I+    D   A G+   IP     PE +   + + T +SDV+ YGVVL
Sbjct: 212 VVKIADFGLSRNIYSA--DYYKADGN-DAIPIRWMPPE-SIFYNRY-TTESDVWAYGVVL 266

Query: 729 LELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIG 787
            E+ + G +P    Y       ++ +VR       G+  +        PE    E   + 
Sbjct: 267 WEIFSYGLQP----YYGMAHEEVIYYVR------DGNI-LAC------PENCPLELYNLM 309

Query: 788 YLCTADLPLKRPSMQQIVGLLKDI 811
            LC + LP  RPS   I  +L+ +
Sbjct: 310 RLCWSKLPADRPSFCSIHRILQRM 333

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  103 bits (260), Expect = 9e-25
 Identities = 68/311 (21%), Positives = 118/311 (37%), Gaps = 63/311 (20%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
           S       +  G+FG V+ G+      VA+K +  G+  ++++   E E + ++ HP LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLV 66

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L G C+       + ++ME+G L + L                                
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRT----------------------------QR 98

Query: 628 GLLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           GL         + L     +A+L         IHRD+ A +  +  N   ++SDFG+ + 
Sbjct: 99  GLFAAETLLG-MCLDVCEGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRF 153

Query: 687 FGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGD 740
               LD++    +    P     PE     S + + KSDV+ +GV++ E+ + GK P   
Sbjct: 154 V---LDDQYTSSTGTKFPVKWASPE-VFSFSRY-SSKSDVWSFGVLMWEVFSEGKIP--- 205

Query: 741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
            Y       +V  +        G R    K     P        +I   C  + P  RP+
Sbjct: 206 -YENRSNSEVVEDIS------TGFRL--YK-----PRLASTHVYQIMNHCWRERPEDRPA 251

Query: 801 MQQIVGLLKDI 811
             +++  L +I
Sbjct: 252 FSRLLRQLAEI 262

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  103 bits (259), Expect = 2e-24
 Identities = 72/307 (23%), Positives = 115/307 (37%), Gaps = 63/307 (20%)

Query: 513 GTLLAEGKFGPVYRGFLPGG-IHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTG 571
              L  G++G VY G      + VAVK L   +    +E  +E   +  IKHPNLV L G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 572 YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLT 631
            C        I ++M  GNL + L +      +                        LL 
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV---------------------LL- 114

Query: 632 TWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
                  +A   + A+ +L         IHRD+ A +  +  N   +++DFGL+++    
Sbjct: 115 ------YMATQISSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLM--- 161

Query: 691 LDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE 744
             +     +    P     PE +   + F + KSDV+ +GV+L E+ T G  P    YP 
Sbjct: 162 TGDTYTAHAGAKFPIKWTAPE-SLAYNKF-SIKSDVWAFGVLLWEIATYGMSP----YPG 215

Query: 745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
                +   +       K  R    +     PE   E+  ++   C    P  RPS  +I
Sbjct: 216 IDLSQVYELLE------KDYRM--ER-----PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

Query: 805 VGLLKDI 811
               + +
Sbjct: 263 HQAFETM 269

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  104 bits (262), Expect = 2e-24
 Identities = 78/322 (24%), Positives = 121/322 (37%), Gaps = 51/322 (15%)

Query: 510 FDR-----GTLLAEGKFGPVYRGFLPGGIH------VAVKVLVHGSTLTDQEA-ARELEY 557
           F R     G +L  G FG V      G         VAVK+L   +  +++EA   EL+ 
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101

Query: 558 LGRI-KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEED 616
           + ++  H N+V L G C        I++Y   G+L N L          E    +    +
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 617 GTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP 676
               +  +  E LL         A   A+ + FL        +HRD+ A +V +      
Sbjct: 162 EEEDLNVLTFEDLL-------CFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVV 211

Query: 677 RLSDFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLEL 731
           ++ DFGLA+   +  D          +P     PE +  +  + T KSDV+ YG++L E+
Sbjct: 212 KICDFGLARDIMS--DSNYVVRGNARLPVKWMAPE-SLFEGIY-TIKSDVWSYGILLWEI 267

Query: 732 IT-GKKPLGDDYPE-EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL 789
            + G  P    YP    + N    ++       G +    +     P    EE   I   
Sbjct: 268 FSLGVNP----YPGIPVDANFYKLIQ------NGFKM--DQ-----PFYATEEIYIIMQS 310

Query: 790 CTADLPLKRPSMQQIVGLLKDI 811
           C A    KRPS   +   L   
Sbjct: 311 CWAFDSRKRPSFPNLTSFLGCQ 332

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  103 bits (260), Expect = 2e-24
 Identities = 65/321 (20%), Positives = 126/321 (39%), Gaps = 64/321 (19%)

Query: 510 FDRGTL-----LAEGKFGPVYRGFLPGG------IHVAVKVLVHGSTLTDQEA-ARELEY 557
             R  +     L +G FG VY G   G         VA+K +   +++ ++     E   
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81

Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDG 617
           +      ++V L G    G   + I + M  G+L++ L  L   +      +  +  +  
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK-- 139

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
                      ++       ++A   A  +A+L+   +   +HRD+ A +  +  +   +
Sbjct: 140 -----------MI-------QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 178

Query: 678 LSDFGLA-KIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLEL 731
           + DFG+   I+     +   +G  G +P     PE +  D  F T  SDV+ +GVVL E+
Sbjct: 179 IGDFGMTRDIYE---TDYYRKGGKGLLPVRWMSPE-SLKDGVF-TTYSDVWSFGVVLWEI 233

Query: 732 IT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLC 790
            T  ++P    Y       ++ +V       +G   +D       P+   +   ++  +C
Sbjct: 234 ATLAEQP----YQGLSNEQVLRFVM------EGGL-LDK------PDNCPDMLFELMRMC 276

Query: 791 TADLPLKRPSMQQIVGLLKDI 811
               P  RPS  +I+  +K+ 
Sbjct: 277 WQYNPKMRPSFLEIISSIKEE 297

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  102 bits (257), Expect = 5e-24
 Identities = 87/313 (27%), Positives = 131/313 (41%), Gaps = 49/313 (15%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIH------VAVKVLVHGSTLTDQEA-ARELEYLGRI-KHP 564
           G  L  G FG V      G I       VAVK+L   + LT++EA   EL+ L  +  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
           N+V L G C  G   + I +Y   G+L N L         ++       +++    +++ 
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED- 146

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
               LL+        +   A+ +AFL    S   IHRD+ A ++ L      ++ DFGLA
Sbjct: 147 ----LLS-------FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 685 KIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPL 738
           +   N  D          +P     PE +  +  + T +SDV+ YG+ L EL + G  P 
Sbjct: 193 RDIKN--DSNYVVKGNARLPVKWMAPE-SIFNCVY-TFESDVWSYGIFLWELFSLGSSP- 247

Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
              YP            G+  ++K  + I    R   PE    E   I   C    PLKR
Sbjct: 248 ---YP------------GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 799 PSMQQIVGLLKDI 811
           P+ +QIV L++  
Sbjct: 293 PTFKQIVQLIEKQ 305

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  102 bits (256), Expect = 5e-24
 Identities = 69/321 (21%), Positives = 127/321 (39%), Gaps = 59/321 (18%)

Query: 510 FDRGTL-----LAEGKFGPVYRGFLPGG------IHVAVKVLVHGSTLTDQEAARELEYL 558
             R  +     L EG FG V+             + VAVK L   +    ++  RE E L
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 71

Query: 559 GRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGT 618
             ++H ++V   G C  GD  I +++YM++G+L   L                  +    
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGP-------------DAMIL 118

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFL--HHGCSPPIIHRDIKASSVYLDMNLEP 676
              Q   ++G L   +    IA   A  + +L   H      +HRD+   +  +  NL  
Sbjct: 119 VDGQPRQAKGELGLSQM-LHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLV 172

Query: 677 RLSDFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLEL 731
           ++ DFG+++   +   +    G    +P     PE +     F T +SDV+ +GV+L E+
Sbjct: 173 KIGDFGMSRDVYS--TDYYRVGGHTMLPIRWMPPE-SIMYRKF-TTESDVWSFGVILWEI 228

Query: 732 IT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLC 790
            T GK+P    + +     ++  +       +G   ++       P    +E   +   C
Sbjct: 229 FTYGKQP----WFQLSNTEVIECIT------QGRV-LER------PRVCPKEVYDVMLGC 271

Query: 791 TADLPLKRPSMQQIVGLLKDI 811
               P +R ++++I  +L  +
Sbjct: 272 WQREPQQRLNIKEIYKILHAL 292

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  101 bits (255), Expect = 6e-24
 Identities = 69/314 (21%), Positives = 120/314 (38%), Gaps = 69/314 (21%)

Query: 513 GTLLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLV 567
             ++  G FG VY G L       IH AVK L   + + +      E   +    HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 568 PLTGYCIAGD-QRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
            L G C+  +   + +  YM++G+L+N +        V+                     
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-------------------- 129

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
               L+          L  A+ + +L         +HRD+ A +  LD     +++DFGL
Sbjct: 130 ----LI-------GFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGL 174

Query: 684 AKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP 737
           A+   +     +   +   +P      E +     F T KSDV+ +GV+L EL+T G  P
Sbjct: 175 ARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQKF-TTKSDVWSFGVLLWELMTRGAPP 232

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
               YP+    ++  ++       +G R    +     PE   +   ++   C       
Sbjct: 233 ----YPDVNTFDITVYLL------QGRRL--LQ-----PEYCPDPLYEVMLKCWHPKAEM 275

Query: 798 RPSMQQIVGLLKDI 811
           RPS  ++V  +  I
Sbjct: 276 RPSFSELVSRISAI 289

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  101 bits (254), Expect = 7e-24
 Identities = 60/244 (24%), Positives = 97/244 (39%), Gaps = 44/244 (18%)

Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVL----VHGSTLTDQEAARELEYLGRIK 562
            +F+ G  L +GKFG VY          +A+KVL    +  + +  Q   RE+E    ++
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67

Query: 563 HPNLVPLTGYCIAGDQRI-AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           HPN++ L GY      R+  I +Y   G +   L                          
Sbjct: 68  HPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQ------------------------- 101

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                       R    I    A AL++ H   S  +IHRDIK  ++ L    E +++DF
Sbjct: 102 ----KLSKFDEQRTATYITE-LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 153

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
           G +    +    ++  G+  Y+PPE  +        K D++  GV+  E + GK P   +
Sbjct: 154 GWSVHAPSSRRTDLC-GTLDYLPPEMIE--GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

Query: 742 YPEE 745
             +E
Sbjct: 211 TYQE 214

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  102 bits (257), Expect = 7e-24
 Identities = 73/325 (22%), Positives = 117/325 (36%), Gaps = 75/325 (23%)

Query: 515 LLAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-HPNLVPLTGY 572
           +LAEG F  VY    +  G   A+K L+      ++   +E+ ++ ++  HPN+V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 573 CIAGDQRIAIYDY-----ME--NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
              G +             E   G L                             ++ + 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEF--------------------------LKKME 128

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
           S G L+      KI   T RA+  +H    PPIIHRD+K  ++ L      +L DFG A 
Sbjct: 129 SRGPLSCDTVL-KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186

Query: 686 IFGNG------------LDEEIAR-GSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLEL 731
              +             ++EEI R  +P Y  PE     S+FP   K D++  G +L  L
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

Query: 732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK--IGYL 789
              + P  D                 +R   G  +I P      P           I  +
Sbjct: 247 CFRQHPFEDG--------------AKLRIVNGKYSI-P------PHDTQYTVFHSLIRAM 285

Query: 790 CTADLPLKRPSMQQIVGLLKDIEST 814
              + P +R S+ ++V  L++I + 
Sbjct: 286 LQVN-PEERLSIAEVVHQLQEIAAA 309

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  103 bits (258), Expect = 8e-24
 Identities = 70/314 (22%), Positives = 121/314 (38%), Gaps = 69/314 (21%)

Query: 513 GTLLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLV 567
             ++  G FG VY G L       IH AVK L   + + +      E   +    HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 568 PLTGYCIAGD-QRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
            L G C+  +   + +  YM++G+L+N +        V+                     
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-------------------- 193

Query: 625 GSEGLLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
               L+          L  A+ + FL         +HRD+ A +  LD     +++DFGL
Sbjct: 194 ----LI-------GFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGL 238

Query: 684 AKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP 737
           A+   +   + +   +   +P      E +     F T KSDV+ +GV+L EL+T G  P
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVKWMALE-SLQTQKF-TTKSDVWSFGVLLWELMTRGAPP 296

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
               YP+    ++  ++       +G R    +     PE   +   ++   C       
Sbjct: 297 ----YPDVNTFDITVYLL------QGRRL--LQ-----PEYCPDPLYEVMLKCWHPKAEM 339

Query: 798 RPSMQQIVGLLKDI 811
           RPS  ++V  +  I
Sbjct: 340 RPSFSELVSRISAI 353

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (261), Expect = 8e-24
 Identities = 71/310 (22%), Positives = 119/310 (38%), Gaps = 61/310 (19%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
            +      L +G FG V+ G   G   VA+K L  G+  + +   +E + + +++H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLV 242

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L          I + +YM  G+L + L                                
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKG----------------------------ET 273

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
           G          +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++ 
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330

Query: 688 GNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDD 741
               D E         P     PE A     F T KSDV+ +G++L EL T G+ P    
Sbjct: 331 ---EDNEYTARQGAKFPIKWTAPE-AALYGRF-TIKSDVWSFGILLTELTTKGRVP---- 381

Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP      ++  V       +G R   P      P +  E    +   C    P +RP+ 
Sbjct: 382 YPGMVNREVLDQVE------RGYRM--PC-----PPECPESLHDLMCQCWRKEPEERPTF 428

Query: 802 QQIVGLLKDI 811
           + +   L+D 
Sbjct: 429 EYLQAFLEDY 438

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  101 bits (255), Expect = 1e-23
 Identities = 70/322 (21%), Positives = 120/322 (37%), Gaps = 62/322 (19%)

Query: 510 FDRGTL-----LAEGKFGPVYRGFLPGG------IHVAVKVLVHGSTLTDQEAARELEYL 558
             R  +     L EG FG V+             + VAVK L   S    Q+  RE E L
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 97

Query: 559 GRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGT 618
             ++H ++V   G C  G   + +++YM +G+L   L                       
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH--------GPDAKLLAGGED 149

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFL--HHGCSPPIIHRDIKASSVYLDMNLEP 676
            +   +G   LL        +A   A  + +L   H      +HRD+   +  +   L  
Sbjct: 150 VAPGPLGLGQLL-------AVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVV 197

Query: 677 RLSDFGLAK-IFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLE 730
           ++ DFG+++ I+     +    G    +P     PE +     F T +SDV+ +GVVL E
Sbjct: 198 KIGDFGMSRDIYST---DYYRVGGRTMLPIRWMPPE-SILYRKF-TTESDVWSFGVVLWE 252

Query: 731 LIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL 789
           + T GK+P    + +      +  +       +G   ++       P     E   I   
Sbjct: 253 IFTYGKQP----WYQLSNTEAIDCIT------QGRE-LER------PRACPPEVYAIMRG 295

Query: 790 CTADLPLKRPSMQQIVGLLKDI 811
           C    P +R S++ +   L+ +
Sbjct: 296 CWQREPQQRHSIKDVHARLQAL 317

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  104 bits (262), Expect = 1e-23
 Identities = 69/306 (22%), Positives = 113/306 (36%), Gaps = 61/306 (19%)

Query: 513 GTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTG 571
              L  G++G VY G      + VAVK L   +    +E  +E   +  IKHPNLV L G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 572 YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLT 631
            C        I ++M  GNL + L +                                  
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRE----------------------------CNRQEV 315

Query: 632 TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL 691
           +      +A   + A+ +L        IHR++ A +  +  N   +++DFGL+++     
Sbjct: 316 SAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM---T 369

Query: 692 DEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEE 745
            +     +    P     PE +   + F + KSDV+ +GV+L E+ T G  P    YP  
Sbjct: 370 GDTYTAHAGAKFPIKWTAPE-SLAYNKF-SIKSDVWAFGVLLWEIATYGMSP----YPGI 423

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
               +   +       K  R    +     PE   E+  ++   C    P  RPS  +I 
Sbjct: 424 DLSQVYELLE------KDYRM--ER-----PEGCPEKVYELMRACWQWNPSDRPSFAEIH 470

Query: 806 GLLKDI 811
              + +
Sbjct: 471 QAFETM 476

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  102 bits (256), Expect = 1e-23
 Identities = 81/316 (25%), Positives = 123/316 (38%), Gaps = 56/316 (17%)

Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTDQEA-ARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D      E+E +  I K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           H N++ L G C        I +Y   GNL+  L       +       +   +      +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-------RARRPPGMEYSYDINRVPEE 152

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            +  + L+             AR + +L    S   IHRD+ A +V +  N   +++DFG
Sbjct: 153 QMTFKDLV-------SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFG 202

Query: 683 LA-KIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GK 735
           LA  I     D      + G +P     PE A  D  + T +SDV+ +GV++ E+ T G 
Sbjct: 203 LARDINNI--DYYKKTTN-GRLPVKWMAPE-ALFDRVY-THQSDVWSFGVLMWEIFTLGG 257

Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
            P    YP      L   ++      +G R    K     P     E   +   C   +P
Sbjct: 258 SP----YPGIPVEELFKLLK------EGHRM--DK-----PANCTNELYMMMRDCWHAVP 300

Query: 796 LKRPSMQQIVGLLKDI 811
            +RP+ +Q+V  L  I
Sbjct: 301 SQRPTFKQLVEDLDRI 316

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  104 bits (260), Expect = 1e-23
 Identities = 73/310 (23%), Positives = 119/310 (38%), Gaps = 61/310 (19%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
            +      L  G+FG V+         VAVK +  GS  + +    E   +  ++H  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLV 246

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L          I I ++M  G+L + L                               E
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKS----------------------------DE 277

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
           G           +   A  +AF+        IHRD++A+++ +  +L  +++DFGLA++ 
Sbjct: 278 GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI 334

Query: 688 GNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDD 741
               D E         P     PE A     F T KSDV+ +G++L+E++T G+ P    
Sbjct: 335 ---EDNEYTAREGAKFPIKWTAPE-AINFGSF-TIKSDVWSFGILLMEIVTYGRIP---- 385

Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP      ++  +       +G R   P+     PE   EE   I   C  + P +RP+ 
Sbjct: 386 YPGMSNPEVIRALE------RGYRM--PR-----PENCPEELYNIMMRCWKNRPEERPTF 432

Query: 802 QQIVGLLKDI 811
           + I  +L D 
Sbjct: 433 EYIQSVLDDF 442

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  101 bits (253), Expect = 1e-23
 Identities = 72/319 (22%), Positives = 124/319 (38%), Gaps = 71/319 (22%)

Query: 513 GTLLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAA--RELEYLGRIKHPNL 566
           G +L EG+FG V  G L       + VAVK +   ++   +      E   +    HPN+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 567 VPLTGYCIAGDQRIA-----IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           + L G CI    +       I  +M+ G+L   L                          
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL-----------------YSRLETGP 141

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFL--HHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
           +++  + LL       K  +  A  + +L   +      +HRD+ A +  L  ++   ++
Sbjct: 142 KHIPLQTLL-------KFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVA 189

Query: 680 DFGLAK-IFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT 733
           DFGL+K I+     +   +G    +P      E +  D  + T KSDV+ +GV + E+ T
Sbjct: 190 DFGLSKKIYSG---DYYRQGRIAKMPVKWIAIE-SLADRVY-TSKSDVWAFGVTMWEIAT 244

Query: 734 -GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTA 792
            G  P    YP  +   +  ++        G R +        PE  ++E  +I Y C  
Sbjct: 245 RGMTP----YPGVQNHEMYDYLL------HGHR-LKQ------PEDCLDELYEIMYSCWR 287

Query: 793 DLPLKRPSMQQIVGLLKDI 811
             PL RP+   +   L+ +
Sbjct: 288 TDPLDRPTFSVLRLQLEKL 306

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  102 bits (256), Expect = 2e-23
 Identities = 86/317 (27%), Positives = 125/317 (39%), Gaps = 58/317 (18%)

Query: 513 GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTDQEA-ARELEYLGRI-K 562
           G  L EG FG V      G         + VAVK+L   +T  D      E+E +  I K
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQN-LLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           H N++ L G C        I +Y   GNL+  L    P G++ + D              
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-------------- 191

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
            N   E  +T            AR + +L    S   IHRD+ A +V +  N   +++DF
Sbjct: 192 INRVPEEQMTFKDL-VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADF 247

Query: 682 GLA-KIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-G 734
           GLA  I     D      + G +P     PE A  D  + T +SDV+ +GV++ E+ T G
Sbjct: 248 GLARDINNI--DYYKKTTN-GRLPVKWMAPE-ALFDRVY-THQSDVWSFGVLMWEIFTLG 302

Query: 735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL 794
             P    YP      L   ++      +G R    K     P     E   +   C   +
Sbjct: 303 GSP----YPGIPVEELFKLLK------EGHRM--DK-----PANCTNELYMMMRDCWHAV 345

Query: 795 PLKRPSMQQIVGLLKDI 811
           P +RP+ +Q+V  L  I
Sbjct: 346 PSQRPTFKQLVEDLDRI 362

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  100 bits (252), Expect = 2e-23
 Identities = 70/314 (22%), Positives = 120/314 (38%), Gaps = 69/314 (21%)

Query: 513 GTLLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLV 567
             ++ +G FG VY G         I  A+K L   + +   EA  RE   +  + HPN++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 568 PLTGYCIAGDQRI-AIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
            L G  +  +     +  YM +G+L   +        V+                     
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKD-------------------- 125

Query: 625 GSEGLLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
               L+          L  AR + +L         +HRD+ A +  LD +   +++DFGL
Sbjct: 126 ----LI-------SFGLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGL 170

Query: 684 AKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP 737
           A+   +     + +     +P      E +     F T KSDV+ +GV+L EL+T G  P
Sbjct: 171 ARDILDREYYSVQQHRHARLPVKWTALE-SLQTYRF-TTKSDVWSFGVLLWELLTRGAPP 228

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
               Y      +L  ++       +G R   P+     PE   +   ++   C    P  
Sbjct: 229 ----YRHIDPFDLTHFLA------QGRRL--PQ-----PEYCPDSLYQVMQQCWEADPAV 271

Query: 798 RPSMQQIVGLLKDI 811
           RP+ + +VG ++ I
Sbjct: 272 RPTFRVLVGEVEQI 285

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  100 bits (251), Expect = 2e-23
 Identities = 72/307 (23%), Positives = 121/307 (39%), Gaps = 69/307 (22%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGY 572
              + +G+FG V  G    G  VAVK + + +T   Q    E   + +++H NLV L G 
Sbjct: 26  LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV 82

Query: 573 CIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLT 631
            +     + I  +YM  G+L + L                            +G + LL 
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRS---------------------RGRSVLGGDCLL- 120

Query: 632 TWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
                 K +L    A+ +L  +      +HRD+ A +V +  +   ++SDFGL K     
Sbjct: 121 ------KFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK----- 165

Query: 691 LDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE 744
            +    + + G +P     PE A  +  F + KSDV+ +G++L E+ + G+ P    YP 
Sbjct: 166 -EASSTQDT-GKLPVKWTAPE-ALREKKF-STKSDVWSFGILLWEIYSFGRVP----YPR 217

Query: 745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
               ++V  V       KG +          P+       ++   C       RPS  Q+
Sbjct: 218 IPLKDVVPRVE------KGYKM--DA-----PDGCPPAVYEVMKNCWHLDAAMRPSFLQL 264

Query: 805 VGLLKDI 811
              L+ I
Sbjct: 265 REQLEHI 271

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  100 bits (251), Expect = 2e-23
 Identities = 71/311 (22%), Positives = 116/311 (37%), Gaps = 63/311 (20%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
            +      L  G+FG V  G   G   VA+K++  GS  ++ E   E + +  + H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLV 82

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L G C        I +YM NG L N L                  E       Q     
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLR-----------------EMRHRFQTQQ---- 121

Query: 628 GLLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
            LL       ++      A+ +L         +HRD+ A +  ++     ++SDFGL++ 
Sbjct: 122 -LL-------EMCKDVCEAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRY 169

Query: 687 FGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGD 740
               LD+E         P     PE     S F + KSD++ +GV++ E+ + GK P   
Sbjct: 170 V---LDDEYTSSVGSKFPVRWSPPE-VLMYSKF-SSKSDIWAFGVLMWEIYSLGKMP--- 221

Query: 741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
            Y           +       +G R    +     P    E+   I Y C  +   +RP+
Sbjct: 222 -YERFTNSETAEHIA------QGLRL--YR-----PHLASEKVYTIMYSCWHEKADERPT 267

Query: 801 MQQIVGLLKDI 811
            + ++  + D+
Sbjct: 268 FKILLSNILDV 278

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =   99 bits (250), Expect = 2e-23
 Identities = 75/303 (24%), Positives = 127/303 (41%), Gaps = 63/303 (20%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           L  G+FG V  G   G   VAVK++  GS  ++ E  +E + + ++ HP LV   G C  
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRF 635
                 + +Y+ NG L N L     G++ ++                      LL     
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ----------------------LL----- 107

Query: 636 RHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEE 694
             ++       +AFL  H      IHRD+ A +  +D +L  ++SDFG+ +     LD++
Sbjct: 108 --EMCYDVCEGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQ 158

Query: 695 IARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEG 748
                    P     PE       + + KSDV+ +G+++ E+ + GK P    Y      
Sbjct: 159 YVSSVGTKFPVKWSAPE-VFHYFKY-SSKSDVWAFGILMWEVFSLGKMP----YDLYTNS 212

Query: 749 NLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL 808
            +V  V      ++G R    +     P    +   +I Y C  +LP KRP+ QQ++  +
Sbjct: 213 EVVLKV------SQGHRL--YR-----PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259

Query: 809 KDI 811
           + +
Sbjct: 260 EPL 262

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  100 bits (252), Expect = 2e-23
 Identities = 70/320 (21%), Positives = 115/320 (35%), Gaps = 74/320 (23%)

Query: 516 LAEGKFGPVYRGFLPG-----GIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPL 569
           L EG FG V            G  VAVK L   +    +    +E++ L  + H +++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 570 TGYCIAGDQR--IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            G C          + +Y+  G+L++ L    +G+     ++                  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ---------------- 142

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
                      I  G    +A+LH   +   IHRD+ A +V LD +   ++ DFGLAK  
Sbjct: 143 -----------ICEG----MAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184

Query: 688 GNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP---- 737
             G +    R   G  P     PE    +  F    SDV+ +GV L EL+T         
Sbjct: 185 PEGHEYYRVRE-DGDSPVFWYAPE-CLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPP 241

Query: 738 ------LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCT 791
                 +G    +     L   +       +G R   P+     P+K   E   +   C 
Sbjct: 242 TKFLELIGIAQGQMTVLRLTELLE------RGERL--PR-----PDKCPAEVYHLMKNCW 288

Query: 792 ADLPLKRPSMQQIVGLLKDI 811
                 RP+ + ++ +LK +
Sbjct: 289 ETEASFRPTFENLIPILKTV 308

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 31/165 (18%), Positives = 64/165 (38%), Gaps = 8/165 (4%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLL 102
           S  + T  +++ L  + L+  N+T L + +    ++K L ++    +    + I     L
Sbjct: 34  STANITEAQMNSLTYITLANINVTDL-TGIEYAHNIKDLTINNIHATNY--NPISGLSNL 90

Query: 103 EVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNG 162
           E   +   + + +    +S L SL +L +  +    SI   +     + ++DLS N    
Sbjct: 91  ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150

Query: 163 SLPDGFGAAFPKLKSLNLAGNEIKGRD-THFAGLKSITNLNISGN 206
            +        P+LKSLN+  + +   D         +  L     
Sbjct: 151 DI-MPL-KTLPELKSLNIQFDGVH--DYRGIEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 89.6 bits (223), Expect = 1e-20
 Identities = 31/205 (15%), Positives = 76/205 (37%), Gaps = 14/205 (6%)

Query: 152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGS 211
              L  +Q N ++PD   + F    +  L  +     +   A + S+T + ++       
Sbjct: 5   QTGLKASQDNVNIPD---STFKAYLNGLLGQSSTA--NITEAQMNSLTYITLANINVT-D 58

Query: 212 VMGV-FLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQ 270
           + G+ +  +++ + + +       +     S    S L  + +    ++ +   N S   
Sbjct: 59  LTGIEYAHNIKDLTINNIH----ATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLT 112

Query: 271 NLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHL 330
           +L  L ++++        +I TL  +  ++LS    I DI   +  L  L +L++  + +
Sbjct: 113 SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171

Query: 331 TGQIPTVSAKNLGIIDMSHNNLSGE 355
                      L  +      + G+
Sbjct: 172 HDYRGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 87.3 bits (217), Expect = 9e-20
 Identities = 25/137 (18%), Positives = 53/137 (38%), Gaps = 5/137 (3%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS 108
           I     ++ L ++  + T   + +  L +L+ L +    ++     N+     L + D+S
Sbjct: 62  IEYAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120

Query: 109 NNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGF 168
           ++     I   I++L  +  + L  N     I P L     L ++++  + ++       
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--- 176

Query: 169 GAAFPKLKSLNLAGNEI 185
              FPKL  L      I
Sbjct: 177 IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.7 bits (166), Expect = 4e-13
 Identities = 31/133 (23%), Positives = 56/133 (42%), Gaps = 8/133 (6%)

Query: 248 LVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLI 307
           L Y+ L+   ++         A N+K L++     T   +  I  L  LE L +    + 
Sbjct: 46  LTYITLANINVTD--LTGIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVT 101

Query: 308 GDIPSEILQLSSLHTLDLSMNHLTGQIPTVSA--KNLGIIDMSHNNLSGEIPASLLEKLP 365
            D    +  L+SL  LD+S +     I T       +  ID+S+N    +I    L+ LP
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP--LKTLP 159

Query: 366 QMERFNFSYNNLT 378
           +++  N  ++ + 
Sbjct: 160 ELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 20/69 (28%), Positives = 30/69 (43%), Gaps = 2/69 (2%)

Query: 47  TTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
           T I  L K+ S+DLS N        L +L  LKSLN+ ++ +       I +F  L    
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLY 187

Query: 107 LSNNNFSGE 115
             +    G+
Sbjct: 188 AFSQTIGGK 196

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  102 bits (254), Expect = 3e-23
 Identities = 44/318 (13%), Positives = 86/318 (27%), Gaps = 54/318 (16%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
              RGT+L +              G    V V             +  E + R++    +
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTW----------EEDG 617
                     + I  +D +++   + ++           D    +            +  
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL----DERDMWVLSRFFLYPRMQSNLQTF 189

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEP 676
              + +  S         R ++ L   R LA LH +G    ++H  ++   + LD     
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGV 245

Query: 677 RLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP---------TPKSDVYCYGVV 727
            L+ F      G  +       S G+ PPE     +            T   D +  G+V
Sbjct: 246 FLTGFEHLVRDGARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302

Query: 728 LLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIG 787
           +  +     P+  D           W+       +  + I   +R           L + 
Sbjct: 303 IYWIWCADLPITKDAALG----GSEWIF------RSCKNIPQPVRA----------L-LE 341

Query: 788 YLCTADLPLKRPSMQQIV 805
                     R    Q +
Sbjct: 342 GFLRYP-KEDRLLPLQAM 358

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  100 bits (250), Expect = 3e-23
 Identities = 71/345 (20%), Positives = 122/345 (35%), Gaps = 105/345 (30%)

Query: 510 FDRGTL-----LAEGKFGPVYRGFLPG-----GIHVAVKVLVHGSTLTDQEAARELEYLG 559
           F+   L     L +G FG V            G  VAVK L H +    ++  RE+E L 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66

Query: 560 RIKHPNLVPLTGYCIAGDQRIAIY---DYMENGNLQNLL--HDLPLGVQTTEDWSTDTWE 614
            ++H N+V   G C +  +R  +    +Y+  G+L++ L  H   +       +++    
Sbjct: 67  SLQHDNIVKYKGVCYSAGRR-NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ--- 122

Query: 615 EDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMN 673
                                   I  G    + +L         IHRD+   ++ ++  
Sbjct: 123 ------------------------ICKG----MEYLGTKRY----IHRDLATRNILVENE 150

Query: 674 LEPRLSDFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVL 728
              ++ DFGL K+     +    +  PG  P     PE +  +S F +  SDV+ +GVVL
Sbjct: 151 NRVKIGDFGLTKVLPQDKEFFKVKE-PGESPIFWYAPE-SLTESKF-SVASDVWSFGVVL 207

Query: 729 LELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQME-----EA 783
            EL T        Y E+ +     ++R +  +                + QM      E 
Sbjct: 208 YELFT--------YIEKSKSPPAEFMRMIGND---------------KQGQMIVFHLIEL 244

Query: 784 LKIGY------LCTADL-----------PLKRPSMQQIVGLLKDI 811
           LK          C  ++             +RPS + +   +  I
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  100 bits (251), Expect = 3e-23
 Identities = 78/322 (24%), Positives = 123/322 (38%), Gaps = 57/322 (17%)

Query: 510 FDRGTL-----LAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEA-ARELEY 557
           F R  L     L  G FG V      G         VAVK+L  G+T ++  A   EL+ 
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 83

Query: 558 LGRI-KHPNLVPLTGYCIAGDQRI-AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEE 615
           L  I  H N+V L G C      +  I ++ + GNL   L       ++  +        
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKVA 136

Query: 616 DGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE 675
                   +  E L+         +   A+ + FL    S   IHRD+ A ++ L     
Sbjct: 137 PEDLYKDFLTLEHLI-------CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNV 186

Query: 676 PRLSDFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLE 730
            ++ DFGLA+      D +  R     +P     PE    D  + T +SDV+ +GV+L E
Sbjct: 187 VKICDFGLARDIYK--DPDYVRKGDARLPLKWMAPE-TIFDRVY-TIQSDVWSFGVLLWE 242

Query: 731 LIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL 789
           + + G  P    YP            G+  + +  R +    R   P+    E  +    
Sbjct: 243 IFSLGASP----YP------------GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 286

Query: 790 CTADLPLKRPSMQQIVGLLKDI 811
           C    P +RP+  ++V  L ++
Sbjct: 287 CWHGEPSQRPTFSELVEHLGNL 308

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 58/248 (23%), Positives = 92/248 (37%), Gaps = 52/248 (20%)

Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVL----VHGSTLTDQEAARELEYLGRIK 562
            +FD G  L +GKFG VY          +A+KVL    +    +  Q   RE+E    ++
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLR 72

Query: 563 HPNLVPLTGYCIAGDQRI-AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           HPN++ +  Y     +RI  + ++   G L   L                          
Sbjct: 73  HPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQ------------------------- 106

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                 G     R    +    A AL + H      +IHRDIK  ++ +    E +++DF
Sbjct: 107 ----KHGRFDEQRSATFMEE-LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADF 158

Query: 682 GLAKIFGNGLDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           G +          + R    G+  Y+PPE  +        K D++C GV+  E + G  P
Sbjct: 159 GWSV-----HAPSLRRRTMCGTLDYLPPEMIE--GKTHDEKVDLWCAGVLCYEFLVGMPP 211

Query: 738 LGDDYPEE 745
                  E
Sbjct: 212 FDSPSHTE 219

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 99.2 bits (248), Expect = 5e-23
 Identities = 69/320 (21%), Positives = 114/320 (35%), Gaps = 58/320 (18%)

Query: 510 FDRGTL-----LAEGKFGPVYRGFLPGG------IHVAVKVLVHGSTLTDQEA-ARELEY 557
                +     L E +FG VY+G L G         VA+K L   +    +E    E   
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65

Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDG 617
             R++HPN+V L G          I+ Y  +G+L   L                    D 
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSP-------------HSDV 112

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEP 676
            ++  +   +  L    F H +    A  + +L  H      +H+D+   +V +   L  
Sbjct: 113 GSTDDDRTVKSALEPPDFVH-LVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNV 167

Query: 677 RLSDFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLEL 731
           ++SD GL +      D     G+   +P     PE A     F +  SD++ YGVVL E+
Sbjct: 168 KISDLGLFREVYAA-DYYKLLGN-SLLPIRWMAPE-AIMYGKF-SIDSDIWSYGVVLWEV 223

Query: 732 IT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLC 790
            + G +P    Y      ++V  +R           +        P+        +   C
Sbjct: 224 FSYGLQP----YCGYSNQDVVEMIR------NRQV-LPC------PDDCPAWVYALMIEC 266

Query: 791 TADLPLKRPSMQQIVGLLKD 810
             + P +RP  + I   L+ 
Sbjct: 267 WNEFPSRRPRFKDIHSRLRA 286

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 99.7 bits (249), Expect = 6e-23
 Identities = 73/330 (22%), Positives = 117/330 (35%), Gaps = 94/330 (28%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFL--PGG---IHVAVKVLVHGSTLTDQEA-ARELEYLGRI 561
           + F +  +L  G FG VY+G     G    I VA+K L   ++    +    E   +  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTN 619
            +P++  L G C+       I   M  G L + +  H   +G Q                
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQY--------------- 118

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRL 678
                     L  W       +  A+ + +L         +HRD+ A +V +      ++
Sbjct: 119 ----------LLNW------CVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKI 158

Query: 679 SDFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT 733
           +DFGLAK+ G    E  A G  G +P      E +     + T +SDV+ YGV + EL+T
Sbjct: 159 TDFGLAKLLGAEEKEYHAEG--GKVPIKWMALE-SILHRIY-THQSDVWSYGVTVWELMT 214

Query: 734 -GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTA 792
            G KP    Y       + S +       KG R   P I                  CT 
Sbjct: 215 FGSKP----YDGIPASEISSILE------KGERLPQPPI------------------CTI 246

Query: 793 DL-----------PLKRPSMQQIVGLLKDI 811
           D+              RP  ++++     +
Sbjct: 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  102 bits (256), Expect = 6e-23
 Identities = 71/310 (22%), Positives = 119/310 (38%), Gaps = 61/310 (19%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
            +      L +G FG V+ G   G   VA+K L  G+  + +   +E + + +++H  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLV 325

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L          I + +YM  G+L + L                                
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKG----------------------------ET 356

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
           G          +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++ 
Sbjct: 357 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 413

Query: 688 GNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDD 741
               D E         P     PE A     F T KSDV+ +G++L EL T G+ P    
Sbjct: 414 ---EDNEYTARQGAKFPIKWTAPE-AALYGRF-TIKSDVWSFGILLTELTTKGRVP---- 464

Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           YP      ++  V       +G R   P      P +  E    +   C    P +RP+ 
Sbjct: 465 YPGMVNREVLDQVE------RGYRM--PC-----PPECPESLHDLMCQCWRKEPEERPTF 511

Query: 802 QQIVGLLKDI 811
           + +   L+D 
Sbjct: 512 EYLQAFLEDY 521

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 64/311 (20%), Positives = 118/311 (37%), Gaps = 68/311 (21%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE---AARELEYLGRIKH 563
           +NF     +  G+F  VYR   L  G+ VA+K +     +  +      +E++ L ++ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           PN++      I  ++   + +  + G+L  +                          I++
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRM--------------------------IKH 125

Query: 624 VGSEGLL----TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
              +  L    T W++  ++      AL  +H   S  ++HRDIK ++V++      +L 
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCS----ALEHMH---SRRVMHRDIKPANVFITATGVVKLG 178

Query: 680 DFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGK 735
           D GL + F +      A    G+P Y+ PE      +     KSD++  G +L E+   +
Sbjct: 179 DLGLGRFFSSKTT--AAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQ 233

Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK--IGYLCTAD 793
            P   D            +  L    K  +   P +    P     E L+  +      D
Sbjct: 234 SPFYGDKMN---------LYSLC--KKIEQCDYPPL----PSDHYSEELRQLVNMCINPD 278

Query: 794 LPLKRPSMQQI 804
            P KRP +  +
Sbjct: 279 -PEKRPDVTYV 288

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 99.8 bits (249), Expect = 7e-23
 Identities = 71/342 (20%), Positives = 121/342 (35%), Gaps = 99/342 (28%)

Query: 510 FDRGTL-----LAEGKFGPVYRGFLPG-----GIHVAVKVLVHGSTLTDQEAARELEYLG 559
           F+   L     L +G FG V            G  VAVK L H +    ++  RE+E L 
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97

Query: 560 RIKHPNLVPLTGYCIAGDQR--IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDG 617
            ++H N+V   G C +  +R    I +Y+  G+L++ L                      
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--------------------- 136

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEP 676
               + +    LL       +      + + +L         IHRD+   ++ ++     
Sbjct: 137 -KHKERIDHIKLL-------QYTSQICKGMEYLGTKRY----IHRDLATRNILVENENRV 184

Query: 677 RLSDFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLEL 731
           ++ DFGL K+     +    +  PG  P     PE +  +S F +  SDV+ +GVVL EL
Sbjct: 185 KIGDFGLTKVLPQDKEYYKVKE-PGESPIFWYAPE-SLTESKF-SVASDVWSFGVVLYEL 241

Query: 732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQME-----EALKI 786
            T        Y E+ +     ++R +  +                + QM      E LK 
Sbjct: 242 FT--------YIEKSKSPPAEFMRMIGND---------------KQGQMIVFHLIELLKN 278

Query: 787 GY------LCTADL-----------PLKRPSMQQIVGLLKDI 811
                    C  ++             +RPS + +   +  I
Sbjct: 279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 99.3 bits (248), Expect = 9e-23
 Identities = 70/318 (22%), Positives = 127/318 (39%), Gaps = 68/318 (21%)

Query: 513 GTLLAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEAA--RELEYLGRIKHPNL 566
           G +L +G+FG V    L       + VAVK+L      +       RE   +    HP++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 567 VPLTGYCIAGDQRIA------IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
             L G  +    +        I  +M++G+L   L             ++   E      
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL------------ASRIGENPFNLP 135

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
           +Q      L+       +  +  A  + +L    S   IHRD+ A +  L  ++   ++D
Sbjct: 136 LQT-----LV-------RFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVAD 180

Query: 681 FGLA-KIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT- 733
           FGL+ KI+     +   +G    +P      E +  D+ + T  SDV+ +GV + E++T 
Sbjct: 181 FGLSRKIYSG---DYYRQGCASKLPVKWLALE-SLADNLY-TVHSDVWAFGVTMWEIMTR 235

Query: 734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTAD 793
           G+ P    Y   +   + +++        G+R +        P + MEE   + Y C + 
Sbjct: 236 GQTP----YAGIENAEIYNYLI------GGNR-LKQ------PPECMEEVYDLMYQCWSA 278

Query: 794 LPLKRPSMQQIVGLLKDI 811
            P +RPS   +   L++I
Sbjct: 279 DPKQRPSFTCLRMELENI 296

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 82/322 (25%), Positives = 126/322 (39%), Gaps = 60/322 (18%)

Query: 510 FDR-----GTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEA-ARELEY 557
           F R     G  L  G FG V      G       + VAVK+L   +   ++EA   EL+ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102

Query: 558 LGRI-KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEED 616
           +  + +H N+V L G C  G   + I +Y   G+L N L                     
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRK---------------SRV 147

Query: 617 GTNSIQNVGSEGLLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLE 675
                    +    +T       +   A+ +AFL    C    IHRD+ A +V L     
Sbjct: 148 LETDPAFAIANSTASTRDL-LHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHV 202

Query: 676 PRLSDFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLE 730
            ++ DFGLA+   N     I +G+   +P     PE +  D  + T +SDV+ YG++L E
Sbjct: 203 AKIGDFGLARDIMND-SNYIVKGN-ARLPVKWMAPE-SIFDCVY-TVQSDVWSYGILLWE 258

Query: 731 LIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL 789
           + + G  P    YP            G++ N+K  + +    +   P    +    I   
Sbjct: 259 IFSLGLNP----YP------------GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA 302

Query: 790 CTADLPLKRPSMQQIVGLLKDI 811
           C A  P  RP+ QQI   L++ 
Sbjct: 303 CWALEPTHRPTFQQICSFLQEQ 324

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 52/315 (16%), Positives = 107/315 (33%), Gaps = 78/315 (24%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNL 566
            +F    L+  G FG V++      G    +K +       +++A RE++ L ++ H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66

Query: 567 V-------------PLTGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWST 610
           V               +    +  +   ++   ++ + G L+  +     G +  +    
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKV--- 122

Query: 611 DTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL 670
                                      +I       + ++H   S  +I+RD+K S+++L
Sbjct: 123 --------------------LALELFEQITK----GVDYIH---SKKLINRDLKPSNIFL 155

Query: 671 DMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLL 729
               + ++ DFGL     N      ++G+  Y+ PE            + D+Y  G++L 
Sbjct: 156 VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS---SQDYGKEVDLYALGLILA 212

Query: 730 ELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL 789
           EL+            E            +R+   S   D K +             +  L
Sbjct: 213 ELLHVCDT-----AFETSKFFT-----DLRDGIISDIFDKKEKTL-----------LQKL 251

Query: 790 CTADLPLKRPSMQQI 804
            +   P  RP+  +I
Sbjct: 252 LSKK-PEDRPNTSEI 265

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 58/252 (23%), Positives = 98/252 (38%), Gaps = 59/252 (23%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFL-----PGGIHVAVKVLVHGSTLTDQEA-ARELEYLGRI 561
           +   +  +L  G FG V++G          I V +KV+   S     +A    +  +G +
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTN 619
            H ++V L G C  G     +  Y+  G+L + +  H   LG Q                
Sbjct: 73  DHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQL--------------- 116

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRL 678
                     L  W       +  A+ + +L  HG     +HR++ A +V L    + ++
Sbjct: 117 ----------LLNW------GVQIAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQV 156

Query: 679 SDFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT 733
           +DFG+A +     D++    S    P      E       + T +SDV+ YGV + EL+T
Sbjct: 157 ADFGVADLLPP--DDKQLLYSEAKTPIKWMALESIH-FGKY-THQSDVWSYGVTVWELMT 212

Query: 734 -GKKPLGDDYPE 744
            G +P    Y  
Sbjct: 213 FGAEP----YAG 220

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 64/317 (20%), Positives = 107/317 (33%), Gaps = 60/317 (18%)

Query: 513 GTLLAEGKFGPVYRGFLPG-----GIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNL 566
              L EG FG V            G  VAVK L   S         +E+E L  + H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 567 VPLTGYCIAGDQRIAIY---DYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSI 621
           V   G C   D    I    +++ +G+L+  L  +   + ++                  
Sbjct: 86  VKYKGICT-EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ----------------- 127

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
                   L       K A+   + + +L         +HRD+ A +V ++   + ++ D
Sbjct: 128 -------QL-------KYAVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGD 169

Query: 681 FGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-G 734
           FGL K      +    +      P     PE     S F    SDV+ +GV L EL+T  
Sbjct: 170 FGLTKAIETDKEYYTVKD-DRDSPVFWYAPECLM-QSKF-YIASDVWSFGVTLHELLTYC 226

Query: 735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL 794
                   P      ++    G +   +    +    R   P    +E  ++   C    
Sbjct: 227 DSDSS---PMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQ 283

Query: 795 PLKRPSMQQIVGLLKDI 811
           P  R S Q ++   + +
Sbjct: 284 PSNRTSFQNLIEGFEAL 300

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 70/328 (21%), Positives = 120/328 (36%), Gaps = 78/328 (23%)

Query: 510 FDRGTL-----LAEGKFGPVYRGFLPGG------IHVAVKVLVHGSTLTDQEA-ARELEY 557
             R  +     L  G FG VY G + G       + VAVK L    +  D+     E   
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86

Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDG 617
           + +  H N+V   G  +    R  + + M  G+L++ L +           +     +  
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRE-----------TRPRPSQPS 135

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFL--HHGCSPPIIHRDIKASSVYLDMNLE 675
           + ++ +     LL        +A   A    +L  +H      IHRDI A +  L     
Sbjct: 136 SLAMLD-----LL-------HVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGP 178

Query: 676 PRL---SDFGLAK-IFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGV 726
            R+    DFG+A+ I+         +G    +P     PE A  +  F T K+D + +GV
Sbjct: 179 GRVAKIGDFGMARDIYR---ASYYRKGGCAMLPVKWMPPE-AFMEGIF-TSKTDTWSFGV 233

Query: 727 VLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPE--KQMEEA 783
           +L E+ + G  P    YP +    ++ +V        G R      ++      + M + 
Sbjct: 234 LLWEIFSLGYMP----YPSKSNQEVLEFVT------SGGRM--DPPKNCPGPVYRIMTQ- 280

Query: 784 LKIGYLCTADLPLKRPSMQQIVGLLKDI 811
                 C    P  RP+   I+  ++  
Sbjct: 281 ------CWQHQPEDRPNFAIILERIEYC 302

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score =  100 bits (251), Expect = 2e-22
 Identities = 59/395 (14%), Positives = 119/395 (30%), Gaps = 68/395 (17%)

Query: 53  SKLQSLDLSENNIT--ALPSDLWSLGSLKSLNLSYNRIS----GSLPSNIGNFGLLEVFD 106
             +QSLD+    ++       L  L   + + L    ++      + S +     L   +
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 107 LSNNNFSGEIPAAISSLV-----SLRVLKLDGNMFQ----WSIPPGLLNCQSLVTVDLSM 157
           L +N         +   +      ++ L L            +   L    +L  + LS 
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 158 NQLNGS----LPDGFGAAFPKLKSLNLAGNEIKGRDTH-----FAGLKSITNLNISGNLF 208
           N L  +    L +G      +L+ L L    +                    L +S N  
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 209 QGSVMGVFLE-------SLEVIDLRSNQFQ----GHISQV-QFNSSYNWSRLVYVDLSEN 256
             + + V  +        LE + L S          +  +    +S     L  + L  N
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKAS-----LRELALGSN 237

Query: 257 QLSGEIFHNFSQA-----QNLKHLSLAYNRFTRQEFPQIGTLLG----LEHLNLSRTSLI 307
           +L                  L+ L +     T +    +  +L     L+ L+L+    +
Sbjct: 238 KLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE-L 296

Query: 308 GD------IPSEILQLSSLHTLDLSMNHLTGQ----IPTVSAKN--LGIIDMSHNNLSGE 355
           GD        + +     L +L +     T        +V A+N  L  + +S+N L   
Sbjct: 297 GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356

Query: 356 ----IPASLLEKLPQMERFNFSYNNLTL-CASELS 385
               +   L +    +     +  +++    S L+
Sbjct: 357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA 391

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 85.0 bits (211), Expect = 2e-17
 Identities = 66/337 (19%), Positives = 110/337 (32%), Gaps = 63/337 (18%)

Query: 51  KLSKLQSLDLSENNIT-----ALPSDLWSLGS-LKSLNLSYNRISGSLPSNIGNFGL--- 101
            L  LQ L LS+N +       L   L      L+ L L Y  +S +    +    L   
Sbjct: 111 TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA-SVLRAK 169

Query: 102 --LEVFDLSNNNFSGEIPAAIS-----SLVSLRVLKLDGNMFQW----SIPPGLLNCQSL 150
              +   +SNN+ +      +      S   L  LKL+           +   + +  SL
Sbjct: 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL 229

Query: 151 VTVDLSMNQLNGS----LPDGFGAAFPKLKSLNLAGNEIKGRDTHF-----AGLKSITNL 201
             + L  N+L       L  G      +L++L +    I  +            +S+  L
Sbjct: 230 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKEL 289

Query: 202 NISGNLFQGSVMGVFLE-------SLEVIDLRSNQFQG----HISQV-QFNSSYNWSRLV 249
           +++GN        +  E        LE + ++S  F      H S V   N       L+
Sbjct: 290 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF-----LL 344

Query: 250 YVDLSENQLSGEIFHNFSQA-----QNLKHLSLAYNRFTRQEFPQIGTLLG----LEHLN 300
            + +S N+L         Q        L+ L LA    +      +   L     L  L+
Sbjct: 345 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 404

Query: 301 LSRTSLIGDIP----SEILQL--SSLHTLDLSMNHLT 331
           LS    +GD       E ++     L  L L   + +
Sbjct: 405 LSNNC-LGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 80.0 bits (198), Expect = 8e-16
 Identities = 49/301 (16%), Positives = 91/301 (30%), Gaps = 54/301 (17%)

Query: 49  IGKLSKLQSLDLSENNI-----TALPSDL-WSLGSLKSLNLSYNRIS----GSLPSNIGN 98
           +      + L +S N+I       L   L  S   L++L L    ++      L   + +
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225

Query: 99  FGLLEVFDLSNNNFSGE-----IPAAISSLVSLRVLKLDGNMFQW----SIPPGLLNCQS 149
              L    L +N           P  +     LR L +            +   L   +S
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285

Query: 150 LVTVDLSMNQLNGS----LPDGFGAAFPKLKSLNLAGNEIKGRDTHF-----AGLKSITN 200
           L  + L+ N+L       L +       +L+SL +                 A  + +  
Sbjct: 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLE 345

Query: 201 LNISGNLFQGSVMGVFLE-------SLEVIDLRSNQFQ----GHISQV-QFNSSYNWSRL 248
           L IS N  + + +    +        L V+ L            ++     N S     L
Sbjct: 346 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS-----L 400

Query: 249 VYVDLSENQLSGEIFHNFSQA-----QNLKHLSLAYNRFTRQEFPQIGTLL----GLEHL 299
             +DLS N L         ++       L+ L L    ++ +   ++  L      L  +
Sbjct: 401 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460

Query: 300 N 300
           +
Sbjct: 461 S 461

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 53/246 (21%), Positives = 92/246 (37%), Gaps = 46/246 (18%)

Query: 505 SATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE---AARELEYLGR 560
           S   +++    +  G +G   +      G  +  K  +   ++T+ E      E+  L  
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKE-LDYGSMTEAEKQMLVSEVNLLRE 61

Query: 561 IKHPNLVPLTG-YCIAGDQRIAIY-DYMENGNLQNLLHDLPL-GVQTTEDWSTDTWEEDG 617
           +KHPN+V          +  + I  +Y E G+L +++           E+          
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE---------- 111

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH--HGCSPPIIHRDIKASSVYLDMNLE 675
                           R   ++ L    AL   H        ++HRD+K ++V+LD    
Sbjct: 112 -------------FVLRVMTQLTL----ALKECHRRSDGGHTVLHRDLKPANVFLDGKQN 154

Query: 676 PRLSDFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLEL 731
            +L DFGLA+I  +      A+   G+P Y+ PE            KSD++  G +L EL
Sbjct: 155 VKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMN---RMSYNEKSDIWSLGCLLYEL 209

Query: 732 ITGKKP 737
                P
Sbjct: 210 CALMPP 215

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 98.3 bits (245), Expect = 2e-22
 Identities = 46/253 (18%), Positives = 90/253 (35%), Gaps = 47/253 (18%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVL------------------VHGSTLTDQE 550
           ++     L +GKF  +           A+K                    +   +  D  
Sbjct: 32  DYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD- 89

Query: 551 AARELEYLGRIKHPNLVPLTGYCIAGDQRI-AIYDYMENGNLQNLLHDLPLGVQTTEDWS 609
              EL+ +  IK+   +   G  I     +  IY+YMEN ++                  
Sbjct: 90  FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEY------------ 136

Query: 610 TDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY 669
                      + +      +     +  I      + +++H+  +  I HRD+K S++ 
Sbjct: 137 ---------FFVLDKNYTCFIPIQVIKCIIK-SVLNSFSYIHNEKN--ICHRDVKPSNIL 184

Query: 670 LDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLL 729
           +D N   +LSDFG ++   +    + +RG+  ++PPEF   +S +   K D++  G+ L 
Sbjct: 185 MDKNGRVKLSDFGESEYMVDKK-IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243

Query: 730 ELITGKKPLGDDY 742
            +     P     
Sbjct: 244 VMFYNVVPFSLKI 256

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 99.0 bits (247), Expect = 2e-22
 Identities = 85/323 (26%), Positives = 126/323 (39%), Gaps = 59/323 (18%)

Query: 510 FDR-----GTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTDQEA-AREL 555
             R     G  L EG FG V      G           VAVK+L   +T  D      E+
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125

Query: 556 EYLGRI-KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWE 614
           E +  I KH N++ L G C        I +Y   GNL+  L       Q       +   
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-------QARRPPGLEYSY 178

Query: 615 EDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNL 674
               N  + + S+ L+         A   AR + +L    S   IHRD+ A +V +  + 
Sbjct: 179 NPSHNPEEQLSSKDLV-------SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDN 228

Query: 675 EPRLSDFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLL 729
             +++DFGLA+   +  D      + G +P     PE A  D  + T +SDV+ +GV+L 
Sbjct: 229 VMKIADFGLARDIHHI-DYYKKTTN-GRLPVKWMAPE-ALFDRIY-THQSDVWSFGVLLW 284

Query: 730 ELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGY 788
           E+ T G  P    YP      L   ++      +G R    K     P     E   +  
Sbjct: 285 EIFTLGGSP----YPGVPVEELFKLLK------EGHRM--DK-----PSNCTNELYMMMR 327

Query: 789 LCTADLPLKRPSMQQIVGLLKDI 811
            C   +P +RP+ +Q+V  L  I
Sbjct: 328 DCWHAVPSQRPTFKQLVEDLDRI 350

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 66/309 (21%), Positives = 110/309 (35%), Gaps = 69/309 (22%)

Query: 516 LAEGKFGPVYRGFL---PGGIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPLTG 571
           L  G FG V +G        I VA+KVL  G+   D E   RE + + ++ +P +V L G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 572 YCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL 629
            C   +  + + +    G L   L      + V    +                      
Sbjct: 78  VCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ------------------ 118

Query: 630 LTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
                    +++G    + +L         +HRD+ A +V L      ++SDFGL+K  G
Sbjct: 119 ---------VSMG----MKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALG 161

Query: 689 NGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
                  AR + G  P     PE       F + +SDV+ YGV + E ++ G+KP    Y
Sbjct: 162 ADDSYYTARSA-GKWPLKWYAPECIN-FRKF-SSRSDVWSYGVTMWEALSYGQKP----Y 214

Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
            +             ++  +    I+   R   P +   E   +   C       RP   
Sbjct: 215 KK-------------MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFL 261

Query: 803 QIVGLLKDI 811
            +   ++  
Sbjct: 262 TVEQRMRAC 270

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 71/308 (23%), Positives = 115/308 (37%), Gaps = 65/308 (21%)

Query: 516 LAEGKFGPVYRGFLP----GGIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPLT 570
           +  G  G V  G L       + VA+K L  G T   +     E   +G+  HPN++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
           G    G   + + +YMENG+L   L                               +G  
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRT----------------------------HDGQF 148

Query: 631 TTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
           T  +    +  G    + +L   G     +HRD+ A +V +D NL  ++SDFGL+++  +
Sbjct: 149 TIMQLVG-MLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203

Query: 690 GLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
             D        G IP     PE       F +  SDV+ +GVV+ E++  G++P    Y 
Sbjct: 204 DPDAAYTTTG-GKIPIRWTAPEAIA-FRTF-SSASDVWSFGVVMWEVLAYGERP----YW 256

Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
                         + N     +++   R   P        ++   C      +RP   Q
Sbjct: 257 N-------------MTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ 303

Query: 804 IVGLLKDI 811
           IV +L  +
Sbjct: 304 IVSVLDAL 311

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 96.1 bits (240), Expect = 4e-22
 Identities = 77/306 (25%), Positives = 123/306 (40%), Gaps = 63/306 (20%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGY 572
              L  G+FG V+ G+  G   VAVK L  GS  +      E   + +++H  LV L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 573 CIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTT 632
                  I I +YMENG+L + L                                G+  T
Sbjct: 77  VTQEPIYI-ITEYMENGSLVDFLKT----------------------------PSGIKLT 107

Query: 633 WRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL 691
                 +A   A  +AF+         IHRD++A+++ +   L  +++DFGLA++     
Sbjct: 108 INKLLDMAAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI---E 160

Query: 692 DEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEE 745
           D E         P     PE A     F T KSDV+ +G++L E++T G+ P    YP  
Sbjct: 161 DNEYTAREGAKFPIKWTAPE-AINYGTF-TIKSDVWSFGILLTEIVTHGRIP----YPGM 214

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
               ++  +       +G R    +     P+   EE  ++  LC  + P  RP+   + 
Sbjct: 215 TNPEVIQNLE------RGYRM--VR-----PDNCPEELYQLMRLCWKERPEDRPTFDYLR 261

Query: 806 GLLKDI 811
            +L+D 
Sbjct: 262 SVLEDF 267

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 96.1 bits (240), Expect = 4e-22
 Identities = 55/241 (22%), Positives = 99/241 (41%), Gaps = 53/241 (21%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL----VHGSTLTDQEAARELEYLGRIKH 563
           +F  G LL +G F  VYR   +  G+ VA+K++    ++ + +  +    E++   ++KH
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKH 70

Query: 564 PNLVPLTGYCIAGDQRI-AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           P+++ L  Y       +  + +   NG +   L +                         
Sbjct: 71  PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKN------------------------- 104

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                   +    RH +       + +LH HG    I+HRD+  S++ L  N+  +++DF
Sbjct: 105 ---RVKPFSENEARHFMH-QIITGMLYLHSHG----ILHRDLTLSNLLLTRNMNIKIADF 156

Query: 682 GLAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           GLA      L     +     G+P YI PE A   +     +SDV+  G +   L+ G+ 
Sbjct: 157 GLA----TQLKMPHEKHYTLCGTPNYISPEIATRSAH--GLESDVWSLGCMFYTLLIGRP 210

Query: 737 P 737
           P
Sbjct: 211 P 211

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 98.2 bits (245), Expect = 4e-22
 Identities = 73/326 (22%), Positives = 122/326 (37%), Gaps = 74/326 (22%)

Query: 510 FDRGTL-----LAEGKFGPVYRGFLPGG------IHVAVKVLVHGSTLTDQEA-ARELEY 557
             R  +     L  G FG VY G + G       + VAVK L    +  D+     E   
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127

Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDG 617
           + +  H N+V   G  +    R  + + M  G+L++ L +           +     +  
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-----------TRPRPSQPS 176

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFL--HHGCSPPIIHRDIKASSVYLDMNLE 675
           + ++ +     LL        +A   A    +L  +H      IHRDI A +  L     
Sbjct: 177 SLAMLD-----LL-------HVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGP 219

Query: 676 PRL---SDFGLAK-IFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGV 726
            R+    DFG+A+ I+         +G    +P     PE A  +  F T K+D + +GV
Sbjct: 220 GRVAKIGDFGMARDIYRA---GYYRKGGCAMLPVKWMPPE-AFMEGIF-TSKTDTWSFGV 274

Query: 727 VLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK 785
           +L E+ + G  P    YP +    ++ +V        G R +DP      P+       +
Sbjct: 275 LLWEIFSLGYMP----YPSKSNQEVLEFVT------SGGR-MDP------PKNCPGPVYR 317

Query: 786 IGYLCTADLPLKRPSMQQIVGLLKDI 811
           I   C    P  RP+   I+  ++  
Sbjct: 318 IMTQCWQHQPEDRPNFAIILERIEYC 343

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 97.5 bits (243), Expect = 5e-22
 Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 45/237 (18%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE---AARELEYLGRIKHP 564
            + R   + EG FG          G    +K  ++ S ++ +E   + RE+  L  +KHP
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKE-INISRMSSKEREESRREVAVLANMKHP 83

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
           N+V              + DY E G+L   ++    GV   ED                 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK-GVLFQED----------------- 125

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
                     +  +I L    AL  +H      I+HRDIK+ +++L  +   +L DFG+A
Sbjct: 126 ------QILDWFVQICL----ALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172

Query: 685 KIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGKKP 737
           ++  + ++  +AR   G+P Y+ PE  +   + P   KSD++  G VL EL T K  
Sbjct: 173 RVLNSTVE--LARACIGTPYYLSPEICE---NKPYNNKSDIWALGCVLYELCTLKHA 224

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 98.2 bits (245), Expect = 8e-22
 Identities = 70/307 (22%), Positives = 121/307 (39%), Gaps = 69/307 (22%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGY 572
              + +G+FG V  G    G  VAVK + + +T   Q    E   + +++H NLV L G 
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV 254

Query: 573 CIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLT 631
            +     + I  +YM  G+L + L                      +     +G + LL 
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLR---------------------SRGRSVLGGDCLL- 292

Query: 632 TWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
                 K +L    A+ +L  +      +HRD+ A +V +  +   ++SDFGL K     
Sbjct: 293 ------KFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK----- 337

Query: 691 LDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE 744
            +    + + G +P     PE  + +  F + KSDV+ +G++L E+ + G+ P    YP 
Sbjct: 338 -EASSTQDT-GKLPVKWTAPEALR-EKKF-STKSDVWSFGILLWEIYSFGRVP----YPR 389

Query: 745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
               ++V  V       KG +          P+        +   C       RP+  Q+
Sbjct: 390 IPLKDVVPRVE------KGYKM--DA-----PDGCPPAVYDVMKNCWHLDAATRPTFLQL 436

Query: 805 VGLLKDI 811
              L+ I
Sbjct: 437 REQLEHI 443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 97.0 bits (242), Expect = 1e-21
 Identities = 74/308 (24%), Positives = 119/308 (38%), Gaps = 65/308 (21%)

Query: 516 LAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPLT 570
           +  G+FG V  G L       I VA+K L  G T   +     E   +G+  HPN++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
           G        + + +YMENG+L + L                               +   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRK----------------------------HDAQF 144

Query: 631 TTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
           T  +    +  G A  + +L   G     +HRD+ A ++ ++ NL  ++SDFGL ++  +
Sbjct: 145 TVIQLVG-MLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLED 199

Query: 690 GLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
             +        G IP     PE       F T  SDV+ YG+VL E+++ G++P    Y 
Sbjct: 200 DPEAAYTTRG-GKIPIRWTSPEAIA-YRKF-TSASDVWSYGIVLWEVMSYGERP----YW 252

Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
           E             + N    +A+D   R   P        ++   C       RP  +Q
Sbjct: 253 E-------------MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299

Query: 804 IVGLLKDI 811
           IV +L  +
Sbjct: 300 IVSILDKL 307

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 60/313 (19%), Positives = 110/313 (35%), Gaps = 69/313 (22%)

Query: 512 RGTLLAEGKFGPVYRGFLPGG---IHVAVKVLVHGSTLTDQEAA--RELEYLGRIKHPNL 566
               L  G FG V +G+         VAVK+L + +     +     E   + ++ +P +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 567 VPLTGYCIAGDQRIAIYDYMENGNLQN-LLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           V + G C A    + + +  E G L   L  +  +  +   +                  
Sbjct: 81  VRMIGICEAESWML-VMEMAELGPLNKYLQQNRHVKDKNIIELVHQ-------------- 125

Query: 626 SEGLLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
                        +++G    + +L         +HRD+ A +V L      ++SDFGL+
Sbjct: 126 -------------VSMG----MKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLS 164

Query: 685 KIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPL 738
           K      +   A+   G  P     PE       F + KSDV+ +GV++ E  + G+KP 
Sbjct: 165 KALRADENYYKAQTH-GKWPVKWYAPECIN-YYKF-SSKSDVWSFGVLMWEAFSYGQKP- 220

Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
              Y               ++ ++ +  ++   R   P     E   +  LC       R
Sbjct: 221 ---YRG-------------MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 264

Query: 799 PSMQQIVGLLKDI 811
           P    +   L++ 
Sbjct: 265 PGFAAVELRLRNY 277

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 72/309 (23%), Positives = 123/309 (39%), Gaps = 66/309 (21%)

Query: 516 LAEGKFGPVYRGFL-----PGGIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPL 569
           +  G+FG VY+G L        + VA+K L  G T   +     E   +G+  H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 570 TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL 629
            G        + I +YMENG L   L +                             +G 
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE----------------------------KDGE 143

Query: 630 LTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
            +  +    +  G A  + +L +       +HRD+ A ++ ++ NL  ++SDFGL+++  
Sbjct: 144 FSVLQLVG-MLRGIAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLE 198

Query: 689 NGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
           +  +      S G IP     PE       F T  SDV+ +G+V+ E++T G++P    Y
Sbjct: 199 DDPEATYTT-SGGKIPIRWTAPEAIS-YRKF-TSASDVWSFGIVMWEVMTYGERP----Y 251

Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
            E             + N++  +AI+   R   P        ++   C      +RP   
Sbjct: 252 WE-------------LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFA 298

Query: 803 QIVGLLKDI 811
            IV +L  +
Sbjct: 299 DIVSILDKL 307

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 53/258 (20%), Positives = 97/258 (37%), Gaps = 23/258 (8%)

Query: 23  CDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLN 82
            D    +     A  S ++ +V       L  + +L      +T +   +  L +L  L 
Sbjct: 14  PDPALANAIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLE 69

Query: 83  LSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPP 142
           L  N+I+    + + N   +   +LS N     +  AI+ L S++ L L        + P
Sbjct: 70  LKDNQITD--LAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQIT-DVTP 124

Query: 143 GLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLN 202
            L    +L  + L +NQ+  ++     A    L+ L++   ++    T  A L  +T L 
Sbjct: 125 -LAGLSNLQVLYLDLNQIT-NIS-PL-AGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLK 179

Query: 203 ISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEI 262
              N          L +L  + L++NQ    IS V   +  N S L  V L+   ++ + 
Sbjct: 180 ADDNKISDISPLASLPNLIEVHLKNNQ----ISDVSPLA--NTSNLFIVTLTNQTITNQ- 232

Query: 263 FHNFSQAQNLKHLSLAYN 280
                   NL   ++   
Sbjct: 233 --PVFYNNNLVVPNVVKG 248

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 39/239 (16%), Positives = 86/239 (35%), Gaps = 23/239 (9%)

Query: 143 GLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLN 202
                 + + +    + +  ++     A    + +L+  G  +         L ++  L 
Sbjct: 14  PDPALANAIKIAAGKSNVTDTVTQ---ADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLE 69

Query: 203 ISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSG 260
           +  N  Q + +     L  +  ++L  N     +  V   +      +  +DL+  Q++ 
Sbjct: 70  LKDN--QITDLAPLKNLTKITELELSGNP----LKNVSAIA--GLQSIKTLDLTSTQITD 121

Query: 261 EIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSL 320
                 +   NL+ L L  N+ T      +  L  L++L++     + D+ + +  LS L
Sbjct: 122 --VTPLAGLSNLQVLYLDLNQIT--NISPLAGLTNLQYLSIGNAQ-VSDL-TPLANLSKL 175

Query: 321 HTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTL 379
            TL    N ++   P  S  NL  + + +N +S   P   L     +     +   +T 
Sbjct: 176 TTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP---LANTSNLFIVTLTNQTITN 231

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 87.1 bits (216), Expect = 8e-19
 Identities = 48/305 (15%), Positives = 100/305 (32%), Gaps = 68/305 (22%)

Query: 60  LSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAA 119
                I  +     +L +   +    + ++        +   +                 
Sbjct: 4   TQPTAINVI-FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTG-------- 52

Query: 120 ISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLN 179
           ++++                   G+    +L+ ++L  NQ+    P        K+  L 
Sbjct: 53  VTTI------------------EGVQYLNNLIGLELKDNQITDLAPL---KNLTKITELE 91

Query: 180 LAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQF 239
           L+GN +K   +  AGL+SI  L+++                             I+ V  
Sbjct: 92  LSGNPLK-NVSAIAGLQSIKTLDLTST--------------------------QITDVTP 124

Query: 240 NSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHL 299
            +    S L  + L  NQ++       +   NL++LS+   + +  +   +  L  L  L
Sbjct: 125 LAGL--SNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVS--DLTPLANLSKLTTL 178

Query: 300 NLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPAS 359
                  I DI S +  L +L  + L  N ++   P  +  NL I+ +++  ++   P  
Sbjct: 179 KADDNK-ISDI-SPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTIT-NQPVF 235

Query: 360 LLEKL 364
               L
Sbjct: 236 YNNNL 240

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 32/164 (19%), Positives = 58/164 (35%), Gaps = 8/164 (4%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS 108
           +  L+ LQ L +    ++ L + L +L  L +L    N+IS    S + +   L    L 
Sbjct: 147 LAGLTNLQYLSIGNAQVSDL-TPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLK 203

Query: 109 NNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGF 168
           NN  S   P  +++  +L ++ L       + P    N  +LV  ++        +    
Sbjct: 204 NNQISDVSP--LANTSNLFIVTLTNQTIT-NQPVFYNN--NLVVPNVVKGPSGAPIAPAT 258

Query: 169 GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSV 212
            +      S NL  N     +              +   F G+V
Sbjct: 259 ISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSGTV 302

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 61/272 (22%), Positives = 91/272 (33%), Gaps = 54/272 (19%)

Query: 22  VCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKS 80
           V                     +PD         ++LDLS N +  L S   +S   L+ 
Sbjct: 4   VEVVPNITYQ---CMELNFY-KIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQV 56

Query: 81  LNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSI 140
           L+LS   I  ++            +                SL  L  L L GN  Q S+
Sbjct: 57  LDLSRCEIQ-TIEDG--------AYQ---------------SLSHLSTLILTGNPIQ-SL 91

Query: 141 PPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIK--GRDTHFAGLKS 197
             G      SL  +      L  SL +        LK LN+A N I+      +F+ L +
Sbjct: 92  ALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150

Query: 198 ITNLNISGNLFQGSVMGVF--LESLEVI----DLRSNQFQGHISQVQFNSSYNWSRLVYV 251
           + +L++S N  Q         L  + ++    DL  N     I    F       RL  +
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE----IRLKEL 205

Query: 252 DLSENQLS---GEIFHNFSQAQNLKHLSLAYN 280
            L  NQL      IF   +   +L+ + L  N
Sbjct: 206 ALDTNQLKSVPDGIFDRLT---SLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 90.0 bits (224), Expect = 5e-20
 Identities = 47/200 (23%), Positives = 79/200 (39%), Gaps = 15/200 (7%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDL-WSLGSLKSLNLSYNRISGSLPSNI-GNFG 100
            +   +     +LQ LDLS   I  +      SL  L +L L+ N I  SL         
Sbjct: 42  HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLS 100

Query: 101 LLEVFDLSNNNFSGEIPA-AISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMN 158
            L+       N +  +    I  L +L+ L +  N+ Q    P    N  +L  +DLS N
Sbjct: 101 SLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 159 QLNGSLPDGFGAAFPKLK----SLNLAGNEIKGRDTH-FAGLKSITNLNISGNLFQGSVM 213
           ++  S+         ++     SL+L+ N +       F  ++ +  L +  N  +    
Sbjct: 160 KIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLKSVPD 217

Query: 214 GVF--LESLEVIDLRSNQFQ 231
           G+F  L SL+ I L +N + 
Sbjct: 218 GIFDRLTSLQKIWLHTNPWD 237

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 63/279 (22%), Positives = 96/279 (34%), Gaps = 62/279 (22%)

Query: 57  SLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEI 116
           +    E N   +P +L    S K+L+LS+N +   L S          F           
Sbjct: 11  TYQCMELNFYKIPDNLPF--STKNLDLSFNPLR-HLGSY--------SFF---------- 49

Query: 117 PAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAFPKL 175
                S   L+VL L     Q +I  G   +   L T+ L+ N +  SL  G  +    L
Sbjct: 50  -----SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102

Query: 176 KSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQG-SVMGVF--LESLEVIDLRSNQFQ 231
           + L      +    +     LK++  LN++ NL Q   +   F  L +LE +DL SN+ Q
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

Query: 232 GHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLK-HLSLAYNRFTRQEFPQI 290
                                     +         Q   L   L L+ N     + P  
Sbjct: 163 -------------------------SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ-PGA 196

Query: 291 GTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMN 328
              + L+ L L    L   +P  I   L+SL  + L  N
Sbjct: 197 FKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 26/226 (11%)

Query: 139 SIPPGL-LNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH-FAGLK 196
            IP  L  + ++L   DLS N L   L      +FP+L+ L+L+  EI+  +   +  L 
Sbjct: 21  KIPDNLPFSTKNL---DLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS 76

Query: 197 SITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLS 254
            ++ L ++GN  Q   +G F  L SL+ +          +         +   L  ++++
Sbjct: 77  HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIG---HLKTLKELNVA 132

Query: 255 ENQLSGEIFHN-FSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSL------I 307
            N +        FS   NL+HL L+ N+           L  L  + L   SL      +
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS---IYCTDLRVLHQMPLLNLSLDLSLNPM 189

Query: 308 GDIPSEILQLSSLHTLDLSMNHLTGQIPT---VSAKNLGIIDMSHN 350
             I     +   L  L L  N L   +P        +L  I +  N
Sbjct: 190 NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 56.5 bits (137), Expect = 9e-09
 Identities = 27/164 (16%), Positives = 50/164 (30%), Gaps = 34/164 (20%)

Query: 219 SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLA 278
           S + +DL  N     +  +   S +++  L  +DLS  ++       +    +L  L L 
Sbjct: 29  STKNLDLSFNP----LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 279 YNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL-QLSSLHTLDLSMNHLTGQIPTV 337
            N                             +       LSSL  L     +L   +   
Sbjct: 85  GNPIQS-------------------------LALGAFSGLSSLQKLVAVETNLA-SLENF 118

Query: 338 SA---KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
                K L  ++++HN +           L  +E  + S N + 
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 64/340 (18%), Positives = 110/340 (32%), Gaps = 105/340 (30%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFL--PGG--IHVAVKVLVHGSTLTDQEAA---RELEYLGR 560
            +      L +G FG V RG    P G  + VAVK L        +      RE+  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 561 IKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGT 618
           + H NL+ L G  +    ++ + +    G+L + L  H     + T   ++         
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ------- 129

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPR 677
                               +A G    + +L         IHRD+ A ++ L      +
Sbjct: 130 --------------------VAEG----MGYLESKRF----IHRDLAARNLLLATRDLVK 161

Query: 678 LSDFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELI 732
           + DFGL +      D  + +     +P     PE +     F +  SD + +GV L E+ 
Sbjct: 162 IGDFGLMRALPQNDDHYVMQ-EHRKVPFAWCAPE-SLKTRTF-SHASDTWMFGVTLWEMF 218

Query: 733 T-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGY--- 788
           T G++P    +               +  ++    ID                K G    
Sbjct: 219 TYGQEP----WIG-------------LNGSQILHKID----------------KEGERLP 245

Query: 789 ---LCTADL-----------PLKRPSMQQIVGLLKDIEST 814
               C  D+           P  RP+   +   L + + T
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 94.5 bits (235), Expect = 5e-21
 Identities = 52/266 (19%), Positives = 91/266 (34%), Gaps = 34/266 (12%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL----VHGSTLTDQEAA-RELEYLGR 560
              +     + +G +G V            A+K++    +      D E    E+  + +
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 561 IKHPNLVPLTGYCIAGDQRIAIY---DYMENGNL------QNLLHDLPLGVQTTEDWSTD 611
           + HPN+  L       +    I    +    G+L                +   +     
Sbjct: 85  LHHPNIARLYEVY---EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 612 TWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTAR----ALAFLH-HGCSPPIIHRDIKAS 666
             E +      ++        +  R K+     R    AL +LH  G    I HRDIK  
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPE 197

Query: 667 SVYL--DMNLEPRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKS 719
           +     + + E +L DFGL+K F    + E        G+P ++ PE     ++   PK 
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257

Query: 720 DVYCYGVVLLELITGKKPLGDDYPEE 745
           D +  GV+L  L+ G  P       +
Sbjct: 258 DAWSAGVLLHLLLMGAVPFPGVNDAD 283

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 97.6 bits (243), Expect = 5e-21
 Identities = 49/254 (19%), Positives = 79/254 (31%), Gaps = 80/254 (31%)

Query: 515 LLAEGKFGPVYRGF---LPGGIHVAVKVLVHGSTLTDQEAA-RELEYLGRIKHPNLVPLT 570
            +A G  G +Y      + G   V +K LVH      Q  A  E ++L  + HP++V   
Sbjct: 87  CIAHGGLGWIYLALDRNVNGR-PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV--- 142

Query: 571 GYCIAGDQRIAIYDY---------------ME--NG-NLQNLLHDLPLGVQTTEDWSTDT 612
                      I+++               ME   G +L+       L V          
Sbjct: 143 ----------QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIA----- 186

Query: 613 WEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLD 671
                                       L    AL++LH  G    +++ D+K  ++ L 
Sbjct: 187 --------------------------YLLEILPALSYLHSIG----LVYNDLKPENIMLT 216

Query: 672 MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL 731
              + +L D G               G+PG+  PE  +     PT  +D+Y  G  L  L
Sbjct: 217 EE-QLKLIDLGAVSRIN---SFGYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAAL 269

Query: 732 ITGKKPLGDDYPEE 745
                     Y + 
Sbjct: 270 TLDLPTRNGRYVDG 283

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 71/310 (22%), Positives = 115/310 (37%), Gaps = 72/310 (23%)

Query: 516 LAEGKFGPVYRGFL--PGG--IHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPLT 570
           + EG+FG V++G    P    + VA+K   + ++ + +E   +E   + +  HP++V L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           G        I I +    G L++ L      L + +                        
Sbjct: 83  GVITENPVWI-IMELCTLGELRSFLQVRKYSLDLAS------------------------ 117

Query: 629 LLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
           L+         A   + ALA+L         +HRDI A +V +  N   +L DFGL++  
Sbjct: 118 LI-------LYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM 166

Query: 688 GNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDD 741
               D    + S G +P     PE       F T  SDV+ +GV + E++  G KP    
Sbjct: 167 ---EDSTYYKASKGKLPIKWMAPESIN-FRRF-TSASDVWMFGVCMWEILMHGVKP---- 217

Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
           +               V+NN     I+   R   P         +   C A  P +RP  
Sbjct: 218 FQG-------------VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRF 264

Query: 802 QQIVGLLKDI 811
            ++   L  I
Sbjct: 265 TELKAQLSTI 274

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 94.2 bits (234), Expect = 8e-21
 Identities = 79/350 (22%), Positives = 126/350 (36%), Gaps = 74/350 (21%)

Query: 513 GTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEAA-RELEYLGRI-KHP 564
           G  L  G FG V      G         VAVK+L  G+T ++  A   EL+ L  I  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 565 NLVPLTGYCIAGDQRI-AIYDYMENGNLQNLLHD-------------------------- 597
           N+V L G C      +  I ++ + GNL   L                            
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 598 ------LPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHK----IALGTARAL 647
                 L     +    S+   EE   + ++   +   L       +     +   A+ +
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 648 AFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIP--- 704
            FL    S   IHRD+ A ++ L      ++ DFGLA+      D +  R     +P   
Sbjct: 207 EFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK--DPDYVRKGDARLPLKW 261

Query: 705 --PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNN 761
             PE    D  + T +SDV+ +GV+L E+ + G  P    YP            G+  + 
Sbjct: 262 MAPE-TIFDRVY-TIQSDVWSFGVLLWEIFSLGASP----YP------------GVKIDE 303

Query: 762 KGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
           +  R +    R   P+    E  +    C    P +RP+  ++V  L ++
Sbjct: 304 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 96.2 bits (239), Expect = 1e-20
 Identities = 65/309 (21%), Positives = 110/309 (35%), Gaps = 69/309 (22%)

Query: 516 LAEGKFGPVYRGFLPGG---IHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPLTG 571
           L  G FG V +G        I VA+KVL  G+   D E   RE + + ++ +P +V L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 572 YCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGL 629
            C   +  + + +    G L   L      + V    +                      
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ------------------ 444

Query: 630 LTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
                    +++G    + +L         +HR++ A +V L      ++SDFGL+K  G
Sbjct: 445 ---------VSMG----MKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALG 487

Query: 689 NGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDY 742
                  AR + G  P     PE       F + +SDV+ YGV + E ++ G+KP    Y
Sbjct: 488 ADDSYYTARSA-GKWPLKWYAPECIN-FRKF-SSRSDVWSYGVTMWEALSYGQKP----Y 540

Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
            +             ++  +    I+   R   P +   E   +   C       RP   
Sbjct: 541 KK-------------MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFL 587

Query: 803 QIVGLLKDI 811
            +   ++  
Sbjct: 588 TVEQRMRAC 596

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 96.1 bits (239), Expect = 1e-20
 Identities = 72/318 (22%), Positives = 118/318 (37%), Gaps = 72/318 (22%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFL--PGG--IHVAVKVLVHGSTLTDQEA-ARELEYLGRIK 562
              + G  + EG+FG V++G    P    + VA+K   + ++ + +E   +E   + +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNS 620
           HP++V L G        I I +    G L++ L      L + +                
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKFSLDLAS---------------- 492

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                   L+         A   + ALA+L         +HRDI A +V +  N   +L 
Sbjct: 493 --------LI-------LYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLG 533

Query: 680 DFGLAKIFGNGLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT- 733
           DFGL++      D    + S G +P     PE +     F T  SDV+ +GV + E++  
Sbjct: 534 DFGLSRYME---DSTYYKASKGKLPIKWMAPE-SINFRRF-TSASDVWMFGVCMWEILMH 588

Query: 734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTAD 793
           G KP    +               V+NN     I+   R   P         +   C A 
Sbjct: 589 GVKP----FQG-------------VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 631

Query: 794 LPLKRPSMQQIVGLLKDI 811
            P +RP   ++   L  I
Sbjct: 632 DPSRRPRFTELKAQLSTI 649

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 56/253 (22%), Positives = 88/253 (34%), Gaps = 50/253 (19%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL-VHGSTLTDQEAARE----LEYLGRI 561
            +F R + L  G +G V++      G   AVK          D+          E +G  
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG-- 114

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYME--NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           +HP  V L      G     +Y   E    +LQ        G    E             
Sbjct: 115 QHPCCVRLEQAWEEGGI---LYLQTELCGPSLQQHCEAW--GASLPEA------------ 157

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                        W +     L     LA LH   S  ++H D+K ++++L      +L 
Sbjct: 158 -----------QVWGYLRDTLLA----LAHLH---SQGLVHLDVKPANIFLGPRGRCKLG 199

Query: 680 DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP-- 737
           DFGL    G     E+  G P Y+ PE  Q         +DV+  G+ +LE+    +   
Sbjct: 200 DFGLLVELGTAGAGEVQEGDPRYMAPELLQGS---YGTAADVFSLGLTILEVACNMELPH 256

Query: 738 LGDDYPEEKEGNL 750
            G+ + + ++G L
Sbjct: 257 GGEGWQQLRQGYL 269

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 90.7 bits (226), Expect = 3e-20
 Identities = 68/308 (22%), Positives = 109/308 (35%), Gaps = 68/308 (22%)

Query: 516 LAEGKFGPVYRGFLPGG----IHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNLVPLT 570
           L EG FG VY G         I+VAVK      TL ++E    E   +  + HP++V L 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
           G        I I +    G L + L                              ++  L
Sbjct: 80  GIIEEEPTWI-IMELYPYGELGHYLER----------------------------NKNSL 110

Query: 631 TTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGN 689
                    +L   +A+A+L    C    +HRDI   ++ +      +L DFGL++    
Sbjct: 111 KVLTLVL-YSLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI-- 163

Query: 690 GLDEEIARGSPGYIP-----PEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP 743
             DE+  + S   +P     PE       F T  SDV+ + V + E+++ GK+P    + 
Sbjct: 164 -EDEDYYKASVTRLPIKWMSPESIN-FRRF-TTASDVWMFAVCMWEILSFGKQP----FF 216

Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
                         + N      ++   R   P+        +   C    P  RP   +
Sbjct: 217 W-------------LENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTE 263

Query: 804 IVGLLKDI 811
           +V  L D+
Sbjct: 264 LVCSLSDV 271

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 55/204 (26%), Positives = 83/204 (40%), Gaps = 15/204 (7%)

Query: 16  CSWRGVVCDSNK-QHV-------TDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITA 67
            S   V CD      +       T  L  +  L  +    T+   ++L  L+L    +T 
Sbjct: 10  ASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK 69

Query: 68  LPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAI-SSLVSL 126
           L  D  +L  L +L+LS+N++  SLP        L V D+S N  +  +P      L  L
Sbjct: 70  LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGEL 126

Query: 127 RVLKLDGNMFQWSIPPGLLNC-QSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEI 185
           + L L GN  + ++PPGLL     L  + L+ N L   LP G       L +L L  N +
Sbjct: 127 QELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184

Query: 186 KGRDTHFAGLKSITNLNISGNLFQ 209
                 F G   +    + GN + 
Sbjct: 185 YTIPKGFFGSHLLPFAFLHGNPWL 208

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 14/208 (6%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNN 111
           ++    ++  + N+TALP DL        L+LS N +     + +  +  L   +L    
Sbjct: 9   VASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

Query: 112 FSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAA 171
            + ++     +L  L  L L  N  Q S+P       +L  +D+S N+L  SLP G    
Sbjct: 67  LT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRG 122

Query: 172 FPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSN 228
             +L+ L L GNE+K            +  L+++ N       G+   LE+L+ + L+ N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182

Query: 229 QFQGHISQVQFNSSYNWSRLVYVDLSEN 256
                I +  F S      L +  L  N
Sbjct: 183 SLY-TIPKGFFGS----HLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 48/257 (18%), Positives = 73/257 (28%), Gaps = 63/257 (24%)

Query: 75  LGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGN 134
           + S   +N     ++ +LP ++       +  LS N       A +     L  L LD  
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 135 MFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFA 193
             + +          L T+DLS NQL  SLP       P L  L+++ N +         
Sbjct: 66  --ELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLG-QTLPALTVLDVSFNRLTSLPLGALR 121

Query: 194 GLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYV 251
           GL  +  L + GN  +    G+      LE + L +N                       
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-------------------- 161

Query: 252 DLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIP 311
                +L   + +      NL  L L  N                             IP
Sbjct: 162 -----ELPAGLLNGLE---NLDTLLLQENSLYT-------------------------IP 188

Query: 312 SEILQLSSLHTLDLSMN 328
                   L    L  N
Sbjct: 189 KGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 45/244 (18%), Positives = 75/244 (30%), Gaps = 66/244 (27%)

Query: 141 PPGLLNCQ-SLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEI-KGRDTHFAGLKSI 198
           P   ++   S + V+     L  +LP            L+L+ N +             +
Sbjct: 2   PICEVSKVASHLEVNCDKRNL-TALPPD---LPKDTTILHLSENLLYTFSLATLMPYTRL 57

Query: 199 TNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSEN 256
           T LN+     + + + V   L  L  +DL  NQ Q  +  +          L  +D+S N
Sbjct: 58  TQLNLDRA--ELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLL-GQ---TLPALTVLDVSFN 110

Query: 257 QLSGEIFHN-FSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL 315
           +L+  +          L+ L L  N                             +P  +L
Sbjct: 111 RLT-SLPLGALRGLGELQELYLKGNELKT-------------------------LPPGLL 144

Query: 316 Q-LSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSY 374
                L  L L+ N+LT                       E+PA LL  L  ++      
Sbjct: 145 TPTPKLEKLSLANNNLT-----------------------ELPAGLLNGLENLDTLLLQE 181

Query: 375 NNLT 378
           N+L 
Sbjct: 182 NSLY 185

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 47/241 (19%), Positives = 87/241 (36%), Gaps = 54/241 (22%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL----VHGSTLTDQEAARELEYLGRIKH 563
            + RG  L +G F   +           A K++    +      ++  + E+     + H
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAH 100

Query: 564 PNLVPLTGYCIAGDQRIAIYDYME---NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
            ++V   G+    +  +  +  +E     +L  L                          
Sbjct: 101 QHVVGFHGF-FEDNDFV--FVVLELCRRRSLLELHK------------------------ 133

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                    LT    R+ +         +LH +     +IHRD+K  +++L+ +LE ++ 
Sbjct: 134 -----RRKALTEPEARYYLR-QIVLGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIG 183

Query: 680 DFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           DFGLA       D E  +   G+P YI PE         + + DV+  G ++  L+ GK 
Sbjct: 184 DFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKP 239

Query: 737 P 737
           P
Sbjct: 240 P 240

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 90.3 bits (225), Expect = 5e-20
 Identities = 47/241 (19%), Positives = 87/241 (36%), Gaps = 54/241 (22%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL----VHGSTLTDQEAARELEYLGRIKH 563
            + RG  L +G F   +           A K++    +      ++  + E+     + H
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAH 74

Query: 564 PNLVPLTGYCIAGDQRIAIYDYME---NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
            ++V   G+    +  +  +  +E     +L  L                          
Sbjct: 75  QHVVGFHGF-FEDNDFV--FVVLELCRRRSLLELHK------------------------ 107

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                    LT    R+ +         +LH +     +IHRD+K  +++L+ +LE ++ 
Sbjct: 108 -----RRKALTEPEARYYLR-QIVLGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIG 157

Query: 680 DFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           DFGLA       D E  +   G+P YI PE         + + DV+  G ++  L+ GK 
Sbjct: 158 DFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKP 213

Query: 737 P 737
           P
Sbjct: 214 P 214

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 45/248 (18%), Positives = 86/248 (34%), Gaps = 63/248 (25%)

Query: 516 LAEGKFGPVYRGFL--------PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
           L +G F  +++G               V +KVL        +        + ++ H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLL--HDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
              G C+ GD+ I + ++++ G+L   L  +   + +                       
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--------------------- 114

Query: 626 SEGLLTTWRFRHKIALGTARALAFL-HHGCSPPIIHRDIKA-----SSVYLDMNLEPR-- 677
               L       ++A   A A+ FL  +      IH ++ A               P   
Sbjct: 115 ---KL-------EVAKQLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFI 160

Query: 678 -LSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GK 735
            LSD G++      L ++I +    ++PPE  +   +     +D + +G  L E+ + G 
Sbjct: 161 KLSDPGISITV---LPKDILQERIPWVPPECIENPKNL-NLATDKWSFGTTLWEICSGGD 216

Query: 736 KPLGDDYP 743
           KP      
Sbjct: 217 KP----LS 220

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 90.1 bits (224), Expect = 8e-20
 Identities = 58/325 (17%), Positives = 110/325 (33%), Gaps = 80/325 (24%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVK-VLVHGSTLTDQEAARELEYLGRIKHPN 565
           ++F+    L  G FG V+         + A+K + +    L  ++  RE++ L +++HP 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 566 LV---------PLTGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTW 613
           +V           T        ++ +Y         NL++ ++      +          
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS------ 118

Query: 614 EEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMN 673
                                   +IA     A+ FLH   S  ++HRD+K S+++  M+
Sbjct: 119 -----------------VCLHIFLQIAE----AVEFLH---SKGLMHRDLKPSNIFFTMD 154

Query: 674 LEPRLSDFGLAKIFGNGLDEEIAR-------------GSPGYIPPEFAQPDS-DFPTPKS 719
              ++ DFGL        +E+                G+  Y+ PE    +S      K 
Sbjct: 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH---KV 211

Query: 720 DVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQ 779
           D++  G++L EL+    P                    VRN K      P +      ++
Sbjct: 212 DIFSLGLILFELLY---PFST-------QMERVRTLTDVRNLK-----FPPL----FTQK 252

Query: 780 MEEALKIGYLCTADLPLKRPSMQQI 804
                 +     +  P++RP    I
Sbjct: 253 YPCEYVMVQDMLSPSPMERPEAINI 277

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 11/170 (6%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRISGSLPSNIGNFGL 101
           S+P     +L+KL+ L L++N +  LP+ ++  L +L++L ++ N++  +LP  + +  L
Sbjct: 51  SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFD-QL 108

Query: 102 --LEVFDLSNNNFSGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPGLLNC-QSLVTVDLSM 157
             L    L  N     +P  +  SL  L  L L  N  Q S+P G+ +   SL  + L  
Sbjct: 109 VNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYN 166

Query: 158 NQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGN 206
           NQL   +P+G      +LK+L L  N++K   +  F  L+ +  L +  N
Sbjct: 167 NQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 56/187 (29%), Positives = 86/187 (45%), Gaps = 23/187 (12%)

Query: 55  LQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRISGSLPSNI-GNFGLLEVFDLSNNNF 112
            + LDL  N +++LPS  +  L  L+ L L+ N++  +LP+ I      LE   +++N  
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97

Query: 113 SGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPG----LLNCQSLVTVDLSMNQLNGSLPDG 167
              +P  +   LV+L  L+LD N  + S+PP     L     L    L  N+L  SLP G
Sbjct: 98  Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYL---SLGYNELQ-SLPKG 151

Query: 168 FGAAF---PKLKSLNLAGNEIKGRDTH-FAGLKSITNLNISGNLFQGSVMGVF--LESLE 221
               F     LK L L  N++K      F  L  +  L +  N  +    G F  LE L+
Sbjct: 152 ---VFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLK 208

Query: 222 VIDLRSN 228
           ++ L+ N
Sbjct: 209 MLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 13/209 (6%)

Query: 76  GSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNM 135
            +  S++ S  +++ ++PSNI      +  DL +N  S     A   L  LR+L L+ N 
Sbjct: 16  NNKNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK 72

Query: 136 FQWSIPPGLLNC-QSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFA 193
            Q ++P G+    ++L T+ ++ N+L  +LP G       L  L L  N++K      F 
Sbjct: 73  LQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFD 130

Query: 194 GLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYV 251
            L  +T L++  N  Q    GVF  L SL+ + L +NQ +  + +  F+     + L  +
Sbjct: 131 SLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFD---KLTELKTL 186

Query: 252 DLSENQLSGEIFHNFSQAQNLKHLSLAYN 280
            L  NQL       F   + LK L L  N
Sbjct: 187 KLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 38/170 (22%), Positives = 70/170 (41%), Gaps = 23/170 (13%)

Query: 219 SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS---GEIFHNFSQAQNLKHL 275
             + +DL+SN+    +S +   + +  ++L  + L++N+L      IF       NL+ L
Sbjct: 38  DTKKLDLQSNK----LSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK---NLETL 90

Query: 276 SLAYNRFT---RQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL-QLSSLHTLDLSMNHLT 331
            +  N+        F Q   L+ L  L L R   +  +P  +   L+ L  L L  N L 
Sbjct: 91  WVTDNKLQALPIGVFDQ---LVNLAELRLDRNQ-LKSLPPRVFDSLTKLTYLSLGYNELQ 146

Query: 332 GQIPT---VSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
             +P        +L  + + +N L   +P    +KL +++      N L 
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK 194

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 91.7 bits (227), Expect = 3e-19
 Identities = 45/317 (14%), Positives = 112/317 (35%), Gaps = 46/317 (14%)

Query: 47  TTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
            T  +L+ +  +  + ++I ++   +  L ++  L L+ N+++  +   + N   L    
Sbjct: 37  VTQNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLF 93

Query: 107 LSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPD 166
           L  N    ++  ++  L  L+ L L+ N    S   GL++   L ++ L  N++  +   
Sbjct: 94  LDENKIK-DLS-SLKDLKKLKSLSLEHN--GISDINGLVHLPQLESLYLGNNKI--TDIT 147

Query: 167 GFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLR 226
              +   KL +L+L  N+I            I  L               L  L+ + L 
Sbjct: 148 VL-SRLTKLDTLSLEDNQI----------SDIVPLA-------------GLTKLQNLYLS 183

Query: 227 SNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQE 286
            N     IS ++  +      L  ++L   +   +  ++ S       +          E
Sbjct: 184 KNH----ISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE 237

Query: 287 FPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIID 346
                     +  +  + ++   +P    ++S +    +++     +      + L  + 
Sbjct: 238 IIS-------DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVY 290

Query: 347 MSHNNLSGEIPASLLEK 363
               ++ G +  + +E 
Sbjct: 291 TVSYDVDGTVIKTKVEA 307

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 91.3 bits (226), Expect = 3e-19
 Identities = 50/326 (15%), Positives = 101/326 (30%), Gaps = 68/326 (20%)

Query: 55  LQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSG 114
           +         I  +     +       NL    ++            ++    +N++   
Sbjct: 1   MGETITVSTPIKQI-FPDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSD--- 54

Query: 115 EIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPK 174
                I S+                   G+    ++  + L+ N+L    P         
Sbjct: 55  -----IKSV------------------QGIQYLPNVTKLFLNGNKLTDIKPL---TNLKN 88

Query: 175 LKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHI 234
           L  L L  N+I          K +++L               L+ L+ + L  N     I
Sbjct: 89  LGWLFLDENKI----------KDLSSLK-------------DLKKLKSLSLEHNG----I 121

Query: 235 SQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLL 294
           S +      +  +L  + L  N+++       S+   L  LSL  N+ +  +   +  L 
Sbjct: 122 SDINGLV--HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS--DIVPLAGLT 175

Query: 295 GLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSG 354
            L++L LS+   I D+   +  L +L  L+L         P     NL + +   N    
Sbjct: 176 KLQNLYLSKNH-ISDL-RALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTDGS 232

Query: 355 EIPASLLEKLPQMERFNFSYNNLTLC 380
            +   ++      E+ N  ++     
Sbjct: 233 LVTPEIISDDGDYEKPNVKWHLPEFT 258

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 54/245 (22%)

Query: 513 GTLLAEGKFGPVYRGF-LPGGIHVAVKVL----VHGSTLTDQEAARELEYLGRIKHPNLV 567
           G LL EG +G V            AVK+L    +      +    +E++ L R++H N++
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69

Query: 568 PLTGY-CIAGDQRIAIYDYME--NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
            L     +  +++  +Y  ME     +Q +L  +P                         
Sbjct: 70  QL--VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP------------------------- 102

Query: 625 GSEGLLTTWR----FRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLS 679
             E      +    F   I       L +LH  G    I+H+DIK  ++ L      ++S
Sbjct: 103 --EKRFPVCQAHGYFCQLID-----GLEYLHSQG----IVHKDIKPGNLLLTTGGTLKIS 151

Query: 680 DFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
             G+A+       ++  R   GSP + PPE A     F   K D++  GV L  + TG  
Sbjct: 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLY 211

Query: 737 PLGDD 741
           P   D
Sbjct: 212 PFEGD 216

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 41/251 (16%), Positives = 85/251 (33%), Gaps = 42/251 (16%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPS 94
           +   +   +P          Q+L L E ++  +PS    +L ++  + +S +     L S
Sbjct: 19  TCKDIQ-RIP----SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLES 73

Query: 95  NI-GNFGLLEVFDLSNNNFSGEIPA-AISSLVSLRVLKLDGNMFQWSIPPG--LLNCQSL 150
           +   N   +   ++ N      I   A+  L  L+ L +     +   P    + +    
Sbjct: 74  HSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIF 132

Query: 151 VTVDLSMNQLNGSLPDGFGAAFPKL----KSLNLAGNEIKGRDTHFAGLKSITNLNISGN 206
             ++++ N    S+P     AF  L     +L L  N                  ++ G 
Sbjct: 133 FILEITDNPYMTSIPVN---AFQGLCNETLTLKLYNNGFT---------------SVQGY 174

Query: 207 LFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNF 266
            F G+        L+ + L  N++   I +  F   Y  S    +D+S+  ++       
Sbjct: 175 AFNGT-------KLDAVYLNKNKYLTVIDKDAFGGVY--SGPSLLDVSQTSVTALPSKGL 225

Query: 267 SQAQNLKHLSL 277
              + L   + 
Sbjct: 226 EHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 42/257 (16%), Positives = 85/257 (33%), Gaps = 42/257 (16%)

Query: 53  SKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNI-GNFGLLEVFDLSNNN 111
            + +   ++  +I  +PS      S ++L L    +  ++PS+   N   +    +S + 
Sbjct: 11  HQEEDFRVTCKDIQRIPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDV 66

Query: 112 FSGEIPA-AISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDG-F 168
              ++ + +  +L  +  +++        I P  L     L  + +    L    PD   
Sbjct: 67  TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125

Query: 169 GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSN 228
             +      L +  N              +T  +I  N FQG            + L +N
Sbjct: 126 VYSTDIFFILEITDN------------PYMT--SIPVNAFQG-----LCNETLTLKLYNN 166

Query: 229 QFQGHISQVQFNSSYNWSRLVYVDLSENQ----LSGEIFHNFSQAQNLKHLSLAYNRFTR 284
            F   +    FN     ++L  V L++N+    +  + F           L ++    T 
Sbjct: 167 GFT-SVQGYAFNG----TKLDAVYLNKNKYLTVIDKDAFGG--VYSGPSLLDVSQTSVT- 218

Query: 285 QEFPQIGTLLGLEHLNL 301
              P    L  L+ L  
Sbjct: 219 -ALPS-KGLEHLKELIA 233

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 33/242 (13%), Positives = 78/242 (32%), Gaps = 31/242 (12%)

Query: 141 PPGLLNCQSLVTVDLSMNQLNG--SLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKS 197
                 C       ++   +    SLP       P  ++L L    ++      F+ L +
Sbjct: 4   SSPPCECHQEEDFRVTCKDIQRIPSLP-------PSTQTLKLIETHLRTIPSHAFSNLPN 56

Query: 198 ITNLNISGNLFQGSV-MGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLS 254
           I+ + +S ++    +    F  L  +  I++R+ +   +++ +  ++      L ++ + 
Sbjct: 57  ISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR---NLTYIDPDALKELPLLKFLGIF 113

Query: 255 ENQLSGEI--FHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGL----EHLNLSRTSLIG 308
              L                  L +  N         +    GL      L L       
Sbjct: 114 NTGLK-MFPDLTKVYSTDIFFILEITDNP--YMTSIPVNAFQGLCNETLTLKLYNNG-FT 169

Query: 309 DIPSEILQLSSLHTLDLSMNHLTGQIPTVS----AKNLGIIDMSHNNLSGEIPASLLEKL 364
            +       + L  + L+ N     I   +         ++D+S  +++  +P+  LE L
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHL 228

Query: 365 PQ 366
            +
Sbjct: 229 KE 230

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 77.4 bits (191), Expect = 5e-16
 Identities = 27/156 (17%), Positives = 51/156 (32%), Gaps = 12/156 (7%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD--LWSLGSLKSLNLSYNRISGS 91
           + +   L+  +    + +L  L+ L +    +   P    ++S      L ++ N    S
Sbjct: 87  IRNTRNLT-YIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTS 145

Query: 92  LPSNI--GNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLN--C 147
           +P N   G         L NN F+  +     +   L  + L+ N +   I         
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204

Query: 148 QSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGN 183
                +D+S   +  +LP         LK L     
Sbjct: 205 SGPSLLDVSQTSVT-ALPSK---GLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 15/115 (13%), Positives = 37/115 (32%), Gaps = 15/115 (13%)

Query: 271 NLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNH 329
             +   +          P +      + L L  T  +  IPS     L ++  + +S++ 
Sbjct: 12  QEEDFRVTCKDIQ--RIPSLPP--STQTLKLIETH-LRTIPSHAFSNLPNISRIYVSID- 65

Query: 330 LTGQIPTVSA------KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
               +  + +        +  I++ +      I    L++LP ++        L 
Sbjct: 66  --VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 69/329 (20%), Positives = 116/329 (35%), Gaps = 83/329 (25%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPN 565
            S+F+   +L +G FG V +        + A+K + H +         E+  L  + H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63

Query: 566 LV----------PLTGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDT 612
           +V                 A  ++  ++   +Y ENG L +L+H     +    D     
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEY--- 118

Query: 613 WEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLD 671
                               WR   +I      AL+++H  G    IIHRD+K  ++++D
Sbjct: 119 --------------------WRLFRQILE----ALSYIHSQG----IIHRDLKPMNIFID 150

Query: 672 MNLEPRLSDFGLAKIFGNGLDEEIAR---------------GSPGYIPPEFAQPDSDFPT 716
            +   ++ DFGLAK     LD                    G+  Y+  E     +    
Sbjct: 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD-GTGHYN 209

Query: 717 PKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGP 776
            K D+Y  G++  E+I         YP       V+ ++ L      S    P       
Sbjct: 210 EKIDMYSLGIIFFEMI---------YPFSTGMERVNILKKL---RSVSIEFPPDF----D 253

Query: 777 EKQMEEALK-IGYLCTADLPLKRPSMQQI 804
           + +M+   K I  L   D P KRP  + +
Sbjct: 254 DNKMKVEKKIIRLLIDHD-PNKRPGARTL 281

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 51/250 (20%), Positives = 82/250 (32%), Gaps = 83/250 (33%)

Query: 515 LLAEGKFGPVYRGF---LPGGIHVAVKVLVHGSTLTDQEAA----RELEYLGRIKHPNLV 567
            L  G    VY      L   I VA+K +        +E      RE+    ++ H N+V
Sbjct: 18  KLGGGGMSTVYLAEDTIL--NIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 568 PLTGYCIAGDQRIAIYDY----------ME--NG-NLQNLLHDL-PLGVQTTEDWSTDTW 613
                        ++ D           ME   G  L   +    PL V T  +      
Sbjct: 75  -------------SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN------ 115

Query: 614 EEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDM 672
                                            +   H       I+HRDIK  ++ +D 
Sbjct: 116 -------------------------FTNQILDGIKHAHDMR----IVHRDIKPQNILIDS 146

Query: 673 NLEPRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
           N   ++ DFG+AK      +  + +     G+  Y  PE A+   +     +D+Y  G+V
Sbjct: 147 NKTLKIFDFGIAKALS---ETSLTQTNHVLGTVQYFSPEQAK--GEATDECTDIYSIGIV 201

Query: 728 LLELITGKKP 737
           L E++ G+ P
Sbjct: 202 LYEMLVGEPP 211

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 87.3 bits (217), Expect = 7e-19
 Identities = 53/251 (21%), Positives = 81/251 (32%), Gaps = 85/251 (33%)

Query: 515 LLAEGKFGPVYRGF---LPGGIHVAVKVLVHGSTLTDQEAA----RELEYLGRIKHPNLV 567
           L+  G  G VY            VA+K++   +  +D        RE    GR++ P++V
Sbjct: 41  LVGRGGMGDVYEAEDTVRER--IVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 568 PLTGYCIAGDQRIAIYDY----------ME--NG-NLQNLLHDL-PLGVQTTEDWSTDTW 613
           P             I+D+          M   NG +L  +L    PL             
Sbjct: 98  P-------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA------ 138

Query: 614 EEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDM 672
                                    I      AL   H  G      HRD+K  ++ +  
Sbjct: 139 -------------------------IVRQIGSALDAAHAAG----ATHRDVKPENILVSA 169

Query: 673 NLEPRLSDFGLAKIFGNGLDEE------IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGV 726
           +    L DFG+A        +E         G+  Y+ PE  +      T ++D+Y    
Sbjct: 170 DDFAYLVDFGIAS----ATTDEKLTQLGNTVGTLYYMAPE--RFSESHATYRADIYALTC 223

Query: 727 VLLELITGKKP 737
           VL E +TG  P
Sbjct: 224 VLYECLTGSPP 234

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 90.5 bits (224), Expect = 7e-19
 Identities = 62/318 (19%), Positives = 108/318 (33%), Gaps = 59/318 (18%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNL 566
            ++    L  G FG V R      G  VA+K      +  ++E    E++ + ++ HPN+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 567 VPL------TGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
           V               D  +   +Y E G+L+  L+                        
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF---------------------- 112

Query: 621 IQNVGSEGLLTTWRFRHKIA-LGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPR- 677
                +   L     R  ++ +  + AL +LH +     IIHRD+K  ++ L    +   
Sbjct: 113 ----ENCCGLKEGPIRTLLSDI--SSALRYLHENR----IIHRDLKPENIVLQPGPQRLI 162

Query: 678 --LSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
             + D G AK    G       G+  Y+ PE  +      T   D + +G +  E ITG 
Sbjct: 163 HKIIDLGYAKELDQGELCTEFVGTLQYLAPELLE--QKKYTVTVDYWSFGTLAFECITGF 220

Query: 736 KPLGDDYP--------EEKEGNLVSWVRGLVRNNKGSRAI-DPKIRDTGPEKQMEEALKI 786
           +P   ++          EK    +     L    K S  +  P         ++E  L+ 
Sbjct: 221 RPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQC 280

Query: 787 GYLCTADLPLKRPSMQQI 804
             +       +R +  Q 
Sbjct: 281 --MLMWH-QRQRGTDPQN 295

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 54/238 (22%), Positives = 95/238 (39%), Gaps = 35/238 (14%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPN 565
                   +L +G +G VY G  L   + +A+K +    +   Q    E+     +KH N
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80

Query: 566 LVPLTGYCIAGDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
           +V   G   + +  I I+ + +  G+L  LL      ++  E             +I   
Sbjct: 81  IVQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE------------QTIGF- 126

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD-MNLEPRLSDFGL 683
                     +  +I  G    L +LH      I+HRDIK  +V ++  +   ++SDFG 
Sbjct: 127 ----------YTKQILEG----LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGT 169

Query: 684 AK-IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
           +K + G     E   G+  Y+ PE            +D++  G  ++E+ TGK P  +
Sbjct: 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 87.1 bits (216), Expect = 9e-19
 Identities = 49/318 (15%), Positives = 101/318 (31%), Gaps = 56/318 (17%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNL 566
            +    +L +G    V+RG     G   A+KV  + S L   +   RE E L ++ H N+
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 567 VPLTGY-CIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           V L  +               ++   G+L  +L +        E         +    ++
Sbjct: 70  VKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--------EFLIVLR 119

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPR---- 677
           +V                      +  L  +G    I+HR+IK  ++   +  + +    
Sbjct: 120 DVVG-------------------GMNHLRENG----IVHRNIKPGNIMRVIGEDGQSVYK 156

Query: 678 LSDFGLAKIFGNGLDEEIARGSPGYIPPE------FAQPDSDFPTPKSDVYCYGVVLLEL 731
           L+DFG A+   +        G+  Y+ P+        +          D++  GV     
Sbjct: 157 LTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216

Query: 732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCT 791
            TG  P        +   +      + +   G  +             ++ +  +   C+
Sbjct: 217 ATGSLPFRPFEGPRRNKEV------MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS 270

Query: 792 ADLPLKRPSMQQIVGLLK 809
               L+      +  +L+
Sbjct: 271 LSRGLQVLLTPVLANILE 288

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 46/278 (16%), Positives = 98/278 (35%), Gaps = 43/278 (15%)

Query: 51  KLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNN 110
             ++    +L + ++T        L S+  +  + + I  S+   I     +    L+ N
Sbjct: 22  AFAETIKDNLKKKSVTDA-VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN 78

Query: 111 NFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGA 170
             + +I   +++L +L  L LD N  +  +   L + + L ++ L  N +  S  +G   
Sbjct: 79  KLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGI--SDINGL-V 131

Query: 171 AFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQF 230
             P+L+SL L  N+I       + L  +  L++  N          +  +  +       
Sbjct: 132 HLPQLESLYLGNNKITDITV-LSRLTKLDTLSLEDN---------QISDIVPLA------ 175

Query: 231 QGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQI 290
                          ++L  + LS+N +S       +  +NL  L L       +     
Sbjct: 176 -------------GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQ 220

Query: 291 GTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMN 328
             L+    +  +  SL+   P  I         ++  +
Sbjct: 221 SNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH 256

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 45/214 (21%), Positives = 91/214 (42%), Gaps = 19/214 (8%)

Query: 47  TTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
            T  +L+ +  +  + ++I ++   +  L ++  L L+ N+++  +   + N   L    
Sbjct: 40  VTQNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLF 96

Query: 107 LSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPD 166
           L  N    ++  ++  L  L+ L L+ N    S   GL++   L ++ L  N++  +   
Sbjct: 97  LDENKVK-DLS-SLKDLKKLKSLSLEHN--GISDINGLVHLPQLESLYLGNNKI--TDIT 150

Query: 167 GFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEVID 224
              +   KL +L+L  N+I       AGL  + NL +S N    S +     L++L+V++
Sbjct: 151 VL-SRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKN--HISDLRALAGLKNLDVLE 206

Query: 225 LRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQL 258
           L S +          N   N      V  ++  L
Sbjct: 207 LFSQE----CLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 42/238 (17%), Positives = 86/238 (36%), Gaps = 21/238 (8%)

Query: 143 GLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLN 202
                   +  +L    +  ++          +  +    ++IK        L ++T L 
Sbjct: 19  SDDAFAETIKDNLKKKSVTDAVTQ---NELNSIDQIIANNSDIK-SVQGIQYLPNVTKLF 74

Query: 203 ISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSG 260
           ++GN  + + +     L++L  + L  N+    +  +         +L  + L  N +S 
Sbjct: 75  LNGN--KLTDIKPLANLKNLGWLFLDENK----VKDLSSLKDL--KKLKSLSLEHNGIS- 125

Query: 261 EIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSL 320
           +I +       L+ L L  N+ T  +   +  L  L+ L+L     I DI   +  L+ L
Sbjct: 126 DI-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQ-ISDI-VPLAGLTKL 180

Query: 321 HTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
             L LS NH++        KNL ++++         P +    L        +  +L 
Sbjct: 181 QNLYLSKNHISDLRALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTDGSLV 237

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 41/206 (19%), Positives = 75/206 (36%), Gaps = 16/206 (7%)

Query: 173 PKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQG 232
           P           IK   +           N+       +V    L S++ I   ++    
Sbjct: 2   PLGSETITVPTPIKQIFS-DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSD--- 57

Query: 233 HISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGT 292
            I  VQ         +  + L+ N+L+ +I    +  +NL  L L  N+    +   +  
Sbjct: 58  -IKSVQGIQYL--PNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK--DLSSLKD 110

Query: 293 LLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNL 352
           L  L+ L+L     I DI   ++ L  L +L L  N +T          L  + +  N +
Sbjct: 111 LKKLKSLSLEHNG-ISDING-LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQI 168

Query: 353 SGEIPASLLEKLPQMERFNFSYNNLT 378
           S +I    L  L +++    S N+++
Sbjct: 169 S-DIVP--LAGLTKLQNLYLSKNHIS 191

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 52/243 (21%), Positives = 102/243 (41%), Gaps = 46/243 (18%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPN 565
               D    + EG  G V        G  VAVK++        +    E+  +   +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           +V +    + G++   + ++++ G L +++  + L     E+             I  V 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRL----NEEQ------------IATVC 147

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
              L               +ALA+LH   +  +IHRDIK+ S+ L ++   +LSDFG   
Sbjct: 148 EAVL---------------QALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 189

Query: 686 IFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
                + +++ +     G+P ++ PE     S +   + D++  G++++E++ G+ P   
Sbjct: 190 Q----ISKDVPKRKSLVGTPYWMAPEVIS-RSLY-ATEVDIWSLGIMVIEMVDGEPPYFS 243

Query: 741 DYP 743
           D P
Sbjct: 244 DSP 246

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 56/254 (22%), Positives = 92/254 (36%), Gaps = 85/254 (33%)

Query: 515 LLAEGKFGPVYRG---FLPGGIHVAVKVLVHGSTLTDQEAA----RELEYLGRIKHPNLV 567
           +L  G    V+            VAVKVL       D        RE +    + HP +V
Sbjct: 19  ILGFGGMSEVHLARDLRD--HRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 568 PLTGYCIAGDQRIAIYDY--------------ME--NG-NLQNLLHDL-PLGVQTTEDWS 609
                        A+YD               ME  +G  L++++H   P+  +   +  
Sbjct: 76  -------------AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE-- 120

Query: 610 TDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSV 668
                                        +     +AL F H +G    IIHRD+K +++
Sbjct: 121 -----------------------------VIADACQALNFSHQNG----IIHRDVKPANI 147

Query: 669 YLDMNLEPRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYC 723
            +      ++ DFG+A+   +     + +     G+  Y+ PE A+   D    +SDVY 
Sbjct: 148 MISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQAR--GDSVDARSDVYS 204

Query: 724 YGVVLLELITGKKP 737
            G VL E++TG+ P
Sbjct: 205 LGCVLYEVLTGEPP 218

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 87.1 bits (216), Expect = 3e-18
 Identities = 76/326 (23%), Positives = 116/326 (35%), Gaps = 76/326 (23%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-HPNL 566
           +      +L  G  G V       G  VAVK ++         A  E++ L     HPN+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNV 71

Query: 567 VPLTGYCIAGDQRIAIYDYME--NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
           +    YC     R  +Y  +E  N NLQ+L+                   E    S +N+
Sbjct: 72  IRY--YCSETTDR-FLYIALELCNLNLQDLV-------------------ESKNVSDENL 109

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK-------------ASSVYL 670
             +          +I    A  +A LH       IIHRD+K             A     
Sbjct: 110 KLQKEYNPISLLRQI----ASGVAHLHSLK----IIHRDLKPQNILVSTSSRFTADQQTG 161

Query: 671 DMNLEPRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPE-----FAQPDSDFPTPKSD 720
             NL   +SDFGL K   +G            G+ G+  PE              T   D
Sbjct: 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID 221

Query: 721 VYCYGVVLLELIT-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQ 779
           ++  G V   +++ GK P GD Y   +E N++          +G  ++D  ++       
Sbjct: 222 IFSMGCVFYYILSKGKHPFGDKY--SRESNII----------RGIFSLDE-MKCLHDRSL 268

Query: 780 MEEALK-IGYLCTADLPLKRPSMQQI 804
           + EA   I  +   D PLKRP+  ++
Sbjct: 269 IAEATDLISQMIDHD-PLKRPTAMKV 293

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 85.1 bits (211), Expect = 4e-18
 Identities = 55/243 (22%), Positives = 102/243 (41%), Gaps = 46/243 (18%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPN 565
              + R   + +G  G VY    +  G  VA++ +        +    E+  +   K+PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           +V      + GD+   + +Y+  G+L +++ +  +     E              I  V 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQ------------IAAVC 122

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
            E L               +AL FLH   S  +IHRDIK+ ++ L M+   +L+DFG   
Sbjct: 123 RECL---------------QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164

Query: 686 IFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
                +  E ++     G+P ++ PE       +  PK D++  G++ +E+I G+ P  +
Sbjct: 165 Q----ITPEQSKRSTMVGTPYWMAPEVVT-RKAY-GPKVDIWSLGIMAIEMIEGEPPYLN 218

Query: 741 DYP 743
           + P
Sbjct: 219 ENP 221

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 85.2 bits (211), Expect = 6e-18
 Identities = 50/243 (20%), Positives = 83/243 (34%), Gaps = 50/243 (20%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVP 568
                 +  G FG V+R      G   AVK +     L       EL     +  P +VP
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRV-EELVACAGLSSPRIVP 114

Query: 569 LTGYCIAGDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
           L G  +     + I+ + +E G+L  L+                   ED          +
Sbjct: 115 LYG-AVREGPWVNIFMELLEGGSLGQLIK------------QMGCLPED---RALYYLGQ 158

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMN-LEPRLSDFGLAK- 685
            L                 L +LH   +  I+H D+KA +V L  +     L DFG A  
Sbjct: 159 AL---------------EGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200

Query: 686 IFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
           +  +GL + +       G+  ++ PE           K D++    ++L ++ G  P   
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP--CDAKVDIWSSCCMMLHMLNGCHPWTQ 258

Query: 741 DYP 743
            + 
Sbjct: 259 YFR 261

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 85.3 bits (211), Expect = 7e-18
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 25/168 (14%)

Query: 55  LQSLDLSENNITALPSD--LWSLGSLKSLNLSYNRISGSLPSNIGNF-GL--LEVFDLSN 109
              LDLS NN++ L ++     L +L SL LS+N ++  + S    F  +  L   DLS+
Sbjct: 41  TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISS--EAFVPVPNLRYLDLSS 97

Query: 110 NNFSGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDG 167
           N+    +   + S L +L VL L  N     +      +   L  + LS NQ++   P  
Sbjct: 98  NHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVE 154

Query: 168 FGAAF------PKLKSLNLAGNEIKG-RDTHFAGLKSIT--NLNISGN 206
                      PKL  L+L+ N++K    T    L +     L +  N
Sbjct: 155 ---LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 37/170 (21%), Positives = 72/170 (42%), Gaps = 12/170 (7%)

Query: 139 SIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH-FAGLKS 197
           ++P  L +      +DLS N L+    +        L SL L+ N +    +  F  + +
Sbjct: 32  NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89

Query: 198 ITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSE 255
           +  L++S N        +F  L++LEV+ L +N     + +  F    + ++L  + LS+
Sbjct: 90  LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFE---DMAQLQKLYLSQ 145

Query: 256 NQLS---GEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLS 302
           NQ+S    E+  + ++   L  L L+ N+  +     +  L       L 
Sbjct: 146 NQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 32/148 (21%), Positives = 46/148 (31%), Gaps = 33/148 (22%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
            +       +  L+ LDLS N++  L       L +L+ L L  N I   +  N      
Sbjct: 78  FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRN------ 130

Query: 102 LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPG----LLNCQSLVTVDLSM 157
              F+                +  L+ L L  N      P            L+ +DLS 
Sbjct: 131 --AFE---------------DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSS 172

Query: 158 NQLNGSLPDGFGAAFPKLK--SLNLAGN 183
           N+L   LP       P      L L  N
Sbjct: 173 NKLK-KLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 34/185 (18%), Positives = 68/185 (36%), Gaps = 15/185 (8%)

Query: 152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIK--GRDTHFAGLKSITNLNISGNLFQ 209
            +  S  QL  ++P            L+L+ N +     +     L ++ +L +S N   
Sbjct: 22  ILSCSKQQLP-NVPQSL---PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN 77

Query: 210 GSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFS 267
                 F  + +L  +DL SN     +  +      +   L  + L  N +     + F 
Sbjct: 78  FISSEAFVPVPNLRYLDLSSNH----LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFE 133

Query: 268 QAQNLKHLSLAYNRFTR---QEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLD 324
               L+ L L+ N+ +R   +       L  L  L+LS   L     +++ +L +     
Sbjct: 134 DMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193

Query: 325 LSMNH 329
           L +++
Sbjct: 194 LYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 54.5 bits (131), Expect = 7e-08
 Identities = 29/136 (21%), Positives = 56/136 (41%), Gaps = 17/136 (12%)

Query: 251 VDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTR----QEFPQIGTLLGLEHLNLSRTSL 306
           +  S+ QL   +  +         L L++N  +R        +   L  L  L LS    
Sbjct: 23  LSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTR---LTNLHSLLLSHNH- 75

Query: 307 IGDIPSEIL-QLSSLHTLDLSMNHLTGQIPT---VSAKNLGIIDMSHNNLSGEIPASLLE 362
           +  I SE    + +L  LDLS NHL   +        + L ++ + +N++   +  +  E
Sbjct: 76  LNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFE 133

Query: 363 KLPQMERFNFSYNNLT 378
            + Q+++   S N ++
Sbjct: 134 DMAQLQKLYLSQNQIS 149

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 45/257 (17%), Positives = 87/257 (33%), Gaps = 62/257 (24%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKV--LVHGSTLTDQEAARELEYLGRI-K 562
           T+ F     +  G+FG V++      G   A+K        ++ +Q A RE+     + +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 563 HPNLVPLTGY--CIAGDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           H ++V    Y    A D  + I  +Y   G+L + + +                      
Sbjct: 70  HSHVV---RYFSAWAEDDHMLIQNEYCNGGSLADAISE--------------------NY 106

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP--- 676
            I +   E  L              R L ++H   S  ++H DIK S++++     P   
Sbjct: 107 RIMSYFKEAELKDL-LLQ-----VGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAA 157

Query: 677 ----------------RLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSD 720
                           ++ D G      +   EE   G   ++  E  Q +     PK+D
Sbjct: 158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQENYTH-LPKAD 213

Query: 721 VYCYGVVLLELITGKKP 737
           ++   + ++     +  
Sbjct: 214 IFALALTVVCAAGAEPL 230

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 86.0 bits (213), Expect = 8e-18
 Identities = 66/313 (21%), Positives = 105/313 (33%), Gaps = 73/313 (23%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLV 567
           +F    +L  G  G +    +     VAVK ++         A RE++ L    +HPN++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVI 81

Query: 568 PLTGYCIAGDQRIAIYDYME--NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
               +C   D++   Y  +E     LQ  +                          Q   
Sbjct: 82  RY--FCTEKDRQ-FQYIAIELCAATLQEYV-------------------------EQKDF 113

Query: 626 SEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKA-----SSVYLDMNLEPRLS 679
           +   L       +        LA LH       I+HRD+K      S       ++  +S
Sbjct: 114 AHLGLEPITLLQQTT----SGLAHLHSLN----IVHRDLKPHNILISMPNAHGKIKAMIS 165

Query: 680 DFGLAKIFGNGLDEEIAR----GSPGYIPPE-FAQPDSDFPTPKSDVYCYGVVLLELIT- 733
           DFGL K    G      R    G+ G+I PE  ++   + PT   D++  G V   +I+ 
Sbjct: 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

Query: 734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK--IGYLCT 791
           G  P G     +            +     S           PEK  +   +  I  +  
Sbjct: 226 GSHPFGKSLQRQ----------ANILLGACSLDCLH------PEKHEDVIARELIEKMIA 269

Query: 792 ADLPLKRPSMQQI 804
            D P KRPS + +
Sbjct: 270 MD-PQKRPSAKHV 281

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 47/245 (19%), Positives = 100/245 (40%), Gaps = 36/245 (14%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL-VHGSTLTDQEAARELEYLGRIKHPN 565
            +++   ++  G    V   +  P    VA+K + +     +  E  +E++ + +  HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           +V      +  D+   +   +  G++ +++      +    +  +   +E    +I  + 
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIK----HIVAKGEHKSGVLDES---TIATIL 127

Query: 626 SEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL- 683
            E L                 L +LH +G     IHRD+KA ++ L  +   +++DFG+ 
Sbjct: 128 REVL---------------EGLEYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGVS 168

Query: 684 AKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           A +   G            G+P ++ PE  +    +   K+D++ +G+  +EL TG  P 
Sbjct: 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPY 227

Query: 739 GDDYP 743
               P
Sbjct: 228 HKYPP 232

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 50/355 (14%), Positives = 109/355 (30%), Gaps = 79/355 (22%)

Query: 508 SNFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPN 565
           ++F+    +  G FG V+  +  +    +   ++ +    L  ++  RE++ L +++HP 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 566 LVPLTGYCIAGDQRIAIYDYM-----------------ENGNLQNLLHDLPLGVQTTEDW 608
           +V      +         +                           +  +          
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 609 STDTWEEDGTNSIQ-----------------NVGSEGLLTTWRFRHKIALGTARALAFLH 651
                       IQ                 ++             +IA      + FLH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLH 181

Query: 652 HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-------------G 698
              S  ++HRD+K S+++  M+   ++ DFGL        +E+                G
Sbjct: 182 ---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238

Query: 699 SPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLV 758
           +  Y+ PE  Q   +  + K D++  G++L EL+                     +   V
Sbjct: 239 TKLYMSPE--QIHGNNYSHKVDIFSLGLILFELLYSFST----------QMERVRIITDV 286

Query: 759 RNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV--GLLKDI 811
           RN K               ++  +   +     +  P +RP    I+   + +++
Sbjct: 287 RNLK----FPL-----LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 57/245 (23%), Positives = 102/245 (41%), Gaps = 49/245 (20%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD-QEAARELEYLGRIKHP 564
              F +   + +G FG V++G        VA+K++       + ++  +E+  L +   P
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
            +    G  +   +   I +Y+  G+  +LL   PL     E              I  +
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL----DETQ------------IATI 124

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
             E L               + L +LH   S   IHRDIKA++V L  + E +L+DFG+A
Sbjct: 125 LREIL---------------KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA 166

Query: 685 KIFGNGLDEEIAR-----GSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPL 738
                 L +   +     G+P ++ PE  +  + D    K+D++  G+  +EL  G+ P 
Sbjct: 167 G----QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS---KADIWSLGITAIELARGEPPH 219

Query: 739 GDDYP 743
            + +P
Sbjct: 220 SELHP 224

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 48/256 (18%), Positives = 82/256 (32%), Gaps = 65/256 (25%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIKHPN 565
            +     +  G    V++         A+K  V+     +Q       E+ YL +++  +
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKY-VNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 566 L--VPLTGYCIAGDQRIAIYDYME--NGNLQNLLHD---LPLGVQTTEDWSTDTWEEDGT 618
              + L  Y I       IY  ME  N +L + L     +              W+    
Sbjct: 88  DKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSID------PWERKSYWKN--- 135

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPR 677
                                      A+  +H HG    I+H D+K ++  +  +   +
Sbjct: 136 ------------------------MLEAVHTIHQHG----IVHSDLKPANFLIV-DGMLK 166

Query: 678 LSDFGLAKIFGNGLDEEIAR---GSPGYIPPE---------FAQPDSDFPTPKSDVYCYG 725
           L DFG+A          +     G+  Y+PPE                  +PKSDV+  G
Sbjct: 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226

Query: 726 VVLLELITGKKPLGDD 741
            +L  +  GK P    
Sbjct: 227 CILYYMTYGKTPFQQI 242

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 83.8 bits (207), Expect = 3e-17
 Identities = 49/251 (19%), Positives = 87/251 (34%), Gaps = 46/251 (18%)

Query: 507 TSNFDRGTLLAEG--KFGPVYRGF-LPGGIHVAVKV--LVHGSTLTDQEAARELEYLGRI 561
              ++  T++ +G      V      P G +V V+   L   S         EL      
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
            HPN+VP     IA ++   +  +M  G+ ++L+                          
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI----------------------CTHF 121

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
            +  +E  +        I  G  +AL ++H  G     +HR +KAS + + ++ +  LS 
Sbjct: 122 MDGMNELAIAY------ILQGVLKALDYIHHMGY----VHRSVKASHILISVDGKVYLSG 171

Query: 681 FG-LAKIFGNG-------LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
                 +  +G          + +     ++ PE  Q +      KSD+Y  G+   EL 
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231

Query: 733 TGKKPLGDDYP 743
            G  P  D   
Sbjct: 232 NGHVPFKDMPA 242

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 83.0 bits (205), Expect = 5e-17
 Identities = 49/318 (15%), Positives = 101/318 (31%), Gaps = 56/318 (17%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHPNL 566
            +    +L +G    V+RG     G   A+KV  + S L   +   RE E L ++ H N+
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 567 VPLTGY-CIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           V L  +               ++   G+L  +L +        E         +    ++
Sbjct: 70  VKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--------EFLIVLR 119

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPR---- 677
           +V                      +  L  +G    I+HR+IK  ++   +  + +    
Sbjct: 120 DVVG-------------------GMNHLRENG----IVHRNIKPGNIMRVIGEDGQSVYK 156

Query: 678 LSDFGLAKIFGNGLDEEIARGSPGYIPPE------FAQPDSDFPTPKSDVYCYGVVLLEL 731
           L+DFG A+   +        G+  Y+ P+        +          D++  GV     
Sbjct: 157 LTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216

Query: 732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCT 791
            TG  P        +   +      + +   G  +             ++ +  +   C+
Sbjct: 217 ATGSLPFRPFEGPRRNKEV------MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS 270

Query: 792 ADLPLKRPSMQQIVGLLK 809
               L+      +  +L+
Sbjct: 271 LSRGLQVLLTPVLANILE 288

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 61/256 (23%), Positives = 103/256 (40%), Gaps = 58/256 (22%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGRI- 561
              F+   L+  G +G VY+G  +  G   A+KV+     +T  E     +E+  L +  
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM----DVTGDEEEEIKQEINMLKKYS 78

Query: 562 KHPNLVP-----LTGYCIAGDQRIAIY-DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEE 615
            H N+       +       D ++ +  ++   G++ +L+ +        E+W       
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEW------- 130

Query: 616 DGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLE 675
                I  +  E L               R L+ LH      +IHRDIK  +V L  N E
Sbjct: 131 -----IAYICREIL---------------RGLSHLH---QHKVIHRDIKGQNVLLTENAE 167

Query: 676 PRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTP---KSDVYCYGVV 727
            +L DFG++      LD  + R     G+P ++ PE    D +       KSD++  G+ 
Sbjct: 168 VKLVDFGVSA----QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223

Query: 728 LLELITGKKPLGDDYP 743
            +E+  G  PL D +P
Sbjct: 224 AIEMAEGAPPLCDMHP 239

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 82.6 bits (204), Expect = 6e-17
 Identities = 57/275 (20%), Positives = 109/275 (39%), Gaps = 45/275 (16%)

Query: 510 FDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVL-VHGSTLTDQEAARELEYLGRIKHPNLV 567
           F++ + L  G  G V++    P G+ +A K++ +        +  REL+ L     P +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 568 PLTG-YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
              G +   G+  I + ++M+ G+L  +L                         I     
Sbjct: 95  GFYGAFYSDGEISICM-EHMDGGSLDQVLKK--------------------AGRI----P 129

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           E +L       K+++   + L +L       I+HRD+K S++ ++   E +L DFG++  
Sbjct: 130 EQILG------KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181

Query: 687 FGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
               L + +A    G+  Y+ PE  Q      + +SD++  G+ L+E+  G+ P+     
Sbjct: 182 ----LIDSMANSFVGTRSYMSPERLQGTHY--SVQSDIWSMGLSLVEMAVGRYPIPPPDA 235

Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEK 778
           +E E      V G             +  +     
Sbjct: 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 82.1 bits (203), Expect = 6e-17
 Identities = 48/252 (19%), Positives = 82/252 (32%), Gaps = 65/252 (25%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIKHPN 565
            +     +  G    V++         A+K  V+     +Q       E+ YL +++  +
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKY-VNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 566 L--VPLTGYCIAGDQRIAIYDYME--NGNLQNLLHD---LPLGVQTTEDWSTDTWEEDGT 618
              + L  Y I       IY  ME  N +L + L     +              W+    
Sbjct: 69  DKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSID------PWERKSYWKN--- 116

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPR 677
                                      A+  +H HG    I+H D+K ++  +  +   +
Sbjct: 117 ------------------------MLEAVHTIHQHG----IVHSDLKPANFLIV-DGMLK 147

Query: 678 LSDFGLAKIFGNGLDEEIAR---GSPGYIPPE---------FAQPDSDFPTPKSDVYCYG 725
           L DFG+A          +     G+  Y+PPE                  +PKSDV+  G
Sbjct: 148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 207

Query: 726 VVLLELITGKKP 737
            +L  +  GK P
Sbjct: 208 CILYYMTYGKTP 219

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 55/245 (22%), Positives = 98/245 (40%), Gaps = 50/245 (20%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQ--EAARELEYLGRIKH 563
              FD    L EG +G VY+      G  VA+K +     +     E  +E+  + +   
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQEIIKEISIMQQCDS 83

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           P++V   G          + +Y   G++ +++      +  TED             I  
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL--TEDE------------IAT 129

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
           +    L               + L +LH       IHRDIKA ++ L+     +L+DFG+
Sbjct: 130 ILQSTL---------------KGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV 171

Query: 684 AKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           A      L + +A+     G+P ++ PE  Q +  +    +D++  G+  +E+  GK P 
Sbjct: 172 AGQ----LTDTMAKRNTVIGTPFWMAPEVIQ-EIGY-NCVADIWSLGITAIEMAEGKPPY 225

Query: 739 GDDYP 743
            D +P
Sbjct: 226 ADIHP 230

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 82.1 bits (203), Expect = 9e-17
 Identities = 64/365 (17%), Positives = 111/365 (30%), Gaps = 95/365 (26%)

Query: 55  LQSLDLSENNIT-----ALPSDLWSLGSLKSLNLSYNRISG----SLPSNIGNFGLLEVF 105
           ++   L  + IT     ++ + L    S+K + LS N I       L  NI +   LE+ 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 106 DLSNN---NFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNG 162
           + S+        EIP A+  L+                   LL C  L TV LS N    
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQ-----------------ALLKCPKLHTVRLSDNAFGP 108

Query: 163 SLPDGFGAAFPK---LKSLNLAGNEIKGRDTHFAGLKSI----TNLNISGNLFQGSVMGV 215
           +  +       K   L+ L L  N +            I      L ++           
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGP-----QAGAKIARALQELAVNKKAKNAP---- 159

Query: 216 FLESLEVIDLRSNQFQG----HISQV-QFNSSYNWSRLVYVDLSENQLSGE-----IFHN 265
               L  I    N+ +       ++  Q +       L  V + +N +  E     +   
Sbjct: 160 ---PLRSIICGRNRLENGSMKEWAKTFQSHRL-----LHTVKMVQNGIRPEGIEHLLLEG 211

Query: 266 FSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDL 325
            +  Q LK L L  N FT      +   L                        +L  L L
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALK--------------------SWPNLRELGL 251

Query: 326 SMNHLTGQ--------IPTVSAKNLGIIDMSHNNLSGE----IPASLLEKLPQMERFNFS 373
           +   L+ +           +    L  + + +N +  +    +   + EK+P +     +
Sbjct: 252 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 311

Query: 374 YNNLT 378
            N  +
Sbjct: 312 GNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 41/227 (18%), Positives = 63/227 (27%), Gaps = 50/227 (22%)

Query: 51  KLSKLQSLDLSENNIT-----ALPSDLWSLGSLKSLNLSYNRIS--------GSLPSNIG 97
           K  KL ++ LS+N         L   L     L+ L L  N +          +L     
Sbjct: 92  KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV 151

Query: 98  NFGL-----LEVFDLSNNNFSGE----IPAAISSLVSLRVLKLDGNMF-----QWSIPPG 143
           N        L       N               S   L  +K+  N       +  +  G
Sbjct: 152 NKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211

Query: 144 LLNCQSLVTVDLSMNQLNGSLPDG---FGAAF---PKLKSLNLAGNEIK-------GRDT 190
           L  CQ L  +DL  N        G      A    P L+ L L    +            
Sbjct: 212 LAYCQELKVLDLQDNTFT---HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF 268

Query: 191 HFAGLKSITNLNISGNLFQ-------GSVMGVFLESLEVIDLRSNQF 230
                  +  L +  N  +        +V+   +  L  ++L  N+F
Sbjct: 269 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 44/286 (15%), Positives = 78/286 (27%), Gaps = 76/286 (26%)

Query: 49  IGKLSKLQSLDLSENNI-----------TALPSDLWSLGSLKSLNLSYNRISGSLPSNIG 97
           I     L+  + S+                L   L     L ++ LS N    +    + 
Sbjct: 56  IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115

Query: 98  NFGL-----LEVFDLSNNNFSGE----IPAAISSLV---------SLRVLKLDGNMFQ-- 137
           +F L     LE   L NN    +    I  A+  L           LR +    N  +  
Sbjct: 116 DF-LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 174

Query: 138 --WSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAF-------PKLKSLNLAGNEIKGR 188
                     + + L TV +  N +    P+G             +LK L+L  N     
Sbjct: 175 SMKEWAKTFQSHRLLHTVKMVQNGIR---PEGIEHLLLEGLAYCQELKVLDLQDNTF-TH 230

Query: 189 D------THFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSS 242
                         ++  L ++  L         +++   ++                  
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG--------------- 275

Query: 243 YNWSRLVYVDLSENQLSGEIFHNFSQA-----QNLKHLSLAYNRFT 283
                L  + L  N++  +              +L  L L  NRF+
Sbjct: 276 -----LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 64.3 bits (157), Expect = 5e-11
 Identities = 35/198 (17%), Positives = 60/198 (30%), Gaps = 32/198 (16%)

Query: 38  SGLSGSVPDTTIGKLSKLQSLDLSENNIT-----ALPSDLWSLGSLKSLNLSYNRI---- 88
             L     +        L+S+    N +             S   L ++ +  N I    
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 203

Query: 89  -----SGSLPSNIGNFGLLEVFDLSNNNFSGE----IPAAISSLVSLRVLKLDGNMFQ-- 137
                   L         L+V DL +N F+      +  A+ S  +LR L L+  +    
Sbjct: 204 IEHLLLEGLAYCQE----LKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259

Query: 138 --WSIPPGLLNC--QSLVTVDLSMNQLNG----SLPDGFGAAFPKLKSLNLAGNEIKGRD 189
              ++           L T+ L  N++      +L        P L  L L GN     D
Sbjct: 260 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319

Query: 190 THFAGLKSITNLNISGNL 207
                ++ + +    G L
Sbjct: 320 DVVDEIREVFSTRGRGEL 337

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 48/252 (19%), Positives = 82/252 (32%), Gaps = 65/252 (25%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIKHPN 565
            +     +  G    V++         A+K  V+     +Q       E+ YL +++  +
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKY-VNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 566 L--VPLTGYCIAGDQRIAIYDYME--NGNLQNLLHD---LPLGVQTTEDWSTDTWEEDGT 618
              + L  Y I       IY  ME  N +L + L     +              W+    
Sbjct: 116 DKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSID------PWERKSYWKN--- 163

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPR 677
                                      A+  +H HG    I+H D+K ++  +  +   +
Sbjct: 164 ------------------------MLEAVHTIHQHG----IVHSDLKPANFLIV-DGMLK 194

Query: 678 LSDFGLAKIFGNGLDEEIAR---GSPGYIPPE---------FAQPDSDFPTPKSDVYCYG 725
           L DFG+A          +     G+  Y+PPE                  +PKSDV+  G
Sbjct: 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254

Query: 726 VVLLELITGKKP 737
            +L  +  GK P
Sbjct: 255 CILYYMTYGKTP 266

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 60/243 (24%), Positives = 103/243 (42%), Gaps = 45/243 (18%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVP 568
           ++    L +G FG VY+      G   A KV+   S    ++   E+E L    HP +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           L G      +   + ++   G +  ++ +L  G+  TE              IQ V  + 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL--TEPQ------------IQVVCRQM 126

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           L                AL FLH   S  IIHRD+KA +V + +  + RL+DFG++    
Sbjct: 127 L---------------EALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK-- 166

Query: 689 NGLDEEIAR-----GSPGYIPPEFAQPDSDFPTP---KSDVYCYGVVLLELITGKKPLGD 740
               + + +     G+P ++ PE    ++   TP   K+D++  G+ L+E+   + P  +
Sbjct: 167 --NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224

Query: 741 DYP 743
             P
Sbjct: 225 LNP 227

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 33/238 (13%), Positives = 54/238 (22%), Gaps = 73/238 (30%)

Query: 515 LLAEGKFGPVYRGF---LPGGIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKHPNLVP 568
                     ++     L     VA+  +     L D            L RI  P +  
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA- 94

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
                        + D +       ++ +    +              G  S+Q V    
Sbjct: 95  ------------RVLDVVHTRAGGLVVAEW---I-------------RGG-SLQEVADTS 125

Query: 629 LLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
                  R       A A    H  G    +       S V        R+S  G   + 
Sbjct: 126 PSPVGAIR--AMQSLAAAADAAHRAG----VALSIDHPSRV--------RVSIDGDVVL- 170

Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
                       P  +P            P+ D+   G  L  L+  + PL +     
Sbjct: 171 ----------AYPATMPDA---------NPQDDIRGIGASLYALLVNRWPLPEAGVRS 209

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 36/181 (19%), Positives = 72/181 (39%), Gaps = 12/181 (6%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS 108
              L+     +L + ++T L      L  +++ N   + I  SL + +  F  L+   LS
Sbjct: 15  DPGLANAVKQNLGKQSVTDL-VSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLS 71

Query: 109 NNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGF 168
           +N  S ++   +  L  L  L ++ N  + ++    +    L  + L  N+L     D  
Sbjct: 72  HNQIS-DLS-PLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNEL--RDTDSL 124

Query: 169 GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSN 228
                 L+ L++  N++K        L  +  L++ GN    +     L+ +  IDL   
Sbjct: 125 -IHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQ 182

Query: 229 Q 229
           +
Sbjct: 183 K 183

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 12/160 (7%)

Query: 47  TTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
            +  +LS +Q+ +   +NI +L + +    +LK L+LS+N+IS  L S + +   LE   
Sbjct: 35  VSQKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELS 91

Query: 107 LSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPD 166
           ++ N     +         L  L LD N  +      L++ ++L  + +  N+L  S+  
Sbjct: 92  VNRNRLK-NLNG--IPSACLSRLFLDNN--ELRDTDSLIHLKNLEILSIRNNKLK-SIVM 145

Query: 167 GFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGN 206
                  KL+ L+L GNEI         LK +  ++++G 
Sbjct: 146 --LGFLSKLEVLDLHGNEIT-NTGGLTRLKKVNWIDLTGQ 182

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 42/221 (19%), Positives = 79/221 (35%), Gaps = 21/221 (9%)

Query: 60  LSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAA 119
                I  +      L +    NL    ++     +      ++ F+  N+N    +   
Sbjct: 4   QRPTPINQV-FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLA-G 58

Query: 120 ISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLN 179
           +    +L+ L L  N  Q S    L +   L  + ++ N+L     +  G     L  L 
Sbjct: 59  MQFFTNLKELHLSHN--QISDLSPLKDLTKLEELSVNRNRLK----NLNGIPSACLSRLF 112

Query: 180 LAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQF 239
           L  NE++        LK++  L+I  N  +  VM  FL  LEV+DL  N+   +   +  
Sbjct: 113 LDNNELR-DTDSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEIT-NTGGLT- 169

Query: 240 NSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYN 280
                  ++ ++DL+  +   E          L   +   +
Sbjct: 170 ----RLKKVNWIDLTGQKCVNEPVKYQP---ELYITNTVKD 203

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 34/218 (15%), Positives = 65/218 (29%), Gaps = 39/218 (17%)

Query: 170 AAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQ 229
                    NL    +         L  + N N   +          ++SL  +      
Sbjct: 16  PGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSN---------IQSLAGMQ----- 60

Query: 230 FQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQ 289
                          ++ L  + LS NQ+S ++         L+ LS+  NR        
Sbjct: 61  --------------FFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNG-- 102

Query: 290 IGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSH 349
                 L  L L     + D    ++ L +L  L +  N L   +       L ++D+  
Sbjct: 103 -IPSACLSRLFLDNNE-LRDT-DSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHG 159

Query: 350 NNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPE 387
           N ++       L +L ++   + +         +  PE
Sbjct: 160 NEIT-NT--GGLTRLKKVNWIDLTGQKCVNEPVKYQPE 194

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 40/194 (20%), Positives = 72/194 (37%), Gaps = 21/194 (10%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS 108
           +  L+KL+ L ++ N +  L         L  L L  N +      ++ +   LE+  + 
Sbjct: 81  LKDLTKLEELSVNRNRLKNLNGI--PSACLSRLFLDNNELRD--TDSLIHLKNLEILSIR 136

Query: 109 NNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGF 168
           NN     I   +  L  L VL L GN  + +   GL   + +  +DL+  +   + P  +
Sbjct: 137 NNKLK-SIV-MLGFLSKLEVLDLHGN--EITNTGGLTRLKKVNWIDLTGQKCV-NEPVKY 191

Query: 169 GAAFPKLKSLN----LAGNEIKGRDTHFAGLKSITNLNISGNL--FQGSVMGVFLESLEV 222
               P+L   N      G  I     + +   S  +  +   L  +   V   F E +  
Sbjct: 192 ---QPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYIN- 245

Query: 223 IDLRSNQFQGHISQ 236
           +      F G ++Q
Sbjct: 246 VGETEAIFDGTVTQ 259

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 26/154 (16%), Positives = 58/154 (37%), Gaps = 16/154 (10%)

Query: 225 LRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTR 284
            R       I+QV  +     +  V  +L +  ++     +  +   +++ +   +    
Sbjct: 4   QRPTP----INQVFPDP--GLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ- 54

Query: 285 QEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGI 344
                +     L+ L+LS    I D+ S +  L+ L  L ++ N L   +  + +  L  
Sbjct: 55  -SLAGMQFFTNLKELHLSHNQ-ISDL-SPLKDLTKLEELSVNRNRLK-NLNGIPSACLSR 110

Query: 345 IDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           + + +N L  +  +  L  L  +E  +   N L 
Sbjct: 111 LFLDNNELR-DTDS--LIHLKNLEILSIRNNKLK 141

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 4/90 (4%)

Query: 47  TTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
            ++  L  L+ L +  N + ++   L  L  L+ L+L  N I+ +    +     +   D
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWID 178

Query: 107 LSNNNFSGEIPAAISSLVSLRVLK-LDGNM 135
           L+      E       L     +K  DG  
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 35/143 (24%), Positives = 60/143 (41%), Gaps = 28/143 (19%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDL-WSLGSLKSLNLSYNRISGSLPSNIGNFGL 101
            +P        KL+ +DLS N I+ L  D    L SL SL L  N+I+  LP +      
Sbjct: 46  VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKS------ 98

Query: 102 LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQL 160
             +F+                L SL++L L+ N     +      +  +L  + L  N+L
Sbjct: 99  --LFE---------------GLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140

Query: 161 NGSLPDGFGAAFPKLKSLNLAGN 183
             ++  G  +    +++++LA N
Sbjct: 141 Q-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 10/157 (6%)

Query: 56  QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNI-GNFGLLEVFDLSNNNFSG 114
             +D     +T +P++L    ++  + L  N I   +P      +  L   DLSNN  S 
Sbjct: 14  NIVDCRGKGLTEIPTNLPE--TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS- 69

Query: 115 EIPAAI-SSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAF 172
           E+       L SL  L L GN     +P  L     SL  + L+ N++N  L        
Sbjct: 70  ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDL 127

Query: 173 PKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLF 208
             L  L+L  N+++      F+ L++I  ++++ N F
Sbjct: 128 HNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 36/147 (24%), Positives = 65/147 (44%), Gaps = 14/147 (9%)

Query: 139 SIPPGL-LNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG--RDTHFAGL 195
            IP  L      +    L  N +   +P G  + + KL+ ++L+ N+I     D  F GL
Sbjct: 25  EIPTNLPETITEI---RLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDA-FQGL 79

Query: 196 KSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDL 253
           +S+ +L + GN        +F  L SL+++ L +N+    +    F    +   L  + L
Sbjct: 80  RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQ---DLHNLNLLSL 135

Query: 254 SENQLSGEIFHNFSQAQNLKHLSLAYN 280
            +N+L       FS  + ++ + LA N
Sbjct: 136 YDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 32/157 (20%), Positives = 57/157 (36%), Gaps = 37/157 (23%)

Query: 218 ESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN-FSQAQNLKHLS 276
           E++  I L  N     I  +   +   + +L  +DLS NQ+S E+  + F   ++L  L 
Sbjct: 32  ETITEIRLEQNT----IKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLV 86

Query: 277 LAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNHLTGQIP 335
           L  N+ T                         ++P  + + L SL  L L+ N +   + 
Sbjct: 87  LYGNKIT-------------------------ELPKSLFEGLFSLQLLLLNANKIN-CLR 120

Query: 336 T---VSAKNLGIIDMSHNNLSGEIPASLLEKLPQMER 369
                   NL ++ +  N L   I       L  ++ 
Sbjct: 121 VDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQT 156

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 17/111 (15%), Positives = 41/111 (36%), Gaps = 5/111 (4%)

Query: 271 NLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL-QLSSLHTLDLSMNH 329
            +  + L  N               L  ++LS   +  ++  +    L SL++L L  N 
Sbjct: 33  TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNK 91

Query: 330 LTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           +T    ++     +L ++ ++ N ++  +     + L  +   +   N L 
Sbjct: 92  ITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 79.5 bits (196), Expect = 5e-16
 Identities = 43/300 (14%), Positives = 98/300 (32%), Gaps = 67/300 (22%)

Query: 16  CSWRGVVCDSNKQHV--TDFLASNSGLS------GSVPDTTIGKLSKLQSLDLSENNIT- 66
           CS R  +C  +K     +D   +   L         +          L+ +++S+N++  
Sbjct: 9   CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68

Query: 67  ALPSDLWS-LGSLKSLNLS-YNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLV 124
            + +D++S L  L  + +   N +   +                   F          L 
Sbjct: 69  VIEADVFSNLPKLHEIRIEKANNLL-YINPEA---------------FQN--------LP 104

Query: 125 SLRVLKLDGNMFQWSIPPGL-LNCQSLVTVDLSMNQLNGSLPDG-FGAAFPKLKSLNLAG 182
           +L+ L +     +  +P    ++    V +D+  N    ++    F     +   L L  
Sbjct: 105 NLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163

Query: 183 NEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSS 242
           N I+                I  + F G       +  E+    +N     + ++  +  
Sbjct: 164 NGIQ---------------EIHNSAFNG------TQLDELNLSDNNN----LEELPNDVF 198

Query: 243 YNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLS 302
           +  S  V +D+S  ++     +     + L+  S        ++ P +  L+ L   +L+
Sbjct: 199 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL----KKLPTLEKLVALMEASLT 254

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 76.8 bits (189), Expect = 4e-15
 Identities = 30/168 (17%), Positives = 56/168 (33%), Gaps = 9/168 (5%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDL-WSLGSLKSLNLSYNRISGSLPSNI--GNF 99
            +       L  LQ L +S   I  LP            L++  N    ++  N   G  
Sbjct: 94  YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153

Query: 100 GLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMN 158
               +  L+ N    EI  +  +   L  L L  N     +P  +       V +D+S  
Sbjct: 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 212

Query: 159 QLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGN 206
           +++ SLP        KL++ +    +          L ++   +++  
Sbjct: 213 RIH-SLPSYGLENLKKLRARSTYNLKKLPT---LEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 35/248 (14%), Positives = 70/248 (28%), Gaps = 45/248 (18%)

Query: 141 PPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSIT 199
              + +C S        +++   +P            L     +++  +   F+G   + 
Sbjct: 3   HHRICHC-SNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLE 57

Query: 200 NLNISGNLFQGSV-MGVF--LESLEVIDL-RSNQFQGHISQVQFNSSYNWSRLVYVDLSE 255
            + IS N     +   VF  L  L  I + ++N                           
Sbjct: 58  KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL------------------------ 93

Query: 256 NQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL 315
             ++ E F N     NL++L ++               L    L++     I  I     
Sbjct: 94  -YINPEAFQNLP---NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149

Query: 316 Q--LSSLHTLDLSMNHLTGQIPT---VSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERF 370
                    L L+ N +  +I        +   +    +NNL  E+P  +          
Sbjct: 150 VGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVIL 207

Query: 371 NFSYNNLT 378
           + S   + 
Sbjct: 208 DISRTRIH 215

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 54/233 (23%), Positives = 89/233 (38%), Gaps = 33/233 (14%)

Query: 516 LAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEA-ARELEYLGR-IKHPNLVPLTGY 572
           +  G +G V +    P G  +AVK +       +Q+    +L+ + R    P +V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 573 CIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTT 632
                      + M + +       +                    + + +V  E +L  
Sbjct: 90  LFREGDCWICMELM-STSFDKFYKYVY-------------------SVLDDVIPEEILG- 128

Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD 692
                KI L T +AL  L       IIHRDIK S++ LD +   +L DFG++    + + 
Sbjct: 129 -----KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181

Query: 693 EEIARGSPGYIPPEFAQPDSDFP--TPKSDVYCYGVVLLELITGKKPLGDDYP 743
           +    G   Y+ PE   P +       +SDV+  G+ L EL TG+ P      
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 33/179 (18%), Positives = 60/179 (33%), Gaps = 37/179 (20%)

Query: 16  CSWRGVVCDSNK---------QHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT 66
           C    V C + K         Q+  +   +N+  +         KL +L+ ++ S N IT
Sbjct: 11  CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70

Query: 67  ALPSDLW-SLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVS 125
            +    +     +  + L+ NR+  ++           +F                 L S
Sbjct: 71  DIEEGAFEGASGVNEILLTSNRLE-NVQHK--------MFK---------------GLES 106

Query: 126 LRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGN 183
           L+ L L  N     +         S+  + L  NQ+  ++  G       L +LNL  N
Sbjct: 107 LKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 35/147 (23%), Positives = 63/147 (42%), Gaps = 13/147 (8%)

Query: 139 SIPPGL-LNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLK 196
            IP  +      L    L+ N+       G     P+L+ +N + N+I    +  F G  
Sbjct: 25  KIPEHIPQYTAEL---RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81

Query: 197 SITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLS 254
            +  + ++ N  +     +F  LESL+ + LRSN+    I+ V  +S    S +  + L 
Sbjct: 82  GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNR----ITCVGNDSFIGLSSVRLLSLY 137

Query: 255 ENQLSGEIFHN-FSQAQNLKHLSLAYN 280
           +NQ++  +    F    +L  L+L  N
Sbjct: 138 DNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 8/114 (7%)

Query: 270 QNLKHLSLAYNRFTRQEFPQI-GTLLGLEHLNLSRTSLIGDIPSEIL-QLSSLHTLDLSM 327
           Q    L L  N FT  E   I   L  L  +N S    I DI        S ++ + L+ 
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK-ITDIEEGAFEGASGVNEILLTS 90

Query: 328 NHLTGQIPT---VSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           N L   +        ++L  + +  N ++  +       L  +   +   N +T
Sbjct: 91  NRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 24/118 (20%), Positives = 45/118 (38%), Gaps = 13/118 (11%)

Query: 219 SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN-FSQAQNLKHLSL 277
               + L +N+F    +   F       +L  ++ S N+++ +I    F  A  +  + L
Sbjct: 33  YTAELRLNNNEFTVLEATGIFK---KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILL 88

Query: 278 AYNRFTRQEFPQIGT---LLGLEHLNLSRTSLIGDIPSEILQ-LSSLHTLDLSMNHLT 331
             NR   +          L  L+ L L    +   + ++    LSS+  L L  N +T
Sbjct: 89  TSNRL--ENVQH-KMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT 142

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 77.9 bits (191), Expect = 5e-15
 Identities = 30/126 (23%), Positives = 47/126 (37%), Gaps = 6/126 (4%)

Query: 10  YFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALP 69
               S       V       V     ++  L+  +    + +L  +  LDLS N + ALP
Sbjct: 423 DDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLRALP 479

Query: 70  SDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSG-EIPAAISSLVSLRV 128
             L +L  L+ L  S N +  ++   + N   L+   L NN          + S   L +
Sbjct: 480 PALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 537

Query: 129 LKLDGN 134
           L L GN
Sbjct: 538 LNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 77.1 bits (189), Expect = 1e-14
 Identities = 35/172 (20%), Positives = 69/172 (40%), Gaps = 16/172 (9%)

Query: 24  DSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLD---------LSENNITALPSDLWS 74
           ++    +T  L   +         T+   S L+++D         L    +         
Sbjct: 380 ENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKME 439

Query: 75  LGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGN 134
              ++ L+L++  ++  L  ++    L+   DLS+N     +P A+++L  L VL+   N
Sbjct: 440 YADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDN 496

Query: 135 MFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFG-AAFPKLKSLNLAGNEI 185
             + ++  G+ N   L  + L  N+L           + P+L  LNL GN +
Sbjct: 497 ALE-NV-DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.9 bits (178), Expect = 2e-13
 Identities = 43/214 (20%), Positives = 79/214 (36%), Gaps = 15/214 (7%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS 108
                +L   +LS    T L S+L S   L+ L         ++   +     L     +
Sbjct: 345 SATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKET 404

Query: 109 NNNFSGEIPAAISSLVSLRVLKLDG--NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPD 166
              FS      + ++  +R   LD   + F        +    +  + L+   L  ++  
Sbjct: 405 LQYFST-----LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLC 457

Query: 167 GFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGV-FLESLEVIDL 225
                   +  L+L+ N ++      A L+ +  L  S N  + +V GV  L  L+ + L
Sbjct: 458 HLEQ-LLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLL 515

Query: 226 RSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS 259
            +N+ Q   + +Q   S    RLV ++L  N L 
Sbjct: 516 CNNRLQ-QSAAIQPLVSC--PRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.4 bits (169), Expect = 2e-12
 Identities = 51/322 (15%), Positives = 102/322 (31%), Gaps = 12/322 (3%)

Query: 58  LDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIP 117
           L  +E +       +    +  S+  S     GS    +          +      G   
Sbjct: 236 LGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNR 295

Query: 118 AAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKS 177
            +   L  L    L+  + Q +         S     L  ++              +L  
Sbjct: 296 PSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSAT-DEQLFR 353

Query: 178 LNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQV 237
             L+  +     +     K +  L         +++   + +L+ +       Q + S +
Sbjct: 354 CELSVEKSTVLQSELESCKELQELEPENKWCLLTIIL-LMRALDPLLYEKETLQ-YFSTL 411

Query: 238 QFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLE 297
           +   + +  R  Y+D   ++   E      +  +++ L LA+   T      +  LL + 
Sbjct: 412 K---AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVT 466

Query: 298 HLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSA-KNLGIIDMSHNNLSGEI 356
           HL+LS   L   +P  +  L  L  L  S N L   +  V+    L  + + +N L    
Sbjct: 467 HLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQQSA 524

Query: 357 PASLLEKLPQMERFNFSYNNLT 378
               L   P++   N   N+L 
Sbjct: 525 AIQPLVSCPRLVLLNLQGNSLC 546

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 76.3 bits (188), Expect = 5e-15
 Identities = 60/339 (17%), Positives = 100/339 (29%), Gaps = 67/339 (19%)

Query: 53  SKLQSLDLSENNIT---------ALPSDLWSLGSLKSLNLSYNRISGS--------LPSN 95
             + SLDLS NN+          A  +   +  S+ SLNLS N +           L + 
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFAN---TPASVTSLNLSGNSLGFKNSDELVQILAAI 78

Query: 96  IGNFGLLEVFDLSNNNFSGEIPAAISSLV-----SLRVLKLDGNMFQWS----IPPGLLN 146
             N   +   +LS N  S +    +   +     ++ VL L  N F             N
Sbjct: 79  PAN---VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSN 135

Query: 147 C-QSLVTVDLSMNQLNG----SLPDGFGAAFPKLKSLNLAGNEIKGRDTHF--AGLK--- 196
              S+ +++L  N L       L     A    + SLNL GN +  ++       L    
Sbjct: 136 LPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIP 195

Query: 197 -SITNLNISGNLFQGSVMGVFLE-------SLEVIDLRSNQFQGHISQVQFNSSYNWSRL 248
            S+T+L++S NL                   +  ++L  N   G   +       +   L
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255

Query: 249 VYVDLSENQLSG-------EIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNL 301
             V L  + +          +   F   Q +  +              I  L+       
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKA 315

Query: 302 SRTSLIGDIPSEILQL----------SSLHTLDLSMNHL 330
              SL+        +             L     +   L
Sbjct: 316 DVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 53/285 (18%), Positives = 102/285 (35%), Gaps = 57/285 (20%)

Query: 144 LLNCQSLVTVDLSMNQLNGS----LPDGFGAAFPKLKSLNLAGNEIKGRDTHF--AGLKS 197
                 + ++DLS+N L       L   F      + SLNL+GN +  +++      L +
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 198 ----ITNLNISGNLFQ---GSVMGVFLES----LEVIDLRSNQFQG----HISQV--QFN 240
               +T+LN+SGN         +   L +    + V+DL  N F         Q      
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 241 SSYNWSRLVYVDLSENQLSGEIFHNFSQA-----QNLKHLSLAYNRFTRQEFPQIGTLL- 294
           +S     +  ++L  N L  +      Q       N+  L+L  N    +   ++   L 
Sbjct: 138 AS-----ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLA 192

Query: 295 ----GLEHLNLSRTSLIGDIP----SEILQL--SSLHTLDLSMNHLTGQ----IPTVSAK 340
                +  L+LS    +G       + I     + + +L+L +N L G     +  +   
Sbjct: 193 SIPASVTSLDLSANL-LGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251

Query: 341 N--LGIIDMSHN---NLSGEIPASLLEKLPQM---ERFNFSYNNL 377
              L  + + ++   N+S E   +L    P +      + +   +
Sbjct: 252 LKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 57.4 bits (139), Expect = 9e-09
 Identities = 40/256 (15%), Positives = 81/256 (31%), Gaps = 46/256 (17%)

Query: 53  SKLQSLDLSENNIT-----ALPSDLWSL-GSLKSLNLSYNRI--------SGSLPSNIGN 98
             +  LDL  N+ +            +L  S+ SLNL  N +           L +   N
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168

Query: 99  FGLLEVFDLSNNNFSGEIPAAISSLV-----SLRVLKLDGNMFQ----WSIPPGLLNCQ- 148
              +   +L  NN + +  A ++  +     S+  L L  N+        +     +   
Sbjct: 169 ---VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPN 225

Query: 149 SLVTVDLSMNQLNGSLPDGFGAAF---PKLKSLNLAGNEIKGRDTH--------FAGLKS 197
            +V+++L +N L+G   +           L+++ L  + +K             F  ++ 
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQK 285

Query: 198 ITNLNISGNLFQGSVMGVFLESLEVIDLR------SNQFQGHISQVQFNSSY--NWSRLV 249
           I  ++ +G     S        +  +  +       NQ      + Q N         L 
Sbjct: 286 IILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELR 345

Query: 250 YVDLSENQLSGEIFHN 265
               +   L     H+
Sbjct: 346 ESIQTCKPLLEHHHHH 361

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 76.2 bits (187), Expect = 6e-15
 Identities = 33/251 (13%), Positives = 61/251 (24%), Gaps = 50/251 (19%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEAARELEYLGR 560
           +       LL EG F  VY                 +KV    +        + +E L  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 561 IKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
                 +      +  +  + + +    G L N +                       N 
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI-----------------------NL 160

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK-----------ASSVY 669
            +N   + +          A+     +  +H      IIH DIK                
Sbjct: 161 YKNTPEKVMPQGLVI--SFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDE 215

Query: 670 LDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGV 726
            D++    L D G +          I      + G+   E           + D +    
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW--NYQIDYFGVAA 273

Query: 727 VLLELITGKKP 737
            +  ++ G   
Sbjct: 274 TVYCMLFGTYM 284

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 46/235 (19%), Positives = 88/235 (37%), Gaps = 38/235 (16%)

Query: 516 LAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA-ARELEYLGR-IKHPNLVPLTGY 572
           +  G  G V++      G  +AVK +       + +    +L+ + +    P +V   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 573 CIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTT 632
            I         + M     + L   +   +                        E +L  
Sbjct: 93  FITNTDVFIAMELM-GTCAEKLKKRMQGPI-----------------------PERILG- 127

Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD 692
                K+ +   +AL +L       +IHRD+K S++ LD   + +L DFG++    +   
Sbjct: 128 -----KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180

Query: 693 EEIARGSPGYIPPEFAQPDSDFPTP---KSDVYCYGVVLLELITGKKPLGDDYPE 744
           ++ + G   Y+ PE   P          ++DV+  G+ L+EL TG+ P  +   +
Sbjct: 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 36/232 (15%)

Query: 516 LAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEA-ARELEYLGR-IKHPNLVPLTG- 571
           L  G +G V +   +P G  +AVK +       +Q+    +L+   R +  P  V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 572 YCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLT 631
               GD  I + + M + +L      +    QT                      E +L 
Sbjct: 75  LFREGDVWICM-ELM-DTSLDKFYKQVIDKGQTI--------------------PEDILG 112

Query: 632 TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL 691
                 KIA+   +AL  LH   S  +IHRD+K S+V ++   + ++ DFG++    + +
Sbjct: 113 ------KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164

Query: 692 DEEIARGSPGYIPPEFAQPDSDFP--TPKSDVYCYGVVLLELITGKKPLGDD 741
            ++I  G   Y+ PE   P+ +    + KSD++  G+ ++EL   + P    
Sbjct: 165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 72.0 bits (177), Expect = 4e-14
 Identities = 49/182 (26%), Positives = 78/182 (42%), Gaps = 35/182 (19%)

Query: 31  TDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRIS 89
           T+ L   S    ++ D T   L+KL  L+L  N +  L + ++  L  L +L L+ N+++
Sbjct: 37  TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA 96

Query: 90  GSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPG----LL 145
            SLP          VFD                L  L  L L GN  + S+P G    L 
Sbjct: 97  -SLPLG--------VFD---------------HLTQLDKLYLGGNQLK-SLPSGVFDRLT 131

Query: 146 NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGR-DTHFAGLKSITNLNIS 204
             + L    L+ NQL  S+P G       L++L+L+ N+++      F  L  +  + + 
Sbjct: 132 KLKEL---RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187

Query: 205 GN 206
           GN
Sbjct: 188 GN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 59.3 bits (144), Expect = 8e-10
 Identities = 46/163 (28%), Positives = 66/163 (40%), Gaps = 20/163 (12%)

Query: 79  KSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAI-SSLVSLRVLKLDGNMFQ 137
           + L+L    ++    +       L   +L  N     + A +   L  L  L L  N   
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96

Query: 138 WSIPPGLLNC-QSLVTVDLSMNQLNGSLPDGFGAAF---PKLKSLNLAGNEIK----GRD 189
            S+P G+ +    L  + L  NQL  SLP G    F    KLK L L  N+++    G  
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSG---VFDRLTKLKELRLNTNQLQSIPAGA- 150

Query: 190 THFAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQF 230
             F  L ++  L++S N  Q    G F  L  L+ I L  NQF
Sbjct: 151 --FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 55/193 (28%), Positives = 78/193 (40%), Gaps = 34/193 (17%)

Query: 91  SLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNC-QS 149
           S+PS I      E  DL +   +    A    L  L  L LD N  Q ++  G+ +    
Sbjct: 28  SVPSGI--PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84

Query: 150 LVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQ 209
           L T+ L+ NQL  SLP G      +L  L L GN+          LKS+ +         
Sbjct: 85  LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQ----------LKSLPS--------- 124

Query: 210 GSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFS 267
               GVF  L  L+ + L +NQ Q  I    F+     + L  + LS NQL       F 
Sbjct: 125 ----GVFDRLTKLKELRLNTNQLQS-IPAGAFDK---LTNLQTLSLSTNQLQSVPHGAFD 176

Query: 268 QAQNLKHLSLAYN 280
           +   L+ ++L  N
Sbjct: 177 RLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 9/100 (9%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRISGSLPSNIGNF-- 99
           S+P      L++L  L L  N + +LPS ++  L  LK L L+ N++  S+P+  G F  
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPA--GAFDK 153

Query: 100 -GLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQW 138
              L+   LS N        A   L  L+ + L GN  Q+
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN--QF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 33/132 (25%), Positives = 46/132 (34%), Gaps = 9/132 (6%)

Query: 252 DLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSR---TSLIG 308
           DL    L+      F     L  L+L YN+           L  L  L L+     SL  
Sbjct: 41  DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPL 100

Query: 309 DIPSEILQLSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQ 366
            +      L+ L  L L  N L      V      L  + ++ N L   IPA   +KL  
Sbjct: 101 GVFD---HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN 156

Query: 367 MERFNFSYNNLT 378
           ++  + S N L 
Sbjct: 157 LQTLSLSTNQLQ 168

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 59/226 (26%), Positives = 89/226 (39%), Gaps = 37/226 (16%)

Query: 2   SSKSFQASYFSASFCSWRGVVCDSNK---------QHVTDFLASNSGLSGSVPDTTIGKL 52
           S+      +   +F                      +  D + +N+    SV    I  L
Sbjct: 6   STPIK-QIFPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ--GIQYL 62

Query: 53  SKLQSLDLSENNITALPS-DLWSLGSLKSLNLSYNRISGSLPSNIGNFGL--LEVFDLSN 109
             ++ L L  N +  + +     L +L  L L+ N++  SLP+ + +  L  L+   L  
Sbjct: 63  PNVRYLALGGNKLHDISALK--ELTNLTYLILTGNQLQ-SLPNGVFD-KLTNLKELVLVE 118

Query: 110 NNFSGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPG----LLNCQSLVTVDLSMNQLNGSL 164
           N     +P  +   L +L  L L  N  Q S+P G    L N   L   DLS NQL  SL
Sbjct: 119 NQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTEL---DLSYNQLQ-SL 172

Query: 165 PDGFGAAFPKL---KSLNLAGNEIKGR-DTHFAGLKSITNLNISGN 206
           P+G    F KL   K L L  N++K   D  F  L S+  + +  N
Sbjct: 173 PEG---VFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 41/185 (22%), Positives = 68/185 (36%), Gaps = 15/185 (8%)

Query: 197 SITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSEN 256
                N+       +V    L S++ I   ++  +   S        N   L    L  N
Sbjct: 20  ETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIK---SVQGIQYLPNVRYL---ALGGN 73

Query: 257 QLSG-EIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL 315
           +L         +   NL +L L  N+           L  L+ L L    L   +P  + 
Sbjct: 74  KLHDISALKELT---NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-QSLPDGVF 129

Query: 316 -QLSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNF 372
            +L++L  L+L+ N L      V     NL  +D+S+N L   +P  + +KL Q++    
Sbjct: 130 DKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRL 188

Query: 373 SYNNL 377
             N L
Sbjct: 189 YQNQL 193

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 72.8 bits (179), Expect = 7e-14
 Identities = 55/247 (22%), Positives = 89/247 (36%), Gaps = 51/247 (20%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKV--LVHGSTLTD-QEAARELEYLGRIK 562
              F     +  G FG VY    +     VA+K        +    Q+  +E+ +L +++
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           HPN +   G  +       + +Y   G+  +LL      +   E              I 
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPL--QEVE------------IA 157

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
            V    L               + LA+LH   S  +IHRD+KA ++ L      +L DFG
Sbjct: 158 AVTHGAL---------------QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFG 199

Query: 683 LAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGKK 736
            A          +A      G+P ++ PE      +     K DV+  G+  +EL   K 
Sbjct: 200 SA--------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

Query: 737 PLGDDYP 743
           PL +   
Sbjct: 252 PLFNMNA 258

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 41/149 (27%), Positives = 58/149 (38%), Gaps = 30/149 (20%)

Query: 31  TDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRIS 89
              L  +      +       L  L+ L L  N + ALP  ++ SL  L  L+L  N+++
Sbjct: 42  AQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 90  GSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQS 149
             LPS         VFD                LV L+ L +  N     +P G+     
Sbjct: 102 -VLPSA--------VFD---------------RLVHLKELFMCCNKLT-ELPRGIERLTH 136

Query: 150 LVTVDLSMNQLNGSLPDGFGAAFPKLKSL 178
           L  + L  NQL  S+P G   AF +L SL
Sbjct: 137 LTHLALDQNQLK-SIPHG---AFDRLSSL 161

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 31/96 (32%), Positives = 40/96 (41%), Gaps = 6/96 (6%)

Query: 40  LSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRISGSLPSNIGN 98
           L   V D     L++L  LDL  N +T LPS ++  L  LK L +  N+++  LP  I  
Sbjct: 79  LPVGVFD----SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIER 133

Query: 99  FGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGN 134
              L    L  N        A   L SL    L GN
Sbjct: 134 LTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 47/266 (17%), Positives = 84/266 (31%), Gaps = 73/266 (27%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL----VHGSTLTDQEAA----RELEYLG 559
            +   + L  G FG V+          V VK +    V      +         E+  L 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 560 RIKHPNLVPL--------------TGYCIAGDQRIAIYDY-MENGNLQNLLHDLPLGVQT 604
           R++H N++ +                +    D    ++ +   +  L             
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLD----LFAFIDRHPRLD------------ 128

Query: 605 TEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK 664
                     E   + I             FR  ++     A+ +L       IIHRDIK
Sbjct: 129 ----------EPLASYI-------------FRQLVS-----AVGYLRLKD---IIHRDIK 157

Query: 665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCY 724
             ++ +  +   +L DFG A     G       G+  Y  PE    +  +  P+ +++  
Sbjct: 158 DENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNP-YRGPELEMWSL 216

Query: 725 GVVLLELITGKKPLGDDYPEEKEGNL 750
           GV L  L+  + P   +  E  E  +
Sbjct: 217 GVTLYTLVFEENPF-CELEETVEAAI 241

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 51/264 (19%), Positives = 94/264 (35%), Gaps = 73/264 (27%)

Query: 513 GTLLAEGKFGPVYRGF-LPGGIHVAVKVL----------------------VHGSTLTDQ 549
              + +G +G V   +      + A+KVL                        G  +  +
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 550 EAA----RELEYLGRIKHPNLVPLTGYCIAGD-QRIAIY---DYMENGNLQNLLHDLPLG 601
                  +E+  L ++ HPN+V L    +  D     +Y   + +  G +  +    PL 
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL- 134

Query: 602 VQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIH 660
              +ED                           +   +  G    + +LH       IIH
Sbjct: 135 ---SED-----------------------QARFYFQDLIKG----IEYLHYQK----IIH 160

Query: 661 RDIKASSVYLDMNLEPRLSDFGLAKIF--GNGLDEEIARGSPGYIPPE-FAQPDSDFPTP 717
           RDIK S++ +  +   +++DFG++  F   + L      G+P ++ PE  ++    F   
Sbjct: 161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGK 219

Query: 718 KSDVYCYGVVLLELITGKKPLGDD 741
             DV+  GV L   + G+ P  D+
Sbjct: 220 ALDVWAMGVTLYCFVFGQCPFMDE 243

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 72.0 bits (177), Expect = 3e-13
 Identities = 62/333 (18%), Positives = 122/333 (36%), Gaps = 79/333 (23%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL--VHGSTLTDQEAARELEYLGRIKH 563
           +  + R   L  G +G V         +  A+K++     ST ++ +   E+  L  + H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           PN++ L  +         + +  + G L +        +     ++    E D    I+ 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDE-------IIHRMKFN----EVDAAVIIKQ 144

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYL---DMNLEPRLS 679
           V                      + +LH H     I+HRD+K  ++ L   + +   ++ 
Sbjct: 145 V-------------------LSGVTYLHKHN----IVHRDLKPENLLLESKEKDALIKIV 181

Query: 680 DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
           DFGL+ +F N    +   G+  YI PE  +   D    K DV+  GV+L  L+ G  P G
Sbjct: 182 DFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYD---EKCDVWSIGVILFILLAGYPPFG 238

Query: 740 DDYPEE-----KEGNL---------VSW-----VRGLVRNNKGSRAIDPKIRDTGPEKQM 780
               +E     ++G           VS      ++ ++         D + R +      
Sbjct: 239 GQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQML-------QFDSQRRIS-----A 286

Query: 781 EEALK----IGYLCTADLPLKRPSMQQIVGLLK 809
           ++AL+           +  ++ PS+   +  ++
Sbjct: 287 QQALEHPWIKEMCSKKESGIELPSLANAIENMR 319

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 38/144 (26%), Positives = 57/144 (39%), Gaps = 14/144 (9%)

Query: 46  DTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVF 105
           D T+  L   + L LS NNI  + S L  + +L+ L+L  N I   + +       LE  
Sbjct: 41  DATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98

Query: 106 DLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQ-WSIPPGLLNCQSLVTVDLSMNQLNGSL 164
            +S N  +  + + I  LV+LRVL +  N    W     L     L  + L+ N L    
Sbjct: 99  WISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156

Query: 165 PDGFG---------AAFPKLKSLN 179
            +               P LK L+
Sbjct: 157 KENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 67.0 bits (164), Expect = 8e-13
 Identities = 32/132 (24%), Positives = 54/132 (40%), Gaps = 5/132 (3%)

Query: 54  KLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFS 113
           +   L      I  + + L +L + K L LS N I   + S++     L +  L  N   
Sbjct: 26  EKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK 83

Query: 114 GEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFP 173
            +I    +   +L  L +  N    S+  G+    +L  + +S N++         AA  
Sbjct: 84  -KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALD 140

Query: 174 KLKSLNLAGNEI 185
           KL+ L LAGN +
Sbjct: 141 KLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 28/140 (20%), Positives = 55/140 (39%), Gaps = 6/140 (4%)

Query: 240 NSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHL 299
           +     +  V +      +  ++    S  +  KHL+L+ N   +     +  +  L  L
Sbjct: 19  SVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISS--LSGMENLRIL 75

Query: 300 NLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSA-KNLGIIDMSHNNLSGEIPA 358
           +L R  LI  I +      +L  L +S N +   +  +    NL ++ MS+N ++     
Sbjct: 76  SLGRN-LIKKIENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKITNWGEI 133

Query: 359 SLLEKLPQMERFNFSYNNLT 378
             L  L ++E    + N L 
Sbjct: 134 DKLAALDKLEDLLLAGNPLY 153

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 35/164 (21%), Positives = 66/164 (40%), Gaps = 20/164 (12%)

Query: 173 PKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGV-FLESLEVIDLRSNQFQ 231
            +   L+     I+  D   + LK+  +L +S N  +  +  +  +E+L ++ L  N   
Sbjct: 25  AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNL-- 81

Query: 232 GHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTR-QEFPQI 290
             I +++ N       L  + +S NQ+         +  NL+ L ++ N+ T   E  ++
Sbjct: 82  --IKKIE-NLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEIDKL 136

Query: 291 GTLLGLEHLNLSRTSLIGDIPSE----------ILQLSSLHTLD 324
             L  LE L L+   L  D              + +L +L  LD
Sbjct: 137 AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 66.7 bits (163), Expect = 7e-13
 Identities = 25/101 (24%), Positives = 37/101 (36%), Gaps = 4/101 (3%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSN 95
            N   +    +    +   L+ L L    + ++ S+L  L  LK L LS NRI G L   
Sbjct: 32  DNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDML 90

Query: 96  IGNFGLLEVFDLSNNNFS--GEIPAAISSLVSLRVLKLDGN 134
                 L   +LS N       +   +  L  L+ L L   
Sbjct: 91  AEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 27/105 (25%), Positives = 44/105 (41%), Gaps = 6/105 (5%)

Query: 104 VFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGS 163
           V D   +N  G+I    +  V+L  L L       S+   L     L  ++LS N++   
Sbjct: 30  VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRIF-G 85

Query: 164 LPDGFGAAFPKLKSLNLAGNEIKGRDT--HFAGLKSITNLNISGN 206
             D      P L  LNL+GN++K   T      L+ + +L++   
Sbjct: 86  GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 25/104 (24%), Positives = 44/104 (42%), Gaps = 3/104 (2%)

Query: 58  LDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIP 117
           LD  ++N   +        +L+ L+L    +  S+ SN+     L+  +LS N   G + 
Sbjct: 31  LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLD 88

Query: 118 AAISSLVSLRVLKLDGNMFQ-WSIPPGLLNCQSLVTVDLSMNQL 160
                L +L  L L GN  +  S    L   + L ++DL   ++
Sbjct: 89  MLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 49.4 bits (118), Expect = 5e-07
 Identities = 26/143 (18%), Positives = 47/143 (32%), Gaps = 28/143 (19%)

Query: 145 LNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNIS 204
               ++  + L   + N    +G  A F  L+ L+L    +           S++NL   
Sbjct: 21  RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL----------ISVSNLP-- 68

Query: 205 GNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSG-EIF 263
                       L  L+ ++L  N+    I       +     L +++LS N+L      
Sbjct: 69  -----------KLPKLKKLELSENR----IFGGLDMLAEKLPNLTHLNLSGNKLKDISTL 113

Query: 264 HNFSQAQNLKHLSLAYNRFTRQE 286
               + + LK L L     T   
Sbjct: 114 EPLKKLECLKSLDLFNCEVTNLN 136

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 24/123 (19%), Positives = 48/123 (39%), Gaps = 9/123 (7%)

Query: 261 EIFHNFSQAQNLKHLSLAYNRFTRQEFPQIG-TLLGLEHLNLSRTSL--IGDIPSEILQL 317
            +         ++ L L   +    +   +    + LE L+L    L  + ++P     L
Sbjct: 15  HLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPK----L 70

Query: 318 SSLHTLDLSMNHLTGQIPTVSA--KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYN 375
             L  L+LS N + G +  ++    NL  +++S N L        L+KL  ++  +    
Sbjct: 71  PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

Query: 376 NLT 378
            +T
Sbjct: 131 EVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.1 bits (94), Expect = 7e-04
 Identities = 27/86 (31%), Positives = 37/86 (43%), Gaps = 5/86 (5%)

Query: 248 LVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLI 307
           L ++ L    L      N  +   LK L L+ NR           L  L HLNLS  + +
Sbjct: 51  LEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSG-NKL 107

Query: 308 GDIPS-EILQ-LSSLHTLDLSMNHLT 331
            DI + E L+ L  L +LDL    +T
Sbjct: 108 KDISTLEPLKKLECLKSLDLFNCEVT 133

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 67.4 bits (165), Expect = 7e-13
 Identities = 47/150 (31%), Positives = 69/150 (46%), Gaps = 31/150 (20%)

Query: 31  TDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRIS 89
           T +L   +    S+P+    +L+ L  L L  N + +LP+ ++  L SL  LNLS N++ 
Sbjct: 30  TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ 89

Query: 90  GSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLN-CQ 148
            SLP+         VFD                L  L+ L L+ N  Q S+P G+ +   
Sbjct: 90  -SLPNG--------VFD---------------KLTQLKELALNTNQLQ-SLPDGVFDKLT 124

Query: 149 SLVTVDLSMNQLNGSLPDGFGAAFPKLKSL 178
            L  + L  NQL  S+PDG    F +L SL
Sbjct: 125 QLKDLRLYQNQLK-SVPDG---VFDRLTSL 150

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 32/119 (26%), Positives = 48/119 (40%), Gaps = 6/119 (5%)

Query: 116 IPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKL 175
           +P  I        L L+ N  +           SL  + L  N+L  SLP+G       L
Sbjct: 22  VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 176 KSLNLAGNEIKGRDTH-FAGLKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQ 231
             LNL+ N+++      F  L  +  L ++ N  Q    GVF  L  L+ + L  NQ +
Sbjct: 79  TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 71.1 bits (174), Expect = 8e-13
 Identities = 55/376 (14%), Positives = 113/376 (30%), Gaps = 58/376 (15%)

Query: 51  KLSKLQSLDLSENNITALPSDLW------SLGSLKSLNLSYNRISGSLPSNIGNFGL--- 101
               L+ LDL E+++  + S  W      +  SL SLN+S       L S +    L   
Sbjct: 154 TCRNLKELDLRESDVDDV-SGHWLSHFPDTYTSLVSLNIS------CLASEVSFSALERL 206

Query: 102 ------LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG------NMFQWSIPPGLLNCQS 149
                 L+   L+      ++   +     L  L   G            +   L  C+ 
Sbjct: 207 VTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKE 266

Query: 150 LVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRD--THFAGLKSITNLNISGNL 207
           L  +    + +   LP    +   +L +LNL+   ++  D          +  L +   +
Sbjct: 267 LRCLSGFWDAVPAYLP-AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYI 325

Query: 208 FQGSVMGV--FLESLEVIDLRSNQFQGHISQVQFNS------SYNWSRLVYVDLSENQLS 259
               +  +    + L  + +  ++       V          S    +L  V     Q++
Sbjct: 326 EDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMT 385

Query: 260 GEIFHNFSQA-QNLKHLSLAY-NRFTRQEFPQIGTLLG----------LEHLNLSRTSLI 307
                  ++   N+    L                 +G          L  L+LS   L+
Sbjct: 386 NAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS--GLL 443

Query: 308 GD-IPSEILQ-LSSLHTLDLSMNHLTGQ-IPTV--SAKNLGIIDMSHNNLSGEIPASLLE 362
            D +   I      +  L ++    +   +  V     +L  +++       +   +   
Sbjct: 444 TDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANAS 503

Query: 363 KLPQMERFNFSYNNLT 378
           KL  M     S  +++
Sbjct: 504 KLETMRSLWMSSCSVS 519

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 58.4 bits (141), Expect = 6e-09
 Identities = 63/394 (15%), Positives = 108/394 (27%), Gaps = 52/394 (13%)

Query: 25  SNKQHVTDFLASNSGLSGSVPDT---TIGKLSKLQSLDLSENNIT--ALPSDLWSLGSLK 79
             K H  DF     G  G V           + L+ + L    +T   L     S  + K
Sbjct: 74  KGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFK 133

Query: 80  SLNLSY-NRIS-GSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLV----SLRVLKLDG 133
            L LS     S   L +       L+  DL  ++        +S       SL  L +  
Sbjct: 134 VLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC 193

Query: 134 NMFQWSIPPGLL----NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRD 189
              + S    L      C +L ++ L+       L        P+L+ L   G   + R 
Sbjct: 194 LASEVS-FSALERLVTRCPNLKSLKLNRAVPLEKLA-TLLQRAPQLEELGTGGYTAEVRP 251

Query: 190 THFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLV 249
             ++GL    +                L  L         +   +           SRL 
Sbjct: 252 DVYSGLSVALSGCKE------------LRCLSGFWDAVPAYLPAVYS-------VCSRLT 292

Query: 250 YVDLSENQLSGE-IFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLL-GLEHLNLSRTSLI 307
            ++LS   +    +     Q   L+ L +  +         + +    L  L +  +   
Sbjct: 293 TLNLSYATVQSYDLVKLLCQCPKLQRLWV-LDYIEDAGLEVLASTCKDLRELRVFPSEPF 351

Query: 308 GDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQM 367
              P+  L    L ++ +    L              +      ++     ++    P M
Sbjct: 352 VMEPNVALTEQGLVSVSMGCPKLE------------SVLYFCRQMTNAALITIARNRPNM 399

Query: 368 ERFNFSYNNLTLCASELSPETLQTAFFGSSNDCP 401
            RF             L+ E L   F      C 
Sbjct: 400 TRFRLCIIEPKAP-DYLTLEPLDIGFGAIVEHCK 432

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 39/331 (11%), Positives = 95/331 (28%), Gaps = 63/331 (19%)

Query: 56  QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGE 115
           + + +      +  + +     ++S+ L                     F+L  + + G 
Sbjct: 46  RKVFIGNCYAVSPATVIRRFPKVRSVELKGKP-------------HFADFNLVPDGWGGY 92

Query: 116 IPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKL 175
           +   I ++ S                    +   L  + L    +     +    +F   
Sbjct: 93  VYPWIEAMSS--------------------SYTWLEEIRLKRMVVTDDCLELIAKSFKNF 132

Query: 176 KSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHIS 235
           K L L+              +  +   +       + +     +L+ +DLR +       
Sbjct: 133 KVLVLSSC------------EGFSTDGL-------AAIAATCRNLKELDLRESDVDDVSG 173

Query: 236 QVQFNSSYNWSRLVYVDLS--ENQLSGEIFHNFSQA-QNLKHLSLAYNRFTRQEFPQIGT 292
               +    ++ LV +++S   +++S            NLK L L       +    +  
Sbjct: 174 HWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQR 233

Query: 293 LLGLEHLNLSRTSLIGD------IPSEILQLSSLHTLDLSMNHLTGQIPTVS--AKNLGI 344
              LE L     +          +   +     L  L    + +   +P V      L  
Sbjct: 234 APQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTT 293

Query: 345 IDMSHNNLSGEIPASLLEKLPQMERFNFSYN 375
           +++S+  +       LL + P+++R      
Sbjct: 294 LNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 65.1 bits (159), Expect = 1e-12
 Identities = 23/87 (26%), Positives = 36/87 (41%), Gaps = 2/87 (2%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS 108
             +  +L+ L      +T++ ++L  L  LK L LS NR+SG L         L   +LS
Sbjct: 38  TDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96

Query: 109 NNNFSG-EIPAAISSLVSLRVLKLDGN 134
            N          +  L +L+ L L   
Sbjct: 97  GNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 57.4 bits (139), Expect = 7e-10
 Identities = 25/103 (24%), Positives = 43/103 (41%), Gaps = 3/103 (2%)

Query: 57  SLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEI 116
            LD S +N   L         L+ L+     ++ S+ +N+     L+  +LS+N  SG +
Sbjct: 23  VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGL 80

Query: 117 PAAISSLVSLRVLKLDGNMFQ-WSIPPGLLNCQSLVTVDLSMN 158
                   +L  L L GN  +  S    L   ++L ++DL   
Sbjct: 81  EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 49.3 bits (118), Expect = 4e-07
 Identities = 25/145 (17%), Positives = 47/145 (32%), Gaps = 28/145 (19%)

Query: 143 GLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLN 202
                  +  + L  ++ N    +G    F +L+ L+     +           SI NL 
Sbjct: 12  RNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL----------TSIANLP 61

Query: 203 ISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSG-E 261
                         L  L+ ++L  N+    +S      +     L +++LS N++    
Sbjct: 62  -------------KLNKLKKLELSDNR----VSGGLEVLAEKCPNLTHLNLSGNKIKDLS 104

Query: 262 IFHNFSQAQNLKHLSLAYNRFTRQE 286
                 + +NLK L L     T   
Sbjct: 105 TIEPLKKLENLKSLDLFNCEVTNLN 129

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 25/115 (21%), Positives = 49/115 (42%), Gaps = 9/115 (7%)

Query: 269 AQNLKHLSLAYNRFTRQEFPQIG-TLLGLEHLNLSRTSL--IGDIPSEILQLSSLHTLDL 325
             ++K L L  +R    +   +      LE L+     L  I ++P     L+ L  L+L
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK----LNKLKKLEL 71

Query: 326 SMNHLTGQIPTVSA--KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           S N ++G +  ++    NL  +++S N +        L+KL  ++  +     +T
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 4e-04
 Identities = 23/117 (19%), Positives = 43/117 (36%), Gaps = 8/117 (6%)

Query: 217 LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLS 276
              ++ + L +++             +    L ++      L+     N  +   LK L 
Sbjct: 16  PSDVKELVLDNSR-SNEGKLEGLTDEF--EELEFLSTINVGLT--SIANLPKLNKLKKLE 70

Query: 277 LAYNRFTRQEFPQIGTLLGLEHLNLS--RTSLIGDIPSEILQLSSLHTLDLSMNHLT 331
           L+ NR +            L HLNLS  +   +  I   + +L +L +LDL    +T
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNCEVT 126

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 54/252 (21%), Positives = 97/252 (38%), Gaps = 69/252 (27%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIKHP 564
           N+     + +G F  V     +  G  VA+K++   + L         RE+  +  + HP
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII-DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 565 NLVPL-------------TGYCIAGDQRIAIYDY-MENGNLQNLLHDLPLGVQTTEDWST 610
           N+V L               Y   G+    ++DY + +G ++                  
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGE----VFDYLVAHGRMK------------------ 112

Query: 611 DTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL 670
              E++  +  + + S                   A+ + H      I+HRD+KA ++ L
Sbjct: 113 ---EKEARSKFRQIVS-------------------AVQYCHQKR---IVHRDLKAENLLL 147

Query: 671 DMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE-FAQPDSDFPTPKSDVYCYGVVLL 729
           D ++  +++DFG +  F  G   +   G+P Y  PE F     D   P+ DV+  GV+L 
Sbjct: 148 DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD--GPEVDVWSLGVILY 205

Query: 730 ELITGKKPLGDD 741
            L++G  P    
Sbjct: 206 TLVSGSLPFDGQ 217

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 68.2 bits (167), Expect = 4e-12
 Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 51/246 (20%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL--VHGSTLTDQEA-ARELEYLGRIK 562
           +  +    +L +G FG V        G   AVKV+        TD+E+  RE++ L ++ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           HPN++ L  +         + +    G L +        + + + +S    E D    I+
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE-------IISRKRFS----EVDAARIIR 133

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVYLDMNLE 675
            V                      + ++H +     I+HRD+K       S      +  
Sbjct: 134 QV-------------------LSGITYMHKNK----IVHRDLKPENLLLESK---SKDAN 167

Query: 676 PRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
            R+ DFGL+  F      +   G+  YI PE      D    K DV+  GV+L  L++G 
Sbjct: 168 IRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYD---EKCDVWSTGVILYILLSGC 224

Query: 736 KPLGDD 741
            P    
Sbjct: 225 PPFNGA 230

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 64.6 bits (158), Expect = 5e-12
 Identities = 33/132 (25%), Positives = 53/132 (40%), Gaps = 33/132 (25%)

Query: 56  QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGE 115
             L L  N  T +P +L +   L  ++LS NRIS +L +          F          
Sbjct: 34  TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQ--------SFS--------- 75

Query: 116 IPAAISSLVSLRVLKLDGNMFQWSIPPGLLN-CQSLVTVDLSMNQLNGSLPDGFGAAFPK 174
                 ++  L  L L  N  +  IPP   +  +SL  + L  N ++  +P+G   AF  
Sbjct: 76  ------NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEG---AFND 124

Query: 175 LKSLN---LAGN 183
           L +L+   +  N
Sbjct: 125 LSALSHLAIGAN 136

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 67.6 bits (165), Expect = 9e-12
 Identities = 45/240 (18%), Positives = 87/240 (36%), Gaps = 40/240 (16%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPN 565
             ++D    L  G FG V+R      G + A K ++       +   +E++ +  ++HP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           LV L       ++ + IY++M  G L   +             S    E++    ++ V 
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKV------ADEHNKMS----EDEAVEYMRQVC 265

Query: 626 SEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRL--SDFG 682
                                L  +H +      +H D+K  ++         L   DFG
Sbjct: 266 K-------------------GLCHMHENN----YVHLDLKPENIMFTTKRSNELKLIDFG 302

Query: 683 LAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP-LGDD 741
           L          ++  G+  +  PE A+         +D++  GV+   L++G  P  G++
Sbjct: 303 LTAHLDPKQSVKVTTGTAEFAAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 65.3 bits (160), Expect = 1e-11
 Identities = 50/247 (20%), Positives = 88/247 (35%), Gaps = 51/247 (20%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHP 564
              F     L  G FG V+       G+   +K +    +    E    E+E L  + HP
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 565 NLVPLTGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           N++ +       +    +Y   +  E G L   L  +       +  S    E      +
Sbjct: 81  NIIKIFEVF---EDYHNMYIVMETCEGGEL---LERIVSAQARGKALS----EGYVAELM 130

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVYLDMNL 674
           + + +                   ALA+ H       ++H+D+K        +     + 
Sbjct: 131 KQMMN-------------------ALAYFHSQH----VVHKDLKPENILFQDT---SPHS 164

Query: 675 EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
             ++ DFGLA++F +      A G+  Y+ PE  + D      K D++  GVV+  L+TG
Sbjct: 165 PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVT---FKCDIWSAGVVMYFLLTG 221

Query: 735 KKPLGDD 741
             P    
Sbjct: 222 CLPFTGT 228

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 62.8 bits (153), Expect = 1e-11
 Identities = 31/152 (20%), Positives = 51/152 (33%), Gaps = 33/152 (21%)

Query: 58  LDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIG-NFGLLEVFDLSNNNFSGEI 116
           + L+   I        +    + L+L   +I   +  N+G      +  D S+N      
Sbjct: 2   VKLTAELIEQAAQ-YTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNE----- 53

Query: 117 PAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLK 176
              I  L                   G    + L T+ ++ N++   + +G   A P L 
Sbjct: 54  ---IRKL------------------DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLT 91

Query: 177 SLNLAGNEIKGRDT--HFAGLKSITNLNISGN 206
            L L  N +         A LKS+T L I  N
Sbjct: 92  ELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 61.6 bits (150), Expect = 3e-11
 Identities = 24/85 (28%), Positives = 38/85 (44%), Gaps = 4/85 (4%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNN 111
           L +  ++D S+N I  L      L  LK+L ++ NRI             L    L+NN+
Sbjct: 41  LDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99

Query: 112 FS--GEIPAAISSLVSLRVLKLDGN 134
               G++   ++SL SL  L +  N
Sbjct: 100 LVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 57.7 bits (140), Expect = 8e-10
 Identities = 24/135 (17%), Positives = 40/135 (29%), Gaps = 26/135 (19%)

Query: 51  KLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNN 110
              + + LDL    I  + +   +L    +++ S N I   L         L+   ++NN
Sbjct: 17  NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNN 74

Query: 111 NFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGA 170
                      +L  L  L L  N               L  +D         L     A
Sbjct: 75  RICRIGEGLDQALPDLTELILTNNSL-----------VELGDLD--------PL-----A 110

Query: 171 AFPKLKSLNLAGNEI 185
           +   L  L +  N +
Sbjct: 111 SLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 27/130 (20%), Positives = 48/130 (36%), Gaps = 10/130 (7%)

Query: 201 LNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSG 260
           + ++  L + +           +DLR  +    I  ++ N      +   +D S+N++  
Sbjct: 2   VKLTAELIEQAAQYTNAVRDRELDLRGYK----IPVIE-NLGATLDQFDAIDFSDNEIR- 55

Query: 261 EIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLS--RTSLIGDIPSEILQLS 318
                F   + LK L +  NR  R        L  L  L L+      +GD+   +  L 
Sbjct: 56  -KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLK 113

Query: 319 SLHTLDLSMN 328
           SL  L +  N
Sbjct: 114 SLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 18/92 (19%), Positives = 35/92 (38%), Gaps = 4/92 (4%)

Query: 288 PQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSA-KNLGIID 346
            Q    +    L+L R   I  I +    L     +D S N +  ++      + L  + 
Sbjct: 13  AQYTNAVRDRELDL-RGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLL 70

Query: 347 MSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
           +++N +   I   L + LP +     + N+L 
Sbjct: 71  VNNNRIC-RIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 19/87 (21%), Positives = 35/87 (40%), Gaps = 7/87 (8%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRIS--GSLPSNIGNFGLLEVF 105
              L +L++L ++ N I  +   L  +L  L  L L+ N +   G L   + +   L   
Sbjct: 60  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYL 118

Query: 106 DLSNNNFSGEI---PAAISSLVSLRVL 129
            +  N  + +       I  +  +RVL
Sbjct: 119 CILRNPVTNKKHYRLYVIYKVPQVRVL 145

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 51/249 (20%), Positives = 83/249 (33%), Gaps = 64/249 (25%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
            +D    +  G FG             VAVK +       D+   RE+     ++HPN+V
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIV 79

Query: 568 PLTGY-CIAGDQRIAI----------YDYM-ENGNLQNLLHDLPLGVQTTEDWSTDTWEE 615
                  I     +AI          Y+ +   G                        E+
Sbjct: 80  RF--KEVILTPTHLAIIMEYASGGELYERICNAGRFS---------------------ED 116

Query: 616 DGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNL 674
           +                + F+  ++      +++ H       I HRD+K  +  LD + 
Sbjct: 117 EAR--------------FFFQQLLS-----GVSYCHSMQ----ICHRDLKLENTLLDGSP 153

Query: 675 EPRL--SDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
            PRL   DFG +K        +   G+P YI PE      ++    +DV+  GV L  ++
Sbjct: 154 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYDGKIADVWSCGVTLYVML 212

Query: 733 TGKKPLGDD 741
            G  P  D 
Sbjct: 213 VGAYPFEDP 221

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 65.5 bits (160), Expect = 3e-11
 Identities = 54/261 (20%), Positives = 86/261 (32%), Gaps = 63/261 (24%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKV-----LVHGSTLTDQEAA---RELEY 557
              +     L  G  G V   F       VA+++        GS      A     E+E 
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWE 614
           L ++ HP ++ +  +  A D     Y   + ME G L               D       
Sbjct: 194 LKKLNHPCIIKIKNFFDAED----YYIVLELMEGGELF--------------DK------ 229

Query: 615 EDGTNSIQNVGSEGLLTTWRFRHKIALGTAR----ALAFLH-HGCSPPIIHRDIKASSVY 669
                 +            R +             A+ +LH +G    IIHRD+K  +V 
Sbjct: 230 ------VVGNK--------RLKEATCKLYFYQMLLAVQYLHENG----IIHRDLKPENVL 271

Query: 670 LDMNLEP---RLSDFGLAKIFGNGLDEEIARGSPGYIPPE-FAQPDSDFPTPKSDVYCYG 725
           L    E    +++DFG +KI G         G+P Y+ PE      +       D +  G
Sbjct: 272 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331

Query: 726 VVLLELITGKKPLGDDYPEEK 746
           V+L   ++G  P  +   +  
Sbjct: 332 VILFICLSGYPPFSEHRTQVS 352

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 65.7 bits (160), Expect = 3e-11
 Identities = 51/394 (12%), Positives = 104/394 (26%), Gaps = 55/394 (13%)

Query: 25  SNKQHVTDF---LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLG----- 76
             K     F     +  G            L +L+S+      ++    DL  L      
Sbjct: 81  KGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVS--DLDLDRLAKARAD 138

Query: 77  SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMF 136
            L++L L          S     GLL +               ++    ++ L ++ + F
Sbjct: 139 DLETLKLDKC-------SGFTTDGLLSI---------------VTHCRKIKTLLMEESSF 176

Query: 137 QWSIPPGLL----NCQSLVTVDLSMNQLNGSLPDGFGAAF---PKLKSLNLAGNEIKGRD 189
                  L     +  SL  ++  M +     P            L S+ +   EI    
Sbjct: 177 SEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV 236

Query: 190 THFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLV 249
             F    ++             +   ++  +    L                    +++ 
Sbjct: 237 GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIR 296

Query: 250 YVDLSENQLSGE-IFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLL-GLEHLNLSRTSLI 307
            +DL    L  E       +  NL+ L    N    +    +      L+ L + R +  
Sbjct: 297 KLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADE 355

Query: 308 GDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQM 367
             +  E   +S        +  L         + L  + +  ++++ E   S+   L  +
Sbjct: 356 QGMEDEEGLVS-----QRGLIAL-----AQGCQELEYMAVYVSDITNESLESIGTYLKNL 405

Query: 368 ERFNFSYNNLTLCASELSPETLQTAFFGSSNDCP 401
             F      L      ++   L          C 
Sbjct: 406 CDFR--LVLLDRE-ERITDLPLDNGVRSLLIGCK 436

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 54/360 (15%), Positives = 103/360 (28%), Gaps = 45/360 (12%)

Query: 52  LSKLQSLDLSENNITAL-PSDLWSLG----SLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
            + L+ L+        + P DL ++     SL S+ +    I   L         LE F 
Sbjct: 191 NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFKAAANLEEFC 249

Query: 107 LSNNNFSGEIPAAISSLVSLRVLKLDG--NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSL 164
             + N    +P    +LV  R L   G   M    +P        +  +DL    L    
Sbjct: 250 GGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETED 309

Query: 165 PDGFGAAFPKLKSLNLAGN-EIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVI 223
                   P L+ L        +G +      K +  L I     +  +           
Sbjct: 310 HCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGM----------- 358

Query: 224 DLRSNQFQGHISQVQFNS-SYNWSRLVYVDLSENQLSGEIFHNFSQA-QNLKHLSLAY-- 279
                  +G +SQ    + +     L Y+ +  + ++ E   +     +NL    L    
Sbjct: 359 ----EDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLD 414

Query: 280 ------NRFTRQEFPQIGT-LLGLEHLNLSRTS-LIGDIPSEILQLSS----LHTLDLSM 327
                 +         +      L           + D    +  +      +  + L  
Sbjct: 415 REERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTD--LGLSYIGQYSPNVRWMLLGY 472

Query: 328 NHLTGQ-IPTVSA--KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASEL 384
              + + +   S    NL  ++M     S    A+ + KLP +          ++   +L
Sbjct: 473 VGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDL 532

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 42/301 (13%), Positives = 84/301 (27%), Gaps = 41/301 (13%)

Query: 51  KLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSY-NRISGSLPSNIGNFGLLEVFDLSN 109
              KL  L LS      +P        ++ L+L Y    +    + I     LEV +  N
Sbjct: 268 FPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRN 327

Query: 110 NNFSGEIPAAISSLVSLRVLKLDG--NMFQWSIPPGLL----------NCQSLVTVDLSM 157
                 +         L+ L+++   +        GL+           CQ L  + + +
Sbjct: 328 VIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYV 387

Query: 158 NQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFL 217
           + +     +  G     L    L               + IT+L +   +     + +  
Sbjct: 388 SDITNESLESIGTYLKNLCDFRLV---------LLDREERITDLPLDNGV---RSLLIGC 435

Query: 218 ESLEVIDLRSNQFQ------GHISQVQFNSSYNWSRLVYVDLSENQLSGE-IFHNFSQAQ 270
           + L        Q         +I Q           + ++ L     S E +        
Sbjct: 436 KKLRRFAFYLRQGGLTDLGLSYIGQ-------YSPNVRWMLLGYVGESDEGLMEFSRGCP 488

Query: 271 NLKHLSLAYNRFTRQEFPQIGTLL-GLEHLNLSRTSL-IGDIPSEILQLSSLHTLDLSMN 328
           NL+ L +    F+ +      T L  L +L +      +       +     +   +   
Sbjct: 489 NLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548

Query: 329 H 329
            
Sbjct: 549 R 549

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 43/242 (17%), Positives = 83/242 (34%), Gaps = 44/242 (18%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA-RELEYLGRIKHP 564
              +D    L  G FG V+R      G     K  ++     D+     E+  + ++ HP
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDKYTVKNEISIMNQLHHP 108

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNL-QNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
            L+ L        + + I +++  G L   +  +     + +E         +  N ++ 
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSE--------AEVINYMRQ 157

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRL--SD 680
                                  L  +H H     I+H DIK  ++  +      +   D
Sbjct: 158 ACE-------------------GLKHMHEHS----IVHLDIKPENIMCETKKASSVKIID 194

Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP-LG 739
           FGLA         ++   +  +  PE      +     +D++  GV+   L++G  P  G
Sbjct: 195 FGLATKLNPDEIVKVTTATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAG 252

Query: 740 DD 741
           +D
Sbjct: 253 ED 254

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 65.5 bits (160), Expect = 3e-11
 Identities = 51/260 (19%), Positives = 82/260 (31%), Gaps = 69/260 (26%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL-------------VHGSTLTDQEAA 552
             ++ +   L  G +G V       G    A+KV+                     +E  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 553 RELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDT 612
            E+  L  + HPN++ L            + ++ E G L                     
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE------------------- 135

Query: 613 WEEDGTNSIQNVGSEGLLTTWRFRHKIALGTAR----ALAFLH-HGCSPPIIHRDIK--- 664
                   I N          +F    A    +     + +LH H     I+HRDIK   
Sbjct: 136 -------QIINRH--------KFDECDAANIMKQILSGICYLHKHN----IVHRDIKPEN 176

Query: 665 ---ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDV 721
               +    +  L  ++ DFGL+  F          G+  YI PE  +   +    K DV
Sbjct: 177 ILLENK---NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYN---EKCDV 230

Query: 722 YCYGVVLLELITGKKPLGDD 741
           +  GV++  L+ G  P G  
Sbjct: 231 WSCGVIMYILLCGYPPFGGQ 250

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 60.7 bits (148), Expect = 8e-11
 Identities = 48/158 (30%), Positives = 66/158 (41%), Gaps = 38/158 (24%)

Query: 23  CDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSL 81
           C  +   +     ++ GL+ SVP    G  S    L+L  N + +LP  ++  L  L  L
Sbjct: 5   CSCSGTEIR---CNSKGLT-SVP---TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKL 57

Query: 82  NLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIP 141
           +LS N+I  SLP          VFD                L  L +L L  N  Q S+P
Sbjct: 58  SLSQNQIQ-SLPDG--------VFD---------------KLTKLTILYLHENKLQ-SLP 92

Query: 142 PGLL-NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSL 178
            G+      L  + L  NQL  S+PDG    F +L SL
Sbjct: 93  NGVFDKLTQLKELALDTNQLK-SVPDG---IFDRLTSL 126

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 36/119 (30%), Positives = 51/119 (42%), Gaps = 27/119 (22%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRISGSLPSNIGNFGL 101
           S+P     KL++L  L LS+N I +LP  ++  L  L  L L  N++  SLP+       
Sbjct: 42  SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLPNG------ 94

Query: 102 LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQ 159
             VFD                L  L+ L LD N  + S+P G+     SL  + L  N 
Sbjct: 95  --VFD---------------KLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 135

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 64.0 bits (156), Expect = 9e-11
 Identities = 62/250 (24%), Positives = 96/250 (38%), Gaps = 76/250 (30%)

Query: 518 EGKFGPVYRGFL-PGGIHVAVK-VLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCI- 574
            G FG VY+  L   G  VA+K VL        +   REL+ + ++ H N+V L  Y   
Sbjct: 64  NGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLR-YFFY 117

Query: 575 -AGDQRIAIY-----DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
            +G+++  +Y     DY+    +  +        QT                ++      
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV-----------IYVKL----- 160

Query: 629 LLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEP-RLSDFGLAKI 686
                 + +++     R+LA++H  G    I HRDIK  ++ LD +    +L DFG AK 
Sbjct: 161 ------YMYQLF----RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206

Query: 687 FGNG--LDEEIA----R------GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
              G      I     R      G+  Y             T   DV+  G VL EL+ G
Sbjct: 207 LVRGEPNVSYICSRYYRAPELIFGATDY-------------TSSIDVWSAGCVLAELLLG 253

Query: 735 KKPL--GDDY 742
            +P+  GD  
Sbjct: 254 -QPIFPGDSG 262

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 49/214 (22%), Positives = 79/214 (36%), Gaps = 58/214 (27%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPN 565
              F    +L  G F  V+       G   A+K +       D     E+  L +IKH N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLG------VQTTEDWSTDTWEEDGTN 619
           +V              + D  E+     L+  L  G      +     ++    E+D + 
Sbjct: 68  IV-------------TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYT----EKDASL 110

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVYLDM 672
            IQ V                     A+ +LH +G    I+HRD+K       +    + 
Sbjct: 111 VIQQV-------------------LSAVKYLHENG----IVHRDLKPENLLYLTP---EE 144

Query: 673 NLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE 706
           N +  ++DFGL+K+  NG+      G+PGY+ PE
Sbjct: 145 NSKIMITDFGLSKMEQNGIMSTAC-GTPGYVAPE 177

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 55/244 (22%), Positives = 88/244 (36%), Gaps = 58/244 (23%)

Query: 518 EGKFGPVYRGFL-PGGIHVAVK-VLVHGSTLTDQEAARELE---YLGRIKHPNLVPLTGY 572
           +G FG V  G     G+ VA+K V+            REL+    L  + HPN+V L  Y
Sbjct: 33  QGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-----RNRELQIMQDLAVLHHPNIVQLQSY 87

Query: 573 CIAGDQR-------IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
                +R         + +Y+ +  L     +                       I+   
Sbjct: 88  FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPP-----------ILIK--- 132

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD-MNLEPRLSDFGLA 684
                    F  ++     R++  LH   S  + HRDIK  +V ++  +   +L DFG A
Sbjct: 133 --------VFLFQLI----RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179

Query: 685 KIFGNGLD--EEIARGSPGYIPPE--FAQPDSDFPTPKSDVYCYGVVLLELITGKKPL-- 738
           K           I   S  Y  PE  F    +   T   D++  G +  E++ G +P+  
Sbjct: 180 KKLSPSEPNVAYIC--SRYYRAPELIFG---NQHYTTAVDIWSVGCIFAEMMLG-EPIFR 233

Query: 739 GDDY 742
           GD+ 
Sbjct: 234 GDNS 237

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 30/134 (22%), Positives = 50/134 (37%), Gaps = 35/134 (26%)

Query: 56  QSLDLSENNITALPSD--LWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFS 113
             L L++N +  + SD     L  L  L L  N+++  +  N         F+       
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPN--------AFE------- 75

Query: 114 GEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLN-CQSLVTVDLSMNQLNGSLPDGFGAAF 172
                       ++ L+L  N  +  I   +      L T++L  NQ++  +  G   +F
Sbjct: 76  --------GASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPG---SF 122

Query: 173 PKLKSL---NLAGN 183
             L SL   NLA N
Sbjct: 123 EHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 25/119 (21%), Positives = 44/119 (36%), Gaps = 27/119 (22%)

Query: 45  PDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRISGSLPSNIGNFGLLE 103
            D   G+L  L  L+L  N +T +  + +     ++ L L  N+I   + +         
Sbjct: 46  SDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNK-------- 96

Query: 104 VFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLL-NCQSLVTVDLSMNQLN 161
           +F                 L  L+ L L  N     + PG   +  SL +++L+ N  N
Sbjct: 97  MFL---------------GLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFN 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 26/97 (26%), Positives = 38/97 (39%), Gaps = 7/97 (7%)

Query: 139 SIPPGL-LNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLK 196
            IP  + L+   L    L+ N+L     DG     P L  L L  N++ G     F G  
Sbjct: 22  EIPRDIPLHTTEL---LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78

Query: 197 SITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQ 231
            I  L +  N  +     +F  L  L+ ++L  NQ  
Sbjct: 79  HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS 115

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 46/244 (18%), Positives = 80/244 (32%), Gaps = 50/244 (20%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHP 564
              +     +  G +G V         I  A K  +    + D +   +E+E +  + HP
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK-IPKYFVEDVDRFKQEIEIMKSLDHP 66

Query: 565 NLVPLTGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           N++ L       +    IY   +    G L      +       E         D    +
Sbjct: 67  NIIRLYETF---EDNTDIYLVMELCTGGEL---FERVVHKRVFRE--------SDAARIM 112

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYL---DMNLEPR 677
           ++V                     A+A+ H       + HRD+K  +        +   +
Sbjct: 113 KDV-------------------LSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLK 149

Query: 678 LSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           L DFGLA  F  G       G+P Y+ P+  +       P+ D +  GV++  L+ G  P
Sbjct: 150 LIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYG---PECDEWSAGVMMYVLLCGYPP 206

Query: 738 LGDD 741
               
Sbjct: 207 FSAP 210

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 48/258 (18%), Positives = 89/258 (34%), Gaps = 56/258 (21%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKV-------LVHGSTLTDQEAA--RELE 556
             N++   +L  G    V R    P     AVK+             + +   A  +E++
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 557 YLGRIK-HPNLVPLTGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDT 612
            L ++  HPN++ L       +     +   D M+ G L      L   V  +E      
Sbjct: 76  ILRKVSGHPNIIQLKDTY---ETNTFFFLVFDLMKKGEL---FDYLTEKVTLSEK----- 124

Query: 613 WEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLD 671
              +    ++ +                      +  LH       I+HRD+K  ++ LD
Sbjct: 125 ---ETRKIMRAL-------------------LEVICALHKLN----IVHRDLKPENILLD 158

Query: 672 MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP----TPKSDVYCYGVV 727
            ++  +L+DFG +     G       G+P Y+ PE  +   +        + D++  GV+
Sbjct: 159 DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218

Query: 728 LLELITGKKPLGDDYPEE 745
           +  L+ G  P        
Sbjct: 219 MYTLLAGSPPFWHRKQML 236

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 53/249 (21%), Positives = 88/249 (35%), Gaps = 50/249 (20%)

Query: 508 SNFDRGTLLAEGKFGPVYRG-FLPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIKH 563
            +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           P  V L       ++      Y +NG L   +                            
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--------------------------- 122

Query: 624 VGSEGLLTTWRFRH---KIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLS 679
               G       R    +I      AL +LH  G    IIHRD+K  ++ L+ ++  +++
Sbjct: 123 --KIGSFDETCTRFYTAEIVS----ALEYLHGKG----IIHRDLKPENILLNEDMHIQIT 172

Query: 680 DFGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           DFG AK+      +  A    G+  Y+ PE            SD++  G ++ +L+ G  
Sbjct: 173 DFGTAKVLSPESKQARANSFVGTAQYVSPELLT--EKSACKSSDLWALGCIIYQLVAGLP 230

Query: 737 PLGDDYPEE 745
           P        
Sbjct: 231 PFRAGNEYL 239

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 50/268 (18%), Positives = 83/268 (30%), Gaps = 77/268 (28%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKV-----LVHGSTLTDQEAA---RELEY 557
              +     L  G  G V   F       VA+K+        GS      A     E+E 
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 558 LGRIKHPNLVPLTG------------YCIAGD--QRIAIYDYMENGNLQNLLHDLPLGVQ 603
           L ++ HP ++ +                  G+   ++     + N  L+           
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV-----VGNKRLK----------- 112

Query: 604 TTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRD 662
                     E         +                     A+ +LH +G    IIHRD
Sbjct: 113 ----------EATCKLYFYQMLL-------------------AVQYLHENG----IIHRD 139

Query: 663 IKASSVYLDMNLEP---RLSDFGLAKIFGNGLDEEIARGSPGYIPPE-FAQPDSDFPTPK 718
           +K  +V L    E    +++DFG +KI G         G+P Y+ PE      +      
Sbjct: 140 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 199

Query: 719 SDVYCYGVVLLELITGKKPLGDDYPEEK 746
            D +  GV+L   ++G  P  +   +  
Sbjct: 200 VDCWSLGVILFICLSGYPPFSEHRTQVS 227

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 54/246 (21%), Positives = 94/246 (38%), Gaps = 50/246 (20%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLV------HGSTLTDQEAARELEYLGRI 561
            +  G LL  G FG VY G  +   + VA+K +        G          E+  L ++
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 562 KH--PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
                 ++ L              D+ E  +   L+ + P  VQ   D+           
Sbjct: 104 SSGFSGVIRL-------------LDWFERPDSFVLILERPEPVQDLFDF----------- 139

Query: 620 SIQNVG--SEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMN-LE 675
            I   G   E L     F  ++      A+   H  G    ++HRDIK  ++ +D+N  E
Sbjct: 140 -ITERGALQEEL--ARSFFWQVL----EAVRHCHNCG----VLHRDIKDENILIDLNRGE 188

Query: 676 PRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
            +L DFG   +  + +  +   G+  Y PPE+ +    +    + V+  G++L +++ G 
Sbjct: 189 LKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD 246

Query: 736 KPLGDD 741
            P   D
Sbjct: 247 IPFEHD 252

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 44/192 (22%), Positives = 80/192 (41%), Gaps = 40/192 (20%)

Query: 504 LSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE------AARELE 556
           +S++S F +   L  G +  VY+G     G++VA+K +       D E      A RE+ 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-----KLDSEEGTPSTAIREIS 55

Query: 557 YLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEED 616
            +  +KH N+V L       ++   ++++M+N +L+  +    +G               
Sbjct: 56  LMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNT------------P 102

Query: 617 GTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP 676
               +  V                    + LAF H      I+HRD+K  ++ ++   + 
Sbjct: 103 RGLELNLVKY------------FQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQL 147

Query: 677 RLSDFGLAKIFG 688
           +L DFGLA+ FG
Sbjct: 148 KLGDFGLARAFG 159

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 61.1 bits (149), Expect = 4e-10
 Identities = 51/253 (20%), Positives = 93/253 (36%), Gaps = 53/253 (20%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKV-----LVHGSTLTDQEAA-RELEYLG 559
              +D G  L  G+F  V +      G+  A K               +E   RE+  L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 560 RIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           ++ H N++ L          + I + +  G L + L          ++  +   EE+ T+
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--------AQKESLS---EEEATS 119

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVYLDM 672
            I+ +                      + +LH       I H D+K              
Sbjct: 120 FIKQI-------------------LDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIP 156

Query: 673 NLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
           ++  +L DFGLA    +G++ +   G+P ++ PE      +    ++D++  GV+   L+
Sbjct: 157 HI--KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILL 212

Query: 733 TGKKP-LGDDYPE 744
           +G  P LGD   E
Sbjct: 213 SGASPFLGDTKQE 225

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 60.3 bits (147), Expect = 4e-10
 Identities = 54/251 (21%), Positives = 96/251 (38%), Gaps = 62/251 (24%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA--RELEYLGRIKH 563
              ++   +L +G FG V +          AVKV+   S      +   RE+E L ++ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLG------VQTTEDWSTDTWEEDG 617
           PN++ L             ++ +E+ +   ++ +L  G      +   + +S    E D 
Sbjct: 81  PNIMKL-------------FEILEDSSSFYIVGELYTGGELFDEIIKRKRFS----EHDA 123

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVYL 670
              I+ V                      + ++H H     I+HRD+K       S    
Sbjct: 124 ARIIKQV-------------------FSGITYMHKHN----IVHRDLKPENILLESK--- 157

Query: 671 DMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE 730
           + + + ++ DFGL+  F      +   G+  YI PE  +   D    K DV+  GV+L  
Sbjct: 158 EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYD---EKCDVWSAGVILYI 214

Query: 731 LITGKKPLGDD 741
           L++G  P    
Sbjct: 215 LLSGTPPFYGK 225

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 60.3 bits (147), Expect = 5e-10
 Identities = 50/253 (19%), Positives = 92/253 (36%), Gaps = 53/253 (20%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKV-----LVHGSTLTDQEAA-RELEYLG 559
             +++ G  L  G+F  V +      G   A K      L        +E   RE+  L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 560 RIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
            I+HPN++ L          + I + +  G L + L          ++  T   E++ T 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--------AEKESLT---EDEATQ 112

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVYLDM 672
            ++ +                      + +LH       I H D+K            + 
Sbjct: 113 FLKQI-------------------LDGVHYLHSKR----IAHFDLKPENIMLLDKNVPNP 149

Query: 673 NLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
            +  +L DFG+A     G + +   G+P ++ PE      +    ++D++  GV+   L+
Sbjct: 150 RI--KLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILL 205

Query: 733 TGKKP-LGDDYPE 744
           +G  P LG+   E
Sbjct: 206 SGASPFLGETKQE 218

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 58/250 (23%), Positives = 85/250 (34%), Gaps = 44/250 (17%)

Query: 518 EGKFGPVYRGF-LPGGIHVAVK-VLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
            G FG V   F +  G   A+K VL            REL+ +  + H N++ L  Y   
Sbjct: 17  TGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYT 71

Query: 576 GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTT--- 632
                       + + +    +  +           +  +       NV  E +  T   
Sbjct: 72  TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY-----LNVIMEYVPDTLHK 126

Query: 633 -----WRFRHKIALG--------TARALAFLHHGCSPPIIHRDIKASSVYLDMNL-EPRL 678
                 R    I +           RA+ F+H   S  I HRDIK  ++ ++      +L
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKL 183

Query: 679 SDFGLAKIFGNGLD--EEIARGSPGYIPPE--FAQPDSDFPTPKSDVYCYGVVLLELITG 734
            DFG AK           I   S  Y  PE       +   TP  D++  G V  ELI G
Sbjct: 184 CDFGSAKKLIPSEPSVAYIC--SRFYRAPELML---GATEYTPSIDLWSIGCVFGELILG 238

Query: 735 KKPL--GDDY 742
            KPL  G+  
Sbjct: 239 -KPLFSGETS 247

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 61.6 bits (150), Expect = 5e-10
 Identities = 52/252 (20%), Positives = 101/252 (40%), Gaps = 64/252 (25%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIK 562
              ++   +L +G FG V +          AVKV ++ ++  +++ +   RE+E L ++ 
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKV-INKASAKNKDTSTILREVELLKKLD 79

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLG------VQTTEDWSTDTWEED 616
           HPN+             + +++ +E+ +   ++ +L  G      +   + +S    E D
Sbjct: 80  HPNI-------------MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS----EHD 122

Query: 617 GTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVY 669
               I+ V                      + ++H H     I+HRD+K       S   
Sbjct: 123 AARIIKQV-------------------FSGITYMHKHN----IVHRDLKPENILLESK-- 157

Query: 670 LDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLL 729
            + + + ++ DFGL+  F      +   G+  YI PE  +   D    K DV+  GV+L 
Sbjct: 158 -EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYD---EKCDVWSAGVILY 213

Query: 730 ELITGKKPLGDD 741
            L++G  P    
Sbjct: 214 ILLSGTPPFYGK 225

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 57/271 (21%), Positives = 98/271 (36%), Gaps = 79/271 (29%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL----VHGSTLTDQEA--ARELEYLGR 560
           + +  G LL +G FG V+ G  L   + VA+KV+    V G +          E+  L +
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 561 I----KHPNLVPL-------TGYCI-------AGDQRIAIYDY-MENGNLQNLLHDLPLG 601
           +     HP ++ L        G+ +       A D    ++DY  E G L          
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQD----LFDYITEKGPLG--------- 137

Query: 602 VQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIH 660
                        E  +                F   +A     A+   H  G    ++H
Sbjct: 138 -------------EGPSRCF-------------FGQVVA-----AIQHCHSRG----VVH 162

Query: 661 RDIKASSVYLDM-NLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKS 719
           RDIK  ++ +D+     +L DFG   +  +    +   G+  Y PPE+      +    +
Sbjct: 163 RDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVYSPPEWIS-RHQYHALPA 220

Query: 720 DVYCYGVVLLELITGKKPLGDDYPEEKEGNL 750
            V+  G++L +++ G  P  +   E  E  L
Sbjct: 221 TVWSLGILLYDMVCGDIPF-ERDQEILEAEL 250

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 47/241 (19%), Positives = 101/241 (41%), Gaps = 46/241 (19%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA-RELEYLGRIKHPNL 566
              +  +L  G+FG V++      G+ +A K+ +    + D+E    E+  + ++ H NL
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKI-IKTRGMKDKEEVKNEISVMNQLDHANL 148

Query: 567 VPLTGYCIAGDQRIAIYDYMENGNLQNLLHD--LPLGVQTTEDWSTDTWEEDGTNSIQNV 624
           + L     + +  + + +Y++ G L     D  +      TE         D    ++ +
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTE--------LDTILFMKQI 196

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSV-YLDMNLEP-RLSDF 681
                                 +  +H       I+H D+K  ++  ++ + +  ++ DF
Sbjct: 197 CE-------------------GIRHMHQMY----ILHLDLKPENILCVNRDAKQIKIIDF 233

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP-LGD 740
           GLA+ +      ++  G+P ++ PE      DF +  +D++  GV+   L++G  P LGD
Sbjct: 234 GLARRYKPREKLKVNFGTPEFLAPEVVN--YDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291

Query: 741 D 741
           +
Sbjct: 292 N 292

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 59.9 bits (146), Expect = 6e-10
 Identities = 37/143 (25%), Positives = 57/143 (39%), Gaps = 17/143 (11%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPG 701
            + +LH  G    I HRDIK  ++ LD     ++SDFGLA +F     E +     G+  
Sbjct: 117 GVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 702 YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRN- 760
           Y+ PE  +   +F     DV+  G+VL  ++ G+ P     P +       W        
Sbjct: 173 YVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPWDQ--PSDSCQEYSDWKEKKTYLN 229

Query: 761 -----NKGSRAIDPKIRDTGPEK 778
                +    A+  KI    P  
Sbjct: 230 PWKKIDSAPLALLHKILVENPSA 252

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 60.8 bits (148), Expect = 6e-10
 Identities = 52/253 (20%), Positives = 94/253 (37%), Gaps = 53/253 (20%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKV-----LVHGSTLTDQEAA-RELEYLG 559
              +D G  L  G+F  V +      G+  A K               +E   RE+  L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 560 RIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           ++ HPN++ L          + I + +  G L + L          ++  +   EE+ T+
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--------AQKESLS---EEEATS 119

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVYLDM 672
            I+ +                      + +LH       I H D+K              
Sbjct: 120 FIKQI-------------------LDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIP 156

Query: 673 NLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
           ++  +L DFGLA    +G++ +   G+P ++ PE      +    ++D++  GV+   L+
Sbjct: 157 HI--KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILL 212

Query: 733 TGKKP-LGDDYPE 744
           +G  P LGD   E
Sbjct: 213 SGASPFLGDTKQE 225

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 60.4 bits (147), Expect = 7e-10
 Identities = 53/236 (22%), Positives = 96/236 (40%), Gaps = 55/236 (23%)

Query: 518 EGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-HPNLVPLTGYCIA 575
            GK+  V+    +     V VK+L     +  ++  RE++ L  ++  PN++ L    I 
Sbjct: 46  RGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITL--ADIV 100

Query: 576 GDQR----IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLT 631
            D        +++++ N + + L   L     T  D             I+         
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTL-----TDYD-------------IR--------- 133

Query: 632 TWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLD-MNLEPRLSDFGLAKIFGNG 690
              + ++I     +AL + H   S  I+HRD+K  +V +D  + + RL D+GLA+ +  G
Sbjct: 134 --FYMYEIL----KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184

Query: 691 LD--EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GDDY 742
            +    +A  S  +  PE    D        D++  G +L  +I  K+P   G D 
Sbjct: 185 QEYNVRVA--SRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 60.3 bits (147), Expect = 7e-10
 Identities = 42/246 (17%), Positives = 84/246 (34%), Gaps = 53/246 (21%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPN 565
              +     L  G+FG V+R            K  V           +E+  L   +H N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRN 62

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHD--LPLGVQTTEDWSTDTWEEDGTNSIQN 623
           ++ L     + ++ + I++++   ++     +       +  E         +  + +  
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNE--------REIVSYVHQ 110

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVYLDMNLEP 676
           V                     AL FLH H     I H DI+       +       +  
Sbjct: 111 V-------------------CEALQFLHSHN----IGHFDIRPENIIYQTRR--SSTI-- 143

Query: 677 RLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           ++ +FG A+    G +  +   +P Y  PE  Q   D  +  +D++  G ++  L++G  
Sbjct: 144 KIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ--HDVVSTATDMWSLGTLVYVLLSGIN 201

Query: 737 P-LGDD 741
           P L + 
Sbjct: 202 PFLAET 207

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 59.9 bits (146), Expect = 9e-10
 Identities = 43/191 (22%), Positives = 77/191 (40%), Gaps = 45/191 (23%)

Query: 505 SATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQE-------AARELEY 557
                + +   + EG +G VY+     G  VA+K +       D E       A RE+  
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-----RLDAEDEGIPSTAIREISL 72

Query: 558 LGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDG 617
           L  + HPN+V L     +      ++++ME  +L+ +L +   G+Q ++           
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQ----------- 120

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
              I+                      R +A  H      I+HRD+K  ++ ++ +   +
Sbjct: 121 ---IK---------------IYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALK 159

Query: 678 LSDFGLAKIFG 688
           L+DFGLA+ FG
Sbjct: 160 LADFGLARAFG 170

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 59.5 bits (145), Expect = 1e-09
 Identities = 46/256 (17%), Positives = 92/256 (35%), Gaps = 74/256 (28%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE-------AARELEYLGR 560
            +++   + EG +G V++         VA+K +       D +       A RE+  L  
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKE 57

Query: 561 IKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
           +KH N+V L     +  +   ++++ +  +L+         +                  
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDL-----------------D 99

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
            + V S                  + L F H      ++HRD+K  ++ ++ N E +L++
Sbjct: 100 PEIVKS------------FLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLAN 144

Query: 681 FGLAKIFGNGLDE-------------EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV 727
           FGLA+ FG  +               ++  G+  Y             +   D++  G +
Sbjct: 145 FGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY-------------STSIDMWSAGCI 191

Query: 728 LLELITGKKPL--GDD 741
             EL    +PL  G+D
Sbjct: 192 FAELANAGRPLFPGND 207

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 59/262 (22%), Positives = 102/262 (38%), Gaps = 81/262 (30%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE-------AARELEYLG 559
           S +++   + +G FG V++      G  VA+K +     L + E       A RE++ L 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-----LMENEKEGFPITALREIKILQ 71

Query: 560 RIKHPNLVPLTGYCI-----AGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTD 611
            +KH N+V L   C          + +IY   D+ E        HDL             
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDL------------- 110

Query: 612 TWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTA----------RALAFLHHGCSPPIIHR 661
                           GLL+       +    +            L ++H      I+HR
Sbjct: 111 ---------------AGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHR 148

Query: 662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPG-----YIPPEFAQPDSDFPT 716
           D+KA++V +  +   +L+DFGLA+ F    + +  R +       Y PPE    + D+  
Sbjct: 149 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY-G 207

Query: 717 PKSDVYCYGVVLLELITGKKPL 738
           P  D++  G ++ E+ T + P+
Sbjct: 208 PPIDLWGAGCIMAEMWT-RSPI 228

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 26/96 (27%), Positives = 43/96 (44%), Gaps = 10/96 (10%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGY 702
           AL +L    +  IIHRD+K  ++ LD +    ++DF +A +      E       G+  Y
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITTMAGTKPY 180

Query: 703 IPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKP 737
           + PE            + D +  GV   EL+ G++P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 34/115 (29%), Positives = 52/115 (45%), Gaps = 11/115 (9%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPG 701
            + +LH  G    I HRDIK  ++ LD     ++SDFGLA +F     E +     G+  
Sbjct: 117 GVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 702 YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRG 756
           Y+ PE  +   +F     DV+  G+VL  ++ G+ P  D  P +       W   
Sbjct: 173 YVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW-DQ-PSDSCQEYSDWKEK 224

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 59.5 bits (145), Expect = 1e-09
 Identities = 49/205 (23%), Positives = 82/205 (40%), Gaps = 63/205 (30%)

Query: 502 DLLSATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE-----AAREL 555
           D+ S    +++   L EG+F  VY+         VA+K +  G     ++     A RE+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 556 EYLGRIKHPNLVPLTGYCIAGDQRIA-IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWE 614
           + L  + HPN++ L          I+ ++D+ME         DL                
Sbjct: 64  KLLQELSHPNIIGLLD-AFGHKSNISLVFDFME--------TDL---------------- 98

Query: 615 EDGTNSIQNVGSEGLLTTWRFRHKIALGTA----------RALAFLH-HGCSPPIIHRDI 663
                       E ++      + + L  +          + L +LH H     I+HRD+
Sbjct: 99  ------------EVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW----ILHRDL 138

Query: 664 KASSVYLDMNLEPRLSDFGLAKIFG 688
           K +++ LD N   +L+DFGLAK FG
Sbjct: 139 KPNNLLLDENGVLKLADFGLAKSFG 163

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 60.3 bits (146), Expect = 2e-09
 Identities = 27/102 (26%), Positives = 48/102 (47%), Gaps = 5/102 (4%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPP 705
            L  +H   +  +++RD+K +++ LD +   R+SD GLA  F          G+ GY+ P
Sbjct: 304 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAP 359

Query: 706 EFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE 747
           E  Q    +    +D +  G +L +L+ G  P      ++K 
Sbjct: 360 EVLQKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 58.3 bits (142), Expect = 2e-09
 Identities = 37/187 (19%), Positives = 72/187 (38%), Gaps = 45/187 (24%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQE-------AARELEYLGRI 561
            +     + EG +G VY+     G   A+K +       ++E         RE+  L  +
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKEL 57

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           KH N+V L        + + ++++++  +L+ LL     G+                   
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGL-----------------ES 99

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
               S              L     +A+ H      ++HRD+K  ++ ++   E +++DF
Sbjct: 100 VTAKS------------FLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADF 144

Query: 682 GLAKIFG 688
           GLA+ FG
Sbjct: 145 GLARAFG 151

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 58.4 bits (142), Expect = 3e-09
 Identities = 52/250 (20%), Positives = 89/250 (35%), Gaps = 53/250 (21%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKV-----LVHGSTLTDQEAA-RELEYLG 559
              +D G  L  G+F  V +      G+  A K               +E   RE+  L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 560 RIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
            I+HPN++ L          I I + +  G L + L          ++  T   EE+ T 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--------AEKESLT---EEEATE 118

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVYLDM 672
            ++ +                      + +LH       I H D+K              
Sbjct: 119 FLKQI-------------------LNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKP 155

Query: 673 NLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
            +  ++ DFGLA     G + +   G+P ++ PE      +    ++D++  GV+   L+
Sbjct: 156 RI--KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILL 211

Query: 733 TGKKP-LGDD 741
           +G  P LGD 
Sbjct: 212 SGASPFLGDT 221

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 58.4 bits (142), Expect = 3e-09
 Identities = 41/188 (21%), Positives = 75/188 (39%), Gaps = 47/188 (25%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQE------AARELEYLGRI 561
            + +   L EG +  VY+G        VA+K +       + E      A RE+  L  +
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-----RLEHEEGAPCTAIREVSLLKDL 57

Query: 562 KHPNLVPLTGYCIAGDQRIA-IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
           KH N+V L    I  ++ +  +++Y++  +L+  L D    +                 +
Sbjct: 58  KHANIVTLHD-IIHTEKSLTLVFEYLDK-DLKQYLDDCGNII-----------------N 98

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
           + NV                    R LA+ H      ++HRD+K  ++ ++   E +L+D
Sbjct: 99  MHNVKL------------FLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLAD 143

Query: 681 FGLAKIFG 688
           FGLA+   
Sbjct: 144 FGLARAKS 151

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 44/230 (19%), Positives = 84/230 (36%), Gaps = 51/230 (22%)

Query: 490 IFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKV-----LVHG 543
           I +    ++ F D+      ++   ++ +G F  V R      G   AVK+         
Sbjct: 12  ILDMADDDVLFEDV------YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS 65

Query: 544 STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQ 603
             L+ ++  RE      +KHP++V L     +      ++++M+  +L     ++     
Sbjct: 66  PGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRAD 122

Query: 604 TTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRD 662
               +S    E   ++ ++ +                     AL + H +     IIHRD
Sbjct: 123 AGFVYS----EAVASHYMRQI-------------------LEALRYCHDNN----IIHRD 155

Query: 663 IKASSVYLDMNLEP---RLSDFGLAKIFGNGLDEEIAR---GSPGYIPPE 706
           +K   V L         +L  FG+A   G      +A    G+P ++ PE
Sbjct: 156 VKPHCVLLASKENSAPVKLGGFGVAIQLGE--SGLVAGGRVGTPHFMAPE 203

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.4 bits (140), Expect = 3e-09
 Identities = 45/276 (16%), Positives = 77/276 (27%), Gaps = 35/276 (12%)

Query: 498 ITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVL--------VHGSTLTDQ 549
           + F+  L  T    R   + EG FG V++        VA+K++              T +
Sbjct: 11  VPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFE 68

Query: 550 EAARELEYL---------GRIKHPNLVPLTGYCIAGDQRIA--IYDYMENGNLQNLLHDL 598
           E   E+               +    + L              +  +    + +   +D 
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 599 PLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI 658
           P   +  + +    +E  G +  Q       L++      I      +LA          
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--F 183

Query: 659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPK 718
            HRD+   +V L      +L      K             S G          S      
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSST--------IPSCGLQVSIIDYTLSRLERDG 235

Query: 719 SDVYCYGVVLLELITGK-KPLGDDYPEEKEGNLVSW 753
             V+C   +  +L TG      D Y   K+ N   W
Sbjct: 236 IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRW 271

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 50/252 (19%), Positives = 95/252 (37%), Gaps = 52/252 (20%)

Query: 515 LLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTG- 571
           +L  G  G V   F    G   A+K+L         +A +E+++  +    P++V +   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHIVCILDV 90

Query: 572 YCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           Y      +  +    + ME G L + + +      T         E +    ++++G+  
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT---------EREAAEIMRDIGT-- 139

Query: 629 LLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYL---DMNLEPRLSDFGLA 684
                            A+ FLH H     I HRD+K  ++     + +   +L+DFG A
Sbjct: 140 -----------------AIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178

Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           K       +     +P Y+ PE   P+  D      D++  GV++  L+ G  P   +  
Sbjct: 179 KETTQNALQTPC-YTPYYVAPEVLGPEKYD---KSCDMWSLGVIMYILLCGFPPFYSNTG 234

Query: 744 EEKEGNLVSWVR 755
           +     +   +R
Sbjct: 235 QAISPGMKRRIR 246

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 59.0 bits (143), Expect = 4e-09
 Identities = 64/301 (21%), Positives = 103/301 (34%), Gaps = 48/301 (15%)

Query: 447 PKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIFEKPLLNITFADLLSA 506
           P++ V   T   E+      F   T  T     V         I+    L   + +    
Sbjct: 122 PRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPV 181

Query: 507 T-SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAA---RELEYLGRI 561
           T + F +  +L +G FG V    +   G   A K L        +  A    E + L ++
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241

Query: 562 KHPNLVPLTGYCIAGDQRIA-IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
               +V L  Y       +  +   M  G+L    H                        
Sbjct: 242 NSRFVVSLA-YAYETKDALCLVLTLMNGGDL--KFH------------------------ 274

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
           I ++G +      R     A      L  LH      I++RD+K  ++ LD +   R+SD
Sbjct: 275 IYHMG-QAGFPEARAVFYAA-EICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISD 329

Query: 681 FGLAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKK 736
            GLA     G   +  +   G+ GY+ PE  +   +     S D +  G +L E+I G+ 
Sbjct: 330 LGLAVHVPEG---QTIKGRVGTVGYMAPEVVK---NERYTFSPDWWALGCLLYEMIAGQS 383

Query: 737 P 737
           P
Sbjct: 384 P 384

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 59/323 (18%), Positives = 107/323 (33%), Gaps = 58/323 (17%)

Query: 444 RRKPKRWVVKQTSYKEEQNVSGPFSFQTDSTTWVADVKHANSVQVVIFEKPLLNITFADL 503
           R  P     ++ ++          S    +     +       + + F+         D 
Sbjct: 27  RHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDW 86

Query: 504 LSA---TSNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVL--------VHGSTLTDQEA 551
            +A      +D   ++  G    V R      G   AVK++                +  
Sbjct: 87  AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146

Query: 552 ARELEYLGRIK-HPNLVPLTGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTED 607
            RE   L ++  HP+++ L       +    ++   D M  G L      L   V  +E 
Sbjct: 147 RRETHILRQVAGHPHIITLIDSY---ESSSFMFLVFDLMRKGEL---FDYLTEKVALSEK 200

Query: 608 WSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKAS 666
                   +  + ++++                     A++FLH +     I+HRD+K  
Sbjct: 201 --------ETRSIMRSLLE-------------------AVSFLHANN----IVHRDLKPE 229

Query: 667 SVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE----FAQPDSDFPTPKSDVY 722
           ++ LD N++ RLSDFG +     G       G+PGY+ PE               + D++
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289

Query: 723 CYGVVLLELITGKKPLGDDYPEE 745
             GV+L  L+ G  P        
Sbjct: 290 ACGVILFTLLAGSPPFWHRRQIL 312

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 57.2 bits (139), Expect = 5e-09
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 4/96 (4%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPP 705
           A+ + H      ++HRD+K  +V LD ++  +++DFGL+ +  +G     + GSP Y  P
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179

Query: 706 EFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
           E       +  P+ D++  GV+L  L+ G  P  D+
Sbjct: 180 EVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 58.1 bits (141), Expect = 6e-09
 Identities = 58/248 (23%), Positives = 91/248 (36%), Gaps = 73/248 (29%)

Query: 518 EGKFGPVYRGFLPGGIHVAVK-VLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAG 576
            G FG V++  L     VA+K VL        +   REL+ +  +KHPN+V L  +  + 
Sbjct: 50  NGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSN 104

Query: 577 DQRIA------IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
             +        + +Y+    +           QT                I+        
Sbjct: 105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM-----------LLIKL------- 145

Query: 631 TTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEP-RLSDFGLAKIFG 688
               + +++     R+LA++H  G    I HRDIK  ++ LD      +L DFG AKI  
Sbjct: 146 ----YMYQLL----RSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193

Query: 689 NGLD--EEIA----R------GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
            G      I     R      G+  Y             T   D++  G V+ EL+ G +
Sbjct: 194 AGEPNVSYICSRYYRAPELIFGATNY-------------TTNIDIWSTGCVMAELMQG-Q 239

Query: 737 PL--GDDY 742
           PL  G+  
Sbjct: 240 PLFPGESG 247

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 57.2 bits (139), Expect = 6e-09
 Identities = 40/186 (21%), Positives = 73/186 (39%), Gaps = 41/186 (22%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE-----AARELEYLGRIK 562
           NF +   + EG +G VY+      G  VA+K +   +   + E     A RE+  L  + 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELN 60

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           HPN+V L       ++   +++++   +L+  +    L                    I+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL-------------IK 106

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
                                 + LAF H      ++HRD+K  ++ ++     +L+DFG
Sbjct: 107 ---------------SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFG 148

Query: 683 LAKIFG 688
           LA+ FG
Sbjct: 149 LARAFG 154

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 57.8 bits (140), Expect = 8e-09
 Identities = 55/261 (21%), Positives = 90/261 (34%), Gaps = 69/261 (26%)

Query: 508 SNFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIK 562
            +F+   ++  G FG V   +      +  A+K+L     L   E A    E + L    
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVF-AMKILNKWEMLKRAETACFREERDVLVNGD 132

Query: 563 HPNLVPLTGYCIAGDQRI-AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
              +  L  Y    D  +  + DY   G+L  LL                          
Sbjct: 133 SKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS------------------------- 166

Query: 622 QNVGSEGLLTTWRFRHKIALGTAR--------ALAFLH-HGCSPPIIHRDIKASSVYLDM 672
                       +F  ++    AR        A+  +H        +HRDIK  ++ +DM
Sbjct: 167 ------------KFEDRLPEEMARFYLAEMVIAIDSVHQLH----YVHRDIKPDNILMDM 210

Query: 673 NLEPRLSDFGLAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFP---TPKSDVYCY 724
           N   RL+DFG        +++   +     G+P YI PE  Q          P+ D +  
Sbjct: 211 NGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267

Query: 725 GVVLLELITGKKPLGDDYPEE 745
           GV + E++ G+ P   +   E
Sbjct: 268 GVCMYEMLYGETPFYAESLVE 288

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 57.4 bits (139), Expect = 9e-09
 Identities = 55/261 (21%), Positives = 93/261 (35%), Gaps = 51/261 (19%)

Query: 508 SNFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIK 562
            +F+   ++  G F  V   +    G ++ A+K++     L   E +    E + L    
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVY-AMKIMNKWDMLKRGEVSCFREERDVLVNGD 119

Query: 563 HPNLVPLTGYCIAGDQRI-AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
              +  L  +    +  +  + +Y   G+L  LL     G +   + +            
Sbjct: 120 RRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMA------------ 164

Query: 622 QNVGSEGLLTTWRF-RHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                       RF   +I +    A+  +H  G     +HRDIK  ++ LD     RL+
Sbjct: 165 ------------RFYLAEIVM----AIDSVHRLG----YVHRDIKPDNILLDRCGHIRLA 204

Query: 680 DFGLAKIFGNGLDEE--IARGSPGYIPPEFAQPDSDFPTPKS-----DVYCYGVVLLELI 732
           DFG              +A G+P Y+ PE  Q     P   S     D +  GV   E+ 
Sbjct: 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264

Query: 733 TGKKPLGDDYPEEKEGNLVSW 753
            G+ P   D   E  G +V +
Sbjct: 265 YGQTPFYADSTAETYGKIVHY 285

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 4/96 (4%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPP 705
           A+ + H      I+HRD+K  ++ LD NL  +++DFGL+ I  +G   + + GSP Y  P
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 176

Query: 706 EFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
           E       +  P+ DV+  G+VL  ++ G+ P  D+
Sbjct: 177 EVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 52/244 (21%), Positives = 89/244 (36%), Gaps = 47/244 (19%)

Query: 512 RGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA--RELEYLGRIKH-PNLV 567
               L  GKF  V +      G   A K L       D  A    E+  L   K  P ++
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L        + I I +Y   G + +L       + +         E D    I+ +   
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS---------ENDVIRLIKQI--- 140

Query: 628 GLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK-----ASSVYLDMNLEPRLSDF 681
                              + +LH +     I+H D+K      SS+Y   ++  ++ DF
Sbjct: 141 ----------------LEGVYYLHQNN----IVHLDLKPQNILLSSIYPLGDI--KIVDF 178

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP-LGD 740
           G+++  G+  +     G+P Y+ PE      D  T  +D++  G++   L+T   P +G+
Sbjct: 179 GMSRKIGHACELREIMGTPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGE 236

Query: 741 DYPE 744
           D  E
Sbjct: 237 DNQE 240

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 40/187 (21%), Positives = 72/187 (38%), Gaps = 44/187 (23%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE-----AARELEYLGRIK 562
            ++   L+ EG +G V +      G  VA+K  +      D +     A RE++ L +++
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLR 82

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           H NLV L   C    +   +++++++  + + L   P G+                  +Q
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQV--------------VQ 127

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                          K        + F H H     IIHRDIK  ++ +  +   +L DF
Sbjct: 128 ---------------KYLFQIINGIGFCHSHN----IIHRDIKPENILVSQSGVVKLCDF 168

Query: 682 GLAKIFG 688
           G A+   
Sbjct: 169 GFARTLA 175

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.3 bits (135), Expect = 2e-08
 Identities = 20/107 (18%), Positives = 33/107 (30%), Gaps = 2/107 (1%)

Query: 56  QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSN-IGNFGLLEVFDLSNNNFSG 114
             L  + +        L    +L  L +   +    L    +   G L    +  +    
Sbjct: 11  SGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70

Query: 115 EIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLN 161
             P A      L  L L  N  + S+    +   SL  + LS N L+
Sbjct: 71  VAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.0 bits (129), Expect = 8e-08
 Identities = 21/105 (20%), Positives = 36/105 (34%), Gaps = 12/105 (11%)

Query: 47  TTIGKLSKLQSLDLSENN-ITALPS-DLWSLGSLKSLNLSYNRISGSLPSNI-GNFGLLE 103
             +     L  L +     +  L   DL  LG L++L +  + +   +  +       L 
Sbjct: 25  HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLS 83

Query: 104 VFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQ 148
             +LS N     +       +SL+ L L GN       P   +C 
Sbjct: 84  RLNLSFNALE-SLSWKTVQGLSLQELVLSGN-------PLHCSCA 120

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 17/80 (21%), Positives = 32/80 (40%), Gaps = 3/80 (3%)

Query: 34  LASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSL 92
           + +   L   +    +  L +L++L + ++ +  +  D       L  LNLS+N +  SL
Sbjct: 38  IENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SL 95

Query: 93  PSNIGNFGLLEVFDLSNNNF 112
                    L+   LS N  
Sbjct: 96  SWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.8 bits (113), Expect = 8e-06
 Identities = 15/95 (15%), Positives = 32/95 (33%), Gaps = 2/95 (2%)

Query: 139 SIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH-FAGLKS 197
                L   ++L  + +   Q    L         +L++L +  + ++      F     
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 198 ITNLNISGNLFQGSVMGVFLE-SLEVIDLRSNQFQ 231
           ++ LN+S N  +          SL+ + L  N   
Sbjct: 82  LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.1 bits (106), Expect = 6e-05
 Identities = 22/163 (13%), Positives = 43/163 (26%), Gaps = 14/163 (8%)

Query: 309 DIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLG---IIDMSHNNLSGEIPASLLEKLP 365
           D    +    +L  L +        +     + LG    + +  + L   +        P
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 366 QMERFNFSYNNLT-LCASELSPETLQTAFFGSSN---DCPIAANPSFFKRKAANHKGLKL 421
           ++ R N S+N L  L    +   +LQ      +     C +     + +         KL
Sbjct: 81  RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKL 140

Query: 422 ALALTLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVS 464
                  +             C     +  V   S     +V 
Sbjct: 141 QCHGQGPLAH------MPNASCGVPTLKVQVPNASVDVGDDVL 177

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 57/257 (22%), Positives = 100/257 (38%), Gaps = 48/257 (18%)

Query: 508 SNFDRGTLLAEGKFGPVY--RGFLPGGIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIK 562
            +++   ++  G FG V   R      ++ A+K+L     +   ++A    E + +    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVY-AMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127

Query: 563 HPNLVPLTGYCIAGDQRI-AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
            P +V L  Y    D+ +  + +YM  G+L NL+ +  +     E W+            
Sbjct: 128 SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKWA------------ 170

Query: 622 QNVGSEGLLTTWRFRH-KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
                       RF   ++ L    AL  +H   S   IHRD+K  ++ LD +   +L+D
Sbjct: 171 ------------RFYTAEVVL----ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD 211

Query: 681 FGLAKIFGNGLDEE--IARGSPGYIPPEF--AQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           FG               A G+P YI PE   +Q    +   + D +  GV L E++ G  
Sbjct: 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

Query: 737 PLGDDYPEEKEGNLVSW 753
           P   D        +++ 
Sbjct: 272 PFYADSLVGTYSKIMNH 288

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 54/241 (22%), Positives = 79/241 (32%), Gaps = 48/241 (19%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKH 563
             F    +L  G FG V+   +   G   A K L        +       E + L ++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 564 PNLVPLTGYCIAGDQRIA-IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
             +V L  Y       +  +   M  G++    H                        I 
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDI--RYH------------------------IY 277

Query: 623 NVGS-EGLLTTWRFRH---KIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRL 678
           NV          R      +I       L  LH      II+RD+K  +V LD +   R+
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVS----GLEHLH---QRNIIYRDLKPENVLLDDDGNVRI 330

Query: 679 SDFGLAKIFGNGLDEEIAR-GSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKK 736
           SD GLA     G  +     G+PG++ PE            S D +  GV L E+I  + 
Sbjct: 331 SDLGLAVELKAGQTKTKGYAGTPGFMAPELLL---GEEYDFSVDYFALGVTLYEMIAARG 387

Query: 737 P 737
           P
Sbjct: 388 P 388

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 66/372 (17%), Positives = 119/372 (31%), Gaps = 85/372 (22%)

Query: 3   SKSFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTI-------GKLSKL 55
            K +       S      +   +    VT  L S   ++   P + +           ++
Sbjct: 36  CKRWYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRV 95

Query: 56  QSLDLSENNIT--ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSN-NNF 112
           Q +DLS + I    L   L     L++L+L   R+S  + + +     L   +LS  + F
Sbjct: 96  QHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 155

Query: 113 SGEIPAAI-SSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAA 171
           S      + SS   L  L L               C      +  +      +       
Sbjct: 156 SEFALQTLLSSCSRLDELNLSW-------------CFDF--TEKHVQVAVAHVS------ 194

Query: 172 FPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQ 231
              +  LNL+G             K++                     L  +        
Sbjct: 195 -ETITQLNLSGY-----------RKNLQK-----------------SDLSTL-------- 217

Query: 232 GHISQVQFNSSYNWSRLVYVDLSE-NQLSGEIFHNFSQAQNLKHLSLAY-NRFTRQEFPQ 289
                           LV++DLS+   L  + F  F Q   L+HLSL+       +   +
Sbjct: 218 ----------VRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLE 267

Query: 290 IGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTG-QIPTVSAKNLGIIDMS 348
           +G +  L+ L +    ++ D   ++L   +L  L ++ +H T    PT+  K    I   
Sbjct: 268 LGEIPTLKTLQVF--GIVPDGTLQLL-KEALPHLQINCSHFTTIARPTIGNKKNQEIWGI 324

Query: 349 HNNLSGEIPASL 360
              L+ + P+ L
Sbjct: 325 KCRLTLQKPSCL 336

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 35/199 (17%), Positives = 70/199 (35%), Gaps = 11/199 (5%)

Query: 191 HFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVY 250
            +  L S  +L  + +L   ++       L    + + +             ++  R+ +
Sbjct: 38  RWYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQH 97

Query: 251 VDLSENQLSGEIFHNFSQA-QNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGD 309
           +DLS + +     H        L++LSL   R +      +     L  LNLS  S   +
Sbjct: 98  MDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE 157

Query: 310 IP-SEILQ-LSSLHTLDLS-MNHLT----GQIPTVSAKNLGIIDMS--HNNLSGEIPASL 360
                +L   S L  L+LS     T           ++ +  +++S    NL     ++L
Sbjct: 158 FALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTL 217

Query: 361 LEKLPQMERFNFSY-NNLT 378
           + + P +   + S    L 
Sbjct: 218 VRRCPNLVHLDLSDSVMLK 236

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 52/320 (16%), Positives = 93/320 (29%), Gaps = 80/320 (25%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLG--------SLKSLNLSYNRISGSLPSNIGNFGLLE 103
           LS L+ L+L+   +T  P     +         +L  +NL+  ++        G   LL 
Sbjct: 71  LSSLRQLNLAGVRMT--PVKCTVVAAVLGSGRHALDEVNLASCQL-----DPAGLRTLLP 123

Query: 104 VF------DLSNNNFSGEIPAAISSL-----VSLRVLKLDGNMFQWS----IPPGLLNCQ 148
           VF       L  N+   E    +  L       +  L+L  N    +    +  GL    
Sbjct: 124 VFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNT 183

Query: 149 SLVTVDLSMNQLNGSLPDGFGAAF--------PKLKSLNLAGNEIKGRDTHFAGLKSITN 200
           S+  + L    L        G            +L+ LN+A N             ++  
Sbjct: 184 SVTHLSLLHTGLGDE-----GLELLAAQLDRNRQLQELNVAYNGAGD-----TAALALAR 233

Query: 201 LNISGNLFQGSVMGVFLESLEVIDLRSNQFQ----GHISQVQFNSSYNWSRLVYVDLSEN 256
                +            SLE++ L  N+        +  +   +    +R+V       
Sbjct: 234 A-AREH-----------PSLELLHLYFNELSSEGRQVLRDLGGAAEGG-ARVVVSLTEGT 280

Query: 257 QLSGEIFHNFSQA-QNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL 315
            +S       S+  +NL     A          ++   L L   +L  +      P    
Sbjct: 281 AVSEYWSVILSEVQRNLNSWDRA----------RVQRHLELLLRDLEDSRGATLNPWRKA 330

Query: 316 QL----SSLHTLDLSMNHLT 331
           QL      +  L   +    
Sbjct: 331 QLLRVEGEVRALLEQLGSSG 350

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.4 bits (135), Expect = 4e-08
 Identities = 105/719 (14%), Positives = 199/719 (27%), Gaps = 236/719 (32%)

Query: 153 VDLSMNQLNGS----LPDGFGAAFPK----------LKSLNLAGNEIKGRDTHFAGLKSI 198
           +D    +        L   F  AF             KS+ L+  EI     H   + S 
Sbjct: 7   MDFETGEHQYQYKDILSV-FEDAFVDNFDCKDVQDMPKSI-LSKEEID----HI--IMSK 58

Query: 199 TNLNISGNLF------QGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNW--SRLVY 250
             ++ +  LF      Q  ++  F+E +    LR N              Y +  S +  
Sbjct: 59  DAVSGTLRLFWTLLSKQEEMVQKFVEEV----LRIN--------------YKFLMSPIKT 100

Query: 251 VDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDI 310
                 Q S        Q   L      YN    Q F +          N+SR      +
Sbjct: 101 EQ---RQPSMMTRMYIEQRDRL------YN--DNQVFAK---------YNVSRLQPYLKL 140

Query: 311 PSEILQLSS-----LH----------TLDLSMNHLTGQIPTVSAKNLGI--IDMSHNNLS 353
              +L+L       +            LD+ +++           +  I  +++ + N  
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSY-----KVQCKMDFKIFWLNLKNCN-- 193

Query: 354 GEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAANPSFFKRKA 413
              P ++LE L              L   ++ P     +   S+    I +  +  +R  
Sbjct: 194 --SPETVLEML------------QKLL-YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL 238

Query: 414 ANHKGLKLALALTLSMICLLAGLLCLAFGCRRKPKRWVVKQTSYKEEQNVSGPFSFQTDS 473
              K  +  L L L  +            C+      ++  T +K+              
Sbjct: 239 K-SKPYENCL-LVLLNVQNAKAWNAFNLSCK------ILLTTRFKQ-------------- 276

Query: 474 TTWVADVKHANSVQVVIFEKPLLNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGI 533
              V D   A +   +  +   + +T  ++ S         LL   K+       LP   
Sbjct: 277 ---VTDFLSAATTTHISLDHHSMTLTPDEVKS---------LLL--KYLDCRPQDLP--- 319

Query: 534 HVAVKV--LVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRI--AIYDYME 587
              +          +       A   +     KH N   LT         I  +  + +E
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLAT-WDNW---KHVNCDKLT--------TIIESSLNVLE 367

Query: 588 NGNLQNLLHDL---PLGVQTTEDWSTDTWEEDGTNSIQNVGSE----GLLTTWRFRHKIA 640
               + +   L   P          +  W +   + +  V ++     L+        I 
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI- 426

Query: 641 LGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSP 700
                    +                 +YL++ ++   +++ L +     +D        
Sbjct: 427 --------SIPS---------------IYLELKVKLE-NEYALHRSI---VDH------- 452

Query: 701 GYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRN 760
            Y  P+    D D   P  D Y Y             +G      +    ++  R +  +
Sbjct: 453 -YNIPKTFDSD-DLIPPYLDQYFY-----------SHIGHHLKNIEHPERMTLFRMVFLD 499

Query: 761 NKGSRAIDPKIRDTGPEKQMEEA-------LKI--GYLCTADLPLKRPSMQQIVGLLKD 810
               R ++ KIR          +       LK    Y+C  D     P  +++V  + D
Sbjct: 500 ---FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDND-----PKYERLVNAILD 550

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 1e-06
 Identities = 66/427 (15%), Positives = 123/427 (28%), Gaps = 127/427 (29%)

Query: 17  SWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSD----- 71
            ++ ++       V +F   +      V D     LSK + +D    +I           
Sbjct: 17  QYKDILSVFEDAFVDNFDCKD------VQDMPKSILSK-EEID----HIIMSKDAVSGTL 65

Query: 72  --LWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVL 129
              W+L S K   +    +   L  N   F L+              P+ ++ +   +  
Sbjct: 66  RLFWTLLS-KQEEMVQKFVEEVLRINYK-F-LMSPIKTEQRQ-----PSMMTRMYIEQRD 117

Query: 130 KL--DGNMFQ----------WSIPPGLLNCQS--LVTVDLSMNQLNGSLPDGFGAAFPKL 175
           +L  D  +F             +   LL  +    V +D  +         G G      
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID-GVL--------GSG------ 162

Query: 176 KSLNLAGNEIK--GRDTHFAG----------------LKSITNL--NISGNLFQGSVMGV 215
           K+  +A +                             L+ +  L   I  N    S    
Sbjct: 163 KTW-VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS---- 217

Query: 216 FLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFS-QAQNL-- 272
             +    I LR +  Q  + ++  +  Y    LV +++     + + ++ F+   + L  
Sbjct: 218 --DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ----NAKAWNAFNLSCKILLT 271

Query: 273 ---KHLSLAYNRFTRQEFPQIGTLLGLEH---LNLSRTSL---IGDIPSEILQLSSLHTL 323
              K ++   +  T          + L      +L    L     D+P E+L  +     
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR-- 329

Query: 324 DLSM------NHLT--GQIPTVSAKNLG-IIDMSHNNLSGE-----------------IP 357
            LS+      + L        V+   L  II+ S N L                    IP
Sbjct: 330 -LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIP 388

Query: 358 ASLLEKL 364
             LL  +
Sbjct: 389 TILLSLI 395

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 2e-05
 Identities = 68/351 (19%), Positives = 127/351 (36%), Gaps = 79/351 (22%)

Query: 2   SSKSFQASYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLS 61
           ++K++ A  F+ S C  + ++    KQ VTDFL++ +    S+   ++  L+  +   L 
Sbjct: 255 NAKAWNA--FNLS-C--KILLTTRFKQ-VTDFLSAATTTHISLDHHSMT-LTPDEVKSLL 307

Query: 62  ENNITALPSDL---WSLGSLKSLNLSYNRISGSL---PSNIGNF------GLLEVFDLSN 109
              +   P DL       + + L++    I+ S+    +   N+       L  + + S 
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSI----IAESIRDGLATWDNWKHVNCDKLTTIIESSL 363

Query: 110 NNFSGEIPAAISSL-VSLRVLKLDGNMFQWSIPPGLLNCQSLV-------TVDLSMNQL- 160
           N      PA    +   L V     +     IP  LL   SL+        V + +N+L 
Sbjct: 364 NVLE---PAEYRKMFDRLSVFPPSAH-----IPTILL---SLIWFDVIKSDVMVVVNKLH 412

Query: 161 NGSL----PDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITN-LNISGNLFQGSVMGV 215
             SL    P     + P +  L L          H    +SI +  NI            
Sbjct: 413 KYSLVEKQPKESTISIPSI-YLELKVKLENEYALH----RSIVDHYNIPKTFDSDD---- 463

Query: 216 FLESLEVIDLRSNQFQG-HISQVQFNSSYNWSRLVYVDLS--ENQL---------SGEIF 263
                  +D       G H+  ++        R+V++D    E ++         SG I 
Sbjct: 464 --LIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL 521

Query: 264 HNFSQAQN-LKHLSLAYNRFTR-----QEF-PQIGT-LLGLEHLNLSRTSL 306
           +   Q +    ++     ++ R      +F P+I   L+  ++ +L R +L
Sbjct: 522 NTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIAL 572

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 6/97 (6%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIP 704
            + + H H     ++HRD+K  +V LD ++  +++DFGL+ +  +G     + GSP Y  
Sbjct: 128 GVDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAA 183

Query: 705 PEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
           PE       +  P+ D++  GV+L  L+ G  P  DD
Sbjct: 184 PEVIS-GRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 36/187 (19%), Positives = 67/187 (35%), Gaps = 44/187 (23%)

Query: 516 LAEGKFGPVYRG----FLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTG 571
           +  G +G VY+             A+K +    T     A RE+  L  +KHPN++ L  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKD-YALKQI--EGTGISMSACREIALLRELKHPNVISLQK 85

Query: 572 YCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWS-TDTWEEDGTNSIQNVGSE 627
                     ++   DY E        HDL         W           N        
Sbjct: 86  -VFLSHADRKVWLLFDYAE--------HDL---------WHIIKFHRASKANKKPVQLPR 127

Query: 628 GLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPR----LSDFG 682
           G++ +  ++          + +LH +     ++HRD+K +++ +      R    ++D G
Sbjct: 128 GMVKSLLYQ------ILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMG 177

Query: 683 LAKIFGN 689
            A++F +
Sbjct: 178 FARLFNS 184

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 54.5 bits (132), Expect = 4e-08
 Identities = 39/184 (21%), Positives = 73/184 (39%), Gaps = 38/184 (20%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVK--VLVHGSTLTDQEAARELEYLGRIKHPN 565
            +++   + EG +G V++      G  VA+K  +      +  + A RE+  L ++KHPN
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           LV L        +   +++Y ++  + + L     GV                  ++   
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHL--------------VK--- 105

Query: 626 SEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
                        I   T +A+ F H H      IHRD+K  ++ +  +   +L DFG A
Sbjct: 106 ------------SITWQTLQAVNFCHKHN----CIHRDVKPENILITKHSVIKLCDFGFA 149

Query: 685 KIFG 688
           ++  
Sbjct: 150 RLLT 153

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 54.5 bits (132), Expect = 5e-08
 Identities = 43/201 (21%), Positives = 78/201 (38%), Gaps = 54/201 (26%)

Query: 505 SATSNFDRGTLLAEGKFGPVYRG--FLPGGIHVAVKVLVHGSTLTDQE-------AARE- 554
            A   ++    + EG +G V++      GG  VA+K                     RE 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK-----RVRVQTGEEGMPLSTIREV 62

Query: 555 --LEYLGRIKHPNLVPL----TGYCIAGDQRIA-IYDYMENGNLQNLLHDLPLGVQTTED 607
             L +L   +HPN+V L    T      + ++  ++++++  +L   L  +P     TE 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121

Query: 608 WSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS 667
                ++              LL              R L FLH      ++HRD+K  +
Sbjct: 122 IKDMMFQ--------------LL--------------RGLDFLHSHR---VVHRDLKPQN 150

Query: 668 VYLDMNLEPRLSDFGLAKIFG 688
           + +  + + +L+DFGLA+I+ 
Sbjct: 151 ILVTSSGQIKLADFGLARIYS 171

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 54.6 bits (132), Expect = 5e-08
 Identities = 52/242 (21%), Positives = 87/242 (35%), Gaps = 58/242 (23%)

Query: 516 LAEGKFGPVYRGF-LPGGIHVAVKVL--VHGSTLTDQEAARELEYLGRIKHPNLVPLTGY 572
           +  G +G V        G  VA+K L     S L  + A REL  L  ++H N+      
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV------ 86

Query: 573 CIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTT 632
                  I + D        +   D  L         TD         +  +     L  
Sbjct: 87  -------IGLLDVFTPDETLDDFTDFYL---VMPFMGTD---------LGKLMKHEKLGE 127

Query: 633 WRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD 692
            R +  +     + L ++H   +  IIHRD+K  ++ ++ + E ++ DFGLA+   + + 
Sbjct: 128 DRIQF-LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183

Query: 693 E----------EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GD 740
                      E+      Y             T   D++  G ++ E+ITG K L  G 
Sbjct: 184 GYVVTRWYRAPEVILNWMRY-------------TQTVDIWSVGCIMAEMITG-KTLFKGS 229

Query: 741 DY 742
           D+
Sbjct: 230 DH 231

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 53.7 bits (130), Expect = 8e-08
 Identities = 48/211 (22%), Positives = 84/211 (39%), Gaps = 49/211 (23%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIK 562
           + N+D    L +G F  V R      G+  A K+ ++   L+ ++     RE     +++
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI-INTKKLSARDFQKLEREARICRKLQ 63

Query: 563 HPNLVPLTGYCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           HPN+V L        +    Y   D +  G L   +          E +S    E D ++
Sbjct: 64  HPNIVRLHDSI---QEESFHYLVFDLVTGGELFEDI-------VAREFYS----EADASH 109

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEP-- 676
            IQ +                     ++A+ H +G    I+HR++K  ++ L    +   
Sbjct: 110 CIQQI-------------------LESIAYCHSNG----IVHRNLKPENLLLASKAKGAA 146

Query: 677 -RLSDFGLAKIFGNGLDEEIARGSPGYIPPE 706
            +L+DFGLA    +        G+PGY+ PE
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 53.7 bits (130), Expect = 8e-08
 Identities = 49/198 (24%), Positives = 75/198 (37%), Gaps = 46/198 (23%)

Query: 505 SATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVK-VLVH----GSTLTDQEAARE---L 555
            ATS ++    +  G +G VY+      G  VA+K V V     G         RE   L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 556 EYLGRIKHPNLVPLTGYCI--AGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWST 610
             L   +HPN+V L   C     D+ I +    ++++  +L+  L   P      E    
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 611 DTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL 670
              +               L              R L FLH  C   I+HRD+K  ++ +
Sbjct: 125 LMRQ--------------FL--------------RGLDFLHANC---IVHRDLKPENILV 153

Query: 671 DMNLEPRLSDFGLAKIFG 688
                 +L+DFGLA+I+ 
Sbjct: 154 TSGGTVKLADFGLARIYS 171

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 53.8 bits (130), Expect = 9e-08
 Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 13/98 (13%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-----GS 699
           AL  LH  G    II+RDIK  ++ LD N    L+DFGL+K     + +E  R     G+
Sbjct: 171 ALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKE---FVADETERAYDFCGT 223

Query: 700 PGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
             Y+ P+  +          D +  GV++ EL+TG  P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 49/216 (22%), Positives = 87/216 (40%), Gaps = 59/216 (27%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIK 562
           + N+D    L +G F  V R      G+  A K+ ++   L+ ++     RE     +++
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI-INTKKLSARDFQKLEREARICRKLQ 86

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLG------VQTTEDWSTDTWEED 616
           HPN+V L             +D ++  +   L+ DL  G      +   E +S    E D
Sbjct: 87  HPNIVRL-------------HDSIQEESFHYLVFDLVTGGELFEDIVAREFYS----EAD 129

Query: 617 GTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK-----ASSVYL 670
            ++ IQ +                     ++A+ H +G    I+HR++K      +S   
Sbjct: 130 ASHCIQQI-------------------LESIAYCHSNG----IVHRNLKPENLLLASKAK 166

Query: 671 DMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE 706
              +  +L+DFGLA    +        G+PGY+ PE
Sbjct: 167 GAAV--KLADFGLAIEVNDSEAWHGFAGTPGYLSPE 200

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 41/192 (21%), Positives = 68/192 (35%), Gaps = 48/192 (25%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQE-----AARELEYLGRI 561
             + R T L EG +G VY+         VA+K +       ++E     A RE+  L  +
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKEL 90

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           +H N++ L        +   I++Y E        +DL   +    D S            
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMR---------- 132

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR---- 677
             + S                    + F H       +HRD+K  ++ L ++        
Sbjct: 133 -VIKS------------FLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVL 176

Query: 678 -LSDFGLAKIFG 688
            + DFGLA+ FG
Sbjct: 177 KIGDFGLARAFG 188

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 64/281 (22%), Positives = 106/281 (37%), Gaps = 60/281 (21%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAAR---ELEYLGRIKH 563
           + F+   LL +G FG V        G + A+K+L     +   E A    E   L   +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 564 PNLVPLTGYCIAGDQRIA-IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           P L  L  Y      R+  + +Y   G L    H                        + 
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGEL--FFH------------------------LS 240

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
               E + +  R R   A     AL +LH   +  +++RD+K  ++ LD +   +++DFG
Sbjct: 241 R---ERVFSEDRARFYGA-EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFG 294

Query: 683 LAKIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP-L 738
           L K      D    +   G+P Y+ PE  + D+D+     D +  GVV+ E++ G+ P  
Sbjct: 295 LCKE--GIKDGATMKTFCGTPEYLAPEVLE-DNDY-GRAVDWWGLGVVMYEMMCGRLPFY 350

Query: 739 GDD--------------YPEEKEGNLVSWVRGLVRNNKGSR 765
             D              +P        S + GL++ +   R
Sbjct: 351 NQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 48/215 (22%), Positives = 84/215 (39%), Gaps = 61/215 (28%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA-ARELEYLGRIKHP 564
           +  F+  + L  G    VYR          A+KVL       D++    E+  L R+ HP
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL---KKTVDKKIVRTEIGVLLRLSHP 108

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLG------VQTTEDWSTDTWEEDGT 618
           N++ L              +  E     +L+ +L  G      +     +S    E D  
Sbjct: 109 NIIKL-------------KEIFETPTEISLVLELVTGGELFDRIVEKGYYS----ERDAA 151

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVYLD 671
           ++++ +                     A+A+LH +G    I+HRD+K      A+     
Sbjct: 152 DAVKQI-------------------LEAVAYLHENG----IVHRDLKPENLLYATP---A 185

Query: 672 MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPE 706
            +   +++DFGL+KI  + +  +   G+PGY  PE
Sbjct: 186 PDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 52.7 bits (127), Expect = 3e-07
 Identities = 29/110 (26%), Positives = 49/110 (44%), Gaps = 29/110 (26%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE----------E 694
           R L ++H   S  IIHRD+K S++ ++ + E ++ DFGLA+   + +            E
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPE 199

Query: 695 IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GDDY 742
           I      Y                 D++  G ++ EL+TG + L  G D+
Sbjct: 200 IMLNWMHY-------------NQTVDIWSVGCIMAELLTG-RTLFPGTDH 235

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 46/246 (18%), Positives = 84/246 (34%), Gaps = 86/246 (34%)

Query: 532 GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA---------- 581
              VA+K +V     + + A RE++ + R+ H N+V +         ++           
Sbjct: 36  DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95

Query: 582 ----IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRH 637
               + +YME  +L N+L   PL     E+                             H
Sbjct: 96  SVYIVQEYMET-DLANVLEQGPL----LEE-----------------------------H 121

Query: 638 K--IALGTARALAFLHHGCSPPIIHRDIKASSVYLD-MNLEPRLSDFGLAKIFGNGLDE- 693
                    R L ++H   S  ++HRD+K ++++++  +L  ++ DFGLA+I        
Sbjct: 122 ARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178

Query: 694 ---------------EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
                           +      Y             T   D++  G +  E++TG K L
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNY-------------TKAIDMWAAGCIFAEMLTG-KTL 224

Query: 739 --GDDY 742
             G   
Sbjct: 225 FAGAHE 230

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 25/110 (22%), Positives = 47/110 (42%), Gaps = 29/110 (26%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDE----------E 694
           + L ++H   S  ++HRD+K  ++ ++ + E ++ DFGLA+     +            E
Sbjct: 137 KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPE 193

Query: 695 IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GDDY 742
           +      Y                 D++  G ++ E++TG K L  G DY
Sbjct: 194 VILSWMHY-------------NQTVDIWSVGCIMAEMLTG-KTLFKGKDY 229

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 51.3 bits (123), Expect = 8e-07
 Identities = 44/207 (21%), Positives = 74/207 (35%), Gaps = 53/207 (25%)

Query: 513 GTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA-RELEYLGRI-KHPNLVPL 569
             +L  G  G V + F        A+K+L       D   A RE+E   R  + P++V +
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRI 120

Query: 570 TG-YCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
              Y      R  +    + ++ G L      +       +   T   E + +  ++++G
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL---FSRI---QDRGDQAFT---EREASEIMKSIG 171

Query: 626 SEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASS-VYLDMNLEP--RLSDF 681
                               A+ +LH       I HRD+K  + +Y         +L+DF
Sbjct: 172 E-------------------AIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDF 208

Query: 682 GLAKIF--GNGLDEEIARGSPGYIPPE 706
           G AK     N L       +P Y+ PE
Sbjct: 209 GFAKETTSHNSLTTPC--YTPYYVAPE 233

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 51.1 bits (123), Expect = 8e-07
 Identities = 47/218 (21%), Positives = 75/218 (34%), Gaps = 62/218 (28%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL-VHGSTLTDQEA-ARELEYLGRIKH 563
           T  +     L +G F  V R   +  G   A  ++     +  D +   RE      +KH
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLG------VQTTEDWSTDTWEEDG 617
           PN+             + ++D +       L+ DL  G      +   E +S    E D 
Sbjct: 70  PNI-------------VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS----EADA 112

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVYL 670
           ++ IQ +                     A+   H  G    ++HR++K      AS    
Sbjct: 113 SHCIQQI-------------------LEAVLHCHQMG----VVHRNLKPENLLLASK--- 146

Query: 671 DMNLEPRLSDFGLAKIFGNGLDE--EIARGSPGYIPPE 706
                 +L+DFGLA             A G+PGY+ PE
Sbjct: 147 LKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPE 183

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 47/241 (19%), Positives = 80/241 (33%), Gaps = 71/241 (29%)

Query: 515 LLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA-RELEYLGRIK-HPNLVPLTG 571
           +L EG    V     L      AVK+ +       +    RE+E L + + H N++ L  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKI-IEKQPGHIRSRVFREVEMLYQCQGHRNVLEL-- 76

Query: 572 YCIAGDQRIAIYDYMENGNLQNLLHDLPLG------VQTTEDWSTDTWEEDGTNSIQNVG 625
                       ++ E  +   L+ +   G      +     ++    E + +  +Q+V 
Sbjct: 77  -----------IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN----ELEASVVVQDVA 121

Query: 626 SEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIK------ASSVYLDMNLEPRL 678
           S                   AL FLH  G    I HRD+K            +     ++
Sbjct: 122 S-------------------ALDFLHNKG----IAHRDLKPENILCEHP---NQVSPVKI 155

Query: 679 SDFGLAKIFGNGLDEEIAR--------GSPGYIPPEFAQPDSDFPT---PKSDVYCYGVV 727
            DF L        D             GS  Y+ PE  +  S+  +    + D++  GV+
Sbjct: 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

Query: 728 L 728
           L
Sbjct: 216 L 216

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 42/215 (19%), Positives = 81/215 (37%), Gaps = 60/215 (27%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGR-IKHP 564
           T  ++    +  G +    R       +  AVK++      + ++   E+E L R  +HP
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIEILLRYGQHP 76

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLG------VQTTEDWSTDTWEEDGT 618
           N++ L              D  ++G    ++ +L  G      +   + +S    E + +
Sbjct: 77  NIITL-------------KDVYDDGKYVYVVTELMKGGELLDKILRQKFFS----EREAS 119

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASS-VYLDMNLEP 676
             +  +                      + +LH  G    ++HRD+K S+ +Y+D +  P
Sbjct: 120 AVLFTITK-------------------TVEYLHAQG----VVHRDLKPSNILYVDESGNP 156

Query: 677 ---RLSDFGLAKIF--GNGLDEEIARGSPGYIPPE 706
              R+ DFG AK     NGL       +  ++ PE
Sbjct: 157 ESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPE 190

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 27/121 (22%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIP 704
           + + +LH   S  ++HRD+K S++ L+     +++DFGL++ F N               
Sbjct: 120 KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 705 PEFAQPDSDF------------P---------TPKSDVYCYGVVLLELITGKKPL--GDD 741
            E    D               P         T   D++  G +L E++ G KP+  G  
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSS 235

Query: 742 Y 742
            
Sbjct: 236 T 236

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 55/263 (20%), Positives = 93/263 (35%), Gaps = 78/263 (29%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD-QEAARELEYLGRIKHP 564
              +   + + EG +G V   +     + VA+K +      T  Q   RE++ L R +H 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 565 NLVPLTGYCIAGDQRI-----AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           N++ +     A           + D ME  +L  LL    L               D   
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHL-------------SNDHIC 131

Query: 620 SI--QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
               Q      +L              R L ++H   S  ++HRD+K S++ L+   + +
Sbjct: 132 YFLYQ------IL--------------RGLKYIH---SANVLHRDLKPSNLLLNTTCDLK 168

Query: 678 LSDFGLAKIFGNGLDE----------------EIARGSPGYIPPEFAQPDSDFPTPKSDV 721
           + DFGLA++     D                 EI   S GY             T   D+
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY-------------TKSIDI 215

Query: 722 YCYGVVLLELITGKKPL--GDDY 742
           +  G +L E+++  +P+  G  Y
Sbjct: 216 WSVGCILAEMLSN-RPIFPGKHY 237

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 49.1 bits (118), Expect = 3e-06
 Identities = 27/97 (27%), Positives = 46/97 (47%), Gaps = 14/97 (14%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPG 701
           AL  LH  G    II+RD+K  ++ L+     +L+DFGL K   +  D  +     G+  
Sbjct: 133 ALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGTIE 186

Query: 702 YIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKP 737
           Y+ PE           ++ D +  G ++ +++TG  P
Sbjct: 187 YMAPEILM---RSGHNRAVDWWSLGALMYDMLTGAPP 220

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 49.1 bits (118), Expect = 3e-06
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 12/96 (12%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPG 701
           AL  LH  G    II+RD+K  ++ LD     +L+DFGL+K   +   E+ A    G+  
Sbjct: 138 ALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVE 191

Query: 702 YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           Y+ PE         T  +D + +GV++ E++TG  P
Sbjct: 192 YMAPEVVN-RRGH-TQSADWWSFGVLMFEMLTGTLP 225

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 49.1 bits (118), Expect = 3e-06
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 10/95 (10%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGY 702
           AL +LH   S  +++RDIK  ++ LD +   +++DFGL K      D    +   G+P Y
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEY 171

Query: 703 IPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           + PE  + D+D+     D +  GVV+ E++ G+ P
Sbjct: 172 LAPEVLE-DNDY-GRAVDWWGLGVVMYEMMCGRLP 204

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 22/109 (20%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-------- 697
            L FL    S  II+RD+K  +V LD     +++DFG+ K       E I          
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------ENIWDGVTTKTFC 503

Query: 698 GSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKPLGDDYPEE 745
           G+P YI PE        P  KS D + +GV+L E++ G+ P   +  +E
Sbjct: 504 GTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 49.1 bits (118), Expect = 3e-06
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 12/104 (11%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPG 701
            L FLH  G    I++RD+K  ++ LD +   +++DFG+ K   N L +       G+P 
Sbjct: 130 GLQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNTFCGTPD 183

Query: 702 YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
           YI PE             D + +GV+L E++ G+ P      EE
Sbjct: 184 YIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 37/138 (26%), Positives = 57/138 (41%), Gaps = 34/138 (24%)

Query: 23  CDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSL 81
           C  ++  V      N  L+ SVP    G  +  Q L L+ N IT L   ++  L +L+ L
Sbjct: 10  CSCDQTLVN---CQNIRLA-SVP---AGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQL 62

Query: 82  NLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIP 141
             + N+++ ++P+         VFD                L  L  L L+ N  + SIP
Sbjct: 63  YFNSNKLT-AIPTG--------VFD---------------KLTQLTQLDLNDNHLK-SIP 97

Query: 142 PGLL-NCQSLVTVDLSMN 158
            G   N +SL  + L  N
Sbjct: 98  RGAFDNLKSLTHIYLYNN 115

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.8 bits (115), Expect = 5e-06
 Identities = 27/140 (19%), Positives = 48/140 (34%), Gaps = 20/140 (14%)

Query: 246 SRLVYVDLSENQLSGEIFHNFSQAQ--NLKHLSLAYNRFTR---------QEFPQIGTLL 294
             L  +++    L   +  +   +   NL+ L L                +         
Sbjct: 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFP 252

Query: 295 GLEHLNLSRTSLIGDIPSEILQ---LSSLHTLDLSMNHLTGQIPTVSA------KNLGII 345
            L+ L +        +    L+   L  L T+D+S   LT +   +        K+L  I
Sbjct: 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI 312

Query: 346 DMSHNNLSGEIPASLLEKLP 365
           +M +N LS E+   L + LP
Sbjct: 313 NMKYNYLSDEMKKELQKSLP 332

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.4 bits (114), Expect = 5e-06
 Identities = 24/127 (18%), Positives = 40/127 (31%), Gaps = 19/127 (14%)

Query: 271 NLKHLSLAYNRFTRQEFPQIGT--LLGLEHLNLSRTS--LIGDIPSEILQ-------LSS 319
           NLK L +            I    L  LE L L         D    + +         +
Sbjct: 194 NLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPN 253

Query: 320 LHTLDLSMNHLTGQIPTVSA-----KNLGIIDMSHNNLSGEIPASLLEKLPQM---ERFN 371
           L  L +        +  +         L  +D+S   L+ E    LL+ + ++   +  N
Sbjct: 254 LKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFIN 313

Query: 372 FSYNNLT 378
             YN L+
Sbjct: 314 MKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.4 bits (114), Expect = 6e-06
 Identities = 29/176 (16%), Positives = 71/176 (40%), Gaps = 23/176 (13%)

Query: 114 GEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAA-F 172
            ++   + ++  L  LK+ G     ++  G     +L ++++    L  S+ +    +  
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 173 PKLKSLNL-AGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQ 231
           P L+ L L  G E  G D      + + + +                +L+ + +   + Q
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDR-------------FPNLKWLGIVDAEEQ 265

Query: 232 GHISQVQFNSSYNWSRLVYVDLSENQLSGE----IFHNFSQAQNLKHLSLAYNRFT 283
             + ++ F  S    +L  +D+S   L+ E    +  +  + ++LK +++ YN  +
Sbjct: 266 NVVVEM-FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.6 bits (112), Expect = 9e-06
 Identities = 28/155 (18%), Positives = 50/155 (32%), Gaps = 21/155 (13%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGL-----LE 103
           +  +  L +L +   N  ++        +LKSL +    +  S+  +I    L     L 
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIG--KKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLV 225

Query: 104 VFDLSNNNFSGEIPAAISSLVS------LRVLKLDGNMFQWSIPPGLLNCQ---SLVTVD 154
           ++    +            L S      L+ L +     Q  +    L       L T+D
Sbjct: 226 LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285

Query: 155 LSMNQLNGS----LPDGFGAAFPKLKSLNLAGNEI 185
           +S   L       L D        LK +N+  N +
Sbjct: 286 ISAGVLTDEGARLLLDHV-DKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.2 bits (103), Expect = 1e-04
 Identities = 11/101 (10%), Positives = 38/101 (37%), Gaps = 8/101 (7%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNIT-ALPSDLWS---LGSLKSLNLSYNRISGS 91
            +  ++   P  +  +   L+ L + +      +         L  L+++++S   ++  
Sbjct: 235 FDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294

Query: 92  ----LPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRV 128
               L  ++     L+  ++  N  S E+   +   + +++
Sbjct: 295 GARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKI 335

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.2 bits (103), Expect = 1e-04
 Identities = 15/150 (10%), Positives = 41/150 (27%), Gaps = 23/150 (15%)

Query: 51  KLSKLQSLDLSENNITA----------LPS----DLWSLGSLKSLNLSYNRISGSLPSNI 96
               L+SL++    +            LP+     L+        +   N        + 
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKD- 249

Query: 97  GNFGLLEVFDLSNNNFSGEIPAAISS---LVSLRVLKLDGNMFQ----WSIPPGLLNCQS 149
             F  L+   + +      +         L  L  + +   +        +   +   + 
Sbjct: 250 -RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308

Query: 150 LVTVDLSMNQLNGSLPDGFGAAFPKLKSLN 179
           L  +++  N L+  +      + P    ++
Sbjct: 309 LKFINMKYNYLSDEMKKELQKSLPMKIDVS 338

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.6 bits (99), Expect = 4e-04
 Identities = 15/65 (23%), Positives = 31/65 (47%), Gaps = 6/65 (9%)

Query: 52  LSKLQSLDLSENNIT-----ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFD 106
           L +L+++D+S   +T      L   +  +  LK +N+ YN +S  +   +    L    D
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK-SLPMKID 336

Query: 107 LSNNN 111
           +S++ 
Sbjct: 337 VSDSQ 341

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 41.9 bits (97), Expect = 7e-04
 Identities = 28/229 (12%), Positives = 66/229 (28%), Gaps = 32/229 (13%)

Query: 55  LQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSG 114
              +  ++          W     +   +S+      L   +    LL    +   N   
Sbjct: 128 ADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQ-VDLSPVLDAMPLLNNLKIKGTN--- 183

Query: 115 EIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQ--SLVTVDLSMNQLNGSLPDG----- 167
            +        +L+ L++       S+   +L     +L  + L +   +           
Sbjct: 184 NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR 243

Query: 168 ---FGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVID 224
                  FP LK L +   E                      + +  +    L  LE +D
Sbjct: 244 PLFSKDRFPNLKWLGIVDAEE------------------QNVVVEMFLESDILPQLETMD 285

Query: 225 LRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLK 273
           + +       +++  +       L ++++  N LS E+     ++  +K
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK 334

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 48.1 bits (115), Expect = 6e-06
 Identities = 44/234 (18%), Positives = 89/234 (38%), Gaps = 56/234 (23%)

Query: 516 LAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-HPNLVPLTGYC 573
           L EG F    +          AVK+ +      + +  +E+  L   + HPN+V L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKI-ISKRMEANTQ--KEITALKLCEGHPNIVKLHEVF 75

Query: 574 IAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
                ++  +   + +  G L      +    +  + +S    E + +  ++ + S    
Sbjct: 76  ---HDQLHTFLVMELLNGGEL---FERI----KKKKHFS----ETEASYIMRKLVS---- 117

Query: 631 TTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSV-YLDMNLEP--RLSDFGLAKI 686
                          A++ +H  G    ++HRD+K  ++ + D N     ++ DFG A++
Sbjct: 118 ---------------AVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158

Query: 687 F--GNGLDEEIARGSPGYIPPE-FAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
               N   +     +  Y  PE   Q   D      D++  GV+L  +++G+ P
Sbjct: 159 KPPDNQPLKTPC-FTLHYAAPELLNQNGYD---ESCDLWSLGVILYTMLSGQVP 208

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 47.6 bits (114), Expect = 8e-06
 Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 12/96 (12%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPGY 702
           AL FLH      II+RD+K  +V LD     +L+DFG+ K      +        G+P Y
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDY 190

Query: 703 IPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKP 737
           I PE  Q   +     + D +  GV+L E++ G  P
Sbjct: 191 IAPEILQ---EMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 45.7 bits (109), Expect = 9e-06
 Identities = 39/138 (28%), Positives = 54/138 (39%), Gaps = 34/138 (24%)

Query: 23  CDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSL 81
           C  +   V     S   L+ SVP    G  +  Q L L +N IT L   ++  L  L  L
Sbjct: 7   CSCSGTTVD---CSGKSLA-SVP---TGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRL 59

Query: 82  NLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIP 141
           +L  N+++  LP+         VFD                L  L  L L+ N  + SIP
Sbjct: 60  DLDNNQLT-VLPAG--------VFD---------------KLTQLTQLSLNDNQLK-SIP 94

Query: 142 PGLL-NCQSLVTVDLSMN 158
            G   N +SL  + L  N
Sbjct: 95  RGAFDNLKSLTHIWLLNN 112

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 47.6 bits (114), Expect = 9e-06
 Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 14/97 (14%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR---GSPG 701
           AL +LH  G    II+RD+K  +V LD     +L+D+G+ K        +      G+P 
Sbjct: 122 ALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPN 175

Query: 702 YIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKP 737
           YI PE  +         S D +  GV++ E++ G+ P
Sbjct: 176 YIAPEILR---GEDYGFSVDWWALGVLMFEMMAGRSP 209

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 47.6 bits (114), Expect = 9e-06
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 24/102 (23%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR------- 697
            L FL   G    II+RD+K  +V LD     +++DFG+ K       E I         
Sbjct: 133 GLFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCK-------ENIWDGVTTKTF 181

Query: 698 -GSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKP 737
            G+P YI PE        P  KS D + +GV+L E++ G+ P
Sbjct: 182 CGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQAP 220

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 47.6 bits (114), Expect = 1e-05
 Identities = 32/102 (31%), Positives = 46/102 (45%), Gaps = 24/102 (23%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR------- 697
           AL +LH       I++RD+K  ++ LD      L+DFGL K       E I         
Sbjct: 151 ALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCK-------ENIEHNSTTSTF 199

Query: 698 -GSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKP 737
            G+P Y+ PE        P  ++ D +C G VL E++ G  P
Sbjct: 200 CGTPEYLAPEVLH---KQPYDRTVDWWCLGAVLYEMLYGLPP 238

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 47.2 bits (113), Expect = 1e-05
 Identities = 30/111 (27%), Positives = 49/111 (44%), Gaps = 18/111 (16%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPG--- 701
           RA+  LH      +IHRD+K S++ ++ N + ++ DFGLA+I      +           
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 702 --------YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GDDY 742
                   Y  PE     + + +   DV+  G +L EL    +P+  G DY
Sbjct: 180 VEFVATRWYRAPEVMLTSAKY-SRAMDVWSCGCILAELFLR-RPIFPGRDY 228

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 27/106 (25%), Positives = 45/106 (42%), Gaps = 19/106 (17%)

Query: 646 ALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-----GSP 700
              +LH   S  +I+RD+K  ++ +D     +++DFG AK           R     G+P
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------RTWTLCGTP 202

Query: 701 GYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKPLGDDYPEE 745
             + PE           K+ D +  GV++ E+  G  P   D P +
Sbjct: 203 EALAPEIIL---SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 46.8 bits (112), Expect = 2e-05
 Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 21/107 (19%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR-----GS 699
           AL +LH       II+RD+K  ++ LD N   +++DFG AK                 G+
Sbjct: 118 ALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAK-------YVPDVTYTLCGT 166

Query: 700 PGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKPLGDDYPEE 745
           P YI PE        P  KS D + +G+++ E++ G  P  D    +
Sbjct: 167 PDYIAPEVVS---TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 24/102 (23%)

Query: 646 ALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR------- 697
           AL +LH  G    II+RD+K  +V LD     +L+D+G+ K       E +         
Sbjct: 165 ALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDTTSTF 213

Query: 698 -GSPGYIPPEFAQPDSDFPTPKS-DVYCYGVVLLELITGKKP 737
            G+P YI PE  +         S D +  GV++ E++ G+ P
Sbjct: 214 CGTPNYIAPEILR---GEDYGFSVDWWALGVLMFEMMAGRSP 252

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 22/112 (19%), Positives = 37/112 (33%), Gaps = 31/112 (27%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG--LDE--------- 693
             L  LH      ++HRD+   ++ L  N +  + DF LA+                   
Sbjct: 145 LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRA 201

Query: 694 -EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GDDY 742
            E+     G+             T   D++  G V+ E+    K L  G  +
Sbjct: 202 PELVMQFKGF-------------TKLVDMWSAGCVMAEMFNR-KALFRGSTF 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 14/103 (13%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG--LDEEIA-RGSPG 701
             +  LH   S  IIHRD+K S++ +  +   ++ DFGLA+  G    +   +  R    
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---Y 191

Query: 702 YIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GDDY 742
           Y  PE             D++  G ++ E+I G   L  G D+
Sbjct: 192 YRAPEVIL--GMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDH 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 26/111 (23%), Positives = 43/111 (38%), Gaps = 30/111 (27%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG--LDEEIA------ 696
             +  LH   S  IIHRD+K S++ +  +   ++ DFGLA+  G    +   +       
Sbjct: 175 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 697 ---RGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL--GDDY 742
                  GY                 D++  G ++ E++   K L  G DY
Sbjct: 232 PEVILGMGY-------------KENVDIWSVGCIMGEMVRH-KILFPGRDY 268

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 44.8 bits (106), Expect = 9e-05
 Identities = 13/74 (17%), Positives = 27/74 (36%), Gaps = 3/74 (4%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIP 704
             + ++H   S  I+HRD+K ++  ++ +   ++ DFGLA+      +            
Sbjct: 167 VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 705 PEFAQPDSDFPTPK 718
                        K
Sbjct: 224 DMNLVTFPHTKNLK 237

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 44.4 bits (105), Expect = 1e-04
 Identities = 17/69 (24%), Positives = 28/69 (40%), Gaps = 3/69 (4%)

Query: 645 RALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIP 704
               F+H      IIHRD+K ++  L+ +   ++ DFGLA+   +  D  I         
Sbjct: 140 LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 705 PEFAQPDSD 713
           P     +  
Sbjct: 197 PGPHNKNLK 205

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176

 Score = 41.7 bits (98), Expect = 2e-04
 Identities = 10/86 (11%), Positives = 30/86 (34%), Gaps = 6/86 (6%)

Query: 247 RLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAY-NRFTRQEFPQIGTL----LGLEHLNL 301
           ++  +D +++ +    F +    Q ++ + L   +        ++  L      +  + +
Sbjct: 62  KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEI 121

Query: 302 SRTSLIGDI-PSEILQLSSLHTLDLS 326
                + D     +    +L  L LS
Sbjct: 122 ISCGNVTDKGIIALHHFRNLKYLFLS 147

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 33/148 (22%), Positives = 49/148 (33%), Gaps = 32/148 (21%)

Query: 40  LSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISG--SLPSNIG 97
           L G   D  +   +    L+        L     ++  L SLNLS NR+     + S + 
Sbjct: 134 LKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQ 193

Query: 98  NFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSM 157
               L++ +LS N         + S   L  +K            GL     L  + L  
Sbjct: 194 KAPNLKILNLSGNE--------LKSERELDKIK------------GL----KLEELWLDG 229

Query: 158 NQLNGSLPDGFG------AAFPKLKSLN 179
           N L  +  D           FPKL  L+
Sbjct: 230 NSLCDTFRDQSTYISAIRERFPKLLRLD 257

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 41.5 bits (98), Expect = 7e-04
 Identities = 38/184 (20%), Positives = 66/184 (35%), Gaps = 49/184 (26%)

Query: 513 GTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA-RELEYLGRI-KHPNLVPL 569
             +L  G  G V + F        A+K+L       D   A RE+E   R  + P++V +
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRI 76

Query: 570 TG-YCIAGDQRIAIY---DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
              Y      R  +    + ++ G L      +       +   T   E + +  ++++G
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGEL---FSRI---QDRGDQAFT---EREASEIMKSIG 127

Query: 626 SEGLLTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYL---DMNLEPRLSDF 681
                               A+ +LH       I HRD+K  ++       N   +L+DF
Sbjct: 128 E-------------------AIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDF 164

Query: 682 GLAK 685
           G AK
Sbjct: 165 GFAK 168

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	815
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-53
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-49
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-48
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-48
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-46
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-46
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-45
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-45
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-44
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-43
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-42
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-42
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-41
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-41
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-41
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-41
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-40
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-40
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-39
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-39
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-38
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-38
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-37
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-37
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-35
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-35
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-34
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-34
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-32
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-32
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-32
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-31
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-30
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-30
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-29
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-29
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-28
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-28
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-27
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-27
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-27
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-27
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-27
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-26
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-06
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-04
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-21
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-08
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-08
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-15
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-14
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-13
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-12
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-11
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-11
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-11
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-09
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-08
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-07
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	8e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	7e-04
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	2e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.001
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-53
 Identities = 71/314 (22%), Positives = 121/314 (38%), Gaps = 55/314 (17%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIKHP 564
                G  +  G FG VY+G   G   VAVK+L + +  T Q+      E+  L + +H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
           N++   GY  A    I +  + E  +L + LH                            
Sbjct: 65  NILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHI--------------------------- 96

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
             E           IA  TA+ + +LH      IIHRD+K+++++L  +L  ++ DFGLA
Sbjct: 97  -IETKFE-MIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151

Query: 685 KIFGNGLDEEI---ARGSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGKKPLGD 740
            +              GS  ++ PE  +     P + +SDVY +G+VL EL+TG+ P  +
Sbjct: 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211

Query: 741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
               ++   +V             R               +   ++   C      +RP 
Sbjct: 212 INNRDQIIFMV------------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL 259

Query: 801 MQQIVGLLKDIEST 814
             QI+  ++ +  +
Sbjct: 260 FPQILASIELLARS 273

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-50
 Identities = 72/306 (23%), Positives = 123/306 (40%), Gaps = 53/306 (17%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
                   L  G+FG V+ G+  G   VAVK L  GS ++      E   + +++H  LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L          I I +YMENG+L + L                                
Sbjct: 72  RLYAVVTQEPIYI-ITEYMENGSLVDFLKT----------------------------PS 102

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
           G+  T      +A   A  +AF+        IHRD++A+++ +   L  +++DFGLA++ 
Sbjct: 103 GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159

Query: 688 GNGLDE--EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
            +      E A+    +  PE     +   T KSDV+ +G++L E++T  +     YP  
Sbjct: 160 EDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIP---YPGM 214

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
               ++  +       +G R +        P+   EE  ++  LC  + P  RP+   + 
Sbjct: 215 TNPEVIQNLE------RGYRMVR-------PDNCPEELYQLMRLCWKERPEDRPTFDYLR 261

Query: 806 GLLKDI 811
            +L+D 
Sbjct: 262 SVLEDF 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 2e-49
 Identities = 56/309 (18%), Positives = 115/309 (37%), Gaps = 53/309 (17%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
           S       +  G+FG V+ G+      VA+K +     +++++   E E + ++ HP LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L G C+       ++++ME+G L + L                              ++
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLR-----------------------------TQ 94

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
             L        + L        + +     +IHRD+ A +  +  N   ++SDFG+ +  
Sbjct: 95  RGLFAAETLLGMCLDVCEG---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151

Query: 688 GNG--LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
            +         +    +  PE         + KSDV+ +GV++ E+ +  K   ++    
Sbjct: 152 LDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
           +   +V  +        G R   P++             +I   C  + P  RP+  +++
Sbjct: 210 E---VVEDIS------TGFRLYKPRLAS-------THVYQIMNHCWKERPEDRPAFSRLL 253

Query: 806 GLLKDIEST 814
             L +I  +
Sbjct: 254 RQLAEIAES 262

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (437), Expect = 7e-49
 Identities = 75/326 (23%), Positives = 124/326 (38%), Gaps = 37/326 (11%)

Query: 496 LNITFADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIH------VAVKVL-VHGSTLTD 548
           LN     L    +N +    + EG FG V++   PG +       VAVK+L    S    
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 549 QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDW 608
            +  RE   +    +PN+V L G C  G     +++YM  G+L   L         +   
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS------MSPHT 114

Query: 609 STDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV 668
                  D +   +         +   +  IA   A  +A+L        +HRD+   + 
Sbjct: 115 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC 171

Query: 669 YLDMNLEPRLSDFGLAKIFGNGLDEEI---ARGSPGYIPPEFAQPDSDFPTPKSDVYCYG 725
            +  N+  +++DFGL++   +    +          ++PPE      +  T +SDV+ YG
Sbjct: 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYG 229

Query: 726 VVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK 785
           VVL E+ +        Y       ++ +VR            D  I    PE    E   
Sbjct: 230 VVLWEIFSYGLQP---YYGMAHEEVIYYVR------------DGNILAC-PENCPLELYN 273

Query: 786 IGYLCTADLPLKRPSMQQIVGLLKDI 811
           +  LC + LP  RPS   I  +L+ +
Sbjct: 274 LMRLCWSKLPADRPSFCSIHRILQRM 299

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-48
 Identities = 61/318 (19%), Positives = 106/318 (33%), Gaps = 55/318 (17%)

Query: 516 LAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA 575
           + +G+FG V+RG   G   VAVK+              E+     ++H N++        
Sbjct: 11  IGKGRFGEVWRGKWRGEE-VAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 576 GDQRIA----IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLT 631
            +        + DY E+G+L + L+   +                               
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYTV------------------------------- 97

Query: 632 TWRFRHKIALGTARALAFLHHGC-----SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           T     K+AL TA  LA LH         P I HRD+K+ ++ +  N    ++D GLA  
Sbjct: 98  TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157

Query: 687 FGNGLDEEIAR-----GSPGYIPPEFAQPDSDF----PTPKSDVYCYGVVLLELITGKKP 737
             +  D          G+  Y+ PE      +        ++D+Y  G+V  E+      
Sbjct: 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217

Query: 738 LGDDYPEEK---EGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQ-MEEALKIGYLCTAD 793
            G     +    +          +R     + + P I +     + +    KI   C   
Sbjct: 218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277

Query: 794 LPLKRPSMQQIVGLLKDI 811
               R +  +I   L  +
Sbjct: 278 NGAARLTALRIKKTLSQL 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-48
 Identities = 60/307 (19%), Positives = 110/307 (35%), Gaps = 55/307 (17%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
            +      L  G+FG V  G   G   VA+K++    ++++ E   E + +  + H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L G C        I +YM NG L N L +                              
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE-----------------------------M 93

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
                 +   ++      A+ +L        +HRD+ A +  ++     ++SDFGL++  
Sbjct: 94  RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150

Query: 688 GNGLDEEI--ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE 744
            +        ++    + PPE         + KSD++ +GV++ E+ + GK P       
Sbjct: 151 LDDEYTSSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208

Query: 745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           E                     I   +R   P    E+   I Y C  +   +RP+ + +
Sbjct: 209 ETA-----------------EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251

Query: 805 VGLLKDI 811
           +  + D+
Sbjct: 252 LSNILDV 258

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 9e-48
 Identities = 76/313 (24%), Positives = 120/313 (38%), Gaps = 38/313 (12%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEAA-RELEYLGR 560
            N + G +L  G FG V      G       I VAVK+L   +  +++EA   EL+ + +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 561 I-KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           +  H N+V L G C        I++Y   G+L N L          E +S D  E +   
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS------KREKFSEDEIEYENQK 150

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
            ++      +LT +      A   A+ + FL        +HRD+ A +V +      ++ 
Sbjct: 151 RLEEEEDLNVLT-FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKIC 206

Query: 680 DFGLAKIFGNGLDEEI---ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           DFGLA+   +  +  +   AR    ++ PE         T KSDV+ YG++L E+ +   
Sbjct: 207 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYGILLWEIFSLGV 264

Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL 796
                 P +                   + I    +   P    EE   I   C A    
Sbjct: 265 NPYPGIPVDANFY---------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSR 309

Query: 797 KRPSMQQIVGLLK 809
           KRPS   +   L 
Sbjct: 310 KRPSFPNLTSFLG 322

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-47
 Identities = 83/320 (25%), Positives = 124/320 (38%), Gaps = 45/320 (14%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIH------VAVKVLVHGSTLTDQEAA-RELEYLGR 560
           +    G  L  G FG V      G I       VAVK+L   + LT++EA   EL+ L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 561 IK-HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           +  H N+V L G C  G   + I +Y   G+L N L         ++       +++   
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA- 141

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                               +   A+ +AFL    S   IHRD+ A ++ L      ++ 
Sbjct: 142 -----------LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKIC 187

Query: 680 DFGLAKIFGNGLDEEI---ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           DFGLA+   N  +  +   AR    ++ PE     +   T +SDV+ YG+ L EL +   
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGS 245

Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL 796
                 P + +                 + I    R   PE    E   I   C    PL
Sbjct: 246 SPYPGMPVDSKFY---------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPL 290

Query: 797 KRPSMQQIVGLLKDI--EST 814
           KRP+ +QIV L++    EST
Sbjct: 291 KRPTFKQIVQLIEKQISEST 310

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-46
 Identities = 66/309 (21%), Positives = 119/309 (38%), Gaps = 40/309 (12%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGG---IHVAVKVLVHGSTLTD-QEAARELEYLGRI-K 562
           ++     ++ EG FG V +  +      +  A+K +   ++  D ++ A ELE L ++  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           HPN++ L G C          +Y  +GNL + L              +   E D   +I 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK------------SRVLETDPAFAIA 117

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
           N  +  L  + +     A   AR +    +      IHRD+ A ++ +  N   +++DFG
Sbjct: 118 NSTASTL--SSQQLLHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFG 172

Query: 683 LAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY 742
           L++     + + + R    ++  E         T  SDV+ YGV+L E+++        Y
Sbjct: 173 LSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGT---PY 227

Query: 743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ 802
                  L                +    R   P    +E   +   C  + P +RPS  
Sbjct: 228 CGMTCAELY-------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 274

Query: 803 QIVGLLKDI 811
           QI+  L  +
Sbjct: 275 QILVSLNRM 283

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  166 bits (421), Expect = 1e-46
 Identities = 70/333 (21%), Positives = 120/333 (36%), Gaps = 70/333 (21%)

Query: 499 TFADLLSATSNFDR---------GTLLAEGKFGPVYRGFLPG----GIHVAVKVLVHGST 545
           TF D   A   F +           ++  G+FG V  G L       I VA+K L  G T
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 546 LTD-QEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQT 604
               ++   E   +G+  HPN++ L G        + I ++MENG+L + L         
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-------- 119

Query: 605 TEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK 664
            ++    T  +                       +  G A  + +L        +HRD+ 
Sbjct: 120 -QNDGQFTVIQ--------------------LVGMLRGIAAGMKYLAD---MNYVHRDLA 155

Query: 665 ASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIAR------GSPGYIPPEFAQPDSDFPTPK 718
           A ++ ++ NL  ++SDFGL++   +   +              +  PE  Q      T  
Sbjct: 156 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ--YRKFTSA 213

Query: 719 SDVYCYGVVLLELITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEK 778
           SDV+ YG+V+ E+++  +     Y +    +++              AI+   R   P  
Sbjct: 214 SDVWSYGIVMWEVMSYGERP---YWDMTNQDVI-------------NAIEQDYRLPPPMD 257

Query: 779 QMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI 811
                 ++   C       RP   QIV  L  +
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 8e-46
 Identities = 64/306 (20%), Positives = 117/306 (38%), Gaps = 53/306 (17%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
            +      L +G FG V+ G   G   VA+K L    T++ +   +E + + +++H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L          I + +YM  G+L + L                             G  
Sbjct: 76  QLYAVVSEEPIYI-VTEYMSKGSLLDFLK----------------------------GET 106

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
           G          +A   A  +A++        +HRD++A+++ +  NL  +++DFGLA++ 
Sbjct: 107 GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI 163

Query: 688 GNG--LDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
            +      + A+    +  PE A       T KSDV+ +G++L EL T  +     YP  
Sbjct: 164 EDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVP---YPGM 218

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
               ++               ++   R   P +  E    +   C    P +RP+ + + 
Sbjct: 219 VNREVL-------------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 265

Query: 806 GLLKDI 811
             L+D 
Sbjct: 266 AFLEDY 271

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  161 bits (408), Expect = 5e-45
 Identities = 67/307 (21%), Positives = 111/307 (36%), Gaps = 53/307 (17%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNL 566
           ++      L  G++G VY G      + VAVK L    T+  +E  +E   +  IKHPNL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 75

Query: 567 VPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
           V L G C        I ++M  GNL + L +                             
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE----------------------------C 107

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
                +      +A   + A+ +L        IHRD+ A +  +  N   +++DFGL+++
Sbjct: 108 NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164

Query: 687 FGNGLDEEI--ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE 744
                      A+    +  PE    +    + KSDV+ +GV+L E+ T        YP 
Sbjct: 165 MTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSP---YPG 219

Query: 745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
                +                ++   R   PE   E+  ++   C    P  RPS  +I
Sbjct: 220 IDLSQVY-------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266

Query: 805 VGLLKDI 811
               + +
Sbjct: 267 HQAFETM 273

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 6e-45
 Identities = 61/307 (19%), Positives = 111/307 (36%), Gaps = 55/307 (17%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
                   + +G+FG V  G   G   VAVK + + +T   Q    E   + +++H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 568 PLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
            L G  +     + I  +YM  G+L + L                               
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS----------------------------R 95

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
              +       K +L    A+ +L        +HRD+ A +V +  +   ++SDFGL K 
Sbjct: 96  GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152

Query: 687 FGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEK 746
             +   ++  +    +  PE  +      + KSDV+ +G++L E+ +  +     YP   
Sbjct: 153 ASS--TQDTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVP---YPRIP 205

Query: 747 EGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG 806
             ++V  V          +          P+       ++   C       RPS  Q+  
Sbjct: 206 LKDVVPRVE---------KGYKMDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252

Query: 807 LLKDIES 813
            L+ I++
Sbjct: 253 QLEHIKT 259

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 3e-44
 Identities = 61/327 (18%), Positives = 119/327 (36%), Gaps = 63/327 (19%)

Query: 506 ATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL-VHGSTLTDQEAARELEYLGRIKH 563
              +F++ + L  G  G V++    P G+ +A K++ +        +  REL+ L     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           P +V   G   +  +     ++M+ G+L  +L                            
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------------------------- 97

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
               G +   +   K+++   + L +L       I+HRD+K S++ ++   E +L DFG+
Sbjct: 98  ---AGRIP-EQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV 151

Query: 684 AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           +    + +      G+  Y+ PE  Q      + +SD++  G+ L+E+  G+ P+     
Sbjct: 152 SGQLIDSMANSFV-GTRSYMSPERLQ--GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

Query: 744 EEKEGNLVSWVRGLV-----RNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCT------- 791
           +E E      V G       R     R +     D+ P   + E L              
Sbjct: 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG 268

Query: 792 ------ADL--------PLKRPSMQQI 804
                  D         P +R  ++Q+
Sbjct: 269 VFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-43
 Identities = 71/317 (22%), Positives = 119/317 (37%), Gaps = 63/317 (19%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPG----GIHVAVKVLVHGSTLTD-QEAARELEYLGRIKH 563
           +F+   ++  G FG VY G L       IH AVK L   + + +  +   E   +    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 564 PNLVPLTGYCIAGDQRIAI-YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           PN++ L G C+  +    +   YM++G+L+N + +                         
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN------------------------- 122

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
               E    T +      L  A+ +       S   +HRD+ A +  LD     +++DFG
Sbjct: 123 ----ETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFG 175

Query: 683 LAKIFGNGLDEEI-----ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           LA+   +   + +     A+    ++  E  Q      T KSDV+ +GV+L EL+T   P
Sbjct: 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAP 233

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
              D       N       L++            R   PE   +   ++   C       
Sbjct: 234 PYPDV------NTFDITVYLLQGR----------RLLQPEYCPDPLYEVMLKCWHPKAEM 277

Query: 798 RPSMQQIVGLLKDIEST 814
           RPS  ++V  +  I ST
Sbjct: 278 RPSFSELVSRISAIFST 294

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-42
 Identities = 61/314 (19%), Positives = 112/314 (35%), Gaps = 60/314 (19%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPGG-----IHVAVKVLVHGSTLTDQ-EAARELEYLGRI 561
           S   R  ++  G+FG VY+G L        + VA+K L  G T   + +   E   +G+ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
            H N++ L G        + I +YMENG L   L +                        
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF------------------- 107

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                     +      +  G A  +    +  +   +HRD+ A ++ ++ NL  ++SDF
Sbjct: 108 ----------SVLQLVGMLRGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDF 154

Query: 682 GLAKIFGNGLDEEI----ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           GL+++  +  +        +    +  PE            SDV+ +G+V+ E++T  + 
Sbjct: 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT--SASDVWSFGIVMWEVMTYGER 212

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
              +    +                  +AI+   R   P        ++   C      +
Sbjct: 213 PYWELSNHEV----------------MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERAR 256

Query: 798 RPSMQQIVGLLKDI 811
           RP    IV +L  +
Sbjct: 257 RPKFADIVSILDKL 270

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 4e-42
 Identities = 66/309 (21%), Positives = 111/309 (35%), Gaps = 53/309 (17%)

Query: 505 SATSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD--QEAARELEYLGRI 561
           S   +++    +  G +G   +      G  +  K L +GS      Q    E+  L  +
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 562 KHPNLVPLTGYCIAGDQRIA--IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           KHPN+V      I         + +Y E G+L +++                        
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG--------------------- 99

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLH--HGCSPPIIHRDIKASSVYLDMNLEPR 677
                  E       F  ++      AL   H        ++HRD+K ++V+LD     +
Sbjct: 100 -----TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154

Query: 678 LSDFGLAKIFGNGLDE-EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           L DFGLA+I  +     +   G+P Y+ PE     S     KSD++  G +L EL     
Sbjct: 155 LGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS--YNEKSDIWSLGCLLYELCALMP 212

Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL 796
           P      +E        + G +R  K       +I    P +  +E  +I          
Sbjct: 213 PFTAFSQKE--------LAGKIREGK-----FRRI----PYRYSDELNEIITRMLNLKDY 255

Query: 797 KRPSMQQIV 805
            RPS+++I+
Sbjct: 256 HRPSVEEIL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 2e-41
 Identities = 65/320 (20%), Positives = 106/320 (33%), Gaps = 62/320 (19%)

Query: 502 DLLSATSNFDRGTL-LAEGKFGPVYRGFL---PGGIHVAVKVLVHGSTLTD-QEAARELE 556
            L     N     + L  G FG V +G        I VA+KVL  G+   D +E  RE +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 557 YLGRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEED 616
            + ++ +P +V L G C   +  + + +    G L   L                     
Sbjct: 62  IMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLV-------------------- 100

Query: 617 GTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP 676
                   G    +       ++    +  + +L        +HRD+ A +V L      
Sbjct: 101 --------GKREEIP-VSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYA 148

Query: 677 RLSDFGLAKIFGNGLDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELI 732
           ++SDFGL+K  G       AR        +  PE         + +SDV+ YGV + E +
Sbjct: 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF--SSRSDVWSYGVTMWEAL 206

Query: 733 T-GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCT 791
           + G+KP       E        V   +   K         R   P +   E   +   C 
Sbjct: 207 SYGQKPYKKMKGPE--------VMAFIEQGK---------RMECPPECPPELYALMSDCW 249

Query: 792 ADLPLKRPSMQQIVGLLKDI 811
                 RP    +   ++  
Sbjct: 250 IYKWEDRPDFLTVEQRMRAC 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 5e-41
 Identities = 55/298 (18%), Positives = 105/298 (35%), Gaps = 58/298 (19%)

Query: 516 LAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTD--QEAARELEYLGRIKHPNLVPLTGY 572
           +  G F  VY+G      + VA   L          Q    E E L  ++HPN+V     
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 573 CIAGDQR----IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
             +  +     + + + M +G L+  L    +                            
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---------------------------- 108

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL-DMNLEPRLSDFGLAKIF 687
                +          + L FLH   +PPIIHRD+K  ++++       ++ D GLA + 
Sbjct: 109 --MKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165

Query: 688 GNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE 747
                + +  G+P ++ PE  +          DVY +G+ +LE+ T + P  +     + 
Sbjct: 166 RASFAKAVI-GTPEFMAPEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQ- 220

Query: 748 GNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
             +   V   V+     +   P++++            I   C      +R S++ ++
Sbjct: 221 --IYRRVTSGVKPASFDKVAIPEVKE------------IIEGCIRQNKDERYSIKDLL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 6e-41
 Identities = 54/301 (17%), Positives = 106/301 (35%), Gaps = 52/301 (17%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
            ++    L +G FG VY+       +  A KV+   S    ++   E++ L    HPN+V
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L       +    + ++   G +  ++ +L   +                         
Sbjct: 73  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPL------------------------- 107

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIF 687
               T      +   T  AL +LH      IIHRD+KA ++   ++ + +L+DFG++   
Sbjct: 108 ----TESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160

Query: 688 GNGLDE-EIARGSPGYIPPEFAQPDSDFP---TPKSDVYCYGVVLLELITGKKPLGDDYP 743
              +   +   G+P ++ PE    ++        K+DV+  G+ L+E+   + P  +  P
Sbjct: 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220

Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
                        L++  K       +     P +           C       R +  Q
Sbjct: 221 MRV----------LLKIAKSEPPTLAQ-----PSRWSSNFKDFLKKCLEKNVDARWTTSQ 265

Query: 804 I 804
           +
Sbjct: 266 L 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 6e-41
 Identities = 57/306 (18%), Positives = 99/306 (32%), Gaps = 63/306 (20%)

Query: 516 LAEGKFGPVYRGFLPG---GIHVAVKVLVHGSTLTD--QEAARELEYLGRIKHPNLVPLT 570
           L  G FG V +G+         VAVK+L + +       E   E   + ++ +P +V + 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 571 GYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLL 630
           G C A    + + +  E G L   L                                   
Sbjct: 75  GICEAESWML-VMEMAELGPLNKYLQQNRH------------------------------ 103

Query: 631 TTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNG 690
              +   ++    +  + +L        +HRD+ A +V L      ++SDFGL+K     
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160

Query: 691 LDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPEE 745
            +   A+        +  PE         + KSDV+ +GV++ E  + G+KP       E
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV 805
                                ++   R   P     E   +  LC       RP    + 
Sbjct: 219 VT-----------------AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVE 261

Query: 806 GLLKDI 811
             L++ 
Sbjct: 262 LRLRNY 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (377), Expect = 1e-40
 Identities = 58/305 (19%), Positives = 103/305 (33%), Gaps = 59/305 (19%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD---QEAARELEYLGRIK 562
              F     +  G FG VY    +     VA+K + +    ++   Q+  +E+ +L +++
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQ-NLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           HPN +   G  +       + +Y          +H  PL                     
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPL--------------------- 112

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                            +  G  + LA+LH   S  +IHRD+KA ++ L      +L DF
Sbjct: 113 ----------QEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDF 159

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFP-TPKSDVYCYGVVLLELITGKKPLGD 740
           G A I           G+P ++ PE      +     K DV+  G+  +EL   K PL +
Sbjct: 160 GSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216

Query: 741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
                   ++       +++   S                E        C   +P  RP+
Sbjct: 217 MNAMSALYHIAQNESPALQSGHWS----------------EYFRNFVDSCLQKIPQDRPT 260

Query: 801 MQQIV 805
            + ++
Sbjct: 261 SEVLL 265

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 5e-40
 Identities = 72/319 (22%), Positives = 113/319 (35%), Gaps = 48/319 (15%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTD-QEAARELEYL 558
                G  L EG FG V      G           VAVK+L   +T  D  +   E+E +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 559 GRI-KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDG 617
             I KH N++ L G C        I +Y   GNL+  L                      
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA--------------RRPPGL 118

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
             S     +     + +     A   AR +    +  S   IHRD+ A +V +  +   +
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGM---EYLASKKCIHRDLAARNVLVTEDNVMK 175

Query: 678 LSDFGLAKIFGNGLDEE---IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG 734
           ++DFGLA+   +    +     R    ++ PE         T +SDV+ +GV+L E+ T 
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTL 233

Query: 735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL 794
                   P E        +  L++            R   P     E   +   C   +
Sbjct: 234 GGSPYPGVPVE-------ELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAV 277

Query: 795 PLKRPSMQQIVGLLKDIES 813
           P +RP+ +Q+V  L  I +
Sbjct: 278 PSQRPTFKQLVEDLDRIVA 296

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 8e-40
 Identities = 59/316 (18%), Positives = 106/316 (33%), Gaps = 63/316 (19%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPG----GIHVAVKVLVHGSTLTDQEAA----RELEYLGR 560
           +      L +G FG V RG         + VAVK L     L+  EA     RE+  +  
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMDDFIREVNAMHS 67

Query: 561 IKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
           + H NL+ L G  +    ++ + +    G+L + L                         
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK----------------------- 103

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
                 +G         + A+  A  + +L    S   IHRD+ A ++ L      ++ D
Sbjct: 104 -----HQGHFL-LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGD 154

Query: 681 FGLAKIFGNGLDEEI----ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           FGL +      D  +     +    +  PE  +  +   +  SD + +GV L E+ T  +
Sbjct: 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQ 212

Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL 796
                +       ++  +                 R   PE   ++   +   C A  P 
Sbjct: 213 EP---WIGLNGSQILHKI------------DKEGERLPRPEDCPQDIYNVMVQCWAHKPE 257

Query: 797 KRPSMQQIVGLLKDIE 812
            RP+   +   L + +
Sbjct: 258 DRPTFVALRDFLLEAQ 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-39
 Identities = 58/301 (19%), Positives = 103/301 (34%), Gaps = 54/301 (17%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL-VHGSTLTDQEAARELEYLGRIKHPNL 566
           ++D    L EG +G V           VAVK++ +  +    +   +E+     + H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 567 VPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
           V   G+   G+ +    +Y   G L + +                               
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIE------------------------------ 95

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
             +        +        + +LH      I HRDIK  ++ LD     ++SDFGLA +
Sbjct: 96  PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 152

Query: 687 FGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           F     E +     G+  Y+ PE  +   +F     DV+  G+VL  ++ G+ P   D P
Sbjct: 153 FRYNNRERLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPW--DQP 209

Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
            +       W              + K      +K     L + +    + P  R ++  
Sbjct: 210 SDSCQEYSDW-------------KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 256

Query: 804 I 804
           I
Sbjct: 257 I 257

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (363), Expect = 4e-39
 Identities = 64/302 (21%), Positives = 110/302 (36%), Gaps = 58/302 (19%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQ---EAARELEYLGRIKH 563
            +F+ G  L +GKFG VY          +A+KVL            +  RE+E    ++H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           PN++ L GY     +   I +Y   G +   L             S    +         
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----------LSKFDEQR-------- 107

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
                               A AL++ H   S  +IHRDIK  ++ L    E +++DFG 
Sbjct: 108 ------------TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW 152

Query: 684 AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           +    +     +  G+  Y+PPE  +        K D++  GV+  E + GK P   +  
Sbjct: 153 SVHAPSSRRTTLC-GTLDYLPPEMIE--GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209

Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
           +E    +                   ++  T P+   E A  +        P +RP +++
Sbjct: 210 QETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLRE 251

Query: 804 IV 805
           ++
Sbjct: 252 VL 253

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 7e-39
 Identities = 57/314 (18%), Positives = 112/314 (35%), Gaps = 51/314 (16%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTD-QEAARELEYLGR 560
                   L +G FG VY G   G         VA+K +   +++ +  E   E   +  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 561 IKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
               ++V L G    G   + I + M  G+L++ L  L   +      +  +  +     
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK----- 134

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
                            ++A   A  +A+L    +   +HRD+ A +  +  +   ++ D
Sbjct: 135 ---------------MIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGD 176

Query: 681 FGLAKIFGNGLDEEI---ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           FG+ +                   ++ PE  +      T  SDV+ +GVVL E+ T  + 
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQ 234

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
               Y       ++ +V            ++  + D  P+   +   ++  +C    P  
Sbjct: 235 P---YQGLSNEQVLRFV------------MEGGLLDK-PDNCPDMLFELMRMCWQYNPKM 278

Query: 798 RPSMQQIVGLLKDI 811
           RPS  +I+  +K+ 
Sbjct: 279 RPSFLEIISSIKEE 292

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 6e-38
 Identities = 60/313 (19%), Positives = 110/313 (35%), Gaps = 60/313 (19%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG-----GIHVAVKVLVHG-STLTDQEAARELEYLGRI 561
           + F +  +L  G FG VY+G          I VA+K L    S   ++E   E   +  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
            +P++  L G C+    ++ I   M  G L + + +                        
Sbjct: 69  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE------------------------ 103

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                       ++     +  A+ + +L       ++HRD+ A +V +      +++DF
Sbjct: 104 -----HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDF 155

Query: 682 GLAKIFGNGLDEEIA---RGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           GLAK+ G    E  A   +    ++  E         T +SDV+ YGV + EL+T     
Sbjct: 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKP 213

Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
            D  P                 ++ S  ++   R   P     +   I   C       R
Sbjct: 214 YDGIP----------------ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 257

Query: 799 PSMQQIVGLLKDI 811
           P  ++++     +
Sbjct: 258 PKFRELIIEFSKM 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 7e-38
 Identities = 56/300 (18%), Positives = 107/300 (35%), Gaps = 53/300 (17%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPN 565
              + R   + +G  G VY    +  G  VA++ +        +    E+  +   K+PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           +V      + GD+   + +Y+  G+L +++ +                            
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-------------------------- 112

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
                        +     +AL FLH   S  +IHRDIK+ ++ L M+   +L+DFG   
Sbjct: 113 -----MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164

Query: 686 IFGNGLDE-EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE 744
                  +     G+P ++ PE     +    PK D++  G++ +E+I G+ P  ++ P 
Sbjct: 165 QITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222

Query: 745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
                + +               +       PEK           C      KR S +++
Sbjct: 223 RALYLIAT---------------NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-37
 Identities = 70/316 (22%), Positives = 112/316 (35%), Gaps = 46/316 (14%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGSTLTDQEA-ARELEYLGR 560
                G  L  G FG V      G         VAVK+L  G+T ++  A   EL+ L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 561 IKH-PNLVPLTGYCI-AGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGT 618
           I H  N+V L G C   G   + I ++ + GNL   L          +    D +++   
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--- 129

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRL 678
                        T       +   A+ + FL    S   IHRD+ A ++ L      ++
Sbjct: 130 -----------FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKI 175

Query: 679 SDFGLAKIFGNGLDEEI---ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK 735
            DFGLA+      D      AR    ++ PE         T +SDV+ +GV+L E+ +  
Sbjct: 176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLG 233

Query: 736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLP 795
                         +       ++            R   P+    E  +    C    P
Sbjct: 234 ASPYPGV------KIDEEFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEP 278

Query: 796 LKRPSMQQIVGLLKDI 811
            +RP+  ++V  L ++
Sbjct: 279 SQRPTFSELVEHLGNL 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  139 bits (352), Expect = 7e-37
 Identities = 54/299 (18%), Positives = 102/299 (34%), Gaps = 51/299 (17%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
           ++D    L  G FG V+R      G + A K ++       +   +E++ +  ++HP LV
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L       ++ + IY++M  G L   + D                             E
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVAD-----------------------------E 117

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYL--DMNLEPRLSDFGLAK 685
               +     +      + L  +H       +H D+K  ++      + E +L DFGL  
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA 174

Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
                   ++  G+  +  PE A+         +D++  GV+   L++G  P G +  +E
Sbjct: 175 HLDPKQSVKVTTGTAEFAAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
              N+ S               D  + D+      E+            P  R ++ Q 
Sbjct: 233 TLRNVKSC--------------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-35
 Identities = 61/311 (19%), Positives = 106/311 (34%), Gaps = 58/311 (18%)

Query: 508 SNFDRGTLLAEGKFGPVYRGFLPG----GIHVAVKVLVHGSTLTDQEAA-RELEYLGRIK 562
              + G  + EG+FG V++G         + VA+K   + ++ + +E   +E   + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           HP++V L G        I I +    G L++ L      +                    
Sbjct: 67  HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKYSL-------------------- 105

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
                            A   + ALA+L    S   +HRDI A +V +  N   +L DFG
Sbjct: 106 ---------DLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 153

Query: 683 LAKIFGNGLDEE--IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
           L++   +    +    +    ++ PE         T  SDV+ +GV + E++        
Sbjct: 154 LSRYMEDSTYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQ 211

Query: 741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS 800
                        V G + N +         R   P         +   C A  P +RP 
Sbjct: 212 GVKNN-------DVIGRIENGE---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPR 255

Query: 801 MQQIVGLLKDI 811
             ++   L  I
Sbjct: 256 FTELKAQLSTI 266

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  134 bits (337), Expect = 8e-35
 Identities = 47/299 (15%), Positives = 88/299 (29%), Gaps = 51/299 (17%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
            +D    L  G FG V+R      G     K +     L       E+  + ++ HP L+
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 568 PLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSE 627
            L        + + I +++  G L + +                              +E
Sbjct: 90  NLHDAFEDKYEMVLILEFLSGGELFDRIA-----------------------------AE 120

Query: 628 GLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR--LSDFGLAK 685
               +              L  +H      I+H DIK  ++  +        + DFGLA 
Sbjct: 121 DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177

Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
                   ++   +  +  PE    +       +D++  GV+   L++G  P   +   E
Sbjct: 178 KLNPDEIVKVTTATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
              N+              +  D +  +        EA           P KR ++   
Sbjct: 236 TLQNV--------------KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 4e-34
 Identities = 58/305 (19%), Positives = 102/305 (33%), Gaps = 60/305 (19%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIKHP 564
           +F  G +L EG F  V     L      A+K+L     + + +     RE + + R+ HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
             V L       ++      Y +NG L   +                             
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--------------------------- 101

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
              G              TA  ++ L +     IIHRD+K  ++ L+ ++  +++DFG A
Sbjct: 102 --IGSFDETC----TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 155

Query: 685 KIFGNGLDEEIAR---GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
           K+      +  A    G+  Y+ PE     S      SD++  G ++ +L+ G  P    
Sbjct: 156 KVLSPESKQARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAG 213

Query: 742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSM 801
                   ++                  K+    PEK   +A  +          KR   
Sbjct: 214 NEYLIFQKII------------------KLEYDFPEKFFPKARDLVEKLLVLDATKRLGC 255

Query: 802 QQIVG 806
           +++ G
Sbjct: 256 EEMEG 260

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 8e-34
 Identities = 44/301 (14%), Positives = 97/301 (32%), Gaps = 55/301 (18%)

Query: 510 FDR---GTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPN 565
           +++      L  G+FG V+R            K  V           +E+  L   +H N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRN 62

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           ++ L     + ++ + I++++   ++   ++                             
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERIN----------------------------- 93

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR--LSDFGL 683
           +       R           AL FLH   S  I H DI+  ++           + +FG 
Sbjct: 94  TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150

Query: 684 AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           A+    G +  +   +P Y  PE  Q   D  +  +D++  G ++  L++G  P   +  
Sbjct: 151 ARQLKPGDNFRLLFTAPEYYAPEVHQ--HDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208

Query: 744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ 803
           ++   N+++               +    +   ++   EA+             R +  +
Sbjct: 209 QQIIENIMNA--------------EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254

Query: 804 I 804
            
Sbjct: 255 A 255

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  125 bits (316), Expect = 2e-32
 Identities = 55/300 (18%), Positives = 97/300 (32%), Gaps = 48/300 (16%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA-RELEYLGRIKHP 564
              +D   +L  G F  V           VA+K +   +    + +   E+  L +IKHP
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
           N+V L     +G     I   +  G L + + +                           
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--------------------------- 100

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
             +G  T  R   ++      A+ +LH         +        LD + +  +SDFGL+
Sbjct: 101 --KGFYT-ERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157

Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE 744
           K+   G     A G+PGY+ PE         +   D +  GV+   L+ G  P  D+   
Sbjct: 158 KMEDPGSVLSTACGTPGYVAPEVLAQKP--YSKAVDCWSIGVIAYILLCGYPPFYDENDA 215

Query: 745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
           +    ++                + +      +   + A           P KR + +Q 
Sbjct: 216 KLFEQILKA--------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 5e-32
 Identities = 53/311 (17%), Positives = 105/311 (33%), Gaps = 48/311 (15%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL--VHGSTLTDQEAARELEYLGRIKHPN 565
           NF +   + EG +G VY+      G  VA+K +     +      A RE+  L  + HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           +V L       ++   +++++     + +      G+                       
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----------------------- 99

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
                              + LAF     S  ++HRD+K  ++ ++     +L+DFGLA+
Sbjct: 100 ------PLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

Query: 686 IFGNGLDEEIAR-GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE 744
            FG  +        +  Y  PE       + +   D++  G +  E++T +     D   
Sbjct: 151 AFGVPVRTYTHEVVTLWYRAPEILL-GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209

Query: 745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL---------- 794
           ++   +   +              P  + + P+   ++  K+      D           
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY 269

Query: 795 -PLKRPSMQQI 804
            P KR S +  
Sbjct: 270 DPNKRISAKAA 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  124 bits (313), Expect = 5e-32
 Identities = 53/242 (21%), Positives = 86/242 (35%), Gaps = 41/242 (16%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIKH 563
            +F     L  G FG V+       G + A+KVL     +  ++      E   L  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           P ++ + G      Q   I DY+E G L +LL                            
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-------------------------- 97

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
                  +            A     L +  S  II+RD+K  ++ LD N   +++DFG 
Sbjct: 98  -------SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 150

Query: 684 AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           AK   +        G+P YI PE     +       D + +G+++ E++ G  P  D   
Sbjct: 151 AKYVPD--VTYTLCGTPDYIAPEVVS--TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206

Query: 744 EE 745
            +
Sbjct: 207 MK 208

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  123 bits (310), Expect = 6e-32
 Identities = 48/310 (15%), Positives = 107/310 (34%), Gaps = 48/310 (15%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVL--VHGSTLTDQEAARELEYLGRIKHPNL 566
            +     + EG +G VY+     G   A+K +              RE+  L  +KH N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 567 VPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
           V L        + + ++++++    + L                                
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV-----------------------------C 93

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI 686
           EG L +   +  +     + L  + +     ++HRD+K  ++ ++   E +++DFGLA+ 
Sbjct: 94  EGGLESVTAKSFLL----QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA 149

Query: 687 FGNGLDEEIAR-GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
           FG  + +      +  Y  P+       + +   D++  G +  E++ G          +
Sbjct: 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208

Query: 746 ---------KEGNLVSW--VRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL 794
                       N  +W  V  L + +      +P   ++  +   E  + +        
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD 268

Query: 795 PLKRPSMQQI 804
           P +R + +Q 
Sbjct: 269 PNQRITAKQA 278

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  123 bits (309), Expect = 8e-32
 Identities = 52/311 (16%), Positives = 104/311 (33%), Gaps = 62/311 (19%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD---------QEAARELEYL 558
           N++   +L  G    V R    P     AVK++      +          +   +E++ L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 559 GRIK-HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDG 617
            ++  HPN++ L            ++D M+ G L + L +                    
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-------------------- 103

Query: 618 TNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR 677
                    +  L+  +   KI       +  LH      I+HRD+K  ++ LD ++  +
Sbjct: 104 ---------KVTLS-EKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIK 150

Query: 678 LSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQP----DSDFPTPKSDVYCYGVVLLELIT 733
           L+DFG +     G       G+P Y+ PE  +     +      + D++  GV++  L+ 
Sbjct: 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210

Query: 734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTAD 793
           G  P            ++S               + +      +   +    +       
Sbjct: 211 GSPPFWHRKQMLMLRMIMSG--------------NYQFGSPEWDDYSDTVKDLVSRFLVV 256

Query: 794 LPLKRPSMQQI 804
            P KR + ++ 
Sbjct: 257 QPQKRYTAEEA 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  125 bits (314), Expect = 1e-31
 Identities = 54/295 (18%), Positives = 92/295 (31%), Gaps = 53/295 (17%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQ------EAARELEYLGRI 561
           +F    ++  G FG VY       G   A+K L        Q           L  +   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 562 KHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
             P +V ++      D+   I D M  G+L   L                          
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS------------------------- 99

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                +  + +       A      L  +H   +  +++RD+K +++ LD +   R+SD 
Sbjct: 100 -----QHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDL 151

Query: 682 GLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD 741
           GLA  F          G+ GY+ PE  Q    +    +D +  G +L +L+ G  P    
Sbjct: 152 GLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQH 209

Query: 742 YPEEKEGNLVSWVRGLVRNNKG-SR----------AIDPKIRDTGPEKQMEEALK 785
             ++K       +   V      S             D   R     +  +E  +
Sbjct: 210 KTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 2e-31
 Identities = 56/315 (17%), Positives = 102/315 (32%), Gaps = 45/315 (14%)

Query: 506 ATSNFDRGTLLAEGKFGPVYRGF--LPGGIHVAVKVL-----VHGSTLTDQEAARELEYL 558
           A   ++    + EG +G V++      GG  VA+K +       G  L+       L +L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 559 GRIKHPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGT 618
              +HPN+V L   C            +   ++   L                       
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY-------------------- 104

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRL 678
             +  V   G+         +     R L FLH   S  ++HRD+K  ++ +  + + +L
Sbjct: 105 --LDKVPEPGV--PTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKL 157

Query: 679 SDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
           +DFGLA+I+   +       +  Y  PE             D++  G +  E+   K   
Sbjct: 158 ADFGLARIYSFQMALTSVVVTLWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRKPLF 215

Query: 739 GDDYPEEKEGNLVS---------WVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL 789
                 ++ G ++          W R +    +   +   +  +       E    +   
Sbjct: 216 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK 275

Query: 790 CTADLPLKRPSMQQI 804
           C    P KR S    
Sbjct: 276 CLTFNPAKRISAYSA 290

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 5e-31
 Identities = 60/315 (19%), Positives = 105/315 (33%), Gaps = 54/315 (17%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
           ++    ++  G FG VY+  L   G  VA+K ++       +   REL+ + ++ H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76

Query: 568 PLTGYCIAGDQRIA------IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
            L  +  +  ++        + DY+     +   H           +             
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY------------- 123

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMN-LEPRLSD 680
                                  R+LA++H   S  I HRDIK  ++ LD +    +L D
Sbjct: 124 --------------VKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCD 166

Query: 681 FGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD 740
           FG AK    G        S  Y  PE     +D+ T   DV+  G VL EL+ G+     
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPG 225

Query: 741 DYPEEKEGNLVS-----------WVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYL 789
           D   ++   ++             +       K  +            +   EA+ +   
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285

Query: 790 CTADLPLKRPSMQQI 804
                P  R +  + 
Sbjct: 286 LLEYTPTARLTPLEA 300

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-30
 Identities = 52/321 (16%), Positives = 108/321 (33%), Gaps = 58/321 (18%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD-QEAARELEYLGRIKHP 564
              +   + + EG +G V   +     + VA+K +      T  Q   RE++ L R +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 565 NLVPLTGYCIAGD----QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
           N++ +     A      + + +  ++   +L  LL    L                    
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHL-------------------- 106

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
                      +            R L ++H   S  ++HRD+K S++ L+   + ++ D
Sbjct: 107 -----------SNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICD 152

Query: 681 FGLAKIFGNGLDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           FGLA++     D          +  Y  PE    +S   T   D++  G +L E+++ + 
Sbjct: 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNRP 211

Query: 737 PLGDDYPEEKEGNLVS---------WVRGLVRNNKGSRAIDPKIRDTGPEKQM----EEA 783
                +  ++  +++              +    +      P        +       +A
Sbjct: 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 271

Query: 784 LKIGYLCTADLPLKRPSMQQI 804
           L +        P KR  ++Q 
Sbjct: 272 LDLLDKMLTFNPHKRIEVEQA 292

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (298), Expect = 3e-30
 Identities = 44/314 (14%), Positives = 88/314 (28%), Gaps = 58/314 (18%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVP 568
           +  G  +  G FG +Y G  +  G  VA+K+    +     +   E +    ++    +P
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIP 66

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
              +C A      +   +   +L++L +                                
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNF-----------------------------CS 97

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVY---LDMNLEPRLSDFGLAK 685
              + +    +A      + ++H   S   IHRD+K  +             + DFGLAK
Sbjct: 98  RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

Query: 686 IFGNGLDEEI--------ARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
            + +    +           G+  Y             + + D+   G VL+    G  P
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHL--GIEQSRRDDLESLGYVLMYFNLGSLP 212

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
                   K           +            +    P     E       C +     
Sbjct: 213 WQGLKAATKRQKYERISEKKMSTP------IEVLCKGYP----SEFATYLNFCRSLRFDD 262

Query: 798 RPSMQQIVGLLKDI 811
           +P    +  L +++
Sbjct: 263 KPDYSYLRQLFRNL 276

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 5e-29
 Identities = 63/308 (20%), Positives = 104/308 (33%), Gaps = 53/308 (17%)

Query: 515 LLAEGKFGPVYRGFLPG-GIHVAVKVLVHGSTLTDQEAA-----RELEYLGRIKHPNLVP 568
            L EG+F  VY+         VA+K +  G     ++       RE++ L  + HPN++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
           L            ++D+ME      +                                  
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKD------------------------------NS 94

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFG 688
           L+ T        L T + L +LH      I+HRD+K +++ LD N   +L+DFGLAK FG
Sbjct: 95  LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 151

Query: 689 NGLDEEIAR-GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEEKE 747
           +       +  +  Y  PE       +     D++  G +L EL+     L  D   ++ 
Sbjct: 152 SPNRAYTHQVVTRWYRAPELLFGARMY-GVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 210

Query: 748 GNLVS---------WVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK--IGYLCTADLPL 796
             +           W       +  +    P I          + L   I  L   + P 
Sbjct: 211 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN-PC 269

Query: 797 KRPSMQQI 804
            R +  Q 
Sbjct: 270 ARITATQA 277

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 9e-29
 Identities = 57/306 (18%), Positives = 103/306 (33%), Gaps = 60/306 (19%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA------RELEYLGRIK 562
           +D G  L  G+F  V +      G+  A K +    T + +         RE+  L  I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
           HPN++ L          I I + +  G L +                 ++  E+      
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFD------------FLAEKESLTEEEATEF- 118

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPR----L 678
                                 + L  +++  S  I H D+K  ++ L     P+    +
Sbjct: 119 --------------------LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158

Query: 679 SDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL 738
            DFGLA     G + +   G+P ++ PE      +    ++D++  GV+   L++G  P 
Sbjct: 159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPF 216

Query: 739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKR 798
             D  +E   N+               A++ +  D         A           P KR
Sbjct: 217 LGDTKQETLANV--------------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 262

Query: 799 PSMQQI 804
            ++Q  
Sbjct: 263 MTIQDS 268

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  114 bits (285), Expect = 2e-28
 Identities = 40/318 (12%), Positives = 82/318 (25%), Gaps = 62/318 (19%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLV 567
           ++  G  + EG FG ++ G  L     VA+K     S     +   E      +     +
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGI 63

Query: 568 P-LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGS 626
           P +  +   G   + + D +       L                                
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDL------------------------------ 93

Query: 627 EGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP-----RLSDF 681
            G   + +     A      +  +H      +++RDIK  +  +            + DF
Sbjct: 94  CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150

Query: 682 GLAKIFGNGLDEEIAR--------GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT 733
           G+ K + + + ++           G+  Y+            + + D+   G V +  + 
Sbjct: 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLR 208

Query: 734 GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTAD 793
           G  P                     +  +                  EE  K  +     
Sbjct: 209 GSLPWQGLKAATN----------KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNL 258

Query: 794 LPLKRPSMQQIVGLLKDI 811
                P    + GL   +
Sbjct: 259 AFDATPDYDYLQGLFSKV 276

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  113 bits (284), Expect = 2e-28
 Identities = 63/317 (19%), Positives = 111/317 (35%), Gaps = 67/317 (21%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA----RELEYLGRIKHP 564
           ++ G +L  G    V+    L     VAVKVL       D        RE +    + HP
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHP 67

Query: 565 NLVPLTGYCI----AGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNS 620
            +V +         AG     + +Y++   L++++H               T +      
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----------EGPMTPKR----- 112

Query: 621 IQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSD 680
                            ++     +AL   +      IIHRD+K +++ +      ++ D
Sbjct: 113 ---------------AIEVIADACQAL---NFSHQNGIIHRDVKPANIMISATNAVKVMD 154

Query: 681 FGLAKIFGNGLDEEIAR----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           FG+A+   +  +         G+  Y+ PE A+ DS     +SDVY  G VL E++TG+ 
Sbjct: 155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEP 212

Query: 737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPL 796
           P   D P             +   +     I P  R  G    ++  +       A  P 
Sbjct: 213 PFTGDSPVS-----------VAYQHVREDPIPPSARHEGLSADLDAVVL---KALAKNPE 258

Query: 797 KRP-SMQQIVGLLKDIE 812
            R  +  +   +  D+ 
Sbjct: 259 NRYQTAAE---MRADLV 272

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-27
 Identities = 63/323 (19%), Positives = 116/323 (35%), Gaps = 56/323 (17%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTD--QEAARELEYLGRIKHP 564
           S +++   + +G FG V++      G  VA+K ++  +        A RE++ L  +KH 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 565 NLVPLTGYCIAGDQRIAIYD---YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSI 621
           N+V L   C              Y+     ++ L  L   V      S            
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE----------- 118

Query: 622 QNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDF 681
                       R    +  G       L++     I+HRD+KA++V +  +   +L+DF
Sbjct: 119 ----------IKRVMQMLLNG-------LYYIHRNKILHRDMKAANVLITRDGVLKLADF 161

Query: 682 GLAKIFGNGLDEEIAR-----GSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK 736
           GLA+ F    + +  R      +  Y PPE    + D+  P  D++  G ++ E+ T   
Sbjct: 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSP 220

Query: 737 PLGDDYPEEK-------EGNLVSWVRGLVRNNKGSRAID------PKIRDTGPEKQMEEA 783
            +  +  + +        G++   V   V N +    ++       K++D       +  
Sbjct: 221 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY 280

Query: 784 LK--IGYLCTADLPLKRPSMQQI 804
               I  L   D P +R      
Sbjct: 281 ALDLIDKLLVLD-PAQRIDSDDA 302

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-27
 Identities = 57/299 (19%), Positives = 105/299 (35%), Gaps = 57/299 (19%)

Query: 515 LLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGY 572
           +L  G  G V + F        A+K+L         +A RE+E   R  + P++V +   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 73

Query: 573 C---IAGDQRIAI-YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
                AG + + I  + ++ G L +                           IQ+ G + 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSR--------------------------IQDRGDQA 107

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP---RLSDFGLAK 685
              T R   +I      A+ +LH   S  I HRD+K  ++           +L+DFG AK
Sbjct: 108 F--TEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162

Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
              +         +P Y+ PE   P+        D++  GV++  L+ G  P   ++   
Sbjct: 163 ETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI 804
               + + +          R    +  +    +  EE   +        P +R ++ + 
Sbjct: 221 ISPGMKTRI----------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-27
 Identities = 53/243 (21%), Positives = 87/243 (35%), Gaps = 41/243 (16%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEA---ARELEYLGR-IKH 563
           +F    +L +G FG V+           A+K L     L D +      E   L    +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
           P L  +       +    + +Y+  G+L                             IQ+
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYH--------------------------IQS 96

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
                L     +  +I LG       L    S  I++RD+K  ++ LD +   +++DFG+
Sbjct: 97  CHKFDLSRATFYAAEIILG-------LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM 149

Query: 684 AKIFGNGLDEE-IARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY 742
            K    G  +     G+P YI PE             D + +GV+L E++ G+ P     
Sbjct: 150 CKENMLGDAKTNTFCGTPDYIAPEILL--GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207

Query: 743 PEE 745
            EE
Sbjct: 208 EEE 210

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (274), Expect = 4e-27
 Identities = 50/312 (16%), Positives = 104/312 (33%), Gaps = 50/312 (16%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL--VHGSTLTDQEAARELEYLGRIKHPN 565
            +++   + EG +G V++         VA+K +            A RE+  L  +KH N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 566 LVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVG 625
           +V L     +  +   ++++ +    +                + D   E          
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-----------CNGDLDPEI--------- 102

Query: 626 SEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAK 685
                    F  ++  G       L    S  ++HRD+K  ++ ++ N E +L++FGLA+
Sbjct: 103 ------VKSFLFQLLKG-------LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149

Query: 686 IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE 745
            FG  +    A     +  P      +   +   D++  G +  EL    +PL      +
Sbjct: 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209

Query: 746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK-------------IGYLCTA 792
            +   +  + G     +             P      +L              +  L   
Sbjct: 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC 269

Query: 793 DLPLKRPSMQQI 804
           + P++R S ++ 
Sbjct: 270 N-PVQRISAEEA 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 8e-27
 Identities = 55/307 (17%), Positives = 102/307 (33%), Gaps = 68/307 (22%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL------VHGSTLTDQEAARELEYLGR 560
           S +  G LL  G FG VY G  +   + VA+K +        G          E+  L +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 561 IK--HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGT 618
           +      ++ L  +    D  + I +  E                               
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF----------------------- 100

Query: 619 NSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMN-LEPR 677
             I   G+        F  ++          + H  +  ++HRDIK  ++ +D+N  E +
Sbjct: 101 --ITERGALQEELARSFFWQVLEA-------VRHCHNCGVLHRDIKDENILIDLNRGELK 151

Query: 678 LSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           L DFG   +  + +  +   G+  Y PPE+ +    +    + V+  G++L +++ G  P
Sbjct: 152 LIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIP 209

Query: 738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLK 797
              D                    +G      ++          E   +   C A  P  
Sbjct: 210 FEHDEEI----------------IRGQVFFRQRVS--------SECQHLIRWCLALRPSD 245

Query: 798 RPSMQQI 804
           RP+ ++I
Sbjct: 246 RPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-26
 Identities = 57/242 (23%), Positives = 92/242 (38%), Gaps = 40/242 (16%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIKHP 564
           +FD   LL +G FG V        G + A+K+L     +   E A    E   L   +HP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
            L  L       D+   + +Y   G L   L                             
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLS---------------------------- 97

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
             E + T  R R   A      ++ L +  S  +++RDIK  ++ LD +   +++DFGL 
Sbjct: 98  -RERVFTEERARFYGA----EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152

Query: 685 K-IFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           K    +G   +   G+P Y+ PE  + +        D +  GVV+ E++ G+ P  +   
Sbjct: 153 KEGISDGATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210

Query: 744 EE 745
           E 
Sbjct: 211 ER 212

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-25
 Identities = 57/248 (22%), Positives = 87/248 (35%), Gaps = 44/248 (17%)

Query: 509 NFDRGTLLAEGKFGPVYRGFLPG----GIHVAVKVLVHGSTLTDQEAA----RELEYLGR 560
           NF+   +L  G +G V+          G   A+KVL   + +   +       E + L  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 561 IKH-PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           I+  P LV L        +   I DY+  G L   L       + TE             
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ---RERFTEHE----------- 130

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                              + +     +  L H     II+RDIK  ++ LD N    L+
Sbjct: 131 -------------------VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 171

Query: 680 DFGLAKIFGNGLDE--EIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
           DFGL+K F     E      G+  Y+ P+  +          D +  GV++ EL+TG  P
Sbjct: 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

Query: 738 LGDDYPEE 745
              D  + 
Sbjct: 232 FTVDGEKN 239

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  103 bits (257), Expect = 1e-24
 Identities = 52/321 (16%), Positives = 108/321 (33%), Gaps = 65/321 (20%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-HPNL 566
           ++     L  GK+  V+    +     V VK+L     +  ++  RE++ L  ++  PN+
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNI 92

Query: 567 VPLTGYCIAGDQRIA--IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
           + L         R    +++++ N + + L   L                          
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT------------------------- 127

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDM-NLEPRLSDFGL 683
                               +AL + H      I+HRD+K  +V +D  + + RL D+GL
Sbjct: 128 --------DYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 176

Query: 684 AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           A+ +  G +  +   S  +  PE       +     D++  G +L  +I  K+P    + 
Sbjct: 177 AEFYHPGQEYNVRVASRYFKGPELLVDYQMY-DYSLDMWSLGCMLASMIFRKEPFFHGHD 235

Query: 744 EEKEGNLVSWVRGLVRN----NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL----- 794
              +   ++ V G        +K +  +DP+  D       +   +  +     L     
Sbjct: 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA 295

Query: 795 -----------PLKRPSMQQI 804
                         R + ++ 
Sbjct: 296 LDFLDKLLRYDHQSRLTAREA 316

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  101 bits (251), Expect = 1e-23
 Identities = 50/241 (20%), Positives = 79/241 (32%), Gaps = 41/241 (17%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAA---RELEYLGRIKHP 564
            FDR   L  G FG V        G H A+K+L     +  ++      E   L  +  P
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
            LV L            + +Y+  G + + L                             
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--------------------------- 134

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
              G  +        A        +LH   S  +I+RD+K  ++ +D     +++DFG A
Sbjct: 135 --IGRFS-EPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE 744
           K            G+P  + PE     S       D +  GV++ E+  G  P   D P 
Sbjct: 189 KRVKG--RTWTLCGTPEALAPE--IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

Query: 745 E 745
           +
Sbjct: 245 Q 245

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  101 bits (251), Expect = 2e-23
 Identities = 64/362 (17%), Positives = 117/362 (32%), Gaps = 53/362 (14%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNN 111
           L++     L + N+T   S    L  + +L      I  S+   +     L   + SNN 
Sbjct: 21  LAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQ 77

Query: 112 FSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAA 171
            +   P  + +L  L  + ++ N      P   L   + +T+  +       L +     
Sbjct: 78  LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135

Query: 172 FPKLKSLNL---------------AGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF 216
             +L S  +               +           A L ++  L+IS N      +   
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195

Query: 217 LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLS 276
           L +LE +   +NQ                + L  + L+ NQL        +   NL  L 
Sbjct: 196 LTNLESLIATNNQISDITPL------GILTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 277 LAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ-------------------- 316
           LA N+ +      +  L  L  L L    +    P   L                     
Sbjct: 248 LANNQIS--NLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305

Query: 317 LSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNN 376
           L +L  L L  N+++   P  S   L  +  ++N +S  + +  L  L  +   +  +N 
Sbjct: 306 LKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VSS--LANLTNINWLSAGHNQ 362

Query: 377 LT 378
           ++
Sbjct: 363 IS 364

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 98.2 bits (243), Expect = 2e-22
 Identities = 58/385 (15%), Positives = 125/385 (32%), Gaps = 52/385 (13%)

Query: 24  DSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNL 83
           D+        +   + ++ +V   +   L ++ +L      I ++   +  L +L  +N 
Sbjct: 18  DTALAEKMKTVLGKTNVTDTV---SQTDLDQVTTLQADRLGIKSIDG-VEYLNNLTQINF 73

Query: 84  SYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPG 143
           S N+++   P  + N   L    ++NN  +   P A  + ++   L  +       +   
Sbjct: 74  SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 144 LLNCQ------SLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT------- 190
               +      ++  +       +                 NL   E     +       
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 191 HFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVY 250
             A L ++ +L  + N          L +L+ + L  NQ +         +  + + L  
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD------IGTLASLTNLTD 245

Query: 251 VDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFT--------------------RQEFPQI 290
           +DL+ NQ+S       S    L  L L  N+ +                     ++   I
Sbjct: 246 LDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPI 303

Query: 291 GTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHN 350
             L  L +L L   ++    P  +  L+ L  L  + N ++      +  N+  +   HN
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHN 361

Query: 351 NLSGEIPASLLEKLPQMERFNFSYN 375
            +S   P   L  L ++ +   +  
Sbjct: 362 QISDLTP---LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 76.2 bits (186), Expect = 3e-15
 Identities = 42/212 (19%), Positives = 75/212 (35%), Gaps = 32/212 (15%)

Query: 15  FCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWS 74
                 +   +   ++   +A+N+ +S   P   +   + L  L L+ N +  + + L S
Sbjct: 184 SNKVSDISVLAKLTNLESLIATNNQISDITPLGIL---TNLDELSLNGNQLKDIGT-LAS 239

Query: 75  LGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIP----------------- 117
           L +L  L+L+ N+IS   P  +     L    L  N  S   P                 
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 297

Query: 118 ---AAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPK 174
              + IS+L +L  L L  N      P    +   L  +  + N+++             
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLA-NLTN 352

Query: 175 LKSLNLAGNEIKGRDTHFAGLKSITNLNISGN 206
           +  L+   N+I    T  A L  IT L ++  
Sbjct: 353 INWLSAGHNQISDL-TPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 65.0 bits (157), Expect = 1e-11
 Identities = 21/102 (20%), Positives = 45/102 (44%), Gaps = 6/102 (5%)

Query: 9   SYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITAL 68
           +    +      +   SN +++T      + +S   P   +  L+KLQ L  + N ++ +
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP---VSSLTKLQRLFFANNKVSDV 344

Query: 69  PSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNN 110
            S L +L ++  L+  +N+IS   P  + N   +    L++ 
Sbjct: 345 SS-LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 2e-06
 Identities = 31/242 (12%), Positives = 69/242 (28%), Gaps = 16/242 (6%)

Query: 146 NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISG 205
                +   L    +  ++         ++ +L      IK  D     L ++T +N S 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSID-GVEYLNNLTQINFSN 75

Query: 206 NLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN 265
           N          L  L  I + +NQ           +    +         + L      N
Sbjct: 76  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135

Query: 266 FSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTS---------LIGDIPSEILQ 316
             +  +     ++                  +   L+  +               S + +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195

Query: 317 LSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNN 376
           L++L +L  + N ++   P     NL  + ++ N L        L  L  +   + + N 
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD---IGTLASLTNLTDLDLANNQ 252

Query: 377 LT 378
           ++
Sbjct: 253 IS 254

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 3e-23
 Identities = 51/313 (16%), Positives = 98/313 (31%), Gaps = 48/313 (15%)

Query: 508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL--VHGSTLTDQEAARELEYLGRIKHP 564
           + +     +  G +G V        G  VA+K L     S L  + A REL  L  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 565 NLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNV 624
           N++ L       +      D+                                      +
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG-------------------------KL 112

Query: 625 GSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLA 684
                L        +     + L ++H   +  IIHRD+K  ++ ++ + E ++ DFGLA
Sbjct: 113 MKHEKL-GEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 168

Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE 744
           +   + +   +   +  Y  PE       + T   D++  G ++ E+ITGK         
Sbjct: 169 RQADSEMTGYV--VTRWYRAPEVILNWMRY-TQTVDIWSVGCIMAEMITGKTLFKGSDHL 225

Query: 745 EKEGNLVSWV-----RGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADL----- 794
           ++   ++          + R          K      +K     L        +L     
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285

Query: 795 ---PLKRPSMQQI 804
                +R +  + 
Sbjct: 286 VLDAEQRVTAGEA 298

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 96.6 bits (239), Expect = 2e-22
 Identities = 50/283 (17%), Positives = 99/283 (34%), Gaps = 15/283 (5%)

Query: 55  LQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSG 114
           L+ +  S+  +  +P DL        L+L  N+I+     +  N   L    L NN  S 
Sbjct: 12  LRVVQCSDLGLEKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 115 EIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPK 174
             P A + LV L  L L  N  +          Q L   +  + ++  S+ +G       
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN-QMIV 128

Query: 175 LKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHI 234
           ++            +  F G+K ++ + I+      ++      SL  + L  N+     
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVD 187

Query: 235 SQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLL 294
           +     S    + L  + LS N +S     + +   +L+ L L  N+  +     +    
Sbjct: 188 A----ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG-GLADHK 242

Query: 295 GLEHLNLSRTSLIG------DIPSEILQLSSLHTLDLSMNHLT 331
            ++ + L   ++          P    + +S   + L  N + 
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.4 bits (228), Expect = 4e-21
 Identities = 52/316 (16%), Positives = 99/316 (31%), Gaps = 33/316 (10%)

Query: 77  SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMF 136
            L+ +  S   +   +P ++       + DL NN  +        +L +L  L L  N  
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 137 QWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLK 196
               P        L  + LS NQL   LP+       +L+       +++    +     
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126

Query: 197 SITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLS 254
            +  L  +     G   G F  ++ L  I +        I Q    S      L  + L 
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS------LTELHLD 179

Query: 255 ENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEI 314
            N+++     +     NL  L L++N  +  +   +     L  L+L+   L+  +P  +
Sbjct: 180 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 238

Query: 315 LQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSY 374
                +  + L  N+++                         P     K       +   
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFC-----------------PPGYNTKKASYSGVSLFS 281

Query: 375 NNLTLCASELSPETLQ 390
           N +     E+ P T +
Sbjct: 282 NPVQYW--EIQPSTFR 295

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 90.5 bits (223), Expect = 2e-20
 Identities = 62/321 (19%), Positives = 100/321 (31%), Gaps = 36/321 (11%)

Query: 16  CSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITAL-PSDLWS 74
           C  R V C            S+ GL   VP            LDL  N IT +   D  +
Sbjct: 10  CHLRVVQC------------SDLGLE-KVPK---DLPPDTALLDLQNNKITEIKDGDFKN 53

Query: 75  LGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGN 134
           L +L +L L  N+IS   P        LE   LS N           +L  LRV + +  
Sbjct: 54  LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEIT 113

Query: 135 MFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAG 194
             + S+  GL     +  +  +  + +G     F     KL  + +A   I         
Sbjct: 114 KVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQ-GMKKLSYIRIADTNITTIPQGL-- 169

Query: 195 LKSITNLNISGNLFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVD 252
             S+T L++ GN            L +L  + L  N            S  N   L  + 
Sbjct: 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV----DNGSLANTPHLRELH 225

Query: 253 LSENQLSGEIFHNFSQAQNLKHLSLAYNRFTR------QEFPQIGTLLGLEHLNLSRTSL 306
           L+ N+L           + ++ + L  N  +                     ++L    +
Sbjct: 226 LNNNKLVKVPGGLADH-KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284

Query: 307 -IGDIPSEILQ-LSSLHTLDL 325
              +I     + +     + L
Sbjct: 285 QYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 40.4 bits (93), Expect = 6e-04
 Identities = 15/87 (17%), Positives = 25/87 (28%), Gaps = 7/87 (8%)

Query: 10  YFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALP 69
               SF S   V   S            +          +     +Q + L  NNI+A+ 
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIG 258

Query: 70  SD-------LWSLGSLKSLNLSYNRIS 89
           S+            S   ++L  N + 
Sbjct: 259 SNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.9 bits (232), Expect = 3e-21
 Identities = 55/329 (16%), Positives = 92/329 (27%), Gaps = 71/329 (21%)

Query: 509 NFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL--VHGSTLTDQEAARELEYLGRIKHPN 565
            +     +  G  G V   +      +VA+K L     +    + A REL  +  + H N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 566 LVPLTGYCIA------GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTN 619
           ++ L                  + + M+    Q +  +L                     
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------------------- 117

Query: 620 SIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLS 679
                              +       +  LH      IIHRD+K S++ +  +   ++ 
Sbjct: 118 -------------HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 161

Query: 680 DFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG 739
           DFGLA+  G          +  Y  PE             D++  G ++ E++  K    
Sbjct: 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGEMVRHKILFP 219

Query: 740 DD---------------YPEEKEGNLVSWVRGLVRNNKGSRAID-PKIRDTGPEKQMEEA 783
                               E    L   VR  V N      +  PK+          E 
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279

Query: 784 LKIGYLCTADL--------PLKRPSMQQI 804
            K+      DL        P KR S+   
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDDA 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.3 bits (223), Expect = 4e-20
 Identities = 58/315 (18%), Positives = 97/315 (30%), Gaps = 50/315 (15%)

Query: 507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVL--VHGSTLTDQEAARELEYLGRIKH 563
              +   + +  G +G V   F    G+ VAVK L     S +  +   REL  L  +KH
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 564 PNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQN 623
            N++ L              D                 V        +   +        
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYL--------------VTHLMGADLNNIVKCQKL---- 118

Query: 624 VGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGL 683
                   T      +     R L ++H   S  IIHRD+K S++ ++ + E ++ DFGL
Sbjct: 119 --------TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167

Query: 684 AKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP 743
           A+   +  +      +  Y  PE    +        D++  G ++ EL+TG+        
Sbjct: 168 ARHTDD--EMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224

Query: 744 EE------------KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALK--IGYL 789
            +                L        RN   S    PK+                +  +
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 284

Query: 790 CTADLPLKRPSMQQI 804
              D   KR +  Q 
Sbjct: 285 LVLD-SDKRITAAQA 298

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 86.7 bits (213), Expect = 4e-19
 Identities = 59/291 (20%), Positives = 120/291 (41%), Gaps = 31/291 (10%)

Query: 16  CSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT---ALPSDL 72
            +W GV+CD++                        +  ++ +LDLS  N+     +PS L
Sbjct: 36  RTWLGVLCDTD-----------------------TQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 73  WSLGSLKSLNLSYN-RISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKL 131
            +L  L  L +     + G +P  I     L    +++ N SG IP  +S + +L  L  
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 132 DGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTH 191
             N    ++PP + +  +LV +    N+++G++PD +G+      S+ ++ N + G+   
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192

Query: 192 FAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYV 251
                ++  +++S N+ +G    +F       + +      +              L  +
Sbjct: 193 TFANLNLAFVDLSRNMLEGDASVLF---GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL 249

Query: 252 DLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLS 302
           DL  N++ G +    +Q + L  L++++N     E PQ G L   +    +
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC-GEIPQGGNLQRFDVSAYA 299

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 82.1 bits (201), Expect = 1e-17
 Identities = 41/268 (15%), Positives = 85/268 (31%), Gaps = 7/268 (2%)

Query: 94  SNIGNFGLLEVFDLSNNNFSG--EIPAAISSLVSLRVLKLDGNM-FQWSIPPGLLNCQSL 150
                   +   DLS  N      IP+++++L  L  L + G       IPP +     L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 151 VTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQG 210
             + ++   ++G++PD        +                 + L ++  +   GN   G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 211 SVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQ 270
           ++            L ++                 +  +        +          + 
Sbjct: 164 AIPD---SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD 220

Query: 271 NLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHL 330
                          +  ++G    L  L+L    + G +P  + QL  LH+L++S N+L
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280

Query: 331 TGQIPTVSA-KNLGIIDMSHNNLSGEIP 357
            G+IP     +   +   ++N      P
Sbjct: 281 CGEIPQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 61.7 bits (148), Expect = 8e-11
 Identities = 19/60 (31%), Positives = 25/60 (41%), Gaps = 1/60 (1%)

Query: 82  NLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIP 141
           +L  NRI G+LP  +     L   ++S NN  GEIP    +L    V     N      P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.4 bits (142), Expect = 4e-10
 Identities = 22/60 (36%), Positives = 28/60 (46%), Gaps = 2/60 (3%)

Query: 59  DLSENNIT-ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIP 117
           DL  N I   LP  L  L  L SLN+S+N + G +P   GN    +V   +NN      P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 53.2 bits (126), Expect = 5e-08
 Identities = 13/79 (16%), Positives = 29/79 (36%), Gaps = 1/79 (1%)

Query: 15  FCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWS 74
                 +      +++      N+ + G++P   + +L  L SL++S NN+        +
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQG-LTQLKFLHSLNVSFNNLCGEIPQGGN 289

Query: 75  LGSLKSLNLSYNRISGSLP 93
           L        + N+     P
Sbjct: 290 LQRFDVSAYANNKCLCGSP 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 87.0 bits (214), Expect = 6e-19
 Identities = 38/233 (16%), Positives = 76/233 (32%), Gaps = 24/233 (10%)

Query: 510 FDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVP 568
           +     L  G F  V+    +    HVA+K++  G  +  + A  E++ L R+   +   
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 569 LTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEG 628
                   +  + + D+  +     +   +   V      +     E             
Sbjct: 74  EDSMGA--NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP-------- 123

Query: 629 LLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEP----RLSDFGLA 684
                 +  +I+      L ++H  C   IIH DIK  +V +++   P    ++    L 
Sbjct: 124 ----LIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG 177

Query: 685 KIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP 737
                      +  +  Y  PE            +D++    ++ ELITG   
Sbjct: 178 NACWYDEHYTNSIQTREYRSPEVLLGAPW--GCGADIWSTACLIFELITGDFL 228

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.1 bits (206), Expect = 2e-18
 Identities = 50/279 (17%), Positives = 96/279 (34%), Gaps = 12/279 (4%)

Query: 79  KSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQW 138
            + +     +  ++P  I      +   L  N  S    A+  +  +L +L L  N+   
Sbjct: 14  VTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70

Query: 139 SIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKS 197
                      L  +DLS N    S+         +L +L+L    ++      F GL +
Sbjct: 71  IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130

Query: 198 ITNLNISGNLFQGSVMGVFLE--SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSE 255
           +  L +  N  Q      F +  +L  + L  N+           +      L  + L +
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP----ERAFRGLHSLDRLLLHQ 186

Query: 256 NQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEIL 315
           N+++    H F     L  L L  N  +      +  L  L++L L+    + D  +  L
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL 246

Query: 316 QLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSG 354
             + L     S + +   +P        +  ++ N+L G
Sbjct: 247 -WAWLQKFRGSSSEVPCSLPQ-RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.1 bits (193), Expect = 1e-16
 Identities = 57/301 (18%), Positives = 96/301 (31%), Gaps = 57/301 (18%)

Query: 57  SLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEI 116
           +    +  + A+P  + +  + + + L  NRIS    ++      L +  L +N  +   
Sbjct: 15  TTSCPQQGLQAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 117 -------------------------PAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLV 151
                                    PA    L  L  L LD    Q   P       +L 
Sbjct: 73  AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132

Query: 152 TVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGS 211
            + L  N L     D F      L  L L GN I                 +    F+G 
Sbjct: 133 YLYLQDNALQALPDDTFR-DLGNLTHLFLHGNRISS---------------VPERAFRG- 175

Query: 212 VMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQN 271
                L SL+ + L  N     ++ V  ++  +  RL+ + L  N LS       +  + 
Sbjct: 176 -----LHSLDRLLLHQN----RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226

Query: 272 LKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLT 331
           L++L L  N +   +         L+    S + +   +P     L+      L+ N L 
Sbjct: 227 LQYLRLNDNPW-VCDCRARPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQ 282

Query: 332 G 332
           G
Sbjct: 283 G 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 2e-08
 Identities = 38/158 (24%), Positives = 55/158 (34%), Gaps = 5/158 (3%)

Query: 54  KLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNF 112
            LQ L L +N + ALP D    LG+L  L L  NRIS            L+   L  N  
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189

Query: 113 SGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAF 172
           +   P A   L  L  L L  N         L   ++L  + L+ N             +
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLW 247

Query: 173 PKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQG 210
             L+    + +E+    +    L       ++ N  QG
Sbjct: 248 AWLQKFRGSSSEVPC--SLPQRLAGRDLKRLAANDLQG 283

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 73.3 bits (179), Expect = 2e-15
 Identities = 34/228 (14%), Positives = 58/228 (25%), Gaps = 51/228 (22%)

Query: 513 GTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGST----------LTDQEAARELEYLGRIK 562
           G L+ EGK   V+  +        VK    G T            D   +       R +
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 563 HPNLVPLTGYCIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQ 622
              L  L G  +       +Y +  N  L              E                
Sbjct: 65  FRALQKLQGLAV-----PKVYAWEGNAVL-------------MELIDAKELYRV------ 100

Query: 623 NVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSVYLDMNLEPRLSDFG 682
                          ++       +A  +H     I+H D+   +V +       + DF 
Sbjct: 101 ---------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFP 147

Query: 683 LAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE 730
            +   G     EI       I   F++        + D+      +L+
Sbjct: 148 QSVEVGEEGWREILERDVRNIITYFSRTYR----TEKDINSAIDRILQ 191

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 71.4 bits (173), Expect = 9e-14
 Identities = 57/319 (17%), Positives = 98/319 (30%), Gaps = 21/319 (6%)

Query: 53  SKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNF 112
            +   L+L+   +++LP        L+SL  S N ++  LP    +   L V + +    
Sbjct: 38  RQAHELELNNLGLSSLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93

Query: 113 SGEIPAAISSLVSLRVLKLDGNM-----FQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDG 167
           S   P      VS   L+    +      +          +             G+    
Sbjct: 94  SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153

Query: 168 FGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRS 227
                  L  L     +            S+ ++    N+ +       L  L  I   +
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213

Query: 228 NQFQGHISQVQFNSSYNWSRLVYVDLSE----NQLSGEIFHNFSQAQNLKHLSLAYNRFT 283
           N  +          + N       DL E            + FS    L       N  +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273

Query: 284 RQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLG 343
            +          LE LN+S   LI ++P+       L  L  S NHL  ++P    +NL 
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE-LPQNLK 327

Query: 344 IIDMSHNNLSG--EIPASL 360
            + + +N L    +IP S+
Sbjct: 328 QLHVEYNPLREFPDIPESV 346

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 68.3 bits (165), Expect = 8e-13
 Identities = 19/77 (24%), Positives = 33/77 (42%), Gaps = 8/77 (10%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNN 111
              L+ L++S N +  LP+       L+ L  S+N ++  +P    N   L+   +  N 
Sbjct: 283 PPSLEELNVSNNKLIELPA---LPPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNP 335

Query: 112 FSGEIPAAISSLVSLRV 128
              E P    S+  LR+
Sbjct: 336 LR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 53.3 bits (126), Expect = 5e-08
 Identities = 19/78 (24%), Positives = 34/78 (43%), Gaps = 9/78 (11%)

Query: 73  WSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLD 132
               SL+ LN+S N++   LP+       LE    S N+ + E+P       +L+ L ++
Sbjct: 281 DLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP---ELPQNLKQLHVE 332

Query: 133 GNMFQWSIPPGLLNCQSL 150
            N  +   P    + + L
Sbjct: 333 YNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 22/99 (22%), Positives = 32/99 (32%), Gaps = 13/99 (13%)

Query: 82  NLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIP 141
               N  S  + S       LE  ++SNN    E+PA       L  L    N     +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP 320

Query: 142 PGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNL 180
               N + L    +  N L    PD        ++ L +
Sbjct: 321 ELPQNLKQL---HVEYNPLR-EFPDIPE----SVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.3 bits (113), Expect = 2e-06
 Identities = 49/302 (16%), Positives = 86/302 (28%), Gaps = 23/302 (7%)

Query: 77  SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMF 136
               L L+   +S SLP    +   LE    S N+ + E+P    SL SL V   +    
Sbjct: 39  QAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93

Query: 137 QWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLK 196
               P       S   ++                       L +   +            
Sbjct: 94  SDLPPLLEYLGVSNNQLEKLPE-------------LQNSSFLKIIDVDNNSLKKLPDLPP 140

Query: 197 SITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSEN 256
           S+  +    N  +       L  L  I   +N  +          S      +  +L E 
Sbjct: 141 SLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPEL 200

Query: 257 QLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ 316
           Q    +   ++    LK L                     E         + +     L 
Sbjct: 201 QNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLS 260

Query: 317 LSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNN 376
               +   L+ +    +       +L  +++S+N L  E+PA      P++ER   S+N+
Sbjct: 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP----PRLERLIASFNH 315

Query: 377 LT 378
           L 
Sbjct: 316 LA 317

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 2e-04
 Identities = 22/95 (23%), Positives = 37/95 (38%), Gaps = 12/95 (12%)

Query: 134 NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFA 193
           N     I        SL  +++S N+L   LP       P+L+ L  + N +        
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP----PRLERLIASFNHLAEVPEL-- 322

Query: 194 GLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSN 228
             +++  L++  N  +        ES+E  DLR N
Sbjct: 323 -PQNLKQLHVEYNPLRE--FPDIPESVE--DLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.2 bits (92), Expect = 7e-04
 Identities = 23/87 (26%), Positives = 35/87 (40%), Gaps = 16/87 (18%)

Query: 216 FLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHL 275
              SLE +++ +N+                 RL  +  S N L+ E+       QNLK L
Sbjct: 282 LPPSLEELNVSNNKLI--------ELPALPPRLERLIASFNHLA-EVPELP---QNLKQL 329

Query: 276 SLAYNRFTRQEFPQIGTLLGLEHLNLS 302
            + YN     EFP I     +E L ++
Sbjct: 330 HVEYNPLR--EFPDI--PESVEDLRMN 352

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.5 bits (158), Expect = 3e-12
 Identities = 48/293 (16%), Positives = 98/293 (33%), Gaps = 24/293 (8%)

Query: 56  QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGE 115
           Q+LDL+  N+    +       + +     + +   L  +   F  ++  DLSN+     
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61

Query: 116 -IPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPK 174
            +   +S    L+ L L+G      I   L    +LV   L+++  +G            
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVR--LNLSGCSGFSEFALQTLLSS 119

Query: 175 LKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHI 234
              L+          T      ++ +++ +                    L   +     
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLN---------------LSGYRKNLQK 164

Query: 235 SQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAY-NRFTRQEFPQIGTL 293
           S +        + +         L  + F  F Q   L+HLSL+       +   ++G +
Sbjct: 165 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224

Query: 294 LGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTG-QIPTVSAKNLGII 345
             L+ L +    ++ D   ++L   +L  L ++ +H T    PT+  K    I
Sbjct: 225 PTLKTLQVF--GIVPDGTLQLL-KEALPHLQINCSHFTTIARPTIGNKKNQEI 274

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 5e-08
 Identities = 40/240 (16%), Positives = 83/240 (34%), Gaps = 39/240 (16%)

Query: 27  KQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT--ALPSDLWSLGSLKSLNLS 84
            Q V  F    S +   + +       ++Q +DLS + I    L   L     L++L+L 
Sbjct: 22  SQGVIAFRCPRSFMDQPLAEH--FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79

Query: 85  YNRISGSLPSNIGNFGLLEVFDLS--NNNFSGEIPAAISSLVSLRVLK------------ 130
             R+S  + + +     L   +LS  +      +   +SS   L  L             
Sbjct: 80  GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 139

Query: 131 ------------------LDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAF 172
                                N+ +  +   +  C +LV +DLS + +  +         
Sbjct: 140 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 199

Query: 173 PKLKSLNLAGNEIKGRDT--HFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQF 230
             L+ L+L+       +T      + ++  L + G +  G++  +  E+L  + +  + F
Sbjct: 200 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ-LLKEALPHLQINCSHF 258

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 60.1 bits (145), Expect = 2e-11
 Identities = 31/126 (24%), Positives = 57/126 (45%), Gaps = 7/126 (5%)

Query: 56  QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGE 115
           + L L+  ++T L   L  L  +  L+LS+NR+    P+ +     LEV     ++ + E
Sbjct: 1   RVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNALE 56

Query: 116 IPAAISSLVSLRVLKLDGNMFQ-WSIPPGLLNCQSLVTVDLSMNQLNG--SLPDGFGAAF 172
               +++L  L+ L L  N  Q  +    L++C  LV ++L  N L     + +      
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 173 PKLKSL 178
           P + S+
Sbjct: 117 PSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 59.0 bits (142), Expect = 4e-11
 Identities = 28/120 (23%), Positives = 50/120 (41%), Gaps = 5/120 (4%)

Query: 79  KSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQW 138
           + L+L++  ++     ++    L+   DLS+N      PA +++L  L VL    +    
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNAL 55

Query: 139 SIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSI 198
               G+ N   L  + L  N+L  S       + P+L  LNL GN +   +     L  +
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.3 bits (130), Expect = 1e-09
 Identities = 26/106 (24%), Positives = 40/106 (37%), Gaps = 3/106 (2%)

Query: 273 KHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTG 332
           + L LA+   T      +  LL + HL+LS   L    P+ +  L  L  L  S N L  
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57

Query: 333 QIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
                +   L  + + +N L        L   P++   N   N+L 
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 2e-05
 Identities = 25/123 (20%), Positives = 46/123 (37%), Gaps = 6/123 (4%)

Query: 154 DLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVM 213
            L+   L  ++          +  L+L+ N ++      A L+ +  L  S N  +    
Sbjct: 4   HLAHKDL--TVLCHLEQ-LLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 214 GVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLK 273
              L  L+ + L +N+ Q   +        +  RLV ++L  N L  E       A+ L 
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLV---SCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117

Query: 274 HLS 276
            +S
Sbjct: 118 SVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.6 bits (97), Expect = 4e-05
 Identities = 19/104 (18%), Positives = 31/104 (29%), Gaps = 26/104 (25%)

Query: 252 DLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGL--------------- 296
            L+   L+  +  +  Q   + HL L++NR      P +  L  L               
Sbjct: 4   HLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVDG 60

Query: 297 -------EHLNLSRTSLIG-DIPSEILQLSSLHTLDLSMNHLTG 332
                  + L L    L        ++    L  L+L  N L  
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.7 bits (150), Expect = 7e-11
 Identities = 23/91 (25%), Positives = 43/91 (47%), Gaps = 14/91 (15%)

Query: 53  SKLQSLDLSENNIT-----ALPSDLWSLGSLKSLNLSYNRISGSLPSNIG-----NFGLL 102
           S L+ L L++ +++     +L + L +  SL+ L+LS N +  +    +         LL
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 103 EVFDLSNNNFSGEIPAAISSLV----SLRVL 129
           E   L +  +S E+   + +L     SLRV+
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.7 bits (137), Expect = 3e-09
 Identities = 13/95 (13%), Positives = 29/95 (30%), Gaps = 11/95 (11%)

Query: 55  LQSLDLSENNIT--ALPSDLWSLGSLKSLNLSYNRISG----SLPSNIGNFGLLEVFDLS 108
           +QSLD+    ++       L  L   + + L    ++      + S +     L   +L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 109 NNNFSGEIPAAISSLV-----SLRVLKLDGNMFQW 138
           +N         +   +      ++ L L       
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.5 bits (134), Expect = 6e-09
 Identities = 16/91 (17%), Positives = 31/91 (34%), Gaps = 9/91 (9%)

Query: 102 LEVFDLSNNNFSGE-IPAAISSLVSLRVLKLDGNMFQW----SIPPGLLNCQSLVTVDLS 156
           ++  D+     S       +  L   +V++LD           I   L    +L  ++L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 157 MNQLNG----SLPDGFGAAFPKLKSLNLAGN 183
            N+L       +  G      K++ L+L   
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 9e-07
 Identities = 16/88 (18%), Positives = 30/88 (34%), Gaps = 5/88 (5%)

Query: 271 NLKHLSLAYNRFTRQEFPQIGTLL-GLEHLNLSRTSL----IGDIPSEILQLSSLHTLDL 325
           +++ L +     +   + ++  LL   + + L    L      DI S +    +L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 326 SMNHLTGQIPTVSAKNLGIIDMSHNNLS 353
             N L         + L         LS
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLS 90

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 9e-07
 Identities = 15/87 (17%), Positives = 27/87 (31%), Gaps = 10/87 (11%)

Query: 36  SNSGLSGSVPDTTIGKLSKLQSLDLSENNIT-----ALPSDLWSLGSLKSLNLSYNRISG 90
               LS +     +  L + Q + L +  +T      + S L    +L  LNL  N +  
Sbjct: 10  QCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGD 69

Query: 91  SLPSNIG-----NFGLLEVFDLSNNNF 112
                +          ++   L N   
Sbjct: 70  VGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 17/92 (18%), Positives = 27/92 (29%), Gaps = 10/92 (10%)

Query: 248 LVYVDLSENQLSGEIF-HNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLG----LEHLNLS 302
           +  +D+   +LS   +       Q  + + L     T      I + L     L  LNL 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 303 RTSLIGDIPSEILQL-----SSLHTLDLSMNH 329
              L       +LQ        +  L L    
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 4e-06
 Identities = 14/83 (16%), Positives = 28/83 (33%), Gaps = 9/83 (10%)

Query: 244 NWSRLVYVDLSENQLSGEIFHNFSQA----QNLKHLSLAYNRFTRQEFPQIGTLL----- 294
             S L  + L++  +S     + +       +L+ L L+ N        Q+   +     
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 295 GLEHLNLSRTSLIGDIPSEILQL 317
            LE L L       ++   +  L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 7e-06
 Identities = 14/79 (17%), Positives = 26/79 (32%), Gaps = 7/79 (8%)

Query: 294 LGLEHLNLSRTSLIGDIPSEIL-QLSSLHTLDLSMNHLTGQIPTV------SAKNLGIID 346
           L ++ L++    L     +E+L  L     + L    LT                L  ++
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 347 MSHNNLSGEIPASLLEKLP 365
           +  N L       +L+ L 
Sbjct: 62  LRSNELGDVGVHCVLQGLQ 80

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 8e-06
 Identities = 17/85 (20%), Positives = 25/85 (29%), Gaps = 9/85 (10%)

Query: 69  PSDLWSLGSLKSLNLSYNRISG----SLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLV 124
                    L+ L L+   +S     SL + +     L   DLSNN         +   V
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 125 -----SLRVLKLDGNMFQWSIPPGL 144
                 L  L L    +   +   L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 15/138 (10%), Positives = 42/138 (30%), Gaps = 12/138 (8%)

Query: 149 SLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRD-----THFAGLKSITNLNI 203
            + ++D+   +L+ +          + + + L    +         +      ++  LN+
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 204 SGNLFQGSVMGVFLE-------SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSEN 256
             N      +   L+        ++ + L++    G    V  ++      L  + LS+N
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122

Query: 257 QLSGEIFHNFSQAQNLKH 274
            L         +      
Sbjct: 123 LLGDAGLQLLCEGLLDPQ 140

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 17/85 (20%), Positives = 28/85 (32%), Gaps = 14/85 (16%)

Query: 296 LEHLNLSRTSL----IGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAK-------NLGI 344
           L  L L+   +       + + +L   SL  LDLS N L         +        L  
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 345 IDMSHNNLSGEIP---ASLLEKLPQ 366
           + +     S E+     +L +  P 
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPS 455

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 5e-05
 Identities = 15/99 (15%), Positives = 30/99 (30%), Gaps = 13/99 (13%)

Query: 264 HNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLG----LEHLNLSRTSLIGDIPSEILQ--- 316
                   L+ L LA    +      +   L     L  L+LS   L      ++++   
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422

Query: 317 --LSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLS 353
                L  L L   + + ++       L  ++    +L 
Sbjct: 423 QPGCLLEQLVLYDIYWSEEME----DRLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 16/92 (17%), Positives = 29/92 (31%), Gaps = 24/92 (26%)

Query: 98  NFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSM 157
              +L V  L++ + S    +++++                     LL   SL  +DLS 
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAA--------------------TLLANHSLRELDLSN 406

Query: 158 NQLNGSLPDGFGAAFP----KLKSLNLAGNEI 185
           N L  +       +       L+ L L     
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 438

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 13/92 (14%), Positives = 26/92 (28%), Gaps = 7/92 (7%)

Query: 219 SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQA----QNLKH 274
            ++ +D++  +                     V L +  L+     + S A      L  
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQ---CQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 275 LSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSL 306
           L+L  N         +   L      + + SL
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 10/66 (15%), Positives = 21/66 (31%), Gaps = 6/66 (9%)

Query: 319 SLHTLDLSMNHLTGQIPTVSA---KNLGIIDMSHNNLSGEIP---ASLLEKLPQMERFNF 372
            + +LD+    L+           +   ++ +    L+       +S L   P +   N 
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 373 SYNNLT 378
             N L 
Sbjct: 63  RSNELG 68

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 2e-04
 Identities = 15/96 (15%), Positives = 28/96 (29%), Gaps = 5/96 (5%)

Query: 204 SGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIF 263
           +G       +G     L V+ L               +      L  +DLS N L     
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414

Query: 264 HNFSQA-----QNLKHLSLAYNRFTRQEFPQIGTLL 294
               ++       L+ L L    ++ +   ++  L 
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 8e-04
 Identities = 14/71 (19%), Positives = 27/71 (38%), Gaps = 10/71 (14%)

Query: 318 SSLHTLDLSMNHLTGQIPTVSA------KNLGIIDMSHNNLSGEIPASLLEKLPQ----M 367
           S L  L L+   ++    +  A       +L  +D+S+N L       L+E + Q    +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 368 ERFNFSYNNLT 378
           E+        +
Sbjct: 429 EQLVLYDIYWS 439

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 8e-04
 Identities = 16/94 (17%), Positives = 30/94 (31%), Gaps = 8/94 (8%)

Query: 197 SITNLNISGN-LFQGSVMGVF--LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDL 253
            I +L+I    L       +   L+  +V+ L          +   ++      L  ++L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 254 SENQLSGEIFHNFSQA-----QNLKHLSLAYNRF 282
             N+L     H   Q        ++ LSL     
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.9 bits (146), Expect = 1e-10
 Identities = 30/210 (14%), Positives = 54/210 (25%), Gaps = 11/210 (5%)

Query: 74  SLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG 133
            + S   +N     ++ +LP ++       +  LS N       A +     L  L LD 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 134 -NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHF 192
             + +  +   L    +L      +  L              +    L    +       
Sbjct: 65  AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124

Query: 193 AGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVD 252
              +     N    L  G +          +   +N      +            L  + 
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLA--NNNLTELPA----GLLNGLENLDTLL 178

Query: 253 LSENQLSGEIFHNFSQAQNLKHLSLAYNRF 282
           L EN L   I   F  +  L    L  N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.7 bits (143), Expect = 2e-10
 Identities = 35/216 (16%), Positives = 65/216 (30%), Gaps = 12/216 (5%)

Query: 45  PDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEV 104
           P   + K++    ++  + N+TALP DL        L+LS N +     + +  +  L  
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 105 FDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSL 164
            +L     +         ++    L  +       +   L     L      +  L    
Sbjct: 60  LNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 165 PDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVF--LESLEV 222
             G G         N       G  T       +  L+++ N       G+   LE+L+ 
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPT---PKLEKLSLANNNLTELPAGLLNGLENLDT 176

Query: 223 IDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQL 258
           + L+ N              +    L +  L  N  
Sbjct: 177 LLLQENSLYTIPKGF-----FGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 7e-05
 Identities = 11/44 (25%), Positives = 18/44 (40%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYN 86
            +P   +  L  L +L L EN++  +P   +    L    L  N
Sbjct: 162 ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.9 bits (89), Expect = 0.002
 Identities = 12/64 (18%), Positives = 27/64 (42%), Gaps = 2/64 (3%)

Query: 313 EILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNF 372
           E+ +++S   ++    +LT  +P    K+  I+ +S N L      + L    ++ + N 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYT-FSLATLMPYTRLTQLNL 62

Query: 373 SYNN 376
               
Sbjct: 63  DRAE 66

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 57.6 bits (137), Expect = 2e-09
 Identities = 43/329 (13%), Positives = 94/329 (28%), Gaps = 29/329 (8%)

Query: 54  KLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISG----SLPSNIGNFGLLEVFDLSN 109
            L+   ++  +  ++ + L    S+K + LS N I       L  NI +   LE+ + S+
Sbjct: 9   SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 110 N---NFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPD 166
                   EIP A+  L+   +     +  + S        Q  +   LS +     L  
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 167 GFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLE-------- 218
                 P+  +      +    +        + ++    N  +   M  + +        
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 219 ---SLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHL 275
               +    +R    +  + +            +  +   +  S  +        NL+ L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 276 SLAYNRFTRQEFPQIGTLLG------LEHLNLSRTSLIGDIPSEILQ-----LSSLHTLD 324
            L     + +    +           L+ L L    +  D    +       +  L  L+
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 325 LSMNHLTGQIPTVSAKNLGIIDMSHNNLS 353
           L+ N  + +   V              L 
Sbjct: 309 LNGNRFSEEDDVVDEIREVFSTRGRGELD 337

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 44/302 (14%), Positives = 89/302 (29%), Gaps = 31/302 (10%)

Query: 49  IGKLSKLQSLDLSENNIT-----ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLE 103
           + +   ++ + LS N I       L  ++ S   L+    S                LL 
Sbjct: 27  LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 86

Query: 104 VFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLS--MNQLN 161
              L          +  +   + +   +D       +    L+   L     +     L 
Sbjct: 87  QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ 146

Query: 162 GSLPDGFGAAFPKLKSLNLAGNEI-----KGRDTHFAGLKSITNLNISGNLFQGSVMGVF 216
               +      P L+S+    N +     K     F   + +  + +  N  +   +   
Sbjct: 147 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL 206

Query: 217 -------LESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQA 269
                   + L+V+DL+ N F    S     +  +W  L  + L++  LS         A
Sbjct: 207 LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 266

Query: 270 ------QNLKHLSLAYNRFTRQEFPQIGTLLG-----LEHLNLSRTSLIGDIPSEILQLS 318
                   L+ L L YN         + T++      L  L L+      +    + ++ 
Sbjct: 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR-FSEEDDVVDEIR 325

Query: 319 SL 320
            +
Sbjct: 326 EV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.9 bits (99), Expect = 9e-05
 Identities = 27/307 (8%), Positives = 70/307 (22%), Gaps = 31/307 (10%)

Query: 102 LEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQ----WSIPPGLLNCQSLVTVDLSM 157
           L++  ++  +    + A +    S++ + L GN         +   + + + L   + S 
Sbjct: 10  LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 158 NQLNGSLPDG------FGAAFPKLKSLNLAGNEIKG----RDTHFAGLKSITNLNISGNL 207
                   +          A  K   L+                     S         L
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 208 FQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFS 267
               +       +          +   +     S       +     +        H   
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 268 QAQNLKHLSLAYNRFTRQEFPQIGTLLGL----EHLNLSRTSLIGDIPSEILQLSSLHTL 323
               +    +            +     L       N         +   +    +L  L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 324 DLSMNHLTGQIPTVSAK--------NLGIIDMSHNNLSGE----IPASLLEKLPQMERFN 371
            L+   L+ +                L  + + +N +  +    +   + EK+P +    
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 372 FSYNNLT 378
            + N  +
Sbjct: 309 LNGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 7e-04
 Identities = 21/108 (19%), Positives = 35/108 (32%), Gaps = 9/108 (8%)

Query: 15  FCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNIT-----ALP 69
                    +  +  + D L S  G +  V   +  +   LQ+L L  N I       L 
Sbjct: 235 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 294

Query: 70  SDLWS-LGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEI 116
           + +   +  L  L L+ NR        +    + EVF         E+
Sbjct: 295 TVIDEKMPDLLFLELNGNRF-SEEDDVVDE--IREVFSTRGRGELDEL 339

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.3 bits (124), Expect = 5e-08
 Identities = 27/216 (12%), Positives = 63/216 (29%), Gaps = 18/216 (8%)

Query: 146 NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISG 205
              + + +    + +  ++     A    + +L+  G  +   +     L ++  L +  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQ---ADLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKD 72

Query: 206 NLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGE---- 261
           N          L  +  ++L  N  +   +     S                L+G     
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 262 --------IFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSE 313
                   I +    A       L+       +   +  L  L  L      +    P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 314 ILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSH 349
           +  L +L  + L  N ++   P  +  NL I+ +++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.2 bits (121), Expect = 1e-07
 Identities = 28/251 (11%), Positives = 71/251 (28%), Gaps = 43/251 (17%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNN 111
           L+    +   ++N+T   +    L  + +L+     ++                 +    
Sbjct: 18  LANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVT----------------TIEG-- 58

Query: 112 FSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAA 171
                   +  L +L  L+L  N      P   L   + + +  +  +            
Sbjct: 59  --------VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLK------------ 98

Query: 172 FPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQ 231
                +   +   +    T    +  +  L+    L+        +  L  +        
Sbjct: 99  NVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSI 158

Query: 232 GHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIG 291
           G+          N S+L  +   +N++S       +   NL  + L  N+ +  +   + 
Sbjct: 159 GNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQIS--DVSPLA 214

Query: 292 TLLGLEHLNLS 302
               L  + L+
Sbjct: 215 NTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 7e-06
 Identities = 32/219 (14%), Positives = 61/219 (27%), Gaps = 19/219 (8%)

Query: 24  DSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNL 83
           D    +     A  S ++ +V   T   L  + +L      +T +   +  L +L  L L
Sbjct: 15  DPALANAIKIAAGKSNVTDTV---TQADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLEL 70

Query: 84  SYNRI----------SGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG 133
             N+I            +     GN            +       +        +  L  
Sbjct: 71  KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 134 NMFQWSIPPGLLNCQSLVTVDLSMN---QLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT 190
               +     + N   L  +                   A   KL +L    N+I     
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS- 189

Query: 191 HFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQ 229
             A L ++  +++  N            +L ++ L +NQ
Sbjct: 190 PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTL-TNQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 15/75 (20%), Positives = 29/75 (38%), Gaps = 4/75 (5%)

Query: 10  YFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALP 69
           Y S        +   +N   +T   A ++ +S   P   +  L  L  + L  N I+ + 
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP---LASLPNLIEVHLKNNQISDVS 211

Query: 70  SDLWSLGSLKSLNLS 84
             L +  +L  + L+
Sbjct: 212 P-LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 31/219 (14%), Positives = 61/219 (27%), Gaps = 19/219 (8%)

Query: 160 LNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLES 219
           +N   PD    A      +    + +    T  A L  IT L+  G          +L +
Sbjct: 9   INVIFPD---PALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTIEGVQYLNN 64

Query: 220 LEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAY 279
           L  ++L+ NQ                        + + ++G          + +   +  
Sbjct: 65  LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124

Query: 280 NRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSA 339
                                L          S +  L++L  L +    ++   P  + 
Sbjct: 125 LAGLSN------------LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANL 172

Query: 340 KNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLT 378
             L  +    N +S   P   L  LP +   +   N ++
Sbjct: 173 SKLTTLKADDNKISDISP---LASLPNLIEVHLKNNQIS 208

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.2 bits (123), Expect = 6e-08
 Identities = 31/224 (13%), Positives = 71/224 (31%), Gaps = 4/224 (1%)

Query: 56  QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGE 115
           +     E+ +T +PSDL    +   L     ++          FG LE  ++S N+    
Sbjct: 11  RVFLCQESKVTEIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68

Query: 116 IPAAISSLVSLRVLKLDGNMFQWSI--PPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFP 173
           I A + S +                  P    N  +L  + +S   +          +  
Sbjct: 69  IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128

Query: 174 KLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGH 233
           K+         I   + +     S  ++ +  N      +     +   +D  +     +
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188

Query: 234 ISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSL 277
           + ++  +  +  S  V +D+S  ++     +     + L+  S 
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.2 bits (110), Expect = 2e-06
 Identities = 14/54 (25%), Positives = 24/54 (44%), Gaps = 4/54 (7%)

Query: 42  GSVPDTTIGKLSKLQSLDLSENNITALPSD-LWSLGSLKSLNLSYNRISGSLPS 94
             +P+      S    LD+S   I +LPS  L +L  L++ +    +    LP+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.4 bits (108), Expect = 5e-06
 Identities = 32/243 (13%), Positives = 74/243 (30%), Gaps = 13/243 (5%)

Query: 141 PPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSIT 199
              + +C +        +++   +P            L     +++  +   F+G   + 
Sbjct: 2   HHRICHCSNR-VFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLE 56

Query: 200 NLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLS 259
            + IS N     +      +L  +     +   ++  +   +  N   L Y+ +S   + 
Sbjct: 57  KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116

Query: 260 GEIFHNFSQAQNLKHLSLAY--NRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQL 317
                +   +     L +    N  T +    +G       L L++  +           
Sbjct: 117 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGT 176

Query: 318 SSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYN 375
                     N+L      V   A    I+D+S   +   +P+  LE L ++   +    
Sbjct: 177 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--Y 233

Query: 376 NLT 378
           NL 
Sbjct: 234 NLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (102), Expect = 3e-05
 Identities = 37/262 (14%), Positives = 75/262 (28%), Gaps = 30/262 (11%)

Query: 77  SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMF 136
           S +      ++++  +PS++                      A S    L  +++  N  
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 137 QWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLK 196
              I   + +    +                               N +      F  L 
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKA----------------------NNLLYINPEAFQNLP 103

Query: 197 SITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSEN 256
           ++  L IS    +       + SL+ + L         +  + +        V + L++N
Sbjct: 104 NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 163

Query: 257 QLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQ 316
            +       F+  Q  +      N              G   L++SRT  I  +PS  L+
Sbjct: 164 GIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTR-IHSLPSYGLE 222

Query: 317 -LSSLHTLDLSMNHLTGQIPTV 337
            L  L        +L  ++PT+
Sbjct: 223 NLKKLRARST--YNLK-KLPTL 241

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (116), Expect = 2e-07
 Identities = 21/139 (15%), Positives = 42/139 (30%), Gaps = 3/139 (2%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNN 111
             + + LDL    I  + +   +L    +++ S N I             L+   ++NN 
Sbjct: 17  AVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLLVNNNR 74

Query: 112 FSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAA 171
                     +L  L  L L  N          L     +T    +     +        
Sbjct: 75  ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYV 134

Query: 172 FPKLKSLN-LAGNEIKGRD 189
             K+  +  L   ++K ++
Sbjct: 135 IYKVPQVRVLDFQKVKLKE 153

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (102), Expect = 1e-05
 Identities = 15/134 (11%), Positives = 38/134 (28%)

Query: 172 FPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQ 231
             + + L+L G +I   +   A L     ++ S N  +       L  L+ + + +N+  
Sbjct: 17  AVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRIC 76

Query: 232 GHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIG 291
                +          ++  +        +   +      L  L              I 
Sbjct: 77  RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIY 136

Query: 292 TLLGLEHLNLSRTS 305
            +  +  L+  +  
Sbjct: 137 KVPQVRVLDFQKVK 150

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (100), Expect = 3e-05
 Identities = 17/136 (12%), Positives = 42/136 (30%), Gaps = 2/136 (1%)

Query: 285 QEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGI 344
           ++  Q    +    L+L     I  I +    L     +D S N +         + L  
Sbjct: 9   EQAAQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKT 67

Query: 345 IDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSPETLQTAFFGSSNDCPIAA 404
           + +++N +         + LP +     + N+L          +L++  +      P+  
Sbjct: 68  LLVNNNRICRIGEGL-DQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126

Query: 405 NPSFFKRKAANHKGLK 420
              +          ++
Sbjct: 127 KKHYRLYVIYKVPQVR 142

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.0 bits (108), Expect = 3e-06
 Identities = 30/143 (20%), Positives = 49/143 (34%), Gaps = 22/143 (15%)

Query: 46  DTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISG--SLPSNIGNFGLLE 103
           D  +   +    L+   +    L     ++  L SLNLS NR+     + S +     L+
Sbjct: 35  DPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94

Query: 104 VFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGS 163
           + +LS N    E        + L  L LDGN    +         ++             
Sbjct: 95  ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR------------ 142

Query: 164 LPDGFGAAFPKLKSLNLAGNEIK 186
                   FPKL  L+  G+E+ 
Sbjct: 143 ------ERFPKLLRLD--GHELP 157

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 6e-05
 Identities = 26/148 (17%), Positives = 46/148 (31%), Gaps = 10/148 (6%)

Query: 106 DLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLP 165
           +L       ++   +S         LD    +    P L+     V ++   +       
Sbjct: 3   ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA--TL 57

Query: 166 DGFGAAFPKLKSLNLAGNEIKGRD---THFAGLKSITNLNISGNLFQGSVMGVFLESL-- 220
                  P+L SLNL+ N +   D   +      ++  LN+SGN  +       ++ L  
Sbjct: 58  RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117

Query: 221 EVIDLRSNQFQGHISQVQFNSSYNWSRL 248
           E + L  N             S    R 
Sbjct: 118 EELWLDGNSLSDTFRDQSTYISAIRERF 145

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (89), Expect = 8e-04
 Identities = 24/102 (23%), Positives = 37/102 (36%), Gaps = 12/102 (11%)

Query: 43  SVPDTTIGKLSKLQSLDLSENNIT---ALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNF 99
           +        + +L SL+LS N +     + S +    +LK LNLS N +      +    
Sbjct: 55  ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKG 114

Query: 100 GLLEVFDLSNNNFSGEIP-------AAISSLVSLRVLKLDGN 134
             LE   L  N+ S           A       L   +LDG+
Sbjct: 115 LKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLL--RLDGH 154

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 5e-06
 Identities = 29/197 (14%), Positives = 67/197 (34%), Gaps = 22/197 (11%)

Query: 24  DSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNL 83
           D               ++ +V   T  +L+ +  +  + ++I ++   +  L ++  L L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAV---TQNELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFL 75

Query: 84  SYNRISG---------------SLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRV 128
           + N+++                          L ++  L + +      + I+ LV L  
Sbjct: 76  NGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135

Query: 129 LKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGR 188
           L+             +L+  + +      +     +     A   KL++L L+ N I   
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYLSKNHISDL 193

Query: 189 DTHFAGLKSITNLNISG 205
               AGLK++  L +  
Sbjct: 194 R-ALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 2e-05
 Identities = 30/194 (15%), Positives = 64/194 (32%), Gaps = 22/194 (11%)

Query: 52  LSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNN 111
            ++    +L + ++T   +    L S+  +  + + I       I     +    L+ N 
Sbjct: 23  FAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNK 79

Query: 112 FSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLP------ 165
            +   P  +++L +L  L LD N  +       L     ++++ +       L       
Sbjct: 80  LTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137

Query: 166 ----------DGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGV 215
                     D    +           +         AGL  + NL +S N         
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALA 197

Query: 216 FLESLEVIDLRSNQ 229
            L++L+V++L  +Q
Sbjct: 198 GLKNLDVLEL-FSQ 210

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 1e-04
 Identities = 32/203 (15%), Positives = 61/203 (30%), Gaps = 16/203 (7%)

Query: 146 NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISG 205
                +  +L    +  ++          +  +    ++IK        L ++T L ++G
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQ---NELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNG 77

Query: 206 NLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN 265
           N          L++L  + L  N+ +   S        + S         N L       
Sbjct: 78  NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137

Query: 266 FSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDL 325
                N K   +                L          + I DI   +  L+ L  L L
Sbjct: 138 SLYLGNNKITDITVLSR-----------LTKLDTLSLEDNQISDIV-PLAGLTKLQNLYL 185

Query: 326 SMNHLTGQIPTVSAKNLGIIDMS 348
           S NH++        KNL ++++ 
Sbjct: 186 SKNHISDLRALAGLKNLDVLELF 208

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.9 bits (94), Expect = 2e-04
 Identities = 37/195 (18%), Positives = 67/195 (34%), Gaps = 22/195 (11%)

Query: 16  CSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSL 75
           C    V C               GL   +P            L L++N +  + SD    
Sbjct: 8   CEGTTVDCTGR------------GLK-EIPR---DIPLHTTELLLNDNELGRISSDGLFG 51

Query: 76  G--SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG 133
               L  L L  N+++G  P+       ++   L  N            L  L+ L L  
Sbjct: 52  RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYD 111

Query: 134 NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFA 193
           N     +P    +  SL +++L+ N  N +    + A + + KSLN  G   +      +
Sbjct: 112 NQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLN--GGAARC--GAPS 167

Query: 194 GLKSITNLNISGNLF 208
            ++ +   ++  + F
Sbjct: 168 KVRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.4 bits (90), Expect = 7e-04
 Identities = 26/187 (13%), Positives = 55/187 (29%), Gaps = 9/187 (4%)

Query: 146 NCQ-SLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNIS 204
            C     TVD +   L   +P            L L  NE+    +     +    + + 
Sbjct: 5   MCHCEGTTVDCTGRGLK-EIPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLE 60

Query: 205 GNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFH 264
               Q + +                 +  I ++         +L  ++L +NQ+S  +  
Sbjct: 61  LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG 120

Query: 265 NFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLD 324
           +F    +L  L+   +               L   +L+  +     PS+   +  +   D
Sbjct: 121 SFEHLNSLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKD 176

Query: 325 LSMNHLT 331
           L  +   
Sbjct: 177 LPHSEFK 183

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 35/181 (19%), Positives = 60/181 (33%), Gaps = 23/181 (12%)

Query: 25  SNKQHVTDFLASNSGLSGSVP-----DTTIGKLSKLQSLDLSENNITALPSDLWSLGSLK 79
             ++ V    A    L G +P     D T+  L   + L LS NNI  + S L  + +L+
Sbjct: 15  EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISS-LSGMENLR 73

Query: 80  SLNLSYNRI--SGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQ 137
            L+L  N I    +L +       L +      + SG        ++ +   K+      
Sbjct: 74  ILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEI 133

Query: 138 WSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFG---------AAFPKLKSLNLAGNEIKGR 188
             +         L  + L+ N L     +               P LK L+  G  +   
Sbjct: 134 DKLA----ALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDVD 187

Query: 189 D 189
           +
Sbjct: 188 E 188

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 27/197 (13%), Positives = 57/197 (28%), Gaps = 16/197 (8%)

Query: 146 NCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISG 205
                +   L    +  ++         ++ +L      IK  D     L ++T +N S 
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSID-GVEYLNNLTQINFSN 71

Query: 206 NLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHN 265
           N                  L++      I       +         +L+   L      +
Sbjct: 72  NQLTDITP-----------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD 120

Query: 266 FSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDL 325
               +NL +L+               + L         ++ + D+   +  L++L  LD+
Sbjct: 121 IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDI 179

Query: 326 SMNHLTGQIPTVSAKNL 342
           S N ++         NL
Sbjct: 180 SSNKVSDISVLAKLTNL 196

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.003
 Identities = 11/33 (33%), Positives = 20/33 (60%), Gaps = 1/33 (3%)

Query: 49  IGKLSKLQSLDLSENNITALPSDLWSLGSLKSL 81
           +  L+ L+ LD+S N ++ +   L  L +L+SL
Sbjct: 168 LANLTTLERLDISSNKVSDISV-LAKLTNLESL 199

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.3 bits (82), Expect = 0.004
 Identities = 12/84 (14%), Positives = 25/84 (29%), Gaps = 2/84 (2%)

Query: 77  SLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPA-AISSLVSLRVLKLDGNM 135
               L  + +        ++     L    + N      +    +  L  LR L +  + 
Sbjct: 9   GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 136 FQWSIPPGLLNCQSLVTVDLSMNQ 159
            ++  P        L  ++LS N 
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNA 91

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	815
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.96
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.96
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.94
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.92
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.92
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.92
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.92
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.92
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.92
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.88
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.87
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.83
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.82
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.82
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.8
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.78
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.76
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.74
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.69
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.67
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.66
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.64
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.61
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.06
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.99
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.84
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.28
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.26
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	98.25
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.9
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.89
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.85

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=384.11  Aligned_cols=256  Identities=23%  Similarity=0.399  Sum_probs=213.1

Q ss_pred             CCCCCCCEECCCCCEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEECC
Q ss_conf             29999980102498003999919994999999614895129999999999628999992134228882994699998078
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYME  587 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  587 (815)
                      ++|++.+.||+|+||.||+|.+.++..||||+++.. ....++|.+|++++++++||||++++|+|...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf             995888898208882999999889999999998788-6768999999999996689975653524315993379998369


Q ss_pred             CCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCC
Q ss_conf             99944330039888755567877764557876533468878655899999999999999988840899991533688996
Q 003504          588 NGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASS  667 (815)
Q Consensus       588 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N  667 (815)
                      +|+|.+++...                             ...+++..+..++.|+|.||.|||   +++|+||||||+|
T Consensus        84 ~g~L~~~l~~~-----------------------------~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~N  131 (263)
T d1sm2a_          84 HGCLSDYLRTQ-----------------------------RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARN  131 (263)
T ss_dssp             TCBHHHHHHTT-----------------------------TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGG
T ss_pred             CCCHHHHHHCC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---CCCEEECCCCHHH
T ss_conf             99189975201-----------------------------347889999999999999877653---1643104431532


Q ss_pred             EEECCCCCEEECCCCCCEECCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCC
Q ss_conf             477699981451444540028997--5432346654248843489999999768522288999998839-9889999984
Q 003504          668 VYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG-KKPLGDDYPE  744 (815)
Q Consensus       668 ili~~~~~~ki~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg-~~pf~~~~~~  744 (815)
                      ||++.++.+||+|||+|+......  ......||..|+|||++.+..  ++.++|||||||++|||+|+ ++||......
T Consensus       132 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~  209 (263)
T d1sm2a_         132 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS  209 (263)
T ss_dssp             EEECGGGCEEECSCC------------------CTTSCCHHHHTTCC--CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred             EEECCCCCEEECCCCHHEECCCCCCEEECCEECCCCCCCHHHHCCCC--CCCHHHHCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf             66668877686553210023688733504300176667857860799--9840332105999999987898887789999


Q ss_pred             CCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf             32333899999988528787544664458899899999999995402559999999999999998645209
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIESTA  815 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~~~  815 (815)
                          .+.   ......          .+...|..++.++.+++.+||+.||++||+|++|++.|+++.+++
T Consensus       210 ----~~~---~~i~~~----------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~esg  263 (263)
T d1sm2a_         210 ----EVV---EDISTG----------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG  263 (263)
T ss_dssp             ----HHH---HHHHHT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----HHH---HHHHHC----------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf             ----999---999806----------888995436799999999976579768919999999999998577

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=381.77  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=209.0

Q ss_pred             CCCCCCCEECCCCCEEEEEEECCC-C---CEEEEEEEECCCC-CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEE
Q ss_conf             299999801024980039999199-9---4999999614895-1299999999996289999921342288829946999
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG-G---IHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  582 (815)
                      ++|++.+.||+|+||+||+|.... +   ..||||.+..... ...+.|.+|+.++++++|||||+++|++...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf             04278569802788299999995799788999999978445989999999999999857998886189999628877999


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECC
Q ss_conf             98078999443300398887555678777645578765334688786558999999999999999888408999915336
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  662 (815)
                      |||+++|+|.+++...                             ...++|..+..++.|+|.||.|||   +++|+|||
T Consensus       106 ~Ey~~~g~L~~~~~~~-----------------------------~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrD  153 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN-----------------------------DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRD  153 (299)
T ss_dssp             EECCTTEEHHHHHHTT-----------------------------TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEECCCCCCEEEECCC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCC
T ss_conf             9722798530021045-----------------------------679999999999999999889885---27983576


Q ss_pred             CCCCCEEECCCCCEEECCCCCCEECCCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CC
Q ss_conf             889964776999814514445400289975------43234665424884348999999976852228899999883-99
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLD------EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GK  735 (815)
Q Consensus       663 lk~~Nili~~~~~~ki~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~ellt-g~  735 (815)
                      |||+|||++.++.+||+|||+|+.......      .....|+..|+|||++.+..  ++.++|||||||++|||+| |+
T Consensus       154 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~el~t~g~  231 (299)
T d1jpaa_         154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK--FTSASDVWSYGIVMWEVMSYGE  231 (299)
T ss_dssp             CCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCCEEEECCCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCC--CCCCCCCCCCHHHHHHHHHCCC
T ss_conf             15044898899919988844315756777765365025666883003878883699--7861214453578999986799


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf             8899999843233389999998852878754466445889989999999999540255999999999999999864520
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       736 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~~  814 (815)
                      .||.+....+    +.   .... .         ..+...+..++.++.+++.+||+.||++||+|.+|++.|+++.+.
T Consensus       232 ~Pf~~~~~~~----~~---~~i~-~---------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         232 RPYWDMTNQD----VI---NAIE-Q---------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             CTTTTCCHHH----HH---HHHH-T---------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCCHHH----HH---HHHH-C---------CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             9999999999----99---9997-3---------788999742269999999997587976892999999999998418

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=381.11  Aligned_cols=261  Identities=26%  Similarity=0.397  Sum_probs=210.4

Q ss_pred             HCCCCCCCEECCCCCEEEEEEECCCCCEEEEEEEECCC--CCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEE
Q ss_conf             22999998010249800399991999499999961489--5129999999999628999992134228882994699998
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  584 (815)
                      .++|.+.+.||+|+||+||+|.+++  .||||+++...  ....+.|.+|+.++++++|||||+++|++.. +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEECC--EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf             4518998898307885899999999--89999997346998999999999999984799878645679715-58999996


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCC
Q ss_conf             07899944330039888755567877764557876533468878655899999999999999988840899991533688
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  664 (815)
                      |+++|+|.++++..                             ...+++..+..++.|+|.||+|||   +++|+|||||
T Consensus        84 y~~~g~L~~~l~~~-----------------------------~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlK  131 (276)
T d1uwha_          84 WCEGSSLYHHLHII-----------------------------ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK  131 (276)
T ss_dssp             CCCEEEHHHHHHTS-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred             CCCCCCHHHHHHHC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCC
T ss_conf             58998889998523-----------------------------578999999999999999988875---0999516147


Q ss_pred             CCCEEECCCCCEEECCCCCCEECCCCC---CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf             996477699981451444540028997---543234665424884348999-9999768522288999998839988999
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       665 ~~Nili~~~~~~ki~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~sDvwSlGvil~elltg~~pf~~  740 (815)
                      |+|||++.++.+||+|||+|+......   ......||+.|+|||++.+.. ..++.++|||||||++|||+||+.||.+
T Consensus       132 p~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~  211 (276)
T d1uwha_         132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN  211 (276)
T ss_dssp             GGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             HHHEEECCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf             89979818997887500221333556776312566557431799999505689999531516359999999978899899


Q ss_pred             CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf             99843233389999998852878754466445889989999999999540255999999999999999864520
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~~  814 (815)
                      ......   +    ........    ..|.. ...+..++.++.+++.+||+.||++||||+++++.|+.+.++
T Consensus       212 ~~~~~~---~----~~~~~~~~----~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         212 INNRDQ---I----IFMVGRGY----LSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             CCCHHH---H----HHHHHHTS----CCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCHHHH---H----HHHHHCCC----CCCCC-HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             896999---9----99996588----89860-003655549999999997588976892999999999999970

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=382.47  Aligned_cols=259  Identities=25%  Similarity=0.347  Sum_probs=212.6

Q ss_pred             HHCCCCCCCEECCCCCEEEEEEECC-CCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEE
Q ss_conf             8229999980102498003999919-994999999614895129999999999628999992134228882994699998
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFLP-GGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  584 (815)
                      ..++|++.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+.++++++|||||+++|++.+.+..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEE
T ss_conf             579939865982088808999999999969999997776-1039999999999986799988267752745785478763


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCC
Q ss_conf             07899944330039888755567877764557876533468878655899999999999999988840899991533688
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  664 (815)
                      |+++|+|.+++...                            ....+++..+..++.|+|.||+|||   +++|+|||||
T Consensus        94 ~~~~g~l~~~l~~~----------------------------~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlK  142 (287)
T d1opja_          94 FMTYGNLLDYLREC----------------------------NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLA  142 (287)
T ss_dssp             CCTTCBHHHHHHHS----------------------------CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             CCCCCCHHHHHHHC----------------------------CCCCHHHHHHHHHHHHHHHHHHHHH---HCCCCCCCCC
T ss_conf             14676067775303----------------------------5541579999999999999788898---7893057604


Q ss_pred             CCCEEECCCCCEEECCCCCCEECCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             996477699981451444540028997--543234665424884348999999976852228899999883998899999
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       665 ~~Nili~~~~~~ki~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~  742 (815)
                      |+|||++.++.+||+|||+|+......  ......|+..|+|||++.+..  ++.++|||||||++|||++|..||....
T Consensus       143 p~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~k~DiwS~Gv~l~ell~~~~p~~~~~  220 (287)
T d1opja_         143 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGI  220 (287)
T ss_dssp             GGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCEEEECCCCCEEECCCCCEEECCCCCCEEECCCCCCCCCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             57689989992898324454653788722103556654666927872799--9810430217899999986799887742


Q ss_pred             CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf             843233389999998852878754466445889989999999999540255999999999999999864520
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~~  814 (815)
                      ..   ..+..    ....         ..+...+..++.++.+++.+||+.||++||||+++++.|+.+.+.
T Consensus       221 ~~---~~~~~----~i~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         221 DL---SQVYE----LLEK---------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CH---HHHHH----HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             HH---HHHHH----HHHC---------CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             59---99999----9855---------888888743309999999997577976893999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=371.21  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=209.3

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEEC
Q ss_conf             2999998010249800399991-999499999961489512999999999962899999213422888299469999807
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  586 (815)
                      ++|++.+.||+|+||+||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf             05388789812858299999998999899999984301727999999999998679998805857798899989999703


Q ss_pred             CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCC
Q ss_conf             89994433003988875556787776455787653346887865589999999999999998884089999153368899
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~  666 (815)
                      ++|+|.+++..                               ..++......++.|++.||+|||   +++|+||||||+
T Consensus       100 ~gg~L~~~~~~-------------------------------~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~  145 (293)
T d1yhwa1         100 AGGSLTDVVTE-------------------------------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSD  145 (293)
T ss_dssp             TTCBHHHHHHH-------------------------------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGG
T ss_pred             CCCCHHHHHHC-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHH
T ss_conf             79808988641-------------------------------59999999999999999999999---879722677688


Q ss_pred             CEEECCCCCEEECCCCCCEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             6477699981451444540028997-543234665424884348999999976852228899999883998899999843
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 Nili~~~~~~ki~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~~~  745 (815)
                      |||++.++.+||+|||+|+...... .....+||+.|+|||++.+..  ++.++||||+||++|||++|+.||.+.... 
T Consensus       146 NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~~~~-  222 (293)
T d1yhwa1         146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPL-  222 (293)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSC--BCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-
T ss_pred             HEEECCCCCEEECCCHHHEEECCCCCCCCCCCCCCCCCCHHHHCCCC--CCCHHCEEHHHHHHHHHHHCCCCCCCCCHH-
T ss_conf             86887899686425156413213666444444477736826644799--880120313729999980488998997999-


Q ss_pred             CCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             2333899999988528787544664458899899999999995402559999999999999
Q 003504          746 KEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                            ...........        .....+...+.++.+++.+||+.||.+||++.|+++
T Consensus       223 ------~~~~~~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         223 ------RALYLIATNGT--------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ------HHHHHHHHHCS--------CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ------HHHHHHHHCCC--------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ------99999985799--------988885537999999999986699668909999964

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=378.63  Aligned_cols=256  Identities=27%  Similarity=0.417  Sum_probs=208.2

Q ss_pred             HCCCCCCCEECCCCCEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEEC
Q ss_conf             22999998010249800399991999499999961489512999999999962899999213422888299469999807
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  586 (815)
                      .++|++.+.||+|+||.||+|.++++..||||+++.. ....+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf             8993886798107982899999999999999998647-6888999999999986799988578731045-9769999957


Q ss_pred             CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCC
Q ss_conf             89994433003988875556787776455787653346887865589999999999999998884089999153368899
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~  666 (815)
                      ++|+|.+++...                            ....+++..+++++.|+|.||.|||   +++|+||||||+
T Consensus        90 ~~g~L~~~~~~~----------------------------~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~  138 (272)
T d1qpca_          90 ENGSLVDFLKTP----------------------------SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAA  138 (272)
T ss_dssp             TTCBHHHHTTSH----------------------------HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred             CCCCHHHHHHHC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHH
T ss_conf             898288887514----------------------------7898878899999999999999997---489546756422


Q ss_pred             CEEECCCCCEEECCCCCCEECCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             6477699981451444540028997--54323466542488434899999997685222889999988399889999984
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       667 Nili~~~~~~ki~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~~  744 (815)
                      |||++.++.+||+|||+|+......  ......|+..|+|||++....  ++.++|||||||++|||+||..|+..... 
T Consensus       139 NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-  215 (272)
T d1qpca_         139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMT-  215 (272)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTTCC-
T ss_pred             HEEEECCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHHCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_conf             515620244042341014773588644203567744445828983799--98245645257999999968988888889-


Q ss_pred             CCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             323338999999885287875446644588998999999999954025599999999999999986452
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~  813 (815)
                           .......+..          ..+...|..++.++.+++.+||+.||++||||++|++.|+++-.
T Consensus       216 -----~~~~~~~i~~----------~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         216 -----NPEVIQNLER----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -----HHHHHHHHHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHHHHHHH----------CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             -----9999999970----------68888965571999999999758897689399999998611321

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=369.84  Aligned_cols=253  Identities=24%  Similarity=0.385  Sum_probs=212.8

Q ss_pred             HCCCCCCCEECCCCCEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEEC
Q ss_conf             22999998010249800399991999499999961489512999999999962899999213422888299469999807
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  586 (815)
                      .++|++.++||+|+||+||+|+++++..||||.++.. ....++|.+|+.++++++||||++++|+|.+.+..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf             6997996898207883999999889989999998747-577899999999999668986015889985078169999704


Q ss_pred             CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCC
Q ss_conf             89994433003988875556787776455787653346887865589999999999999998884089999153368899
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~  666 (815)
                      ++|+|..++...                             ...+++..+.+++.|+|.||.|||   +.+|+||||||+
T Consensus        82 ~~g~l~~~~~~~-----------------------------~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~  129 (258)
T d1k2pa_          82 ANGCLLNYLREM-----------------------------RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAAR  129 (258)
T ss_dssp             TTEEHHHHHHSG-----------------------------GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGG
T ss_pred             CCCCHHHHHHCC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCE
T ss_conf             899388864102-----------------------------467768999999999999999875---468434665413


Q ss_pred             CEEECCCCCEEECCCCCCEECCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf             6477699981451444540028997--543234665424884348999999976852228899999883-9988999998
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP  743 (815)
Q Consensus       667 Nili~~~~~~ki~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~~~~~  743 (815)
                      ||+++.++.+||+|||+++......  ......|+..|+|||++....  ++.++|||||||++|||+| |+.||.....
T Consensus       130 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~  207 (258)
T d1k2pa_         130 NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTN  207 (258)
T ss_dssp             GEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred             EEEECCCCCEEECCCHHHEECCCCCCEEECCCCCCCCCCCCHHHCCCC--CCCCEEECCCCHHHHHHHHCCCCCCCCCCH
T ss_conf             588769984798861442023578722524657887757807863799--885210336432467397559999889999


Q ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             43233389999998852878754466445889989999999999540255999999999999999864
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~  811 (815)
                      .+.    .   ..+. ..         .+...|..++.++.+++.+||+.||++||||+++++.|.+|
T Consensus       208 ~~~----~---~~i~-~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         208 SET----A---EHIA-QG---------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             HHH----H---HHHH-TT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             HHH----H---HHHH-HC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf             999----9---9998-07---------97899654659999999997668976893999999874188

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=368.03  Aligned_cols=252  Identities=18%  Similarity=0.241  Sum_probs=212.2

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEEC
Q ss_conf             2999998010249800399991-999499999961489512999999999962899999213422888299469999807
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  586 (815)
                      ++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf             03599899931778299999998999799999988726467999999999998679979891999999899999999828


Q ss_pred             CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCC
Q ss_conf             89994433003988875556787776455787653346887865589999999999999998884089999153368899
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~  666 (815)
                      ++|+|.+++...                             ...++......++.|++.||.|||   +.+|+||||||+
T Consensus       109 ~gg~L~~~~~~~-----------------------------~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~  156 (352)
T d1koba_         109 SGGELFDRIAAE-----------------------------DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPE  156 (352)
T ss_dssp             CCCBHHHHTTCT-----------------------------TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             CCCHHHHHHHHC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCC
T ss_conf             998088889863-----------------------------899899999999999999999999---779265131445


Q ss_pred             CEEEC--CCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             64776--9998145144454002899754323466542488434899999997685222889999988399889999984
Q 003504          667 SVYLD--MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       667 Nili~--~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~~  744 (815)
                      |||++  .++.+||+|||+|+............|++.|+|||++.+..  ++.++||||+||++|||++|+.||.+....
T Consensus       157 NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyelltG~~Pf~~~~~~  234 (352)
T d1koba_         157 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSPFAGEDDL  234 (352)
T ss_dssp             GEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCC--BCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred             CCCCCCCCCCEEEEEECCCCEECCCCCCEEECCCCCCCCCHHHHCCCC--CCCCCCHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf             531134678848995256303437887201004764534899974799--897633389899999999688998997999


Q ss_pred             CCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             323338999999885287875446644588998999999999954025599999999999999
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~  807 (815)
                      +       .........       .......+...+.++.+++.+||+.||.+||++.|+++.
T Consensus       235 ~-------~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         235 E-------TLQNVKRCD-------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             H-------HHHHHHHCC-------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             H-------HHHHHHHCC-------CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             9-------999998478-------898930024799999999999756996689189999609

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=370.43  Aligned_cols=253  Identities=20%  Similarity=0.299  Sum_probs=211.7

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEE
Q ss_conf             22999998010249800399991-99949999996148951299999999996289999921342288829946999980
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  585 (815)
                      .++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             65758988984076819999998899989999998452431699999999999867997999299999989999999985


Q ss_pred             CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCC
Q ss_conf             78999443300398887555678777645578765334688786558999999999999999888408999915336889
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~  665 (815)
                      +++|+|.+++...                             ...+++.....++.|++.||.|||   +++|+||||||
T Consensus       105 ~~gg~L~~~l~~~-----------------------------~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp  152 (350)
T d1koaa2         105 MSGGELFEKVADE-----------------------------HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKP  152 (350)
T ss_dssp             CCSCBHHHHHTCT-----------------------------TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred             CCCCCHHHHHHHH-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCEEEEECH
T ss_conf             7998899999762-----------------------------378999999999999999999997---56976000154


Q ss_pred             CCEEECC--CCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             9647769--99814514445400289975432346654248843489999999768522288999998839988999998
Q 003504          666 SSVYLDM--NLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       666 ~Nili~~--~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~  743 (815)
                      +|||++.  ++.+||+|||+|+............||+.|+|||++.+..  ++.++||||+||++|||++|+.||.+...
T Consensus       153 ~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~  230 (350)
T d1koaa2         153 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPFGGEND  230 (350)
T ss_dssp             GGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCC--BCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHEEECCCCCCEEEEEECCHHEECCCCCCCCEECCCCCCCCHHHHCCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf             6736416889869995452104425654320006862421889975899--87267655465999999859899899799


Q ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             4323338999999885287875446644588998999999999954025599999999999999
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~  807 (815)
                      .       ..+........       ..........+.++.+++.+||..||++|||++|+++.
T Consensus       231 ~-------~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         231 D-------ETLRNVKSCDW-------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             H-------HHHHHHHHTCC-------CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             H-------HHHHHHHHCCC-------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             9-------99999984788-------98942235899999999999756896679089998629

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.94  Aligned_cols=250  Identities=21%  Similarity=0.261  Sum_probs=204.3

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCC-CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEE
Q ss_conf             2999998010249800399991-9994999999614895-1299999999996289999921342288829946999980
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  585 (815)
                      ++|++.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEC
T ss_conf             46089989721748099999999999799999984566412799999999999857998884696540467436798864


Q ss_pred             CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCC
Q ss_conf             78999443300398887555678777645578765334688786558999999999999999888408999915336889
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~  665 (815)
                      +++|+|.+++..                              ...+++.....++.|++.||+|||   +++|+||||||
T Consensus        85 ~~gg~L~~~l~~------------------------------~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp  131 (271)
T d1nvra_          85 CSGGELFDRIEP------------------------------DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKP  131 (271)
T ss_dssp             CTTEEGGGGSBT------------------------------TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred             CCCCCHHHHHHC------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCH
T ss_conf             589808999753------------------------------799999999999999999999999---75983575468


Q ss_pred             CCEEECCCCCEEECCCCCCEECCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             96477699981451444540028997---543234665424884348999999976852228899999883998899999
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       666 ~Nili~~~~~~ki~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~  742 (815)
                      +|||++.++.+||+|||+|+......   .....+||+.|+|||++.+... ++.++||||+||++|||++|+.||....
T Consensus       132 ~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~~~DiwSlGvilyeml~G~~pf~~~~  210 (271)
T d1nvra_         132 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF-HAEPVDVWSCGIVLTAMLAGELPWDQPS  210 (271)
T ss_dssp             GGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSB-CHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred             HHEEECCCCCEEECCCHHHEEECCCCCCCCCCCEEECCCCCCHHHHCCCCC-CCCCEEEEHHHHHHHHHHHCCCCCCCCC
T ss_conf             997887899879832314224046886531113255747428728618999-9971016173799999982997888898


Q ss_pred             CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             8432333899999988528787544664458899899999999995402559999999999999
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      ....  ...    . ....        ......+...+.++.+++.+||+.||++|||++|+++
T Consensus       211 ~~~~--~~~----~-~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         211 DSCQ--EYS----D-WKEK--------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTSH--HHH----H-HHTT--------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHH--HHH----H-HHCC--------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             5999--999----9-8638--------8878864469999999999976799668909999961

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=370.07  Aligned_cols=252  Identities=21%  Similarity=0.283  Sum_probs=208.0

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEEC
Q ss_conf             2999998010249800399991-999499999961489512999999999962899999213422888299469999807
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  586 (815)
                      +.|++.+.||+|+||.||+|.. .++..||+|++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf             37598479930778199999999999399999987289999999999999998679999884988980099589999627


Q ss_pred             CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCC
Q ss_conf             89994433003988875556787776455787653346887865589999999999999998884089999153368899
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~  666 (815)
                      ++|+|.+++...                             ...+++..+..++.|++.||.|||   +++|+||||||+
T Consensus        92 ~~g~L~~~~~~~-----------------------------~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~  139 (288)
T d2jfla1          92 AGGAVDAVMLEL-----------------------------ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAG  139 (288)
T ss_dssp             TTEEHHHHHHHH-----------------------------TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGG
T ss_pred             CCCCHHHHHHHC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEECCHH
T ss_conf             998188999862-----------------------------899999999999999999999999---889887140700


Q ss_pred             CEEECCCCCEEECCCCCCEECCCCC-CCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             6477699981451444540028997-543234665424884348999---999976852228899999883998899999
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDS---DFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       667 Nili~~~~~~ki~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~~sDvwSlGvil~elltg~~pf~~~~  742 (815)
                      |||++.++.+||+|||+|+...... ......||+.|+|||++....   ..++.++|||||||++|||++|+.||.+..
T Consensus       140 NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~  219 (288)
T d2jfla1         140 NILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN  219 (288)
T ss_dssp             GEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             HEEECCCCCEEEEECHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             31487899989971612303577864100102562647999983202578888806657878999999820889999989


Q ss_pred             CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             8432333899999988528787544664458899899999999995402559999999999999
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      +.+..       ........        .....+...+.++.+++.+||+.||++|||++|+++
T Consensus       220 ~~~~~-------~~i~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         220 PMRVL-------LKIAKSEP--------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             GGGHH-------HHHHHSCC--------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHH-------HHHHCCCC--------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             99999-------99970799--------877765669999999999976699668919999962

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=369.71  Aligned_cols=253  Identities=23%  Similarity=0.348  Sum_probs=205.0

Q ss_pred             CCCCCCC-EECCCCCEEEEEEECC---CCCEEEEEEEECCCC-CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEE
Q ss_conf             2999998-0102498003999919---994999999614895-1299999999996289999921342288829946999
Q 003504          508 SNFDRGT-LLAEGKFGPVYRGFLP---GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  582 (815)
                      ++|.+.+ +||+|+||.||+|.+.   ++..||||+++.... ...+.|.+|++++++++|||||+++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf             4718878487306080999999960897689999998820397899999999999986799888068656036-807999


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECC
Q ss_conf             98078999443300398887555678777645578765334688786558999999999999999888408999915336
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  662 (815)
                      |||+++|+|.+++...                             ...+++..+..++.|+|.||+|||   +++|+|||
T Consensus        87 mE~~~~g~L~~~l~~~-----------------------------~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrD  134 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK-----------------------------REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRD  134 (285)
T ss_dssp             EECCTTEEHHHHHTTC-----------------------------TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred             EEECCCCCHHHHHHCC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCC
T ss_conf             9807899689975212-----------------------------569999999999999999878998---68810576


Q ss_pred             CCCCCEEECCCCCEEECCCCCCEECCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCC
Q ss_conf             88996477699981451444540028997----543234665424884348999999976852228899999883-9988
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       663 lk~~Nili~~~~~~ki~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~ellt-g~~p  737 (815)
                      |||+||+++.++.+||+|||+|+.+....    ......||..|+|||++....  ++.++|||||||++|||+| |+.|
T Consensus       135 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gv~l~E~lt~G~~P  212 (285)
T d1u59a_         135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKP  212 (285)
T ss_dssp             CSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCHHHEEECCCCCEEECCCHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCC--CCCCCHHHCCHHHHHHHHHCCCCC
T ss_conf             764660454688542033134211554343211356211374335868872799--995412322017899999389999


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             999998432333899999988528787544664458899899999999995402559999999999999998645
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       738 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~  812 (815)
                      |.+....+    +...    +...         .+...|..++.++.+++.+||+.||++||+|.+|.+.|+.+-
T Consensus       213 f~~~~~~~----~~~~----i~~~---------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         213 YKKMKGPE----VMAF----IEQG---------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             TTTCCTHH----HHHH----HHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCHHH----HHHH----HHCC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             99979999----9999----9818---------999999767899999999975779768909999999999999

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.31  Aligned_cols=258  Identities=24%  Similarity=0.374  Sum_probs=208.4

Q ss_pred             HCCCCCCCEECCCCCEEEEEEECCCC-----CEEEEEEEECCCC-CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEE
Q ss_conf             22999998010249800399991999-----4999999614895-12999999999962899999213422888299469
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGG-----IHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRI  580 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  580 (815)
                      .+.|++.+.||+|+||.||+|.+...     ..||||.+..... .....|.+|+.++.+++|||||+++|++.+....+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf             89968615981177909999999689987879999999884459689999999999998568987832367783388038


Q ss_pred             EEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEE
Q ss_conf             99980789994433003988875556787776455787653346887865589999999999999998884089999153
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  660 (815)
                      +|+||+.+|++.+++...                             ...++|..+..++.|++.||+|||   +++|+|
T Consensus        86 ~v~e~~~~~~l~~~~~~~-----------------------------~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiH  133 (283)
T d1mqba_          86 IITEYMENGALDKFLREK-----------------------------DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVH  133 (283)
T ss_dssp             EEEECCTTEEHHHHHHHT-----------------------------TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             EEEEECCCCCCHHHHHCC-----------------------------CCCCCHHHHHHHHHHHHHHHHHCC---CCCCCC
T ss_conf             999721357402221023-----------------------------454208999999999998541212---123425


Q ss_pred             CCCCCCCEEECCCCCEEECCCCCCEECCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf             3688996477699981451444540028997----543234665424884348999999976852228899999883998
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       661 ~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~  736 (815)
                      |||||+|||++.++.+||+|||+|+......    ......||..|+|||++.+..  ++.++|||||||++|||+++..
T Consensus       134 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~~sDI~S~Gvil~el~t~~~  211 (283)
T d1mqba_         134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGE  211 (283)
T ss_dssp             SCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCCCCEEEECCCCEEEECCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCC--CCCCCCCCCCHHHHHHHHHCCC
T ss_conf             76564427888998499845510300357876526742677773434888870499--9973556344898999996798


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf             899999843233389999998852878754466445889989999999999540255999999999999999864520
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       737 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~~  814 (815)
                      |+......   ..+.   ... ..         ..+...+..++.++.+++.+||+.||++||+|.+|++.|+++.+.
T Consensus       212 ~~~~~~~~---~~~~---~~i-~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         212 RPYWELSN---HEVM---KAI-ND---------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CTTTTCCH---HHHH---HHH-HT---------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCCH---HHHH---HHH-HC---------CCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             86556899---9999---998-63---------578998504579999999997767976893999999999998669

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.33  Aligned_cols=245  Identities=26%  Similarity=0.385  Sum_probs=206.4

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECC---CCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEE
Q ss_conf             2999998010249800399991-99949999996148---9512999999999962899999213422888299469999
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG---STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++.+.   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf             37699889851778589999998999499999981688567689999999999998568888885999999899989998


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCC
Q ss_conf             80789994433003988875556787776455787653346887865589999999999999998884089999153368
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  663 (815)
                      ||+++|+|.+++..                              ...+++.....++.|++.||+|||   +++|+||||
T Consensus        86 Ey~~~g~L~~~l~~------------------------------~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDi  132 (263)
T d2j4za1          86 EYAPLGTVYRELQK------------------------------LSKFDEQRTATYITELANALSYCH---SKRVIHRDI  132 (263)
T ss_dssp             ECCTTCBHHHHHHH------------------------------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCC
T ss_pred             EECCCCCHHHHHHH------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEE
T ss_conf             50479858988750------------------------------489999999999999999999999---889465220


Q ss_pred             CCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             89964776999814514445400289975432346654248843489999999768522288999998839988999998
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       664 k~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~  743 (815)
                      ||+|||++.++.+||+|||+|+..... ......||+.|+|||++.+..  ++.++|||||||++|||++|+.||.+...
T Consensus       133 Kp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~  209 (263)
T d2j4za1         133 KPENLLLGSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPFEANTY  209 (263)
T ss_dssp             CGGGEEECTTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             CCCCCEECCCCCEEECCCCEEEECCCC-CCCCCCCCCCCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHCCCCCCCCCCH
T ss_conf             234414668998711555633544888-523557887634999975899--89314404675999998329999888999


Q ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             432333899999988528787544664458899899999999995402559999999999999
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      .+       .........           ...|...++++.+++.+||+.||++|||++|+++
T Consensus       210 ~~-------~~~~i~~~~-----------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         210 QE-------TYKRISRVE-----------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HH-------HHHHHHTTC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH-------HHHHHHCCC-----------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             99-------999997189-----------9998668999999999976479768909999971

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=370.00  Aligned_cols=275  Identities=26%  Similarity=0.350  Sum_probs=211.1

Q ss_pred             HCCCCCCCEECCCCCEEEEEEECCC------CCEEEEEEEECCC-CCCHHHHHHHHHHHCCC-CCCCCEEEEEEEEECCE
Q ss_conf             2299999801024980039999199------9499999961489-51299999999996289-99992134228882994
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPG------GIHVAVKVLVHGS-TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQ  578 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  578 (815)
                      .++|++.+.||+|+||+||+|...+      ...||+|.+.... ......+.+|+.++.++ +|||||+++|++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf             89939701983078819999998578855420499999966335878999999999999971589968687788862995


Q ss_pred             EEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCE
Q ss_conf             69999807899944330039888755567877764557876533468878655899999999999999988840899991
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~i  658 (815)
                      .++||||+++|+|.++++..+......      ....... ...........+++..++.++.|++.||+|||   +++|
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~------~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~I  185 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSED------EIEYENQ-KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSC  185 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC----------------------------CCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCH------HHHHCCC-CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCE
T ss_conf             899997279995999998625777510------2210000-12220012577899999999999999999997---3990


Q ss_pred             EECCCCCCCEEECCCCCEEECCCCCCEECCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-C
Q ss_conf             5336889964776999814514445400289975---43234665424884348999999976852228899999883-9
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-G  734 (815)
Q Consensus       659 vH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~ellt-g  734 (815)
                      +||||||+||+++.++.+||+|||+|+.......   .....||+.|+|||++.+..  ++.++|||||||++|||++ |
T Consensus       186 iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHTTTS
T ss_pred             EECCCCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCC--CCCCEECCCHHHHHHHHHHCC
T ss_conf             505270321443459828985142222045778615623435787657838872799--996330300039999998389


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf             988999998432333899999988528787544664458899899999999995402559999999999999998
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLK  809 (815)
Q Consensus       735 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~  809 (815)
                      +.||.+....+.   +.    .....         ..+...|..++.++.+++.+||+.||++||||++|++.|.
T Consensus       264 ~~Pf~~~~~~~~---~~----~~~~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         264 VNPYPGIPVDAN---FY----KLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSSTTCCCSHH---HH----HHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCHHHH---HH----HHHHC---------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             999999898999---99----99856---------9989988767899999999975889668939999999974

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=372.28  Aligned_cols=272  Identities=21%  Similarity=0.313  Sum_probs=208.1

Q ss_pred             HHCCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCC-CCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEE
Q ss_conf             822999998010249800399991-999499999961489-512999999999962899999213422888299469999
Q 003504          506 ATSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS-TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       506 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  583 (815)
                      ..++|++.+.||+|+||+||+|.. .++..||+|+++... ....+.+.+|+.++++++|||||++++++.+....++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf             75688897897127780999999989996999999875409789999999999998679999994999999899999999


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCC
Q ss_conf             80789994433003988875556787776455787653346887865589999999999999998884089999153368
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  663 (815)
                      ||+++|+|.+++..                              ...+++..+..++.|++.||.|||+  .++|+||||
T Consensus        84 Ey~~gg~L~~~l~~------------------------------~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDi  131 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK------------------------------AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDV  131 (322)
T ss_dssp             ECCTTEEHHHHHHH------------------------------HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCC
T ss_pred             ECCCCCCHHHHHHH------------------------------CCCCCHHHHHHHHHHHHHHHHHHHH--HCCEECCCC
T ss_conf             76799868998742------------------------------4999999999999999999999998--599971445


Q ss_pred             CCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             89964776999814514445400289975432346654248843489999999768522288999998839988999998
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       664 k~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~  743 (815)
                      ||+|||++.++.+||+|||+|+..... .....+||+.|+|||++.+..  ++.++||||+||++|||++|+.||.....
T Consensus       132 KP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~--y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         132 KPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             SGGGEEECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSC--CCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             CHHHEEECCCCCEEEEECCCCCCCCCC-CCCCCCCCCCCCCCHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf             779946878998999548776256788-621113771411946875899--89488899899999999988899899887


Q ss_pred             CCCCCCHHHHHHHHHH--------CCC--CCCCC----------------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCC
Q ss_conf             4323338999999885--------287--87544----------------664458899899999999995402559999
Q 003504          744 EEKEGNLVSWVRGLVR--------NNK--GSRAI----------------DPKIRDTGPEKQMEEALKIGYLCTADLPLK  797 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~--------~~~--~~~~~----------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~  797 (815)
                      .+..............        ...  .....                ............+.++.+++.+||..||.+
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~  288 (322)
T d1s9ja_         209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE  288 (322)
T ss_dssp             THHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHH
T ss_conf             89999998875177545774212333221111222354134778876650268766764448999999999986899467


Q ss_pred             CCCHHHHHH--HHHHHH
Q ss_conf             999999999--998645
Q 003504          798 RPSMQQIVG--LLKDIE  812 (815)
Q Consensus       798 RPs~~~il~--~L~~~~  812 (815)
                      |||++|+++  .+++..
T Consensus       289 R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         289 RADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             SCCHHHHHTSHHHHHHH
T ss_pred             CCCHHHHHHCHHHCCCC
T ss_conf             90899996098647698

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=367.07  Aligned_cols=251  Identities=23%  Similarity=0.307  Sum_probs=208.2

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCC-CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEE
Q ss_conf             2999998010249800399991-9994999999614895-1299999999996289999921342288829946999980
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  585 (815)
                      +.|++.+.||+|+||+||+|.. .+++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             66699889940658399999999999899999981577312899999999999867998999198999989988898852


Q ss_pred             CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCC
Q ss_conf             78999443300398887555678777645578765334688786558999999999999999888408999915336889
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~  665 (815)
                      +++|+|.+++..                              ...+++.....++.|++.||+|||   +++|+||||||
T Consensus        89 ~~gg~L~~~l~~------------------------------~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp  135 (307)
T d1a06a_          89 VSGGELFDRIVE------------------------------KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKP  135 (307)
T ss_dssp             CCSCBHHHHHHT------------------------------CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred             CCCCCHHHHHHC------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCEEEEEEECC
T ss_conf             689848886530------------------------------367887899999999999987524---13055687046


Q ss_pred             CCEEEC---CCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             964776---99981451444540028997543234665424884348999999976852228899999883998899999
Q 003504          666 SSVYLD---MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       666 ~Nili~---~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~  742 (815)
                      +||++.   .++.+||+|||+|+...........+||+.|+|||++.+..  ++.++||||+||++|||++|+.||.+..
T Consensus       136 ~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~  213 (307)
T d1a06a_         136 ENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP--YSKAVDCWSIGVIAYILLCGYPPFYDEN  213 (307)
T ss_dssp             GGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCEEECCCCCCCEEEEECCCEEEECCCCCEEEEEEECCCCCCCHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             30011046888249983154358725897044003284225918873799--9807873451599999985979999989


Q ss_pred             CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             84323338999999885287875446644588998999999999954025599999999999999
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~  807 (815)
                      ..+       .........       .......+...++++.+++.+||+.||++|||++|+++.
T Consensus       214 ~~~-------~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         214 DAK-------LFEQILKAE-------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             HHH-------HHHHHHTTC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHH-------HHHHHHCCC-------CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             999-------999986168-------777876666789999999999760897579189998629

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.86  Aligned_cols=245  Identities=23%  Similarity=0.345  Sum_probs=200.6

Q ss_pred             CEECCCCCEEEEEEECC---CCCEEEEEEEECCCC--CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEECCC
Q ss_conf             80102498003999919---994999999614895--1299999999996289999921342288829946999980789
Q 003504          514 TLLAEGKFGPVYRGFLP---GGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYMEN  588 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  588 (815)
                      ++||+|+||+||+|.+.   .++.||||+++....  ...+.|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505-977999974788


Q ss_pred             CCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCE
Q ss_conf             99443300398887555678777645578765334688786558999999999999999888408999915336889964
Q 003504          589 GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKASSV  668 (815)
Q Consensus       589 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Ni  668 (815)
                      |+|.++++.                              ...+++..+..++.|+|.||+|||   +++|+||||||+||
T Consensus        92 g~L~~~l~~------------------------------~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Ni  138 (277)
T d1xbba_          92 GPLNKYLQQ------------------------------NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNV  138 (277)
T ss_dssp             EEHHHHHHH------------------------------CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred             CCHHHHHHH------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCHHH
T ss_conf             968999752------------------------------257899999999999999976687---47955677761131


Q ss_pred             EECCCCCEEECCCCCCEECCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf             776999814514445400289975----43234665424884348999999976852228899999883-9988999998
Q 003504          669 YLDMNLEPRLSDFGLAKIFGNGLD----EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYP  743 (815)
Q Consensus       669 li~~~~~~ki~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~~~~~  743 (815)
                      |++.++.+||+|||+|+.......    .....||..|+|||.+.+..  ++.++|||||||++|||++ |+.||.+...
T Consensus       139 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~  216 (277)
T d1xbba_         139 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKG  216 (277)
T ss_dssp             EEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             CCCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCEECCCHHHCCCC--CCCHHHHCCCHHHHHHHHHCCCCCCCCCCH
T ss_conf             023567512341345331343234432244567784203916653799--984344303403132896589999999899


Q ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             43233389999998852878754466445889989999999999540255999999999999999864
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~  811 (815)
                      .+    +..   . ....         .+...|..++.++.+++.+||+.||++||+|++|.+.|+..
T Consensus       217 ~~----~~~---~-i~~~---------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         217 SE----VTA---M-LEKG---------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             HH----HHH---H-HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HH----HHH---H-HHCC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf             99----999---9-9828---------99999865679999999997588976890989999985288

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=369.54  Aligned_cols=286  Identities=25%  Similarity=0.352  Sum_probs=219.3

Q ss_pred             HHHHHHHHCCCCCCCEECCCCCEEEEEEECC------CCCEEEEEEEECCCCC-CHHHHHHHHHHHCCCCCCCCEEEEEE
Q ss_conf             8899998229999980102498003999919------9949999996148951-29999999999628999992134228
Q 003504          500 FADLLSATSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGY  572 (815)
Q Consensus       500 ~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~  572 (815)
                      +.+++...++|++.+.||+|+||+||+|...      ++..||||++...... ..+.|.+|+.++++++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf             33113898893886798207883999999888765778829999998821085799999999999996689976552466


Q ss_pred             EEECCEEEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC
Q ss_conf             88299469999807899944330039888755567877764557876533468878655899999999999999988840
Q 003504          573 CIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHH  652 (815)
Q Consensus       573 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~  652 (815)
                      |......++++||+++|+|.++++...........+...      .............+++..++.++.|+|.||+||| 
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH-  157 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL------STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-  157 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------------CCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCC------CHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-
T ss_conf             605980389998158992999998527554210000111------0012103467889899999999999999855413-


Q ss_pred             CCCCCEEECCCCCCCEEECCCCCEEECCCCCCEECCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             899991533688996477699981451444540028997---54323466542488434899999997685222889999
Q 003504          653 GCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLL  729 (815)
Q Consensus       653 ~~~~~ivH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~  729 (815)
                        +++++||||||+|||++.++.+||+|||+|+......   ......|+..|+|||++.+..  ++.++|||||||++|
T Consensus       158 --~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~t~ksDVwS~Gvvl~  233 (301)
T d1lufa_         158 --ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLW  233 (301)
T ss_dssp             --HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHH
T ss_pred             --CCCEEEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCHHHHHCCCHHHHH
T ss_conf             --5786854884011689899928983314421136776411157777676767989972688--980563025236299


Q ss_pred             HHHHCC-CCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf             988399-8899999843233389999998852878754466445889989999999999540255999999999999999
Q 003504          730 ELITGK-KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLL  808 (815)
Q Consensus       730 elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L  808 (815)
                      ||++|. +||.+....+.    .   .. +....         ....+..++.++.+++.+||+.||++||||.+|+++|
T Consensus       234 ell~~~~~p~~~~~~~e~----~---~~-v~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L  296 (301)
T d1lufa_         234 EIFSYGLQPYYGMAHEEV----I---YY-VRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL  296 (301)
T ss_dssp             HHHTTTCCTTTTSCHHHH----H---HH-HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHCCCCCCCCCCCHHHH----H---HH-HHCCC---------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf             998068999999899999----9---99-97399---------7888732529999999997488965793999999999


Q ss_pred             HHHHH
Q ss_conf             86452
Q 003504          809 KDIES  813 (815)
Q Consensus       809 ~~~~~  813 (815)
                      ++|.+
T Consensus       297 ~~i~~  301 (301)
T d1lufa_         297 QRMCE  301 (301)
T ss_dssp             HHTTC
T ss_pred             HHHCC
T ss_conf             98429

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=362.08  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=201.8

Q ss_pred             CCCCCCCEECCCCCEEEEEEE-CCCCCEEEEEEEECCCCCC---HHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEE
Q ss_conf             299999801024980039999-1999499999961489512---999999999962899999213422888299469999
Q 003504          508 SNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLT---DQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  583 (815)
                      +.|+..+.||+|+||+||+|. ..+++.||||++.......   .+.+.+|+.++++++|||||+++|++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             85676279701888099999998999399999984444358899999999999999778999823899999899889999


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCC
Q ss_conf             80789994433003988875556787776455787653346887865589999999999999998884089999153368
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  663 (815)
                      ||+++|+|..++..                              ...+++..+..++.|++.||.|||   +++|+||||
T Consensus        95 E~~~~g~l~~~~~~------------------------------~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDi  141 (309)
T d1u5ra_          95 EYCLGSASDLLEVH------------------------------KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDV  141 (309)
T ss_dssp             ECCSEEHHHHHHHH------------------------------TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCC
T ss_pred             EECCCCCHHHHHHH------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCC
T ss_conf             80699945789973------------------------------799999999999999999999998---689766678


Q ss_pred             CCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             8996477699981451444540028997543234665424884348999-999976852228899999883998899999
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDS-DFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~sDvwSlGvil~elltg~~pf~~~~  742 (815)
                      ||+|||++.++.+||+|||+|+....   .....||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.+..
T Consensus       142 Kp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~  218 (309)
T d1u5ra_         142 KAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (309)
T ss_dssp             SGGGEEEETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCCEEEECCCCCEEEEECCCCCCCCC---CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             84217987999789844365334677---873134766368899834678886721454558999999987889999979


Q ss_pred             CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             8432333899999988528787544664458899899999999995402559999999999999
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      ..       ..........      .+..   .+...+.++.+++.+||+.||.+|||++++++
T Consensus       219 ~~-------~~~~~i~~~~------~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         219 AM-------SALYHIAQNE------SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HH-------HHHHHHHHSC------CCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HH-------HHHHHHHHCC------CCCC---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             99-------9999998289------9988---87888999999999977379657918999971

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.77  Aligned_cols=255  Identities=24%  Similarity=0.314  Sum_probs=205.1

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCC--CCHHHHHHHHHHHCCCCCCCCEEEEEEEEE--CCEEEE
Q ss_conf             22999998010249800399991-9994999999614895--129999999999628999992134228882--994699
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIA--GDQRIA  581 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  581 (815)
                      .++|++.+.||+|+||+||+|.. .+++.||+|.+.....  ...+.+.+|++++++++||||+++++++.+  ....++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf             33379967983088919999999999979999998746579799999999999999778999824899999178998999


Q ss_pred             EEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCCEE
Q ss_conf             9980789994433003988875556787776455787653346887865589999999999999998884089--99915
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC--SPPII  659 (815)
Q Consensus       582 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~--~~~iv  659 (815)
                      ||||+++|+|.+++....                          .....+++..+..++.|++.||.|||+..  ..+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~--------------------------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~Ii  136 (269)
T d2java1          83 VMEYCEGGDLASVITKGT--------------------------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL  136 (269)
T ss_dssp             EEECCTTEEHHHHHHHHH--------------------------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------
T ss_pred             EEECCCCCCHHHHHHHCC--------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEE
T ss_conf             995689993899998515--------------------------457899999999999999999999997167788788


Q ss_pred             ECCCCCCCEEECCCCCEEECCCCCCEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf             33688996477699981451444540028997-54323466542488434899999997685222889999988399889
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       660 H~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf  738 (815)
                      ||||||+|||++.++.+||+|||+|+...... ......||+.|+|||++.+..  ++.++|||||||++|||++|+.||
T Consensus       137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~~~DIwSlGvilyel~tg~~Pf  214 (269)
T d2java1         137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS--YNEKSDIWSLGCLLYELCALMPPF  214 (269)
T ss_dssp             ---CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ECCCCHHHCCCCCCCCEEEEECCCEEECCCCCCCCCCCCCCCCCCCHHHHCCCC--CCHHHHHHHHCHHHHHHHHCCCCC
T ss_conf             586765425747888579800100032245777556677882327999983999--993898875278999980188998


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             99998432333899999988528787544664458899899999999995402559999999999999
Q 003504          739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      .+....+       ........ ..         ...+...+.++.+++.+||+.||.+||++.|+++
T Consensus       215 ~~~~~~~-------~~~~i~~~-~~---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         215 TAFSQKE-------LAGKIREG-KF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCSSHHH-------HHHHHHHT-CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCHHH-------HHHHHHCC-CC---------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             9989999-------99999718-99---------8897435999999999976799557918999972

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.70  Aligned_cols=254  Identities=24%  Similarity=0.361  Sum_probs=207.4

Q ss_pred             CCCCCCCEECCCCCEEEEEEECC-CCC----EEEEEEEECC-CCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEE
Q ss_conf             29999980102498003999919-994----9999996148-95129999999999628999992134228882994699
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLP-GGI----HVAVKVLVHG-STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  581 (815)
                      .+|++.+.||+|+||+||+|.+. +++    +||+|.++.. .....+.|.+|+.++++++|||||+++|+|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf             999783198208992999999958998898999999965134979999999999999867998881589999619-8369


Q ss_pred             EEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEC
Q ss_conf             99807899944330039888755567877764557876533468878655899999999999999988840899991533
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  661 (815)
                      ++||+.+|+|.+++...                             ...+++..+.+++.|+|.||+|||   +++|+||
T Consensus        88 v~e~~~~~~l~~~~~~~-----------------------------~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHr  135 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH-----------------------------KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR  135 (317)
T ss_dssp             EEECCTTCBHHHHHHHT-----------------------------SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEECCCCCCCCCCCCC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCC
T ss_conf             99842687401011133-----------------------------457999999999999999999998---7695047


Q ss_pred             CCCCCCEEECCCCCEEECCCCCCEECCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCC
Q ss_conf             6889964776999814514445400289975---43234665424884348999999976852228899999883-9988
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGLD---EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKP  737 (815)
Q Consensus       662 Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~ellt-g~~p  737 (815)
                      ||||+|||++.++.+||+|||+|+.......   .....||..|+|||++.+..  ++.++|||||||++|||+| |+.|
T Consensus       136 DlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDvwS~Gvil~el~t~g~~p  213 (317)
T d1xkka_         136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP  213 (317)
T ss_dssp             CCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCHHHCCEECCCCCEEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHHHHCCC--CCHHHHHHHHHHHHHHHHHCCCCC
T ss_conf             621203116799875860255222335444532236510586446708874699--983565440799999999779999


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             9999984323338999999885287875446644588998999999999954025599999999999999986452
Q 003504          738 LGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       738 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~  813 (815)
                      |.+....+    +...+.    .         ..+...|..++.++.+++.+||+.||.+||+|.++++.|..+.+
T Consensus       214 ~~~~~~~~----~~~~i~----~---------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         214 YDGIPASE----ISSILE----K---------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             TTTSCGGG----HHHHHH----H---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHHH----HHHHHH----C---------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             99999899----999997----5---------99899985568999999998478993469199999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.78  Aligned_cols=250  Identities=23%  Similarity=0.310  Sum_probs=207.3

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCC------CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEE
Q ss_conf             2999998010249800399991-9994999999614895------12999999999962899999213422888299469
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST------LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRI  580 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  580 (815)
                      ++|++.+.||+|+||+||+|+. .+++.||||++.+...      ...+.+.+|+.++++++|||||++++++.+....+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf             67798279811789599999999999899999987566321340689999999999998679989993889999799899


Q ss_pred             EEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEE
Q ss_conf             99980789994433003988875556787776455787653346887865589999999999999998884089999153
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  660 (815)
                      +||||+++|+|.+++..                              ...+++.....++.|++.||+|||   +++|+|
T Consensus        90 iv~E~~~gg~L~~~i~~------------------------------~~~l~~~~~~~~~~qi~~al~yLH---~~~ivH  136 (293)
T d1jksa_          90 LILELVAGGELFDFLAE------------------------------KESLTEEEATEFLKQILNGVYYLH---SLQIAH  136 (293)
T ss_dssp             EEEECCCSCBHHHHHHH------------------------------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             EEEECCCCCCCCCHHCC------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEE
T ss_conf             99986778643100103------------------------------564215578999999999987666---254221


Q ss_pred             CCCCCCCEEECCCC----CEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf             36889964776999----81451444540028997543234665424884348999999976852228899999883998
Q 003504          661 RDIKASSVYLDMNL----EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       661 ~Dlk~~Nili~~~~----~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~  736 (815)
                      |||||+||+++.++    .+|++|||+|+....+.......|++.|+|||++.+..  ++.++||||+||++|||++|+.
T Consensus       137 rDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~  214 (293)
T d1jksa_         137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGAS  214 (293)
T ss_dssp             CCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCCCEEEEECCCCCCCCEEECCHHHHHHCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCC
T ss_conf             13330127982589866646964334421057776312247777430999981899--9976652214099999970889


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             8999998432333899999988528787544664458899899999999995402559999999999999
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       737 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      ||.+....+.       ........       .......+...+.++.+++.+||+.||++||+++++++
T Consensus       215 Pf~~~~~~~~-------~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         215 PFLGDTKQET-------LANVSAVN-------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             SSCCSSHHHH-------HHHHHTTC-------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHH-------HHHHHHCC-------CCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             9889999999-------99998168-------88870104788999999999986389668919999961

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.07  Aligned_cols=246  Identities=22%  Similarity=0.309  Sum_probs=205.4

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECC---CCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEE
Q ss_conf             2999998010249800399991-99949999996148---9512999999999962899999213422888299469999
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG---STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||+||+|.. .+++.||||++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             87789889850879099999998999799999986577557778999999999998768888617999999899889999


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCC
Q ss_conf             80789994433003988875556787776455787653346887865589999999999999998884089999153368
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  663 (815)
                      ||+++|+|.+++..                              ...+++.....++.|++.||+|||   +++|+||||
T Consensus        88 Ey~~gg~L~~~~~~------------------------------~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDi  134 (288)
T d1uu3a_          88 SYAKNGELLKYIRK------------------------------IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDL  134 (288)
T ss_dssp             CCCTTEEHHHHHHH------------------------------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred             ECCCCCCHHHHHHC------------------------------CCCCCHHHHHHHHHHHHHHHHHHC---CCCEECCCC
T ss_conf             70489877776531------------------------------599999999999999999997621---650884767


Q ss_pred             CCCCEEECCCCCEEECCCCCCEECCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf             8996477699981451444540028997---5432346654248843489999999768522288999998839988999
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       664 k~~Nili~~~~~~ki~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~  740 (815)
                      ||+|||++.++.+||+|||+|+.+....   .....+||+.|+|||++.+..  ++.++||||+||++|||++|+.||.+
T Consensus       135 Kp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~  212 (288)
T d1uu3a_         135 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRA  212 (288)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCC--CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCCCCCCCCEEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCC--CCCCCCEEHHHHHHHHHHHCCCCCCC
T ss_conf             7412366888538860321024225677643335556775525844002689--89666230456999998038899899


Q ss_pred             CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             998432333899999988528787544664458899899999999995402559999999999999
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      ....+       .........           ...|...+.++.+++.+||+.||++|||++|+++
T Consensus       213 ~~~~~-------~~~~i~~~~-----------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         213 GNEYL-------IFQKIIKLE-----------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             SSHHH-------HHHHHHTTC-----------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CCHHH-------HHHHHHCCC-----------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf             59999-------999997189-----------9998547999999999985579768919789737

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=356.53  Aligned_cols=247  Identities=24%  Similarity=0.279  Sum_probs=206.8

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECC---CCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEE
Q ss_conf             22999998010249800399991-99949999996148---951299999999996289999921342288829946999
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG---STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  582 (815)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++++.   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             47428988983176849999999899989999998156544979999999999999867999887787640356421110


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECC
Q ss_conf             98078999443300398887555678777645578765334688786558999999999999999888408999915336
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  662 (815)
                      |||+++|+|.+++..                              ...++......++.|++.||+|||   +++|+|||
T Consensus        84 ~ey~~gg~L~~~~~~------------------------------~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRD  130 (337)
T d1o6la_          84 MEYANGGELFFHLSR------------------------------ERVFTEERARFYGAEIVSALEYLH---SRDVVYRD  130 (337)
T ss_dssp             EECCTTCBHHHHHHH------------------------------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCC
T ss_pred             EECCCCCCHHHHHHC------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCC
T ss_conf             003579860555532------------------------------567759999999999965211343---15962246


Q ss_pred             CCCCCEEECCCCCEEECCCCCCEECCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf             889964776999814514445400289-9754323466542488434899999997685222889999988399889999
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGN-GLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       663 lk~~Nili~~~~~~ki~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~  741 (815)
                      |||+|||++.++.+||+|||+|+.... .......+||+.|+|||++.+..  ++.++||||+||++|||++|+.||.+.
T Consensus       131 lKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~--y~~~~DiwSlGvilyeml~G~~pf~~~  208 (337)
T d1o6la_         131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQ  208 (337)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC--BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCHHHEEECCCCCEEEEECCCCCCCCCCCCCCCCCEECHHHHHHHHCCCCC--CCHHHCCCCHHHHHHHHHHCCCCCCCC
T ss_conf             477784765899888820565200356786205510088996666504898--883331022306788998789999996


Q ss_pred             CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             98432333899999988528787544664458899899999999995402559999999-----999999
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS-----MQQIVG  806 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~il~  806 (815)
                      ...+       .........           ...|...+.++.+++.+||+.||.+||+     ++++++
T Consensus       209 ~~~~-------~~~~i~~~~-----------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         209 DHER-------LFELILMEE-----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             SHHH-------HHHHHHHCC-----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CHHH-------HHHHHHCCC-----------CCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf             9999-------999985289-----------989866899999999866638934422565234999972

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=362.56  Aligned_cols=256  Identities=24%  Similarity=0.361  Sum_probs=209.1

Q ss_pred             HCCCCCCCEECCCCCEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEEC
Q ss_conf             22999998010249800399991999499999961489512999999999962899999213422888299469999807
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  586 (815)
                      .++|++.+.||+|+||.||+|.+.++..||||++... ....+.|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf             7997984699307980999999999999999998804-4888999999999986666788689999823-9759999944


Q ss_pred             CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCC
Q ss_conf             89994433003988875556787776455787653346887865589999999999999998884089999153368899
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~  666 (815)
                      ++|+|..++...                            ....++|..++.++.|+|.||+|||   +.+|+||||||+
T Consensus        94 ~~g~l~~~~~~~----------------------------~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~  142 (285)
T d1fmka3          94 SKGSLLDFLKGE----------------------------TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAA  142 (285)
T ss_dssp             TTCBHHHHHSHH----------------------------HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             CCCCHHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHH---HHHEECCCCCCE
T ss_conf             799435420000----------------------------3553059999999999999999875---411433531230


Q ss_pred             CEEECCCCCEEECCCCCCEECCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             6477699981451444540028997--54323466542488434899999997685222889999988399889999984
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       667 Nili~~~~~~ki~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~~  744 (815)
                      |||++.++.+||+|||+|+......  ......|+..|+|||++....  ++.++|||||||++|||++|..|+..... 
T Consensus       143 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~S~Giil~el~t~~~p~~~~~~-  219 (285)
T d1fmka3         143 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMV-  219 (285)
T ss_dssp             GEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCC-
T ss_pred             EEEECCCCCEEECCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHHCCC--CCCHHHHHCCHHHHHHHHHCCCCCCCCCC-
T ss_conf             799989992998442555425688733524545566545808983799--89177413235899999868999998888-


Q ss_pred             CCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             323338999999885287875446644588998999999999954025599999999999999986452
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~  813 (815)
                        ...+...   ...          ..+...+..++.++.+++.+||+.||++||+|++|++.|++...
T Consensus       220 --~~~~~~~---i~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         220 --NREVLDQ---VER----------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             --HHHHHHH---HHT----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             --HHHHHHH---HHH----------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf             --9999999---982----------68999983237999999999756697589199999998766623

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.40  Aligned_cols=268  Identities=24%  Similarity=0.295  Sum_probs=203.5

Q ss_pred             CCCCCCCEECCCCCEEEEEEECCCCCEEEEEEEECCCCCCHHHH--HHHHHHHCCCCCCCCEEEEEEEEECC----EEEE
Q ss_conf             29999980102498003999919994999999614895129999--99999962899999213422888299----4699
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEA--ARELEYLGRIKHPNLVPLTGYCIAGD----QRIA  581 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l  581 (815)
                      ++|...+.||+|+||.||+|++. ++.||||+++..   ..+.+  +.|+..+.+++||||++++|+|.+.+    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf             68999889820788199999999-989999998720---04679999999999627998683268899837986048999


Q ss_pred             EEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----CCC
Q ss_conf             998078999443300398887555678777645578765334688786558999999999999999888408-----999
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHG-----CSP  656 (815)
Q Consensus       582 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~-----~~~  656 (815)
                      ||||+++|+|.++++..                               .++|..+.+++.|+|.||+|+|+.     .++
T Consensus        79 v~Ey~~~g~L~~~l~~~-------------------------------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~  127 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY-------------------------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP  127 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-------------------------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred             EEECCCCCCHHHHHHCC-------------------------------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf             99646698989998658-------------------------------99989999999999999999887665204689


Q ss_pred             CEEECCCCCCCEEECCCCCEEECCCCCCEECCCCC-----CCCCCCCCCCCCCCCCCCCCCC----CCCCCCCCHHHHHH
Q ss_conf             91533688996477699981451444540028997-----5432346654248843489999----99976852228899
Q 003504          657 PIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-----DEEIARGSPGYIPPEFAQPDSD----FPTPKSDVYCYGVV  727 (815)
Q Consensus       657 ~ivH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~----~~~~~sDvwSlGvi  727 (815)
                      +|+||||||+|||++.++.+||+|||+++......     ......||+.|+|||++.+...    .++.++|||||||+
T Consensus       128 ~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvv  207 (303)
T d1vjya_         128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV  207 (303)
T ss_dssp             EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred             CEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHH
T ss_conf             86615317313578688776887638662346777620013552503547678221056545467776750122015999


Q ss_pred             HHHHHHCCCCCCCCCCCCC-------CCCHHHHHHHHHHCCCCCCCCCCCCCCCC-CHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             9998839988999998432-------33389999998852878754466445889-989999999999540255999999
Q 003504          728 LLELITGKKPLGDDYPEEK-------EGNLVSWVRGLVRNNKGSRAIDPKIRDTG-PEKQMEEALKIGYLCTADLPLKRP  799 (815)
Q Consensus       728 l~elltg~~pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RP  799 (815)
                      +|||+||..||........       ................    .+|.+.... ..+.+..+.+++.+||+.||++||
T Consensus       208 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  283 (303)
T d1vjya_         208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARL  283 (303)
T ss_dssp             HHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC
T ss_pred             HHHHHHCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHHHCCC----CCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCC
T ss_conf             999962899887663112410122556430999999875024----6888776557768999999999997606985895


Q ss_pred             CHHHHHHHHHHHHHC
Q ss_conf             999999999864520
Q 003504          800 SMQQIVGLLKDIEST  814 (815)
Q Consensus       800 s~~~il~~L~~~~~~  814 (815)
                      ||.||++.|+++.+.
T Consensus       284 s~~ei~~~L~~i~~~  298 (303)
T d1vjya_         284 TALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHH
T ss_conf             999999999988886

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=352.40  Aligned_cols=250  Identities=22%  Similarity=0.237  Sum_probs=200.2

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCC---CCHHHHH---HHHHHHCCCCCCCCEEEEEEEEECCEE
Q ss_conf             22999998010249800399991-9994999999614895---1299999---999996289999921342288829946
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST---LTDQEAA---RELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~  579 (815)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.+...   .....+.   .++.+++.++|||||++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf             77685101884288909999999999979999998458754266799999999999998508998588999999989988


Q ss_pred             EEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEE
Q ss_conf             99998078999443300398887555678777645578765334688786558999999999999999888408999915
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~iv  659 (815)
                      ++||||+++|+|.+++..                              ...+++.....++.|++.||.|||   +++|+
T Consensus        83 ~ivmE~~~gg~L~~~l~~------------------------------~~~~~e~~~~~~~~qi~~aL~ylH---~~~ii  129 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ------------------------------HGVFSEADMRFYAAEIILGLEHMH---NRFVV  129 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH------------------------------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             EEEEEECCCCCHHHHHHH------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCC
T ss_conf             999991489838999873------------------------------255327899999999999999999---77962


Q ss_pred             ECCCCCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf             33688996477699981451444540028997543234665424884348999999976852228899999883998899
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLG  739 (815)
Q Consensus       660 H~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~  739 (815)
                      ||||||+|||++.++.+||+|||+|+..... ......||+.|+|||++..... ++.++||||+||++|||++|+.||.
T Consensus       130 HrDlKP~NILl~~~g~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~  207 (364)
T d1omwa3         130 YRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFR  207 (364)
T ss_dssp             CCCCSGGGEEECSSSCEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCC-CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CEEECCCEEEECCCCCEEEEEECEEEECCCC-CCCCCCCCCCCCHHHHHHCCCC-CCCCCCHHHHHHHHHHHHHCCCCCC
T ss_conf             2044422167858896798220102333788-6433113455421687603899-9844104677899999985999888


Q ss_pred             CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             9998432333899999988528787544664458899899999999995402559999999-----999999
Q 003504          740 DDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS-----MQQIVG  806 (815)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~il~  806 (815)
                      .....+.    .......    .       ......+...++++.+++.+||+.||++||+     ++++++
T Consensus       208 ~~~~~~~----~~~~~~~----~-------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         208 QHKTKDK----HEIDRMT----L-------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSCSSCH----HHHHHHS----S-------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCHHHH----HHHHHHC----C-------CCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf             8998999----9999860----4-------688878877899999999998566988808874357999974

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.12  Aligned_cols=271  Identities=23%  Similarity=0.335  Sum_probs=212.5

Q ss_pred             CCCCCCCEECCCCCEEEEEEECCC-CC--EEEEEEEECCC-CCCHHHHHHHHHHHCCC-CCCCCEEEEEEEEECCEEEEE
Q ss_conf             299999801024980039999199-94--99999961489-51299999999996289-999921342288829946999
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPG-GI--HVAVKVLVHGS-TLTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  582 (815)
                      ++|++.++||+|+||.||+|.+.+ +.  .||||.+.... ....+.+.+|++++.++ +||||++++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf             99688779820788289999998999699999999782338579999999999998622899883678888418736999


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECC
Q ss_conf             98078999443300398887555678777645578765334688786558999999999999999888408999915336
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  662 (815)
                      |||+++|+|.++++.......              .............+++..+.+++.|+|.||.|+|   +++|+|||
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~--------------~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrD  152 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLET--------------DPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRD  152 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHH--------------CHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred             EEECCCCCHHHHHHHCCCCCC--------------CHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---CCCCCCCC
T ss_conf             980289869999864035555--------------5123101234578999999999999999987663---08954555


Q ss_pred             CCCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCC
Q ss_conf             8899647769998145144454002899754323466542488434899999997685222889999988399-889999
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK-KPLGDD  741 (815)
Q Consensus       663 lk~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~-~pf~~~  741 (815)
                      |||+|||++.++.+||+|||+|+............||..|+|||.+....  ++.++|||||||++|||++|. .||.+.
T Consensus       153 lkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDvwSfGvil~ell~~~~~p~~~~  230 (309)
T d1fvra_         153 LAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGM  230 (309)
T ss_dssp             CSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCCCEEEECCCCCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCC--CCCCCEEEHHHHHHHHHHHCCCCCCCCC
T ss_conf             05204898688763874344322444223455301377555538752699--9962215313889999983689999999


Q ss_pred             CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf             9843233389999998852878754466445889989999999999540255999999999999999864520
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~~  814 (815)
                      ...       .....+..          ..+...+..+++++.+++.+||+.||++||+|++|++.|+++.+.
T Consensus       231 ~~~-------~~~~~i~~----------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         231 TCA-------ELYEKLPQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             CHH-------HHHHHGGG----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CHH-------HHHHHHHH----------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             999-------99999982----------688888766789999999997678966894999999999999861

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.91  Aligned_cols=252  Identities=28%  Similarity=0.395  Sum_probs=202.5

Q ss_pred             CCEECCCCCEEEEEEECCC----CCEEEEEEEECC-CCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEEC-CEEEEEEEEC
Q ss_conf             9801024980039999199----949999996148-951299999999996289999921342288829-9469999807
Q 003504          513 GTLLAEGKFGPVYRGFLPG----GIHVAVKVLVHG-STLTDQEAARELEYLGRIKHPNLVPLTGYCIAG-DQRIAIYDYM  586 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~  586 (815)
                      .++||+|+||+||+|.+..    ...||||+++.. .....+.|.+|++++++++||||++++|++... ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf             66981368809999999779987999999998843697899999999999986789998678678980699438999874


Q ss_pred             CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCC
Q ss_conf             89994433003988875556787776455787653346887865589999999999999998884089999153368899
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~  666 (815)
                      ++|+|.++++..                             ....++..+++++.|+|.||.|+|   +++|+||||||+
T Consensus       112 ~~g~l~~~~~~~-----------------------------~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~  159 (311)
T d1r0pa_         112 KHGDLRNFIRNE-----------------------------THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAAR  159 (311)
T ss_dssp             TTCBHHHHHHCT-----------------------------TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             ECCCHHHHHCCC-----------------------------CCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHH
T ss_conf             067414421013-----------------------------454048999999999887652003---367625776687


Q ss_pred             CEEECCCCCEEECCCCCCEECCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf             6477699981451444540028997-----54323466542488434899999997685222889999988399889999
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       667 Nili~~~~~~ki~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~  741 (815)
                      |||++.++.+||+|||+++......     ......|+..|+|||++....  ++.++||||||+++|||++|+.||...
T Consensus       160 NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~SfGivl~El~t~~~p~~~~  237 (311)
T d1r0pa_         160 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPD  237 (311)
T ss_dssp             GEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred             HEEECCCCCEEEECCCCHHHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf             576779998899106523225566555310025655564556768874379--997457466199999999789999888


Q ss_pred             CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf             9843233389999998852878754466445889989999999999540255999999999999999864520
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~~  814 (815)
                      ...   ..+..+   ....   .       +...|..++.++.+++.+||+.||++||+|.||++.|+++.+.
T Consensus       238 ~~~---~~~~~~---i~~g---~-------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         238 VNT---FDITVY---LLQG---R-------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             --------CHHH---HHTT---C-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCH---HHHHHH---HHCC---C-------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             999---999999---9808---9-------8899644759999999997688976893999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=352.91  Aligned_cols=245  Identities=24%  Similarity=0.297  Sum_probs=204.6

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECC---CCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEE
Q ss_conf             22999998010249800399991-99949999996148---951299999999996289999921342288829946999
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG---STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  582 (815)
                      .++|++.+.||+|+||+||+|+. .+++.||||++++.   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf             54708888972076808999999899979999998457754889999999999999863696753303568528800567


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECC
Q ss_conf             98078999443300398887555678777645578765334688786558999999999999999888408999915336
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  662 (815)
                      |||+++|+|..++..                              ....+......++.|++.||+|||   +++|+|||
T Consensus        83 mE~~~gg~l~~~~~~------------------------------~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrD  129 (316)
T d1fota_          83 MDYIEGGELFSLLRK------------------------------SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRD  129 (316)
T ss_dssp             ECCCCSCBHHHHHHH------------------------------TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCC
T ss_pred             EEECCCCCCCCCCCC------------------------------CCCCCCCHHHHHHHHHHHHHHHHC---CCCEECCC
T ss_conf             650378632234322------------------------------221110079999999987655412---47677055


Q ss_pred             CCCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             88996477699981451444540028997543234665424884348999999976852228899999883998899999
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       663 lk~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~  742 (815)
                      |||+|||++.++.+||+|||+|+.....  ....+||+.|+|||++.+..  ++.++||||+||++|||++|+.||.+..
T Consensus       130 iKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~--y~~~~DiwSlGvilyemltG~~Pf~~~~  205 (316)
T d1fota_         130 LKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKP--YNKSIDWWSFGILIYEMLAGYTPFYDSN  205 (316)
T ss_dssp             CCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCC--BCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CCCHHEEECCCCCEEEECCCCCEEECCC--CCCCCCCCCCCCHHHHCCCC--CCCHHHCCCCCHHHHHHHHCCCCCCCCC
T ss_conf             6810503868998898317521671245--64345763435999983899--9804304653336899975989999969


Q ss_pred             CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             843233389999998852878754466445889989999999999540255999999-----9999999
Q 003504          743 PEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~il~  806 (815)
                      ..+       .........           ...|...+.++.+++.+||..||.+||     +++++++
T Consensus       206 ~~~-------~~~~i~~~~-----------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         206 TMK-------TYEKILNAE-----------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHH-------HHHHHHHCC-----------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHH-------HHHHHHCCC-----------CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf             999-------999997089-----------889977899999999999544997666431021999981

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.34  Aligned_cols=253  Identities=24%  Similarity=0.349  Sum_probs=209.6

Q ss_pred             HCCCCCCCEECCCCCEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEE-CCEEEEEEEE
Q ss_conf             229999980102498003999919994999999614895129999999999628999992134228882-9946999980
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIA-GDQRIAIYDY  585 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  585 (815)
                      .++|++.+.||+|+||.||+|.+. +..||||+++..  ...+.+.+|++++++++||||++++|+|.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf             899488579820798089999999-909999998857--77999999999998678989854987887238928999963


Q ss_pred             CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCC
Q ss_conf             78999443300398887555678777645578765334688786558999999999999999888408999915336889
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~  665 (815)
                      +++|+|.+++...                            ....++|..+++++.|+|.||.|||   +.+|+||||||
T Consensus        83 ~~~g~L~~~l~~~----------------------------~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp  131 (262)
T d1byga_          83 MAKGSLVDYLRSR----------------------------GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAA  131 (262)
T ss_dssp             CTTEEHHHHHHHH----------------------------HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             CCCCCHHHHHHHC----------------------------CCCCCCHHHHHHHHHHHHHHCCCCC---CCCEECCCCCH
T ss_conf             6999899998745----------------------------7888899999999999985232113---37655366656


Q ss_pred             CCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCC
Q ss_conf             96477699981451444540028997543234665424884348999999976852228899999883-99889999984
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPLGDDYPE  744 (815)
Q Consensus       666 ~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf~~~~~~  744 (815)
                      +||+++.++.+|++|||+++.....  .....++..|+|||++.+..  ++.++|||||||++|||+| |+.||......
T Consensus       132 ~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~--~t~~sDIwSfG~il~el~t~~~~p~~~~~~~  207 (262)
T d1byga_         132 RNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  207 (262)
T ss_dssp             GGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred             HHHEECCCCCEEECCCCCCEECCCC--CCCCCCCCCCCCHHHHHCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH
T ss_conf             7601468997763245600344787--76556664677817872798--8858877757999999997899999999999


Q ss_pred             CCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf             3233389999998852878754466445889989999999999540255999999999999999864520
Q 003504          745 EKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~~  814 (815)
                          ++...+.    .         ..+.+.+..+++++.+++.+||+.||.+||+|.++++.|++++.+
T Consensus       208 ----~~~~~i~----~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         208 ----DVVPRVE----K---------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             ----GHHHHHT----T---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHHH----C---------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             ----9999998----0---------899999765799999999997566976893999999999999867

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.92  Aligned_cols=244  Identities=21%  Similarity=0.333  Sum_probs=194.1

Q ss_pred             CCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCC--CCCHHHHHHHHHHHCCCCCCCCEEEEEEEEE----CCEEEEEE
Q ss_conf             9998010249800399991-999499999961489--5129999999999628999992134228882----99469999
Q 003504          511 DRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS--TLTDQEAARELEYLGRIKHPNLVPLTGYCIA----GDQRIAIY  583 (815)
Q Consensus       511 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  583 (815)
                      ...++||+|+||+||+|.. .++..||+|.+....  ....+.+.+|++++++++|||||++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf             85169700828499999999999599999985122798999999999999985799985069999840334588899999


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCC--EEEC
Q ss_conf             80789994433003988875556787776455787653346887865589999999999999998884089999--1533
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP--IIHR  661 (815)
Q Consensus       584 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~  661 (815)
                      ||+++|+|.+++..                              ...+++..+..++.|++.||+|||   +++  |+||
T Consensus        92 E~~~~g~L~~~l~~------------------------------~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHr  138 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR------------------------------FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHR  138 (270)
T ss_dssp             ECCCSCBHHHHHHH------------------------------HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCS
T ss_pred             ECCCCCCHHHHHHC------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEEC
T ss_conf             57898948999751------------------------------355469999999999999999999---789979968


Q ss_pred             CCCCCCEEEC-CCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf             6889964776-999814514445400289975432346654248843489999999768522288999998839988999
Q 003504          662 DIKASSVYLD-MNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       662 Dlk~~Nili~-~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~  740 (815)
                      ||||+|||++ .++.+||+|||+|+..... ......||+.|+|||++.+ .  ++.++|||||||++|||++|+.||.+
T Consensus       139 DiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~-~--~~~~~DIwSlGvilyel~~g~~Pf~~  214 (270)
T d1t4ha_         139 DLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-K--YDESVDVYAFGMCMLEMATSEYPYSE  214 (270)
T ss_dssp             CCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-C--CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCHHHCEEECCCCCEEEEECCCCEECCCC-CCCCCCCCCCCCCHHHHCC-C--CCCCCCHHHHHHHHHHHHHCCCCCCC
T ss_conf             767435116679998898005765423687-6677553813008988478-9--99867110079999999878899987


Q ss_pred             CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             998432333899999988528787544664458899899999999995402559999999999999
Q 003504          741 DYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      ....      ........ ..    ...+..    +...++++.+++.+||+.||++|||++|+++
T Consensus       215 ~~~~------~~~~~~i~-~~----~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         215 CQNA------AQIYRRVT-SG----VKPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CSSH------HHHHHHHT-TT----CCCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCH------HHHHHHHH-CC----CCCCCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             6559------99999997-38----998656----7557899999999976379758929999967

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.97  Aligned_cols=255  Identities=24%  Similarity=0.328  Sum_probs=208.4

Q ss_pred             HCCCCCCCEECCCCCEEEEEEECCC----CCEEEEEEEECCCCC-CHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEE
Q ss_conf             2299999801024980039999199----949999996148951-29999999999628999992134228882994699
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPG----GIHVAVKVLVHGSTL-TDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  581 (815)
                      .++|++.+.||+|+||.||+|.+..    +..||||.++..... ..+.+.+|+.++++++||||++++|++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf             8996987799307882999999936996449999999365668799999999999998689999856988995-374799


Q ss_pred             EEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEC
Q ss_conf             99807899944330039888755567877764557876533468878655899999999999999988840899991533
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  661 (815)
                      ||||+++|+|.+++...                             ...+++..+..++.|++.||.|||   +++++||
T Consensus        85 v~E~~~~g~l~~~~~~~-----------------------------~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHr  132 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR-----------------------------KYSLDLASLILYAYQLSTALAYLE---SKRFVHR  132 (273)
T ss_dssp             EEECCTTEEHHHHHHHT-----------------------------TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEECCCCCHHHHHHCC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHC---CCCEECC
T ss_conf             99840698077654224-----------------------------789999999999999987752302---2674414


Q ss_pred             CCCCCCEEECCCCCEEECCCCCCEECCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCC
Q ss_conf             688996477699981451444540028997--543234665424884348999999976852228899999883-99889
Q 003504          662 DIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-GKKPL  738 (815)
Q Consensus       662 Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~ellt-g~~pf  738 (815)
                      ||||+||+++.++.+||+|||+|+......  ......||+.|+|||++....  ++.++|||||||++|||++ |.+||
T Consensus       133 DlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~--~~~~~DiwSlGvil~e~lt~g~~P~  210 (273)
T d1mp8a_         133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPF  210 (273)
T ss_dssp             CCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCHHHEEECCCCCEEECCCHHHEECCCCCCEECCCEECCCCCCHHHHHCCCC--CCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf             10265532067896787650342133677623305400583103266751699--8874524442478999982699998


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             999984323338999999885287875446644588998999999999954025599999999999999986452
Q 003504          739 GDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~  813 (815)
                      .+....+.    ...+   . ..         .....+..++.++.+++.+||+.||++|||+.+|++.|+++.+
T Consensus       211 ~~~~~~~~----~~~i---~-~~---------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         211 QGVKNNDV----IGRI---E-NG---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             TTCCGGGH----HHHH---H-TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHH----HHHH---H-CC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             88999999----9999---8-18---------9998987779999999999768797689299999999999977

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.33  Aligned_cols=280  Identities=24%  Similarity=0.296  Sum_probs=211.2

Q ss_pred             HHHHHHHHCCCCCCCEECCCCCEEEEEEECC------CCCEEEEEEEECCCC-CCHHHHHHHHHHHCCC-CCCCCEEEEE
Q ss_conf             8899998229999980102498003999919------994999999614895-1299999999996289-9999213422
Q 003504          500 FADLLSATSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGST-LTDQEAARELEYLGRI-KHPNLVPLTG  571 (815)
Q Consensus       500 ~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~  571 (815)
                      ..+++...++|++.+.||+|+||.||+|...      +++.||||.++.... ...+.+.+|...+.++ +|+||+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEE
T ss_conf             82526167997984498416783999999867775557839999998600171789999999999886149984997411


Q ss_pred             EEEECC-EEEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf             888299-4699998078999443300398887555678777645578765334688786558999999999999999888
Q 003504          572 YCIAGD-QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFL  650 (815)
Q Consensus       572 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~L  650 (815)
                      ++...+ ..++||||+++|+|.++++........              ............+++..+..++.|++.||+||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~--------------~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl  150 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP--------------YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  150 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-------------------------CBCHHHHHHHHHHHHHHHHHH
T ss_pred             EECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCC--------------CCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf             5404797579999845899299999853666665--------------32220233214689999999999999999988


Q ss_pred             HCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEECCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf             40899991533688996477699981451444540028997---543234665424884348999999976852228899
Q 003504          651 HHGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV  727 (815)
Q Consensus       651 H~~~~~~ivH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvi  727 (815)
                      |   +++|+||||||+|||++.++.+||+|||+|+......   ......||..|+|||++.+..  ++.++|||||||+
T Consensus       151 H---~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gvi  225 (299)
T d1ywna1         151 A---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVL  225 (299)
T ss_dssp             H---HTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC--CCHHHHHHHHHHH
T ss_pred             H---HCCCCCCCCCCCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCC--CCCCCCEEEHHHH
T ss_conf             7---3797178677310657799828984575200113566522247516672102036864688--9966322136789


Q ss_pred             HHHHHHC-CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9998839-988999998432333899999988528787544664458899899999999995402559999999999999
Q 003504          728 LLELITG-KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       728 l~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      +|||++| ..||......+   .+.    ......         .+...+..+++++.+++.+||+.||++||||.++++
T Consensus       226 l~ellt~~~~p~~~~~~~~---~~~----~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~  289 (299)
T d1ywna1         226 LWEIFSLGASPYPGVKIDE---EFC----RRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  289 (299)
T ss_dssp             HHHHHTTSCCSSTTCCCSH---HHH----HHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHCCCCCCCCCCHHH---HHH----HHHHCC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             9999868899998999899---999----999638---------988888657899999999976779667919999999


Q ss_pred             HHHHHHHC
Q ss_conf             99864520
Q 003504          807 LLKDIEST  814 (815)
Q Consensus       807 ~L~~~~~~  814 (815)
                      .|+++.|+
T Consensus       290 ~L~~ilq~  297 (299)
T d1ywna1         290 HLGNLLQA  297 (299)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHC
T ss_conf             99799867

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=351.13  Aligned_cols=244  Identities=22%  Similarity=0.239  Sum_probs=204.4

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECC---CCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEE
Q ss_conf             2999998010249800399991-99949999996148---9512999999999962899999213422888299469999
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG---STLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  583 (815)
                      ++|++.+.||+|+||.||+|+. .+++.||||++...   .....+.+.+|+.+++.++||||+++++++......++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             37089889611768089999998999899999982677458899999999999999748772740344443222223222


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCC
Q ss_conf             80789994433003988875556787776455787653346887865589999999999999998884089999153368
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  663 (815)
                      ||+.+|+|..++..                              ...++......++.|++.||.|||   +++||||||
T Consensus       121 e~~~~g~l~~~l~~------------------------------~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDI  167 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR------------------------------IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDL  167 (350)
T ss_dssp             ECCTTCBHHHHHHH------------------------------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred             CCCCCCCHHHHHHH------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCC
T ss_conf             23346622666751------------------------------589899999999999999899998---599861767


Q ss_pred             CCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             89964776999814514445400289975432346654248843489999999768522288999998839988999998
Q 003504          664 KASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       664 k~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~  743 (815)
                      ||+|||++.++.+||+|||+|+.....  .....||+.|+|||++.+..  ++.++||||+||++|||++|+.||.+...
T Consensus       168 KP~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~~~  243 (350)
T d1rdqe_         168 KPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKG--YNKAVDWWALGVLIYEMAAGYPPFFADQP  243 (350)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CHHHCCCCCCCCEEEEECEEEEECCCC--CCCCCCCCCCCCHHHHCCCC--CCCCCCCCCHHHHHHHHHHCCCCCCCCCH
T ss_conf             999936077897886101033322566--64336763567889971799--88533114500789999758899899599


Q ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             43233389999998852878754466445889989999999999540255999999-----9999999
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-----SMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~~il~  806 (815)
                             ...........           ...+...+.++.+++.+||..||.+|+     +++++++
T Consensus       244 -------~~~~~~i~~~~-----------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         244 -------IQIYEKIVSGK-----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -------HHHHHHHHHCC-----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------HHHHHHHHCCC-----------CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf             -------99999986179-----------889766899999999998340998606553454999971

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.32  Aligned_cols=251  Identities=17%  Similarity=0.230  Sum_probs=207.0

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEE
Q ss_conf             22999998010249800399991-99949999996148951299999999996289999921342288829946999980
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  585 (815)
                      .++|++.+.||+|+||+||+|.. .+++.||+|.++.. ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf             01058878983177839999999899969999997578-66599999999999857997989098999889988999953


Q ss_pred             CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCC
Q ss_conf             78999443300398887555678777645578765334688786558999999999999999888408999915336889
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~  665 (815)
                      +++|+|.+++...                             ...++......++.|++.||+|||   +.+|+||||||
T Consensus        83 ~~gg~L~~~i~~~-----------------------------~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp  130 (321)
T d1tkia_          83 ISGLDIFERINTS-----------------------------AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRP  130 (321)
T ss_dssp             CCCCBHHHHHTSS-----------------------------SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred             CCCCCHHHHHHHC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCC
T ss_conf             8998088998753-----------------------------899999999999999999999998---76997513554


Q ss_pred             CCEEECCC--CCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             96477699--9814514445400289975432346654248843489999999768522288999998839988999998
Q 003504          666 SSVYLDMN--LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       666 ~Nili~~~--~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~  743 (815)
                      +|||++.+  ..+||+|||+++............+++.|+|||...+..  ++.++||||+||++|||++|+.||.....
T Consensus       131 ~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~--~~~~~DiWSlGvily~ll~G~~Pf~~~~~  208 (321)
T d1tkia_         131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLAETN  208 (321)
T ss_dssp             GGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCE--ECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             CCEEECCCCCEEEEECCCCHHHCCCCCCCCCCCCCCCCCCCCHHCCCCC--CCCHHHCCCHHHHHHHHHHCCCCCCCCCH
T ss_conf             4434437885189976441110034677532122332223402104877--78401130279999999828999999899


Q ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             432333899999988528787544664458899899999999995402559999999999999
Q 003504          744 EEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      .+       ..........       ......+...+.++.+++.+||..||.+||++.|+++
T Consensus       209 ~~-------~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         209 QQ-------IIENIMNAEY-------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HH-------HHHHHHHTCC-------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HH-------HHHHHHHCCC-------CCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             99-------9999983899-------9880223678999999999986699668909999963

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=349.44  Aligned_cols=252  Identities=21%  Similarity=0.260  Sum_probs=200.8

Q ss_pred             HCCCCCCC-EECCCCCEEEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHCCC-CCCCCEEEEEEEEE----CCEE
Q ss_conf             22999998-010249800399991-99949999996148951299999999996289-99992134228882----9946
Q 003504          507 TSNFDRGT-LLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRI-KHPNLVPLTGYCIA----GDQR  579 (815)
Q Consensus       507 ~~~~~~~~-~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  579 (815)
                      .++|.+.. .||+|+||.||+|.. .+++.||||+++.     ...+.+|++++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf             14879810796545486999999889998999999897-----4779999999998669999782989995034689789


Q ss_pred             EEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEE
Q ss_conf             99998078999443300398887555678777645578765334688786558999999999999999888408999915
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~iv  659 (815)
                      ++|||||++|+|.+++...                            ....+++.....++.|++.||+|||   +.+|+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~----------------------------~~~~l~e~~~~~i~~qi~~al~ylH---~~~ii  133 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR----------------------------GDQAFTEREASEIMKSIGEAIQYLH---SINIA  133 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC----------------------------SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             EEEEECCCCCCHHHHHHHC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCCC
T ss_conf             9999778998499999862----------------------------7877579999999999999999999---76986


Q ss_pred             ECCCCCCCEEECC---CCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf             3368899647769---9981451444540028997543234665424884348999999976852228899999883998
Q 003504          660 HRDIKASSVYLDM---NLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       660 H~Dlk~~Nili~~---~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~  736 (815)
                      ||||||+|||++.   .+.+||+|||+|+............||+.|+|||++.+..  ++.++||||+||++|||++|+.
T Consensus       134 HRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--y~~~~DiwSlGvily~lltg~~  211 (335)
T d2ozaa1         134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYP  211 (335)
T ss_dssp             CCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGG--GSHHHHHHHHHHHHHHHTTSSC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCHHHCCCC--CCHHHHHHHHCHHHHHHHHCCC
T ss_conf             44410022011355556631135455123336888643226775637927774898--8888888764516778865889


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             8999998432333899999988528787544664458899899999999995402559999999999999
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       737 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      ||.+....+....+.       ......   ............++++.+++.+||+.||++||++.|+++
T Consensus       212 Pf~~~~~~~~~~~~~-------~~i~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         212 PFYSNHGLAISPGMK-------TRIRMG---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCEETTCC---------------CCCSC---SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHH-------HHHHCC---CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             988988778899999-------998538---888898543469999999999975699657909999970

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.66  Aligned_cols=255  Identities=23%  Similarity=0.317  Sum_probs=205.7

Q ss_pred             HCCCCCCCEECCCCCEEEEEEECC--C--CCEEEEEEEECCC---CCCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEE
Q ss_conf             229999980102498003999919--9--9499999961489---51299999999996289999921342288829946
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP--G--GIHVAVKVLVHGS---TLTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~--~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  579 (815)
                      .++|++.+.||+|+||.||+|...  +  ...||||.+....   ....+.|.+|+.++++++||||++++|++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf             4891997898038883999999988999079999999983555798999999999999986899998789877740-100


Q ss_pred             EEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEE
Q ss_conf             99998078999443300398887555678777645578765334688786558999999999999999888408999915
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~iv  659 (815)
                      ++|+||+++|++.+++...                             ...+++..+++++.|+|.||.|||   +++|+
T Consensus        86 ~lv~e~~~~~~l~~~~~~~-----------------------------~~~l~~~~~~~~~~qi~~gl~ylH---~~~ii  133 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKH-----------------------------QGHFLLGTLSRYAVQVAEGMGYLE---SKRFI  133 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHH-----------------------------GGGSCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             HEEEEEECCCCHHHHHHCC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEE
T ss_conf             1146542386125444212-----------------------------689999999999999999998752---17875


Q ss_pred             ECCCCCCCEEECCCCCEEECCCCCCEECCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-C
Q ss_conf             336889964776999814514445400289975----43234665424884348999999976852228899999883-9
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLD----EEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-G  734 (815)
Q Consensus       660 H~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~ellt-g  734 (815)
                      ||||||+||+++.++.+||+|||+++.......    .....|+..|+|||++.+..  ++.++|||||||++|||+| |
T Consensus       134 HrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~S~Gvil~emlt~G  211 (273)
T d1u46a_         134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYG  211 (273)
T ss_dssp             CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTS
T ss_pred             EEEECHHHHCCCCCCCEEECCCHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHCC
T ss_conf             205668881565565433256115553035887526547632573107999983799--994215661489999999689


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             988999998432333899999988528787544664458899899999999995402559999999999999998645
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       735 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~  812 (815)
                      +.||.+....+       ........         ..+.+.+..++.++.+++.+||+.||++||||.+|.+.|.+.+
T Consensus       212 ~~Pf~~~~~~~-------~~~~i~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         212 QEPWIGLNGSQ-------ILHKIDKE---------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             CCTTTTCCHHH-------HHHHHHTS---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCCCCCCHHH-------HHHHHHHC---------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf             99999969999-------99999847---------9999985445399999999976889667929999999999649

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.29  Aligned_cols=274  Identities=28%  Similarity=0.384  Sum_probs=212.4

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEC------CCCCEEEEEEEECCCC-CCHHHHHHHHHHHCCC-CCCCCEEEEEEEEECCE
Q ss_conf             22999998010249800399991------9994999999614895-1299999999996289-99992134228882994
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL------PGGIHVAVKVLVHGST-LTDQEAARELEYLGRI-KHPNLVPLTGYCIAGDQ  578 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  578 (815)
                      .++|++.++||+|+||.||+|.+      ..++.||||+++.... .....+.+|+.++.++ +|||||+++|+|.+...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf             89969854982068829999998066447788699999987424877999999999998762699988789989831997


Q ss_pred             EEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCE
Q ss_conf             69999807899944330039888755567877764557876533468878655899999999999999988840899991
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~i  658 (815)
                      .++||||+++|+|.++++......... ...           ..........+++..+.+++.|+|.||+|||   ++++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~-~~~-----------~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~i  166 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICS-KTS-----------PAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNC  166 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCC-CCC-----------CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCE
T ss_conf             899997379987999998535665444-445-----------3322233458899999999999999999887---5792


Q ss_pred             EECCCCCCCEEECCCCCEEECCCCCCEECCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-C
Q ss_conf             533688996477699981451444540028997---543234665424884348999999976852228899999883-9
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT-G  734 (815)
Q Consensus       659 vH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~ellt-g  734 (815)
                      +||||||+||+++.++.+|++|||.++......   ......|++.|+|||++....  ++.++|||||||++|||+| |
T Consensus       167 vHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DIwS~G~~l~ellt~g  244 (311)
T d1t46a_         167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLG  244 (311)
T ss_dssp             CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTT
T ss_pred             EECCCCCCCCCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCC--CCCCCCCCCHHHHHHHHHHCC
T ss_conf             666241021000025752102340102336788615862013596876778861799--997400102589999998589


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             9889999984323338999999885287875446644588998999999999954025599999999999999986452
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIES  813 (815)
Q Consensus       735 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~  813 (815)
                      ++||......+.   +..    ....         ..+...+...+.++.+++.+||+.||.+||+|++|++.|+++.+
T Consensus       245 ~p~~~~~~~~~~---~~~----~i~~---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         245 SSPYPGMPVDSK---FYK----MIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             CCSSTTCCSSHH---HHH----HHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHH---HHH----HHHC---------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf             988778998999---999----9866---------89889854365999999999757796579299999999987653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=348.19  Aligned_cols=253  Identities=21%  Similarity=0.320  Sum_probs=208.3

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCC---------CHHHHHHHHHHHCCCC-CCCCEEEEEEEEEC
Q ss_conf             2999998010249800399991-99949999996148951---------2999999999962899-99921342288829
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL---------TDQEAARELEYLGRIK-HPNLVPLTGYCIAG  576 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  576 (815)
                      ++|++.+.||+|+||+||+|+. .+++.||||++......         ..+.+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf             63888528841768499999999999899999996244641147888999999999999999850799747997621467


Q ss_pred             CEEEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf             94699998078999443300398887555678777645578765334688786558999999999999999888408999
Q 003504          577 DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSP  656 (815)
Q Consensus       577 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~  656 (815)
                      +..++||||+++|+|.+++..                              ...+++.....++.|++.||+|||   ++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~------------------------------~~~l~e~~~~~~~~qi~~al~~lH---~~  129 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE------------------------------KVTLSEKETRKIMRALLEVICALH---KL  129 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH------------------------------HSSCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             CCEEEEEECCCCCHHHHHHHH------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HC
T ss_conf             605999976898668999986------------------------------599999999999999999999998---75


Q ss_pred             CEEECCCCCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCC----CCCCCCCCCCHHHHHHHHHHH
Q ss_conf             9153368899647769998145144454002899754323466542488434899----999997685222889999988
Q 003504          657 PIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPD----SDFPTPKSDVYCYGVVLLELI  732 (815)
Q Consensus       657 ~ivH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~sDvwSlGvil~ell  732 (815)
                      +|+||||||+||+++.++.+||+|||+++....+.......||..|+|||++.+.    ...++.++||||+||++|||+
T Consensus       130 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml  209 (277)
T d1phka_         130 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL  209 (277)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCEEEECCCCCEEECCCHHEEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHC
T ss_conf             99432346254898689983871240316726887213452467888988860534456788992331856560231032


Q ss_pred             HCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             399889999984323338999999885287875446644588998999999999954025599999999999999
Q 003504          733 TGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       733 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~  807 (815)
                      +|+.||.+....+.       .........       ..........++++.+++.+||+.||.+||++.|+++.
T Consensus       210 ~g~~Pf~~~~~~~~-------~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         210 AGSPPFWHRKQMLM-------LRMIMSGNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HSSCSSCCSSHHHH-------HHHHHHTCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CCCCCCCCCCHHHH-------HHHHHHCCC-------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             28889889999999-------999981898-------88985434689999999999765896689199999739

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.01  Aligned_cols=272  Identities=27%  Similarity=0.332  Sum_probs=213.5

Q ss_pred             HCCCCCCCEECCCCCEEEEEEECCC--------CCEEEEEEEECCCCC-CHHHHHHHHHHHCCC-CCCCCEEEEEEEEEC
Q ss_conf             2299999801024980039999199--------949999996148951-299999999996289-999921342288829
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTL-TDQEAARELEYLGRI-KHPNLVPLTGYCIAG  576 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  576 (815)
                      .++|++++.||+|+||.||+|...+        +..||||+++..... ...++.+|...+.++ +|||||+++|+|.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf             89969700985167828999998578755566754999999881128688999999999999813999697346522018


Q ss_pred             CEEEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf             94699998078999443300398887555678777645578765334688786558999999999999999888408999
Q 003504          577 DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSP  656 (815)
Q Consensus       577 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~  656 (815)
                      ...++||||+++|+|.+++...+....              .............+++..+++++.|+|.||+|||   +.
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~--------------~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~  154 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGL--------------EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SK  154 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC--------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             CEEEEEEECCCCCCHHHHHHHHCCCCC--------------CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HC
T ss_conf             868999973699909999986067764--------------3222334574346799999999999999998766---37


Q ss_pred             CEEECCCCCCCEEECCCCCEEECCCCCCEECCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             91533688996477699981451444540028997---543234665424884348999999976852228899999883
Q 003504          657 PIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELIT  733 (815)
Q Consensus       657 ~ivH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~ellt  733 (815)
                      +|+||||||+|||++.++.+||+|||+++......   ......|+..|+|||.+.+..  ++.++|||||||++|||++
T Consensus       155 ~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~--y~~k~DiwS~Gvvl~ell~  232 (299)
T d1fgka_         155 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFT  232 (299)
T ss_dssp             TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHT
T ss_pred             CEEEEEECCCCEEECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCC--CCCHHHHHHHHHHHHHHCC
T ss_conf             97863022102245478976762211101135555543146678884663266751798--8825554775888887401


Q ss_pred             -CCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             -9988999998432333899999988528787544664458899899999999995402559999999999999998645
Q 003504          734 -GKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       734 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~  812 (815)
                       |+.||.+....    .+.    ..+...         .....+..++.++.+++.+||+.||++||||.+|++.|+++.
T Consensus       233 ~g~~p~~~~~~~----~~~----~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         233 LGGSPYPGVPVE----ELF----KLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             TSCCSSTTCCHH----HHH----HHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHH----HHH----HHHHCC---------CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             798989999999----999----999728---------888987435299999999976679767939999999998886


Q ss_pred             HC
Q ss_conf             20
Q 003504          813 ST  814 (815)
Q Consensus       813 ~~  814 (815)
                      +.
T Consensus       296 a~  297 (299)
T d1fgka_         296 AL  297 (299)
T ss_dssp             HH
T ss_pred             HC
T ss_conf             04

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.75  Aligned_cols=266  Identities=21%  Similarity=0.287  Sum_probs=209.9

Q ss_pred             HCCCCCCCEECCCCCEEEEEEECC------CCCEEEEEEEECCCC-CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEE
Q ss_conf             229999980102498003999919------994999999614895-1299999999996289999921342288829946
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFLP------GGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  579 (815)
                      .++|.+.+.||+|+||.||+|.+.      ++..||||+++.... .....|.+|+.++++++||||++++|+|......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf             89918835982078818999998786447789689999987012868999999999999976999884125478428810


Q ss_pred             EEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEE
Q ss_conf             99998078999443300398887555678777645578765334688786558999999999999999888408999915
Q 003504          580 IAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPII  659 (815)
Q Consensus       580 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~iv  659 (815)
                      ++||||+++|+|.++++......                   . .......+++..+.+++.|+|.||.|||   +.+|+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~-------------------~-~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~iv  155 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAM-------------------A-NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFV  155 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHH-------------------H-HCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCB
T ss_pred             EEEEEECCCCCHHHHHHHCCCCC-------------------C-CCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEE
T ss_conf             67776048998899987503321-------------------1-3444688799999999999999999876---47965


Q ss_pred             ECCCCCCCEEECCCCCEEECCCCCCEECCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-
Q ss_conf             33688996477699981451444540028997---54323466542488434899999997685222889999988399-
Q 003504          660 HRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL---DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGK-  735 (815)
Q Consensus       660 H~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~-  735 (815)
                      ||||||+|||++.++++||+|||+|+......   ......|++.|+|||.+.+..  ++.++||||||+++|||+||. 
T Consensus       156 HrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~--~~~~~Dv~S~G~il~El~t~~~  233 (308)
T d1p4oa_         156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAE  233 (308)
T ss_dssp             CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSC
T ss_pred             ECEECCCCEEECCCCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCC--CCCCCCCCCHHHHHHHHHHCCC
T ss_conf             43286775403599649994245420235776303134023163237888873699--8833344437899999996899


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf             8899999843233389999998852878754466445889989999999999540255999999999999999864520
Q 003504          736 KPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIEST  814 (815)
Q Consensus       736 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~~~  814 (815)
                      .||.+...       ......+....          ....+..++..+.+++.+||+.||++||||++|++.|++..+.
T Consensus       234 ~p~~~~~~-------~~~~~~i~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         234 QPYQGLSN-------EQVLRFVMEGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             CTTTTSCH-------HHHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             CCCCCCCH-------HHHHHHHHHCC----------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf             99999899-------99999998088----------8888633539999999997577965893999999997876177

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=343.81  Aligned_cols=258  Identities=24%  Similarity=0.327  Sum_probs=209.9

Q ss_pred             HCCCCCCCEECCCCCEEEEEEE-CCCCCEEEEEEEECCCCCC---HHHHHHHHHHHCCCCCCCCEEEEEEEEECC----E
Q ss_conf             2299999801024980039999-1999499999961489512---999999999962899999213422888299----4
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGSTLT---DQEAARELEYLGRIKHPNLVPLTGYCIAGD----Q  578 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  578 (815)
                      .++|++.+.||+|+||.||+|. ..+++.||+|+++.....+   .+.+.+|+.+++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf             62069868996089929999999999989999998556646989999999999999856999887311435432688766


Q ss_pred             EEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCE
Q ss_conf             69999807899944330039888755567877764557876533468878655899999999999999988840899991
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~i  658 (815)
                      .++||||+++|+|.+++..                              ...+++.....++.|++.||+|||   +++|
T Consensus        86 ~~lvmE~~~g~~L~~~~~~------------------------------~~~l~~~~~~~i~~qi~~al~~lH---~~~i  132 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT------------------------------EGPMTPKRAIEVIADACQALNFSH---QNGI  132 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH------------------------------HCSCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             EEEEEECCCCCEEHHHHCC------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCC
T ss_conf             9999977889871011203------------------------------589999999999999999999998---5795


Q ss_pred             EECCCCCCCEEECCCCCEEECCCCCCEECCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             533688996477699981451444540028997----5432346654248843489999999768522288999998839
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG  734 (815)
Q Consensus       659 vH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg  734 (815)
                      +||||||+|||++.++..+++|||.+.......    ......||+.|+|||++.+..  ++.++||||+||++|||++|
T Consensus       133 iHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~~DiwSlGvilyelltG  210 (277)
T d1o6ya_         133 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTG  210 (277)
T ss_dssp             ECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHS
T ss_pred             CCCCCCCCCCCCCCCCCCEEEHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCCEECCCCHHHHHHHHHC
T ss_conf             2763467556657543201003444322123544333346425762436999983999--99663202652899999769


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHHH
Q ss_conf             98899999843233389999998852878754466445889989999999999540255999999-99999999986452
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRP-SMQQIVGLLKDIES  813 (815)
Q Consensus       735 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~~il~~L~~~~~  813 (815)
                      +.||.+..+.       ...........       ..........+.++.+++.+||+.||++|| +++++++.|.++..
T Consensus       211 ~~Pf~~~~~~-------~~~~~~~~~~~-------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         211 EPPFTGDSPV-------SVAYQHVREDP-------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             SCSCCCSSHH-------HHHHHHHHCCC-------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             CCCCCCCCHH-------HHHHHHHHCCC-------CCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf             7998996999-------99999984699-------997100347899999999998667976777399999999999758

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.18  Aligned_cols=246  Identities=23%  Similarity=0.304  Sum_probs=201.4

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCC---CCCHHHHHHHHHHHC-CCCCCCCEEEEEEEEECCEEEEE
Q ss_conf             2999998010249800399991-999499999961489---512999999999962-89999921342288829946999
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGS---TLTDQEAARELEYLG-RIKHPNLVPLTGYCIAGDQRIAI  582 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  582 (815)
                      ++|++.+.||+|+||+||+|.. .+++.||||++++..   ....+.+.+|..++. .++||||+++++++.+.+..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf             97188658940878289999999999899999980555338489999999999999847999687898897049831677


Q ss_pred             EEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECC
Q ss_conf             98078999443300398887555678777645578765334688786558999999999999999888408999915336
Q 003504          583 YDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRD  662 (815)
Q Consensus       583 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D  662 (815)
                      |||+++|+|.+++..                              ...++......++.|++.||+|||   +++|+|||
T Consensus        82 mEy~~~g~L~~~i~~------------------------------~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrD  128 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS------------------------------CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRD  128 (320)
T ss_dssp             EECCTTCBHHHHHHH------------------------------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCC
T ss_pred             EEECCCCCHHHHHHC------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECC
T ss_conf             750379808998640------------------------------478999999999999999999998---68934034


Q ss_pred             CCCCCEEECCCCCEEECCCCCCEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf             88996477699981451444540028997-54323466542488434899999997685222889999988399889999
Q 003504          663 IKASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDD  741 (815)
Q Consensus       663 lk~~Nili~~~~~~ki~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~  741 (815)
                      |||+|||++.++.+||+|||+|+...... ......||+.|+|||++.+..  ++.++||||+||++|||++|+.||.+.
T Consensus       129 ikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~PF~~~  206 (320)
T d1xjda_         129 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQ  206 (320)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCCCEEECCCCCEECCCCCHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf             765404444899630155530232356653345457877768999982799--883232011227898987388999998


Q ss_pred             CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf             9843233389999998852878754466445889989999999999540255999999999-9999
Q 003504          742 YPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ-QIVG  806 (815)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-~il~  806 (815)
                      ...+.       .......       .+    ..|...+.++.+++.+||..||++||++. ++++
T Consensus       207 ~~~~~-------~~~i~~~-------~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         207 DEEEL-------FHSIRMD-------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             SHHHH-------HHHHHHC-------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CHHHH-------HHHHHCC-------CC----CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf             99999-------9999718-------99----8975679999999999654489878388999980

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.41  Aligned_cols=260  Identities=23%  Similarity=0.229  Sum_probs=196.0

Q ss_pred             CCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCCC-----HHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEEC
Q ss_conf             98010249800399991-999499999961489512-----999999999962899999213422888299469999807
Q 003504          513 GTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLT-----DQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDYM  586 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  586 (815)
                      .+.||+|+||+||+|.. .+++.||||+++......     .+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf             63851272829999999999969999998420212456799999999999998679999868985422587402204553


Q ss_pred             CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCC
Q ss_conf             89994433003988875556787776455787653346887865589999999999999998884089999153368899
Q 003504          587 ENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKAS  666 (815)
Q Consensus       587 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~  666 (815)
                      .++++..+...                              ...++...+..++.|++.||+|||   +++|+||||||+
T Consensus        83 ~~~~~~~~~~~------------------------------~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~  129 (299)
T d1ua2a_          83 ETDLEVIIKDN------------------------------SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPN  129 (299)
T ss_dssp             SEEHHHHHTTC------------------------------CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGG
T ss_pred             CCHHHHHHHHC------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCC
T ss_conf             45077655412------------------------------667789999999999999998863---163550357762


Q ss_pred             CEEECCCCCEEECCCCCCEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             6477699981451444540028997-543234665424884348999999976852228899999883998899999843
Q 003504          667 SVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPEE  745 (815)
Q Consensus       667 Nili~~~~~~ki~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~~~  745 (815)
                      |||++.++.+||+|||.|+...... .....+||+.|+|||++..... ++.++||||+||++|||++|+.||.+....+
T Consensus       130 NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwSlGvil~el~~g~~pf~~~~~~~  208 (299)
T d1ua2a_         130 NLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM-YGVGVDMWAVGCILAELLLRVPFLPGDSDLD  208 (299)
T ss_dssp             GEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCCCEECCHHHCCHHHHCCCCC-CCHHHHHHHCCHHHHHHHHCCCCCCCCCHHH
T ss_conf             588537784114657610005787554330204733363999726778-8805643630428999985969999999999


Q ss_pred             CCCCHHHHHHHHHHCCCCC--C----CCCCCCCCCC----CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             2333899999988528787--5----4466445889----9899999999995402559999999999999
Q 003504          746 KEGNLVSWVRGLVRNNKGS--R----AIDPKIRDTG----PEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      ....+..............  .    ..........    ....+.++.+++.+||+.||++|||++|+++
T Consensus       209 ~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         209 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             99999985189972545210002134430347898867856568999999999976389456908999967

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.68  Aligned_cols=268  Identities=21%  Similarity=0.274  Sum_probs=204.0

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCC--CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEE
Q ss_conf             2999998010249800399991-9994999999614895--129999999999628999992134228882994699998
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  584 (815)
                      ++|++.+.||+|+||+||+|.. .+++.||||+++....  ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99776517723768099999999999799999980222575899999999999986799838874453322432037886


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCC
Q ss_conf             07899944330039888755567877764557876533468878655899999999999999988840899991533688
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  664 (815)
                      |+.++ +..++...                            ....+++..+..++.|++.||+|||   +.+|||||||
T Consensus        82 ~~~~~-~~~~~~~~----------------------------~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiK  129 (298)
T d1gz8a_          82 FLHQD-LKKFMDAS----------------------------ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLK  129 (298)
T ss_dssp             CCSEE-HHHHHHHT----------------------------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred             ECCCC-HHHHHHHH----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCC
T ss_conf             23774-45554420----------------------------2568888999999999999999865---2889921357


Q ss_pred             CCCEEECCCCCEEECCCCCCEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             996477699981451444540028997-5432346654248843489999999768522288999998839988999998
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~Nili~~~~~~ki~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~  743 (815)
                      |+|||++.++.+||+|||.|+...... ......|++.|+|||++..... ++.++||||+||++|+|++|+.||.+...
T Consensus       130 peNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~-~~~~~DiwSlGvily~m~~G~~Pf~~~~~  208 (298)
T d1gz8a_         130 PQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMVTRRALFPGDSE  208 (298)
T ss_dssp             GGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSS-CCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CHHEEECCCCCCEECCCCCCEECCCCCCCCEEECCCCEEEEHHHHCCCCC-CCCCCCCCCCCHHHHHHHHCCCCCCCCCH
T ss_conf             11401134676210357861343688641001036521541122136657-77422103333134279668799898899


Q ss_pred             CCCCCCHHHHHHHHHHCC-C-CCCC-CCCCC-------CCC----CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--
Q ss_conf             432333899999988528-7-8754-46644-------588----998999999999954025599999999999999--
Q 003504          744 EEKEGNLVSWVRGLVRNN-K-GSRA-IDPKI-------RDT----GPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL--  807 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~-~-~~~~-~~~~~-------~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~--  807 (815)
                      .+....+.   ....... . .... ..+..       ...    .....+.++.+++.+||..||++|||++|+++.  
T Consensus       209 ~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f  285 (298)
T d1gz8a_         209 IDQLFRIF---RTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF  285 (298)
T ss_dssp             HHHHHHHH---HHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             HHHHHHHH---HHCCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf             99999999---832898333144422242124345432222044416678999999999976399557918999967870


Q ss_pred             HHHH
Q ss_conf             9864
Q 003504          808 LKDI  811 (815)
Q Consensus       808 L~~~  811 (815)
                      ++++
T Consensus       286 f~~~  289 (298)
T d1gz8a_         286 FQDV  289 (298)
T ss_dssp             GTTC
T ss_pred             HCCC
T ss_conf             1469

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=336.72  Aligned_cols=265  Identities=17%  Similarity=0.194  Sum_probs=205.1

Q ss_pred             CCCCCCCEECCCCCEEEEEEECCCCCEEEEEEEECCCC--CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEEE
Q ss_conf             29999980102498003999919994999999614895--1299999999996289999921342288829946999980
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  585 (815)
                      ++|++.++||+|+||+||+|...+++.||||+++....  ...+.+.+|+.++++++||||+++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf             99634318722778189999968999999999812326858999999999999867998687660120467731589974


Q ss_pred             CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCC
Q ss_conf             78999443300398887555678777645578765334688786558999999999999999888408999915336889
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~  665 (815)
                      +.++.+..+...                              ...++......++.|++.||+|||   +.+|+||||||
T Consensus        82 ~~~~~~~~~~~~------------------------------~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp  128 (286)
T d1ob3a_          82 LDQDLKKLLDVC------------------------------EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKP  128 (286)
T ss_dssp             CSEEHHHHHHTS------------------------------TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred             EHHHHHHHHHHH------------------------------CCCCCHHHHHHHHHHHHHHHHHHC---CCCEEECCCCC
T ss_conf             004567899860------------------------------477514456899999999999860---57488267877


Q ss_pred             CCEEECCCCCEEECCCCCCEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             96477699981451444540028997-54323466542488434899999997685222889999988399889999984
Q 003504          666 SSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYPE  744 (815)
Q Consensus       666 ~Nili~~~~~~ki~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~~  744 (815)
                      +|||++.++.+|++|||.|....... ......+++.|+|||.+.+... ++.++||||+||++|||++|+.||.+....
T Consensus       129 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~~DiwslGv~l~el~~G~~pf~~~~~~  207 (286)
T d1ob3a_         129 QNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK-YSTTIDIWSVGCIFAEMVNGTPLFPGVSEA  207 (286)
T ss_dssp             GGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCS-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             CEEEECCCCCEEECCCCCCEECCCCCCCCCEECCCCHHHHHHHHHCCCC-CCCCEEEHHCCCHHHHHHHCCCCCCCCCHH
T ss_conf             5056868997873236643011467654101024311013788717888-884100211175899997797998988989


Q ss_pred             CCCCCHHHHHHHH--------HHCCCC---CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             3233389999998--------852878---7544664458899899999999995402559999999999999
Q 003504          745 EKEGNLVSWVRGL--------VRNNKG---SRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       745 ~~~~~~~~~~~~~--------~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      +....+.......        ......   .....+..........+.++.+++.+||+.||++|||++|+++
T Consensus       208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             9999999863899711042123332214333335676466651258999999999986689668909999856

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=332.82  Aligned_cols=268  Identities=22%  Similarity=0.268  Sum_probs=198.1

Q ss_pred             CCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEEC------CEEEE
Q ss_conf             999998010249800399991-99949999996148951299999999996289999921342288829------94699
Q 003504          509 NFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPLTGYCIAG------DQRIA  581 (815)
Q Consensus       509 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  581 (815)
                      +|...++||+|+||+||+|+. .+++.||||++......    ..+|+.++++++||||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf             767516982176839999999999979999998816068----9999999986689898738789974476577318999


Q ss_pred             EEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEC
Q ss_conf             99807899944330039888755567877764557876533468878655899999999999999988840899991533
Q 003504          582 IYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHR  661 (815)
Q Consensus       582 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  661 (815)
                      ||||+++|.+..+.+..                           .....+++..+..++.|++.||+|||   +++|+||
T Consensus        97 v~Ey~~~~~~~~l~~~~---------------------------~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHr  146 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYS---------------------------RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHR  146 (350)
T ss_dssp             EEECCSEEHHHHHHHHH---------------------------HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECC
T ss_pred             EEECCCCCCHHHHHHHH---------------------------HCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCC
T ss_conf             98416886078888631---------------------------03689999999999999999999998---6687645


Q ss_pred             CCCCCCEEECCCC-CEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf             6889964776999-814514445400289975432346654248843489999999768522288999998839988999
Q 003504          662 DIKASSVYLDMNL-EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGD  740 (815)
Q Consensus       662 Dlk~~Nili~~~~-~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~  740 (815)
                      ||||+|||++.++ .+||+|||+++............|+..|+|||.+.+... ++.++||||+||++|||++|+.||..
T Consensus       147 DiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DIwSlG~il~el~~g~~pf~~  225 (350)
T d1q5ka_         147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQPIFPG  225 (350)
T ss_dssp             CCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSS-CCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             CCCCCEEEEECCCCCEEEECCCCHHHCCCCCCCCCCCCCCCCCCHHHHHCCCC-CCCCEEECCCCEEEEEHHHCCCCCCC
T ss_conf             78860378735897116733660544047765320025555568277640468-88210002465277855028799898


Q ss_pred             CCCCCCCCCHHHHHH----HHH-HC-CCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--
Q ss_conf             998432333899999----988-52-8787544664-----4588998999999999954025599999999999999--
Q 003504          741 DYPEEKEGNLVSWVR----GLV-RN-NKGSRAIDPK-----IRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGL--  807 (815)
Q Consensus       741 ~~~~~~~~~~~~~~~----~~~-~~-~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~--  807 (815)
                      ....+....+.....    ..+ .. .......-+.     .........++++.+|+.+||..||++|||+.|+++.  
T Consensus       226 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  305 (350)
T d1q5ka_         226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  305 (350)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCHHHHHHHHHHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf             79999999999974898177654306210110355445674444315689999999999976589557929999966984


Q ss_pred             HHHH
Q ss_conf             9864
Q 003504          808 LKDI  811 (815)
Q Consensus       808 L~~~  811 (815)
                      ++++
T Consensus       306 f~~~  309 (350)
T d1q5ka_         306 FDEL  309 (350)
T ss_dssp             GGGG
T ss_pred             HCCC
T ss_conf             5246

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=336.22  Aligned_cols=271  Identities=19%  Similarity=0.248  Sum_probs=201.0

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEC-CC-CCEEEEEEEECCC--CCCHHHHHHHHHHHCCC---CCCCCEEEEEEEEE----
Q ss_conf             22999998010249800399991-99-9499999961489--51299999999996289---99992134228882----
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PG-GIHVAVKVLVHGS--TLTDQEAARELEYLGRI---KHPNLVPLTGYCIA----  575 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  575 (815)
                      .++|++.+.||+|+||+||+|+. .+ ++.||||+++...  ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf             58979888992155869999999888998999999802324516799999999999987425898802366322146666


Q ss_pred             -CCEEEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC
Q ss_conf             -9946999980789994433003988875556787776455787653346887865589999999999999998884089
Q 003504          576 -GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGC  654 (815)
Q Consensus       576 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~  654 (815)
                       ....++++||+++|.+......                             ....+++.....++.|++.||+|||   
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~qi~~aL~yLH---  133 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV-----------------------------PEPGVPTETIKDMMFQLLRGLDFLH---  133 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS-----------------------------CTTCSCHHHHHHHHHHHHHHHHHHH---
T ss_pred             CCCEEEEEEEECCCCCHHHHHHC-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH---
T ss_conf             67469999974058714444430-----------------------------3789998999999999999999997---


Q ss_pred             CCCEEECCCCCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             99915336889964776999814514445400289975432346654248843489999999768522288999998839
Q 003504          655 SPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG  734 (815)
Q Consensus       655 ~~~ivH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg  734 (815)
                      +++|+||||||+|||++.++.+||+|||.++............||+.|+|||++.+..  ++.++||||+||++|||++|
T Consensus       134 ~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~--y~~~~DiwSlG~il~ell~g  211 (305)
T d1blxa_         134 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRR  211 (305)
T ss_dssp             HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHS
T ss_pred             HCCEEECCCCCCEEEECCCCCEEECCHHHHHHHCCCCCCCCCCCCHHHCCCCHHCCCC--CCHHEHHHCHHHHHHHHHHC
T ss_conf             5889835798627898589975421000101100234577765485114831001798--88111000328999999878


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC---------CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf             98899999843233389999998852878754---------466445889989999999999540255999999999999
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRA---------IDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIV  805 (815)
Q Consensus       735 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il  805 (815)
                      +.||.+....+....+................         ..+......+...++++.+|+.+||+.||++|||+.|++
T Consensus       212 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L  291 (305)
T d1blxa_         212 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL  291 (305)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf             79989989899999999840799611053211110333022345645440445899999999998748966791899996


Q ss_pred             HH--HHHH
Q ss_conf             99--9864
Q 003504          806 GL--LKDI  811 (815)
Q Consensus       806 ~~--L~~~  811 (815)
                      +.  ++++
T Consensus       292 ~Hpff~~i  299 (305)
T d1blxa_         292 SHPYFQDL  299 (305)
T ss_dssp             TSGGGTTC
T ss_pred             CCHHHCCC
T ss_conf             69634075

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.07  Aligned_cols=240  Identities=22%  Similarity=0.368  Sum_probs=195.4

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCC------CHHHHHHHHHHHCCCC--CCCCEEEEEEEEECCE
Q ss_conf             2999998010249800399991-99949999996148951------2999999999962899--9992134228882994
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTL------TDQEAARELEYLGRIK--HPNLVPLTGYCIAGDQ  578 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  578 (815)
                      ++|++.+.||+|+||.||+|.. .+++.||||++......      ....+.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf             83799679840878399999999999799999985688443345567999999999999743589881279999830996


Q ss_pred             EEEEEEECCC-CCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf             6999980789-994433003988875556787776455787653346887865589999999999999998884089999
Q 003504          579 RIAIYDYMEN-GNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       579 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~  657 (815)
                      .++||||+.+ +++.+++..                              ...+++.....++.|++.||+|||   +++
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~------------------------------~~~l~e~~~~~~~~qi~~al~~lH---~~~  130 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE------------------------------RGALQEELARSFFWQVLEAVRHCH---NCG  130 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH------------------------------HCSCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             EEEEEEECCCCCHHHHHHHC------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCC
T ss_conf             89999833686228999861------------------------------589999999999999999999998---779


Q ss_pred             EEECCCCCCCEEECCC-CCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf             1533688996477699-981451444540028997543234665424884348999999976852228899999883998
Q 003504          658 IIHRDIKASSVYLDMN-LEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       658 ivH~Dlk~~Nili~~~-~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~  736 (815)
                      |+||||||+|||++.+ +.+||+|||+|+..... ......||+.|+|||++.+... ++.++||||+||++|||++|+.
T Consensus       131 iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~-~~~~~DiwSlGvilyell~g~~  208 (273)
T d1xwsa_         131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRY-HGRSAAVWSLGILLYDMVCGDI  208 (273)
T ss_dssp             EECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCB-CHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCCCCCCCEEEECCCCEEEECCCCCCEECCCC-CCCCCCCCCCCCCHHHHCCCCC-CCCCCCCCCCEEEEHHHHHCCC
T ss_conf             7556676111477447884897754653532444-5566565877479999848997-8865332554034536756889


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             8999998432333899999988528787544664458899899999999995402559999999999999
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       737 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      ||...      .       ......           ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       209 Pf~~~------~-------~i~~~~-----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         209 PFEHD------E-------EIIRGQ-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             SCCSH------H-------HHHHCC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCC------H-------HHHHCC-----------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             98873------6-------776154-----------4778779999999999976089758939999853

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=321.08  Aligned_cols=266  Identities=20%  Similarity=0.241  Sum_probs=197.3

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECC--CCCCHHHHHHHHHHHCCCCCCCCEEEEEEEEEC-------
Q ss_conf             22999998010249800399991-99949999996148--951299999999996289999921342288829-------
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHG--STLTDQEAARELEYLGRIKHPNLVPLTGYCIAG-------  576 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  576 (815)
                      .++|++.++||+|+||+||+|.. .+++.||||++...  .....+.+.+|+.++++++|||++++++++...       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf             27988999972274829999999899979999998422246378999999999999835999660676540246544445


Q ss_pred             -CEEEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf             -9469999807899944330039888755567877764557876533468878655899999999999999988840899
Q 003504          577 -DQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCS  655 (815)
Q Consensus       577 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~  655 (815)
                       ...++||||+.++.+......                              ...........++.|++.||.|||   +
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~------------------------------~~~~~~~~~~~i~~qil~~l~~lH---~  135 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV------------------------------LVKFTLSEIKRVMQMLLNGLYYIH---R  135 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT------------------------------TCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred             CCEEEEEEECCCCCCCCHHHHC------------------------------CCCCCCHHHHHHHHHHHHHHHHHC---C
T ss_conf             7638999853578741012220------------------------------344330899999999999998852---2


Q ss_pred             CCEEECCCCCCCEEECCCCCEEECCCCCCEECCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             991533688996477699981451444540028997-----543234665424884348999999976852228899999
Q 003504          656 PPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL-----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLE  730 (815)
Q Consensus       656 ~~ivH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~e  730 (815)
                      .+|+||||||+|||++.++.+|++|||+++......     .....+||+.|+|||++.+... ++.++||||+||++||
T Consensus       136 ~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~-~~~k~DiwSlGvil~e  214 (318)
T d3blha1         136 NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAE  214 (318)
T ss_dssp             TTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSS-CCTHHHHHHHHHHHHH
T ss_pred             CCEEECCCCCHHEEECCCCCEEEEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCC-CCCHHHCCCCCCEEEE
T ss_conf             998856767222036689968763135002235544432113566024978742899707999-8917870067864661


Q ss_pred             HHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-------CCCCC-CCCH-------HHHHHHHHHHHHCCCCCC
Q ss_conf             88399889999984323338999999885287875446-------64458-8998-------999999999954025599
Q 003504          731 LITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAID-------PKIRD-TGPE-------KQMEEALKIGYLCTADLP  795 (815)
Q Consensus       731 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~-~~~~-------~~~~~l~~l~~~cl~~dP  795 (815)
                      |++|+.||.+....+....+........ .........       ..... ..+.       ....++.+|+.+||+.||
T Consensus       215 l~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP  293 (318)
T d3blha1         215 MWTRSPIMQGNTEQHQLALISQLCGSIT-PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP  293 (318)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHHCCCC-TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSST
T ss_pred             HHHCCCCCCCCCHHHHHHHHHHHCCCCC-HHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCH
T ss_conf             7448799899899999999998418998-255344320344433201334455503340444599899999999873896


Q ss_pred             CCCCCHHHHHHH
Q ss_conf             999999999999
Q 003504          796 LKRPSMQQIVGL  807 (815)
Q Consensus       796 ~~RPs~~~il~~  807 (815)
                      ++|||++|+++.
T Consensus       294 ~~R~sa~elL~H  305 (318)
T d3blha1         294 AQRIDSDDALNH  305 (318)
T ss_dssp             TTSCCHHHHHHS
T ss_pred             HHCCCHHHHHCC
T ss_conf             589099999749

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=324.10  Aligned_cols=262  Identities=18%  Similarity=0.209  Sum_probs=198.8

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCC--CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECC------
Q ss_conf             22999998010249800399991-9994999999614895--12999999999962899999213422888299------
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGD------  577 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  577 (815)
                      .++|++.+.||+|+||+||+|.. .+++.||||+++....  ...+.+.+|+.++++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf             77189988980177819999999999989999998522259699999999999998668987547999863576555541


Q ss_pred             EEEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf             46999980789994433003988875556787776455787653346887865589999999999999998884089999
Q 003504          578 QRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPP  657 (815)
Q Consensus       578 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~  657 (815)
                      ..++||||+ +++|..++..                               ..+++.....++.|++.||.|||   +++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-------------------------------~~l~~~~~~~~~~qi~~aL~~LH---~~~  141 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-------------------------------EKLGEDRIQFLVYQMLKGLRYIH---AAG  141 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             EEEEEEECC-CCCHHHHHHH-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCC
T ss_conf             599998405-5218999874-------------------------------02269999999999999999987---378


Q ss_pred             EEECCCCCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf             15336889964776999814514445400289975432346654248843489999999768522288999998839988
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKP  737 (815)
Q Consensus       658 ivH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~p  737 (815)
                      |+||||||+|||++.++.+|++|||.|+....  ......|++.|+|||++.+... ++.++||||+||++|||++|+.|
T Consensus       142 IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwSlGvil~ell~g~~p  218 (346)
T d1cm8a_         142 IIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMR-YTQTVDIWSVGCIMAEMITGKTL  218 (346)
T ss_dssp             EECCCCCGGGEEECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTC-CCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCCCCCCHHHCCCCCCCCCCCCCCEECCCC--CCCCCCCCCCCCCHHHHCCCCC-CCCCCHHHCCHHHHHHHHHCCCC
T ss_conf             76456685111121001221134310220687--6310245533358899817878-99650103003899999978699


Q ss_pred             CCCCCCCCCCCCHHHHHH----HHHHCC----------CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf             999998432333899999----988528----------787544664458899899999999995402559999999999
Q 003504          738 LGDDYPEEKEGNLVSWVR----GLVRNN----------KGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQ  803 (815)
Q Consensus       738 f~~~~~~~~~~~~~~~~~----~~~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  803 (815)
                      |.+....+..........    ......          .......... .......++++.+|+.+||..||.+|||+.|
T Consensus       219 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e  297 (346)
T d1cm8a_         219 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGE  297 (346)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCCCHHHHHHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCH-HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf             888976899999985037884888865300034433115786665566-7755689999999999977299557929999


Q ss_pred             HHHH
Q ss_conf             9999
Q 003504          804 IVGL  807 (815)
Q Consensus       804 il~~  807 (815)
                      +++.
T Consensus       298 iL~H  301 (346)
T d1cm8a_         298 ALAH  301 (346)
T ss_dssp             HHHS
T ss_pred             HHCC
T ss_conf             9639

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=320.84  Aligned_cols=259  Identities=19%  Similarity=0.245  Sum_probs=199.7

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCC-CCCCEEEEEEEEEC--CEEEEEE
Q ss_conf             2999998010249800399991-999499999961489512999999999962899-99921342288829--9469999
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-HPNLVPLTGYCIAG--DQRIAIY  583 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  583 (815)
                      ++|++.++||+|+||+||+|+. .+++.||+|+++.   ...+.+.+|+.++.++. ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf             671897898317481999999889997999999888---99999999999998515799876799999816877126888


Q ss_pred             EECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCC
Q ss_conf             80789994433003988875556787776455787653346887865589999999999999998884089999153368
Q 003504          584 DYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDI  663 (815)
Q Consensus       584 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  663 (815)
                      ||+++|+|..+.+                                 .++......++.|++.||.|||   +++|+||||
T Consensus       112 e~~~~~~L~~~~~---------------------------------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDi  155 (328)
T d3bqca1         112 EHVNNTDFKQLYQ---------------------------------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDV  155 (328)
T ss_dssp             ECCCSCBGGGTTT---------------------------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred             EECCCCCHHHHHC---------------------------------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCC
T ss_conf             6317985899746---------------------------------8999999999999999998876---433443456


Q ss_pred             CCCCEEECCCC-CEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             89964776999-81451444540028997543234665424884348999999976852228899999883998899999
Q 003504          664 KASSVYLDMNL-EPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDY  742 (815)
Q Consensus       664 k~~Nili~~~~-~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~  742 (815)
                      ||+|||++.++ .+||+|||+|+............+|..|+|||.+.+... ++.++||||+||++||+++|+.||....
T Consensus       156 Kp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         156 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM-YDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             SGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCC-CCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             CCCCEEECCCCCEEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHCCCCCCCCCCC
T ss_conf             441237748998366415654266468874443224864247610268888-8845232335455587604889998876


Q ss_pred             CCCC-CCCHHHHHH-----HHHHCCCC--------------CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf             8432-333899999-----98852878--------------754466445889989999999999540255999999999
Q 003504          743 PEEK-EGNLVSWVR-----GLVRNNKG--------------SRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQ  802 (815)
Q Consensus       743 ~~~~-~~~~~~~~~-----~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  802 (815)
                      .... ...+.....     ........              ................++++.+|+.+||..||++|||++
T Consensus       235 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~  314 (328)
T d3bqca1         235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR  314 (328)
T ss_dssp             SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf             01899999999878841555554225444743000003334331121155211244899999999998669956890899


Q ss_pred             HHHH
Q ss_conf             9999
Q 003504          803 QIVG  806 (815)
Q Consensus       803 ~il~  806 (815)
                      |+++
T Consensus       315 e~L~  318 (328)
T d3bqca1         315 EAME  318 (328)
T ss_dssp             HHHT
T ss_pred             HHHC
T ss_conf             9964

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=324.15  Aligned_cols=266  Identities=18%  Similarity=0.221  Sum_probs=197.5

Q ss_pred             HCCCCCCCEECCCCCEEEEEEE-CCCCCEEEEEEEECCCC-CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECC----EEE
Q ss_conf             2299999801024980039999-19994999999614895-12999999999962899999213422888299----469
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST-LTDQEAARELEYLGRIKHPNLVPLTGYCIAGD----QRI  580 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  580 (815)
                      +.+|++.+.||+|+||+||+|. ..+++.||||++..... ...+.+.+|+.++++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf             89859978994064809999999999949999998031095899999999999997689898858889950564554149


Q ss_pred             EEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEE
Q ss_conf             99980789994433003988875556787776455787653346887865589999999999999998884089999153
Q 003504          581 AIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIH  660 (815)
Q Consensus       581 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  660 (815)
                      ++++|+.+|+|.+++..                               ..+++.....++.|++.||+|||   +++|+|
T Consensus        87 ~l~~~~~~g~L~~~l~~-------------------------------~~l~~~~i~~i~~qil~al~yLH---~~~iiH  132 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT-------------------------------QHLSNDHICYFLYQILRGLKYIH---SANVLH  132 (345)
T ss_dssp             EEEEECCCEEHHHHHHH-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             EEEEEECCCCHHHHHHC-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCC
T ss_conf             99996259865664405-------------------------------89999999999999999999999---789867


Q ss_pred             CCCCCCCEEECCCCCEEECCCCCCEECCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf             3688996477699981451444540028997----543234665424884348999999976852228899999883998
Q 003504          661 RDIKASSVYLDMNLEPRLSDFGLAKIFGNGL----DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       661 ~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~  736 (815)
                      |||||+|||++.++.+||+|||+|+......    ......|++.|+|||++..... ++.++||||+||++|||++|+.
T Consensus       133 RDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~DiwSlG~il~eml~g~~  211 (345)
T d1pmea_         133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNRP  211 (345)
T ss_dssp             CCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCS-CSTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCCCEEEECCCCCEEECCCCCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCCC-CCCHHHHHCCCCEEHHHHHCCC
T ss_conf             778764378879997787545705650477764101011026520003878604788-8741010046701337766979


Q ss_pred             CCCCCCCCCCCCCHHHHHH----HHHHCCCC-----CCCCCCCCCCC----CCHHHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf             8999998432333899999----98852878-----75446644588----99899999999995402559999999999
Q 003504          737 PLGDDYPEEKEGNLVSWVR----GLVRNNKG-----SRAIDPKIRDT----GPEKQMEEALKIGYLCTADLPLKRPSMQQ  803 (815)
Q Consensus       737 pf~~~~~~~~~~~~~~~~~----~~~~~~~~-----~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~~  803 (815)
                      ||......+..........    ........     .....+.....    .....+.++.+++.+||..||.+||++++
T Consensus       212 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e  291 (345)
T d1pmea_         212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ  291 (345)
T ss_dssp             SCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf             97888889999987652069975664234332222024467755778777837899999999999976489567908999


Q ss_pred             HHHH
Q ss_conf             9999
Q 003504          804 IVGL  807 (815)
Q Consensus       804 il~~  807 (815)
                      +++.
T Consensus       292 ~L~h  295 (345)
T d1pmea_         292 ALAH  295 (345)
T ss_dssp             HHTS
T ss_pred             HHCC
T ss_conf             8619

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=327.44  Aligned_cols=252  Identities=26%  Similarity=0.291  Sum_probs=204.3

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC----CCCCEEEEEEEECCC----CCCHHHHHHHHHHHCCCCC-CCCEEEEEEEEECCE
Q ss_conf             2999998010249800399991----999499999961489----5129999999999628999-992134228882994
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL----PGGIHVAVKVLVHGS----TLTDQEAARELEYLGRIKH-PNLVPLTGYCIAGDQ  578 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  578 (815)
                      ++|++.+.||+|+||+||+|..    .+++.||||.+....    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf             02599989832878399999987658879489999983677210168999999999999864679839996200024873


Q ss_pred             EEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCE
Q ss_conf             69999807899944330039888755567877764557876533468878655899999999999999988840899991
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~i  658 (815)
                      .++++||+.+|+|.+++..                              ...........++.|++.|++|+|   +.+|
T Consensus       104 ~~~v~e~~~~~~L~~~i~~------------------------------~~~~~e~~~~~~~~Qi~~al~~lH---~~~i  150 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ------------------------------RERFTEHEVQIYVGEIVLALEHLH---KLGI  150 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH------------------------------HSCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             EEEEEECCCCCHHHHHHHH------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---CCCE
T ss_conf             0012312341179999873------------------------------045437888888999999998851---4998


Q ss_pred             EECCCCCCCEEECCCCCEEECCCCCCEECCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf             533688996477699981451444540028997--543234665424884348999999976852228899999883998
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGL--DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKK  736 (815)
Q Consensus       659 vH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~  736 (815)
                      +||||||+||+++.++.+||+|||+|+.+....  ......|+..|+|||.+.+....++.++||||+||++|||++|+.
T Consensus       151 vHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~  230 (322)
T d1vzoa_         151 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS  230 (322)
T ss_dssp             CCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred             EECCCCCCCEEECCCCCEEEEECCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf             96547732012469998887413202220344443221222333331068760577688713251777799999976899


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             8999998432333899999988528787544664458899899999999995402559999999-----999999
Q 003504          737 PLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPS-----MQQIVG  806 (815)
Q Consensus       737 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~~il~  806 (815)
                      ||......+....+.   ......           ....+...+.++.+++.+||..||.+||+     ++|+++
T Consensus       231 PF~~~~~~~~~~~i~---~~~~~~-----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         231 PFTVDGEKNSQAEIS---RRILKS-----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             TTSCTTSCCCHHHHH---HHHHHC-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCCCCCHHHHHHHHH---HHCCCC-----------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf             988887777999999---833568-----------9988654799999999997445898819997450999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=320.23  Aligned_cols=258  Identities=17%  Similarity=0.215  Sum_probs=199.2

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCCCCCEEE-EEEEEECCEEEEEEEE
Q ss_conf             2999998010249800399991-9994999999614895129999999999628999992134-2288829946999980
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKHPNLVPL-TGYCIAGDQRIAIYDY  585 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~  585 (815)
                      ++|++.+.||+|+||.||+|.. .+++.||||++.....  ...+..|+++++.++|++++.. .++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf             889996898507880999999988998999999721005--888999999999703899601799999519877899987


Q ss_pred             CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCC
Q ss_conf             78999443300398887555678777645578765334688786558999999999999999888408999915336889
Q 003504          586 MENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIKA  665 (815)
Q Consensus       586 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~  665 (815)
                      +.+ ++...+...                             ...+++..+..++.|++.||+|||   +++|+||||||
T Consensus        85 ~~~-~l~~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp  131 (299)
T d1ckia_          85 LGP-SLEDLFNFC-----------------------------SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKP  131 (299)
T ss_dssp             CCC-BHHHHHHHT-----------------------------TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred             CCC-CHHHHHHHC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCH
T ss_conf             387-133324430-----------------------------688768999999999999999999---79944266787


Q ss_pred             CCEEECC---CCCEEECCCCCCEECCCCC--------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             9647769---9981451444540028997--------5432346654248843489999999768522288999998839
Q 003504          666 SSVYLDM---NLEPRLSDFGLAKIFGNGL--------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITG  734 (815)
Q Consensus       666 ~Nili~~---~~~~ki~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg  734 (815)
                      +|||++.   +..+|++|||+|+......        ......||+.|+|||.+.+..  ++.++|||||||++|||++|
T Consensus       132 ~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~el~tg  209 (299)
T d1ckia_         132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLG  209 (299)
T ss_dssp             GGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC--CCHHHHHHHHHHHHHHHHHS
T ss_pred             HHCCCCCCCCCCEEEEECCCCCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCC--CCCHHHEEECCHHHHHHHHC
T ss_conf             6606433577761565046751342554455410001357767873532999991899--89832188617789999849


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             988999998432333899999988528787544664458899899999999995402559999999999999998645
Q 003504          735 KKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDIE  812 (815)
Q Consensus       735 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~~  812 (815)
                      +.||.......................      .+..    +..++.++.+++..||+.+|++||+++++.+.|+.+-
T Consensus       210 ~~P~~~~~~~~~~~~~~~~~~~~~~~~------~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         210 SLPWQGLKAATKRQKYERISEKKMSTP------IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             SCTTCCCC-------HHHHHHHHHHSC------HHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHHCCCCCCC------HHHH----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             876655305779999998523567898------3575----3478899999999984399557919999999999999

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=313.75  Aligned_cols=262  Identities=18%  Similarity=0.211  Sum_probs=203.1

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCC--CCHHHHHHHHHHHCCCCCCCCEEEEEEEEECCEEEEEEE
Q ss_conf             2999998010249800399991-9994999999614895--129999999999628999992134228882994699998
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  584 (815)
                      ++|++.++||+|+||+||+|+. .+++.||||+++....  .....+.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99786269712868199999999999699999980321786899999999999985675788821354444431158863


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCC
Q ss_conf             07899944330039888755567877764557876533468878655899999999999999988840899991533688
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  664 (815)
                      ++.++++..++..                              ....++..+..++.|++.||+|||   +++|+|||||
T Consensus        82 ~~~~~~l~~~~~~------------------------------~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiK  128 (292)
T d1unla_          82 FCDQDLKKYFDSC------------------------------NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLK  128 (292)
T ss_dssp             CCSEEHHHHHHHT------------------------------TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             ECCCCCCCCCCCC------------------------------CCCCCHHHHHHHHHHHHHHHHHHH---CCCEEEECCC
T ss_conf             0233222112123------------------------------565403678999999999987743---3998600146


Q ss_pred             CCCEEECCCCCEEECCCCCCEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             996477699981451444540028997-5432346654248843489999999768522288999998839988999998
Q 003504          665 ASSVYLDMNLEPRLSDFGLAKIFGNGL-DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPLGDDYP  743 (815)
Q Consensus       665 ~~Nili~~~~~~ki~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf~~~~~  743 (815)
                      |+|||++.++.+||+|||.|+...... ......++..|+|||++..... ++.++||||+||++|||++|+.||.....
T Consensus       129 P~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~~DiwSlG~il~ell~g~~p~~~~~~  207 (292)
T d1unla_         129 PQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRPLFPGND  207 (292)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSC-CCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred             CCCCCCCCCCCEEEEECCHHHCCCCCCCCCEEECCCCCHHHHHHHCCCCC-CCCHHHCCCCCHHHHHHHHCCCCCCCCCC
T ss_conf             76121133782665204601104688751001034431014667506988-88044402654188998518999988999


Q ss_pred             CCCCCCHHHHHHHHHHCCC--C-------CC------CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             4323338999999885287--8-------75------44664458899899999999995402559999999999999
Q 003504          744 EEKEGNLVSWVRGLVRNNK--G-------SR------AIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVG  806 (815)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~--~-------~~------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~  806 (815)
                      ..   .....+........  .       ..      ................++.+++.+|++.||.+|||++|+++
T Consensus       208 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         208 VD---DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HH---HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HH---HHHHHHHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             99---9999998611899735513443222113344454431043306568999999999986499668909999964

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=321.94  Aligned_cols=262  Identities=18%  Similarity=0.185  Sum_probs=201.4

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCC--CCHHHHHHHHHHHCCCCCCCCEEEEEEEEEC------CE
Q ss_conf             2999998010249800399991-9994999999614895--1299999999996289999921342288829------94
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAG------DQ  578 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  578 (815)
                      ++|++.++||+|+||+||+|+. .+++.||||++.....  ...+.+.+|+.++++++||||+++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf             77599889621758599999999999899999988233697999999999999986489876489989702564345762


Q ss_pred             EEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCE
Q ss_conf             69999807899944330039888755567877764557876533468878655899999999999999988840899991
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~i  658 (815)
                      .|+||||+.++.+ +.+..                                .+++.....++.|++.||.|||   +++|
T Consensus        97 ~~iv~Ey~~~~l~-~~~~~--------------------------------~~~~~~i~~~~~qil~gl~~LH---~~gi  140 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQM--------------------------------ELDHERMSYLLYQMLCGIKHLH---SAGI  140 (355)
T ss_dssp             EEEEEECCSEEHH-HHHTS--------------------------------CCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             EEEEEECCCHHHH-HHHHC--------------------------------CCCHHHHHHHHHHHHHHHHHHH---HCCC
T ss_conf             6999841446778-76503--------------------------------8999999999999999998865---2211


Q ss_pred             EECCCCCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf             53368899647769998145144454002899754323466542488434899999997685222889999988399889
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       659 vH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf  738 (815)
                      +||||||+|||++.++.+|++|||+++............+|+.|+|||++.+..  ++.++||||+||++|||++|+.||
T Consensus       141 iHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~--~~~~~DiwSlG~~l~ell~g~~pF  218 (355)
T d2b1pa1         141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMVRHKILF  218 (355)
T ss_dssp             CCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCCCCCCCCCCCCCCCEEEECHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCCCCCCCCCCHHHHHHHCCCCC
T ss_conf             245677632113654431320102321146665533221465555813314777--787743335662578986598998


Q ss_pred             CCCCCCCCCCCHHH---------------HHHHHHHCCC-CCC-----CCCCCCCC---CCCHHHHHHHHHHHHHCCCCC
Q ss_conf             99998432333899---------------9999885287-875-----44664458---899899999999995402559
Q 003504          739 GDDYPEEKEGNLVS---------------WVRGLVRNNK-GSR-----AIDPKIRD---TGPEKQMEEALKIGYLCTADL  794 (815)
Q Consensus       739 ~~~~~~~~~~~~~~---------------~~~~~~~~~~-~~~-----~~~~~~~~---~~~~~~~~~l~~l~~~cl~~d  794 (815)
                      .+.........+..               .......... ...     ........   ......+.++.+|+.+|+..|
T Consensus       219 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d  298 (355)
T d2b1pa1         219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID  298 (355)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred             CCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf             88977889999997205898799987656677776417543566642126433354321013337999999999987699


Q ss_pred             CCCCCCHHHHHHH
Q ss_conf             9999999999999
Q 003504          795 PLKRPSMQQIVGL  807 (815)
Q Consensus       795 P~~RPs~~~il~~  807 (815)
                      |++|||++|+++.
T Consensus       299 P~~R~ta~elL~H  311 (355)
T d2b1pa1         299 PAKRISVDDALQH  311 (355)
T ss_dssp             TTTSCCHHHHHTS
T ss_pred             HHHCCCHHHHHCC
T ss_conf             4579089999669

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=315.63  Aligned_cols=260  Identities=15%  Similarity=0.186  Sum_probs=203.5

Q ss_pred             HCCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCC-CCCEEEEEEEEECCEEEEEEE
Q ss_conf             22999998010249800399991-9994999999614895129999999999628999-992134228882994699998
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKH-PNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  584 (815)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....  ....+.+|++.+..+.| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf             980699799841788299999998899799999975025--829999999999996489998779999601881179999


Q ss_pred             ECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCC
Q ss_conf             07899944330039888755567877764557876533468878655899999999999999988840899991533688
Q 003504          585 YMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPIIHRDIK  664 (815)
Q Consensus       585 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  664 (815)
                      |+ +|+|.++++..                             ...+++.....++.|++.||+|||   +.+|+|||||
T Consensus        82 ~~-~~~l~~~~~~~-----------------------------~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiK  128 (293)
T d1csna_          82 LL-GPSLEDLLDLC-----------------------------GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIK  128 (293)
T ss_dssp             CC-CCBHHHHHHHT-----------------------------TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCC
T ss_pred             EC-CCCHHHHHHHH-----------------------------CCCHHHHHHHHHHHHHHHHHHHHH---HCCCEECCCC
T ss_conf             64-88879999752-----------------------------031106899999999999999999---7796626677


Q ss_pred             CCCEEECC-----CCCEEECCCCCCEECCCCC--------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             99647769-----9981451444540028997--------5432346654248843489999999768522288999998
Q 003504          665 ASSVYLDM-----NLEPRLSDFGLAKIFGNGL--------DEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLEL  731 (815)
Q Consensus       665 ~~Nili~~-----~~~~ki~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~el  731 (815)
                      |+|||++.     ++.+||+|||+|+......        ......||+.|+|||.+.+..  ++.++|||||||++|||
T Consensus       129 p~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~--~~~~~DiwSlG~~l~el  206 (293)
T d1csna_         129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYF  206 (293)
T ss_dssp             GGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHH
T ss_pred             CCCEEECCCCCCCCCCEEECCCCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCC--CCHHHHHHHHHHHHHHH
T ss_conf             1315234754344795687236605771467665411102467627751026798964888--88699989831999999


Q ss_pred             HHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             83998899999843233389999998852878754466445889989999999999540255999999999999999864
Q 003504          732 ITGKKPLGDDYPEEKEGNLVSWVRGLVRNNKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQIVGLLKDI  811 (815)
Q Consensus       732 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~il~~L~~~  811 (815)
                      ++|+.||.+....................      ..+.+    +..+++++.+++..|++.+|++||+++.+.+.|+++
T Consensus       207 ltg~~Pf~~~~~~~~~~~~~~i~~~~~~~------~~~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         207 LRGSLPWQGLKAATNKQKYERIGEKKQST------PLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHSSCTTSSCCSCCHHHHHHHHHHHHHHS------CHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HHCCCCCCCCCCHHHHHHHHHHHHCCCCC------CHHHH----CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf             86987678853021999999997056799------95896----579989999999998439930085999999999999


Q ss_pred             HH
Q ss_conf             52
Q 003504          812 ES  813 (815)
Q Consensus       812 ~~  813 (815)
                      .+
T Consensus       277 ~~  278 (293)
T d1csna_         277 LE  278 (293)
T ss_dssp             HH
T ss_pred             HH
T ss_conf             99

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=314.83  Aligned_cols=262  Identities=20%  Similarity=0.244  Sum_probs=197.9

Q ss_pred             HCCCCCCCEECCCCCEEEEEEE-CCCCCEEEEEEEECCCC--CCHHHHHHHHHHHCCCCCCCCEEEEEEEEEC-----CE
Q ss_conf             2299999801024980039999-19994999999614895--1299999999996289999921342288829-----94
Q 003504          507 TSNFDRGTLLAEGKFGPVYRGF-LPGGIHVAVKVLVHGST--LTDQEAARELEYLGRIKHPNLVPLTGYCIAG-----DQ  578 (815)
Q Consensus       507 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  578 (815)
                      +++|++.++||+|+||+||+|+ ..+++.||||++.....  ...+.+.+|+.++++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf             98718888983178839999999999979999998820028689999999999998668987425999996346456686


Q ss_pred             EEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCE
Q ss_conf             69999807899944330039888755567877764557876533468878655899999999999999988840899991
Q 003504          579 RIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHGCSPPI  658 (815)
Q Consensus       579 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~i  658 (815)
                      .+++++|+.+|+|.++++.                               ..++......++.|++.||+|||   +++|
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-------------------------------~~l~e~~~~~i~~qil~aL~~LH---~~gi  142 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-------------------------------QKLTDDHVQFLIYQILRGLKYIH---SADI  142 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             EEEEEEEECCCCHHHHCCC-------------------------------CCCCHHHHHHHHHHHHHHHHHHH---HCCC
T ss_conf             4999996258862320022-------------------------------45309999999999999999997---3887


Q ss_pred             EECCCCCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf             53368899647769998145144454002899754323466542488434899999997685222889999988399889
Q 003504          659 IHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVLLELITGKKPL  738 (815)
Q Consensus       659 vH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil~elltg~~pf  738 (815)
                      +||||||+|||++.++.+|++|||.+.....  ......|+..|+|||...+... ++.++||||+||++|+|++|+.||
T Consensus       143 iHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~-~~~~~DiwSlGv~l~~ll~g~~pF  219 (348)
T d2gfsa1         143 IHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGRTLF  219 (348)
T ss_dssp             CCCCCCGGGEEECTTCCEEECCC----CCTG--GGSSSCHHHHTSCHHHHTTCSC-CCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHCCCCC--CCCCCCCCCCCCCCHHHCCCCC-CCCCCCHHHHHHHHHHHHHCCCCC
T ss_conf             6516677633455432200132100012575--4444345435558355337756-785512432058999997688997


Q ss_pred             CCCCCCCCCCCHHHHHHH----HHHC----------CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf             999984323338999999----8852----------87875446644588998999999999954025599999999999
Q 003504          739 GDDYPEEKEGNLVSWVRG----LVRN----------NKGSRAIDPKIRDTGPEKQMEEALKIGYLCTADLPLKRPSMQQI  804 (815)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~----~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~~i  804 (815)
                      .+.........+......    ....          ..........+. ......+.++.+|+.+|+..||++|||++|+
T Consensus       220 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~el  298 (348)
T d2gfsa1         220 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQA  298 (348)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCHHHHHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf             889889999999973079975773200102445444303557875556-6267899999999999775883459389998


Q ss_pred             HH
Q ss_conf             99
Q 003504          805 VG  806 (815)
Q Consensus       805 l~  806 (815)
                      ++
T Consensus       299 L~  300 (348)
T d2gfsa1         299 LA  300 (348)
T ss_dssp             HT
T ss_pred             HC
T ss_conf             55

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=282.24  Aligned_cols=266  Identities=18%  Similarity=0.175  Sum_probs=191.5

Q ss_pred             CCCCCCCEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCC-----------CCCCEEEEEEEEE
Q ss_conf             2999998010249800399991-999499999961489512999999999962899-----------9992134228882
Q 003504          508 SNFDRGTLLAEGKFGPVYRGFL-PGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-----------HPNLVPLTGYCIA  575 (815)
Q Consensus       508 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  575 (815)
                      ++|+++++||+|+||+||+|+. .+++.||||+++.. ....+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             8579989975077818999999999979999998343-133689999999999840145555542276764789987631


Q ss_pred             --CCEEEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC
Q ss_conf             --994699998078999443300398887555678777645578765334688786558999999999999999888408
Q 003504          576 --GDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHHG  653 (815)
Q Consensus       576 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~  653 (815)
                        ....+++++++..+.........                           .............++.|++.||.|||+ 
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~i~~i~~qil~al~~lh~-  143 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK---------------------------YEHRGIPLIYVKQISKQLLLGLDYMHR-  143 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH---------------------------TTTSCCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             CCCCCEEEEEEECCCCCCCCCCCCC---------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHH-
T ss_conf             2565202343200035420000012---------------------------234678689999999999999888764-


Q ss_pred             CCCCEEECCCCCCCEEECCCCC------EEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf             9999153368899647769998------1451444540028997543234665424884348999999976852228899
Q 003504          654 CSPPIIHRDIKASSVYLDMNLE------PRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVV  727 (815)
Q Consensus       654 ~~~~ivH~Dlk~~Nili~~~~~------~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvi  727 (815)
                       ..+|+||||||+|||++.++.      ++++|||.+.....  ......|++.|+|||++....  ++.++||||+||+
T Consensus       144 -~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~i  218 (362)
T d1q8ya_         144 -RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP--WGCGADIWSTACL  218 (362)
T ss_dssp             -TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC--CCTHHHHHHHHHH
T ss_pred             -HCCCCCCCCCHHHEEEECCCCCCCCCEEEEEECCCCCCCCC--CCCCCCCCCCCCCHHHCCCCC--CCCCCCCCCHHHH
T ss_conf             -05864656770570563057656443056753144212344--542236652105713214667--7764320123789


Q ss_pred             HHHHHHCCCCCCCCCCCCCCCC---HHHHHHHH-------HHCC----------CCCCCCCC----------CCCCCCCH
Q ss_conf             9998839988999998432333---89999998-------8528----------78754466----------44588998
Q 003504          728 LLELITGKKPLGDDYPEEKEGN---LVSWVRGL-------VRNN----------KGSRAIDP----------KIRDTGPE  777 (815)
Q Consensus       728 l~elltg~~pf~~~~~~~~~~~---~~~~~~~~-------~~~~----------~~~~~~~~----------~~~~~~~~  777 (815)
                      ++||++|+.||...........   +...+..+       ....          ........          ......+.
T Consensus       219 l~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
T d1q8ya_         219 IFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK  298 (362)
T ss_dssp             HHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCH
T ss_pred             HHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCC
T ss_conf             99998788998987554321026899999998379987886245322000132012202432357764442100015674


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             999999999954025599999999999999
Q 003504          778 KQMEEALKIGYLCTADLPLKRPSMQQIVGL  807 (815)
Q Consensus       778 ~~~~~l~~l~~~cl~~dP~~RPs~~~il~~  807 (815)
                      ..+.++.+|+.+|+..||.+|||++|+++.
T Consensus       299 ~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         299 DEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             HHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             358999999999877994579089999669

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=7e-45  Score=259.19  Aligned_cols=273  Identities=28%  Similarity=0.511  Sum_probs=156.0

Q ss_pred             CCCCCC-CCCCCC--CEEEEEECCCCC--EEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf             100012-677874--100168639998--389986489997567894102599988899776897998993557999988
Q 003504            5 SFQASY-FSASFC--SWRGVVCDSNKQ--HVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLK   79 (815)
Q Consensus         5 ~~~~~~-~~~~~c--~~~~v~c~~~~~--~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~ls~n~l~~i~~~~~~l~~L~   79 (815)
                      +..++| .+++||  +|.||.|+....  ||+.++++++++.|..                      .+|..++.+++|+
T Consensus        22 ~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~----------------------~lp~~l~~L~~L~   79 (313)
T d1ogqa_          22 TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY----------------------PIPSSLANLPYLN   79 (313)
T ss_dssp             GGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCE----------------------ECCGGGGGCTTCS
T ss_pred             CCCCCCCCCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCC----------------------CCCHHHHCCCCCC
T ss_conf             867788999999889488969748999479889989899888888----------------------7984784675335


Q ss_pred             EEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf             898318-8378669846459999869984587489888033207867898872898236558920005654615653687
Q 003504           80 SLNLSY-NRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMN  158 (815)
Q Consensus        80 ~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  158 (815)
                      +|+|++ |++.+.+|..|+++++|++|+|++|++.+..+..+..+.+|+.++++.|.+....|..+..++.|+.+++++|
T Consensus        80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n  159 (313)
T d1ogqa_          80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCC
T ss_conf             20202654333002431145420011020356434433222220111001111224555568512206740000002355


Q ss_pred             CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCHHHHHCCCCEEEECCCCCCCCCCCC
Q ss_conf             67999984121169998789727983567898-87788778867556885788642543025555420255456755310
Q 003504          159 QLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT-HFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQV  237 (815)
Q Consensus       159 ~i~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~n~l~~~~~~~  237 (815)
                      .+.+.+|..+......++.+.++.|++++... .+.                                            
T Consensus       160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~--------------------------------------------  195 (313)
T d1ogqa_         160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA--------------------------------------------  195 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGG--------------------------------------------
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--------------------------------------------
T ss_conf             335620312144311232310224643533243322--------------------------------------------


Q ss_pred             CCCCCCCCCCCEEEECCCCCCCCCHHHCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCC
Q ss_conf             12444677641699857986674000012368887879810785767895111224689858668983767891322069
Q 003504          238 QFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQL  317 (815)
Q Consensus       238 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  317 (815)
                            ++ ....++++++...+..+..+..+++++.+++++|.+.... +.+..+++|+.|+|++|.+++.+|..+..+
T Consensus       196 ------~l-~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L  267 (313)
T d1ogqa_         196 ------NL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQL  267 (313)
T ss_dssp             ------GC-CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGC
T ss_pred             ------CC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCEECCCCCHHHHCC
T ss_conf             ------22-2223333334332222222222222111222222222222-222245544444476570666087688479


Q ss_pred             CCCCEEECCCCCCCCCCCCC-CCCCCCEEECCCCC
Q ss_conf             99988858789588988845-78875679855884
Q 003504          318 SSLHTLDLSMNHLTGQIPTV-SAKNLGIIDMSHNN  351 (815)
Q Consensus       318 ~~L~~L~ls~N~l~~~~~~~-~~~~L~~L~ls~N~  351 (815)
                      ++|++|++++|+++|.+|.. .+.+|+.+++++|+
T Consensus       268 ~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         268 KFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK  302 (313)
T ss_dssp             TTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCC
T ss_conf             99998979588351668986667998978868895

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=5.6e-38  Score=221.30  Aligned_cols=302  Identities=22%  Similarity=0.266  Sum_probs=167.7

Q ss_pred             CCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEE
Q ss_conf             59998889977689799899355799998889831883786698464599998699845874898880332078678988
Q 003504           50 GKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVL  129 (815)
Q Consensus        50 ~~l~~L~~L~ls~n~l~~i~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  129 (815)
                      ..+.+|++|++++++|+.+. ++..+++|++|+|++|+|+++.  .|+++++|++|+|++|.|.++.  .+.++++|+.|
T Consensus        41 ~~l~~l~~L~l~~~~I~~l~-gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L  115 (384)
T d2omza2          41 TDLDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGL  115 (384)
T ss_dssp             HHHTTCCEEECCSSCCCCCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred             HHHCCCCEEECCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCC
T ss_conf             89578789989998987762-4245899998968188179886--3347711010301343332222--11123343334


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-----------------------------------------CCCCHH
Q ss_conf             728982365589200056546156536876799-----------------------------------------998412
Q 003504          130 KLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNG-----------------------------------------SLPDGF  168 (815)
Q Consensus       130 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~-----------------------------------------~~~~~~  168 (815)
                      ++++|.+++...  ......+..+....|.+..                                         ... ..
T Consensus       116 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  192 (384)
T d2omza2         116 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI-SV  192 (384)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC-GG
T ss_pred             CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC-CC
T ss_conf             433222222222--222222211213466313100232222112222212322011112454211011222433321-10


Q ss_pred             HCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             11699987897279835678988778877886755688578864254302555542025545675531012444677641
Q 003504          169 GAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRL  248 (815)
Q Consensus       169 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~l~~L  248 (815)
                      ...+++++.+.+++|.++.+.+ +...++|+.|++++|.++.++....+++|+.|++++|++++..      .+..+++|
T Consensus       193 ~~~l~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~------~~~~~~~L  265 (384)
T d2omza2         193 LAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLA------PLSGLTKL  265 (384)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCG------GGTTCTTC
T ss_pred             CCCCCCCCEEECCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCHHHCCCCCCHHCCCCCCCCCCC------CCCCCCCC
T ss_conf             0223532333035774478786-4445778788887777789613432565341004467447877------53554668


Q ss_pred             EEEECCCCCCCCCHHHCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCC
Q ss_conf             69985798667400001236888787981078576789511122468985866898376789132206999988858789
Q 003504          249 VYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMN  328 (815)
Q Consensus       249 ~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N  328 (815)
                      +.|++++|.+.+..  .+...+.++.+.++.|.++.+  ..+..+++++.|++++|.+.+..  .+..+++|+.|++++|
T Consensus       266 ~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n  339 (384)
T d2omza2         266 TELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANN  339 (384)
T ss_dssp             SEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSS
T ss_pred             CEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC--CCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCC
T ss_conf             77545674457877--323565222233232333332--21000024676777788778984--5366898898989899


Q ss_pred             CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCEEECCCC
Q ss_conf             58898884578875679855884765477577623898863430389
Q 003504          329 HLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYN  375 (815)
Q Consensus       329 ~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~~l~~l~l~~n  375 (815)
                      ++++......+++|+.|++++|++++..|   +.++++|+.+++++|
T Consensus       340 ~l~~l~~l~~l~~L~~L~l~~N~l~~l~~---l~~l~~L~~L~L~~N  383 (384)
T d2omza2         340 KVSDVSSLANLTNINWLSAGHNQISDLTP---LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCCCCGGGGGCTTCCEEECCSSCCCBCGG---GTTCTTCSEEECCCE
T ss_pred             CCCCCHHHCCCCCCCEEECCCCCCCCCHH---HCCCCCCCEEECCCC
T ss_conf             89997467089999989897995899800---003999999639789

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=2.3e-37  Score=217.94  Aligned_cols=300  Identities=22%  Similarity=0.315  Sum_probs=199.9

Q ss_pred             CEEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             83899864899975678941025999888997768979989935579999888983188378669846459999869984
Q 003504           28 QHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDL  107 (815)
Q Consensus        28 ~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~ls~n~l~~i~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (815)
                      .+++.++++++++. .++  .+..+++|++|+|++|+|+.++. +..+++|++|++++|.|.++.  .++++++|+.|++
T Consensus        44 ~~l~~L~l~~~~I~-~l~--gl~~L~nL~~L~Ls~N~l~~l~~-l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~  117 (384)
T d2omza2          44 DQVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTL  117 (384)
T ss_dssp             TTCCEEECCSSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCCC-CCC--CCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCC
T ss_conf             78789989998987-762--42458999989681881798863-347711010301343332222--1112334333443


Q ss_pred             CCCCCCCCCHHHHCCCCCCCEEECCCCCCCC-----------------------------------------CCCCCCCC
Q ss_conf             5874898880332078678988728982365-----------------------------------------58920005
Q 003504          108 SNNNFSGEIPAAISSLVSLRVLKLDGNMFQW-----------------------------------------SIPPGLLN  146 (815)
Q Consensus       108 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-----------------------------------------~~~~~~~~  146 (815)
                      ++|.+++..+  ......+..+....|.+..                                         .....+..
T Consensus       118 ~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (384)
T d2omza2         118 FNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK  195 (384)
T ss_dssp             CSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGG
T ss_pred             CCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             3222222222--22222221121346631310023222211222221232201111245421101122243332110022


Q ss_pred             CCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCEEEEC
Q ss_conf             65461565368767999984121169998789727983567898877887788675568857886425430255554202
Q 003504          147 CQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLR  226 (815)
Q Consensus       147 l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~  226 (815)
                      +++++.+.+++|.+++ ++..  ...++|+.|++++|.++.++ .+..+++|+.|++++|.++.+++...+++|+.|+++
T Consensus       196 l~~~~~l~l~~n~i~~-~~~~--~~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~  271 (384)
T d2omza2         196 LTNLESLIATNNQISD-ITPL--GILTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLG  271 (384)
T ss_dssp             CTTCSEEECCSSCCCC-CGGG--GGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred             CCCCCEEECCCCCCCC-CCCC--CCCCCCCEEECCCCCCCCCC-HHHCCCCCCHHCCCCCCCCCCCCCCCCCCCCEEECC
T ss_conf             3532333035774478-7864--44577878888777778961-343256534100446744787753554668775456


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf             55456755310124446776416998579866740000123688878798107857678951112246898586689837
Q 003504          227 SNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSL  306 (815)
Q Consensus       227 ~n~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  306 (815)
                      +|++.+..      .+.+++.++.+.+..|.+.+.  ..+...++++.|++++|+++++.  .+..+++|+.|++++|.+
T Consensus       272 ~~~l~~~~------~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l  341 (384)
T d2omza2         272 ANQISNIS------PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV  341 (384)
T ss_dssp             SSCCCCCG------GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCC
T ss_pred             CCCCCCCC------CCCCCCCCCCCCCCCCCCCCC--CCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCC
T ss_conf             74457877------323565222233232333332--21000024676777788778984--536689889898989989


Q ss_pred             CCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf             678913220699998885878958898884578875679855884
Q 003504          307 IGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNN  351 (815)
Q Consensus       307 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~L~~L~ls~N~  351 (815)
                      ++ ++ .+..+++|++|++++|++++..|...+++|+.|++++|.
T Consensus       342 ~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         342 SD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQA  384 (384)
T ss_dssp             CC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCEE
T ss_pred             CC-CH-HHCCCCCCCEEECCCCCCCCCHHHCCCCCCCEEECCCCC
T ss_conf             99-74-670899999898979958998000039999996397895

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.2e-36  Score=212.58  Aligned_cols=284  Identities=19%  Similarity=0.241  Sum_probs=159.8

Q ss_pred             CCCCCCCCCEEEEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC-CCCCCCEEECCCCC
Q ss_conf             12677874100168639998389986489997567894102599988899776897998993557-99998889831883
Q 003504            9 SYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNR   87 (815)
Q Consensus         9 ~~~~~~~c~~~~v~c~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~ls~n~l~~i~~~~~-~l~~L~~L~L~~n~   87 (815)
                      .||..|-|.|.+|.|.+..             ..++|.. +  .+++++|+|++|+|+.+|...+ .+++|++|++++|.
T Consensus         3 ~~p~~c~c~~~~~~C~~~~-------------L~~lP~~-l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~   66 (305)
T d1xkua_           3 VCPFRCQCHLRVVQCSDLG-------------LEKVPKD-L--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK   66 (305)
T ss_dssp             CCCTTCEEETTEEECTTSC-------------CCSCCCS-C--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCCCEECCCEEEECCCC-------------CCCCCCC-C--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCC
T ss_conf             8999889559999855999-------------8851988-8--9997989784991898696576046565231123443


Q ss_pred             CCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCH
Q ss_conf             78669846459999869984587489888033207867898872898236558920005654615653687679999841
Q 003504           88 ISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDG  167 (815)
Q Consensus        88 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~  167 (815)
                      +..+.+..|.++++|+.|++++|+|+.+...   ....|..|.+.+|.+....+..+....                   
T Consensus        67 ~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~---~~~~l~~L~~~~n~l~~l~~~~~~~~~-------------------  124 (305)
T d1xkua_          67 ISKISPGAFAPLVKLERLYLSKNQLKELPEK---MPKTLQELRVHENEITKVRKSVFNGLN-------------------  124 (305)
T ss_dssp             CCCBCTTTTTTCTTCCEEECCSSCCSBCCSS---CCTTCCEEECCSSCCCBBCHHHHTTCT-------------------
T ss_pred             CCCCCHHHHHCCCCCCEECCCCCCCCCCCCC---HHHHHHHHHCCCCCHHHHHHHHHHCCC-------------------
T ss_conf             4452356652798557831568756767640---011132321024610234444540133-------------------


Q ss_pred             HHCCCCCCCEEECCCCCCCC---CCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCEEEECCCCCCCCCCCCCCCCCCC
Q ss_conf             21169998789727983567---898877887788675568857886425430255554202554567553101244467
Q 003504          168 FGAAFPKLKSLNLAGNEIKG---RDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYN  244 (815)
Q Consensus       168 ~~~~l~~L~~L~L~~N~l~~---~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~  244 (815)
                            .+..+....|....   ....|..+++|+.+++++|.+..++... .                           
T Consensus       125 ------~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~-~---------------------------  170 (305)
T d1xkua_         125 ------QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL-P---------------------------  170 (305)
T ss_dssp             ------TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSC-C---------------------------
T ss_pred             ------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-C---------------------------
T ss_conf             ------110000123333346777642234565671203467745167101-7---------------------------


Q ss_pred             CCCCEEEECCCCCCCCCHHHCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEE
Q ss_conf             76416998579866740000123688878798107857678951112246898586689837678913220699998885
Q 003504          245 WSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLD  324 (815)
Q Consensus       245 l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  324 (815)
                       ++|+.|++++|.+....+..+...+.++.|++++|.++.+++..+..+++|+.|+|++|.++ .+|..+..+++|+.|+
T Consensus       171 -~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~  248 (305)
T d1xkua_         171 -PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY  248 (305)
T ss_dssp             -TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred             -CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEE
T ss_conf             -76678989788677888267641341330154455332223454334433224302554002-4631103346789898


Q ss_pred             CCCCCCCCCCCCC--------CCCCCCEEECCCCCCC-CCCCHHHHHCCCC
Q ss_conf             8789588988845--------7887567985588476-5477577623898
Q 003504          325 LSMNHLTGQIPTV--------SAKNLGIIDMSHNNLS-GEIPASLLEKLPQ  366 (815)
Q Consensus       325 ls~N~l~~~~~~~--------~~~~L~~L~ls~N~l~-~~~p~~~~~~~~~  366 (815)
                      +++|+|+.+....        ...+|+.|++++|+++ +.++...|.-+..
T Consensus       249 Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~  299 (305)
T d1xkua_         249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV  299 (305)
T ss_dssp             CCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCC
T ss_pred             CCCCCCCCCCHHHCCCCCHHCCCCCCCEEECCCCCCCCCCCCHHHHCCCCC
T ss_conf             989865763810026721002158889788989957667689768300245

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3e-35  Score=206.40  Aligned_cols=268  Identities=21%  Similarity=0.276  Sum_probs=198.8

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCC
Q ss_conf             88899776897998993557999988898318837866984645999986998458748988803320786789887289
Q 003504           54 KLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG  133 (815)
Q Consensus        54 ~L~~L~ls~n~l~~i~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  133 (815)
                      ..+.+++++++++++|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.|.+|.++++|+.|++++
T Consensus        11 ~~~~~~C~~~~L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_          11 HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             ETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CCCEEEECCCCCCCCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCC
T ss_conf             59999855999885198889--9979897849918986965760465652311234434452356652798557831568


Q ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCC
Q ss_conf             823655892000565461565368767999984121169998789727983567898-8778877886755688578864
Q 003504          134 NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT-HFAGLKSITNLNISGNLFQGSV  212 (815)
Q Consensus       134 N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~  212 (815)
                      |+++. .|..+  ...+..|.+.+|.+.                         .++. .+.....+..++...|......
T Consensus        89 n~l~~-l~~~~--~~~l~~L~~~~n~l~-------------------------~l~~~~~~~~~~~~~l~~~~n~~~~~~  140 (305)
T d1xkua_          89 NQLKE-LPEKM--PKTLQELRVHENEIT-------------------------KVRKSVFNGLNQMIVVELGTNPLKSSG  140 (305)
T ss_dssp             SCCSB-CCSSC--CTTCCEEECCSSCCC-------------------------BBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred             CCCCC-CCCCH--HHHHHHHHCCCCCHH-------------------------HHHHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf             75676-76400--111323210246102-------------------------344445401331100001233333467


Q ss_pred             HHHHHCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHCCCCCCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf             25430255554202554567553101244467764169985798667400001236888787981078576789511122
Q 003504          213 MGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGT  292 (815)
Q Consensus       213 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~  292 (815)
                                              .....+..+++|+.+++++|.+... +..  ..++|+.|++++|.++...+..+..
T Consensus       141 ------------------------~~~~~~~~l~~L~~l~l~~n~l~~l-~~~--~~~~L~~L~l~~n~~~~~~~~~~~~  193 (305)
T d1xkua_         141 ------------------------IENGAFQGMKKLSYIRIADTNITTI-PQG--LPPSLTELHLDGNKITKVDAASLKG  193 (305)
T ss_dssp             ------------------------BCTTGGGGCTTCCEEECCSSCCCSC-CSS--CCTTCSEEECTTSCCCEECTGGGTT
T ss_pred             ------------------------CCCCCCCCCCCCCCCCCCCCCCCCC-CCC--CCCCCCEEECCCCCCCCCCHHHHHC
T ss_conf             ------------------------7764223456567120346774516-710--1776678989788677888267641


Q ss_pred             CCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCC-CCCCCCEEECCCCCCCCCCCHHHH------HCCC
Q ss_conf             468985866898376789132206999988858789588988845-788756798558847654775776------2389
Q 003504          293 LLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV-SAKNLGIIDMSHNNLSGEIPASLL------EKLP  365 (815)
Q Consensus       293 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~~L~~L~ls~N~l~~~~p~~~~------~~~~  365 (815)
                      ++.++.|++++|.+.+..+..+..+++|++|++++|+++.+.+.. .+++|+.|++++|+|+ .++...|      ...+
T Consensus       194 ~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~  272 (305)
T d1xkua_         194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKA  272 (305)
T ss_dssp             CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCHHCCCC
T ss_conf             34133015445533222345433443322430255400246311033467898989898657-63810026721002158


Q ss_pred             CCCEEECCCCCCCC
Q ss_conf             88634303897766
Q 003504          366 QMERFNFSYNNLTL  379 (815)
Q Consensus       366 ~l~~l~l~~n~l~~  379 (815)
                      +++.+++++|++..
T Consensus       273 ~L~~L~L~~N~~~~  286 (305)
T d1xkua_         273 SYSGVSLFSNPVQY  286 (305)
T ss_dssp             CCSEEECCSSSSCG
T ss_pred             CCCEEECCCCCCCC
T ss_conf             88978898995766

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=5.6e-37  Score=215.84  Aligned_cols=256  Identities=29%  Similarity=0.455  Sum_probs=197.6

Q ss_pred             CCCCEEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf             998889831883786--6984645999986998458-7489888033207867898872898236558920005654615
Q 003504           76 GSLKSLNLSYNRISG--SLPSNIGNFGLLEVFDLSN-NNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVT  152 (815)
Q Consensus        76 ~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  152 (815)
                      ..++.|+|++|.+.+  .+|..++++++|++|+|++ |.+++.+|..|.++++|++|+|++|++.+..+..+..+..|+.
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCC
T ss_conf             79889989899888888798478467533520202654333002431145420011020356434433222220111001


Q ss_pred             EECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCEEEECCCCCC
Q ss_conf             65368767999984121169998789727983567-89887788778867556885788642543025555420255456
Q 003504          153 VDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG-RDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQ  231 (815)
Q Consensus       153 L~l~~N~i~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~n~l~  231 (815)
                      +++++|.+.+.+|..+. .++.++.+++++|.+.+ ++..+..+.                                   
T Consensus       130 l~l~~N~~~~~~p~~l~-~l~~L~~l~l~~n~l~~~ip~~~~~l~-----------------------------------  173 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSIS-SLPNLVGITFDGNRISGAIPDSYGSFS-----------------------------------  173 (313)
T ss_dssp             EECCSSEEESCCCGGGG-GCTTCCEEECCSSCCEEECCGGGGCCC-----------------------------------
T ss_pred             CCCCCCCCCCCCCHHHC-CCCCCCEEECCCCCCCCCCCCCCCCCC-----------------------------------
T ss_conf             11122455556851220-674000000235533562031214431-----------------------------------


Q ss_pred             CCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf             75531012444677641699857986674000012368887879810785767895111224689858668983767891
Q 003504          232 GHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIP  311 (815)
Q Consensus       232 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  311 (815)
                                    ..++.++++.|.+.+..+..+..+. ...+++..|......+..+..++.++.+++++|.+.+.+ 
T Consensus       174 --------------~l~~~l~~~~n~l~~~~~~~~~~l~-~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-  237 (313)
T d1ogqa_         174 --------------KLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-  237 (313)
T ss_dssp             --------------TTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-
T ss_pred             --------------CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-
T ss_conf             --------------1232310224643533243322222-223333334332222222222222111222222222222-


Q ss_pred             HHHHCCCCCCEEECCCCCCCCCCCCC--CCCCCCEEECCCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf             32206999988858789588988845--7887567985588476547757762389886343038977666789996
Q 003504          312 SEILQLSSLHTLDLSMNHLTGQIPTV--SAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFSYNNLTLCASELSP  386 (815)
Q Consensus       312 ~~~~~l~~L~~L~ls~N~l~~~~~~~--~~~~L~~L~ls~N~l~~~~p~~~~~~~~~l~~l~l~~n~l~~~~~~~~~  386 (815)
                      ..+..++.|+.|++++|++++.+|..  .+++|+.|++++|+|+|.+|.  +.++.+|+.+++++|+. .|+.|+++
T Consensus       238 ~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~--~~~L~~L~~l~l~~N~~-l~g~plp~  311 (313)
T d1ogqa_         238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKC-LCGSPLPA  311 (313)
T ss_dssp             GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC--STTGGGSCGGGTCSSSE-EESTTSSC
T ss_pred             CCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC--CCCCCCCCHHHHCCCCC-CCCCCCCC
T ss_conf             2222455444444765706660876884799999897958835166898--66679989788688950-01989889

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-34  Score=200.83  Aligned_cols=249  Identities=21%  Similarity=0.197  Sum_probs=130.8

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECC-CC
Q ss_conf             89977689799899355799998889831883786698464599998699845874898880332078678988728-98
Q 003504           56 QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLD-GN  134 (815)
Q Consensus        56 ~~L~ls~n~l~~i~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~-~N  134 (815)
                      ..+++++++++++|..+.  .++++|+|++|+|+.+.+.+|.++++|++|++++|+|..+.+..+..+..+..+... .|
T Consensus        14 ~~v~c~~~~L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~   91 (284)
T d1ozna_          14 VTTSCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (284)
T ss_dssp             CEEECCSSCCSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEEECCCCCCCCCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             699847999894497889--998889774881798797786414213000013445433211121222222222222102


Q ss_pred             CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCH
Q ss_conf             23655892000565461565368767999984121169998789727983567898-87788778867556885788642
Q 003504          135 MFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDT-HFAGLKSITNLNISGNLFQGSVM  213 (815)
Q Consensus       135 ~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~~  213 (815)
                      .+....+..|.++++|++|++++|.+. .++...+....+|+.+++.+|.|+.++. .|..+++|+.|++++|       
T Consensus        92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N-------  163 (284)
T d1ozna_          92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN-------  163 (284)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-------
T ss_pred             CCCCCCCHHHCCCCCCCEEECCCCCCC-CCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCC-------
T ss_conf             235446201010102778756885443-201353320001211020014314458057404340502231417-------


Q ss_pred             HHHHCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHCCCCCCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf             54302555542025545675531012444677641699857986674000012368887879810785767895111224
Q 003504          214 GVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTL  293 (815)
Q Consensus       214 ~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  293 (815)
                                                                 .+....+..|.++++|+.+++++|.++.+.+..|..+
T Consensus       164 -------------------------------------------~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l  200 (284)
T d1ozna_         164 -------------------------------------------RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL  200 (284)
T ss_dssp             -------------------------------------------CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             -------------------------------------------CCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHH
T ss_conf             -------------------------------------------6566256665465634131421143466281676653


Q ss_pred             CCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCC-CCCCCCEEECCCCCCCCCCC
Q ss_conf             68985866898376789132206999988858789588988845-78875679855884765477
Q 003504          294 LGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTV-SAKNLGIIDMSHNNLSGEIP  357 (815)
Q Consensus       294 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~~L~~L~ls~N~l~~~~p  357 (815)
                      ++|+.|++++|.+.+..+..|..+++|+.|++++|++....+.. ....++.+....+++.+..|
T Consensus       201 ~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p  265 (284)
T d1ozna_         201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP  265 (284)
T ss_dssp             TTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred             HHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCHHHHHHHHHCCCCCCCEEECCC
T ss_conf             20002333335221000002355465688981199887875646999999867388886674796

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-33  Score=195.94  Aligned_cols=218  Identities=28%  Similarity=0.291  Sum_probs=164.6

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC-CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC-CCCC
Q ss_conf             489997567894102599988899776897998993557-99998889831883786698464599998699845-8748
Q 003504           35 ASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLS-NNNF  112 (815)
Q Consensus        35 ~~~~~~~~~~~~~~~~~l~~L~~L~ls~n~l~~i~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~N~i  112 (815)
                      .+++++. .+|.. +  .+++++|+|++|+|+.+|...+ .+++|++|++++|+|..+.+..+.+...++.++.. .|.+
T Consensus        18 c~~~~L~-~iP~~-i--p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~   93 (284)
T d1ozna_          18 CPQQGLQ-AVPVG-I--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL   93 (284)
T ss_dssp             CCSSCCS-SCCTT-C--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred             CCCCCCC-CCCCC-C--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             4799989-44978-8--999888977488179879778641421300001344543321112122222222222210223


Q ss_pred             CCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCC-CC
Q ss_conf             98880332078678988728982365589200056546156536876799998412116999878972798356789-88
Q 003504          113 SGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRD-TH  191 (815)
Q Consensus       113 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~  191 (815)
                      +.+.+.+|.++++|+.|++++|.+....+..+...++|+.+++++|.++ .++...+..+++|+.|++++|.++.++ ..
T Consensus        94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~  172 (284)
T d1ozna_          94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERA  172 (284)
T ss_dssp             CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred             CCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCC-CCCHHHHCCCCCHHHCCCCCCCCCCCCHHH
T ss_conf             5446201010102778756885443201353320001211020014314-458057404340502231417656625666


Q ss_pred             CCCCCCCCEEECCCCCCCCCCHHHHHCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHCCCCCCC
Q ss_conf             77887788675568857886425430255554202554567553101244467764169985798667400001236888
Q 003504          192 FAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQN  271 (815)
Q Consensus       192 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~  271 (815)
                      |.++++|+.+++++|.++.+.+..|                          .++++|+.|++++|.+.+..+..|..+++
T Consensus       173 f~~l~~L~~l~l~~N~l~~i~~~~f--------------------------~~l~~L~~L~l~~N~i~~~~~~~~~~~~~  226 (284)
T d1ozna_         173 FRGLHSLDRLLLHQNRVAHVHPHAF--------------------------RDLGRLMTLYLFANNLSALPTEALAPLRA  226 (284)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTT--------------------------TTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             HCCCCCCCHHHHHHCCCCCCCHHHH--------------------------HHHHHCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             5465634131421143466281676--------------------------65320002333335221000002355465


Q ss_pred             CCEEEECCCCCC
Q ss_conf             787981078576
Q 003504          272 LKHLSLAYNRFT  283 (815)
Q Consensus       272 L~~L~L~~N~l~  283 (815)
                      |+.|+|++|++.
T Consensus       227 L~~L~l~~N~l~  238 (284)
T d1ozna_         227 LQYLRLNDNPWV  238 (284)
T ss_dssp             CCEEECCSSCEE
T ss_pred             CCEEEECCCCCC
T ss_conf             688981199887

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.6e-30  Score=179.44  Aligned_cols=128  Identities=28%  Similarity=0.319  Sum_probs=80.3

Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEE
Q ss_conf             99988899776897998993557999988898318837866984645999986998458748988803320786789887
Q 003504           51 KLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLK  130 (815)
Q Consensus        51 ~l~~L~~L~ls~n~l~~i~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  130 (815)
                      ....+.++++++++++++|..+.  +++++|+|++|+|+.+.+..|.++++|++|+|++|+|+.+  ..+..+++|+.|+
T Consensus         8 ~~~~~~~v~C~~~~L~~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l--~~~~~l~~L~~L~   83 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLD   83 (266)
T ss_dssp             CSTTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE--ECCSCCTTCCEEE
T ss_pred             CCCCCEEEECCCCCCCEECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCC
T ss_conf             26898699806999886196757--6889898849928985977863456552213566544443--1111122321111


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCC
Q ss_conf             289823655892000565461565368767999984121169998789727983
Q 003504          131 LDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNE  184 (815)
Q Consensus       131 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~L~~N~  184 (815)
                      |++|+++. .+..+.++++|+.|++++|.+. .++...+..+.+++.|++++|.
T Consensus        84 Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~-~~~~~~~~~l~~l~~L~l~~n~  135 (266)
T d1p9ag_          84 LSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNE  135 (266)
T ss_dssp             CCSSCCSS-CCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSC
T ss_pred             CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC-EEECCCCCCCCCCCCCCCCCCC
T ss_conf             12222211-1112122222222222223110-1100112222111122124342

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.6e-30  Score=176.60  Aligned_cols=80  Identities=25%  Similarity=0.183  Sum_probs=35.2

Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             99888983188378669846459999869984587489888033207867898872898236558920005654615653
Q 003504           76 GSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDL  155 (815)
Q Consensus        76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  155 (815)
                      ..+.+.+.++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|+.|+|++|+|+...  .+..+++|+.|++
T Consensus        10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~L   84 (266)
T d1p9ag_          10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDL   84 (266)
T ss_dssp             TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEEC
T ss_pred             CCCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCC
T ss_conf             89869980699988-6196757--68898988499289859778634565522135665444431--1111223211111


Q ss_pred             CCCCC
Q ss_conf             68767
Q 003504          156 SMNQL  160 (815)
Q Consensus       156 ~~N~i  160 (815)
                      ++|++
T Consensus        85 s~N~l   89 (266)
T d1p9ag_          85 SHNQL   89 (266)
T ss_dssp             CSSCC
T ss_pred             CCCCC
T ss_conf             22222

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.96  E-value=1.8e-25  Score=152.95  Aligned_cols=298  Identities=25%  Similarity=0.257  Sum_probs=168.6

Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             89986489997567894102599988899776897998993557999988898318837866984645999986998458
Q 003504           30 VTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSN  109 (815)
Q Consensus        30 ~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~ls~n~l~~i~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  109 (815)
                      ++.++++++++. .+|+    .+++|++|+|++|+|+.+|..   +.+|+.|++++|+++.+ +..   .+.|++|+|++
T Consensus        40 l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~~l-~~l---p~~L~~L~L~~  107 (353)
T d1jl5a_          40 AHELELNNLGLS-SLPE----LPPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSN  107 (353)
T ss_dssp             CSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCS
T ss_pred             CCEEEECCCCCC-CCCC----CCCCCCEEECCCCCCCCCCCC---HHHHHHHHHHHCCCCHH-HHH---CCCCCCCCCCC
T ss_conf             989993799988-7889----878988898999979633620---33203326655143203-210---22111113345


Q ss_pred             CCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCC
Q ss_conf             74898880332078678988728982365589200056546156536876799998412116999878972798356789
Q 003504          110 NNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRD  189 (815)
Q Consensus       110 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  189 (815)
                      |.++.+ | .+..+++|+.|++++|.+.. .+..   ...+..+.+..+... .. ..+ ..++.++.+.+..|.+...+
T Consensus       108 n~l~~l-p-~~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~-~~-~~l-~~l~~l~~L~l~~n~~~~~~  178 (353)
T d1jl5a_         108 NQLEKL-P-ELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE-EL-PEL-QNLPFLTAIYADNNSLKKLP  178 (353)
T ss_dssp             SCCSSC-C-CCTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SC-CCC-TTCTTCCEEECCSSCCSSCC
T ss_pred             CCCCCC-C-CHHHHCCCEEECCCCCCCCC-CCCC---CCCCCCHHHCCCCCC-CC-CCC-CCCCCCEECCCCCCCCCCCC
T ss_conf             543222-1-00110131231135651001-3223---333210000122222-33-320-00122200111233443222


Q ss_pred             CCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHCCCCC
Q ss_conf             88778877886755688578864254302555542025545675531012444677641699857986674000012368
Q 003504          190 THFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQA  269 (815)
Q Consensus       190 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  269 (815)
                      ..   ......+....+.+..++....++.|+.+++++|......        .....+..+.+..+.+....    ...
T Consensus       179 ~~---~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~--------~~~~~l~~~~~~~~~~~~~~----~~~  243 (353)
T d1jl5a_         179 DL---PLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLP--------DLPPSLEALNVRDNYLTDLP----ELP  243 (353)
T ss_dssp             CC---CTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCC--------SCCTTCCEEECCSSCCSCCC----CCC
T ss_pred             CC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--------CCCCCCCCCCCCCCCCCCCC----CCC
T ss_conf             21---2222223344432222122345553331222542223455--------32334333222333334443----334


Q ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             88787981078576789511122468985866898376789132206999988858789588988845788756798558
Q 003504          270 QNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSH  349 (815)
Q Consensus       270 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~L~~L~ls~  349 (815)
                      ..+...++..|.+..+.    .........++..|.+.+.    ...+++|++|++++|+++.+ |. ..++|+.|++++
T Consensus       244 ~~l~~~~~~~~~~~~l~----~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~~l-p~-~~~~L~~L~L~~  313 (353)
T d1jl5a_         244 QSLTFLDVSENIFSGLS----ELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLIEL-PA-LPPRLERLIASF  313 (353)
T ss_dssp             TTCCEEECCSSCCSEES----CCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCSCC-CC-CCTTCCEEECCS
T ss_pred             CCCCCCCCCCCCCCCCC----CCCCHHCCCCCCCCCCCCC----CCCCCCCCEEECCCCCCCCC-CC-CCCCCCEEECCC
T ss_conf             43222222223332223----4530001233335753234----56689889897979916835-66-548799898999


Q ss_pred             CCCCCCCCHHHHHCCCCCCEEECCCCCCC
Q ss_conf             84765477577623898863430389776
Q 003504          350 NNLSGEIPASLLEKLPQMERFNFSYNNLT  378 (815)
Q Consensus       350 N~l~~~~p~~~~~~~~~l~~l~l~~n~l~  378 (815)
                      |+|+ .+|.    .+++|+.+++++|+++
T Consensus       314 N~L~-~l~~----~~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         314 NHLA-EVPE----LPQNLKQLHVEYNPLR  337 (353)
T ss_dssp             SCCS-CCCC----CCTTCCEEECCSSCCS
T ss_pred             CCCC-CCCC----CCCCCCEEECCCCCCC
T ss_conf             9687-5453----2288898987699189

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.96  E-value=4.2e-25  Score=150.97  Aligned_cols=281  Identities=24%  Similarity=0.255  Sum_probs=182.7

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCC
Q ss_conf             88899776897998993557999988898318837866984645999986998458748988803320786789887289
Q 003504           54 KLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG  133 (815)
Q Consensus        54 ~L~~L~ls~n~l~~i~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  133 (815)
                      ++++|||++++++.+|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++.+ +.   -.+.|++|++++
T Consensus        39 ~l~~LdLs~~~L~~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~---lp~~L~~L~L~~  107 (353)
T d1jl5a_          39 QAHELELNNLGLSSLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SD---LPPLLEYLGVSN  107 (353)
T ss_dssp             TCSEEECTTSCCSCCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CS---CCTTCCEEECCS
T ss_pred             CCCEEEECCCCCCCCCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCCHH-HH---HCCCCCCCCCCC
T ss_conf             998999379998878898---789888989999796-336203---3203326655143203-21---022111113345


Q ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCH
Q ss_conf             82365589200056546156536876799998412116999878972798356789887788778867556885788642
Q 003504          134 NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRDTHFAGLKSITNLNISGNLFQGSVM  213 (815)
Q Consensus       134 N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~~  213 (815)
                      |.+.. .| .+..+++|+.+++.+|.+. ..+..    ...+..+.+..+..... ..+..++.++.|.++.|.+...+.
T Consensus       108 n~l~~-lp-~~~~l~~L~~L~l~~~~~~-~~~~~----~~~l~~l~~~~~~~~~~-~~l~~l~~l~~L~l~~n~~~~~~~  179 (353)
T d1jl5a_         108 NQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLPDL----PPSLEFIAAGNNQLEEL-PELQNLPFLTAIYADNNSLKKLPD  179 (353)
T ss_dssp             SCCSS-CC-CCTTCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSSCCSSCCC
T ss_pred             CCCCC-CC-CHHHHCCCEEECCCCCCCC-CCCCC----CCCCCCHHHCCCCCCCC-CCCCCCCCCEECCCCCCCCCCCCC
T ss_conf             54322-21-0011013123113565100-13223----33321000012222233-320001222001112334432222


Q ss_pred             HHHHCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHCCCCCCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf             54302555542025545675531012444677641699857986674000012368887879810785767895111224
Q 003504          214 GVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTL  293 (815)
Q Consensus       214 ~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  293 (815)
                      ..  .....+....+.+..      ......++.++.+++++|..... +   ....++..+.+..|.+....    ...
T Consensus       180 ~~--~~~~~l~~~~~~~~~------~~~~~~l~~L~~l~l~~n~~~~~-~---~~~~~l~~~~~~~~~~~~~~----~~~  243 (353)
T d1jl5a_         180 LP--LSLESIVAGNNILEE------LPELQNLPFLTTIYADNNLLKTL-P---DLPPSLEALNVRDNYLTDLP----ELP  243 (353)
T ss_dssp             CC--TTCCEEECCSSCCSS------CCCCTTCTTCCEEECCSSCCSSC-C---SCCTTCCEEECCSSCCSCCC----CCC
T ss_pred             CC--CCCCCCCCCCCCCCC------CCCCCCCCCCCCCCCCCCCCCCC-C---CCCCCCCCCCCCCCCCCCCC----CCC
T ss_conf             12--222223344432222------12234555333122254222345-5---32334333222333334443----334


Q ss_pred             CCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCEEECC
Q ss_conf             68985866898376789132206999988858789588988845788756798558847654775776238988634303
Q 003504          294 LGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDMSHNNLSGEIPASLLEKLPQMERFNFS  373 (815)
Q Consensus       294 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~~l~~l~l~  373 (815)
                      ..+...++..+.+.+..    .-.......++..|.+.+...  ..++|+.|++++|+|+ .+|.    .+++|+.++++
T Consensus       244 ~~l~~~~~~~~~~~~l~----~l~~~~~~~~~~~~~~~~~~~--~~~~L~~L~Ls~N~l~-~lp~----~~~~L~~L~L~  312 (353)
T d1jl5a_         244 QSLTFLDVSENIFSGLS----ELPPNLYYLNASSNEIRSLCD--LPPSLEELNVSNNKLI-ELPA----LPPRLERLIAS  312 (353)
T ss_dssp             TTCCEEECCSSCCSEES----CCCTTCCEEECCSSCCSEECC--CCTTCCEEECCSSCCS-CCCC----CCTTCCEEECC
T ss_pred             CCCCCCCCCCCCCCCCC----CCCCHHCCCCCCCCCCCCCCC--CCCCCCEEECCCCCCC-CCCC----CCCCCCEEECC
T ss_conf             43222222223332223----453000123333575323456--6898898979799168-3566----54879989899


Q ss_pred             CCCCCCC
Q ss_conf             8977666
Q 003504          374 YNNLTLC  380 (815)
Q Consensus       374 ~n~l~~~  380 (815)
                      +|.++..
T Consensus       313 ~N~L~~l  319 (353)
T d1jl5a_         313 FNHLAEV  319 (353)
T ss_dssp             SSCCSCC
T ss_pred             CCCCCCC
T ss_conf             9968754

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.5e-30  Score=178.72  Aligned_cols=349  Identities=19%  Similarity=0.137  Sum_probs=206.1

Q ss_pred             EEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCC-C
Q ss_conf             389986489997567894102599988899776897998-----993557999988898318837866----984645-9
Q 003504           29 HVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-----LPSDLWSLGSLKSLNLSYNRISGS----LPSNIG-N   98 (815)
Q Consensus        29 ~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~ls~n~l~~-----i~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~-~   98 (815)
                      .+++++++.+++++..-...+..++++++|+|++|+++.     +...+...++|++|+|++|.|++.    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf             87779820895886899999976779999982899998899999999985399988897959859728999999998437


Q ss_pred             CCCCCEEECCCCCCCCCC----HHHHCCCCCCCEEECCCCCCCCCCCCCCC-----CCCCCCEEECCCCCCCCCCCC---
Q ss_conf             999869984587489888----03320786789887289823655892000-----565461565368767999984---
Q 003504           99 FGLLEVFDLSNNNFSGEI----PAAISSLVSLRVLKLDGNMFQWSIPPGLL-----NCQSLVTVDLSMNQLNGSLPD---  166 (815)
Q Consensus        99 l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~l~~N~i~~~~~~---  166 (815)
                      ..+|+.|+|++|.|++..    +.++..+++|+.|+|++|.+.......+.     .......+......+. ....   
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~-~~~~~~~  161 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS-AASCEPL  161 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCB-GGGHHHH
T ss_pred             CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC-HHHHCCC
T ss_conf             887788778887754322101211000034320024443320234555544301355433322222232220-0110011


Q ss_pred             -HHHCCCCCCCEEECCCCCCCCCC-----CCC-CCCCCCCEEECCCCCCCCCCHHHH------HCCCCEEEECCCCCCCC
Q ss_conf             -12116999878972798356789-----887-788778867556885788642543------02555542025545675
Q 003504          167 -GFGAAFPKLKSLNLAGNEIKGRD-----THF-AGLKSITNLNISGNLFQGSVMGVF------LESLEVIDLRSNQFQGH  233 (815)
Q Consensus       167 -~~~~~l~~L~~L~L~~N~l~~~~-----~~~-~~l~~L~~L~l~~N~l~~~~~~~~------~~~L~~L~l~~n~l~~~  233 (815)
                       ........++.+.++.+.+....     ..+ ........+++..+.+.......+      .+.++.++++.|++...
T Consensus       162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~  241 (460)
T d1z7xw1         162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  241 (460)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf             22233332222233222212455554323433211221001241124542101101223322222210010021122334


Q ss_pred             CC-CCCCCCCCCCCCCEEEECCCCCCCCCHH----HCCCCCCCCCEEEECCCCCCCCCCCCC-----CCCCCCCEEECCC
Q ss_conf             53-1012444677641699857986674000----012368887879810785767895111-----2246898586689
Q 003504          234 IS-QVQFNSSYNWSRLVYVDLSENQLSGEIF----HNFSQAQNLKHLSLAYNRFTRQEFPQI-----GTLLGLEHLNLSR  303 (815)
Q Consensus       234 ~~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~~~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~  303 (815)
                      .. ............++.+++++|.+.....    ..+...+.++.+++++|.++......+     .....|+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~  321 (460)
T d1z7xw1         242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS  321 (460)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             CCCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCC
T ss_conf             42011000111111100001345433212334332211123433344444333224564211101233344433332333


Q ss_pred             CCCCCCCCH----HHHCCCCCCEEECCCCCCCCCC----CCC---CCCCCCEEECCCCCCCCCCC---HHHHHCCCCCCE
Q ss_conf             837678913----2206999988858789588988----845---78875679855884765477---577623898863
Q 003504          304 TSLIGDIPS----EILQLSSLHTLDLSMNHLTGQI----PTV---SAKNLGIIDMSHNNLSGEIP---ASLLEKLPQMER  369 (815)
Q Consensus       304 N~l~~~~~~----~~~~l~~L~~L~ls~N~l~~~~----~~~---~~~~L~~L~ls~N~l~~~~p---~~~~~~~~~l~~  369 (815)
                      |.+......    .+...++|++|+|++|++++..    +..   ....|+.|++++|+|+..-.   ...+...++|+.
T Consensus       322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~  401 (460)
T d1z7xw1         322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE  401 (460)
T ss_dssp             SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred             CCHHHHHHHHCCCCCCCCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCE
T ss_conf             41023344321332211011113201210135766400111220456777889897997975999999999962998898


Q ss_pred             EECCCCCCC
Q ss_conf             430389776
Q 003504          370 FNFSYNNLT  378 (815)
Q Consensus       370 l~l~~n~l~  378 (815)
                      +++++|+++
T Consensus       402 L~Ls~N~i~  410 (460)
T d1z7xw1         402 LDLSNNCLG  410 (460)
T ss_dssp             EECCSSSCC
T ss_pred             EECCCCCCC
T ss_conf             989999698

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6.5e-26  Score=155.44  Aligned_cols=218  Identities=17%  Similarity=0.112  Sum_probs=98.6

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCHHHHCCCCCCCEEECC-C
Q ss_conf             89977689799899355799998889831883786698464599998699845874898-880332078678988728-9
Q 003504           56 QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSG-EIPAAISSLVSLRVLKLD-G  133 (815)
Q Consensus        56 ~~L~ls~n~l~~i~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~-~  133 (815)
                      +.+++++++++.+|..++  +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+.. +.+.+|.++++++.+.+. .
T Consensus        11 ~~i~c~~~~l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~   88 (242)
T d1xwdc1          11 RVFLCQESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   88 (242)
T ss_dssp             SEEEEESCSCSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred             CEEEEECCCCCCCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCC
T ss_conf             999981899887688889--988999876991896496686146432321102211242010011222222222111112


Q ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCC-CCCCCCC-CCCEEECCCCCCCCC
Q ss_conf             82365589200056546156536876799998412116999878972798356789-8877887-788675568857886
Q 003504          134 NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKGRD-THFAGLK-SITNLNISGNLFQGS  211 (815)
Q Consensus       134 N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l~-~L~~L~l~~N~l~~~  211 (815)
                      |.+....+..|.++++|+.+++.+|.+....+......+..+..+...++.+..++ ..|.+++ .+..|++++|.++.+
T Consensus        89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i  168 (242)
T d1xwdc1          89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI  168 (242)
T ss_dssp             TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCC
T ss_conf             34322222212222222222342111125543332221111222222212111222222222233100122001233332


Q ss_pred             CHHHHHCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHCCCCCCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             42543025555420255456755310124446776416998579866740000123688878798107857678951112
Q 003504          212 VMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIG  291 (815)
Q Consensus       212 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~  291 (815)
                      +...+                          ......+.+++.+|.+....+..|..+++|+.|+|++|+++.++...|.
T Consensus       169 ~~~~~--------------------------~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~  222 (242)
T d1xwdc1         169 HNCAF--------------------------NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE  222 (242)
T ss_dssp             CTTTT--------------------------TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCT
T ss_pred             CCCCC--------------------------CCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCHHHHC
T ss_conf             22222--------------------------2011101212354324642478866899999898979928945977973


Q ss_pred             CCCCCCEEEC
Q ss_conf             2468985866
Q 003504          292 TLLGLEHLNL  301 (815)
Q Consensus       292 ~l~~L~~L~L  301 (815)
                      .+++|+.+++
T Consensus       223 ~l~~L~~l~~  232 (242)
T d1xwdc1         223 NLKKLRARST  232 (242)
T ss_dssp             TCCEEESSSE
T ss_pred             CCCCCCCCCC
T ss_conf             7713414767

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=2.8e-27  Score=162.92  Aligned_cols=169  Identities=15%  Similarity=0.110  Sum_probs=116.8

Q ss_pred             CCCCEECCCCCEEEEEEECCCCCEEEEEEEECCCCC------------------CHHHHHHHHHHHCCCCCCCCEEEEEE
Q ss_conf             999801024980039999199949999996148951------------------29999999999628999992134228
Q 003504          511 DRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTL------------------TDQEAARELEYLGRIKHPNLVPLTGY  572 (815)
Q Consensus       511 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l~~~  572 (815)
                      .++++||+|+||.||+|...+++.||||+++.....                  ......+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf             22778024856599999979999999999860443466655656300088899999977899999998169991449986


Q ss_pred             EEECCEEEEEEEECCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC
Q ss_conf             88299469999807899944330039888755567877764557876533468878655899999999999999988840
Q 003504          573 CIAGDQRIAIYDYMENGNLQNLLHDLPLGVQTTEDWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFLHH  652 (815)
Q Consensus       573 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~  652 (815)
                      .    ..+++|||++++.+..+-.                                     .....++.|++.++.||| 
T Consensus        83 ~----~~~lvme~~~~~~~~~l~~-------------------------------------~~~~~i~~ql~~~l~~lH-  120 (191)
T d1zara2          83 E----GNAVLMELIDAKELYRVRV-------------------------------------ENPDEVLDMILEEVAKFY-  120 (191)
T ss_dssp             E----TTEEEEECCCCEEGGGCCC-------------------------------------SCHHHHHHHHHHHHHHHH-
T ss_pred             C----CCEEEEEEECCCCCCCHHH-------------------------------------HHHHHHHHHHHHHHHHHH-
T ss_conf             2----8889999504565420015-------------------------------------789999999999999982-


Q ss_pred             CCCCCEEECCCCCCCEEECCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             8999915336889964776999814514445400289975432346654248843489999999768522288999
Q 003504          653 GCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKIFGNGLDEEIARGSPGYIPPEFAQPDSDFPTPKSDVYCYGVVL  728 (815)
Q Consensus       653 ~~~~~ivH~Dlk~~Nili~~~~~~ki~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~sDvwSlGvil  728 (815)
                        +.+|+||||||+|||++.+ .++++|||.|.....+........... .-.+.+. ..  ++.++|+||..--+
T Consensus       121 --~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~-~~~~~f~-r~--y~~~~d~~s~~~~~  189 (191)
T d1zara2         121 --HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVR-NIITYFS-RT--YRTEKDINSAIDRI  189 (191)
T ss_dssp             --HTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHH-HHHHHHH-HH--HCCCCCHHHHHHHH
T ss_pred             --HCCEEECCCCHHHEEEECC-CEEEEECCCCCCCCCCCCHHHHHHHHH-HHHHHHC-CC--CCCCCCHHHHHHHH
T ss_conf             --6888983689036114289-899987788430899870999987799-9999975-78--99844689999987

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.2e-24  Score=148.44  Aligned_cols=201  Identities=14%  Similarity=0.168  Sum_probs=141.3

Q ss_pred             CCCCEEEEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC-CCCCCCEEECCCCCCCC-C
Q ss_conf             874100168639998389986489997567894102599988899776897998993557-99998889831883786-6
Q 003504           14 SFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLW-SLGSLKSLNLSYNRISG-S   91 (815)
Q Consensus        14 ~~c~~~~v~c~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~ls~n~l~~i~~~~~-~l~~L~~L~L~~n~l~~-~   91 (815)
                      |-|++..|.|.+.            ++. .+|...+   +++++|++++|.|+.+|...| .+++|++|+|++|.+.. +
T Consensus         6 C~C~~~~i~c~~~------------~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i   69 (242)
T d1xwdc1           6 CHCSNRVFLCQES------------KVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI   69 (242)
T ss_dssp             EEECSSEEEEESC------------SCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEE
T ss_pred             CCCCCCEEEEECC------------CCC-CCCCCCC---CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEE
T ss_conf             8873999998189------------988-7688889---98899987699189649668614643232110221124201


Q ss_pred             CCCCCCCCCCCCEEECCC-CCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCHHH
Q ss_conf             984645999986998458-7489888033207867898872898236558920-00565461565368767999984121
Q 003504           92 LPSNIGNFGLLEVFDLSN-NNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPG-LLNCQSLVTVDLSMNQLNGSLPDGFG  169 (815)
Q Consensus        92 ~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~l~~N~i~~~~~~~~~  169 (815)
                      .+..|.++++++.|++.. |.+....+..|.++++|+.|++++|.+....+.. +..+..+..+...++.+. .++...+
T Consensus        70 ~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~-~i~~~~~  148 (242)
T d1xwdc1          70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSF  148 (242)
T ss_dssp             CSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC-EECTTSS
T ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCC
T ss_conf             001122222222211111234322222212222222222342111125543332221111222222212111-2222222


Q ss_pred             CCC-CCCCEEECCCCCCCCCCCCCCCCCCCCEE-ECCCCCCCCCCHHHH--HCCCCEEEECCCCCC
Q ss_conf             169-99878972798356789887788778867-556885788642543--025555420255456
Q 003504          170 AAF-PKLKSLNLAGNEIKGRDTHFAGLKSITNL-NISGNLFQGSVMGVF--LESLEVIDLRSNQFQ  231 (815)
Q Consensus       170 ~~l-~~L~~L~L~~N~l~~~~~~~~~l~~L~~L-~l~~N~l~~~~~~~~--~~~L~~L~l~~n~l~  231 (815)
                      ..+ ..+..|++.+|+++.++.......++..+ .+++|.++.++...|  +++|+.|++++|+++
T Consensus       149 ~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~  214 (242)
T d1xwdc1         149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH  214 (242)
T ss_dssp             TTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCC
T ss_conf             222331001220012333322222220111012123543246424788668999998989799289

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.92  E-value=3.5e-25  Score=151.40  Aligned_cols=137  Identities=21%  Similarity=0.317  Sum_probs=80.8

Q ss_pred             CCCCCCCCCEEEEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCCCCC-CCCCCCEEECCCC
Q ss_conf             12677874100168639998389986489997567894102599988899776897998-993557-9999888983188
Q 003504            9 SYFSASFCSWRGVVCDSNKQHVTDFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITA-LPSDLW-SLGSLKSLNLSYN   86 (815)
Q Consensus         9 ~~~~~~~c~~~~v~c~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~ls~n~l~~-i~~~~~-~l~~L~~L~L~~n   86 (815)
                      +|+..|-|+|..|.|+++.            + ..+|...   .+++++|+|++|.|+. ++...| .+++|+.|+|++|
T Consensus         1 ~CP~~C~C~~~~v~Cs~~~------------L-~~iP~~l---p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N   64 (192)
T d1w8aa_           1 DCPAMCHCEGTTVDCTGRG------------L-KEIPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRN   64 (192)
T ss_dssp             CCCTTSEEETTEEECTTSC------------C-SSCCSCC---CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSS
T ss_pred             CCCCCCEECCCEEEEECCC------------C-CCCCCCC---CCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCC
T ss_conf             9399989769999970899------------6-7029898---9787889848987755302002578762721301363


Q ss_pred             CCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             378669846459999869984587489888033207867898872898236558920005654615653687679
Q 003504           87 RISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLN  161 (815)
Q Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~  161 (815)
                      ++..+.+..|..+++|+.|+|++|+|+.+.+.+|.++++|++|+|++|+|+.+.++.|..+++|++|++++|.+.
T Consensus        65 ~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~  139 (192)
T d1w8aa_          65 QLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             CCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             CCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf             221212122211222210100355344349799807974655245774535359778568753342000364434

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.92  E-value=6.5e-24  Score=144.49  Aligned_cols=56  Identities=23%  Similarity=0.352  Sum_probs=19.2

Q ss_pred             CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             1224689858668983767891322069999888587895889888457887567985
Q 003504          290 IGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDLSMNHLTGQIPTVSAKNLGIIDM  347 (815)
Q Consensus       290 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~L~~L~l  347 (815)
                      ++.+++|+.|+|++|.+.+ + ..+..+++|++|++++|+++++.+...+++|+.|++
T Consensus       169 l~~l~~L~~L~Ls~n~l~~-l-~~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~l  224 (227)
T d1h6ua2         169 LANLSKLTTLKADDNKISD-I-SPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTL  224 (227)
T ss_dssp             GTTCTTCCEEECCSSCCCC-C-GGGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEE
T ss_pred             HCCCCCCEECCCCCCCCCC-C-HHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEEE
T ss_conf             0564633564458884177-8-534479999989795996899802036999898971

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.92  E-value=9e-24  Score=143.74  Aligned_cols=75  Identities=17%  Similarity=0.287  Sum_probs=34.7

Q ss_pred             CCCEEEECCCCCCCCCHHHCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEC
Q ss_conf             64169985798667400001236888787981078576789511122468985866898376789132206999988858
Q 003504          246 SRLVYVDLSENQLSGEIFHNFSQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSRTSLIGDIPSEILQLSSLHTLDL  325 (815)
Q Consensus       246 ~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  325 (815)
                      ++|+.|++++|.+.+..  .+..+++|+.|+|++|.+++++  .+..+++|+.|+|++|++++. + .+..+++|+.|++
T Consensus       151 ~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~l  224 (227)
T d1h6ua2         151 TNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTL  224 (227)
T ss_dssp             TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEE
T ss_pred             CCCCCCCCCCCCCCCCH--HHCCCCCCEECCCCCCCCCCCH--HHCCCCCCCEEECCCCCCCCC-C-CCCCCCCCCEEEE
T ss_conf             11100233333333100--1056463356445888417785--344799999897959968998-0-2036999898971


Q ss_pred             C
Q ss_conf             7
Q 003504          326 S  326 (815)
Q Consensus       326 s  326 (815)
                      +
T Consensus       225 s  225 (227)
T d1h6ua2         225 T  225 (227)
T ss_dssp             E
T ss_pred             E
T ss_conf             2

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.92  E-value=3.4e-25  Score=151.53  Aligned_cols=130  Identities=24%  Similarity=0.266  Sum_probs=110.8

Q ss_pred             CCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCC
Q ss_conf             889977689799899355799998889831883786-6984645999986998458748988803320786789887289
Q 003504           55 LQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISG-SLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDG  133 (815)
Q Consensus        55 L~~L~ls~n~l~~i~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  133 (815)
                      .++++++++++++||..+.  +++++|+|++|+|+. +.+..|.++++|+.|+|++|.+..+.+.+|..+++|+.|+|++
T Consensus        10 ~~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          10 GTTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TTEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEEECCCCCCCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECC
T ss_conf             9999970899670298989--78788984898775530200257876272130136322121212221122221010035


Q ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCC
Q ss_conf             823655892000565461565368767999984121169998789727983567
Q 003504          134 NMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIKG  187 (815)
Q Consensus       134 N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~L~~N~l~~  187 (815)
                      |+|+.+.+..|.++++|++|+|++|+|+ .++..+|..+++|++|+|++|.+..
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~  140 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf             5344349799807974655245774535-3597785687533420003644343

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.6e-27  Score=164.22  Aligned_cols=108  Identities=18%  Similarity=0.181  Sum_probs=42.0

Q ss_pred             CCCEEECCCCCCCCC--CCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCHHHHC-----C
Q ss_conf             888997768979989--93557999988898318837866----984645999986998458748988803320-----7
Q 003504           54 KLQSLDLSENNITAL--PSDLWSLGSLKSLNLSYNRISGS----LPSNIGNFGLLEVFDLSNNNFSGEIPAAIS-----S  122 (815)
Q Consensus        54 ~L~~L~ls~n~l~~i--~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~-----~  122 (815)
                      +|++||+++++++..  ..-+..+++++.|+|++|.|+..    +...+...++|+.|||++|.|+......+.     .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf             87779820895886899999976779999982899998899999999985399988897959859728999999998437


Q ss_pred             CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCC
Q ss_conf             86789887289823655----8920005654615653687679
Q 003504          123 LVSLRVLKLDGNMFQWS----IPPGLLNCQSLVTVDLSMNQLN  161 (815)
Q Consensus       123 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~i~  161 (815)
                      ..+|+.|+|++|+++..    .+..+..+++|++|++++|.+.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf             8877887788877543221012110000343200244433202

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.88  E-value=6.1e-22  Score=133.74  Aligned_cols=179  Identities=20%  Similarity=0.225  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCC
Q ss_conf             45874898880332078678988728982365589200056546156536876799998412116999878972798356
Q 003504          107 LSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIK  186 (815)
Q Consensus       107 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~L~~N~l~  186 (815)
                      +..+.+++..+.  ..+.+|+.|++++|.++....  +..+++|++|++++|+++ .++.  ...+++|+.|++++|+|+
T Consensus        31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~-~l~~--~~~l~~L~~L~l~~n~i~  103 (210)
T d1h6ta2          31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT-DIKP--LANLKNLGWLFLDENKVK  103 (210)
T ss_dssp             TTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCC
T ss_pred             HCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCC-CCCC--CCCCCCCCCCCCCCCCCC
T ss_conf             575765775188--795484589782798887444--764899898769896025-8601--135862120143333321


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHCC
Q ss_conf             78988778877886755688578864254302555542025545675531012444677641699857986674000012
Q 003504          187 GRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNF  266 (815)
Q Consensus       187 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  266 (815)
                      +++ .+..+++|+.|++++|.+..++....++.++.+++++|.++      .......+++|+.+++++|.+.+..+  +
T Consensus       104 ~l~-~l~~l~~L~~L~l~~~~~~~~~~l~~l~~l~~l~~~~n~l~------~~~~~~~l~~L~~l~l~~n~l~~i~~--l  174 (210)
T d1h6ta2         104 DLS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKIT------DITVLSRLTKLDTLSLEDNQISDIVP--L  174 (210)
T ss_dssp             CGG-GGTTCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCC------CCGGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred             CCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCC--C
T ss_conf             222-12122211122345653221122011111222112223334------54310001332100134643025645--3


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             3688878798107857678951112246898586689
Q 003504          267 SQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHLNLSR  303 (815)
Q Consensus       267 ~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  303 (815)
                      ..+++|+.|+|++|.++.++  .+..+++|+.|+|++
T Consensus       175 ~~l~~L~~L~Ls~N~i~~l~--~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         175 AGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELFS  209 (210)
T ss_dssp             TTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEEE
T ss_pred             CCCCCCCEEECCCCCCCCCH--HHCCCCCCCEEECCC
T ss_conf             67898999989799899872--116999989997118

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.87  E-value=5.6e-21  Score=128.49  Aligned_cols=175  Identities=21%  Similarity=0.262  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCC
Q ss_conf             45874898880332078678988728982365589200056546156536876799998412116999878972798356
Q 003504          107 LSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKLKSLNLAGNEIK  186 (815)
Q Consensus       107 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~L~~N~l~  186 (815)
                      ++.+.+++.  .....+.+|+.|++++|.++  ..+.+..+++|++|++++|+++ .++.  +..+++|+.|++++|.+.
T Consensus        25 l~~~~~~~~--~~~~~l~~l~~L~l~~~~i~--~l~~l~~l~nL~~L~Ls~N~l~-~~~~--l~~l~~L~~L~l~~n~~~   97 (199)
T d2omxa2          25 LGKTNVTDT--VSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLT-DITP--LKNLTKLVDILMNNNQIA   97 (199)
T ss_dssp             TTCSSTTSE--ECHHHHTTCCEEECTTSCCC--CCTTGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCC
T ss_pred             HCCCCCCCC--CCHHHHCCCCEEECCCCCCC--CCCCCCCCCCCCCCCCCCCCCC-CCCC--CCCCCCCCCCCCCCCCCC
T ss_conf             677877885--59879468789989999997--7520213788675754565566-7640--167752231111222222


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHCC
Q ss_conf             78988778877886755688578864254302555542025545675531012444677641699857986674000012
Q 003504          187 GRDTHFAGLKSITNLNISGNLFQGSVMGVFLESLEVIDLRSNQFQGHISQVQFNSSYNWSRLVYVDLSENQLSGEIFHNF  266 (815)
Q Consensus       187 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  266 (815)
                      .++. +.+++.|+.|++++|.+........+++|+.|++++|++.      ....+..+++++.|++.+|.+.+..+  +
T Consensus        98 ~~~~-l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~------~~~~l~~~~~L~~L~l~~n~l~~l~~--l  168 (199)
T d2omxa2          98 DITP-LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS------DISALSGLTSLQQLNFSSNQVTDLKP--L  168 (199)
T ss_dssp             CCGG-GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCC------CCGGGTTCTTCSEEECCSSCCCCCGG--G
T ss_pred             CCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC------CCCCCCCCCCCCCCCCCCCCCCCCCC--C
T ss_conf             2211-1112232221112222223210001223677643111100------23433321111112234555567701--1


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             368887879810785767895111224689858
Q 003504          267 SQAQNLKHLSLAYNRFTRQEFPQIGTLLGLEHL  299 (815)
Q Consensus       267 ~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  299 (815)
                      .++++|+.|++++|++++++  .++.+++|+.|
T Consensus       169 ~~l~~L~~L~ls~N~i~~i~--~l~~L~~L~~L  199 (199)
T d2omxa2         169 ANLTTLERLDISSNKVSDIS--VLAKLTNLESL  199 (199)
T ss_dssp             TTCTTCCEEECCSSCCCCCG--GGGGCTTCSEE
T ss_pred             CCCCCCCEEECCCCCCCCCC--CCCCCCCCCCC
T ss_conf             67998999978799799881--01278998949

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.83  E-value=1.2e-22  Score=137.53  Aligned_cols=38  Identities=16%  Similarity=0.294  Sum_probs=15.8

Q ss_pred             CCCCEEECCCCCCCCC----CCHHHHHCCCCCCEEECCCCCC
Q ss_conf             8756798558847654----7757762389886343038977
Q 003504          340 KNLGIIDMSHNNLSGE----IPASLLEKLPQMERFNFSYNNL  377 (815)
Q Consensus       340 ~~L~~L~ls~N~l~~~----~p~~~~~~~~~l~~l~l~~n~l  377 (815)
                      ..|+.|++++|+|+..    +......+.++++.+++++|.+
T Consensus       273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~  314 (344)
T d2ca6a1         273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF  314 (344)
T ss_dssp             CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred             CCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCC
T ss_conf             888989898986980899999999970389999897879808

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.82  E-value=3.3e-21  Score=129.73  Aligned_cols=39  Identities=21%  Similarity=0.146  Sum_probs=15.8

Q ss_pred             CCCCCCCCEEECCCCCCCC-----CCCCCCCCCCCCEEECCCCC
Q ss_conf             2599988899776897998-----99355799998889831883
Q 003504           49 IGKLSKLQSLDLSENNITA-----LPSDLWSLGSLKSLNLSYNR   87 (815)
Q Consensus        49 ~~~l~~L~~L~ls~n~l~~-----i~~~~~~l~~L~~L~L~~n~   87 (815)
                      +.....+++|+|++|.|+.     +...+...++|+.|+++++.
T Consensus        27 L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~   70 (344)
T d2ca6a1          27 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF   70 (344)
T ss_dssp             HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCC
T ss_pred             HHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             96389978897849837789999999999858998888887775

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=5.7e-21  Score=128.43  Aligned_cols=80  Identities=20%  Similarity=0.135  Sum_probs=38.8

Q ss_pred             CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-HHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             888983188378669846459999869984587489888-0332078678988728982365589200056546156536
Q 003504           78 LKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEI-PAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLS  156 (815)
Q Consensus        78 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  156 (815)
                      +..+.+....+..... ......+|+.|||+++.++... ...+.++++|++|+|+++.++...+..+..+++|+.|+++
T Consensus        25 ~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls  103 (284)
T d2astb2          25 VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS  103 (284)
T ss_dssp             CSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred             CEEEECCCCCCCCCHH-HHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCC
T ss_conf             4274652333455224-425678788788989845777999999748776514523467986789998518997571510


Q ss_pred             CC
Q ss_conf             87
Q 003504          157 MN  158 (815)
Q Consensus       157 ~N  158 (815)
                      ++
T Consensus       104 ~c  105 (284)
T d2astb2         104 GC  105 (284)
T ss_dssp             TC
T ss_pred             CC
T ss_conf             01

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=2.4e-20  Score=124.99  Aligned_cols=125  Identities=18%  Similarity=0.172  Sum_probs=63.7

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCCC
Q ss_conf             986489997567894102599988899776897998993557999988898318837866-9846459999869984587
Q 003504           32 DFLASNSGLSGSVPDTTIGKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGS-LPSNIGNFGLLEVFDLSNN  110 (815)
Q Consensus        32 ~l~~~~~~~~~~~~~~~~~~l~~L~~L~ls~n~l~~i~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N  110 (815)
                      .+|+++..+.+......+.  ..+..+.++++.+.......+...+|++|+|+++.+.+. ....+...++|++|+|+++
T Consensus         4 ~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~   81 (284)
T d2astb2           4 TLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL   81 (284)
T ss_dssp             EEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             EEECCCCCCCCHHHHHHHH--CCCEEEECCCCCCCCCHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCC
T ss_conf             7978999788147999874--55427465233345522442567878878898984577799999974877651452346


Q ss_pred             CCCCCCHHHHCCCCCCCEEECCCC-CCCCCC-CCCCCCCCCCCEEECCCC
Q ss_conf             489888033207867898872898-236558-920005654615653687
Q 003504          111 NFSGEIPAAISSLVSLRVLKLDGN-MFQWSI-PPGLLNCQSLVTVDLSMN  158 (815)
Q Consensus       111 ~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~-~~~~~~l~~L~~L~l~~N  158 (815)
                      .+++..+..+..+++|+.|+|+++ .++... ...+.++++|++|+++++
T Consensus        82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c  131 (284)
T d2astb2          82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC  131 (284)
T ss_dssp             BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred             CCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCC
T ss_conf             79867899985189975715100134123554036578874356522453

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=4.6e-19  Score=118.04  Aligned_cols=110  Identities=18%  Similarity=0.105  Sum_probs=46.0

Q ss_pred             CCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEE
Q ss_conf             59998889977689799899355799998889831883786698464599998699845874898880332078678988
Q 003504           50 GKLSKLQSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVL  129 (815)
Q Consensus        50 ~~l~~L~~L~ls~n~l~~i~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  129 (815)
                      .....+++|+|++|+|+.++.....+++|+.|+|++|.|+.+  +.|..+++|++|+|++|+|+.+.+..+..+++|+.|
T Consensus        15 ~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L   92 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL   92 (162)
T ss_dssp             ECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred             CCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             685748489788997886576200414599898979978764--774457613064310213457776322334534434


Q ss_pred             ECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCC
Q ss_conf             72898236558-920005654615653687679
Q 003504          130 KLDGNMFQWSI-PPGLLNCQSLVTVDLSMNQLN  161 (815)
Q Consensus       130 ~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~i~  161 (815)
                      ++++|++.... ...+..+++|++|++++|.+.
T Consensus        93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             EECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf             203000166542110013653206640799634

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=1.4e-18  Score=115.37  Aligned_cols=113  Identities=21%  Similarity=0.202  Sum_probs=58.8

Q ss_pred             CCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCC
Q ss_conf             45999986998458748988803320786789887289823655892000565461565368767999984121169998
Q 003504           96 IGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMNQLNGSLPDGFGAAFPKL  175 (815)
Q Consensus        96 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L  175 (815)
                      |.+..+|++|||++|+|+.+ +..+..+++|+.|+|++|+|+..  +.|..+++|++|++++|+++ .++..++..+++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L   89 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDL   89 (162)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTC
T ss_pred             CCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCC-CCCCCCCCCCCCC
T ss_conf             16857484897889978865-76200414599898979978764--77445761306431021345-7776322334534


Q ss_pred             CEEECCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCC
Q ss_conf             789727983567898--8778877886755688578864
Q 003504          176 KSLNLAGNEIKGRDT--HFAGLKSITNLNISGNLFQGSV  212 (815)
Q Consensus       176 ~~L~L~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~  212 (815)
                      +.|++++|+|+.++.  .+..+++|+.|++++|.++..+
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~  128 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK  128 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGST
T ss_pred             CCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCC
T ss_conf             434203000166542110013653206640799634561

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.74  E-value=2.1e-17  Score=108.96  Aligned_cols=119  Identities=29%  Similarity=0.419  Sum_probs=62.4

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCC
Q ss_conf             89977689799899355799998889831883786698464599998699845874898880332078678988728982
Q 003504           56 QSLDLSENNITALPSDLWSLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNM  135 (815)
Q Consensus        56 ~~L~ls~n~l~~i~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~  135 (815)
                      ++|+|++|+|+.++ .+..+++|++|++++|.|+ .+|..|+.+++|+.|++++|.|+..  ..+..+++|+.|++++|+
T Consensus         1 R~L~Ls~n~l~~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           1 RVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNR   76 (124)
T ss_dssp             SEEECTTSCCSSCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCSSCCEEECCSSC
T ss_pred             CEEECCCCCCCCCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCC--CCCCCCCCCCEEECCCCC
T ss_conf             98986899898871-0105898898979787168-6521565543135453243211235--741233555768888986


Q ss_pred             CCCCC-CCCCCCCCCCCEEECCCCCCCC--CCCCHHHCCCCCCCEE
Q ss_conf             36558-9200056546156536876799--9984121169998789
Q 003504          136 FQWSI-PPGLLNCQSLVTVDLSMNQLNG--SLPDGFGAAFPKLKSL  178 (815)
Q Consensus       136 l~~~~-~~~~~~l~~L~~L~l~~N~i~~--~~~~~~~~~l~~L~~L  178 (815)
                      ++... ...+..+++|+.|++++|++..  ..+..+...+|+|+.|
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHHHHHCCCCCEE
T ss_conf             5888882565379999999897996886826799999989673138

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.69  E-value=7.2e-17  Score=106.05  Aligned_cols=103  Identities=17%  Similarity=0.105  Sum_probs=50.1

Q ss_pred             EECCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCC
Q ss_conf             97768979989935579999888983188-37866984645999986998458748988803320786789887289823
Q 003504           58 LDLSENNITALPSDLWSLGSLKSLNLSYN-RISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMF  136 (815)
Q Consensus        58 L~ls~n~l~~i~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  136 (815)
                      +++++++++.+|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|.++++|+.|+|++|+|
T Consensus        13 l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l   92 (156)
T d2ifga3          13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL   92 (156)
T ss_dssp             EECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCC
T ss_pred             EEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCC
T ss_conf             98528997658600257656574316898664436921225666667216202124774201112455433332267878


Q ss_pred             CCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             6558920005654615653687679
Q 003504          137 QWSIPPGLLNCQSLVTVDLSMNQLN  161 (815)
Q Consensus       137 ~~~~~~~~~~l~~L~~L~l~~N~i~  161 (815)
                      +...+..|..+ +|+.|+|++|.+.
T Consensus        93 ~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          93 ESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             SCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             CCCCHHHHCCC-CCCCCCCCCCCCC
T ss_conf             51574563353-2124335798633

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.67  E-value=3.9e-16  Score=102.05  Aligned_cols=102  Identities=26%  Similarity=0.357  Sum_probs=45.0

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf             88983188378669846459999869984587489888033207867898872898236558920005654615653687
Q 003504           79 KSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVSLRVLKLDGNMFQWSIPPGLLNCQSLVTVDLSMN  158 (815)
Q Consensus        79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  158 (815)
                      +.|+|++|+|+.. + .+..+++|++|+|++|+|+ ..|..|..+++|+.|++++|.|+..  +.+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCSSCCEEECCSS
T ss_pred             CEEECCCCCCCCC-C-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCC--CCCCCCCCCCEEECCCC
T ss_conf             9898689989887-1-0105898898979787168-6521565543135453243211235--74123355576888898


Q ss_pred             CCCCCCCC-HHHCCCCCCCEEECCCCCCC
Q ss_conf             67999984-12116999878972798356
Q 003504          159 QLNGSLPD-GFGAAFPKLKSLNLAGNEIK  186 (815)
Q Consensus       159 ~i~~~~~~-~~~~~l~~L~~L~L~~N~l~  186 (815)
                      ++. .++. ..+..+++|+.|++++|.++
T Consensus        76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             CCC-CCCCCHHHCCCCCCCEEECCCCCCC
T ss_conf             658-8888256537999999989799688

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.66  E-value=1.1e-18  Score=115.91  Aligned_cols=14  Identities=50%  Similarity=0.515  Sum_probs=4.5

Q ss_pred             CCCCCEEECCCCCC
Q ss_conf             99988898318837
Q 003504           75 LGSLKSLNLSYNRI   88 (815)
Q Consensus        75 l~~L~~L~L~~n~l   88 (815)
                      +++|++|+|++|+|
T Consensus        47 L~~L~~L~Ls~n~I   60 (198)
T d1m9la_          47 LKACKHLALSTNNI   60 (198)
T ss_dssp             TTTCCEEECSEEEE
T ss_pred             CCCCCEEECCCCCC
T ss_conf             60461519944689

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=1.1e-15  Score=99.63  Aligned_cols=89  Identities=21%  Similarity=0.239  Sum_probs=58.9

Q ss_pred             CCCCCCCCCEEECCCC-CCCCCCCCCC-CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCC
Q ss_conf             0259998889977689-7998993557-9999888983188378669846459999869984587489888033207867
Q 003504           48 TIGKLSKLQSLDLSEN-NITALPSDLW-SLGSLKSLNLSYNRISGSLPSNIGNFGLLEVFDLSNNNFSGEIPAAISSLVS  125 (815)
Q Consensus        48 ~~~~l~~L~~L~ls~n-~l~~i~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  125 (815)
                      .+..+++|++|++++| .|+.++...| .+++|+.|+|++|+|+.+.+.+|..+++|++|+|++|+|+.+.++.|..+ +
T Consensus        26 ~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-~  104 (156)
T d2ifga3          26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-S  104 (156)
T ss_dssp             TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-C
T ss_pred             CCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCC-C
T ss_conf             025765657431689866443692122566666721620212477420111245543333226787851574563353-2


Q ss_pred             CCEEECCCCCCC
Q ss_conf             898872898236
Q 003504          126 LRVLKLDGNMFQ  137 (815)
Q Consensus       126 L~~L~L~~N~l~  137 (815)
                      |+.|+|++|.+.
T Consensus       105 l~~L~L~~Np~~  116 (156)
T d2ifga3         105 LQELVLSGNPLH  116 (156)
T ss_dssp             CCEEECCSSCCC
T ss_pred             CCCCCCCCCCCC
T ss_conf             124335798633

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.61  E-value=1.4e-18  Score=115.41  Aligned_cols=15  Identities=27%  Similarity=0.326  Sum_probs=4.8

Q ss_pred             CCCCCEEECCCCCCC
Q ss_conf             999869984587489
Q 003504           99 FGLLEVFDLSNNNFS  113 (815)
Q Consensus        99 l~~L~~L~L~~N~i~  113 (815)
                      +++|++|+|++|+|+
T Consensus        47 L~~L~~L~Ls~n~I~   61 (198)
T d1m9la_          47 LKACKHLALSTNNIE   61 (198)
T ss_dssp             TTTCCEEECSEEEES
T ss_pred             CCCCCEEECCCCCCC
T ss_conf             604615199446899

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.06  E-value=5.5e-10  Score=68.47  Aligned_cols=94  Identities=7%  Similarity=-0.058  Sum_probs=60.8

Q ss_pred             HHHHHHHCCCCCCCEECCCCCEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCC-CCCCEEEEEEEEECCEE
Q ss_conf             89999822999998010249800399991999499999961489512999999999962899-99921342288829946
Q 003504          501 ADLLSATSNFDRGTLLAEGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQR  579 (815)
Q Consensus       501 ~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  579 (815)
                      .++....+.|...+..+.++.+.||+.... +..+++|+...........+.+|...+..+. +-.+.+++++....+..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf             999975135279976789987718999908-9869999848876532556999999999876069987289997508964


Q ss_pred             EEEEEECCCCCHHHHH
Q ss_conf             9999807899944330
Q 003504          580 IAIYDYMENGNLQNLL  595 (815)
Q Consensus       580 ~lv~e~~~~gsL~~~l  595 (815)
                      ++||+++++..+.+..
T Consensus        86 ~lv~~~l~G~~~~~~~  101 (263)
T d1j7la_          86 NLLMSEADGVLCSEEY  101 (263)
T ss_dssp             EEEEECCSSEEHHHHT
T ss_pred             EEEEEECCCCCCCCCC
T ss_conf             9999860433435433

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.99  E-value=1.2e-11  Score=77.59  Aligned_cols=10  Identities=30%  Similarity=0.730  Sum_probs=4.7

Q ss_pred             HHCCCCCCEE
Q ss_conf             6238988634
Q 003504          361 LEKLPQMERF  370 (815)
Q Consensus       361 ~~~~~~l~~l  370 (815)
                      ++.+|+|+.+
T Consensus       142 ~~~~P~L~~L  151 (162)
T d1koha1         142 RERFPKLLRL  151 (162)
T ss_dssp             HTTSTTCCEE
T ss_pred             HHHCCCCCEE
T ss_conf             9988997879

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.84  E-value=1e-08  Score=61.53  Aligned_cols=159  Identities=15%  Similarity=0.071  Sum_probs=83.2

Q ss_pred             EECCCCC-EEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCC--CCCCEEEEEEEEECCEEEEEEEECCCCCH
Q ss_conf             0102498-00399991999499999961489512999999999962899--99921342288829946999980789994
Q 003504          515 LLAEGKF-GPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK--HPNLVPLTGYCIAGDQRIAIYDYMENGNL  591 (815)
Q Consensus       515 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL  591 (815)
                      .+..|.. +.||+....++..+++|......   ...+..|...++.+.  .-.+.++++++.+.+..++|+++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf             7678654775899993898789999589667---7689999999999986599988613222456615999874413554


Q ss_pred             HHHH--------------CCCCCCCCCCCCCCCCC--CC-------CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf             4330--------------03988875556787776--45-------5787653346887865589999999999999998
Q 003504          592 QNLL--------------HDLPLGVQTTEDWSTDT--WE-------EDGTNSIQNVGSEGLLTTWRFRHKIALGTARALA  648 (815)
Q Consensus       592 ~~~l--------------~~~~~~~~~~~~~~~~~--~~-------~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~  648 (815)
                      .+..              .....-...........  ..       ...................          ...+.
T Consensus        94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~  163 (255)
T d1nd4a_          94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP----------AELFA  163 (255)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH----------HHHHH
T ss_pred             CCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHH----------HHHHH
T ss_conf             32212689999999999998736885448875541246889999998754110113401121379----------99999


Q ss_pred             HHH----CCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf             884----08999915336889964776999814514445400
Q 003504          649 FLH----HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI  686 (815)
Q Consensus       649 ~LH----~~~~~~ivH~Dlk~~Nili~~~~~~ki~Dfg~a~~  686 (815)
                      .+.    ......++|+|+.+.||+++.+..+-|.||+.+..
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             998718765795678678887635773796589998533265

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.28  E-value=2e-07  Score=54.54  Aligned_cols=114  Identities=13%  Similarity=0.164  Sum_probs=0.0

Q ss_pred             HHHCCCCCCCEEECCC-CCCCC-----CCCCCCCCCCCCEEECCCCCCCCCCHHHH------HCCCCEEEECCCCCCCCC
Q ss_conf             1211699987897279-83567-----89887788778867556885788642543------025555420255456755
Q 003504          167 GFGAAFPKLKSLNLAG-NEIKG-----RDTHFAGLKSITNLNISGNLFQGSVMGVF------LESLEVIDLRSNQFQGHI  234 (815)
Q Consensus       167 ~~~~~l~~L~~L~L~~-N~l~~-----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~------~~~L~~L~l~~n~l~~~~  234 (815)
                      .+....++|++|+|++ +.++.     +-..+...+.|+.|++++|.+.......+      .+.|+.|++++|.++...
T Consensus         9 ~l~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g   88 (167)
T d1pgva_           9 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL   88 (167)
T ss_dssp             HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred             HHHHCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHH
T ss_conf             99828999819782799998989999999997637764540120156215679887531000234330033010214599


Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCCCCC-------HHHCCCCCCCCCEEEECCC
Q ss_conf             310124446776416998579866740-------0001236888787981078
Q 003504          235 SQVQFNSSYNWSRLVYVDLSENQLSGE-------IFHNFSQAQNLKHLSLAYN  280 (815)
Q Consensus       235 ~~~~~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~~~~L~~L~L~~N  280 (815)
                      ...-..++..-+.|+.|++++|.+...       +...+...+.|+.|+++.+
T Consensus        89 ~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~  141 (167)
T d1pgva_          89 LARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA  141 (167)
T ss_dssp             HHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred             HHHHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCC
T ss_conf             99999999848938987788776888657999999999972998538648688

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.26  E-value=4e-06  Score=47.37  Aligned_cols=77  Identities=14%  Similarity=0.079  Sum_probs=48.0

Q ss_pred             CCEECCCCCEEEEEEECCC-CCEEEEEEEECC-------CCCCHHHHHHHHHHHCCCC-C--CCCEEEEEEEEECCEEEE
Q ss_conf             9801024980039999199-949999996148-------9512999999999962899-9--992134228882994699
Q 003504          513 GTLLAEGKFGPVYRGFLPG-GIHVAVKVLVHG-------STLTDQEAARELEYLGRIK-H--PNLVPLTGYCIAGDQRIA  581 (815)
Q Consensus       513 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l  581 (815)
                      .+.||.|....||++...+ ++.+++|.-...       ..........|.+.++.+. +  ..+.++++  .+.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECCCCCEE
T ss_conf             9980798527689999579984899961771303467778887789999999999865057988552899--85988779


Q ss_pred             EEEECCCCCH
Q ss_conf             9980789994
Q 003504          582 IYDYMENGNL  591 (815)
Q Consensus       582 v~e~~~~gsL  591 (815)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEECCCCCCC
T ss_conf             8713577653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=98.25  E-value=2.5e-06  Score=48.53  Aligned_cols=161  Identities=11%  Similarity=0.035  Sum_probs=79.7

Q ss_pred             EEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCCC-----CCCEEEEE--EEEECCEEEEEEEECCCCCHHH-
Q ss_conf             003999919994999999614895129999999999628999-----99213422--8882994699998078999443-
Q 003504          522 GPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIKH-----PNLVPLTG--YCIAGDQRIAIYDYMENGNLQN-  593 (815)
Q Consensus       522 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv~l~~--~~~~~~~~~lv~e~~~~gsL~~-  593 (815)
                      -.||++...+|..+++|+.+.+ ....+++..|...+..+..     +..+..-|  .....+..+.++++++|..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             CEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCC
T ss_conf             0269998389997999984787-788999999999999998559987875206898056653479999865277688999


Q ss_pred             -------------HHCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HCCCCCC
Q ss_conf             -------------3003988875556--78777645578765334688786558999999999999999888-4089999
Q 003504          594 -------------LLHDLPLGVQTTE--DWSTDTWEEDGTNSIQNVGSEGLLTTWRFRHKIALGTARALAFL-HHGCSPP  657 (815)
Q Consensus       594 -------------~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~L-H~~~~~~  657 (815)
                                   .+|..-.......  ......+........... ..-...........+..+...+.-. ......+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDA-TLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTC-SSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf             9999999899999988630357865567789788766568999874-769988989999999999999998454568712


Q ss_pred             EEECCCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf             15336889964776999814514445400
Q 003504          658 IIHRDIKASSVYLDMNLEPRLSDFGLAKI  686 (815)
Q Consensus       658 ivH~Dlk~~Nili~~~~~~ki~Dfg~a~~  686 (815)
                      ++|+|+.+.|||++.+  ..+.||+.++.
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             EECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             0247888042878389--35886520146

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.90  E-value=0.00018  Score=38.38  Aligned_cols=182  Identities=15%  Similarity=0.076  Sum_probs=86.0

Q ss_pred             CCHHHHHHHHCCCCCCCEEC-----CCCCEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHCCCC-----CCCCE
Q ss_conf             59889999822999998010-----249800399991999499999961489512999999999962899-----99921
Q 003504          498 ITFADLLSATSNFDRGTLLA-----EGKFGPVYRGFLPGGIHVAVKVLVHGSTLTDQEAARELEYLGRIK-----HPNLV  567 (815)
Q Consensus       498 ~~~~~l~~~~~~~~~~~~ig-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv  567 (815)
                      .+-+++.....+|.+++...     .|---+.|+....+++ +++|+.....  ..++...|++.+..+.     -|..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             89999999998679998568523788852673899978972-8999807899--98899999999875430255545564


Q ss_pred             EEE-E--EEEECCEEEEEEEECCCCCHHHH--------------HCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCC
Q ss_conf             342-2--88829946999980789994433--------------0039888755567877-7645578765334688786
Q 003504          568 PLT-G--YCIAGDQRIAIYDYMENGNLQNL--------------LHDLPLGVQTTEDWST-DTWEEDGTNSIQNVGSEGL  629 (815)
Q Consensus       568 ~l~-~--~~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  629 (815)
                      ... |  +.........++.+..+......              ++.............. ..+...........   . 
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-  155 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER---A-  155 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG---G-
T ss_pred             EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHH---H-
T ss_conf             104897621341255024531146553332046788888998764544432024531011101200245677776---5-


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHH-CCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf             5589999999999999998884-08999915336889964776999814514445400
Q 003504          630 LTTWRFRHKIALGTARALAFLH-HGCSPPIIHRDIKASSVYLDMNLEPRLSDFGLAKI  686 (815)
Q Consensus       630 ~~~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlk~~Nili~~~~~~ki~Dfg~a~~  686 (815)
                      ..........+......+.... .....++||+|+.++||+++.+...-+.||+.+..
T Consensus       156 ~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         156 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf             3114127999999987642048554545033378636564020454126742221236

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.89  E-value=2.5e-06  Score=48.54  Aligned_cols=114  Identities=16%  Similarity=0.194  Sum_probs=0.0

Q ss_pred             HHCCCCCCCEEECCC-CCCCC-----CCCCCCCCCCCCEEECCCCCCCCCCHHHH------HCCCCEEEECCCCCCCCCC
Q ss_conf             211699987897279-83567-----89887788778867556885788642543------0255554202554567553
Q 003504          168 FGAAFPKLKSLNLAG-NEIKG-----RDTHFAGLKSITNLNISGNLFQGSVMGVF------LESLEVIDLRSNQFQGHIS  235 (815)
Q Consensus       168 ~~~~l~~L~~L~L~~-N~l~~-----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~------~~~L~~L~l~~n~l~~~~~  235 (815)
                      +....++|++|++++ +.|+.     +...+...++|+.|++++|.+.......+      .+.++.+++++|.++....
T Consensus        12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~   91 (166)
T d1io0a_          12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI   91 (166)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHHCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHH
T ss_conf             99559998688768999989899999998884198257430158961177899999877521221012102543220147


Q ss_pred             CCCCCCCCCCCCCEE--EECCCCCCCC----CHHHCCCCCCCCCEEEECCCC
Q ss_conf             101244467764169--9857986674----000012368887879810785
Q 003504          236 QVQFNSSYNWSRLVY--VDLSENQLSG----EIFHNFSQAQNLKHLSLAYNR  281 (815)
Q Consensus       236 ~~~~~~~~~l~~L~~--L~L~~N~l~~----~~~~~~~~~~~L~~L~L~~N~  281 (815)
                      ..-...+...+.|+.  |++++|.+..    .+...+...++|+.|+++.+.
T Consensus        92 ~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          92 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             8899999848652477321677867679999999999849984788581898

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.85  E-value=6.1e-05  Score=40.91  Aligned_cols=73  Identities=14%  Similarity=0.094  Sum_probs=46.0

Q ss_pred             CEECCCCCEEEEEEECCC--------CCEEEEEEEECCCCCCHHHHHHHHHHHCCCC-CCCCEEEEEEEEECCEEEEEEE
Q ss_conf             801024980039999199--------9499999961489512999999999962899-9992134228882994699998
Q 003504          514 TLLAEGKFGPVYRGFLPG--------GIHVAVKVLVHGSTLTDQEAARELEYLGRIK-HPNLVPLTGYCIAGDQRIAIYD  584 (815)
Q Consensus       514 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  584 (815)
                      +.++.|-.-.+|++....        ...|.+++.-.  ........+|..+++.+. +.-..++++++.+    ..|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf             9917853343489996887754457898179996599--61165899999999999757999808998189----56999


Q ss_pred             ECCCCCHH
Q ss_conf             07899944
Q 003504          585 YMENGNLQ  592 (815)
Q Consensus       585 ~~~~gsL~  592 (815)
                      |+++..+.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EECCCCCC
T ss_conf             73455488